code_type,code,description,gross_charge,discounted_cash,min_negotiated,max_negotiated,payer_entries ,,Bilateral Procedures,,,,,0 ,,Bilateral Services,,,,,0 ,,CT services furnished with equipment that don't meet NEMA standard,,,,,0 ,,Computed radiography x-ray,,,,,0 ,,Computed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (NEMA) XR-29-2013 standard,,,,,0 ,,Discontinued OP Hospital/ASC Procedure Prior to Administration of Anesthesia,,,,,0 ,,Discontinued Procedure,,,,,0 ,,Excepted off-campus service,,,,,0 ,,Non-excepted off-campus service,,,,,0 ,,Reduced Services,,,,,0 ,,X-ray taken using film,,,,,0 ,,X-ray was performed using film,,,,,0 ,,X-ray was taken using computed radiography technology/cassette-based imaging,,,,,0 CDM,11100001,HC UNCH PRIVATE ROOM,2374.0,1424.4,1129.0,4998.0,4 CDM,11100005,HC HBR PRIVATE ROOM,2374.0,1424.4,1129.0,4998.0,4 CDM,11130001,HC UNCH PEDS PRIVATE ROOM,2374.0,1424.4,1129.0,4998.0,4 CDM,11140001,HC UNCH PSYCH PRIVATE ROOM,2967.0,1780.2,1318.0,4481.0,4 CDM,11150005,HC UNCH HOSPICE PRIVATE ROOM,1667.0,1000.2,889.0,4481.0,4 CDM,11180001,HC UNCH REHAB PRIVATE ROOM,2374.0,1424.4,1511.0,3481.0,9 CDM,11200001,HC UNCH SEMI PRIVATE ROOM,2374.0,1424.4,1129.0,4998.0,4 CDM,11200002,HC UNCH INPT EATING DISORDERS SEMI PRIVATE ROOM,3460.0,2076.0,1318.0,4481.0,4 CDM,11240001,HC UNCH PSYCH SEMI PRIVATE ROOM,2967.0,1780.2,1318.0,4481.0,4 CDM,11280001,HC UNCH REHAB SEMI PRIVATE ROOM,2374.0,1424.4,721.0,3481.0,11 CDM,11300001,HC UNCH SEMI PRIVATE ROOM 3-4,2374.0,1424.4,721.0,3481.0,11 CDM,11711001,HC UNCH LEVEL 1 NURSERY ROOM,1922.0,1153.2,717.0,4481.0,6 CDM,11720001,HC UNCH LEVEL 2 NURSERY ROOM,3282.0,1969.2,2242.0,4481.0,6 CDM,11730001,HC UNCH LEVEL 3 INTERMEDIATE NURSERY ROOM,4760.0,2856.0,3277.0,5721.0,6 CDM,11740001,HC UNCH LEVEL 4 INTENSIVE NURSERY ROOM,7297.0,4378.2,4058.0,6610.0,6 CDM,12000001,HC UNCH ICU ROOM,7185.0,4311.0,1129.0,9879.0,4 CDM,12020001,HC UNCH MED SURG ICU ROOM,7185.0,4311.0,1129.0,9879.0,4 CDM,12020005,HC HBR MED SURG ICU ROOM,7185.0,4311.0,1129.0,9879.0,4 CDM,12030001,HC UNCH PEDIATRIC ICU ROOM,6797.0,4078.2,1129.0,9879.0,4 CDM,12060001,HC UNCH INTERMEDIATE CARE ROOM,4832.0,2899.2,1129.0,8213.0,4 CDM,12060002,HC UNCH BURN INTERMEDIATE CARE ROOM,4606.0,2763.6,1129.0,8213.0,4 CDM,12060005,HC HBR INTERMEDIATE CARE ROOM,4832.0,2899.2,1129.0,8213.0,4 CDM,12070001,HC UNCH BURN ICU ROOM,9868.0,5920.8,1129.0,7894.4,3 CDM,17620001,HC UNCH OBSERVATION CARE PER HOUR,100.0,60.0,23.2,8596.0,24 CDM,17620002,HC UNCH OBSERVATION DIRECT ADMISSION,184.0,110.4,51.0,8596.0,34 CDM,17620003,HC HBR OBSERVATION CARE PER HOUR,100.0,60.0,23.2,8596.0,24 CDM,17620004,HC HBR OBSERVATION DIRECT ADMISSION,184.0,110.4,51.0,8596.0,34 CDM,21501002,HC VAD,72000.0,43200.0,4481.0,63100.8,27 CDM,21501003,HC VENTRICULAR ASSIST DEVICE ACUTE,22248.0,13348.8,4481.0,19498.15,27 CDM,21502174,HC CENTRIMAG BLOOD TUBING,598.0,358.8,138.74,4481.0,27 CDM,21502208,HC LONG TERM OXYGENATOR,4132.0,2479.2,958.62,4481.0,24 CDM,21502216,HC CENTRIMAG ACCESSORY PACK,390.0,234.0,90.48,4481.0,27 CDM,21506027,HC HW CONTROLLER ALARM ADAPTER,1266.0,759.6,293.71,4481.0,27 CDM,21506035,HC HW CONTROLLER AC ADAPTER,4031.0,2418.6,935.19,4481.0,27 CDM,21506043,HC HW CONTROLLER DC ADAPTER,6927.0,4156.2,1607.06,6070.82,27 CDM,21506050,HC HW PATIENT PACK,1954.0,1172.4,453.33,4481.0,27 CDM,21506068,HC HW BATTERY,3024.0,1814.4,701.57,4481.0,27 CDM,21506076,HC HW SHOWER BAG,1380.0,828.0,320.16,4481.0,27 CDM,21506084,HC HW BATTERY CHARGER,14201.0,8520.6,3294.63,12445.76,27 CDM,21508015,HC PEDIMAG BLOOD TUBING,598.0,358.8,138.74,4481.0,27 CDM,21509021,HC HW MONITOR HOSP ONLY,8108.0,4864.8,1881.06,7105.85,27 CDM,21509161,HC HM SHOWER BAG,1118.0,670.8,259.38,4481.0,27 CDM,21509203,HC HM CONSOLIDATED BAG LEFT OR RIGHT,1615.0,969.0,374.68,4481.0,27 CDM,21509211,HC HM TRAVEL BAG,794.0,476.4,184.21,4481.0,27 CDM,21509278,HC HM II SYSTEM CONTROLLER,13170.0,7902.0,3055.44,11542.19,27 CDM,21509286,HC POWER MODULE PM,20113.0,12067.8,4481.0,17627.03,27 CDM,21509294,HC HM BATTERY CHARGER,18102.0,10861.2,4199.66,15864.59,27 CDM,21509302,HC HM 14V LI ION BATTERY EACH,2722.0,1633.2,631.5,4481.0,27 CDM,21509310,HC HM BATTERY CLIPS SET OF 2,4789.0,2873.4,1111.05,4481.0,27 CDM,21509344,HC HM HOLSTER VEST SM MED LG,1962.0,1177.2,455.18,4481.0,27 CDM,21509351,HC HM PATIENT CABLE 14 VOLT,5443.0,3265.8,1262.78,4770.25,27 CDM,21509369,HC HM DISPLAY MONITOR HOSP ONLY,1490.0,894.0,345.68,4481.0,27 CDM,21509385,HC HM PM CAR ADAPTER,1118.0,670.8,259.38,4481.0,27 CDM,21509519,HC HMII POCKET CONTROLLER,12804.0,7682.4,2970.53,11221.43,27 CDM,21509520,HC HEARTWARE CONTROLLER,16646.0,9987.6,3861.87,14588.55,27 CDM,21509526,HC HM WEARABLE ACCESSORIES KIT,845.0,507.0,196.04,4481.0,27 CDM,21509534,HC HM BATTERY HOLSTER,981.0,588.6,227.59,4481.0,27 CDM,21509542,HC HW WAIST PACK,2110.0,1266.0,489.52,4481.0,27 CDM,21509559,HC HW SHOULDER BAG,2236.0,1341.6,518.75,4481.0,27 CDM,21509567,HC SORIN DIALATOR KIT,801.0,480.6,185.83,4481.0,27 CDM,21509575,HC HM 11V LI ION BACKUP BATTERY,2484.0,1490.4,576.29,4481.0,27 CDM,21509576,HC HM 3 CONTROLLER,13170.0,7902.0,3055.44,11542.19,27 CDM,21509577,HC HM 3 MODULAR DRIVELINE,14744.0,8846.4,3420.61,12921.64,24 CDM,21509578,HC HM MOBILE POWER UNIT,19156.0,11493.6,4444.19,16788.32,27 CDM,21509579,HC BERLIN HEART EXCOR BLOOD PUMP,59709.0,35825.4,4481.0,52328.97,27 CDM,21509580,HC BERLIN HEART EXCOR APEX CANNULA,12669.0,7601.4,2939.21,11103.11,24 CDM,21509581,HC BERLIN HEART EXCOR ATRIAL CANNULA,9888.0,5932.8,2294.02,8665.84,24 CDM,21509582,HC BERLIN HEART EXCOR ARTERIAL CANNULA,9888.0,5932.8,2294.02,8665.84,24 CDM,21509583,HC BERLIN HEART EXCOR ACCESSORY KIT,7416.0,4449.6,1720.51,6499.38,24 CDM,21509584,HC BERLIN HEART EXCOR DRIVELINE,1545.0,927.0,358.44,4481.0,24 CDM,21509585,HC BERLIN HEART EXCOR CONNECTOR SET,2781.0,1668.6,645.19,4481.0,24 CDM,21509586,HC MPU AC POWER CORD,469.0,281.4,108.81,4481.0,24 CDM,21509587,HC HM PM BATT CHARGER AC POWER CORD,458.0,274.8,106.26,4481.0,24 CDM,22700002,HC ABDOMINAL BINDER,67.0,40.2,15.54,4481.0,24 CDM,22700003,HC IP ARCTIC GEL PAD,3723.0,2233.8,863.74,4481.0,24 CDM,22700004,HC A SPLINT MATERIALS,6.0,3.6,1.39,4481.0,24 CDM,22700005,HC B SPLINT MATERIALS,9.0,5.4,2.09,4481.0,24 CDM,22700006,HC C SPLINT MATERIALS,22.0,13.2,5.1,4481.0,24 CDM,22700007,HC D SPLINT MATERIALS,27.0,16.2,6.26,4481.0,24 CDM,22700008,HC E SPLINT MATERIALS,32.0,19.2,7.42,4481.0,24 CDM,22700009,HC F SPLINT MATERIALS,46.0,27.6,10.67,4481.0,24 CDM,22700011,HC G SPLINT MATERIALS,52.0,31.2,12.06,4481.0,24 CDM,22700012,HC H SPLINT MATERIALS,58.0,34.8,13.46,4481.0,24 CDM,22700013,HC I SPLINT MATERIALS,70.0,42.0,16.24,4481.0,24 CDM,22700014,HC J SPLINT MATERIALS,78.0,46.8,18.1,4481.0,24 CDM,22700015,HC K SPLINT MATERIALS,86.0,51.6,19.95,4481.0,24 CDM,22700016,HC L SPLINT MATERIALS,104.0,62.4,24.13,4481.0,24 CDM,22700017,HC M SPLINT MATERIALS,121.0,72.6,28.07,4481.0,24 CDM,22700018,HC N SPLINT MATERIALS,138.0,82.8,32.02,4481.0,24 CDM,22700019,HC O SPLINT MATERIALS,174.0,104.4,40.37,4481.0,24 CDM,22700020,HC P SPLINT MATERIALS,197.0,118.2,45.7,4481.0,24 CDM,22700023,HC 02 PL ELECTRODE,2584.0,1550.4,599.49,4481.0,24 CDM,22700024,HC 02 SS ELECTRODE,2010.0,1206.0,466.32,4481.0,24 CDM,22700025,HC 04 PL ELECTRODE,3330.0,1998.0,772.56,4481.0,24 CDM,22700026,HC 04 SS ELECTRODE,2231.0,1338.6,517.59,4481.0,24 CDM,22700027,HC 08 PL ELECTRODE,4540.0,2724.0,1053.28,4481.0,24 CDM,22700028,HC 20 PL ELECTRODE,6807.0,4084.2,1579.22,5965.65,24 CDM,22700029,HC 20 SS ELECTRODE,4433.0,2659.8,1028.46,4481.0,24 CDM,22700030,HC 2X8 PL ELECTRODE,5159.0,3095.4,1196.89,4521.35,24 CDM,22700031,HC 32 PL ELECTRODE,3727.0,2236.2,864.66,4481.0,24 CDM,22700032,HC 32 SS ELECTRODE,4561.0,2736.6,1058.15,4481.0,24 CDM,22700033,HC 4C PLAT DEPTH ELECTRODE,2326.0,1395.6,539.63,4481.0,24 CDM,22700034,HC 4C STNLS DEPTH ELECTRODE,1700.0,1020.0,394.4,4481.0,24 CDM,22700035,HC 64C PL ELECTRODE,7270.0,4362.0,1686.64,6371.43,24 CDM,22700036,HC 6C PLAT DEPT ELECTRODE,2800.0,1680.0,649.6,4481.0,24 CDM,22700037,HC 6C STNLS DEPTH ELECTRODE,1870.0,1122.0,433.84,4481.0,24 CDM,22700038,HC 8C PLAT DEPTH ELECTRODE,3763.0,2257.8,873.02,4481.0,24 CDM,22700039,HC 8C STNLS DEPTH ELECTRODE,2177.0,1306.2,505.06,4481.0,24 CDM,22700040,HC ELECTRODE PR,62.0,37.2,14.38,4481.0,24 CDM,22700045,HC TENCHOFF DRESSING CHANGE,135.0,81.0,31.32,4481.0,24 CDM,22700052,HC 06 ELECTRODE,3406.0,2043.6,790.19,4481.0,24 CDM,22700057,HC ACE WRAPS,9.0,5.4,2.09,4481.0,24 CDM,22700059,HC COMPRESSION GLOVE,136.0,81.6,31.55,4481.0,24 CDM,22700060,HC COMPRESSION GLOVE CUSTOM,244.0,146.4,56.61,4481.0,24 CDM,22700061,HC COMPRESSION SLEEVE,120.0,72.0,27.84,4481.0,24 CDM,22700062,HC COMPRESSION SLEEVE CUSTOM,120.0,72.0,27.84,4481.0,24 CDM,22700075,HC CUFF W/COOLER KNEE CRYO,333.0,199.8,77.26,4481.0,24 CDM,22700076,HC CUFF W/COOLER SHOULDER C,374.0,224.4,86.77,4481.0,24 CDM,22700077,"HC HOSE, STY 3071 TED THI LEN S",33.0,19.8,7.66,4481.0,24 CDM,22700078,"HC HOSE, STY 3310 TED THI LEN M",32.0,19.2,7.42,4481.0,24 CDM,22700079,HC KNEE SLING MED 7104-14,115.0,69.0,26.68,4481.0,24 CDM,22700080,HC MS DIAL A FLOW,22.0,13.2,5.1,4481.0,24 CDM,22700081,HC MS FOAM DONUT 9 INCH,5.0,3.0,1.16,4481.0,24 CDM,22700082,HC MS LONCHA HUMIDIFIER,68.0,40.8,15.78,4481.0,24 CDM,22700083,HC MS-ABOVE KNEE HOSE EX-LG-LONG,22.0,13.2,5.1,4481.0,24 CDM,22700084,HC MS-ABOVE KNEE HOSE EX-LG-REG,22.0,13.2,5.1,4481.0,24 CDM,22700085,HC MS-KNEE LENGTH HOSE MED-REG,22.0,13.2,5.1,4481.0,24 CDM,22700086,HC MS-KNEE LENGTH HOSE SMALL-LONG,22.0,13.2,5.1,4481.0,24 CDM,22700087,HC MS-KNEE LENGTH HOSE SMALL-REG,22.0,13.2,5.1,4481.0,24 CDM,22700089,HC ABDOMINOPLASTY GARMENT SMALL,337.0,202.2,78.18,4481.0,24 CDM,22700090,HC ABDOMINOPLASTY GARMNT M/LG/XLG,246.0,147.6,57.07,4481.0,24 CDM,22700091,HC AEROSOL THERAPY SUPPLY PER DAY,124.0,74.4,28.77,4481.0,24 CDM,22700092,HC AEROSOL THERAPY SUPPLY EACH,104.0,62.4,24.13,4481.0,24 CDM,22700093,HC ARCTIC GEL PAD,4099.0,2459.4,950.97,4481.0,24 CDM,22700096,HC CAMISOLE POST MASTECTOMY,180.0,108.0,41.76,4481.0,24 CDM,22700101,HC CYTOLOGY BRUSH,64.0,38.4,14.85,4481.0,24 CDM,22700102,HC DEPTH ELECTR,719.0,431.4,166.81,4481.0,24 CDM,22700103,HC DISPOSABLE NEBULIZER SUPPLY,28.0,16.8,6.5,4481.0,24 CDM,22700105,HC EDCP-4,1941.0,1164.6,450.31,4481.0,24 CDM,22700106,HC EDCP-6,2336.0,1401.6,541.95,4481.0,24 CDM,22700107,HC EDCP-8,2848.0,1708.8,660.74,4481.0,24 CDM,22700113,HC FREDERICK SUPPORT BRA,431.0,258.6,99.99,4481.0,24 CDM,22700115,HC GOLD EYE WEIGHT,1298.0,778.8,301.14,4481.0,24 CDM,22700117,"HC INFANT HOOD,INITIAL",147.0,88.2,34.1,4481.0,24 CDM,22700127,HC PULMONARY OXIMIZER PENDANT,65.0,39.0,15.08,4481.0,24 CDM,22700133,HC OT PERCENTO FACE MASK,6.0,3.6,1.39,4481.0,24 CDM,22700134,HC PERMARK PIGMENT EA,155.0,93.0,35.96,4481.0,24 CDM,22700146,HC SURGI-BRA,306.0,183.6,70.99,4481.0,24 CDM,22700151,HC VEST WRAP AIRWAY CLR MD 050772,325.0,195.0,75.4,4481.0,24 CDM,22700160,HC COMPRESSION GAUNTLET,98.0,58.8,22.74,4481.0,24 CDM,22700552,HC CENTRIFUGAL PUMP AND SUPPLIES,7331.0,4398.6,1700.79,6424.89,24 CDM,22700553,HC HEART LUNG MACHINE AND SUPPLIES,4836.0,2901.6,1121.95,4481.0,24 CDM,22700557,HC ANESTHESIA PSC ANES SUPPORT/SUPPLIES,1078.0,646.8,250.1,4481.0,24 CDM,22700573,HC PT PERCENTO FACE MASK,6.0,3.6,1.39,4481.0,24 CDM,22700574,HC PT OXYGEN THERAPY SUPPLY,26.0,15.6,6.03,4481.0,24 CDM,22700575,HC OT OXYGEN THERAPY SUPPLY,26.0,15.6,6.03,4481.0,24 CDM,22700626,HC BREASTPUMP HARMONY MANUAL,71.0,42.6,16.47,4481.0,24 CDM,22700749,HC MRI EEG ELECTRODES,273.0,163.8,63.34,4481.0,24 CDM,22700750,HC 35 PLELECTRODE,4075.0,2445.0,945.4,4481.0,24 CDM,22700751,HC 6 PL ELECTRODE,701.0,420.6,162.63,4481.0,24 CDM,22700752,HC 16 PL ELECTRODE,1859.0,1115.4,431.29,4481.0,24 CDM,22700753,HC 64 PL ELECTRODE,7450.0,4470.0,1728.4,6529.18,24 CDM,22700754,HC 48 PL ELECTRODE,5589.0,3353.4,1296.65,4898.2,24 CDM,22700755,HC 10 PL ELECTRODE,1164.0,698.4,270.05,4481.0,24 CDM,22700756,HC 10 PL DEPTH ELECTRODE,1306.0,783.6,302.99,4481.0,24 CDM,22700757,HC 6 PL DEPTH ELECTRODE,784.0,470.4,181.89,4481.0,24 CDM,22700896,HC MASTECTOMY BREAST BINDER,70.0,42.0,16.24,4481.0,24 CDM,22700933,HC POWDER STOMAHESIVE 1 OZ 050829,3.0,1.8,0.696,4481.0,24 CDM,22700934,HC RING STOMA BRAVA MODABLE 2MM 052951,5.0,3.0,1.16,4481.0,24 CDM,22700946,HC 12 CONTACT PLATINUM DEPTH ELECTRODE,1566.0,939.6,363.31,4481.0,24 CDM,22700947,HC 14 CONTACT PLATINUM DEPTH ELECTRODE,1829.0,1097.4,424.33,4481.0,24 CDM,22700948,HC 16 CONTACT PLATINUM DEPTH ELECTRODE,2089.0,1253.4,484.65,4481.0,24 CDM,22700965,HC CERIBELL HEADBAND,1860.0,1116.0,431.52,4481.0,24 CDM,22700977,HC WATERPROOF CASTING SUPPLY,56.0,33.6,12.99,4481.0,24 CDM,22710013,HC GEL CAP INSERTION DEVICE EACH,164.0,98.4,38.05,4481.0,27 CDM,22710018,HC CLEANING DEV TEVP REPL ONLY,24.0,14.4,5.57,4481.0,27 CDM,22710019,HC INSERT INTEP REPLACE ONLY EACH,171.0,102.6,39.67,4481.0,27 CDM,22710068,HC OXYHOOD SET UP,45.0,27.0,10.44,4481.0,24 CDM,22720058,HC CATH SUPRAPUBIC,166.0,99.6,38.51,4481.0,27 CDM,22720059,HC PICC SUPPLIES,875.0,525.0,203.0,4481.0,24 CDM,22720060,HC PICC PROTECTOR,124.0,74.4,28.77,4481.0,24 CDM,22720061,HC STATLOCK PICC PLUS VPPDFP,32.0,19.2,7.42,4481.0,24 CDM,22720062,HC SUTURE REMOVAL SUPPLIES,52.0,31.2,12.06,4481.0,24 CDM,22720063,HC 2.5 DUAL LUM UMB VS CTH,81.0,48.6,18.79,4481.0,24 CDM,22720064,HC 3.5 DUAL LUM UMB VS CTH,152.0,91.2,35.26,4481.0,24 CDM,22720065,HC 5.0 DUAL LUM UMB VS CTH,152.0,91.2,35.26,4481.0,24 CDM,22720066,HC 5.0 TRIPLE LUM UMB VS CTH,217.0,130.2,50.34,4481.0,24 CDM,22720067,HC 60X6 POSITIONING TUBE,218.0,130.8,50.58,4481.0,24 CDM,22720068,HC IP ACAPELLA BREATHING EXERCISER,216.0,129.6,50.11,4481.0,24 CDM,22720069,HC ACTICOAT 16X16 DRESSING,331.0,198.6,76.79,4481.0,24 CDM,22720070,HC AQUADEX HEMATOCRIT A2000,849.0,509.4,196.97,4481.0,24 CDM,22720071,HC AQUADEX INSERTION KIT A1665,122.0,73.2,28.3,4481.0,24 CDM,22720072,HC ARCTIC SUN GEL LARGE PAD,3296.0,1977.6,764.67,4481.0,24 CDM,22720073,HC ARCTIC SUN GEL MEDIUM PAD,3296.0,1977.6,764.67,4481.0,24 CDM,22720074,HC ARCTIC SUN GEL SMALL PAD,3296.0,1977.6,764.67,4481.0,24 CDM,22720075,HC ARCTIC SUN GEL UNIVERSAL SINGLE PAD,1154.0,692.4,267.73,4481.0,24 CDM,22720076,HC ARCTIC SUN GEL XSM,3296.0,1977.6,764.67,4481.0,24 CDM,22720077,HC BIVONA CUSTOM TRACH EXPRESS,1123.0,673.8,260.54,4481.0,24 CDM,22720078,HC BIVONA CUSTOM TRACH SAME DAY,2843.0,1705.8,659.58,4481.0,24 CDM,22720079,HC BIVONA CUSTOM TRACH STANDARD,757.0,454.2,175.62,4481.0,24 CDM,22720080,HC BIVONA STOCK AIRE CUFF TRACH,767.0,460.2,177.94,4481.0,24 CDM,22720081,HC BIVONA STOCK CUFFED TRACH TUBE,1042.0,625.2,241.74,4481.0,24 CDM,22720082,HC BIVONA STOCK UNCUFD TRACH TUBE,264.0,158.4,61.25,4481.0,24 CDM,22720083,HC BOWEL MGMT SYST ACTIFLOW DRAIN,1238.0,742.8,287.22,4481.0,24 CDM,22720084,HC CAMINO CATH W LICOX CAPABILITY,2659.0,1595.4,616.89,4481.0,24 CDM,22720085,HC CAMINO CATHETER,2576.0,1545.6,597.63,4481.0,24 CDM,22720086,HC CANISTER WND VAC 1000ML,251.0,150.6,58.23,4481.0,24 CDM,22720087,HC CANISTER WND VAC 500ML,129.0,77.4,29.93,4481.0,24 CDM,22720088,HC CANNULA SHILEY INNER XLT 6,259.0,155.4,60.09,4481.0,24 CDM,22720089,HC CATHETER EVD BIGBOY,1535.0,921.0,356.12,4481.0,24 CDM,22720090,HC CATHETER OXIMETRIC SWAN GANZ,755.0,453.0,175.16,4481.0,24 CDM,22720091,HC CIAGLIA BLUE RHINO PERC 6MM,1494.0,896.4,346.61,4481.0,24 CDM,22720092,HC CIAGLIA BLUE RHINO PERC 8MM,1494.0,896.4,346.61,4481.0,24 CDM,22720094,HC DRESSING GRANUFOAM WND VAC LG,224.0,134.4,51.97,4481.0,24 CDM,22720095,HC DRESSING GRANUFOAM WND VAC MED,187.0,112.2,43.38,4481.0,24 CDM,22720096,HC DRESSING GRANUFOAM WND VAC SM,148.0,88.8,34.34,4481.0,24 CDM,22720097,HC DRESSING GRANUFOAM WND VAC XLG,465.0,279.0,107.88,4481.0,24 CDM,22720099,HC FULL BODY NESTING POSITIONER,555.0,333.0,128.76,4481.0,24 CDM,22720100,HC GTUBE 20FR,231.0,138.6,53.59,4481.0,24 CDM,22720101,HC GTUBE 24FR,294.0,176.4,68.21,4481.0,24 CDM,22720102,HC INFANT OXIMETER SENSOR,781.0,468.6,181.19,4481.0,24 CDM,22720103,HC INITIAL PICC LINE INS 3PT SUPP,576.0,345.6,133.63,4481.0,24 CDM,22720104,HC INTRACRANIAL PRESS MONITOR KT,2752.0,1651.2,638.46,4481.0,24 CDM,22720105,HC LICOX CATHETER,4570.0,2742.0,1060.24,4481.0,24 CDM,22720106,HC LUMBAR DRAIN AND CATHETER,977.0,586.2,226.66,4481.0,24 CDM,22720107,HC LUMBAR DRAIN PLACEMENT KIT,546.0,327.6,126.67,4481.0,24 CDM,22720109,HC MULTI LUMEN CVC PRES 7FR 20CM,431.0,258.6,99.99,4481.0,24 CDM,22720110,HC OASIS CHEST DRAIN ATRIUM,114.0,68.4,26.45,4481.0,24 CDM,22720111,HC OXYMIZER PENDANT,105.0,63.0,24.36,4481.0,24 CDM,22720112,HC PED ADULT OXIMETER SENSOR,650.0,390.0,150.8,4481.0,24 CDM,22720113,HC IP PICC SUPPLIES,875.0,525.0,203.0,4481.0,24 CDM,22720114,HC PICCO MONITOR KIT,197.0,118.2,45.7,4481.0,24 CDM,22720115,HC PICCO THERM CATH W NWIRE 16CM,1049.0,629.4,243.37,4481.0,24 CDM,22720116,HC PICCO THERM CATH W NWIRE 20CM,1049.0,629.4,243.37,4481.0,24 CDM,22720117,HC PRONE AND UTILITY POSITIONER,80.0,48.0,18.56,4481.0,24 CDM,22720120,HC SENSOR FLO TRAC,1049.0,629.4,243.37,4481.0,24 CDM,22720121,HC SHILEY SPECIALZD TRACH UNCUFF,492.0,295.2,114.14,4481.0,24 CDM,22720122,HC SHILEY STOCK CUFFED TRACH TUBE,166.0,99.6,38.51,4481.0,24 CDM,22720123,HC SHILEY STOCK UNCUFD TRACH TUBE,124.0,74.4,28.77,4481.0,24 CDM,22720124,HC SHILY CUSTOM NEONAT TRACH TUBE,573.0,343.8,132.94,4481.0,24 CDM,22720126,HC STATLOCK PICC PLUS,32.0,19.2,7.42,4481.0,24 CDM,22720127,HC STERILE 15MM NEEDLE SET,495.0,297.0,114.84,4481.0,24 CDM,22720128,HC STERILE 25MM NEEDLE SET,495.0,297.0,114.84,4481.0,24 CDM,22720129,HC STERILE 45MM NEEDLE SET,543.0,325.8,125.98,4481.0,24 CDM,22720130,HC SUBDURAL EVAC PORT SYSTEM,5590.0,3354.0,1296.88,4899.08,24 CDM,22720131,HC TRACH PLACEMENT KIT,431.0,258.6,99.99,4481.0,24 CDM,22720133,HC UNIVERSAL ARCTIC GEL PAD,1415.0,849.0,328.28,4481.0,24 CDM,22720134,HC VENTRIC CATH PLACEMENT KIT,1013.0,607.8,235.02,4481.0,24 CDM,22720135,HC VENTRIC CATHETER RT 7,1375.0,825.0,319.0,4481.0,24 CDM,22720136,HC VENTRIC DRAINAGE BAG,114.0,68.4,26.45,4481.0,24 CDM,22720137,HC VENTRIC DRAINAGE CATHETER,927.0,556.2,215.06,4481.0,24 CDM,22720138,HC VENTRIC DRAINAGE KIT BECKER,692.0,415.2,160.54,4481.0,24 CDM,22720139,HC VEST WRAP AIRWAY CLEARANCE LG,291.0,174.6,67.51,4481.0,24 CDM,22720140,HC VEST WRAP AIRWAY CLEARANCE MED,291.0,174.6,67.51,4481.0,24 CDM,22720141,HC VEST WRAP AIRWAY CLEARANCE XLG,291.0,174.6,67.51,4481.0,24 CDM,22720143,HC UNC SICU PNEUMOTHORAX PLACE KIT,646.0,387.6,149.87,4481.0,24 CDM,22720147,HC FETAL SCALP ELECTRODE,22.0,13.2,5.1,4481.0,24 CDM,22720149,HC FLEXI NEEDLE 15G,93.0,55.8,21.58,4481.0,24 CDM,22720151,HC BRACHYTHERAPY NEEDLES,93.0,55.8,21.58,4481.0,24 CDM,22720156,HC LARGE TRACH COLLAR,88.0,52.8,20.42,4481.0,23 CDM,22720157,HC MED TRACH COLLAR,78.0,46.8,18.1,4481.0,23 CDM,22720158,HC MS ENDOTRACH TUBE,112.0,67.2,25.98,4481.0,24 CDM,22720162,HC TRACH TUBE BIVONA ALL SIZES,1171.0,702.6,271.67,4481.0,24 CDM,22720163,HC TRACH TUBE LOW PRESSURE CUFFED,281.0,168.6,65.19,4481.0,24 CDM,22720164,HC TRACH TUBE LOWPRESSURE NO CUFF,208.0,124.8,48.26,4481.0,24 CDM,22720165,HC TRACH TUBE PEDIATRIC ALL SIZES,183.0,109.8,42.46,4481.0,24 CDM,22720166,HC TRACH TUBE XLT ALL STYLES,403.0,241.8,93.5,4481.0,24 CDM,22720172,HC BURN CHIN STRAP CUSTOM,197.0,118.2,45.7,4481.0,24 CDM,22720173,HC BURN GARMENT ARM SLEEVE,122.0,73.2,28.3,4481.0,24 CDM,22720174,HC BURN GARMENT GLOVE ADULT,138.0,82.8,32.02,4481.0,24 CDM,22720175,HC BURN GARMENT GLOVE PEDIATRIC,104.0,62.4,24.13,4481.0,24 CDM,22720176,HC BURN GARMENT KNEE HIGH,138.0,82.8,32.02,4481.0,24 CDM,22720177,HC BURN GARMENT KNEE HIGH CUSTOM,138.0,82.8,32.02,4481.0,24 CDM,22720178,HC BURN GARMENT THIGH HIGH,197.0,118.2,45.7,4481.0,24 CDM,22720179,HC BURN GLOVE TO WRIST CUSTOM,248.0,148.8,57.54,4481.0,24 CDM,22720182,HC GELATIN CAPS REPL ONLY PER 10,58.0,34.8,13.46,4481.0,27 CDM,22720241,HC COMB SPINAL EPID PROC SUPPLIES,259.0,155.4,60.09,4481.0,24 CDM,22720243,HC EPIDURAL SUPPLIES,240.0,144.0,55.68,4481.0,24 CDM,22720250,HC MS BLOOD WARMING BAG,51.0,30.6,11.83,4481.0,24 CDM,22720251,HC MS PERCUTANEOUS CATHETER,161.0,96.6,37.35,4481.0,24 CDM,22720252,HC MS TRANSDUCER DOME,46.0,27.6,10.67,4481.0,24 CDM,22720253,HC MS TRANSFUSION FILTER,29.0,17.4,6.73,4481.0,24 CDM,22720255,HC BALLOON TAMPANADE CATHETER,519.0,311.4,120.41,4481.0,24 CDM,22720261,HC BRONCH ALVEOLAR LAVAGE KIT,144.0,86.4,33.41,4481.0,24 CDM,22720263,HC BUTTON SEPTAL,1136.0,681.6,263.55,4481.0,24 CDM,22720264,HC RADONC CATH BRACHYTHERAPY SEED ADMIN,62.0,37.2,14.38,4481.0,24 CDM,22720279,HC COLLECT PERITON FLD ASP SUPPLY,228.0,136.8,52.9,4481.0,24 CDM,22720281,HC DIALYSIS CATHETER SUPPLY,950.0,570.0,220.4,4481.0,27 CDM,22720294,HC FOLEY CATHETER,26.0,15.6,6.03,4481.0,24 CDM,22720297,HC FRESENIUS BAXTER PD SUPPLIES,253.0,151.8,58.7,4481.0,24 CDM,22720302,HC INTRAUTERINE PRESSURE CATHETER,129.0,77.4,29.93,4481.0,24 CDM,22720304,HC ITP IMMUNOADSORPTION COLUMN,3809.0,2285.4,883.69,4481.0,24 CDM,22720310,HC OXYGEN NASAL PRONGS,29.0,17.4,6.73,4481.0,24 CDM,22720312,HC PERITON DIAL CATH FLUSH SUPPLY,183.0,109.8,42.46,4481.0,24 CDM,22720320,HC RECTAL CATHETER,26.0,15.6,6.03,4481.0,24 CDM,22720326,HC SCD SLEEVE,208.0,124.8,48.26,4481.0,24 CDM,22720332,HC STERI CATHS,75.0,45.0,17.4,4481.0,24 CDM,22720340,HC TUBING EXCHANGE SUPPLIES,253.0,151.8,58.7,4481.0,24 CDM,22720341,HC UTERINE STAPLER,1669.0,1001.4,387.21,4481.0,24 CDM,22720342,HC VACUUM EXTRACTOR,138.0,82.8,32.02,4481.0,24 CDM,22720343,HC VAGINAL DILATOR,41.0,24.6,9.51,4481.0,24 CDM,22720345,HC SINGLE PICC CATHETER,446.0,267.6,103.47,4481.0,27 CDM,22720346,HC IP DUAL PICC CATHETER,495.0,297.0,114.84,4481.0,27 CDM,22720348,HC DUAL POWER PICC,751.0,450.6,174.23,4481.0,27 CDM,22720351,HC SINGLE POWER PICC,731.0,438.6,169.59,4481.0,27 CDM,22720352,HC TRIPLE POWER PICC,865.0,519.0,200.68,4481.0,27 CDM,22720372,HC SILICONE SILO BAG,839.0,503.4,194.65,4481.0,24 CDM,22720438,HC ED CATH SUPRAPUBIC CYSTOSCOPIC,698.0,418.8,161.94,4481.0,27 CDM,22720475,HC ECMO CARDIOHELP CIRCUIT EXCHANGE,43328.0,25996.8,4481.0,37972.66,24 CDM,22720479,HC ECMO PUMP CIRCUIT CHANGE,7370.0,4422.0,1709.84,6459.07,24 CDM,22720484,HC SPINAL PROCEDURE SUPPLIES,146.0,87.6,33.87,4481.0,24 CDM,22720486,HC PLEURX CATHETER UNC,1383.0,829.8,320.86,4481.0,27 CDM,22720510,HC PICC SHEATH INTRODUCER 1.9 FR,135.0,81.0,31.32,4481.0,24 CDM,22720511,HC BROVIAC REPAIR SUPPLIES,504.0,302.4,116.93,4481.0,24 CDM,22720513,HC FOOTPRINT 1.4 CATHETER,44.0,26.4,10.21,4481.0,24 CDM,22720514,HC FOOTPRINT 1.4 INTRODUCER,40.0,24.0,9.28,4481.0,24 CDM,22720515,HC FOOTPRINT 1.9 INTRODUCER,39.0,23.4,9.05,4481.0,24 CDM,22720572,HC HYALOMATRIX WOUND DRESSING MSS4044 10X10CM EACH,2907.0,1744.2,674.42,4481.0,24 CDM,22720573,HC HYALOMATRIX WOUND DRESSING MSS4022 5X5CM EACH,805.0,483.0,186.76,4481.0,24 CDM,22720574,HC HYALOMATRIX WOUND DRESSING MSS4022H 5X5CM EACH,995.0,597.0,230.84,4481.0,24 CDM,22720575,HC HYALOMATRIX WOUND DRESSING MSS 4048 10X20CM EACH,5170.0,3102.0,1199.44,4530.99,24 CDM,22720661,HC MB BREAST PUMP KANESON,71.0,42.6,16.47,4481.0,24 CDM,22720811,HC ECMO AVALON ELITE BICAVAL 13 FR,8372.0,5023.2,1942.3,7337.22,24 CDM,22720812,HC ECMO AVALON ELITE BICAVAL 16 FR,8372.0,5023.2,1942.3,7337.22,24 CDM,22720813,HC ECMO AVALON ELITE BICAVAL 19 FR,8372.0,5023.2,1942.3,7337.22,24 CDM,22720814,HC ECMO AVALON ELITE BICAVAL 20 FR,8372.0,5023.2,1942.3,7337.22,24 CDM,22720815,HC ECMO AVALON ELITE BICAVAL 23 FR,8372.0,5023.2,1942.3,7337.22,24 CDM,22720816,HC ECMO AVALON ELITE BICAVAL 27 FR,8372.0,5023.2,1942.3,7337.22,24 CDM,22720817,HC ECMO AVALON ELITE BICAVAL 31 FR,8372.0,5023.2,1942.3,7337.22,24 CDM,22720818,HC ECMO BEQ HLS CANNULA 19F AL 23CM,1634.0,980.4,379.09,4481.0,24 CDM,22720819,HC ECMO BEQ HLS CANNULA 21F AL 23CM,1634.0,980.4,379.09,4481.0,24 CDM,22720820,HC ECMO BEQ HLS CANNULA 23F AL 23CM,1634.0,980.4,379.09,4481.0,24 CDM,22720821,HC ECMO BEQ HLS CANNULA 15F AS 15CM,1634.0,980.4,379.09,4481.0,24 CDM,22720822,HC ECMO BEQ HLS CANNULA 17F AS 15CM,1634.0,980.4,379.09,4481.0,24 CDM,22720823,HC ECMO BEQ HLS CANNULA 19F AS 15CM,1634.0,980.4,379.09,4481.0,24 CDM,22720824,HC ECMO BEQ HLS CANNULA 21F AS 15CM,1634.0,980.4,379.09,4481.0,24 CDM,22720825,HC ECMO BEQ HLS CANNULA 23F AS 15CM,1634.0,980.4,379.09,4481.0,24 CDM,22720826,HC ECMO BEQ HLS CANNULA 19F VS 38CM,1634.0,980.4,379.09,4481.0,24 CDM,22720827,HC ECMO BEQ HLS CANNULA 21F VS 38CM,2268.0,1360.8,526.18,4481.0,24 CDM,22720828,HC ECMO BEQ HLS CANNULA 23F VS 38CM,2268.0,1360.8,526.18,4481.0,24 CDM,22720829,HC ECMO BEQ HLS CANNULA 25F VS 38 M,2268.0,1360.8,526.18,4481.0,24 CDM,22720830,HC ECMO BEQ HLS CANNULA 25F VEN LONG 55CM ADULT,1814.0,1088.4,420.85,4481.0,24 CDM,22720831,HC ECMO CANNULA ARTERIAL 8 FR CB96820 008,679.0,407.4,157.53,4481.0,24 CDM,22720832,HC ECMO CANNULA ARTERIAL 10 FR CB96820 010,679.0,407.4,157.53,4481.0,24 CDM,22720833,HC ECMO CANNULA ARTERIAL 12 FR CB96820 012,679.0,407.4,157.53,4481.0,24 CDM,22720834,HC ECMO CANNULA ARTERIAL 14 FR CB96820 014,679.0,407.4,157.53,4481.0,24 CDM,22720835,HC ECMO CANNULA FEMORAL ARTERIAL 15 FR CB96535 015,1151.0,690.6,267.03,4481.0,24 CDM,22720836,HC ECMO CANNULA FEMORAL ARTERIAL 17 FR CB96535 017,1167.0,700.2,270.74,4481.0,24 CDM,22720837,HC ECMO CANNULA FEMORAL ARTERIAL 19 FR CB96535 019,1167.0,700.2,270.74,4481.0,24 CDM,22720838,HC ECMO CANNULA FEMORAL ARTERIAL 21 FR CB96535 021,1192.0,715.2,276.54,4481.0,24 CDM,22720839,HC ECMO CANNULA VENOUS 8 FR CB96835 008,679.0,407.4,157.53,4481.0,24 CDM,22720840,HC ECMO CANNULA VENOUS 10 FR CB96835 010,679.0,407.4,157.53,4481.0,24 CDM,22720841,HC ECMO CANNULA VENOUS 12 FR,679.0,407.4,157.53,4481.0,24 CDM,22720842,HC ECMO CANNULA VENOUS 14 FR ECMO,679.0,407.4,157.53,4481.0,24 CDM,22720843,HC ECMO CANNULA FEMORAL VENOUS 15 FR CB96605 015,1151.0,690.6,267.03,4481.0,24 CDM,22720844,HC ECMO CANNULA FEMORAL VENOUS 17 FR CB96605 017,1167.0,700.2,270.74,4481.0,24 CDM,22720845,HC ECMO CANNULA FEMORAL VENOUS 19 FR CB96605 019,1167.0,700.2,270.74,4481.0,24 CDM,22720846,HC ECMO CANNULA FEMORAL VENOUS 21 FR CB96605 021,1192.0,715.2,276.54,4481.0,24 CDM,22720847,HC ECMO CANNULA FEMORAL VENOUS 23 FR CB,1122.0,673.2,260.3,4481.0,24 CDM,22720848,HC ECMO CANNULA BIO MED 14 ART,1224.0,734.4,283.97,4481.0,24 CDM,22720849,HC ECMO CANNULA BIO MED 12 ART,1224.0,734.4,283.97,4481.0,24 CDM,22720850,HC ECMO CANNULA BIO MED 12 VEN,1224.0,734.4,283.97,4481.0,24 CDM,22720851,HC ECMO CANNULA BIO MED 14 VEN,1224.0,734.4,283.97,4481.0,24 CDM,22720852,HC ECMO DOUBLE LUMEN CATHETER 13 FR,659.0,395.4,152.89,4481.0,24 CDM,22720853,HC ECMO DOUBLE LUMEN CATHETER 16F REPLACES 15F,1872.0,1123.2,434.3,4481.0,24 CDM,22720854,HC ECMO DOUBLE LUMEN CATHETER 19F REPLACES 18F,2227.0,1336.2,516.66,4481.0,24 CDM,22720894,HC ECMO CIRCUIT SET UP,34428.0,20656.8,4481.0,30172.7,24 CDM,22720989,HC BIVONA TRACHEOSTOMY TUBES,640.0,384.0,148.48,4481.0,24 CDM,22720990,HC CATHETER UMBILICAL 8 FR ARGYLE PVC,68.0,40.8,15.78,4481.0,24 CDM,22720991,HC CANNULAIDE INFANT CPAP SEAL,593.0,355.8,137.58,4481.0,24 CDM,22720992,HC O2 SAT SENSOR LNCS NEOPT 500 NON ADHESIVE,39.0,23.4,9.05,4481.0,24 CDM,22720993,HC GASTROSTOMY TUBE MIC KEY LOW PROFILE,293.0,175.8,67.98,4481.0,24 CDM,22720994,HC FEEDING SET MIC KEY EXTENSION,35.0,21.0,8.12,4481.0,24 CDM,22720995,HC MINI ONE BALLOON BUTTON,293.0,175.8,67.98,4481.0,24 CDM,22720996,HC NEOHELP,52.0,31.2,12.06,4481.0,24 CDM,22720997,HC OMNI ISOLETTE SLEEVES FOR HUMITY,56.0,33.6,12.99,4481.0,24 CDM,22720998,HC POSITION AID 7X10 UTILITY,56.0,33.6,12.99,4481.0,24 CDM,22720999,HC TRANSWARMER TRANSPORT MATTRESS,93.0,55.8,21.58,4481.0,24 CDM,22721003,HC URETEROSCOPE DISP,2614.0,1568.4,606.45,4481.0,24 CDM,22721019,HC AMBIO 5 SIZE 4X4,865.0,519.0,200.68,4481.0,24 CDM,22721021,HC 12 MM AMBIODISK,393.0,235.8,91.18,4481.0,24 CDM,22721022,HC 9MM AMBIODISK,381.0,228.6,88.39,4481.0,24 CDM,22721023,HC 15MM AMBIODISK,425.0,255.0,98.6,4481.0,24 CDM,22721035,HC CENTRIMAG VENOUS CANNULA,3328.0,1996.8,772.1,4481.0,24 CDM,22721036,HC UNCH REBOA CATHETER,5533.0,3319.8,1283.66,4849.12,24 CDM,22721037,HC UNCH CATHETER INTRODUCER,499.0,299.4,115.77,4481.0,24 CDM,22721043,HC CVW SINGLE PICC CATHETER,450.0,270.0,104.4,4481.0,27 CDM,22721044,HC CVW IP DUAL PICC CATHETER,500.0,300.0,116.0,4481.0,27 CDM,22721045,HC CVW IP TRIPLE PICC CATHETER,548.0,328.8,127.14,4481.0,27 CDM,22721072,HC PICC FOOTPRINT POLY COMPLETE 1.9FR LW053150,284.0,170.4,65.89,4481.0,27 CDM,22721073,HC PICC FOOTPRINT POLY COMPLETE DUAL LUMEN 1.9FR LW053151,376.0,225.6,87.23,4481.0,27 CDM,22721074,HC PICC FOOTPRINT POLY COMPLETE 1.4FR LW053152,289.0,173.4,67.05,4481.0,27 CDM,22721076,HC 4FR SL POWER PICC,722.0,433.2,167.5,4481.0,27 CDM,22721077,HC 5FR DL POWER PICC,742.0,445.2,172.14,4481.0,27 CDM,22721078,HC 5FR TL POWER PICC,742.0,445.2,172.14,4481.0,27 CDM,22721079,HC 4FR DL POWER PICC PROVENA,836.0,501.6,193.95,4481.0,27 CDM,22721084,HC NEONATAL HYDROGEL COATED PAD 1.8-4.5KG,2529.0,1517.4,586.73,4481.0,24 CDM,22721085,HC GRS DILATOR PACKAGE 4,584.0,350.4,135.49,4481.0,24 CDM,22721086,HC RAPID INFUSER,469.0,281.4,108.81,4481.0,24 CDM,22721087,HC VAT PROVENA MIDLINE CATHETER 4FR DL,590.0,354.0,136.88,4481.0,27 CDM,22721100,HC SUPRATHEL DRESSING 18X23CM,744.0,446.4,172.61,4481.0,24 CDM,22721101,HC AMBIO5 4X4CM AMNIOTIC MEMBRANE,2078.0,1246.8,482.1,4481.0,24 CDM,22721102,HC LICOX DIALYSIS CATHETER,4877.0,2926.2,1131.46,4481.0,24 CDM,22721112,HC AMNIOTIC MEMBRANE PROKERA CLASSIC SINGLE LAYER INNER DIAMETER 15.5 MM AND OUTER 21.6 MM,3453.0,2071.8,801.1,4481.0,24 CDM,22721113,HC AMNIOTIC MEMBRANE PROKERA PRO SINGLE LAYER INNER DIAMETER 15.5 MM AND OUTER 21.6 MM,3817.0,2290.2,885.54,4481.0,24 CDM,22721115,HC VAT DUAL POWER PICC,751.0,450.6,174.23,4481.0,27 CDM,22721116,HC VAT SINGLE POWER PICC,731.0,438.6,169.59,4481.0,27 CDM,22721117,HC VAT TRIPLE POWER PICC,865.0,519.0,200.68,4481.0,27 CDM,22721118,HC JADA INTRAUTERINE VACUUM HEMORRHAGE,3188.0,1912.8,739.62,4481.0,24 CDM,22721123,HC ECMO CATH RA JUGULAR DUAL LUMEN 13FR CRESCENT 70413,8100.0,4860.0,1879.2,7098.84,24 CDM,22721124,HC ECMO CATH RA JUGULAR DUAL LUMEN 15FR CRESCENT 70415,8100.0,4860.0,1879.2,7098.84,24 CDM,22721125,HC ECMO CATH RA JUGULAR DUAL LUMEN 19FR CRESCENT 70419,8100.0,4860.0,1879.2,7098.84,24 CDM,22721126,HC ECMO CATH RA JUGULAR DUAL LUMEN 24FR CRESCENT 70124,7200.0,4320.0,1670.4,6310.08,24 CDM,22721127,HC ECMO CATH RA JUGULAR DUAL LUMEN 26FR CRESCENT 70126,7200.0,4320.0,1670.4,6310.08,24 CDM,22721128,HC ECMO CATH RA JUGULAR DUAL LUMEN 28FR CRESCENT 70128,7200.0,4320.0,1670.4,6310.08,24 CDM,22721129,HC ECMO CATH RA JUGULAR DUAL LUMEN 30FR CRESCENT 70130,7200.0,4320.0,1670.4,6310.08,24 CDM,22721130,HC ECMO CANNULA PROTEK DUO ECLS 29FR 5140-4629,23400.0,14040.0,4481.0,20507.76,24 CDM,22721131,HC ECMO CANNULA PROTEK DUO ECLS 31FR 5140-5131,23400.0,14040.0,4481.0,20507.76,24 CDM,22721132,HC ECMO OXYGENATOR PMP NEONATAL US5088,5610.0,3366.0,1301.52,4916.6,24 CDM,22721133,HC ECMO OXYGENATOR PMP PEDIATRIC US5087,5610.0,3366.0,1301.52,4916.6,24 CDM,22721134,HC ECMO OXYGENATOR PMP ADULT US5062,2160.0,1296.0,501.12,4481.0,24 CDM,22721135,HC ECMO DEVICE VAD CENTRIMAG 102953,18900.0,11340.0,4384.8,16563.96,24 CDM,22721136,HC ECMO DEVICE VAD PEDIMAG 201-90052,18450.0,11070.0,4280.4,16169.58,24 CDM,22721144,HC VAT HYDROMID SL MB MIDLINE CATHETER 4FR SL,435.0,261.0,100.92,4481.0,24 CDM,22721153,HC IRRAFLOW INTRACRANIAL FLUID MANAGEMENT SYSTEM,10000.0,6000.0,2320.0,8764.0,24 CDM,22721154,HC LIMITORR VOLUME LIMITING EXTERNAL CSF DRAIN AND MONITOR SYSTEM,2202.0,1321.2,510.86,4481.0,24 CDM,22721155,HC SUBDURAL EVACUATING PORT SYSTEM,6648.0,3988.8,1542.34,5826.31,24 CDM,22723002,HC CATHETER DRAINAGE N C,2.0,1.2,0.464,4481.0,27 CDM,22723003,HC CATHETER DIALYSIS LONG TERM T S,2.0,1.2,0.464,4481.0,27 CDM,22723004,HC CATHETER CENTRAL LINE T S,2.0,1.2,0.464,4481.0,27 CDM,22723005,HC CATHETER DIALYSIS SHORT TERM T S,2.0,1.2,0.464,4481.0,27 CDM,22723006,HC CATHETER THROM EMBO T S,2.0,1.2,0.464,4481.0,24 CDM,22723007,HC CATHETER URETERAL T S,2.0,1.2,0.464,4481.0,27 CDM,22723008,HC GUIDEWIRE T S,2.0,1.2,0.464,4481.0,24 CDM,22723009,HC GUIDING CATHETER T S,2.0,1.2,0.464,4481.0,24 CDM,22723010,HC SHEATH INTRODUCER T S,2.0,1.2,0.464,4481.0,24 CDM,22723011,HC PORT INDWELLING T S,2.0,1.2,0.464,4481.0,27 CDM,22723016,HC VAT POWERGLIDE MIDLINE 8CM,187.0,112.2,43.38,4481.0,27 CDM,22723017,HC VAT POWERGLIDE MIDLINE 10CM,187.0,112.2,43.38,4481.0,27 CDM,22723018,HC HIPEC PERFUSION PUMP AND SUPPLIES,10227.0,6136.2,2372.66,8962.94,24 CDM,22730002,HC SISSOR OR SB 5,5.0,3.0,1.16,4481.0,22 CDM,22730005,HC BANDAGE ACE ELASTIC 6 IN,4.0,2.4,0.928,4481.0,22 CDM,22730007,HC BAG URINARY DRAINAGE,27.0,16.2,6.26,4481.0,22 CDM,22730009,HC CATHETER CONDOM SMALL,4.0,2.4,0.928,4481.0,22 CDM,22730012,HC CATHETER ROBINSON 12FR DISP,2.0,1.2,0.464,4481.0,22 CDM,22730013,HC CATHETER ROBINSON 14 FR DISP,2.0,1.2,0.464,4481.0,22 CDM,22730015,HC CLEANSER ANTIMICROBIAL HIBICL,32.0,19.2,7.42,4481.0,22 CDM,22730020,HC GAUZE DRESSING 5X9 STRIP OVRW,4.0,2.4,0.928,4481.0,22 CDM,22730021,HC GAUZE DRESSING NON ADHER STERL,5.0,3.0,1.16,4481.0,22 CDM,22730024,HC SPNGE LAP RFD 18X18 STR 5PK,17.0,10.2,3.94,4481.0,22 CDM,22730025,HC GAUZE VASELINE 3X9,3.0,1.8,0.696,4481.0,22 CDM,22730027,HC GLOVE SURG ESTEEM SMT 7,6.0,3.6,1.39,4481.0,22 CDM,22730028,HC GLOVE SURG ESTEEM SMT 8.0 50PR,6.0,3.6,1.39,4481.0,22 CDM,22730029,HC GLOVE SURG ESTEEM SMT 8.5,6.0,3.6,1.39,4481.0,22 CDM,22730030,HC MASKS SURGEONS DISP,25.0,15.0,5.8,4481.0,22 CDM,22730031,HC OPSITE 5CM X 7,2.0,1.2,0.464,4481.0,22 CDM,22730032,HC OPSITE 10CM X 14CM,3.0,1.8,0.696,4481.0,22 CDM,22730033,HC PADS DRAIN COTT&CELLULOSE 5X9,3.0,1.8,0.696,4481.0,22 CDM,22730035,HC PADS TELFA STERILE 3 IN X 4 IN,4.0,2.4,0.928,4481.0,22 CDM,22730036,HC PADS TELFA 3X8,2.0,1.2,0.464,4481.0,21 CDM,22730038,HC ROLLS BANDAGE ELAST LIKE KERLX,3.0,1.8,0.696,4481.0,22 CDM,22730040,HC SPONGE GAUZE 2X2 STERILE 8 PL,5.0,3.0,1.16,4481.0,22 CDM,22730041,HC SPONGES GAUZE 12 PLY 2S,4.0,2.4,0.928,4481.0,22 CDM,22730042,HC SPONGES CELLULOSE PREWRAP 4X4,6.0,3.6,1.39,4481.0,22 CDM,22730043,HC SPONGES ALL GAUZE 12 PLY 10S,2.0,1.2,0.464,4481.0,22 CDM,22730044,HC SPONGE TRACH IV DRAIN 40FR,2.0,1.2,0.464,4481.0,22 CDM,22730045,HC STRAPS MONTGOMERY PERF 8,4.0,2.4,0.928,4481.0,22 CDM,22730046,HC STRIPS GAUZE PACKNG STER PL,9.0,5.4,2.09,4481.0,22 CDM,22730047,HC SURGIFIX SIZE 2,50.0,30.0,11.6,4481.0,22 CDM,22730048,HC SURGIFIX SIZE 6,139.0,83.4,32.25,4481.0,22 CDM,22730049,HC SURGIFIX SIZE 7,221.0,132.6,51.27,4481.0,22 CDM,22730050,HC SURGIFIX SIZE 8,314.0,188.4,72.85,4481.0,22 CDM,22730052,HC TAPE ADHESIVE CLOTH HYPO ALG,2.0,1.2,0.464,4481.0,21 CDM,22730053,HC TAPE ANTI IRRIT 1 RL NON WOVE,2.0,1.2,0.464,4481.0,22 CDM,22730054,HC TAPE SILICONE 2 X 1,4.0,2.4,0.928,4481.0,22 CDM,22730059,HC WOUND DRESSING AIRSTRIP 8,4.0,2.4,0.928,4481.0,22 CDM,22730072,HC LEG BAG,44.0,26.4,10.21,4481.0,22 CDM,22730074,HC TAPE SILICONE 1 X1,2.0,1.2,0.464,4481.0,22 CDM,22730077,HC ACE BANDAGE 4 IN ADHESIVE,2.0,1.2,0.464,4481.0,22 CDM,22730078,HC BINDER ABDOMINAL 46 TO 62 INCH,68.0,40.8,15.78,4481.0,22 CDM,22730079,HC BRIEF EZ LARGE,5.0,3.0,1.16,4481.0,22 CDM,22730080,HC BRIEF EZ XL,5.0,3.0,1.16,4481.0,22 CDM,22730081,HC SPONGE 4X4 200 PKG,29.0,17.4,6.73,4481.0,22 CDM,22730082,HC ALCOHOL WIPES,4.0,2.4,0.928,4481.0,22 CDM,22730083,HC NORMAL SALINE 250CC,3.0,1.8,0.696,4481.0,22 CDM,22730098,HC BREAST PUMP OHP W FLEXISH,165.0,99.0,38.28,4481.0,22 CDM,22730100,HC TRUFORM BRA,267.0,160.2,61.94,4481.0,22 CDM,22730101,HC BRUN INTERSORB PAD 18 X 18IN,5.0,3.0,1.16,4481.0,22 CDM,22730112,HC KIT DRAINAGE PLEURX,256.0,153.6,59.39,4481.0,22 CDM,22730113,HC CAP VALVE REPLACEMENT PLEURX,25.0,15.0,5.8,4481.0,22 CDM,22730114,HC SET LINE DRAINAGE PLEURX,77.0,46.2,17.86,4481.0,22 CDM,22730115,HC DRESNG PAD 8X16 NONADH 050530,6.0,3.6,1.39,4481.0,22 CDM,22730116,HC INTERDRY AG 10INX12FT 050536,292.0,175.2,67.74,4481.0,22 CDM,22730122,HC KIT FEEDING GASTR 16FR 001730,434.0,260.4,100.69,4481.0,22 CDM,22730136,HC TRACH PEDS 3.0FR 001833,168.0,100.8,38.98,4481.0,22 CDM,22730148,HC BARRIER SKIN 4X4 EAKIN 050310,26.0,15.6,6.03,4481.0,22 CDM,22730153,HC SHIELD NIPPLE 20MM 6CA,19.0,11.4,4.41,4481.0,22 CDM,22730154,HC SHIELD NIPPLE 24MM 6CA,19.0,11.4,4.41,4481.0,22 CDM,22730155,HC GLVE EXAM NITRILE PF SM 150BX,37.0,22.2,8.58,4481.0,22 CDM,22730156,HC GLVE EXAM NITRILE PF LG 150BX,37.0,22.2,8.58,4481.0,22 CDM,22730157,HC GLVE EXAM NITRILE PF MED 150BX,37.0,22.2,8.58,4481.0,22 CDM,22730158,HC GLVE EXAM NITRILE PF XLG 150BX,37.0,22.2,8.58,4481.0,22 CDM,22730159,HC DRESSNG PAD 3X8 050668,3.0,1.8,0.696,4481.0,22 CDM,22730160,HC DRSSG FOAM 4X4 TEGADRM 050335,21.0,12.6,4.87,4481.0,22 CDM,22730162,HC SET DRAIN CHEST MIN 500 050737,317.0,190.2,73.54,4481.0,22 CDM,22730163,HC CARSEAT INFANT UP 22LB 050074,267.0,160.2,61.94,4481.0,22 CDM,22730164,HC CARSEAT BABY GREATER THAN 22LB 050075,228.0,136.8,52.9,4481.0,22 CDM,22730166,HC PUMP BREAST HARMONY 050626,89.0,53.4,20.65,4481.0,22 CDM,22730168,HC CLAMP BLUE BLOOD TUBE 000253,2.0,1.2,0.464,4481.0,22 CDM,22730170,HC STETHOSCOPE ADULT BLUE 60CA,10.0,6.0,2.32,4481.0,22 CDM,22730171,HC SYRINGE IRRIG 2OZ CATH 000609,2.0,1.2,0.464,4481.0,22 CDM,22730172,HC CATH FOLEY SILICONE 12 001478,19.0,11.4,4.41,4481.0,22 CDM,22730177,HC BANDAGE ELAS 2 ACE WRAP 002020,2.0,1.2,0.464,4481.0,22 CDM,22730178,HC BANDAGE ELAS 3 ACE WRAP 002021,2.0,1.2,0.464,4481.0,22 CDM,22730179,HC SET TRACH CARE 002045,5.0,3.0,1.16,4481.0,22 CDM,22730180,HC KIT DRESSING CENTRAL LINE 50CA,22.0,13.2,5.1,4481.0,22 CDM,22730181,HC PAD BURN 36X36 002231,21.0,12.6,4.87,4481.0,22 CDM,22730182,HC FILM CAVILON 3M 050338,51.0,30.6,11.83,4481.0,22 CDM,22730185,HC SISSOR IRIS 4,4.0,2.4,0.928,4481.0,22 CDM,22730190,HC A ADAPTIVE DEVICE,6.0,3.6,1.39,4481.0,22 CDM,22730191,HC B ADAPTIVE DEVICE,8.0,4.8,1.86,4481.0,22 CDM,22730192,HC C ADAPTIVE DEVICE,22.0,13.2,5.1,4481.0,22 CDM,22730193,HC D ADAPTIVE DEVICE,27.0,16.2,6.26,4481.0,22 CDM,22730194,HC E ADAPTIVE DEVICE,32.0,19.2,7.42,4481.0,22 CDM,22730195,HC F ADAPTIVE DEVICE,46.0,27.6,10.67,4481.0,22 CDM,22730200,HC G ADAPTIVE DEVICE,52.0,31.2,12.06,4481.0,22 CDM,22730201,HC H ADAPTIVE DEVICE,58.0,34.8,13.46,4481.0,22 CDM,22730202,HC I ADAPTIVE DEVICE,70.0,42.0,16.24,4481.0,22 CDM,22730203,HC J ADAPTIVE DEVICE,78.0,46.8,18.1,4481.0,22 CDM,22730204,HC K ADAPTIVE DEVICE,86.0,51.6,19.95,4481.0,22 CDM,22730205,HC L ADAPTIVE DEVICE,104.0,62.4,24.13,4481.0,22 CDM,22730206,HC M ADAPTIVE DEVICE,121.0,72.6,28.07,4481.0,22 CDM,22730207,HC N ADAPTIVE DEVICE,138.0,82.8,32.02,4481.0,22 CDM,22730208,HC O ADAPTIVE DEVICE,197.0,118.2,45.7,4481.0,22 CDM,22730209,HC TUBIGRIP A,29.0,17.4,6.73,4481.0,22 CDM,22730210,HC TUBIGRIP B,41.0,24.6,9.51,4481.0,22 CDM,22730211,HC TUBIGRIP C,50.0,30.0,11.6,4481.0,22 CDM,22730212,HC THERABAND 1 TO 2 YD,27.0,16.2,6.26,4481.0,22 CDM,22730213,HC OT TAPING MATERIALS,98.0,58.8,22.74,4481.0,22 CDM,22730214,HC GRAD COMP STOCKING BK 30-40 EA,138.0,82.8,32.02,4481.0,21 CDM,22730215,HC GRAD COMP STOCKING TH 30-40 EA,197.0,118.2,45.7,4481.0,21 CDM,22730216,HC HABERMAN FEEDER,58.0,34.8,13.46,4481.0,22 CDM,22730217,HC ISOTONER GLOVE ONE PAIR,62.0,37.2,14.38,4481.0,22 CDM,22730218,HC AL REPLACE BAT ACCESS ANY TYPE,478.0,286.8,110.9,4481.0,22 CDM,22730219,HC OT PEP SUPPLIES,153.0,91.8,35.5,4481.0,22 CDM,22730221,HC MICRO PLUS SPIROMETER,2321.0,1392.6,538.47,4481.0,22 CDM,22730223,HC BANDAGE STRETCH CONFORM 2X5,2.0,1.2,0.464,4481.0,22 CDM,22730227,HC CALF RIBBED STYLE,90.0,54.0,20.88,4481.0,22 CDM,22730228,HC CT CALF PETITE,82.0,49.2,19.02,4481.0,22 CDM,22730231,HC IODINE POVIONE 051009,8.0,4.8,1.86,4481.0,22 CDM,22730232,HC PT PEP SUPPLIES,153.0,91.8,35.5,4481.0,22 CDM,22730233,HC PT TAPING MATERIALS,98.0,58.8,22.74,4481.0,22 CDM,22730238,HC CAR BOOSTER SEAT UP TO 80LBS,190.0,114.0,44.08,4481.0,21 CDM,22730239,HC OPTILOCK NON ADHESIVE 5X5.5 LAWSON 224146,7.0,4.2,1.62,4481.0,21 CDM,22730240,HC OPTILOCK NON ADHESIVE 6.5X10 LAWSON 224270,15.0,9.0,3.48,4481.0,21 CDM,22732001,HC TAKE HOME SUPPLIES,22.0,13.2,5.1,4481.0,21 CDM,22732003,HC STOCKING MENS ACC CMP CALF PR,94.0,56.4,21.81,4481.0,22 CDM,22732004,HC STOCKING MENS ACC THIGHHI PR,157.0,94.2,36.42,4481.0,22 CDM,22732005,HC COMPRESSION THERAPY CALF,82.0,49.2,19.02,4481.0,22 CDM,22732006,HC CT THIGH W TOP BAND,124.0,74.4,28.77,4481.0,22 CDM,22732007,HC CT THIGH PETITE W TOP BAND,124.0,74.4,28.77,4481.0,22 CDM,22732008,HC PANTY W NON ADJ WAISTBAND,148.0,88.8,34.34,4481.0,22 CDM,22732009,HC OT CALF,82.0,49.2,19.02,4481.0,22 CDM,22732011,HC OT THIGH W TOP BAND,124.0,74.4,28.77,4481.0,22 CDM,22732012,HC OT THIGH PETITE W TOP BAND,124.0,74.4,28.77,4481.0,22 CDM,22732013,HC JUZO STOCKING KNEE HI 4411,93.0,55.8,21.58,4481.0,22 CDM,22732014,HC JUZO STOCKING THIGH HI 4411,140.0,84.0,32.48,4481.0,22 CDM,22732015,HC ACAPELLA BREATHING EXERCISER,216.0,129.6,50.11,4481.0,24 CDM,22732016,HC ANAL DILATORS,75.0,45.0,17.4,4481.0,22 CDM,22732017,HC BANDAGE ELASTIC W RUBBER 3X5,23.0,13.8,5.34,4481.0,22 CDM,22732018,HC CIRCAID JUXTACURE SHORT COMPRESSION SYSTEM,409.0,245.4,94.89,4481.0,21 CDM,22732019,HC CIRCAID JUXTACURE STANDARD COMPRESSION SYSTEM,409.0,245.4,94.89,4481.0,21 CDM,22732020,HC CIRCAID JUXTACURE LONG COMPRESSION SYSTEM,409.0,245.4,94.89,4481.0,21 CDM,22740012,HC CERVICAL COLLAR SOFT,68.0,40.8,15.78,4481.0,27 CDM,22740013,HC CERVICAL COLLAR SEMIRIGID 2PC,337.0,202.2,78.18,4481.0,27 CDM,22740015,HC MS KNEE SPLINT 20 INCH,52.0,31.2,12.06,4481.0,27 CDM,22740018,HC WRIST FX VELCRO SPLINT,23.0,13.8,5.34,4481.0,27 CDM,22740019,HC SLEEVE COMPRESSION LARGE THIGH SCD EXPRESS 28 TO 36IN THIGH CIRCUMFERENCE,58.0,34.8,13.46,4481.0,27 CDM,22740022,HC COLLAR CERVICAL ADULT LG,47.0,28.2,10.9,4481.0,27 CDM,22740023,HC COLLAR CERVICAL ADULT MED,47.0,28.2,10.9,4481.0,27 CDM,22740024,HC COLLAR CERVICAL ADULT SMA,47.0,28.2,10.9,4481.0,27 CDM,22740025,HC COLLAR CERVICAL INFANT 8-12,58.0,34.8,13.46,4481.0,27 CDM,22740026,HC COLLAR CERVICAL INFANT SM,58.0,34.8,13.46,4481.0,27 CDM,22740027,HC COLLAR CERVICAL STOUT 14-2,47.0,28.2,10.9,4481.0,27 CDM,22740029,HC MS CERVICAL UNIVERSAL COLLAR,22.0,13.2,5.1,4481.0,27 CDM,22740117,HC CLAVICLE STRAP STRING,14.0,8.4,3.25,4481.0,27 CDM,22740130,HC CERVICAL COLLAR MIAMI J,110.0,66.0,25.52,4481.0,27 CDM,22740156,HC HUMERAL FRACTURE ORTHOTIC,14.0,8.4,3.25,4481.0,27 CDM,22740157,HC WALKING BOOT PREFABRICATED,132.0,79.2,30.62,4481.0,27 CDM,22740158,HC KNEE IMMOBILIZER PREFABRICATED,50.0,30.0,11.6,4481.0,27 CDM,22740160,HC WRIST FX SPLINT PREFABRICATED,23.0,13.8,5.34,4481.0,27 CDM,22740161,HC WRIST SPLINT PREFABRICATED,23.0,13.8,5.34,4481.0,27 CDM,22740162,HC ANKLE STIRRUP PREFABRICATED,31.0,18.6,7.19,4481.0,27 CDM,22780087,HC NEUROSTIM ELECTRODE,4021.0,2412.6,932.87,4481.0,27 CDM,22780088,HC LEAD NEUROSTIM TEST KIT,504.0,302.4,116.93,4481.0,27 CDM,22780090,HC 125 HI ACT SEED NS,330.0,198.0,83.49,4481.0,37 CDM,22780092,HC LDR IR192 SEED,93.0,55.8,23.53,4481.0,37 CDM,22780093,HC BRACHYTX HDR IR-192 NON STRANDED,1490.0,894.0,322.37,4481.0,37 CDM,22780097,HC I125 NS PROST BRACHY PER SEED,224.0,134.4,33.06,4481.0,37 CDM,22780099,HC PD103 SEED NS,224.0,134.4,56.67,4481.0,37 CDM,22780140,HC NEUROSTIM LEAD BSCI INFINION16,7985.0,4791.0,1852.52,6998.05,27 CDM,22780149,HC UNC ADULT SURG ONC DISPOSABLE ENDOSCOPE,1272.0,763.2,295.1,4481.0,24 CDM,22780425,HC TISSUE MARKER,347.0,208.2,80.5,4481.0,26 CDM,22780428,HC CYMETRA 2CC SYRINGE PER 1CC,960.0,576.0,222.72,4481.0,24 CDM,22780467,HC BRACHYTHERAPY PLANAR SOURCE PD-103 5X10 PER SQ MM,6.0,3.6,1.52,4481.0,37 CDM,22780468,HC BRACHYTHERAPY PLANAR SOURCE PD-103 5X15 PER SQ MM,6.0,3.6,1.52,4481.0,37 CDM,22780469,HC MAMMO REFLECTOR,2076.0,1245.6,481.63,4481.0,26 CDM,22780479,HC LINQII DEVICE MYCARE MONITOR,13448.0,8068.8,3119.94,11785.83,27 CDM,22780481,HC SPRINT PNS SINGLE LEAD SYSTEM 9244-6001,12807.0,7684.2,2971.22,11224.05,27 CDM,22780482,HC SPRINT PNS DUAL LEAD SYSTEM 9288-6002,21694.0,13016.4,4481.0,19012.62,27 CDM,22780487,HC ST JUDE LOOP RECORDER,12546.0,7527.6,2910.67,10995.31,27 CDM,22780488,HC BIOTRONIK LOOP RECORDER,11762.0,7057.2,2728.78,10308.22,27 CDM,22780500,HC BSCIEN LUX DX LOOP RECORDER,11762.0,7057.2,2728.78,10308.22,24 CDM,22780514,HC MILD DEVICE,8622.0,5173.2,2000.3,7556.32,27 CDM,22780527,HC SPACEOAR HYDROGEL,0.01,0.01,0.00232,4481.0,27 CDM,22780534,HC VIA DISC NP TISSUE ALLOGRAFT,0.01,0.01,0.00232,4481.0,27 CDM,22780535,HC BARRIGEL,0.01,0.01,0.00232,4481.0,27 CDM,22780536,HC ABBOTT DM5500 ASSERT IQ EL LOOP RECORDER,10547.0,6328.2,2446.9,9243.39,27 CDM,22780537,HC ABBOTT DM5300 ASSERT IQ 3+ LOOP RECORDER,12355.0,7413.0,2866.36,10827.92,27 CDM,22780539,HC UNC UROLOGY DISPOSABLE URINARY TRACT ENDOSCOPE,668.0,400.8,154.98,4481.0,24 CDM,22780543,HC UNC GI EVO ENDO DISPOSABLE ENDOSCOPE,4000.0,2400.0,928.0,4481.0,24 CDM,22783001,HC VENA CAVA FILTER A,2.0,1.2,0.464,4481.0,24 CDM,22784001,HC CALYPSO BEACON MARKER EACH,1763.0,1057.8,409.02,4481.0,26 CDM,22784002,HC COUPLED FIDUCIAL MARKER EACH,341.0,204.6,79.11,4481.0,26 CDM,22920002,HC EAR MOLD IMPRESSION EACH,67.0,40.2,15.54,4481.0,22 CDM,33610001,HC FNAA FNA W ATND PATHOL PRESNT,666.0,399.6,184.62,6610.0,34 CDM,33610002,HC LDL IMMUNOADSORPTION PROCEDURE,9324.0,5594.4,1543.44,7459.2,33 CDM,33610003,HC PBSC COLLECTION ALLOGENIC,5074.0,3044.4,1177.17,242660.0,26 CDM,33610004,HC PBSC COLLECTION AUTOLOGOUS,4337.0,2602.2,1202.22,6610.0,33 CDM,33610005,HC CRYOPRESERVATION,1517.0,910.2,411.62,6610.0,34 CDM,33610006,HC THAWING AND INFUSION FEE PBSC BM,2408.0,1444.8,411.62,6610.0,34 CDM,33610007,HC CORD BLOOD THAW WASH,843.0,505.8,233.68,6610.0,34 CDM,33610008,HC BM PBSC HARVEST MOD CD34SELECT,16371.0,9822.6,411.62,13096.8,34 CDM,33610009,HC RED CELL REDUCTION,1252.0,751.2,347.05,6610.0,34 CDM,33610010,HC PLASMA REDUCTION,674.0,404.4,186.83,6610.0,34 CDM,33610011,HC BUFFY COAT PROCESSING,2167.0,1300.2,411.62,6610.0,34 CDM,39400001,HC THERAPEUTIC PHLEBOTOMY,418.0,250.8,115.87,4481.0,29 CDM,42600001,HC HYDRATION IV INITIAL 31MIN-1HR,549.0,329.4,152.18,4481.0,34 CDM,42600002,HC HYDRATION IV EACH ADDTL HR,377.0,226.2,43.45,4481.0,34 CDM,42600003,HC IV INFUSION INITIAL UP TO 1HR,585.0,351.0,162.16,4481.0,34 CDM,42600004,HC IV INFUSION EACH ADDTL HR,377.0,226.2,43.45,4481.0,34 CDM,42600005,HC IV INFUSION SEQUENTIAL UP TO 1 HR,377.0,226.2,67.01,4481.0,34 CDM,42600006,HC IV INFUSION CONCURRENT,255.0,153.0,59.16,4481.0,24 CDM,42600007,HC INJECTION ADMIN INTRA ARTERIAL,293.0,175.8,81.22,4481.0,34 CDM,42600008,HC IV PUSH SINGLE INITIAL,441.0,264.6,122.25,4481.0,34 CDM,42600009,HC IV PUSH SEQ EA ADD NEW DRUG,279.0,167.4,43.45,4481.0,34 CDM,42600010,HC IV PUSH SAME DRUG EA ADD,275.0,165.0,63.8,4481.0,24 CDM,42600015,HC SOLN NACL FLUSH 10ML SYR,2.0,1.2,0.464,4481.0,22 CDM,42600018,HC DIALYSIS HYDRATION IV INITIAL 31MIN-1HR,555.0,333.0,153.85,4481.0,34 CDM,42600019,HC DIALYSIS IV INFUSION INITIAL UP TO 1HR,592.0,355.2,164.1,4481.0,34 CDM,42600020,HC DIALYSIS IV INFUSION EACH ADDTL HR,377.0,226.2,43.45,4481.0,34 CDM,42600021,HC DIALYSIS IV INFUSION SEQUENTIAL UPTO1HR,377.0,226.2,67.01,4481.0,34 CDM,42600022,HC DIALYSIS IV PUSH SINGLE INITIAL,441.0,264.6,122.25,4481.0,34 CDM,42600023,HC DIALYSIS IV PUSH SEQ EA ADD NEW DRUG,279.0,167.4,43.45,4481.0,34 CDM,42600024,HC DIALYSIS IV PUSH SAME DRUG EA ADD,275.0,165.0,63.8,4481.0,24 CDM,42600025,HC CAR T CELL ADMINISTRATION,1830.0,1098.0,312.3,4481.0,32 CDM,42600026,HC HEMATOPOIETIC PROGENITOR CELL BOOST INF,1940.0,1164.0,491.0,5449.0,37 CDM,42720001,HC GAS NITRIC OXIDE HOURLY,503.0,301.8,116.7,4481.0,24 CDM,42720003,HC ECMO OXYGENATOR EXCHANGE,3497.0,2098.2,811.3,4481.0,24 CDM,43000002,HC SEMEN ANALYSIS QUALITATIVE,72.0,43.2,6.3,4481.0,34 CDM,43000003,HC COLLECTION BLOOD VENIPUNCTURE,35.0,21.0,4.18,4481.0,34 CDM,43000009,HC BLOOD GAS PACKAGE,83.0,49.8,23.01,4481.0,34 CDM,43000011,HC RT LACTIC ACID,62.0,37.2,11.22,4481.0,34 CDM,43100001,HC TRANSCUT HEMOGLOBIN MONITORING POC,77.0,46.2,4.87,4481.0,34 CDM,43300001,HC REFL MAINT IMPL PUMP INTRATHCL INCL ANALYSIS,1104.0,662.4,306.03,4481.0,33 CDM,43300002,HC CHEMO INJ SQ IM NON HORMONAL,330.0,198.0,67.01,4481.0,32 CDM,43300003,HC CHEMO INJ SQ IM HORMONAL,330.0,198.0,67.01,4481.0,32 CDM,43300004,HC INTRALESIONAL CHEMO 1-7 LESIONS,584.0,350.4,67.01,4481.0,32 CDM,43300005,HC INTRALESIONAL CHEMO 8+ LESIONS,411.0,246.6,113.93,4481.0,32 CDM,43300006,HC CHEMO IV PUSH SINGLE INITIAL,463.0,277.8,128.34,4481.0,32 CDM,43300007,HC CHEMO IV PUSH EACH ADDITIONAL SUBSTANCE DRUG,420.0,252.0,67.01,4481.0,32 CDM,43300009,HC CHEMOTHERAPY PERITONEAL CAVITY PORT OR CATH,1272.0,763.2,312.3,4481.0,32 CDM,43300010,HC SIMULATION SIMPLE,1434.0,860.4,125.0,4481.0,33 CDM,43300011,HC SIMULATION INTERMEDIATE,1757.0,1054.2,344.67,4481.0,33 CDM,43300012,HC SIMULATION COMPLEX,3586.0,2151.6,344.67,4481.0,33 CDM,43300013,HC 3-D SIMULATION AIDED FIELD SETTING,6859.0,4115.4,1008.0,5487.2,33 CDM,43300014,HC DOSIMETRY BASIC,867.0,520.2,125.0,4481.0,33 CDM,43300015,HC IMRT TX PLANNING,7271.0,4362.6,1008.0,5816.8,33 CDM,43300020,HC IMRT PLANNING PER COURSE,7271.0,4362.6,1008.0,5816.8,33 CDM,43300024,HC SPECIAL TELETHERAPY PORT PLAN,2822.0,1693.2,344.67,4481.0,33 CDM,43300028,HC SPECIAL DOSIMETRY,1044.0,626.4,125.0,4481.0,33 CDM,43300029,HC TREATMENT DEVICES SIMPLE,987.0,592.2,125.0,4481.0,33 CDM,43300030,HC TREATMENT DEVICES INTERMEDIATE,1575.0,945.0,125.0,4481.0,33 CDM,43300031,HC TREATMENT DEVICES COMPLEX,1897.0,1138.2,344.67,4481.0,33 CDM,43300032,HC CONTINUING PHYSICS CONSULT,1227.0,736.2,125.0,4481.0,33 CDM,43300033,HC MLC DESIGN PER IMRT PLAN,7596.0,4557.6,344.67,6076.8,33 CDM,43300034,HC SPECIAL MEDICAL PHYSIC CONSULT,1780.0,1068.0,125.0,4481.0,33 CDM,43300035,HC SBRT 1-5 FX,8584.0,5150.4,1653.26,6867.2,33 CDM,43300047,HC PORT FILMS,578.0,346.8,134.1,4481.0,23 CDM,43300051,HC IORT ELECTRONS SNGL TX SESSN,1803.0,1081.8,499.79,7865.41,33 CDM,43300053,HC SPECIAL TX PROCEDURE,4723.0,2833.8,544.65,4481.0,33 CDM,43300055,HC INTRACAVITARY RADIOELEMT SIMPLE 1-4,2458.0,1474.8,544.65,4481.0,33 CDM,43300056,HC INTRACAVITARY INTERM 5-10,2565.0,1539.0,544.65,4481.0,33 CDM,43300057,HC INTRACAV COMPLX MORE THAN 10,2664.0,1598.4,653.25,4481.0,33 CDM,43300058,HC INTERSTITIAL SIMPLE 1-4,1576.0,945.6,103.1,4481.0,33 CDM,43300059,HC INTERSTITIAL INTERMEDIATE 5-10,2590.0,1554.0,103.1,4481.0,33 CDM,43300060,HC INTERSTITIAL COMPLEX INCL SUPERV HANDLE LOAD,2999.0,1799.4,653.25,4481.0,33 CDM,43300064,HC SURFACE APPL RADIOELEMENT LDR,316.0,189.6,87.6,4481.0,33 CDM,43300065,HC SUPERVISION HANDLING LOADING,321.0,192.6,74.47,4481.0,23 CDM,43300070,HC SRS ROBOT 1ST TX CYBERKNIFE,27819.0,16691.4,4481.0,23809.0,33 CDM,43300071,HC SBRT,8584.0,5150.4,1653.26,6867.2,33 CDM,43300072,HC CHEMO IV INITIAL UP TO 1HR,1076.0,645.6,298.27,4481.0,32 CDM,43300073,HC CHEMO IV EACH ADDITIONAL HOUR,496.0,297.6,67.01,4481.0,32 CDM,43300074,HC CHEMO INFUSION PROLONGED 8+ HRS,613.0,367.8,169.92,4481.0,32 CDM,43300075,HC CHEMO IV SEQ DIFF DRUG TO 1HR,496.0,297.6,67.01,4481.0,32 CDM,43300085,HC REFILLING AND MAINTENANCE OF PORTABLE PUMP,572.0,343.2,158.56,4481.0,28 CDM,43300086,HC REFILLING AND MAINTENANCE OF IMPLANTABLE PUMP OR RESERVOIR,1591.0,954.6,198.37,4481.0,28 CDM,43300087,HC CHEMO ADMIN INTR ARTERIAL PUSH,411.0,246.6,113.93,4481.0,32 CDM,43300092,HC RESPIRATORY MOTION MGMT SIMUL,1032.0,619.2,239.42,4481.0,23 CDM,43300093,HC RT TRMT SIMPLE,889.0,533.4,103.1,4481.0,33 CDM,43300094,HC RT TRMT INTERMEDIATE,1163.0,697.8,247.6,4481.0,33 CDM,43300095,HC RT TRMT COMPLEX,1433.0,859.8,247.6,4481.0,33 CDM,43300096,HC RT TRMT COMPLEX 2ND VISIT,1433.0,859.8,332.46,4481.0,23 CDM,43300097,HC IMRT SIMPLE,3819.0,2291.4,544.65,4481.0,33 CDM,43300098,HC IMRT SIMPLE 2ND VISIT,3819.0,2291.4,886.01,4481.0,23 CDM,43300099,HC IMRT COMPLEX,4020.0,2412.0,544.65,4481.0,33 CDM,43300100,HC IMRT COMPLEX 2ND VISIT,4020.0,2412.0,932.64,4481.0,23 CDM,43300101,HC ISODOSE PLANNING SIMPLE,2304.0,1382.4,344.67,4481.0,33 CDM,43300102,HC ISODOSE PLANNING COMPLEX,2679.0,1607.4,344.67,4481.0,33 CDM,43300104,HC BRACHYTHERAPY ISODOSE SIMPLE,1747.0,1048.2,344.67,4481.0,33 CDM,43300105,HC BRACHYTHERAPY ISODOSE INTERM,2121.0,1272.6,344.67,4481.0,33 CDM,43300106,HC BRACHYTHERAPY ISODOSE COMPLEX,2495.0,1497.0,344.67,4481.0,33 CDM,43300107,HC STEREOSCOPIC XRAY GUIDANCE,421.0,252.6,97.67,4481.0,23 CDM,43300108,HC DAILY INTRAFRACTION LOC AND TRACKG,421.0,252.6,97.67,4481.0,23 CDM,43300109,HC CHEMO INJ SUBARACH/INTRAVENT VIA SUBQ RESV SGL MULTI,323.0,193.8,89.54,4481.0,32 CDM,43300111,HC BRACHYTHERAPY RDNCL NTRSTL/INTRCAV  1 CHANNEL,3824.0,2294.4,653.25,4481.0,33 CDM,43300112,HC BRACHYTHERAPY RDNCL NTRSTL INTRCAV  2-12 CHANNELS,4396.0,2637.6,653.25,4481.0,33 CDM,43300113,HC BRACHYTHERAPY RDNCL NTRSTL/INTRCAV  OVER 12 CHANNELS,4396.0,2637.6,653.25,4481.0,33 CDM,43300127,HC TRANSPERINEAL PLCMT OF BIODEGRADABLE MATERIAL INCL GUIDE,12584.0,7550.4,3488.28,21454.0,35 CDM,43600001,HC EXPLORATORY LAPAROTOMY,3454.0,2072.4,801.33,6610.0,22 CDM,43600004,HC HYSTERECTOMY,6013.0,3607.8,1395.02,6610.0,22 CDM,43600005,HC HYSTERECTOMY FOLLOW C SECTION,4967.0,2980.2,1152.34,6610.0,22 CDM,43600006,HC ABDOMINAL CERCLAGE,5284.0,3170.4,1225.89,6610.0,22 CDM,43600008,HC VAGINAL DELIVERY IN OR,4745.0,2847.0,1100.84,6610.0,22 CDM,43600009,HC TUBAL LIGATION FOLLOW C SECTION,1389.0,833.4,322.25,6610.0,22 CDM,43600010,HC TUBAL LIGATION FOLLOW VAG DEL,2065.0,1239.0,479.08,6610.0,22 CDM,43600011,HC C SECTION EMERGENCY,3461.0,2076.6,802.95,6610.0,22 CDM,43600012,HC C SECTION NORMAL DELIVERY,3208.0,1924.8,744.26,6610.0,22 CDM,43600016,HC D AND E,7528.0,4516.8,1746.5,12615.0,56 CDM,43600017,HC BRONCHOSCOPY CT GUIDED,3767.0,2260.2,777.0,6610.0,24 CDM,43610001,HC THERAPEUTIC APHERESIS PLASMA EXCHANGE,5222.0,3133.2,1447.54,7278.0,34 CDM,43610002,HC MIDLINE INSERT OVER 3YRS,419.0,251.4,21.25,6610.0,22 CDM,43610003,HC FETAL NON STRESS TEST,480.0,288.0,133.06,4481.0,33 CDM,43610004,HC FETAL SHUNT PLACEMENT W/US,3569.0,2141.4,286.41,6610.0,35 CDM,43610005,HC D AND C,3942.0,2365.2,914.54,6610.0,22 CDM,43610006,HC WOUND REPAIR DEBRIDEMENT,2164.0,1298.4,502.05,6610.0,23 CDM,43610008,HC CYSTOSCOPY LIMITED,2184.0,1310.4,605.4,6610.0,35 CDM,43610009,HC EXTERNAL CEPHALIC VERSION WITH OR WITHOUT TOCOLYSIS,1182.0,709.2,327.65,9324.0,34 CDM,43610010,HC VAGINAL CERCLAGE,3072.0,1843.2,712.7,6610.0,22 CDM,43610011,HC STIMULUS EVOKED RESPONSE,151.0,90.6,41.86,6610.0,33 CDM,43610012,HC NASOTRACHEAL ASPIRATION,367.0,220.2,101.73,5449.0,34 CDM,43610013,HC ARTERIAL CATHETER PLACEMENT,415.0,249.0,96.28,9423.0,25 CDM,43610015,HC RT TRACH TUBE EXCHANGE,1140.0,684.0,218.65,6610.0,35 CDM,43610016,HC TRACHEOBRONCH THRU EST TRACH,4317.0,2590.2,479.48,6610.0,69 CDM,43610018,HC BRONCHOSCOPY DIAGNOSTIC,5031.0,3018.6,1167.19,7278.0,91 CDM,43610019,HC BRONCH W BRUSHINGS,3364.0,2018.4,932.5,7278.0,35 CDM,43610020,HC RT BRONCHIAL ALVEOLAR LAV CATH,2606.0,1563.6,722.38,7278.0,35 CDM,43610021,HC BRONCH W LAVAGE,5666.0,3399.6,1570.62,7278.0,35 CDM,43610023,HC BRONCH WITH BRONCH OR ENDOBRONCH BIOPSY,5666.0,3399.6,1570.62,7278.0,35 CDM,43610025,HC BRONCH W TB BX SNGLE LOBE,4682.0,2809.2,1297.85,7278.0,35 CDM,43610026,HC BRONCH W TB NDL ASP BX,4682.0,2809.2,1297.85,13194.0,35 CDM,43610027,HC BRONCH W TRACH BRONCH DILATION,5589.0,3353.4,1549.27,13194.0,35 CDM,43610028,HC BRONCH W TB BX EA ADDL LOBE,3767.0,2260.2,777.0,7278.0,25 CDM,43610029,HC BRONCH W TB NDL ASP BX EAADD,3767.0,2260.2,777.0,7278.0,25 CDM,43610030,HC BRONCH W REMOVAL FOREIGN BODY,3364.0,2018.4,932.5,7278.0,35 CDM,43610031,HC BRONCH W THERAPEUTIC ASP INIT,3767.0,2260.2,1044.21,7278.0,35 CDM,43610032,HC BRONCH W THERAPEUTIC ASP SUBS,1663.0,997.8,365.61,6610.0,35 CDM,43610035,HC DIRECT LARYNGOSCOPY,1212.0,727.2,182.79,7278.0,34 CDM,43610036,HC BRONCH INTRACAV APPL,3915.0,2349.0,1085.24,7278.0,35 CDM,43610037,HC TRANSPERINEAL PLACEMT NEEDLES,4404.0,2642.4,1220.79,17457.0,35 CDM,43610038,HC INSERT TANDEMS VAG OVOIDS HDR,2096.0,1257.6,581.01,7278.0,35 CDM,43610039,HC INSERT VAG RAD AFTERLOAD APP BRACHYTHERAPY,1513.0,907.8,286.41,7278.0,35 CDM,43610040,HC VOICE STROBOSCOPY,861.0,516.6,238.67,7278.0,34 CDM,43610043,HC REM TUNNELED PLEURAL CATH,2293.0,1375.8,582.12,6610.0,34 CDM,43610044,HC ECMO INITIATION VENO VENOUS,68554.0,41132.4,2533.0,54843.2,23 CDM,43610045,HC ECMO DAILY MGMT VENO VENOUS DO NOT CHARGE W 33948,5130.0,3078.0,1190.16,6610.0,23 CDM,43610046,HC ECMO INITIATION VENO ARTERIAL,55528.0,33316.8,2533.0,44422.4,23 CDM,43610047,HC ECMO DAILY MGMT VENO ARTERIAL DO NOT CHARGE W 33947,5130.0,3078.0,1190.16,6610.0,23 CDM,43610048,HC ARTERIAL CATHETER PLACEMENT BY RESPIRATORY THERAPY,170.0,102.0,39.44,6610.0,24 CDM,43610055,HC ECMO PATIENT MGMNT OSH RETRIEVAL NOT INCLUDING INITIATION,2429.0,1457.4,563.53,6610.0,22 CDM,43610056,HC ECMO DAILY CHARGE FOR NON CARDIOHELP DAILY ROUNDING,2031.0,1218.6,471.19,6610.0,22 CDM,43610059,HC SELECTIVE LASER PHOTOCOAGULATION FOR TTTS,3931.0,2358.6,911.99,6610.0,22 CDM,43610060,HC RADIOFREQUENCY ABLATION FOR FETAL REDUCTION,16496.0,9897.6,286.41,13196.8,35 CDM,43610061,HC SALPINGECTOMY COMPLETE OR PARTIAL UNILATERAL OR BILATERAL SEPARATE PROCEDURE,2171.0,1302.6,503.67,13194.0,24 CDM,43610062,HC VAT MIDLINE INSERT OVER 3YRS,419.0,251.4,21.25,6610.0,22 CDM,43910001,HC TRANSFUSION INTRAUTERINE FETAL,3015.0,1809.0,411.62,5449.0,34 CDM,43910002,HC DIALYSIS TRANSFUSION BLD BLD COMPONENTS,1162.0,697.2,322.11,5449.0,34 CDM,43910003,HC BLOOD EXCHANGE TRANSFUSION,1058.0,634.8,293.28,5449.0,34 CDM,44020002,HC US GUIDANCE INTRST RADIOELEMENT APPLICATION,278.0,166.8,64.5,4481.0,24 CDM,44100001,HC INTUBATION,119.0,71.4,32.99,5449.0,33 CDM,44100002,HC NEBULIZER TREATMENT,95.0,57.0,26.33,4481.0,33 CDM,44100003,HC MDI METRD DOSE INHAL,109.0,65.4,30.21,4481.0,33 CDM,44100005,HC CHEST PHYSICAL THERAPY INITIAL,75.0,45.0,20.79,4481.0,33 CDM,44100006,HC TREATMENT W ACT THERAPY INITIAL,355.0,213.0,98.41,4481.0,33 CDM,44100007,HC CHEST VEST THERAPY INITIAL,717.0,430.2,106.0,4481.0,33 CDM,44100008,HC CHEST PHYSICAL THERAPY SUBSEQUENT,75.0,45.0,20.79,4481.0,33 CDM,44100009,HC TREATMENT W ACT THERAPY SUBSEQUENT,75.0,45.0,20.79,4481.0,33 CDM,44100010,HC CHEST VEST THERAPY SUBSEQUENT,56.0,33.6,15.52,4481.0,33 CDM,44100014,HC CONTINUOUS MEDICATION NEBULIZER TREATMENT,200.0,120.0,55.44,4481.0,33 CDM,44100015,HC CONTINUOUS MEDICATION NEBULIZER PER HR,163.0,97.8,37.82,4481.0,23 CDM,44100017,HC SPUTUM COLLECTION,113.0,67.8,31.32,4481.0,33 CDM,44100018,HC COUGH ASSIST,124.0,74.4,34.37,4481.0,33 CDM,44120015,HC SURFACTANT ADMINISTRATION THROUGH ENDOTRACHEAL TUBE,149.0,89.4,41.3,4481.0,33 CDM,44120017,HC AEROSOL TREATMENT,109.0,65.4,30.21,4481.0,33 CDM,44120020,HC IPV TREATMENT INITIAL,806.0,483.6,106.0,4481.0,33 CDM,44120021,HC IPV TREATMENT SUBSEQUENT,109.0,65.4,30.21,4481.0,33 CDM,44120022,HC AEROSOL INHAL OF PENTAMINDINE,234.0,140.4,64.86,4481.0,33 CDM,44120024,HC BIPAP CPAP,770.0,462.0,106.0,4481.0,33 CDM,44120026,HC PATIENT DEMO EVALUATION OF NEBULIZER INHALER IPPB DEVICE,68.0,40.8,18.85,4481.0,33 CDM,44120031,HC BIPAP CPAP WITH PATIENTS OWN EQUIPMENT,39.0,23.4,10.81,4481.0,33 CDM,44200001,HC PT BIOFEEDBACK TRAIN ANY MODALITY,238.0,142.8,55.22,4481.0,24 CDM,44200003,HC PT CANALITH REPOSITIONING PER DAY,162.0,97.2,37.58,4481.0,24 CDM,44200004,HC PT HOT OR COLD PACK APPLICATION,12.0,7.2,2.78,4481.0,23 CDM,44200005,HC PT TRACTION MECHANICAL,121.0,72.6,28.07,4481.0,23 CDM,44200008,HC PT E STIM ATTENDED 15MIN,150.0,90.0,34.8,4481.0,23 CDM,44200009,HC PT THERAPEUTIC EXERCISE 15MIN,163.0,97.8,37.82,4481.0,23 CDM,44200010,HC PT NEUROMUSC RE EDUCATION 15MIN,128.0,76.8,29.7,4481.0,23 CDM,44200011,HC PT GAIT TRAINING 15MIN,110.0,66.0,25.52,4481.0,23 CDM,44200012,HC PT MASSAGE 15MIN,80.0,48.0,18.56,4481.0,23 CDM,44200013,HC PT MANUAL THERAPY TECHNIQUE 15MIN,164.0,98.4,38.05,4481.0,23 CDM,44200014,HC PT THERAPEUTIC ACTIVITIES 15MIN,160.0,96.0,37.12,4481.0,23 CDM,44200015,HC PT WHEELCHAIR MGMNT 15MIN,147.0,88.2,34.1,4481.0,23 CDM,44200016,HC PT WORK HARD COND INITIAL 2 HR,618.0,370.8,143.38,4481.0,23 CDM,44200017,HC PT WORK HARD COND ADD HR,300.0,180.0,69.6,4481.0,23 CDM,44200018,HC PT PHY PERF TEST MEAS 15MIN,165.0,99.0,38.28,4481.0,24 CDM,44200019,HC PT ASSISTIVE TECH ASSESSMNT 15MIN,128.0,76.8,29.7,4481.0,23 CDM,44200040,HC PT E STIM UNATTENDED,139.0,83.4,32.25,4481.0,24 CDM,44200044,HC PT WHIRLPOOL,204.0,122.4,47.33,4481.0,23 CDM,44200045,HC PT IONTOPHORESIS 15MIN,117.0,70.2,27.14,4481.0,23 CDM,44200046,HC PT ULTRASOUND 15MIN,129.0,77.4,29.93,4481.0,23 CDM,44200047,HC PT AQUATIC TX W THERAPEUTIC EX 15 MIN,151.0,90.6,35.03,4481.0,23 CDM,44200049,HC PT GROUP THERAPY PROCEDURE,148.0,88.8,34.34,4481.0,23 CDM,44200050,HC PT SENSORY INTEGRATION 15MIN,85.0,51.0,19.72,4481.0,23 CDM,44200051,HC PT SELFCARE HOME MGMT TRAINING 15 MIN,130.0,78.0,30.16,4481.0,23 CDM,44200064,HC PT DEBRID OPEN WOUND 1ST 20 SQ CM OR LESS,480.0,288.0,111.36,5449.0,24 CDM,44200065,HC PT DEBRID OPEN WOUND EA ADDL 20 SQ CM,480.0,288.0,111.36,5449.0,24 CDM,44200068,HC PT PARAFFIN BATH,92.0,55.2,21.34,4481.0,23 CDM,44200070,HC PT 6 MIN WALK PULM STRESS TEST,649.0,389.4,150.57,4481.0,24 CDM,44200130,HC PT PROSTHETIC TRAINING UE LE TRUNK INITIAL ENCOUNTER EACH 15MINS,185.0,111.0,42.92,4481.0,23 CDM,44200131,HC PT ORTH PROSTH MNGMT TRAIN UE LE TRUNK SUBSQ ENCOUNTER EACH 15MINS,128.0,76.8,29.7,4481.0,23 CDM,44200171,HC PT ORTHOTIC MNGMT TRAIN UE LE TRUNK INITIAL ENCOUNTER EACH 15MINS,154.0,92.4,35.73,4481.0,23 CDM,44200181,HC PT CAREGIVER TRAINING 1ST 30 MINS,130.0,78.0,30.16,4481.0,24 CDM,44200182,HC PT CAREGIVER TRAINING EACH ADDL 15 MINS,70.0,42.0,16.24,4481.0,24 CDM,44200183,HC PT CAREGIVER GROUP TRAINING,30.0,18.0,6.96,4481.0,24 CDM,44240005,HC PT EVALUATION 20 MINS W PATIENT AND OR FAMILY,306.0,183.6,70.99,4481.0,23 CDM,44240006,HC PT EVALUATION 30 MINS W PATIENT AND OR FAMILY,423.0,253.8,98.14,4481.0,23 CDM,44240007,HC PT EVALUATION 45 MINS W PATIENT AND OR FAMILY,432.0,259.2,100.22,4481.0,23 CDM,44240014,HC PT RE EVALUATION 20 MINS W PATIENT AND OR FAMILY,292.0,175.2,67.74,4481.0,23 CDM,44300002,HC OT PARAFFIN BATH,91.0,54.6,21.11,4481.0,23 CDM,44300003,HC OT WHIRLPOOL,204.0,122.4,47.33,4481.0,23 CDM,44300004,HC OT IONTOPHORESIS 15MIN,118.0,70.8,27.38,4481.0,23 CDM,44300005,HC OT ULTRASOUND 15MIN,130.0,78.0,30.16,4481.0,23 CDM,44300006,HC OT AQUATIC TX W THERAPEUTIC EX 15 MIN,153.0,91.8,35.5,4481.0,23 CDM,44300009,HC OT GROUP THERAPY PROCEDURE,148.0,88.8,34.34,4481.0,23 CDM,44300010,HC OT COGNITIVE SKILL DEVELOPMENT 15MIN,72.0,43.2,16.7,4481.0,23 CDM,44300011,HC OT SENSORY INTEGRATION 15MIN,86.0,51.6,19.95,4481.0,23 CDM,44300012,HC OT SELFCARE HOME MGMT TRAINING 15 MIN,129.0,77.4,29.93,4481.0,23 CDM,44300013,HC OT COMMUNITY WORK REINTEGRATION TRAINING 15MIN,118.0,70.8,27.38,4481.0,23 CDM,44300041,HC OT THERAPEUTIC EXERCISE 15MIN,164.0,98.4,38.05,4481.0,23 CDM,44300042,HC OT NEUROMUSC RE EDUCATION 15MIN,129.0,77.4,29.93,4481.0,23 CDM,44300043,HC OT MASSAGE 15MIN,80.0,48.0,18.56,4481.0,23 CDM,44300044,HC OT MANUAL THERAPY TECHNIQ 15MIN,165.0,99.0,38.28,4481.0,23 CDM,44300045,HC OT THERAPEUTIC ACTIVITIES 15MIN,161.0,96.6,37.35,4481.0,23 CDM,44300046,HC OT WHEELCHAIR MGMNT 15MIN,146.0,87.6,33.87,4481.0,23 CDM,44300047,HC OT WORK HARD COND INITIAL 2 HR,618.0,370.8,143.38,4481.0,23 CDM,44300048,HC OT PHY PERF TEST MEAS 15MIN,167.0,100.2,38.74,4481.0,24 CDM,44300049,HC OT ASSISTIVE TECH ASSESSMNT 15MIN,128.0,76.8,29.7,4481.0,23 CDM,44300068,HC OT DEBRID OPEN WOUND 1ST 20 SQ CM OR LESS,480.0,288.0,111.36,5449.0,24 CDM,44300069,HC OT DEBRIDE OPEN WOUND EA ADDL 20 SQ CM,480.0,288.0,111.36,5449.0,24 CDM,44300077,HC OT SWALLOWING THERAPY,339.0,203.4,78.65,4481.0,24 CDM,44300090,HC OT ORTHOTIC MNGMT TRAIN UE LE TRUNK INITIAL ENCOUNTER EACH 15MINS,152.0,91.2,35.26,4481.0,23 CDM,44300091,HC OT ORTH PROSTH MNGMT TRAIN UE LE TRUNK SUBQ ENCOUNTER EACH 15MINS,127.0,76.2,29.46,4481.0,23 CDM,44300102,HC OT COGNITIVE SKILL DEVELOPMENT EACH ADDITIONAL 15 MIN,77.0,46.2,17.86,4481.0,23 CDM,44300141,HC OT CAREGIVER TRAINING 1ST 30 MINS,130.0,78.0,30.16,4481.0,24 CDM,44300142,HC OT CAREGIVER TRAINING EACH ADDL 15 MINS,70.0,42.0,16.24,4481.0,24 CDM,44300143,HC OT CAREGIVER GROUP TRAINING,30.0,18.0,6.96,4481.0,24 CDM,44340004,HC OT SWALLOWING EVALUATION,356.0,213.6,82.59,4481.0,24 CDM,44340006,HC OT EVALUATION 30 MINS W PATIENT AND OR FAMILY,319.0,191.4,74.01,4481.0,23 CDM,44340007,HC OT EVALUATION 45 MINS W PATIENT AND OR FAMILY,403.0,241.8,93.5,4481.0,23 CDM,44340008,HC OT EVALUATION 60 MINS W PATIENT AND OR FAMILY,415.0,249.0,96.28,4481.0,23 CDM,44340009,HC OT RE EVALUATION 30 MINS W PATIENT AND OR FAMILY,202.0,121.2,46.86,4481.0,23 CDM,44400001,HC SP TREATMENT S L V,356.0,213.6,82.59,4481.0,23 CDM,44400002,HC SP TREATMENT GROUP S L V,214.0,128.4,49.65,4481.0,23 CDM,44400003,HC SP LARYNGEAL FUNC STUDIES,770.0,462.0,155.0,4481.0,24 CDM,44400004,HC SP SWALLOWING THERAPY,336.0,201.6,77.95,4481.0,24 CDM,44400005,HC SP THERAPY SPEECH GENERATING DEV,285.0,171.0,66.12,4481.0,24 CDM,44400006,HC SP APHASIA ASSESSMENT,269.0,161.4,62.41,4481.0,24 CDM,44400007,HC SP DEVELOPMENTAL TESTING LIMITED,433.0,259.8,100.46,4481.0,24 CDM,44400028,HC SP BIOFEEDBACK TRAIN ANY MODALITY,238.0,142.8,55.22,4481.0,24 CDM,44400029,HC SP COGNITIVE PERFORMANCE TESTING,315.0,189.0,73.08,4481.0,24 CDM,44400048,HC EVAL SPEECH FLUENCY,358.0,214.8,83.06,4481.0,23 CDM,44400049,HC SPEECH SOUND PRODUCTION,331.0,198.6,76.79,4481.0,23 CDM,44400050,HC EVAL SPEECH SOUND LANG COMP/EXP,655.0,393.0,151.96,4481.0,23 CDM,44400051,HC BEHAVRL QUAL ANALYS VOICE,432.0,259.2,100.22,4481.0,23 CDM,44400087,HC SP CAREGIVER TRAINING 1ST 30 MINS,130.0,78.0,30.16,4481.0,24 CDM,44400088,HC SP CAREGIVER TRAINING EACH ADDL 15 MINS,70.0,42.0,16.24,4481.0,24 CDM,44400089,HC SP CAREGIVER GROUP TRAINING,30.0,18.0,6.96,4481.0,24 CDM,44440002,HC SP EVAL FOR USE FIT VOICE PROSTH,446.0,267.6,103.47,4481.0,24 CDM,44440003,HC SP EVAL FOR PRESCRIP SP GEN DEV,435.0,261.0,100.92,4481.0,24 CDM,44440004,HC SP EVAL FOR PRESCRIP ADD 30 MIN,91.0,54.6,21.11,4481.0,24 CDM,44440005,HC SP SWALLOWING EVALUATION,353.0,211.8,81.9,4481.0,24 CDM,44440006,HC SP MOTION FLUORO EVAL SWALLOW FUNC,549.0,329.4,127.37,4481.0,24 CDM,44440007,HC SP FLEX ENDO EVAL SWALLOW,591.0,354.6,137.11,4481.0,24 CDM,44440008,HC SP EVAL AUDITORY FUNCTION CANDIDACY OR POSTOP SURG IMPL DEVICE 1ST HOUR,450.0,270.0,104.4,4481.0,24 CDM,44440009,HC SP EVAL AUDITORY FUNCTION CANDIDACY OR POSTOP SURG IMPL DEVICE EA ADDL 15 MINS,117.0,70.2,27.14,4481.0,24 CDM,44600001,HC SPIROMETRY,856.0,513.6,147.31,4481.0,34 CDM,44600002,HC SPIROMETRY INFANT,554.0,332.4,147.31,4481.0,34 CDM,44600003,HC SPIROMETRY PRE POST INFANT,895.0,537.0,201.0,4481.0,34 CDM,44600004,HC THORACIC GAS VOL INFANT,509.0,305.4,141.09,4481.0,34 CDM,44600005,HC SPIROMETRY PRE POST,1442.0,865.2,201.0,4481.0,34 CDM,44600006,HC BRONCHOSPASM PROVOCATN EVAL,2652.0,1591.2,201.0,4481.0,34 CDM,44600007,HC VITAL CAPACITY TOTAL,139.0,83.4,38.53,4481.0,34 CDM,44600008,HC MAXIMUM VOLUNTARY VENTILATION,149.0,89.4,41.3,4481.0,34 CDM,44600009,HC RESPIRATORY FLOW VOL LOOP,581.0,348.6,161.05,4481.0,34 CDM,44600010,HC HIGH ALTITUDE SIMULATION TEST,566.0,339.6,121.37,4481.0,34 CDM,44600011,HC HIGH ALTITUDE SIMULATION W 02,609.0,365.4,121.37,4481.0,34 CDM,44600012,HC 6 MIN WALK PULM STRESS TEST,649.0,389.4,121.37,4481.0,34 CDM,44600013,HC 6 MIN PULMONARY STRESS TEST SIMPLE,649.0,389.4,121.37,4481.0,34 CDM,44600014,HC PULMONARY STRESS TEST COMPLEX,1763.0,1057.8,201.0,4481.0,34 CDM,44600015,HC PULMONARY SHUNT STUDY,474.0,284.4,131.39,4481.0,34 CDM,44600016,HC METABOLIC TESTING CALO,911.0,546.6,201.0,4481.0,34 CDM,44600017,HC INDIRECT CALORIMETRY,210.0,126.0,55.93,4481.0,34 CDM,44600018,HC LUNG VOL BODY BOX,581.0,348.6,161.05,4481.0,34 CDM,44600019,HC LUNG VOL N2 WASHOUT,633.0,379.8,147.31,4481.0,34 CDM,44600020,HC AIRWAY RESISTANCE,575.0,345.0,147.31,4481.0,34 CDM,44600021,HC DLCO CARB MON DIFFUS CAPCTY,614.0,368.4,142.45,4481.0,24 CDM,44600027,HC RT TRANSCUTANEOUS MONITORING,220.0,132.0,60.98,4481.0,34 CDM,44600034,HC PEDS EXERCISE TEST FOR BRONCHOSPASM INCL PRE AND POST SPIROMETRY WITH ECG,644.0,386.4,121.37,4481.0,34 CDM,44700001,HC HEARING AID CHECK MONAURAL,153.0,91.8,35.5,4481.0,24 CDM,44700002,HC HEARING AID CHECK BINAURAL,244.0,146.4,56.61,4481.0,24 CDM,44700003,HC ELECTROACOUSTIC EVAL MONAURAL,198.0,118.8,45.94,4481.0,24 CDM,44700004,HC ELECTROACOUSTIC EVAL BINAURAL,367.0,220.2,85.14,4481.0,24 CDM,44700005,HC TYMPANOMETRY AND REFLX THRES MEAS,406.0,243.6,112.54,4481.0,34 CDM,44700006,HC PURE TONE AUDIO AIR ONLY,178.0,106.8,49.34,4481.0,34 CDM,44700007,HC AUDIOMETRY AIR AND BONE,366.0,219.6,101.46,4481.0,34 CDM,44700008,HC SPEECH AUDIOMETRY THRESHOLD,135.0,81.0,37.42,4481.0,34 CDM,44700009,HC SPEECH AUDIO THRES W SP RECOG,270.0,162.0,55.93,4481.0,34 CDM,44700010,HC COMP AUDIO EVAL AND SPEECH RECOG,410.0,246.0,113.65,4481.0,34 CDM,44700011,HC STENGER TEST PURE TONE,118.0,70.8,32.71,4481.0,34 CDM,44700012,HC TYMPANOMETRY,158.0,94.8,36.96,4481.0,34 CDM,44700013,HC ACOUSTIC REFLEX TEST THRESHOLD,120.0,72.0,33.26,4481.0,34 CDM,44700014,HC ACOUSTIC IMMITTANCE TESTING,366.0,219.6,101.46,4481.0,34 CDM,44700015,HC VISUAL REINFORCEMENT AUDIOMETR,478.0,286.8,132.5,4481.0,34 CDM,44700016,HC PLAY AUDIOMETRY,478.0,286.8,132.5,4481.0,34 CDM,44700019,HC OTOACOUSTIC EMISSIONS LIMITED EVAL,757.0,454.2,209.84,4481.0,34 CDM,44700020,HC OAE COMPREHENSIVE,923.0,553.8,235.0,4481.0,34 CDM,44700021,HC COCHLEAR IMPLANT PROGRAMMING,633.0,379.8,147.31,4481.0,34 CDM,44700022,HC TRANSFUSION BLD BLD COMPONENTS,1170.0,702.0,324.32,5449.0,34 CDM,44700024,HC REPAIR MODIFICATION OF HEARING AID,513.0,307.8,119.02,4481.0,22 CDM,44700025,HC DISPENSING FEE FM,256.0,153.6,59.39,4481.0,22 CDM,44700026,HC HEARING AID MONAURAL DISPENSING FEE PER DEVICE,438.0,262.8,101.62,4481.0,22 CDM,44700027,HC HEARING AID REPLACEMENT FEE,384.0,230.4,89.09,4481.0,22 CDM,44700032,HC EARMOLD PER EAR,133.0,79.8,30.86,4481.0,22 CDM,44700033,HC BATTERIES PACK,23.0,13.8,5.34,4481.0,22 CDM,44700034,HC ACCESSORIES DEHUMIDIFIER,21.0,12.6,4.87,4481.0,22 CDM,44700035,HC ACCESSORIES BATTERY TESTER,30.0,18.0,6.96,4481.0,22 CDM,44700049,HC FM SYSTEM BINAURAL,7723.0,4633.8,1791.74,6178.4,22 CDM,44700050,HC EARMOLD ACCESS DISPENSING FEE,31.0,18.6,7.19,4481.0,22 CDM,44700052,HC ADHESIVE DISC EACH,7.0,4.2,1.62,4481.0,26 CDM,44700054,HC ARTIFICIAL LARYNX ANY TYPE,1840.0,1104.0,426.88,4481.0,27 CDM,44700055,HC BLOWING TOY,3.0,1.8,0.696,4481.0,24 CDM,44700057,HC FILTER HEAT MOIST EXCH SYST,47.0,28.2,10.9,4481.0,26 CDM,44700058,HC FILTER HOLDER AND FILTER W O ADHES,168.0,100.8,38.98,4481.0,26 CDM,44700059,HC FILTER HOLDER AND FILTER W ADHES,169.0,101.4,39.21,4481.0,26 CDM,44700060,HC FILTER HOLDER OR FILTER CAP EA,120.0,72.0,27.84,4481.0,26 CDM,44700063,HC HOUSING REUSABLE W O ADHES,23.0,13.8,5.34,4481.0,26 CDM,44700064,HC HOUSING INTEGRATED ADHESIVE,22.0,13.2,5.1,4481.0,26 CDM,44700065,HC INFATRAINER CUP,53.0,31.8,12.3,4481.0,24 CDM,44700068,HC MAROON SPOON LARGE,4.0,2.4,0.928,4481.0,24 CDM,44700071,HC PIGEON BOTTLE,44.0,26.4,10.21,4481.0,24 CDM,44700072,HC PIGEON NIPPLE,17.0,10.2,3.94,4481.0,24 CDM,44700073,HC SOFT SPOUT CUP,28.0,16.8,6.5,4481.0,24 CDM,44700074,HC TE PUN DILATOR REPLACE ONLY EA,224.0,134.4,51.97,4481.0,27 CDM,44700076,HC TEVP PROVIDER INSERTED,680.0,408.0,157.76,4481.0,27 CDM,44700078,HC TRACH SPEAK VALVE PMSV,303.0,181.8,70.3,4481.0,27 CDM,44700079,HC TRACHEOSTOMA VALVE INCL DIAPH,539.0,323.4,125.05,4481.0,26 CDM,44700080,HC TEVP PATIENT INSERT EACH,195.0,117.0,45.24,4481.0,27 CDM,44700081,HC FM SYSTEM MONAURAL,5101.0,3060.6,1183.43,4481.0,22 CDM,44700085,HC REPAIR OR REPLACE MINOR PARTS OF PROSTHETIC DEVICE,35.0,21.0,8.12,4481.0,24 CDM,44700086,HC REPAIR LABOR COMPONENT OF PROSTHETIC DEVICE PER 15 MINS,35.0,21.0,8.12,4481.0,24 CDM,44700089,HC BAHA FITTING PROGRAMMING OR TROUBLESHOOTING,172.0,103.2,23.06,4481.0,34 CDM,44700092,HC HEARING AID FITTING ORIENTATION CHECKING,438.0,262.8,101.62,4481.0,22 CDM,44700094,HC DISPENSING FEE BINAURAL,873.0,523.8,202.54,4481.0,22 CDM,44700097,HC HEARING AID DISPENSING FEE CROS/BICROS,256.0,153.6,59.39,4481.0,22 CDM,44700126,HC ELECTROCOCHLEOGRAPHY,1098.0,658.8,147.31,4481.0,34 CDM,44700127,HC DIAGNOSTIC ANALYSIS WITH PROGRAMMING OF AUDITORY BRAINSTEM IMPLANT PER HR,620.0,372.0,147.31,4481.0,34 CDM,44710001,HC EVAL AUDITORY FUNCTION CANDIDACY OR POSTOP SURG IMPL DEVICE 1ST HOUR,450.0,270.0,124.74,4481.0,34 CDM,44710002,HC EVAL AUDITORY FUNCTION CANDIDACY OR POSTOP SURG IMPL DEVICE EA ADDL 15 MINS,117.0,70.2,27.14,4481.0,24 CDM,44710003,HC COCHLEAR IMPLANT REPROGRAMMING,506.0,303.6,140.26,4481.0,34 CDM,44710004,HC TINNITUS ASSESSMENT,235.0,141.0,65.14,4481.0,34 CDM,44710005,HC LOUDNESS BALANCE TEST BINAURAL AND MONAURAL,149.0,89.4,41.3,4481.0,34 CDM,44710006,HC AUDITORY EVOKED POTENTIAL THRESHOLD ESTIMATION MULTIPLE FREQUENCIES INTERP AND RPT,1410.0,846.0,235.0,4481.0,34 CDM,44710007,HC AUDITORY EVOKED POTENTIAL NEURODIAGNOSTIC INTERP AND RPT,1410.0,846.0,235.0,4481.0,34 CDM,44710008,HC AUDITORY EVOKED POTENTIAL SCREEN W STIMULI AUTO ANALYSIS,437.0,262.2,101.38,4481.0,24 CDM,44710009,HC AUDITORY EVOKED POTENTIAL HEARING STATUS DETER BROADBAND STIMULI INTERP AND RPT,437.0,262.2,121.14,4481.0,34 CDM,46000004,HC HOSPICE ROUTINE HOME CARE,317.0,190.2,73.54,4481.0,22 CDM,46000005,HC HOSPICE CONTINUOUS HOME CARE,95.0,57.0,22.04,4481.0,22 CDM,46000006,HC HOSPICE INPATIENT RESPITE,738.0,442.8,171.22,4481.0,24 CDM,46000007,HC HOSPICE GENERAL INPATIENT,1667.0,1000.2,386.74,4481.0,24 CDM,46000015,HC HH/HOSPICE MSW INITIAL VISIT EA 15 MINS,88.0,52.8,20.42,4481.0,22 CDM,46000017,HC HH/HOSPICE PT ROUTINE VISIT PER 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000018,HC HH/HOSPICE PT INITIAL EVAL VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000021,HC HH/HOSPICE OT ROUTINE VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000022,HC HH/HOSPICE OT INITIAL VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000026,HC HH/HOSPICE SPEECH INITIAL VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000027,HC HH/HOSPICE RN INITIAL VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,22 CDM,46000028,HC HH/HOSPICE RN ROUTINE VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,22 CDM,46000029,HC HH/HOSPICE RN MANAGEMENT AND EVALUATION EA 15 MINS,75.0,45.0,17.4,4481.0,22 CDM,46000031,HC HH/HOSPICE RN TRAINING AND EDUCATION,75.0,45.0,17.4,4481.0,22 CDM,46000032,HC HH/HOSPICE MSW ROUTINE VISIT EA 15 MINS,88.0,52.8,20.42,4481.0,22 CDM,46000033,HC HH/HOSPICE HHA VISIT EA 15 MINS,38.0,22.8,8.82,4481.0,22 CDM,46000038,HC HH/HOSPICE LPN ROUTINE VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,22 CDM,46000055,HC HH/HOSPICE INFUSION RN VISIT EA 15 MINS,75.0,45.0,17.4,4481.0,22 CDM,46000058,HC HH/HOSPICE SPEECH VISIT ASSESSMENT EA 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000059,HC HH/HOSPICE MSW VISIT ASSESSMENT EA 15 MINS,75.0,45.0,17.4,4481.0,22 CDM,46000063,HC HOSPICE RESIDENTIAL ROOM AND BOARD,250.0,150.0,58.0,4481.0,21 CDM,46000066,HC HH/HOSPICE PT EVAL/REASSESS EA 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000070,HC HH/HOSPICE SP EVAL/REASSESS PER 15 MINS,75.0,45.0,17.4,4481.0,24 CDM,46000121,HC HH TELEVISIT EST PT 5-10 MINS,108.0,64.8,25.06,4481.0,44 CDM,46000122,HC HH TELEVISIT EST PT 11-20 MINS,176.0,105.6,40.83,4481.0,44 CDM,46000123,HC HH TELEVISIT EST PT 21-30 MINS,250.0,150.0,58.0,4481.0,44 CDM,47100001,HC RECOVERY ROOM UP TO 1 HOUR,459.0,275.4,106.49,4481.0,24 CDM,47100002,HC RECOVERY ROOM GREATER THAN 1-2 HOURS,639.0,383.4,148.25,4481.0,24 CDM,47100003,HC RECOVERY ROOM GREATER THAN 2-3 HOURS,816.0,489.6,189.31,4481.0,24 CDM,47100004,HC RECOVERY ROOM GREATER THAN 3-4 HOURS,992.0,595.2,230.14,4481.0,24 CDM,47100005,HC RECOVERY ROOM GREATER THAN 4-5 HOURS,1171.0,702.6,271.67,4481.0,24 CDM,47100006,HC RECOVERY ROOM GREATER THAN 5-6 HOURS,1349.0,809.4,312.97,4481.0,24 CDM,47100007,HC RECOVERY IN LABOR ROOM UP TO 1 HOUR,513.0,307.8,119.02,4481.0,24 CDM,47100008,HC RECOVERY IN LABOR ROOM GREATER THAN 1-2 HOURS,708.0,424.8,164.26,4481.0,24 CDM,47100009,HC RECOVERY IN LABOR ROOM GREATER THAN 2-3 HOURS,905.0,543.0,209.96,4481.0,24 CDM,47100010,HC RECOVERY ROOM GREATER THAN 6-7 HOURS,1525.0,915.0,353.8,4481.0,24 CDM,47100011,HC RECOVERY ROOM GREATER THAN 7-8 HOURS,1703.0,1021.8,395.1,4481.0,24 CDM,47100012,HC RECOVERY ROOM GREATER THAN 8-9 HOURS,1881.0,1128.6,436.39,4481.0,24 CDM,47100013,HC RECOVERY ROOM GREATER THAN 9-10 HOURS,2060.0,1236.0,477.92,4481.0,24 CDM,47200001,HC VAGINAL DEL W FORCEPS VACUUM,1937.0,1162.2,449.38,4481.0,24 CDM,47200002,HC VAGINAL DELIVERY FEE,3078.0,1846.8,714.1,4481.0,24 CDM,47200005,HC TRIAGE OUTPATIENT FIRST HOUR,964.0,578.4,223.65,4481.0,24 CDM,47200006,HC TRIAGE OUTPATIENT EACH ADDITIONAL HOUR,660.0,396.0,153.12,4481.0,24 CDM,47200007,HC DIRECT ADMIT 1ST HOUR,542.0,325.2,125.74,4481.0,24 CDM,47200008,HC LABOR ROOM PER HOUR,230.0,138.0,53.36,4481.0,24 CDM,47200009,HC LABOR ROOM HIGH RISK PER HOUR,368.0,220.8,85.38,4481.0,24 CDM,47200010,HC DIRECT ADMIT HIGH RISK 1ST HR,718.0,430.8,166.58,4481.0,24 CDM,47200011,HC ADMIT HIGH RISK W TR 1ST HR LR,1347.0,808.2,312.5,4481.0,24 CDM,47200012,HC ADMIT W TRIAGE 1ST HR LABR RM,1166.0,699.6,270.51,4481.0,24 CDM,47200013,HC L AND D OR 1ST 30MIN,1807.0,1084.2,419.22,6610.0,22 CDM,47200014,HC L AND D OR EA ADD 30MINS,843.0,505.8,195.58,6610.0,22 CDM,47200015,HC VAGINAL DELIVERY W CMPLTD RECV,4540.0,2724.0,952.0,5449.0,34 CDM,47200019,HC TRIAGE EXTENDED GREATER THAN 1-2 HOURS,1650.0,990.0,382.8,4481.0,24 CDM,47200020,HC TRIAGE EXTENDED GREATER THAN 2-3 HOURS,1884.0,1130.4,437.09,4481.0,24 CDM,47200021,HC TRIAGE EXTENDED GREATER THAN 3-4 HOURS,2117.0,1270.2,491.14,4481.0,24 CDM,47200062,HC INPATIENT WOMENS SPECIALTY BREXANOLONE INFUSION,2965.0,1779.0,687.88,4481.0,24 CDM,47200063,HC INPATIENT WOMENS POSTPARTUM MAGNESIUM INFUSION,671.0,402.6,155.67,4481.0,24 CDM,47610003,HC NB CARSEAT TEST ADD 30 MIN,95.0,57.0,22.04,4481.0,24 CDM,47610004,HC NB CARSEAT TEST 60 MIN,189.0,113.4,36.96,4481.0,34 CDM,47700001,HC RSV MONOCLONAL ANTIBODY IM ADMIN,112.0,67.2,25.98,4481.0,24 CDM,48010003,HC THERAPEUTIC APHERESIS RED BLOOD CELL,4648.0,2788.8,814.0,7278.0,29 CDM,48010007,HC HDX ADULT IP DU 2:1,596.0,357.6,138.27,4481.0,24 CDM,48010009,HC HDX ADULT ACUTE IP 1:1,903.0,541.8,209.5,4481.0,24 CDM,48010010,HC EMERGENT HDX ESRD PEDS OP,1282.0,769.2,355.37,4481.0,34 CDM,48010011,HC HDX PEDS ACUTE IP 1:1,1173.0,703.8,272.14,4481.0,24 CDM,48010012,HC EMERGENT HDX ESRD ADULT OP,1282.0,769.2,355.37,4481.0,34 CDM,48010013,HC HDX PEDS IP DU 2:1,903.0,541.8,209.5,4481.0,24 CDM,48010015,HC ADULT CRRT START UP,1713.0,1027.8,397.42,4481.0,24 CDM,48010017,HC CRRT ADULT,1297.0,778.2,300.9,4481.0,24 CDM,48010018,HC EMERGENT CCPD ESRD PEDS OP,1282.0,769.2,355.37,4481.0,34 CDM,48010019,HC PEDS CRRT START UP,1737.0,1042.2,402.98,4481.0,24 CDM,48010020,HC EMERGENT CCPD ESRD ADULT OP,1282.0,769.2,355.37,4481.0,34 CDM,48010021,HC CRRT PEDS,1175.0,705.0,272.6,4481.0,24 CDM,48010023,HC PEDS IP PD DIALYNATE,855.0,513.0,198.36,4481.0,24 CDM,48010026,HC SINGLE EXCHANGE CAPD,608.0,364.8,168.54,4481.0,34 CDM,48010027,HC CCPD PEDS IP,831.0,498.6,192.79,4481.0,24 CDM,48010028,HC CCPD ADULT IP,609.0,365.4,141.29,4481.0,24 CDM,48010032,HC EP EVAL SINGLE OR DUAL CD LEADS INCLUDING DEFIB THRESHOLD EVAL AT TIME OF INITIAL IMPLANT REPLACE,2786.0,1671.6,646.35,15291.0,25 CDM,48010042,HC HDX ADULT IP DU 1:1,903.0,541.8,209.5,4481.0,24 CDM,48010043,HC HDX PEDS IP DU 1:1,1173.0,703.8,272.14,4481.0,24 CDM,48010044,HC NON EMERGENT HDX ESRD ADULT OP,1193.0,715.8,330.7,4481.0,34 CDM,48010045,HC NON EMERGENT HDX ESRD PEDS OP,1193.0,715.8,330.7,4481.0,34 CDM,48100001,HC BONE MARROW TRANSP AUTOLOGOUS,6101.0,3660.6,1415.43,4880.8,24 CDM,48100009,HC LIVER PROCUREMENT LD,138375.0,83025.0,4481.0,110700.0,26 CDM,48100010,HC KIDNEY PROCUREMENT LD,139933.0,83959.8,4481.0,111946.4,25 CDM,48100011,HC HEART PROCUREMENT CD,176884.0,106130.4,4481.0,149129.0,26 CDM,48100012,HC LUNG PROCUREMENT CD,276769.0,166061.4,4481.0,221415.2,26 CDM,48100013,HC LIVER PROCUREMENT CAD,138375.0,83025.0,4481.0,110700.0,26 CDM,48100014,HC PANCREAS PROCUREMENT CD,117875.0,70725.0,4481.0,94300.0,26 CDM,48100016,HC KIDNEY PROCUREMENT CD,122461.0,73476.6,4481.0,97968.8,25 CDM,48100017,HC BONE MARROW TRANSP ALLOGENIC,7829.0,4697.4,1816.33,242660.0,26 CDM,49010001,HC ELECTROCONVULSIVE THERAPY,1495.0,897.0,414.41,4481.0,36 CDM,49100011,HC SEEKING SAFETY WOMEN GROUP,106.0,63.6,29.38,4481.0,27 CDM,49100012,HC INTERACTIVE COMPLEXITY D,143.0,85.8,33.18,4481.0,22 CDM,49100013,HC COMPREHENSIVE ASSESSMENT ADULT D,422.0,253.2,116.98,4481.0,32 CDM,49100014,HC COMPREHENSIVE ASSESSMENT ADOLESCENT D,422.0,253.2,116.98,4481.0,32 CDM,49100015,HC PSYCHOTHERAPY 30 MIN WITH PATIENT D,172.0,103.2,47.68,4481.0,32 CDM,49100016,HC PSYCHOTHERAPY 45 MIN WITH PATIENT D,252.0,151.2,69.85,4481.0,32 CDM,49100017,HC PSYCHOTHERAPY 60 MIN WITH PATIENT D,416.0,249.6,115.32,4481.0,32 CDM,49100018,HC CRISIS THERAPY 60MINS D,286.0,171.6,79.28,4481.0,32 CDM,49100019,HC CRISIS THERAPY ADD 30MIN D,144.0,86.4,33.41,4481.0,22 CDM,49100020,HC FAMILY PSYCHOTHERAPY 50 MINS W O PATIENT D,252.0,151.2,69.85,4481.0,32 CDM,49100021,HC FAMILY PSYCHOTHERAPY 50 MINS W PATIENT D,252.0,151.2,69.85,4481.0,32 CDM,49100022,HC OUTPATIENT GROUP ADULT D,105.0,63.0,29.11,4481.0,32 CDM,49100023,HC EARLY INTERVENTION 2HR GRP D,106.0,63.6,29.38,4481.0,32 CDM,49100024,HC OUTPATIENT MENS GROUP D,106.0,63.6,29.38,4481.0,32 CDM,49100025,HC ADOLESCENT GROUP THERAPY 2HR D,106.0,63.6,29.38,4481.0,32 CDM,49100026,HC INTERACTIVE COMPLEXITY A,143.0,85.8,33.18,4481.0,22 CDM,49100027,HC COMPREHENSIVE ASSESSMENT ADULT A,422.0,253.2,116.98,4481.0,32 CDM,49100028,HC COMPREHENSIVE ASSESSMENT ADOLESCENT A,422.0,253.2,116.98,4481.0,32 CDM,49100029,HC PSYCHOTHERAPY 30 MIN WITH PATIENT A,174.0,104.4,48.23,4481.0,32 CDM,49100030,HC PSYCHOTHERAPY 45 MIN WITH PATIENT A,254.0,152.4,70.41,4481.0,32 CDM,49100031,HC PSYCHOTHERAPY 60 MIN WITH PATIENT A,420.0,252.0,116.42,4481.0,32 CDM,49100032,HC CRISIS THERAPY 60MINS A,286.0,171.6,79.28,4481.0,32 CDM,49100033,HC CRISIS THERAPY ADD 30MIN A,144.0,86.4,33.41,4481.0,22 CDM,49100034,HC FAMILY PSYCHOTHERAPY 50 MINS W/O PATIENT A,249.0,149.4,69.02,4481.0,32 CDM,49100035,HC FAMILY PSYCHOTHERAPY 50 MINS W/ PATIENT A,249.0,149.4,69.02,4481.0,32 CDM,49100036,HC OUTPATIENT GROUP ADULT A,106.0,63.6,29.38,4481.0,32 CDM,49100037,HC EARLY INTERVENTION 2HR GRP A,106.0,63.6,29.38,4481.0,32 CDM,49100038,HC ADOLESCENT GROUP THERAPY 2HR A,106.0,63.6,29.38,4481.0,32 CDM,49100039,HC CRISIS INTERVENTION MENTAL HEALTH SERVICES PER HOUR,138.0,82.8,32.01,4481.0,19 CDM,49100041,HC ALCOHOL AND OR DRUG SERVICES SUB ACUTE DETOX,2309.0,1385.4,285.0,4481.0,19 CDM,49100042,HC MULTI FAMILY GROUP A,105.0,63.0,29.11,4481.0,32 CDM,49100043,HC MULTI FAMILY GROUP D,105.0,63.0,29.11,4481.0,32 CDM,49100068,HC REDUCTION INTERVENTIONS 15 MINS,52.0,31.2,12.06,4481.0,17 CDM,49100069,HC REDUCTION INTERVENTIONS 30 MINS,124.0,74.4,28.77,4481.0,17 CDM,49100070,HC REDUCTION INTERVENTIONS 45 MINS,224.0,134.4,51.97,4481.0,17 CDM,49100071,HC REDUCTION INTERVENITONS 60 MINS,247.0,148.2,57.3,4481.0,17 CDM,49200002,HC ELECTRO OCULOGRAM EOG,351.0,210.6,97.3,4481.0,34 CDM,49200003,HC MAX INSP EXP MUSC PRES,290.0,174.0,80.39,4481.0,34 CDM,49200004,HC SLEEP MULT SLEEP LAT TEST,6104.0,3662.4,499.58,4883.2,34 CDM,49200005,HC SLEEP MAINT OF WAKEFULNESS TEST,6104.0,3662.4,499.58,4883.2,34 CDM,49200009,HC SLEEP OVERNIGHT SCREEN,1017.0,610.2,147.31,4481.0,34 CDM,49200011,HC POLYSOM LESS THAN 6 HRS AND 6 YRS OLD OR MORE,4171.0,2502.6,670.0,4481.0,34 CDM,49200012,HC QST TOUCH PRESSURE STIM PEREXT,605.0,363.0,36.96,4481.0,34 CDM,49200013,HC POLYSOM 6 YRS AND OLDER 4 OR MORE PARAMETERS,4200.0,2520.0,670.0,4481.0,34 CDM,49200014,HC QST VIBRATION STIMULI PER EXT,605.0,363.0,36.96,4481.0,34 CDM,49200016,HC QST COOLING STIMULI PER EXT,605.0,363.0,55.93,4481.0,34 CDM,49200018,HC QST HEAT PAIN STIMULI PER EXT,605.0,363.0,36.96,4481.0,34 CDM,49200019,HC POLYSOM 6 YRS AND OLDER 4 OR MORE PARAMETERS W CPAP,4195.0,2517.0,670.0,4481.0,34 CDM,49200020,HC QST OTHER STIMULI PER EXT,605.0,363.0,121.37,4481.0,34 CDM,49200022,HC CV DUPLEX COMPL BILAT,1154.0,692.4,227.59,4481.0,34 CDM,49200023,HC EEG EXTENDED 41-60 MIN,748.0,448.8,207.35,4481.0,34 CDM,49200024,HC CV DUPLEX LTD UNIL,565.0,339.0,100.12,4481.0,34 CDM,49200026,HC TRANSCRANIAL DOPP COMPL,733.0,439.8,203.19,4481.0,34 CDM,49200027,HC EEG AWAKE AND DROWSY,963.0,577.8,266.94,4481.0,34 CDM,49200028,HC UE OR LE ARTERY PHYSIOLOGIC LTD BIL 1 TO 2 LEVELS,550.0,330.0,121.37,4481.0,34 CDM,49200029,HC EEG AWAKE AND ASLEEP,956.0,573.6,265.0,4481.0,34 CDM,49200030,HC UE OR LE ARTERY PHYSIOLOGIC COMPL BIL 3 OR MORE LEVELS,1062.0,637.2,147.31,4481.0,34 CDM,49200031,HC EEG SLEEP ONLY,740.0,444.0,205.13,4481.0,34 CDM,49200032,HC LE ARTERY OR GRAFT DUPLEX COMPL BIL,1271.0,762.6,227.59,4481.0,34 CDM,49200033,HC EEG CEREBRAL DEATH EVAL,558.0,334.8,154.68,4481.0,34 CDM,49200034,HC LE ARTERY OR GRAFT DUPLEX LTD UNIL,728.0,436.8,100.12,4481.0,34 CDM,49200035,HC ELECTROCORTICOGRAPHY IN OR,534.0,320.4,123.89,4481.0,24 CDM,49200036,HC UE ARTERY OR GRAFT DUPLEX COMP BIL,1126.0,675.6,227.59,4481.0,34 CDM,49200038,HC UE ARTERY OR GRAFT DUPLEX LTD UNIL,758.0,454.8,100.12,4481.0,34 CDM,49200039,HC BLINK REFLEX,263.0,157.8,55.93,4481.0,34 CDM,49200044,HC VENOUS EXTREMITY DUPLEX LTD UNIL,957.0,574.2,100.12,4481.0,34 CDM,49200046,HC DUPLEX AORTA IVC ILIAC OR GRAFTS COMPL BIL,581.0,348.6,161.05,4481.0,34 CDM,49200047,HC EEG OPERATING ROOM,722.0,433.2,167.5,4481.0,24 CDM,49200048,HC DUPLEX AORTA IVC ILIAC OR GRAFTS LTD UNIL,467.0,280.2,100.12,4481.0,34 CDM,49200050,HC PENILE VESSEL DUPLEX LTD OR FOLLOW UP,989.0,593.4,100.12,4481.0,34 CDM,49200052,HC HEMODIALYSIS ACCESS DUPLEX,641.0,384.6,100.12,4481.0,34 CDM,49200055,HC DIGITAL ANALYSIS OF EEG,558.0,334.8,129.46,4481.0,24 CDM,49200056,HC POLYSOM LESS THAN 6 YRS 4 OR MORE PARAMETERS,5800.0,3480.0,265.0,4640.0,34 CDM,49200057,HC EEG WADA TEST,973.0,583.8,269.72,4481.0,34 CDM,49200059,HC CORTICAL MAPPING INITIAL HR,825.0,495.0,228.69,4481.0,34 CDM,49200060,HC POLYSOM LESS THAN 6 YRS 4 OR MORE PARAMETERS CPAP OR BILVL,6323.0,3793.8,265.0,5058.4,34 CDM,49200061,HC CORTICAL MAPPING EA ADDL HR,778.0,466.8,180.5,4481.0,24 CDM,49200064,HC SPHENOIDAL ELECTRODE INSERTION,1577.0,946.2,365.86,4481.0,24 CDM,49200065,HC EMG 1 EXTREMITY,834.0,500.4,121.37,4481.0,34 CDM,49200066,HC EMG 2 EXTREMITY,834.0,500.4,121.37,4481.0,34 CDM,49200067,HC EMG 3 EXTREMITY,834.0,500.4,147.31,4481.0,34 CDM,49200068,HC EMG 4 EXTREMITY,834.0,500.4,147.31,4481.0,34 CDM,49200069,HC EMG NEEDLE LARYNX BIL,554.0,332.4,121.37,4481.0,34 CDM,49200070,HC EMG NEEDLE LARYNX UNIL,544.0,326.4,121.37,4481.0,34 CDM,49200071,HC EMG NEEDLE HEMIDIAPHRAGM,353.0,211.8,97.85,4481.0,34 CDM,49200072,HC EMG CRANIAL UNIL,634.0,380.4,175.74,4481.0,34 CDM,49200073,HC EMG THORACIC PARASPINAL,384.0,230.4,106.44,4481.0,34 CDM,49200074,HC EMG LIMITED 1 EXTREMITY OR NON LIMB MUSCLES,411.0,246.6,113.93,4481.0,34 CDM,49200075,HC EMG SINGLE FIBER,458.0,274.8,126.96,4481.0,34 CDM,49200076,HC ELECTRL STIM GUIDANCE CHEMODEN,295.0,177.0,68.44,4481.0,24 CDM,49200077,HC EMG NEEDLE GUIDANCE CHEMODENRV,271.0,162.6,62.87,4481.0,24 CDM,49200078,HC EMG LTD W NCV 4 OR LESS MUSCLES PER EXT,558.0,334.8,129.46,4481.0,24 CDM,49200079,HC EMG COMPL W NCV 5 OR MORE MUSCLES PER EXT,558.0,334.8,129.46,4481.0,24 CDM,49200080,HC EMG NON EXTREMITY W NCV,987.0,592.2,228.98,4481.0,24 CDM,49200081,HC NERVE CONDUCTION 1-2 STUDIES,823.0,493.8,147.31,4481.0,34 CDM,49200082,HC NERVE CONDUCTION 3-4 STUDIES,1098.0,658.8,293.19,4481.0,34 CDM,49200083,HC NERVE CONDUCTION 5-6 STUDIES,1499.0,899.4,293.19,4481.0,34 CDM,49200084,HC NERVE CONDUCTION 7-8 STUDIES,1773.0,1063.8,293.19,4481.0,34 CDM,49200085,HC NERVE CONDUCTION 9-10 STUDIES,2111.0,1266.6,499.58,4481.0,34 CDM,49200086,HC NERVE CONDUCTION 11-12 STUDIES,2386.0,1431.6,499.58,4481.0,34 CDM,49200087,HC NERVE CONDUCTION 13 OR GREATER THAN STUDIES,2681.0,1608.6,499.58,4481.0,34 CDM,49200088,HC AUTONOMIC CARDIOVAGAL W RR INTERVAL,677.0,406.2,147.31,4481.0,34 CDM,49200089,HC AUTONOMIC VASOMOTOR,557.0,334.2,121.37,4481.0,34 CDM,49200090,HC AUTONOMIC SUDOMOTOR,1327.0,796.2,121.37,4481.0,34 CDM,49200091,HC SOMATOSENSORY EVOKED POTENTIAL UE,911.0,546.6,252.53,4481.0,34 CDM,49200092,HC SOMATOSENSORY EVOKED POTENTIAL LE,790.0,474.0,218.99,4481.0,34 CDM,49200093,HC CENTRAL MOTOR EVOKED POTENTIAL UPPER,718.0,430.8,199.03,4481.0,34 CDM,49200094,HC CENTRAL MOTOR EVOKED POTENTIAL LOWER,718.0,430.8,199.03,4481.0,34 CDM,49200095,HC VISUAL EVOKED POTENTIAL,415.0,249.0,115.04,4481.0,34 CDM,49200096,HC SOMATOSENSORY EVOKED POTENTIAL UE AND LE,2720.0,1632.0,499.58,4481.0,34 CDM,49200097,HC CENTRAL MOTOR EVOKED POTENTIAL UE AND LE,2720.0,1632.0,753.98,4481.0,34 CDM,49200098,HC INTRA OP MONITORING PER 15MINS,155.0,93.0,35.96,4481.0,24 CDM,49200099,HC EMG QUANTITATIVE,71.0,42.6,19.68,4481.0,34 CDM,49200103,HC ACTIGRAPHY,181.0,108.6,50.17,4481.0,34 CDM,49200104,HC EXTRAOCULAR EMG BIL,746.0,447.6,55.93,4481.0,34 CDM,49200105,HC EXTRAOCULAR EMG UNIL,746.0,447.6,55.93,4481.0,34 CDM,49200106,HC HOME SLEEP UNATTENDED AMB LESS THAN 6HRS,505.0,303.0,139.99,4481.0,34 CDM,49200115,HC HOME SLEEP STUDY,528.0,316.8,146.36,4481.0,34 CDM,49200119,HC SCREENING AAA ULTRASOUND,125.0,75.0,34.65,4481.0,34 CDM,49200123,HC CAROLINA CLINIC VASCULAR SCREENING PACKAGE,133.0,79.8,30.86,4481.0,24 CDM,49200126,HC ALYS BRN NPGT PRGRMG 15 MIN,239.0,143.4,66.25,4481.0,29 CDM,49200127,HC ALYS BRN NPGT PRGRMG ADDL 15,239.0,143.4,55.45,4481.0,19 CDM,49200128,HC ALYS SIMPLE CN NPGT PRGRMG,269.0,161.4,35.11,4481.0,34 CDM,49200129,HC ALYS COMPLEX CN NPGT PRGRMG,269.0,161.4,74.57,4481.0,34 CDM,49200134,HC EEG CONT REC W VID EEG TECH MIN 8 CHANNELS,597.0,358.2,147.31,4481.0,34 CDM,49200135,HC EEG W O VID 2-12 HR UNMNTR,1442.0,865.2,293.19,4481.0,34 CDM,49200136,HC EEG WO VID 2-12HR INTMT MNTR,1741.0,1044.6,293.19,4481.0,34 CDM,49200137,HC EEG W O VID 2-12HR CONT MNTR,2089.0,1253.4,293.19,4481.0,34 CDM,49200138,HC EEG WO VID EA 12-26HR UNMNTR,3034.0,1820.4,499.58,4481.0,34 CDM,49200139,HC EEG W O VID EA 12-26HR INTMT,3283.0,1969.8,499.58,4481.0,34 CDM,49200140,HC EEG W O VID EA 12-26HR CONT,4227.0,2536.2,499.58,4481.0,34 CDM,49200141,HC VEEG 2-12 HR UNMNTR,2487.0,1492.2,293.19,4481.0,34 CDM,49200142,HC VEEG 2-12 HR INTMT MNTR,2785.0,1671.0,293.19,4481.0,34 CDM,49200143,HC VEEG 2-12 HR CONT MNTR,3084.0,1850.4,499.58,4481.0,34 CDM,49200144,HC VEEG EA 12-26 HR UNMNTR,4974.0,2984.4,499.58,4481.0,34 CDM,49200145,HC VEEG EA 12-26HR INTMT MNTR,5570.0,3342.0,499.58,4481.0,34 CDM,49200146,HC VEEG EA 12-26HR CONT MNTR,6217.0,3730.2,670.0,4973.6,34 CDM,49200157,HC EEG EXTENDED 61-119 MINUTES,984.0,590.4,272.76,4481.0,34 CDM,49400003,HC INJECTION ADMIN SQ IM,188.0,112.8,52.11,4481.0,29 CDM,49400004,HC ECMO HEMOFILTRATION,1202.0,721.2,278.86,4481.0,19 CDM,49400006,HC DIALYSIS INJECTION ADMIN SQ IM,189.0,113.4,52.39,4481.0,34 CDM,49400007,HC PHOTOTHERAPY,157.0,94.2,36.96,4481.0,29 CDM,49400015,HC ON BODY INJECTION APPLICATION,243.0,145.8,43.45,5449.0,29 CDM,49420011,HC NUTR TRNG EDU PHP 45+ GREATER THAN MIN IND,364.0,218.4,84.45,4481.0,24 CDM,49420012,HC NUTR TRNG EDU PHP 45+ GREATER THAN MIN GRP,364.0,218.4,84.45,4481.0,24 CDM,49420013,HC MNT REASSESS 2ND REFL DX 15MIN,61.0,36.6,14.15,4481.0,24 CDM,49420014,HC MNT REASSESS 2ND REFL DX 30MIN,339.0,203.4,78.65,4481.0,24 CDM,49420018,HC IMMUNIZATION ADMIN 1ST VACCINE THRU 18YRS,48.0,28.8,11.14,4481.0,24 CDM,49420019,HC IMMUNIZATION ADMIN ADDL VACCINE THRU 18YRS,48.0,28.8,11.14,4481.0,24 CDM,49420020,HC IMMUNIZATION ADMIN ONE VACCINE,118.0,70.8,21.0,4481.0,34 CDM,49420021,HC INFLUENZA VAC ADMIN,118.0,70.8,21.0,4481.0,34 CDM,49420022,HC PNEUMOCOCCAL VAC ADMIN,118.0,70.8,21.0,4481.0,34 CDM,49420023,HC HEPATITIS B VAC ADMIN,119.0,71.4,21.0,4481.0,34 CDM,49420025,HC IMMUNIZATION ADMIN EACH ADDITIONAL VACCINE,107.0,64.2,21.0,4481.0,24 CDM,49420031,HC IMMUN ADMIN PO NASAL,43.0,25.8,11.92,4481.0,34 CDM,49420206,HC IV OR SQ INJ ADMIN CASIRIVIMAB/IMDEVIMAB INCL POST ADMIN MONITORING,775.0,465.0,179.8,4481.0,24 CDM,49420209,HC IV ADMIN BAMLANIVIMAB AND ETESEVIMAB INCL POST ADMIN MONITORING,775.0,465.0,179.8,4481.0,24 CDM,49420228,HC IV OR SQ INJ ADMIN CASIRIVIMAB/IMDEVIMAB INCL POST ADMIN MONITOR REPEAT DOSES,775.0,465.0,179.8,4481.0,24 CDM,49420232,HC IV ADMIN SOTROVIMAB INCL POST ADMIN MONITORING,775.0,465.0,179.8,4481.0,24 CDM,49420233,HC INJ IM ADMIN EVUSHELD TIXAGEVIMAB CILGAVIMAB INCL POST ADMIN MONITORING,775.0,465.0,21.0,4481.0,24 CDM,49420237,HC IV INJ ADMIN BEBTELOVIMAB INCL POST ADMIN MONITORING,775.0,465.0,21.0,4481.0,24 CDM,49420261,HC COVID19 VACCINE ADMINISTRATION,75.0,45.0,20.79,4481.0,34 CDM,49900002,HC TREATMENT ACCENT MODIF,122.0,73.2,28.3,4481.0,22 CDM,49900003,HC ASSESSMENT ACCENT MODIF,446.0,267.6,103.47,4481.0,22 CDM,49900004,HC CURRICULUM ACCENT MODIF,259.0,155.4,60.09,4481.0,22 CDM,49900035,HC PT DRY NEEDLING,67.0,40.2,15.54,5449.0,24 CDM,49900045,HC SELF PAY MRI BREAST FAST W CONTRAST,409.0,245.4,94.89,4481.0,22 CDM,52720001,HC PERC ELECTRICAL NERVE FIELD STIMULATOR SYSTEM,3123.0,1873.8,724.54,4481.0,24 CDM,53610001,HC FNA W O IMAGING,666.0,399.6,112.09,6610.0,101 CDM,53610002,HC INCISION AND DRAINAGE ABSCESS SIMPLE SINGLE,488.0,292.8,135.27,6610.0,68 CDM,53610003,HC INCISION AND DRAINAGE ABSCESS COMPL MULT,633.0,379.8,175.47,6610.0,69 CDM,53610004,HC INCISION AND DRAINAGE HEMATOMA SEROMA OR FLUID,1752.0,1051.2,485.65,6610.0,68 CDM,53610005,HC INCISION AND DRAINAGE POSTOP WOUND INFECTION COMPLEX,3875.0,2325.0,1074.15,7278.0,34 CDM,53610006,HC DEBRIDEMENT MUSCLE SKIN TISSUE 1ST 20SQCM,955.0,573.0,264.73,7278.0,35 CDM,53610007,HC DEBRIDEMENT BONE SKIN TISSUE MUSCLE 1ST 20SQCM,2844.0,1706.4,788.36,7278.0,35 CDM,53610008,HC DEBRIDEMENT TISSUE SKIN ADD 20SQCM,886.0,531.6,205.55,6610.0,24 CDM,53610009,HC DEBRIDEMENT MUSCLE SKIN TISSUE ADD 20SQCM,955.0,573.0,221.56,6610.0,48 CDM,53610010,HC DEBRIDEMENT BONE SKIN TISSUE MUSCLE ADD 20SQCM,2844.0,1706.4,659.81,6610.0,48 CDM,53610011,HC PARING BENIGN LESION SINGLE,198.0,118.8,54.89,5449.0,34 CDM,53610012,HC PARING BENIGN LESION 2-4,207.0,124.2,57.38,5449.0,34 CDM,53610013,HC PARING BENIGN LESION GREATER THAN 4,277.0,166.2,76.78,5449.0,34 CDM,53610015,HC EXCISION BENIGN LESION T A L 0.6 TO 1 CM,569.0,341.4,157.73,5449.0,34 CDM,53610016,HC TRIM NONDYSTROPHIC NAILS,114.0,68.4,31.6,4481.0,34 CDM,53610017,HC DEBRID NAILS ANY METHOD 1-5,207.0,124.2,55.93,5449.0,34 CDM,53610018,HC DEBRID NAILS ANY METHOD 6 AND GREATER,304.0,182.4,55.93,5449.0,34 CDM,53610019,HC AVULSION NAIL PLATE P C S SNGL,588.0,352.8,162.99,5449.0,34 CDM,53610020,HC AVULSION NAIL PLATE EA ADD,347.0,208.2,80.5,5449.0,24 CDM,53610021,HC EXCISION NAIL AND MATRIX PARTIAL OR COMPLETE,1060.0,636.0,293.83,5449.0,34 CDM,53610036,HC DESTRUCTION BENIGN LESIONS UP TO 14,298.0,178.8,82.61,5449.0,34 CDM,53610037,HC DESTROY BENIGN LESIONS 15+,238.0,142.8,65.97,5449.0,34 CDM,53610038,HC WOUND CAUTERY CHEMICAL,120.0,72.0,33.26,6610.0,68 CDM,53610039,HC ASPIRAT PUNCT BREAST CYST,1079.0,647.4,299.1,5449.0,34 CDM,53610040,HC INJ CARPAL TUNNEL THERPTC,411.0,246.6,113.93,6610.0,35 CDM,53610041,HC INJECTION SINGLE TENDON SHEATH OR LIGAMENT,234.0,140.4,64.86,6610.0,35 CDM,53610043,HC INJECTION TRIGGER POINT 1 OR 2 MUSCLES,770.0,462.0,213.44,6610.0,69 CDM,53610044,HC INJECTION TRIGGER POINT 3 OR MORE MUSCLES,638.0,382.8,176.85,6610.0,35 CDM,53610045,HC ASPIRATION AND OR INJECTION GANGLION CYST,238.0,142.8,65.97,6610.0,35 CDM,53610046,HC REM TONGS HALO APPLY OTH PHY,123.0,73.8,34.1,5449.0,34 CDM,53610047,HC REMVL FB FOOT SUBCUTANEOUS,125.0,75.0,34.65,7278.0,34 CDM,53610048,HC APPLIC CAST SHORT LEG,352.0,211.2,97.57,4481.0,34 CDM,53610049,HC APPLICATION CAST RIG TOTAL CONT LEG,445.0,267.0,123.35,4481.0,34 CDM,53610050,HC STRAPPING ANKLE AND OR FOOT,406.0,243.6,112.54,4481.0,34 CDM,53610052,HC TRACH TUBE EXCHANGE,1140.0,684.0,218.65,5449.0,34 CDM,53610053,HC SPIDER VEINS INJ SINGLE OR MULT LIMB OR TRUNK,390.0,234.0,108.11,6610.0,34 CDM,53610054,HC INJ SCLEROSING SOLUTION SINGLE VEIN,499.0,299.4,138.32,6610.0,34 CDM,53610055,HC INJ SCLEROSING SOLUTION MULT VEINS SAME LEG,1039.0,623.4,288.01,6610.0,34 CDM,53610056,HC COLLECT BLOOD VIA VENOUS CATH,156.0,93.6,43.24,4481.0,34 CDM,53610057,HC DECLOT IMPLNTD VASC ACC DEV,754.0,452.4,209.01,6610.0,68 CDM,53610058,HC BIOPSY LIVER NEEDLE PERCUTAN,2295.0,1377.0,636.17,6610.0,69 CDM,53610059,HC US MEASURE POST VOID BLAD CAP,162.0,97.2,44.91,6610.0,67 CDM,53610062,HC BIOPSY VULVA PERINEUM 1 LESION,489.0,293.4,135.55,6610.0,69 CDM,53610063,HC BIOPSY VULVA PERINEUM EA ADDL LESION,489.0,293.4,113.45,6610.0,48 CDM,53610064,HC COLPOSCOPY CERVIX INCL UP VAG,549.0,329.4,152.18,7278.0,34 CDM,53610065,HC COLPOSCOPY CERVIX W BX AND CURRETAGE,549.0,329.4,152.18,7278.0,34 CDM,53610066,HC COLPOSCOPY CERVIX W BX,350.0,210.0,97.02,5449.0,34 CDM,53610067,HC COLPOSCOPY CERVIX W ENDO CUR,350.0,210.0,97.02,5449.0,34 CDM,53610068,HC BIOPSY CERVIX 1 OR MORE,498.0,298.8,138.05,6610.0,69 CDM,53610069,HC ENDOCERVICAL CURETTAGE,340.0,204.0,94.25,6610.0,69 CDM,53610072,HC CERVICAL DILATION,5875.0,3525.0,1628.55,5449.0,34 CDM,53610073,HC BX ENDOMETRIAL WO DILATION,483.0,289.8,133.89,6610.0,68 CDM,53610074,HC IUD INSERTION,233.0,139.8,54.06,6610.0,48 CDM,53610075,HC IUD REMOVAL,226.0,135.6,62.65,6610.0,69 CDM,53610076,HC PLACEMENT CERVICAL DILATOR,679.0,407.4,188.22,6610.0,35 CDM,53610077,HC PUNCTURE OF SHUNT OR PUMP FOR INJECTION,820.0,492.0,227.3,6610.0,35 CDM,53610078,HC REPROG PROG CEREBROSPIN SHNT,177.0,106.2,49.06,4481.0,34 CDM,53610079,HC PERC EPIDURAL ADHESIOLYS 1 DAY,1393.0,835.8,386.14,6610.0,35 CDM,53610080,HC LUMBAR PUNCTURE THERAPY,692.0,415.2,191.82,6610.0,35 CDM,53610081,HC INJ EPID BLOOD PATCH,1182.0,709.2,327.65,6610.0,35 CDM,53610082,HC INJ DISCOGRAPHY LUMB EA LVL,1461.0,876.6,338.95,6610.0,24 CDM,53610087,HC PUMP ANALYSIS ONLY,466.0,279.6,129.18,7278.0,34 CDM,53610088,HC PUMP ANALYSIS W REPROGRAM,777.0,466.2,215.38,7278.0,35 CDM,53610089,HC PUMP REFILL W ANLYS AND PROGRAM,894.0,536.4,247.82,4481.0,34 CDM,53610090,HC PERC IMPLANT NEURO ELECTRODE,13382.0,8029.2,3709.49,21454.0,35 CDM,53610093,HC INJECTION ANESTHETIC AGENT CERVICAL PLEXUS,545.0,327.0,151.07,6610.0,34 CDM,53610099,HC INJECTION ANESTHETIC AGENT SCIATIC NERVE SINGLE INCL IMG GUIDANCE,1643.0,985.8,455.44,6610.0,35 CDM,53610103,HC INJECTION ANESTHETIC AGENT FACET JOINT C T 2ND LEVEL,1198.0,718.8,277.94,5449.0,24 CDM,53610104,HC INJECTION ANESTHETIC AGENT FACET JOINT C T 3RD LEVEL AND MORE,1198.0,718.8,277.94,5449.0,24 CDM,53610105,HC INJECTION ANESTHETIC AGENT SPHENOPALATINE GANGLION,1431.0,858.6,277.93,5449.0,34 CDM,53610106,HC INJECTION ANESTHETIC AGENT STELLATE GANGLION,1275.0,765.0,353.43,5449.0,34 CDM,53610107,HC INJECTION ANESTHETC AGENT L T PARAVERTEBRAL,2110.0,1266.0,584.89,5449.0,34 CDM,53610108,HC PERC IMPL NEURO ELCTR PER NRV,10167.0,6100.2,2818.29,8133.6,34 CDM,53610109,HC CHEMODNRVTN PAROTD SUBM SAL BL,209.0,125.4,57.93,5449.0,34 CDM,53610111,HC CHEMODNRVTN NECK MUSCL,785.0,471.0,217.6,6610.0,68 CDM,53610113,HC RF DENERV C T SNGL W IG,2666.0,1599.6,739.02,9324.0,35 CDM,53610114,HC RF DENERV C T ADD W IG,1600.0,960.0,371.2,6610.0,24 CDM,53610115,HC DESTROY PERIPH NERVE BRANCH,1491.0,894.6,413.31,6610.0,69 CDM,53610116,HC BOTOX INJ ECCRI GLND BTH AXILA,103.0,61.8,28.55,5449.0,34 CDM,53610117,HC BOTOX INJ SCALP NECK FACE,103.0,61.8,28.55,5449.0,34 CDM,53610118,HC DESTR SUPER HYPOGASTRIC PLEX,2429.0,1457.4,673.32,7278.0,35 CDM,53610119,HC GANGLION IMPAR BLOCK,432.0,259.2,119.75,6610.0,34 CDM,53610125,HC REMOVE IMPACTED EAR WAX REQ INSTRUMENTATION UNILATERAL,120.0,72.0,33.26,5449.0,34 CDM,53610126,HC SMART PILL,2596.0,1557.6,719.61,4481.0,34 CDM,53610127,HC DEBRIDE OPEN WOUND 1ST 20 SQ CM OR LESS,623.0,373.8,172.7,6610.0,69 CDM,53610128,HC DEBRIDE OPEN WOUND EA ADDL 20 SQ CM,803.0,481.8,186.3,6610.0,49 CDM,53610132,HC TRIM DYSTROPHIC NAILS ANY NUMBER,92.0,55.2,25.5,4481.0,34 CDM,53610133,HC NEG PRESS WOUND TX NOT USING DME 50 SQ CM OR LESS SNAP TREATMENT,1341.0,804.6,371.73,4481.0,34 CDM,53610134,HC NEG PRESS WOUND TX NOT USING DME 50 SQ CM OR MORE SNAP TREATMENT,1341.0,804.6,371.73,4481.0,34 CDM,53610135,HC PEDS MPR EA ADDTL 1/2HR GREATER THAN 3HRS,399.0,239.4,92.57,6610.0,22 CDM,53610136,HC PEDS MPR 2:31-3:00HR,3001.0,1800.6,696.23,6610.0,22 CDM,53610137,HC PEDS MPR 2:01-2:30HR,2629.0,1577.4,609.93,6610.0,22 CDM,53610138,HC PEDS MPR 1:31-2:00HR,2350.0,1410.0,545.2,6610.0,22 CDM,53610139,HC PEDS MPR 1:01-1:30HR,1690.0,1014.0,392.08,6610.0,22 CDM,53610140,HC PEDS MPR 0:31-1:00HR,1129.0,677.4,261.93,6610.0,22 CDM,53610141,HC PEDS MPR 0:16-0:30,942.0,565.2,218.54,6610.0,22 CDM,53610142,HC PEDS MPR 0:00-0:15,301.0,180.6,69.83,6610.0,22 CDM,53610152,HC DONOR LYMPHOCYTE INFUSION,1030.0,618.0,285.52,6610.0,73 CDM,53610154,HC DRESS DEBRIDEMENT PARTIAL THICK BURN SM LESS THAN 5% TOTAL BODY SURFACE AREA,278.0,166.8,77.06,6610.0,35 CDM,53610155,HC DRESS DEBRIDEMENT PARTIAL THICK BURN MD 5-10% TOTAL BODY SURFACE AREA,338.0,202.8,93.69,7278.0,35 CDM,53610156,HC DRESS DEBRIDEMENT PARTIAL THICK BURN LG GREATER THAN 10% TOTAL BODY SURFACE AREA,464.0,278.4,128.62,7278.0,35 CDM,53610157,HC BIOPSY ANORECTAL WALL,1906.0,1143.6,528.34,6610.0,35 CDM,53610158,HC DESTR RECTAL TUMOR TRANSANAL,4791.0,2874.6,1328.07,7278.0,34 CDM,53610159,HC INCISION AND DRAINAGE PERIANAL ABSCESS SUPERFICIAL,356.0,213.6,98.68,5449.0,34 CDM,53610160,HC INC THROMBOSED HEMORRHOID EXT,421.0,252.6,116.7,5449.0,34 CDM,53610161,HC HEMORRHOIDECTOMY RUBBER BAND,658.0,394.8,152.66,6610.0,56 CDM,53610162,HC EXC THROMBOSED HEMORRHOID EXT,541.0,324.6,149.97,6610.0,35 CDM,53610163,HC ANOSCOPY W BX SNGL OR MULT,1692.0,1015.2,469.02,5449.0,34 CDM,53610164,HC DESTR LESION ANUS SIMPLE CHEM,574.0,344.4,159.11,5449.0,34 CDM,53610165,HC INJECTION ANESTHETIC AGENT SUPERIOR HYPOGASTRIC PLEXUS,1600.0,960.0,443.52,7278.0,35 CDM,53610166,HC IMPLANT SACRAL NEUROSTIM ELECT,14841.0,8904.6,4113.93,21454.0,35 CDM,53610167,HC EXCISION BENIGN LESION T A L 0.5CM OR LESS,550.0,330.0,152.46,5449.0,34 CDM,53610168,HC INCISION AND DRAINAGE DEEP BELOW FASCIA,4218.0,2530.8,1169.23,8413.0,34 CDM,53610169,HC DISCARDED APLIGRAF PER SQ CM,106.0,63.6,24.59,4481.0,24 CDM,53610170,HC DISCARDED OASIS PER SQ CM,6.0,3.6,1.39,4481.0,24 CDM,53610172,HC ENDOMETRIAL BX W COLPOSCOPY,483.0,289.8,112.06,6610.0,24 CDM,53610173,HC CHEMODNRVTN 1 EXTREMITY 1 TO 4 MUSCLES,785.0,471.0,217.6,6610.0,68 CDM,53610174,HC CHEMODNRVTN 1 EXTREMITY 5 OR MORE MUSCLES,649.0,389.4,179.9,6610.0,68 CDM,53610175,HC CHEMODNRVTN ADDITIONAL EXTREMITIES 1 TO 4 MUSCLES,785.0,471.0,182.12,6610.0,48 CDM,53610176,HC CHEMODNRVTN ADDITIONAL EXTREMITIES 5 OR MORE MUSCLES,649.0,389.4,150.57,5449.0,24 CDM,53610177,HC CHEMODNRVTN TRUNK 1 TO 5 MUSCLES,649.0,389.4,179.9,6610.0,68 CDM,53610178,HC CHEMODNRVTN TRUNK 6 OR MORE MUSCLES,649.0,389.4,179.9,6610.0,68 CDM,53610179,HC CHEMODENERVATION MUSCLE BILATERAL FACIAL TRIGEMINAL CERVICAL ACCESSORY NERVE,225.0,135.0,62.37,6610.0,68 CDM,53610189,HC EXCISION BENIGN LESION T A L 1.1 TO 2 CM,584.0,350.4,161.88,5449.0,34 CDM,53610190,HC RF DENERV PUDENDAL NRV,874.0,524.4,242.27,7278.0,35 CDM,53610191,HC TREATMENT MISSED ABORTION COMPLETED SURGICALLY 1ST TRIMESTER,8364.0,5018.4,2318.5,12615.0,34 CDM,53610192,HC INSERTION OF LAMINARIA,789.0,473.4,218.71,5449.0,34 CDM,53610193,HC CHEMODENERVATION MUSCLE FACIAL NERVE UNILATERAL,163.0,97.8,45.18,6610.0,69 CDM,53610195,HC INDUCED ABORTION BY D AND C,8364.0,5018.4,2318.5,12615.0,34 CDM,53610218,HC REPAIR WOUNDS FACE EARS EYELIDS NOSE LIPS INTERM 2.5CM OR GREATER,794.0,476.4,220.1,6610.0,34 CDM,53610241,HC INJECTION DIAGNOSTIC OR THERAPEUTIC INCL NEEDLE PLACEMENT C T WO GUID,3895.0,2337.0,652.03,6610.0,35 CDM,53610242,HC INJECTION DIAGNOSTIC OR THERAPEUTIC INCL NEEDLE PLACEMENT C T W GUID,3895.0,2337.0,652.03,6610.0,35 CDM,53610243,HC INJECTION DIAGNOSTIC OR THERAPEUTIC INCL NEEDLE PLACEMENT L S WO GUIDE,1913.0,1147.8,530.28,6610.0,35 CDM,53610244,HC INJECTION DIAGNOSTIC OR THERAPEUTIC INCL NEEDLE PLACEMENT L S W GUID,3103.0,1861.8,652.03,6610.0,35 CDM,53610245,HC INJECTION INCL INDWELLING CATHETER PLACEMENT CONTINUOUS FLOW CERV THOR WO IMG GUIDANCE,1653.0,991.8,458.21,6610.0,35 CDM,53610246,HC INJECTION INCL INDWELLING CATHETER PLACEMENT CONTINUOUS FLOW CERV THOR W IMG GUIDANCE,1653.0,991.8,458.21,6610.0,35 CDM,53610247,HC INJECTION INCL INDWELLING CATHETER PLACEMENT CONTINUOUS FLOW L S W O GUID,1340.0,804.0,371.45,6610.0,35 CDM,53610248,HC INJECTION INCL INDWELLING CATHETER PLACEMENT CONTINUOUS FLOW L S W GUID,1340.0,804.0,371.45,6610.0,35 CDM,53610250,HC TAP BLOCK UNILATERAL,405.0,243.0,93.96,7278.0,24 CDM,53610251,HC EXCISION TUMOR SOFT TISSUE BACK FLANK SUBQ 3 OR MORE CM,3193.0,1915.8,885.1,8413.0,34 CDM,53610252,HC EXC TUMOR SOFT TISSUE ABDOMINAL WALL SUBQ 3+CM,5502.0,3301.2,1525.15,8413.0,34 CDM,53610260,HC PRESSURE TREATMENT ESOPHAGEAL,81.0,48.6,22.45,6610.0,32 CDM,53610262,HC SPINAL HARDWARE INJ,1976.0,1185.6,277.93,6610.0,34 CDM,53610265,HC FECAL CAPSULE TRANSPLANT,3211.0,1926.6,744.95,6610.0,56 CDM,53610266,HC COOLED RF ABLATION CERVICAL,5244.0,3146.4,1453.64,9324.0,35 CDM,53610267,HC COOLED RF ABLATION CERVICAL EA ADDL LVL,4799.0,2879.4,777.0,6610.0,24 CDM,53610268,HC COOLED RF ABLATION LUMB SACRAL,5777.0,3466.2,1601.38,9350.0,35 CDM,53610269,HC COOLED RF ABLATION LUMB SACRAL EA ADDL LVL,5155.0,3093.0,777.0,6610.0,24 CDM,53610270,HC COOLED RF ABLATION OTHER NERVE,6201.0,3720.6,838.24,6610.0,35 CDM,53610271,HC TAP BLOCK BILATERAL,811.0,486.6,188.15,7278.0,24 CDM,53610276,HC PULSED RFA,2839.0,1703.4,277.93,6610.0,34 CDM,53610279,HC ADJACENT TISSUE TRANSFER F C C M N A G H F 10 SQ CM OR LESS,3384.0,2030.4,938.04,7278.0,34 CDM,53610286,HC INSERTION OF FIDUCIAL MARKERS,2271.0,1362.6,277.93,5449.0,34 CDM,53610287,HC PERC ENDOVENOUS VALVE FORMATION CLINICAL TRIAL,1120.0,672.0,310.46,7278.0,34 CDM,53610289,HC INJECTION ANESTHETIC AGENT AND OR STEROID TRIGEMINAL NERVE EA BRANCH,542.0,325.2,150.24,5449.0,34 CDM,53610290,HC INJECTION ANESTHETIC AGENT AND OR STEROID GREATER OCCIPITAL NERVE,644.0,386.4,178.52,5449.0,34 CDM,53610291,HC INJECTION ANESTHETIC AGENT AND OR STEROID BRACHIAL PLEXUS INCL IMG GUIDANCE,1671.0,1002.6,463.2,5449.0,34 CDM,53610292,HC INJECTION ANESTHETIC AGENT AND OR STEROID SUPRASCAPULAR NERVE,404.0,242.4,111.99,5449.0,34 CDM,53610293,HC INJECTION ANESTHETIC AGENT AND OR STEROID INTERCOSTAL NERVE SINGLE LEVEL,1257.0,754.2,348.44,6610.0,69 CDM,53610294,HC INJECTION ANESTHETIC AGENT AND OR STEROID INTERCOSTAL NERVE EACH ADDL LEVEL,2060.0,1236.0,571.03,5449.0,34 CDM,53610295,HC INJECTION ANESTHETIC AGENT AND OR STEROID ILIOINGUINAL ILIOHYPOGASTRIC NERVES,467.0,280.2,129.45,5449.0,34 CDM,53610296,HC INJECTION ANESTHETIC AGENT AND OR STEROID PUDENDAL NERVE,788.0,472.8,218.43,5449.0,34 CDM,53610297,HC INJECTION ANESTHETIC AGENT AND OR STEROID FEMORAL NERVE INCL IMG GUIDANCE,1674.0,1004.4,464.03,6610.0,68 CDM,53610298,HC INJECTION ANESTHETIC AGENT AND OR STEROID LUMBAR PLEXUS POSTERIOR APPROACH CONTINUOUS INFUSION BY CATH INCL PLACEMENT,588.0,352.8,162.99,6610.0,69 CDM,53610299,HC INJECTION ANESTHETIC AGENT ANDOR STEROID OTHER PERIPHERAL NERVE BRANCH,1005.0,603.0,278.59,6610.0,69 CDM,53610300,HC INJECTION ANESTHETIC AGENT STEROID NERVES SI JOINT INCL IMAGING GUIDANCE,1641.0,984.6,454.89,5449.0,34 CDM,53610301,HC INJECTION ANESTHETIC AGENT STEROID GENICULAR NERVE BRANCHES INCL IMAGING GUIDANCE,1641.0,984.6,454.89,5449.0,34 CDM,53610302,HC DESTRUCTION NEUROLYTIC AGENT GENICULAR NERVE INCLD IMG GUIDANCE,2044.0,1226.4,566.6,9324.0,69 CDM,53610303,HC RF ABLATION NERVE SI JOINT INCLD CT FLUORO GUIDANCE,4710.0,2826.0,1305.61,12408.0,69 CDM,53610308,HC EXCISION TUMOR BACK FLANK SUBFASCIAL LESS THAN 5CM,5274.0,3164.4,1461.95,7278.0,34 CDM,53610313,HC PERC TIBIAL NERVE STIMULATION,221.0,132.6,61.26,6610.0,35 CDM,53610317,HC ABLATION BENIGN THYROID NODULE(S) PERC LASER INCLD GUIDANCE,8044.0,4826.4,1525.52,6610.0,35 CDM,53610323,HC VAT DECLOT IMPLNTD VASC ACC DEV,754.0,452.4,209.01,6610.0,34 CDM,53610324,HC CHEMODENERVATION INTERNAL ANAL SPHINCTER,2249.0,1349.4,623.42,6610.0,35 CDM,53610325,HC NON OPHTHALMIC FLUORESCENT VASCULAR ANGIOGRAPHY,733.0,439.8,203.19,6610.0,32 CDM,53610326,HC RADIOFREQUENCY ABLATION OF ONE OR MORE THYROID NODULES IN ONE LOBE OR ISTHMUS PERC INCL IMG GUIDANCE,5103.0,3061.8,1414.55,6610.0,34 CDM,53610327,HC RADIOFREQUENCY ABLATION OF ONE OR MORE THYROID NODULES EACH ADDITIONAL LOBE PERC INCL IMG GUIDANCE,259.0,155.4,60.09,6610.0,24 CDM,53610328,HC MICROWAVE FETAL UMBILICAL CORD OCCLUSION INCL US GUIDANCE,13676.0,8205.6,286.41,10940.8,35 CDM,54120001,HC CONTINUOUS INHALATION TREATMENT W AEROSOL MED 1ST HR,194.0,116.4,53.78,4481.0,33 CDM,54120002,HC CONTINUOUS INHALATION TREATMENT W AEROSOL MED EA ADD HR,160.0,96.0,37.12,4481.0,23 CDM,54130001,HC HYPERBARIC OXYGEN TX FBC 30MIN,711.0,426.6,129.83,4481.0,34 CDM,54300001,HC TH2 ROTARY BASE FEE SVC PRVDR CJS,14754.0,8852.4,3422.93,11803.2,25 CDM,54300002,HC TH 2 HELICOPTER LOADED MILES,119.0,71.4,27.61,4620.0,25 CDM,54300003,HC TH 3 ROTARY BASE FEE SVC PRVDR CJS,14754.0,8852.4,3422.93,11803.2,25 CDM,54300004,HC TH 3 HELICOPTER LOADED MILES,119.0,71.4,27.61,4620.0,25 CDM,54300005,HC TH 4 ROTARY BASE FEE SVC PRVDR CJS,14754.0,8852.4,3422.93,11803.2,25 CDM,54300006,HC TH 4 HELICOPTER LOADED MILES,119.0,71.4,27.61,4620.0,25 CDM,54300007,HC TH SPARE ROTARY BASE FEE SVC PRVDR CJS,14754.0,8852.4,3422.93,11803.2,25 CDM,54300008,HC TH SPARE HELICOPTER LOADED MILES,119.0,71.4,27.61,4620.0,25 CDM,54500001,HC ARTERIAL PUNCT DRAW BLD FOR DX,103.0,61.8,28.55,4481.0,34 CDM,54500002,HC ED PROCEDURE LEVEL 6,3713.0,2227.8,861.42,4481.0,22 CDM,54500003,HC ED PROCEDURE LEVEL 5,3073.0,1843.8,712.94,4481.0,22 CDM,54500004,HC ED PROCEDURE LEVEL 4,2435.0,1461.0,564.92,4481.0,22 CDM,54500005,HC DEBRIDEMENT SQ TISSUE SKIN 1ST 20SQCM,984.0,590.4,272.76,7278.0,69 CDM,54500006,HC ED PROCEDURE LEVEL 3,1356.0,813.6,314.59,4481.0,22 CDM,54500007,HC ED PROCEDURE LEVEL 2,857.0,514.2,198.82,4481.0,22 CDM,54500008,HC ED PROCEDURE LEVEL 1,418.0,250.8,96.98,4481.0,22 CDM,54500010,HC NASOPHARYNGOSCOPY,501.0,300.6,138.88,6610.0,67 CDM,54500011,HC ED VISIT LEVEL 1,184.0,110.4,49.92,4481.0,34 CDM,54500012,HC ED VISIT LEVEL 2,386.0,231.6,104.72,4481.0,34 CDM,54500013,HC ED VISIT LEVEL 3,937.0,562.2,254.21,4481.0,34 CDM,54500014,HC ED VISIT LEVEL 4,1837.0,1102.2,400.93,4481.0,34 CDM,54500015,HC ED VISIT LEVEL 5,2351.0,1410.6,577.26,4481.0,34 CDM,54500016,HC ED CRITICAL CARE 1ST 30-74 MIN,3372.0,2023.2,793.35,5152.0,34 CDM,54500017,HC ED CRITICAL CARE EACH ADDL 30 MIN,472.0,283.2,109.5,5152.0,22 CDM,54500018,HC CARDIOPULMONARY RESUSCITATION,1210.0,726.0,293.19,6610.0,34 CDM,54500019,HC TRAUMA ACTIVATION FULL TEAM,9658.0,5794.8,1245.82,7726.4,34 CDM,54500020,HC TRAUMA ACTIVATION PARTIAL TEAM,3670.0,2202.0,1017.32,5872.0,34 CDM,54500024,HC GROUNDED LOADED MILES,32.0,19.2,7.42,4481.0,25 CDM,54500025,HC ALS 1 NON EMERGENCY,918.0,550.8,212.98,4481.0,25 CDM,54500026,HC ALS 1 EMERGENCY,1012.0,607.2,234.78,4481.0,25 CDM,54500028,HC BLS NON EMERGENCY,548.0,328.8,127.14,4481.0,25 CDM,54500029,HC BLS EMERGENCY,757.0,454.2,175.62,4481.0,25 CDM,54500030,HC ALS LEVEL 2,1102.0,661.2,255.66,4481.0,25 CDM,54500031,HC SPECIALTY CARE TRANSPORT,2848.0,1708.8,645.0,4481.0,25 CDM,54500032,HC FIXED WING TRANSPORT,16398.0,9838.8,3804.34,13118.4,25 CDM,54500033,HC TH1 ROTARY BASE FEE SVC PRVDR CJS,14754.0,8852.4,3422.93,11803.2,25 CDM,54500035,HC FIXED WING LOADED MILES,114.0,68.4,26.45,4620.0,25 CDM,54500037,HC TH1 HELICOPTER LOADED MILES,119.0,71.4,27.61,4620.0,25 CDM,54500046,HC ED TELEPSYCH ORIGINATING SITE FACILITY FEE,185.0,111.0,42.92,4481.0,22 CDM,54500051,HC MODERATE SEDATION INITIAL 15 MINUTES YOUNGER THAN 5 YEARS OF AGE,538.0,322.8,124.82,4481.0,24 CDM,54500052,HC MODERATE SEDATION INITIAL 15 MINUTES 5 YEARS OF AGE OR OLDER,444.0,266.4,103.01,4481.0,24 CDM,54500053,HC MODERATE SEDATION EACH ADDITIONAL 15 MINUTES,285.0,171.0,66.12,4481.0,24 CDM,54500056,HC FIXED WING GROUND TRANSPORT,2091.0,1254.6,485.11,4481.0,25 CDM,54800001,HC AMBULATORY BP MONITOR RPT AUTOMATED WORN 24 HRS RPT ONLY,190.0,114.0,52.67,6610.0,34 CDM,54800002,HC AMBULATORY BP MONITOR RPT AUTOMATED WORN 24 HRS LONGER SCAN ANLY W RPT,260.0,156.0,72.07,6610.0,34 CDM,54830001,HC STRESS ECHO W CONTINUOUS EKG WO CONT,2736.0,1641.6,516.24,4481.0,34 CDM,55100004,HC NEW PATIENT LEVEL 2,201.0,120.6,33.83,4481.0,23 CDM,55100006,HC NEW PATIENT LEVEL 3,249.0,149.4,41.91,4481.0,23 CDM,55100008,HC NEW PATIENT LEVEL 4,317.0,190.2,53.35,4481.0,23 CDM,55100010,HC NEW PATIENT LEVEL 5,371.0,222.6,62.44,4481.0,23 CDM,55100012,HC ESTABLISHED PATIENT LEVEL 1,181.0,108.6,30.46,4481.0,23 CDM,55100014,HC OUTPATIENT NURSE VISIT,182.0,109.2,30.63,4481.0,23 CDM,55100015,HC NURSE VISIT ESTAB PATIENT LVL1,182.0,109.2,30.63,4481.0,23 CDM,55100016,HC ESTABLISHED PATIENT LEVEL 2,227.0,136.2,38.2,4481.0,23 CDM,55100018,HC ESTABLISHED PATIENT LEVEL 3,267.0,160.2,44.94,4481.0,23 CDM,55100020,HC ESTABLISHED PATIENT LEVEL 4,406.0,243.6,68.33,4481.0,23 CDM,55100023,HC ESTABLISHED PATIENT LEVEL 5,437.0,262.2,73.55,4481.0,23 CDM,55100105,HC LACTATION INDIVIDUAL EDUCATION AND TRAINING FACE TO FACE EACH 30 MINS,123.0,73.8,20.7,4481.0,23 CDM,56230001,HC GLASCOCK EAR DRESSING KIT,97.0,58.2,22.5,4481.0,24 CDM,56360001,HC APLIGRAF PER SQ CM,106.0,63.6,24.59,4481.0,25 CDM,56360002,HC OASIS TISSUE NONHUM PER SQ CM,5.0,3.0,1.16,4481.0,25 CDM,56360003,HC DERMAGRAFT PER SQ CM,129.0,77.4,29.93,4481.0,25 CDM,56360013,HC DISCARDED DERMAGRAFT PER SQ CM,129.0,77.4,29.93,4481.0,24 CDM,56360026,HC GRAFIX CORE 2X3 PER SQCM,685.0,411.0,158.92,4481.0,25 CDM,56360027,HC GRAFIX CORE 5X5 PER SQCM,398.0,238.8,92.34,4481.0,25 CDM,56360028,HC GRAFIX PRIME 2X3 PER SQCM,685.0,411.0,158.92,4481.0,25 CDM,56360029,HC GRAFIX PRIME 5X5 PER SQCM,398.0,238.8,92.34,4481.0,25 CDM,56360032,HC OASIS ULTRA TRI LAYER MATRIX 3X3.5 CM PAD,52.0,31.2,5.6,4481.0,25 CDM,56360033,HC OASIS ULTRA TRI LAYER MATRIX 3X7 CM PAD,48.0,28.8,5.6,4481.0,25 CDM,56360034,HC OASIS ULTRA TRI LAYER MATRIX 5X7 CM PAD,31.0,18.6,5.6,4481.0,25 CDM,56360035,HC GRAFIX CORE 3X4 PER SQ CM,402.0,241.2,93.26,4481.0,25 CDM,56360036,HC GRAFIX PRIME 3X4 PER SQ CM,402.0,241.2,93.26,4481.0,25 CDM,56360037,HC GRAFIX CORE 1.5X2 PER SQ CM,950.0,570.0,220.4,4481.0,25 CDM,56360038,HC GRAFIX PRIME 1.5X2 PER SQ CM,950.0,570.0,220.4,4481.0,25 CDM,56360041,HC EPIFIX 2X4 PER SQ CM,191.0,114.6,44.31,4481.0,25 CDM,56360042,HC DISCARDED OASIS ULTRA TRI LAYER MATRIX 5X7 CM PAD PER SQ CM,31.0,18.6,5.6,4481.0,24 CDM,56360043,HC DISCARDED OASIS ULTRA TRI LAYER MATRIX 3X7 CM PAD PER SQ CM,48.0,28.8,5.6,4481.0,24 CDM,56360044,HC DISCARDED OASIS ULTRA TRI LAYER MATRIX 3X3.5 CM PAD PER SQ CM,52.0,31.2,5.6,4481.0,24 CDM,56360045,HC GRAFIX PRIME 14MM DISC PER SQ CM,802.0,481.2,186.06,4481.0,25 CDM,56360046,HC PURAPLY AM 4SQCM 2X2 PER SQ CM,528.0,316.8,122.5,4481.0,25 CDM,56360047,HC PURAPLY AM 8SQCM 2X4 PER SQ CM,400.0,240.0,92.8,4481.0,25 CDM,56360048,HC PURAPLY AM 25SQCM 5X5 PER SQ CM,400.0,240.0,92.8,4481.0,25 CDM,56360050,HC EPIFIX MESH 12.25SQCM 3.5X3.5 PER SQ CM,200.0,120.0,46.4,4481.0,25 CDM,56360051,HC EPIFIX 18MM DISC,1404.0,842.4,325.73,4481.0,25 CDM,56360052,HC EPIFIX MESH 4CMX4.5CM,148.0,88.8,34.34,4481.0,25 CDM,56360054,HC INTEGRA OMNIGRAFT 4X4 PER SQ CM,253.0,151.8,58.7,4481.0,25 CDM,56360056,HC DISCARDED PURAPLY AM 4SQCM 2X2 PER SQ CM,505.0,303.0,117.16,4481.0,24 CDM,56360057,HC DISCARDED PURAPLY AM 8SQCM 2X4 PER SQ CM,400.0,240.0,92.8,4481.0,24 CDM,56360058,HC DISCARDED PURAPLY AM 25SQCM 5X5 PER SQ CM,400.0,240.0,92.8,4481.0,24 CDM,56360062,HC THERASKIN 6SQCM 2X3 PER SQ CM,299.0,179.4,69.37,4481.0,25 CDM,56360074,HC GRAFIX PRIME 16 MM DISC PER SQ CM,8020.0,4812.0,312.17,6938.1,25 CDM,56360076,HC THERASKIN WOUND CTR 6.25 SQ CM 2.5 X 2.5 PER SQ CM,546.0,327.6,118.69,4481.0,25 CDM,56360077,HC THERASKIN WOUND CTR 12.75 SQ CM 2.5CM X 5.1CM PER SQ CM,281.0,168.6,65.19,4481.0,25 CDM,56360078,HC THERASKIN 39 SQ CM 5.1 X 7.6 PER SQ CM,123.0,73.8,28.54,4481.0,25 CDM,56360079,HC DISCARDED THERASKIN 2.5X2.5 PER SQ CM,546.0,327.6,118.69,4481.0,24 CDM,56360080,HC DISCARDED THERASKIN 2.5X5.1 PER SQ CM,281.0,168.6,65.19,4481.0,24 CDM,56360081,HC DISCARDED THERASKIN 5.1X7.6 PER SQ CM,123.0,73.8,28.54,4481.0,24 CDM,56360118,HC DISCARDED THERASKIN 6 SQCM 2X3 PER SQ CM,299.0,179.4,69.37,4481.0,24 CDM,56360145,HC DISCARDED INTEGRA OMNIGRAFT 4X4 PER SQ CM,253.0,151.8,58.7,4481.0,24 CDM,56360149,HC THERASKIN 7.6CM X 15.2CM PER SQ CM,58.0,34.8,13.46,4481.0,25 CDM,56360153,HC THERASKIN 4.0CM X 6.5CM PER SQ CM,81.0,48.6,18.79,4481.0,25 CDM,56360154,HC RESTRATA WOUND MATRIX 6.25 SQ CM 2.5 X 2.5 PER SQ CM,321.0,192.6,74.47,4481.0,25 CDM,56360155,HC DISCARDED RESTRATA WOUND MATRIX 2.5CM X 2.5CM PER SQ CM,321.0,192.6,74.47,4481.0,24 CDM,56360156,HC RESTRATA WOUND MATRIX 12.5 SQ CM 2.5 X 5 PER SQ CM,285.0,171.0,66.12,4481.0,25 CDM,56360157,HC DISCARDED RESTRATA WOUND MATRIX 2.5CM X 5.0CM PER SQ CM,267.0,160.2,61.94,4481.0,24 CDM,56360158,HC RESTRATA WOUND MATRIX 2.5CM X 7.5CM PER SQ CM,246.0,147.6,57.07,4481.0,25 CDM,56360159,HC DISCARDED RESTRATA WOUND MATRIX 2.5CM X 7.5CM PER SQ CM,246.0,147.6,57.07,4481.0,24 CDM,56360160,HC RESTRATA WOUND MATRIX 25 SQ CM 5 X 5 PER SQ CM,230.0,138.0,53.36,4481.0,25 CDM,56360161,HC DISCARDED RESTRATA WOUND MATRIX 5.0CM X 5.0CM PER SQ CM,230.0,138.0,53.36,4481.0,24 CDM,56360162,HC RESTRATA WOUND MATRIX 56.25 SQ CM 7.5 X 7.5 PER SQ CM,123.0,73.8,28.54,4481.0,25 CDM,56360163,HC DISCARDED RESTRATA WOUND MATRIX 7.5CM X 7.5CM PER SQ CM,123.0,73.8,28.54,4481.0,24 CDM,56360164,HC RESTRATA WOUND MATRIX 10CM X 12.5CM PER SQ CM,74.0,44.4,17.17,4481.0,25 CDM,56360165,HC DISCARDED RESTRATA WOUND MATRIX 10CM X 12.5CM PER SQ CM,74.0,44.4,17.17,4481.0,24 CDM,56360171,HC DISCARDED THERASKIN 4.0 X 6.5 PER SQ CM,81.0,48.6,18.79,4481.0,24 CDM,56360172,HC DISCARDED THERASKIN 7.6 X 15.2 PER SQ CM,58.0,34.8,13.46,4481.0,24 CDM,56360175,HC DISCARDED EPIFIX MESH 4CMX4.5CM,148.0,88.8,34.34,4481.0,24 CDM,56360177,HC DISCARDED EPIFIX 2X4 PER SQ CM,191.0,114.6,44.31,4481.0,24 CDM,56360178,HC DISCARDED EPIFIX MESH 12.25SQCM 3.5X3.5 PER SQ CM,200.0,120.0,46.4,4481.0,24 CDM,56360187,HC ACTIGRAFT AUTOLOGOUS WHOLE BLOOD MATRIX,513.0,307.8,119.02,4481.0,24 CDM,56360202,HC THERASKIN 116 SQ CM 7.6 X 15.24 PER SQ CM,57.0,34.2,13.22,4481.0,25 CDM,56360211,HC DISCARDED GRAFIX PRIME 3X4 PER SQ CM,402.0,241.2,93.26,4481.0,24 CDM,56360212,HC DISCARDED GRAFIX PRIME 5X5 PER SQCM,398.0,238.8,92.34,4481.0,24 CDM,56360226,HC GRAFIX PL 16 MM DISC,990.0,594.0,229.68,4481.0,25 CDM,56360230,HC RESTRATA MESHED 3.8CM X 5CM PER SQ CM,158.0,94.8,36.66,4481.0,27 CDM,56360232,HC RESTRATA WOUND MATRIX 3.5CM X 5.0CM PER SQ CM,238.0,142.8,55.22,4481.0,27 CDM,56360233,HC RESTRATA WOUND MATRIX 5.0CM X 5.0CM MESHED PER SHEET,5896.0,3537.6,1367.87,5167.25,27 CDM,56360244,HC SUPRA SDRM 26 SQ CM 5.1 X 5.1 PER SQ CM,104.0,62.4,24.13,4481.0,24 CDM,56360246,HC CYTAL BURN MATRIX 70 SQ CM 7 X 10 PER SQ CM,29.0,17.4,6.73,4481.0,25 CDM,56360247,HC MATRISTEM MICROMATRIX 500MG PER 1 MG,5.0,3.0,1.16,4481.0,25 CDM,56360248,HC MATRISTEM MICROMATRIX 1000MG PER 1 MG,4.0,2.4,0.928,4481.0,25 CDM,56360249,HC CYTAL BURN MATRIX 150 SQ CM 10 X 15 PER SQ CM,25.0,15.0,5.8,4481.0,25 CDM,56360250,HC CYTAL WOUND MATRIX 70 SQ CM 7 X 10 PER SQ CM,53.0,31.8,12.3,4481.0,25 CDM,56360251,HC CYTAL WOUND MATRIX 150 SQ CM 10 X 15 PER SQ CM,43.0,25.8,9.98,4481.0,25 CDM,56360252,HC RESTRATA WOUND MATRIX 19 SQ CM 3.8 X 5 PER SQ CM,158.0,94.8,36.66,4481.0,25 CDM,56360253,HC MAXXEUS CRYOPRESERVED NON MESH MATRIX 464 SQ CM PER SQ CM,4.0,2.4,0.928,4481.0,24 CDM,56360254,HC NOVOSORB SYNPATH DERMAL MATRIX BTM 800 SQ CM 20 X 40 PER SQ CM,21.0,12.6,4.87,4481.0,24 CDM,56360255,HC INTEGRA BILAYER MATRIX WOUND DRESSING 125 SQCM 10 X 12.5 PER SQ CM,92.0,55.2,21.34,4481.0,25 CDM,56360256,HC INTEGRA BILAYER MATRIX WOUND DRESSING 500 SQ CM 20 X 25 PER SQ CM,63.0,37.8,14.62,4481.0,25 CDM,56360257,HC INTEGRA BILAYER WOUND MATRIX 250 SQ CM 10 X 25 PER SQ CM,75.0,45.0,17.4,4481.0,25 CDM,56360258,HC THERASKIN OR 12.75 SQ CM 2.5CM X 5.1CM PER SQ CM,160.0,96.0,37.12,4481.0,25 CDM,56360259,HC THERASKIN OR 6.25 SQ CM 2.5CM X 2.5CM PER SQ CM,287.0,172.2,66.58,4481.0,25 CDM,56360260,HC CYTAL WOUND MATRIX 25 SQ CM 5 X 5 PER SQ CM,70.0,42.0,16.24,4481.0,25 CDM,56360261,HC MAXXEUS CRYOPRESERVED NON MESH MATRIX 232 SQ CM PER SQ CM,4.0,2.4,0.928,4481.0,24 CDM,56360262,HC CYTAL WOUND MATRIX 560 SQ CM 16 X 35 PER SQ CM,29.0,17.4,6.73,4481.0,25 CDM,56360263,HC CYTAL WOUND MATRIX 400 SQ CM 16 X 25 PER SQ CM,32.0,19.2,7.42,4481.0,25 CDM,56360264,HC BIODESIGN 6 SQ CM 2 X 3 PER SQ CM,85.0,51.0,19.72,4481.0,24 CDM,56360265,HC RESTRATA MINIMATRIX 250 MG PER 5 MG,60.0,36.0,13.92,4481.0,24 CDM,56360266,HC BIODESIGN 28 SQ CM 4 X 7 PER SQ CM,44.0,26.4,10.21,4481.0,24 CDM,56360268,HC THERAGENESIS MESHED BILAYER WOUND MATRIX 24 SQ CM 4 X 6 PER CM,146.0,87.6,33.87,4481.0,25 CDM,56360270,HC THERAGENESIS MESHED BILAYER WOUND MATRIX 73.8 SQ CM 8.2 X 9 PER CM,68.0,40.8,15.78,4481.0,25 CDM,56360272,HC THERAGENESIS MESHED BILAYER WOUND MATRIX 288 SQ CM 12 X 24 PER CM,38.0,22.8,8.82,4481.0,25 CDM,56360280,HC RESTRATA MINIMATRIX 1000 MG PER 5 MG,47.0,28.2,10.9,4481.0,24 CDM,56360281,HC RESTRATA MINIMATRIX 100 MG PER 5 MG,90.0,54.0,20.88,4481.0,24 CDM,56360283,HC RESTRATA MESHED 125 SQ CM 10 X 12.5 PER SQ CM,79.0,47.4,18.33,4481.0,25 CDM,56360284,HC RESTRATA MESHED 218.75 SQ CM 12.5 X 17.5 PER SQ CM,90.0,54.0,20.88,4481.0,25 CDM,56360285,HC RESTRATA MINIMATRIX 2000 MG PER 5 MG,42.0,25.2,9.74,4481.0,24 CDM,56360290,HC CYTAL WOUND MATRIX 10.5 SQ CM 3.5 X 3 PER SQ CM,17.0,10.2,3.94,4481.0,25 CDM,56360292,HC NOVOSORB SYNPATH DERMAL MATRIX BTM 200 SQ CM 10 X 20 PER SQ CM,21.0,12.6,4.87,4481.0,24 CDM,56360293,HC MATRISTEM MICROMATRIX 200MG PER 1 MG,6.0,3.6,1.39,4481.0,25 CDM,56360303,HC PERMEADERM B 322 SQ CM 12.7 X 25.4 PER SQ CM,1.0,0.6,0.232,4481.0,24 CDM,56360304,HC DISCARDED PERMEADERM B 322 SQ CM 12.7 X 25.4 PER SQ CM,1.0,0.6,0.232,4481.0,24 CDM,56360305,HC PERMEADERM B 968 SQ CM 25.4 X 38.1 PER SQ CM,1.0,0.6,0.232,4481.0,24 CDM,56360306,HC DISCARDED PERMEADERM B 968 SQ CM 25.4 X 38.1 PER SQ CM,1.0,0.6,0.232,4481.0,24 CDM,56360307,HC PERMEADERM B 2093 SQ CM 38.1 X 76.2 PER SQ CM,2.0,1.2,0.464,4481.0,24 CDM,56360308,HC DISCARDED PERMEADERM B 2093 SQ CM 38.1 X 76.2 PER SQ CM,2.0,1.2,0.464,4481.0,24 CDM,56360309,HC PERMEADERM GLOVE XL EACH GLOVE,569.0,341.4,132.01,4481.0,24 CDM,56360312,HC MICROMATRIX FLEX PER MG,7.0,4.2,1.62,4481.0,24 CDM,56360313,HC MATRISTEM MICROMATRIX 100MG PER 1 MG,6.0,3.6,1.39,4481.0,25 CDM,56360317,HC EPICEL 60 SQ CM 10 X 6 PER SQ CM,169.0,101.4,39.21,4481.0,24 CDM,56360321,HC KERECIS SURGICLOSE 70 SQ CM 7 X 10 PER SQ CM,98.0,58.8,22.74,4481.0,25 CDM,56360322,HC KERECIS SURGIBIND FENESTRATED 70 SQ CM 7 X 10 PER SQ CM,89.0,53.4,20.65,4481.0,25 CDM,56361002,HC AFFINITY 2.5CMX2.5CM PER SQ CM,346.0,207.6,80.27,4481.0,25 CDM,56361003,HC DISCARDED AFFINITY 2.5CMX2.5CM PER SQ CM,346.0,207.6,80.27,4481.0,24 CDM,56361004,HC NUSHIELD DISC 1.6 PER SQ CM,538.0,322.8,124.82,6264.85,25 CDM,56361005,HC DISCARDED NUSHIELD DISC 1.6 PER SQ CM,538.0,322.8,124.82,6264.85,24 CDM,56361006,HC NUSHIELD 2X3 PER SQ CM,289.0,173.4,67.05,6264.85,25 CDM,56361007,HC DISCARDED NUSHIELD 2X3 PER SQ CM,289.0,173.4,67.05,6264.85,24 CDM,56361008,HC NUSHIELD 2X4 PER SQ CM,259.0,155.4,60.09,6264.85,25 CDM,56361009,HC DISCARDED NUSHIELD 2X4 PER SQ CM,259.0,155.4,60.09,6264.85,24 CDM,56361010,HC NUSHIELD 3X4 PER SQ CM,254.0,152.4,58.93,6264.85,25 CDM,56361011,HC DISCARDED NUSHIELD 3X4 PER SQ CM,254.0,152.4,58.93,6264.85,24 CDM,56361012,HC NUSHIELD 4X4 PER SQ CM,254.0,152.4,58.93,6264.85,25 CDM,56361013,HC DISCARDED NUSHIELD 4X4 PER SQ CM,254.0,152.4,58.93,6264.85,24 CDM,56361014,HC NUSHIELD 4X6 PER SQ CM,237.0,142.2,54.98,6264.85,25 CDM,56361015,HC DISCARDED NUSHIELD 4X6 PER SQ CM,237.0,142.2,54.98,6264.85,24 CDM,56361016,HC NUSHIELD 6X6 PER SQ CM,215.0,129.0,49.88,6264.85,25 CDM,56361017,HC DISCARDED NUSHIELD 6X6 PER SQ CM,215.0,129.0,49.88,6264.85,24 CDM,56361073,HC INTEGRA MESHED DERMAL REGENERATION 125 SQ CM 4X5 PER SQ CM,74.0,44.4,17.17,4481.0,25 CDM,56361074,HC RESTRATA MESHED 56.25 SQ CM 7.5X7.5 PER SQ CM,133.0,79.8,30.86,4481.0,25 CDM,56361083,HC RESTRATA MINIMATRIX 500 MG PER 5 MG,50.0,30.0,11.6,4481.0,24 CDM,56361088,HC SUPRA SDRM 18MM DISC,1258.0,754.8,291.86,4481.0,24 CDM,56361095,HC SUPRA SDRM 4 SQ CM 2 X 2 PER SQ CM,450.0,270.0,104.4,4481.0,24 CDM,56361096,HC SUPRA SDRM 81 SQ CM 9 X 9 PER SQ CM,40.0,24.0,9.28,4481.0,24 CDM,56361097,HC SUPRA SDRM 108 SQ CM 9 X 12 PER SQ CM,48.0,28.8,11.14,4481.0,24 CDM,56361098,HC SUPRA SDRM 162 SQ CM 18 X 9 PER SQ CM,21.0,12.6,4.87,4481.0,24 CDM,56361099,HC SUPRA SDRM 324 SQ CM 18 X 18 PER SQ CM,21.0,12.6,4.87,4481.0,24 CDM,57100015,HC POST ANES RECOVERY 0-30MINS,271.5,162.9,15.78,4481.0,48 CDM,57100016,HC POST ANES RECOVERY 31-60MINS,404.5,242.7,32.25,4481.0,48 CDM,57100017,HC POST ANES RECOVERY 61-90MINS,540.5,324.3,48.95,4481.0,48 CDM,57300001,HC EKG,295.0,177.0,55.93,4481.0,34 CDM,57300008,HC ZP HOOKUP W RECORD GREATER THAN 48 HRS LESS THAN 7 DAYS,637.0,382.2,36.96,4481.0,34 CDM,57300009,HC ZP HOOKUP W RECORD GREATER THAN 7 DAYS LESS THAN 15 DAYS,637.0,382.2,36.96,4481.0,34 CDM,57300010,HC ZP SCANNING W REPORT GREATER THAN 48 HRS LESS THAN 7 DAYS,573.0,343.8,121.37,4481.0,34 CDM,57300011,HC ZP SCANNING W REPORT GREATER THAN 7 DAYS LESS THAN 15 DAYS,573.0,343.8,121.37,4481.0,34 CDM,57610036,HC INJECTION INTRALESIONAL 312 UNIT/ML (5 ML) INJECTION SOLN,3303.05,1981.83,64.64,4481.0,35 CDM,RX-126252,LIDOCAINE (PF) 20 MG/ML (2 %) INTRAVENOUS SOLUTION,30.65,18.39,0.0225,4481.0,24 CDM,RX-126393,ADALIMUMAB 40 MG/0.8 ML SUBCUTANEOUS PEN KIT,13515.15,8109.09,88.98,11691.96,34 CDM,RX-126420,TESTOSTERONE 50 MG/5 GRAM (1 %) TRANSDERMAL GEL,82.0,49.2,19.02,4481.0,19 CDM,RX-126458,"NEOMYCIN-BACITRACN ZN-POLYMYXN 3.5 MG-400 UNIT-5,000 UNIT TOP OINT PKT",1.25,0.75,0.29,4481.0,19 CDM,RX-126554,EPINEPHRINE HCL (PF) 1 MG/ML (1 ML) INJECTION SOLUTION,20.3,12.18,2.38,4481.0,24 CDM,RX-126644,HEPATITIS B IMMUNE GLOBULIN 110 UNIT/0.5 ML INTRAMUSCULAR SYRINGE,397.65,238.59,100.61,4481.0,36 CDM,RX-126862,"HEPATITIS A VACCINE (PF) 1,440 ELISA UNIT/ML INTRAMUSCULAR SYRINGE",278.25,166.95,64.55,4481.0,25 CDM,RX-126867,ZINC OXIDE 12.8 % TOPICAL OINTMENT,11.2,6.72,2.6,4481.0,19 CDM,RX-127020,HEPATITIS A AND B VIRUS VACCINE(PF)720 ELISA UNIT-20 MCG/ML IM SYRINGE,414.8,248.88,96.23,4481.0,25 CDM,RX-12724,TERBINAFINE HCL 250 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-127326,GENTAMICIN SULFATE (PEDIATRIC) (PF) 20 MG/2 ML INJECTION SOLUTION,40.1,24.06,4.97,4481.0,24 CDM,RX-127439,FAMOTIDINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION,64.5,38.7,0.0225,4481.0,24 CDM,RX-127496,MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK,112.0,67.2,1.08,4481.0,24 CDM,RX-127571,MAGNESIUM SULFATE 20 GRAM/500 ML (4 %) IN WATER INTRAVENOUS SOLUTION,85.9,51.54,1.08,4481.0,24 CDM,RX-127584,WHITE PETROLATUM-MINERAL OIL 80 %-20 % EYE OINTMENT,12.4,7.44,2.88,4481.0,19 CDM,RX-127606,PARENTERAL AMINO ACID 10 % COMBINATION NO.6 INTRAVENOUS SOLUTION,276.4,165.84,64.12,4481.0,24 CDM,RX-127647,TETANUS AND DIPHTHERIA TOX (PF) 5 LF UNIT-2 LF UNIT/0.5 ML IM SUSP,144.25,86.55,33.47,4481.0,25 CDM,RX-127698,PARENTERAL AMINO ACID 10 % COMBINATION NO.7 INTRAVENOUS SOLUTION,314.8,188.88,55.59,4481.0,38 CDM,RX-127700,PHENYTOIN 100 MG/4 ML ORAL SUSPENSION,36.1,21.66,8.38,4481.0,19 CDM,RX-127771,TETANUS IMMUNE GLOBULIN (PF) 250 UNIT/ML INTRAMUSCULAR SYRINGE,2430.25,1458.15,575.21,4481.0,35 CDM,RX-127818,MORPHINE (PF) 30 MG/30 ML (1 MG/ML) PCA INTRAVENOUS SOLUTION,64.2,38.52,14.89,4481.0,24 CDM,RX-127858,MILRINONE 40 MG/200 ML(200 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS PIGGYBK,184.95,110.97,3.26,4481.0,24 CDM,RX-127972,SALIVA STIMULANT COMBINATION NO.3 ORAL MUCOSAL SPRAY,9.75,5.85,2.26,4481.0,19 CDM,RX-127974,DIMETHYL SULFOXIDE 50 % INTRAVESICAL SOLUTION,2862.05,1717.23,724.1,4481.0,35 CDM,RX-127978,LIDOCAINE 2 % MUCOSAL JELLY IN APPLICATOR,23.7,14.22,5.5,4481.0,19 CDM,RX-127981,VINCRISTINE 1 MG/ML INTRAVENOUS SOLUTION (2 MG MAX DOSE),326.0,195.6,18.5,4481.0,24 CDM,RX-127983,LANOLIN ALCOHOLS-MINERAL OIL-W.PETROLATUM-CERESIN TOPICAL CREAM,1.05,0.63,0.2436,4481.0,19 CDM,RX-128003,CLEVIDIPINE 50 MG/100 ML INTRAVENOUS EMULSION,703.6,422.16,2.76,4481.0,35 CDM,RX-128026,THROMBIN(HUM PLAS)-FIBRIN-APROT-CA 2.5 TO 6.5 UNIT/ML(2ML) TOPICAL SYR,986.9,592.14,137.63,4481.0,34 CDM,RX-128027,THROMBIN(HUM PLAS)-FIBRIN-APROT-CA 2.5 TO 6.5 UNIT/ML(4ML) TOPICAL SYR,1665.3,999.18,137.63,4481.0,36 CDM,RX-128028,THROMBIN(HM PLAS)-FIBRIN-APROT-CA 2.5 TO 6.5 UNIT/ML(10ML) TOPICAL SYR,3699.8,2219.88,137.63,4481.0,36 CDM,RX-12803,PILOCARPINE 5 MG TABLET,22.85,13.71,5.3,4481.0,19 CDM,RX-128099,DOPAMINE 400 MG/10 ML (40 MG/ML) INTRAVENOUS SOLUTION,82.1,49.26,1.8,4481.0,24 CDM,RX-128197,FENTANYL (PF) 250 MCG/5 ML (50 MCG/ML) INTRAVENOUS SYRINGE,38.45,23.07,2.48,4481.0,24 CDM,RX-128202,LEVETIRACETAM 500 MG/5 ML (5 ML) ORAL SOLUTION,33.4,20.04,7.75,4481.0,19 CDM,RX-128227,HYLAN G-F 20 48 MG/6 ML INTRA-ARTICULAR SYRINGE,5357.55,3214.53,7.71,4481.0,35 CDM,RX-128364,MULTIVITAMIN-IRON 9 MG-FOLIC ACID 400 MCG-CALCIUM AND MINERALS TABLET,1.25,0.75,0.29,4481.0,19 CDM,RX-128492,THYROID (PORK) 30 MG TABLET,18.1,10.86,4.2,4481.0,19 CDM,RX-128494,THYROID (PORK) 90 MG TABLET,19.6,11.76,4.55,4481.0,19 CDM,RX-128540,TREPROSTINIL 1.74 MG/2.9 ML (0.6 MG/ML) SOLUTION FOR NEBULIZATION,2396.0,1437.6,555.87,4481.0,23 CDM,RX-128552,MAGNESIUM OXIDE-MAGNESIUM AMINO ACID CHELATE 133 MG TABLET,1.15,0.69,0.2668,4481.0,19 CDM,RX-128669,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL SOLUTION,3.55,2.13,0.8236,4481.0,19 CDM,RX-128755,SODIUM CITRATE 4 % (3 ML) INTRA-CATHETER INJECTION SYRINGE,51.8,31.08,12.02,4481.0,19 CDM,RX-128763,WHITE PETROLATUM-MINERAL OIL 57.3 %-42.5 % EYE OINTMENT,14.3,8.58,3.32,4481.0,19 CDM,RX-128781,METHYLPREDNISOLONE SOD SUCC (PF) 40 MG/ML SOLUTION FOR INJECTION,41.25,24.75,0.2037,4481.0,35 CDM,RX-128782,METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/2 ML SOLUTION FOR INJECTION,56.65,33.99,0.2037,4481.0,35 CDM,RX-128805,"HEPARIN (PORCINE) 5,000 UNIT/ML (1 ML) INJECTION CARTRIDGE",29.7,17.82,0.4725,4481.0,24 CDM,RX-128832,ZINC OXIDE-COD LIVER OIL 40 % TOPICAL PASTE,10.85,6.51,2.52,4481.0,19 CDM,RX-12886,CLARITHROMYCIN 250 MG/5 ML ORAL SUSPENSION,539.5,323.7,125.16,4481.0,19 CDM,RX-128932,MULTIVIT AND MINERALS-FERROUS GLUCONATE 9 MG IRON/15 ML ORAL LIQUID,1.45,0.87,0.3364,4481.0,19 CDM,RX-128975,HYDROCORTISONE SOD SUCCINATE (PF) 250 MG/2 ML SOLUTION FOR INJECTION,189.7,113.82,44.01,4481.0,24 CDM,RX-128976,HYDROCORTISONE SOD SUCCINATE (PF) 100 MG/2 ML SOLUTION FOR INJECTION,109.9,65.94,25.5,4481.0,24 CDM,RX-129072,PRENATAL VITAMINS WITH CALCIUM NO.72-IRON 27 MG-FOLIC ACID 1 MG TABLET,1.15,0.69,0.2668,4481.0,19 CDM,RX-129093,FENTANYL (PF) 100 MCG/10 ML (10 MCG/ML) IN 0.9 % NACL IV SYRINGE,25.15,15.09,2.48,4481.0,24 CDM,RX-129095,NOREPINEPHRINE BITARTRATE 8 MG/250 ML (32 MCG/ML) IN DEXTROSE 5 % IV,189.7,113.82,44.01,4481.0,19 CDM,RX-129101,PHENYLEPHRINE 0.8 MG/10 ML (80 MCG/ML) IN 0.9 %SOD.CHLORIDE IV SYRINGE,18.05,10.83,0.0225,4481.0,24 CDM,RX-129103,SUCCINYLCHOLINE CHLORIDE 100 MG/5 ML (20 MG/ML) INTRAVENOUS SYRINGE,91.65,54.99,2.07,4481.0,24 CDM,RX-129162,THIAMINE MONONITRATE (VITAMIN B1) 100 MG TABLET,1.3,0.78,0.3016,4481.0,19 CDM,RX-129312,FENTANYL (PF) 50 MCG/ML INTRAVENOUS SOLUTION,72.3,43.38,2.48,4481.0,24 CDM,RX-129315,MIDAZOLAM 10 MG/5 ML (2 MG/ML) ORAL SYRUP,40.6,24.36,9.42,4481.0,19 CDM,RX-12933,"TACROLIMUS 1 MG CAPSULE, IMMEDIATE-RELEASE",20.5,12.3,0.3825,4481.0,24 CDM,RX-12934,"TACROLIMUS 5 MG CAPSULE, IMMEDIATE-RELEASE",51.9,31.14,0.3825,4481.0,24 CDM,RX-12935,TACROLIMUS 5 MG/ML INTRAVENOUS SOLUTION,64.35,38.61,16.28,4481.0,35 CDM,RX-129380,IMMUNE GLOBU G 1 GRAM/10 ML(10 %)-GLY-IGA AVE 46 MCG/ML INFUSION SOLN,616.2,369.72,47.49,7576.38,35 CDM,RX-129383,IMMUNE GLOB G 10 GRAM/100 ML(10%)-GLY-IGA AVE 46 MCG/ML INFUSION SOLN,5468.85,3281.31,47.49,7576.38,35 CDM,RX-129384,IMMUNE GLOB G 20 GRAM/200 ML(10%)-GLY-IGA AVE 46 MCG/ML INFUSION SOLN,10860.65,6516.39,47.49,8688.52,35 CDM,RX-129423,TETRACAINE HCL (PF) 0.5 % EYE DROPS,57.8,34.68,13.41,4481.0,19 CDM,RX-129515,LIDOCAINE 0.9 % BUFFERED WITH 8.4 % SODIUM BICARB (1 ML) INJ SYRINGE,16.15,9.69,3.75,4481.0,19 CDM,RX-129549,IRON SUCROSE 200 MG IRON/10 ML INTRAVENOUS SOLUTION,275.4,165.24,0.5175,4481.0,24 CDM,RX-129667,LEUPROLIDE 7.5 MG INTRAMUSCULAR SYRINGE KIT,7379.3,4427.58,171.16,26039.58,35 CDM,RX-129759,METHOHEXITAL 100 MG/10 ML (10 MG/ML) IN STERILE WATER (PF) IV SYRINGE,113.75,68.25,26.39,4481.0,19 CDM,RX-129810,EPOPROSTENOL 1.5 MG INTRAVENOUS SOLUTION,243.75,146.25,36.45,4481.0,24 CDM,RX-129817,"FENTANYL (PF) 2,500 MCG/50 ML (50 MCG/ML) INTRAVENOUS PCA SYRINGE",75.6,45.36,2.48,4481.0,24 CDM,RX-1299,"CALCIUM 500 MG/5 ML (AS CALCIUM CARB 1,250 MG/5 ML) ORAL SUSPENSION",4.325,2.595,0.3016,4481.0,38 CDM,RX-129912,HYDROMORPHONE 50 MG/50 ML (1 MG/ML) IN 0.9 % SOD.CHLORIDE IV PUMP RESV,329.05,197.43,0.2025,4481.0,24 CDM,RX-129917,"ANTIHEMOPHILIC FVIII,REC B-DOMAIN DELETED 1,000 (+/-) UNIT IV SYRINGE",83.6,50.16,1.62,4481.0,35 CDM,RX-129978,PHENYLEPHRINE 20 MG/250 ML (80 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,121.3,72.78,0.0225,4481.0,24 CDM,RX-129983,MORPHINE (PF) 100 MG/100 ML(1 MG/ML) IN 0.9% SOD.CHLORIDE IV PUMP RESV,52.45,31.47,12.17,4481.0,19 CDM,RX-130097,DOCUSATE SODIUM 283 MG/5 ML ENEMA,2.75,1.65,0.638,4481.0,19 CDM,RX-130109,VALPROIC ACID (AS SODIUM SALT) 250 MG/5 ML (5 ML) ORAL SOLUTION,20.15,12.09,4.67,4481.0,19 CDM,RX-130136,MORPHINE (PF) 2 MG/2 ML(1 MG/ML) IN 0.9% SODIUM CHLORIDE IV SYRINGE,36.25,21.75,8.41,4481.0,24 CDM,RX-130151,POVIDONE-IODINE 10 % TOPICAL LIQUID PACKET,2.55,1.53,0.5916,4481.0,19 CDM,RX-1302,"CALCIUM 600 MG (AS CALCIUM CARBONATE 1,500 MG) TABLET",1.05,0.63,0.2436,4481.0,19 CDM,RX-130235,"MVI,ADULT NO.4 WITH VIT K 3300 UNIT-150 MCG/10 ML INTRAVENOUS SOLUTION",71.45,42.870000000000005,15.52,4481.0,38 CDM,RX-130353,ISOFLURANE 99.9 % INHALATION LIQUID,182.0,109.2,42.22,4481.0,19 CDM,RX-130441,EPINEPHRINE HCL 8 MG/250 ML (32 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS,271.6,162.96,63.01,4481.0,19 CDM,RX-130504,C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION,16675.3,10005.18,73.58,13340.24,35 CDM,RX-1306,CALCIUM CHLORIDE 100 MG/ML (10 %) INTRAVENOUS SYRINGE,55.0,33.0,0.0675,4481.0,24 CDM,RX-130603,HEPATITIS A VIRUS VACCINE (PF) 25 UNIT/0.5 ML INTRAMUSCULAR SYRINGE,139.75,83.85,32.42,4481.0,25 CDM,RX-130797,GABAPENTIN 300 MG/6 ML (6 ML) ORAL SOLUTION,27.25,16.35,6.32,4481.0,19 CDM,RX-1308,CALCIUM 200 MG (AS CALCIUM CITRATE 950 MG) TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-130862,EPOPROSTENOL 0.5 MG INTRAVENOUS SOLUTION,153.4,92.04,35.59,4481.0,24 CDM,RX-130882,ATROPINE 0.8 MG/2 ML (0.4 MG/ML) INTRAVENOUS SYRINGE,68.8,41.28,0.198,4481.0,24 CDM,RX-13089,LISINOPRIL 2.5 MG TABLET,16.1,9.66,3.74,4481.0,19 CDM,RX-130928,HYDROCODONE-HOMATROPINE 5 MG-1.5 MG/5 ML (5 ML) ORAL SOLUTION,24.25,14.55,5.63,4481.0,19 CDM,RX-131010,MULTIVIT-MINS-FERROUS GLUCONATE 9 MG IRON/15 ML (15 ML) ORAL LIQUID,5.1,3.06,1.18,4481.0,19 CDM,RX-131011,MEGESTROL 400 MG/10 ML (10 ML) ORAL SUSPENSION,41.75,25.05,9.69,4481.0,19 CDM,RX-1312,CALCIUM GLUCONATE 100 MG/ML (10 %) INTRAVENOUS SOLUTION,75.625,45.375,0.09,4481.0,48 CDM,RX-13133,VALACYCLOVIR 500 MG TABLET,25.6,15.36,5.94,4481.0,19 CDM,RX-1350,CAPSAICIN 0.025 % TOPICAL CREAM,11.8,7.08,2.74,4481.0,19 CDM,RX-13506,DESMOPRESSIN 150 MCG/SPRAY (0.1 ML) NASAL SPRAY,1220.0,732.0,283.04,4481.0,19 CDM,RX-1355,CARBAMAZEPINE 100 MG CHEWABLE TABLET,17.5,10.5,4.06,4481.0,19 CDM,RX-1357,CARBAMAZEPINE 200 MG TABLET,18.7,11.22,4.34,4481.0,19 CDM,RX-13577,FLUCONAZOLE 150 MG TABLET,22.05,13.23,5.12,4481.0,19 CDM,RX-13691,LEUPROLIDE 3.75 MG INTRAMUSCULAR SYRINGE KIT,6236.7,3742.02,1577.89,252434.28,35 CDM,RX-13818,BACITRACIN ZINC 500 UNIT/GRAM TOPICAL OINTMENT,8.25,4.95,1.91,4481.0,19 CDM,RX-13860,SODIUM HYDROXIDE (BULK) 10 % SOLUTION,50.1,30.06,4.69,4481.0,38 CDM,RX-13884,COLESTIPOL 1 GRAM TABLET,19.2,11.52,4.45,4481.0,19 CDM,RX-13981,LAMOTRIGINE 25 MG TABLET,16.6,9.96,3.85,4481.0,19 CDM,RX-13982,LAMOTRIGINE 100 MG TABLET,16.6,9.96,3.85,4481.0,19 CDM,RX-14057,AMPICILLIN-SULBACTAM 15 GRAM SOLUTION FOR INJECTION,272.65,163.59,3.13,4481.0,24 CDM,RX-14123,BALANCED SALT IRRIGATION INTRAOCULAR SOLUTION COMBINATION NO.1,373.5,224.1,86.65,4481.0,19 CDM,RX-14132,KETOCONAZOLE 2 % SHAMPOO,82.5,49.5,19.14,4481.0,19 CDM,RX-14203,VINORELBINE 10 MG/ML INTRAVENOUS SOLUTION,357.75,214.65,5.33,4481.0,24 CDM,RX-14233,FLUCONAZOLE 40 MG/ML ORAL SUSPENSION,192.55,115.53,44.67,4481.0,19 CDM,RX-1445,CEFAZOLIN 1 GRAM SOLUTION FOR INJECTION,67.5,40.5,1.8,4481.0,24 CDM,RX-1446,CEFAZOLIN 10 GRAM SOLUTION FOR INJECTION,59.1,35.46,1.8,4481.0,24 CDM,RX-14471,DORZOLAMIDE 2 % EYE DROPS,91.25,54.75,21.17,4481.0,19 CDM,RX-14472,PORFIMER 75 MG INTRAVENOUS SOLUTION,77474.15,46484.49,4481.0,466585.35,35 CDM,RX-14550,TERAZOSIN 1 MG CAPSULE,16.55,9.93,3.84,4481.0,19 CDM,RX-14551,TERAZOSIN 2 MG CAPSULE,16.55,9.93,3.84,4481.0,19 CDM,RX-14552,TERAZOSIN 10 MG CAPSULE,16.55,9.93,3.84,4481.0,19 CDM,RX-14553,TERAZOSIN 5 MG CAPSULE,16.55,9.93,3.84,4481.0,19 CDM,RX-14632,TRAMADOL 50 MG TABLET,22.45,13.47,5.21,4481.0,19 CDM,RX-14634,CYTOMEGALOVIRUS IMMUNE GLOBULIN 50 MG/ML INTRAVENOUS SOLUTION,6445.6,3867.36,1630.74,321716.85,35 CDM,RX-14643,"EPOETIN ALFA 20,000 UNIT/ML INJECTION SOLUTION",2100.55,1260.33,8.28,4481.0,33 CDM,RX-1465,CEFUROXIME SODIUM 750 MG SOLUTION FOR INJECTION,27.4,16.44,4.16,4481.0,24 CDM,RX-14719,METFORMIN 850 MG TABLET,16.65,9.99,3.86,4481.0,19 CDM,RX-14720,GRANISETRON HCL 1 MG TABLET,46.0,27.6,10.67,4481.0,19 CDM,RX-14792,TIZANIDINE 2 MG TABLET,19.25,11.55,4.47,4481.0,19 CDM,RX-14793,TIZANIDINE 4 MG TABLET,17.95,10.77,4.16,4481.0,19 CDM,RX-14823,LOSARTAN 25 MG TABLET,17.55,10.53,4.07,4481.0,19 CDM,RX-14824,LOSARTAN 50 MG TABLET,17.85,10.71,4.14,4481.0,19 CDM,RX-14825,FOSFOMYCIN TROMETHAMINE 3 GRAM ORAL PACKET,257.0,154.2,59.62,4481.0,19 CDM,RX-14845,"DOPAMINE 400 MG/250 ML (1,600 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS SOLN",117.3,70.38,1.8,4481.0,24 CDM,RX-14847,DOXYLAMINE SUCCINATE 25 MG TABLET,1.3,0.78,0.3016,4481.0,19 CDM,RX-14869,LIDOCAINE (PF) 8 MG/ML (0.8 %) IN 5 % DEXTROSE INTRAVENOUS SOLUTION,92.55,55.53,0.0225,4481.0,24 CDM,RX-14870,"LIDOCAINE-EPINEPHRINE 0.5 %-1:200,000 INJECTION SOLUTION",16.35,9.81,0.0225,4481.0,24 CDM,RX-14953,ATOVAQUONE 750 MG/5 ML ORAL SUSPENSION,115.5,69.3,26.8,4481.0,19 CDM,RX-14979,"WATER FOR INJECTION, BACTERIOSTATIC INJECTION SOLUTION",40.5,24.3,9.4,4481.0,19 CDM,RX-15065,FAMOTIDINE 10 MG TABLET,1.15,0.69,0.2668,4481.0,19 CDM,RX-15156,DEXRAZOXANE HCL 250 MG INTRAVENOUS SOLUTION,1085.65,651.39,61.17,12799.29,35 CDM,RX-15157,DEXRAZOXANE HCL 500 MG INTRAVENOUS SOLUTION,2155.2,1293.12,61.17,12799.29,35 CDM,RX-15327,SUMATRIPTAN 25 MG TABLET,17.0,10.2,3.94,4481.0,19 CDM,RX-15328,SUMATRIPTAN 50 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-15330,ADENOSINE (DIAGNOSTIC) 3 MG/ML INTRAVENOUS SOLUTION,573.75,344.25,1.25,4481.0,24 CDM,RX-15349,CETIRIZINE 5 MG TABLET,1.25,0.75,0.29,4481.0,19 CDM,RX-15426,LEUCOVORIN CALCIUM 200 MG SOLUTION FOR INJECTION,172.0,103.2,7.25,4481.0,24 CDM,RX-15706,SODIUM CITRATE-CITRIC ACID 500 MG-334 MG/5 ML ORAL SOLUTION,15.95,9.57,2.06,4481.0,38 CDM,RX-15723,SOTALOL 120 MG TABLET,17.15,10.29,3.98,4481.0,19 CDM,RX-15738,CALCITONIN (SALMON) 200 UNIT/ACTUATION NASAL SPRAY,241.4,144.84,56.0,4481.0,19 CDM,RX-15746,BICALUTAMIDE 50 MG TABLET,28.05,16.83,6.51,4481.0,19 CDM,RX-15749,CARVEDILOL 12.5 MG TABLET,16.15,9.69,3.75,4481.0,19 CDM,RX-15797,AZITHROMYCIN 200 MG/5 ML ORAL SUSPENSION,76.05,45.63,17.64,4481.0,19 CDM,RX-15847,"HEPARIN (PORCINE) (PF) 1,000 UNIT/500 ML IN 0.9 % SODIUM CHLORIDE IV",82.05,49.23,0.4725,4481.0,24 CDM,RX-15849,"HEPARIN (PORCINE) 25,000 UNIT/250 ML IN 0.45 % SODIUM CHLORIDE IV SOLN",104.0,62.4,0.4725,4481.0,24 CDM,RX-15852,MORPHINE (PF) 1 MG/ML INJECTION SOLUTION,28.35,17.01,6.58,4481.0,48 CDM,RX-15859,NITROGLYCERIN 50 MG/250 ML (200 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS,148.75,89.25,3.35,4481.0,24 CDM,RX-15880,LAMIVUDINE 150 MG TABLET,38.5,23.1,8.93,4481.0,19 CDM,RX-15881,LAMIVUDINE 10 MG/ML ORAL SOLUTION,348.65,209.19,80.89,4481.0,19 CDM,RX-15950,SODIUM HYPOCHLORITE 0.25 % SOLUTION,23.0,13.8,5.34,4481.0,19 CDM,RX-15956,"LIDOCAINE-EPINEPHRINE (PF) 1.5 %-1:200,000 INJECTION SOLUTION",18.35,11.01,0.0225,4481.0,24 CDM,RX-15985,"LIDOCAINE-EPINEPHRINE (PF) 1 %-1:200,000 INJECTION SOLUTION",18.05,10.83,0.0225,4481.0,24 CDM,RX-15996,METHADONE 10 MG/ML ORAL CONCENTRATE,26.85,16.11,6.23,4481.0,19 CDM,RX-16005,TRETINOIN (ANTINEOPLASTIC) 10 MG CAPSULE,132.6,79.56,30.76,4481.0,19 CDM,RX-16014,POTASSIUM CHLORIDE 20 MEQ/L-LACTATED RINGERS-5 % DEXTROSE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 CDM,RX-16050,GLUCOSE 4 GRAM CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-16052,DESMOPRESSIN 0.1 MG TABLET,18.25,10.95,4.23,4481.0,19 CDM,RX-16124,RILUZOLE 50 MG TABLET,18.0,10.8,4.18,4481.0,19 CDM,RX-16162,MAGNESIUM SULFATE 1 GRAM/100 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,98.45,59.07,1.08,4481.0,24 CDM,RX-16168,CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTION,49.15,29.490000000000002,10.05,4481.0,38 CDM,RX-16169,CISATRACURIUM CONCENTRATE 10 MG/ML (ICU USE ONLY) INTRAVENOUS SOLUTION,665.75,399.45,154.45,4481.0,19 CDM,RX-16205,ANASTROZOLE 1 MG TABLET,26.2,15.72,6.08,4481.0,19 CDM,RX-16218,CALCITRIOL 1 MCG/ML ORAL SOLUTION,36.05,21.63,8.36,4481.0,19 CDM,RX-1623,CHLORDIAZEPOXIDE 25 MG CAPSULE,23.65,14.19,5.49,4481.0,19 CDM,RX-162737,LINACLOTIDE 145 MCG CAPSULE,72.8,43.68,16.89,4481.0,19 CDM,RX-162827,DARUNAVIR 800 MG TABLET,25.9,15.54,6.01,4481.0,19 CDM,RX-162964,MAGNESIUM CARBONATE 54 MG/5 ML ORAL LIQUID,42.65,25.59,9.89,4481.0,19 CDM,RX-163024,APIXABAN 2.5 MG TABLET,46.35,27.81,10.75,4481.0,19 CDM,RX-163053,PONATINIB 15 MG TABLET,3134.35,1880.61,727.17,4481.0,19 CDM,RX-163073,"METHYLPHENIDATE 5 MG/ML (25 MG/5 ML) ORAL SUSP,EXTENDED RELEASE 24 HR",45.15,27.09,10.47,4481.0,19 CDM,RX-163141,APIXABAN 5 MG TABLET,46.35,27.81,10.75,4481.0,19 CDM,RX-163231,LEVONORGESTREL 14 MCG/24 HR (UP TO 3 YRS) 13.5 MG INTRAUTERINE DEVICE,4067.55,2440.53,943.67,165907.14,24 CDM,RX-163306,"BACLOFEN 40,000 MCG/20 ML (2,000 MCG/ML) INTRATHECAL SYRINGE",4337.55,2602.53,175.78,4481.0,35 CDM,RX-1634,CHLOROPROCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION,110.8,66.48,0.09,4481.0,24 CDM,RX-163403,GLYCEROL PHENYLBUTYRATE 1.1 GRAM/ML ORAL LIQUID,17758.0,10654.8,4119.86,14206.4,19 CDM,RX-1635,CHLOROPROCAINE (PF) 30 MG/ML (3 %) INJECTION SOLUTION,103.3,61.98,0.09,4481.0,24 CDM,RX-163525,ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION,13480.7,8088.42,40.9,10784.56,35 CDM,RX-163526,ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION,21404.1,12842.46,40.9,17123.28,35 CDM,RX-163569,"ARIPIPRAZOLE ER 400 MG INTRAMUSCULAR SUSPENSION,EXTENDED RELEASE",0.2,0.12,0.0506,4481.0,35 CDM,RX-16369,CEFEPIME 1 GRAM SOLUTION FOR INJECTION,35.7,21.42,2.75,4481.0,24 CDM,RX-16371,CEFEPIME 2 GRAM SOLUTION FOR INJECTION,55.2,33.12,2.75,4481.0,24 CDM,RX-163918,DEXMEDETOMIDINE 400 MCG/100 ML (4 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,234.7,140.82,54.45,4481.0,19 CDM,RX-1649,CHLORPROMAZINE 25 MG/ML INJECTION SOLUTION,136.89999999999998,82.14,29.86,4481.0,48 CDM,RX-1653,CHLORPROMAZINE 10 MG TABLET,28.9,17.34,6.7,4481.0,19 CDM,RX-1654,CHLORPROMAZINE 100 MG TABLET,22.8,13.68,5.29,4481.0,19 CDM,RX-1656,CHLORPROMAZINE 25 MG TABLET,18.6,11.16,4.32,4481.0,19 CDM,RX-1661,CHLORTHALIDONE 25 MG TABLET,21.75,13.05,5.05,4481.0,19 CDM,RX-16632,PAROXETINE 10 MG TABLET,18.0,10.8,4.18,4481.0,19 CDM,RX-168114,"DIPHTH,PERTUSSIS(ACEL),TETANUS 2.5 LF UNIT-8 MCG-5 LF/0.5ML IM SYRINGE",161.5,96.9,37.47,4481.0,25 CDM,RX-168118,TRACE ELEMENTS (ADDAMEL) #1 5.33 MCG-0.34 MG-0.54 MG/ML INTRAVENOUS SOLUTION,78.4,47.04,18.19,4481.0,19 CDM,RX-168122,"TACROLIMUS XL 5 MG CAPSULE,EXTENDED RELEASE 24 HR",102.7,61.62,1.33,4481.0,24 CDM,RX-168273,FLUTICASONE FUROATE 100 MCG-VILANTEROL 25 MCG/DOSE INHALATION POWDER,488.25,292.95,113.27,4481.0,19 CDM,RX-16830,MELATONIN 3 MG TABLET,1.2,0.72,0.2784,4481.0,19 CDM,RX-168357,DICYCLOMINE 10 MG/5 ML ORAL SOLUTION,16.75,10.05,3.89,4481.0,19 CDM,RX-168440,NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTION,51.1,30.66,1.73,4481.0,24 CDM,RX-1685,CHROMIUM CHLORIDE 4 MCG/ML INTRAVENOUS SOLUTION,87.35,52.41,20.27,4481.0,19 CDM,RX-168575,COAGULATION FACTOR IX (RECOMB) 250 UNIT INTRAVENOUS SOLUTION,83.0,49.8,1.79,4481.0,35 CDM,RX-168576,COAGULATION FACTOR IX (RECOMB) 500 UNIT INTRAVENOUS SOLUTION,83.0,49.8,1.79,4481.0,35 CDM,RX-168577,"COAGULATION FACTOR IX (RECOMB) 1,000 UNIT INTRAVENOUS SOLUTION",83.0,49.8,1.79,4481.0,35 CDM,RX-168623,COPPER 380 SQUARE MM INTRAUTERINE DEVICE,4578.0,2746.8,1062.1,170749.32,24 CDM,RX-168624,DEXTROSE 2.45 GRAM-SOD CITRATE 2.2 GRAM-CITRIC AC 730 MG/100 ML SOLN,153.0,91.8,35.5,4481.0,19 CDM,RX-168656,AFATINIB 20 MG TABLET,1597.25,958.35,370.56,4481.0,22 CDM,RX-168657,AFATINIB 30 MG TABLET,1597.25,958.35,370.56,4481.0,22 CDM,RX-168658,AFATINIB 40 MG TABLET,1597.25,958.35,370.56,4481.0,22 CDM,RX-168682,GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION,6600.4,3960.24,10.71,5280.32,35 CDM,RX-168702,"TACROLIMUS XL 1 MG CAPSULE,EXTENDED RELEASE 24 HR",33.35,20.01,1.33,4481.0,24 CDM,RX-168748,CLOBAZAM 2.5 MG/ML ORAL SUSPENSION,51.525000000000006,30.915,9.59,4481.0,38 CDM,RX-168817,DOLUTEGRAVIR 50 MG TABLET,248.55,149.13,57.66,4481.0,19 CDM,RX-168972,LURASIDONE 60 MG TABLET,157.9,94.74,36.63,4481.0,19 CDM,RX-169081,VORTIOXETINE 5 MG TABLET,67.45,40.47,15.65,4481.0,19 CDM,RX-169082,VORTIOXETINE 10 MG TABLET,67.45,40.47,15.65,4481.0,19 CDM,RX-169083,VORTIOXETINE 20 MG TABLET,67.45,40.47,15.65,4481.0,19 CDM,RX-169109,RIOCIGUAT 0.5 MG TABLET,486.35,291.81,112.83,4481.0,19 CDM,RX-169110,RIOCIGUAT 1 MG TABLET,486.35,291.81,112.83,4481.0,19 CDM,RX-169113,RIOCIGUAT 2.5 MG TABLET,486.35,291.81,112.83,4481.0,19 CDM,RX-169182,MACITENTAN 10 MG TABLET,1311.5,786.9,304.27,4481.0,19 CDM,RX-170645,LIDOCAINE-XYLOMETAZOLINE 4%-0.1% NASAL SOLUTION,32.5,19.5,7.54,4481.0,19 CDM,RX-170650,EPINEPHRINE 90 MG/1000 ML NS IRRIGATION,2531.85,1519.11,1.08,4481.0,24 CDM,RX-170657,STUDY RESEARCH EMERGENCY MEDICATION,0.2,0.12,0.0464,4481.0,17 CDM,RX-170663,STUDY 2474 ULARITIDE/PLACEBO 2.5 MG/5ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-170665,ALEMTUZUMAB (CAMPATH) SYRINGE 3 MG/ML (ONCOLOGY),0.2,0.12,0.0506,379123.29,35 CDM,RX-170902,MIDAZOLAM (PF) 5 MG/ML INJECTION SOLUTION,25.8,15.48,0.3375,4481.0,48 CDM,RX-170903,MIDAZOLAM (PF) 1 MG/ML INJECTION SOLUTION,22.35,13.41,0.3375,4481.0,24 CDM,RX-170938,"OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION",30065.95,18039.57,76.63,24052.76,35 CDM,RX-170971,WHITE PETROLATUM 42 % TOPICAL OINTMENT,9.85,5.91,2.29,4481.0,19 CDM,RX-171171,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 1,500 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 CDM,RX-17121,GEMCITABINE 200 MG INTRAVENOUS SOLUTION,315.05,189.03,7.04,4481.0,24 CDM,RX-17122,GEMCITABINE 1 GRAM INTRAVENOUS SOLUTION,413.65,248.19,7.04,4481.0,24 CDM,RX-171862,DROXIDOPA 100 MG CAPSULE,19.35,11.61,4.49,4481.0,19 CDM,RX-171864,DROXIDOPA 300 MG CAPSULE,190.9,114.54,44.29,4481.0,19 CDM,RX-171941,EMPAGLIFLOZIN 25 MG TABLET,78.95,47.37,18.32,4481.0,19 CDM,RX-171943,EMPAGLIFLOZIN 10 MG TABLET,78.95,47.37,18.32,4481.0,19 CDM,RX-172066,POLIDOCANOL 1 % INTRAVENOUS FOAM,1223.85,734.31,283.93,4481.0,19 CDM,RX-172068,"TREPROSTINIL DIOLAMINE ER 0.25 MG TABLET,EXTENDED RELEASE",60.55,36.33,14.05,4481.0,19 CDM,RX-172070,"TREPROSTINIL DIOLAMINE ER 1 MG TABLET,EXTENDED RELEASE",194.2,116.52,45.05,4481.0,19 CDM,RX-172071,"TREPROSTINIL DIOLAMINE ER 2.5 MG TABLET,EXTENDED RELEASE",461.4,276.84,107.04,4481.0,19 CDM,RX-172072,UMECLIDINIUM 62.5 MCG-VILANTEROL 25 MCG/ACTUATION POWDR FOR INHALATION,369.85,221.91,85.81,4481.0,19 CDM,RX-172122,ELOSULFASE ALFA 5 MG/5 ML (1 MG/ML) INTRAVENOUS SOLUTION,4990.9,2994.54,299.42,48111.63,35 CDM,RX-172195,TESTOSTERONE UNDECANOATE 750 MG/3 ML (250MG/ML) INTRAMUSCULAR SOLUTION,6260.2,3756.12,2.01,5415.7,35 CDM,RX-172210,MORPHINE 2 MG/ML INTRAVENOUS SYRINGE,28.45,17.07,4.91,4481.0,24 CDM,RX-172219,GLUTAMINE 15 GRAM ORAL POWDER PACKET,3.95,2.37,0.9164,4481.0,19 CDM,RX-172244,POSACONAZOLE 300 MG/16.7 ML INTRAVENOUS SOLUTION,1797.55,1078.53,417.03,4481.0,19 CDM,RX-172456,RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION,25113.1,15067.86,72.13,20090.48,35 CDM,RX-17280,SELEGILINE 5 MG CAPSULE,21.05,12.63,4.88,4481.0,19 CDM,RX-17285,TOPOTECAN 4 MG INTRAVENOUS SOLUTION,738.4,443.04,3.65,4481.0,24 CDM,RX-172946,"SODIUM CHLORIDE, SODIUM BICARB-NASAL RINSE SQUEEZE BOTTLE WITH PACKET",14.95,8.97,3.47,4481.0,19 CDM,RX-173082,CYCLOPHOSPHAMIDE 25 MG CAPSULE,55.0,33.0,2.48,4481.0,24 CDM,RX-173083,CYCLOPHOSPHAMIDE 50 MG CAPSULE,80.0,48.0,2.48,4481.0,24 CDM,RX-173109,SILTUXIMAB 100 MG INTRAVENOUS SOLUTION,5542.25,3325.35,160.86,26739.3,35 CDM,RX-173110,SILTUXIMAB 400 MG INTRAVENOUS SOLUTION,21343.85,12806.31,160.86,26739.3,35 CDM,RX-173157,MERCAPTOPURINE 20 MG/ML ORAL SUSPENSION,5252.2,3151.32,1218.51,4481.0,19 CDM,RX-173179,"HUMAN PROTHROMBIN COMPLEX,4-FACTOR 500 UNIT (400-620 UNIT) IV SOLUTION",87.25,52.35,2.08,4481.0,35 CDM,RX-173205,VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,30669.95,18401.97,20.67,24535.96,35 CDM,RX-173219,DALBAVANCIN 500 MG INTRAVENOUS SOLUTION,6954.65,4172.79,15.14,6016.47,35 CDM,RX-173271,PEDI MULTIVIT NO.77-VIT D3 750 UNIT-VIT K 500 MCG/0.5 ML ORAL DROPS,1.75,1.05,0.406,4481.0,19 CDM,RX-173282,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 3,000 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 CDM,RX-173321,TEDIZOLID 200 MG INTRAVENOUS SOLUTION,1274.5,764.7,1.9,4481.0,35 CDM,RX-173322,TEDIZOLID 200 MG TABLET,1411.25,846.75,327.41,4481.0,19 CDM,RX-173336,SUNITINIB MALATE 37.5 MG CAPSULE,2792.05,1675.23,647.76,4481.0,19 CDM,RX-173339,"HUM PROTHROMBIN CPLX, 4-FACTOR 1,000 UNIT (800-1,240 UNIT) IV SOLUTION",87.25,52.35,2.08,4481.0,35 CDM,RX-17377,RISPERIDONE 1 MG/ML ORAL SOLUTION,106.0,63.6,24.59,4481.0,19 CDM,RX-17378,CIDOFOVIR 75 MG/ML INTRAVENOUS SOLUTION,2482.8,1489.68,529.9,78865.5,35 CDM,RX-173781,BELINOSTAT 500 MG INTRAVENOUS SOLUTION,8650.25,5190.15,50.9,7907.13,35 CDM,RX-17379,MEROPENEM 500 MG INTRAVENOUS SOLUTION,72.85,43.71,0.945,4481.0,24 CDM,RX-173793,SODIUM CHLORIDE-HYPOCHLOROUS ACID 0.033 % IRRIGATION SOLUTION,38.325,22.994999999999997,6.44,4481.0,38 CDM,RX-17380,MEROPENEM 1 GRAM INTRAVENOUS SOLUTION,82.3,49.38,0.945,4481.0,24 CDM,RX-17381,HYLAN G-F 20 16 MG/2 ML INTRA-ARTICULAR SYRINGE,1796.55,1077.93,7.71,4481.0,35 CDM,RX-173869,DANTROLENE 250 MG INTRAVENOUS SUSPENSION,10901.0,6540.6,2529.03,8720.8,19 CDM,RX-1740,CLINDAMYCIN HCL 150 MG CAPSULE,17.35,10.41,4.03,4481.0,19 CDM,RX-17405,INSULIN LISPRO (U-100) 100 UNIT/ML SUBCUTANEOUS SOLUTION,275.0,165.0,0.5175,4481.0,24 CDM,RX-1742,CLINDAMYCIN PHOSPHATE 1 % TOPICAL SOLUTION,124.4,74.64,28.86,4481.0,19 CDM,RX-174279,SILDENAFIL (PULMONARY HYPERTENSION) 10 MG/ML ORAL POWDR FOR SUSPENSION,346.0,207.6,80.27,4481.0,19 CDM,RX-174283,GLATIRAMER 20 MG/ML SUBCUTANEOUS SYRINGE,940.85,564.51,143.44,4481.0,35 CDM,RX-174307,"ANTIHEMOPHILIC FACTOR-VWF 2,000 (800 VWF) UNIT/10 ML INTRAVENOUS SOLN",81.75,49.05,1.21,4481.0,35 CDM,RX-17451,ETOPOSIDE PHOSPHATE 100 MG INTRAVENOUS SOLUTION,838.9,503.34,2.12,4481.0,24 CDM,RX-17464,BUSPIRONE 15 MG TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-17465,MIRTAZAPINE 30 MG TABLET,17.05,10.23,3.96,4481.0,19 CDM,RX-17466,MIRTAZAPINE 15 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-174711,IPRATROPIUM 20 MCG-ALBUTEROL 100 MCG/ACTUATION MIST FOR INHALATION,1533.15,919.89,355.69,4481.0,19 CDM,RX-174722,COBICISTAT 150 MG TABLET,47.5,28.5,11.02,4481.0,19 CDM,RX-17482,AZITHROMYCIN 500 MG TABLET,19.85,11.91,4.61,4481.0,19 CDM,RX-174868,"ANTIHEMOPHILIC FACTOR VIII,PORCINE REC 500(+/-) UNIT RANGE IV SOLUTION",87.15,52.29,3.13,4481.0,35 CDM,RX-174932,VASOPRESSIN 20 UNIT/ML INTRAVENOUS SOLUTION,35.5,21.3,2.09,4481.0,48 CDM,RX-174968,ALEMTUZUMAB (LEMTRADA) 12 MG/1.2 ML INTRAVENOUS SOLUTION (NON-ONCOLOGY),97326.7,58396.02,2356.99,379123.29,35 CDM,RX-175246,PERAMIVIR (PF) 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION,1098.5,659.1,1.63,4481.0,35 CDM,RX-175253,UMECLIDINIUM 62.5 MCG/ACTUATION BLISTER POWDER FOR INHALATION,241.9,145.14,56.12,4481.0,19 CDM,RX-175263,FLUTICASONE FUROATE 100 MCG/ACTUATION BLISTER POWDER FOR INHALATION,308.85,185.31,71.65,4481.0,19 CDM,RX-175264,FLUTICASONE FUROATE 200 MCG/ACTUATION BLISTER POWDER FOR INHALATION,408.1,244.86,94.68,4481.0,19 CDM,RX-175329,BLINATUMOMAB 35 MCG INTRAVENOUS KIT,18667.95,11200.77,159.32,24925.32,35 CDM,RX-175351,"HUMAN PAPILLOMAVIRUS VACCINE,9-VALENT(PF) 0.5 ML INTRAMUSCULAR SYRINGE",1007.05,604.23,233.64,4481.0,25 CDM,RX-175394,CEFTOLOZANE-TAZOBACTAM 1.5 GRAM INTRAVENOUS SOLUTION,696.05,417.63,8.8,4481.0,35 CDM,RX-1754,CLOMIPRAMINE 50 MG CAPSULE,18.05,10.83,4.19,4481.0,19 CDM,RX-175414,NIVOLUMAB 40 MG/4 ML INTRAVENOUS SOLUTION,4657.0,2794.2,31.97,5024.46,35 CDM,RX-175415,NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION,11229.8,6737.88,31.97,8983.84,35 CDM,RX-1755,CLONIDINE HCL 0.1 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-1756,CLONIDINE HCL 0.2 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-175606,"MENINGOCOCCAL B VAC,4-CMP 50 MCG-50 MCG-50 MCG-25 MCG/0.5ML IM SYRINGE",731.15,438.69,169.63,4481.0,25 CDM,RX-175608,"OXYCODONE ER 10 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",39.7,23.82,9.21,4481.0,19 CDM,RX-175610,"OXYCODONE ER 20 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",54.95,32.97,12.75,4481.0,19 CDM,RX-175611,"OXYCODONE ER 30 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",66.7,40.02,15.47,4481.0,19 CDM,RX-175612,"OXYCODONE ER 40 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",78.4,47.04,18.19,4481.0,19 CDM,RX-175613,"OXYCODONE ER 60 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",99.9,59.94,23.18,4481.0,19 CDM,RX-1757,CLONIDINE HCL 0.3 MG TABLET,16.2,9.72,3.76,4481.0,19 CDM,RX-175704,PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR,25046.2,15027.72,86.66,20036.96,35 CDM,RX-175735,PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,20186.95,12112.17,58.48,16149.56,35 CDM,RX-1760,CLORAZEPATE DIPOTASSIUM 7.5 MG TABLET,26.25,15.75,6.09,4481.0,19 CDM,RX-176000,PASIREOTIDE PAMOATE 20 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 CDM,RX-176001,PASIREOTIDE PAMOATE 40 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 CDM,RX-176002,PASIREOTIDE PAMOATE 60 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 CDM,RX-17601,SODIUM PHENYLBUTYRATE 0.94 GRAM/GRAM ORAL POWDER,13560.0,8136.0,3145.92,10848.0,19 CDM,RX-176010,NALOXEGOL 12.5 MG TABLET,59.65,35.79,13.84,4481.0,19 CDM,RX-176011,NALOXEGOL 25 MG TABLET,59.65,35.79,13.84,4481.0,19 CDM,RX-176034,DEXMEDETOMIDINE 80 MCG/20 ML (4 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,148.05,88.83,34.35,4481.0,19 CDM,RX-176043,PALBOCICLIB 75 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 CDM,RX-176044,PALBOCICLIB 100 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 CDM,RX-176045,PALBOCICLIB 125 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 CDM,RX-176080,SOTALOL 5 MG/ML ORAL SOLUTION,1780.0,1068.0,412.96,4481.0,19 CDM,RX-176389,ISAVUCONAZONIUM SULFATE 186 MG CAPSULE,363.25,217.95,84.27,4481.0,19 CDM,RX-176622,IVABRADINE 5 MG TABLET,47.3,28.38,10.97,4481.0,19 CDM,RX-176623,IVABRADINE 7.5 MG TABLET,47.3,28.38,10.97,4481.0,19 CDM,RX-176625,"OCTREOTIDE,MICROSPHERES ER 20 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",18019.6,10811.76,197.47,30919.98,35 CDM,RX-176626,"OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",26975.0,16185.0,197.47,30919.98,35 CDM,RX-176627,"OCTREOTIDE,MICROSPHERES ER 10 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",13757.4,8254.44,197.47,30919.98,35 CDM,RX-176631,PHENYLEPHRINE 1 %-KETOROLAC 0.3 % INTRAOCULAR CONCENTRATE FOR IRRIG,1856.8,1114.08,91.25,4481.0,34 CDM,RX-176637,CEFTAZIDIME-AVIBACTAM 2.5 GRAM INTRAVENOUS SOLUTION,1421.25,852.75,101.59,4481.0,35 CDM,RX-176660,LEVONORGESTREL 20.4 MCG/24 HR (UP TO 8 YRS) 52 MG INTRAUTERINE DEVICE,3748.95,2249.37,869.76,141324.33,24 CDM,RX-176681,DEFERASIROX 180 MG TABLET,347.0,208.2,80.5,4481.0,19 CDM,RX-1767,CLOTRIMAZOLE 1 % TOPICAL CREAM,8.05,4.83,1.87,4481.0,19 CDM,RX-176866,GLUCAGON HCL 1 MG/ML SOLUTION FOR INJECTION,1001.5,600.9,144.52,4481.0,35 CDM,RX-177070,FLUTICASONE FUROATE 200 MCG-VILANTEROL 25 MCG/DOSE INHALATION POWDER,488.25,292.95,113.27,4481.0,19 CDM,RX-177077,"IMMUNE GLOB,GAMM(IGG) 10 %-PRO-IGA 0 TO 50 MCG/ML INTRAVENOUS SOLUTION",13986.85,8392.11,49.22,11189.48,35 CDM,RX-177083,DINUTUXIMAB 3.5 MG/ML INTRAVENOUS SOLUTION,63321.5,37992.9,4481.0,54779.43,25 CDM,RX-177307,"IMMUNE GLOB,GAMMA(IGG) 15 %-18 % RANGE-GLYCINE INTRAMUSCULAR SOLUTION",1127.225,676.335,47.56,4481.0,70 CDM,RX-177318,"IMMUNE GLOB,GAMMA(IGG) 5 GRAM-GLY-GLUC-IGA 0 TO 50 MCG/ML IV SOLUTION",4202.65,2521.59,76.44,12694.92,35 CDM,RX-177319,"IMMUNE GLOB,GAMMA(IGG) 10 GRAM-GLY-GLUC-IGA 0 TO 50 MCG/ML IV SOLUTION",8328.25,4996.95,76.44,12694.92,35 CDM,RX-177342,CANGRELOR 50 MG INTRAVENOUS SOLUTION,3920.7,2352.42,19.38,4481.0,35 CDM,RX-177412,SACUBITRIL 24 MG-VALSARTAN 26 MG TABLET,51.3,30.78,11.9,4481.0,19 CDM,RX-177413,SACUBITRIL 49 MG-VALSARTAN 51 MG TABLET,51.3,30.78,11.9,4481.0,19 CDM,RX-177414,SACUBITRIL 97 MG-VALSARTAN 103 MG TABLET,51.3,30.78,11.9,4481.0,19 CDM,RX-177439,BREXPIPRAZOLE 1 MG TABLET,167.6,100.56,38.88,4481.0,19 CDM,RX-178016,FILGRASTIM-SNDZ 480 MCG/0.8 ML INJECTION SYRINGE,1728.05,1036.83,0.4462,4481.0,35 CDM,RX-178017,FILGRASTIM-SNDZ 300 MCG/0.5 ML INJECTION SYRINGE,1086.05,651.63,0.4462,4481.0,35 CDM,RX-178019,"TACROLIMUS XR 0.75 MG TABLET,EXTENDED RELEASE 24 HR",31.95,19.17,4.12,4481.0,24 CDM,RX-178020,"TACROLIMUS XR 1 MG TABLET,EXTENDED RELEASE 24 HR",37.25,22.35,4.12,4481.0,24 CDM,RX-178021,"TACROLIMUS XR 4 MG TABLET,EXTENDED RELEASE 24 HR",100.9,60.54,4.12,4481.0,24 CDM,RX-178034,SULFUR HEXAFLUORIDE MICROSPHERES 25 MG INTRAVENOUS SUSPENSION,169.0,101.4,39.21,4481.0,23 CDM,RX-178201,TRIFLURIDINE 15 MG-TIPIRACIL 6.14 MG TABLET,897.2,538.32,208.15,4481.0,19 CDM,RX-178202,TRIFLURIDINE 20 MG-TIPIRACIL 8.19 MG TABLET,1187.9,712.74,275.59,4481.0,19 CDM,RX-178304,TRABECTEDIN 1 MG INTRAVENOUS SOLUTION,12486.75,7492.05,379.34,59552.64,35 CDM,RX-17837,ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,84.4,50.64,19.58,4481.0,19 CDM,RX-178436,MIDAZOLAM (PF) 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,112.3,67.38,0.45,4481.0,24 CDM,RX-178443,DIMETHICONE 1.2 %-COLLOIDAL OATMEAL LOTION,5.2,3.12,1.21,4481.0,19 CDM,RX-178450,IDARUCIZUMAB 2.5 GRAM/50 ML INTRAVENOUS SOLUTION,8405.45,5043.27,1950.06,6724.36,19 CDM,RX-178467,IRINOTECAN LIPOSOMAL 4.3 MG/ML INTRAVENOUS,10135.5,6081.3,64.02,10683.96,35 CDM,RX-178488,TALIMOGENE LAHERPAREPVEC 10EXP6 (1 MILLION) PFU/ML SUSP FOR INJECTION,506.3,303.78,71.72,11518.92,35 CDM,RX-178489,TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION,23398.0,14038.8,71.72,18718.4,35 CDM,RX-178589,COAGULATION FACTOR X 500 (+/-) UNIT RANGE INTRAVENOUS SOLUTION,116.15,69.69,9.49,4481.0,35 CDM,RX-178590,BUPRENORPHINE HCL 75 MCG BUCCAL FILM,44.9,26.94,10.42,4481.0,19 CDM,RX-178591,BUPRENORPHINE HCL 150 MCG BUCCAL FILM,44.9,26.94,10.42,4481.0,19 CDM,RX-178592,BUPRENORPHINE HCL 300 MCG BUCCAL FILM,57.95,34.77,13.44,4481.0,19 CDM,RX-178637,MEPOLIZUMAB 100 MG SUBCUTANEOUS SOLUTION,14067.0,8440.2,30.33,11253.6,35 CDM,RX-178644,ELVITEG 150 MG-COB 150 MG-EMTRICIT 200 MG-TENOFO ALAFENAM 10 MG TABLET,437.65,262.59,101.53,4481.0,19 CDM,RX-178688,OSIMERTINIB 40 MG TABLET,2375.8,1425.48,551.19,4481.0,19 CDM,RX-178689,OSIMERTINIB 80 MG TABLET,2375.8,1425.48,551.19,4481.0,19 CDM,RX-17881,BRIMONIDINE 0.2 % EYE DROPS,59.65,35.79,13.84,4481.0,19 CDM,RX-178831,ELOTUZUMAB 400 MG INTRAVENOUS SOLUTION,10519.0,6311.4,7.65,8415.2,35 CDM,RX-178868,BENDAMUSTINE (BENDEKA) 25 MG/ML INTRAVENOUS SOLUTION,8463.3,5077.98,13.09,6770.64,35 CDM,RX-178871,SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION,33449.7,20069.82,523.71,77433.72,35 CDM,RX-178892,ALECTINIB 150 MG CAPSULE,349.45,209.67,81.07,4481.0,19 CDM,RX-178923,SELEXIPAG 200 MCG TABLET,783.45,470.07,181.76,4481.0,19 CDM,RX-178926,SELEXIPAG 800 MCG TABLET,1209.5,725.7,280.6,4481.0,19 CDM,RX-178998,SUGAMMADEX 100 MG/ML INTRAVENOUS SOLUTION,546.95,328.17,126.89,4481.0,19 CDM,RX-179011,SELENIUM SULFIDE 2.5 % LOTION,16.45,9.87,3.82,4481.0,19 CDM,RX-179315,CARIPRAZINE 1.5 MG CAPSULE,167.9,100.74,38.95,4481.0,19 CDM,RX-179316,CARIPRAZINE 3 MG CAPSULE,167.9,100.74,38.95,4481.0,19 CDM,RX-17936,OLANZAPINE 5 MG TABLET,17.5,10.5,4.06,4481.0,19 CDM,RX-17937,OLANZAPINE 10 MG TABLET,17.05,10.23,3.96,4481.0,19 CDM,RX-179567,INSULIN REGULAR HUMAN U-500 (CONCENTRATE) 500 UNIT/ML(3 ML) SUBCUT PEN,880.2,528.12,0.5175,4481.0,24 CDM,RX-17961,ZIDOVUDINE 300 MG TABLET,18.25,10.95,4.23,4481.0,19 CDM,RX-179687,EPINEPHRINE HCL 100 MCG/10 ML(10 MCG/ML) IN 0.9 % SOD CHLOR IV SYRINGE,43.15,25.89,3.06,4481.0,24 CDM,RX-179871,INFLIXIMAB-DYYB 100 MG INTRAVENOUS SOLUTION,3157.35,1894.41,19.39,4481.0,35 CDM,RX-179913,MILTEFOSINE 50 MG CAPSULE,1730.3,1038.18,401.43,4481.0,19 CDM,RX-179915,DEFIBROTIDE 80 MG/ML INTRAVENOUS SOLUTION,3970.65,2382.39,921.19,4481.0,19 CDM,RX-180043,VENETOCLAX 10 MG (14)-50 MG (7)-100 MG (21) TABLETS IN A DOSE PACK,13510.9,8106.54,3134.53,10808.72,19 CDM,RX-180044,VENETOCLAX 10 MG TABLET,77.05,46.23,17.88,4481.0,19 CDM,RX-180045,VENETOCLAX 50 MG TABLET,285.4,171.24,66.21,4481.0,19 CDM,RX-180046,VENETOCLAX 100 MG TABLET,545.6,327.36,126.58,4481.0,19 CDM,RX-180172,LEVONORGESTREL 17.5 MCG/24 HOUR (5 YEARS) INTRAUTERINE DEVICE,4649.2,2789.52,1078.61,184236.57,24 CDM,RX-180236,BRIVARACETAM 50 MG/5 ML INTRAVENOUS SOLUTION,212.05,127.23,49.2,4481.0,19 CDM,RX-180240,BRIVARACETAM 50 MG TABLET,96.65,57.99,22.42,4481.0,19 CDM,RX-180242,BRIVARACETAM 100 MG TABLET,96.65,57.99,22.42,4481.0,19 CDM,RX-180320,HYDROMORPHONE (PF) 50 MG/50 ML (1 MG/ML) IN 0.9 % NACL IV SYRINGE,64.15,38.49,0.2025,4481.0,24 CDM,RX-180347,EPHEDRINE SULFATE 50 MG/ML INTRAVENOUS SOLUTION,89.4,53.64,20.74,4481.0,19 CDM,RX-180358,"ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION",38635.8,23181.48,88.6,30908.64,35 CDM,RX-180428,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 5,000 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 CDM,RX-180455,TADALAFIL 20 MG TABLET (PULMONARY HYPERTENSION),224.5,134.7,52.08,4481.0,19 CDM,RX-180948,FAT EMULSION-SOYBEAN OIL-MCT-OLIVE OIL-FISH OIL 20 % INTRAVENOUS,171.6,102.96,39.81,4481.0,19 CDM,RX-180978,SODIUM POLYSTYRENE SULFONATE 15 GRAM-SORBITOL 20 GRAM/60 ML ORAL SUSP,90.35,54.21,20.96,4481.0,19 CDM,RX-181003,LISINOPRIL 1 MG/ML ORAL SOLUTION,2064.4,1238.64,478.94,4481.0,19 CDM,RX-181156,METHYLENE BLUE (ANTIDOTE) 5 MG/ML INTRAVENOUS SOLUTION,930.15,558.09,6.19,4481.0,36 CDM,RX-181281,USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION,6994.3,4196.58,12.6,5595.44,35 CDM,RX-181334,TENOFOVIR ALAFENAMIDE 25 MG TABLET,168.7,101.22,39.14,4481.0,19 CDM,RX-181494,ENALAPRIL MALEATE 1 MG/ML ORAL SOLUTION,49.95,29.97,11.59,4481.0,19 CDM,RX-181503,BEZLOTOXUMAB 25 MG/ML INTRAVENOUS SOLUTION,12489.0,7493.4,38.64,10804.23,35 CDM,RX-181599,NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION,570581.95,342349.17,1241.84,456465.56,34 CDM,RX-181816,LINACLOTIDE 72 MCG CAPSULE,72.8,43.68,16.89,4481.0,19 CDM,RX-18192,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJECTION SOLUTION,59.1,35.46,0.1125,4481.0,72 CDM,RX-18194,ROPIVACAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,82.4,49.44,0.1125,4481.0,24 CDM,RX-18195,ROPIVACAINE (PF) 5 MG/ML (0.5 %) INJECTION SOLUTION,31.65,18.99,0.1125,4481.0,24 CDM,RX-182015,CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION,69989.85,41993.91,137.35,55991.88,35 CDM,RX-182018,NITROPRUSSIDE 50 MG/100 ML (0.5 MG/ML) IN 0.9% SODIUM CHLORIDE IV SOLN,242.85,145.71,56.34,4481.0,19 CDM,RX-182066,AVELUMAB 20 MG/ML INTRAVENOUS SOLUTION,7206.25,4323.75,97.09,15899.52,35 CDM,RX-182080,OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION,67558.95,40535.37,57.63,54047.16,35 CDM,RX-1821,COLCHICINE 0.6 MG TABLET,43.9,26.34,10.18,4481.0,19 CDM,RX-182121,THIOTEPA 100 MG SOLUTION FOR INJECTION,6233.0,3739.8,10.22,5392.17,35 CDM,RX-182286,TRASTUZUMAB 150 MG INTRAVENOUS SOLUTION,5433.45,3260.07,72.78,11339.58,35 CDM,RX-182317,CLINDAMYCIN 300 MG/50 ML IN 0.9% SODIUM CHLORIDE INTRAVENOUS PIGGYBACK,90.1,54.06,4.69,4481.0,24 CDM,RX-182318,CLINDAMYCIN 600 MG/50 ML IN 0.9% SODIUM CHLORIDE INTRAVENOUS PIGGYBACK,103.8,62.28,4.69,4481.0,24 CDM,RX-182320,METHOTREXATE 2.5 MG/ML ORAL SOLUTION,10026.8,6016.08,22.0,8674.18,35 CDM,RX-182328,MIDOSTAURIN 25 MG CAPSULE,896.7,538.02,208.03,4481.0,19 CDM,RX-182334,DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION,9088.525,5453.115,82.57,13726.86,70 CDM,RX-182391,CERLIPONASE ALFA 150 MG/5 ML INTRAVENTRICULAR SOLUTION,108816.7,65290.02,116.75,87053.36,33 CDM,RX-182522,"RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN",22043.5,13226.1,35.59,17634.8,35 CDM,RX-182556,UREA 15 GRAM ORAL POWDER PACKET,6.65,3.99,1.54,4481.0,19 CDM,RX-182561,BLINATUMOMAB 35 MCG INTRAVENOUS SOLUTION,18667.95,11200.77,159.32,24925.32,35 CDM,RX-182616,HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION,36661.3,21996.78,33.15,31715.69,35 CDM,RX-18262,TRACE ELEMENTS CR-CU-MN-ZN 10 MCG-1 MG-0.5 MG-5 MG/ML INTRAVENOUS SOLN,63.8,38.28,14.8,4481.0,19 CDM,RX-182620,"RITUXIMAB 1,600 MG/13.4 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN",25153.25,15091.95,35.59,20122.6,35 CDM,RX-182718,INFLIXIMAB-ABDA 100 MG INTRAVENOUS SOLUTION,2526.6,1515.96,26.19,4481.0,35 CDM,RX-182808,SPIRONOLACTONE 25 MG/5 ML ORAL SUSPENSION,1312.75,787.65,304.56,4481.0,19 CDM,RX-182858,LIDOCAINE 4 %-RACEPINEPHRINE 0.05 %-TETRACAINE 0.5 % TOPICAL GEL,39.85,23.91,9.25,4481.0,19 CDM,RX-182891,DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION,36618.8,21971.28,248.41,40760.16,35 CDM,RX-182904,INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN,79436.8,47662.08,2617.11,435080.31,35 CDM,RX-18292,TORSEMIDE 10 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-18293,TORSEMIDE 20 MG TABLET,17.05,10.23,3.96,4481.0,19 CDM,RX-18294,TORSEMIDE 100 MG TABLET,17.25,10.35,4.0,4481.0,19 CDM,RX-18302,PIPERACILLIN-TAZOBACTAM 4.5 GRAM INTRAVENOUS SOLUTION,85.45,51.27,2.41,4481.0,24 CDM,RX-18303,PIPERACILLIN-TAZOBACTAM 3.375 GRAM INTRAVENOUS SOLUTION,81.0,48.6,2.41,4481.0,24 CDM,RX-18304,PIPERACILLIN-TAZOBACTAM 2.25 GRAM INTRAVENOUS SOLUTION,74.25,44.55,2.41,4481.0,24 CDM,RX-183050,COPANLISIB 60 MG INTRAVENOUS SOLUTION,17664.45,10598.67,200.95,14131.56,23 CDM,RX-18307,GABAPENTIN 400 MG CAPSULE,16.6,9.96,3.85,4481.0,19 CDM,RX-18308,GABAPENTIN 300 MG CAPSULE,16.45,9.87,3.82,4481.0,19 CDM,RX-18309,GABAPENTIN 100 MG CAPSULE,16.4,9.84,3.8,4481.0,19 CDM,RX-18313,RISPERIDONE 1 MG TABLET,17.3,10.38,4.01,4481.0,19 CDM,RX-183201,MEROPENEM-VABORBACTAM 2 GRAM INTRAVENOUS SOLUTION,790.6,474.36,2.11,4481.0,35 CDM,RX-183205,TOCOPHERSOLAN (VITAMIN E TPGS) 75 UNIT/ML ORAL DROPS,66.1,39.66,15.34,4481.0,19 CDM,RX-183322,"VARICELLA-ZOSTER GLYCOE VACC-AS01B ADJ(PF) 50 MCG/0.5 ML IM SUSP, KIT",668.55,401.13,155.1,4481.0,24 CDM,RX-183324,VARICELLA-ZOSTER GLYCOP E VACCINE (VIAL 2 OF 2) 50 MCG IM SUSPENSION,668.55,401.13,155.1,4481.0,24 CDM,RX-183325,"ADJUVANT AS01B (PF), COMPONENT VIAL 1 OF 2 INTRAMUSCULAR SUSPENSION",454.6,272.76,105.47,4481.0,24 CDM,RX-183570,LETERMOVIR 480 MG TABLET,839.2,503.52,194.69,4481.0,19 CDM,RX-183572,LETERMOVIR 480 MG/24 ML INTRAVENOUS SOLUTION,1303.8,782.28,302.48,4481.0,19 CDM,RX-183586,BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE,22819.5,13691.7,159.65,26729.01,35 CDM,RX-183651,"LIPASE-PROTEASE-AMYLASE (PORK) 20,000-63,000-84K UNIT CAPSULE, DEL REL",2491.9,1495.14,578.12,4481.0,19 CDM,RX-183656,"LIPASE-PROTEASE-AMYLASE(PORK) 40,000-126,000-168K UNIT CAPSULE,DEL REL",64.9,38.94,15.06,4481.0,19 CDM,RX-183685,ARSENIC TRIOXIDE 2 MG/ML INTRAVENOUS SOLUTION,4499.5,2699.7,7.91,4481.0,35 CDM,RX-183750,"FIBRINOGEN 1 GRAM (700 MG-1,300 MG) INTRAVENOUS SOLUTION",80.8,48.48,1.19,4481.0,35 CDM,RX-18385,"BUPROPION HCL SR 100 MG TABLET,12 HR SUSTAINED-RELEASE",18.4,11.04,4.27,4481.0,19 CDM,RX-183891,NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION,26566.65,15939.99,31.97,21253.32,35 CDM,RX-183907,ANGIOTENSIN II 2.5 MG/ML INTRAVENOUS SOLUTION,5834.55,3500.73,1353.62,5047.47,26 CDM,RX-18398,REMIFENTANIL 1 MG INTRAVENOUS SOLUTION,206.4,123.84,47.88,4481.0,19 CDM,RX-184107,"LIPASE-PROTEASE-AMYLASE (PORK) 25,000-79,000-105K UNIT CAPSULE,DEL REL",3079.9,1847.94,714.54,4481.0,19 CDM,RX-184238,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION FOR MI,32375.35,19425.21,167.05,28007.92,35 CDM,RX-184262,MORPHINE 100 MG/100 ML(1 MG/ML) IN 0.9% SODIUM CHLOR IV PUMP RESERVOIR,196.3,117.78,27.11,4481.0,24 CDM,RX-184291,IBALIZUMAB-UIYK 200 MG/1.33 ML (150 MG/ML) INTRAVENOUS SOLUTION,49914.2,29948.52,76.88,39931.36,35 CDM,RX-184475,"LIPASE-PROTEASE-AMYLASE(PORK)10,000-32,000-42,000 UNIT CAPSULE,DEL REL",1278.1,766.86,296.52,4481.0,19 CDM,RX-184619,IRON DEXTRAN 50 MG/ML INJECTION SOLUTION,52.4,31.44,13.26,4517.31,35 CDM,RX-184716,"LIPASE-PROTEASE-AMYLASE (PORK) 3,000-10,000-14K UNIT CAPSULE,DEL REL",685.3,411.18,158.99,4481.0,19 CDM,RX-184820,BARICITINIB 2 MG TABLET,292.75,175.65,67.92,4481.0,19 CDM,RX-184832,"EPOETIN ALFA-EPBX 2,000 UNIT/ML INJECTION SOLUTION",102.05,61.23,7.61,4481.0,33 CDM,RX-184833,"EPOETIN ALFA-EPBX 3,000 UNIT/ML INJECTION SOLUTION",145.1,87.06,7.61,4481.0,33 CDM,RX-184834,"EPOETIN ALFA-EPBX 4,000 UNIT/ML INJECTION SOLUTION",188.1,112.86,7.61,4481.0,33 CDM,RX-184835,"EPOETIN ALFA-EPBX 10,000 UNIT/ML INJECTION SOLUTION",446.2,267.72,7.61,4481.0,33 CDM,RX-184836,"EPOETIN ALFA-EPBX 40,000 UNIT/ML INJECTION SOLUTION",1736.7,1042.02,7.61,4481.0,33 CDM,RX-184898,TOFACITINIB 10 MG TABLET,319.7,191.82,74.17,4481.0,19 CDM,RX-184928,ENCORAFENIB 75 MG CAPSULE,389.15,233.49,90.28,4481.0,19 CDM,RX-184929,BINIMETINIB 15 MG TABLET,382.25,229.35,88.68,4481.0,19 CDM,RX-185041,PEGFILGRASTIM-JMDB 6 MG/0.6 ML SUBCUTANEOUS SYRINGE,8157.3,4894.38,96.16,18477.9,35 CDM,RX-185234,PARENTERAL AMINO ACID 15 % COMBINATION NO.5 INTRAVENOUS SOLUTION,565.95,339.57,131.3,4481.0,19 CDM,RX-185236,SODIUM ZIRCONIUM CYCLOSILICATE 10 GRAM ORAL POWDER PACKET,102.2,61.32,23.71,4481.0,19 CDM,RX-185241,HEPATITIS B VACCINE 20 MCG/0.5 ML-ADJUVANT CPG 1018 (PF) IM SYRINGE,489.25,293.55,113.51,4481.0,26 CDM,RX-185291,MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION,16104.75,9662.85,241.04,39876.69,35 CDM,RX-185294,PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION,32059.95,19235.97,96.97,25647.96,35 CDM,RX-185327,PASIREOTIDE PAMOATE 10 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 CDM,RX-185328,PASIREOTIDE PAMOATE 30 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 CDM,RX-185476,FILGRASTIM-AAFI 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,870.1,522.06,0.291,4481.0,35 CDM,RX-185477,FILGRASTIM-AAFI 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,1382.6,829.56,0.291,4481.0,35 CDM,RX-18551,CARVEDILOL 3.125 MG TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-185552,DORAVIRINE 100 MG TABLET,200.0,120.0,46.4,4481.0,19 CDM,RX-185701,AMINOLEVULINIC ACID HCL 30 MG/ML ORAL SOLUTION,9604.0,5762.4,2228.13,7683.2,22 CDM,RX-185706,RIVAROXABAN 2.5 MG TABLET,45.95,27.57,10.66,4481.0,19 CDM,RX-185713,CANNABIDIOL 100 MG/ML ORAL SOLUTION,5146.0,3087.6,1193.87,4481.0,19 CDM,RX-185743,CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION,36436.65,21861.99,28.41,29149.32,35 CDM,RX-185843,BALOXAVIR MARBOXIL 40 MG TABLET,522.5,313.5,121.22,4481.0,19 CDM,RX-185947,FATTY ACID NO.6-FISH OIL-GLYCERIN 10 % IV EMULSION,405.4,243.24,94.05,4481.0,19 CDM,RX-185950,OMALIZUMAB 75 MG/0.5 ML SUBCUTANEOUS SYRINGE,2887.9,1732.74,43.26,6119.61,35 CDM,RX-185952,OMALIZUMAB 150 MG/ML SUBCUTANEOUS SYRINGE,5759.8,3455.88,43.26,6119.61,35 CDM,RX-186007,LORLATINIB 25 MG TABLET,974.35,584.61,226.05,4481.0,19 CDM,RX-186008,LORLATINIB 100 MG TABLET,2872.95,1723.77,666.52,4481.0,19 CDM,RX-186090,GILTERITINIB 40 MG TABLET,1313.0,787.8,304.62,4481.0,19 CDM,RX-186126,"ALBUMIN, HUMAN-KJDA 25 % INTRAVENOUS SOLUTION",330.75,198.45,76.73,4481.0,48 CDM,RX-186134,OMADACYCLINE 100 MG INTRAVENOUS SOLUTION,1624.65,974.79,3.9,4481.0,35 CDM,RX-186141,FLUOCINOLONE 0.18 MG INTRAVITREAL IMPLANT,36546.0,21927.6,513.99,85862.7,35 CDM,RX-186144,PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE,16298.5,9779.1,103.14,26777.52,35 CDM,RX-18621,LATANOPROST 0.005 % EYE DROPS,30.9,18.54,7.17,4481.0,19 CDM,RX-186326,ETHYL ALCOHOL 99 % INTRA-ARTERIAL SOLUTION,3896.5,2337.9,903.99,4481.0,19 CDM,RX-186334,"CALCIUM GLUCONATE 1 GRAM/50 ML IN SODIUM CHLORIDE, ISO-OSM IV SOLUTION",138.25,82.95,0.2025,4481.0,24 CDM,RX-186335,EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION,35689.025,21413.415,373.3,62444.13,68 CDM,RX-186342,DEXTROSE 2.45 GRAM-SOD CITRATE 2.2 GRAM-CITRIC AC 800 MG/100 ML SOLN,78.75,47.25,18.27,4481.0,19 CDM,RX-186373,"FACTOR XA,INACTIVATED-ZHZO (RECOMBINANT) 200 MG INTRAVENOUS SOLUTION",8672.0,5203.2,127.44,7502.15,35 CDM,RX-186408,ARGININE 25 MG/ML-LYSINE 25 MG/ML IN 0.9 % NACL INTRAVENOUS SOLUTION,444.0,266.4,103.01,4481.0,19 CDM,RX-186440,PRUCALOPRIDE 2 MG TABLET,71.75,43.05,16.65,4481.0,19 CDM,RX-186457,FILGRASTIM-AAFI 300 MCG/ML INJECTION SOLUTION,870.1,522.06,0.291,4481.0,35 CDM,RX-186458,FILGRASTIM-AAFI 480 MCG/1.6 ML INJECTION SOLUTION,1382.6,829.56,0.291,4481.0,35 CDM,RX-186478,CAPLACIZUMAB-YHDP 11 MG SOLUTION FOR INJECTION,28092.4,16855.44,1788.37,24302.74,23 CDM,RX-186612,"TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION",84777.15,50866.29,346.22,67821.72,35 CDM,RX-186649,ESKETAMINE 56 MG (28 MG X 2) NASAL SPRAY,1290.0,774.0,34.2,4481.0,23 CDM,RX-186650,ESKETAMINE 84 MG (28 MG X 3) NASAL SPRAY,1290.0,774.0,34.2,4481.0,23 CDM,RX-186675,ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION,27127.6,16276.56,88.6,21702.08,35 CDM,RX-186766,"TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION",15750.05,9450.03,59.6,12600.04,35 CDM,RX-186806,ROMOSOZUMAB-AQQG 210 MG/2.34 ML(105 MG/1.17 ML X2)SUBCUTANEOUS SYRINGE,10268.8,6161.28,11.71,8215.04,35 CDM,RX-186809,ARTIFICIAL TEARS (HYPROMELLOSE) (PF) 1.7 % EYE DROPS WITH APPLICATOR,39.75,23.85,9.22,4481.0,19 CDM,RX-186824,PARENTERAL AMINO ACID 15 % COMBINATION NO.6 INTRAVENOUS SOLUTION,215.4,129.24,49.97,4481.0,19 CDM,RX-186918,LEVOTHYROXINE 20 MCG/ML INTRAVENOUS SOLUTION,308.25,184.95,6.63,4481.0,35 CDM,RX-186941,"EPINEPHRINE 1 MG/10 ML (100 MCG/ML) IN SODIUM CHLOR,ISO-OSM IV SYRINGE",35.5,21.3,1.08,4481.0,24 CDM,RX-187005,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2527893.575,1516736.145,4481.0,379707196.05,726 CDM,RX-187079,SELENIUM 60 MCG/ML INTRAVENOUS SOLUTION,1400.6,840.36,324.94,4481.0,19 CDM,RX-187113,CISPLATIN 50 MG INTRAVENOUS POWDER FOR SOLUTION,1930.0,1158.0,5.15,4481.0,24 CDM,RX-187119,POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION,61878.8,37127.28,132.57,49503.04,35 CDM,RX-187220,BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION,6048.7,3629.22,27.02,7610.32,70 CDM,RX-187224,"CALCIUM GLUCONATE 2 GRAM/100 ML IN SODIUM CHLORIDE,ISO-OSM IV SOLUTION",213.5,128.1,0.2025,4481.0,24 CDM,RX-187311,AMLODIPINE BENZOATE 1 MG/ML ORAL SUSPENSION,48.0,28.8,11.14,4481.0,19 CDM,RX-187367,DAROLUTAMIDE 300 MG TABLET,500.15,300.09,116.03,4481.0,19 CDM,RX-187584,"ANTI-INHIBITOR COAGULANT COMPLEX 700 UNIT-1,300 UNIT INTRAVENOUS SOLN",86.3,51.78,2.34,4481.0,35 CDM,RX-187587,INSULIN REGULAR 100 UNIT/100 ML (1 UNIT/ML) IN 0.9 % NACL IV SOLUTION,196.35,117.81,0.5175,4481.0,24 CDM,RX-187787,CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION,96384.6,57830.76,79.62,77107.68,34 CDM,RX-18786,DONEPEZIL 5 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-18787,DONEPEZIL 10 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-188032,RITUXIMAB-ABBS 10 MG/ML INTRAVENOUS SOLUTION,8671.35,5202.81,28.5,11415.12,70 CDM,RX-188104,LUSPATERCEPT-AAMT 25 MG SUBCUTANEOUS SOLUTION,13513.0,8107.8,40.72,10810.4,35 CDM,RX-188105,LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION,40412.75,24247.65,40.72,32330.2,35 CDM,RX-188124,CRIZANLIZUMAB-TMCA 10 MG/ML INTRAVENOUS SOLUTION,8084.15,4850.49,125.6,21195.93,35 CDM,RX-188137,ROMIPLOSTIM 125 MCG SUBCUTANEOUS SOLUTION,5384.5,3230.7,10.68,4481.0,35 CDM,RX-188247,AFLIBERCEPT 2 MG/0.05 ML INTRAVITREAL SYRINGE,7591.1,4554.66,748.41,120279.81,35 CDM,RX-188260,"MINERAL OIL, LIGHT STERILE",84.35,50.61,19.57,4481.0,19 CDM,RX-188339,ENFORTUMAB VEDOTIN-EJFV 20 MG INTRAVENOUS SOLUTION,9572.8,5743.68,35.64,7658.24,35 CDM,RX-188340,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION,14221.7,8533.02,35.64,11377.36,35 CDM,RX-188344,FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION,10491.25,6294.75,29.08,8393.0,35 CDM,RX-188418,BEVACIZUMAB-BVZR 25 MG/ML INTRAVENOUS SOLUTION,5350.925,3210.555,25.0,6717.16,70 CDM,RX-188420,RITUXIMAB-PVVR 10 MG/ML INTRAVENOUS SOLUTION,7392.849999999999,4435.71,27.01,9710.44,70 CDM,RX-188421,IMIPENEM-CILASTATIN-RELEBACTAM 1.25 GRAM INTRAVENOUS SOLUTION,1096.8,658.08,2.53,4481.0,35 CDM,RX-188516,TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION,58985.0,35391.0,348.41,57707.79,35 CDM,RX-188595,TRASTUZUMAB-QYYP 420 MG INTRAVENOUS SOLUTION,11499.5,6899.7,27.15,9199.6,35 CDM,RX-188599,CEFIDEROCOL 1 GRAM INTRAVENOUS SOLUTION,824.4,494.64,2.35,4481.0,35 CDM,RX-188765,CENOBAMATE 50 MG TABLET,145.2,87.12,33.69,4481.0,19 CDM,RX-188768,CENOBAMATE 200 MG TABLET,145.2,87.12,33.69,4481.0,19 CDM,RX-18877,ONDANSETRON HCL 4 MG/5 ML ORAL SOLUTION,23.6,14.16,4.32,4481.0,38 CDM,RX-188784,ASCORBIC ACID (VITAMIN C) 500 MG/5 ML ORAL LIQUID,1.4,0.84,0.3248,4481.0,19 CDM,RX-188789,EPTINEZUMAB-JJMR 100 MG/ML INTRAVENOUS SOLUTION,6407.05,3844.23,19.37,5125.64,35 CDM,RX-188809,ISATUXIMAB-IRFC 20 MG/ML INTRAVENOUS SOLUTION,8913.325,5347.995,79.44,12906.6,70 CDM,RX-18908,SODIUM NITROPRUSSIDE 25 MG/ML INTRAVENOUS SOLUTION,128.4,77.04,29.79,4481.0,19 CDM,RX-189111,SACITUZUMAB GOVITECAN-HZIY 180 MG INTRAVENOUS SOLUTION,8760.2,5256.12,35.19,7008.16,35 CDM,RX-189115,MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT,82842.95,49705.77,308.97,66274.36,35 CDM,RX-18918,LEVOFLOXACIN 250 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-189186,INFLIXIMAB-AXXQ 100 MG INTRAVENOUS SOLUTION,1698.0,1018.8,19.8,4481.0,35 CDM,RX-18919,LEVOFLOXACIN 500 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-18920,TOPIRAMATE 25 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-189210,NIMODIPINE 30 MG/5 ML ORAL SYRINGE (FOR ORAL USE ONLY),176.25,105.75,40.89,4481.0,19 CDM,RX-18922,TOPIRAMATE 100 MG TABLET,17.45,10.47,4.05,4481.0,19 CDM,RX-189220,LEUPROLIDE 45 MG (PEDIATRIC 6 MONTH) SUBCUTANEOUS SYRINGE,91111.6,54666.96,136.76,72889.28,35 CDM,RX-189467,INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION,142853.05,85711.83,480.68,114282.44,35 CDM,RX-189593,DILUENT FOR MITOMYCIN INTRA-PYELOCALYCEAL SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-189603,FENFLURAMINE 2.2 MG/ML ORAL SOLUTION,3032.325,1819.395,121.51,48182.6,76 CDM,RX-189607,PEDIATRIC MULTIVITAMIN NO.192 250 MCG-50 MG-10 MCG/ML ORAL DROPS,1.1,0.66,0.2552,4481.0,19 CDM,RX-189618,"PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN",46338.75,27803.25,60.24,37071.0,35 CDM,RX-189619,PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN,30982.95,18589.77,60.24,24786.36,35 CDM,RX-189636,ATROPINE 1.2 MG/3 ML (0.4 MG/ML) IN 0.9 % SODIUM CHLORIDE IV SYRINGE,65.05,39.03,0.198,4481.0,24 CDM,RX-189662,"MIDAZOLAM (PF) 1 MG/ML IN SODIUM CHLORIDE,ISO-OSM INTRAVENOUS SOLUTION",88.25,52.95,0.3375,4481.0,24 CDM,RX-189818,TAFASITAMAB-CXIX 200 MG INTRAVENOUS SOLUTION,4895.35,2937.21,13.88,4481.0,35 CDM,RX-189986,FERRIC DERISOMALTOSE 100 MG IRON/ML INTRAVENOUS SOLUTION,12005.65,7203.39,21.36,10386.09,35 CDM,RX-190013,"SMALLPOX,MPOX LIVE VACCINE(PF) 0.5X TO 3.95X 10EXP8/0.5 ML SUBCUT SUSP",0.2,0.12,0.0097,4481.0,36 CDM,RX-190105,POLATUZUMAB VEDOTIN-PIIQ 30 MG INTRAVENOUS SOLUTION,13475.85,8085.51,132.57,21723.66,35 CDM,RX-190237,AMINO ACID 6 % IN DEXTROSE 5 % WATER INTRAVENOUS SOLUTION,264.95,158.97,61.47,4481.0,17 CDM,RX-190244,AMINO ACIDS 8 %-DEXTROSE 14 %-ELECTROLYTES INTRAVENOUS SOLUTION,303.05,181.83,70.31,4481.0,17 CDM,RX-190245,AMINO ACIDS 8 %-DEXTROSE 10 %-ELECTROLYTES INTRAVENOUS SOLUTION,314.5,188.7,72.96,4481.0,17 CDM,RX-190246,AMINO ACID 8 % IN DEXTROSE 10% WATER INTRAVENOUS SOLUTION,264.95,158.97,61.47,4481.0,17 CDM,RX-190247,AMINO ACID 8 % IN DEXTROSE 14 % WATER INTRAVENOUS SOLUTION,299.25,179.55,69.43,4481.0,17 CDM,RX-190261,RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION,49902.799999999996,29941.68,218.36,62706.12,70 CDM,RX-190522,FIDAXOMICIN 40 MG/ML ORAL SUSPENSION,15631.0,9378.6,3626.39,12504.8,19 CDM,RX-190526,REMIMAZOLAM 20 MG INTRAVENOUS SOLUTION,153.9,92.34,5.04,4481.0,24 CDM,RX-190548,"EPOETIN ALFA-EPBX 20,000 UNIT/ML INJECTION SOLUTION",876.35,525.81,7.61,4481.0,33 CDM,RX-190553,NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION,323818.0,194290.8,665.42,259054.4,35 CDM,RX-190732,DILUENT FOR CAPLACIZUMAB-YHDP (STERILE WATER) 1 ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-190824,"CABOTEGRAVIR ER 400 MG/2 ML-RILPIVIRINE ER 600 MG/2ML IM SUSPENSION,ER",18109.4,10865.64,22.94,14487.52,35 CDM,RX-190833,VOCLOSPORIN 7.9 MG CAPSULE,280.25,168.15,65.02,4481.0,19 CDM,RX-190886,SEMAGLUTIDE 1 MG/DOSE (4 MG/3 ML) SUBCUTANEOUS PEN INJECTOR,3906.6,2343.96,906.33,4481.0,19 CDM,RX-190938,TEPOTINIB 225 MG TABLET,1742.8,1045.68,404.33,4481.0,19 CDM,RX-190965,EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION,94258.45,56555.07000000001,187.95,117108.8,70 CDM,RX-190973,TRILACICLIB 300 MG INTRAVENOUS SOLUTION,5337.65,3202.59,5.3,4481.0,35 CDM,RX-191086,ENZALUTAMIDE 40 MG TABLET,521.9,313.14,121.08,4481.0,19 CDM,RX-191087,ENZALUTAMIDE 80 MG TABLET,1018.75,611.25,236.35,4481.0,19 CDM,RX-191110,TRASTUZUMAB-QYYP 150 MG INTRAVENOUS SOLUTION,4283.8,2570.28,27.15,4481.0,35 CDM,RX-191193,DEXMEDETOMIDINE 20 MCG/5 ML (4 MCG/ML) IN 0.9 % SODIUM CHLR IV SYRINGE,102.1,61.26,23.69,4481.0,19 CDM,RX-191365,THYROTROPIN ALFA 0.9 MG INTRAMUSCULAR SOLUTION,7902.3,4741.38,1999.28,314159.58,35 CDM,RX-191370,ARTESUNATE 110 MG INTRAVENOUS SOLUTION,17650.7,10590.42,50.28,15269.62,35 CDM,RX-191379,"CABOTEGRAVIR ER 600 MG/3 ML-RILPIVIRINE ER 900 MG/3ML IM SUSPENSION,ER",27156.1,16293.66,22.94,21724.88,35 CDM,RX-191513,LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION,94019.95,56411.97,210.39,75215.96,35 CDM,RX-191521,DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION,40095.2,24057.12,236.4,39304.86,35 CDM,RX-191706,BUPIVACAINE-MELOXICAM ER 400 MG-12 MG/14 ML SURGICAL SITE INSTILL SOLN,165.0,99.0,0.7566,4481.0,35 CDM,RX-191708,BUPIVACAINE-MELOXICAM ER 200 MG-6 MG/7 ML SURGICAL SITE INSTILL SOLN,170.7,102.42,0.7566,4481.0,35 CDM,RX-191712,"PEGCETACOPLAN 1,080 MG/20 ML SUBCUTANEOUS SOLUTION",15952.1,9571.26,3700.89,12761.68,22 CDM,RX-191720,AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION,12875.15,7725.09,21.86,10300.12,35 CDM,RX-19176,ATORVASTATIN 10 MG TABLET,17.15,10.29,3.98,4481.0,19 CDM,RX-19177,ATORVASTATIN 40 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-19178,ATORVASTATIN 20 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-19179,AZELASTINE 137 MCG (0.1 %) NASAL SPRAY,81.5,48.9,18.91,4481.0,19 CDM,RX-191935,SEMAGLUTIDE (NON-DIABETES) 1.7 MG/0.75 ML SUBCUTANEOUS PEN INJECTOR,1331.3,798.78,308.86,4481.0,19 CDM,RX-191985,NIMODIPINE 60 MG/10 ML ORAL SOLUTION,180.5,108.3,41.88,4481.0,19 CDM,RX-192104,BALOXAVIR MARBOXIL 80 MG TABLET,522.5,313.5,121.22,4481.0,19 CDM,RX-192119,PNEUMOCOCCAL 20-VALENT CONJ VACCINE-DIP CRM (PF) 0.5 ML IM SYRINGE,843.6,506.16,195.72,4481.0,26 CDM,RX-192150,ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION,17851.1,10710.66,53.81,14280.88,35 CDM,RX-19226,CABERGOLINE 0.5 MG TABLET,156.4,93.84,36.28,4481.0,19 CDM,RX-192273,ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION,17853.9,10712.34,17.54,14283.12,35 CDM,RX-192296,AVALGLUCOSIDASE ALFA-NGPT 100 MG INTRAVENOUS SOLUTION,6431.0,3858.6,78.48,12737.55,35 CDM,RX-192514,TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION,24771.65,14862.99,183.1,30877.35,35 CDM,RX-192644,AVACOPAN 10 MG CAPSULE,314.0,188.4,72.85,4481.0,19 CDM,RX-192774,TOPIRAMATE 25 MG/ML ORAL SOLUTION,1017.2,610.32,235.99,4481.0,19 CDM,RX-192861,INCLISIRAN 284 MG/1.5 ML SUBCUTANEOUS SYRINGE,14008.15,8404.89,11.95,11206.52,35 CDM,RX-192891,SIROLIMUS-PROTEIN BOUND 100 MG INTRAVENOUS SUSPENSION,27476.25,16485.75,82.03,21981.0,35 CDM,RX-192958,EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION,20305.55,12183.33,31.19,16244.44,35 CDM,RX-192961,"CABOTEGRAVIR ER 600 MG/3 ML (200 MG/ML) IM SUSPENSION,EXTENDED RELEASE",16106.85,9664.11,6.81,12885.48,35 CDM,RX-193033,RIVAROXABAN 1 MG/ML ORAL SUSPENSION,1810.0,1086.0,419.92,4481.0,19 CDM,RX-193050,TEZEPELUMAB-EKKO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS SYRINGE,14184.7,8510.82,17.47,11347.76,35 CDM,RX-193093,TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION,69751.9,41851.14,210.58,55801.52,35 CDM,RX-193199,BACLOFEN 25 MG/5 ML (5 MG/ML) ORAL SUSPENSION,34.15,20.49,7.92,4481.0,19 CDM,RX-193221,VASOPRESSIN 0.2 UNIT/ML INTRAVENOUS SOLUTION,226.5,135.9,2.09,4481.0,24 CDM,RX-193278,CEFAZOLIN 2 GRAM SOLUTION FOR INJECTION,82.15,49.29,1.8,4481.0,24 CDM,RX-19333,"CLONIDINE (PF) 1,000 MCG/10 ML (100 MCG/ML) EPIDURAL SOLUTION",75.3,45.18,17.47,4481.0,24 CDM,RX-193333,PACRITINIB 100 MG CAPSULE,663.05,397.83,153.83,4481.0,22 CDM,RX-193338,FILGRASTIM-AYOW 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,636.1,381.66,0.3686,4481.0,35 CDM,RX-193339,FILGRASTIM-AYOW 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,1008.2,604.92,0.3686,4481.0,35 CDM,RX-193424,"UPADACITINIB ER 45 MG TABLET,EXTENDED RELEASE 24 HR",1366.55,819.93,317.04,4481.0,19 CDM,RX-193432,NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION,51321.8,30793.08,191.9,41057.44,35 CDM,RX-193789,POTASSIUM CHLORIDE 100 MEQ/50 ML (2 MEQ/ML) IN WATER IV SYRINGE (CONC),64.65,38.79,15.0,4481.0,26 CDM,RX-193892,CARDIOPLEGIC-ORGAN PRESERVATION SOLUTION NO.1 9 MMOL-198 MMOL-2 MMOL/L,855.5,513.3,198.48,4481.0,24 CDM,RX-193923,TREPROSTINIL 16 MCG CARTRIDGE WITH INHALER,2635.0,1581.0,611.32,4481.0,24 CDM,RX-193924,TREPROSTINIL 32 MCG CARTRIDGE WITH INHALER,1139.75,683.85,264.42,4481.0,19 CDM,RX-193925,TREPROSTINIL 48 MCG CARTRIDGE WITH INHALER,1139.75,683.85,264.42,4481.0,19 CDM,RX-193926,TREPROSTINIL 64 MCG CARTRIDGE WITH INHALER,2635.0,1581.0,611.32,4481.0,19 CDM,RX-193986,VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE,465484.9,279290.94,4481.0,811244.49,35 CDM,RX-193994,RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION,34829.75,20897.85,14.49,27863.8,35 CDM,RX-19433,WARFARIN 3 MG TABLET,17.2,10.32,3.99,4481.0,19 CDM,RX-194383,PAFOLACIANINE 3.2 MG/1.6 ML INTRAVENOUS SOLUTION,13960.5,8376.3,304.81,12077.23,23 CDM,RX-194385,TRIAMCINOLONE ACETONIDE (PF) 40 MG/ML SUPRACHOROIDAL SUSPENSION,731.0,438.6,169.59,4481.0,26 CDM,RX-19451,"DIPH,PERTUS(ACEL),TET PED(PF) 25 LF UNIT-58 MCG-10 LF/0.5ML IM SYRINGE",104.05,62.43,24.14,4481.0,25 CDM,RX-194624,ZONISAMIDE 100 MG/5 ML ORAL SUSPENSION,1274.65,764.79,295.72,4481.0,19 CDM,RX-194680,OLIPUDASE ALFA-RPCP 20 MG INTRAVENOUS SOLUTION,24837.3,14902.38,381.85,62401.5,35 CDM,RX-194684,SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION,91306.75,54784.05,63.76,73045.4,35 CDM,RX-194770,SODIUM THIOSULFATE 12.5 GRAM/100 ML (125 MG/ML) INTRAVENOUS SOLUTION,37396.95,22438.17,92.26,29917.56,35 CDM,RX-194853,TERLIPRESSIN 0.85 MG INTRAVENOUS POWDER FOR SOLUTION,3293.8,1976.28,764.16,4481.0,22 CDM,RX-194932,TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION,74478.7,44687.22,136.67,109813.12,70 CDM,RX-194935,TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION,34856.4,20913.84,32.57,27885.12,35 CDM,RX-194936,TECLISTAMAB-CQYV 10 MG/ML SUBCUTANEOUS SOLUTION,7055.65,4233.39,32.57,5644.52,35 CDM,RX-195043,"MENINGOCOCCAL VAC A,C,Y,W-135 DIP(PF) 10 MCG-5 MCG/0.5 ML IM SOLUTION",520.0,312.0,120.64,4481.0,25 CDM,RX-195084,ANGIOTENSIN II 0.5 MG/ML INTRAVENOUS SOLUTION,1668.6,1001.16,67.01,4481.0,34 CDM,RX-195085,MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION,22724.65,13634.79,67.41,18179.72,35 CDM,RX-195097,TEPLIZUMAB-MZWV 1 MG/ML INTRAVENOUS SOLUTION,48129.3,28877.58,36.53,38503.44,35 CDM,RX-195325,LENACAPAVIR 309 MG/ML SUBCUTANEOUS SOLUTION,76066.0,45639.6,21.49,60852.8,35 CDM,RX-195326,LENACAPAVIR 300 MG TABLET,2453.5,1472.1,569.21,4481.0,19 CDM,RX-195327,MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION,32302.425000000003,19381.454999999998,592.35,104912.43,70 CDM,RX-195425,UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION,36392.75,21835.65,68.63,29114.2,35 CDM,RX-195482,LECANEMAB-IRMB 100 MG/ML INTRAVENOUS SOLUTION,1557.925,934.7550000000001,1.28,4481.0,70 CDM,RX-195636,VELMANASE ALFA-TYCV 10 MG INTRAVENOUS SOLUTION,14415.05,8649.03,451.27,72834.09,35 CDM,RX-195645,TEZEPELUMAB-EKKO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS PEN INJECTOR,18249.2,10949.52,17.47,14599.36,35 CDM,RX-195941,RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION,49074.35,29444.61,29.64,39259.48,35 CDM,RX-196341,EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION,54824.8,32894.88,54.16,43859.84,35 CDM,RX-196342,EPCORITAMAB-BYSP 4 MG/0.8 ML SUBCUTANEOUS SOLUTION,3684.4,2210.64,54.16,8980.23,35 CDM,RX-19636,PHENYLEPHRINE 10 % EYE DROPS,136.4,81.84,31.64,4481.0,19 CDM,RX-196539,REZAFUNGIN 200 MG INTRAVENOUS SOLUTION,6896.15,4137.69,10.31,5516.92,35 CDM,RX-196543,PEDIATRIC MULTIVITAMIN NO.226-FERROUS SULFATE 18 MG CHEWABLE TABLET,1.2,0.72,0.2784,4481.0,24 CDM,RX-196631,GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION,9246.2,5547.72,2339.29,453849.27,70 CDM,RX-196644,"EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN",52672.3,31603.38,32.87,42137.84,35 CDM,RX-196662,ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION,30484.8,18290.88,22.47,24387.84,35 CDM,RX-196721,NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION,51341.7,30805.02,4481.0,10350356.73,35 CDM,RX-196835,QUIZARTINIB 26.5 MG TABLET,2362.1,1417.26,548.01,4481.0,19 CDM,RX-196836,QUIZARTINIB 17.7 MG TABLET,2362.1,1417.26,548.01,4481.0,19 CDM,RX-19691,BENZOCAINE 20 % MUCOSAL GEL,10.05,6.03,2.33,4481.0,19 CDM,RX-196954,NIRSEVIMAB-ALIP 50 MG/0.5 ML INTRAMUSCULAR SYRINGE,2184.95,1310.97,506.91,88292.61,25 CDM,RX-196955,NIRSEVIMAB-ALIP 100 MG/ML INTRAMUSCULAR SYRINGE,2184.95,1310.97,506.91,88292.61,25 CDM,RX-19696,BENZOCAINE 20 % MUCOSAL AEROSOL SPRAY,1.85,1.11,0.4292,4481.0,19 CDM,RX-197032,AVACINCAPTAD PEGOL (PF) 2 MG/0.1 ML INTRAVITREAL SOLUTION,8206.0,4923.6,101.97,17585.61,35 CDM,RX-19704,CARBACHOL 0.01 % INTRAOCULAR SOLUTION,62.65,37.59,14.53,4481.0,19 CDM,RX-197053,TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION,38515.55,23109.33,70.44,30812.44,35 CDM,RX-197054,TALQUETAMAB-TGVS 2 MG/ML SUBCUTANEOUS SOLUTION,3143.05,1885.83,70.44,11455.71,35 CDM,RX-197082,ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION,7741.4,4644.84,178.55,29949.78,70 CDM,RX-197106,AFLIBERCEPT 8 MG/0.07 ML INTRAVITREAL SOLUTION FOR INJECTION,10667.1,6400.26,302.04,52571.61,35 CDM,RX-19711,CLINDAMYCIN 1 % LOTION,305.55,183.33,70.89,4481.0,19 CDM,RX-19713,DIAZOXIDE 50 MG/ML ORAL SUSPENSION,1475.8,885.48,342.39,4481.0,19 CDM,RX-19714,DICLOFENAC 0.1 % EYE DROPS,58.15,34.89,13.49,4481.0,19 CDM,RX-197294,"MIDAZOLAM (PF) 50 MG/50 ML (1 MG/ML) IN SOD CHLOR,ISO-OSM IV SYRINGE",85.25,51.15,19.78,4481.0,26 CDM,RX-19733,KETOROLAC 0.5 % EYE DROPS,100.3,60.18,23.27,4481.0,19 CDM,RX-197341,MOMELOTINIB 100 MG TABLET,3873.9,2324.34,898.74,4481.0,22 CDM,RX-197343,MOMELOTINIB 200 MG TABLET,3873.9,2324.34,898.74,4481.0,22 CDM,RX-19746,OFLOXACIN 0.3 % EYE DROPS,61.15,36.69,14.19,4481.0,19 CDM,RX-19760,SODIUM FLUORIDE 1.1 % DENTAL GEL,73.0,43.8,16.94,4481.0,19 CDM,RX-197605,SECUKINUMAB 25 MG/ML INTRAVENOUS SOLUTION,7259.2,4355.52,17.3,5807.36,35 CDM,RX-197736,MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION,31432.85,18859.71,41.76,25146.28,35 CDM,RX-197747,TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION,31794.55,19076.73,38.23,25435.64,35 CDM,RX-19791,POVIDONE-IODINE 5 % EYE SOLUTION,69.5,41.7,16.12,4481.0,19 CDM,RX-197960,TRAVOPROST 75 MCG INTRACAMERAL IMPLANT,54421.0,32652.6,189.85,43536.8,35 CDM,RX-198112,PEGFILGRASTIM-CBQV 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUT INJECTOR,16298.5,9779.1,103.14,26777.52,35 CDM,RX-198130,OMALIZUMAB 300 MG/2 ML SUBCUTANEOUS SYRINGE,11503.6,6902.16,43.26,9202.88,35 CDM,RX-198388,MELPHALAN HCL 50 MG INTRA-ARTERIAL SOLUTION,124400.0,74640.0,771.15,107618.44,35 CDM,RX-198431,VANCOMYCIN 1500 MG/300 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,241.35,144.81,0.0675,4481.0,24 CDM,RX-198437,VANCOMYCIN 1250 MG/250 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,236.4,141.84,0.0675,4481.0,24 CDM,RX-198456,"METHADONE 10 MG/ML IN SODIUM CHLORIDE,ISO-OSMOTIC INTRAVENOUS SYRINGE",148.45,89.07,34.44,4481.0,26 CDM,RX-198468,PEMIVIBART 125 MG/ML INTRAVENOUS SOLUTION (EUA),20827.55,12496.53,4481.0,23978.46,25 CDM,RX-198679,TOVORAFENIB 25 MG/ML ORAL SUSPENSION,73744.85,44246.91,4481.0,63796.67,26 CDM,RX-198680,TOVORAFENIB 400 MG/WEEK (100 MG X 4) TABLET,9240.0,5544.0,2143.68,7993.52,26 CDM,RX-198681,NOGAPENDEKIN ALFA INBAKICEPT-PMLN 400 MCG/0.4 ML INTRAVESICAL SOLUTION,118773.0,71263.8,91.82,95018.4,35 CDM,RX-198682,TOVORAFENIB 500 MG/WEEK (100 MG X 5) TABLET,7397.0,4438.2,1716.1,6399.14,26 CDM,RX-198683,TOVORAFENIB 600 MG/WEEK (100 MG X 6) TABLET,6168.35,3701.01,1431.06,5336.24,26 CDM,RX-19882,SERTRALINE 25 MG TABLET,17.15,10.29,3.98,4481.0,19 CDM,RX-198978,TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION,49925.0,29955.0,1517.7,257101.53,35 CDM,RX-198979,TARLATAMAB-DLLE 1 MG INTRAVENOUS SOLUTION,5637.25,3382.35,1426.22,257101.53,35 CDM,RX-199151,IMETELSTAT 47 MG INTRAVENOUS SOLUTION,8572.85,5143.71,55.32,7416.37,35 CDM,RX-199153,IMETELSTAT 188 MG INTRAVENOUS SOLUTION,34102.35,20461.41,55.32,29501.94,35 CDM,RX-199176,PNEUMOCOCCAL 21-VALENT CONJ VACCINE-DIP CRM (PF) 0.5 ML IM SYRINGE,926.05,555.63,214.84,4481.0,26 CDM,RX-199269,SELPERCATINIB 40 MG TABLET,552.3,331.38,128.13,4481.0,26 CDM,RX-199270,SELPERCATINIB 80 MG TABLET,815.95,489.57,189.3,4481.0,26 CDM,RX-199271,SELPERCATINIB 120 MG TABLET,1606.85,964.11,372.79,4481.0,26 CDM,RX-199272,SELPERCATINIB 160 MG TABLET,1606.85,964.11,372.79,4481.0,26 CDM,RX-199311,DONANEMAB-AZBT 17.5 MG/ML INTRAVENOUS SOLUTION,2366.3,1419.78,4.01,4481.0,35 CDM,RX-199746,GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION,47695.3,28617.18,73.69,38156.24,35 CDM,RX-199756,"OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN",161015.5,96609.3,45.81,128812.4,35 CDM,RX-199759,"ATEZOLIZUMAB 1,875 MG-HYALURONIDASE-TQJS 30,000 UNIT/15 ML SUBCUT SOLN",38635.8,23181.48,30.63,30908.64,35 CDM,RX-200024,ZOLBETUXIMAB-CLZB 100 MG INTRAVENOUS SOLUTION,5571.0,3342.6,31.74,5080.32,35 CDM,RX-200137,FLU VACC 2025-26(65YR UP)-MF59C(PF) 45 MCG(15 MCGX3)/0.5 ML IM SYRINGE,278.45,167.07,64.6,4481.0,26 CDM,RX-200146,FLU VACCINE TS 2025-26(6MOS UP)(PF) 45 MCG(15MCG X3)/0.5 ML IM SYRINGE,81.25,48.75,18.85,4481.0,26 CDM,RX-200257,REVUMENIB 110 MG TABLET,2658.35,1595.01,616.74,4481.0,19 CDM,RX-200258,REVUMENIB 160 MG TABLET,2658.35,1595.01,616.74,4481.0,19 CDM,RX-200408,ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION,78887.5,47332.5,31.92,68245.58,35 CDM,RX-200676,AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION,26672.625,16003.575,53.98,30265.2,70 CDM,RX-200677,LETERMOVIR 20 MG ORAL PELLETS IN PACKET,50.3,30.18,11.67,4481.0,19 CDM,RX-200678,LETERMOVIR 120 MG ORAL PELLETS IN PACKET,221.8,133.08,51.46,4481.0,19 CDM,RX-2007,"CYANOCOBALAMIN (VIT B-12) 1,000 MCG/ML INJECTION SOLUTION",17.35,10.41,2.25,4481.0,24 CDM,RX-200710,"NIVOLUMAB 600 MG-HYALURONIDASE-NVHY 10,000 UNIT/5 ML SUBCUT SOLUTION",26566.6,15939.96,26.54,21253.28,35 CDM,RX-20077,MESNA 400 MG TABLET,339.4,203.64,78.74,4481.0,19 CDM,RX-200800,DATOPOTAMAB DERUXTECAN-DLNK 100 MG INTRAVENOUS SOLUTION,16464.45,9878.67,50.01,14243.4,35 CDM,RX-2009,"CYANOCOBALAMIN (VIT B-12) 1,000 MCG TABLET",1.35,0.81,0.3132,4481.0,19 CDM,RX-200920,LINVOSELTAMAB-GCPT 20 MG/ML INTRAVENOUS SOLUTION,8053.5,4832.1,1868.41,6442.8,22 CDM,RX-200922,LINVOSELTAMAB-GCPT 2 MG/ML INTRAVENOUS SOLUTION,1830.7,1098.42,424.72,4481.0,22 CDM,RX-200943,TREOSULFAN 5 GRAM INTRAVENOUS SOLUTION,10370.5,6222.3,31.36,8971.52,35 CDM,RX-200946,HYDROXYUREA (SICKLE CELL) 100 MG/ML ORAL SOLUTION,2295.95,1377.57,532.66,4481.0,19 CDM,RX-200948,TREOSULFAN 1 GRAM INTRAVENOUS SOLUTION,2294.1,1376.46,31.36,4481.0,35 CDM,RX-201300,ECULIZUMAB-AAGH 300 MG/30 ML INTRAVENOUS SOLUTION,14993.85,8996.31,30.41,11995.08,35 CDM,RX-201302,REVUMENIB 25 MG TABLET,1358.35,815.01,315.14,4481.0,19 CDM,RX-20156,CYTARABINE (PF) 100 MG/ML INJECTION,344.2,206.52,1.87,4481.0,24 CDM,RX-2017,CYCLOBENZAPRINE 10 MG TABLET,16.55,9.93,3.84,4481.0,19 CDM,RX-202035,TENECTEPLASE 25 MG INTRAVENOUS SOLUTION FOR STROKE,32375.35,19425.21,167.05,28007.92,35 CDM,RX-202036,TELISOTUZUMAB VEDOTIN-TLLV 100 MG INTRAVENOUS SOLUTION,46548.8,27929.28,139.67,40269.37,35 CDM,RX-202037,TELISOTUZUMAB VEDOTIN-TLLV 20 MG INTRAVENOUS SOLUTION,9529.8,5717.88,139.67,8244.23,35 CDM,RX-202058,COVID VACC 2025-2026 (12 YRS UP) (PFIZER)(PF) 30 MCG/0.3 ML IM SYRINGE,465.1,279.06,107.9,4481.0,26 CDM,RX-202237,COVID VAC 2025-26 (6MO-11YR)(MODERNA) (PF) 25 MCG/0.25 ML IM SYRINGE,409.0,245.4,94.89,4481.0,26 CDM,RX-2025,CYCLOPENTOLATE 1 % EYE DROPS,111.475,66.885,23.27,4481.0,38 CDM,RX-202546,GEMCITABINE 225 MG INTRAVESICAL IMPLANT,228665.0,137199.0,4481.0,182932.0,22 CDM,RX-202599,"PEMBROLIZUMAB 395 MG-BERAHYALURONID-PMPH 4,800 UNIT/2.4 ML SUBCUT SOLN",40098.85,24059.31,4481.0,32079.08,22 CDM,RX-202600,"PEMBROLIZUMAB 790 MG-BERAHYALURONID-PMPH 9,600 UNIT/4.8 ML SUBCUT SOLN",79922.65,47953.59,4481.0,63938.12,22 CDM,RX-2032,CYPROHEPTADINE 2 MG/5 ML ORAL SYRUP,176.35,105.81,40.91,4481.0,19 CDM,RX-20446,ANAGRELIDE 0.5 MG CAPSULE,18.5,11.1,4.29,4481.0,19 CDM,RX-20472,ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTION,81.0,48.6,18.79,4481.0,19 CDM,RX-20566,MELOXICAM 7.5 MG TABLET,16.5,9.9,3.83,4481.0,19 CDM,RX-20580,MELOXICAM 15 MG TABLET,16.6,9.96,3.85,4481.0,19 CDM,RX-20887,VALPROATE SODIUM 500 MG/5 ML (100 MG/ML) INTRAVENOUS SOLUTION,85.9,51.54,19.93,4481.0,19 CDM,RX-2091,DACARBAZINE 200 MG INTRAVENOUS SOLUTION,314.75,188.85,7.76,4481.0,24 CDM,RX-20919,"MORPHINE ER 100 MG TABLET,EXTENDED RELEASE",38.65,23.19,8.97,4481.0,19 CDM,RX-20920,"MORPHINE ER 15 MG TABLET,EXTENDED RELEASE",24.8,14.88,5.75,4481.0,19 CDM,RX-20921,"MORPHINE ER 30 MG TABLET,EXTENDED RELEASE",26.85,16.11,6.23,4481.0,19 CDM,RX-20922,"MORPHINE ER 60 MG TABLET,EXTENDED RELEASE",24.7,14.82,5.73,4481.0,19 CDM,RX-20943,AZITHROMYCIN 250 MG TABLET,21.25,12.75,4.93,4481.0,19 CDM,RX-20952,LEVOCARNITINE 330 MG TABLET,2.4,1.44,0.5568,4481.0,19 CDM,RX-20954,LEVOCARNITINE 200 MG/ML INTRAVENOUS SOLUTION,167.65,100.59,38.89,4481.0,24 CDM,RX-21044,LEUPROLIDE ACETATE 11.25 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT,18160.2,10896.12,1678.41,252434.28,35 CDM,RX-21045,LEUPROLIDE ACETATE 22.5 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT,21587.7,12952.62,171.16,26039.58,35 CDM,RX-21058,ARTIFICIAL TEARS (HYPROMELLOSE) 0.3 % EYE GEL,11.1,6.66,2.58,4481.0,19 CDM,RX-21061,OXCARBAZEPINE 300 MG TABLET,18.65,11.19,4.33,4481.0,19 CDM,RX-21062,CITALOPRAM 20 MG TABLET,16.2,9.72,3.76,4481.0,19 CDM,RX-21063,AZITHROMYCIN 500 MG INTRAVENOUS SOLUTION,79.35,47.61,4.59,4481.0,24 CDM,RX-21135,DESMOPRESSIN 10 MCG/SPRAY (0.1 ML) NASAL SPRAY (NON-REFRIGERATED),386.65,231.99,89.7,4481.0,19 CDM,RX-2120,DANAZOL 200 MG CAPSULE,37.6,22.56,8.72,4481.0,19 CDM,RX-21228,ALPROSTADIL 20 MCG INTRACAVERNOSAL KIT,428.75,257.25,1.3,4481.0,24 CDM,RX-21287,PRAMIPEXOLE 0.125 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-21288,PRAMIPEXOLE 1 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-21290,PRAMIPEXOLE 0.25 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-21300,"PENTOXIFYLLINE ER 400 MG TABLET,EXTENDED RELEASE",17.3,10.38,4.01,4481.0,19 CDM,RX-2131,DAPSONE 100 MG TABLET,19.25,11.55,4.47,4481.0,19 CDM,RX-21321,PROGESTERONE MICRONIZED 8 % VAGINAL GEL,110.45,66.27,25.62,4481.0,19 CDM,RX-21372,WARFARIN 4 MG TABLET,17.2,10.32,3.99,4481.0,19 CDM,RX-21374,MYCOPHENOLATE MOFETIL 500 MG TABLET,19.3,11.58,0.36,4481.0,24 CDM,RX-21509,LETROZOLE 2.5 MG TABLET,133.65,80.19,31.01,4481.0,19 CDM,RX-21672,CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT,17751.8,10651.08,231.31,22004.43,35 CDM,RX-21688,ROPINIROLE 0.25 MG TABLET,17.65,10.59,4.09,4481.0,19 CDM,RX-21689,ROPINIROLE 1 MG TABLET,17.75,10.65,4.12,4481.0,19 CDM,RX-21690,ROPINIROLE 2 MG TABLET,16.4,9.84,3.8,4481.0,19 CDM,RX-21800,ROPINIROLE 0.5 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-21823,QUETIAPINE 25 MG TABLET,17.0,10.2,3.94,4481.0,19 CDM,RX-21824,QUETIAPINE 100 MG TABLET,17.6,10.56,4.08,4481.0,19 CDM,RX-21825,QUETIAPINE 200 MG TABLET,19.15,11.49,4.44,4481.0,19 CDM,RX-21827,TIAGABINE 4 MG TABLET,35.05,21.03,8.13,4481.0,19 CDM,RX-21900,AMPHOTERICIN B LIPOSOME 50 MG INTRAVENOUS SUSPENSION,896.05,537.63,20.84,4481.0,35 CDM,RX-22120,"RABIES VACCINE, PURIFIED CHICKEN EMBRYO CELL (PF) 2.5 UNIT IM SUSP",1325.85,795.51,304.27,4481.0,36 CDM,RX-22149,"RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS",9604.475,5762.6849999999995,72.96,12659.28,70 CDM,RX-22185,FOMEPIZOLE 1 GRAM/ML INTRAVENOUS SOLUTION,5725.4,3435.24,6.09,4953.04,35 CDM,RX-22240,TOBRAMYCIN 300 MG/5 ML IN 0.225 % SODIUM CHLORIDE FOR NEBULIZATION,51.25,30.75,11.89,4481.0,19 CDM,RX-22257,OFLOXACIN 0.3 % EAR DROPS,18.75,11.25,4.35,4481.0,19 CDM,RX-22289,CEFDINIR 300 MG CAPSULE,19.65,11.79,4.56,4481.0,19 CDM,RX-22469,"LACTASE 3,000 UNIT TABLET",1.15,0.69,0.2668,4481.0,19 CDM,RX-22472,KETOROLAC 15 MG/ML INJECTION SOLUTION,30.65,18.39,0.2813,4481.0,34 CDM,RX-22473,KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION,38.25,22.95,0.2813,4481.0,34 CDM,RX-22509,MONTELUKAST 10 MG TABLET,17.5,10.5,4.06,4481.0,19 CDM,RX-22510,MONTELUKAST 5 MG CHEWABLE TABLET,18.85,11.31,4.37,4481.0,19 CDM,RX-22560,SULFAMETHOXAZOLE 200 MG-TRIMETHOPRIM 40 MG/5 ML ORAL SUSPENSION,145.15,87.09,33.67,4481.0,19 CDM,RX-22588,LOSARTAN 100 MG TABLET,18.1,10.86,4.2,4481.0,19 CDM,RX-22661,DAUNORUBICIN (CERUBIDINE) SYRINGE 5 MG/ML,719.05,431.43,21.05,4481.0,35 CDM,RX-22719,PRAMIPEXOLE 0.5 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-2283,DESIPRAMINE 10 MG TABLET,16.4,9.84,3.8,4481.0,19 CDM,RX-2286,DESIPRAMINE 25 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-2287,DESIPRAMINE 50 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-22960,PARICALCITOL 5 MCG/ML INTRAVENOUS SOLUTION,112.55,67.53,1.83,4481.0,24 CDM,RX-22982,DORZOLAMIDE 22.3 MG-TIMOLOL 6.8 MG/ML EYE DROPS,166.5,99.9,38.63,4481.0,19 CDM,RX-22988,CIPROFLOXACIN 500 MG/5 ML ORAL SUSPENSION,472.9,283.74,109.71,4481.0,19 CDM,RX-23082,BASILIXIMAB 20 MG INTRAVENOUS SOLUTION,15269.65,9161.79,3863.22,727914.6,35 CDM,RX-23123,EPTIFIBATIDE 0.75 MG/ML INTRAVENOUS SOLUTION,390.0,234.0,22.95,4481.0,24 CDM,RX-23124,EPTIFIBATIDE 2 MG/ML INTRAVENOUS SOLUTION,161.1,96.66,22.95,4481.0,24 CDM,RX-2320,DEXAMETHASONE 0.5 MG/5 ML ORAL SOLUTION,168.65,101.19,0.045,4481.0,24 CDM,RX-2322,DEXAMETHASONE 0.5 MG TABLET,16.55,9.93,0.045,4481.0,24 CDM,RX-2326,DEXAMETHASONE 2 MG TABLET,17.9,10.74,4.15,4481.0,19 CDM,RX-2327,DEXAMETHASONE 4 MG TABLET,19.05,11.43,0.045,4481.0,24 CDM,RX-2332,DEXAMETHASONE SODIUM PHOSPHATE 4 MG/ML INJECTION SOLUTION,19.05,11.43,0.2025,4481.0,24 CDM,RX-2335,DEXAMETHASONE SODIUM PHOSPHATE 0.1 % EYE DROPS,178.25,106.95,41.35,4481.0,19 CDM,RX-23461,LIDOCAINE 4 % TOPICAL CREAM,11.85,7.11,2.75,4481.0,19 CDM,RX-23490,CITALOPRAM 40 MG TABLET,16.2,9.72,3.76,4481.0,19 CDM,RX-2357,DEXTROSE 10 % IN WATER (D10W) INTRAVENOUS SOLUTION,87.0,52.2,20.18,4481.0,17 CDM,RX-2359,DEXTROSE 20 % IN WATER (D20W) INTRAVENOUS SOLUTION,106.5,63.9,24.71,4481.0,17 CDM,RX-23617,LEUCOVORIN CALCIUM 500 MG SOLUTION FOR INJECTION,560.3,336.18,7.25,4481.0,24 CDM,RX-2364,DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION,81.0,48.6,7.0,4481.0,21 CDM,RX-2365,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SOLUTION,36.3,21.78,8.42,4481.0,17 CDM,RX-2367,DEXTROSE 70 % IN WATER (D70W) INTRAVENOUS SOLUTION,78.0,46.8,18.1,4481.0,17 CDM,RX-23796,INFLIXIMAB 100 MG INTRAVENOUS SOLUTION,3881.8,2329.08,30.16,4783.38,35 CDM,RX-23814,ATOVAQUONE 250 MG-PROGUANIL 100 MG TABLET,33.55,20.13,7.78,4481.0,19 CDM,RX-23872,LEFLUNOMIDE 10 MG TABLET,19.3,11.58,4.48,4481.0,19 CDM,RX-23873,LEFLUNOMIDE 20 MG TABLET,19.3,11.58,4.48,4481.0,19 CDM,RX-23968,MYCOPHENOLATE 500 MG INTRAVENOUS SOLUTION,416.1,249.66,0.81,4481.0,24 CDM,RX-2401,DIAZEPAM 5 MG/ML INJECTION SOLUTION,196.2,117.72,16.54,4481.0,24 CDM,RX-2402,DIAZEPAM 5 MG/5 ML (1 MG/ML) ORAL SOLUTION,198.35,119.01,46.02,4481.0,19 CDM,RX-2403,DIAZEPAM 10 MG TABLET,22.25,13.35,5.16,4481.0,19 CDM,RX-2404,DIAZEPAM 2 MG TABLET,22.2,13.32,5.15,4481.0,19 CDM,RX-2405,DIAZEPAM 5 MG TABLET,22.25,13.35,5.16,4481.0,19 CDM,RX-24119,NEVIRAPINE 50 MG/5 ML ORAL SUSPENSION,53.9,32.34,12.5,4481.0,19 CDM,RX-2412,DIBUCAINE 1 % TOPICAL OINTMENT,5.95,3.57,1.38,4481.0,19 CDM,RX-2414,DICLOXACILLIN 250 MG CAPSULE,18.05,10.83,4.19,4481.0,19 CDM,RX-2418,DICYCLOMINE 10 MG CAPSULE,17.65,10.59,4.09,4481.0,19 CDM,RX-24188,"ANTIVENIN LATRODECTUS MACTANS 6,000 UNIT SOLUTION FOR INJECTION",124.1,74.46,28.79,4481.0,19 CDM,RX-2420,DICYCLOMINE 20 MG TABLET,17.4,10.44,4.04,4481.0,19 CDM,RX-24268,"ISOSORBIDE MONONITRATE ER 60 MG TABLET,EXTENDED RELEASE 24 HR",17.25,10.35,4.0,4481.0,19 CDM,RX-24385,HYDROCORTISONE-ACETIC ACID 1 %-2 % EAR DROPS,423.75,254.25,98.31,4481.0,19 CDM,RX-24398,"METFORMIN 1,000 MG TABLET",16.55,9.93,3.84,4481.0,19 CDM,RX-24419,LAMIVUDINE 100 MG TABLET,51.2,30.72,11.88,4481.0,19 CDM,RX-24425,VALRUBICIN 40 MG/ML INTRAVESICAL SOLUTION,6399.35,3839.61,1283.65,218317.05,35 CDM,RX-24438,ABACAVIR 300 MG TABLET,42.5,25.5,9.86,4481.0,19 CDM,RX-2444,DIGOXIN 125 MCG (0.125 MG) TABLET,20.05,12.03,4.65,4481.0,19 CDM,RX-24500,CELECOXIB 100 MG CAPSULE,20.35,12.21,4.72,4481.0,19 CDM,RX-24501,CELECOXIB 200 MG CAPSULE,22.1,13.26,5.13,4481.0,19 CDM,RX-24513,"EPOETIN ALFA 40,000 UNIT/ML INJECTION SOLUTION",4185.1,2511.06,8.28,4481.0,33 CDM,RX-24521,"ISOSORBIDE MONONITRATE ER 30 MG TABLET,EXTENDED RELEASE 24 HR",17.15,10.29,3.98,4481.0,19 CDM,RX-24559,CHOLECALCIFEROL (VITAMIN D3) 10 MCG (400 UNIT) TABLET,1.4,0.84,0.3248,4481.0,19 CDM,RX-24585,ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG INTRAVENOUS SOLUTION,4135.1,2481.06,969.39,145865.16,35 CDM,RX-24586,LACTULOSE 20 GRAM ORAL PACKET,17.5,10.5,4.06,4481.0,19 CDM,RX-24695,BUSULFAN 60 MG/10 ML INTRAVENOUS SOLUTION,1930.0,1158.0,0.8536,4481.0,35 CDM,RX-24731,BELLADONNA ALKALOIDS-OPIUM 16.2 MG-60 MG RECTAL SUPPOSITORY,103.4,62.04,23.99,4481.0,19 CDM,RX-2475,DILTIAZEM 30 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-2476,DILTIAZEM 60 MG TABLET,16.25,9.75,3.77,4481.0,19 CDM,RX-2477,DILTIAZEM 90 MG TABLET,21.4,12.84,4.96,4481.0,19 CDM,RX-24914,"TACROLIMUS 0.5 MG CAPSULE, IMMEDIATE-RELEASE",21.95,13.17,0.3825,4481.0,24 CDM,RX-24915,LEVALBUTEROL 0.63 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 CDM,RX-24916,LEVALBUTEROL 1.25 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 CDM,RX-24926,"ANTIHEMOPHILIC FACTOR (RECOMB) 1,000 (+/-) UNIT INTRAVENOUS SOLUTION",83.75,50.25,1.56,4481.0,35 CDM,RX-24932,SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE 62.5 MG/5 ML INTRAVENOUS,167.0,100.2,4.54,4481.0,24 CDM,RX-24945,MIRTAZAPINE 45 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-24984,POLYETHYLENE GLYCOL 3350 17 GRAM/DOSE ORAL POWDER,13.55,8.13,3.14,4481.0,19 CDM,RX-250,ALBUTEROL SULFATE 2.5 MG/3 ML (0.083 %) SOLUTION FOR NEBULIZATION,16.9,10.14,3.92,4481.0,19 CDM,RX-25005,MYCOPHENOLATE MOFETIL 200 MG/ML ORAL POWDER FOR SUSPENSION,48.4,29.04,0.36,4481.0,24 CDM,RX-2508,DIPHENHYDRAMINE 50 MG/ML INJECTION SOLUTION,20.6,12.36,1.71,4481.0,24 CDM,RX-251,ALBUTEROL SULFATE CONCENTRATE 5 MG/ML(0.5 %) SOLUTION FOR NEBULIZATION,425.2,255.12,19.58,4481.0,38 CDM,RX-2511,DIPHENHYDRAMINE 12.5 MG/5 ML ORAL ELIXIR,7.45,4.47,1.73,4481.0,19 CDM,RX-25118,CIPROFLOXACIN 250 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-2516,DIPHENOXYLATE-ATROPINE 2.5 MG-0.025 MG TABLET,23.45,14.07,5.44,4481.0,19 CDM,RX-2528,DIPYRIDAMOLE 25 MG TABLET,17.5,10.5,4.06,4481.0,19 CDM,RX-2529,DIPYRIDAMOLE 50 MG TABLET,21.75,13.05,5.05,4481.0,19 CDM,RX-253,ALBUTEROL SULFATE 2 MG TABLET,34.7,20.82,8.05,4481.0,19 CDM,RX-2530,DIPYRIDAMOLE 75 MG TABLET,19.25,11.55,4.47,4481.0,19 CDM,RX-2535,DISOPYRAMIDE PHOSPHATE 100 MG CAPSULE,22.0,13.2,5.1,4481.0,19 CDM,RX-25365,CEFAZOLIN 1 GRAM/50 ML IN DEXTROSE (ISO-OSMOTIC) INTRAVENOUS PIGGYBACK,112.95,67.77,1.8,4481.0,24 CDM,RX-2540,DISULFIRAM 250 MG TABLET,24.5,14.7,5.68,4481.0,19 CDM,RX-25424,POLYETHYLENE GLYCOL 3350 17 GRAM ORAL POWDER PACKET,3.3,1.98,0.7656,4481.0,19 CDM,RX-25471,KETOTIFEN 0.025 % (0.035 %) EYE DROPS,17.45,10.47,4.05,4481.0,19 CDM,RX-25519,RISPERIDONE 0.25 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-25528,PIOGLITAZONE 15 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-25529,PIOGLITAZONE 30 MG TABLET,16.55,9.93,3.84,4481.0,19 CDM,RX-25530,PIOGLITAZONE 45 MG TABLET,16.6,9.96,3.85,4481.0,19 CDM,RX-2566,DOCUSATE SODIUM 100 MG CAPSULE,1.3,0.78,0.3016,4481.0,19 CDM,RX-2568,DOCUSATE SODIUM 50 MG CAPSULE,1.4,0.84,0.3248,4481.0,19 CDM,RX-25820,IVERMECTIN 3 MG TABLET,28.45,17.07,6.6,4481.0,19 CDM,RX-25893,TEMOZOLOMIDE 20 MG CAPSULE,49.55,29.73,0.9735,4481.0,24 CDM,RX-2595,DOPAMINE 200 MG/5 ML (40 MG/ML) INTRAVENOUS SOLUTION,76.1,45.66,1.8,4481.0,24 CDM,RX-2596,DOPAMINE 400 MG/5 ML (80 MG/ML) INTRAVENOUS SOLUTION,73.7,44.22,1.8,4481.0,24 CDM,RX-2608,DOXEPIN 10 MG CAPSULE,17.6,10.56,4.08,4481.0,19 CDM,RX-2611,DOXEPIN 25 MG CAPSULE,18.45,11.07,4.28,4481.0,19 CDM,RX-2612,DOXEPIN 50 MG CAPSULE,18.95,11.37,4.4,4481.0,19 CDM,RX-2616,DOXORUBICIN 2 MG/ML INTRAVENOUS SOLUTION,672.2,403.32,6.79,4481.0,24 CDM,RX-2619,DOXORUBICIN 50 MG INTRAVENOUS SOLUTION,1145.65,687.39,6.79,4481.0,24 CDM,RX-2622,DOXYCYCLINE HYCLATE 100 MG INTRAVENOUS POWDER FOR SOLUTION,149.1,89.46,0.2475,4481.0,24 CDM,RX-26225,"PANTOPRAZOLE 40 MG TABLET,DELAYED RELEASE",16.55,9.93,3.84,4481.0,19 CDM,RX-26226,PANTOPRAZOLE 40 MG INTRAVENOUS SOLUTION,79.6,47.76,4.34,4481.0,24 CDM,RX-2625,DOXYCYCLINE HYCLATE 100 MG TABLET,27.5,16.5,6.38,4481.0,19 CDM,RX-26404,SOMATROPIN 0.2 MG/0.25 ML SUBCUTANEOUS SYRINGE,137.25,82.35,34.72,4481.0,35 CDM,RX-26431,IMIGLUCERASE 400 UNIT INTRAVENOUS SOLUTION,5733.65,3440.19,41.89,6341.58,35 CDM,RX-2654,DROPERIDOL 2.5 MG/ML INJECTION SOLUTION,25.45,15.27,5.9,4481.0,24 CDM,RX-26546,OSELTAMIVIR 75 MG CAPSULE,23.8,14.28,5.52,4481.0,19 CDM,RX-26547,ENTACAPONE 200 MG TABLET,28.4,17.04,6.59,4481.0,19 CDM,RX-26550,PROGESTERONE MICRONIZED 200 MG CAPSULE,111.05,66.63,25.76,4481.0,19 CDM,RX-26551,EXEMESTANE 25 MG TABLET,178.5,107.1,41.41,4481.0,19 CDM,RX-26816,LEVETIRACETAM 250 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-26817,LEVETIRACETAM 500 MG TABLET,16.65,9.99,3.86,4481.0,19 CDM,RX-26818,LEVETIRACETAM 750 MG TABLET,17.2,10.32,3.99,4481.0,19 CDM,RX-26965,DOFETILIDE 125 MCG CAPSULE,20.8,12.48,4.83,4481.0,19 CDM,RX-26966,DOFETILIDE 250 MCG CAPSULE,20.0,12.0,4.64,4481.0,19 CDM,RX-26967,DOFETILIDE 500 MCG CAPSULE,17.0,10.2,3.94,4481.0,19 CDM,RX-27038,"PREDNISOLONE ACETATE 0.12 % EYE DROPS,SUSPENSION",498.85,299.31,115.73,4481.0,19 CDM,RX-27047,PORACTANT ALFA 120 MG/1.5 ML INTRATRACHEAL SUSPENSION,2351.95,1411.17,545.65,4481.0,19 CDM,RX-27049,OXCARBAZEPINE 150 MG TABLET,17.65,10.59,4.09,4481.0,19 CDM,RX-27050,NORETHINDRONE ACETATE 1 MG-ETHINYL ESTRADIOL 5 MCG TABLET,23.55,14.13,5.46,4481.0,19 CDM,RX-27096,NITROGLYCERIN 400 MCG/SPRAY TRANSLINGUAL,579.1,347.46,134.35,4481.0,19 CDM,RX-27103,DEXMEDETOMIDINE 100 MCG/ML INTRAVENOUS SOLUTION,80.2,48.12,18.61,4481.0,19 CDM,RX-27234,MONTELUKAST 4 MG CHEWABLE TABLET,19.15,11.49,4.44,4481.0,19 CDM,RX-27278,"ISOSORBIDE MONONITRATE ER 120 MG TABLET,EXTENDED RELEASE 24 HR",16.35,9.81,3.79,4481.0,19 CDM,RX-27314,SOMATROPIN 5 MG SUBCUTANEOUS SOLUTION,1147.0,688.2,47.45,4481.0,35 CDM,RX-27327,MILRINONE 1 MG/ML INTRAVENOUS SOLUTION,88.25,52.95,3.26,4481.0,48 CDM,RX-27392,MORPHINE (PF) 25 MG/ML INJECTION SOLUTION,1086.55,651.93,27.11,4481.0,24 CDM,RX-27430,PENTAMIDINE 300 MG SOLUTION FOR INJECTION,367.0,220.2,85.14,4481.0,19 CDM,RX-27431,"DOXORUBICIN, PEGYLATED LIPOSOMAL 2 MG/ML INTRAVENOUS SUSPENSION",3088.5,1853.1,105.22,22320.48,70 CDM,RX-27456,TESTOSTERONE 75 MG IMPLANT PELLET,350.9,210.54,81.41,4481.0,19 CDM,RX-27466,DEXTROSE 40 % ORAL GEL,4.4,2.64,1.02,4481.0,19 CDM,RX-27472,NITROGLYCERIN 0.2 MG/HR TRANSDERMAL 24 HOUR PATCH,18.15,10.89,4.21,4481.0,19 CDM,RX-27474,NITROGLYCERIN 0.4 MG/HR TRANSDERMAL 24 HOUR PATCH,18.45,11.07,4.28,4481.0,19 CDM,RX-27475,NITROGLYCERIN 0.6 MG/HR TRANSDERMAL 24 HOUR PATCH,19.15,11.49,4.44,4481.0,19 CDM,RX-27506,CLONIDINE 0.2 MG/24 HR WEEKLY TRANSDERMAL PATCH,149.85,89.91,34.77,4481.0,19 CDM,RX-27614,"THEOPHYLLINE ER 300 MG TABLET,EXTENDED RELEASE,12 HR",19.9,11.94,4.62,4481.0,19 CDM,RX-27629,RIZATRIPTAN 5 MG DISINTEGRATING TABLET,22.15,13.29,5.14,4481.0,19 CDM,RX-27631,"DIVALPROEX 125 MG CAPSULE,DELAYED RELEASE SPRINKLE",18.55,11.13,4.3,4481.0,19 CDM,RX-27633,"CARBAMAZEPINE ER 300 MG CAPSULE,EXTENDED RELEASE 12HR",26.4,15.84,6.12,4481.0,19 CDM,RX-27634,"CARBAMAZEPINE ER 100 MG TABLET,EXTENDED RELEASE,12 HR",17.35,10.41,4.03,4481.0,19 CDM,RX-27635,"CARBAMAZEPINE ER 200 MG TABLET,EXTENDED RELEASE,12 HR",18.4,11.04,4.27,4481.0,19 CDM,RX-27644,"ASPIRIN 25 MG-DIPYRIDAMOLE 200 MG CAPSULE,EXT.RELEASE 12 HR MULTIPHASE",19.0,11.4,4.41,4481.0,19 CDM,RX-27659,"NIFEDIPINE ER 60 MG TABLET,EXTENDED RELEASE 24 HR",16.85,10.11,3.91,4481.0,19 CDM,RX-27696,SCOPOLAMINE 1 MG OVER 3 DAYS TRANSDERMAL PATCH,44.5,26.7,10.32,4481.0,19 CDM,RX-27697,ONDANSETRON 4 MG DISINTEGRATING TABLET,18.1,10.86,4.2,4481.0,19 CDM,RX-27735,DIATRIZOATE MEGLUMINE 30 % URETHRAL SOLUTION,67.55,40.53,0.18,4481.0,25 CDM,RX-27780,ZONISAMIDE 100 MG CAPSULE,17.7,10.62,4.11,4481.0,19 CDM,RX-27796,PERITON.DIALYSIS SOLN 6-1.5 % DEXTROS LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,200.225,120.135,14.62,4481.0,115 CDM,RX-27797,PERITONEAL DIALYSIS SOLN 4-1.5 % DEXTR CA+ 3.5 MEQ/L-LOW MAG 0.5 MEQ/L,188.75,113.25,17.27,4481.0,115 CDM,RX-27799,PERITON. DIALYSIS SOLN 19-1.5 % DEXTROSE CALC 3.5 MEQ/L-MAG 1.5 MEQ/L,93.5,56.1,19.93,4481.0,57 CDM,RX-27800,PERITONEAL DIALYSIS SOLN 7-2.5 % DEXT.LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,215.05,129.03,14.62,4481.0,92 CDM,RX-27804,PERITON. DIALYSIS SOLN 8-4.25 % DEXTROSE CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,212.55,127.53,47.58,4481.0,115 CDM,RX-27805,PERITON. DIALYSIS SOLN 3-4.25 % DEXTROSE CALC 3.5 MEQ/L-MAG 0.5 MEQ/L,125.9,75.53999999999999,14.62,4481.0,92 CDM,RX-27838,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION,78.0,46.8,4.39,4481.0,21 CDM,RX-27857,"VENLAFAXINE ER 37.5 MG CAPSULE,EXTENDED RELEASE 24 HR",17.5,10.5,4.06,4481.0,19 CDM,RX-27858,"VENLAFAXINE ER 75 MG CAPSULE,EXTENDED RELEASE 24 HR",17.65,10.59,4.09,4481.0,19 CDM,RX-27859,"VENLAFAXINE ER 150 MG CAPSULE,EXTENDED RELEASE 24 HR",17.9,10.74,4.15,4481.0,19 CDM,RX-27860,NICOTINE 7 MG/24 HR DAILY TRANSDERMAL PATCH,3.9,2.34,0.9048,4481.0,19 CDM,RX-27862,NICOTINE 14 MG/24 HR DAILY TRANSDERMAL PATCH,3.7,2.22,0.8584,4481.0,19 CDM,RX-27863,NICOTINE 21 MG/24 HR DAILY TRANSDERMAL PATCH,3.7,2.22,0.8584,4481.0,19 CDM,RX-27905,FENTANYL 25 MCG/HR TRANSDERMAL PATCH,43.7,26.22,10.14,4481.0,19 CDM,RX-27906,FENTANYL 50 MCG/HR TRANSDERMAL PATCH,60.55,36.33,14.05,4481.0,19 CDM,RX-27907,FENTANYL 75 MCG/HR TRANSDERMAL PATCH,82.9,49.74,19.23,4481.0,19 CDM,RX-27908,FENTANYL 100 MCG/HR TRANSDERMAL PATCH,61.55,36.93,14.28,4481.0,19 CDM,RX-27990,CARBOXYMETHYLCELLULOSE SODIUM 0.25 % EYE DROPS,15.475000000000001,9.285,3.11,4481.0,38 CDM,RX-28001,SILVER NITRATE 0.5 % TOPICAL SOLUTION,226.7,136.02,52.59,4481.0,19 CDM,RX-28028,GELATIN ABSORBABLE EYE FILM,5972.8,3583.68,1385.69,4778.24,19 CDM,RX-28048,BENZOCAINE 20 %-MENTHOL 0.5 % TOPICAL AEROSOL,10.0,6.0,2.32,4481.0,19 CDM,RX-28079,ELECTROLYTE-R IN DEXTROSE 5 % INTRAVENOUS SOLUTION,102.0,61.2,23.66,4481.0,19 CDM,RX-28113,ELECTROLYTE-A INTRAVENOUS SOLUTION,114.0,68.4,26.45,4481.0,19 CDM,RX-28158,OLANZAPINE 20 MG TABLET,18.85,11.31,4.37,4481.0,19 CDM,RX-28159,OLANZAPINE 5 MG DISINTEGRATING TABLET,18.6,11.16,4.32,4481.0,19 CDM,RX-28160,OLANZAPINE 10 MG DISINTEGRATING TABLET,19.8,11.88,4.59,4481.0,19 CDM,RX-28162,OLANZAPINE 20 MG DISINTEGRATING TABLET,23.4,14.04,5.43,4481.0,19 CDM,RX-28224,LINEZOLID 600 MG TABLET,34.55,20.73,8.02,4481.0,19 CDM,RX-28225,LINEZOLID 100 MG/5 ML ORAL SUSPENSION,1026.25,615.75,238.09,4481.0,19 CDM,RX-28229,VERTEPORFIN 15 MG INTRAVENOUS SOLUTION,5653.8,3392.28,11.19,4523.04,35 CDM,RX-28235,PENTAMIDINE 300 MG SOLUTION FOR INHALATION,518.35,311.01,120.26,4481.0,19 CDM,RX-28278,RIVASTIGMINE 1.5 MG CAPSULE,17.75,10.65,4.12,4481.0,19 CDM,RX-28282,INSULIN GLARGINE (U-100) 100 UNIT/ML SUBCUTANEOUS SOLUTION,266.65,159.99,0.5175,4481.0,24 CDM,RX-28400,"WATER FOR INJECTION, STERILE INTRAVENOUS SOLUTION",87.0,52.2,18.79,4481.0,38 CDM,RX-28408,ESTRADIOL 0.05 MG/24 HR WEEKLY TRANSDERMAL PATCH,71.7,43.02,16.63,4481.0,19 CDM,RX-28409,ESTRADIOL 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,71.7,43.02,16.63,4481.0,19 CDM,RX-2848,EPINEPHRINE 0.1 MG/ML INJECTION SYRINGE,69.6,41.76,1.08,4481.0,24 CDM,RX-2850,EPINEPHRINE 1 MG/ML (1 ML) INJECTION SOLUTION,21.85,13.11,3.06,4481.0,24 CDM,RX-2863,"ERGOCALCIFEROL (VITAMIN D2) 1,250 MCG (50,000 UNIT) CAPSULE",1.35,0.81,0.3132,4481.0,19 CDM,RX-28643,"NIFEDIPINE ER 30 MG TABLET,EXTENDED RELEASE 24 HR",20.5,12.3,4.76,4481.0,19 CDM,RX-28645,ATORVASTATIN 80 MG TABLET,18.05,10.83,4.19,4481.0,19 CDM,RX-28750,"METHYLPHENIDATE ER 18 MG TABLET,EXTENDED RELEASE 24 HR",61.25,36.75,14.21,4481.0,19 CDM,RX-28751,"METHYLPHENIDATE ER 36 MG TABLET,EXTENDED RELEASE 24 HR",28.3,16.98,6.57,4481.0,19 CDM,RX-28774,BUDESONIDE 0.25 MG/2 ML SUSPENSION FOR NEBULIZATION,42.15,25.29,9.78,4481.0,19 CDM,RX-28775,BUDESONIDE 0.5 MG/2 ML SUSPENSION FOR NEBULIZATION,44.05,26.43,10.22,4481.0,19 CDM,RX-28810,"NEOMYCIN-POLYMYXIN-HYDROCORT 3.5 MG-10,000 UNIT/ML-1 % EAR DROPS,SUSP",268.55,161.13,62.3,4481.0,19 CDM,RX-28842,CYCLOSPORINE MODIFIED 25 MG CAPSULE,19.3,11.58,1.8,4481.0,24 CDM,RX-28843,CYCLOSPORINE MODIFIED 100 MG CAPSULE,29.2,17.52,4.59,4481.0,24 CDM,RX-28844,CYCLOSPORINE MODIFIED 100 MG/ML ORAL SOLUTION,1938.85,1163.31,4.59,4481.0,24 CDM,RX-28849,HYDROCORTISONE 1 %-PRAMOXINE 1 % RECTAL FOAM,601.1,360.66,139.46,4481.0,19 CDM,RX-2888,ERYTHROMYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT,49.75,29.85,11.54,4481.0,19 CDM,RX-2889,ERYTHROMYCIN 250 MG TABLET,35.85,21.51,8.32,4481.0,19 CDM,RX-28911,CARMUSTINE 100 MG INTRAVENOUS SOLUTION,9004.8,5402.88,231.31,22004.43,35 CDM,RX-28912,DACTINOMYCIN (COSMEGEN) SYRINGE 0.5 MG/ML,9240.3,5544.18,318.49,43645.77,35 CDM,RX-28947,ARGATROBAN 100 MG/ML INTRAVENOUS SOLUTION,684.3,410.58,0.776,4481.0,35 CDM,RX-28958,SIROLIMUS 1 MG TABLET,57.65,34.59,1.96,4481.0,24 CDM,RX-28964,LEVOFLOXACIN 750 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-28975,MIFEPRISTONE 200 MG TABLET,145.0,87.0,33.64,4481.0,19 CDM,RX-28995,"METFORMIN ER 500 MG TABLET,EXTENDED RELEASE 24 HR",17.5,10.5,4.06,4481.0,19 CDM,RX-2900,ERYTHROMYCIN ETHYLSUCCINATE 400 MG/5 ML ORAL POWDER FOR SUSPENSION,115.25,69.15,26.74,4481.0,19 CDM,RX-2903,ERYTHROMYCIN LACTOBIONATE 500 MG INTRAVENOUS SOLUTION,339.45,203.67,78.75,4481.0,24 CDM,RX-29031,"EPINEPHRINE (JR) 0.15 MG/0.3 ML INJECTION,AUTO-INJECTOR",601.0,360.6,1.08,4481.0,24 CDM,RX-29048,ALENDRONATE 70 MG TABLET,17.9,10.74,4.15,4481.0,19 CDM,RX-29071,ARSENIC TRIOXIDE 1 MG/ML INTRAVENOUS SOLUTION,2241.15,1344.69,7.91,4481.0,35 CDM,RX-29072,ALENDRONATE 35 MG TABLET,18.65,11.19,4.33,4481.0,19 CDM,RX-29132,IRON SUCROSE 100 MG IRON/5 ML INTRAVENOUS SOLUTION,275.4,165.24,0.5175,4481.0,24 CDM,RX-29169,GABAPENTIN 250 MG/5 ML ORAL SOLUTION,295.2,177.12,68.49,4481.0,19 CDM,RX-29267,QUETIAPINE 300 MG TABLET,18.05,10.83,4.19,4481.0,19 CDM,RX-29270,"DILTIAZEM CD 120 MG CAPSULE,EXTENDED RELEASE 24 HR",18.45,11.07,4.28,4481.0,19 CDM,RX-29272,"DILTIAZEM CD 180 MG CAPSULE,EXTENDED RELEASE 24 HR",18.45,11.07,4.28,4481.0,19 CDM,RX-29274,"DILTIAZEM CD 240 MG CAPSULE,EXTENDED RELEASE 24 HR",17.85,10.71,4.14,4481.0,19 CDM,RX-29276,"DILTIAZEM CD 300 MG CAPSULE,EXTENDED RELEASE 24 HR",20.8,12.48,4.83,4481.0,19 CDM,RX-29302,PREDNISOLONE SODIUM PHOSPHATE 15 MG/5 ML (3 MG/ML) ORAL SOLUTION,19.3,11.58,0.5175,4481.0,24 CDM,RX-29313,CROTALIDAE POLYVAL IMMUNE FAB SOLUTION FOR INJECTION,11669.75,7001.85,1773.86,10095.5,35 CDM,RX-29335,PROPRANOLOL 1 MG/ML INTRAVENOUS SOLUTION,60.8,36.48,14.11,4481.0,24 CDM,RX-2938,CONJUGATED ESTROGENS 1.25 MG TABLET,37.25,22.35,8.64,4481.0,19 CDM,RX-29396,BIVALIRUDIN 250 MG INTRAVENOUS POWDER FOR SOLUTION,289.0,173.4,0.3825,4481.0,24 CDM,RX-29443,TACROLIMUS 0.1 % TOPICAL OINTMENT,423.65,254.19,98.29,4481.0,19 CDM,RX-29449,"RIMABOTULINUMTOXINB 5,000 UNIT/ML INTRAMUSCULAR SOLUTION",1254.45,752.67,12.89,4481.0,35 CDM,RX-29464,MORPHINE (PF) 0.5 MG/ML INJECTION SOLUTION,26.075,15.645,5.51,4481.0,48 CDM,RX-29676,SODIUM CHLORIDE 0.65 % NASAL SPRAY AEROSOL,2.45,1.47,0.5684,4481.0,19 CDM,RX-29778,ZIPRASIDONE 20 MG CAPSULE,24.35,14.61,5.65,4481.0,19 CDM,RX-29779,ZIPRASIDONE 40 MG CAPSULE,24.35,14.61,5.65,4481.0,19 CDM,RX-29805,"ESMOLOL 2,500 MG/250 ML (10 MG/ML) IN SODIUM CHLORIDE (ISO-OSMOTIC) IV",367.15,220.29,0.495,4481.0,24 CDM,RX-29858,"METOPROLOL SUCCINATE ER 25 MG TABLET,EXTENDED RELEASE 24 HR",18.95,11.37,4.4,4481.0,19 CDM,RX-29967,BUSPIRONE 7.5 MG TABLET,16.8,10.08,3.9,4481.0,19 CDM,RX-30070,"METOPROLOL SUCCINATE ER 50 MG TABLET,EXTENDED RELEASE 24 HR",18.95,11.37,4.4,4481.0,19 CDM,RX-30071,"METOPROLOL SUCCINATE ER 100 MG TABLET,EXTENDED RELEASE 24 HR",20.2,12.12,4.69,4481.0,19 CDM,RX-30072,"METOPROLOL SUCCINATE ER 200 MG TABLET,EXTENDED RELEASE 24 HR",17.1,10.26,3.97,4481.0,19 CDM,RX-3013,"FACTOR IX COMPLEX NO.4, 3-FACTOR 500 (+/-) UNIT INTRAVENOUS SOLUTION",82.1,49.26,1.65,4481.0,35 CDM,RX-30148,VALGANCICLOVIR 450 MG TABLET,28.55,17.13,6.62,4481.0,19 CDM,RX-30275,CARDIOPLEGIC SOLUTION 16 MEQ/L (POTASSIUM) FOR PERFUSION,340.95,204.57,79.1,4481.0,19 CDM,RX-3037,FENTANYL (PF) 50 MCG/ML INJECTION SOLUTION,42.5,25.5,2.48,4481.0,24 CDM,RX-30479,OXCARBAZEPINE 300 MG/5 ML (60 MG/ML) ORAL SUSPENSION,25.95,15.57,6.02,4481.0,19 CDM,RX-30538,GUAR GUM ORAL PACKET,1.75,1.05,0.406,4481.0,19 CDM,RX-3059,FERRIC SUBSULFATE (BULK) 20 TO 22 GRAM/100 ML SOLUTION,3.35,2.01,0.7772,4481.0,19 CDM,RX-3071,FERROUS SULFATE 300 MG (60 MG IRON)/5 ML ORAL LIQUID,6.3,3.78,1.46,4481.0,19 CDM,RX-3074,FERROUS SULFATE 325 MG (65 MG IRON) TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-30961,CALCIUM ACETATE(PHOSPHATE BINDERS) 667 MG CAPSULE,20.2,12.12,4.69,4481.0,19 CDM,RX-310,ALLOPURINOL 100 MG TABLET,17.25,10.35,4.0,4481.0,19 CDM,RX-31025,"PACLITAXEL 6 MG/ML CONCENTRATE,INTRAVENOUS",511.05,306.63,0.297,4481.0,24 CDM,RX-311,ALLOPURINOL 300 MG TABLET,18.25,10.95,4.23,4481.0,19 CDM,RX-31209,VALSARTAN 80 MG TABLET,19.25,11.55,4.47,4481.0,19 CDM,RX-31210,VALSARTAN 160 MG TABLET,19.65,11.79,4.56,4481.0,19 CDM,RX-31270,PERFLUTREN LIPID MICROSPHERES 1.1 MG/ML INTRAVENOUS SUSPENSION,265.05,159.03,61.49,4481.0,23 CDM,RX-31310,ALTEPLASE 2 MG INTRA-CATHETER SOLUTION,738.2,442.92,91.62,4481.0,35 CDM,RX-31432,DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION,18107.75,10864.65,4481.0,16457.93,35 CDM,RX-31576,"BUDESONIDE DR - ER 3 MG CAPSULE,DELAYED,EXTENDED RELEASE",19.0,11.4,4.41,4481.0,19 CDM,RX-31587,"DEXTROAMPHETAMINE-AMPHETAMINE ER 10 MG 24HR CAPSULE,EXTEND RELEASE",26.25,15.75,6.09,4481.0,19 CDM,RX-31684,TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,23.1,13.86,5.36,4481.0,19 CDM,RX-31688,PARICALCITOL 2 MCG/ML INTRAVENOUS SOLUTION,82.85,49.71,1.83,4481.0,24 CDM,RX-3177,FLOXURIDINE 0.5 GRAM SOLUTION FOR INJECTION,13634.2,8180.52,3449.45,619321.29,35 CDM,RX-31784,ANAKINRA 100 MG/0.67 ML SUBCUTANEOUS SYRINGE,837.7,502.62,194.35,4481.0,19 CDM,RX-31846,DEXMETHYLPHENIDATE 5 MG TABLET,23.0,13.8,5.34,4481.0,19 CDM,RX-3185,FLUOCINOLONE 0.025 % TOPICAL OINTMENT,270.15,162.09,62.67,4481.0,19 CDM,RX-31875,BOSENTAN 62.5 MG TABLET,686.7,412.02,159.31,4481.0,19 CDM,RX-3189,FLUOCINONIDE 0.05 % TOPICAL OINTMENT,94.05,56.43,21.82,4481.0,19 CDM,RX-3190,FLUOCINONIDE 0.05 % TOPICAL SOLUTION,76.15,45.69,17.67,4481.0,19 CDM,RX-31906,MOXIFLOXACIN 400 MG/250 ML-SODIUM CHLORIDE(ISO) INTRAVENOUS PIGGYBACK,230.65,138.39,20.27,4481.0,24 CDM,RX-31921,ENOXAPARIN 150 MG/ML SUBCUTANEOUS SYRINGE,70.45,42.27,1.33,4481.0,24 CDM,RX-31922,ERTAPENEM 1 GRAM SOLUTION FOR INJECTION,250.0,150.0,22.18,4481.0,24 CDM,RX-3208,"FLUOROMETHOLONE 0.1 % EYE DROPS,SUSPENSION",249.1,149.46,57.79,4481.0,19 CDM,RX-32128,PRAVASTATIN 80 MG TABLET,17.2,10.32,3.99,4481.0,19 CDM,RX-3215,FLUPHENAZINE DECANOATE 25 MG/ML INJECTION SOLUTION,62.8,37.68,14.57,4481.0,24 CDM,RX-3216,FLUPHENAZINE 2.5 MG/ML INJECTION SOLUTION,53.5,32.1,7.12,4481.0,35 CDM,RX-3218,FLUPHENAZINE 1 MG TABLET,18.1,10.86,4.2,4481.0,19 CDM,RX-3221,FLUPHENAZINE 5 MG TABLET,29.7,17.82,6.89,4481.0,19 CDM,RX-32215,FONDAPARINUX 2.5 MG/0.5 ML SUBCUTANEOUS SOLUTION SYRINGE,106.05,63.63,1.62,4481.0,24 CDM,RX-32298,EFAVIRENZ 600 MG TABLET,24.05,14.43,5.58,4481.0,19 CDM,RX-3232,FOLIC ACID 5 MG/ML INJECTION SOLUTION,21.0,12.6,0.135,4481.0,24 CDM,RX-32329,LEVALBUTEROL 0.31 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 CDM,RX-3233,FOLIC ACID 1 MG TABLET,16.55,9.93,3.84,4481.0,19 CDM,RX-324,ALPRAZOLAM 0.25 MG TABLET,22.15,13.29,5.14,4481.0,19 CDM,RX-325,ALPRAZOLAM 0.5 MG TABLET,23.15,13.89,5.37,4481.0,19 CDM,RX-32589,PAMIDRONATE 30 MG/10 ML (3 MG/ML) INTRAVENOUS SOLUTION,107.15,64.29,21.69,4481.0,24 CDM,RX-32654,"METHYLPHENIDATE ER 27 MG TABLET,EXTENDED RELEASE 24 HR",62.2,37.32,14.43,4481.0,19 CDM,RX-32700,ONABOTULINUMTOXINA 100 UNIT SOLUTION FOR INJECTION,2554.9,1532.94,6.3,4481.0,35 CDM,RX-32855,PAMIDRONATE 90 MG/10 ML (9 MG/ML) INTRAVENOUS SOLUTION,83.5,50.1,19.37,4481.0,24 CDM,RX-32893,LEUPROLIDE 7.5 MG (1 MONTH) SUBCUTANEOUS SYRINGE,1770.1,1062.06,171.16,26039.58,35 CDM,RX-3291,FUROSEMIDE 10 MG/ML INJECTION SOLUTION,32.35,19.41,0.045,4481.0,72 CDM,RX-3292,FUROSEMIDE 10 MG/ML ORAL SOLUTION,36.2,21.72,8.4,4481.0,19 CDM,RX-32931,TREPROSTINIL SODIUM 1 MG/ML INJECTION SOLUTION,2871.4249999999997,1722.855,53.07,8670.06,70 CDM,RX-32932,TREPROSTINIL SODIUM 2.5 MG/ML INJECTION SOLUTION,7154.575,4292.745,53.07,9944.72,70 CDM,RX-32933,TREPROSTINIL SODIUM 5 MG/ML INJECTION SOLUTION,14293.125,8575.875,53.07,19876.6,70 CDM,RX-32934,TREPROSTINIL SODIUM 10 MG/ML INJECTION SOLUTION,28570.225,17142.135,53.07,39740.4,70 CDM,RX-3294,FUROSEMIDE 20 MG TABLET,16.55,9.93,3.84,4481.0,19 CDM,RX-32979,IMATINIB 100 MG TABLET,399.6,239.76,92.71,4481.0,19 CDM,RX-33005,"DEXTROAMPHETAMINE-AMPHETAMINE ER 5 MG 24HR CAPSULE,EXTEND RELEASE",43.7,26.22,10.14,4481.0,19 CDM,RX-33010,VORICONAZOLE 200 MG INTRAVENOUS SOLUTION,259.2,155.52,1.73,4481.0,24 CDM,RX-33083,MIDODRINE 10 MG TABLET,20.25,12.15,4.7,4481.0,19 CDM,RX-33175,ZIPRASIDONE 20 MG/ML (FINAL CONCENTRATION) INTRAMUSCULAR SOLUTION,199.3,119.58,8.55,4481.0,24 CDM,RX-33227,AMOXICILLIN 500 MG-POTASSIUM CLAVULANATE 125 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-33228,AMOXICILLIN 875 MG-POTASSIUM CLAVULANATE 125 MG TABLET,17.8,10.68,4.13,4481.0,19 CDM,RX-33230,AMOXICILLIN 400 MG-POTASSIUM CLAVULANATE 57 MG/5 ML ORAL SUSPENSION,59.8,35.88,13.87,4481.0,19 CDM,RX-33512,ESCITALOPRAM 10 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-33513,ESCITALOPRAM 20 MG TABLET,16.55,9.93,3.84,4481.0,19 CDM,RX-33541,VALSARTAN 40 MG TABLET,18.5,11.1,4.29,4481.0,19 CDM,RX-33591,RASBURICASE 1.5 MG INTRAVENOUS SOLUTION,3682.9,2209.74,366.19,55987.89,35 CDM,RX-33669,LEUPROLIDE ACETATE 22.5 MG (3 MONTH) SUBCUTANEOUS SYRINGE,4760.3,2856.18,171.16,26039.58,35 CDM,RX-3378,GEMFIBROZIL 600 MG TABLET,16.8,10.08,3.9,4481.0,19 CDM,RX-33937,LAMIVUDINE 300 MG TABLET,20.0,12.0,4.64,4481.0,19 CDM,RX-34153,EZETIMIBE 10 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-3423,GENTAMICIN 0.1 % TOPICAL CREAM,134.9,80.94,31.3,4481.0,19 CDM,RX-3426,GENTAMICIN 40 MG/ML INJECTION SOLUTION,90.02499999999999,54.015,4.97,4481.0,48 CDM,RX-3430,GENTIAN VIOLET 1 % TOPICAL SOLUTION,1.05,0.63,0.2436,4481.0,19 CDM,RX-34369,ARIPIPRAZOLE 10 MG TABLET,17.9,10.74,4.15,4481.0,19 CDM,RX-34370,ARIPIPRAZOLE 15 MG TABLET,21.55,12.93,5.0,4481.0,19 CDM,RX-34418,"DIVALPROEX ER 250 MG TABLET,EXTENDED RELEASE 24 HR",20.45,12.27,4.74,4481.0,19 CDM,RX-34444,ATOMOXETINE 10 MG CAPSULE,20.9,12.54,4.85,4481.0,19 CDM,RX-34445,ATOMOXETINE 18 MG CAPSULE,20.9,12.54,4.85,4481.0,19 CDM,RX-34446,ATOMOXETINE 25 MG CAPSULE,20.9,12.54,4.85,4481.0,19 CDM,RX-34447,ATOMOXETINE 40 MG CAPSULE,35.0,21.0,8.12,4481.0,19 CDM,RX-34448,ATOMOXETINE 60 MG CAPSULE,20.2,12.12,4.69,4481.0,19 CDM,RX-34505,HYDROCODONE 5 MG-ACETAMINOPHEN 325 MG TABLET,23.9,14.34,5.54,4481.0,19 CDM,RX-34550,HEP B-DP(A)T-POLIO VACC (PF) 10 MCG-25LF-25 MCG-10LF/0.5 ML IM SYRINGE,321.65,192.99,74.62,4481.0,25 CDM,RX-34574,GUAIFENESIN 400 MG TABLET,1.55,0.93,0.3596,4481.0,19 CDM,RX-34652,ADALIMUMAB 40 MG/0.8 ML SUBCUTANEOUS SYRINGE KIT,13515.15,8109.09,88.98,11691.96,34 CDM,RX-34711,BUPRENORPHINE HCL 2 MG SUBLINGUAL TABLET,22.15,13.29,5.14,4481.0,19 CDM,RX-34712,BUPRENORPHINE HCL 8 MG SUBLINGUAL TABLET,26.5,15.9,6.15,4481.0,19 CDM,RX-34713,BUPRENORPHINE 2 MG-NALOXONE 0.5 MG SUBLINGUAL TABLET,33.85,20.31,7.85,4481.0,23 CDM,RX-34714,BUPRENORPHINE 8 MG-NALOXONE 2 MG SUBLINGUAL TABLET,37.3,22.38,8.65,4481.0,23 CDM,RX-34769,NICOTINE (POLACRILEX) 2 MG BUCCAL LOZENGE,1.6,0.96,0.3712,4481.0,19 CDM,RX-34770,NICOTINE (POLACRILEX) 4 MG BUCCAL LOZENGE,1.6,0.96,0.3712,4481.0,19 CDM,RX-34814,"NEOMYCIN-POLYMYXIN-HYDROCORT 3.5 MG/ML-10,000 UNIT/ML-1 % EAR SOLUTION",268.55,161.13,62.3,4481.0,19 CDM,RX-3489,GLYBURIDE 5 MG TABLET,16.8,10.08,3.9,4481.0,19 CDM,RX-34897,ESCITALOPRAM 5 MG/5 ML ORAL SOLUTION,22.6,13.56,5.24,4481.0,19 CDM,RX-3497,GLYCOPYRROLATE 0.2 MG/ML INJECTION SOLUTION,66.7,40.02,0.4462,4481.0,35 CDM,RX-35184,CYCLOBENZAPRINE 5 MG TABLET,24.1,14.46,5.59,4481.0,19 CDM,RX-35209,CYCLOSPORINE 0.05 % EYE DROPS IN A DROPPERETTE,48.3,28.98,11.21,4481.0,19 CDM,RX-35236,LEUPROLIDE 30 MG (4 MONTH) SUBCUTANEOUS SYRINGE,6255.4,3753.24,171.16,26039.58,35 CDM,RX-35262,SIROLIMUS 2 MG TABLET,38.5,23.1,1.96,4481.0,24 CDM,RX-353,ALUMINUM HYDROXIDE GEL 320 MG/5 ML ORAL SUSPENSION,1.7,1.02,0.3944,4481.0,19 CDM,RX-3534,GRISEOFULVIN ULTRAMICROSIZE 125 MG TABLET,28.0,16.8,6.5,4481.0,19 CDM,RX-3536,GRISEOFULVIN ULTRAMICROSIZE 250 MG TABLET,31.3,18.78,7.26,4481.0,19 CDM,RX-3542,GUAIFENESIN 100 MG/5 ML ORAL LIQUID,2.25,1.35,0.522,4481.0,19 CDM,RX-35488,APREPITANT 80 MG CAPSULE,505.1,303.06,6.14,4481.0,24 CDM,RX-35489,APREPITANT 125 MG CAPSULE,780.15,468.09,6.14,4481.0,24 CDM,RX-35625,CLONAZEPAM 0.125 MG DISINTEGRATING TABLET,24.85,14.91,5.77,4481.0,19 CDM,RX-35626,CLONAZEPAM 0.25 MG DISINTEGRATING TABLET,24.85,14.91,5.77,4481.0,19 CDM,RX-35640,ZOLEDRONIC ACID 4 MG/5 ML INTRAVENOUS SOLUTION,308.25,184.95,11.38,4481.0,24 CDM,RX-35686,RISPERIDONE 0.5 MG DISINTEGRATING TABLET,21.0,12.6,4.87,4481.0,19 CDM,RX-35687,RISPERIDONE 1 MG DISINTEGRATING TABLET,28.3,16.98,6.57,4481.0,19 CDM,RX-35688,RISPERIDONE 2 MG DISINTEGRATING TABLET,35.95,21.57,8.34,4481.0,19 CDM,RX-35699,MOXIFLOXACIN 0.5 % EYE DROPS,61.15,36.69,14.19,4481.0,19 CDM,RX-35771,"METFORMIN ER 750 MG TABLET,EXTENDED RELEASE 24 HR",17.3,10.38,4.01,4481.0,19 CDM,RX-35775,AGALSIDASE BETA 35 MG INTRAVENOUS SOLUTION,25658.85,15395.31,223.25,32754.54,35 CDM,RX-35779,LARONIDASE 2.9 MG/5 ML INTRAVENOUS SOLUTION,3703.8,2222.28,38.67,6960.45,35 CDM,RX-3578,HALOPERIDOL 0.5 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-3579,HALOPERIDOL 1 MG TABLET,17.25,10.35,4.0,4481.0,19 CDM,RX-3581,HALOPERIDOL 2 MG TABLET,17.7,10.62,4.11,4481.0,19 CDM,RX-3583,HALOPERIDOL 5 MG TABLET,18.75,11.25,4.35,4481.0,19 CDM,RX-35839,BORTEZOMIB (VELCADE) IV SYRINGE 1 MG/ML,5580.95,3348.57,4.32,4481.0,24 CDM,RX-3584,HALOPERIDOL LACTATE 5 MG/ML INJECTION SOLUTION,17.4,10.44,1.8,4481.0,24 CDM,RX-3585,HALOPERIDOL LACTATE 2 MG/ML ORAL CONCENTRATE,17.4,10.44,3.87,4481.0,38 CDM,RX-35942,"POTASSIUM CHLORIDE ER 10 MEQ TABLET,EXTENDED RELEASE(PART/CRYST)",17.5,10.5,4.06,4481.0,19 CDM,RX-35943,"POTASSIUM CHLORIDE ER 20 MEQ TABLET,EXTENDED RELEASE(PART/CRYST)",17.55,10.53,4.07,4481.0,19 CDM,RX-36151,OMALIZUMAB 150 MG SUBCUTANEOUS SOLUTION,4878.95,2927.37,43.26,6119.61,35 CDM,RX-364,AMANTADINE HCL 100 MG CAPSULE,22.0,13.2,5.1,4481.0,19 CDM,RX-36417,INTERFERON BETA-1A 30 MCG/0.5 ML INTRAMUSCULAR SYRINGE KIT,28866.15,17319.69,57.13,24972.11,35 CDM,RX-36438,ARIPIPRAZOLE 5 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-365,AMANTADINE HCL 50 MG/5 ML ORAL SOLUTION,27.85,16.71,6.46,4481.0,19 CDM,RX-36590,LEVETIRACETAM 100 MG/ML ORAL SOLUTION,105.4,63.24,24.45,4481.0,19 CDM,RX-36591,PALONOSETRON 0.25 MG/5 ML INTRAVENOUS SOLUTION,92.45,55.47,0.765,4481.0,24 CDM,RX-36962,DOCUSATE SODIUM 50 MG/5 ML ORAL LIQUID,3.6,2.16,0.8352,4481.0,19 CDM,RX-36966,MEMANTINE 10 MG TABLET,18.05,10.83,4.19,4481.0,19 CDM,RX-3697,HYDRALAZINE 20 MG/ML INJECTION SOLUTION,74.5,44.7,12.6,4481.0,24 CDM,RX-36976,PHENOL 1.4 % MUCOSAL AEROSOL SPRAY,4.85,2.91,1.13,4481.0,19 CDM,RX-3698,HYDRALAZINE 10 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-36983,EPLERENONE 25 MG TABLET,20.2,12.12,4.69,4481.0,19 CDM,RX-36984,EPLERENONE 50 MG TABLET,20.2,12.12,4.69,4481.0,19 CDM,RX-36987,ZONISAMIDE 25 MG CAPSULE,16.65,9.99,3.86,4481.0,19 CDM,RX-36989,DAPTOMYCIN 500 MG INTRAVENOUS SOLUTION,161.1,96.66,0.0675,4481.0,24 CDM,RX-37170,MEMANTINE 5 MG TABLET,17.3,10.38,4.01,4481.0,19 CDM,RX-3720,HYDROCHLOROTHIAZIDE 25 MG TABLET,16.65,9.99,3.86,4481.0,19 CDM,RX-37219,FLUORIDE 0.5 MG (1.1 MG SODIUM FLUORIDE)/ML ORAL DROPS,1.05,0.63,0.2436,4481.0,19 CDM,RX-3726,HYDROCORTISONE 1 % TOPICAL CREAM,4.3,2.58,0.9976,4481.0,19 CDM,RX-3727,HYDROCORTISONE 2.5 % TOPICAL CREAM,24.75,14.85,5.74,4481.0,19 CDM,RX-3731,HYDROCORTISONE 1 % TOPICAL OINTMENT,4.3,2.58,0.9976,4481.0,19 CDM,RX-3732,HYDROCORTISONE 2.5 % TOPICAL OINTMENT,25.9,15.54,6.01,4481.0,19 CDM,RX-3733,HYDROCORTISONE 10 MG TABLET,21.05,12.63,4.88,4481.0,19 CDM,RX-3734,HYDROCORTISONE 20 MG TABLET,17.55,10.53,4.07,4481.0,19 CDM,RX-3738,HYDROCORTISONE ACETATE 25 MG RECTAL SUPPOSITORY,50.5,30.3,11.72,4481.0,19 CDM,RX-3752,HYDROGEN PEROXIDE 3 % SOLUTION,3.2,1.92,0.7424,4481.0,19 CDM,RX-37567,"CARBAMAZEPINE ER 100 MG CAPSULE,EXTENDED RELEASE 12HR",25.3,15.18,5.87,4481.0,19 CDM,RX-3760,HYDROMORPHONE 2 MG TABLET,22.6,13.56,5.24,4481.0,19 CDM,RX-3761,HYDROMORPHONE 4 MG TABLET,22.7,13.62,5.27,4481.0,19 CDM,RX-37635,ESCITALOPRAM 5 MG TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-37637,METOPROLOL TARTRATE 25 MG TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-3768,"HYDROXOCOBALAMIN 1,000 MCG/ML INTRAMUSCULAR SOLUTION",113.5,68.1,0.0097,4481.0,35 CDM,RX-3769,HYDROXYZINE HCL 25 MG/ML INTRAMUSCULAR SOLUTION,135.25,81.15,31.38,4481.0,24 CDM,RX-3770,HYDROXYZINE HCL 50 MG/ML INTRAMUSCULAR SOLUTION,147.5,88.5,34.22,4481.0,24 CDM,RX-3771,HYDROXYZINE HCL 10 MG/5 ML ORAL SOLUTION,18.6,11.16,4.32,4481.0,19 CDM,RX-3774,HYDROXYZINE HCL 25 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-3783,HYOSCYAMINE SULFATE 0.125 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-37894,PEMETREXED DISODIUM 500 MG INTRAVENOUS POWDER FOR SOLUTION,771.5,462.9,4.23,4481.0,35 CDM,RX-37989,CETUXIMAB 100 MG/50 ML IV,3043.85,1826.31,76.02,11827.62,35 CDM,RX-38062,"MYCOPHENOLATE SODIUM 180 MG TABLET,DELAYED RELEASE",16.55,9.93,0.765,4481.0,24 CDM,RX-38063,"MYCOPHENOLATE SODIUM 360 MG TABLET,DELAYED RELEASE",17.15,10.29,0.765,4481.0,24 CDM,RX-38066,SODIUM HYALURONATE 30 MG/2 ML INTRA-ARTICULAR SYRINGE,1880.2,1128.12,111.1,19812.66,35 CDM,RX-38072,"RHO(D) IMMUNE GLOBULIN 1,500 UNIT (300 MCG)/2 ML INJECTION SYRINGE",693.8,416.28,10.94,4481.0,24 CDM,RX-38100,CINACALCET 30 MG TABLET,96.7,58.02,22.43,4481.0,19 CDM,RX-38101,CINACALCET 60 MG TABLET,18.7,11.22,4.34,4481.0,19 CDM,RX-38102,CINACALCET 90 MG TABLET,19.9,11.94,4.62,4481.0,19 CDM,RX-38103,VORICONAZOLE 200 MG/5 ML (40 MG/ML) ORAL SUSPENSION,1857.85,1114.71,431.02,4481.0,19 CDM,RX-38245,LACTULOSE 10 GRAM/15 ML ORAL SOLUTION,16.7,10.02,3.87,4481.0,19 CDM,RX-38263,OLANZAPINE 10 MG INTRAMUSCULAR SOLUTION,94.0,56.4,1.96,4481.0,24 CDM,RX-38270,CYCLOPHOSPHAMIDE (CYTOXAN) 1 GM INJECTION,2129.8,1277.88,0.4656,4481.0,35 CDM,RX-38271,CYCLOPHOSPHAMIDE 500 MG INTRAVENOUS POWDER FOR SOLUTION,1202.45,721.47,0.4656,4481.0,35 CDM,RX-38280,CYCLOPHOSPHAMIDE 2 GRAM INTRAVENOUS POWDER FOR SOLUTION,3984.65,2390.79,0.4656,4481.0,35 CDM,RX-38303,ACETYLCYSTEINE 200 MG/ML (20 %) INTRAVENOUS SOLUTION,79.4,47.64,0.855,4481.0,24 CDM,RX-38321,CARBOXYMETHYLCELLULOSE SODIUM 1 % EYE GEL IN A DROPPERETTE,1.5,0.9,0.348,4481.0,19 CDM,RX-3841,IBUPROFEN 200 MG TABLET,1.15,0.69,0.2668,4481.0,19 CDM,RX-3843,IBUPROFEN 400 MG TABLET,16.25,9.75,3.77,4481.0,19 CDM,RX-3844,IBUPROFEN 600 MG TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-3845,IBUPROFEN 800 MG TABLET,16.25,9.75,3.77,4481.0,19 CDM,RX-38488,FLUOXETINE 20 MG/5 ML (4 MG/ML) ORAL SOLUTION,19.15,11.49,4.44,4481.0,19 CDM,RX-38489,ETHOSUXIMIDE 250 MG/5 ML ORAL SOLUTION,185.25,111.15,42.98,4481.0,19 CDM,RX-3860,IMIPRAMINE 10 MG TABLET,16.55,9.93,3.84,4481.0,19 CDM,RX-3861,IMIPRAMINE 25 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-3862,IMIPRAMINE 50 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-38703,ADENOSINE 3 MG/ML INTRAVENOUS SOLUTION,27.7,16.62,1.25,4481.0,24 CDM,RX-3897,INDOMETHACIN 25 MG CAPSULE,17.1,10.26,3.97,4481.0,19 CDM,RX-3901,INDOMETHACIN 50 MG RECTAL SUPPOSITORY,1047.45,628.47,243.01,4481.0,19 CDM,RX-39063,RIFAXIMIN 200 MG TABLET,49.7,29.82,11.53,4481.0,19 CDM,RX-391,AMILORIDE 5 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-39136,"NYSTATIN 100,000 UNIT/GRAM TOPICAL POWDER",37.1,22.26,8.61,4481.0,19 CDM,RX-39254,NITAZOXANIDE 500 MG TABLET,191.65,114.99,44.46,4481.0,19 CDM,RX-39255,EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,200.25,120.15,1.68,4481.0,35 CDM,RX-39265,CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,479.0,287.4,5.56,4481.0,24 CDM,RX-39301,ABACAVIR 600 MG-LAMIVUDINE 300 MG TABLET,26.0,15.6,6.03,4481.0,19 CDM,RX-39522,CEFDINIR 250 MG/5 ML ORAL SUSPENSION,91.0,54.6,21.11,4481.0,19 CDM,RX-39744,FLUMAZENIL 0.1 MG/ML INTRAVENOUS SOLUTION,95.875,57.525,20.0,4481.0,38 CDM,RX-39918,TOBRAMYCIN 40 MG/ML INJECTION SOLUTION,65.525,39.315,5.33,4481.0,48 CDM,RX-39970,LEVOFLOXACIN 250 MG/10 ML ORAL SOLUTION,1607.2,964.32,372.87,4481.0,19 CDM,RX-40009,FENOFIBRATE NANOCRYSTALLIZED 48 MG TABLET,19.75,11.85,4.58,4481.0,19 CDM,RX-40010,FENOFIBRATE NANOCRYSTALLIZED 145 MG TABLET,25.9,15.54,6.01,4481.0,19 CDM,RX-400291,SODIUM CHLORIDE 0.9% IV BOLUS,85.5,51.3,1.46,4481.0,93 CDM,RX-400293,DEXTROSE 5 % IV BOLUS,82.5,49.5,4.07,4481.0,93 CDM,RX-400294,DEXTROSE 5 % AND 0.9 % NACL IV BOLUS,67.5,40.5,3.17,4481.0,21 CDM,RX-400295,DEXTROSE 5 % AND 0.45 % NACL IV BOLUS,66.0,39.6,3.17,4481.0,21 CDM,RX-400296,LACTATED RINGERS IV BOLUS,66.75,40.05,5.42,4481.0,21 CDM,RX-400297,DEXTROSE 5 % IN LACTATED RINGERS IV BOLUS,72.0,43.2,16.7,4481.0,21 CDM,RX-400302,DEXTROSE 10 % IV BOLUS,69.0,41.4,16.01,4481.0,17 CDM,RX-400485,CLOPIDOGREL 5 MG/ML ORAL SUSPENSION,113.2,67.92,26.26,4481.0,19 CDM,RX-400515,DEXTROSE 5% IVPB SOLN,70.65,42.39,4.07,4481.0,21 CDM,RX-400516,SODIUM CHLORIDE 0.9% IVPB SOLN,73.5,44.1,1.46,4481.0,114 CDM,RX-40120,NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION,29098.05,17458.83,23.28,23278.44,35 CDM,RX-401499,"MAGIC MOUTHWASH ORAL SUSPENSION (DIPHENHYDRAMINE, NYSTATIN)",16.2,9.72,3.76,4481.0,19 CDM,RX-4025,ISONIAZID 50 MG/5 ML ORAL SOLUTION,1023.5,614.1,237.45,4481.0,19 CDM,RX-403,AMINOCAPROIC ACID 250 MG/ML INTRAVENOUS SOLUTION,24.05,14.43,3.85,4481.0,24 CDM,RX-40392,SOLIFENACIN 5 MG TABLET,17.2,10.32,3.99,4481.0,19 CDM,RX-40413,ILOPROST 10 MCG/ML SOLUTION FOR NEBULIZATION,128.45,77.07,29.8,4481.0,19 CDM,RX-40475,PACLITAXEL-PROTEIN BOUND (ABRAXANE) INTRAVENOUS SUSPENSION,5505.0,3303.0,10.22,4481.0,35 CDM,RX-40515003,STUDY LCCC2152-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40574,ZICONOTIDE 100 MCG/ML INTRATHECAL SOLUTION,4794.1,2876.46,9.84,4481.0,35 CDM,RX-4064,ISOSORBIDE DINITRATE 10 MG TABLET,18.8,11.28,4.36,4481.0,19 CDM,RX-4065,ISOSORBIDE DINITRATE 20 MG TABLET,18.75,11.25,4.35,4481.0,19 CDM,RX-4067,ISOSORBIDE DINITRATE 40 MG TABLET,56.1,33.66,13.02,4481.0,19 CDM,RX-4068,ISOSORBIDE DINITRATE 5 MG TABLET,18.7,11.22,4.34,4481.0,19 CDM,RX-40697,FLUTICASONE PROPIONATE 44 MCG/ACTUATION HFA AEROSOL INHALER,416.2,249.72,96.56,4481.0,19 CDM,RX-40698,FLUTICASONE PROPIONATE 110 MCG/ACTUATION HFA AEROSOL INHALER,551.8,331.08,128.02,4481.0,19 CDM,RX-40800001,BORTEZOMIB (VELCADE) SUBCUTANEOUS SYRINGE 2.5 MG/ML,5580.95,3348.57,4.32,4481.0,24 CDM,RX-40800005,BLEOMYCIN (BLENOXANE) SYRINGE 15 UNITS/ML,331.6,198.96,48.42,4481.0,24 CDM,RX-40800008,MITOMYCIN BLADDER INSTILLATION (2 MG/ML; 40 MG VIAL),4458.75,2675.25,19.74,4481.0,35 CDM,RX-40800009,MITOMYCIN BLADDER INSTILLATION (1 MG/ML; 40 MG VIAL),4458.75,2675.25,19.74,4481.0,35 CDM,RX-408000123,ACETYLCYSTEINE 200 MG/ML (20 %) INHALATION SOLUTION,40.0,24.0,9.28,4481.0,19 CDM,RX-40800013,DECITABINE (DACOGEN) SYRINGE 10 MG/ML,5357.05,3214.23,2.75,4634.38,24 CDM,RX-40800025,GEMCITABINE 38 MG/ML INJECTABLE SOLUTION WRAPPER,574.85,344.91,7.04,4481.0,24 CDM,RX-40800030,IPILIMUMAB (YERVOY) 5 MG/ML INJECTION WRAPPER,75202.85,45121.71,177.98,96127.6,70 CDM,RX-40800031,FLUDARABINE (FLUDARA) 50 MG INJECTION WRAPPER,1174.95,704.97,66.15,9659.37,35 CDM,RX-40800033,OFATUMUMAB (ARZERRA) 20 MG/ML INJECTION WRAPPER,11259.375,6755.625,60.36,16197.24,70 CDM,RX-40800034,DOXORUBICIN (ADRIAMYCIN) 25 MG/ML INJECTION,309.0,185.4,6.79,4481.0,24 CDM,RX-40800035,FLUOROURACIL (ADRUCIL) 50 MG/ML IV SOLUTION WRAPPER,286.35,171.81,4.48,4481.0,24 CDM,RX-408000554,METHOTREXATE INJECTION (PF) 25 MG/ML (NON-ONCOLOGY),397.65,238.59,6.15,4481.0,24 CDM,RX-40800058,CARBOPLATIN 0.1 MG/ML INJECTION,308.1,184.86,5.56,4481.0,24 CDM,RX-408000580,PROCARBAZINE ORAL SUSPENSION (10 MG/ML),4192.0,2515.2,972.54,4481.0,19 CDM,RX-40800061,ERLOTINIB 50 MG/ML ORAL SUSPENSION,720.6,432.36,167.18,4481.0,19 CDM,RX-40800073,BLEOMYCIN FOR WARTS SYRINGE,464.35,278.61,48.42,4481.0,24 CDM,RX-40800074,DOCETAXEL (TAXOTERE) 10 MG/ML INJECTION WRAPPER,1599.0,959.4,1.04,4481.0,24 CDM,RX-40800076,OXALIPLATIN (ELOXATIN) 0.05 MG/ML INJECTION,275.3,165.18,0.18,4481.0,24 CDM,RX-40800077,CISPLATIN (PLATINOL) 0.1 MG/ML INJECTION,275.1,165.06,5.15,4481.0,24 CDM,RX-40800078,ALEMTUZUMAB (CAMPATH) SYRINGE 10 MG/ML (ONCOLOGY),0.2,0.12,0.0506,379123.29,35 CDM,RX-4080010655,MORPHINE CONCENTRATE 20 MG/ML ORAL SOLUTION WRAPPER,22.85,13.71,5.3,4481.0,19 CDM,RX-40800114,GANCICLOVIR 2 MG/0.1 ML OPHTHALMIC INJECTION,74.3,44.58,17.24,4849.53,24 CDM,RX-4080011565,TOBRAMYCIN 1.2 GRAM POWDER (OSM),328.0,196.8,5.33,4481.0,24 CDM,RX-4080011664,WARFARIN 1 MG/ML ORAL SUSPENSION,16.3,9.78,3.78,4481.0,19 CDM,RX-40800117,METHOTREXATE 400 MCG/0.1 ML OPHTHALMIC INJECTION,276.25,165.75,6.15,4481.0,24 CDM,RX-40800118,METHOTREXATE SODIUM (PF) 2.5 MG/ML INJECTION,277.05,166.23,6.15,4481.0,24 CDM,RX-40800119,GEMCITABINE BLADDER INSTILLATION (38 MG/ML),424.95,254.97,7.04,4481.0,24 CDM,RX-40800122,TOCILIZUMAB (ACTEMRA) 20 MG/ML INJECTION WRAPPER,4405.3,2643.18,5.54,6998.04,105 CDM,RX-40800128175,EPHEDRINE (PF) 25 MG/5 ML (5 MG/ML) IN 0.9% SODIUM CHLORIDE IV SYRINGE WRAPPER,64.2,38.52,14.89,4481.0,19 CDM,RX-40800128781,METHYLPREDNISOLONE SOD SUCC 40 MG/ML SOLUTION FOR INJECTION WRAPPER,41.25,24.75,0.2037,4481.0,35 CDM,RX-40800128782,METHYLPREDNISOLONE SOD SUCC 125 MG/2 ML SOLUTION FOR INJECTION WRAPPER,56.65,33.99,0.2037,4481.0,35 CDM,RX-40800129102,PHENYLEPHRINE 1 MG/10 ML (100 MCG/ML) IN 0.9 % SOD.CHLORIDE IV WRAPPER,18.65,11.19,0.0225,4481.0,24 CDM,RX-40800129248,HYDROMORPHONE (PF) 10 MCG/ML-BUPIVACAINE 0.125 % IN 0.9 %NACL EPIDURAL,52.1,31.26,12.09,4481.0,19 CDM,RX-40800129599,"HEPARIN (PORCINE) 10,000 UNIT/1,000 ML IN 0.9 % SOD. CHLORIDE IV SOLN",85.9,51.54,0.4725,4481.0,24 CDM,RX-40800129758,REMIFENTANIL 100 MCG/2 ML (50 MCG/ML) IN 0.9 % NACL IV SYRINGE,26.65,15.99,6.18,4481.0,19 CDM,RX-40800129912,HYDROMORPHONE 50 MG/50 ML (1 MG/ML) IN 0.9 % SOD.CHLORIDE IV PUMP RESV,103.75,62.25,0.2025,4481.0,24 CDM,RX-40800141,VINCRISTINE 1 MG/ML INTRAVENOUS SOLUTION (>2 MG MAX DOSE),326.0,195.6,18.5,4481.0,24 CDM,RX-408001621,CHLORAL HYDRATE 500 MG/5 ML ORAL SYRUP,436.75,262.05,101.33,4481.0,19 CDM,RX-40800163215,"LIDOCAINE 4 %-EPINEPHRINE BITA 1:1,000-TETRACAINE 0.5 % TOP.SOLN(BULK)",30.6,18.36,7.1,4481.0,19 CDM,RX-40800183577,EPINEPHRINE 100 MCG/10 ML (10 MCG/ML) IV SYRINGE WRAPPER,18.05,10.83,1.08,4481.0,24 CDM,RX-40800186054,ROPIVACAINE(PF) 0.2 % 545 ML INFIL RATE ELAST PUMP WRAPPER,1682.65,1009.59,0.1125,4481.0,24 CDM,RX-40800198561,CEFAZOLIN 3 G IV VIAL FOR IVPB (WRAPPER),91.7,55.02,1.8,4481.0,24 CDM,RX-4080030851,MORPHINE 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS WRAPPER,56.65,33.99,13.14,4481.0,24 CDM,RX-4080034270,MIDAZOLAM 1 MG/ML INFUSION WRAPPER,112.3,67.38,0.3375,4481.0,24 CDM,RX-408003497,GLYCOPYRROLATE 0.2 MG/ML SYRINGE WRAPPER,55.0,33.0,0.4462,4481.0,35 CDM,RX-408004161,STUDY 80202135EBF3001 NIPOCALIMAB OR PLACEBO INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408004384,STUDY LT3001-205 LT3001/PLACEBO,0.2,0.12,0.0464,4481.0,22 CDM,RX-408004388,STUDY JR-141-GS31 PABINAFUSP ALFA OR IDURSULFASE 10 MG INJECTION VIAL,0.2,0.12,0.0464,4481.0,22 CDM,RX-408004646,STUDY IND 143335 CAFFEINE CITRATE 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408004654,STUDY ARGX-113-2308 ARGX-113 (EFGARTIGIMOD)/PLACEBO 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408004664,STUDY 22-002587 DARATUMUMAB 120 MG/ML-RHUPH20 2000 UNITS/ML 15 ML INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-408004789,STUDY JR-141-GS32 PABINAFUSP ALFA 10 MG INJECTION VIAL,0.2,0.12,0.0464,4481.0,22 CDM,RX-408004844,STUDY IMVT-1402-3101 300 MG/2 ML INJECTOR PEN OR PLACEBO,0.2,0.12,0.0464,4481.0,17 CDM,RX-40800500,LEUCOVORIN CALCIUM 500 MG SOL FOR INJ (10 MG/ML),288.45,173.07,7.25,4481.0,24 CDM,RX-4080070004,STUDY CHUGAI SA309JG SA237 120 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070005,STUDY CHUGAI SA309JG SA237/PLACEBO 120 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-40800700100,STUDY RPC02-201 RPC4046 150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007002,CEFAZOLIN 1 GRAM INJ SOLR IM,22.8,13.68,1.8,4481.0,24 CDM,RX-4080070035,STUDY CLEE011XUS03 LEE011 50 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070036,STUDY CLEE011XUS03 LEE011 200 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070037,STUDY ECU-MG-302 ECULIZUMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070038,STUDY ECU-MG-302 ECULIZUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,7333.83,35 CDM,RX-408007004,CEFEPIME 1 GRAM INJ SOLR IM,40.8,24.48,2.75,4481.0,24 CDM,RX-4080070048,STUDY 2628 TREPROSTINIL/PLACEBO 2.9 ML SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007005,CEFOTAXIME 1 GRAM INJ SOLR IM,54.25,32.55,12.59,4481.0,24 CDM,RX-408007007,CEFTAZIDIME 1 GRAM INJ SOLR IM,33.55,20.13,3.53,4481.0,24 CDM,RX-4080070070,STUDY BAY-73-4506 REGORAFENIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070071,STUDY BAY-73-4506 REGORAFENIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070079,STUDY MK-3475-045 PEMBROLIZUMAB INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-408007009,CEFTRIAXONE 1 GRAM INJ SOLR IM,29.65,17.79,0.9675,4481.0,24 CDM,RX-4080070096,STUDY RPC02-201 RPC4046/PLACEBO 75/150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070105,STUDY COG AHEP0731 TEMSIROLIMUS 10MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4581.99,35 CDM,RX-408007011,CEFTRIAXONE 250 MG INJ SOLR IM,19.0,11.4,0.9675,4481.0,24 CDM,RX-4080070110,STUDY NCT01954056 HYDROCORTISONE/PLACEBO INTRAVENOUS,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070111,STUDY NCT01954056 HYDROCORTISONE/PLACEBO ORAL,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070112,STUDY NCT01954056 HYDROCORTISONE/PLACEBO INTRAMUSCULAR,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070114,STUDY M13-741 ABT-981/PLACEBO 25/100/200 MG/ 2ML INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070115,STUDY AZ D5134C00001 (SOCRATES) ASPIRIN/PLACEBO 100 MG TABLETS,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070116,STUDY AZ D5134C00001 (SOCRATES) TICAGRELOR/PLACEBO 90MG TABLETS,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070117,STUDY IRC 003 OSELTAMIVIR/RIBAVIRIN/AMANTIDINE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007013,CEFUROXIME SODIUM 750 MG INJ SOLR IM,27.4,16.44,4.16,4481.0,24 CDM,RX-4080070132,STUDY CRLX030A2209 SERELAXIN/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070143,STUDY HEAT BIOLOGICS HS410-101 BCG LIVE VACCINE INTRAVESICAL SUSPENSIN,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070145,STUDY DFCI 13-559 PALBOCICLIB 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070146,STUDY DFCI 13-559 PALBOCICLIB CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070148,STUDY COG AOST 1322 ERIBULIN 0.5 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070156,STUDY 2691 FLUCONAZOLE 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070157,STUDY 2691 MICAFUNGIN 10 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070159,STUDY 2691 SCY-078 250 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070160,STUDY ATROPINE 0.1 MG/ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070161,STUDY FAMOTIDINE 10 MG/ML INJ SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070162,STUDY 2665 VPI-2690B 30 MG/ML WHITE LABEL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070163,STUDY 2665 VPI-2690B 30 MG/ML BLUE LABEL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070183,STUDY 14-2797 MEDICATION A 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070184,STUDY 14-2797 MEDICATION A 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070185,STUDY CBGJ398XUS04 BGJ398 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070186,STUDY CBGJ398XUS04 BGJ398 CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070187,STUDY D0816C00010 OLAPARIB TABLET 100 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070188,STUDY D0816C00010 OLAPARIB TABLET 150 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070191,STUDY C15009 MLN4924 INTRAVENOUS SOLUTION 10 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070193,STUDY CRAD001A2433 EVEROLIMUS TABLET 0.25 MG,0.2,0.12,0.0464,4481.0,20 CDM,RX-4080070194,STUDY CRAD001A2433 EVEROLIMUS TABLET 0.5 MG,0.2,0.12,0.0464,4481.0,20 CDM,RX-4080070195,STUDY CRAD001A2433 EVEROLIMUS TABLET 0.75 MG,0.2,0.12,0.0464,4481.0,20 CDM,RX-4080070196,STUDY CRAD001A2433 EVEROLIMUS TABLET 1 MG,0.2,0.12,0.0464,4481.0,20 CDM,RX-4080070214,STUDY AHOD1331 BRENTUXIMAB VEDOTIN (SGN-35) 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-4080070218,STUDY R668-EE-1324.01 DUPILUMAB/PLACEBO 150 MG/ML LOADING DOSE-600MG- 2 KITS,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070221,STUDY R668-EE-1324.01 DUPILUMAB/PLACEBO 150 MG/ML MAINTENANCE DOSE 300 MG = 1 KIT,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070224,STUDY PS-D202 SODIUM CHLORIDE 7 % FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070225,STUDY PS-D202 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070231,STUDY SHIRE SHP-609-302 IDURSULFASE INTRATHECAL 10 MG/ML SYRINGE,0.2,0.12,0.0506,81999.54,35 CDM,RX-4080070238,STUDY MAST MST-188-01 MST-188/PLACEBO 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070246,STUDY CTRC 10-0742 NICARDIPINE 20 MG/200 ML IN SODIUM CHLORIDE(ISO) IB,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070255,STUDY 14-2797 MEDICATION A 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070256,STUDY SHIRE HGT-SAN-093 HGT-1410 (RECOMBINANT HUMAN HEPARAN N SULFATASE) 45 MG/3 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070263,STUDY ACTG A5342 VRC01/PLACEBO 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070280,STUDY CNS7056-008 REMIMAZOLAM/PLACEBO 2.5 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070281,STUDY CNS7056-008 REMIMAZOLAM/PLACEBO 2.5 MG/ML TOP-UP DOSE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070282,STUDY CNS7056-008 MIDAZOLAM 1 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070283,STUDY CNS7056-008 MIDAZOLAM 1 MG/ML TOP-UP DOSE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070284,STUDY CNS7056-008 FENTANYL 0.05 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070285,STUDY CNS7056-008 FENTANYL 0.05 MG/ML FOLLOW-UP DOSE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070289,STUDY ALBUTEROL SULFATE 2.5 MG/3 ML (0.083 %) SOLUTION FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070290,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 50 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070291,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070292,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 200 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070293,STUDY B0401016 PF-04447943/PLACEBO 5 MG/15 MG TABLETS,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070296,STUDY CHAP NIIFEDIPINE EXTENDED RELEASE (ER) 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070297,STUDY CHAP LABETOLOL 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070298,STUDY HOFFMAN-LAROCHE GA29145 ETROLIZUMAB PREFILLED SYRINGE 105MG/0.,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070305,STUDY LBS-SS201 LB1148/PLACEBO RECONSTITUTED SOLUTION 700 ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070320,STUDY ONDANSETRON HCL 8 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070328,STUDY IRB 14-1455 APIXABAN 5 MG TABLETS,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070329,STUDY IM128027 BMS-931699/PLACEBO SYRINGE 1.25 MG/5 MG/12.5MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070374,STUDY GOG-3007 EVEROLIMUS 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070375,STUDY GOG-3007 EVEROLIMUS 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070376,STUDY GOG-3007 EVEROLIMUS 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070380,STUDY BAYER BAY 59-7939/17454 ASPIRIN 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070386,MISOPROSTOL 25 MCG SPLIT TABLET,16.5,9.9,3.83,4481.0,19 CDM,RX-4080070401,STUDY 2826 GEN-003 + MATRIX -M2 OR PLACEBO 0.8 ML VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070402,STUDY NICHD PROSPECT PROGESTERONE/PLACEBO 200 MG MICRONIZED CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070430,STUDY R2222-RSV-1332 REGN2222/PLACEBO 150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070431,STUDY IGHID 11525 ZANAMIVIR 10 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070433,STUDY IGHID 11525 ZANAMIVIR 10 MG/ML PEDIATRIC SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070447,STUDY INTREPID TICAGRELOR 90 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070448,STUDY INTREPID ASPIRIN 81 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070449,STUDY SHIRE SHP-610-201 HGT-1410 (RECOMBINANT HUMAN HEPARAN N SULFATASE) 45 MG/3 ML SY,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070451,STUDY XENCOR XMAB5871/PLACEBO INFUSION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070452,STUDY ALS-8176-503 ALS-008176/PLACEBO 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070453,STUDY ALS-8176-503 ALS-008176/PLACEBO 9.1 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070454,STUDY BAYER BAY 59-7939/16573 RIVAROXABAN/PLACEBO 15 MG TABLETT,0.2,0.12,0.0464,4481.0,23 CDM,RX-4080070470,STUDY SHIRE SHP621-301 COSYNTROPIN 0.25 MG SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070473,STUDY IRB #15-2770 D3-CREATINE 4 MG/ML IN 20% HEAVY WATER (D20),0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070474,STUDY IRB #15-2770 D3-CREATINE 7.5 MG/ML IN 20% HEAVY WATER (D2O),0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070476,STUDY ABLYNX ALX0681-C301 CAPLACIZUMAB/PLACEBO 12.5 MG/ML,0.2,0.12,0.0464,4481.0,21 CDM,RX-4080070477,STUDY ABLYNX ALX0681-C301 CAPLACIZUMAB 12.5 MG/ML,0.2,0.12,0.0464,4481.0,21 CDM,RX-408007048,ACETAMINOPHEN (OFIRMEV) 10 MG/ML INJECTION,94.4,56.64,0.132,4481.0,24 CDM,RX-4080070486,STUDY PACIRA 402-C-331 BUPIVICAINE (PF) 0.5 % (5 MG/ML) INJECTION SOL,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070487,STUDY PACIRA 402-C-331 BUPIVACAINE LIPOSOME/PLACEBO (PF) 266 MG/20 ML (13.3 M,0.2,0.12,0.0506,4481.0,34 CDM,RX-4080070490,STUDY IRB 15-2865 BISACODYL TABLETS 5 MG,0.2,0.12,0.0464,4481.0,23 CDM,RX-4080070491,STUDY IRB 15-2865 POLYETHYLENE GLYCOL-ELECTROLYTE SOLUTION 4000,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070492,STUDY CRFB002H2301 RANIBIZUMAB 0.5 MG/0.05 ML INTRAVITREAL SOLUTION FOR INJECTION,0.2,0.12,0.0506,14039.97,35 CDM,RX-4080070493,STUDY MLN0002-3026 VEDOLIZUMAB/PLACEBO 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4080070495,STUDY MLN0002-3026 ADALIMUMAB/PLACEBO 40 MG PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,30 CDM,RX-4080070496,STUDY HVTN 704/HPTN 085 VRC01/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070500,STUDY B0401016 PF-04447943/PLACEBO 5 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070501,STUDY A-TREAT TRANEXAMIC ACID/PLACEBO TABLET 650 MG,0.2,0.12,0.0464,4481.0,23 CDM,RX-4080070504,STUDY 39039039 RIVAROXABAN 15 MG (42)-20 MG (9) TABLETS IN A DOSE PACK,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070505,STUDY 39039039 RIVAROXABAN 15 MG (42)-20 MG (9) TABLETS IN A DOSE PACK,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070506,STUDY B5201002 RIVIPANSEL/PLACEBO 30 MG/ML INTRAVENOUS SOLN,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070511,STUDY PROTEON PRT-201-320 VONAPANITASE (PRT-201)/PLACEBO 0012 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070517,STUDY IRB 16-0739 FMT UPPER DELIVERY MICROBIOTA PREPARATIONN,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070601,STUDY ML29966 OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTI,0.2,0.12,0.0506,9460.92,70 CDM,RX-4080070613,STUDY SHIRE SHP621-302 COSYNTROPIN 0.25 MG SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070615,STUDY EXPANDED ACCESS ABBV-8E12 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070619,STUDY FAMOTIDINE 20 MG TABLET,0.2,0.12,0.0464,4481.0,23 CDM,RX-4080070629,STUDY EDGE EG-01-1962-03 EG-1962/PLACEBO 600 MG SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070630,STUDY EDGE EG-01-1962-03 NIMODIPINE/PLACEBO CAPSULE 30 MG,0.2,0.12,0.0464,4481.0,23 CDM,RX-4080070633,STUDY EDGE EG-01-1962-03 NIMODIPINE/PLACEBO ORAL SOLUTION 30 MG/ML,0.2,0.12,0.0464,4481.0,23 CDM,RX-4080070634,STUDY IMMUPHARM IPP-201101/005 IPP-201101/PLACEBO SUBCUTANEOUS SOLUTION 200 MG/ML,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070635,STUDY 2819-CL-0202 FIDAXOMICIN TABLET 200 MG,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070636,STUDY 2819-CL-0202 FIDAXOMICIN 40 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070637,STUDY 2819-CL-0202 VANCOMYCIN CAPSULE 125 MG,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070638,STUDY 2819-CL-0202 VANCOMYCIN 25 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070641,STUDY 20130295 AMG EVOLOCUMAB 140 MG/ML SUBCUTANEOUS AUTOINJECTOR,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070645,STUDY RAD-IFN-CS-003 RAD-IFN (INSTILADRIN) 3X10E11 VPS/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070646,STUDY RAD-IFN-CS-003 SYN 3 (POLYAMIDE SURFACTANT),0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070647,STUDY RAD-IFN-CS-003 DILUENT,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070649,STUDY BI 1293.10 METHYLPREDNISOLONE SODIUM SUCC 500 MG INTRAVENOUS SON,0.2,0.12,0.0506,4481.0,35 CDM,RX-4080070651,STUDY BI 1293.10 BI655064 0/120/180 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070659,STUDY IRB 16-0129 IBUTILIDE 0.1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4080070661,STUDY IRB 16-0129 MAGNESIUM SULFATE 2 GM IN 50 ML DEXTROSE 5% INFUSIN,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080070662,STUDY IRB 16-2363 FLU VACCINE QUADRIVALENT 15 MCG/STRAIN (QUIV) OR HIGH-DOSE TRIVALENT 60 MCG/STRAIN (TIV),0.2,0.12,0.0464,4481.0,26 CDM,RX-4080070666,STUDY GA28950 ETROLIZUMAB/PLACEBO 105 MG 0.7 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070667,STUDY C0168IBD4020 ADAPT INFLIXIMAB INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4783.38,35 CDM,RX-4080070684,STUDY D3461C00007 ANIFROLUMAB/PLACEBO 150 MG INTRAVENOUS SOLUTION FOR 1ST 3 MONTHS,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070687,STUDY D3461C00007 ANIFROLUMAB/PLACEBO 150 MG INTRAVENOUS SOLUTION MAINTENANCE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070693,STUDY XENCOR XMAB5871-04 METHYLPREDNISOLONE ACETATE 80 MG/ML INJECTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4080070694,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 10 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070695,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.045,4481.0,24 CDM,RX-4080070697,STUDY GSK 201023 DANIRIXIN/PLACEBO 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4080070698,STUDY GSK 201023 OSELTAMIVIR 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,23 CDM,RX-4080070699,STUDY GSK 201023 SODIUM CHLORIDE 0.9% (NS) INFUSION,0.2,0.12,0.0464,4481.0,21 CDM,RX-4080070702,STUDY GSK 201023 OSELTAMIVIR SUSPENSION 6 MG/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080070703,STUDY HAL-MPE1/PLACEBO 0.1 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070704,STUDY HAL-MPE1/PLACEBO 1 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070705,STUDY HAL-MPE1/PLACEBO 2 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070706,STUDY HAL-MPE1/PLACEBO 20 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070707,STUDY HAL-MPE1/PLACEBO 40 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070708,STUDY HAL-MPE1/PLACEBO 375 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070709,STUDY HAL-MPE1/PLACEBO 750 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070712,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 2 MG/ML INJECTION SOLUTION,0.2,0.12,0.045,4481.0,24 CDM,RX-4080070713,STUDY MLN0002SC-3031 VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4080070715,STUDY MLN0002SC-3031 VEDOLIZUMAB/PLACEBO 108 MG/0.68 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4080070726,STUDY ACTG A5315 ROMIDEPSIN/PLACEBO 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5162.64,35 CDM,RX-4080070730,STUDY ARGX-113-1602 ARGX-113/PLACEBO 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080070734,STUDY DEXAMETHASONE 4 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007120,AMPHOTERICIN B INTRATHECAL SOLUTION 0.25 MG/ML DILUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007246,STUDY 1966 BORTEZOMIB IV SYRINGE 1 MG/ML,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007320,STUDY 1090 BELATACEPT 25 MG/ML,0.2,0.12,0.0506,4481.0,35 CDM,RX-408007342,STUDY 1937 INFLIXIMAB/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007343,STUDY 1937 INFLIXIMAB 10 MG/ML,0.2,0.12,0.0506,4783.38,35 CDM,RX-408007347,STUDY 1903 IDURSULFASE 2 MG/ML,0.2,0.12,0.0506,81999.54,35 CDM,RX-408007348,STUDY 1903 IDURSULFASE (INTRATHECAL) 10MG/1ML VIAL,0.2,0.12,0.0506,81999.54,35 CDM,RX-408007381,STUDY 2040 AZITHROMYCIN 500 MG /PLACEBO,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007383,STUDY 2072 BTX-A-HAC (DYSPORT)/PLACECO 0/1000/1500 UN,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007386,STUDY 2075 BMS-936557 (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408007391,STUDY 2076 LY2127399/PLACEBO 120 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007402,STUDY 2117 MIND-USA STUDY MEDICATION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007405,STUDY 2163 LIDOCAINE/PLACEBO 2%,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007406,STUDY 2184 QUADRIVALENT HPV VACCINE/ PLACEBO 0.5 ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007411,STUDY 2208 OMALIZUMAB (XOLAIR) 150MG/ 1.2 ML,0.2,0.12,0.0506,6119.61,35 CDM,RX-408007412,STUDY 2208 OMALIZUMAB (XOLAIR) 300MG/ 2.4 ML,0.2,0.12,0.0506,6119.61,35 CDM,RX-408007413,STUDY 2208 OMALIZUMAB (XOLAIR) 450MG/ 3.6 ML,0.2,0.12,0.0506,6119.61,35 CDM,RX-408007415,STUDY 2214 BMS-936557 250 MG VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007419,STUDY 2214 BMS-936557 0/10/20/MG/KG,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007420,STUDY 2214 BMS-936557 (MAINTENANCE) 0/7.5/15 MG/KG,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007432,STUDY 2277 LY2127399 O/120 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007436,STUDY 2320 AA4500 0.9 MG / 0.39 ML VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007437,STUDY 2320 PAPAVARINE 16.7 MG/PHENTOLAMINE 0.56 MG/PROSTOGLE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007440,STUDY 2326 N6022/PLACEBO 1 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007445,STUDY 2377 BELIMUMAB/PLACEBO 80MG/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007447,STUDY 2377 BELIMUMAB 80MG/ML,0.2,0.12,0.0506,8308.44,35 CDM,RX-408007449,STUDY 2404 BELIMUMAB/PLACEBO 80MG/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007453,STUDY 2339 ECULIZUMAB 10 MG/ML,0.2,0.12,0.0506,7333.83,35 CDM,RX-408007456,STUDY 2346 ART-123/ PLACEBO 6 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007457,STUDY 2073 BTX-A-HAC (DYSPORT),0.2,0.12,0.0464,4481.0,19 CDM,RX-408007458,STUDY 2111 BTX-A-HAC (DYSPORT)/PLACEBO 0 UNITS/500 UNITS/1000 UNITS,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007459,STUDY 2176 BTX-A-HAC (DYSPORT) 1000 UNITS/ 1500 UNITS,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007462,STUDY 2333 RAD-IFN 5 X 10E11 PARITCLES PER ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007463,STUDY 2333 SYN 3 (POLYAMIDE SURFACTANT),0.2,0.12,0.0464,4481.0,17 CDM,RX-408007464,STUDY 2333 DILUENT (PLACEBO SOLUTION),0.2,0.12,0.0464,4481.0,19 CDM,RX-408007469,STUDY 2249 PF-00547659/PLACEBO SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007473,STUDY 2369 PF-00547659/PLACEBO SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007478,STUDY 2290 PF-04236921 0/10/50/200 MG PER DOSE SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007479,STUDY 2333 RAD-IFN 5 X 10E11 PARITCLES PER ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007480,STUDY PROPOFOL 10 MG/ML IV,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007481,STUDY FLUMAZENIL 0.1 MG/ML IV,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007482,STUDY MIDAZOLAM 5 MG/ML IV INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007484,STUDY ACETAMINOPHEN 325 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007485,STUDY DIPHENHYDRAMINE 25 MG CAPSULE/TABLET WRAPPER,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007486,STUDY MEDROXYPROGESTERONE 150 MG/ML IM SUSP,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007487,STUDY TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007488,STUDY ACETAMINOPHEN 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007489,"STUDY EPINEPHRINE 0.3MG/0.3 ML (1:1,000) IM PEN INJECTOR",0.2,0.12,0.0464,4481.0,19 CDM,RX-408007490,STUDY LORATADINE 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007491,STUDY ALBUTEROL SULFATE HFA 90 MCG / ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007492,STUDY AEROCHAMBER DEVICE ADULT,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007493,"STUDY EPINEPHRINE 1 MG/ML (1:1,000) (1ML) INJECTION",0.2,0.12,0.0464,4481.0,24 CDM,RX-408007495,STUDY ONDANSETRON 4 MG DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007496,STUDY ONDANSETRON HCL 2 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007497,STUDY DIPHENHYDRAMINE 50 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007498,STUDY METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/2ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408007507,STUDY 1966 BORTEZOMIB SUBCUTANEOUS SYRINGE 2.5 MG/ML,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007509,STUDY LPS-13649 METHYLPREDNISOLONE 1000 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408007515,STUDY 2347 BELIMUMAB 80 MG/ML,0.2,0.12,0.0506,8308.44,35 CDM,RX-408007516,STUDY 2305 TOLVAPTAN/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007564,STUDY 2323 NNC0109-0012/PLACEBO 25MG/50MG/100 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007608,ACETYLCYSTEINE 20% (200 MG/ML) OPHTHALMIC SOLUTION,259.65,155.79,60.24,4481.0,19 CDM,RX-408007610,CEFTAZIDIME 5% (50 MG/ML) OPHTHALMIC SOLUTION,43.9,26.34,10.18,4481.0,19 CDM,RX-408007612,GENTAMICIN 1.5% (15 MG/ML) OPHTHALMIC SOLUTION,30.4,18.24,4.97,4481.0,24 CDM,RX-408007615,MITOMYCIN 0.04% (400 MCG/1 ML) OPHTHALMIC SOLUTION,130.0,78.0,30.16,4481.0,19 CDM,RX-408007616,CLINDAMYCIN 1% (10 MG/ML) INTRAOCULAR SYRINGE,16.1,9.66,3.74,4481.0,24 CDM,RX-408007617,CEFTAZIDIME 2.25% (22.5 MG/ML) INTRAOCULAR SYRINGE,63.05,37.83,3.53,4481.0,24 CDM,RX-408007620,AMPHOTERICIN B CONVENTIONAL 5 MG/ML NASAL IRRIGATION,220.0,132.0,51.04,4481.0,24 CDM,RX-408007627,STUDY 2546 USL261(MIDAZOLAM)/PLACEBO,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007632,STUDY 2473 EXENATIDE 250 MCG/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007646,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION FOR PRESSURE LINES,75.0,45.0,2.83,4481.0,21 CDM,RX-408007647,STUDY 2536 SERELAXIN/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007649,STUDY 2430 NICOTINAMIDE 500 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007650,STUDY 2545 ECULIZUMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007665,STUDY 2496 OXYCODONE ORAL SOLUTION 1 MG/1ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007667,STUDY 2545 MENINGOCOCCAL CONJUGATE VACCINE (MENACTRA),0.2,0.12,0.0464,4481.0,25 CDM,RX-408007674,STUDY PROMETHAZINE 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007675,STUDY PROMETHAZINE 25 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007682,STUDY 2330 MIDAZOLAM 5 MG/ML VIAL,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007684,STUDY 2330 PENTOBARBITAL 50 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007686,STUDY 2330 PENTOBARBITAL 50 MG/ML VIAL,0.2,0.12,0.0464,4481.0,24 CDM,RX-408007702,STUDY 2420 LEUPROLIDE/PLACEBO 3.75 MG/ML SYRINGE,0.2,0.12,0.0506,252434.28,35 CDM,RX-408007703,STUDY 2422 USTEKINUMAB (STELARA) 90 MG SYRINGE,0.2,0.12,0.0506,23352.42,35 CDM,RX-408007704,STUDY 2423 ETANERCEPT/PLACEBO 25 MG/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007705,STUDY 2424 MEDI8968/PLACEBO 150 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007706,STUDY 2425 SELG1/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007708,STUDY 2426 HYDROXYPROGESTERONE CAPROATE 250 MG/ML,0.2,0.12,0.0464,4481.0,23 CDM,RX-408007709,STUDY 2445 PDA-002 100 MILLION CELLS IN 5ML SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007711,STUDY 2445 PDA-002 3 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007712,STUDY 2445 PDA-002 30 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007713,STUDY 2458 RITUXIMAB 10 MG/ML,0.2,0.12,0.05544,4481.0,31 CDM,RX-408007715,STUDY 2504 DFA-02/PLACEBO,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007716,STUDY 2452 BELIMUMAB/PLACEBO 80 MG/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007718,STUDY 2403 H.P. ACTHAR GEL/PLACEBO 80 UNITS/ML,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007719,STUDY 2301 DRCR AFL-BEV-RAN STUDY,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007722,STUDY 2414 CROTALIDAE POLYVALENT IMMUNE FAB (OVINE)/PLACEBO,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007724,STUDY 2477 APLIGRAF TOPICAL GEL,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007727,STUDY 2471 IOHEXOL IODINE (OMNIPAQUE) 300 MG/ML,0.2,0.12,0.0464,4481.0,25 CDM,RX-408007728,STUDY 2467 NKA (NEO-KIDNEY AUGMENT),0.2,0.12,0.0464,4481.0,17 CDM,RX-408007729,STUDY 2418 CALCIPOTRIENE/PLACEBO FOAM 0.005%,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007735,STUDY 2445 PDA-002 10 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080077411,CAFFEINE CITRATE 20 MG/ML (FOR ORAL USE) INJECTION SOLUTION,76.05,45.63,2.77,4481.0,23 CDM,RX-408007745,STUDY 2538 DAPSONE/PLACEBO GEL 7.5%,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080077659,STUDY METHYLPREDNISOLONE SOD SUCC (PF) 40 MG/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408007782,STUDY 2358 BMS-188667 ABATACEPT/PLACEBO 250 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408007863,STUDY ACTG A5326 BMS-963559/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007958,STUDY NICHD NRN INS-3 INOSITOL/PLACEBO 50 MG/ML INTRAVENOUSNS,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007964,STUDY 2444 IDURSULFASE (INTRATHECAL) 10MG/1ML VIAL,0.2,0.12,0.0506,81999.54,35 CDM,RX-408007972,STUDY NICHD NRN INS-3 INOSITOL/PLACEBO 50MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408007977,"STUDY WATER FOR INJECTION, STERILE INTRAVENOUS SOLUTION",0.2,0.12,0.0464,4481.0,24 CDM,RX-408007986,STUDY 1VIT13035 FERRIC CARBOXYMALTOSE 50 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408007991,STUDY 2637 PEG ELECTROLYTE ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40800951,THIOTEPA (TEPADINA) 15 MG SOLUTION FOR INJECTION,2721.7,1633.02,10.22,4481.0,35 CDM,RX-40801,LEUPROLIDE ACETATE 45 MG (6 MONTH) SUBCUTANEOUS SYRINGE,9245.55,5547.33,171.16,26039.58,35 CDM,RX-408010289,INSULIN REGULAR 100 UNIT/ML CORRECTION SCALE ADULT,190.0,114.0,0.5175,4481.0,24 CDM,RX-4080107671,CEFTAROLINE FOSAMIL 600 MG/20ML IV WETTED VIAL,904.9,542.94,4.1,4481.0,35 CDM,RX-408012021,STUDY IRB# 17-1500 PYRIDOXINE/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408012022,STUDY M14-327 UPADACITINIB ER 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408012023,STUDY M14-327 UPADACITINIB ER 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408012024,STUDY I4V-MC-JAIR BARICITINIB/PLACEBO 2 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408012025,STUDY I4V-MC-JAIR BARICITINIB/PLACEBO 4 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408012211,DORNASE ALFA 1 MG/ML SOLUTION FOR CHEST TUBE,818.65,491.19,189.93,4481.0,19 CDM,RX-4080129102,PHENYLEPHRINE FOR PRIAPISM 100 MCG/ML VIAL/SYRINGE WRAPPER,42.15,25.29,0.0225,4481.0,24 CDM,RX-4080173219,DALBAVANCIN 20 MG/ML DESENSITIZATION SOLN-DILUTION 1,6752.5,4051.5,15.14,5841.59,35 CDM,RX-4080173220,DALBAVANCIN 1 MG/ML DESENSITIZATION SOLN-DILUTION 2,289.0,173.4,15.14,4481.0,35 CDM,RX-4080173221,DALBAVANCIN 0.1 MG/ML DESENSITIZATION SOLN-DILUTION 3,74.3,44.58,15.14,4481.0,35 CDM,RX-4080177411,CAFFEINE CITRATE 20 MG/ML ORAL SOLUTION (COMPOUND),33.3,19.98,7.73,4481.0,19 CDM,RX-4080181794,HYDROMORPHONE 0.5 MG/0.5 ML INJECTION SYRINGE WRAPPER,34.5,20.7,0.2025,4481.0,24 CDM,RX-4080189367,PEDIATRIC MULTIVITAMIN-FERROUS SULFATE 11 MG/ML ORAL DROPS WRAPPER,7.425,4.455,0.2552,4481.0,57 CDM,RX-4080189607,PEDIATRIC MULTIVITAMIN ORAL DROPS WRAPPER,2.05,1.23,0.2552,4481.0,38 CDM,RX-4080193177,FARICIMAB-SVOA 6 MG/0.05 ML INTRAVITREAL INJ WRAPPER,9168.9,5501.34,32.86,7335.12,35 CDM,RX-408024984,POLYETHYLENE GLYCOL 3350 ORAL POWDER FOR LARGE DOSE,42.55,25.53,9.87,4481.0,19 CDM,RX-408031968,STUDY IRB# 20-3016 LIRAGLUTIDE/PLACEBO 6 MG/ML (18 MG/3 ML) INJECTION PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-408034654,STUDY ARGX-113-2308 ARGX-113 (EFGARTIGIMOD) 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408054572,STUDY UX143-CL314 DEXTROSE 5% FLUSH SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408070436,STUDY GILEAD GS-US-326-1100 GS-5745/PLACEBO 150 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080800004,FLUOROURACIL INFUSION (CADD),286.35,171.81,4.48,4481.0,24 CDM,RX-4080800034,ETOPOSIDE 10 MG/ML SUSPENSION,595.75,357.45,2.12,4481.0,24 CDM,RX-4080800061,STUDY NBTX-1100 NBTXR3 54.2 G/L,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080800079,STUDY NICHD NRN0058 IRON DEXTRAN INJECTION,0.2,0.12,0.05544,4481.0,33 CDM,RX-4080800081,STUDY NICHD NRN0058 DARBEPOETIN OR PLACEBO SYRINGE,0.2,0.12,0.05544,4481.0,33 CDM,RX-4080800117,STUDY ALN-TTRSC02-002 VUTRISIRAN (ALN-TTRSC02) 25 MG/0.5 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,811244.49,35 CDM,RX-4080800122,STUDY C0221002 PF-06730512 120 MG/ML INJ,0.2,0.12,0.0225,4481.0,24 CDM,RX-4080800124,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828)/PLACEBO 100 MG/ML PREFILLED SYRINGE #2 OF 2,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080800125,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 100 MG/ML PREFILLED SYRINGE #2 OF 2,0.2,0.12,0.0506,7785.12,35 CDM,RX-4080800126,STUDY CV010-031 BMS-986177 25 MG / 100 MG / PLACEBO CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080800127,STUDY CV010-031 CLOPIDOGREL 75 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4080800128,STUDY CV010-031 ASPIRIN 100 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4080800131,STUDY GSK MHE 112562 MEPOLIZUMAB 100 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4080800133,STUDY CETIRIZINE 1 MG/ML ORAL SOLUTION,0.2,0.12,0.0225,4481.0,24 CDM,RX-4080800143,STUDY CETIRIZINE 5 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080800144,STUDY CNTO1959CRD3001 GUSELKUMAB/PLACEBO 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4080800146,STUDY CNTO1959CRD3001 USTEKINUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4080800164,STUDY PROCLAIM MISOPROSTOL/PLACEBO 100 MCG CAPSULE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4080800167,STUDY A5377 SAR441236 25 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 CDM,RX-4080800171,STUDY TAK-079-2001 TAK-079 100 MG/ML OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,72 CDM,RX-4080800218,LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION,27582.5,16549.5,200.92,33560.1,35 CDM,RX-4080800221,STUDY CA-ALT-803-01-14 ALT-803 1 MG/ML INTRAVESICAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4080800223,STUDY CA-ALT-803-01-14 BCG 50 MG INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4080818,MORPHINE 100 MG/100 ML IN NS PCA CADD WRAPPER,52.45,31.47,12.17,4481.0,24 CDM,RX-4080901,STUDY IND MAGROLIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40810008,MITOMYCIN BLADDER INSTILLATION (2 MG/ML; 20 MG VIAL),2366.9,1420.14,19.74,4481.0,35 CDM,RX-40810009,MITOMYCIN BLADDER INSTILLATION (1 MG/ML; 20 MG VIAL),2366.9,1420.14,19.74,4481.0,35 CDM,RX-408102325,INSULIN LISPRO 100 UNIT/ML PERCENTAGE MEAL EATEN ADULT,275.0,165.0,0.5175,4481.0,24 CDM,RX-40810289,INSULIN REGULAR 100 UNIT/ML PERCENTAGE MEAL EATEN ADULT,190.0,114.0,0.5175,4481.0,24 CDM,RX-4081031066,STUDY VRC-HIVMAB075-00-AB (VRC07-523LS) 100 MG/ML INJ,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031070,STUDY LIMIT-JIA ABATACEPT (ORENCIA) 125 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031071,STUDY LIMIT-JIA ABATACEPT (ORENCIA) 50 MG/0.4 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031072,STUDY LIMIT-JIA ABATACEPT (ORENCIA) 87.5 MG/0.7 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031074,STUDY D3253C00001 BENRALIZUMAB 30 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0506,26729.01,35 CDM,RX-4081031075,STUDY D3253C00001 BENRALIZUMAB 30 MG/ML OR PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031077,STUDY D3253C00001 MEPOLIZUMAB 100 MG/ML OR PLACEBO VIAL,0.2,0.12,0.0506,4999.47,35 CDM,RX-4081031085,STUDY RA101495-02.302 ZILUCOPLAN PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031086,STUDY RA101495-02.302 MENINGOCOCCAL QUADRIVALENT CONJUGATE (MENACTRA) INJECTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031087,STUDY RA101495-02.302 MENINGOCOCCAL GROUP B (BEXSERO) INJECTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031089,STUDY GILEAD GS-US-200-4334 GS-6207 450 MG/1.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031094,STUDY IRB# 19-2343 LEUPROLIDE DEPOT 3.75 MG INJECTION,0.2,0.12,0.0506,252434.28,35 CDM,RX-4081031096,STUDY ACTG A5379 HEPATITIS B VIRUS VACCINE (ENGERIX-B) SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031097,STUDY ACTG A5379 HEPATITIS B VACCINE 20 MCG/0.5 ML-ADJUVANT CPG 1018 (PF) IM SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031100,KETAMINE 10 MG/ML INTRANASAL SOLUTION,81.55,48.93,18.92,4481.0,19 CDM,RX-4081031101,"STUDY VIOLET VITAMIN D3 EMULSION/PLACEBO 540,000 IU/5 ML ORAL",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031104,STUDY DEXTROSE 5% IN WATER (D5W) INTRAVENOUS SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031106,STUDY 3265 MIDAZOLAM/PLACEBO 2 MG/ML ORAL SOLUTION (ROUND 0.2 ML),0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031111,GADOBUTROL 1 MMOL/ML INTRAVENOUS WRAPPER,11.75,7.05,0.6075,4481.0,138 CDM,RX-4081031112,STUDY ACCRU-SC-1601 APIXABAN 2.5 MG OR 5 MG TABLET,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031113,STUDY ACCRU-SC-1601 APIXABAN 5 MG TABLET,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031114,STUDY SAATELLITE MEDI4893 50 MG/ML OR PLACEBO VIAL,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031117,STUDY EVADE MEDI3902 200 MG (50 MG/ML) OR PLACEBO VIAL,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031120,STUDY CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031122,STUDY CISATRACURIUM CONCENTRATE 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031131,STUDY CEUS VKD PERFLUTREN (DEFINITY) VIAL,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031132,SODIUM CHLORIDE 0.9% SOLUTION FOR PCN TESTING,16.15,9.69,3.75,4481.0,38 CDM,RX-4081031135,STUDY CEUS VKD PERFLUTREN (DEFINITY) SYRINGE,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031138,STUDY COSYNTROPIN 0.25 MG SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031154,STUDY RAP-MD-20 RAPASTINEL 450 MG OR PLACEBO INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031172,STUDY MISLE MESENCHYMAL STEM CELLS/PLACEBO IV INFUSION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031175,PROPRANOLOL 0.05 MG/ML PEDIATRIC DILUTION,115.7,69.42,22.36,4481.0,48 CDM,RX-4081031188,STUDY AK002-003 AK002/PLACEBO VIAL,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031194,ONDANSETRON HCL 2 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,18.35,11.01,0.2475,4481.0,24 CDM,RX-4081031199,STUDY 101EP201 NATALIZUMAB/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031201,STUDY 101EP201 NATALIZUMAB 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031207,STUDY D5551C00002 EXENATIDE/PLACEBO 2 MG DUAL CHAMBER PREFILLED PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031208,STUDY IFX-1-P2.4 IFX-1/PLACEBO 10 MG/ML VIAL,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031209,STUDY IFX-1-P2.4 IFX-1/PLACEBO 400/800/1200 MG IN 0.9% SODIUM CHLORIDE IVPB,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031211,STUDY IFX-1-P2.4 IFX-1 10 MG/ML VIAL,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031226,STUDY DU176B-D-U312 ENOXAPARIN 10 MG/0.1 ML SYRINGE,0.2,0.12,0.0464,4481.0,72 CDM,RX-4081031227,STUDY WARFARIN 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031228,STUDY DU176B-D-U312 EDOXABAN 6 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031229,STUDY EDOXABAN 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031236,"ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 1,000 MG (+/-) IV SOLN WRAPPER",65.0,39.0,5.3,4481.0,35 CDM,RX-4081031240,STUDY LIDOCAINE-PRILOCAINE 2.5 %-2.5 % TOPICAL CREAM,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031241,STUDY VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031242,STUDY MLN0002-2003 VEDOLIZUMAB 150/300 MG IVPB,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031243,STUDY MLN0002-2003 VEDOLIZUMAB 100/200 MG IVPB,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031244,"STUDY EPINEPHRINE 0.15 MG/0.3 ML INJECTION, AUTO-INJECTOR",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031245,STUDY ACETAMINOPHEN 160 MG/5 ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031256,STUDY LILLY I6T-MC-AMAN MIRIKIZUMAB (LY3074828)/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031258,STUDY CV013-011 BMS-986231/PLACEBO INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031259,STUDY CV013-011 BMS-986231/PLACEBO WITH POTASSIUM ACETATE IN 120 ML D5W IVPB,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031260,STUDY ARGX-113-1704 ARGX-113/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031262,AMPICILLIN (10 MG/ML) DILUTION (PCN TESTING),63.35,38.01,1.24,4481.0,24 CDM,RX-4081031263,STUDY ACETAMINOPHEN 500 MG/15 ML ORAL LIQUID,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031264,STUDY IA-001 FLU-IGIV/PLACEBO IN 0.9% SODIUM CHLORIDE IVPB,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031270,STUDY ACTG A5378 VRC07-523LS 100 MG/ML VIAL,0.2,0.12,0.0464,4481.0,34 CDM,RX-4081031274,STUDY HAEMOPH B POLYSAC CONJ-MENING (PF) 7.5 MCG/0.5 ML IIM SOLN,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031275,"STUDY MENINGOC VAC A,C,Y,W-135 DIP (PF) 4 MCG/0.5 ML IM SOLUTION",0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031276,"STUDY MENNGOCOCCAL B VAC,4-CMP 50 MCG-50 MCG-50 MCG-25 MCG/0.5 ML IM E",0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031277,STUDY PNEUMOCOCCAL 13-VAL CONJ VACCINE-DIP CRM (PF) 0.5 ML IM SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031278,STUDY HAEMOPHILUS B POLYSACCHARID CONJ-TETANUS TOX (PF) (ACTHIB) IM SOLN,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031279,STUDY GILEAD GS-US-420-3902 GS-9722/PLACEBO 50 MG/ML VIAL,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031284,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SYRINGE/VIAL WRAPPER,54.45,32.67,12.63,4481.0,19 CDM,RX-4081031286,STUDY IRB# 18-0431 MEPOLIZUMAB / PLACEBO 100 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031288,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828)/PLACEBO 100 MG/ML PREFILLED SYRINGE #1 OF 2,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031289,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 100 MG/ML PREFILLED SYRINGE #1 OF 2,0.2,0.12,0.0506,7785.12,35 CDM,RX-4081031290,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 20 MG/ML VIAL,0.2,0.12,0.0506,7785.12,35 CDM,RX-4081031292,STUDY ROCHE CP40617 BALOXAVIR/PLACEBO 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031293,STUDY ROCHE CP40617 BALOXAVIR 2 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031294,STUDY ROCHE CP40617 OSELTAMIVIR 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031295,STUDY ROCHE CP40617 OSELTAMIVIR 6 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031302,STUDY COFAR-11 OMALIZUMAB OR PLACEBO PREFILLED SYRINGE 150 MG/ML,0.2,0.12,0.0506,6119.61,35 CDM,RX-4081031303,STUDY COFAR-11 OMALIZUMAB OR PLACEBO PREFILLED SYRINGE 75 MG/0.5 ML,0.2,0.12,0.0506,6119.61,35 CDM,RX-4081031307,STUDY CAFFEINE CITRATE 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031309,STUDY NWU2015-09-02 HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031310,STUDY ALXN1210-MG-306 MENINGOCOCCAL CONJUGATE (MENACTRA) VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031311,STUDY ALXN1210-MG-306 MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031317,STUDY ALXN1210-MG-306 RAVULIZUMAB/PLACEBO 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031319,STUDY ALXN1210-MG-306 RAVULIUMAB 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031332,STUDY PNEU-PED V114 VACCINE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031333,STUDY IBUPROFEN 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031340,STUDY RA101495-02.301 ZILUCOPLAN OR PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-40810313400,STUDY ALXN1210-NMO-307 RAVULIZUMAB 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031341,STUDY RA101495-02.301 MENINGOCOCCAL QUADRIVALENT CONJUGATE (MENACTRA)),0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031342,STUDY RA101495-02.301 MENINGOCOCCAL GROUP B (BEXSERO) INJECTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031343,STUDY IRB 18-2650 ANAKINRA/PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031346,STUDY MEDI8897/PLACEBO 100 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031354,STUDY EFC15804 BOREAS UNC IDS#19-0049 DUPILUMAB 300 MG/PLACEBO INJECTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031359,URSODIOL 60 MG/ML ORAL SUSPENSION,204.3,122.58,47.4,4481.0,19 CDM,RX-4081031362,"EPOETIN ALFA-EPBX (RETACRIT) 4,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",188.1,112.86,7.61,4481.0,33 CDM,RX-4081031363,"EPOETIN ALFA EPBX (RETACRIT) 10,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",446.2,267.72,7.61,4481.0,33 CDM,RX-4081031364,"EPOETIN ALFA EPBX (RETACRIT) 40,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",1736.7,1042.02,7.61,4481.0,33 CDM,RX-4081031365,"EPOETIN ALFA EPBX (RETACRIT) 1,000 UNIT/ML INJECTION (PEDIATRICS DILUTION) SYRINGE",188.55,113.13,7.61,4481.0,33 CDM,RX-4081031366,STUDY NICHD MFMU PRAVASTATIN/PLACEBO 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031367,STUDY CNTO1959CRD3001 USTEKINUMAB/PLACEBO 130 MG/26 ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031370,STUDY CNTO1959CRD3001 USTEKINUMAB/PLACEBO 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031371,STUDY HAZ COVID HYDROXYCHLOROQUINE/PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031372,STUDY HAZ COVID AZITHROMYCIN/PLACEBO 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031375,GENTAMICIN 1 MG/ML (2 ML) LOCK IN NS,23.75,14.25,4.97,4481.0,24 CDM,RX-4081031376,GENTAMCIN 1 MG/ML (5 ML) LOCK IN NS,26.35,15.81,4.97,4481.0,24 CDM,RX-4081031379,STUDY CX-280-202 CB-280/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031380,STUDY CX-280-202 CB-280/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031381,STUDY CX-280-202 COSYNTROPIN 0.25 MG/ML 0.9% SODIUM CHLORIDE INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031382,STUDY HPTN 083 CABOTEGRAVIR (GSK1265744) 200 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031383,STUDY HPTN 083 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031384,STUDY 20170625 VESALIUS EVOLOCUMAB/PLACEBO 140 MG/ML INJECTION PEN,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031385,STUDY 20170625 VESALIUS PLACEBO INJECTION PEN,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031392,STUDY VIS649-201 0/2/4/8 MG/KG IN 0.9% SODIUM CHLORIDE (NS) IVPB,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031393,STUDY R10933-10987-COV-2066 REGN10933+REGN10987/PLACEBO 0/2.4/8.0 G IVPB,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031394,STUDY IM011074 BMS-98616501/PLACEBO 0/3/6/12 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031400,STUDY AK002-014 AK002/PLACEBO 15 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031402,STUDY AK002-014 AK002 15 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031413,STUDY IRB 19-3149 DROSPIRENONE 3 MG-ETHINYL ESTRADIOL 0.03 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031416,STUDY AK002-016 PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031417,STUDY AK002-016 AK002/PLACEBO 15 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031419,STUDY ACP-2566-003 TROFINETIDE/PLACEBO 1 G/5 ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031423,STUDY PATH HHT 133646-2 IRB# 19-3071 POMALIDOMIDE/PLACEBO 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031424,STUDY PATH HHT 133646-2 IRB# 19-3071 POMALIDOMIDE/PLACEBO 3 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031425,STUDY PATH HHT 133646-2 IRB# 19-3071 POMALIDOMIDE/PLACEBO 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031429,STUDY TAK-079-2001 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AERSOL INH,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031433,SPIRONOLACTONE 12.5 MG SPLIT TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-4081031434,STUDY ACTIV-1 IM REMDESIVIR 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031436,STUDY ACTIV-1 IM INFLIXIMAB/PLACEBO 10 MG/ML SOLUTION,0.2,0.12,0.0506,4783.38,35 CDM,RX-4081031438,STUDY ACTIV-1 IM ABATACEPT/PLACEBO 250 MG INTRAVENOUS SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-4081031440,STUDY ACTIV-1 IM CENICRIVIROC (CVC)/PLACEBO 150 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031441,STUDY ACTIV-1 IM CENICRIVIROC (CVC)/PLACEBO 7.5 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031444,STUDY COFAR-11 OMALIZUMAB PREFILLED SYRINGE 150 MG/ML,0.2,0.12,0.0506,6119.61,35 CDM,RX-4081031445,STUDY COFAR-11 OMALIZUMAB PREFILLED SYRINGE 75 MG/0.5 ML,0.2,0.12,0.0506,6119.61,35 CDM,RX-4081031449,STUDY ECU-NMO-303 ECULIZUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,7333.83,35 CDM,RX-4081031451,STUDY INCB 54707-204 INCB054707/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031452,STUDY INCB 54707-204 INCB054707 15 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031461,STUDY IRB# 19-2343 PROGESTERONE 200 MG / ESTRADIOL 2 MG / PLACEBO CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031466,STUDY ARMOR (C20-0155) IRB# 19-2850 ARAMCHOL 300 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031469,STUDY PNEUMOCOCCAL 23 POLYVALENT VACCINE 25 MCG/0.5 ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031475,COLCHICINE 0.3 MG SPLIT TABLET,43.9,26.34,10.18,4481.0,19 CDM,RX-4081031477,METHIMAZOLE 2.5 MG SPLIT TABLET,16.15,9.69,3.75,4481.0,19 CDM,RX-4081031481,STUDY ION-682884-CS3 ISIS 420915 (INOTERSEN) SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031482,STUDY ION-682884-CS3 ION-682884 150 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031484,STUDY COFAR-11 OPEN OFC ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031485,STUDY COFAR-11 IDE RESCUE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031486,STUDY COFAR-11 BUILD-UP/MAINTENANCE RESCUE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031487,STUDY COFAR-11 BLINDED DBPCFC ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031488,STUDY COFAR-11 BLINDED IDE ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031489,STUDY COFAR-11 BLINDED BUILD-UP/MAINTENANCE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031492,STUDY COFAR-11 MAINTENANCE ONLY RESCUE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031493,STUDY COFAR-11 BLINDED MAINTENANCE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031496,STUDY ION-682884-CS2 (CARDIO-TTRANSFORM) ION-682884/PLACEBO SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031497,"STUDY ION-682884-CS2 (CARDIO-TTRANSFORM) VITAMIN A 3,000 MCG (10,000 IU) CAPSULE",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031498,STUDY ALXN1210-NEPH-202 RAVULIZUMAB (ALXN1210)/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,36062.04,35 CDM,RX-4081031500,STUDY ALXN1210-NEPH-202 MENINGOCOCCAL CONJUGATE (MENACTRA) INTRAMUSCULAR SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031501,STUDY ALXN1210-NEPH-202 MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031502,STUDY ALXN1210-NEPH-202 PNEUMOCOCCAL 13-VAL CONJ VACCINE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031503,STUDY ALXN1210-NEPH-202 PNEUMOCOCCAL 23 POLYVALENT VACCINE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031509,STUDY ALXN1210-NEPH-202 HAEMOPHILUS B POLYSACCHARID CONJ-TETANUS TOX VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031513,STUDY RPC-1063-MS-001 OZANIMOD 0.25 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031514,STUDY RPC-1063-MS-001 OZANIMOD 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031515,STUDY D3251C00014 RESOLUTE BENRALIZUMAB/PLACEBO 100 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031522,STUDY IND IRB# 21-1333 AT-007 200 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031523,OCTREOTIDE ACETATE 500 MCG/ML SYRINGE (PEDS),209.8,125.88,1.37,4481.0,24 CDM,RX-4081031524,STUDY C3671008 RESPIRATORY SYNCYTIAL VIRUS (RSV)/PLACEBO VACCINE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031526,STUDY IND IRB# 21-1333 AT-007 ORA-PLUS COMPOUNDING VEHICLE SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031527,STUDY SB2640-CLIN-007 TVB-2640 25 MG/50 MG/PLACEBO TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031531,STUDY CEGIR 7810 DEGAS UNC IRB#21-0025 DUPILUMAB/PLACEBO 150 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031534,STUDY CEGIR 7810 DEGAS UNC IRB#21-0025 DUPILUMAB 150 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031536,"HYALURONIDASE, HUMAN RECOMBINANT 15 UNIT/ML (DILUTION) INJECTION",59.55,35.73,0.81,4481.0,24 CDM,RX-4081031537,STUDY CQGE031G12301 LIGELIZUMAB/PLACEBO 120 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031541,STUDY NOVAVAX 2019NCOV-301 SARS-COV-2 RS WITH MATRIX-M1 VACCINE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031543,STUDY IRB# 21-1548 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031544,STUDY IRB# 21-1689 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031546,STUDY NN9389-4606 UNC IRB#21-2634 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031547,STUDY NN9389-4606 UNC IRB#21-2634 SEMAGLUTIDE/PLACEBO 3.0 MG/ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031548,STUDY NN9389-4606 UNC IRB#21-2634 NNC0480-0389/PLACEBO 10 MG/ML CARTRIDGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031549,STUDY NN9389-4606 UNC IRB#21-2634 NNC0480-0389/PLACEBO 30 MG/ML CARTRIDGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031550,STUDY PEEPS UNC IRB# 21-2230 ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031551,STUDY PEEPS UNC IRB# 21-2230 PROGESTERONE 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031560,"STUDY BEST TRIAL UNC IRB# 21-3271 DULOXETINE 30 MG CAPSULE, DELAYED RELEASE",0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031563,STUDY IND TECOVIRIMAT SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031570,STUDY ARC008 IDE AR101 PEANUT PROTEIN KIT,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031571,STUDY ARC008 MAINTENANCE AR101 PEANUT PROTEIN KIT,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031572,STUDY ARC008 DOSE BUILD-UP AR101 PEANUT PROTEIN KIT,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031573,STUDY ARC008 OLFC PEANUT FLOUR PACKET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031574,STUDY ARC008 DBPCFC PEANUT/PLACEBO PACKET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031577,CLOBAZAM 5 MG SPLIT TABLET,24.0,14.4,5.57,4481.0,19 CDM,RX-4081031578,CLOBAZAM 2.5 MG SPLIT TABLET,23.0,13.8,5.34,4481.0,19 CDM,RX-4081031579,STUDY RM-493-035 SETMELANOTIDE/PLACEBO 10 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031581,STUDY SP-1011-004 APT-1011 3 MG ORALLY DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031588,STUDY ALXN2050-MG-201 ALXN2050/PLACEBO 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031589,STUDY ALXN2050-MG-201 ALXN2050 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031590,STUDY ALXN2050-MG-201 MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031591,STUDY ALXN2050-MG-201 MENINGOCOCCAL CONJUGATE (MENACTRA) VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031592,RABIES IMMUNE GLOBULIN (PF) 300 UNIT/ML INTRAMUSCULAR - 5 ML VIALS,12411.0,7446.6,271.45,10736.76,36 CDM,RX-4081031603,STUDY NN9535-4984 SEMAMAX SEMAGLUTIDE B/PLACEBO 9.6 MG/ML CARTRIDGE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031604,STUDY 6058-SCD-101 FTX-6058 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031605,STUDY 6058-SCD-101 FTX-6058 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031606,STUDY INFLAMMATION AND SOCIAL BEHAVIOR IRB# 22-1024 FLU VACCINE/PLACEBO (QS 2023-24 6 MO UP),0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031607,STUDY SKOAP IRB# 22-1526 BUPIVACAINE LIPSOME(PF) 1.3 % (13.3 MG/ML) SUSPENSION,0.2,0.12,0.0506,4481.0,34 CDM,RX-4081031612,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 1 MG/ML + 0.5 MG/ML, CAGRILINTIDE 1 MG/ML, SEMAGLUTIDE 0.5 MG/ML OR PLACEBO PEN",0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031613,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 2 MG/ML + 1 MG/ML, CAGRILINTIDE 2 MG/ML, SEMAGLUTIDE 1 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031614,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 4 MG/ML + 2 MG/ML, CAGRILINTIDE 4 MG/ML, SEMAGLUTIDE 2 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031615,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 6.8 MG/ML + 3.4 MG/ML, CAGRILINTIDE 6.8 MG/ML, SEMAGLUTIDE 3.4 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031616,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 9.6 MG/ML + 4.8 MG/ML, CAGRILINTIDE 9.6 MG/ML, SEMAGLUTIDE 4.8 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031617,STUDY IM011134 IRB# 22-2162 DEUCRAVACITINIB/PLACEBO 6 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031618,STUDY PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031619,STUDY M21-471 IRB# 22-0783 ONABOTULINUMTOXINA/PLACEBO 50 UNIT/ML SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031620,STUDY CC-93538-EE-002 CC-93538 360 MG/2 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031621,STUDY AEZS-130-P02 DETECT CLONIDINE 0.75 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031622,STUDY AEZS-130-P02 DETECT ARGININE HCL (L-ARGININE) 10 % INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031623,STUDY AEZS-130-P02 DETECT MACIMORELIN 0.5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031624,STUDY MENINGOCOCCAL CONJUGATE (MENVEO) VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031625,STUDY ADRN-12 IRB# 22-1668 VANICREAM MOISTURIZER,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031626,STUDY ADRN-12 IRB# 22-1668 HYDROCORTISONE 2.5 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031627,STUDY ADRN-12 IRB# 22-1668 TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031628,STUDY ADRN-12 IRB# 22-1668 DUPILUMAB 300 MG/2 ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031629,STUDY ADRN-12 IRB# 22-1668 DUPILUMAB 200 MG/1.14 ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031630,STUDY 718-CIH-201 IRB# 22-0706 SAGE-718/PLACEBO 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031631,STUDY 718-CIH-201 IRB# 22-0706 SAGE-718/PLACEBO 0.9 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031632,STUDY 718-CIH-201 IRB# 22-0706 SAGE-718/PLACEBO 1.2 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031634,STUDY LYR-220-2021-001 BEACON IRB# 22-0807 LYR-220-16 SYSTEM (MOMETASONE FUROATE/PLACEBO),0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031635,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031636,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 5 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031637,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 1 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031638,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031639,STUDY R668-BP-1902 IRB# 22-1408 DUPILUMAB/PLACEBO 300 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031641,STUDY EVOLVE-MI IRB# 22-1820 EVOLOCUMAB 140 MG/ML SUBCUTANEOUS PEN INJECTOR,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031644,STUDY HBS-101-CL IRB# PITOLISANT 4.45 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031645,STUDY HBS-101-CL-005 IRB# PITOLISANT 17.8 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031649,STUDY GS-US-563-6041 IRB# 21-2334 LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031650,STUDY GS-US-563-6041 IRB# 21-2334 ISLATRAVIR 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031651,STUDY GS-US-563-6041 IRB# 21-2334 BICTEGRAVIR 50 MG/EMTRICITABINE 200 MG/TENOFOVIR 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031655,STUDY HBS-101-CL-005 IRB# PITOLISANT/PLACEBO TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031659,STUDY HMI-203-101 IRB# 22-0517 HMI-203 VECTOR GENOMES (+/-) INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031661,"STUDY TACROLIMUS XL 0.5 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031662,"STUDY TACROLIMUS XL 1 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031663,"STUDY TACROLIMUS XL 5 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031664,"STUDY TACROLIMUS XR 0.75 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031665,"STUDY TACROLIMUS XR 1 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031666,"STUDY TACROLIMUS XR 4 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031667,STUDY INCB 18424-220 IRB# 22-2205 RUXOLITINIB 1.5%/PLACEBO CREAM,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031668,STUDY INCB 18424-220 IRB# 22-2205 RUXOLITINIB 1.5% CREAM,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031669,STUDY A011-13 HYPERION SOTATERCEPT/PLACEBO 50 MG/ML (0.3 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031670,STUDY A011-13 HYPERION SOTATERCEPT/PLACEBO 50 MG/ML (0.7 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031671,STUDY DEXAMETHASONE 6 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031672,STUDY DEXAMETHASONE 4 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031673,STUDY DEXAMETHASONE 2 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031674,STUDY DEXAMETHASONE 1.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031675,STUDY DEXAMETHASONE 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031676,STUDY ARGX-117-2002 ARGX-113/PLACEBO 120 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031678,STUDY MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 CDM,RX-4081031680,STUDY D5244C00001 TEZEPELUMAB/PLACEBO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031681,STUDY D5244C00001 TEZEPELUMAB 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031682,STUDY C4671026 PF-07321332 (NIRMATRELVIR) 150 MG/RITONAVIR 100 MG POWDER,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031686,STUDY AL001-3 AL001 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031687,STUDY SEXTANT IRB# 22-2127 VANCOMYCIN 1000 MG POWDER,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031688,STUDY SEXTANT IRB# 22-2127 TOBRAMYCIN 1.2 GRAM POWDER,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031689,STUDY FLUTE-3 SP-1011-005 APT-1011 3 MG ORALLY DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031690,STUDY FLUTE-3 SP-1011-005 APT-1011/PLACEBO 3 MG ORALLY DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031692,STUDY DRCR AF FENOFIBRATE/PLACEBO 160 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031693,STUDY DRCR AF FENOFIBRATE/PLACEBO 54 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031694,STUDY LCCC2139 IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031695,STUDY BAYER 22186 EFFEKTOR FINERENONE BAY 94-8862/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031698,STUDY FLUTE-3 SP-1011-005 COSYNTROPIN 0.25 MG/ML INJECTION VIAL,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031699,STUDY IND JZP150 IRB# 22-3339 JZP150 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031700,STUDY A011-12 SOTERIA SOTATERCEPT/PLACEBO 50 MG/ML (0.3 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031701,STUDY A011-12 SOTERIA SOTATERCEPT/PLACEBO 50 MG/ML (0.7 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031702,STUDY ALE10 (DIVERT) VOCLOSPORIN/PLACEBO 7.9 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031703,STUDY ALE10 (DIVERT) MYCOPHENOLATE MOFETIL (MMF)/PLACEBO 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031704,STUDY ALE10 (DIVERT) METHYLPREDNISOLONE ACETATE 80 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031705,STUDY ALE10 (DIVERT) TRIAMCINOLONE ACETONIDE 40 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031706,STUDY 1042-TSC-3002 GANAXOLONE 50 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031707,STUDY AZ D5985C00006 HFO/HFA MDI INHALER,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031709,STUDY V712-306 VITESSE DBV712 (VIASKIN)/PLACEBO 250 MICROGRAM PATCH,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031710,STUDY HYDROCORTISONE 2.5% OINTMENT,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031724,STUDY EX6018-4915 ZILTIVEKIMAB B/PLACEBO 15 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031726,STUDY IRB# 21-1689 SEMAGLUTIDE/PLACEBO 2 MG/3 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031727,STUDY IRB# 21-1548 SEMAGLUTIDE/PLACEBO 2 MG/3 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031736,STUDY 20604 BAY 2433334 ASUNDEXIAN/PLACEBO 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031742,STUDY ALE10 (DIVERT) TRIAMCINOLONE ACETONIDE 80 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031744,STUDY HYDROCORTISONE 1 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031745,STUDY D5180C00016 TEZEPELUMAB/PLACEBO 110 MG/ML SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031746,STUDY RNLC3132 IRB# 23-1481 RIFAXIMIN/PLACEBO 40 MG SDD-IR TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031747,STUDY J2L-MC-EZBB LY3461767/PLACEBO 10 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031749,STUDY ARGX-113-2007 EFGARTIGIMOD PH20/PLACEBO SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031754,STUDY DNLI-I-0001 DNL126 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031755,STUDY REM-PH-418 GLYCINE DILUENT INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031760,STUDY MK7240-001-01 MK-7240 (TULISOKIBART) 100 MG/ML SOLUTION FOR INFUSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031762,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 1000 MG/500 MG IV INFUSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031763,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 500 MG/250 MG IV INFUSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031764,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 200 MG/ML AUTO-INJECTOR,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031765,STUDY HEALEY ALS PLATFORM REGIMEN G DNL343/PLACEBO 100 MG STICK,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031768,STUDY IRB# 22-2062 ACETAZOLAMIDE 500 MG INJECTION VIAL,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031770,STUDY D6970C00002 BAXDROSTAT/PLACEBO 1 MG/2 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031771,STUDY D6970C00002 BAXDROSTAT 2 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031772,STUDY M23-732 RISANKIZUMAB 150 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031773,STUDY M23-732 RISANKIZUMAB 55 MG/0.37 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031774,STUDY M23-732 ADALIMUMAB 20 MG/0.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,30 CDM,RX-4081031775,STUDY M23-732 ADALIMUMAB 40 MG/0.4 ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,30 CDM,RX-4081031776,STUDY IRB# 21-2453 GOS/HGOS/PLACEBO 5 G SACHET KIT,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031777,STUDY R668-EGE-2213 IRB# 22-2246 DUPILUMAB/PLACEBO 300 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031781,STUDY IRB# 21-2453 GOS/HGOS/PLACEBO 7.5 G SACHET KIT,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031782,STUDY LPS17558 IRB# 23-1878 DUPILUMAB/PLACEBO 300 MG/2 ML INJECTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031783,STUDY LPS17558 IRB# 23-1878 DUPILUMAB 300 MG/2 ML INJECTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031784,STUDY EFC14771 IRB# 23-2814 DUPILUMAB/PLACEBO 300 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031785,STUDY EFC14771 IRB# 23-2814 DUPILUMAB/PLACEBO 200 MG/1.14 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031786,STUDY EFC14771 IRB# 23-2814 DUPILUMAB 300 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031787,STUDY EFC14771 IRB# 23-2814 DUPILUMAB 200 MG/1.14 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031788,STUDY F901318/0041 AMPHOTERICIN B LIPOSOME 50 MG INTRAVENOUS SUSPENSION,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031793,STUDY F901318/0041 OLOROFIM (F901318) 30 MG FILM COATED TABLET,0.2,0.12,0.0225,4481.0,21 CDM,RX-4081031795,STUDY VX21-147-301 VX-147/PLACEBO 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031796,STUDY IND 072807/171784/IRB# 24-0781 MAT2203 (AMPHOTERICIN B LNC) 20 MG/ML ORAL SUSPENSION,0.2,0.12,0.05544,4481.0,31 CDM,RX-4081031797,STUDY 1042-SE-3003 GANAXOLONE 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031799,STUDY FPA-AS-30094 FP/ABS EMDPI 30/117 MCG OR FP/ABS EMDPI 55/117 MCG OR ABS EMDPI 117 MCG INHALER,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031800,STUDY FPA-AS-30094 ALBUTEROL SALBUTAMOL (PROAIR RESPICLICK) 117 MCG INHALER,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031803,STUDY GS-US-528-6020 LENACAPAVIR 309 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031804,STUDY GS-US-528-6020 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031805,STUDY GS-US-528-6020 LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031806,STUDY PIKASO METFORMIN/PLACEBO 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031809,STUDY IRB# 24-0191 ANIFROLUMAB-FNIA 150 MG/ML INTRAVENOUS INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031811,STUDY FPA-AS-30094 ALBUTEROL SULFATE MDI 90 MCG/ACTUATION INHALER,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031812,STUDY AMG 569 20230070 IRB# 24-0683 AVACOPAN 10 MG GELATIN CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031813,STUDY AMG 569 20230070 IRB# 24-0683 AVACOPAN 3 MG/ML ORAL LIQUID,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031814,STUDY PT-01 PEANUT 4320 DU SLIT-TABLET (PHASE 3 ONLY),0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031815,STUDY M23-784 RISANKIZUMAB/PLACEBO 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031816,STUDY M23-784 RISANKIZUMAB 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031819,STUDY PALV-09 IRB# 24-0156 PTX-022 3.9% W/W TOPICAL GEL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031820,STUDY IND 172688 CLOFAZIMINE 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031821,STUDY 718-CIH-301 SAGE-718 0.9 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031824,STUDY FPA-AS-30094 ALBUTEROL SULFATE 2.5 MG/3 ML (0.083%) SOLUTION FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031826,STUDY HPTN 106 TENOFOVIR (TFV) RECTAL DOUCHE SACHET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031827,STUDY HPTN 106 EMTRICITABINE 200 MG-TENOFOVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031828,STUDY HPTN 106 SUPPLEMENTAL SUPPLIES,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031829,STUDY IMVT-1401-2401 BATOCLIMAB/PLACEBO 340 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031830,STUDY IMVT-1401-2401 BATOCLIMAB 340 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031835,STUDY AP-SA02-101 5X10E10 (2.5X10E10 PFU/PHAGE) OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4081031836,STUDY 70033093AFL3002 JNJ-70033093 (MILVEXIAN)/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031837,STUDY 70033093AFL3002 APIXABAN/PLACEBO 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031838,STUDY 70033093AFL3002 APIXABAN/PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031840,STUDY ARGX-113-2011 EFGARTIGIMOD PH20 SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031841,STUDY BT015 PERFLUTREN (DEFINITY) VIAL,0.2,0.12,0.0464,4481.0,23 CDM,RX-4081031843,STUDY 24-1476 DEXTROSE 20% INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031844,STUDY V712-306 VITESSE DBV712 (VIASKIN) 250 MICROGRAM PATCH,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031845,STUDY CLINPRT-6 MBP091 (EAP) 50 MG/ML CONCENTRATE VIAL,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031857,STUDY DRI17476 FREXALIMAB/PLACEBO 150 MG/ML VIAL/SYRINGE,0.2,0.12,0.0464,4481.0,21 CDM,RX-4081031861,STUDY APL2-C3G-801 PEGCETACOPLAN 1080 MG/20 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031862,STUDY ISLEND-1 ISLATRAVIR (MK-8591) 2 MG / LENACAPAVIR (GS-6207-02) 300 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031863,STUDY ISLEND-1 ISLATRAVIR (MK-8591) 0.5 MG / LENACAPAVIR (GS-6207-02) 300 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031864,STUDY ISLEND-1 BICTEGRAVIR 50 MG / EMTRICITABINE 200 MG / TENOFOVIR 25 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031870,STUDY UNC IRB# 24-1715 ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031871,STUDY UNC IRB# 24-1715 PROGESTERONE MICRONIZED/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031872,STUDY RE104-201-PPD RE104 1.5 MG/0.05 ML / 30 MG/ML SUBCUTAENOUS INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031874,STUDY RE104-201-PPD ONDANSETRON 4 MG ODT,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031875,STUDY RE104-201-PPD RISPERIDONE 1 MG TABLET ODT,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031876,STUDY FMGX-CS-301 CASPOFUNGIN/PLACEBO 50 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031878,STUDY FMGX-CS-301 CASPOFUNGIN/PLACEBO 70 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031880,STUDY FMGX-CS-301 FOSMANOGEPIX/PLACEBO 400 MG TABLET,0.2,0.12,0.0464,4481.0,21 CDM,RX-4081031881,STUDY FMGX-CS-301 FLUCONAZOLE/PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031882,STUDY FMGX-CS-301 FOSMANOGEPIX/PLACEBO 20 MG/ML SOLUTION VIAL,0.2,0.12,0.0464,4481.0,21 CDM,RX-4081031885,STUDY ALAMERE SOLRIKITUG/PLACEBO 0/125/250/500 MG SUBCUTANEOUS INJECTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031886,STUDY ALAMERE SOLRIKITUG/PLACEBO 0/125/250/500 MG SUBCUTANEOUS INJECTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031887,STUDY ALAMERE SOLRIKITUG 250 MG SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031888,STUDY EAST-002 NECTERO EAST STABILIZER MIXTURE BOX,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031893,STUDY AK-US-001-0106 EFRUXIFERMIN/PLACEBO 50 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031894,STUDY NMD670-02-0002 NMD670/PLACEBO 100 MG OR 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031897,STUDY ION582-CS1 ION582 20 MG/15 ML INTRATHECAL INJECTION (21 ML DILUENT),0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031898,STUDY ION582-CS1 ION582 40 MG/15 ML INTRATHECAL INJECTION (21 ML DILUENT),0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031899,STUDY ION582-CS1 ION582 80 MG/15 ML INTRATHECAL INJECTION (21 ML DILUENT),0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031901,STUDY LCCC2425 MEMANTINE/PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031902,STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 125 MCG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031903,STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 63 MCG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031904,STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 94 MCG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031905,STUDY CHARGE BG9418 INTERFERON BETA-1A 30 MCG/0.5 ML (AVONEX) INTRAMUSCULAR PEN/SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-4081031906,STUDY CHARGE BG9418 INTERFERON BETA-1A (AVONEX) TITRATION DEVICE KIT,0.2,0.12,0.05544,4481.0,31 CDM,RX-4081031907,STUDY NMD670-02-0002 NMD670/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031908,STUDY NMD670-02-0002 NMD670/PLACEBO 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031919,STUDY PT-01 PEANUT SLIT-TABLET/PLACEBO,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031920,STUDY TN-31 ABROCITINIB/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031921,STUDY TN-31 RITLECITINIB/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031922,STUDY DS102A-10-RD2 EPELEUTON 500 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031927,STUDY PALV-10 IRB# 25-0413 PTX-022 (SIROLIMUS) 3.9% TOPICAL GEL W/W DISPENSER,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031929,STUDY D5180C00016 TEZEPELUMAB 110 MG/ML SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031930,STUDY PVT-2201-203 BREPOCITINIB/PLACEBO 0/15/45 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031931,STUDY RCT2100-101 RCT2100 5 MG/5 ML DISPERSION SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031936,STUDY RCT2100-101 RCT2100/PLACEBO 5 MG/5 ML DISPERSION SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031937,STUDY IRB# 24-2214 MIRIKIZUMAB-MRKZ 100 MG/ML PRE-FILLED SYRINGE/PEN,0.2,0.12,0.0506,7785.12,35 CDM,RX-4081031938,STUDY IRB# 24-2214 MIRIKIZUMAB-MRKZ 20 MG/ML VIAL,0.2,0.12,0.0506,7785.12,35 CDM,RX-4081031940,STUDY GB45429 GDC-6988/PLACEBO 7 MG CAPSULE FOR DPI INHALATION,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031944,STUDY OWED-T IRB 25-0864 OMALIZUMAB 150 MG SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,6119.61,35 CDM,RX-4081031945,STUDY OWED-T IRB 25-0864 OMALIZUMAB 150 MG/ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0506,6119.61,35 CDM,RX-4081031946,STUDY OWED-T IRB 25-0864 OMALIZUMAB 75 MG/0.5 ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0506,6119.61,35 CDM,RX-4081031948,STUDY B7981094 RITLECITINIB/PLACEBO 100 MG CAPSULE (WHITE LABEL),0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031949,STUDY B7981094 RITLECITINIB/PLACEBO 50 MG CAPSULE (YELLOW LABEL),0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031950,STUDY GB002-3102 SERALUTINIB 15 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031951,STUDY GB002-3102 DRY POWDER INHALER DEVICE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031953,STUDY R668-EGE-2213 IRB# 22-2246 DUPILUMAB 300 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-4081031954,STUDY M14-671 UPADACITINIB 0.5 MG/ML / 1.0 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031955,STUDY M14-671 UPADACITINIB 1.0 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031956,STUDY M14-671 UPADACITINIB ER 15 MG / 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031957,STUDY M14-671 UPADACITINIB ER 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031958,STUDY M14-671 UPADACITINIB ER 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031959,STUDY M14-671 UPADACITINIB ER 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031960,STUDY MIDAS MILRINONE/PLACEBO 1 MG/ML INTRAVENOUS SOLUTION VIAL,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031964,STUDY BUL-8/EEA BUDESONIDE/PLACEBO 1 MG/2 MG ORODISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031967,STUDY J4Z-MC-GIDI TIRZEPATIDE/PLACEBO 2.5 MG/5 MG/7.5 MG/10 MG/12.5 MG/15 MG PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031968,STUDY J4Z-MC-GIDI BIMAGRUMAB/PLACEBO 150 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031969,STUDY TAK-279-PSO-3004 ZASOCITINIB (TAK-279)/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031970,STUDY TAK-279-PSO-3004 DEUCRAVACITINIB/PLACEBO 6 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031971,STUDY ARGX-113-2315 EFGARTIGIMOD PH20/PLACEBO 200 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031972,STUDY ARGX-113-2315 EFGARTIGIMOD PH20 200 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031973,STUDY EIND 31920 PSA1/PSA16/AFR22/KEN13 BACTERIOPHAGE FOR INFUSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031982,STUDY MK8527-011 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG (EQ 245 MG TD) OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031983,STUDY MK8527-011 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (EQ 245 MG TD),0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031984,STUDY MK8527-011 MK-8527/PLACEBO 11 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031986,STUDY 20230151 AMG691/PLACEBO 140 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4081031987,STUDY 20230151 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION INHALER,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031988,STUDY 20230151 INHALATION SPACER,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081031989,STUDY U44-MNLT-01 MOON101 1 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031990,STUDY U44-MNLT-01 MOON101 10 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031991,STUDY U44-MNLT-01 MOON101 25 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031992,STUDY U44-MNLT-01 MOON101 50 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031993,STUDY U44-MNLT-01 MOON101 PLACEBO MN STAMP,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081031998,STUDY RUGONERSEN EAP/COMPASSIONATE USE PROGRAM RUGONERSEN 24 MG/ML INTRATHECAL INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-4081031999,STUDY TAK-881-3003 RHUPH20 SYRINGE FOR INFUSION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,44 CDM,RX-4081032000,STUDY TAK-881-3003 IGSC (TAK-881) 20% INFUSION SOLUTION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,44 CDM,RX-4081032001,STUDY TAK-881-3003 IGI (HYQVIA) 10% INFUSION SOLUTION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,44 CDM,RX-4081032002,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 0.75 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081032003,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 1.5 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081032004,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 3.0 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081032005,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 4.5 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 CDM,RX-4081032009,STUDY GB45429 SMART DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,24 CDM,RX-4081032011,STUDY TAK-881-3003 RHUPH20 SYRINGE FOR INFUSION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,44 CDM,RX-4081032012,STUDY TAK-881-3003 IGI (HYQVIA) 10% INFUSION SOLUTION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,44 CDM,RX-4081032013,STUDY TAK-881-3003 IGSC (TAK-881) 20% INFUSION SOLUTION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,44 CDM,RX-4081032018,STUDY IND 178958 CLOFAZIMINE 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408103481,STUDY FLOW/NN9535-4321 SEMAGLUTIDE 2 MG/1.5 ML OR PLACEBO SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,24 CDM,RX-408103507,STUDY ARGX-113-1802 EFGARTIGIMOD PH20/PLACEBO 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 CDM,RX-408103508,STUDY ARGX-113-1802 EFGARTIGIMOD PH20 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 CDM,RX-40810372,LABETALOL 5 MG/ML PEDIATRIC SYRINGE,75.95,45.57,0.765,4481.0,24 CDM,RX-408106783,FOSAPREPITANT 150 MG IN 0.9 % SODIUM CHLORIDE 100 ML IVPB PREMADE,145.75,87.45,0.225,4481.0,24 CDM,RX-408111,AMPICILLIN SODIUM 1 GRAM INJ SOLR IM,37.6,22.56,1.24,4481.0,24 CDM,RX-408112,AMPICILLIN SODIUM 2 GRAM INJ SOLR IM,43.75,26.25,1.24,4481.0,24 CDM,RX-408113,AMPICILLIN SODIUM 250 MG INJ SOLR IM,26.45,15.87,1.24,4481.0,24 CDM,RX-408114,AMPICILLIN SODIUM 500 MG INJ SOLR IM,27.0,16.2,1.24,4481.0,24 CDM,RX-408115,AMPICILLIN-SULBACTAM 1.5 GRAM INJ SOLR IM,31.2,18.72,3.13,4481.0,24 CDM,RX-408121968,STUDY D3258C00001 BENRALIZUMAB/PLACEBO 30 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408125480,"BUPIVACAINE (PF) 0.1 % (1,000 MCG/ML) IN 0.9% SODIUM CHLORIDE EPIDURAL",25.75,15.45,0.0225,4481.0,24 CDM,RX-40815001,STUDY LCCC2128-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408170,KETOROLAC 30 MG/ML INJECTION WRAPPER,38.25,22.95,0.2813,4481.0,34 CDM,RX-408173,SODIUM BICARBONATE 1 MEQ/ML (8.4 %) INJECTION (COMBINED) WRAPPER,77.35,46.41,17.95,4481.0,19 CDM,RX-4081751968,STUDY IRB# 22-1421 PSILOCYBIN 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408177077,ORAL HUMAN IMMUNE GLOBULIN FOR NOROVIRUS (OFF-LABEL USE),1468.0,880.8,49.22,7707.21,105 CDM,RX-408180,NXSTAGE RFP 400 (+/- BB) - CONTAINS 2 MEQ/L POTASSIUM,243.0,145.8,56.38,4481.0,19 CDM,RX-408186,NXSTAGE RFP 404 - CONTAINS 4 MEQ/L POTASSIUM,243.0,145.8,56.38,4481.0,19 CDM,RX-408188,SODIUM CITRATE 4 % (5 ML) INTRA-CATHETER INJECTION SYRINGE,22.65,13.59,5.25,4481.0,19 CDM,RX-408189,"GENTAMICIN 1 MG/ML, SODIUM CITRATE 4% (2.4 ML) INTRA-CATHETER SYRINGE",23.2,13.92,5.38,4481.0,19 CDM,RX-408191968,STUDY D3258C00001 BENRALIZUMAB 30 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-40819636,PHENYLEPHRINE 10 % EYE DROPS (MULTI-PATIENT),17.0,10.2,3.94,4481.0,19 CDM,RX-408202,HYDROMORPHONE 1 MG/ML INJECTION WRAPPER,29.85,17.91,0.2025,4481.0,24 CDM,RX-4082025,CYCLOPENTOLATE 1 % EYE DROPS (MULTI-PATIENT),17.75,10.65,4.12,4481.0,19 CDM,RX-408204,BICTEGRAVIR 50 MG-EMTRICITABINE 200 MG-TENOFOVIR ALAFENAM 25 MG TABLET,437.65,262.59,101.53,4481.0,19 CDM,RX-40821435,STUDY M20-356 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 CDM,RX-408219231,PROMETHAZINE 12.5 MG IN NS 50 ML IVPB PREMADE,100.0,60.0,6.64,4481.0,24 CDM,RX-408219241,ACETYLCYSTEINE 10% (100 MG/ML) OPHTHALMIC SOLUTION,259.65,155.79,60.24,4481.0,19 CDM,RX-408221968,STUDY 21177 FINERENONE 10 MG / 20 MG / PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-4082401968,STUDY D9090C00008 AZD5462 20 MG/40 MG/180 MG/PLACEBO TABLET (WHITE LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-4082411968,STUDY D9090C00008 AZD5462 20 MG/40 MG/180 MG/PLACEBO TABLET (BLUE LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-4082641968,STUDY IRB# 24-2210 AZITHROMYCIN/PLACEBO IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40827284,NAFCILLIN 1 GRAM INJ SOLR IM,101.3,60.78,0.1125,4481.0,24 CDM,RX-40827285,NAFCILLIN 2 GRAM INJ SOLR IM,134.95,80.97,0.1125,4481.0,24 CDM,RX-408291968,STUDY RTRX-RE021-201 SPARSENTAN 80 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408320001,NXSTAGE RFP 453 - CONTAINS POTASSIUM 2 MEQ/L (CALCIUM FREE),291.6,174.96,67.65,4481.0,19 CDM,RX-408320002,NXSTAGE RFP 454 - CONTAINS POTASSIUM 4 MEQ/L (CALCIUM FREE),291.6,174.96,67.65,4481.0,19 CDM,RX-408371968,STUDY TPN-101-C9-201 TPN-101/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408381968,STUDY TPN-101-C9-201 TPN-101 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408400021,MAGNESIUM SULFATE 4 MEQ/ML (50 %) INJECTION WRAPPER,24.9,14.94,1.08,4481.0,24 CDM,RX-4084000855,"BACITRACIN 500 UNIT-POLYMYXIN B 10,000 UNIT/GRAM TOPICAL OINTMENT (+/- ZINC) WRAPPER",7.1,4.26,1.65,4481.0,19 CDM,RX-40840026,PROPOFOL INFUSION 10 MG/ML,161.1,96.66,0.2025,4481.0,24 CDM,RX-40840050,TACROLIMUS 1 MG/ML ORAL SUSPENSION,405.05,243.03,0.3825,4481.0,24 CDM,RX-40840076,BUSULFAN 2MG/ML ORAL SUSPENSION,1337.0,802.2,81.68,4481.0,35 CDM,RX-40840080,ACETAZOLAMIDE 25 MG/ML ORAL SUSPENSION,155.0,93.0,35.96,4481.0,19 CDM,RX-40840081,ALLOPURINOL 20MG/ML ORAL SUSPENSION,18.55,11.13,4.3,4481.0,19 CDM,RX-40840082,AMIODARONE 5 MG/ML ORAL SUSPENSION,23.2,13.92,5.38,4481.0,19 CDM,RX-40840083,AMILORIDE 1 MG/ML ORAL SUSPENSION,24.4,14.64,5.66,4481.0,19 CDM,RX-40840085,AMITRIPTYLINE 1 MG/ML ORAL SUSPENSION,18.4,11.04,4.27,4481.0,19 CDM,RX-40840087,AZATHIOPRINE 50 MG/ML ORAL SUSPENSION,520.0,312.0,0.135,4481.0,24 CDM,RX-40840089,BETHANECHOL 1 MG/ML ORAL SUSPENSION,25.0,15.0,5.8,4481.0,19 CDM,RX-40840092,CARVEDILOL 1.67 MG/ML ORAL SUSP,23.2,13.92,5.38,4481.0,19 CDM,RX-40840093,CINACALCET 1 MG/ML ORAL SUSP,76.3,45.78,17.7,4481.0,19 CDM,RX-40840095,CLONAZEPAM 0.1 MG/ML ORAL SUSP,22.15,13.29,5.14,4481.0,19 CDM,RX-40840098,DAPSONE 2 MG/ML ORAL SUSP,79.0,47.4,18.33,4481.0,19 CDM,RX-40840099,DESMOPRESSIN 10 MCG/ML ORAL SOLN,1673.2,1003.92,388.18,4481.0,19 CDM,RX-40840100,DILTIAZEM 12 MG/ML ORAL SUSP,102.4,61.44,23.76,4481.0,19 CDM,RX-40840101,DIPYRIDAMOLE 10 MG/ML ORAL SUSP,149.2,89.52,34.61,4481.0,19 CDM,RX-40840105,FOLIC ACID 1 MG/ML ORAL SOLN,70.3,42.18,16.31,4481.0,19 CDM,RX-40840107,HYDRALAZINE 4 MG/ML ORAL SOLN,803.5,482.1,186.41,4481.0,19 CDM,RX-408401083,DIGOXIN 25 MCG/ML NEONATAL DILUTION,65.5,39.3,10.89,4481.0,24 CDM,RX-40840109,HYDROXYCHLOROQUINE 25 MG/ML ORAL SUSP,64.9,38.94,15.06,4481.0,19 CDM,RX-40840110,HYDROXYUREA 100 MG/ML ORAL SUSP,511.0,306.6,118.55,4481.0,19 CDM,RX-40840111,KETOCONAZOLE 20 MG/ML ORAL SUSP,19.0,11.4,4.41,4481.0,19 CDM,RX-40840112,LABETALOL 40 MG/ML ORAL SUSP,25.0,15.0,5.8,4481.0,19 CDM,RX-40840113,LAMOTRIGINE 1 MG/ML ORAL SOLN,19.0,11.4,4.41,4481.0,19 CDM,RX-40840115,LOSARTAN 2.5 MG/ML ORAL SUSP,70.0,42.0,16.24,4481.0,19 CDM,RX-40840120,METOLAZONE 1 MG/ML ORAL SUSP,34.0,20.4,7.89,4481.0,19 CDM,RX-40840121,METOPROLOL TARTRATE 10 MG/ML ORAL SOLN,59.2,35.52,13.73,4481.0,19 CDM,RX-40840122,METRONIDAZOLE 50 MG/ML ORAL SUSP,79.05,47.43,18.34,4481.0,19 CDM,RX-40840123,MEXILETINE 10 MG/ML ORAL SUSP,52.0,31.2,12.06,4481.0,19 CDM,RX-40840125,PHENAZOPYRIDINE 10 MG/ML ORAL SUSP,3.0,1.8,0.696,4481.0,19 CDM,RX-40840126,POTASSIUM PHOSPHATE 3 MMOL/ML ORAL SOLN,19.45,11.67,4.51,4481.0,19 CDM,RX-40840128,PROPAFENONE 20 MG/ML ORAL SUSP,3.0,1.8,0.696,4481.0,19 CDM,RX-40840129,PROPYLTHIOURACIL 5 MG/ML ORAL SUSP,92.2,55.32,21.39,4481.0,19 CDM,RX-40840130,PYRAZINAMIDE 100 MG/ML ORAL SUSP,7.3,4.38,1.69,4481.0,19 CDM,RX-40840134,SELENIUM 60 MCG/ML ORAL SOLN,51.0,30.6,11.83,4481.0,19 CDM,RX-40840135,SEVELAMER 50 MG/ML ORAL SOLN,376.0,225.6,87.23,4481.0,19 CDM,RX-40840137,SODIUM ACETATE 2 MEQ/ML ORAL SOLN,16.1,9.66,3.74,4481.0,19 CDM,RX-40840139,SODIUM BENZOATE 166.6 MG/ML ORAL SOLN,301.0,180.6,69.83,4481.0,19 CDM,RX-40840140,SODIUM BICARBONATE 1 MEQ/ML ORAL SOLN,3.0,1.8,0.696,4481.0,19 CDM,RX-40840141,SODIUM CHLORIDE 4 MEQ/ML ORAL SOLN,16.45,9.87,3.82,4481.0,19 CDM,RX-40840142,SODIUM PHENYLBUTYRATE 100 MG/ML ORAL SOLN,980.5,588.3,227.48,4481.0,19 CDM,RX-40840151,THIOGUANINE 20 MG/ML ORAL SUSP,32.85,19.71,7.62,4481.0,19 CDM,RX-40840155,ZINC ACETATE 10 MG ELEMENTAL ZINC/ML ORAL SOLN,1.05,0.63,0.2436,4481.0,19 CDM,RX-40840171,CIDOFOVIR 1% TOPICAL GEL,289.15,173.49,67.08,4481.0,19 CDM,RX-40840179,LCD 10% IN AQUAPHOR,306.25,183.75,71.05,4481.0,19 CDM,RX-40840181,LCD-SALICYLIC ACID 10%-2% IN UNIBASE/AQUAPHOR,37.4,22.44,8.68,4481.0,19 CDM,RX-40840182,LEECH,66.35,39.81,15.39,4481.0,19 CDM,RX-40840187,SILVER SULFADIAZINE-NYSTATIN-BACITRACIN TOPICAL CREAM,88.5,53.1,20.53,4481.0,19 CDM,RX-40840188,SILVER SULFADIAZINE-NYSTATIN TOPICAL CREAM,303.95,182.37,70.52,4481.0,19 CDM,RX-40840195,TRIAMCINOLONE 0.05% IN MODIFIED EUCERIN CREAM,115.75,69.45,26.85,4481.0,19 CDM,RX-40840215,PANTOPRAZOLE 2 MG/ML ORAL SUSPENSION,77.8,46.68,18.05,4481.0,19 CDM,RX-40840228,NXSTAGE/MULTIBIC RFP 401 (+/- BB) - CONTAINS 4 MEQ/L POTASSIUM,291.6,174.96,67.65,4481.0,19 CDM,RX-40840229,NXSTAGE RFP 402 - CONTAINS NO POTASSIUM,243.0,145.8,56.38,4481.0,19 CDM,RX-40840278,DEXTROSE 5 % IN WATER (D5W) IV EXCEL,70.35,42.21,16.32,4481.0,17 CDM,RX-40840303,AMIKACIN 2% OPHTHALMIC SOLN,40.15,24.09,1.42,4481.0,24 CDM,RX-40840306,AMPHOTERICIN B 0.15% OPHTHALMIC SOLN,113.5,68.1,26.33,4481.0,24 CDM,RX-40840307,AMPHOTERICIN B 0.3% OPHTHALMIC SOLN,28.65,17.19,6.65,4481.0,24 CDM,RX-40840309,AZATHIOPRINE 25 MG SPLIT TAB,17.05,10.23,0.135,4481.0,24 CDM,RX-40840313,GENTAMICIN 2% OPHTHALMIC SOLN,22.0,13.2,4.97,4481.0,24 CDM,RX-40840316,BLOOD CARDIO - COLD INDUCTION,134.95,80.97,31.31,4481.0,19 CDM,RX-40840317,BLOOD CARDIO. - MAINTENANCE,240.6,144.36,55.82,4481.0,19 CDM,RX-40840318,BLOOD CARDIO. - REPERFUSION,517.55,310.53,120.07,4481.0,19 CDM,RX-40840322,CEFTAZIDIME (FORTAZ) 10 MG/0.5 ML INTRAOCULAR SYRINGE,63.05,37.83,3.53,4481.0,24 CDM,RX-40840323,CLINDAMYCIN 0.9 MG/ML ORAL IRRIGATION,79.45,47.67,18.43,4481.0,19 CDM,RX-40840325,COSYNTROPIN 2.5 MCG/ML DILUTION INJECTION,63.8,38.28,14.8,4481.0,24 CDM,RX-40840341,MERCAPTOPURINE 25 MG SPLIT TAB,25.55,15.33,5.93,4481.0,19 CDM,RX-40840350,HYDROCHLORIC ACID 0.2N SOLUTION,108.4,65.04,25.15,4481.0,19 CDM,RX-40840372,SODIUM CHLORIDE 0.9% NON-PVC,72.75,43.650000000000006,2.83,4481.0,42 CDM,RX-40840379,VANCOMYCIN 5% OPHTHALMIC SOLN,31.5,18.9,0.0675,4481.0,24 CDM,RX-40840382,VORICONAZOLE 1% OPHTHALMIC SOLN,3.0,1.8,0.696,4481.0,24 CDM,RX-40840383,WARFARIN 0.5 MG SPLIT TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-40840385,TOBRAMYCIN 1.4% OPHTHALMIC SOLN,116.65,69.99,27.06,4481.0,19 CDM,RX-40840389,MORPHINE 10 MG/ML INJ COMBINED WRAPPER,25.85,15.51,4.91,4481.0,24 CDM,RX-40840408,DIPHENHYDRAMINE 50 MG VIAL/SYRINGE WRAPPER,17.15,10.29,1.71,4481.0,24 CDM,RX-40840439,CIPROFLOXACIN DESENSITIZATION 0.1 MG/ML,63.0,37.8,6.32,4481.0,24 CDM,RX-40840440,CIPROFLOXACIN DESENSITIZATION 1 MG/ML,63.0,37.8,6.32,4481.0,24 CDM,RX-40840441,CIPROFLOXACIN DESENSITIZATION 2MG/ML,114.7,68.82,6.32,4481.0,24 CDM,RX-40840446,COLISTIMETHATE DESENSITIZATION 10 MG/ML,97.8,58.68,22.69,4481.0,24 CDM,RX-40840450,COLISTIMETHATE DESENSITIZATION 0.1 MG/ML,63.0,37.8,14.62,4481.0,24 CDM,RX-40840452,COLISTIMETHATE DESENSITIZATION 0.01 MG/ML,63.0,37.8,14.62,4481.0,24 CDM,RX-40840454,COLISTIMETHATE DESENSITIZATION 0.001 MG/ML,63.0,37.8,14.62,4481.0,24 CDM,RX-40840479,HEPARIN 500 UNITS IN 500 ML NS (FOR VASCULAR SERVICE),87.55,52.53,0.4725,4481.0,24 CDM,RX-40840554,AMPICILLIN (0.001 MG/ML) DESENSITIZATION DILUTION,63.05,37.83,1.24,4481.0,24 CDM,RX-40840555,AMPICILLIN (0.01 MG/ML) DESENSITIZATION DILUTION,63.05,37.83,1.24,4481.0,24 CDM,RX-40840556,AMPICILLIN (0.1 MG/ML) DESENSITIZATION DILUTION,63.05,37.83,1.24,4481.0,24 CDM,RX-40840557,AMPICILLIN (1 MG/ML) DESENSITIZATION DILUTION,63.2,37.92,1.24,4481.0,24 CDM,RX-40840558,AMPICILLIN (10 MG/ML) DESENSITIZATION DILUTION,64.8,38.88,1.24,4481.0,24 CDM,RX-40840572,CEFAZOLIN DESENSITIZATION 0.001 MG/ML,63.0,37.8,1.8,4481.0,24 CDM,RX-40840574,CEFAZOLIN DESENSITIZATION 0.01 MG/ML,63.0,37.8,1.8,4481.0,24 CDM,RX-40840576,CEFAZOLIN DESENSITIZATION 0.1 MG/ML,63.0,37.8,1.8,4481.0,24 CDM,RX-40840578,CEFAZOLIN DESENSITIZATION 1 MG/ML,16.0,9.6,1.8,4481.0,24 CDM,RX-40840580,CEFAZOLIN DESENSITIZATION 10 MG/ML,63.0,37.8,1.8,4481.0,24 CDM,RX-40840583,CEFAZOLIN DESENSITIZATION 100 MG/ML,65.45,39.27,1.8,4481.0,24 CDM,RX-40840591,CITRULLINE 5 GRAM POWDER FOR ORAL SOLN,1.1,0.66,0.2552,4481.0,19 CDM,RX-40840592,DEXAMETHASONE 1 MG/ML SYRUP WITHOUT ALCOHOL,318.4,191.04,73.87,4481.0,19 CDM,RX-40840593,LACTULOSE ENEMA 200 G/300 ML,78.7,47.22,18.26,4481.0,19 CDM,RX-40840595,ARGININE (L) 5 GRAM POWDER (100 MG/ML) FOR ORAL SOLN,23.35,14.01,5.42,4481.0,19 CDM,RX-40840621,HYDROMORPHONE 500MG/50 ML (10MG/ML) PCA CADD,283.9,170.34,0.2025,4481.0,24 CDM,RX-40840654,NEONATAL AA 2.5%/HEPARIN 0.5 UNIT/ML DEXTROSE 10% WATER,539.25,323.55,125.11,4481.0,19 CDM,RX-40840656,NEONATAL AA ISOTONIC 3.6%/HEPARIN 1 UNIT/ML,118.65,71.19,27.53,4481.0,19 CDM,RX-40840657,SODIUM PHOSPHATE 3 MMOL/ML ORAL SOLUTION,19.6,11.76,4.13,4481.0,38 CDM,RX-40840661,MUPIROCIN 440 MG/1000 ML NASAL IRRIGATION,16.95,10.17,3.93,4481.0,19 CDM,RX-40840663,NIFEDIPINE 0.3%-LIDOCAINE 1.5% IN PETROLATUM,40.8,24.48,9.47,4481.0,19 CDM,RX-40840701,SELENIUM 10 MCG/ML DILUTION,292.6,175.56,67.88,4481.0,19 CDM,RX-40840702,IRON DEXTRAN 2.5 MG/ML DILUTION,718.0,430.8,17.57,4517.31,35 CDM,RX-40840739,PHENYLEPHRINE (PITKIN) 10 MG IN LR 1000 ML IRRIGATION,69.55,41.73,0.0225,4481.0,24 CDM,RX-40840762,CEFAZOLIN (ANCEF) 100 MG/ML SYRINGE (PEDIATRIC),65.25,39.15,1.8,4481.0,24 CDM,RX-40840763,CEFUROXIME (ZINACEF) 90 MG/ML SYRINGE (PEDIATRIC),82.15,49.29,4.16,4481.0,24 CDM,RX-40840766,LINEZOLID 2 MG/ML IV PEDIATRIC,252.35,151.41,8.03,4481.0,24 CDM,RX-40840780,FAMOTIDINE 10 MG/ML INJ SOLUTION (MULTI-VIAL SIZE),64.5,38.7,0.0225,4481.0,72 CDM,RX-40840781,"HEPARIN (PORCINE) 5,000 UNIT/ML INJ SOLUTION (MULTI-VIAL SIZE WRAPPER)",26.25,15.75,0.4725,4481.0,48 CDM,RX-40840788,SODIUM BICARBONATE 1 MEQ/ML INJ SOLUTION WRAPPER (MULTI-VIAL SIZE),77.35,46.41,17.95,4481.0,19 CDM,RX-40840789,NALOXONE 0.4 MG/ML INJ SOLUTION (COMBINED) WRAPPER,55.0,33.0,0.18,4481.0,24 CDM,RX-40840790,PHYTONADIONE 1 MG/0.5 ML INJ SOLUTION (MULTI-VIAL SIZE),112.45,67.47,6.14,4481.0,23 CDM,RX-408408100,FAT EMULSION SMOFLIPID 20 % INFUSION 8 ML SYRINGE (PEDS),19.6,11.76,4.55,4481.0,19 CDM,RX-408408101,FAT EMULSION SMOFLIPID 20 % INFUSION 24 ML SYRINGE (PEDS),26.7,16.02,6.19,4481.0,19 CDM,RX-408408102,FAT EMULSION SMOFLIPID 20 % INFUSION 50 ML SYRINGE (PEDS),38.25,22.95,8.87,4481.0,19 CDM,RX-408408103,FAT EMULSION SMOFLIPID 20 % (500 ML) INFUSION,171.6,102.96,39.81,4481.0,19 CDM,RX-408408104,FAT EMULSION SMOFLIPID 20 % (750 ML) INFUSION,280.2,168.12,39.81,4481.0,38 CDM,RX-408408105,FAT EMULSION SMOFLIPID 20 % (1000 ML) INFUSION,334.475,200.685,39.81,4481.0,38 CDM,RX-408408123,KETAMINE 50 MG/ML ORAL SOLUTION,26.825000000000003,16.095,5.36,4481.0,38 CDM,RX-408408129,PROMETHAZINE 1 MG/ML PEDIATRIC DILUTION INJECTION (20 MIN),21.8,13.08,5.06,4481.0,24 CDM,RX-408408130,HYDRALAZINE 20 MG/ML IV,798.75,479.25,12.6,4481.0,24 CDM,RX-408408131,KETOROLAC 15 MG/ML IV PEDIATRIC,75.3,45.18,0.2813,4481.0,34 CDM,RX-408408138,IMIPENEM-CILASTATIN FOR INHALATION,161.05,96.63,18.98,4481.0,24 CDM,RX-408408140,PANTOPRAZOLE 4 MG/ML NS PEDIATRIC INJECTION,66.1,39.66,15.34,4481.0,19 CDM,RX-408408141,PANTOPRAZOLE 40 MG/50 ML NS PEDIATRIC INFUSION,81.5,48.9,18.91,4481.0,19 CDM,RX-408408142,PANTOPRAZOLE 80 MG/100 ML NS PEDIATRIC DILUTION,100.0,60.0,23.2,4481.0,19 CDM,RX-408408144,AMPICILLIN-SULBACTAM 1.5 GRAM MBP/ADV WRAPPER,46.1,27.66,3.13,4481.0,24 CDM,RX-408408145,HYDROMORPHONE (PF) 10 MG/ML INJECTION SOLUTION FOR PEDS PCA COMPONENT,50.4,30.24,0.2025,4481.0,72 CDM,RX-408408146,FLUCYTOSINE 50 MG/ML ORAL SUSPENSION,2881.25,1728.75,668.45,4481.0,19 CDM,RX-408408147,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 50 ML INFUSION (PEDS),302.9,181.74,70.27,4481.0,19 CDM,RX-408408151,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 200 ML INFUSION (PEDS),747.75,448.65,173.48,4481.0,19 CDM,RX-408408152,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 300 ML INFUSION (PEDS),1090.15,654.09,252.91,4481.0,19 CDM,RX-408408154,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 400 ML INFUSION (PEDS),1432.5,859.5,332.34,4481.0,19 CDM,RX-408408155,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 500 ML INFUSION (PEDS),1774.85,1064.91,411.77,4481.0,19 CDM,RX-408408181,FENTANYL 50 MCG/ML INTRANASAL SOLUTION,32.3,19.38,2.48,4481.0,120 CDM,RX-408408256,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION WRAPPER FOR MI,32375.35,19425.21,167.05,28007.92,35 CDM,RX-408408257,GENTAMICIN 40 MG/ML INJ SOLN FOR ORAL USE,116.0,69.6,4.97,4481.0,24 CDM,RX-408408259,LEUCOVORIN CALCIUM 100 MG SOLN FOR INJ (10 MG/ML),94.0,56.4,7.25,4481.0,24 CDM,RX-408408261,LEUCOVORIN CALCIUM 200 MG SOLN FOR INJ (10 MG/ML),407.4,244.44,7.25,4481.0,24 CDM,RX-408408264,CISATRACURIUM 2 MG/ML PEDIATRIC INFUSION (CSAC),473.2,283.92,109.78,4481.0,19 CDM,RX-40840829,DOPAMINE 1600 MCG/ML IN DEXTROSE 5% 4 ML PEDIATRIC,63.65,38.19,1.8,4481.0,24 CDM,RX-40840830,DOPAMINE 1600 MCG/ML IN DEXTROSE 5% 8 ML PEDIATRIC,64.25,38.55,1.8,4481.0,24 CDM,RX-40840831,DOPAMINE 1600 MCG/ML IN DEXTROSE 5% 50 ML PEDIATRIC,70.55,42.33,1.8,4481.0,24 CDM,RX-40840834,LIDOCAINE (PF) 8 MG/ML IN DEXTROSE 5% 50 ML PEDIATRIC INFUSION,64.5,38.7,0.0225,4481.0,24 CDM,RX-408408365,ALKALINE SALINE 2% MOUTH RINSE,1.1,0.6599999999999999,0.2436,4481.0,38 CDM,RX-408408369,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 2 ML,159.8,95.88,37.07,4481.0,19 CDM,RX-40840837,HEPARIN 100 UNITS/ML IN SODIUM CHLORIDE 0.45% 50 ML PEDIATRIC,72.35,43.41,0.4725,4481.0,24 CDM,RX-408408372,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 8 ML,450.2,270.12,104.45,4481.0,19 CDM,RX-408408374,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 50 ML,2482.8,1489.68,576.01,4481.0,19 CDM,RX-408408380,SILDENAFIL PEDIATRIC LOADING DOSE INFUSION,667.95,400.77,154.96,4481.0,19 CDM,RX-408408382,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION WRAPPER,87.95,52.77,14.01,4481.0,57 CDM,RX-408408383,KETOROLAC 15 MG/ML INJECTION SOLUTION WRAPPER,30.65,18.39,0.2813,4481.0,34 CDM,RX-408408386,SODIUM BICARBONATE 0.5 MEQ/ML INJ SOLUTION (PEDIATRIC),239.75,143.85,55.62,4481.0,19 CDM,RX-408408389,CEFTRIAXONE IM PEDIATRIC SYRINGE,72.5,43.5,0.9675,4481.0,24 CDM,RX-40840840,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) PEDIATRIC 10 ML INFUSION,123.7,74.22,0.0675,4481.0,24 CDM,RX-40840841,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) PEDIATRIC 30 ML INFUSION,245.0,147.0,0.0675,4481.0,24 CDM,RX-408408414,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 4 ML,66.4,39.84,15.4,4481.0,19 CDM,RX-40840842,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) 50 ML PEDIATRIC INFUSION,366.3,219.78,0.0675,4481.0,24 CDM,RX-408408422,VANCOMYCIN-HEPARIN (2.5 MG-10 UNITS/ML) IN NS NEONATAL LOCK SOLUTION,63.25,37.95,0.0675,4481.0,24 CDM,RX-408408425,DEXMEDETOMIDINE 8 MCG/ 2 ML (4 MCG/ML) NS PEDIATRIC INFUSION,66.7,40.02,15.47,4481.0,19 CDM,RX-408408429,CEFTOLOZANE-TAZOBACTAM (20 MG OF CEFTOLOZANE/ML) PEDIATRIC INJECTION,471.75,283.05,109.45,4481.0,26 CDM,RX-408408444,PENTOBARBITAL 50MG/ML PEDIATRIC INFUSION 10 ML,1843.4,1106.04,121.21,4481.0,24 CDM,RX-408408486,SOMATROPIN (1 MG/ML) SUBCUTANEOUS PEDIATRIC DILUTION,252.7,151.62,47.45,4481.0,35 CDM,RX-408408488,DEXTROSE 20 % IN WATER (FOR ORAL USE) INTRAVENOUS SOLUTION,24.35,14.61,5.65,4481.0,17 CDM,RX-40840849,MILRINONE 200 MCG/ML IN DEXTROSE 5% 8 ML PEDIATRIC,67.2,40.32,3.26,4481.0,24 CDM,RX-40840850,MILRINONE 200 MCG/ML IN DEXTROSE 5% 50 ML PEDIATRIC,89.2,53.52,3.26,4481.0,24 CDM,RX-408408555,MORPHINE (PF) 0.5 MG/ML INJECTION SOLUTION WRAPPER,28.4,17.04,5.51,4481.0,72 CDM,RX-408408571,GLYBURIDE 1 MG/ML ORAL SUSPENSION,20.8,12.48,4.83,4481.0,19 CDM,RX-408408595,HYDROMORPHONE (PF) 10 MG/50 ML (0.2 MG/ML) IN NS IV PEDIATRIC SYRINGE,48.55,29.13,11.26,4481.0,25 CDM,RX-40840865,NITROGLYCERIN 400MCG/ML IN D5W 8 ML PEDIATRIC INFUSION,65.6,39.36,3.35,4481.0,24 CDM,RX-40840866,NITROGLYCERIN 400MCG/ML IN D5W 50ML PEDIATRIC INFUSIO,79.05,47.43,3.35,4481.0,24 CDM,RX-40840871,PENTOBARBITAL 50MG/ML PEDIATRIC INFUSION 100 ML,13609.15,8165.49,121.21,11773.28,24 CDM,RX-40840873,ROCURONIUM 10 MG/ML PEDIATRIC INFUSION 4 ML,72.75,43.65,16.88,4481.0,19 CDM,RX-40840874,ROCURONIUM 10 MG/ML PEDIATRIC INFUSION 8 ML,82.45,49.47,19.13,4481.0,19 CDM,RX-40840875,ROCURONIUM 10 MG/ML PEDIATRIC INFUSION 50 ML,184.5,110.7,42.8,4481.0,19 CDM,RX-40840878,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 40ML,96.9,58.14,22.48,4481.0,19 CDM,RX-40840879,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSON 100ML,147.7,88.62,34.27,4481.0,19 CDM,RX-40840884,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 50ML INFUSION,94.9,56.94,22.02,4481.0,19 CDM,RX-40840885,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 200ML INFUSION,190.55,114.33,44.21,4481.0,19 CDM,RX-40840889,INSULIN REGULAR HUMAN 100 UNIT/ML INJECTION (IV USE),208.9,125.34,0.5175,4481.0,24 CDM,RX-40840890,FAMOTIDINE 2 MG/ML PEDIATRIC DILUTION,147.05,88.23,0.0225,4481.0,24 CDM,RX-40840892,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 100 ML INFUSION,126.8,76.08,29.42,4481.0,19 CDM,RX-40840895,LEVOFLOXACIN 5 MG/ML IN 5 % DEXTROSE PEDIATRIC,76.75,46.05,5.33,4481.0,24 CDM,RX-40840896,METRONIDAZOLE 5 MG/ML IN SODIUM CHLORIDE (ODD DOSE),71.05,42.63,0.0675,4481.0,24 CDM,RX-40841007,CEFOTAXIME 100 MG/ML IV PEDIATRIC,77.75,46.65,18.04,4481.0,24 CDM,RX-40841008,CEFOXITIN 100 MG/ML SYRINGE PEDIATRIC,108.65,65.19,10.76,4481.0,24 CDM,RX-40841010,CEFEPIME 40 MG/ML PEDIATRIC DILUTION,386.75,232.05,2.75,4481.0,24 CDM,RX-40841015,CLINDAMYCIN 18 MG/ML SYRINGE PEDIATRIC,105.7,63.42,4.12,4481.0,24 CDM,RX-40841017,MEROPENEM 20 MG/ML PEDIATRIC DILUTION,455.4,273.24,0.945,4481.0,24 CDM,RX-40841018,MEROPENEM 50 MG/ML PEDIATRIC IV,82.3,49.38,0.945,4481.0,24 CDM,RX-40841026,GLUCAGON 1 MG SOLUTION FOR INJECTION (COMBINED VIALS) WRAPPER,1001.5,600.9,144.52,4481.0,35 CDM,RX-40841027,CEFUROXIME 1.5 GRAM (COMBINED) INJECTION WRAPPER,38.8,23.28,4.16,4481.0,24 CDM,RX-40841043,POTASSIUM CHLORIDE 0.1 MEQ/ML (PERIPHERAL LINE) IV PEDIATRIC,79.05,47.43,0.2475,4481.0,21 CDM,RX-40841044,POTASSIUM CHLORIDE 0.2 MEQ/ML (CENTRAL LINE) IV PEDIATRIC,71.85,43.11,0.2475,4481.0,24 CDM,RX-40841048,AMINOPHYLLINE 25 MG/ML PEDIATRIC INJECTION,105.1,63.06,22.61,4481.0,24 CDM,RX-40841053,LEVETIRACETAM 10 MG/ML IV PEDIATRIC,133.35,80.01,0.09,4481.0,24 CDM,RX-40841056,CEFTRIAXONE 40 MG/ML PEDIATRIC DILUTION,189.55,113.73,0.9675,4481.0,24 CDM,RX-40841057,VANCOMYCIN 5 MG/ML PEDIATRIC DILUTION,412.9,247.74,0.0675,4481.0,24 CDM,RX-40841058,VANCOMYCIN 10 MG/ML (CENTRAL) PEDIATRIC DILUTION,762.8,457.68,0.0675,4481.0,24 CDM,RX-40841059,GENTAMICIN SULFATE 10 MG/ML PEDIATRIC DILUTION,99.65,59.79,4.97,4481.0,24 CDM,RX-40841061,CYCLOSPORINE 1 MG/ML NS AVIVA INFUSION,88.05,52.83,20.43,10791.27,24 CDM,RX-40841062,ARGININE HCL (L-ARGININE) 0.1 G/ML (METABOLIC DIS) INFUSION,200.35,120.21,46.48,4481.0,19 CDM,RX-40841066,CYCLOSPORINE 1 MG/ML NS AVIVA IV,193.8,116.28,44.96,10791.27,24 CDM,RX-40841070,HYDROCORTISONE SOD SUCCINATE (PF) 50 MG/ML PEDIATRIC,90.7,54.42,21.04,4481.0,24 CDM,RX-40841071,METHYLPREDNISOLONE SOD SUCC 62.5 MG/ML IV PEDIATRIC,206.85,124.11,0.2037,4481.0,35 CDM,RX-40841077,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) IV PEDIATRIC,104.3,62.58,0.0675,4481.0,24 CDM,RX-40841084,HYDRALAZINE 0.5 MG/ML PEDIATRIC DILUTION,70.375,42.225,12.6,4481.0,48 CDM,RX-40841087,TERBUTALINE (BRETHINE) 16 MG/16 ML PEDIATRIC INFUSION,1093.75,656.25,7.46,4481.0,24 CDM,RX-40841089,CHLOROTHIAZIDE SODIUM 28 MG/ML (PEDIATRIC),389.4,233.64,88.76,4481.0,24 CDM,RX-40841123,ARGATROBAN 20 MG/20 ML (1 MG/ML) PEDIATRIC SYRINGE,359.95,215.97,0.776,4481.0,35 CDM,RX-40841124,ARGATROBAN 50 MG/50 ML (1 MG/ML) PEDIATRIC SYRINGE,805.3,483.18,0.776,4481.0,35 CDM,RX-40841126,TACROLIMUS INFUSION 0.01 MG/ML (50 ML SYRINGE),236.35,141.81,59.8,4481.0,35 CDM,RX-40841127,CALCIUM GLUCONATE (PICU-UNC) 100 MG/ML PEDIATRIC BOLUS,95.8,57.48,0.09,4481.0,24 CDM,RX-40841131,ACHS(CASH) OTIC INSUFFLATE CAPSULE,194.65,116.79,45.16,4481.0,19 CDM,RX-40841132,GENTAMICIN 30 MG/ML BUFFERED STERILE SOLUTION (ENT),101.1,60.66,23.46,4481.0,19 CDM,RX-40841133,TOLUIDINE BLUE 1 % SOLUTION,24.35,14.61,5.65,4481.0,19 CDM,RX-40841136,TRICHLOROACETIC ACID 40% (W/V) TOPICAL SOLUTION,21.3,12.78,4.94,4481.0,19 CDM,RX-40841137,ARGININE HCL (L-ARGININE) 0.1 G/ML (METABOLIC DIS) BOLUS,223.05,133.83,51.75,4481.0,19 CDM,RX-40841140,ENOXAPARIN 20 MG/ML DILUTION PEDIATRIC INJECTION,107.8,64.68,1.33,4481.0,24 CDM,RX-40841151,PHENYLEPHRINE 4 MG/50 ML (80 MCG/ML) IN 0.9% SODIUM CHLORIDE,69.55,41.73,0.0225,4481.0,24 CDM,RX-40841153,GENTAMICIN-VANCOMYCIN 40-500 MG IN NS IRRIGATION 500 ML,79.35,47.61,4.97,4481.0,24 CDM,RX-40841198,DEXMEDETOMIDINE 200 MCG/50 ML (4 MCG/ML) NS PEDIATRIC INFUSION,154.6,92.76,35.87,4481.0,19 CDM,RX-40841230,INSULIN DILUTION (INSULIN REGULAR) TEN UNIT/ML INJECTION,549.25,329.55,0.5175,4481.0,24 CDM,RX-40841232,DEXMEDETOMIDINE 4 MCG/ML BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,19 CDM,RX-40841233,ESMOLOL 500 MG/50 ML NS SYRINGE,147.7,88.62,0.495,4481.0,24 CDM,RX-40841236,CISATRACURIUM (NIMBEX) 0.5 MG/ML PEDIATRIC BOLUS FROM BAG,0.2,0.12,0.0464,4481.0,19 CDM,RX-40841238,CISATRACURIUM (NIMBEX) 2 MG/ML PEDIATRIC BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,19 CDM,RX-40841239,FENTANYL (PF) 10 MCG/ML PEDIATRIC BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,24 CDM,RX-40841240,FENTANYL (PF) 50 MCG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40841246,MORPHINE 1 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,26 CDM,RX-40841247,MORPHINE 5 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,26 CDM,RX-40841248,MORPHINE 0.1 MG/ML (NCCC COOLING PROTOCOL) BOLUS,0.2,0.12,0.0464,4481.0,26 CDM,RX-40841249,PENTOBARBITAL (NEMBUTAL) 50 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40841258,SODIUM CHLORIDE 0.9% INTRAVENOUS SOLUTION FOR DIALYSIS,78.0,46.8,4.39,4481.0,21 CDM,RX-40841259,PAPAVARINE 16.7 MG/PHENTOLAMINE 0.56 MG/PROSTOGLANDIN,133.6,80.16,31.0,4481.0,19 CDM,RX-40841260,INSULIN REGULAR 0.5 UNIT/ML PEDIATRIC DILUTION,72.85,43.71,0.5175,4481.0,24 CDM,RX-40841261,INSULIN DILUTION (INSULIN REGULAR) ONE UNIT/ML INJECTION,63.2,37.92,0.5175,4481.0,24 CDM,RX-40841263,SMOG ENEMA 240ML,2.9,1.74,0.6728,4481.0,19 CDM,RX-40841268,PYRIMETHAMINE 2 MG/ML ORAL SUSPENSION,29.2,17.52,6.77,4481.0,19 CDM,RX-40841269,FUROSEMIDE 10 MG/ML PEDIATRIC SYRINGE,32.1,19.26,0.045,4481.0,24 CDM,RX-40841274,HYDROCORTISONE SOD SUCCINATE (PF) 1 MG/ML PEDIATRIC DILUTION,69.55,41.73,16.14,4481.0,24 CDM,RX-40841285,DEXTROSE 5 % IN WATER IV FLUSH,16.5,9.9,3.83,4481.0,21 CDM,RX-40841291,METHYLPREDNISOLONE SOD SUCC 4 MG/ML PEDIATRIC DILUTION,1403.7,842.22,0.2037,4481.0,35 CDM,RX-40841292,DEXAMETHASONE 0.1 MG/ML PEDIATRIC DILUTION,67.6,40.56,0.2025,4481.0,24 CDM,RX-40841296,AMPHOTERICIN B CONVENTIONAL SOLUTION FOR INHALATION,220.0,132.0,51.04,4481.0,24 CDM,RX-40841297,CARBIDOPA-LEVODOPA 1.25-5 MG/1 ML ORAL SUSPENSION,32.5,19.5,7.54,4481.0,19 CDM,RX-40841310,WARFARIN 2.5MG TABLET (SPLITTABLE),17.2,10.32,3.99,4481.0,19 CDM,RX-40841325,BUMETANIDE 0.25 MG/ML PEDIATRIC 18 ML INFUSION,82.7,49.62,0.3589,4481.0,35 CDM,RX-40841327,BUMETANIDE 0.25 MG/ML PEDIATRIC 8 ML INFUSION,76.95,46.17,0.3589,4481.0,35 CDM,RX-40841330,CELECOXIB 10 MG/ML ORAL SUSPENSION,18.4,11.04,4.27,4481.0,19 CDM,RX-40841351,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 2 ML,64.7,38.82,15.01,4481.0,19 CDM,RX-40841368,FENTANYL (PF) 10 MCG/ML NEONATAL DILUTION INJECTION,40.05,24.03,2.48,4481.0,24 CDM,RX-40841372,BALANCED SALT IRRIGATION INTRAOCULAR SOLUTION 500ML,178.5,107.1,41.41,4481.0,19 CDM,RX-40841401,DEXMEDETOMIDINE 200 MCG/2 ML INTRANASAL SOLUTION,80.2,48.12,18.61,4481.0,19 CDM,RX-40841405,STUDY CETIRIZINE 10 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-40841427,TRETINOIN (CHEMOTHERAPY) 10 MG/1 ML ORAL SUSPENSION,6857.0,4114.2,1590.82,5485.6,19 CDM,RX-40841428,CALCIUM GLUCONATE 2.5 % TOPICAL GEL,8.25,4.95,1.91,4481.0,19 CDM,RX-40841434,MIDAZOLAM 5 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,26.1,15.66,0.3375,4481.0,72 CDM,RX-40841446,MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) INTRAVENOUS PIGGYBACK WRAPPER,124.75,74.85,1.08,4481.0,24 CDM,RX-40841450,SODIUM ACETATE 0.9% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),72.35,43.41,0.4725,4481.0,24 CDM,RX-40841451,SODIUM CHLORIDE 0.45% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),66.3,39.78,0.4725,4481.0,24 CDM,RX-40841452,SODIUM CHLORIDE 0.9% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),66.3,39.78,15.38,4481.0,19 CDM,RX-40841459,SODIUM ACETATE 0.45% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),69.25,41.55,0.4725,4481.0,24 CDM,RX-40841475,TERBUTALINE 200 MCG/ML (BOLUS FROM INFUSION),0.2,0.12,0.0464,4481.0,24 CDM,RX-40841477,CHLORHEXIDINE GLUCONATE 0.02% OPHTHALMIC SOLUTION,626.8,376.08,145.42,4481.0,19 CDM,RX-40841488,MAGNESIUM SULFATE 2 GRAM/50 ML (40MG/ML) PEDIATRIC INFUSION,116.0,69.6,1.08,4481.0,24 CDM,RX-40841489,MAGNESIUM SULFATE 40 MG/ML (PERIPHERAL) PEDIATRIC IV,116.0,69.6,1.08,4481.0,24 CDM,RX-40841492,METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/ML PED-CARD SURGERY,206.85,124.11,0.2037,4481.0,35 CDM,RX-40841493,MAGNESIUM SULFATE 100 MG/ML (CENTRAL) PEDIATRIC DILUTION,87.55,52.53,1.08,4481.0,24 CDM,RX-40841516,ROCURONIUM 10 MG/ML INFUSION CSAC,184.5,110.7,42.8,4481.0,19 CDM,RX-40841524,ALTEPLASE 1 MG/ML 2 ML PEDIATRIC INFUSION,668.5,401.1,91.62,4481.0,35 CDM,RX-40841525,ALTEPLASE 1 MG/ML 8 ML PEDIATRIC INFUSION,1526.0,915.6,91.62,4481.0,35 CDM,RX-40841526,ALTEPLASE 1 MG/ML 100 ML PEDIATRIC INFUSION,28840.2,17304.12,91.62,24949.66,35 CDM,RX-40841532,PHYTONADIONE 1 MG/ML ORAL SUSPENSION,104.3,62.58,24.2,4481.0,19 CDM,RX-40841534,VALACYCLOVIR 50MG/ML ORAL SUSPENSION,113.8,68.28,26.4,4481.0,19 CDM,RX-40841535,SODIUM BICARBONATE 1 MEQ/ML INJ SOLUTION (PEDIATRIC),77.35,46.41,17.95,4481.0,19 CDM,RX-40841552,BUDESONIDE 0.5 MG/2 ML SLURRY FOR ORAL USE,31.4,18.84,7.28,4481.0,19 CDM,RX-40841562,VASOPRESSIN 20 UNIT/ML INJECTION SOLUTION WRAPPER,35.5,21.3,2.09,4481.0,24 CDM,RX-40841565,ONDANSETRON (PF) 4 MG/2 ML PEDIATRIC INJECTION,17.9,10.74,0.2475,4481.0,24 CDM,RX-40841569,IPRATROPIUM BROMIDE 0.02 % SOLN FOR CONTINUOUS NEBULIZATION,16.95,10.17,3.93,4481.0,19 CDM,RX-40841572,SUCCINYLCHOLINE CHLORIDE 20MG/ML SYRINGE/VIAL WRAPPER,50.2,30.12,2.07,4481.0,24 CDM,RX-40841589,"HEPARIN (PORCINE) 1,000 UNIT/500 ML IN 0.9% SODIUM CHLORIDE IV (COMBINED)",82.05,49.23,0.4725,4481.0,24 CDM,RX-40841590,STUDY HYDROCORTISONE 2.5% TOPICAL CREAM,0.2,0.12,0.0464,4481.0,19 CDM,RX-40841599,STUDY D5551C00002 EXENATIDE/PLACEBO 2 MG POWDER FOR INJECTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40841600,MEDROXYPROGESTERONE 150 MG/ML INTRAMUSCULAR COMBINED WRAPPER,221.3,132.78,1.28,4481.0,24 CDM,RX-40841606,BLOOD CARDIOPLEGIA (DEL NIDO),287.8,172.68,66.77,4481.0,19 CDM,RX-40841608,CARDIOPLEGIC PERFUSION (PLEGISOL) 80 MEQ/L (HIGH K),340.95,204.57,79.1,4481.0,19 CDM,RX-40841609,CARDIOPLEGIC PERFUSION (PLEGISOL) 10 MEQ/L (LOW K),340.95,204.57,79.1,4481.0,19 CDM,RX-40841610,RIFAXIMIN 20 MG/ML ORAL SUSPENSION,113.1,67.86,26.24,4481.0,19 CDM,RX-40841613,AMPICILLIN 30 MG/ML PEDIATRIC DILUTION,255.95,153.57,1.24,4481.0,24 CDM,RX-40841626,LACOSAMIDE 10 MG/1 ML INTRAVENOUS SOLUTION (PEDS),320.25,192.15,0.45,4481.0,23 CDM,RX-40841628,SODIUM CHLORIDE 3 % INTRAVENOUS BOLUS SOLUTION,79.5,47.7,0.2805,4481.0,24 CDM,RX-40841708,STUDY CC-5013-AML-002 LENALIDOMIDE 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 CDM,RX-40841709,STUDY CC-5013-AML-002 LENALIDOMIDE 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 CDM,RX-40841718,STUDY IND INOTUZUMAB OZOGAMICIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40841753,ERTAPENEM 1 GRAM IM INJECTION,250.0,150.0,22.18,4481.0,24 CDM,RX-40841760,CIPROFLOXACIN 400 MG/200 ML IN D5W (ODD DOSE),89.7,53.82,6.32,4481.0,24 CDM,RX-40841771,INSULIN REGULAR 0.5 UNIT/ML NEONATAL 4 ML INFUSION,63.9,38.34,0.5175,4481.0,24 CDM,RX-40841793,METOCLOPRAMIDE 0.1 MG/ML IV SYRINGE NEONATAL,95.7,57.42,2.45,4481.0,24 CDM,RX-40841794,ENALAPRILAT 125 MCG/ML IV SYRINGE NEONATAL,72.15,43.29,16.74,4481.0,19 CDM,RX-40841845,AMPICILLIN-SULBACTAM DILUTION 25 MG AS AMPICILLIN/ML,140.8,84.48,3.13,4481.0,24 CDM,RX-4084188938,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION (SYRINGE) PEDS,80.5,48.3,0.0675,4481.0,24 CDM,RX-40841889388,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION PEDS 100 ML,98.0,58.8,0.0675,4481.0,24 CDM,RX-40841889389,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION PEDS 200 ML,203.0,121.8,0.0675,4481.0,24 CDM,RX-40841891,MORPHINE 0.4 MG/ML ORAL SOLUTION (NEONATAL),22.15,13.29,5.14,4481.0,19 CDM,RX-40841897,ATROPINE 0.1 MG/ML INJECTION (PEDIATRIC),123.4,74.04,0.198,4481.0,24 CDM,RX-40841971,STUDY IND INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.05544,6070.61,31 CDM,RX-4084198938,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 100 ML,98.0,58.8,0.0675,4481.0,24 CDM,RX-40841989388,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 200 ML,133.0,79.8,0.0675,4481.0,24 CDM,RX-40841989389,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 400 ML,203.0,121.8,0.0675,4481.0,24 CDM,RX-40842002,APREPITANT 20 MG/ML ORAL SUSPENSION,505.5,303.3,6.14,4481.0,24 CDM,RX-40842142,STUDY TBCRC-037 FULVESTRANT 250 MG/5 ML INTRAMUSCULAR SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-40842218,NITROGLYCERIN 100 MCG/ML BOLUS INJECTION (10 ML SYRINGE),63.1,37.86,3.35,4481.0,24 CDM,RX-40842263,ALTEPLASE 1 MG/ML INTRATHECAL INJECTION,365.75,219.45,91.62,4481.0,35 CDM,RX-40842272,BENZOCAINE 20 % MUCOSAL SPRAY WRAPPER,48.4,29.04,11.23,4481.0,19 CDM,RX-40842274,EPINEPHRINE (PEDIATRIC PITKIN) 0.8 MG IN 500 ML SODIUM CHLORIDE 0.9 %,126.8,76.08,1.08,4481.0,23 CDM,RX-40842275,EPINEPHRINE (PEDIATRIC) 30 MG/1000 ML NS IRRIGATION,174.2,104.52,1.08,4481.0,24 CDM,RX-40842285,ALTEPLASE 15 MG STEMI BOLUS,34337.45,20602.47,91.62,29705.33,35 CDM,RX-40842286,ALTEPLASE STEMI INFUSION,34337.45,20602.47,91.62,29705.33,35 CDM,RX-40842331,NICARDIPINE 0.2 MG/ML IN NS 50 ML PEDIATRIC INFUSION,229.3,137.58,0.1575,4481.0,24 CDM,RX-40842350,DOPAMINE 3200 MCG/ML IN DEXTROSE 5% 2 ML PEDIATRIC,63.55,38.13,1.8,4481.0,24 CDM,RX-40842353,VITAMIN-BIOTIN 5 MG/ML ORAL SUSPENSION,1.35,0.81,0.3132,4481.0,19 CDM,RX-40842356,DOPAMINE 3200 MCG/ML IN DEXTROSE 5% 8 ML PEDIATRIC,65.1,39.06,1.8,4481.0,24 CDM,RX-40842357,DOPAMINE 3200 MCG/ML IN DEXTROSE 5% 50 ML PEDIATRIC,75.95,45.57,1.8,4481.0,24 CDM,RX-40842409,STUDY S1602 BCG TOKYO-172 STRAIN 40 MG/ML INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,23 CDM,RX-40842411,STUDY S1602 BCG TOKYO-172 STRAIN 0.5 MG/ML INTRADERMAL INJECTION,0.2,0.12,0.0464,4481.0,23 CDM,RX-408426027,CYCLOSPORINE 1 MG/ML NS AVIVA IVPB,193.8,116.28,44.96,10791.27,24 CDM,RX-408426045,METOPROLOL TARTRATE 6.25 MG SPLIT QUARTER TABLET,16.05,9.63,3.72,4481.0,19 CDM,RX-408426085,STUDY MB-105-201 RITUXIMAB-ABBS 10 MG/ML INTRAVENOUS SOLN,0.2,0.12,0.0506,5030.34,35 CDM,RX-4084318,LACTATED RINGERS IRRIGATING INTRACRANIAL CATHETER,78.0,46.8,5.42,4481.0,21 CDM,RX-408450001,VECURONIUM 1 MG/ML PEDIATRIC BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408450008,BOSENTAN 6.25 MG/ML ORAL SUSPENSION,307.4,184.44,71.32,4481.0,19 CDM,RX-408450019,DOXYCYCLINE HYCLATE 500 MG INTRAPLEURAL SYRINGE,149.1,89.46,0.2475,4481.0,24 CDM,RX-408450030,MEROPENEM-VABORBACTAM DILUTION 8 MG OF MEROPENEM/ML PEDIATRIC INJECTION,602.55,361.53,2.11,4481.0,35 CDM,RX-408450040,TRIAMCINOLONE ACETONIDE - FOR INTRAPERICARDIAL USE ONLY,126.92500000000001,76.155,1.89,4481.0,48 CDM,RX-408450043,MIDAZOLAM 5 MG/ML INFUSION (MAXIMUM CONCENTRATION),248.4,149.04,0.3375,4481.0,24 CDM,RX-408450051,(ANES) DEXAMETHASONE (PF) 10 MG/ML INJECTION SOLUTION,32.95,19.77,0.2025,4481.0,24 CDM,RX-408450091,ATROPINE 1% SUBLINGUAL SYRINGE,17.25,10.35,4.0,4481.0,19 CDM,RX-408450147,"FACTOR XA,INACTIVATED-ZHZO (RECOMBINANT) 200 MG INTRAVENOUS BOLUS",8672.0,5203.2,127.44,7502.15,35 CDM,RX-408450163,CEFAZOLIN 2 GRAM SOLUTION FOR IVPB WRAPPER,82.15,49.29,1.8,4481.0,24 CDM,RX-408450164,FLUCONAZOLE 2 MG/ML (ODD DOSE) IN SODIUM CHLORIDE 0.9% IVPB (120MIN ADMIN),131.05,78.63,5.08,4481.0,24 CDM,RX-408450168,SODIUM BICARBONATE 150 MEQ/1000 ML IN DEXTROSE 5 % CONT INFUSION PREMIX,161.7,97.02,37.51,4481.0,19 CDM,RX-408451019,ALTEPLASE 1 MG/1 ML SOLUTION FOR INJECTION,314.5,188.7,79.57,4481.0,35 CDM,RX-408451041,STUDY LCCC1824 PERFLUTREN LIPID MICROSPHERES INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408451049,STUDY MEK-NF-201 PD-0325901 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451062,STUDY I6T-MC-AMAP MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451071,STUDY MEK-NF-201 PD-0325901 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451078,STUDY A071701-CIRB ABEMACICLIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408451079,STUDY A071701-CIRB ENTRECTINIB 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-408451080,STUDY A071701-CIRB PAXALISIB (GDC-0084) 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 CDM,RX-408451086,STUDY 252BN201 BIIB093/PLACEBO 1 MG/ML IV SOLN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451089,VANCOMYCIN 1 G TOPICAL POWDER,64.15,38.49,0.0675,4481.0,24 CDM,RX-408451091,STUDY ITN080AI (REBOOT) BELIMUMAB/PLACEBO 200 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,8308.44,35 CDM,RX-408451092,STUDY ITN080AI (REBOOT) RITUXIMAB 10 MG/ML IV SOLN,0.2,0.12,0.0506,12511.17,35 CDM,RX-408451098,STUDY ITN080AI (REBOOT) BELIMUMAB 200 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,8308.44,35 CDM,RX-408451099,STUDY TBCRC-047 AVELUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,15899.52,35 CDM,RX-408451101,STUDY TBCRC-047 BINIMETINIB 15 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408451121,STUDY CACZ885D2310 CANAKINUMAB (ACZ885)/PLACEBO 150 MG/ML IV SOLUTION,0.2,0.12,0.0506,20638.8,35 CDM,RX-408451123,STUDY CJWT629A12301 AZITHROMYCIN/PLACEBO 250 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451124,STUDY CJWT629A12301 HYDROXYCHLOROQUINE/PLACEBO 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451130,STUDY A031803-CIRB PEMBROLIZUMAB (MK-3475) 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-408451141,STUDY VX17-445-105 VX-445 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451142,STUDY VX17-445-105 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451143,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3127),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451148,STUDY D798KC00001 PEMETREXED 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451170,STUDY DNLI-E-0002 DNL310 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451177,STUDY GCT1046-01 GEN1046 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451182,STUDY CAEL101-302 CAEL-101/PLACEBO 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451190,STUDY AMT-101-201 (PHASE 2) AMT-101 3 MG/10 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451191,STUDY AMT-101-201 (PHASE 3) AMT-101/PLACEBO 3 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451192,STUDY AMT-101-201 (PHASE 3) AMT-101/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451198,STUDY I6T-MC-AMAX MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451199,STUDY I6T-MC-AMAX MIRIKIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451201,STUDY ASPIRE APIXABAN/PLACEBO 5 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451202,STUDY ASPIRE APIXABAN/PLACEBO 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451203,STUDY ASPIRE ASPIRIN/PLACEBO 81 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451204,STUDY RRP-001 INO-3107 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451209,STUDY VERSATILE002 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-408451211,STUDY VERSATILE002 PDS0101 (R-DOTAP/HPVMIX) 0.5 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451216,STUDY CNTO1959CRD3001 GUSELKUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-408451238,STUDY IRB# 20-1112 GABAPENTIN 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451239,STUDY 217-PPD-301 SAGE-217/PLACEBO 40 MG KIT,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451240,STUDY 217-PPD-301 SAGE-217/PLACEBO 50 MG KIT,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451245,STUDY ACTIV-2/A5401 AEROGEN ULTRA NEBULIZER DEVICE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451252,STUDY MT-12 DESLORATADINE 0.5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451253,STUDY MT-12 LORATADINE 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451254,STUDY MT-12 MOMETASONE FUROATE 50 MCG/ACTUATION NASAL SPRAY,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451255,STUDY MT-12 OLOPATADINE 0.1% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451256,STUDY ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451257,STUDY PEDIATRIC AEROSOL CHAMBER DEVICE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451259,STUDY I8F-MC-GPHK(A) TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451264,STUDY IOBP PIVOTAL INUSLIN LISPRO (HUMALOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451265,STUDY IOBP PIVOTAL INUSLIN ASPART (NOVOLOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451266,"STUDY IOBP PIVOTAL INUSLIN ASPART (FIASP) ""FASTER ASPART"" 100 UNITS/ML INJECTION CARTRIDGE",0.2,0.12,0.0464,4481.0,17 CDM,RX-408451267,STUDY VX19-445-107 VX-445 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451268,STUDY VX19-445-107 VX-445 50 MG-TEZ 25 MG-IVA 37.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451269,STUDY VX19-445-107 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451270,STUDY VX19-445-107 IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451271,STUDY 20203331 APIXABAN/PLACEBO 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451273,STUDY 021FSGS16010 DUPLEX SPARSENTAN 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451278,STUDY ABT-CIP-10305 ASPIRIN/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451282,STUDY AK002-016X AK002 15 MG/ML IV SOLN,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451284,STUDY COVID-19-004 MODERNA/PFIZER BIONTECH/PLACEBO COVID-19 VACCINE,0.2,0.12,0.0464,4481.0,22 CDM,RX-408451287,STUDY I6T-MC-AMAX MIRIKIZUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451288,STUDY BP41674 RO7248824 50 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451289,STUDY BP41674 RO7248824 (IDDP) 35 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451290,STUDY BP41674 RO7248824 20 ML DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451293,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 100 MG / 200 MG / 300 MG / PLACEBO,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451294,STUDY I8F-MC-GPHM TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451295,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451296,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 2.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451297,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451298,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 7.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451299,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 10 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451300,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 12.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451301,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 15 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451302,STUDY BRE18-360 OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451303,STUDY BRE18-360 OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451304,STUDY BRE18-360 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-408451306,STUDY HPTN 083 CABOTEGRAVIR (GSK1265744) 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451310,STUDY AL001-3 AL001/PLACEBO 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451315,STUDY CNTO1959UCO3001 GUSELKUMAB/PLACEBO 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451317,STUDY A5391 DORAVIRINE 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451318,STUDY J2L-MC-EZBB LY3461767/PLACEBO 8.7 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451322,STUDY BACTERIOSTATIC WATER INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451323,STUDY NHLBI-2019-SIL SILDENAFIL/PLACEBO 10 MG/12.5 ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451324,STUDY NHLBI-2019-SIL SILDENAFIL/PLACEBO 10 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 CDM,RX-408451331,STUDY THE NEXIS TRIAL PARENTERAL AMINO ACID 15% IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451332,STUDY THE NEXIS TRIAL PARENTERAL AMINO ACID 7.5% IV INFUSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451340,STUDY A5404 MRNA-1273 100 MCG/0.5 ML INJECTION SOLUTION COVID 19 VACCINE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451341,STUDY M20-259 RISANKIZUMAB 90 MG/ML IV SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-408451343,STUDY M20-259 RISANKIZUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,31 CDM,RX-408451344,STUDY M20-259 USTEKINUMAB 90 MG/ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-408451345,STUDY M20-259 USTEKINUMAB 130 MG/26 ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451348,STUDY ACTIV-2B/A5405 RITONAVIR/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451349,STUDY 024-00 ISL/PLACEBO 60 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451350,STUDY 024-00 FTC-TDF/PLACEBO 200-300 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451351,STUDY 024-00 FTC-TAF/PLACEBO 200-25 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451355,STUDY A5386 N-803 2 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451358,STUDY A5386 VRC07-523LS 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451362,STUDY A5355 CMV-MVA TRIPLEX/PLACEBO 5.2 X 10E8 PFU/ML INJECTION SOLUTION CYTOMEGALOVIRUS VACCINE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451363,STUDY A5355 CMV-MVA TRIPLEX/PLACEBO 8 X 10E8 PFU/ML INJECTION SOLUTION CYTOMEGALOVIRUS VACCINE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451366,STUDY SHP620 MARIBAVIR 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451372,STUDY IOBP2X INSULIN ASPART (NOVOLOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451373,STUDY IOBP2X INSULIN LISPRO (HUMALOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451380,STUDY IRB# 20-0052 DORAVIRINE 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451381,STUDY SOBI003-EA SOBI003 20 MG/ML INTRAVENOUS SOLN,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451385,STUDY CC-93538-EE-001 CC-93538/PLACEBO 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451386,STUDY ARGX-113-2001 EFGARTIGIMOD 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5299.35,35 CDM,RX-408451388,STUDY ARGX-113-2001 EFGARTIGIMOD PH20 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 CDM,RX-408451391,STUDY CBYL719F12201 ALPELISIB (BYL719)/PLACEBO 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451392,STUDY CBYL719F12201 ALPELISIB (BYL719)/PLACEBO 125 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451393,STUDY CBYL719F12201 ALPELISIB (BYL719) 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451394,STUDY CBYL719F12201 ALPELISIB (BYL719) 125 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451395,STUDY CBYL719F12201 ALPELISIB (BYL719) 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451397,STUDY CNTO1959CRD3001 GUSELKUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-408451398,STUDY ACTIV-2/A5401 INTERFERON-B1A (SNG001) 12 MIU/ML NEBULIZED INHALATION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451399,"STUDY ACTIV-2/A5401 SAB-185 38,753 UNITS/ML IV SOLN",0.2,0.12,0.0464,4481.0,17 CDM,RX-408451401,STUDY ACTIV-2/A5401 C135-LS 100 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451402,STUDY ACTIV-2/A5401 C144-LS 100 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451403,STUDY ACTIV-2/A5401 CASIRIVIMAB 120 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451404,STUDY ACTIV-2/A5401 IMDEVIMAB 120 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451406,STUDY ACTIV-2/A5401 CASIRIVIMAB 60 MG-IMDEVIMAB 60 MG/ML INTRAVENOUS SOLUTION (CO-FORMULATED),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451415,STUDY CLN-PXT3003-06 PXT3003/PLACEBO ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451416,STUDY D1690C00078 DAPAGLIFLOZIN/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451417,STUDY HS0005 BIMEKIZUMAB 160 MG/ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451429,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451431,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451432,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451434,STUDY ACTIV-4D TRV027/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451436,STUDY ACTIV-4D TXA127/PLACEBO 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451439,STUDY ACTIV-4D FOSTAMATINIB/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451440,STUDY ACTIV-4D FOSTAMATINIB/PLACEBO 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451441,STUDY 1042-EAP-3005 GANAXOLONE 50 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451443,STUDY IND CASIRIVIMAB-IMDEVIMAB 60 MG-60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451452,STUDY GS-US-528-9023 LENACAPAVIR/PLACEBO 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451453,STUDY GS-US-528-9023 LENACAPAVIR/PLACEBO 309 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451454,STUDY GS-US-528-9023 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG/PLACEBO TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451455,STUDY GS-US-528-9023 LENACAPAVIR 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451456,STUDY GS-US-528-9023 LENACAPAVIR 309 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451457,STUDY GS-US-528-9023 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG TABLET,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451458,STUDY IRB# 21-2224 BREXANOLONE 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,21 CDM,RX-408451460,STUDY IND EXEBACASE (CF-301) 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451462,STUDY A35-004 AMX0035/PLACEBO 4 G SACHET (TAURURSODIOL 1 G-PB 3 G),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451465,STUDY V712-305 VIASKIN (DBV712) 250 MCG EPICUTANEOUS PATCH,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451466,STUDY V712-305 ORAL FOOD CHALLENGE KIT,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451467,STUDY A5386 10-1074-LS (GS-2872) 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451469,STUDY GT-031 BELAPECTIN 2 MG/KG LBM / 4 MG/KG LBM / PLACEBO IVPB,0.2,0.12,0.0464,4481.0,22 CDM,RX-408451470,STUDY GT-031 BELAPECTIN/PLACEBO 27 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451472,STUDY ZYN2-CL-033 ZYN002/PLACEBO 4.2% TRANSDERMAL GEL,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451487,STUDY VX20-445-112 ELX 100 MG-TEZ 50 MG-IVA 75 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451488,STUDY VX20-445-112 IVA 75 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451489,STUDY VX20-445-112 ELX 80 MG-TEZ 40 MG-IVA 60 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451490,STUDY VX20-445-112 IVA 59.5 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451491,STUDY VX20-445-112 ELX 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451492,STUDY VX20-445-112 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451493,STUDY DMID 21-0018 MENINGOCOCCAL B VACCINE / INFLUENZA VACCINE / TETANUS DIPTHERIA VACCINE 0.5 ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451496,STUDY RVT-1201-2002 RODATRISTAT ETHYL/PLACEBO 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451497,STUDY RVT-1201-2002 RODATRISTAT ETHYL 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451498,STUDY DMID 21-0018 CEFTRIAXONE 250 MG IM INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,21 CDM,RX-408451499,STUDY DMID 21-0018 CEFIXIME 400 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451500,STUDY DMID 21-0018 CIPROFLOXACIN 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451502,STUDY VX20-445-112 ELX 50 MG-TEZ 25 MG-IVA 37.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451503,STUDY VX20-445-112 IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451512,STUDY A5357 CABOTEGRAVIR 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451513,STUDY A5357 CABOTEGRAVIR LA 200 MG/ML IM SUSPENSION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451514,STUDY A5357 VRC07-523LS 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451526,STUDY ION582-CS1 ION582 20 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451527,STUDY ION582-CS1 ION582 DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451529,STUDY REGEN-004 RENAL AUTOLOGOUS CELL THERAPY 100X10E6 CELLS/ML PERCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451534,STUDY 022-00 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451535,STUDY 024-00 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451536,STUDY 024-00 EMTRICITABINE 200 MG-TENOFOVIR ALAFENAMIDE 25 MG TABLET,0.2,0.12,0.0506,4481.0,35 CDM,RX-408451537,STUDY RM-493-034 SETMELANOTIDE 10 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451538,STUDY RM-493-034 SETMELANOTIDE/PLACEBO 10 MG/ML SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451539,STUDY 22-SRC-03-GIRDLER ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451540,STUDY 22-SRC-03-GIRDLER PROGESTERONE MICRONIZED 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451543,STUDY C4671026 NIRMATRELVIR 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451544,STUDY C4671026 RITONAVIR 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451545,STUDY ZX008-2103 FENFLURAMINE HCL (ZX008) 1.25 MG/ML OR 2.5 MG/ML OR 5 MG/ML OR PLACEBO ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451548,STUDY ZX008-2103 FENFLURAMINE HCL (ZX008) 5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451551,STUDY NICHD-NRN-0064 (BIB) BUDESONIDE/PLACEBO 0.5 MG/2 ML SUSPENSION (NEONATAL),0.2,0.12,0.0464,4481.0,19 CDM,RX-408451555,STUDY MK-5475-007 DRY POWDER INHALER TRAINING DEVICE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451556,STUDY MK-5475-007 MK-5475 32 MCG/INH OR 100 MCG/INH OR 380 MCG/INH OR PLACEBO DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451557,STUDY CC-93538-EE-002 CC-93538 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451558,STUDY IRB# 21-3111 MINOCYCLINE/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408451559,STUDY IND GANAXOLONE 1 MG/ML INTRAVENOUS SOLUTION (PEDIATRIC),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451560,STUDY IND GANAXOLONE 1 MG/ML BOLUS FROM BAG (PEDIATRIC),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451565,STUDY ACV01 MRNA (12YR UP) (PFIZER) (PF) 30 MCG/0.3 ML IM SUSPENSION (GRAY),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451566,STUDY ACV01 MRNA (12YR UP) (PFIZER) (PF) 30 MCG/0.3 ML IM SUSPENSION (PURPLE),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451567,STUDY ACV01 MRNA (5-11YR) (PFIZER) (PF) 10 MCG/0.2 ML IM SUSPENSION (ORANGE),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451569,STUDY NAB-BC-3781-1202 LEFAMULIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451575,STUDY DNLI-E-0007 DNL310 OR IDURSULFASE IVPB,0.2,0.12,0.0464,4481.0,51 CDM,RX-408451576,STUDY DNLI-E-0007 DNL310 30 MG/ML INTRAVENOUS SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 CDM,RX-408451580,STUDY DNLI-E-0007 IDURSULFASE 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,81999.54,35 CDM,RX-408451591,STUDY REGEN-006 RENAL AUTOLOGOUS CELL THERAPY 100X10E6 CELLS/ML PERCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451603,STUDY VX21-147-301 VX-147/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451634,STUDY CS1-003 CS1 (SODIUM VALPROATE) 160 MG DELAYED-RELEASE CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-408451636,STUDY A5359 RILPIVIRINE LA 300 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,34 CDM,RX-408451637,STUDY A5359 CABOTEGRAVIR LA 200 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,34 CDM,RX-408451646,STUDY IRB# 22-1987 IND JZP150 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451659,STUDY LAIV IN COPD FLU VACC QV LIVE 2022-2023 10E6.5-7.5 FF UNIT/0.2 ML NASAL SPRAY,0.2,0.12,0.0464,4481.0,17 CDM,RX-408451664,STUDY I6T-MC-AMAX MIRIKIZUMAB 300 MG/3 ML PRE-FILLED SYRINGE KIT,0.2,0.12,0.0506,7785.12,35 CDM,RX-408451968,STUDY REM-PH-418 TREPROSTINIL 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452862,STUDY AFT-66 (CAMBRIA-2) CAMIZESTRANT 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452865,STUDY MGT-AQP1-202 AAV2-HAQP1/TMN200P SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452867,STUDY MGT-AQP1-202 GLYCOPYRROLATE 0.2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408452868,STUDY MGT-AQP1-202 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,23 CDM,RX-408452870,STUDY 61186372COR3001 AMIVANTAMAB 160 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-408452871,STUDY 61186372COR3001 CETUXIMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,11827.62,35 CDM,RX-408452872,STUDY BMT-CTN-2207 THYMOGLOBULIN (RABBIT ATG) 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,145865.16,35 CDM,RX-408452876,STUDY RRP-331 INO-3107/PLACEBO 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452879,STUDY RRP-331 INO-3107 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452880,STUDY M24-064 TELISOTUZUMAB ADIZUTECAN (ABBV-400) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452885,"HEPARIN 5,000 UNIT/ML NEBULIZATION",28.15,16.89,6.53,4481.0,26 CDM,RX-408452889,STUDY M24-064 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-408452891,STUDY DSC-08-2357-32 GIVINOSTAT 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408452892,STUDY DSC-08-2357-32 GIVINOSTAT 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408452893,STUDY DSC-08-2357-32 GIVINOSTAT 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408452894,STUDY DSC-08-2357-32 HYDROXYUREA 500 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408452898,STUDY A032102 VALEMETOSTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452899,STUDY A032102 VALEMETOSTAT 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452906,STUDY LCCC2255 CEMIPLIMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4733.4,35 CDM,RX-408452908,STUDY LCCC2255 XL092 (ZANZALINTINIB) 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452909,STUDY LCCC2255 XL092 (ZANZALINTINIB) 40 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452910,STUDY LCCC2255 XL092 (ZANZALINTINIB) 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452911,STUDY LCCC2255 XL092 (ZANZALINTINIB) 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452912,STUDY YL201-INT-101-01 YL201 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452914,STUDY CHS-388-202 CASDOZOKITUG 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452916,STUDY CHS-388-202 TORIPALIMAB 40 MG/ML IV SOLUTION,0.2,0.12,0.0506,6398.91,35 CDM,RX-408452918,STUDY CHS-388-202 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,35 CDM,RX-408452924,STUDY A092205-CIRB PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-408452926,STUDY TBCRC-064 TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 CDM,RX-408452928,STUDY TBCRC-064 DATOPOTAMAB DERUXTECAN (DATO-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408452938,STUDY BIPAVE-001 AI-081 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452940,STUDY ZE50-0134-0002 ZE50-0134 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452942,STUDY IMA203-301 ALDESLEUKIN 3.6 MILLION UNITS/ML SOLUTION,0.2,0.12,0.0506,327745.32,35 CDM,RX-408452943,STUDY IMA203-301 FLUDARABINE 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9659.37,35 CDM,RX-408452949,STUDY IMA203-301 CYCLOPHOSPHAMIDE 1 GM,0.2,0.12,0.0464,4481.0,25 CDM,RX-408452951,STUDY BMT-CTN-2203 RUXOLITINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452952,STUDY A032201-CIRB TIVOZANIB 1.34 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408452953,STUDY A032201-CIRB TIVOZANIB 0.89 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408452955,STUDY ZE50-0134-0002 ZE50-0134 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452956,STUDY ZE50-0134-0002 ZE50-0134 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-408452959,STUDY VERSATILE-003 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-408452961,STUDY VERSATILE-003 PDS0101 (R-DOTAP/HPVMIX) 0.5 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452962,STUDY M24-533 TELISOTUZUMAB ADIZUTECAN (ABBV-400) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408452966,STUDY NRG-GU014 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-408452972,STUDY GOG-3115/M25-231 MIRVETUXIMAB SORAVTANSINE 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,11142.6,35 CDM,RX-408452976,STUDY 8951-CL-0305 ZOLBETUXIMAB/PLACEBO 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-408452979,STUDY DF-HCC24-121 EPCORITAMAB 60 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8980.23,35 CDM,RX-408452980,STUDY DF-HCC24-121 EPCORITAMAB 5 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8980.23,35 CDM,RX-408452982,STUDY DF-HCC24-121 EPCORITAMAB 0.16 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 CDM,RX-408452983,STUDY DF-HCC24-121 EPCORITAMAB 0.8 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 CDM,RX-408452991,STUDY JZP598-303 TRASTUZUMAB-PKRB 21 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408452993,STUDY JZP598-303 ZANIDATAMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408452998,STUDY DOC-GBM2 FILGRASTIM (NEUPOGEN) 300 MCG/0.5 ML INJECTION SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-408452999,STUDY DOC-GBM2 FILGRASTIM (NEUPOGEN) 480 MCG/0.8 ML INJECTION SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-408453000,STUDY DOC-GBM2 PEGINTERFERON ALFA-2A (PIFN) 180 MCG/0.5 ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,26 CDM,RX-408453007,STUDY YL201-INT-101-01 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 CDM,RX-408453351,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 3 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453352,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 7 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453353,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 14 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453354,STUDY A5332 PITAVASTATIN/PLACEBO 4 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453364,NAFCILLIN DESENSITIZATION DILUTION 0.001 MG/ML,101.3,60.78,0.1125,4481.0,24 CDM,RX-408453365,NAFCILLIN DESENSITIZATION DILUTION 0.01 MG/ML,101.3,60.78,0.1125,4481.0,24 CDM,RX-408453366,NAFCILLIN DESENSITIZATION DILUTION 0.1 MG/ML,101.3,60.78,0.1125,4481.0,24 CDM,RX-408453367,NAFCILLIN DESENSITIZATION DILUTION 1 MG/ML,101.3,60.78,0.1125,4481.0,24 CDM,RX-408453368,NAFCILLIN DESENSITIZATION DILUTION 10 MG/ML,101.3,60.78,0.1125,4481.0,24 CDM,RX-408453378,STUDY IRB 20-2267 TRANEXAMIC ACID/PLACEBO 100 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453381,STUDY ZUL-PPP-01 BREXANOLONE 5 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,21 CDM,RX-408453399,STUDY DICTATE-AHF DAPAGLIFLOZIN 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453400,STUDY HM-TRIA-201 HM15211 2 MG / 4 MG / 6 MG / PLACEBO PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453661,STUDY I8F-MC-GPHL TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453669,STUDY MS200527_0082 EVOBRUTINIB/PLACEBO 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453670,STUDY MS200527_0082 TERIFLUNOMIDE/PLACEBO 14 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453671,STUDY MS200527_0082 EVOBRUTINIB 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453691,STUDY IM011127 BMS-986165/PLACEBO 12 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453692,STUDY IM011127 BMS-986165 6 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453698,STUDY CNTO1275JPA3001 USTEKINUMAB 45 MG/0.5 ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-408453699,STUDY CNTO1275JPA3001 USTEKINUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,31 CDM,RX-408453707,STUDY ANBL1531 LORLATINIB 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408453708,STUDY ANBL1531 LORLATINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,20 CDM,RX-408453726,STUDY VAL-10-001 VAL-413 IRINOTECAN HCL 5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453727,STUDY VAL-10-001 IRN-IVPO IRINOTECAN HCL 20 MG/ML INJ FOR ORAL USE,0.2,0.12,0.0464,4481.0,24 CDM,RX-408453729,STUDY SELCLAX VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453730,STUDY SELCLAX VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453732,STUDY SELCLAX VENETOCLAX 25 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453733,STUDY SELCLAX VENETOCLAX 100 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453734,STUDY SELCLAX SELINEXOR 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453747,STUDY IND DABRAFENIB 10 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408453748,STUDY IND TRAMETINIB 0.05 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-408453749,STUDY LOXO-FG3-22001 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-408453752,STUDY LOXO-FG3-22001 LOXO-435 6 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453753,STUDY LOXO-FG3-22001 LOXO-435 20 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453754,STUDY LOXO-FG3-22001 LOXO-435 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453764,STUDY ACNS2031 SODIUM THIOSULFATE (STS) ANHYDROUS 80 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453767,STUDY ACCL2031 MEMANTINE / PLACEBO 2 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-408453774,STUDY A22-301 ROPEGINTERFERON ALFA-2B-NJFT 500 MCG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453786,STUDY AHOD2131 BRENTUXIMAB VEDOTIN 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,37621.71,35 CDM,RX-408453788,STUDY AHOD2131 NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 CDM,RX-408453796,STUDY NCI-10553-CIRB DAROLUTAMIDE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453798,STUDY SELCLAX VENETOCLAX 10 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453799,STUDY NRG-GU010-CIRB DAROLUTAMIDE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453800,STUDY NRG-GY028-CIRB IPATASERTIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453801,STUDY NRG-GY028-CIRB IPATASERTIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453808,STUDY ACCL1931 LEVOCARNITINE 330 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453809,STUDY ACCL1931 LEVOCARNITINE 100 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453810,STUDY ACCL1931 LEVOCARNITINE 200 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408453812,STUDY GS-US-595-6184 SACITUZUMAB GOVITECAN-HZIY 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5859.42,35 CDM,RX-408453822,STUDY A092105-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 CDM,RX-408453824,STUDY A092105-CIRB IPILIMUMAB 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,27236.16,35 CDM,RX-408453826,STUDY A092105-CIRB CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408453827,STUDY NRG-BN011-CIRB LOMUSTINE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453828,STUDY NRG-BN011-CIRB LOMUSTINE 40 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453829,STUDY NRG-BN011-CIRB LOMUSTINE 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453836,STUDY 77242113UCO2001 JNJ-77242113 100 MG / 200 MG / PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453837,STUDY IMVT-1401-3201 BATOCLIMAB/PLACEBO 340 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453838,STUDY GB002-3101 SERALUTINIB/PLACEBO 15 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453840,STUDY J1I-MC-GZQA RETATRUTIDE/PLACEBO 2 MG / 4 MG / 6 MG / 9 MG / 12 MG SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453845,STUDY ALXN2220-ATTRCM-301 ALXN2220/PLACEBO 50 MG/ML IVPB,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453846,STUDY GB002-3101 DRY POWDER INHALER DEVICE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453847,STUDY UMI21-05-01 OBETICHOLIC ACID/PLACEBO 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453849,STUDY FBF-001-001 FBF-001 20 MG/ML STERILE SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453851,"STUDY FBF-001-001 ELLIOTTS B SOLUTION, BUFFERED INTRATHECAL ELECTROLYTE/DEXTROSE SOLUTION FOR INJECTION",0.2,0.12,0.0464,4481.0,17 CDM,RX-408453852,STUDY SP-624-202 SP-624/PLACEBO 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453853,STUDY GBT440-041 VOXELOTOR 100 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453854,STUDY GBT440-041 VOXELOTOR 300 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453855,STUDY TTP399-302 TTP399/PLACEBO 400 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453856,ANAKINRA (KINERET) IV SYRINGE,837.7,502.62,194.35,4481.0,19 CDM,RX-408453864,STUDY B7981041 RITLECITINIB/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453865,STUDY B7981041 RITLECITINIB/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453866,STUDY EX6018-4979 ZILTIVEKIMAB C/PLACEBO 15 MG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453868,STUDY BLADE-VG2 CALCIUM SULFATE CARRIER POWDER,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453869,STUDY BLADE-VG2 VANCOMYCIN HYDROCHLORIDE 500 MG POWDER,0.2,0.12,0.0464,4481.0,24 CDM,RX-408453870,STUDY BLADE-VG2 GENTAMICIN SULFATE 80 MG/2 ML SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-408453872,STUDY CKJX839A1US10 INCLISIRAN 284 MG/1.5 ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-408453874,STUDY LT3001-203 LT3001/PLACEBO 4 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453876,STUDY BLADE-VG2 HEMISPHERICAL BEADS 3 MM USING MOLD MAT,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453877,STUDY RT234-PAH-CL202 VARDENAFIL HYDROCHLORIDE 0.5 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453878,STUDY RT234-PAH-CL202 AXIAL OSCILLATING SPHERE DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453882,STUDY AHAEMI EMICIZUMAB 150 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408453883,STUDY DV0013 ZILUCOPLAN 40 MG/ML (16.6 MG/0.416 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453884,STUDY DV0013 ZILUCOPLAN 40 MG/ML (23.0 MG/0.574 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453885,STUDY DV0013 ZILUCOPLAN 40 MG/ML (32.4 MG/0.810 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 CDM,RX-408453888,STUDY LTI-401 TREPROSTINIL 26.5 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453889,STUDY LTI-401 TREPROSTINIL 53 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453890,STUDY LTI-401 TREPROSTINIL 79.5 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453891,STUDY LTI-401 TREPROSTINIL 106 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453894,STUDY 230LE305 BIIB059 (LITIFILIMAB) 225 MG PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453895,STUDY GTX-102-CL301 GTX-102 2 MG/ML INTRATHECAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453897,"STUDY GTX-102-CL301 GTX/UX DILUENT AND FLUSH SOLUTION, BUFFERED (INTRATHECAL USE)",0.2,0.12,0.0464,4481.0,17 CDM,RX-408453898,STUDY BHV7000-303 BVH-7000 50 MG / 25 MG / PLACEBO EXTENDED RELEASE TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453899,"STUDY MK7240-008-00 TULISOKIBART/PLACEBO 200 MG/ML, 1.2 ML AUTOINJECTOR",0.2,0.12,0.0464,4481.0,17 CDM,RX-408453900,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453903,STUDY MK7240-008-00 TULISOKIBART 100 MG/ML INTRAVENOUS SOLUTION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453906,STUDY RPL554-NCFB-220 ENSIFENTRINE/PLACEBO 3 MG INHALATION SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453907,STUDY NEU-411-PD201 NEU-411/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453908,STUDY IRB# 24-2276 KETOROLAC/PLACEBO 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453909,STUDY MKC-CI-002 MKND-101 (CLOFAZIMINE) 80 MG / 50 MG / PLACEBO INHALATION SUSPENSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453910,STUDY MKC-CI-002 MNKD-101 (CLOFAZIMINE) 80 MG INHALATION SUSPENSION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453911,STUDY MKC-CI-002 MNKD-101 (CLOFAZIMINE) 50 MG INHALATION SUSPENSION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453912,STUDY ION582-CS2 ION582 40 MG / 80 MG / PLACEBO INTRATHECAL SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453916,STUDY NEU-411-PD201 NEU-411/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453917,STUDY ARRC AZITHROMYCIN/PLACEBO 500 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,21 CDM,RX-408453920,STUDY ION582-CS2 ION582 40 MG INTRATHECAL SYRINGE (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453921,STUDY ION582-CS2 ION582 80 MG INTRATHECAL SYRINGE (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453922,STUDY NN9838-8484 CAGRILINTIDE 1 MG/ML + SEMAGLUTIDE 0.5 MG/ML (CAGRISEMA)/PLACEBO (DOSE 0.25 MG/0.25 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453923,STUDY NN9838-8484 CAGRILINTIDE 2 MG/ML + SEMAGLUTIDE 1 MG/ML (CAGRISEMA)/PLACEBO (DOSE 0.5 MG/0.5 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453924,STUDY NN9838-8484 CAGRILINTIDE 4 MG/ML + SEMAGLUTIDE 2 MG/ML (CAGRISEMA)/PLACEBO (DOSE 1 MG/1 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453925,STUDY NN9838-8484 CAGRILINTIDE 6.8 MG/ML + SEMAGLUTIDE 3.4 MG/ML (CAGRISEMA)/PLACEBO (DOSE 1.7 MG/1.7 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453926,STUDY NN9838-8484 CAGRILINTIDE 9.6 MG/ML + SEMAGLUTIDE 4.8 MG/ML (CAGRISEMA)/PLACEBO (DOSE 2.4 MG/2.4 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453927,STUDY NN9838-8484 CAGRILINTIDE 1 MG/ML + SEMAGLUTIDE 0.5 MG/ML (CAGRISEMA) (DOSE 0.25 MG/0.25 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453928,STUDY NN9838-8484 CAGRILINTIDE 2 MG/ML + SEMAGLUTIDE 1 MG/ML (CAGRISEMA) (DOSE 0.5 MG/0.5 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453929,STUDY NN9838-8484 CAGRILINTIDE 4 MG/ML + SEMAGLUTIDE 2 MG/ML (CAGRISEMA) (DOSE 1 MG/1 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453930,STUDY NN9838-8484 CAGRILINTIDE 6.8 MG/ML + SEMAGLUTIDE 3.4 MG/ML (CAGRISEMA) (DOSE 1.7 MG/1.7 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453931,STUDY NN9838-8484 CAGRILINTIDE 9.6 MG/ML + SEMAGLUTIDE 4.8 MG/ML (CAGRISEMA) (DOSE 2.4 MG/2.4 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453932,STUDY TL-895-201 TL-895 25 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453933,STUDY TL-895-201 TL-895 50 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453934,STUDY TL-895-201 TL-895 75 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453935,STUDY TL-895-201 TL-895 100 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453936,STUDY TL-895-201 TL-895 150 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453939,STUDY BP-ARDS-P2-001 VILOBELIMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453941,STUDY BP-ARDS-P2-001 PARIDIPRUBART/PLACEBO 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453943,STUDY BP-ARDS-P2-001 BEVACIZUMAB/PLACEBO 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453945,STUDY VX24-147-202 VX-147 (INAXAPLIN) 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453946,STUDY GTX-102-CL301 DEXAMETHASONE 4 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,21 CDM,RX-408453947,STUDY NICHD-2023-MON01 MONTELUKAST/PLACEBO 4 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453948,STUDY IND 116002 CEFEPIME-ZIDEBACTAM 3 GRAM INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453950,STUDY 222291 GSK4532990 25 MG / 100 MG / 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453951,STUDY CPI-IFE-008 IFETROBAN/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453952,STUDY STK-001-DS-301 ZOREVUNERSEN (STK-001)/SHAM 70 MG INTRATHECAL SYRINGE 10 ML (LOADING DOSE),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453953,STUDY STK-001-DS-301 ZOREVUNERSEN (STK-001)/SHAM 45 MG INTRATHECAL SYRINGE 10 ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453954,STUDY GS-US-721-7286 (PURPOSE 365) LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453955,STUDY GS-US-721-7286 (PURPOSE 365) LENACAPAVIR 500 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453956,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3204),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453957,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3735),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453958,STUDY IGHID 12430/DELIVER-02 MGD020 4 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453959,STUDY IGHID 12430/DELIVER-02 MGV002 VEHICLE INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453962,STUDY IGHID 12430/DELIVER-02 VOR 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453966,METHYLNALTREXONE 12 MG/0.6 ML SYRINGE (PEDIATRIC),457.85,274.71,3.26,4481.0,24 CDM,RX-408453969,STUDY 222291 GSK4532990 25 MG / 100 MG / 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453970,STUDY 222291 GSK4532990 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453971,STUDY 222291 GSK4532990 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,17 CDM,RX-408453974,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 1000 MG OR 500 MG IVPB IN 275 ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408453975,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 500 MG OR 250 MG IVPB IN 275 ML,0.2,0.12,0.0464,4481.0,17 CDM,RX-408454006,CARFILZOMIB (KYPROLIS) IVPB 2 MG/ML,11983.1,7189.86,53.98,9586.48,35 CDM,RX-408454007,STUDY A032103-CIRB RELATLIMAB (BMS-986016) 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454009,STUDY A032103-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5024.46,35 CDM,RX-408454014,CARBOPLATIN (PARAPLATIN) 10 MG/ML IVPB (BY AUC),479.0,287.4,5.56,4481.0,24 CDM,RX-408454018,CISPLATIN (PLATINOL) IVPB 1 MG/ML,391.35,234.81,5.15,4481.0,48 CDM,RX-408454022,CISPLATIN (POWDER) 1 MG/ML IVPB,1930.0,1158.0,5.15,4481.0,24 CDM,RX-408454030,CARBOPLATIN (PARAPLATIN) 10 MG/ML IVPB (BY MG/M2),479.0,287.4,5.56,4481.0,24 CDM,RX-408454040,CYCLOPHOSPHAMIDE (POWDER) (CYTOXAN) 20 MG/ML IVPB,2129.8,1277.88,0.4656,4481.0,35 CDM,RX-408454053,STUDY PROFFI FISETIN / PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 CDM,RX-408454061,STUDY RC48G001 DISITAMAB VEDOTIN 7.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408454063,STUDY RC48G001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-408454076,STUDY BO45217 SOTORASIB 120 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454077,STUDY BO45217 ADAGRASIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-408454081,STUDY BO45217 DIVARASIB 400 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-408454095,STUDY S22-11168 ROPIDOXURIDINE 120 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-408454098,STUDY HQP1351CG301-POLARIS-2 OLVEREMBATINIB 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408454106,STUDY TBCRC-065 TUCATINIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454107,STUDY TBCRC-065 TUCATINIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454111,STUDY GOG-3112/DS8201-772 FAM-TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 CDM,RX-408454115,STUDY LCCC2220 ERLOTINIB 25 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454121,STUDY RTOG-1216 ATEZOLIZUMAB (MPCL3280A) 60 MG /ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 CDM,RX-408454127,STUDY LCCC2215 DATOPOTAMAB-DERUXTECAN (DATO-DXD) 100 MG POWDER FOR SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-408454137,RITUXIMAB 10 MG/ML INTRALESIONAL SOLUTION,586.0,351.6,72.96,12511.17,70 CDM,RX-408454146,STUDY PEAK-1 CASDATIFAN / PLACEBO 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-408454147,STUDY PEAK-1 CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454148,STUDY PEAK-1 CABOZANTINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454149,STUDY PEAK-1 CABOZANTINIB 60 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-408454150,STUDY NRG-HN014 CEMIPLIMAB (REGN2810) 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4733.4,35 CDM,RX-40846025,"BUPROPION HCL SR 150 MG TABLET,SUSTAINED-RELEASE (COMBINED) WRAPPER",17.85,10.71,4.14,4481.0,19 CDM,RX-40846040,SODIUM POLYSTYRENE SULFONATE 15 GRAM/60 ML ORAL COMBINED WRAPPER,90.35,54.21,20.96,4481.0,19 CDM,RX-40846042,CHLOROTHIAZIDE SODIUM 28 MG/ML,389.4,233.64,88.76,4481.0,24 CDM,RX-40846054,STUDY ADARE SP-1011-002 COSYNTROPIN 0.25 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,21 CDM,RX-40846058,STUDY RESOLVE RSLV-132-03/PLACEBO 10 MG/ML (COMPONENT),0.2,0.12,0.0464,4481.0,22 CDM,RX-40846071,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) INTRAVENOUS SOLUTION (PED)",128.4,77.04,29.79,4481.0,19 CDM,RX-40846072,BUMETANIDE 0.25 MG/ML ORAL SOLUTION,25.85,15.51,6.0,4481.0,19 CDM,RX-40846075,STUDY IPRATROPIUM BROMIDE 0.02 % SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40846076,STUDY PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-40846089,ACETAZOLAMIDE 100 MG/ML IV PEDIATRIC,166.05,99.63,38.52,4481.0,24 CDM,RX-40846093,STUDY LIDOCAINE 1% INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40846097,HISTAMINE 1 MG/ML (2.75 MG/ML) PERCUTANEOUS SOLUTION,127.75,76.65,29.64,4481.0,19 CDM,RX-40846117,STUDY DEXAMETHASONE 0.1% OPHTHALMIC SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40846119,STUDY ARTIFICIAL TEARS (PF) OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-40846162,STUDY NANT17-01/MIBG-D DINUTUXIMAB 3.5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-40846180,STUDY A041702-CIRB IBRUTINIB 140 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40846181,STUDY A041702-CIRB VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40846182,STUDY A041702-CIRB VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40846183,STUDY A041702-CIRB VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40846184,STUDY A041702-CIRB OBINUTUZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11677.68,35 CDM,RX-40846187,STUDY CA-ALT-803-01-16 ALT-803 1 MG/ML INTRAVESICAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40846189,STUDY BRIMONIDINE 0.2% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40846190,STUDY SGNTV-001 TISOTUMAB VEDOTIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,30877.35,35 CDM,RX-40846197,STUDY AK002-003X IN 0.9% SODIUM CHLORIDE,0.2,0.12,0.0464,4481.0,19 CDM,RX-40846202,STUDY EAA173CIRB DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40846210,STUDY GS-US-546-5857 MAGROLIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40846243,STUDY LCCC1944 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,70 CDM,RX-40846249,STUDY NCI-10434-CIRB POMALIDOMIDE 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40846250,STUDY NCI-10434-CIRB POMALIDOMIDE 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40846301,"TRANEXAMIC ACID 2,000 MG/20 ML (100 MG/ML) INFUSION (PED)",193.7,116.22,44.94,4481.0,19 CDM,RX-408470072,CEFTAROLINE FOSAMIL 1 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 CDM,RX-408470073,CEFTAROLINE FOSAMIL 0.1 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 CDM,RX-408470148,VANCOMYCIN 1 G TOPICAL POWDER (OPTIME),64.15,38.49,0.0675,4481.0,24 CDM,RX-408470157,HYDROMORPHONE 1 MG/ML IN NS INFUSION WRAPPER,73.8,44.28,0.2025,4481.0,24 CDM,RX-408470177,NITROGLYCERIN 200 MCG/ML IN D5W 8 ML PEDIATRIC INFUSION,64.1,38.46,3.35,4481.0,24 CDM,RX-408470197,MIDAZOLAM 2 MG/ML ORAL LIQUID WRAPPER,130.15,78.09,9.42,4481.0,38 CDM,RX-408470198,BUMETANIDE 20 MG/80 ML (0.25 MG/ML) INFUSION CSAC,148.85,89.31,0.3589,4481.0,35 CDM,RX-408470212,NITROGLYCERIN 200 MCG/ML BOLUS INJECTION (VIR/CATH),63.2,37.92,3.35,4481.0,24 CDM,RX-408470228,SELENIUM 12 MCG/ML DILUTION,1360.75,816.45,315.69,4481.0,19 CDM,RX-408470247,EPINEPHRINE 0.1 MG/ML INJECTION SYRINGE WRAPPER,35.5,21.3,1.08,4481.0,24 CDM,RX-408470277,FENTANYL (PF) 50 MCG/ML INFUSION,156.4,93.84,2.48,4481.0,24 CDM,RX-408470296,REMDESIVIR 100 MG INTRAVENOUS POWDER FOR SOLUTION,2023.05,1213.83,6.53,4481.0,35 CDM,RX-408470311,"PENICILLIN G POTASSIUM 100,000 UNITS/ML IV (PED DILUTION)",17.0,10.2,1.78,4481.0,24 CDM,RX-408470314,OXYTOCIN 30 UNIT/500 ML IN NS PMB BOLUS (OB 1 HR),101.1,60.66,3.22,4481.0,23 CDM,RX-408470315,OXYTOCIN 30 UNIT/500 ML IN NS PMB BOLUS (OB 4 HR),101.1,60.66,3.22,4481.0,23 CDM,RX-408470320,TRACE ELEMENTS ZN 3 MG-CU 0.3 MG-MN 55 MCG-SE 60 MCG/ML IV SOLUTION,125.95,75.57,29.22,4481.0,19 CDM,RX-408470332,CISATRACURIUM 2 MG/ML CONTINUOUS INFUSION (2 MG/ML VIALS) (CSAC),1088.5,653.1,252.53,4481.0,19 CDM,RX-4084703901,THIAMINE IN NS (5 MG/ML) PEDIATRIC DILUTION,95.45,57.27,4.09,4481.0,24 CDM,RX-4084703911,PYRIDOXINE IN NS (5 MG/ML) PEDIATRIC DILUTION,205.2,123.12,13.61,4481.0,24 CDM,RX-4084703921,FOLIC ACID IN NS (500 MCG/ML) PEDIATRIC DILUTION,272.0,163.2,0.135,4481.0,24 CDM,RX-408470396,CEFTAZIDIME-AVIBACTAM 40 MG/ML PEDIATRIC DILUTION,1236.95,742.17,101.59,4481.0,35 CDM,RX-408470433,EPINEPHRINE 1000 MCG/100 ML (10 MCG/ML) NS SUBCUTANEOUS (OR),112.05,67.23,3.06,4481.0,24 CDM,RX-408470437,"PENICILLIN G POTASSIUM 100,000 UNITS/ML IM DILUTION",65.55,39.33,1.78,4481.0,24 CDM,RX-408470501,LIDOCAINE 1 G (LASER TUMESCENT) IN 500 ML LR,215.1,129.06,0.0225,4481.0,24 CDM,RX-408470509,SODIUM FERRIC GLUCONATE 250 MG IN 100 ML PREMIX (SSC),478.95,287.37,4.54,4481.0,24 CDM,RX-40847151,NAFCILLIN 1 GRAM INJ COMBINED WRAPPER,101.3,60.78,0.1125,4481.0,24 CDM,RX-40847152,NAFCILLIN 2 GRAM INJ COMBINED WRAPPER,103.9,62.34,0.1125,4481.0,24 CDM,RX-40847153,CEFEPIME 1 GRAM INJ COMBINED WRAPPER,40.8,24.48,2.75,4481.0,24 CDM,RX-40847154,CEFEPIME 2 GRAM INJ COMBINED WRAPPER,71.15,42.69,2.75,4481.0,24 CDM,RX-40847164,AMPICILLIN 1 GRAM INJ COMBINED WRAPPER,34.9,20.94,1.24,4481.0,24 CDM,RX-40847165,AMPICILLIN 2 GRAM INJ COMBINED WRAPPER,43.75,26.25,1.24,4481.0,24 CDM,RX-40847169,CEFTAZIDIME 1 GRAM INJECTION COMBINED WRAPPER,33.55,20.13,3.53,4481.0,24 CDM,RX-40847170,CEFTAZIDIME 2 GRAM INJECTION COMBINED WRAPPER,55.0,33.0,3.53,4481.0,24 CDM,RX-40847176,AMIKACIN 250 MG/ML INJECTION SOLUTION WRAPPER,45.25,27.15,1.42,4481.0,24 CDM,RX-40847209,SQUARIC ACID 5 % IN ACETONE,164.5,98.7,38.16,4481.0,19 CDM,RX-40849112,BUPIVACAINE (PF) 0.5 % (5 MG/ML) PAIN BALL 270 ML,141.6,84.96,0.0225,4481.0,24 CDM,RX-40849119,POLYMYXIN/GENTAMICIN (DAB SOLUTION) FOR IRRIGATION (OR),90.1,54.06,20.9,4481.0,19 CDM,RX-40849120,DEXMEDETOMIDINE 20 MCG/5 ML SYRINGE (OR),107.15,64.29,24.86,4481.0,19 CDM,RX-40849121,EPINEPHRINE (PED) 250 MCG/250 ML NS SUBCUTANEOUS (OR),81.0,48.6,1.08,4481.0,24 CDM,RX-40849126,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 8 ML SYRINGE (PEDS),24.4,14.64,5.66,4481.0,19 CDM,RX-40849127,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 24 ML SYRINGE (PEDS),41.2,24.72,9.56,4481.0,19 CDM,RX-40849128,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 50 ML SYRINGE (PEDS),68.5,41.1,15.89,4481.0,19 CDM,RX-40849130,ASPIRIN ORAL DESENSITIZATION 1 MG/ML BULK SOLUTION,16.05,9.63,3.72,4481.0,19 CDM,RX-40849143,ALTEPLASE 10 MG/10 ML SYRINGE FOR IRRIGATION,2764.4,1658.64,91.62,4481.0,35 CDM,RX-40849145,AMPHOTERICIN B LIPOSOME (AMBISOME) INHALATION,583.45,350.07,20.84,4481.0,35 CDM,RX-40849151,PENTOBARBITAL 2500MG/50 ML ADULT INFUSION,6815.6,4089.36,121.21,5896.18,24 CDM,RX-40849154,GENTAMICIN 100 MG IN LR 1000 ML (KIDNEY FLUSH),82.65,49.59,4.97,4481.0,24 CDM,RX-40849164,BUPIVACAINE 0.125% IN NS EPIDURAL SYRINGE FOR OR,28.8,17.28,0.0225,4481.0,24 CDM,RX-40849167,"HEPARIN 30,000 UNITS (CELL SAVER) IN 1000 ML NS",31.6,18.96,0.4725,4481.0,24 CDM,RX-40849169,TRIVEX TUMESCENT SOLUTION (LIDOCAINE500MG/EPINEPHRINE2MG/NS),141.5,84.9,0.0225,4481.0,24 CDM,RX-40849170,LIDOCAINE 2 G (LASER TUMESCENT) IN 1000 ML LR,367.15,220.29,0.0225,4481.0,24 CDM,RX-40849172,DEFEROXAMINE 500 MG SOLUTION FOR IV ADMIXTURE USE,66.6,39.96,15.45,4481.0,24 CDM,RX-40849174,CUPRIC CHLORIDE 40 MCG/ML INTRAVENOUS DILUTION,64.65,38.79,15.0,4481.0,19 CDM,RX-40849175,LEVOCARNITINE 25 MG/ML INTRAVENOUS DILUTION,155.2,93.12,36.01,4481.0,24 CDM,RX-40849176,MAGNESIUM SULFATE 2.03 MEQ/ML INJECTION DILUTION,45.65,27.39,1.08,4481.0,24 CDM,RX-40849177,ZINC CHLORIDE 0.5 MG/ML INTRAVENOUS DILUTION,200.9,120.54,46.61,4481.0,19 CDM,RX-40849178,LIDOCAINE 300 MG-EPINEPHRINE 1 MG IN LR 1000 ML (PLASTICS-TUMESCENT),99.0,59.4,0.0225,4481.0,24 CDM,RX-40849195,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (200 ML),268.0,160.8,62.18,4481.0,19 CDM,RX-40849196,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (300 ML),370.5,222.3,85.96,4481.0,19 CDM,RX-40849197,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (400 ML),473.0,283.8,109.74,4481.0,19 CDM,RX-40849198,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (500 ML),575.45,345.27,133.5,4481.0,19 CDM,RX-40849199,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (600 ML),677.95,406.77,157.28,4481.0,19 CDM,RX-40849200,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (700 ML),780.45,468.27,181.06,4481.0,19 CDM,RX-40849201,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (800 ML),882.95,529.77,204.84,4481.0,19 CDM,RX-40849202,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (900 ML),985.45,591.27,228.62,4481.0,19 CDM,RX-40849205,FLUCONAZOLE 800 MG/400 ML NS IVPB,199.05,119.43,5.08,4481.0,24 CDM,RX-40849208,FLUCONAZOLE 2 MG/ML (ODD DOSE) IN SODIUM CHLORIDE 0.9% IVPB (60MIN ADMIN),131.05,78.63,5.08,4481.0,24 CDM,RX-40849209,BECLOMETHASONE 1 MG/ML IN CORN OIL EMULSION,16.2,9.72,3.76,4481.0,19 CDM,RX-40849240,ALTEPLASE 0.81 MG/KG STROKE INFUSION,34337.45,20602.47,91.62,29705.33,35 CDM,RX-40849242,ARGATROBAN CRRT REGIONAL CIRCUIT INFUSION (50 MG/50 ML),456.9,274.14,0.776,4481.0,35 CDM,RX-40849245,POTASSIUM CHLORIDE FOR THERAPEUTIC ABORTION,71.6,42.96,0.2475,4481.0,24 CDM,RX-40849253,IBUTILIDE FUMARATE 0.1 MG/ML (FOR OR USE) INTRAVENOUS SOLUTION,1893.65,1136.19,167.14,4481.0,35 CDM,RX-40849260,GLYCINE DILUENT INTRAVENOUS SOLUTION,104.4,62.64,24.22,4481.0,19 CDM,RX-40849310,NITROGLYCERIN 12 MG/120 ML (100 MCG/ML) IN HEPARINIZED SALINE 120 ML,64.1,38.46,3.35,4481.0,24 CDM,RX-40849341,DILTIAZEM 100 MCG/ML IN NS,63.05,37.83,14.63,4481.0,19 CDM,RX-40849344,BIVALIRUDIN 250 MG/50 ML INFUSION (CATH LAB),126.8,76.08,0.3825,4481.0,24 CDM,RX-40849347,FOSCARNET 2.4 MG/0.1 ML INTRAVITREAL SOLUTION,63.55,38.13,15.6,4481.0,35 CDM,RX-40849375,ALTEPLASE 125 MCG/ML INTRAOCULAR INJECTION,18.85,11.31,4.77,4481.0,35 CDM,RX-40849376,ALTEPLASE 250 MCG/ML INTRAOCULAR INJECTION,174498.9,104699.34,91.62,150959.0,35 CDM,RX-40849378,AMPHOTERICIN B 50 MCG/ML INTRAOCULAR INJECTION,16.05,9.63,3.72,4481.0,24 CDM,RX-40849380,VANCOMYCIN 1 MG/0.1 ML (1%) INTRAOCULAR SYRINGE,63.1,37.86,0.0675,4481.0,24 CDM,RX-40849381,VORICONAZOLE (VFEND) 0.1% (100 MCG/0.1 ML) INTRAOCULAR,64.25,38.55,1.73,4481.0,24 CDM,RX-40849384,AMINOPHYLLINE 300 MG IN 50 ML NS (CATH LAB OSM),377.6,226.56,22.61,4481.0,24 CDM,RX-40849386,"LIPASE-PROTEASE-AMYLASE 24,000-76,000-120,000 UNIT CAPSULE,DELAYED REL (TUBE DECLOG)",41.55,24.93,9.64,4481.0,19 CDM,RX-40849442,EPINEPHRINE 1 MG IN LR 1000 ML (PLASTICS-TUMESCENT),72.85,43.71,3.06,4481.0,24 CDM,RX-40849443,FACTOR VIIA RECOMB (NOVOSEVEN) INTERMITTENT INFUSION,86.7,52.02,2.58,4481.0,35 CDM,RX-40849461,VANCOMYCIN 2.5 MG/ML (2 ML) LOCK IN NS,22.3,13.38,0.0675,4481.0,24 CDM,RX-40849462,VANCOMYCIN 2.5 MG/ML (5 ML) LOCK IN NS,28.7,17.22,0.0675,4481.0,24 CDM,RX-40849463,VANCOMYCIN-GENTAMICIN 2.5-1 MG/ML (2 ML) LOCK IN NS,24.0,14.4,0.0675,4481.0,24 CDM,RX-40849464,VANCOMYCIN-GENTAMICIN 2.5-1 MG/ML (5 ML) LOCK IN NS,27.0,16.2,0.0675,4481.0,24 CDM,RX-40849468,DEXMEDETOMIDINE 800 MCG/200 ML (4 MCG/ML) IN 0.9 % NS,429.25,257.55,99.59,4481.0,19 CDM,RX-40849484,TOBRAMYCIN 5 MG/3 ML NS INTRATHECAL,79.65,47.79,5.33,4481.0,24 CDM,RX-40849487,AMPHOTERICIN B CONVENTIONAL 0.5 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 CDM,RX-40849501,KETAMINE 10 MG/ML INJECTION SYRINGE WRAPPER,46.85,28.11,8.42,4481.0,57 CDM,RX-40849530,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION NON-PVC,72.0,43.2,1.46,4481.0,63 CDM,RX-40849532,STUDY IRB #15-1307 CEFTOLOZANE-TAZOBACTAM 1.5 GRAM INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40849537,CEFTAZIDIME DESENSITIZATION 0.001 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 CDM,RX-40849539,CEFTAZIDIME DESENSITIZATION 0.01 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 CDM,RX-40849541,CEFTAZIDIME DESENSITIZATION 0.1 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 CDM,RX-40849543,CEFTAZIDIME DESENSITIZATION 1 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 CDM,RX-40849545,CEFTAZIDIME DESENSITIZATION 10 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 CDM,RX-40849572,CEFUROXIME 1MG/0.1ML INTRACAMERAL INJECTION,63.05,37.83,4.16,4481.0,24 CDM,RX-40849579,FORMALDEHYDE (FORMALIN) 4 % IN SWFI 300 ML,186.6,111.96,43.29,4481.0,19 CDM,RX-40849580,AMPHOTERICIN B 100 MCG/ML INTRAOCULAR INJECTION,16.05,9.63,3.72,4481.0,24 CDM,RX-40849655,MANNITOL 25 % INTRAVENOUS INFUSION,39.8,23.88,0.135,4481.0,21 CDM,RX-40849705,PIPERACILLIN-TAZO 200 MG/ML DESENS SOL'N #1,72.8,43.68,2.41,4481.0,24 CDM,RX-40849706,PIPERACILLIN-TAZO 100 MG/ML DESENS SOL'N #2,63.05,37.83,2.41,4481.0,24 CDM,RX-40849707,PIPERACILLIN-TAZO 10 MG/ML DESENS SOL'N #3,63.05,37.83,2.41,4481.0,24 CDM,RX-40849708,PIPERACILLIN-TAZO 1 MG/ML DESENS SOL'N #4,63.05,37.83,2.41,4481.0,24 CDM,RX-40849709,PIPERACILLIN-TAZO 0.1 MG/ML DESENS SOL'N #5,63.05,37.83,2.41,4481.0,24 CDM,RX-40849737,"FENTANYL 12.5 MCG, BUPIVACAINE 0.2% (1.25 ML SYRINGE) CSE",22.65,13.59,5.25,4481.0,19 CDM,RX-40849738,FENTANYL 50 MCG BUPIVACAINE 0.125% IN SODIUM CHLORIDE 0.9% (15 ML SYRINGE),24.85,14.91,2.48,4481.0,24 CDM,RX-40849747,EPTIFIBATIDE 0.75 MG/ML BOLUS (CATH),390.0,234.0,22.95,4481.0,24 CDM,RX-40849764,NALOXONE 1 MG/ML INTRANASAL SOLUTION,144.7,86.82,0.18,4481.0,24 CDM,RX-40849770,HUM PROTHROMBIN CPLX(PCC)4FACT 500 UNIT/20 ML IV KIT,87.25,52.35,2.08,4481.0,35 CDM,RX-40849771,HYDROCORTISONE SOD SUCCINATE (PF) 100 MG/2 ML SOLUTION INJ ACTOVIAL/VIAL WRAPPER,90.7,54.42,21.04,4481.0,24 CDM,RX-40849773,TOBRAMYCIN SULFATE (PEDIATRIC) 10 MG/ML (PF),99.65,59.79,5.33,4481.0,24 CDM,RX-40849774,NITROGLYCERIN 400 MCG/ML BOLUS INJECTION (VIR/CATH),63.1,37.86,3.35,4481.0,24 CDM,RX-40849781,FENTANYL (PF) 25 MCG/2.5 ML (10 MCG/ML) INJECTION,24.1,14.46,2.48,4481.0,24 CDM,RX-40849788,FENTANYL (PF) 25 MCG/2.5 ML (10 MCG/ML) INFUSION SYRINGE,24.1,14.46,2.48,4481.0,24 CDM,RX-40849802,EPINEPHRINE 1 MG/ML INJECTION WRAPPER,308.5,185.1,2.38,4481.0,24 CDM,RX-40849811,MORPHINE 2 MG/ML INJECTION PF WRAPPER,25.25,15.15,4.91,4481.0,24 CDM,RX-40849812,MORPHINE 4 MG/ML INJECTION WRAPPER,24.95,14.97,4.91,4481.0,24 CDM,RX-40849817,"(FVIII DOSING) ANTIHEMOPHILIC FACTOR-VWF 1,000 UNIT-2,400 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 CDM,RX-40849821,PHENYLEPHRINE 40 MCG/ML DILUTION,62.8,37.68,0.0225,4481.0,24 CDM,RX-40849831,"HEPARIN (PORCINE) 10,000 UNIT/1,000 ML IN NS (UNCH CUPID)",154.45,92.67,0.4725,4481.0,24 CDM,RX-40849835,CHOLESTYRAMINE 20% IN AQUAPHOR OINTMENT,108.1,64.86,25.08,4481.0,19 CDM,RX-40849837,MEROPENEM DESENSITIZATION DILUTION 0.0001 MG/ML,63.2,37.92,0.945,4481.0,24 CDM,RX-40849839,MEROPENEM DESENSITIZATION DILUTION 0.001 MG/ML,63.2,37.92,0.945,4481.0,24 CDM,RX-40849841,MEROPENEM DESENSITIZATION DILUTION 0.01 MG/ML,63.2,37.92,0.945,4481.0,24 CDM,RX-40849843,MEROPENEM DESENSITIZATION DILUTION 0.1 MG/ML,63.25,37.95,0.945,4481.0,24 CDM,RX-40849845,MEROPENEM DESENSITIZATION DILUTION 1 MG/ML,63.85,38.31,0.945,4481.0,24 CDM,RX-40849849,DESENSITIZATION DILUTION 0.0001 MG/ML,63.0,37.8,1.8,4481.0,24 CDM,RX-40849850,DESENSITIZATION DILUTION 0.001 MG/ML,16.0,9.6,1.8,4481.0,24 CDM,RX-40849851,DESENSITIZATION DILUTION 0.01 MG/ML,16.0,9.6,1.8,4481.0,24 CDM,RX-40849852,DESENSITIZATION DILUTION 0.1 MG/ML,16.0,9.6,1.8,4481.0,24 CDM,RX-40849853,DESENSITIZATION DILUTION 1 MG/ML,16.0,9.6,1.8,4481.0,24 CDM,RX-40849854,DESENSITIZATION DILUTION 10 MG/ML,16.0,9.6,1.8,4481.0,24 CDM,RX-40849855,MEROPENEM DESENSITIZATION DILUTION 10 MG/ML,69.75,41.85,0.945,4481.0,24 CDM,RX-40849886,CEFAZOLIN 2 GRAM/50 ML IN DEXTROSE WRAPPER,119.25,71.55,1.8,4481.0,24 CDM,RX-40849890,HEPATITIS B VACC RECMB(PF) 0.5 ML IM WRAPPER,107.55,64.53,24.95,4481.0,26 CDM,RX-40849896,KETAMINE 100 MG/ML INTRANASAL SOLUTION,47.05,28.23,10.92,4481.0,19 CDM,RX-40849902,MENTHOL LOZENGES WRAPPER,1.05,0.63,0.2436,4481.0,19 CDM,RX-40849909,CEFEPIME 1 GRAM SOLUTION FOR IV PUSH,39.4,23.64,2.75,4481.0,24 CDM,RX-40849910,CEFEPIME 2 GRAM SOLUTION FOR IV PUSH',55.0,33.0,2.75,4481.0,24 CDM,RX-40849916,CEFUROXIME SODIUM 750 MG SOLUTION FOR IV PUSH,24.9,14.94,4.16,4481.0,24 CDM,RX-40849917,CEFUROXIME SODIUM 1.5 GRAM SOLUTION FOR IV PUSH,33.55,20.13,4.16,4481.0,24 CDM,RX-40849918,DAPTOMYCIN 500 MG SOLUTION FOR IV PUSH,177.45,106.47,0.0675,4481.0,24 CDM,RX-40849929,AMPICILLIN-SULBACTAM 3 GRAM MBP/ADV WRAPPER,72.8,43.68,3.13,4481.0,24 CDM,RX-40849952,CEFTRIAXONE 1 GRAM SOLUTION FOR IV PUSH,21.95,13.17,0.9675,4481.0,24 CDM,RX-40849972,"DOBUTAMINE 32 MG/8 ML (4,000 MCG/ML) IN 5 % DEXTROSE (8 ML)",66.1,39.66,15.34,4481.0,24 CDM,RX-40849973,"DOBUTAMINE 200 MG/50 ML (4,000 MCG/ML) IN 5 % DEXTROSE (50 ML)",79.35,47.61,15.93,4481.0,24 CDM,RX-40849994,LORAZEPAM 2 MG/ML INJECTION WRAPPER,23.45,14.07,3.1,4481.0,24 CDM,RX-40850034,STUDY ARST1431 TEMSIROLIMUS 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4581.99,35 CDM,RX-40850042,BUMETANIDE 0.25 MG/ML PEDIATRIC 2 ML INFUSION,66.5,39.9,0.3589,4481.0,35 CDM,RX-40850045,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) TOPICAL OR INHALATION SOLUTION",94.0,56.4,21.81,4481.0,19 CDM,RX-40850049,HYDROCHLOROTHIAZIDE 5 MG/ML ORAL SUSPENSION,20.65,12.39,4.79,4481.0,19 CDM,RX-40850068,MIDAZOLAM 5 MG/ML (COMBINED) INTRANASAL SOLUTION WRAPPER,32.35,19.41,0.3375,4481.0,96 CDM,RX-40850075,CLONIDINE 20 MCG/ML ORAL SOLN,17.65,10.59,4.09,4481.0,19 CDM,RX-40850080,LIDOCAINE (PF) 10 MG/ML (1 %) FOR NEBULIZATION,25.25,15.15,5.14,4481.0,57 CDM,RX-40850081,FLECAINIDE 20 MG/ML ORAL SUSPENSION,17.65,10.59,4.09,4481.0,19 CDM,RX-40850084,HYDROCORTISONE 2 MG/ML ORAL SUSPENSION,16.35,9.81,3.79,4481.0,19 CDM,RX-40850091,SQUARIC ACID 2 % IN ACETONE,78.7,47.22,18.26,4481.0,19 CDM,RX-40850094,NAFCILLIN 20 MG/ML PEDIATRIC DILUTION,427.65,256.59,0.1125,4481.0,24 CDM,RX-40850097,GLUTAMINE 250 MG/ML ORAL SUSPENSION,2.85,1.71,0.6612,4481.0,19 CDM,RX-40850106,STUDY TBCRC-059 ABEMACICLIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850107,STUDY TBCRC-058 ENZALUTAMIDE 40 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850108,STUDY TBCRC-058 MIFEPRISTONE 300 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-40850117,STUDY PUMA-ALI-1201 FULVESTRANT 250 MG/5 ML INTRAMUSCULAR,0.2,0.12,0.0506,4481.0,35 CDM,RX-40850118,STUDY PUMA-ALI-1201 ANASTROZOLE 1 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850119,STUDY PUMA-ALI-1201 LETROZOLE 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850120,STUDY PUMA-ALI-1201 EXEMESTANE 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850121,STUDY PUMA-ALI-1201 TAMOXIFEN 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850123,STUDY (PUMA-ALI-1201) ALISERTIB ENTERIC-COATED 10 MG TABLET,0.2,0.12,0.0464,4481.0,20 CDM,RX-40850125,STUDY AC220-168 QUIZARTINIB/PLACEBO 20 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-40850126,STUDY AC220-168 QUIZARTINIB/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-40850127,STUDY CPI-818-004 SOQUELITINIB (CPI-818) 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850128,STUDY J3M-MC-JZQB OLOMORASIB (LY3537982)/PLACEBO 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850129,STUDY J3M-MC-JZQB OLOMORASIB (LY3537982)/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850130,STUDY D798KC00001 VOLRUSTOMIG 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850132,STUDY M22-574 BORTEZOMIB 1 MG/ML IV SYRINGE,0.2,0.12,0.0464,4481.0,24 CDM,RX-40850133,STUDY M22-574 BORTEZOMIB 2.5 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,24 CDM,RX-40850134,STUDY M22-574 CARFILZOMIB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,7908.6,35 CDM,RX-40850139,STUDY M22-574 ELOTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40850141,STUDY M22-574 POMALIDOMIDE 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850142,STUDY M22-574 POMALIDOMIDE 3 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850143,STUDY M22-574 POMALIDOMIDE 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850144,STUDY M22-574 POMALIDOMIDE 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850145,STUDY M22-574 SELINEXOR 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850146,STUDY M22-574 SELINEXOR 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850147,STUDY M22-574 SELINEXOR 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850148,STUDY M22-574 SELINEXOR 60 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850149,STUDY INBRX106-01-201 INBRX-106 0.1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850150,STUDY INBRX106-01-201 INBRX-106/PLACEBO 0.1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850151,STUDY JNJ-90301900NSC2001 JNJ-90301900 54.2 G/L INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850152,STUDY MCLA-158-CL02 PETOSEMTAMAB (MCLA-158) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850160,STUDY 21820 BAY 3375968 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850162,STUDY 21820 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40850164,STUDY RPL-003-19 RP1 (VUSOLIMOGENE ODERPAREPVEC) 1 X 10E6 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850165,STUDY RPL-003-19 RP1 (VUSOLIMOGENE ODERPAREPVEC) 1 X 10E7 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850196,STUDY 3265 MIDAZOLAM/PLACEBO 2 MG/ML ORAL SOLUTION (ROUND 0.1 ML),0.2,0.12,0.0464,4481.0,19 CDM,RX-408501968,STUDY REM-PH-418 TREPROSTINIL 2.5 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850274,STUDY NRG-GI004-CIRB ATEZOLIZUMAB 60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-40850324,STUDY CA-ALT-803-01-16 BCG 50 MG INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40850383,STUDY ETCTN10186-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 CDM,RX-40850389,STUDY IND LOXO-305 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850390,STUDY IND LOXO-305 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850414,BETHANECHOL 5 MG/ML ORAL SUSPENSION,34.0,20.4,7.89,4481.0,19 CDM,RX-40850415,RIFAMPIN 25 MG/ML ORAL SUSPENSION,88.0,52.8,20.42,4481.0,19 CDM,RX-40850416,CEFTAROLINE FOSAMIL 0.01 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 CDM,RX-40850417,CEFTAROLINE FOSAMIL 0.001 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 CDM,RX-40850418,CEFTAROLINE FOSAMIL 10 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 CDM,RX-40850440,STUDY 54767414MMY3021 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40850448,STUDY A031702-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850451,STUDY EAA173CIRB DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11069.1,35 CDM,RX-40850457,STUDY A031704-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850473,STUDY 56021927PCR3011 LEUPROLIDE 22.5 MG INTRAMUSCULAR INJECTION,0.2,0.12,0.0506,26039.58,35 CDM,RX-40850474,STUDY 56021927PCR3011 LEUPROLIDE 22.5 MG SUBCUTANEOUS INJECTION,0.2,0.12,0.0506,26039.58,35 CDM,RX-40850483,STUDY A041703-CIRB INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,435080.31,35 CDM,RX-40850485,STUDY A041703-CIRB BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 CDM,RX-40850495,STUDY S1803-CIRB DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40850519,STUDY SODIUM CHLORIDE 0.9% BACTERIOSTATIC INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40850523,STUDY MK7902-010-WIRB PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40850529,STUDY AALL1732 INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,435080.31,35 CDM,RX-40850555,STUDY 849-001 CETUXIMAB 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11827.62,35 CDM,RX-40850556,STUDY LOXO-RAS-20001 CETUXIMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,11827.62,35 CDM,RX-40850579,STUDY DEXAMETHASONE 0.1% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850582,STUDY IND TAFASITAMAB 40 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40850585,STUDY LCCC2037 OLANZAPINE / PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850586,STUDY LCCC2037 OLANZAPINE / PLACEBO 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850587,TACROLIMUS 0.01 MG/ML IV SYRINGE,236.35,141.81,59.8,4481.0,35 CDM,RX-40850612,STUDY INCB57643-103 INCB057643 2 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850613,STUDY INCB57643-103 INCB057643 4 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850635,STUDY AFT-41 DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11069.1,35 CDM,RX-40850641,STUDY AFT-41 LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850702,STUDY AALL1821 BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 CDM,RX-40850711,STUDY GSK-209626-DREAMM12 BELANTAMAB MAFODOTIN 50 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-40850739,REMDESIVIR 100 MG INTRAVENOUS POWDER FOR SOLUTION (EUA),2023.05,1213.83,6.53,4481.0,35 CDM,RX-40850748,STUDY DF-HCC-20-166 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40850750,STUDY DF-HCC-20-166 SACITUZUMAB GOVITECAN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5859.42,35 CDM,RX-40850759,STUDY A031801-CIRB CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,26 CDM,RX-40850760,STUDY A031801-CIRB CABOZANTINIB 60 MG TABLET,0.2,0.12,0.0464,4481.0,26 CDM,RX-40850768,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (5 MCG/M2/DAY, 24-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 CDM,RX-40850770,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 24-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 CDM,RX-40850772,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (5 MCG/M2/DAY, 48-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 CDM,RX-40850774,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 48-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 CDM,RX-40850776,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 7-DAY INFUSION)",18667.95,11200.77,159.32,24925.32,35 CDM,RX-40850798,STUDY LP-118-US-I01 LP-118 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850799,STUDY LP-118-US-I01 LP-118 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850812,STUDY LCCC2047 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40850814,STUDY LCCC2047 OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,20 CDM,RX-40850815,STUDY LCCC2047 OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,20 CDM,RX-40850818,STUDY IND GLOFITAMAB 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,453849.27,35 CDM,RX-40850820,STUDY IND OBINUTUZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11677.68,35 CDM,RX-40850825,STUDY LCCC1915 PERFLUTREN LIPID MICROSPHERES INTRAVENOUS SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-408508256,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION FOR STROKE,32375.35,19425.21,167.05,28007.92,35 CDM,RX-40850826,STUDY R5458-ONC-2012 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,52 CDM,RX-40850831,STUDY TBCRC-053 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40850833,STUDY HCRN-AML20-472 TAGRAXOFUSP 100 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,55411.65,35 CDM,RX-40850835,STUDY A051902-CIRB CC-486 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850836,STUDY A051902-CIRB CC-486 150 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850838,STUDY A051902-CIRB DUVELISIB 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-40850839,STUDY A051902-CIRB DUVELISIB 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-40850840,STUDY AFT-41 LENALIDOMIDE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850841,STUDY AFT-41 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40850842,STUDY 56021927PCR3011 APALUTAMIDE 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850844,STUDY LCCC2117 TRILACICLIB 15 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40850846,STUDY LCCC2036 ONC201 125 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850847,STUDY LCCC2036 ATEZOLIZUMAB 60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,14630.91,70 CDM,RX-40850849,STUDY LOXO-NGR-21001 LOXO-260 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850850,STUDY LOXO-NGR-21001 LOXO-260 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850857,STUDY 20200469 TARLATAMAB 0.9 MG/ML INTRAVENOUS SOLUTION (1 MG VIAL),0.2,0.12,0.0506,257101.53,35 CDM,RX-40850860,STUDY 20200469 TARLATAMAB 2.4 MG/ML INTRAVENOUS SOLUTION (10 MG VIAL),0.2,0.12,0.0506,257101.53,35 CDM,RX-40850862,STUDY 20200469 TARLATAMAB 4.8 MG/ML INTRAVENOUS SOLUTION (25 MG VIAL),0.2,0.12,0.0506,257101.53,35 CDM,RX-40850867,STUDY DSP-5336-101 DSP-5336 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850868,STUDY INCB57643-103 RUXOLITINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850876,STUDY 64407564MMY3002 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40850877,STUDY 64407564MMY3002 TALQUETAMAB 2 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,11455.71,35 CDM,RX-40850885,STUDY NANORAY312 CETUXIMAB 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11827.62,35 CDM,RX-40850887,STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850889,STUDY DF-HCC-20-347-ADEPT TRASTUZUMAB 21 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11339.58,35 CDM,RX-40850891,"STUDY DF-HCC-20-347-ADEPT TRASTUZUMAB 600 MG-HYALURONIDASE 10,000 UNITS/5 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10297.35,35 CDM,RX-40850892,"STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURONIDASE 30,000 UNITS/15 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 CDM,RX-40850893,"STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONIDASE 20,000 UNITS/10 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 CDM,RX-40850894,STUDY GCT1046-01 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40850898,STUDY 64407564MMY3002 TALQUETAMAB 40 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,11455.71,35 CDM,RX-40850915,"STUDY NRG-GY026-CIRB TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNITS/5 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10297.35,35 CDM,RX-40850916,"STUDY NRG-GY026-CIRB PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURONIDASE-ZZXF 30,000 UNITS/15 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 CDM,RX-40850917,"STUDY NRG-GY026-CIRB PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONIDASE-ZZXF 20,000 UNITS/10 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 CDM,RX-40850919,STUDY IND DSP-0509 0.3 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850924,STUDY LCCC2119 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,70 CDM,RX-40850933,STUDY NRG-HN005-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850935,STUDY PBI-MST-01 PEMBROLIZUMAB 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40850936,STUDY PBI-MST-01 MK-0482 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-40850937,STUDY PBI-MST-01 MK-4830 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-40850938,STUDY PBI-MST-01 CIVO GLO YELLOW 400 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-40850939,STUDY PBI-MST-01 CIVO GLO RED 400 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-40850941,STUDY TBCRC-047 SACITUZUMAB GOVITECAN 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5859.42,35 CDM,RX-40850943,STUDY 20200469 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 CDM,RX-40850948,STUDY NX-1607-101 NX-1607 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850949,STUDY NX-1607-101 NX-1607 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850950,STUDY GOG-3078-GLORIOSA MIRVETUXIMAB SORAVTANSINE 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,11142.6,35 CDM,RX-40850964,STUDY S1925 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 CDM,RX-40850966,STUDY S1925 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850967,STUDY S1925 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850968,STUDY S1925 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850969,STUDY LCCC2115-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40850971,STUDY A051901-CIRB LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850972,STUDY A051901-CIRB LENALIDOMIDE 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40850973,STUDY A051901-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40850979,STUDY NCI-10464-CIRB DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 CDM,RX-40850981,STUDY NCI-10464-CIRB OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,20 CDM,RX-40850982,STUDY NCI-10464-CIRB OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,20 CDM,RX-40850990,STUDY CO43613 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 CDM,RX-40850994,STUDY CO43613 PACLITAXEL 6 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40850996,STUDY CO43613 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851003,STUDY EA9181-CIRB BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 CDM,RX-40851016,STUDY IND TARLATAMAB 0.9 MG/ML INTRAVENOUS SOLUTION (1 MG VIAL),0.2,0.12,0.0506,257101.53,35 CDM,RX-40851018,STUDY IND TARLATAMAB 2.4 MG/ML INTRAVENOUS SOLUTION (10 MG VIAL),0.2,0.12,0.0506,257101.53,35 CDM,RX-40851022,STUDY IND NIROGACESTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851025,STUDY M24-108 ETENTAMIG (ABBV-383) 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851032,STUDY GFH009X2101 GFH009 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851035,STUDY CABL001AUS08 ASCIMINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851053,STUDY GCT1046-01 CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851057,STUDY GCT1046-01 PEMETREXED 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851059,STUDY GCT1046-01 NAB-PACLITAXEL 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851060,STUDY GCT1046-01 CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851061,STUDY GCT1046-01 PACLITAXEL 6 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851065,STUDY NCI10522-CIRB CA-4948 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851070,STUDY SGNTV-001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851072,STUDY SGNTV-001 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851074,STUDY R5458-ONC-2012 REGN5458 (LINVOSELTAMAB) 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851076,STUDY R5458-ONC-2012 NIROGACESTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851077,STUDY R5458-ONC-2012 NIROGACESTAT 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851083,STUDY NCI-10538 ASTX727 (CEDAZURIDINE 100 MG-DECITABINE 35 MG) TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851084,STUDY NCI-10538 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851085,STUDY NCI-10538 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851086,STUDY NCI-10538 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851087,STUDY FP2CLI004 BEXMARILIMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851089,STUDY MGT-AQP1-201 GLYCOPYRROLATE 0.2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851091,STUDY MGT-AQP1-201 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-40851092,STUDY MGT-AQP1-201 TMN200P DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851094,STUDY MGT-AQP1-201 AAV2-HAQP1/TMN200P SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851095,STUDY FX-909-CLINPRO-1 FX-909 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851096,STUDY FX-909-CLINPRO-1 FX-909 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851097,STUDY CO44668 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 CDM,RX-40851100,STUDY CO44668 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,35 CDM,RX-40851101,STUDY CO44668 TIRAGOLUMAB / PLACEBO 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 CDM,RX-40851103,STUDY LOXO-RAS-20001 LY3537982 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851104,STUDY LOXO-RAS-20001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40851106,STUDY LCCC2032 SODIUM BUTYRATE/SODIUM PROPIONATE (SCFA) OR PLACEBO ORAL POWDER,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851108,STUDY SER-155-01 VANCOMYCIN / PLACEBO 125 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851109,STUDY SER-155-01 SER-155 / PLACEBO PART 1 (6.9 X 10E6 CFU) CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851110,STUDY SER-155-01 SER-155 / PLACEBO PART 2 (3.1 X 10E7 CFU) CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851113,STUDY PT217X1101 PT217 15 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851115,STUDY PT217X1101 PT217 0.5 MG/ML IV SYRINGE OR IVPB,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851117,STUDY LCCC2060-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851123,STUDY A22-203 ROPEGINTERFERON ALFA-2B-NJFT 500 MCG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851124,STUDY R1979-HM-2298 ODRONEXTAMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851125,STUDY R1979-HM-2298 ODRONEXTAMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851130,STUDY OSU-22114 TAFASITAMAB 40 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851132,STUDY TSCAN-002 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851134,STUDY TSCAN-002 FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 CDM,RX-40851139,STUDY EGFR-008-001 JANX008 0.05 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851140,STUDY EGFR-008-001 JANX008 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851141,STUDY P-CD19CD20-ALLO1-001 RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851145,STUDY CA0611001 (23-1564) FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 CDM,RX-40851147,STUDY CA0611001 (23-1564) CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851149,STUDY CA0611001 (23-1564) TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851152,STUDY R5458-ONC-2012 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851154,STUDY LCCC2032 SODIUM BUTYRATE/SODIUM PROPIONATE (SCFA) ORAL POWDER,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851155,STUDY LOXO-RAS-20001 PEMETREXED 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851157,STUDY LOXO-RAS-20001 CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851159,STUDY LOXO-RAS-20001 CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851161,STUDY CAB-201-001 (23-2231) FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 CDM,RX-40851163,STUDY CAB-201-001 (23-2231) CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-40851165,STUDY CAB-201-001 (23-2231) TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851167,STUDY ISB2001-101 ISB 2001 77 MG/ML (77000 MCG/ML) SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851168,STUDY ISB2001-101 ISB 2001 9.6 MG/ML (9600 MCG/ML) SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851169,STUDY ISB2001-101 ISB 2001 1 MG/ML (1000 MCG/ML) SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851171,STUDY R1979-HM-2298 RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 CDM,RX-40851173,"STUDY R1979-HM-2298 RITUXIMAB 1400 MG-HYALURONIDASE 23,400 UNITS/11.7N",0.2,0.12,0.0506,6141.66,35 CDM,RX-40851174,STUDY R1979-HM-2298 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-40851176,STUDY R1979-HM-2298 DOXORUBICIN 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851177,STUDY R1979-HM-2298 VINCRISTINE 1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851179,STUDY R1979-HM-2298 PREDNISONE 50 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-40851180,STUDY R1979-HM-2298 BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851182,STUDY R1979-HM-2298 ALBUMIN HUMAN 5% IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851183,STUDY R1979-HM-2298 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851185,STUDY A052101-CIRB ZANUBRUTINIB 80 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851186,STUDY IND VORASIDENIB 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851187,STUDY IND VORASIDENIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851188,STUDY EMERALD-Y90 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,70 CDM,RX-40851190,STUDY EMERALD-Y90 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 CDM,RX-40851194,STUDY SC9-GBM-03 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,38 CDM,RX-40851195,STUDY SCCC-03121 CDX-1140 3 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-408511968,STUDY REM-PH-418 TREPROSTINIL 1 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851197,STUDY SC9-GBM-03 PERFLUTREN LIPID MICROSPHERES IV SUSPENSION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851200,STUDY SCCC-03121 CDX-301 2500 MCG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851201,STUDY PRESERVE-006 ONC-392 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851219,STUDY IND MIRDAMETINIB 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851220,STUDY IND MIRDAMETINIB 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851226,STUDY D9470C00001 AZD9829 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851227,STUDY D9470C00001 STABILIZER SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851233,STUDY LCCC2223-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851244,STUDY NCI10596-CIRB SNDX-5613 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851245,STUDY NCI10596-CIRB SNDX-5613 113 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851246,STUDY NCI10596-CIRB SNDX-5613 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851253,STUDY M24-147 LIVMONIPLIMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851255,STUDY M24-147 BUDIGALIMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851257,STUDY M24-147 LENVATINIB 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851258,STUDY M24-147 SORAFENIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851269,STUDY PT217X1101 PT217 0.5 MG/ML IVPB OVER 2 HOURS (DL 1 AND 2; DOSE 25-50 MG),0.2,0.12,0.0464,4481.0,22 CDM,RX-40851270,STUDY AC676-001 AC676 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851271,STUDY AC676-001 AC676 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851274,STUDY MSK-22-424 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40851275,STUDY BGB-11417-301 SONROTOCLAX 1 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851276,STUDY BGB-11417-301 SONROTOCLAX 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851277,STUDY BGB-11417-301 SONROTOCLAX 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851278,STUDY BGB-11417-301 SONROTOCLAX 80 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851279,STUDY BGB-11417-301 ZANUBRUTINIB 80 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851280,STUDY BGB-11417-301 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851281,STUDY BGB-11417-301 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851282,STUDY BGB-11417-301 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851283,STUDY BGB-11417-301 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 CDM,RX-40851289,STUDY TAPUR FUTIBATINIB 4 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851290,STUDY AK117-205 AK117 (LIGUFALIMAB) / PLACEBO 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851292,STUDY AK117-205 AZACITIDINE 25 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851296,STUDY DFHCC-23-429 GLOFITAMAB 1 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 CDM,RX-40851299,STUDY DFHCC-23-429 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 CDM,RX-40851301,STUDY DFHCC-23-429 POLATUZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,21723.66,35 CDM,RX-40851303,STUDY DFHCC-23-429 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 CDM,RX-40851305,STUDY DFHCC-23-429 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851307,STUDY 61186372HNC2002 AMIVANTAMAB 160 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.05544,4481.0,62 CDM,RX-40851308,STUDY DB-1303-O-3002 DB-1303 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851310,STUDY IMGN151-1001 IMGN151 12 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851312,STUDY M22-574 ETENTAMIG (ABBV-383) 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851314,STUDY TBCRC-059 DEGARELIX 80 MG SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851315,STUDY TBCRC-059 DEGARELIX 120 MG SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851317,STUDY DS3201-324 VALEMETOSTAT 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851318,STUDY DS3201-324 VALEMETOSTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851319,STUDY DS3201-324 VALEMETOSTAT 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851320,STUDY DS3201-324 TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 CDM,RX-40851322,STUDY RP1-104 VUSOLIMOGENE ODERPAREPVEC 1 X 10E6 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851323,STUDY RP1-104 VUSOLIMOGENE ODERPAREPVEC 1 X 10E7 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851324,STUDY RP1-104 NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5024.46,35 CDM,RX-40851328,STUDY DS3201-324 DS-1062A (DATO-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851330,STUDY A062102-CIRB IBERDOMIDE 0.45 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851331,STUDY A062102-CIRB IBERDOMIDE 0.6 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851332,STUDY A062102-CIRB IBERDOMIDE 0.75 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851333,STUDY A062102-CIRB IBERDOMIDE 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851334,STUDY AAAU4206 ZIMBERELIMAB 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851336,STUDY AAAU4206 QUEMLICLUSTAT 12.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851338,STUDY AAAU4206 ETRUMADENANT 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851339,STUDY NX-1607-101 PACLITAXEL 6 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851342,STUDY NX-1607-101 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40851343,STUDY NCI-10440-CIRB IXAZOMIB 2.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-40851344,STUDY NCI-10440-CIRB IXAZOMIB 3 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-40851345,STUDY NCI-10440-CIRB IXAZOMIB 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 CDM,RX-40851346,STUDY NCI-10440-CIRB VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851347,STUDY NCI-10440-CIRB VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851348,STUDY NCI-10440-CIRB VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851349,STUDY BDTX-1535-101 BDTX-1535 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851350,STUDY BDTX-1535-101 BDTX-1535 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851351,STUDY BAML16-001 S21 ZE46-0134 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851353,STUDY SMT112-3003 IVONESCIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851354,STUDY SMT112-3003 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851356,STUDY 1719-001 MRTX1719 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851357,STUDY 1719-001 MRTX1719 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851358,STUDY 1719-001 MRTX1719 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851361,STUDY GO44145-SKYGLO GLOFITAMAB 1 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 CDM,RX-40851364,STUDY GO44145-SKYGLO POLATUZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,21723.66,35 CDM,RX-40851366,STUDY GO44145-SKYGLO RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 CDM,RX-40851369,STUDY GO44145-SKYGLO TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851371,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851372,STUDY R10597-ONC-22114 REGN10597 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851373,STUDY R10597-ONC-22114 REGN10597 1 MG/ML IV SOLUTION (INTERMEDIATE DILUTION),0.2,0.12,0.0464,4481.0,22 CDM,RX-40851374,STUDY R10597-ONC-22114 REGN10597 SOLUTION STABILIZER,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851383,STUDY OSU-23199 SNDX-5613 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851384,STUDY OSU-23199 SNDX-5613 113 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851385,STUDY ACCRU-LY-2201 EPCORITAMAB 0.16 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 CDM,RX-40851386,STUDY ACCRU-LY-2201 EPCORITAMAB 0.8 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 CDM,RX-40851387,STUDY ACCRU-LY-2201 EPCORITAMAB 60 MG/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8980.23,35 CDM,RX-40851390,STUDY CELLULAR THERAPY PRODUCT INFUSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851391,STUDY GENE THERAPY PRODUCT INFUSION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851398,STUDY IND MIFAMURTIDE 0.08 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851400,FLUOROURACIL (ADRUCIL) 50 MG/ML IV SOLUTION WRAPPER (UNC HOMECARE),372.0,223.2,4.48,4481.0,24 CDM,RX-40851401,STUDY PBI-MST-01 RILVEGOSTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-40851402,STUDY PBI-MST-01 VOLRUSTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-40851403,STUDY PBI-MST-01 SABESTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 CDM,RX-40851406,STUDY DFHCC-23-429 GLOFITAMAB 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 CDM,RX-40851407,STUDY D798KC00001 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-40851409,STUDY IND BAY2927088 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851416,STUDY JNJ-90301900NSC2001 JNJ-90301900 54.2 G/L PRIMING SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851417,STUDY J3M-MC-JZQB CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851419,STUDY J3M-MC-JZQB CISPLATIN 1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851421,STUDY J3M-MC-JZQB PEMETREXED 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851423,STUDY J3M-MC-JZQB PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 CDM,RX-40851425,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 72-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 CDM,RX-40851427,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 96-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 CDM,RX-40851429,STUDY 1463-0001 BI 765179 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851434,STUDY D798KC00001 MYCOPHENOLATE MOFETIL 500 MG TABLET,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851437,STUDY M20-356 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851438,STUDY M20-356 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851439,STUDY M20-356 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851440,STUDY AK117-205 AK117 (LIGUFALIMAB) / PLACEBO 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851441,STUDY 20230238 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851443,STUDY CAAA614A12101 NAB-PACLITAXEL 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851444,STUDY LBS-007-CT01 LBS-007 0.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851448,STUDY CAEL101-302 CAEL-101 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851450,STUDY R10597-ONC-22114 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851452,STUDY SMT112-3007 IVONESCIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851453,STUDY SMT112-3007 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851455,STUDY OSU-23199 SNDX-5613 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851456,STUDY OSU-23199 SNDX-5613 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851457,STUDY OSU-23199 SNDX-5613 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851458,STUDY OSU-23199 SNDX-5613 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851459,STUDY S095031-178 IVOSIDENIB 250 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851460,STUDY S095031-178 AZACITIDINE 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851462,STUDY S095031-178 AZACITIDINE 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851463,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851464,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851465,IRINOTECAN 20 MG/ML ORAL SOLUTION,93.7,56.22,3.81,4481.0,24 CDM,RX-40851466,STUDY IND BELANTAMAB MAFODOTIN 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851468,STUDY PRT7732-01 PRT7732 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851469,STUDY PRT7732-01 PRT7732 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851471,STUDY APVO436-5201 APVO436 1.06 MCG/ML IV SOLUTION (DILUTION),0.2,0.12,0.0464,4481.0,17 CDM,RX-40851472,STUDY APVO436-5201 APVO436 10.3 MCG/ML IV SOLUTION (DILUTION),0.2,0.12,0.0464,4481.0,17 CDM,RX-40851484,STUDY AUTX-703-001 AUTX-703 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851485,STUDY AUTX-703-001 AUTX-703 3 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851486,STUDY AUTX-703-001 AUTX-703 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851487,STUDY LCCC2415 TIRZEPATIDE 5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851488,STUDY LCCC2415 TIRZEPATIDE 2.5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851489,STUDY LCCC2502 TIRZEPATIDE 5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851490,STUDY LCCC2502 TIRZEPATIDE 2.5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851491,STUDY MK2140-011 ZILOVERTAMAB VEDOTIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851494,STUDY D798KC00001 INFLIXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,4783.38,35 CDM,RX-40851495,STUDY PT217X1101 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,26 CDM,RX-40851505,STUDY MM1OA-EA02 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851506,STUDY MM1OA-EA02 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851507,STUDY MM1OA-EA02 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851508,STUDY MM1OA-EA02 GILTERITINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,26 CDM,RX-40851509,STUDY LOXO-FG3-22001 LOXO-435 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851510,STUDY ALTE2131 TRIPTORELIN 22.5 MG INTRAMUSCULAR SUSPENSION,0.2,0.12,0.0464,4481.0,26 CDM,RX-40851511,STUDY GSK-218670 BELANTAMAB MAFODOTIN 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-40851514,STUDY GSK-218670 BELANTAMAB 75 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-40851521,STUDY TAPUR TALAZOPARIB 0.25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851522,STUDY TAPUR TALAZOPARIB 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851523,STUDY RMC-6236-301 RMC-6236 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851524,STUDY RMC-6236-301 RMC-6236 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851525,STUDY RMC-6236-301 DOCETAXEL 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851526,STUDY RMC-6236-301 DOCETAXEL 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 CDM,RX-40851529,STUDY NCI10596-CIRB SNDX-5613 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851530,STUDY NCI10596-CIRB SNDX-5613 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851531,STUDY NCI10596-CIRB SNDX-5613 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851533,STUDY 1719-001 MRTX1719 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851534,STUDY MK2140-011 PEGFILGRASTIM 6 MG/0.6 ML WEARABLE SUBCUTANEOUS INJECTOR,0.2,0.12,0.0464,4481.0,25 CDM,RX-40851535,STUDY PUL-042-207 PAM2CSK4 / ODN M362 OR PLACEBO 5 ML INHALATION SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851536,STUDY M25-059 ETENTAMIG (ABBV-383) 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851538,STUDY M25-059 LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851539,STUDY M25-059 LENALIDOMIDE 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851540,STUDY M25-059 LENALIDOMIDE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851541,STUDY M25-059 LENALIDOMIDE 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851542,STUDY M25-059 LENALIDOMIDE 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851543,STUDY M25-059 LENALIDOMIDE 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851544,STUDY LOXO-RAS-20001 LY3537982 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851545,STUDY AAAU4206 ETRUMADENANT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851546,STUDY AAAU4206 ETRUMADENANT 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851547,STUDY M25-059 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40851548,STUDY M25-059 CARFILZOMIB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,7908.6,35 CDM,RX-40851550,STUDY EG-70-101 EG-70 0.8 MG/ML INTRAVESICAL SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851551,STUDY TNG462-C102 TNG462 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851552,STUDY TNG462-C102 TNG462 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851553,STUDY TNG462-C102 TNG462 150 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851554,STUDY TNG462-C102 RMC-6236 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851555,STUDY TNG462-C102 RMC-6236 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851556,STUDY CRSP-AID-500 FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 CDM,RX-40851558,STUDY CRSP-AID-500 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 CDM,RX-40851560,STUDY CRSP-AID-500 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40851562,STUDY TNG462-C102 RMC-9805 300 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851563,STUDY BGB-11417-303 SONROTOCLAX 1 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851564,STUDY BGB-11417-303 SONROTOCLAX 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851565,STUDY BGB-11417-303 SONROTOCLAX 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851566,STUDY BGB-11417-303 SONROTOCLAX 80 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851567,STUDY BGB-11417-303 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851568,STUDY BGB-11417-303 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851569,STUDY BGB-11417-303 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851570,STUDY BGB-11417-303 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 CDM,RX-40851572,STUDY BGB-11417-303 RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,70 CDM,RX-40851574,STUDY M25-275 ABBV-453 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851575,STUDY M25-275 ABBV-453 80 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851576,STUDY M25-275 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 CDM,RX-40851580,STUDY KO-MEN-017 ZIFTOMENIB / PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851581,STUDY AALL2321 BLINATUMOMAB 12.5 MCG/ML IV SOLUTION,0.2,0.12,0.0506,24925.32,35 CDM,RX-40851590,STUDY APVO436-5201 APVO436 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851599,STUDY SLV-324-01TX SLV-324 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 CDM,RX-40851608,STUDY 20230238 XALURITAMIG (AMG 509) 0.09 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40851610,STUDY 20230238 XALURITAMIG (AMG 509) 0.46 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 CDM,RX-40859487,AMPHOTERICIN B CONVENTIONAL 1 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 CDM,RX-40860001,MEPERIDINE (PF) 25 MG/ML INJECTION WRAPPER,40.2,24.12,9.33,4481.0,24 CDM,RX-40860003,HYDROMORPHONE 2 MG/ML INJECTION WRAPPER,23.05,13.83,0.2025,4481.0,24 CDM,RX-40860004,EPHEDRINE 50 MG/ML INJECTION WRAPPER,129.3,77.58,30.0,4481.0,19 CDM,RX-40860007,MEPERIDINE (PF) 50 MG/ML INJECTION WRAPPER,30.0,18.0,6.96,4481.0,24 CDM,RX-40860008,WHITE PETROLATUM-MINERAL OIL-LANOLIN TOPICAL CREAM WRAPPER,12.4,7.44,2.88,4481.0,19 CDM,RX-40860010,ARGATROBAN 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS WRAPPER,456.9,274.14,0.776,4481.0,35 CDM,RX-40860011,COCAINE 4 % SOLUTION WRAPPER,766.8,460.08,3.87,4481.0,23 CDM,RX-40860012,LIDOCAINE (PF) 20 MG/ML (2 %) INECTION SOLUTION WRAPPER,29.05,17.43,0.0225,4481.0,72 CDM,RX-40860013,"HEPATITIS A VACCINE (PF) 1,440 ELISA UNIT/ML INTRAMUSCULAR WRAPPER",278.25,166.95,64.55,4481.0,25 CDM,RX-40860014,BACITRACIN 500 UNIT/GRAM TOPICAL PACKET WRAPPER,1.15,0.69,0.2668,4481.0,19 CDM,RX-40860015,TIMOLOL MALEATE 0.5 % EYE DROPS WRAPPER,45.625,27.375,7.54,4481.0,38 CDM,RX-40860017,HALOPERIDOL LACTATE 5 MG/ML INJECTION WRAPPER,20.7,12.42,1.8,4481.0,24 CDM,RX-40860018,PEG-ELECTROLYTE ORAL SOLUTION WRAPPER,88.25,52.95,20.47,4481.0,19 CDM,RX-40860021,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION WRAPPER",566.375,339.825,93.55,4481.0,48 CDM,RX-40860022,ACETAMINOPHEN 650 MG/20.3 ML ORAL LIQUID WRAPPER,3.85,2.31,0.8932,4481.0,19 CDM,RX-40860023,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL LIQUID WRAPPER,3.55,2.13,0.8236,4481.0,19 CDM,RX-40860220,VANCOMYCIN 750 MG/250 ML NS IVPB PREMADE (282.5 ML TOTAL VOLUME),188.65,113.19,0.0675,4481.0,24 CDM,RX-40860221,VANCOMYCIN 1250 MG/250 ML NS IVPB PREMADE (287.5 ML TOTAL VOLUME),229.45,137.67,0.0675,4481.0,24 CDM,RX-40860222,VANCOMYCIN 1500 MG/500 ML NS IVPB PREMADE (555 ML TOTAL VOLUME),246.3,147.78,0.0675,4481.0,24 CDM,RX-40860223,VANCOMYCIN 1750 MG/500 ML NS IVPB PREMADE (557.5 ML TOTAL VOLUME),199.75,119.85,0.0675,4481.0,24 CDM,RX-40860224,VANCOMYCIN 2000 MG/500 ML NS IVPB PREMADE (560 ML TOTAL VOLUME),216.85,130.11,0.0675,4481.0,24 CDM,RX-40860227,VANCOMYCIN 1000 MG/250 ML NS IVPB PREMADE (285 ML TOTAL VOLUME),145.05,87.03,0.0675,4481.0,24 CDM,RX-4086246,PHENYLEPHRINE 2.5 % EYE DROPS (MULTI-PATIENT),16.95,10.17,3.93,4481.0,19 CDM,RX-408651968,"STUDY IRB#22-1310 ERGOCALCIFEROL/PLACEBO 50,000 IU CAPSULE",0.2,0.12,0.0464,4481.0,17 CDM,RX-408661968,STUDY 1346-0013 BI 425809/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 CDM,RX-40869487,AMPHOTERICIN B CONVENTIONAL 1.5 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 CDM,RX-4087108639,VITAMIN A ORAL SOLUTION 2500 MCG RAE/ML,2.25,1.35,0.522,4481.0,19 CDM,RX-40871198250,BEVACIZUMAB 2.25 MG/0.09 ML INTRAVITREAL SYRINGE,251.95,151.17,1.78,4481.0,36 CDM,RX-40871731,ATROPINE 0.4 MG/ML INJECTION WRAPPER,59.8,35.88,0.315,4481.0,25 CDM,RX-40872,MIDAZOLAM 1 MG/ML INJECTION SOLUTION,23.0,13.8,0.3375,4481.0,24 CDM,RX-40872026854,MOXIFLOXACIN 20 MG/ML ORAL SUSPENSION,124.0,74.4,28.77,4481.0,19 CDM,RX-408722020,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJ SOLN OSM,95.6,57.36,0.1125,4481.0,24 CDM,RX-408729001,ISRADIPINE 1 MG/ML ORAL SUSPENSION,77.8,46.68,18.05,4481.0,19 CDM,RX-4088250,TROPICAMIDE 1 % EYE DROPS (MULTI-PATIENT),16.1,9.66,3.74,4481.0,19 CDM,RX-4088800500,ETOPOSIDE 0.2 MG/ML INTRAVENOUS SOLUTION,275.2,165.12,2.12,4481.0,24 CDM,RX-4088800502,ETOPOSIDE 0.02 MG/ML INTRAVENOUS SOLUTION,275.2,165.12,2.12,4481.0,24 CDM,RX-408880075,MERCAPTOPURINE 25 MG (ONCOLOGY) SPLIT TAB,20.8,12.48,4.83,4481.0,19 CDM,RX-408880076,MERCAPTOPURINE 50 MG (ONCOLOGY) TABLET,37.7,22.62,8.75,4481.0,19 CDM,RX-408880078,METHOTREXATE SODIUM 2.5 MG (ONCOLOGY) TABLET,32.1,19.26,0.4275,4481.0,24 CDM,RX-408880092,RITUXIMAB (RITUXAN) SYRINGE 10 MG/ML OPHTHALMIC INTRAVITREAL,306.1,183.66,72.96,4481.0,31 CDM,RX-408880104,OXYMETAZOLINE 0.05 % NASAL SPRAY (MULTIPLE PATIENTS),1.05,0.63,0.2436,4481.0,19 CDM,RX-408880105,LIDOCAINE 1% IN SODIUM CHLORIDE 0.9% TOPICAL SOLN (MULTIPLE PATIENTS),16.2,9.72,3.76,4481.0,19 CDM,RX-408880107,TEMOZOLOMIDE 10 MG/ML ORAL SUSPENSION,15105.0,9063.0,0.9735,13067.34,24 CDM,RX-408880108,IMATINIB 40 MG/ML ORAL SUSPENSION,443.0,265.8,102.78,4481.0,19 CDM,RX-408880109,LENALIDOMIDE (2.5 MICROGRAM/ML) DESENSITIZATION ORAL SUSPENSION,25.1,15.06,5.82,4481.0,19 CDM,RX-408880110,LENALIDOMIDE (0.025 MG/ML) DESENSITIZATION ORAL SUSPENSION,25.6,15.36,5.94,4481.0,19 CDM,RX-408880111,LENALIDOMIDE (1 MG/ML) DESENSITIZATION ORAL SUSPENSION,84.75,50.85,19.66,4481.0,19 CDM,RX-408880114,LETROZOLE 1.25 MG/ML ORAL SUSPENSION,26.8,16.08,6.22,4481.0,19 CDM,RX-408880146,GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN,34022.75,20413.65,229.52,38155.32,35 CDM,RX-408880161,BLEOMYCIN INTRALESIONAL SYRINGE 1 UNIT/ML,442.05,265.23,48.42,4481.0,24 CDM,RX-408880162,BLEOMYCIN INTRALESIONAL SYRINGE 4 UNITS/ML,442.05,265.23,48.42,4481.0,24 CDM,RX-408880163,BLEOMYCIN INTRALESIONAL SYRINGE 5 UNITS/ML,442.05,265.23,48.42,4481.0,24 CDM,RX-408880164,BLEOMYCIN INTRALESIONAL SYRINGE 2 UNITS/ML,442.05,265.23,48.42,4481.0,24 CDM,RX-408880165,BLEOMYCIN INTRALESIONAL SYRINGE 3 UNITS/ML,442.05,265.23,48.42,4481.0,24 CDM,RX-408880192,METHOTREXATE 2.5 MG/ML (ONCOLOGY) ORAL SOLUTION,10026.8,6016.08,2326.22,8021.44,19 CDM,RX-408880255,AMINO ACID 5 % (L-ARGININE 25 G/L & L-LYSINE 25 G/L) INTRAVENOUS SOLUTION,291.6,174.96,67.65,4481.0,19 CDM,RX-408880287,ATEZOLIZUMAB (TECENTRIQ) 60 MG/ML INJECTION SOLUTION WRAPPER,32881.7,19729.02,88.6,30908.64,70 CDM,RX-408880288,ENTRECTINIB 100 MG CAPSULE,960.35,576.21,222.8,4481.0,19 CDM,RX-408880289,ENTRECTINIB 200 MG CAPSULE,960.35,576.21,222.8,4481.0,19 CDM,RX-408880316,IMATINIB 50 MG SPLIT TABLET,27.45,16.47,6.37,4481.0,19 CDM,RX-408880317,TAGRAXOFUSP-ERZS 100 MCG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION,84777.15,50866.29,346.22,67821.72,35 CDM,RX-408880319,DOCETAXEL (TAXOTERE) 20 MG/ML INJECTION WRAPPER,490.15,294.09,1.04,4481.0,24 CDM,RX-408880328,METHOTREXATE SODIUM (PF) 25 MG/ML INJECTION SOLUTION FOR INTRATHECAL,396.55,237.93,6.15,4481.0,24 CDM,RX-408880336,"DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN",35267.9,21160.74,53.9,28214.32,35 CDM,RX-408880458,CETUXIMAB IVPB OVER 2 HOURS,4428.25,2656.95,76.02,11827.62,70 CDM,RX-408880459,CETUXIMAB IVPB OVER 3 HOURS,4428.25,2656.95,76.02,11827.62,70 CDM,RX-408880460,CETUXIMAB IVPB OVER 1 HOUR,4428.25,2656.95,76.02,11827.62,70 CDM,RX-408880481,CISPLATIN SKIN TEST PERCUTANEOUS,278.35,167.01,5.15,4481.0,48 CDM,RX-408880495,ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION SPLIT SYRINGES,17851.1,10710.66,53.81,14280.88,35 CDM,RX-408880530,FILGRASTIM-AAFI 300 MCG/ML SUBCUTANEOUS SOLUTION (COMPOUNDED SYRINGE),870.1,522.06,0.2716,4481.0,35 CDM,RX-408880592,ERLOTINIB 10 MG/ML ORAL SUSPENSION (SUGAR FREE),720.6,432.36,167.18,4481.0,19 CDM,RX-408880697,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 100 MG),14221.7,8533.02,35.64,11377.36,35 CDM,RX-408880698,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 75 MG),14221.7,8533.02,35.64,11377.36,35 CDM,RX-408880699,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 50 MG),14221.7,8533.02,35.64,11377.36,35 CDM,RX-408880702,TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION (FOR 0.8 MG/KG DOSAGE),38515.55,23109.33,70.44,30812.44,35 CDM,RX-408880703,EPCORITAMAB-BYSP 0.16 MG/ML SUBCUTANEOUS SOLUTION DILUTION B,456.85,274.11,54.16,8980.23,35 CDM,RX-408880704,EPCORITAMAB-BYSP 0.8 MG/ML SUBCUTANEOUS SOLUTION DILUTION A,1184.2,710.52,54.16,8980.23,35 CDM,RX-408880712,NIRSEVIMAB-ALIP (STATE SUPPLIED) 50 MG/0.5 ML INTRAMUSCULAR SYRINGE,0.2,0.12,0.0464,88292.61,25 CDM,RX-408880716,RITUXIMAB-ABBS 10 MG/ML INTRALESIONAL SOLUTION,554.9,332.94,28.5,5030.34,35 CDM,RX-408880720,MELPHALAN (ALKERAN) SYRINGE,1930.0,1158.0,93.02,24394.65,35 CDM,RX-408880747,NATIONAL MARROW DONOR PROGRAM SUPPLIED FILGRASTIM-AYOW (RELEUKO) 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-408880748,NATIONAL MARROW DONOR PROGRAM SUPPLIED FILGRASTIM-AYOW (RELEUKO) 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 CDM,RX-408880806,TOCILIZUMAB-AAZG (TYENNE) 20 MG/ML INJECTION WRAPPER,3265.0,1959.0,4.29,5173.6,105 CDM,RX-408880815,TOCILIZUMAB-AAZG (FOR COVID-19) 20 MG/ML INJECTION (EUA) WRAPPER,3265.0,1959.0,4.29,5173.6,105 CDM,RX-4088900002,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 200 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900003,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 300 MG,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900047,STUDY 1042-SE-3003 GANAXOLONE 1 MG/ML OR PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900050,STUDY ABX NAIL IRB# 23-0204 VANCOMYCIN 1 GRAM VIAL,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900051,STUDY ABX NAIL IRB# 23-0204 GENTAMICIN 80 MG/2 ML VIAL,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900058,STUDY A5415 CENICRIVIROC MESYLATE (CVC)/PLACEBO 150 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900063,STUDY J3E-MC-EZDB LY3540378 20 MG/ML OR PLACEBO SYRINGE/VIAL,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900068,STUDY ICI-M 1201 ABATACEPT/PLACEBO 25 MG/ML INJECTION,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900070,STUDY BP41315 ALOGABAT 3 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900071,STUDY BP41315 ALOGABAT 4 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900072,STUDY BP41315 ALOGABAT 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900073,STUDY BP41315 ALOGABAT 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900074,STUDY 230LE301 BIIB059/PLACEBO 150 MG/ML SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900078,STUDY EIND 167902 V-073 (POCAPAVIR) GRANULATED POWDER,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900081,STUDY B7981040 RITLECITINIB 50 MG/PLACEBO CAPSULES,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900087,STUDY EIP21-NFD-504 NEFLAMAPIMOD/PLACEBO 40 MG CAPSULE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900088,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 1,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900089,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 2,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900090,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 3,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900091,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 4,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900092,STUDY AP-SA02-101 LOW DOSE 1X10E9 PFU/DOSE OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900093,STUDY AP-SA02-101 HIGH DOSE 1X10E10 PFU/DOSE OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900095,STUDY EX6018-4758 ZILTIVEKIMAB C 30 MG/ML OR PLACEBO PFS 0.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900099,STUDY PTK0796-NTM-20203 OMADACYCLINE (PTK 0796) 150 MG/PLACEBO TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900100,STUDY 218672 GSK4532990 100 MG/200 MG OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900101,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (16.6 MG/0.416 ML) PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900102,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (23 MG/0.574 ML) PRE-FILLE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900103,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (32.4 MG/0.810 ML) PRE-FIE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900104,STUDY MG0011 MENVEO 0.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900105,STUDY MG0011 BEXSERO 0.5 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 CDM,RX-4088900106,STUDY IRB# 23-0632 DEXTROSE 20% INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 CDM,RX-4088900108,STUDY 1346-0014 BI 425809 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4088900109,STUDY EXE A841790 EXE-346 1500 X 10^9 CFU SACHET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4088900112,STUDY 19-0021 CRS3123 200 MG/400 MG/VANCOMYCIN 125 MG/PLACEBO CAPSULE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4088900116,STUDY GBT021601-021 GBT021601 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4088900117,STUDY GBT021601-021 GBT021601 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4088900119,FOSPHENYTOIN IV 500 MG PE NS 50 ML INFUSION (TOTAL VOLUME 67 ML),231.05,138.63,5.89,4481.0,24 CDM,RX-4088900123,STUDY TAK-609-5005 IDURSULFASE INTRATHECAL 10 MG/ML SYRINGE,0.2,0.12,0.0506,81999.54,35 CDM,RX-4088900124,STUDY ALXN1210-MG-319 RAVULIZUMAB (ALXN1210) 100 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,81999.54,35 CDM,RX-4088900126,STUDY A5374 CHADOX1.THIVCONSV1 2.5 X 10E10 VP OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900127,STUDY A5374 CHADOX1.HIVCONSV62 2.5 X 10E10 VP OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900128,STUDY A5374 MVA.THIVCONSV3 1 X 10E8 PFU OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900129,STUDY A5374 MVA.THIVCONSV4 0.9 X 10E8 PFU OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900130,STUDY A5374 VES OR PLACEBO 2 MG TABLET,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900132,STUDY A5374 GS-5423 150 MG/ML OR PLACEBO INJECTION,0.2,0.12,0.0506,81999.54,35 CDM,RX-4088900134,STUDY A5374 GS-2872 150 MG/ML OR PLACEBO INJECTION,0.2,0.12,0.0506,81999.54,35 CDM,RX-4088900146,STUDY AP-SA02-101 HIGH DOSE 4X10E10 PFU (2X10E10 PFU/PHAGE) OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 CDM,RX-4088900147,STUDY IRB# 23-2111 RIFAXIMIN 550 MG TABLET,0.2,0.12,0.0464,4481.0,22 CDM,RX-4088900158,STUDY ION-682884-CS12 (CARDIO-TTRANSFORM) ION-682884 SYRINGE,0.2,0.12,0.0464,4481.0,22 CDM,RX-4088900159,"STUDY ION-682884-CS12 (CARDIO-TTRANSFORM) VITAMIN A 3,000 MCG (10,000E",0.2,0.12,0.0464,4481.0,24 CDM,RX-4088900160,STUDY ION-682884-CS12 (CARDIO-TTRANSFORM) ION-682884 AUTO-INJECTOR,0.2,0.12,0.0464,4481.0,22 CDM,RX-408911982,(TAKE HOME) CLINDAMYCIN HCL 150 MG CAPSULE,17.35,10.41,4.03,4481.0,19 CDM,RX-408911986,(TAKE HOME) EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,612.1,367.26,142.01,4481.0,19 CDM,RX-408911998,"(TAKE HOME) NIRMATRELVIR 300 MG (150 MG X2)-RITONAVIR 100 MG TABLET,DOSE PACK",16.1,9.66,3.74,4481.0,19 CDM,RX-408912011,(TAKE HOME) RALTEGRAVIR 400 MG TABLET,641.0,384.6,148.71,4481.0,19 CDM,RX-408912013,(TAKE HOME) SULFAMETHOXAZOLE 800 MG-TRIMETHOPRIM 160 MG TABLET,27.05,16.23,6.28,4481.0,19 CDM,RX-408912019,(TAKE HOME) ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,84.4,50.64,19.58,4481.0,19 CDM,RX-408912023,(TAKE HOME) MOLNUPIRAVIR 200 MG CAPSULE (EUA),16.05,9.63,3.72,4481.0,19 CDM,RX-408912033,(TAKE HOME) CIPROFLOXACIN 0.3 % EYE DROPS,58.15,34.89,13.49,4481.0,19 CDM,RX-408912062,(TAKE HOME) NALOXONE 1 MG/ML INJECTION SYRINGE,144.7,86.82,0.18,4481.0,24 CDM,RX-408912063,(TAKE HOME) ERYTHROMYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT,61.8,37.08,14.34,4481.0,19 CDM,RX-408912066,(TAKE HOME) DOLUTEGRAVIR 50 MG TABLET,713.55,428.13,165.54,4481.0,19 CDM,RX-408912088,STUDY CA088-1000 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 CDM,RX-40891712,GENTAMICIN SULFATE (PF) 20 MG/2 ML INJ SOLN WRAPPER,40.1,24.06,4.97,4481.0,24 CDM,RX-4089308,BUMETANIDE 0.25 MG/ML INJECTION PEDIATRIC SYRINGE,27.8,16.68,0.3589,4481.0,35 CDM,RX-408999307,METHIMAZOLE 3 MG/ML ORAL SUSPENSION,25.3,15.18,5.87,4481.0,24 CDM,RX-40940147,SULFASALAZINE 100 MG/ML ORAL SUSP,128.9,77.34,29.9,4481.0,19 CDM,RX-40940149,SULFADIAZINE 100 MG/ML ORAL SUSP,27.1,16.26,6.29,4481.0,19 CDM,RX-40940266,DEXTROSE 5% WATER (D5W) NON-PVC,74.25,44.55,4.07,4481.0,76 CDM,RX-41003,GLYCERIN (ADULT) RECTAL SUPPOSITORY,1.25,0.75,0.29,4481.0,19 CDM,RX-41144,MICAFUNGIN 50 MG INTRAVENOUS SOLUTION,368.75,221.25,0.585,4481.0,24 CDM,RX-41147,ENTECAVIR 0.5 MG TABLET,20.0,12.0,4.64,4481.0,19 CDM,RX-41149,ENTECAVIR 0.05 MG/ML ORAL SOLUTION,153.25,91.95,35.55,4481.0,19 CDM,RX-41382,FENTANYL 12 MCG/HR TRANSDERMAL PATCH,71.4,42.84,16.56,4481.0,19 CDM,RX-41412,PEG 400-HYPROMELLOSE-GLYCERIN 1 %-0.2 %-0.2 % EYE DROPS,3.65,2.19,0.8468,4481.0,19 CDM,RX-41463,SODIUM CHLORIDE 0.9 % INJECTION SOLUTION,20.55,12.33,4.36,4481.0,57 CDM,RX-41545,"DEXMETHYLPHENIDATE ER 5 MG CAPSULE,EXTENDED RELEASE BIPHASIC50-50",25.95,15.57,6.02,4481.0,19 CDM,RX-41548,"DEXMETHYLPHENIDATE ER 10 MG CAPSULE,EXTENDED RELEASE BIPHASIC50-50",25.95,15.57,6.02,4481.0,19 CDM,RX-41550,GALSULFASE 5 MG/5 ML INTRAVENOUS SOLUTION,8195.5,4917.3,1144.71,73279.5,24 CDM,RX-41623,LEVOCARNITINE (WITH SUGAR) 100 MG/ML ORAL SOLUTION,127.2,76.32,29.51,4481.0,19 CDM,RX-41673,VINORELBINE 50 MG/5 ML INTRAVENOUS SOLUTION,572.9,343.74,5.33,4481.0,24 CDM,RX-41787,SODIUM TETRADECYL SULFATE 1 % (10 MG/ML) INTRAVENOUS SOLUTION,126.9,76.14,29.44,4481.0,19 CDM,RX-41793,SODIUM TETRADECYL SULFATE 3 % (30 MG/ML) INTRAVENOUS SOLUTION,126.9,76.14,29.44,4481.0,19 CDM,RX-41831,LIDOCAINE 5 % TOPICAL OINTMENT,61.15,36.69,14.19,4481.0,19 CDM,RX-42162,PREGABALIN 25 MG CAPSULE,26.1,15.66,6.06,4481.0,19 CDM,RX-42163,PREGABALIN 50 MG CAPSULE,26.1,15.66,6.06,4481.0,19 CDM,RX-42164,PREGABALIN 75 MG CAPSULE,26.1,15.66,6.06,4481.0,19 CDM,RX-42165,PREGABALIN 100 MG CAPSULE,26.1,15.66,6.06,4481.0,19 CDM,RX-42166,PREGABALIN 150 MG CAPSULE,24.9,14.94,5.78,4481.0,19 CDM,RX-42219,LOPERAMIDE 1 MG/7.5 ML ORAL LIQUID,5.1,3.06,1.18,4481.0,19 CDM,RX-4236,KETAMINE 10 MG/ML INJECTION SOLUTION,80.1,48.06,18.58,4481.0,19 CDM,RX-4237,KETAMINE 100 MG/ML INJECTION SOLUTION,47.05,28.23,10.92,4481.0,19 CDM,RX-4238,KETAMINE 50 MG/ML INJECTION SOLUTION,41.3,24.78,9.58,4481.0,19 CDM,RX-4294,CYSTEINE (L-CYSTEINE) 50 MG/ML INTRAVENOUS SOLUTION,372.7,223.62,86.47,4481.0,19 CDM,RX-4318,LACTATED RINGERS INTRAVENOUS SOLUTION,78.0,46.8,5.42,4481.0,21 CDM,RX-4319,LACTATED RINGERS IRRIGATION SOLUTION,90.0,54.0,20.88,4481.0,17 CDM,RX-432,AMITRIPTYLINE 10 MG TABLET,17.25,10.35,4.0,4481.0,19 CDM,RX-433,AMITRIPTYLINE 100 MG TABLET,19.45,11.67,4.51,4481.0,19 CDM,RX-43391,LOPINAVIR-RITONAVIR 200 MG-50 MG TABLET,38.15,22.89,8.85,4481.0,19 CDM,RX-435,AMITRIPTYLINE 25 MG TABLET,17.3,10.38,4.01,4481.0,19 CDM,RX-43547,LANTHANUM 750 MG CHEWABLE TABLET,48.4,29.04,11.23,4481.0,19 CDM,RX-43548,"LANTHANUM 1,000 MG CHEWABLE TABLET",32.7,19.62,7.59,4481.0,19 CDM,RX-43556,DIGOXIN 50 MCG/ML (0.05 MG/ML) ORAL SOLUTION,435.95,261.57,101.14,4481.0,19 CDM,RX-436,AMITRIPTYLINE 50 MG TABLET,17.75,10.65,4.12,4481.0,19 CDM,RX-43717,LIDOCAINE HCL 4 % LARYNGOTRACHEAL SOLUTION,106.95,64.17,24.81,4481.0,19 CDM,RX-43718,LENALIDOMIDE 5 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 CDM,RX-43719,LENALIDOMIDE 10 MG CAPSULE,3591.2,2154.72,833.16,4481.0,19 CDM,RX-4392,LEUCOVORIN CALCIUM 100 MG SOLUTION FOR INJECTION,94.0,56.4,7.25,4481.0,24 CDM,RX-4393,LEUCOVORIN CALCIUM 350 MG SOLUTION FOR INJECTION,506.7,304.02,7.25,4481.0,24 CDM,RX-4394,LEUCOVORIN CALCIUM 50 MG SOLUTION FOR INJECTION,304.15,182.49,7.25,4481.0,24 CDM,RX-4397,LEUCOVORIN CALCIUM 25 MG TABLET,49.9,29.94,11.58,4481.0,19 CDM,RX-4398,LEUCOVORIN CALCIUM 5 MG TABLET,23.9,14.34,5.54,4481.0,19 CDM,RX-4420,LEVOTHYROXINE 25 MCG TABLET,17.4,10.44,4.04,4481.0,19 CDM,RX-4421,LEVOTHYROXINE 50 MCG TABLET,17.45,10.47,4.05,4481.0,19 CDM,RX-4422,LEVOTHYROXINE 75 MCG TABLET,17.8,10.68,4.13,4481.0,19 CDM,RX-4423,LEVOTHYROXINE 100 MCG TABLET,17.85,10.71,4.14,4481.0,19 CDM,RX-4424,LEVOTHYROXINE 125 MCG TABLET,18.15,10.89,4.21,4481.0,19 CDM,RX-4425,LEVOTHYROXINE 150 MCG TABLET,18.2,10.92,4.22,4481.0,19 CDM,RX-4426,LEVOTHYROXINE 200 MCG TABLET,19.0,11.4,4.41,4481.0,19 CDM,RX-4451,LIDOCAINE HCL 5 MG/ML (0.5 %) INJECTION SOLUTION,34.55,20.73,0.0225,4481.0,24 CDM,RX-4452,LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION,27.85,16.71,0.0225,4481.0,48 CDM,RX-4453,LIDOCAINE (PF) 15 MG/ML (1.5 %) INJECTION SOLUTION,69.55,41.73,0.0225,4481.0,24 CDM,RX-4454,LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION,37.725,22.634999999999998,0.0225,4481.0,48 CDM,RX-4455,LIDOCAINE (PF) 40 MG/ML (4 %) INJECTION SOLUTION,34.9,20.94,0.0225,4481.0,24 CDM,RX-4459,LIDOCAINE (PF) 100 MG/5 ML (2 %) INTRAVENOUS SYRINGE,50.95,30.57,0.0225,4481.0,24 CDM,RX-450,AMOXICILLIN 250 MG CAPSULE,16.35,9.81,3.79,4481.0,19 CDM,RX-4504,LIOTHYRONINE 25 MCG TABLET,18.65,11.19,4.33,4481.0,19 CDM,RX-451,AMOXICILLIN 500 MG CAPSULE,16.3,9.78,3.78,4481.0,19 CDM,RX-4526,LISINOPRIL 20 MG TABLET,16.4,9.84,3.8,4481.0,19 CDM,RX-4531,LITHIUM CARBONATE 300 MG TABLET,16.85,10.11,3.91,4481.0,19 CDM,RX-4533,LITHIUM CITRATE 8 MEQ/5 ML ORAL SOLUTION,796.0,477.6,184.67,4481.0,19 CDM,RX-454,AMOXICILLIN 250 MG/5 ML ORAL SUSPENSION,16.475,9.885,3.82,4481.0,38 CDM,RX-4560,LOPERAMIDE 2 MG CAPSULE,2.35,1.41,0.5452,4481.0,19 CDM,RX-4571,LORAZEPAM 2 MG/ML ORAL CONCENTRATE,70.775,42.464999999999996,5.48,4481.0,38 CDM,RX-4600,LOXAPINE SUCCINATE 25 MG CAPSULE,19.3,11.58,4.48,4481.0,19 CDM,RX-4601,LOXAPINE SUCCINATE 5 MG CAPSULE,17.65,10.59,4.09,4481.0,19 CDM,RX-464,AMPHOTERICIN B 50 MG SOLUTION FOR INJECTION,203.2,121.92,47.14,4481.0,24 CDM,RX-469,AMPICILLIN 1 GRAM SOLUTION FOR INJECTION,34.9,20.94,1.24,4481.0,24 CDM,RX-470,AMPICILLIN 10 GRAM SOLUTION FOR INJECTION,308.5,185.1,1.24,4481.0,24 CDM,RX-4712,MAGNESIUM CITRATE ORAL SOLUTION,28.95,17.37,6.72,4481.0,19 CDM,RX-472,AMPICILLIN 2 GRAM SOLUTION FOR INJECTION,43.75,26.25,1.24,4481.0,24 CDM,RX-4720,MAGNESIUM SULFATE 500 MG/ML (50 %) INJECTION SOLUTION,24.9,14.94,1.08,4481.0,24 CDM,RX-473,AMPICILLIN 250 MG SOLUTION FOR INJECTION,26.45,15.87,1.24,4481.0,24 CDM,RX-474,AMPICILLIN 500 MG SOLUTION FOR INJECTION,27.0,16.2,1.24,4481.0,24 CDM,RX-4749,MANNITOL 20 % INTRAVENOUS SOLUTION,78.4,47.04,0.135,4481.0,21 CDM,RX-4750,MANNITOL 25 % INTRAVENOUS SOLUTION,27.8,16.68,0.135,4481.0,21 CDM,RX-4854,MEDROXYPROGESTERONE 10 MG TABLET,20.2,12.12,4.69,4481.0,19 CDM,RX-4855,MEDROXYPROGESTERONE 2.5 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-4870,MEGESTROL 20 MG TABLET,25.8,15.48,5.99,4481.0,19 CDM,RX-4904,MEPERIDINE (PF) 50 MG/ML INJECTION SOLUTION,30.0,18.0,6.96,4481.0,24 CDM,RX-4952,METHADONE 5 MG/5 ML ORAL SOLUTION,28.15,16.89,6.53,4481.0,19 CDM,RX-4954,METHADONE 5 MG TABLET,23.25,13.95,5.39,4481.0,19 CDM,RX-4970,METHOCARBAMOL 100 MG/ML INJECTION SOLUTION,27.65,16.59,6.41,4481.0,24 CDM,RX-4971,METHOCARBAMOL 500 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-4973,METHOTREXATE SODIUM 2.5 MG TABLET,37.2,22.32,0.4275,4481.0,24 CDM,RX-4974,METHOTREXATE SODIUM (CONTAINS PRESERVATIVES) 25 MG/ML INJECTION SOLUTION,342.65,205.59,6.15,4481.0,48 CDM,RX-4985,METHYLENE BLUE (ANTIDOTE) 1 % (10 MG/ML) INTRAVENOUS SOLUTION,40.4,24.24,6.19,4481.0,36 CDM,RX-4986,METHYLPHENIDATE 10 MG TABLET,22.9,13.74,5.31,4481.0,19 CDM,RX-4988,METHYLPHENIDATE 5 MG TABLET,22.6,13.56,5.24,4481.0,19 CDM,RX-4992,METHYLPREDNISOLONE 16 MG TABLET,23.5,14.1,0.2475,4481.0,24 CDM,RX-4993,METHYLPREDNISOLONE 4 MG TABLET,21.05,12.63,0.2475,4481.0,24 CDM,RX-4995,METHYLPREDNISOLONE ACETATE 40 MG/ML SUSPENSION FOR INJECTION,25.4,15.24,0.1164,4481.0,35 CDM,RX-4996,METHYLPREDNISOLONE ACETATE 80 MG/ML SUSPENSION FOR INJECTION,86.325,51.795,0.1164,4481.0,70 CDM,RX-5005,METOCLOPRAMIDE 10 MG TABLET,18.4,11.04,4.27,4481.0,19 CDM,RX-5007,METOPROLOL TARTRATE 5 MG/5 ML INTRAVENOUS SOLUTION,19.9,11.94,0.27,4481.0,24 CDM,RX-5008,METOPROLOL TARTRATE 100 MG TABLET,16.85,10.11,3.91,4481.0,19 CDM,RX-5009,METOPROLOL TARTRATE 50 MG TABLET,16.35,9.81,3.79,4481.0,19 CDM,RX-5015,METRONIDAZOLE 250 MG TABLET,17.25,10.35,4.0,4481.0,19 CDM,RX-5016,METRONIDAZOLE 500 MG TABLET,18.25,10.95,4.23,4481.0,19 CDM,RX-5018,METRONIDAZOLE 500 MG/100 ML IN SODIUM CHLOR(ISO) INTRAVENOUS PIGGYBACK,75.2,45.12,0.0675,4481.0,24 CDM,RX-5039,MICONAZOLE NITRATE 2 % TOPICAL CREAM,7.8,4.68,1.81,4481.0,19 CDM,RX-5040,MICONAZOLE NITRATE 2 % VAGINAL CREAM,10.25,6.15,2.38,4481.0,19 CDM,RX-5110,MINOCYCLINE 100 MG CAPSULE,19.3,11.58,4.48,4481.0,19 CDM,RX-5111,MINOCYCLINE 50 MG CAPSULE,16.8,10.08,3.9,4481.0,19 CDM,RX-5114,MINOXIDIL 10 MG TABLET,17.95,10.77,4.16,4481.0,19 CDM,RX-5115,MINOXIDIL 2.5 MG TABLET,17.6,10.56,4.08,4481.0,19 CDM,RX-5168,MORPHINE 10 MG/ML INJECTION SOLUTION,26.6,15.96,6.17,4481.0,24 CDM,RX-5176,MORPHINE 10 MG/5 ML ORAL SOLUTION,36.55,21.93,5.43,4481.0,38 CDM,RX-5178,MORPHINE 15 MG IMMEDIATE RELEASE TABLET,24.35,14.61,5.65,4481.0,19 CDM,RX-5330,NADOLOL 20 MG TABLET,16.5,9.9,3.83,4481.0,23 CDM,RX-5333,NAFCILLIN 1 GRAM SOLUTION FOR INJECTION,99.0,59.4,0.1125,4481.0,24 CDM,RX-5334,NAFCILLIN 10 GRAM SOLUTION FOR INJECTION,122.1,73.26,0.1125,4481.0,24 CDM,RX-5335,NAFCILLIN 2 GRAM SOLUTION FOR INJECTION,134.95,80.97,0.1125,4481.0,24 CDM,RX-5339,NALBUPHINE 10 MG/ML INJECTION SOLUTION,33.4,20.04,7.75,4481.0,24 CDM,RX-5373,NALOXONE 0.4 MG/ML INJECTION SOLUTION,55.0,33.0,0.18,4481.0,24 CDM,RX-5374,NALOXONE 1 MG/ML INJECTION SYRINGE,144.7,86.82,0.18,4481.0,24 CDM,RX-5391,NAPROXEN 250 MG TABLET,16.8,10.08,3.9,4481.0,19 CDM,RX-5393,NAPROXEN 500 MG TABLET,16.4,9.84,3.8,4481.0,19 CDM,RX-5473,NEOMYCIN SULFATE (BULK) POWDER,194.25,116.55,45.07,4481.0,19 CDM,RX-5558,NIFEDIPINE 10 MG CAPSULE,18.6,11.16,4.32,4481.0,19 CDM,RX-5599,NITROGLYCERIN 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION,113.85,68.31,3.35,4481.0,24 CDM,RX-5604,NITROGLYCERIN 0.4 MG SUBLINGUAL TABLET,23.8,14.28,5.52,4481.0,19 CDM,RX-5606,NITROGLYCERIN 2 % TRANSDERMAL OINTMENT,23.3,13.98,5.41,4481.0,19 CDM,RX-5674,NORTRIPTYLINE 10 MG CAPSULE,16.6,9.96,3.85,4481.0,19 CDM,RX-5676,NORTRIPTYLINE 50 MG CAPSULE,17.0,10.2,3.94,4481.0,19 CDM,RX-5749,"NYSTATIN 100,000 UNIT/GRAM TOPICAL CREAM",55.1,33.06,12.78,4481.0,19 CDM,RX-5750,"NYSTATIN 100,000 UNIT/GRAM TOPICAL OINTMENT",58.15,34.89,13.49,4481.0,19 CDM,RX-5751,"NYSTATIN 100,000 UNIT/ML ORAL SUSPENSION",16.875,10.125,3.85,4481.0,38 CDM,RX-5940,OXYCODONE-ACETAMINOPHEN 5 MG-325 MG TABLET,23.75,14.25,5.51,4481.0,19 CDM,RX-5943,OXYMETAZOLINE 0.05 % NASAL SPRAY,4.3,2.58,0.9976,4481.0,19 CDM,RX-5944,OXYTOCIN 10 UNIT/ML INJECTION SOLUTION,18.625,11.175,3.22,4481.0,48 CDM,RX-6030,PAPAVERINE 30 MG/ML INJECTION SOLUTION,142.75,85.65,33.12,4481.0,24 CDM,RX-6085,PENICILLIN G POTASSIUM 20 MILLION UNIT SOLUTION FOR INJECTION,214.45,128.67,1.78,4481.0,24 CDM,RX-6086,PENICILLIN G POTASSIUM 5 MILLION UNIT SOLUTION FOR INJECTION,65.65,39.39,1.78,4481.0,24 CDM,RX-6087,PENICILLIN G SODIUM 5 MILLION UNIT SOLUTION FOR INJECTION,195.75,117.45,45.41,4481.0,19 CDM,RX-6091,PENICILLIN V POTASSIUM 250 MG/5 ML ORAL SOLUTION,42.7,25.62,9.91,4481.0,19 CDM,RX-6092,PENICILLIN V POTASSIUM 250 MG TABLET,16.25,9.75,3.77,4481.0,19 CDM,RX-6093,PENICILLIN V POTASSIUM 500 MG TABLET,16.6,9.96,3.85,4481.0,19 CDM,RX-6097,PENTOBARBITAL SODIUM 50 MG/ML INJECTION SOLUTION,3664.1,2198.46,121.21,4481.0,24 CDM,RX-6157,PERPHENAZINE 2 MG TABLET,19.0,11.4,4.41,4481.0,19 CDM,RX-6159,PERPHENAZINE 8 MG TABLET,22.35,13.41,5.19,4481.0,19 CDM,RX-6193,PHENAZOPYRIDINE 100 MG TABLET,17.0,10.2,3.94,4481.0,19 CDM,RX-6194,PHENAZOPYRIDINE 200 MG TABLET,17.45,10.47,4.05,4481.0,19 CDM,RX-6212,PHENOBARBITAL 20 MG/5 ML (4 MG/ML) ORAL ELIXIR,35.6,21.36,8.26,4481.0,19 CDM,RX-6215,PHENOBARBITAL 16.2 MG TABLET,17.3,10.38,4.01,4481.0,19 CDM,RX-6217,PHENOBARBITAL 32.4 MG TABLET,23.2,13.92,5.38,4481.0,19 CDM,RX-6219,PHENOBARBITAL 64.8 MG TABLET,18.05,10.83,4.19,4481.0,19 CDM,RX-6220,PHENOBARBITAL 97.2 MG TABLET,24.9,14.94,5.78,4481.0,19 CDM,RX-6221,PHENOBARBITAL SODIUM 130 MG/ML INJECTION SOLUTION,227.9,136.74,52.87,4481.0,24 CDM,RX-6224,PHENOBARBITAL SODIUM 65 MG/ML INJECTION SOLUTION,101.35,60.81,23.51,4481.0,24 CDM,RX-6242,PHENYLEPHRINE 10 MG/ML INJECTION SOLUTION,80.35,48.21,0.0225,4481.0,72 CDM,RX-6243,PHENYLEPHRINE 0.25 % NASAL SPRAY,6.4,3.84,1.48,4481.0,19 CDM,RX-6244,PHENYLEPHRINE 0.5 % NASAL SPRAY,6.4,3.84,1.48,4481.0,19 CDM,RX-6246,PHENYLEPHRINE 2.5 % EYE DROPS,113.85,68.31,26.41,4481.0,19 CDM,RX-6255,PHENYTOIN 125 MG/5 ML ORAL SUSPENSION,17.4,10.44,4.04,4481.0,19 CDM,RX-6256,PHENYTOIN SODIUM 50 MG/ML INTRAVENOUS SOLUTION,28.450000000000003,17.07,1.01,4481.0,48 CDM,RX-6279,PILOCARPINE 1 % EYE DROPS,253.4,152.04,58.79,4481.0,19 CDM,RX-6280,PILOCARPINE 2 % EYE DROPS,258.8,155.28,60.04,4481.0,19 CDM,RX-6282,PILOCARPINE 4 % EYE DROPS,270.55,162.33,62.77,4481.0,19 CDM,RX-6393,"POLYMYXIN B SULFATE 500,000 UNIT SOLUTION FOR INJECTION",55.0,33.0,12.76,4481.0,19 CDM,RX-6420,POTASSIUM ACETATE 2 MEQ/ML INTRAVENOUS SOLUTION,80.7,48.42,18.72,4481.0,19 CDM,RX-6429,POTASSIUM CHLORIDE 2 MEQ/ML INTRAVENOUS SOLUTION,71.6,42.96,0.2475,4481.0,24 CDM,RX-6432,POTASSIUM CHLORIDE 20 MEQ/15 ML ORAL LIQUID,189.15,113.49,43.88,4481.0,19 CDM,RX-6434,POTASSIUM CHLORIDE 20 MEQ ORAL PACKET,20.6,12.36,4.78,4481.0,19 CDM,RX-6445,POTASSIUM IODIDE 1 GRAM/ML ORAL SOLUTION,30.25,18.15,7.02,4481.0,19 CDM,RX-6451,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION,159.9,95.94,20.4,4481.0,57 CDM,RX-6462,PRALIDOXIME 1 GRAM SOLUTION FOR INJECTION,354.15,212.49,82.16,4481.0,24 CDM,RX-6468,PRAZOSIN 1 MG CAPSULE,17.3,10.38,4.01,4481.0,19 CDM,RX-6469,PRAZOSIN 2 MG CAPSULE,17.95,10.77,4.16,4481.0,19 CDM,RX-6470,PRAZOSIN 5 MG CAPSULE,26.3,15.78,6.1,4481.0,19 CDM,RX-6487,"PREDNISOLONE ACETATE 1 % EYE DROPS,SUSPENSION",280.9,168.54,34.61,4481.0,57 CDM,RX-6489,PREDNISOLONE SODIUM PHOSPHATE 1 % EYE DROPS,174.7,104.82,40.53,4481.0,19 CDM,RX-6492,PREDNISONE 5 MG/5 ML ORAL SOLUTION,946.0,567.6,0.0225,4481.0,24 CDM,RX-6493,PREDNISONE 1 MG TABLET,16.7,10.02,0.0225,4481.0,24 CDM,RX-6494,PREDNISONE 10 MG TABLET,16.65,9.99,0.0225,4481.0,24 CDM,RX-6496,PREDNISONE 20 MG TABLET,16.6,9.96,0.0225,4481.0,24 CDM,RX-6497,PREDNISONE 5 MG TABLET,16.55,9.93,0.0225,4481.0,24 CDM,RX-6498,PREDNISONE 50 MG TABLET,17.05,10.23,0.0225,4481.0,24 CDM,RX-6541,PRIMAQUINE 15 MG TABLET,22.15,13.29,5.14,4481.0,19 CDM,RX-6544,PRIMIDONE 250 MG TABLET,17.1,10.26,3.97,4481.0,19 CDM,RX-6561,PROBENECID 500 MG TABLET,22.05,13.23,5.12,4481.0,19 CDM,RX-6562,PROCAINAMIDE 100 MG/ML INJECTION SOLUTION,175.85,105.51,44.49,4481.0,35 CDM,RX-6563,PROCAINAMIDE 500 MG/ML INJECTION SOLUTION,2356.0,1413.6,285.85,4481.0,35 CDM,RX-6582,PROCHLORPERAZINE MALEATE 10 MG TABLET,17.6,10.56,4.08,4481.0,19 CDM,RX-6583,PROCHLORPERAZINE MALEATE 5 MG TABLET,19.35,11.61,4.49,4481.0,19 CDM,RX-6597,PROGESTERONE 50 MG/ML INTRAMUSCULAR OIL,17.35,10.41,1.57,4481.0,24 CDM,RX-6618,PROMETHAZINE 25 MG/ML INJECTION SOLUTION,23.25,13.95,5.39,4481.0,24 CDM,RX-6621,PROMETHAZINE 12.5 MG TABLET,17.35,10.41,4.03,4481.0,19 CDM,RX-663,ASCORBIC ACID (VITAMIN C) 250 MG TABLET,1.05,0.63,0.2436,4481.0,19 CDM,RX-664,ASCORBIC ACID (VITAMIN C) 500 MG TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-6644,PROPARACAINE 0.5 % EYE DROPS,16.4,9.84,3.8,4481.0,19 CDM,RX-6654,PROPRANOLOL 20 MG/5 ML (4 MG/ML) ORAL SOLUTION,161.5,96.9,37.47,4481.0,19 CDM,RX-6656,PROPRANOLOL 10 MG TABLET,16.75,10.05,3.89,4481.0,19 CDM,RX-6657,PROPRANOLOL 20 MG TABLET,17.4,10.44,4.04,4481.0,19 CDM,RX-6658,PROPRANOLOL 40 MG TABLET,17.45,10.47,4.05,4481.0,19 CDM,RX-6660,PROPRANOLOL 80 MG TABLET,17.15,10.29,3.98,4481.0,19 CDM,RX-6662,PROPYLTHIOURACIL 50 MG TABLET,24.4,14.64,5.66,4481.0,19 CDM,RX-6677,PROTAMINE 10 MG/ML INTRAVENOUS SOLUTION,140.925,84.555,3.92,4481.0,48 CDM,RX-6714,PSEUDOEPHEDRINE 30 MG TABLET,1.05,0.63,0.2436,4481.0,19 CDM,RX-6738,PYRAZINAMIDE 500 MG TABLET,29.3,17.58,6.8,4481.0,19 CDM,RX-6744,PYRIDOXINE (VITAMIN B6) 100 MG/ML INJECTION SOLUTION,58.4,35.04,13.55,4481.0,24 CDM,RX-6748,PYRIDOXINE (VITAMIN B6) 50 MG TABLET,1.4,0.84,0.3248,4481.0,19 CDM,RX-679,ASPIRIN 81 MG CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-681,ASPIRIN 325 MG TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-685,"ASPIRIN 325 MG TABLET,DELAYED RELEASE",1.05,0.63,0.2436,4481.0,19 CDM,RX-693,ASPIRIN 300 MG RECTAL SUPPOSITORY,2.85,1.71,0.6612,4481.0,19 CDM,RX-70267,NELARABINE (ARRANON) IVPB,2462.95,1477.77,77.46,10867.71,35 CDM,RX-7028,"SODIUM CHLORIDE 0.9 %, BACTERIOSTATIC INJECTION SOLUTION",33.2,19.92,2.83,4481.0,23 CDM,RX-70284,"POTASSIUM, SODIUM PHOSPHATES 280 MG-160 MG-250 MG ORAL POWDER PACKET",1.85,1.11,0.4292,4481.0,19 CDM,RX-70287,ABATACEPT (WITH MALTOSE) 250 MG INTRAVENOUS SOLUTION,5131.5,3078.9,42.79,6554.73,35 CDM,RX-70306,ARIPIPRAZOLE 2 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-7034,SALSALATE 500 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-70404,ANTIHEMOPHILIC FACTOR-VWF 250 UNIT-600 UNIT INTRAVENOUS SOLUTION,82.7,49.62,1.45,4481.0,35 CDM,RX-70405,"ANTIHEMOPHILIC FACTOR-VWF 500 UNIT-1,200 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 CDM,RX-70406,"(VWF DOSING) ANTIHEMOPHILIC FACTOR-VWF 1,000 UNIT-2,400 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 CDM,RX-70425,SUNITINIB MALATE 25 MG CAPSULE,1869.7,1121.82,433.77,4481.0,19 CDM,RX-70426,SUNITINIB MALATE 50 MG CAPSULE,3236.4,1941.84,750.84,4481.0,19 CDM,RX-70476,"ROTAVIRUS VACCINE LIVE, PENTAVALENT 2 ML ORAL SOLUTION",328.0,196.8,76.1,4481.0,25 CDM,RX-70536,"FLUTICASONE PROPIONATE 50 MCG/ACTUATION NASAL SPRAY,SUSPENSION",30.049999999999997,18.03,6.7,4481.0,38 CDM,RX-70545,METHOHEXITAL 500 MG SOLUTION FOR INJECTION,357.75,214.65,83.0,4481.0,19 CDM,RX-70838,CETIRIZINE 1 MG/ML ORAL SOLUTION,1.2,0.72,0.2784,4481.0,19 CDM,RX-7139,SELENIUM 200 MCG TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-716,ATENOLOL 100 MG TABLET,16.65,9.99,3.86,4481.0,19 CDM,RX-717,ATENOLOL 25 MG TABLET,16.55,9.93,3.84,4481.0,19 CDM,RX-718,ATENOLOL 50 MG TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-7224,SILVER SULFADIAZINE 1 % TOPICAL CREAM,164.1,98.46,38.07,4481.0,19 CDM,RX-7227,SIMETHICONE 80 MG CHEWABLE TABLET,1.4,0.84,0.3248,4481.0,19 CDM,RX-7228,"SIMETHICONE 40 MG/0.6 ML ORAL DROPS,SUSPENSION",1.05,0.63,0.2436,4481.0,19 CDM,RX-730,ATROPINE 0.1 MG/ML INJECTION SYRINGE,60.7,36.42,0.198,4481.0,24 CDM,RX-7301,SODIUM ACETATE 2 MEQ/ML INTRAVENOUS SOLUTION,59.7,35.82,13.85,4481.0,19 CDM,RX-7302,SODIUM ACETATE 4 MEQ/ML INTRAVENOUS SOLUTION,91.8,55.08,21.3,4481.0,19 CDM,RX-7306,SODIUM BICARBONATE 4.2 % (0.5 MEQ/ML) INTRAVENOUS SYRINGE,102.3,61.38,23.73,4481.0,19 CDM,RX-7309,SODIUM BICARBONATE 50 MEQ/50 ML (8.4 %) INTRAVENOUS SYRINGE,92.85,55.71,21.54,4481.0,19 CDM,RX-7312,SODIUM BICARBONATE 650 MG TABLET,1.25,0.75,0.29,4481.0,19 CDM,RX-7318,SODIUM CHLORIDE 0.45 % INTRAVENOUS SOLUTION,78.75,47.25,2.83,4481.0,42 CDM,RX-7321,SODIUM CHLORIDE 3 % HYPERTONIC INTRAVENOUS INJECTION SOLUTION,82.5,49.5,0.2805,4481.0,24 CDM,RX-7322,SODIUM CHLORIDE 23.4% (4 MEQ/ML) INTRAVENOUS SOLUTION,84.175,50.504999999999995,0.2805,4481.0,48 CDM,RX-7325,SODIUM CHLORIDE 0.9 % FOR NEBULIZATION,16.9,10.14,3.92,4481.0,19 CDM,RX-7326,SODIUM CHLORIDE 10 % FOR NEBULIZATION,16.75,10.05,3.89,4481.0,19 CDM,RX-7327,SODIUM CHLORIDE 3 % FOR NEBULIZATION,17.9,10.74,4.15,4481.0,19 CDM,RX-7331,SODIUM CHLORIDE 5 % EYE OINTMENT,27.05,16.23,6.28,4481.0,19 CDM,RX-7332,SODIUM CHLORIDE 5 % EYE DROPS,1.1,0.66,0.2552,4481.0,19 CDM,RX-7351,SODIUM PHOSPHATE 3 MMOL/ML INTRAVENOUS SOLUTION,105.45,63.269999999999996,17.23,4481.0,38 CDM,RX-736,ATROPINE 1 % EYE DROPS,268.25,160.95,34.3,4481.0,38 CDM,RX-7364,SODIUM THIOSULFATE 12.5 GRAM/50 ML (250 MG/ML) INTRAVENOUS SOLUTION,321.35,192.81,1.84,4481.0,24 CDM,RX-7437,SPIRONOLACTONE 25 MG TABLET,16.3,9.78,3.78,4481.0,19 CDM,RX-7485,"WATER FOR IRRIGATION, STERILE SOLUTION",75.75,45.45,16.36,4481.0,76 CDM,RX-7536,SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION,49.15,29.49,2.07,4481.0,24 CDM,RX-7554,SULFADIAZINE 500 MG TABLET,64.1,38.46,14.87,4481.0,19 CDM,RX-7555,SULFAMETHOXAZOLE 800 MG-TRIMETHOPRIM 160 MG TABLET,16.8,10.08,3.9,4481.0,19 CDM,RX-7556,SULFAMETHOXAZOLE 400 MG-TRIMETHOPRIM 80 MG/5 ML INTRAVENOUS SOLUTION,104.05,62.43,0.1125,4481.0,24 CDM,RX-7562,SULFASALAZINE 500 MG TABLET,16.6,9.96,3.85,4481.0,19 CDM,RX-7578,SULINDAC 150 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-7579,SULINDAC 200 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-76334,DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE,4543.9,2726.34,2.84,4481.0,35 CDM,RX-76338,"HYALURONIDASE, HUMAN RECOMBINANT 150 UNIT/ML INJECTION SOLUTION",233.65,140.19,0.81,4481.0,24 CDM,RX-76353,ALGLUCOSIDASE ALFA 50 MG INTRAVENOUS SOLUTION,3311.3,1986.78,200.39,30464.28,35 CDM,RX-76364,DECITABINE 50 MG INTRAVENOUS SOLUTION,2261.0,1356.6,2.75,4481.0,24 CDM,RX-76366,"ANTIHEMOPHILIC FACTOR VIII, FULL LENGTH 500 (+/-) UNIT IV SOLUTION",83.75,50.25,1.56,4481.0,35 CDM,RX-76444,VARENICLINE TARTRATE 0.5 MG TABLET,18.95,11.37,4.4,4481.0,19 CDM,RX-76445,VARENICLINE TARTRATE 1 MG TABLET,55.1,33.06,12.78,4481.0,19 CDM,RX-76472,LORATADINE 5 MG/5 ML ORAL SOLUTION,1.45,0.87,0.3364,4481.0,19 CDM,RX-76527,"NALTREXONE ER 380 MG INTRAMUSCULAR SUSPENSION,EXTENDED RELEASE",6608.35,3965.01,4.11,5286.68,35 CDM,RX-76641,ACETYLCHOLINE CHLORIDE 1 % (20 MG/2 ML) INTRAOCULAR KIT,409.05,245.43,94.9,4481.0,19 CDM,RX-767,AZATHIOPRINE 100 MG SOLUTION FOR INJECTION,991.0,594.6,246.45,4481.0,35 CDM,RX-76719,DASATINIB 70 MG TABLET,1374.85,824.91,318.97,4481.0,19 CDM,RX-76720,SODIUM HYPOCHLORITE 0.125 % SOLUTION,23.0,13.8,5.34,4481.0,19 CDM,RX-76780,IBUPROFEN LYSINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION,1554.95,932.97,360.75,4481.0,19 CDM,RX-76783,LENALIDOMIDE 15 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 CDM,RX-76784,LENALIDOMIDE 25 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 CDM,RX-76843,APREPITANT 40 MG CAPSULE,279.85,167.91,6.14,4481.0,24 CDM,RX-76878,IDURSULFASE 6 MG/3 ML INTRAVENOUS SOLUTION,10624.8,6374.88,541.71,81999.54,35 CDM,RX-76950,"CHOLECALCIFEROL (VITAMIN D3) 25 MCG (1,000 UNIT) TABLET",1.1,0.66,0.2552,4481.0,19 CDM,RX-76962,DARBEPOETIN ALFA 25 MCG/ML IN POLYSORBATE INJECTION,770.65,462.39,2.84,4481.0,35 CDM,RX-76965,DARBEPOETIN ALFA 100 MCG/ML IN POLYSORBATE INJECTION,3034.6,1820.76,2.84,4481.0,35 CDM,RX-76974,GLYCERIN (CHILD) RECTAL SUPPOSITORY,1.6,0.96,0.3712,4481.0,19 CDM,RX-76988,HYDROCHLOROTHIAZIDE 12.5 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-77009,MORPHINE (PF) 10 MG/ML INJECTION SOLUTION,648.1,388.86,27.11,4481.0,24 CDM,RX-77012,ETONOGESTREL 68 MG SUBDERMAL IMPLANT,4880.55,2928.33,1132.29,164995.74,24 CDM,RX-7711,TAMOXIFEN 10 MG TABLET,26.95,16.17,6.25,4481.0,19 CDM,RX-77195,LEVETIRACETAM 500 MG/5 ML INTRAVENOUS SOLUTION,75.75,45.45,0.09,4481.0,24 CDM,RX-77308,SELENIUM 40 MCG/ML INTRAVENOUS SOLUTION,85.15,51.09,19.75,4481.0,19 CDM,RX-77371,POSACONAZOLE 200 MG/5 ML (40 MG/ML) ORAL SUSPENSION,118.85,71.31,27.57,4481.0,19 CDM,RX-7753,TEMAZEPAM 15 MG CAPSULE,22.3,13.38,5.17,4481.0,19 CDM,RX-77581,ARFORMOTEROL 15 MCG/2 ML SOLUTION FOR NEBULIZATION,23.5,14.1,5.45,4481.0,19 CDM,RX-77685,MICAFUNGIN 100 MG INTRAVENOUS SOLUTION,220.0,132.0,0.585,4481.0,24 CDM,RX-7784,TESTOSTERONE CYPIONATE 200 MG/ML INTRAMUSCULAR OIL,36.0,21.6,0.0675,4481.0,24 CDM,RX-7797,TETRACYCLINE 500 MG CAPSULE,21.1,12.66,4.9,4481.0,19 CDM,RX-7800,TETRAHYDROZOLINE 0.05 % EYE DROPS,6.25,3.75,1.45,4481.0,19 CDM,RX-78064,"PALIPERIDONE ER 3 MG TABLET,EXTENDED RELEASE 24 HR",22.55,13.53,5.23,4481.0,19 CDM,RX-78310,"MESALAMINE 1.2 GRAM TABLET,DELAYED RELEASE",29.35,17.61,6.81,4481.0,19 CDM,RX-78420,AZACITIDINE (VIDAZA) SYRINGE 25 MG/ML,2212.15,1327.29,0.5775,4481.0,24 CDM,RX-78615,ESOMEPRAZOLE MAGNESIUM DR 20 MG GRANULES DELAYED RELEASE FOR SUSP,39.45,23.67,9.15,4481.0,19 CDM,RX-78616,ESOMEPRAZOLE MAGNESIUM DR 40 MG GRANULES DELAYED RELEASE FOR SUSP,39.45,23.67,9.15,4481.0,19 CDM,RX-78752,LAPATINIB 250 MG TABLET,296.4,177.84,68.76,4481.0,19 CDM,RX-7876,THIAMINE HCL (VITAMIN B1) 100 MG/ML INJECTION SOLUTION,21.85,13.11,4.09,4481.0,24 CDM,RX-7886,THIOGUANINE 40 MG TABLET,1954.65,1172.79,453.48,4481.0,19 CDM,RX-7901,THIOTEPA 15 MG SOLUTION FOR INJECTION,2757.5,1654.5,10.22,4481.0,35 CDM,RX-7902,THIOTHIXENE 1 MG CAPSULE,18.85,11.31,4.37,4481.0,19 CDM,RX-7906,THIOTHIXENE 5 MG CAPSULE,21.75,13.05,5.05,4481.0,19 CDM,RX-7993,TOBRAMYCIN 10 MG/ML INJECTION SOLUTION,65.9,39.54,5.33,4481.0,24 CDM,RX-7995,TOBRAMYCIN 0.3 % EYE DROPS,62.7,37.62,14.55,4481.0,19 CDM,RX-8083,TRAZODONE 100 MG TABLET,16.6,9.96,3.85,4481.0,19 CDM,RX-8084,TRAZODONE 150 MG TABLET,17.75,10.65,4.12,4481.0,19 CDM,RX-8085,TRAZODONE 50 MG TABLET,16.4,9.84,3.8,4481.0,19 CDM,RX-8113,TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAM,26.85,16.11,6.23,4481.0,19 CDM,RX-8117,TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL OINTMENT,40.6,24.36,9.42,4481.0,19 CDM,RX-8118,TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENT,29.6,17.76,6.87,4481.0,19 CDM,RX-8120,TRIAMCINOLONE ACETONIDE 40 MG/ML SUSPENSION FOR INJECTION,52.55,31.53,1.89,4481.0,24 CDM,RX-8121,TRIAMCINOLONE ACETONIDE 0.1 % DENTAL PASTE,210.1,126.06,48.74,4481.0,19 CDM,RX-8132,TRIAMTERENE 37.5 MG-HYDROCHLOROTHIAZIDE 25 MG TABLET,18.5,11.1,4.29,4481.0,19 CDM,RX-81428,ACTIVATED CHARCOAL-SORBITOL 50 GRAM/240 ML ORAL SUSPENSION,15.7,9.42,3.64,4481.0,19 CDM,RX-81434,ZOLEDRONIC ACID 5 MG/100 ML IN MANNITOL 5 %-WATER INTRAVENOUS PIGGYBCK,1207.5,724.5,11.38,4481.0,24 CDM,RX-81453,BUDESONIDE-FORMOTEROL HFA 80 MCG-4.5 MCG/ACTUATION AEROSOL INHALER,432.6,259.56,100.36,4481.0,19 CDM,RX-81454,BUDESONIDE-FORMOTEROL HFA 160 MCG-4.5 MCG/ACTUATION AEROSOL INHALER,495.2,297.12,114.89,4481.0,19 CDM,RX-81474,LISDEXAMFETAMINE 30 MG CAPSULE,34.55,20.73,8.02,4481.0,19 CDM,RX-8166,TRIHEXYPHENIDYL 2 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-8167,TRIHEXYPHENIDYL 5 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-81696,ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION,21393.2,12835.92,43.48,17114.56,35 CDM,RX-8182,TRIMETHOPRIM 100 MG TABLET,21.55,12.93,5.0,4481.0,19 CDM,RX-81870,COLLOIDAL OATMEAL TOPICAL PACKET,2.05,1.23,0.4756,4481.0,19 CDM,RX-82085,ESMOLOL 100 MG/10 ML (10 MG/ML) INTRAVENOUS SOLUTION,77.4,46.44,0.495,4481.0,24 CDM,RX-82134,SODIUM CHLORIDE 7 % FOR NEBULIZATION,17.9,10.74,4.15,4481.0,19 CDM,RX-82177,PERFLUTREN PROTEIN-TYPE A MICROSPHERES 0.22 MG/ML INTRAVENOUS SUSP,163.85,98.31,38.01,4481.0,23 CDM,RX-82200,FLUOROURACIL 500 MG/10 ML INTRAVENOUS SOLUTION,286.35,171.81,4.48,4481.0,24 CDM,RX-82228,TEMSIROLIMUS 30 MG/3 ML (10 MG/ML) (FIRST DILUTION) INTRAVENOUS SOLN,6896.1,4137.66,25.91,5516.88,35 CDM,RX-82301,CLINDAMYCIN 150 MG/ML INJECTION SOLUTION,32.4,19.439999999999998,4.12,4481.0,96 CDM,RX-82307,AMBRISENTAN 5 MG TABLET,1390.65,834.39,322.63,4481.0,19 CDM,RX-82308,AMBRISENTAN 10 MG TABLET,131.25,78.75,30.45,4481.0,19 CDM,RX-8259,TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL INJECTION SOLUTION,52.925,31.755,11.39,4481.0,57 CDM,RX-8442,"VANCOMYCIN 1,000 MG INTRAVENOUS INJECTION",116.25,69.75,0.0675,4481.0,24 CDM,RX-8444,VANCOMYCIN 5 GRAM INTRAVENOUS SOLUTION,358.2,214.92,0.0675,4481.0,24 CDM,RX-8527,VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTION,87.02499999999999,52.215,7.41,4481.0,38 CDM,RX-8528,VERAPAMIL 120 MG TABLET,16.25,9.75,3.77,4481.0,19 CDM,RX-8530,VERAPAMIL 80 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-856,"BACITRACIN-POLYMYXIN B 500 UNIT-10,000 UNIT/GRAM EYE OINTMENT",85.0,51.0,19.72,4481.0,19 CDM,RX-8594,VINBLASTINE 1 MG/ML INTRAVENOUS SOLUTION,452.95,271.77,11.93,4481.0,24 CDM,RX-860,BACLOFEN 10 MG TABLET,17.6,10.56,4.08,4481.0,19 CDM,RX-8639,"VITAMIN A CAPSULE 3,000 MCG RAE (10000 UNITS)",1.1,0.66,0.2552,4481.0,19 CDM,RX-8717,PHYTONADIONE (VITAMIN K1) 100 MCG TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-8749,WARFARIN 2 MG TABLET,17.15,10.29,3.98,4481.0,19 CDM,RX-8750,WARFARIN 2.5 MG TABLET,17.2,10.32,3.99,4481.0,19 CDM,RX-8751,WARFARIN 5 MG TABLET,17.25,10.35,4.0,4481.0,19 CDM,RX-8752,WARFARIN 7.5 MG TABLET,17.75,10.65,4.12,4481.0,19 CDM,RX-87822,OXYCODONE 20 MG TABLET,23.3,13.98,5.41,4481.0,19 CDM,RX-87861,LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE,34697.4,20818.44,28.94,27757.92,35 CDM,RX-88008,EPIRUBICIN 50 MG/25 ML INTRAVENOUS SOLUTION,434.25,260.55,4.32,4481.0,24 CDM,RX-88009,EPIRUBICIN 200 MG/100 ML INTRAVENOUS SOLUTION,1050.25,630.15,4.32,4481.0,24 CDM,RX-88010,FOSPHENYTOIN 500 MG PE/10 ML INJECTION SOLUTION,116.05,69.63,5.89,4481.0,24 CDM,RX-88011,FOSPHENYTOIN 100 MG PE/2 ML INJECTION SOLUTION,173.7,104.22,5.89,4481.0,24 CDM,RX-88225,FORMOTEROL FUMARATE 20 MCG/2 ML SOLUTION FOR NEBULIZATION,77.5,46.5,17.98,4481.0,19 CDM,RX-88337,"ANTIHEMOPHILIC FACTOR-VWF 1,000 (400 VWF) UNIT/10 ML INTRAVENOUS SOLN",81.75,49.05,1.21,4481.0,35 CDM,RX-88376,CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,392.85,235.71,5.15,4481.0,48 CDM,RX-88505,ACETAMINOPHEN 650 MG/20.3 ML ORAL SUSPENSION,3.85,2.31,0.8932,4481.0,19 CDM,RX-88570,LANREOTIDE 60 MG/0.2 ML SUBCUTANEOUS SYRINGE,23759.2,14255.52,33.03,19007.36,35 CDM,RX-88608,RALTEGRAVIR 400 MG TABLET,120.2,72.12,27.89,4481.0,19 CDM,RX-8865,ZINC CHLORIDE 1 MG/ML INTRAVENOUS SOLUTION,53.0,31.8,12.3,4481.0,19 CDM,RX-88653,IXABEPILONE 45 MG INTRAVENOUS SOLUTION,20279.6,12167.76,135.03,21536.97,35 CDM,RX-88654,HEPATITIS B IMMUNE GLOBULIN-MALTOSE (HEPAGAM B) >312 UNIT/ML (1 ML) INJECTION SOLUTION,814.15,488.49,64.64,4481.0,35 CDM,RX-88704,OSELTAMIVIR 30 MG CAPSULE,21.8,13.08,5.06,4481.0,19 CDM,RX-88720,NILOTINIB HCL 200 MG CAPSULE,798.05,478.83,185.15,4481.0,19 CDM,RX-8880,ZINC SULFATE 50 MG ZINC (220 MG) CAPSULE,1.4,0.84,0.3248,4481.0,19 CDM,RX-89201,SEVELAMER CARBONATE 800 MG TABLET,17.2,10.32,3.99,4481.0,19 CDM,RX-89346,CLOPIDOGREL 300 MG TABLET,58.85,35.31,13.65,4481.0,19 CDM,RX-8943,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL SUSPENSION,2.4,1.44,0.5568,4481.0,19 CDM,RX-8958,BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50 MG-325 MG-40 MG TABLET,27.5,16.5,6.38,4481.0,19 CDM,RX-8962,"ACETAZOLAMIDE ER 500 MG CAPSULE,EXTENDED RELEASE",18.25,10.95,4.23,4481.0,19 CDM,RX-8963,ACETIC ACID 0.25 % IRRIGATION SOLUTION,78.0,46.8,18.1,4481.0,19 CDM,RX-8970,ACYCLOVIR 200 MG/5 ML ORAL SUSPENSION,1084.55,650.73,251.62,4481.0,19 CDM,RX-89783,LISDEXAMFETAMINE 20 MG CAPSULE,34.55,20.73,8.02,4481.0,19 CDM,RX-8979,ALBENDAZOLE 200 MG TABLET,106.0,63.6,24.59,4481.0,19 CDM,RX-8981,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION",566.375,339.825,93.55,4481.0,48 CDM,RX-8982,"ALBUMIN, HUMAN 5 % INTRAVENOUS SOLUTION",245.6,147.36,51.49,4481.0,35 CDM,RX-9001,ALPROSTADIL 500 MCG/ML INJECTION SOLUTION,676.45,405.87,1.3,4481.0,24 CDM,RX-9002,ALTEPLASE 100 MG INTRAVENOUS SOLUTION,34337.45,20602.47,91.62,29705.33,35 CDM,RX-9003,ALTEPLASE 50 MG INTRAVENOUS SOLUTION,17176.75,10306.05,91.62,14859.61,35 CDM,RX-9014,ALUMINUM-MAG HYDROXIDE-SIMETHICONE 400 MG-400 MG-40 MG/5 ML ORAL SUSP,2.6500000000000004,1.59,0.3132,4481.0,38 CDM,RX-9016,ALUMINUM HYDROX-MAGNESIUM CARB 160 MG-105 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 CDM,RX-9062,AMINOCAPROIC ACID 250 MG/ML (25 %) ORAL SOLUTION,8400.9,5040.54,1949.01,6720.72,19 CDM,RX-9063,AMINOCAPROIC ACID 500 MG TABLET,51.05,30.63,11.84,4481.0,19 CDM,RX-9066,AMIODARONE 200 MG TABLET,17.15,10.29,3.98,4481.0,19 CDM,RX-9069,AMLODIPINE 10 MG TABLET,16.5,9.9,3.83,4481.0,19 CDM,RX-9070,AMLODIPINE 2.5 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-9071,AMLODIPINE 5 MG TABLET,16.25,9.75,3.77,4481.0,19 CDM,RX-9083,AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION,46.1,27.66,3.13,4481.0,24 CDM,RX-9084,AMPICILLIN-SULBACTAM 3 GRAM SOLUTION FOR INJECTION,72.8,43.68,3.13,4481.0,24 CDM,RX-90999,SODIUM CITRATE 4 GRAM/100 ML (4 %) SOLUTION,101.1,60.66,23.46,4481.0,19 CDM,RX-91031,ESOMEPRAZOLE MAGNESIUM DR 10 MG GRANULES DELAYED RELEASE FOR SUSP,44.75,26.85,10.38,4481.0,19 CDM,RX-91045,HEPATITIS A VIRUS VACCINE (PF) 25 UNIT/0.5 ML INTRAMUSCULAR SUSPENSION,139.75,83.85,32.42,4481.0,25 CDM,RX-91054,IRINOTECAN 100 MG/5 ML INTRAVENOUS SOLUTION,347.75,208.65,3.81,4481.0,24 CDM,RX-9116,ANTITHROMBIN III (HUMAN) 500 (+/-) UNIT INTRAVENOUS SOLUTION,92.35,55.41,3.98,4481.0,35 CDM,RX-91185,SECRETIN (HUMAN) 16 MCG INTRAVENOUS SOLUTION,1779.75,1067.85,39.3,5400.78,35 CDM,RX-9119,APRACLONIDINE 0.5 % EYE DROPS,209.4,125.64,48.58,4481.0,19 CDM,RX-9123,ARGININE HCL (L-ARGININE) 10 % INTRAVENOUS SOLUTION,223.05,133.83,51.75,4481.0,19 CDM,RX-91278,OCTREOTIDE ACETATE 50 MCG/ML INJECTION SOLUTION,24.8,14.88,1.37,4481.0,24 CDM,RX-91279,OCTREOTIDE ACETATE 100 MCG/ML INJECTION SOLUTION,45.1,27.06,1.37,4481.0,24 CDM,RX-91280,OCTREOTIDE ACETATE 200 MCG/ML INJECTION SOLUTION,54.8,32.88,1.37,4481.0,24 CDM,RX-91281,OCTREOTIDE ACETATE 500 MCG/ML INJECTION SOLUTION,209.8,125.88,1.37,4481.0,24 CDM,RX-91282,"OCTREOTIDE ACETATE 1,000 MCG/ML INJECTION SOLUTION",1953.85,1172.31,1.37,4481.0,24 CDM,RX-91349,KETOROLAC 60 MG/2 ML INTRAMUSCULAR SOLUTION,28.8,17.28,0.2813,4481.0,34 CDM,RX-91408,REGADENOSON 0.4 MG/5 ML INTRAVENOUS SYRINGE,1021.3,612.78,6.79,4481.0,24 CDM,RX-91534,LUBIPROSTONE 8 MCG CAPSULE,34.6,20.76,8.03,4481.0,19 CDM,RX-91651,METHYLNALTREXONE 12 MG/0.6 ML SUBCUTANEOUS SOLUTION,457.85,274.71,3.26,4481.0,24 CDM,RX-9168,ATRACURIUM 10 MG/ML INTRAVENOUS SOLUTION,52.675000000000004,31.605,7.99,4481.0,38 CDM,RX-9183,AZATHIOPRINE 50 MG TABLET,18.05,10.83,0.135,4481.0,24 CDM,RX-9185,AZTREONAM 1 GRAM SOLUTION FOR INJECTION,148.6,89.16,5.69,4481.0,24 CDM,RX-9186,AZTREONAM 2 GRAM SOLUTION FOR INJECTION,277.15,166.29,5.69,4481.0,24 CDM,RX-91870,ALVIMOPAN 12 MG CAPSULE,487.35,292.41,113.07,4481.0,19 CDM,RX-9260,BENZYLPENICILLOYL POLYLYSINE 0.25 ML INTRADERMAL INJECTION SOLUTION,43.75,26.25,10.15,4481.0,19 CDM,RX-9266,BETAMETHASONE ACETATE AND SODIUM PHOS 6 MG/ML SUSPENSION FOR INJECTION,230.65,138.39,15.66,4481.0,24 CDM,RX-9281,BISACODYL 10 MG/30 ML ENEMA,4.05,2.43,0.9396,4481.0,19 CDM,RX-92811,ZINC OXIDE 13 % TOPICAL CREAM,7.05,4.23,1.64,4481.0,19 CDM,RX-9285,BISMUTH SUBSALICYLATE 262 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 CDM,RX-92851,DARUNAVIR 600 MG TABLET,20.95,12.57,4.86,4481.0,19 CDM,RX-92853,"COAGULATION FACTOR VIIA RECOMB 1 MG (1,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 CDM,RX-92854,"COAGULATION FACTOR VIIA RECOMB 2 MG (2,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 CDM,RX-92855,"COAGULATION FACTOR VIIA RECOMB 5 MG (5,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 CDM,RX-9289,BLEOMYCIN 15 UNIT SOLUTION FOR INJECTION,442.05,265.23,48.42,4481.0,24 CDM,RX-92895,VANCOMYCIN 1000 MG/200 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,165.9,99.54,0.0675,4481.0,24 CDM,RX-92897,DASATINIB 100 MG TABLET,2457.85,1474.71,570.22,4481.0,19 CDM,RX-9297,BROMOCRIPTINE 2.5 MG TABLET,25.05,15.03,5.81,4481.0,19 CDM,RX-93025,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 250 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 CDM,RX-93026,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 500 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 CDM,RX-93027,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 1,000 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 CDM,RX-9308,BUMETANIDE 0.25 MG/ML INJECTION SOLUTION,27.8,16.68,0.3589,4481.0,35 CDM,RX-93084,AMIODARONE 50 MG/ML INTRAVENOUS SOLUTION,71.125,42.675,0.9675,4481.0,48 CDM,RX-9309,BUMETANIDE 0.5 MG TABLET,17.05,10.23,3.96,4481.0,19 CDM,RX-9311,BUMETANIDE 2 MG TABLET,18.55,11.13,4.3,4481.0,19 CDM,RX-9316,BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) IN 8.25 % DEXTROSE INJECTION,41.65,24.99,0.0225,4481.0,24 CDM,RX-9321,BUPROPION HCL 100 MG TABLET,18.05,10.83,4.19,4481.0,19 CDM,RX-9322,BUPROPION HCL 75 MG TABLET,19.3,11.58,4.48,4481.0,19 CDM,RX-9323,BUSPIRONE 10 MG TABLET,16.45,9.87,3.82,4481.0,19 CDM,RX-9324,BUSPIRONE 5 MG TABLET,16.35,9.81,3.79,4481.0,19 CDM,RX-9347,CALCITONIN (SALMON) 200 UNIT/ML INJECTION SOLUTION,3136.0,1881.6,470.42,4481.0,35 CDM,RX-9350,CALCITRIOL 0.25 MCG CAPSULE,18.4,11.04,4.27,4481.0,19 CDM,RX-9351,CALCITRIOL 0.5 MCG CAPSULE,17.3,10.38,4.01,4481.0,19 CDM,RX-93566,ROMIPLOSTIM (NPLATE) SYRINGE 500 MCG/ML (250 MCG),10752.8,6451.68,10.68,8602.24,35 CDM,RX-93567,ROMIPLOSTIM (NPLATE) INJECTION 500 MCG/ML (500 MCG),21489.5,12893.7,10.68,17191.6,35 CDM,RX-93747,MITOXANTRONE (NOVANTRONE) INJECTION,989.0,593.4,23.16,4481.0,35 CDM,RX-9385,CALCIUM 200 MG (AS CALCIUM CARBONATE 500 MG) CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 CDM,RX-93931,IPRATROPIUM 0.5 MG-ALBUTEROL 3 MG (2.5 MG BASE)/3 ML NEBULIZATION SOLN,17.2,10.32,3.99,4481.0,19 CDM,RX-93936,CLEVIDIPINE 25 MG/50 ML INTRAVENOUS EMULSION,351.3,210.78,2.76,4481.0,35 CDM,RX-9401,CAPTOPRIL 12.5 MG TABLET,20.25,12.15,4.7,4481.0,19 CDM,RX-9402,CAPTOPRIL 25 MG TABLET,20.65,12.39,4.79,4481.0,19 CDM,RX-9406,CARBIDOPA 10 MG-LEVODOPA 100 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-9407,CARBIDOPA 25 MG-LEVODOPA 100 MG TABLET,17.1,10.26,3.97,4481.0,19 CDM,RX-9413,CARBOPROST TROMETHAMINE 250 MCG/ML INTRAMUSCULAR SOLUTION,562.0,337.2,49.52,4481.0,35 CDM,RX-94158,"SODIUM CHLORIDE 1,000 MG SOLUBLE TABLET",1.45,0.87,0.3364,4481.0,19 CDM,RX-9452,CEFOTAXIME 1 GRAM SOLUTION FOR INJECTION,35.65,21.39,8.27,4481.0,24 CDM,RX-94563,TETRABENAZINE 12.5 MG TABLET,55.25,33.15,12.82,4481.0,19 CDM,RX-94576,NICARDIPINE 40 MG/200 ML(0.2 MG/ML) IN SOD CHLOR(ISO) INTRAVENOUS SOLN,324.6,194.76,0.1575,4481.0,24 CDM,RX-94579,ELTROMBOPAG OLAMINE 25 MG TABLET,798.65,479.19,185.29,4481.0,19 CDM,RX-9461,CEFOXITIN 1 GRAM INTRAVENOUS SOLUTION,95.55,57.33,10.76,4481.0,24 CDM,RX-9463,CEFOXITIN 2 GRAM INTRAVENOUS SOLUTION,95.7,57.42,10.76,4481.0,24 CDM,RX-9474,CEFTAZIDIME 1 GRAM SOLUTION FOR INJECTION,33.55,20.13,3.53,4481.0,24 CDM,RX-9476,CEFTAZIDIME 2 GRAM SOLUTION FOR INJECTION,55.0,33.0,3.53,4481.0,24 CDM,RX-9487,CEFTRIAXONE 1 GRAM SOLUTION FOR INJECTION,21.95,13.17,0.9675,4481.0,24 CDM,RX-9488,CEFTRIAXONE 2 GRAM SOLUTION FOR INJECTION,27.3,16.38,0.9675,4481.0,24 CDM,RX-9489,CEFTRIAXONE 250 MG SOLUTION FOR INJECTION,19.0,11.4,0.9675,4481.0,24 CDM,RX-9490,CEFTRIAXONE 500 MG SOLUTION FOR INJECTION,19.8,11.88,0.9675,4481.0,24 CDM,RX-9491,CEFTRIAXONE 10 GRAM SOLUTION FOR INJECTION,172.45,103.47,0.9675,4481.0,24 CDM,RX-9495,CEFUROXIME AXETIL 250 MG TABLET,27.35,16.41,6.35,4481.0,19 CDM,RX-9496,CEFUROXIME AXETIL 500 MG TABLET,20.15,12.09,4.67,4481.0,19 CDM,RX-9499,CEPHALEXIN 250 MG CAPSULE,17.25,10.35,4.0,4481.0,19 CDM,RX-9500,CEPHALEXIN 500 MG CAPSULE,17.1,10.26,3.97,4481.0,19 CDM,RX-9502,CEPHALEXIN 250 MG/5 ML ORAL SUSPENSION,575.5,345.3,19.72,4481.0,38 CDM,RX-9506,CETIRIZINE 10 MG TABLET,1.25,0.75,0.29,4481.0,19 CDM,RX-9513,CHLORAMBUCIL 2 MG TABLET,2335.3,1401.18,541.79,4481.0,19 CDM,RX-9516,CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASH,17.8,10.68,4.13,4481.0,19 CDM,RX-9525,CHLOROTHIAZIDE 250 MG/5 ML ORAL SUSPENSION,243.55,146.13,56.5,4481.0,19 CDM,RX-9526,CHLOROTHIAZIDE SODIUM 500 MG INTRAVENOUS SOLUTION,259.2,155.52,60.13,4481.0,24 CDM,RX-95692,RUFINAMIDE 400 MG TABLET,95.2,57.12,22.09,4481.0,19 CDM,RX-95794,ONABOTULINUMTOXINA 50 UNIT INTRAMUSCULAR SOLUTION,1427.8,856.68,6.3,4481.0,35 CDM,RX-95811,ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTION,75.15,45.09,17.43,4481.0,19 CDM,RX-95849,PLERIXAFOR 24 MG/1.2 ML (20 MG/ML) SUBCUTANEOUS SOLUTION,38891.5,23334.9,24.57,31113.2,35 CDM,RX-9588,CHOLESTYRAMINE (WITH SUGAR) 4 GRAM POWDER FOR SUSP IN A PACKET,19.0,11.4,4.41,4481.0,19 CDM,RX-9602,IMIPENEM-CILASTATIN 250 MG INTRAVENOUS SOLUTION,118.9,71.34,18.98,4481.0,24 CDM,RX-9603,IMIPENEM-CILASTATIN 500 MG INTRAVENOUS SOLUTION,169.8,101.88,18.98,4481.0,24 CDM,RX-9610,CIPROFLOXACIN 0.3 % EYE DROPS,58.15,34.89,13.49,4481.0,19 CDM,RX-9615,CLADRIBINE 10 MG/10 ML INTRAVENOUS SOLUTION,1714.85,1028.91,10.36,4481.0,35 CDM,RX-9617,CLARITHROMYCIN 500 MG TABLET,30.95,18.57,7.18,4481.0,19 CDM,RX-9623,CLINDAMYCIN 1 % TOPICAL GEL,76.25,45.75,17.69,4481.0,19 CDM,RX-9626,CLINDAMYCIN 600 MG/50 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,103.8,62.28,4.12,4481.0,24 CDM,RX-9627,CLINDAMYCIN 900 MG/50 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,112.75,67.65,4.12,4481.0,24 CDM,RX-9631,CLOBETASOL 0.05 % TOPICAL OINTMENT,259.3,155.58,60.16,4481.0,19 CDM,RX-9638,CLONAZEPAM 1 MG TABLET,23.45,14.07,5.44,4481.0,19 CDM,RX-9644,CLOTRIMAZOLE 10 MG TROCHE,24.25,14.55,5.63,4481.0,19 CDM,RX-9647,CLOZAPINE 100 MG TABLET,21.05,12.63,4.88,4481.0,19 CDM,RX-9648,CLOZAPINE 25 MG TABLET,18.0,10.8,4.18,4481.0,19 CDM,RX-9681,COLISTIN (COLISTIMETHATE SODIUM) 150 MG SOLUTION FOR INJECTION,125.2,75.12,29.05,4481.0,24 CDM,RX-9682,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 250 UNIT/GRAM TOPICAL OINTMENT,971.6,582.96,225.41,4481.0,19 CDM,RX-9686,COSYNTROPIN 0.25 MG SOLUTION FOR INJECTION,431.7,259.02,57.08,4481.0,24 CDM,RX-96930,CHOLECALCIFEROL (VITAMIN D3) 10 MCG/ML (400 UNIT/ML) ORAL DROPS,1.1,0.66,0.2552,4481.0,19 CDM,RX-96948,ARTEMETHER-LUMEFANTRINE 20 MG-120 MG TABLET,32.85,19.71,7.62,4481.0,19 CDM,RX-96968,LACOSAMIDE 50 MG TABLET,25.75,15.45,5.97,4481.0,19 CDM,RX-96969,LACOSAMIDE 100 MG TABLET,31.35,18.81,7.27,4481.0,19 CDM,RX-96972,LACOSAMIDE 200 MG/20 ML INTRAVENOUS SOLUTION,96.6,57.96,0.45,4481.0,23 CDM,RX-96986,DEGARELIX 80 MG SUBCUTANEOUS SOLUTION,1891.8,1135.08,4.32,4481.0,35 CDM,RX-96987,DEGARELIX 120 MG SUBCUTANEOUS SOLUTION,2797.55,1678.53,4.32,4481.0,35 CDM,RX-96988,CONIVAPTAN 20 MG/100 ML IN 5 % DEXTROSE IV,3458.9,2075.34,102.28,4481.0,23 CDM,RX-9699,CYCLOPENTOLATE 0.5 % EYE DROPS,320.75,192.45,74.41,4481.0,19 CDM,RX-9700,CYCLOPENTOLATE 2 % EYE DROPS,155.6,93.36,36.1,4481.0,19 CDM,RX-97009,"DEXLANSOPRAZOLE 60 MG CAPSULE,BIPHASE DELAYED RELEASE",42.25,25.35,9.8,4481.0,19 CDM,RX-9701,CYCLOPENTOLATE-PHENYLEPHRINE 0.2 %-1 % EYE DROPS,169.625,101.775,29.57,4481.0,38 CDM,RX-9705,CYCLOSPORINE 250 MG/5 ML INTRAVENOUS SOLUTION,295.8,177.48,68.63,10791.27,24 CDM,RX-9706,CYCLOSPORINE 100 MG CAPSULE,65.65,39.39,4.59,4481.0,24 CDM,RX-9707,CYCLOSPORINE 25 MG CAPSULE,30.4,18.24,1.8,4481.0,24 CDM,RX-97133,FEBUXOSTAT 40 MG TABLET,49.05,29.43,11.38,4481.0,19 CDM,RX-97134,FEBUXOSTAT 80 MG TABLET,17.5,10.5,4.06,4481.0,19 CDM,RX-97141,CETIRIZINE 5 MG/5 ML ORAL SOLUTION (UNIT DOSE CUPS/SYRINGES),3.25,1.95,0.754,4481.0,19 CDM,RX-9716,DANTROLENE 20 MG INTRAVENOUS SOLUTION,294.9,176.94,68.42,4481.0,19 CDM,RX-9718,DANTROLENE 25 MG CAPSULE,18.45,11.07,4.28,4481.0,19 CDM,RX-9723,DEFEROXAMINE 500 MG SOLUTION FOR INJECTION,151.45,90.87,20.27,4481.0,24 CDM,RX-97252,DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTION,65.05,39.03,0.0675,4481.0,72 CDM,RX-97260,TEMOZOLOMIDE IVPB,3595.3,2157.18,10.08,4481.0,35 CDM,RX-97343,SUMATRIPTAN 6 MG/0.5 ML SUBCUTANEOUS SOLUTION,58.9,35.34,13.66,4481.0,24 CDM,RX-97371,VANCOMYCIN 750 MG INTRAVENOUS SOLUTION,94.1,56.46,0.0675,4481.0,24 CDM,RX-97389,EVEROLIMUS (ANTINEOPLASTIC) 5 MG TABLET,2758.6,1655.16,640.0,4481.0,19 CDM,RX-97390,EVEROLIMUS (ANTINEOPLASTIC) 10 MG TABLET,2758.5,1655.1,639.97,4481.0,19 CDM,RX-97463,"CHOLECALCIFEROL (VITAMIN D3) 125 MCG (5,000 UNIT) TABLET",1.45,0.87,0.3364,4481.0,19 CDM,RX-9748,DESMOPRESSIN 4 MCG/ML INJECTION SOLUTION,860.35,516.21,3.41,4481.0,70 CDM,RX-9759,DEXTRAN 40 10 % IN 5 % DEXTROSE INTRAVENOUS,316.4,189.84,73.4,4481.0,21 CDM,RX-9773,DEXTROMETHORPHAN POLISTIREX ER 30 MG/5 ML ORAL SUSP EXT.RELEASE 12HR,1.7,1.02,0.3944,4481.0,19 CDM,RX-9774,DEXTROMETHORPHAN-GUAIFENESIN 10 MG-100 MG/5 ML ORAL SYRUP,4.6,2.76,1.07,4481.0,19 CDM,RX-97853,CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT,19681.15,11808.69,3.79,15744.92,35 CDM,RX-9788,DEXTROSE 5 % AND LACTATED RINGERS INTRAVENOUS SOLUTION,81.0,48.6,18.32,4481.0,21 CDM,RX-97893,TOLVAPTAN 15 MG TABLET,196.0,117.6,45.47,4481.0,19 CDM,RX-97894,TOLVAPTAN 30 MG TABLET,379.15,227.49,87.96,4481.0,19 CDM,RX-9795,POTASSIUM CHLORIDE 20 MEQ/L IN D5-0.9 % SODIUM CHLORIDE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 CDM,RX-9799,POTASSIUM CHLORIDE 10 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,93.0,55.8,0.2475,4481.0,21 CDM,RX-9800,POTASSIUM CHLORIDE 20 MEQ/L IN DEXTROSE 5 %-0.2 % SODIUM CHLORIDE IV,97.3,58.38,0.2475,4481.0,24 CDM,RX-9801,POTASSIUM CHLORIDE 20 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,85.9,51.54,0.2475,4481.0,24 CDM,RX-98036,"LIPASE-PROTEASE-AMYLAS(PORK)24,000-76,000-120,000 UNIT CAPSULE,DEL REL",2567.2,1540.32,595.59,4481.0,19 CDM,RX-9804,POTASSIUM CHLORIDE 30 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,101.1,60.66,0.2475,4481.0,24 CDM,RX-9807,POTASSIUM CHLORIDE 40 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,101.1,60.66,0.2475,4481.0,24 CDM,RX-9809,DEXTROSE 10 % AND 0.45 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,90.0,54.0,20.88,4481.0,17 CDM,RX-9812,DEXTROSE 5 % AND 0.2 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,81.0,48.6,18.79,4481.0,17 CDM,RX-9814,DEXTROSE 5 % AND 0.45 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,78.75,47.25,17.75,4481.0,34 CDM,RX-9815,DEXTROSE 5 % AND 0.9 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,81.0,48.6,3.17,4481.0,21 CDM,RX-98253,TAPENTADOL 50 MG TABLET,59.05,35.43,13.7,4481.0,19 CDM,RX-98254,TAPENTADOL 75 MG TABLET,49.3,29.58,11.44,4481.0,19 CDM,RX-9828,DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM 66 %-10 % ORAL SOLUTION (37% ORGANICALLY BOUND IODINE),292.85,175.71,0.495,4481.0,24 CDM,RX-98312,FERUMOXYTOL 510 MG/17 ML (30 MG/ML) INTRAVENOUS SOLUTION,3966.15,2379.69,0.3104,4481.0,36 CDM,RX-98329,DRONEDARONE 400 MG TABLET,55.9,33.54,12.97,4481.0,19 CDM,RX-98372,PRASUGREL HCL 5 MG TABLET,18.5,11.1,4.29,4481.0,19 CDM,RX-98373,PRASUGREL HCL 10 MG TABLET,18.5,11.1,4.29,4481.0,19 CDM,RX-98399,CASTOR OIL 100 % ORAL,7.025,4.215,1.58,4481.0,38 CDM,RX-9853,DIGOXIN 100 MCG/ML (0.1 MG/ML) INJECTION SOLUTION,553.15,331.89,10.89,4481.0,24 CDM,RX-989,BENZOYL PEROXIDE 10 % TOPICAL GEL,6.95,4.17,1.61,4481.0,19 CDM,RX-9892,DOBUTAMINE 250 MG/20 ML (12.5 MG/ML) INTRAVENOUS SOLUTION,88.35,53.01,15.93,4481.0,24 CDM,RX-99,ACETAMINOPHEN 80 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 CDM,RX-9902,DOXYCYCLINE MONOHYDRATE 25 MG/5 ML ORAL SUSPENSION,25.15,15.09,5.83,4481.0,19 CDM,RX-9904,DRONABINOL 2.5 MG CAPSULE,28.3,16.98,6.57,4481.0,19 CDM,RX-9905,DRONABINOL 5 MG CAPSULE,74.3,44.58,17.24,4481.0,19 CDM,RX-991,BENZOYL PEROXIDE 5 % TOPICAL GEL,6.6,3.96,1.53,4481.0,23 CDM,RX-9915,ECONAZOLE NITRATE 1 % TOPICAL CREAM,166.75,100.05,38.69,4481.0,19 CDM,RX-9924,ENALAPRIL MALEATE 10 MG TABLET,16.7,10.02,3.87,4481.0,19 CDM,RX-9926,ENALAPRIL MALEATE 20 MG TABLET,16.9,10.14,3.92,4481.0,19 CDM,RX-9929,ENALAPRILAT 1.25 MG/ML INTRAVENOUS SOLUTION,94.05,56.43,21.82,4481.0,19 CDM,RX-9938,"EPOETIN ALFA 10,000 UNIT/ML INJECTION SOLUTION",662.65,397.59,8.28,4481.0,33 CDM,RX-9939,"EPOETIN ALFA 2,000 UNIT/ML INJECTION SOLUTION",224.5,134.7,8.28,4481.0,33 CDM,RX-9940,"EPOETIN ALFA 3,000 UNIT/ML INJECTION SOLUTION",210.0,126.0,8.28,4481.0,33 CDM,RX-99405,OPIUM TINCTURE 10 MG/ML (MORPHINE) ORAL,25.5,15.3,5.92,4481.0,19 CDM,RX-9941,"EPOETIN ALFA 4,000 UNIT/ML INJECTION SOLUTION",274.65,164.79,8.28,4481.0,33 CDM,RX-99413,VIGABATRIN 500 MG ORAL POWDER PACKET,34.0,20.4,7.89,4481.0,19 CDM,RX-9943,"ERGOCALCIFEROL (VITAMIN D2) 200 MCG/ML (8,000 UNIT/ML) ORAL DROPS",1.2999999999999998,0.78,0.2784,4481.0,57 CDM,RX-99461,DEXAMETHASONE 0.7 MG INTRAVITREAL IMPLANT,5514.0,3308.4,198.47,4770.16,35 CDM,RX-99465,ABOBOTULINUMTOXINA 500 UNIT INTRAMUSCULAR SOLUTION,3449.95,2069.97,8.49,4481.0,35 CDM,RX-9967,ESTRADIOL 1 MG TABLET,16.95,10.17,3.93,4481.0,19 CDM,RX-9968,ESTRADIOL 2 MG TABLET,17.25,10.35,4.0,4481.0,19 CDM,RX-9969,ESTRADIOL 0.01% (0.1 MG/GRAM) VAGINAL CREAM,1053.75,632.25,244.47,4481.0,19 CDM,RX-99694,SEVELAMER CARBONATE 0.8 GRAM ORAL POWDER PACKET,44.4,26.64,10.3,4481.0,19 CDM,RX-99695,SEVELAMER CARBONATE 2.4 GRAM ORAL POWDER PACKET,21.7,13.02,5.03,4481.0,19 CDM,RX-99702,PALIPERIDONE PALMITATE 156 MG/ML INTRAMUSCULAR SYRINGE,9296.05,5577.63,14.66,7436.84,35 CDM,RX-9972,CONJUGATED ESTROGENS 25 MG SOLUTION FOR INJECTION,1485.85,891.51,375.92,4481.0,35 CDM,RX-9973,CONJUGATED ESTROGENS 0.3 MG TABLET,37.25,22.35,8.64,4481.0,19 CDM,RX-9974,CONJUGATED ESTROGENS 0.625 MG TABLET,37.25,22.35,8.64,4481.0,19 CDM,RX-9975,CONJUGATED ESTROGENS 0.9 MG TABLET,37.25,22.35,8.64,4481.0,19 CDM,RX-99755,ASENAPINE 10 MG SUBLINGUAL TABLET,31.3,18.78,7.26,4481.0,19 CDM,RX-998,BENZTROPINE 0.5 MG TABLET,17.5,10.5,4.06,4481.0,19 CDM,RX-9980,ETHACRYNIC ACID 25 MG TABLET,23.5,14.1,5.45,4481.0,19 CDM,RX-9982,ETHAMBUTOL 100 MG TABLET,17.4,10.44,4.04,4481.0,19 CDM,RX-9983,ETHAMBUTOL 400 MG TABLET,19.25,11.55,4.47,4481.0,19 CDM,RX-99835,"GUANFACINE ER 1 MG TABLET,EXTENDED RELEASE 24 HR",18.25,10.95,4.23,4481.0,19 CDM,RX-99836,"GUANFACINE ER 2 MG TABLET,EXTENDED RELEASE 24 HR",18.25,10.95,4.23,4481.0,19 CDM,RX-9989,ETHOSUXIMIDE 250 MG CAPSULE,17.3,10.38,4.01,4481.0,19 CDM,RX-999,BENZTROPINE 1 MG TABLET,17.5,10.5,4.06,4481.0,19 CDM,RX-99997,TELAVANCIN 750 MG INTRAVENOUS SOLUTION,2210.35,1326.21,6.9,4481.0,35 CDM,SUP-133921,GRAFT INTEGRA BILAYER MESHED W,28663.03,17197.82,154.82,24796.39,24 CDM,SUP-148836,MEMBRANE AUTOLOGOUS CULTURED CHONDROCYTES,95031.72,57019.03,4481.0,215040.47,24 CDM,SUP-149784,MEMBRANE 2 AUTOLOGOUS CULTURED CHONDROCYTES,156650.0,93990.0,4481.0,215040.47,24 CDM,SUP-239665,SKIN GRAFT SOFT TISS 3X6CM STRAVIX,6895.01,4137.01,312.17,5964.87,25 CDM,SUP-239666,SKIN GRAFT SOFT TISS 2X4CM STRAVIX,5273.99,3164.39,312.17,4562.53,25 CPT,00402,"ANESTHESIA FOR PROCEDURES ON THE INTEGUMENTARY SYSTEM ON THE EXTREMITIES, ANTERIOR TRUNK AND PERINEUM; RECONSTRUCTIVE PROCEDURES ON BREAST (EG, REDUCTION OR AUGMENTATION MAMMOPLASTY, MUSCLE FLAPS)",,,,,0 CPT,0042T,HC CT CEREBRAL PERFUSION STUDY,3259.0,1955.4,756.09,4481.0,24 CPT,0054T,"COMPUTER-ASSISTED MUSCULOSKELETAL SURGICAL NAVIGATIONAL ORTHOPEDIC PROCEDURE, WITH IMAGE-GUIDANCE BASED ON FLUOROSCOPIC IMAGES (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 CPT,0075T,HC STENT ECV IT CAROTID W S AND I FIRST VESSEL,10326.0,6195.6,2395.63,9423.0,48 CPT,0076T,HC STENT ECV IT CAROTID W S AND I EACH ADDITIONAL VESSEL,12349.0,7409.4,2533.0,9879.2,48 CPT,0106T,HC QST TOUCH PRESSURE STIM PEREXT,605.0,363.0,36.96,4481.0,34 CPT,0107T,HC QST VIBRATION STIMULI PER EXT,605.0,363.0,36.96,4481.0,34 CPT,0108T,HC QST COOLING STIMULI PER EXT,605.0,363.0,55.93,4481.0,34 CPT,0109T,HC QST HEAT PAIN STIMULI PER EXT,605.0,363.0,36.96,4481.0,34 CPT,0110T,HC QST OTHER STIMULI PER EXT,605.0,363.0,121.37,4481.0,34 CPT,0200T,HC PERC AUGMENT SACRAL INJ UNIL 1 OR MORE NEEDLES W BIOPSY W IMAGE GUIDANCE,8821.0,5292.6,2445.18,13194.0,34 CPT,0201T,HC PERC AUGMENT SACRAL INJ BIL 2 OR MORE NEEDLES W BIOPSY W IMAGE GUIDANCE,10316.0,6189.6,2859.6,13194.0,34 CPT,0202U,HC BIOFIRE RESPIRATORY PANEL 2.1 RP2.1 TEST,933.0,559.8,258.63,4481.0,34 CPT,0235T,HC ATHERECTOMY VISCERAL W S AND I EACH VESSEL,22439.0,13463.4,2533.0,17951.2,48 CPT,0236T,HC ATHERECTOMY ABD AORTA W S AND I,22439.0,13463.4,4481.0,30725.0,35 CPT,0237T,HC ATHERECTOMY BRACHCPHLC BRCH W S AND I,22439.0,13463.4,4481.0,30725.0,35 CPT,0238T,HC REVASC ATHERECTOMY ILIAC ARTERY INCLD S AND I EACH VESSEL,22439.0,13463.4,4481.0,30725.0,70 CPT,0241U,HC RAPID RSFLU COVID FLURVID CEPHEID - INACTIVE,275.0,165.0,63.8,4481.0,22 CPT,0266T,"IMPLANTATION OR REPLACEMENT OF CAROTID SINUS BAROREFLEX ACTIVATION DEVICE; TOTAL SYSTEM (INCLUDES GENERATOR PLACEMENT, UNILATERAL OR BILATERAL LEAD PLACEMENT, INTRA-OPERATIVE INTERROGATION, PROGRAMMIN",,,18691.0,46301.0,13 CPT,0275T,HC PERC LAMINOTOMY LAMINECTOMY FOR DECOMPRESSION OF NEURAL ELEMENTS,6876.0,4125.6,1906.03,21454.0,34 CPT,0275T,"PERCUTANEOUS LAMINOTOMY/LAMINECTOMY (INTERLAMINAR APPROACH) FOR DECOMPRESSION OF NEURAL ELEMENTS, (WITH OR WITHOUT LIGAMENTOUS RESECTION, DISCECTOMY, FACETECTOMY AND/OR FORAMINOTOMY), ANY METHOD, UNDE",,,6726.11,21454.0,14 CPT,0338T,HC TRANSCATHETER RENAL SYMPATHETIC DENERVATION UNILATERAL INCL FLUORO W S AND I,10837.0,6502.2,3004.02,15291.0,35 CPT,0339T,HC TRANSCATHETER RENAL SYMPATHETIC DENERVATION BILATERAL INCL FLUORO W S AND I,13004.0,7802.4,3604.71,15291.0,35 CPT,0408T,HC INSERT OR REPLACE PERM CARDIAC CCM SYSTEM,9570.0,5742.0,2652.8,38950.0,35 CPT,0442T,HC CRYOABL NERVE PLEXUS OR TRUNCAL NERVE INCL GUIDANCE,6325.0,3795.0,1753.29,15394.0,35 CPT,0449T,"INSERTION OF AQUEOUS DRAINAGE DEVICE, WITHOUT EXTRAOCULAR RESERVOIR, INTERNAL APPROACH, INTO THE SUBCONJUNCTIVAL SPACE; INITIAL DEVICE",,,4858.07,15394.0,14 CPT,0479T,"FRACTIONAL ABLATIVE LASER FENESTRATION OF BURN AND TRAUMATIC SCARS FOR FUNCTIONAL IMPROVEMENT; FIRST 100 CM2 OR PART THEREOF, OR 1% OF BODY SURFACE AREA OF INFANTS AND CHILDREN",,,576.34,5449.0,14 CPT,0479T,HC FRACTIONAL ABL LSR FENESTRATION FIRST 100 SQCM,1763.0,1057.8,488.7,5449.0,34 CPT,0480T,"FRACTIONAL ABLATIVE LASER FENESTRATION OF BURN AND TRAUMATIC SCARS FOR FUNCTIONAL IMPROVEMENT; EACH ADDITIONAL 100 CM2, OR EACH ADDITIONAL 1% OF BODY SURFACE AREA OF INFANTS AND CHILDREN, OR PART THER",,,777.0,5449.0,3 CPT,0483T,HC TMVR IMPLANT OR REPLACE PERCUTANEOUS,9200.0,5520.0,2134.4,7360.0,24 CPT,0512T,HC EXTRACORPOREAL SHOCK WAVE 1ST WOUND,548.0,328.8,151.91,4481.0,34 CPT,0513T,HC EXTRACORPOREAL SHOCK WAVE EACH ADDITIONAL WOUND,161.0,96.6,37.35,4481.0,24 CPT,0559T,HC ANATOMIC MODEL 3D PRINTED,2841.0,1704.6,55.93,4481.0,34 CPT,0560T,HC ANATOMIC MODEL 3D PRINTED EACH ADDITIONAL,2841.0,1704.6,270.0,4481.0,24 CPT,0569T,HC TTVR PERCUTANEOUS INITIAL PROSTHESIS,8472.0,5083.2,1965.5,6777.6,24 CPT,0600T,HC IRE ABLATION 1 OR MORE TUMORS PER ORGAN PERC INCLD IMAGE GUIDANCE,10507.0,6304.2,2912.54,21454.0,35 CPT,0619T,"CYSTOURETHROSCOPY WITH TRANSURETHRAL ANTERIOR PROSTATE COMMISSUROTOMY AND DRUG DELIVERY, INCLUDING TRANSRECTAL ULTRASOUND AND FLUOROSCOPY, WHEN PERFORMED",,,5514.0,9514.39,14 CPT,0624T,HC AUTOMATED QUANTIFICATION CT ANGIO CORONARY ATHEROSCLEROTIC PLAQUE ANALYSIS DATA PREP AND TRANSMISSION,1901.0,1140.6,441.03,4481.0,24 CPT,0625T,HC AUTOMATED QUANTIFICATION CT ANGIO CORONARY ATHEROSCLEROTIC PLAQUE COMPUTERIZED ANALYSIS OF DATA,475.0,285.0,131.67,4481.0,34 CPT,0627T,HC PERCUTANEOUS INJECTION OF ALLOGENEIC CELLULAR PRODUCT UNILAT BILAT FLUOR LUMBAR 1ST LEVEL,34514.0,20708.4,4481.0,27611.2,34 CPT,0644T,HC TRANS CATH REMOVE INTRACARDIAC MASS SUCTION DEVICE PERC INCL GUIDANCE,12397.0,7438.2,3436.45,21454.0,35 CPT,0646T,HC TTVI PERC INCLD PROSTHETIC VALVE RHC TEMP PACER RA RV ANGIO,10944.0,6566.4,2533.0,9423.0,24 CPT,0671T,"INSERTION OF ANTERIOR SEGMENT AQUEOUS DRAINAGE DEVICE INTO THE TRABECULAR MESHWORK, WITHOUT EXTERNAL RESERVOIR, AND WITHOUT CONCOMITANT CATARACT REMOVAL, ONE OR MORE",,,4858.07,9324.0,14 CPT,0673T,HC ABLATION BENIGN THYROID NODULE(S) PERC LASER INCLD GUIDANCE,8044.0,4826.4,1525.52,6610.0,35 CPT,0707T,"INJECTION(S), BONE-SUBSTITUTE MATERIAL (EG, CALCIUM PHOSPHATE) INTO SUBCHONDRAL BONE DEFECT (IE, BONE MARROW LESION, BONE BRUISE, STRESS INJURY, MICROTRABECULAR FRACTURE), INCLUDING IMAGING GUIDANCE A",,,3054.93,13194.0,14 CPT,0721T,HC QUANTITAVE CT TISSUE CHARACTERIZATION WO CONCURRENT CT,651.0,390.6,180.46,4481.0,34 CPT,0722T,HC QUANTITAVE CT TISSUE CHARACTERIZATION W CONCURRENT CT,651.0,390.6,180.46,4481.0,34 CPT,0865T,HC QUANTITATIVE MRI ANALYSIS BRAIN W COMPARISON TO PRIOR MRI WO DX MRI SAME SESSION,1423.0,853.8,227.59,4481.0,34 CPT,0866T,HC QUANTITATIVE MRI ANALYSIS BRAIN W COMPARISON TO PRIOR MRI W DX MRI SAME SESSION,1457.0,874.2,227.59,4481.0,34 CPT,0913T,HC PERC TRANSCATH THERAPY RX INTRACORONARY BALLOON INCL MECH DILATION BY NON RX DELIVERY BALLOON ANGIO IMG USING IVUS OR OCT INCL SINGLE MAJOR CORONARY ARTERY OR BRANCH,8258.0,4954.8,2289.12,21454.0,35 CPT,0914T,HC PERC TRANSCATH THERAPY RX INTRAC BALLOON DONE ON SEP TARGET LESION INCL MECH DILATION BY NON RX DEL BALLOON ANGIO IMG USING IVUS OR OCT INCL SINGLE MAJOR CORONARY ARTERY OR BRANCH,8234.0,4940.4,777.0,9423.0,25 CPT,0933T,HC TRANSCATH IMPLANTATION OF WIRELESS LT ATRIAL PRESSURE SENSOR FOR LONG TERM LT ATRIAL PRESSURE MONITORING,8258.0,4954.8,2289.12,15394.0,35 CPT,10004,HC FNA BIOPSY W OUT GUIDANCE EACH ADDL LESION,1331.0,798.6,308.79,6610.0,48 CPT,10005,"FINE NEEDLE ASPIRATION BIOPSY, INCLUDING ULTRASOUND GUIDANCE; FIRST LESION",,,662.46,5449.0,15 CPT,10005,HC FNA BIOPSY INCL US GUIDANCE 1ST LESION,2561.0,1536.6,662.46,6610.0,69 CPT,10006,"FINE NEEDLE ASPIRATION BIOPSY, INCLUDING ULTRASOUND GUIDANCE; EACH ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 CPT,10006,HC FNA BIOPSY INCL US GUIDANCE EA ADDL LESION,2585.0,1551.0,599.72,6610.0,48 CPT,10007,HC FNA BX INCL FLUORO GUIDANCE 1ST LESION,1920.0,1152.0,532.22,6610.0,35 CPT,10008,HC FNA BX INCL FLUORO GUIDANCE EA ADDL LESION,1920.0,1152.0,445.44,6610.0,24 CPT,10009,HC FNA BX INCL CT GUIDANCE 1ST LESION,3482.0,2089.2,662.46,6610.0,35 CPT,10010,HC FNA BX INCL CT GUIDANCE EA ADDL LESION,3482.0,2089.2,777.0,6610.0,24 CPT,10011,HC FNA BX INCL MR GUIDANCE 1ST LESION,2585.0,1551.0,662.46,6610.0,35 CPT,10012,HC FNA BX INCL MR GUIDANCE EA ADDL LESION,2585.0,1551.0,599.72,6610.0,24 CPT,10021,"FINE NEEDLE ASPIRATION BIOPSY, WITHOUT IMAGING GUIDANCE; FIRST LESION",,,376.18,5449.0,14 CPT,10021,HC FNA W O IMAGING,666.0,399.6,112.09,6610.0,101 CPT,10021,HC FNAA FNA W ATND PATHOL PRESNT,666.0,399.6,184.62,6610.0,34 CPT,10030,HC DRAIN CATH PLMT OTHER,3864.0,2318.4,662.46,7278.0,34 CPT,10035,HC PLACE SOFT TISSUE MARKER 1ST LESION,4107.0,2464.2,662.46,7278.0,35 CPT,10036,HC PLACE SOFT TISSUE MARKER ADDL LESION,4107.0,2464.2,777.0,6610.0,24 CPT,10060,HC INCISION AND DRAINAGE ABSCESS SIMPLE SINGLE,488.0,292.8,135.27,6610.0,68 CPT,10060,"INCISION AND DRAINAGE OF ABSCESS (EG, CARBUNCLE, SUPPURATIVE HIDRADENITIS, CUTANEOUS OR SUBCUTANEOUS ABSCESS, CYST, FURUNCLE, OR PARONYCHIA); SIMPLE OR SINGLE",,,187.08,5449.0,14 CPT,10061,HC INCISION AND DRAINAGE ABSCESS COMPL MULT,633.0,379.8,175.47,6610.0,69 CPT,10061,"INCISION AND DRAINAGE OF ABSCESS (EG, CARBUNCLE, SUPPURATIVE HIDRADENITIS, CUTANEOUS OR SUBCUTANEOUS ABSCESS, CYST, FURUNCLE, OR PARONYCHIA); COMPLICATED OR MULTIPLE",,,376.18,5449.0,15 CPT,10080,HC INCISION AND DRAINAGE PILONIDAL CYST SIMPLE,410.0,246.0,113.65,5449.0,34 CPT,10080,INCISION AND DRAINAGE OF PILONIDAL CYST; SIMPLE,,,662.46,5449.0,14 CPT,10081,INCISION AND DRAINAGE OF PILONIDAL CYST; COMPLICATED,,,662.46,5449.0,28 CPT,10120,HC INCISE AND REMOVE FOREIGN BODY SUBQ TISSUE SIMPLE,474.0,284.4,131.39,5449.0,34 CPT,10120,"INCISION AND REMOVAL OF FOREIGN BODY, SUBCUTANEOUS TISSUES; SIMPLE",,,376.18,5449.0,28 CPT,10121,"INCISION AND REMOVAL OF FOREIGN BODY, SUBCUTANEOUS TISSUES; COMPLICATED",,,1525.52,7278.0,15 CPT,10140,HC INCISION AND DRAINAGE HEMATOMA SEROMA OR FLUID,1752.0,1051.2,485.65,6610.0,68 CPT,10140,"INCISION AND DRAINAGE OF HEMATOMA, SEROMA OR FLUID COLLECTION",,,1525.52,5449.0,14 CPT,10160,HC ASPIR HEMATOMA ABCES BUL CYST,1386.0,831.6,376.18,6610.0,68 CPT,10160,"PUNCTURE ASPIRATION OF ABSCESS, HEMATOMA, BULLA, OR CYST",,,376.18,5449.0,14 CPT,10180,HC INCISION AND DRAINAGE POSTOP WOUND INFECTION COMPLEX,3875.0,2325.0,1074.15,7278.0,34 CPT,10180,"INCISION AND DRAINAGE, COMPLEX, POSTOPERATIVE WOUND INFECTION",,,2694.74,9324.0,15 CPT,11000,DEBRIDEMENT OF EXTENSIVE ECZEMATOUS OR INFECTED SKIN; UP TO 10% OF BODY SURFACE,,,576.34,5449.0,14 CPT,11000,HC DEBRIDEMENT EXTENSIVE ECZEMATOUS INFECTED SKIN,349.0,209.4,96.74,5449.0,34 CPT,11001,HC DEBRIDEMENT EACH ADDL 10% OF BODY SURFACE,349.0,209.4,80.97,5449.0,24 CPT,11004,"DEBRIDEMENT OF SKIN, SUBCUTANEOUS TISSUE, MUSCLE AND FASCIA FOR NECROTIZING SOFT TISSUE INFECTION; EXTERNAL GENITALIA AND PERINEUM",,,2533.0,4850.0,2 CPT,11005,"DEBRIDEMENT OF SKIN, SUBCUTANEOUS TISSUE, MUSCLE AND FASCIA FOR NECROTIZING SOFT TISSUE INFECTION; ABDOMINAL WALL, WITH OR WITHOUT FASCIAL CLOSURE",,,2533.0,4850.0,2 CPT,11006,HC WOUND REPAIR DEBRIDEMENT,2164.0,1298.4,502.05,6610.0,23 CPT,11008,"REMOVAL OF PROSTHETIC MATERIAL OR MESH, ABDOMINAL WALL FOR INFECTION (EG, FOR CHRONIC OR RECURRENT MESH INFECTION OR NECROTIZING SOFT TISSUE INFECTION) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY",,,7444.0,13194.0,2 CPT,11010,"DEBRIDEMENT INCLUDING REMOVAL OF FOREIGN MATERIAL AT THE SITE OF AN OPEN FRACTURE AND/OR AN OPEN DISLOCATION (EG, EXCISIONAL DEBRIDEMENT); SKIN AND SUBCUTANEOUS TISSUES",,,662.46,7278.0,15 CPT,11011,"DEBRIDEMENT INCLUDING REMOVAL OF FOREIGN MATERIAL AT THE SITE OF AN OPEN FRACTURE AND/OR AN OPEN DISLOCATION (EG, EXCISIONAL DEBRIDEMENT); SKIN, SUBCUTANEOUS TISSUE, MUSCLE FASCIA, AND MUSCLE",,,662.46,7278.0,15 CPT,11012,"DEBRIDEMENT INCLUDING REMOVAL OF FOREIGN MATERIAL AT THE SITE OF AN OPEN FRACTURE AND/OR AN OPEN DISLOCATION (EG, EXCISIONAL DEBRIDEMENT); SKIN, SUBCUTANEOUS TISSUE, MUSCLE FASCIA, MUSCLE, AND BONE",,,2246.0,7278.0,15 CPT,11042,"DEBRIDEMENT, SUBCUTANEOUS TISSUE (INCLUDES EPIDERMIS AND DERMIS, IF PERFORMED); FIRST 20 SQ CM OR LESS",,,376.18,7278.0,15 CPT,11042,HC DEBRIDEMENT SQ TISSUE SKIN 1ST 20SQCM,984.0,590.4,272.76,7278.0,69 CPT,11043,"DEBRIDEMENT, MUSCLE AND/OR FASCIA (INCLUDES EPIDERMIS, DERMIS, AND SUBCUTANEOUS TISSUE, IF PERFORMED); FIRST 20 SQ CM OR LESS",,,576.34,7278.0,15 CPT,11043,HC DEBRIDEMENT MUSCLE SKIN TISSUE 1ST 20SQCM,955.0,573.0,264.73,7278.0,35 CPT,11044,"DEBRIDEMENT, BONE (INCLUDES EPIDERMIS, DERMIS, SUBCUTANEOUS TISSUE, MUSCLE AND/OR FASCIA, IF PERFORMED); FIRST 20 SQ CM OR LESS",,,1525.52,7278.0,15 CPT,11044,HC DEBRIDEMENT BONE SKIN TISSUE MUSCLE 1ST 20SQCM,2844.0,1706.4,788.36,7278.0,35 CPT,11045,"DEBRIDEMENT, SUBCUTANEOUS TISSUE (INCLUDES EPIDERMIS AND DERMIS, IF PERFORMED); EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 CPT,11045,HC DEBRIDEMENT TISSUE SKIN ADD 20SQCM,886.0,531.6,205.55,6610.0,24 CPT,11046,"DEBRIDEMENT, MUSCLE AND/OR FASCIA (INCLUDES EPIDERMIS, DERMIS, AND SUBCUTANEOUS TISSUE, IF PERFORMED); EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCED",,,777.0,5449.0,3 CPT,11046,HC DEBRIDEMENT MUSCLE SKIN TISSUE ADD 20SQCM,955.0,573.0,221.56,6610.0,48 CPT,11047,"DEBRIDEMENT, BONE (INCLUDES EPIDERMIS, DERMIS, SUBCUTANEOUS TISSUE, MUSCLE AND/OR FASCIA, IF PERFORMED); EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROC",,,777.0,5449.0,3 CPT,11047,HC DEBRIDEMENT BONE SKIN TISSUE MUSCLE ADD 20SQCM,2844.0,1706.4,659.81,6610.0,48 CPT,11055,HC PARING BENIGN LESION SINGLE,198.0,118.8,54.89,5449.0,34 CPT,11055,"PARING OR CUTTING OF BENIGN HYPERKERATOTIC LESION (EG, CORN OR CALLUS); SINGLE LESION",,,187.08,5449.0,14 CPT,11056,HC PARING BENIGN LESION 2-4,207.0,124.2,57.38,5449.0,34 CPT,11057,HC PARING BENIGN LESION GREATER THAN 4,277.0,166.2,76.78,5449.0,34 CPT,11102,HC TANGENTIAL BIOPSY OF SKIN SINGLE LESION,313.0,187.8,86.76,6610.0,68 CPT,11102,"TANGENTIAL BIOPSY OF SKIN (EG, SHAVE, SCOOP, SAUCERIZE, CURETTE); SINGLE LESION",,,187.08,5449.0,14 CPT,11103,HC TANGENTIAL BIOPSY OF SKIN EA SEPARATE ADDL LESION,195.0,117.0,45.24,5449.0,24 CPT,11103,"TANGENTIAL BIOPSY OF SKIN (EG, SHAVE, SCOOP, SAUCERIZE, CURETTE); EACH SEPARATE/ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 CPT,11104,HC PUNCH BIOPSY OF SKIN SINGLE LESION,315.0,189.0,87.32,6610.0,68 CPT,11104,"PUNCH BIOPSY OF SKIN (INCLUDING SIMPLE CLOSURE, WHEN PERFORMED); SINGLE LESION",,,376.18,5449.0,28 CPT,11105,HC PUNCH BIOPSY OF SKIN EA SEPARATE ADDL LESION,195.0,117.0,45.24,5449.0,24 CPT,11105,"PUNCH BIOPSY OF SKIN (INCLUDING SIMPLE CLOSURE, WHEN PERFORMED); EACH SEPARATE/ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 CPT,11106,HC INCISIONAL BIOPSY OF SKIN W SIMPLE CLOSURE SINGLE LESION,313.0,187.8,86.76,6610.0,69 CPT,11106,"INCISIONAL BIOPSY OF SKIN (EG, WEDGE) (INCLUDING SIMPLE CLOSURE, WHEN PERFORMED); SINGLE LESION",,,576.34,5449.0,15 CPT,11107,HC INCISIONAL BIOPSY OF SKIN W SIMPLE CLOSURE EACH SEPARATE ADDL LESION,195.0,117.0,45.24,5449.0,24 CPT,11200,HC REM SKIN TAGS MULTIPLE FIBROCUTANEOUS TAGS UP TO AND INCLUDE 15 LESIONS,253.0,151.8,70.13,5449.0,34 CPT,11200,"REMOVAL OF SKIN TAGS, MULTIPLE FIBROCUTANEOUS TAGS, ANY AREA; UP TO AND INCLUDING 15 LESIONS",,,187.08,5449.0,28 CPT,11301,HC SHAVE EPIDERMAL DERMAL LESION SINGLE LESION TRUNK ARMS LEGS 0.6 TO 1.0 CM,204.0,122.4,56.55,4481.0,34 CPT,11305,HC SHAVE EPIDERMAL DERMAL LESION SINGLE LESION SCALP NECK HANDS FEET GENITALIA 0.5 CM OR LESS,382.0,229.2,105.89,4481.0,34 CPT,11306,"SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.6 TO 1.0 CM",,,187.08,1251.0,13 CPT,11312,"SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 1.1 TO 2.0 CM",,,376.18,1251.0,13 CPT,11400,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,5449.0,30 CPT,11400,HC EXCISION BENIGN LESION T A L 0.5CM OR LESS,550.0,330.0,152.46,5449.0,34 CPT,11401,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM",,,376.18,5449.0,15 CPT,11401,HC EXCISION BENIGN LESION T A L 0.6 TO 1 CM,569.0,341.4,157.73,5449.0,34 CPT,11402,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,30 CPT,11402,HC EXCISION BENIGN LESION T A L 1.1 TO 2 CM,584.0,350.4,161.88,5449.0,34 CPT,11403,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,662.46,5449.0,15 CPT,11403,HC EXCISION BENIGN LESION T A L 2.1 TO 3 CM,1076.0,645.6,298.27,5449.0,34 CPT,11404,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,5449.0,30 CPT,11404,HC EXCISION BENIGN LESION T A L 3.1 TO 4 CM,1615.0,969.0,447.68,5449.0,34 CPT,11406,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER OVER 4.0 CM",,,1525.52,7278.0,30 CPT,11406,HC EXCISION BENIGN LESION T A L OVER 4 CM,1993.0,1195.8,552.46,7278.0,34 CPT,11420,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS",,,1525.52,7278.0,30 CPT,11420,HC EXCISION BENIGN LESION S N H EX G 0.5 CM OR LESS,1471.0,882.6,407.76,7278.0,34 CPT,11421,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,7278.0,15 CPT,11421,HC EXCISION BENIGN LESION S N H EX G 0.6 TO 1 CM OR LESS,1382.0,829.2,383.09,7278.0,34 CPT,11422,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM",,,1525.52,5449.0,30 CPT,11422,HC EXCISION BENIGN LESION S N H EX G 1.1 TO 2 CM,1600.0,960.0,443.52,5449.0,34 CPT,11423,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,5449.0,15 CPT,11423,HC EXCISION BENIGN LESION S N H EX G 2.1 TO 3 CM,1728.0,1036.8,479.0,5449.0,34 CPT,11424,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,7278.0,15 CPT,11424,HC EXCISION BENIGN LESION S N H EX G 3.1 TO 4 CM,2400.0,1440.0,665.28,7278.0,34 CPT,11426,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,30 CPT,11426,HC EXCISION BENIGN LESION S N H EX G GREATER THAN 4 CM,5502.0,3301.2,1525.15,7278.0,34 CPT,11440,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,7278.0,30 CPT,11440,HC EXCISION BENIGN LESION F E E N L MM 0.5 OR LESS,732.0,439.2,202.91,7278.0,34 CPT,11441,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,7278.0,15 CPT,11441,HC EXCISION BENIGN LESION F E E N L MM 0.6 TO 1 CM,754.0,452.4,209.01,7278.0,34 CPT,11442,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,30 CPT,11442,HC EXCISION BENIGN LESION F E E N L MM 1.1 TO 2 CM,1280.0,768.0,354.82,5449.0,34 CPT,11443,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,5449.0,30 CPT,11443,HC EXCISION BENIGN LESION F E E N L MM 2.1 TO 3 CM,3193.0,1915.8,885.1,5449.0,34 CPT,11444,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,5449.0,15 CPT,11444,HC EXCISION BENIGN LESION F E E N L MM 3.1 TO 4 CM,1722.0,1033.2,477.34,5449.0,34 CPT,11446,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 CPT,11446,HC EXCISION SKIN BENIG GREATER THAN 4 CM FACE FACIAL,3193.0,1915.8,885.1,7278.0,34 CPT,11450,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, AXILLARY; WITH SIMPLE OR INTERMEDIATE REPAIR",,,2694.74,9324.0,30 CPT,11451,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, AXILLARY; WITH COMPLEX REPAIR",,,2694.74,9324.0,15 CPT,11462,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, INGUINAL; WITH SIMPLE OR INTERMEDIATE REPAIR",,,2694.74,9324.0,15 CPT,11463,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, INGUINAL; WITH COMPLEX REPAIR",,,2694.74,9324.0,15 CPT,11470,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, PERIANAL, PERINEAL, OR UMBILICAL; WITH SIMPLE OR INTERMEDIATE REPAIR",,,2694.74,9324.0,15 CPT,11471,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, PERIANAL, PERINEAL, OR UMBILICAL; WITH COMPLEX REPAIR",,,2694.74,9324.0,15 CPT,11600,HC EXCISION MALIGNANT LESION INCL MARGIN T A L 0.5 OR LESS,1306.0,783.6,362.02,5449.0,34 CPT,11601,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,5449.0,30 CPT,11601,HC EXCISION MALIGNANT LESION INCL MARGIN T A L 0.6 TO 1 CM,1306.0,783.6,362.02,5449.0,34 CPT,11602,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM",,,376.18,5449.0,15 CPT,11602,HC EXCISION MALIGNANT LESION INCL MARGIN T A L 1.1 TO 2 CM,861.0,516.6,238.67,5449.0,34 CPT,11603,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,662.46,5449.0,30 CPT,11603,HC EXCISION MALIGNANT LESION INCL MARGIN T A L 2.1 TO 3 CM,1306.0,783.6,362.02,5449.0,34 CPT,11604,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,662.46,7278.0,30 CPT,11604,HC EXCISION MALIGNANT LESION INCL MARGIN T A L 3.1 TO 4 CM,1306.0,783.6,362.02,7278.0,34 CPT,11606,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM",,,1525.52,7278.0,30 CPT,11606,HC EXCISION MALIGNANT LESION INCL MARGIN T A L OVER 4 CM,1993.0,1195.8,552.46,7278.0,34 CPT,11621,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,5449.0,15 CPT,11622,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,15 CPT,11622,HC EXCISION MALIGNANT LESION S N H F G 1.1 TO 2 CM,1605.0,963.0,444.91,5449.0,34 CPT,11623,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,5449.0,14 CPT,11623,HC EXCISION MALIGNANT LESION S N H F G 2.1 TO 3 CM,1679.0,1007.4,465.42,5449.0,34 CPT,11624,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,7278.0,15 CPT,11626,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,30 CPT,11626,HC EXCISION MALIGNANT LESION S N H F G OVER 4.0 CM,5274.0,3164.4,1461.95,7278.0,34 CPT,11640,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,7278.0,15 CPT,11640,HC EXCISION SKIN MALIG LESS THAN 0.5CM FACE FACIAL 11640,1363.0,817.8,377.82,7278.0,34 CPT,11641,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,7278.0,15 CPT,11641,HC EXCISION MALIGNANT LESION F E E N L 0.6 TO 1 CM,754.0,452.4,209.01,7278.0,34 CPT,11642,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,7278.0,15 CPT,11643,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,7278.0,30 CPT,11643,HC EXCISION MALIGNANT LESION F E E N L 2.1 TO 3 CM,3010.0,1806.0,169.0,7278.0,33 CPT,11644,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,7278.0,30 CPT,11646,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,30 CPT,11719,HC TRIM NONDYSTROPHIC NAILS,114.0,68.4,31.6,4481.0,34 CPT,11720,DEBRIDEMENT OF NAIL(S) BY ANY METHOD(S); 1 TO 5,,,55.93,5449.0,14 CPT,11720,HC DEBRID NAILS ANY METHOD 1-5,207.0,124.2,55.93,5449.0,34 CPT,11721,HC DEBRID NAILS ANY METHOD 6 AND GREATER,304.0,182.4,55.93,5449.0,34 CPT,11730,"AVULSION OF NAIL PLATE, PARTIAL OR COMPLETE, SIMPLE; SINGLE",,,187.08,5449.0,14 CPT,11730,HC AVULSION NAIL PLATE P C S SNGL,588.0,352.8,162.99,5449.0,34 CPT,11732,HC AVULSION NAIL PLATE EA ADD,347.0,208.2,80.5,5449.0,24 CPT,11750,"EXCISION OF NAIL AND NAIL MATRIX, PARTIAL OR COMPLETE (EG, INGROWN OR DEFORMED NAIL), FOR PERMANENT REMOVAL",,,376.18,5449.0,15 CPT,11750,HC EXCISION NAIL AND MATRIX PARTIAL OR COMPLETE,1060.0,636.0,293.83,5449.0,34 CPT,11755,"BIOPSY OF NAIL UNIT (EG, PLATE, BED, MATRIX, HYPONYCHIUM, PROXIMAL AND LATERAL NAIL FOLDS) (SEPARATE PROCEDURE)",,,662.46,5449.0,15 CPT,11755,HC BIOSPY OF NAIL UNIT,1121.0,672.6,310.74,5449.0,34 CPT,11760,REPAIR OF NAIL BED,,,576.34,5449.0,14 CPT,11765,"WEDGE EXCISION OF SKIN OF NAIL FOLD (EG, FOR INGROWN TOENAIL)",,,376.18,5449.0,14 CPT,11770,EXCISION OF PILONIDAL CYST OR SINUS; SIMPLE,,,2694.74,9324.0,15 CPT,11771,EXCISION OF PILONIDAL CYST OR SINUS; EXTENSIVE,,,2694.74,9324.0,15 CPT,11772,EXCISION OF PILONIDAL CYST OR SINUS; COMPLICATED,,,2694.74,9324.0,15 CPT,11900,HC INJECTION INTRALESIONAL 312 UNIT/ML (1 ML) INJECTION SOLUTION,814.15,488.49,64.64,4481.0,35 HCPCS,J1571,HEPATITIS B IMMUNE GLOBULIN-MALTOSE (HEPAGAM B) >312 UNIT/ML (5 ML) INJECTION SOLN,3303.05,1981.83,64.64,4481.0,35 HCPCS,J1580,GENTAMCIN 1 MG/ML (5 ML) LOCK IN NS,26.35,15.81,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN 1 MG/ML (2 ML) LOCK IN NS,23.75,14.25,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN 1.5% (15 MG/ML) OPHTHALMIC SOLUTION,30.4,18.24,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN 100 MG IN LR 1000 ML (KIDNEY FLUSH),82.65,49.59,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN 2% OPHTHALMIC SOLN,22.0,13.2,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN 40 MG/ML INJ SOLN FOR ORAL USE,116.0,69.6,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN 40 MG/ML INJECTION SOLUTION,90.02499999999999,54.015,4.97,4481.0,48 HCPCS,J1580,GENTAMICIN SULFATE (PEDIATRIC) (PF) 20 MG/2 ML INJECTION SOLUTION,40.1,24.06,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN SULFATE (PF) 20 MG/2 ML INJ SOLN WRAPPER,40.1,24.06,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN SULFATE 10 MG/ML PEDIATRIC DILUTION,99.65,59.79,4.97,4481.0,24 HCPCS,J1580,GENTAMICIN-VANCOMYCIN 40-500 MG IN NS IRRIGATION 500 ML,79.35,47.61,4.97,4481.0,24 HCPCS,J1580,STUDY BLADE-VG2 GENTAMICIN SULFATE 80 MG/2 ML SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J1595,GLATIRAMER 20 MG/ML SUBCUTANEOUS SYRINGE,940.85,564.51,143.44,4481.0,35 HCPCS,J1596,GLYCOPYRROLATE 0.2 MG/ML INJECTION SOLUTION,66.7,40.02,0.4462,4481.0,35 HCPCS,J1596,GLYCOPYRROLATE 0.2 MG/ML SYRINGE WRAPPER,55.0,33.0,0.4462,4481.0,35 HCPCS,J1596,STUDY MGT-AQP1-201 GLYCOPYRROLATE 0.2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J1596,STUDY MGT-AQP1-202 GLYCOPYRROLATE 0.2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J1602,GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION,6600.4,3960.24,10.71,5280.32,35 HCPCS,J1611,GLUCAGON 1 MG SOLUTION FOR INJECTION (COMBINED VIALS) WRAPPER,1001.5,600.9,144.52,4481.0,35 HCPCS,J1611,GLUCAGON HCL 1 MG/ML SOLUTION FOR INJECTION,1001.5,600.9,144.52,4481.0,35 HCPCS,J1628,GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION,47695.3,28617.18,73.69,38156.24,35 HCPCS,J1630,HALOPERIDOL LACTATE 5 MG/ML INJECTION SOLUTION,17.4,10.44,1.8,4481.0,24 HCPCS,J1630,HALOPERIDOL LACTATE 5 MG/ML INJECTION WRAPPER,20.7,12.42,1.8,4481.0,24 HCPCS,J1630,HALOPERIDOL LACTATE 5 MG/ML INTRAMUSCULAR SYRINGE,22.25,13.35,1.8,4481.0,24 HCPCS,J1631,HALOPERIDOL DECANOATE 50 MG/ML INTRAMUSCULAR SOLUTION,70.8,42.48,9.9,4481.0,24 HCPCS,J1632,STUDY IRB# 21-2224 BREXANOLONE 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,21 HCPCS,J1632,STUDY ZUL-PPP-01 BREXANOLONE 5 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,21 HCPCS,J1640,HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION,36661.3,21996.78,33.15,31715.69,35 HCPCS,J1643,"HEPARIN, PORCINE (PF) 1,000 UNIT/ML INJECTION SOLUTION",62.75,37.65,6.77,4481.0,24 HCPCS,J1644,"HEPARIN (PORCINE) (PF) 1,000 UNIT/500 ML IN 0.9 % SODIUM CHLORIDE IV",82.05,49.23,0.4725,4481.0,24 HCPCS,J1644,"HEPARIN (PORCINE) 1,000 UNIT/500 ML IN 0.9% SODIUM CHLORIDE IV (COMBINED)",82.05,49.23,0.4725,4481.0,24 HCPCS,J1644,"HEPARIN (PORCINE) 1,000 UNIT/ML INJECTION SOLUTION",42.6,25.56,0.4725,4481.0,72 HCPCS,J1644,"HEPARIN (PORCINE) 10,000 UNIT/1,000 ML IN 0.9 % SOD. CHLORIDE IV SOLN",85.9,51.54,0.4725,4481.0,24 HCPCS,J1644,"HEPARIN (PORCINE) 10,000 UNIT/1,000 ML IN NS (UNCH CUPID)",154.45,92.67,0.4725,4481.0,24 HCPCS,J1644,"HEPARIN (PORCINE) 10,000 UNIT/ML INJECTION SOLUTION",39.375,23.625,0.4725,4481.0,48 HCPCS,J1644,"HEPARIN (PORCINE) 25,000 UNIT/250 ML IN 0.45 % SODIUM CHLORIDE IV SOLN",104.0,62.4,0.4725,4481.0,24 HCPCS,J1644,"HEPARIN (PORCINE) 5,000 UNIT/ML (1 ML) INJECTION CARTRIDGE",29.7,17.82,0.4725,4481.0,24 HCPCS,J1644,"HEPARIN (PORCINE) 5,000 UNIT/ML INJ SOLUTION (MULTI-VIAL SIZE WRAPPER)",26.25,15.75,0.4725,4481.0,48 HCPCS,J1644,"HEPARIN (PORCINE) 5,000 UNIT/ML INJECTION SOLUTION",23.35,14.01,0.4725,4481.0,48 HCPCS,J1644,HEPARIN 100 UNITS/ML IN SODIUM CHLORIDE 0.45% 50 ML PEDIATRIC,72.35,43.41,0.4725,4481.0,24 HCPCS,J1644,"HEPARIN 30,000 UNITS (CELL SAVER) IN 1000 ML NS",31.6,18.96,0.4725,4481.0,24 HCPCS,J1644,HEPARIN 500 UNITS IN 500 ML NS (FOR VASCULAR SERVICE),87.55,52.53,0.4725,4481.0,24 HCPCS,J1644,SODIUM ACETATE 0.45% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),69.25,41.55,0.4725,4481.0,24 HCPCS,J1644,SODIUM ACETATE 0.9% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),72.35,43.41,0.4725,4481.0,24 HCPCS,J1644,SODIUM CHLORIDE 0.45% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),66.3,39.78,0.4725,4481.0,24 HCPCS,J1645,"DALTEPARIN (PORCINE) 10,000 ANTI-XA UNIT/ML SUBCUTANEOUS SYRINGE",510.55,306.33,37.22,4481.0,24 HCPCS,J1645,"DALTEPARIN (PORCINE) 12,500 ANTI-XA UNIT/0.5 ML SUBCUTANEOUS SYRINGE",634.25,380.55,37.22,4481.0,24 HCPCS,J1645,"DALTEPARIN (PORCINE) 15,000 ANTI-XA UNIT/0.6 ML SUBCUTANEOUS SYRINGE",757.85,454.71,37.22,4481.0,24 HCPCS,J1645,"DALTEPARIN (PORCINE) 18,000 ANTI-XA UNIT/0.72 ML SUBCUTANEOUS SYRINGE",757.85,454.71,37.22,4481.0,24 HCPCS,J1650,ENOXAPARIN 100 MG/ML SUBCUTANEOUS SYRINGE,52.35,31.41,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 120 MG/0.8 ML SUBCUTANEOUS SYRINGE,132.3,79.38,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 150 MG/ML SUBCUTANEOUS SYRINGE,70.45,42.27,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 20 MG/ML DILUTION PEDIATRIC INJECTION,107.8,64.68,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 30 MG/0.3 ML SUBCUTANEOUS SYRINGE,26.85,16.11,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 300 MG/3 ML SUBCUTANEOUS SOLUTION,140.85,84.51,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 40 MG/0.4 ML SUBCUTANEOUS SYRINGE,30.4,18.24,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 60 MG/0.6 ML SUBCUTANEOUS SYRINGE,51.1,30.66,1.33,4481.0,24 HCPCS,J1650,ENOXAPARIN 80 MG/0.8 ML SUBCUTANEOUS SYRINGE,44.9,26.94,1.33,4481.0,24 HCPCS,J1650,STUDY DU176B-D-U312 ENOXAPARIN 10 MG/0.1 ML SYRINGE,0.2,0.12,0.0464,4481.0,72 HCPCS,J1652,FONDAPARINUX 10 MG/0.8 ML SUBCUTANEOUS SOLUTION SYRINGE,244.15,146.49,1.62,4481.0,24 HCPCS,J1652,FONDAPARINUX 2.5 MG/0.5 ML SUBCUTANEOUS SOLUTION SYRINGE,106.05,63.63,1.62,4481.0,24 HCPCS,J1652,FONDAPARINUX 5 MG/0.4 ML SUBCUTANEOUS SOLUTION SYRINGE,227.85,136.71,1.62,4481.0,24 HCPCS,J1652,FONDAPARINUX 7.5 MG/0.6 ML SUBCUTANEOUS SOLUTION SYRINGE,227.85,136.71,1.62,4481.0,24 HCPCS,J1670,TETANUS IMMUNE GLOBULIN (PF) 250 UNIT/ML INTRAMUSCULAR SYRINGE,2430.25,1458.15,575.21,4481.0,35 HCPCS,J1720,HYDROCORTISONE SOD SUCCINATE (PF) 1 MG/ML PEDIATRIC DILUTION,69.55,41.73,16.14,4481.0,24 HCPCS,J1720,HYDROCORTISONE SOD SUCCINATE (PF) 100 MG/2 ML SOLUTION FOR INJECTION,109.9,65.94,25.5,4481.0,24 HCPCS,J1720,HYDROCORTISONE SOD SUCCINATE (PF) 100 MG/2 ML SOLUTION INJ ACTOVIAL/VIAL WRAPPER,90.7,54.42,21.04,4481.0,24 HCPCS,J1720,HYDROCORTISONE SOD SUCCINATE (PF) 250 MG/2 ML SOLUTION FOR INJECTION,189.7,113.82,44.01,4481.0,24 HCPCS,J1720,HYDROCORTISONE SOD SUCCINATE (PF) 50 MG/ML PEDIATRIC,90.7,54.42,21.04,4481.0,24 HCPCS,J1729,STUDY 2426 HYDROXYPROGESTERONE CAPROATE 250 MG/ML,0.2,0.12,0.0464,4481.0,23 HCPCS,J1742,IBUTILIDE FUMARATE 0.1 MG/ML (FOR OR USE) INTRAVENOUS SOLUTION,1893.65,1136.19,167.14,4481.0,35 HCPCS,J1742,IBUTILIDE FUMARATE 0.1 MG/ML INTRAVENOUS SOLUTION,1893.65,1136.19,167.14,4481.0,35 HCPCS,J1742,STUDY IRB 16-0129 IBUTILIDE 0.1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J1743,IDURSULFASE 6 MG/3 ML INTRAVENOUS SOLUTION,10624.8,6374.88,541.71,81999.54,35 HCPCS,J1743,STUDY 1903 IDURSULFASE (INTRATHECAL) 10MG/1ML VIAL,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY 1903 IDURSULFASE 2 MG/ML,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY 2444 IDURSULFASE (INTRATHECAL) 10MG/1ML VIAL,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY A5374 GS-2872 150 MG/ML OR PLACEBO INJECTION,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY A5374 GS-5423 150 MG/ML OR PLACEBO INJECTION,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY ALXN1210-MG-319 RAVULIZUMAB (ALXN1210) 100 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY DNLI-E-0007 IDURSULFASE 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY SHIRE SHP-609-302 IDURSULFASE INTRATHECAL 10 MG/ML SYRINGE,0.2,0.12,0.0506,81999.54,35 HCPCS,J1743,STUDY TAK-609-5005 IDURSULFASE INTRATHECAL 10 MG/ML SYRINGE,0.2,0.12,0.0506,81999.54,35 HCPCS,J1745,INFLIXIMAB 100 MG INTRAVENOUS SOLUTION,3881.8,2329.08,30.16,4783.38,35 HCPCS,J1745,STUDY 1937 INFLIXIMAB 10 MG/ML,0.2,0.12,0.0506,4783.38,35 HCPCS,J1745,STUDY ACTIV-1 IM INFLIXIMAB/PLACEBO 10 MG/ML SOLUTION,0.2,0.12,0.0506,4783.38,35 HCPCS,J1745,STUDY C0168IBD4020 ADAPT INFLIXIMAB INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4783.38,35 HCPCS,J1745,STUDY D798KC00001 INFLIXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,4783.38,35 HCPCS,J1746,IBALIZUMAB-UIYK 200 MG/1.33 ML (150 MG/ML) INTRAVENOUS SOLUTION,49914.2,29948.52,76.88,39931.36,35 HCPCS,J1747,SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION,91306.75,54784.05,63.76,73045.4,35 HCPCS,J1750,IRON DEXTRAN 2.5 MG/ML DILUTION,718.0,430.8,17.57,4517.31,35 HCPCS,J1750,IRON DEXTRAN 50 MG/ML INJECTION SOLUTION,52.4,31.44,13.26,4517.31,35 HCPCS,J1756,IRON SUCROSE 100 MG IRON/5 ML INTRAVENOUS SOLUTION,275.4,165.24,0.5175,4481.0,24 HCPCS,J1756,IRON SUCROSE 200 MG IRON/10 ML INTRAVENOUS SOLUTION,275.4,165.24,0.5175,4481.0,24 HCPCS,J1786,IMIGLUCERASE 400 UNIT INTRAVENOUS SOLUTION,5733.65,3440.19,41.89,6341.58,35 HCPCS,J1790,DROPERIDOL 2.5 MG/ML INJECTION SOLUTION,25.45,15.27,5.9,4481.0,24 HCPCS,J1800,PROPRANOLOL 0.05 MG/ML PEDIATRIC DILUTION,115.7,69.42,22.36,4481.0,48 HCPCS,J1800,PROPRANOLOL 1 MG/ML INTRAVENOUS SOLUTION,60.8,36.48,14.11,4481.0,24 HCPCS,J1805,ESMOLOL 100 MG/10 ML (10 MG/ML) INTRAVENOUS SOLUTION,77.4,46.44,0.495,4481.0,24 HCPCS,J1805,"ESMOLOL 2,500 MG/250 ML (10 MG/ML) IN SODIUM CHLORIDE (ISO-OSMOTIC) IV",367.15,220.29,0.495,4481.0,24 HCPCS,J1805,ESMOLOL 500 MG/50 ML NS SYRINGE,147.7,88.62,0.495,4481.0,24 HCPCS,J1808,FOLIC ACID 5 MG/ML INJECTION SOLUTION,21.0,12.6,0.135,4481.0,24 HCPCS,J1808,FOLIC ACID IN NS (500 MCG/ML) PEDIATRIC DILUTION,272.0,163.2,0.135,4481.0,24 HCPCS,J1815,INSULIN DILUTION (INSULIN REGULAR) ONE UNIT/ML INJECTION,63.2,37.92,0.5175,4481.0,24 HCPCS,J1815,INSULIN DILUTION (INSULIN REGULAR) TEN UNIT/ML INJECTION,549.25,329.55,0.5175,4481.0,24 HCPCS,J1815,INSULIN GLARGINE (U-100) 100 UNIT/ML SUBCUTANEOUS SOLUTION,266.65,159.99,0.5175,4481.0,24 HCPCS,J1815,INSULIN HUMAN U-100 NPH-REGULR 70-30 MIX 100 UNIT/ML SUBCUTANEOUS SUSP,190.0,114.0,0.5175,4481.0,24 HCPCS,J1815,INSULIN LISPRO (U-100) 100 UNIT/ML SUBCUTANEOUS SOLUTION,275.0,165.0,0.5175,4481.0,24 HCPCS,J1815,INSULIN LISPRO 100 UNIT/ML PERCENTAGE MEAL EATEN ADULT,275.0,165.0,0.5175,4481.0,24 HCPCS,J1815,INSULIN NPH ISOPHANE U-100 HUMAN 100 UNIT/ML SUBCUTANEOUS SUSPENSION,190.0,114.0,0.5175,4481.0,24 HCPCS,J1815,INSULIN REGULAR 0.5 UNIT/ML NEONATAL 4 ML INFUSION,63.9,38.34,0.5175,4481.0,24 HCPCS,J1815,INSULIN REGULAR 0.5 UNIT/ML PEDIATRIC DILUTION,72.85,43.71,0.5175,4481.0,24 HCPCS,J1815,INSULIN REGULAR 100 UNIT/100 ML (1 UNIT/ML) IN 0.9 % NACL IV SOLUTION,196.35,117.81,0.5175,4481.0,24 HCPCS,J1815,INSULIN REGULAR 100 UNIT/ML CORRECTION SCALE ADULT,190.0,114.0,0.5175,4481.0,24 HCPCS,J1815,INSULIN REGULAR 100 UNIT/ML PERCENTAGE MEAL EATEN ADULT,190.0,114.0,0.5175,4481.0,24 HCPCS,J1815,INSULIN REGULAR HUMAN 100 UNIT/ML INJECTION (IV USE),208.9,125.34,0.5175,4481.0,24 HCPCS,J1815,INSULIN REGULAR HUMAN U-500 (CONCENTRATE) 500 UNIT/ML(3 ML) SUBCUT PEN,880.2,528.12,0.5175,4481.0,24 HCPCS,J1815,INSULIN U-100 REGULAR HUMAN 100 UNIT/ML INJECTION SOLUTION,190.0,114.0,0.5175,4481.0,24 HCPCS,J1823,INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION,142853.05,85711.83,480.68,114282.44,35 HCPCS,J1836,METRONIDAZOLE 5 MG/ML IN SODIUM CHLORIDE (ODD DOSE),71.05,42.63,0.0675,4481.0,24 HCPCS,J1836,METRONIDAZOLE 500 MG/100 ML IN SODIUM CHLOR(ISO) INTRAVENOUS PIGGYBACK,75.2,45.12,0.0675,4481.0,24 HCPCS,J1885,KETOROLAC 15 MG/ML INJECTION SOLUTION,30.65,18.39,0.2813,4481.0,34 HCPCS,J1885,KETOROLAC 15 MG/ML INJECTION SOLUTION WRAPPER,30.65,18.39,0.2813,4481.0,34 HCPCS,J1885,KETOROLAC 15 MG/ML IV PEDIATRIC,75.3,45.18,0.2813,4481.0,34 HCPCS,J1885,KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION,38.25,22.95,0.2813,4481.0,34 HCPCS,J1885,KETOROLAC 30 MG/ML INJECTION WRAPPER,38.25,22.95,0.2813,4481.0,34 HCPCS,J1885,KETOROLAC 60 MG/2 ML INTRAMUSCULAR SOLUTION,28.8,17.28,0.2813,4481.0,34 HCPCS,J1920,LABETALOL 5 MG/ML INTRAVENOUS SOLUTION,75.95,45.57,0.765,4481.0,24 HCPCS,J1920,LABETALOL 5 MG/ML PEDIATRIC SYRINGE,75.95,45.57,0.765,4481.0,24 HCPCS,J1930,LANREOTIDE 60 MG/0.2 ML SUBCUTANEOUS SYRINGE,23759.2,14255.52,33.03,19007.36,35 HCPCS,J1931,LARONIDASE 2.9 MG/5 ML INTRAVENOUS SOLUTION,3703.8,2222.28,38.67,6960.45,35 HCPCS,J1932,LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE,34697.4,20818.44,28.94,27757.92,35 HCPCS,J1938,FUROSEMIDE 10 MG/ML INJECTION SOLUTION,32.35,19.41,0.045,4481.0,72 HCPCS,J1938,FUROSEMIDE 10 MG/ML PEDIATRIC SYRINGE,32.1,19.26,0.045,4481.0,24 HCPCS,J1938,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.045,4481.0,24 HCPCS,J1938,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 2 MG/ML INJECTION SOLUTION,0.2,0.12,0.045,4481.0,24 HCPCS,J1939,BUMETANIDE 0.25 MG/ML INJECTION PEDIATRIC SYRINGE,27.8,16.68,0.3589,4481.0,35 HCPCS,J1939,BUMETANIDE 0.25 MG/ML INJECTION SOLUTION,27.8,16.68,0.3589,4481.0,35 HCPCS,J1939,BUMETANIDE 0.25 MG/ML PEDIATRIC 18 ML INFUSION,82.7,49.62,0.3589,4481.0,35 HCPCS,J1939,BUMETANIDE 0.25 MG/ML PEDIATRIC 2 ML INFUSION,66.5,39.9,0.3589,4481.0,35 HCPCS,J1939,BUMETANIDE 0.25 MG/ML PEDIATRIC 8 ML INFUSION,76.95,46.17,0.3589,4481.0,35 HCPCS,J1939,BUMETANIDE 20 MG/80 ML (0.25 MG/ML) INFUSION CSAC,148.85,89.31,0.3589,4481.0,35 HCPCS,J1950,LEUPROLIDE 3.75 MG INTRAMUSCULAR SYRINGE KIT,6236.7,3742.02,1577.89,252434.28,35 HCPCS,J1950,LEUPROLIDE ACETATE 11.25 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT,18160.2,10896.12,1678.41,252434.28,35 HCPCS,J1950,STUDY 2420 LEUPROLIDE/PLACEBO 3.75 MG/ML SYRINGE,0.2,0.12,0.0506,252434.28,35 HCPCS,J1950,STUDY IRB# 19-2343 LEUPROLIDE DEPOT 3.75 MG INJECTION,0.2,0.12,0.0506,252434.28,35 HCPCS,J1951,LEUPROLIDE 45 MG (PEDIATRIC 6 MONTH) SUBCUTANEOUS SYRINGE,91111.6,54666.96,136.76,72889.28,35 HCPCS,J1953,"LEVETIRACETAM 1,000 MG/100 ML IN SODIUM CHLORIDE(ISO-OSM) IV PIGGYBACK",105.3,63.18,0.09,4481.0,24 HCPCS,J1953,"LEVETIRACETAM 1,500 MG/100 ML IN SODIUM CHLORIDE(ISO-OSM) IV PIGGYBACK",120.95,72.57,0.09,4481.0,24 HCPCS,J1953,LEVETIRACETAM 10 MG/ML IV PEDIATRIC,133.35,80.01,0.09,4481.0,24 HCPCS,J1953,LEVETIRACETAM 500 MG/100 ML IN SODIUM CHLORIDE (ISO-OSM) IV PIGGYBACK,133.5,80.1,0.09,4481.0,24 HCPCS,J1953,LEVETIRACETAM 500 MG/5 ML INTRAVENOUS SOLUTION,75.75,45.45,0.09,4481.0,24 HCPCS,J1955,LEVOCARNITINE 200 MG/ML INTRAVENOUS SOLUTION,167.65,100.59,38.89,4481.0,24 HCPCS,J1955,LEVOCARNITINE 25 MG/ML INTRAVENOUS DILUTION,155.2,93.12,36.01,4481.0,24 HCPCS,J1955,STUDY ACCL1931 LEVOCARNITINE 200 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J1956,LEVOFLOXACIN 250 MG/50 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,85.9,51.54,5.33,4481.0,24 HCPCS,J1956,LEVOFLOXACIN 5 MG/ML IN 5 % DEXTROSE PEDIATRIC,76.75,46.05,5.33,4481.0,24 HCPCS,J1956,LEVOFLOXACIN 500 MG/100 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,86.25,51.75,5.33,4481.0,24 HCPCS,J1956,LEVOFLOXACIN 750 MG/150 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,87.05,52.23,5.33,4481.0,24 HCPCS,J1961,LENACAPAVIR 309 MG/ML SUBCUTANEOUS SOLUTION,76066.0,45639.6,21.49,60852.8,35 HCPCS,J1961,STUDY GS-US-528-6020 LENACAPAVIR 309 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J1961,STUDY GS-US-528-9023 LENACAPAVIR 309 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J2002,LIDOCAINE (PF) 8 MG/ML (0.8 %) IN 5 % DEXTROSE INTRAVENOUS SOLUTION,92.55,55.53,0.0225,4481.0,24 HCPCS,J2002,LIDOCAINE (PF) 8 MG/ML IN DEXTROSE 5% 50 ML PEDIATRIC INFUSION,64.5,38.7,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,27.55,16.53,0.0225,4481.0,72 HCPCS,J2003,LIDOCAINE (PF) 100 MG/5 ML (2 %) INTRAVENOUS SYRINGE,50.95,30.57,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE (PF) 15 MG/ML (1.5 %) INJECTION SOLUTION,69.55,41.73,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE (PF) 20 MG/ML (2 %) INECTION SOLUTION WRAPPER,29.05,17.43,0.0225,4481.0,72 HCPCS,J2003,LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION,26.4,15.84,0.0225,4481.0,72 HCPCS,J2003,LIDOCAINE (PF) 20 MG/ML (2 %) INTRAVENOUS SOLUTION,30.65,18.39,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE (PF) 40 MG/ML (4 %) INJECTION SOLUTION,34.9,20.94,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE (PF) 5 MG/ML (0.5 %) INJECTION SOLUTION,72.55,43.53,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE 1 G (LASER TUMESCENT) IN 500 ML LR,215.1,129.06,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE 2 G (LASER TUMESCENT) IN 1000 ML LR,367.15,220.29,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE 300 MG-EPINEPHRINE 1 MG IN LR 1000 ML (PLASTICS-TUMESCENT),99.0,59.4,0.0225,4481.0,24 HCPCS,J2003,LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION,27.85,16.71,0.0225,4481.0,48 HCPCS,J2003,LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION,37.725,22.634999999999998,0.0225,4481.0,48 HCPCS,J2003,LIDOCAINE HCL 5 MG/ML (0.5 %) INJECTION SOLUTION,34.55,20.73,0.0225,4481.0,24 HCPCS,J2003,TRIVEX TUMESCENT SOLUTION (LIDOCAINE500MG/EPINEPHRINE2MG/NS),141.5,84.9,0.0225,4481.0,24 HCPCS,J2004,"LIDOCAINE 1 %-EPINEPHRINE 1:100,000 INJECTION SOLUTION",17.1,10.26,0.0225,4481.0,24 HCPCS,J2004,"LIDOCAINE 20 MG/ML (2 %)-EPINEPHRINE 1:100,000 INJECTION SOLUTION",16.7,10.02,0.0225,4481.0,24 HCPCS,J2004,"LIDOCAINE-EPINEPHRINE (PF) 1 %-1:200,000 INJECTION SOLUTION",18.05,10.83,0.0225,4481.0,24 HCPCS,J2004,"LIDOCAINE-EPINEPHRINE (PF) 1.5 %-1:200,000 INJECTION SOLUTION",18.35,11.01,0.0225,4481.0,24 HCPCS,J2004,"LIDOCAINE-EPINEPHRINE (PF) 2 %-1:200,000 INJECTION SOLUTION",20.6,12.36,0.0225,4481.0,24 HCPCS,J2004,"LIDOCAINE-EPINEPHRINE 0.5 %-1:200,000 INJECTION SOLUTION",16.35,9.81,0.0225,4481.0,24 HCPCS,J2020,LINEZOLID 2 MG/ML IV PEDIATRIC,252.35,151.41,8.03,4481.0,24 HCPCS,J2020,LINEZOLID IN 5% DEXTROSE IN WATER 600 MG/300 ML INTRAVENOUS PIGGYBACK,135.05,81.03,8.03,4481.0,24 HCPCS,J2060,LORAZEPAM 2 MG/ML INJECTION SOLUTION,23.45,14.07,3.1,4481.0,24 HCPCS,J2060,LORAZEPAM 2 MG/ML INJECTION SYRINGE,24.7,14.82,3.1,4481.0,24 HCPCS,J2060,LORAZEPAM 2 MG/ML INJECTION WRAPPER,23.45,14.07,3.1,4481.0,24 HCPCS,J2151,MANNITOL 20 % INTRAVENOUS SOLUTION,78.4,47.04,0.135,4481.0,21 HCPCS,J2151,MANNITOL 25 % INTRAVENOUS INFUSION,39.8,23.88,0.135,4481.0,21 HCPCS,J2151,MANNITOL 25 % INTRAVENOUS SOLUTION,27.8,16.68,0.135,4481.0,21 HCPCS,J2175,MEPERIDINE (PF) 100 MG/ML INJECTION SYRINGE,36.45,21.87,8.46,4481.0,24 HCPCS,J2175,MEPERIDINE (PF) 25 MG/ML INJECTION SYRINGE,40.2,24.12,9.33,4481.0,24 HCPCS,J2175,MEPERIDINE (PF) 25 MG/ML INJECTION WRAPPER,40.2,24.12,9.33,4481.0,24 HCPCS,J2175,MEPERIDINE (PF) 50 MG/ML INJECTION SOLUTION,30.0,18.0,6.96,4481.0,24 HCPCS,J2175,MEPERIDINE (PF) 50 MG/ML INJECTION SYRINGE,44.75,26.85,10.38,4481.0,24 HCPCS,J2175,MEPERIDINE (PF) 50 MG/ML INJECTION WRAPPER,30.0,18.0,6.96,4481.0,24 HCPCS,J2175,MEPERIDINE (PF) 75 MG/ML INJECTION SYRINGE,41.3,24.78,9.58,4481.0,24 HCPCS,J2182,MEPOLIZUMAB 100 MG SUBCUTANEOUS SOLUTION,14067.0,8440.2,30.33,11253.6,35 HCPCS,J2182,STUDY D3253C00001 MEPOLIZUMAB 100 MG/ML OR PLACEBO VIAL,0.2,0.12,0.0506,4999.47,35 HCPCS,J2185,MEROPENEM 1 GRAM INTRAVENOUS SOLUTION,82.3,49.38,0.945,4481.0,24 HCPCS,J2185,MEROPENEM 20 MG/ML PEDIATRIC DILUTION,455.4,273.24,0.945,4481.0,24 HCPCS,J2185,MEROPENEM 50 MG/ML PEDIATRIC IV,82.3,49.38,0.945,4481.0,24 HCPCS,J2185,MEROPENEM 500 MG INTRAVENOUS SOLUTION,72.85,43.71,0.945,4481.0,24 HCPCS,J2185,MEROPENEM DESENSITIZATION DILUTION 0.0001 MG/ML,63.2,37.92,0.945,4481.0,24 HCPCS,J2185,MEROPENEM DESENSITIZATION DILUTION 0.001 MG/ML,63.2,37.92,0.945,4481.0,24 HCPCS,J2185,MEROPENEM DESENSITIZATION DILUTION 0.01 MG/ML,63.2,37.92,0.945,4481.0,24 HCPCS,J2185,MEROPENEM DESENSITIZATION DILUTION 0.1 MG/ML,63.25,37.95,0.945,4481.0,24 HCPCS,J2185,MEROPENEM DESENSITIZATION DILUTION 1 MG/ML,63.85,38.31,0.945,4481.0,24 HCPCS,J2185,MEROPENEM DESENSITIZATION DILUTION 10 MG/ML,69.75,41.85,0.945,4481.0,24 HCPCS,J2186,MEROPENEM-VABORBACTAM 2 GRAM INTRAVENOUS SOLUTION,790.6,474.36,2.11,4481.0,35 HCPCS,J2186,MEROPENEM-VABORBACTAM DILUTION 8 MG OF MEROPENEM/ML PEDIATRIC INJECTION,602.55,361.53,2.11,4481.0,35 HCPCS,J2210,METHYLERGONOVINE 0.2 MG/ML (1 ML) INJECTION SOLUTION,138.0,82.8,32.02,4481.0,24 HCPCS,J2212,METHYLNALTREXONE 12 MG/0.6 ML SUBCUTANEOUS SOLUTION,457.85,274.71,3.26,4481.0,24 HCPCS,J2212,METHYLNALTREXONE 12 MG/0.6 ML SYRINGE (PEDIATRIC),457.85,274.71,3.26,4481.0,24 HCPCS,J2248,MICAFUNGIN 100 MG INTRAVENOUS SOLUTION,220.0,132.0,0.585,4481.0,24 HCPCS,J2248,MICAFUNGIN 50 MG INTRAVENOUS SOLUTION,368.75,221.25,0.585,4481.0,24 HCPCS,J2249,REMIMAZOLAM 20 MG INTRAVENOUS SOLUTION,153.9,92.34,5.04,4481.0,24 HCPCS,J2250,"MIDAZOLAM (PF) 1 MG/ML IN SODIUM CHLORIDE,ISO-OSM INTRAVENOUS SOLUTION",88.25,52.95,0.3375,4481.0,24 HCPCS,J2250,MIDAZOLAM (PF) 1 MG/ML INJECTION SOLUTION,22.35,13.41,0.3375,4481.0,24 HCPCS,J2250,MIDAZOLAM (PF) 5 MG/ML INJECTION SOLUTION,25.8,15.48,0.3375,4481.0,48 HCPCS,J2250,MIDAZOLAM 1 MG/ML INFUSION WRAPPER,112.3,67.38,0.3375,4481.0,24 HCPCS,J2250,MIDAZOLAM 1 MG/ML INJECTION SOLUTION,23.0,13.8,0.3375,4481.0,24 HCPCS,J2250,MIDAZOLAM 5 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,26.1,15.66,0.3375,4481.0,72 HCPCS,J2250,MIDAZOLAM 5 MG/ML (COMBINED) INTRANASAL SOLUTION WRAPPER,32.35,19.41,0.3375,4481.0,96 HCPCS,J2250,MIDAZOLAM 5 MG/ML INFUSION (MAXIMUM CONCENTRATION),248.4,149.04,0.3375,4481.0,24 HCPCS,J2250,MIDAZOLAM 5 MG/ML INJECTION SOLUTION,37.325,22.395,0.3375,4481.0,48 HCPCS,J2250,STUDY 2330 MIDAZOLAM 5 MG/ML VIAL,0.2,0.12,0.0464,4481.0,24 HCPCS,J2250,STUDY CNS7056-008 MIDAZOLAM 1 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,24 HCPCS,J2250,STUDY CNS7056-008 MIDAZOLAM 1 MG/ML TOP-UP DOSE,0.2,0.12,0.0464,4481.0,24 HCPCS,J2250,STUDY MIDAZOLAM 5 MG/ML IV INJECTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J2251,MIDAZOLAM (PF) 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,112.3,67.38,0.45,4481.0,24 HCPCS,J2260,MILRINONE 1 MG/ML INTRAVENOUS SOLUTION,88.25,52.95,3.26,4481.0,48 HCPCS,J2260,MILRINONE 200 MCG/ML IN DEXTROSE 5% 50 ML PEDIATRIC,89.2,53.52,3.26,4481.0,24 HCPCS,J2260,MILRINONE 200 MCG/ML IN DEXTROSE 5% 8 ML PEDIATRIC,67.2,40.32,3.26,4481.0,24 HCPCS,J2260,MILRINONE 40 MG/200 ML(200 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS PIGGYBK,184.95,110.97,3.26,4481.0,24 HCPCS,J2260,STUDY MIDAS MILRINONE/PLACEBO 1 MG/ML INTRAVENOUS SOLUTION VIAL,0.2,0.12,0.0464,4481.0,24 HCPCS,J2265,MINOCYCLINE 100 MG INTRAVENOUS SOLUTION,908.3,544.98,2.59,4481.0,35 HCPCS,J2267,MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION,31432.85,18859.71,41.76,25146.28,35 HCPCS,J2267,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY I6T-MC-AMAP MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY I6T-MC-AMAX MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY I6T-MC-AMAX MIRIKIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY I6T-MC-AMAX MIRIKIZUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY I6T-MC-AMAX MIRIKIZUMAB 300 MG/3 ML PRE-FILLED SYRINGE KIT,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY IRB# 24-2214 MIRIKIZUMAB-MRKZ 100 MG/ML PRE-FILLED SYRINGE/PEN,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY IRB# 24-2214 MIRIKIZUMAB-MRKZ 20 MG/ML VIAL,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 100 MG/ML PREFILLED SYRINGE #1 OF 2,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 100 MG/ML PREFILLED SYRINGE #2 OF 2,0.2,0.12,0.0506,7785.12,35 HCPCS,J2267,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 20 MG/ML VIAL,0.2,0.12,0.0506,7785.12,35 HCPCS,J2270,MORPHINE 10 MG/ML INJ COMBINED WRAPPER,25.85,15.51,4.91,4481.0,24 HCPCS,J2270,MORPHINE 2 MG/ML INJECTION PF WRAPPER,25.25,15.15,4.91,4481.0,24 HCPCS,J2270,MORPHINE 2 MG/ML INTRAVENOUS SYRINGE,28.45,17.07,4.91,4481.0,24 HCPCS,J2270,MORPHINE 4 MG/ML INJECTION WRAPPER,24.95,14.97,4.91,4481.0,24 HCPCS,J2270,MORPHINE 50 MG/ML INTRAVENOUS SOLUTION,185.75,111.45,4.91,4481.0,24 HCPCS,J2272,MORPHINE 10 MG/ML INJECTION SOLUTION,26.6,15.96,6.17,4481.0,24 HCPCS,J2274,MORPHINE (PF) 0.5 MG/ML INJECTION SOLUTION,26.075,15.645,5.51,4481.0,48 HCPCS,J2274,MORPHINE (PF) 0.5 MG/ML INJECTION SOLUTION WRAPPER,28.4,17.04,5.51,4481.0,72 HCPCS,J2274,MORPHINE (PF) 1 MG/ML INJECTION SOLUTION,28.35,17.01,6.58,4481.0,48 HCPCS,J2274,MORPHINE (PF) 10 MG/ML INJECTION SOLUTION,648.1,388.86,27.11,4481.0,24 HCPCS,J2274,MORPHINE (PF) 2 MG/2 ML(1 MG/ML) IN 0.9% SODIUM CHLORIDE IV SYRINGE,36.25,21.75,8.41,4481.0,24 HCPCS,J2274,MORPHINE (PF) 25 MG/ML INJECTION SOLUTION,1086.55,651.93,27.11,4481.0,24 HCPCS,J2274,MORPHINE (PF) 30 MG/30 ML (1 MG/ML) PCA INTRAVENOUS SOLUTION,64.2,38.52,14.89,4481.0,24 HCPCS,J2274,MORPHINE 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS WRAPPER,56.65,33.99,13.14,4481.0,24 HCPCS,J2274,MORPHINE 100 MG/100 ML IN NS PCA CADD WRAPPER,52.45,31.47,12.17,4481.0,24 HCPCS,J2274,MORPHINE 100 MG/100 ML(1 MG/ML) IN 0.9% SODIUM CHLOR IV PUMP RESERVOIR,196.3,117.78,27.11,4481.0,24 HCPCS,J2278,ZICONOTIDE 100 MCG/ML INTRATHECAL SOLUTION,4794.1,2876.46,9.84,4481.0,35 HCPCS,J2280,MOXIFLOXACIN 400 MG/250 ML-SODIUM CHLORIDE(ISO) INTRAVENOUS PIGGYBACK,230.65,138.39,20.27,4481.0,24 HCPCS,J2290,NAFCILLIN 1 GRAM INJ COMBINED WRAPPER,101.3,60.78,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN 1 GRAM INJ SOLR IM,101.3,60.78,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN 1 GRAM SOLUTION FOR INJECTION,99.0,59.4,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN 10 GRAM SOLUTION FOR INJECTION,122.1,73.26,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN 2 GRAM INJ COMBINED WRAPPER,103.9,62.34,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN 2 GRAM INJ SOLR IM,134.95,80.97,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN 2 GRAM SOLUTION FOR INJECTION,134.95,80.97,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN 20 MG/ML PEDIATRIC DILUTION,427.65,256.59,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN DESENSITIZATION DILUTION 0.001 MG/ML,101.3,60.78,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN DESENSITIZATION DILUTION 0.01 MG/ML,101.3,60.78,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN DESENSITIZATION DILUTION 0.1 MG/ML,101.3,60.78,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN DESENSITIZATION DILUTION 1 MG/ML,101.3,60.78,0.1125,4481.0,24 HCPCS,J2290,NAFCILLIN DESENSITIZATION DILUTION 10 MG/ML,101.3,60.78,0.1125,4481.0,24 HCPCS,J2300,NALBUPHINE 10 MG/ML INJECTION SOLUTION,33.4,20.04,7.75,4481.0,24 HCPCS,J2305,NITROGLYCERIN 100 MCG/ML BOLUS INJECTION (10 ML SYRINGE),63.1,37.86,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 12 MG/120 ML (100 MCG/ML) IN HEPARINIZED SALINE 120 ML,64.1,38.46,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 200 MCG/ML BOLUS INJECTION (VIR/CATH),63.2,37.92,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 200 MCG/ML IN D5W 8 ML PEDIATRIC INFUSION,64.1,38.46,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 400 MCG/ML BOLUS INJECTION (VIR/CATH),63.1,37.86,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 400MCG/ML IN D5W 50ML PEDIATRIC INFUSIO,79.05,47.43,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 400MCG/ML IN D5W 8 ML PEDIATRIC INFUSION,65.6,39.36,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION,113.85,68.31,3.35,4481.0,24 HCPCS,J2305,NITROGLYCERIN 50 MG/250 ML (200 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS,148.75,89.25,3.35,4481.0,24 HCPCS,J2312,(TAKE HOME) NALOXONE 1 MG/ML INJECTION SYRINGE,144.7,86.82,0.18,4481.0,24 HCPCS,J2312,NALOXONE 0.4 MG/ML INJ SOLUTION (COMBINED) WRAPPER,55.0,33.0,0.18,4481.0,24 HCPCS,J2312,NALOXONE 0.4 MG/ML INJECTION SOLUTION,55.0,33.0,0.18,4481.0,24 HCPCS,J2312,NALOXONE 0.4 MG/ML INJECTION SYRINGE,76.25,45.75,0.18,4481.0,24 HCPCS,J2312,NALOXONE 1 MG/ML INJECTION SYRINGE,144.7,86.82,0.18,4481.0,24 HCPCS,J2312,NALOXONE 1 MG/ML INTRANASAL SOLUTION,144.7,86.82,0.18,4481.0,24 HCPCS,J2315,"NALTREXONE ER 380 MG INTRAMUSCULAR SUSPENSION,EXTENDED RELEASE",6608.35,3965.01,4.11,5286.68,35 HCPCS,J2323,NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION,29098.05,17458.83,23.28,23278.44,35 HCPCS,J2326,NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION,570581.95,342349.17,1241.84,456465.56,34 HCPCS,J2327,RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION,34829.75,20897.85,14.49,27863.8,35 HCPCS,J2327,STUDY M20-259 RISANKIZUMAB 90 MG/ML IV SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J2327,STUDY M20-259 RISANKIZUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,31 HCPCS,J2327,STUDY M23-732 RISANKIZUMAB 150 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J2327,STUDY M23-732 RISANKIZUMAB 55 MG/0.37 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J2327,STUDY M23-784 RISANKIZUMAB 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J2327,STUDY M23-784 RISANKIZUMAB/PLACEBO 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J2329,UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION,36392.75,21835.65,68.63,29114.2,35 HCPCS,J2350,OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION,67558.95,40535.37,57.63,54047.16,35 HCPCS,J2350,STUDY ML29966 OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTI,0.2,0.12,0.0506,9460.92,70 HCPCS,J2351,"OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN",161015.5,96609.3,45.81,128812.4,35 HCPCS,J2353,"OCTREOTIDE,MICROSPHERES ER 10 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",13757.4,8254.44,197.47,30919.98,35 HCPCS,J2353,"OCTREOTIDE,MICROSPHERES ER 20 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",18019.6,10811.76,197.47,30919.98,35 HCPCS,J2353,"OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",26975.0,16185.0,197.47,30919.98,35 HCPCS,J2354,"OCTREOTIDE ACETATE 1,000 MCG/ML INJECTION SOLUTION",1953.85,1172.31,1.37,4481.0,24 HCPCS,J2354,OCTREOTIDE ACETATE 100 MCG/ML INJECTION SOLUTION,45.1,27.06,1.37,4481.0,24 HCPCS,J2354,OCTREOTIDE ACETATE 200 MCG/ML INJECTION SOLUTION,54.8,32.88,1.37,4481.0,24 HCPCS,J2354,OCTREOTIDE ACETATE 50 MCG/ML INJECTION SOLUTION,24.8,14.88,1.37,4481.0,24 HCPCS,J2354,OCTREOTIDE ACETATE 500 MCG/ML INJECTION SOLUTION,209.8,125.88,1.37,4481.0,24 HCPCS,J2354,OCTREOTIDE ACETATE 500 MCG/ML SYRINGE (PEDS),209.8,125.88,1.37,4481.0,24 HCPCS,J2356,TEZEPELUMAB-EKKO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS PEN INJECTOR,18249.2,10949.52,17.47,14599.36,35 HCPCS,J2356,TEZEPELUMAB-EKKO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS SYRINGE,14184.7,8510.82,17.47,11347.76,35 HCPCS,J2357,OMALIZUMAB 150 MG SUBCUTANEOUS SOLUTION,4878.95,2927.37,43.26,6119.61,35 HCPCS,J2357,OMALIZUMAB 150 MG/ML SUBCUTANEOUS SYRINGE,5759.8,3455.88,43.26,6119.61,35 HCPCS,J2357,OMALIZUMAB 300 MG/2 ML SUBCUTANEOUS SYRINGE,11503.6,6902.16,43.26,9202.88,35 HCPCS,J2357,OMALIZUMAB 75 MG/0.5 ML SUBCUTANEOUS SYRINGE,2887.9,1732.74,43.26,6119.61,35 HCPCS,J2357,STUDY 2208 OMALIZUMAB (XOLAIR) 150MG/ 1.2 ML,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY 2208 OMALIZUMAB (XOLAIR) 300MG/ 2.4 ML,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY 2208 OMALIZUMAB (XOLAIR) 450MG/ 3.6 ML,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY COFAR-11 OMALIZUMAB OR PLACEBO PREFILLED SYRINGE 150 MG/ML,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY COFAR-11 OMALIZUMAB OR PLACEBO PREFILLED SYRINGE 75 MG/0.5 ML,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY COFAR-11 OMALIZUMAB PREFILLED SYRINGE 150 MG/ML,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY COFAR-11 OMALIZUMAB PREFILLED SYRINGE 75 MG/0.5 ML,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY OWED-T IRB 25-0864 OMALIZUMAB 150 MG SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY OWED-T IRB 25-0864 OMALIZUMAB 150 MG/ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0506,6119.61,35 HCPCS,J2357,STUDY OWED-T IRB 25-0864 OMALIZUMAB 75 MG/0.5 ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0506,6119.61,35 HCPCS,J2359,OLANZAPINE 10 MG INTRAMUSCULAR SOLUTION,94.0,56.4,1.96,4481.0,24 HCPCS,J2371,PHENYLEPHRINE (PITKIN) 10 MG IN LR 1000 ML IRRIGATION,69.55,41.73,0.0225,4481.0,24 HCPCS,J2371,PHENYLEPHRINE 0.8 MG/10 ML (80 MCG/ML) IN 0.9 %SOD.CHLORIDE IV SYRINGE,18.05,10.83,0.0225,4481.0,24 HCPCS,J2371,PHENYLEPHRINE 1 MG/10 ML (100 MCG/ML) IN 0.9 % SOD.CHLORIDE IV WRAPPER,18.65,11.19,0.0225,4481.0,24 HCPCS,J2371,PHENYLEPHRINE 10 MG/ML INJECTION SOLUTION,80.35,48.21,0.0225,4481.0,72 HCPCS,J2371,PHENYLEPHRINE 20 MG/250 ML (80 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,121.3,72.78,0.0225,4481.0,24 HCPCS,J2371,PHENYLEPHRINE 4 MG/50 ML (80 MCG/ML) IN 0.9% SODIUM CHLORIDE,69.55,41.73,0.0225,4481.0,24 HCPCS,J2371,PHENYLEPHRINE 40 MCG/ML DILUTION,62.8,37.68,0.0225,4481.0,24 HCPCS,J2371,PHENYLEPHRINE FOR PRIAPISM 100 MCG/ML VIAL/SYRINGE WRAPPER,42.15,25.29,0.0225,4481.0,24 HCPCS,J2401,CHLOROPROCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION,110.8,66.48,0.09,4481.0,24 HCPCS,J2401,CHLOROPROCAINE (PF) 30 MG/ML (3 %) INJECTION SOLUTION,103.3,61.98,0.09,4481.0,24 HCPCS,J2404,NICARDIPINE 0.2 MG/ML IN NS 50 ML PEDIATRIC INFUSION,229.3,137.58,0.1575,4481.0,24 HCPCS,J2404,NICARDIPINE 25 MG/10 ML INTRAVENOUS SOLUTION,132.5,79.5,0.1575,4481.0,24 HCPCS,J2404,NICARDIPINE 40 MG/200 ML(0.2 MG/ML) IN SOD CHLOR(ISO) INTRAVENOUS SOLN,324.6,194.76,0.1575,4481.0,24 HCPCS,J2404,STUDY CTRC 10-0742 NICARDIPINE 20 MG/200 ML IN SODIUM CHLORIDE(ISO) IB,0.2,0.12,0.0464,4481.0,24 HCPCS,J2405,ONDANSETRON (PF) 4 MG/2 ML PEDIATRIC INJECTION,17.9,10.74,0.2475,4481.0,24 HCPCS,J2405,ONDANSETRON HCL (PF) 4 MG/2 ML INJECTION SOLUTION,18.35,11.01,0.2475,4481.0,24 HCPCS,J2405,ONDANSETRON HCL 2 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,18.35,11.01,0.2475,4481.0,24 HCPCS,J2405,ONDANSETRON HCL 2 MG/ML INTRAVENOUS SOLUTION,63.9,38.34,0.2475,4481.0,24 HCPCS,J2405,STUDY ONDANSETRON HCL 2 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J2426,PALIPERIDONE PALMITATE 117 MG/0.75 ML INTRAMUSCULAR SYRINGE,6975.75,4185.45,14.66,5580.6,35 HCPCS,J2426,PALIPERIDONE PALMITATE 156 MG/ML INTRAMUSCULAR SYRINGE,9296.05,5577.63,14.66,7436.84,35 HCPCS,J2426,PALIPERIDONE PALMITATE 234 MG/1.5 ML INTRAMUSCULAR SYRINGE,13935.7,8361.42,14.66,11148.56,35 HCPCS,J2426,PALIPERIDONE PALMITATE 39 MG/0.25 ML INTRAMUSCULAR SYRINGE,2335.8,1401.48,14.66,4481.0,35 HCPCS,J2426,PALIPERIDONE PALMITATE 78 MG/0.5 ML INTRAMUSCULAR SYRINGE,4655.8,2793.48,14.66,4481.0,35 HCPCS,J2430,PAMIDRONATE 30 MG/10 ML (3 MG/ML) INTRAVENOUS SOLUTION,107.15,64.29,21.69,4481.0,24 HCPCS,J2430,PAMIDRONATE 90 MG/10 ML (9 MG/ML) INTRAVENOUS SOLUTION,83.5,50.1,19.37,4481.0,24 HCPCS,J2440,PAPAVERINE 30 MG/ML INJECTION SOLUTION,142.75,85.65,33.12,4481.0,24 HCPCS,J2469,PALONOSETRON 0.25 MG/5 ML INTRAVENOUS SOLUTION,92.45,55.47,0.765,4481.0,24 HCPCS,J2470,PANTOPRAZOLE 40 MG INTRAVENOUS SOLUTION,79.6,47.76,4.34,4481.0,24 HCPCS,J2501,PARICALCITOL 2 MCG/ML INTRAVENOUS SOLUTION,82.85,49.71,1.83,4481.0,24 HCPCS,J2501,PARICALCITOL 5 MCG/ML INTRAVENOUS SOLUTION,112.55,67.53,1.83,4481.0,24 HCPCS,J2502,PASIREOTIDE PAMOATE 10 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 HCPCS,J2502,PASIREOTIDE PAMOATE 20 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 HCPCS,J2502,PASIREOTIDE PAMOATE 30 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 HCPCS,J2502,PASIREOTIDE PAMOATE 40 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 HCPCS,J2502,PASIREOTIDE PAMOATE 60 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 HCPCS,J2505,STUDY MK2140-011 PEGFILGRASTIM 6 MG/0.6 ML WEARABLE SUBCUTANEOUS INJECTOR,0.2,0.12,0.0464,4481.0,25 HCPCS,J2506,PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR,25046.2,15027.72,86.66,20036.96,35 HCPCS,J2507,PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION,100592.6,60355.56,3551.01,538834.38,35 HCPCS,J2515,PENTOBARBITAL (NEMBUTAL) 50 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,24 HCPCS,J2515,PENTOBARBITAL 2500MG/50 ML ADULT INFUSION,6815.6,4089.36,121.21,5896.18,24 HCPCS,J2515,PENTOBARBITAL 50MG/ML PEDIATRIC INFUSION 10 ML,1843.4,1106.04,121.21,4481.0,24 HCPCS,J2515,PENTOBARBITAL 50MG/ML PEDIATRIC INFUSION 100 ML,13609.15,8165.49,121.21,11773.28,24 HCPCS,J2515,PENTOBARBITAL SODIUM 50 MG/ML INJECTION SOLUTION,3664.1,2198.46,121.21,4481.0,24 HCPCS,J2515,STUDY 2330 PENTOBARBITAL 50 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,24 HCPCS,J2515,STUDY 2330 PENTOBARBITAL 50 MG/ML VIAL,0.2,0.12,0.0464,4481.0,24 HCPCS,J2540,PENICILLIN G POT 2 MILLION UNIT/50 ML-DEXTROSE INTRAVENOUS PIGGYBACK,102.45,61.47,1.78,4481.0,24 HCPCS,J2540,PENICILLIN G POT 3 MILLION UNIT/50 ML-DEXTROSE INTRAVENOUS PIGGYBACK,104.0,62.4,1.78,4481.0,24 HCPCS,J2540,"PENICILLIN G POTASSIUM 100,000 UNITS/ML IM DILUTION",65.55,39.33,1.78,4481.0,24 HCPCS,J2540,"PENICILLIN G POTASSIUM 100,000 UNITS/ML IV (PED DILUTION)",17.0,10.2,1.78,4481.0,24 HCPCS,J2540,PENICILLIN G POTASSIUM 20 MILLION UNIT SOLUTION FOR INJECTION,214.45,128.67,1.78,4481.0,24 HCPCS,J2540,PENICILLIN G POTASSIUM 5 MILLION UNIT SOLUTION FOR INJECTION,65.65,39.39,1.78,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZO 0.1 MG/ML DESENS SOL'N #5,63.05,37.83,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZO 1 MG/ML DESENS SOL'N #4,63.05,37.83,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZO 10 MG/ML DESENS SOL'N #3,63.05,37.83,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZO 100 MG/ML DESENS SOL'N #2,63.05,37.83,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZO 200 MG/ML DESENS SOL'N #1,72.8,43.68,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZOBACTAM 2.25 GRAM INTRAVENOUS SOLUTION,74.25,44.55,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZOBACTAM 3.375 GRAM INTRAVENOUS SOLUTION,81.0,48.6,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZOBACTAM 4.5 GRAM INTRAVENOUS SOLUTION,85.45,51.27,2.41,4481.0,24 HCPCS,J2543,PIPERACILLIN-TAZOBACTAM 4.5 GRAM/100 ML DEXTROSE(ISO-OSM) IV PIGGYBACK,159.8,95.88,2.41,4481.0,24 HCPCS,J2547,PERAMIVIR (PF) 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION,1098.5,659.1,1.63,4481.0,35 HCPCS,J2550,PROMETHAZINE 1 MG/ML PEDIATRIC DILUTION INJECTION (20 MIN),21.8,13.08,5.06,4481.0,24 HCPCS,J2550,PROMETHAZINE 12.5 MG IN NS 50 ML IVPB PREMADE,100.0,60.0,6.64,4481.0,24 HCPCS,J2550,PROMETHAZINE 25 MG/ML INJECTION SOLUTION,23.25,13.95,5.39,4481.0,24 HCPCS,J2550,STUDY PROMETHAZINE 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J2560,PHENOBARBITAL SODIUM 130 MG/ML INJECTION SOLUTION,227.9,136.74,52.87,4481.0,24 HCPCS,J2560,PHENOBARBITAL SODIUM 65 MG/ML INJECTION SOLUTION,101.35,60.81,23.51,4481.0,24 HCPCS,J2562,PLERIXAFOR 24 MG/1.2 ML (20 MG/ML) SUBCUTANEOUS SOLUTION,38891.5,23334.9,24.57,31113.2,35 HCPCS,J2590,OXYTOCIN 10 UNIT/ML INJECTION SOLUTION,18.625,11.175,3.22,4481.0,48 HCPCS,J2590,OXYTOCIN 30 UNIT/500 ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS,85.9,51.54,3.22,4481.0,23 HCPCS,J2590,OXYTOCIN 30 UNIT/500 ML IN NS PMB BOLUS (OB 1 HR),101.1,60.66,3.22,4481.0,23 HCPCS,J2590,OXYTOCIN 30 UNIT/500 ML IN NS PMB BOLUS (OB 4 HR),101.1,60.66,3.22,4481.0,23 HCPCS,J2597,DESMOPRESSIN 4 MCG/ML INJECTION SOLUTION,860.35,516.21,3.41,4481.0,70 HCPCS,J2598,VASOPRESSIN 0.2 UNIT/ML INTRAVENOUS SOLUTION,226.5,135.9,2.09,4481.0,24 HCPCS,J2598,VASOPRESSIN 20 UNIT/ML INJECTION SOLUTION WRAPPER,35.5,21.3,2.09,4481.0,24 HCPCS,J2598,VASOPRESSIN 20 UNIT/ML INTRAVENOUS SOLUTION,35.5,21.3,2.09,4481.0,48 HCPCS,J2675,PROGESTERONE 50 MG/ML INTRAMUSCULAR OIL,17.35,10.41,1.57,4481.0,24 HCPCS,J2679,FLUPHENAZINE 2.5 MG/ML INJECTION SOLUTION,53.5,32.1,7.12,4481.0,35 HCPCS,J2680,FLUPHENAZINE DECANOATE 25 MG/ML INJECTION SOLUTION,62.8,37.68,14.57,4481.0,24 HCPCS,J2690,PROCAINAMIDE 100 MG/ML INJECTION SOLUTION,175.85,105.51,44.49,4481.0,35 HCPCS,J2690,PROCAINAMIDE 500 MG/ML INJECTION SOLUTION,2356.0,1413.6,285.85,4481.0,35 HCPCS,J2704,PROPOFOL 10 MG/ML INTRAVENOUS EMULSION,39.4,23.64,0.2025,4481.0,24 HCPCS,J2704,PROPOFOL INFUSION 10 MG/ML,161.1,96.66,0.2025,4481.0,24 HCPCS,J2710,NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTION,51.1,30.66,1.73,4481.0,24 HCPCS,J2720,PROTAMINE 10 MG/ML INTRAVENOUS SOLUTION,140.925,84.555,3.92,4481.0,48 HCPCS,J2730,PRALIDOXIME 1 GRAM SOLUTION FOR INJECTION,354.15,212.49,82.16,4481.0,24 HCPCS,J2760,PHENTOLAMINE 5 MG INJECTION SOLUTION,1926.9,1156.14,419.06,4481.0,35 HCPCS,J2765,METOCLOPRAMIDE 0.1 MG/ML IV SYRINGE NEONATAL,95.7,57.42,2.45,4481.0,24 HCPCS,J2777,FARICIMAB-SVOA 6 MG/0.05 ML INTRAVITREAL INJ WRAPPER,9168.9,5501.34,32.86,7335.12,35 HCPCS,J2778,STUDY CRFB002H2301 RANIBIZUMAB 0.5 MG/0.05 ML INTRAVITREAL SOLUTION FOR INJECTION,0.2,0.12,0.0506,14039.97,35 HCPCS,J2782,AVACINCAPTAD PEGOL (PF) 2 MG/0.1 ML INTRAVITREAL SOLUTION,8206.0,4923.6,101.97,17585.61,35 HCPCS,J2783,RASBURICASE 1.5 MG INTRAVENOUS SOLUTION,3682.9,2209.74,366.19,55987.89,35 HCPCS,J2785,REGADENOSON 0.4 MG/5 ML INTRAVENOUS SYRINGE,1021.3,612.78,6.79,4481.0,24 HCPCS,J2791,"RHO(D) IMMUNE GLOBULIN 1,500 UNIT (300 MCG)/2 ML INJECTION SYRINGE",693.8,416.28,10.94,4481.0,24 HCPCS,J2795,ROPIVACAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,82.4,49.44,0.1125,4481.0,24 HCPCS,J2795,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJ SOLN OSM,95.6,57.36,0.1125,4481.0,24 HCPCS,J2795,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJECTION SOLUTION,59.1,35.46,0.1125,4481.0,72 HCPCS,J2795,ROPIVACAINE (PF) 5 MG/ML (0.5 %) INJECTION SOLUTION,31.65,18.99,0.1125,4481.0,24 HCPCS,J2795,ROPIVACAINE(PF) 0.2 % 545 ML INFIL RATE ELAST PUMP WRAPPER,1682.65,1009.59,0.1125,4481.0,24 HCPCS,J2800,METHOCARBAMOL 100 MG/ML INJECTION SOLUTION,27.65,16.59,6.41,4481.0,24 HCPCS,J2802,ROMIPLOSTIM (NPLATE) INJECTION 500 MCG/ML (500 MCG),21489.5,12893.7,10.68,17191.6,35 HCPCS,J2802,ROMIPLOSTIM (NPLATE) SYRINGE 500 MCG/ML (250 MCG),10752.8,6451.68,10.68,8602.24,35 HCPCS,J2802,ROMIPLOSTIM 125 MCG SUBCUTANEOUS SOLUTION,5384.5,3230.7,10.68,4481.0,35 HCPCS,J2804,RIFAMPIN 600 MG INTRAVENOUS SOLUTION,646.9,388.14,0.315,4481.0,24 HCPCS,J2805,SINCALIDE 5 MCG SOLUTION FOR INJECTION,524.85,314.91,121.77,4481.0,24 HCPCS,J2820,SARGRAMOSTIM 250 MCG SOLUTION FOR INJECTION,1243.05,745.83,48.86,9552.06,35 HCPCS,J2840,SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION,33449.7,20069.82,523.71,77433.72,35 HCPCS,J2850,SECRETIN (HUMAN) 16 MCG INTRAVENOUS SOLUTION,1779.75,1067.85,39.3,5400.78,35 HCPCS,J2860,SILTUXIMAB 100 MG INTRAVENOUS SOLUTION,5542.25,3325.35,160.86,26739.3,35 HCPCS,J2860,SILTUXIMAB 400 MG INTRAVENOUS SOLUTION,21343.85,12806.31,160.86,26739.3,35 HCPCS,J2865,SULFAMETHOXAZOLE 400 MG-TRIMETHOPRIM 80 MG/5 ML INTRAVENOUS SOLUTION,104.05,62.43,0.1125,4481.0,24 HCPCS,J2916,SODIUM FERRIC GLUCONATE 250 MG IN 100 ML PREMIX (SSC),478.95,287.37,4.54,4481.0,24 HCPCS,J2916,SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE 62.5 MG/5 ML INTRAVENOUS,167.0,100.2,4.54,4481.0,24 HCPCS,J2919,METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/2 ML SOLUTION FOR INJECTION,56.65,33.99,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/ML PED-CARD SURGERY,206.85,124.11,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SOD SUCC (PF) 40 MG/ML SOLUTION FOR INJECTION,41.25,24.75,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SOD SUCC 125 MG/2 ML SOLUTION FOR INJECTION WRAPPER,56.65,33.99,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SOD SUCC 4 MG/ML PEDIATRIC DILUTION,1403.7,842.22,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SOD SUCC 40 MG/ML SOLUTION FOR INJECTION WRAPPER,41.25,24.75,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SOD SUCC 62.5 MG/ML IV PEDIATRIC,206.85,124.11,0.2037,4481.0,35 HCPCS,J2919,"METHYLPREDNISOLONE SODIUM SUCCINATE 1,000 MG INTRAVENOUS SOLUTION",206.85,124.11,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SODIUM SUCCINATE 125 MG SOLUTION FOR INJECTION,45.65,27.39,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SODIUM SUCCINATE 2 GRAM INTRAVENOUS SOLUTION,419.0,251.4,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SODIUM SUCCINATE 40 MG SOLUTION FOR INJECTION,34.75,20.85,0.2037,4481.0,35 HCPCS,J2919,METHYLPREDNISOLONE SODIUM SUCCINATE 500 MG INTRAVENOUS SOLUTION,134.95,80.97,0.2037,4481.0,35 HCPCS,J2919,STUDY BI 1293.10 METHYLPREDNISOLONE SODIUM SUCC 500 MG INTRAVENOUS SON,0.2,0.12,0.0506,4481.0,35 HCPCS,J2919,STUDY LPS-13649 METHYLPREDNISOLONE 1000 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J2919,STUDY METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/2ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J2919,STUDY METHYLPREDNISOLONE SOD SUCC (PF) 40 MG/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J2941,SOMATROPIN (1 MG/ML) SUBCUTANEOUS PEDIATRIC DILUTION,252.7,151.62,47.45,4481.0,35 HCPCS,J2941,SOMATROPIN 0.2 MG/0.25 ML SUBCUTANEOUS SYRINGE,137.25,82.35,34.72,4481.0,35 HCPCS,J2941,SOMATROPIN 5 MG SUBCUTANEOUS SOLUTION,1147.0,688.2,47.45,4481.0,35 HCPCS,J2997,ALTEPLASE 0.81 MG/KG STROKE INFUSION,34337.45,20602.47,91.62,29705.33,35 HCPCS,J2997,ALTEPLASE 1 MG/1 ML SOLUTION FOR INJECTION,314.5,188.7,79.57,4481.0,35 HCPCS,J2997,ALTEPLASE 1 MG/ML 100 ML PEDIATRIC INFUSION,28840.2,17304.12,91.62,24949.66,35 HCPCS,J2997,ALTEPLASE 1 MG/ML 2 ML PEDIATRIC INFUSION,668.5,401.1,91.62,4481.0,35 HCPCS,J2997,ALTEPLASE 1 MG/ML 8 ML PEDIATRIC INFUSION,1526.0,915.6,91.62,4481.0,35 HCPCS,J2997,ALTEPLASE 1 MG/ML INTRATHECAL INJECTION,365.75,219.45,91.62,4481.0,35 HCPCS,J2997,ALTEPLASE 10 MG/10 ML SYRINGE FOR IRRIGATION,2764.4,1658.64,91.62,4481.0,35 HCPCS,J2997,ALTEPLASE 100 MG INTRAVENOUS SOLUTION,34337.45,20602.47,91.62,29705.33,35 HCPCS,J2997,ALTEPLASE 125 MCG/ML INTRAOCULAR INJECTION,18.85,11.31,4.77,4481.0,35 HCPCS,J2997,ALTEPLASE 15 MG STEMI BOLUS,34337.45,20602.47,91.62,29705.33,35 HCPCS,J2997,ALTEPLASE 2 MG INTRA-CATHETER SOLUTION,738.2,442.92,91.62,4481.0,35 HCPCS,J2997,ALTEPLASE 250 MCG/ML INTRAOCULAR INJECTION,174498.9,104699.34,91.62,150959.0,35 HCPCS,J2997,ALTEPLASE 50 MG INTRAVENOUS SOLUTION,17176.75,10306.05,91.62,14859.61,35 HCPCS,J2997,ALTEPLASE STEMI INFUSION,34337.45,20602.47,91.62,29705.33,35 HCPCS,J3010,FENTANYL (PF) 10 MCG/ML NEONATAL DILUTION INJECTION,40.05,24.03,2.48,4481.0,24 HCPCS,J3010,FENTANYL (PF) 10 MCG/ML PEDIATRIC BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,24 HCPCS,J3010,FENTANYL (PF) 100 MCG/10 ML (10 MCG/ML) IN 0.9 % NACL IV SYRINGE,25.15,15.09,2.48,4481.0,24 HCPCS,J3010,"FENTANYL (PF) 2,500 MCG/50 ML (50 MCG/ML) INTRAVENOUS PCA SYRINGE",75.6,45.36,2.48,4481.0,24 HCPCS,J3010,FENTANYL (PF) 25 MCG/2.5 ML (10 MCG/ML) INFUSION SYRINGE,24.1,14.46,2.48,4481.0,24 HCPCS,J3010,FENTANYL (PF) 25 MCG/2.5 ML (10 MCG/ML) INJECTION,24.1,14.46,2.48,4481.0,24 HCPCS,J3010,FENTANYL (PF) 250 MCG/5 ML (50 MCG/ML) INTRAVENOUS SYRINGE,38.45,23.07,2.48,4481.0,24 HCPCS,J3010,FENTANYL (PF) 50 MCG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,24 HCPCS,J3010,FENTANYL (PF) 50 MCG/ML INFUSION,156.4,93.84,2.48,4481.0,24 HCPCS,J3010,FENTANYL (PF) 50 MCG/ML INJECTION SOLUTION,42.5,25.5,2.48,4481.0,24 HCPCS,J3010,FENTANYL (PF) 50 MCG/ML INTRAVENOUS SOLUTION,72.3,43.38,2.48,4481.0,24 HCPCS,J3010,FENTANYL 50 MCG BUPIVACAINE 0.125% IN SODIUM CHLORIDE 0.9% (15 ML SYRINGE),24.85,14.91,2.48,4481.0,24 HCPCS,J3010,FENTANYL 50 MCG/ML INTRANASAL SOLUTION,32.3,19.38,2.48,4481.0,120 HCPCS,J3010,STUDY CNS7056-008 FENTANYL 0.05 MG/ML FOLLOW-UP DOSE,0.2,0.12,0.0464,4481.0,24 HCPCS,J3010,STUDY CNS7056-008 FENTANYL 0.05 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,24 HCPCS,J3030,SUMATRIPTAN 6 MG/0.5 ML SUBCUTANEOUS SOLUTION,58.9,35.34,13.66,4481.0,24 HCPCS,J3032,EPTINEZUMAB-JJMR 100 MG/ML INTRAVENOUS SOLUTION,6407.05,3844.23,19.37,5125.64,35 HCPCS,J3055,STUDY 64407564MMY3002 TALQUETAMAB 2 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,11455.71,35 HCPCS,J3055,STUDY 64407564MMY3002 TALQUETAMAB 40 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,11455.71,35 HCPCS,J3055,TALQUETAMAB-TGVS 2 MG/ML SUBCUTANEOUS SOLUTION,3143.05,1885.83,70.44,11455.71,35 HCPCS,J3055,TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION,38515.55,23109.33,70.44,30812.44,35 HCPCS,J3055,TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION (FOR 0.8 MG/KG DOSAGE),38515.55,23109.33,70.44,30812.44,35 HCPCS,J3090,TEDIZOLID 200 MG INTRAVENOUS SOLUTION,1274.5,764.7,1.9,4481.0,35 HCPCS,J3095,TELAVANCIN 750 MG INTRAVENOUS SOLUTION,2210.35,1326.21,6.9,4481.0,35 HCPCS,J3101,TENECTEPLASE 25 MG INTRAVENOUS SOLUTION FOR STROKE,32375.35,19425.21,167.05,28007.92,35 HCPCS,J3101,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION FOR MI,32375.35,19425.21,167.05,28007.92,35 HCPCS,J3101,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION FOR STROKE,32375.35,19425.21,167.05,28007.92,35 HCPCS,J3101,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION WRAPPER FOR MI,32375.35,19425.21,167.05,28007.92,35 HCPCS,J3105,TERBUTALINE (BRETHINE) 16 MG/16 ML PEDIATRIC INFUSION,1093.75,656.25,7.46,4481.0,24 HCPCS,J3105,TERBUTALINE 1 MG/ML SUBCUTANEOUS SOLUTION,92.85,55.71,7.46,4481.0,24 HCPCS,J3105,TERBUTALINE 200 MCG/ML (BOLUS FROM INFUSION),0.2,0.12,0.0464,4481.0,24 HCPCS,J3111,ROMOSOZUMAB-AQQG 210 MG/2.34 ML(105 MG/1.17 ML X2)SUBCUTANEOUS SYRINGE,10268.8,6161.28,11.71,8215.04,35 HCPCS,J3145,TESTOSTERONE UNDECANOATE 750 MG/3 ML (250MG/ML) INTRAMUSCULAR SOLUTION,6260.2,3756.12,2.01,5415.7,35 HCPCS,J3230,CHLORPROMAZINE 25 MG/ML INJECTION SOLUTION,136.89999999999998,82.14,29.86,4481.0,48 HCPCS,J3240,THYROTROPIN ALFA 0.9 MG INTRAMUSCULAR SOLUTION,7902.3,4741.38,1999.28,314159.58,35 HCPCS,J3241,TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION,58985.0,35391.0,348.41,57707.79,35 HCPCS,J3247,SECUKINUMAB 25 MG/ML INTRAVENOUS SOLUTION,7259.2,4355.52,17.3,5807.36,35 HCPCS,J3260,STUDY SEXTANT IRB# 22-2127 TOBRAMYCIN 1.2 GRAM POWDER,0.2,0.12,0.0464,4481.0,24 HCPCS,J3260,TOBRAMYCIN 1.2 GRAM POWDER (OSM),328.0,196.8,5.33,4481.0,24 HCPCS,J3260,TOBRAMYCIN 1.2 GRAM SOLUTION FOR INJECTION,328.0,196.8,5.33,4481.0,24 HCPCS,J3260,TOBRAMYCIN 10 MG/ML INJECTION SOLUTION,65.9,39.54,5.33,4481.0,24 HCPCS,J3260,TOBRAMYCIN 40 MG/ML INJECTION SOLUTION,65.525,39.315,5.33,4481.0,48 HCPCS,J3260,TOBRAMYCIN 5 MG/3 ML NS INTRATHECAL,79.65,47.79,5.33,4481.0,24 HCPCS,J3260,TOBRAMYCIN SULFATE (PEDIATRIC) 10 MG/ML (PF),99.65,59.79,5.33,4481.0,24 HCPCS,J3262,STUDY 20230238 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY CA0611001 (23-1564) TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY CA088-1000 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY CAB-201-001 (23-2231) TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY CRSP-AID-500 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY DFHCC-23-429 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY GO44145-SKYGLO TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY R10597-ONC-22114 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY R1979-HM-2298 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,STUDY R5458-ONC-2012 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3262,TOCILIZUMAB (ACTEMRA) 20 MG/ML INJECTION WRAPPER,4405.3,2643.18,5.54,6998.04,105 HCPCS,J3262,TOCILIZUMAB 200 MG/10 ML (20 MG/ML) INTRAVENOUS SOLUTION,4405.3,2643.18,5.54,4481.0,35 HCPCS,J3262,TOCILIZUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION,8747.55,5248.53,5.54,6998.04,35 HCPCS,J3262,TOCILIZUMAB 80 MG/4 ML (20 MG/ML) INTRAVENOUS SOLUTION,1799.9,1079.94,5.54,4481.0,35 HCPCS,J3263,STUDY CHS-388-202 TORIPALIMAB 40 MG/ML IV SOLUTION,0.2,0.12,0.0506,6398.91,35 HCPCS,J3263,TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION,31794.55,19076.73,38.23,25435.64,35 HCPCS,J3285,TREPROSTINIL SODIUM 1 MG/ML INJECTION SOLUTION,2871.4249999999997,1722.855,53.07,8670.06,70 HCPCS,J3285,TREPROSTINIL SODIUM 10 MG/ML INJECTION SOLUTION,28570.225,17142.135,53.07,39740.4,70 HCPCS,J3285,TREPROSTINIL SODIUM 2.5 MG/ML INJECTION SOLUTION,7154.575,4292.745,53.07,9944.72,70 HCPCS,J3285,TREPROSTINIL SODIUM 5 MG/ML INJECTION SOLUTION,14293.125,8575.875,53.07,19876.6,70 HCPCS,J3301,STUDY ALE10 (DIVERT) TRIAMCINOLONE ACETONIDE 40 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0464,4481.0,24 HCPCS,J3301,STUDY ALE10 (DIVERT) TRIAMCINOLONE ACETONIDE 80 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0464,4481.0,24 HCPCS,J3301,TRIAMCINOLONE ACETONIDE - FOR INTRAPERICARDIAL USE ONLY,126.92500000000001,76.155,1.89,4481.0,48 HCPCS,J3301,TRIAMCINOLONE ACETONIDE 10 MG/ML SUSPENSION FOR INJECTION,18.4,11.04,1.89,4481.0,24 HCPCS,J3301,TRIAMCINOLONE ACETONIDE 40 MG/ML SUSPENSION FOR INJECTION,52.55,31.53,1.89,4481.0,24 HCPCS,J3303,TRIAMCINOLONE HEXACETONIDE 20 MG/ML SUSPENSION FOR INJECTION,269.5,161.7,18.65,4481.0,24 HCPCS,J3357,STUDY 2422 USTEKINUMAB (STELARA) 90 MG SYRINGE,0.2,0.12,0.0506,23352.42,35 HCPCS,J3357,STUDY CNTO1275JPA3001 USTEKINUMAB 45 MG/0.5 ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J3357,STUDY CNTO1275JPA3001 USTEKINUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,31 HCPCS,J3357,USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE,113706.7,68224.02,144.92,90965.36,35 HCPCS,J3358,STUDY CNTO1959CRD3001 USTEKINUMAB/PLACEBO 130 MG/26 ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3358,STUDY M20-259 USTEKINUMAB 130 MG/26 ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3358,STUDY NICHD NRN0058 DARBEPOETIN OR PLACEBO SYRINGE,0.2,0.12,0.05544,4481.0,33 HCPCS,J3358,STUDY NICHD NRN0058 IRON DEXTRAN INJECTION,0.2,0.12,0.05544,4481.0,33 HCPCS,J3358,USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION,6994.3,4196.58,12.6,5595.44,35 HCPCS,J3360,DIAZEPAM 5 MG/ML INJECTION SOLUTION,196.2,117.72,16.54,4481.0,24 HCPCS,J3360,DIAZEPAM 5 MG/ML INJECTION SYRINGE,123.35,74.01,16.54,4481.0,24 HCPCS,J3373,STUDY BLADE-VG2 VANCOMYCIN HYDROCHLORIDE 500 MG POWDER,0.2,0.12,0.0464,4481.0,24 HCPCS,J3373,STUDY SEXTANT IRB# 22-2127 VANCOMYCIN 1000 MG POWDER,0.2,0.12,0.0464,4481.0,24 HCPCS,J3373,VANCOMYCIN 1 G TOPICAL POWDER,64.15,38.49,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1 G TOPICAL POWDER (OPTIME),64.15,38.49,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1 MG/0.1 ML (1%) INTRAOCULAR SYRINGE,63.1,37.86,0.0675,4481.0,24 HCPCS,J3373,"VANCOMYCIN 1,000 MG INTRAVENOUS INJECTION",116.25,69.75,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 10 GRAM INTRAVENOUS SOLUTION,98.275,58.965,0.0675,4481.0,48 HCPCS,J3373,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION (SYRINGE) PEDS,80.5,48.3,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION PEDS 100 ML,98.0,58.8,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION PEDS 200 ML,203.0,121.8,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 10 MG/ML (CENTRAL) PEDIATRIC DILUTION,762.8,457.68,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1000 MG/200 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,165.9,99.54,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1000 MG/250 ML NS IVPB PREMADE (285 ML TOTAL VOLUME),145.05,87.03,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1250 MG/250 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,236.4,141.84,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1250 MG/250 ML NS IVPB PREMADE (287.5 ML TOTAL VOLUME),229.45,137.67,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1500 MG/300 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,241.35,144.81,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1500 MG/500 ML NS IVPB PREMADE (555 ML TOTAL VOLUME),246.3,147.78,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 1750 MG/500 ML NS IVPB PREMADE (557.5 ML TOTAL VOLUME),199.75,119.85,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 2.5 MG/ML (2 ML) LOCK IN NS,22.3,13.38,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 2.5 MG/ML (5 ML) LOCK IN NS,28.7,17.22,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 2000 MG/500 ML NS IVPB PREMADE (560 ML TOTAL VOLUME),216.85,130.11,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 5 GRAM INTRAVENOUS SOLUTION,358.2,214.92,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 100 ML,98.0,58.8,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 200 ML,133.0,79.8,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 400 ML,203.0,121.8,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 5 MG/ML PEDIATRIC DILUTION,412.9,247.74,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 5% OPHTHALMIC SOLN,31.5,18.9,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 750 MG INTRAVENOUS SOLUTION,94.1,56.46,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 750 MG/150 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,109.3,65.58,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN 750 MG/250 ML NS IVPB PREMADE (282.5 ML TOTAL VOLUME),188.65,113.19,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN-GENTAMICIN 2.5-1 MG/ML (2 ML) LOCK IN NS,24.0,14.4,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN-GENTAMICIN 2.5-1 MG/ML (5 ML) LOCK IN NS,27.0,16.2,0.0675,4481.0,24 HCPCS,J3373,VANCOMYCIN-HEPARIN (2.5 MG-10 UNITS/ML) IN NS NEONATAL LOCK SOLUTION,63.25,37.95,0.0675,4481.0,24 HCPCS,J3380,STUDY MLN0002-3026 VEDOLIZUMAB/PLACEBO 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3380,STUDY MLN0002SC-3031 VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3380,STUDY MLN0002SC-3031 VEDOLIZUMAB/PLACEBO 108 MG/0.68 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J3380,STUDY VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J3380,VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,30669.95,18401.97,20.67,24535.96,35 HCPCS,J3385,VELAGLUCERASE ALFA 400 UNIT INTRAVENOUS SOLUTION,4531.05,2718.63,369.92,55023.57,35 HCPCS,J3396,VERTEPORFIN 15 MG INTRAVENOUS SOLUTION,5653.8,3392.28,11.19,4523.04,35 HCPCS,J3399,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2527893.575,1516736.145,4481.0,379707196.05,726 HCPCS,J3406,STUDY MK-3475-045 PEMBROLIZUMAB INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 HCPCS,J3410,HYDROXYZINE HCL 25 MG/ML INTRAMUSCULAR SOLUTION,135.25,81.15,31.38,4481.0,24 HCPCS,J3410,HYDROXYZINE HCL 50 MG/ML INTRAMUSCULAR SOLUTION,147.5,88.5,34.22,4481.0,24 HCPCS,J3411,THIAMINE HCL (VITAMIN B1) 100 MG/ML INJECTION SOLUTION,21.85,13.11,4.09,4481.0,24 HCPCS,J3411,THIAMINE IN NS (5 MG/ML) PEDIATRIC DILUTION,95.45,57.27,4.09,4481.0,24 HCPCS,J3415,PYRIDOXINE (VITAMIN B6) 100 MG/ML INJECTION SOLUTION,58.4,35.04,13.55,4481.0,24 HCPCS,J3415,PYRIDOXINE IN NS (5 MG/ML) PEDIATRIC DILUTION,205.2,123.12,13.61,4481.0,24 HCPCS,J3420,"CYANOCOBALAMIN (VIT B-12) 1,000 MCG/ML INJECTION SOLUTION",17.35,10.41,2.25,4481.0,24 HCPCS,J3424,HYDROXOCOBALAMIN 5 GRAM INTRAVENOUS SOLUTION,3490.0,2094.0,5.03,4481.0,35 HCPCS,J3425,"HYDROXOCOBALAMIN 1,000 MCG/ML INTRAMUSCULAR SOLUTION",113.5,68.1,0.0097,4481.0,35 HCPCS,J3430,PHYTONADIONE (VITAMIN K1) 1 MG/0.5 ML INJECTION SOLUTION,39.4,23.64,6.14,4481.0,24 HCPCS,J3430,PHYTONADIONE (VITAMIN K1) 10 MG/ML INJECTION SOLUTION,49.4,29.64,6.14,4481.0,24 HCPCS,J3430,PHYTONADIONE 1 MG/0.5 ML INJ SOLUTION (MULTI-VIAL SIZE),112.45,67.47,6.14,4481.0,23 HCPCS,J3465,VORICONAZOLE (VFEND) 0.1% (100 MCG/0.1 ML) INTRAOCULAR,64.25,38.55,1.73,4481.0,24 HCPCS,J3465,VORICONAZOLE 1% OPHTHALMIC SOLN,3.0,1.8,0.696,4481.0,24 HCPCS,J3465,VORICONAZOLE 200 MG INTRAVENOUS SOLUTION,259.2,155.52,1.73,4481.0,24 HCPCS,J3473,"HYALURONIDASE, HUMAN RECOMBINANT 15 UNIT/ML (DILUTION) INJECTION",59.55,35.73,0.81,4481.0,24 HCPCS,J3473,"HYALURONIDASE, HUMAN RECOMBINANT 150 UNIT/ML INJECTION SOLUTION",233.65,140.19,0.81,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 1 GRAM/100 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,98.45,59.07,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 100 MG/ML (CENTRAL) PEDIATRIC DILUTION,87.55,52.53,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK,112.0,67.2,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) INTRAVENOUS PIGGYBACK WRAPPER,124.75,74.85,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 2 GRAM/50 ML (40MG/ML) PEDIATRIC INFUSION,116.0,69.6,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 2.03 MEQ/ML INJECTION DILUTION,45.65,27.39,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 20 GRAM/500 ML (4 %) IN WATER INTRAVENOUS SOLUTION,85.9,51.54,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 4 MEQ/ML (50 %) INJECTION WRAPPER,24.9,14.94,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 40 MG/ML (PERIPHERAL) PEDIATRIC IV,116.0,69.6,1.08,4481.0,24 HCPCS,J3475,MAGNESIUM SULFATE 500 MG/ML (50 %) INJECTION SOLUTION,24.9,14.94,1.08,4481.0,24 HCPCS,J3475,STUDY IRB 16-0129 MAGNESIUM SULFATE 2 GM IN 50 ML DEXTROSE 5% INFUSIN,0.2,0.12,0.0464,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 0.1 MEQ/ML (PERIPHERAL LINE) IV PEDIATRIC,79.05,47.43,0.2475,4481.0,21 HCPCS,J3480,POTASSIUM CHLORIDE 0.2 MEQ/ML (CENTRAL LINE) IV PEDIATRIC,71.85,43.11,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 10 MEQ/100ML IN STERILE WATER INTRAVENOUS PIGGYBACK,77.9,46.74,0.2475,4481.0,21 HCPCS,J3480,POTASSIUM CHLORIDE 10 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,93.0,55.8,0.2475,4481.0,21 HCPCS,J3480,POTASSIUM CHLORIDE 2 MEQ/ML INTRAVENOUS SOLUTION,71.6,42.96,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 20 MEQ/100ML IN STERILE WATER INTRAVENOUS PIGGYBACK,78.65,47.19,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 20 MEQ/L IN 0.9 % SODIUM CHLORIDE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 20 MEQ/L IN D5-0.9 % SODIUM CHLORIDE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 20 MEQ/L IN DEXTROSE 5 %-0.2 % SODIUM CHLORIDE IV,97.3,58.38,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 20 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,85.9,51.54,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 20 MEQ/L-LACTATED RINGERS-5 % DEXTROSE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 30 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,101.1,60.66,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 40 MEQ/L IN 0.9 % SODIUM CHLORIDE INTRAVENOUS,108.75,65.25,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE 40 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,101.1,60.66,0.2475,4481.0,24 HCPCS,J3480,POTASSIUM CHLORIDE FOR THERAPEUTIC ABORTION,71.6,42.96,0.2475,4481.0,24 HCPCS,J3485,ZIDOVUDINE 10 MG/ML INTRAVENOUS SOLUTION,158.5,95.1,3.4,4481.0,24 HCPCS,J3486,ZIPRASIDONE 20 MG/ML (FINAL CONCENTRATION) INTRAMUSCULAR SOLUTION,199.3,119.58,8.55,4481.0,24 HCPCS,J3489,ZOLEDRONIC ACID 4 MG/5 ML INTRAVENOUS SOLUTION,308.25,184.95,11.38,4481.0,24 HCPCS,J3489,ZOLEDRONIC ACID 5 MG/100 ML IN MANNITOL 5 %-WATER INTRAVENOUS PIGGYBCK,1207.5,724.5,11.38,4481.0,24 HCPCS,J3490,(TAKE HOME) ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,84.4,50.64,19.58,4481.0,19 HCPCS,J3490,(TAKE HOME) CIPROFLOXACIN 0.3 % EYE DROPS,58.15,34.89,13.49,4481.0,19 HCPCS,J3490,(TAKE HOME) CLINDAMYCIN HCL 150 MG CAPSULE,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,(TAKE HOME) DOLUTEGRAVIR 50 MG TABLET,713.55,428.13,165.54,4481.0,19 HCPCS,J3490,(TAKE HOME) EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,612.1,367.26,142.01,4481.0,19 HCPCS,J3490,(TAKE HOME) ERYTHROMYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT,61.8,37.08,14.34,4481.0,19 HCPCS,J3490,(TAKE HOME) MOLNUPIRAVIR 200 MG CAPSULE (EUA),16.05,9.63,3.72,4481.0,19 HCPCS,J3490,"(TAKE HOME) NIRMATRELVIR 300 MG (150 MG X2)-RITONAVIR 100 MG TABLET,DOSE PACK",16.1,9.66,3.74,4481.0,19 HCPCS,J3490,(TAKE HOME) RALTEGRAVIR 400 MG TABLET,641.0,384.6,148.71,4481.0,19 HCPCS,J3490,(TAKE HOME) SULFAMETHOXAZOLE 800 MG-TRIMETHOPRIM 160 MG TABLET,27.05,16.23,6.28,4481.0,19 HCPCS,J3490,ABACAVIR 300 MG TABLET,42.5,25.5,9.86,4481.0,19 HCPCS,J3490,ABACAVIR 600 MG-LAMIVUDINE 300 MG TABLET,26.0,15.6,6.03,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 120 MG RECTAL SUPPOSITORY,1.5,0.9,0.348,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL LIQUID WRAPPER,3.55,2.13,0.8236,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL SOLUTION,3.55,2.13,0.8236,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL SUSPENSION,2.4,1.44,0.5568,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 325 MG RECTAL SUPPOSITORY,2.6,1.56,0.6032,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 325 MG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 500 MG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 650 MG RECTAL SUPPOSITORY,1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 650 MG/20.3 ML ORAL LIQUID WRAPPER,3.85,2.31,0.8932,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 650 MG/20.3 ML ORAL SUSPENSION,3.85,2.31,0.8932,4481.0,19 HCPCS,J3490,ACETAMINOPHEN 80 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,ACETAZOLAMIDE 25 MG/ML ORAL SUSPENSION,155.0,93.0,35.96,4481.0,19 HCPCS,J3490,ACETAZOLAMIDE 250 MG TABLET,17.05,10.23,3.96,4481.0,19 HCPCS,J3490,"ACETAZOLAMIDE ER 500 MG CAPSULE,EXTENDED RELEASE",18.25,10.95,4.23,4481.0,19 HCPCS,J3490,ACETIC ACID 0.25 % IRRIGATION SOLUTION,78.0,46.8,18.1,4481.0,19 HCPCS,J3490,ACETYLCHOLINE CHLORIDE 1 % (20 MG/2 ML) INTRAOCULAR KIT,409.05,245.43,94.9,4481.0,19 HCPCS,J3490,ACETYLCYSTEINE 10% (100 MG/ML) OPHTHALMIC SOLUTION,259.65,155.79,60.24,4481.0,19 HCPCS,J3490,ACETYLCYSTEINE 20% (200 MG/ML) OPHTHALMIC SOLUTION,259.65,155.79,60.24,4481.0,19 HCPCS,J3490,ACETYLCYSTEINE 200 MG/ML (20 %) INHALATION SOLUTION,40.0,24.0,9.28,4481.0,19 HCPCS,J3490,ACETYLCYSTEINE 200 MG/ML (20 %) SOLUTION,51.95,31.17,12.05,4481.0,19 HCPCS,J3490,ACHS(CASH) OTIC INSUFFLATE CAPSULE,194.65,116.79,45.16,4481.0,19 HCPCS,J3490,ACTIVATED CHARCOAL 25 GRAM/120 ML ORAL SUSPENSION,21.65,12.99,5.02,4481.0,19 HCPCS,J3490,ACTIVATED CHARCOAL 50 GRAM/240 ML ORAL SUSPENSION,15.7,9.42,3.64,4481.0,19 HCPCS,J3490,ACTIVATED CHARCOAL-SORBITOL 50 GRAM/240 ML ORAL SUSPENSION,15.7,9.42,3.64,4481.0,19 HCPCS,J3490,ACYCLOVIR 200 MG/5 ML ORAL SUSPENSION,1084.55,650.73,251.62,4481.0,19 HCPCS,J3490,ALBENDAZOLE 200 MG TABLET,106.0,63.6,24.59,4481.0,19 HCPCS,J3490,ALBUTEROL SULFATE 2 MG TABLET,34.7,20.82,8.05,4481.0,19 HCPCS,J3490,ALBUTEROL SULFATE 2.5 MG/3 ML (0.083 %) SOLUTION FOR NEBULIZATION,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,ALBUTEROL SULFATE CONCENTRATE 2.5 MG/0.5 ML SOLUTION FOR NEBULIZATION,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,ALBUTEROL SULFATE CONCENTRATE 5 MG/ML(0.5 %) SOLUTION FOR NEBULIZATION,425.2,255.12,19.58,4481.0,38 HCPCS,J3490,ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,84.4,50.64,19.58,4481.0,19 HCPCS,J3490,ALECTINIB 150 MG CAPSULE,349.45,209.67,81.07,4481.0,19 HCPCS,J3490,ALENDRONATE 35 MG TABLET,18.65,11.19,4.33,4481.0,19 HCPCS,J3490,ALENDRONATE 70 MG TABLET,17.9,10.74,4.15,4481.0,19 HCPCS,J3490,ALKALINE SALINE 2% MOUTH RINSE,1.1,0.6599999999999999,0.2436,4481.0,38 HCPCS,J3490,ALLOPURINOL 100 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,ALLOPURINOL 20MG/ML ORAL SUSPENSION,18.55,11.13,4.3,4481.0,19 HCPCS,J3490,ALLOPURINOL 300 MG TABLET,18.25,10.95,4.23,4481.0,19 HCPCS,J3490,ALPRAZOLAM 0.25 MG TABLET,22.15,13.29,5.14,4481.0,19 HCPCS,J3490,ALPRAZOLAM 0.5 MG TABLET,23.15,13.89,5.37,4481.0,19 HCPCS,J3490,ALUMINUM HYDROX-MAGNESIUM CARB 160 MG-105 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,ALUMINUM HYDROXIDE GEL 320 MG/5 ML ORAL SUSPENSION,1.7,1.02,0.3944,4481.0,19 HCPCS,J3490,ALUMINUM-MAG HYDROXIDE-SIMETHICONE 400 MG-400 MG-40 MG/5 ML ORAL SUSP,2.6500000000000004,1.59,0.3132,4481.0,38 HCPCS,J3490,ALVIMOPAN 12 MG CAPSULE,487.35,292.41,113.07,4481.0,19 HCPCS,J3490,AMANTADINE HCL 100 MG CAPSULE,22.0,13.2,5.1,4481.0,19 HCPCS,J3490,AMANTADINE HCL 50 MG/5 ML ORAL SOLUTION,27.85,16.71,6.46,4481.0,19 HCPCS,J3490,AMBRISENTAN 10 MG TABLET,131.25,78.75,30.45,4481.0,19 HCPCS,J3490,AMBRISENTAN 5 MG TABLET,1390.65,834.39,322.63,4481.0,19 HCPCS,J3490,AMILORIDE 1 MG/ML ORAL SUSPENSION,24.4,14.64,5.66,4481.0,19 HCPCS,J3490,AMILORIDE 5 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,AMINO ACID 10 % INTRAVENOUS SOLUTION,208.55,125.13,48.38,4481.0,19 HCPCS,J3490,AMINO ACID 5 % (L-ARGININE 25 G/L & L-LYSINE 25 G/L) INTRAVENOUS SOLUTION,291.6,174.96,67.65,4481.0,19 HCPCS,J3490,AMINO ACID 6 % IN DEXTROSE 5 % WATER INTRAVENOUS SOLUTION,264.95,158.97,61.47,4481.0,17 HCPCS,J3490,AMINO ACID 8 % IN DEXTROSE 10% WATER INTRAVENOUS SOLUTION,264.95,158.97,61.47,4481.0,17 HCPCS,J3490,AMINO ACID 8 % IN DEXTROSE 14 % WATER INTRAVENOUS SOLUTION,299.25,179.55,69.43,4481.0,17 HCPCS,J3490,AMINO ACIDS 8 %-DEXTROSE 10 %-ELECTROLYTES INTRAVENOUS SOLUTION,314.5,188.7,72.96,4481.0,17 HCPCS,J3490,AMINO ACIDS 8 %-DEXTROSE 14 %-ELECTROLYTES INTRAVENOUS SOLUTION,303.05,181.83,70.31,4481.0,17 HCPCS,J3490,AMINOCAPROIC ACID 250 MG/ML (25 %) ORAL SOLUTION,8400.9,5040.54,1949.01,6720.72,19 HCPCS,J3490,AMINOCAPROIC ACID 500 MG TABLET,51.05,30.63,11.84,4481.0,19 HCPCS,J3490,AMIODARONE 200 MG TABLET,17.15,10.29,3.98,4481.0,19 HCPCS,J3490,AMIODARONE 5 MG/ML ORAL SUSPENSION,23.2,13.92,5.38,4481.0,19 HCPCS,J3490,AMITRIPTYLINE 1 MG/ML ORAL SUSPENSION,18.4,11.04,4.27,4481.0,19 HCPCS,J3490,AMITRIPTYLINE 10 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,AMITRIPTYLINE 100 MG TABLET,19.45,11.67,4.51,4481.0,19 HCPCS,J3490,AMITRIPTYLINE 25 MG TABLET,17.3,10.38,4.01,4481.0,19 HCPCS,J3490,AMITRIPTYLINE 50 MG TABLET,17.75,10.65,4.12,4481.0,19 HCPCS,J3490,AMLODIPINE 10 MG TABLET,16.5,9.9,3.83,4481.0,19 HCPCS,J3490,AMLODIPINE 2.5 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,AMLODIPINE 5 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,AMLODIPINE BENZOATE 1 MG/ML ORAL SUSPENSION,48.0,28.8,11.14,4481.0,19 HCPCS,J3490,AMMONIUM LACTATE 12 % LOTION,16.15,9.69,3.75,4481.0,19 HCPCS,J3490,AMOXICILLIN 250 MG CAPSULE,16.35,9.81,3.79,4481.0,19 HCPCS,J3490,AMOXICILLIN 250 MG/5 ML ORAL SUSPENSION,16.475,9.885,3.82,4481.0,38 HCPCS,J3490,AMOXICILLIN 400 MG-POTASSIUM CLAVULANATE 57 MG/5 ML ORAL SUSPENSION,59.8,35.88,13.87,4481.0,19 HCPCS,J3490,AMOXICILLIN 500 MG CAPSULE,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,AMOXICILLIN 500 MG-POTASSIUM CLAVULANATE 125 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,AMOXICILLIN 875 MG-POTASSIUM CLAVULANATE 125 MG TABLET,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,AMPHOTERICIN B CONVENTIONAL 0.5 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 HCPCS,J3490,AMPHOTERICIN B CONVENTIONAL 1 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 HCPCS,J3490,AMPHOTERICIN B CONVENTIONAL 1.5 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 HCPCS,J3490,ANAGRELIDE 0.5 MG CAPSULE,18.5,11.1,4.29,4481.0,19 HCPCS,J3490,ANAKINRA (KINERET) IV SYRINGE,837.7,502.62,194.35,4481.0,19 HCPCS,J3490,ANAKINRA 100 MG/0.67 ML SUBCUTANEOUS SYRINGE,837.7,502.62,194.35,4481.0,19 HCPCS,J3490,ANASTROZOLE 1 MG TABLET,26.2,15.72,6.08,4481.0,19 HCPCS,J3490,"ANTIVENIN LATRODECTUS MACTANS 6,000 UNIT SOLUTION FOR INJECTION",124.1,74.46,28.79,4481.0,19 HCPCS,J3490,APIXABAN 2.5 MG TABLET,46.35,27.81,10.75,4481.0,19 HCPCS,J3490,APIXABAN 5 MG TABLET,46.35,27.81,10.75,4481.0,19 HCPCS,J3490,APRACLONIDINE 0.5 % EYE DROPS,209.4,125.64,48.58,4481.0,19 HCPCS,J3490,ARFORMOTEROL 15 MCG/2 ML SOLUTION FOR NEBULIZATION,23.5,14.1,5.45,4481.0,19 HCPCS,J3490,ARGININE (L) 5 GRAM POWDER (100 MG/ML) FOR ORAL SOLN,23.35,14.01,5.42,4481.0,19 HCPCS,J3490,ARGININE 25 MG/ML-LYSINE 25 MG/ML IN 0.9 % NACL INTRAVENOUS SOLUTION,444.0,266.4,103.01,4481.0,19 HCPCS,J3490,ARGININE HCL (L-ARGININE) 0.1 G/ML (METABOLIC DIS) BOLUS,223.05,133.83,51.75,4481.0,19 HCPCS,J3490,ARGININE HCL (L-ARGININE) 0.1 G/ML (METABOLIC DIS) INFUSION,200.35,120.21,46.48,4481.0,19 HCPCS,J3490,ARGININE HCL (L-ARGININE) 10 % INTRAVENOUS SOLUTION,223.05,133.83,51.75,4481.0,19 HCPCS,J3490,ARIPIPRAZOLE 10 MG TABLET,17.9,10.74,4.15,4481.0,19 HCPCS,J3490,ARIPIPRAZOLE 15 MG TABLET,21.55,12.93,5.0,4481.0,19 HCPCS,J3490,ARIPIPRAZOLE 2 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,ARIPIPRAZOLE 5 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,ARTEMETHER-LUMEFANTRINE 20 MG-120 MG TABLET,32.85,19.71,7.62,4481.0,19 HCPCS,J3490,ARTIFICIAL TEARS (HYPROMELLOSE) (PF) 1.7 % EYE DROPS WITH APPLICATOR,39.75,23.85,9.22,4481.0,19 HCPCS,J3490,ARTIFICIAL TEARS (HYPROMELLOSE) 0.3 % EYE GEL,11.1,6.66,2.58,4481.0,19 HCPCS,J3490,ASCORBIC ACID (VITAMIN C) 250 MG TABLET,1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,ASCORBIC ACID (VITAMIN C) 500 MG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,ASCORBIC ACID (VITAMIN C) 500 MG/5 ML ORAL LIQUID,1.4,0.84,0.3248,4481.0,19 HCPCS,J3490,ASENAPINE 10 MG SUBLINGUAL TABLET,31.3,18.78,7.26,4481.0,19 HCPCS,J3490,"ASPIRIN 25 MG-DIPYRIDAMOLE 200 MG CAPSULE,EXT.RELEASE 12 HR MULTIPHASE",19.0,11.4,4.41,4481.0,19 HCPCS,J3490,ASPIRIN 300 MG RECTAL SUPPOSITORY,2.85,1.71,0.6612,4481.0,19 HCPCS,J3490,ASPIRIN 325 MG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,"ASPIRIN 325 MG TABLET,DELAYED RELEASE",1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,ASPIRIN 81 MG CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,ASPIRIN ORAL DESENSITIZATION 1 MG/ML BULK SOLUTION,16.05,9.63,3.72,4481.0,19 HCPCS,J3490,ATENOLOL 100 MG TABLET,16.65,9.99,3.86,4481.0,19 HCPCS,J3490,ATENOLOL 25 MG TABLET,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,ATENOLOL 50 MG TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,ATOMOXETINE 10 MG CAPSULE,20.9,12.54,4.85,4481.0,19 HCPCS,J3490,ATOMOXETINE 18 MG CAPSULE,20.9,12.54,4.85,4481.0,19 HCPCS,J3490,ATOMOXETINE 25 MG CAPSULE,20.9,12.54,4.85,4481.0,19 HCPCS,J3490,ATOMOXETINE 40 MG CAPSULE,35.0,21.0,8.12,4481.0,19 HCPCS,J3490,ATOMOXETINE 60 MG CAPSULE,20.2,12.12,4.69,4481.0,19 HCPCS,J3490,ATORVASTATIN 10 MG TABLET,17.15,10.29,3.98,4481.0,19 HCPCS,J3490,ATORVASTATIN 20 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,ATORVASTATIN 40 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,ATORVASTATIN 80 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,ATOVAQUONE 250 MG-PROGUANIL 100 MG TABLET,33.55,20.13,7.78,4481.0,19 HCPCS,J3490,ATOVAQUONE 750 MG/5 ML ORAL SUSPENSION,115.5,69.3,26.8,4481.0,19 HCPCS,J3490,ATRACURIUM 10 MG/ML INTRAVENOUS SOLUTION,52.675000000000004,31.605,7.99,4481.0,38 HCPCS,J3490,ATROPINE 1 % EYE DROPS,268.25,160.95,34.3,4481.0,38 HCPCS,J3490,ATROPINE 1% SUBLINGUAL SYRINGE,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,AVACOPAN 10 MG CAPSULE,314.0,188.4,72.85,4481.0,19 HCPCS,J3490,AXITINIB 1 MG TABLET,495.3,297.18,114.91,4481.0,19 HCPCS,J3490,AXITINIB 5 MG TABLET,1435.8,861.48,333.11,4481.0,19 HCPCS,J3490,AZELASTINE 137 MCG (0.1 %) NASAL SPRAY,81.5,48.9,18.91,4481.0,19 HCPCS,J3490,AZITHROMYCIN 200 MG/5 ML ORAL SUSPENSION,76.05,45.63,17.64,4481.0,19 HCPCS,J3490,AZITHROMYCIN 250 MG TABLET,21.25,12.75,4.93,4481.0,19 HCPCS,J3490,AZITHROMYCIN 500 MG TABLET,19.85,11.91,4.61,4481.0,19 HCPCS,J3490,"BACITRACIN 500 UNIT-POLYMYXIN B 10,000 UNIT/GRAM TOPICAL OINTMENT (+/- ZINC) WRAPPER",7.1,4.26,1.65,4481.0,19 HCPCS,J3490,BACITRACIN 500 UNIT/GRAM TOPICAL PACKET,1.25,0.75,0.29,4481.0,19 HCPCS,J3490,BACITRACIN 500 UNIT/GRAM TOPICAL PACKET WRAPPER,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,"BACITRACIN ZINC 500 UNIT-POLYMYXIN B 10,000 UNIT/GRAM TOPICAL OINTMENT",6.75,4.05,1.57,4481.0,19 HCPCS,J3490,BACITRACIN ZINC 500 UNIT/GRAM TOPICAL OINTMENT,8.25,4.95,1.91,4481.0,19 HCPCS,J3490,"BACITRACIN-POLYMYXIN B 500 UNIT-10,000 UNIT/GRAM EYE OINTMENT",85.0,51.0,19.72,4481.0,19 HCPCS,J3490,BACLOFEN 10 MG TABLET,17.6,10.56,4.08,4481.0,19 HCPCS,J3490,BACLOFEN 25 MG/5 ML (5 MG/ML) ORAL SUSPENSION,34.15,20.49,7.92,4481.0,19 HCPCS,J3490,BALANCED SALT IRRIGATION INTRAOCULAR SOLUTION 500ML,178.5,107.1,41.41,4481.0,19 HCPCS,J3490,BALANCED SALT IRRIGATION INTRAOCULAR SOLUTION COMBINATION NO.1,373.5,224.1,86.65,4481.0,19 HCPCS,J3490,BALANCED SALT IRRIGATION SOLUTION (BSS PLAIN),100.95,60.57,23.42,4481.0,19 HCPCS,J3490,BALOXAVIR MARBOXIL 40 MG TABLET,522.5,313.5,121.22,4481.0,19 HCPCS,J3490,BALOXAVIR MARBOXIL 80 MG TABLET,522.5,313.5,121.22,4481.0,19 HCPCS,J3490,BARICITINIB 2 MG TABLET,292.75,175.65,67.92,4481.0,19 HCPCS,J3490,BECLOMETHASONE 1 MG/ML IN CORN OIL EMULSION,16.2,9.72,3.76,4481.0,19 HCPCS,J3490,BELLADONNA ALKALOIDS-OPIUM 16.2 MG-60 MG RECTAL SUPPOSITORY,103.4,62.04,23.99,4481.0,19 HCPCS,J3490,BENZOCAINE 20 % MUCOSAL AEROSOL SPRAY,1.85,1.11,0.4292,4481.0,19 HCPCS,J3490,BENZOCAINE 20 % MUCOSAL GEL,10.05,6.03,2.33,4481.0,19 HCPCS,J3490,BENZOCAINE 20 % MUCOSAL SPRAY WRAPPER,48.4,29.04,11.23,4481.0,19 HCPCS,J3490,BENZOCAINE 20 %-MENTHOL 0.5 % TOPICAL AEROSOL,10.0,6.0,2.32,4481.0,19 HCPCS,J3490,BENZOYL PEROXIDE 10 % TOPICAL GEL,6.95,4.17,1.61,4481.0,19 HCPCS,J3490,BENZTROPINE 0.5 MG TABLET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,BENZTROPINE 1 MG TABLET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,BENZTROPINE 2 MG TABLET,17.7,10.62,4.11,4481.0,19 HCPCS,J3490,BENZYLPENICILLOYL POLYLYSINE 0.25 ML INTRADERMAL INJECTION SOLUTION,43.75,26.25,10.15,4481.0,19 HCPCS,J3490,BETHANECHOL 1 MG/ML ORAL SUSPENSION,25.0,15.0,5.8,4481.0,19 HCPCS,J3490,BETHANECHOL 5 MG/ML ORAL SUSPENSION,34.0,20.4,7.89,4481.0,19 HCPCS,J3490,BETHANECHOL CHLORIDE 10 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,BETHANECHOL CHLORIDE 25 MG TABLET,18.8,11.28,4.36,4481.0,19 HCPCS,J3490,BICALUTAMIDE 50 MG TABLET,28.05,16.83,6.51,4481.0,19 HCPCS,J3490,BICTEGRAVIR 50 MG-EMTRICITABINE 200 MG-TENOFOVIR ALAFENAM 25 MG TABLET,437.65,262.59,101.53,4481.0,19 HCPCS,J3490,BINIMETINIB 15 MG TABLET,382.25,229.35,88.68,4481.0,19 HCPCS,J3490,BISACODYL 10 MG RECTAL SUPPOSITORY,1.55,0.93,0.3596,4481.0,19 HCPCS,J3490,BISACODYL 10 MG/30 ML ENEMA,4.05,2.43,0.9396,4481.0,19 HCPCS,J3490,"BISACODYL 5 MG TABLET,DELAYED RELEASE",1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,BISMUTH SUBSALICYLATE 262 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,BISMUTH SUBSALICYLATE 262 MG/15 ML ORAL SUSPENSION,1.7,1.02,0.3828,4481.0,38 HCPCS,J3490,BLOOD CARDIO - COLD INDUCTION,134.95,80.97,31.31,4481.0,19 HCPCS,J3490,BLOOD CARDIO. - MAINTENANCE,240.6,144.36,55.82,4481.0,19 HCPCS,J3490,BLOOD CARDIO. - REPERFUSION,517.55,310.53,120.07,4481.0,19 HCPCS,J3490,BLOOD CARDIOPLEGIA (DEL NIDO),287.8,172.68,66.77,4481.0,19 HCPCS,J3490,BOSENTAN 6.25 MG/ML ORAL SUSPENSION,307.4,184.44,71.32,4481.0,19 HCPCS,J3490,BOSENTAN 62.5 MG TABLET,686.7,412.02,159.31,4481.0,19 HCPCS,J3490,BREXPIPRAZOLE 1 MG TABLET,167.6,100.56,38.88,4481.0,19 HCPCS,J3490,BRIMONIDINE 0.2 % EYE DROPS,59.65,35.79,13.84,4481.0,19 HCPCS,J3490,BRIVARACETAM 100 MG TABLET,96.65,57.99,22.42,4481.0,19 HCPCS,J3490,BRIVARACETAM 50 MG TABLET,96.65,57.99,22.42,4481.0,19 HCPCS,J3490,BRIVARACETAM 50 MG/5 ML INTRAVENOUS SOLUTION,212.05,127.23,49.2,4481.0,19 HCPCS,J3490,BROMOCRIPTINE 2.5 MG TABLET,25.05,15.03,5.81,4481.0,19 HCPCS,J3490,BUDESONIDE 0.25 MG/2 ML SUSPENSION FOR NEBULIZATION,42.15,25.29,9.78,4481.0,19 HCPCS,J3490,BUDESONIDE 0.5 MG/2 ML SLURRY FOR ORAL USE,31.4,18.84,7.28,4481.0,19 HCPCS,J3490,BUDESONIDE 0.5 MG/2 ML SUSPENSION FOR NEBULIZATION,44.05,26.43,10.22,4481.0,19 HCPCS,J3490,"BUDESONIDE DR - ER 3 MG CAPSULE,DELAYED,EXTENDED RELEASE",19.0,11.4,4.41,4481.0,19 HCPCS,J3490,BUDESONIDE-FORMOTEROL HFA 160 MCG-4.5 MCG/ACTUATION AEROSOL INHALER,495.2,297.12,114.89,4481.0,19 HCPCS,J3490,BUDESONIDE-FORMOTEROL HFA 80 MCG-4.5 MCG/ACTUATION AEROSOL INHALER,432.6,259.56,100.36,4481.0,19 HCPCS,J3490,BUMETANIDE 0.25 MG/ML ORAL SOLUTION,25.85,15.51,6.0,4481.0,19 HCPCS,J3490,BUMETANIDE 0.5 MG TABLET,17.05,10.23,3.96,4481.0,19 HCPCS,J3490,BUMETANIDE 2 MG TABLET,18.55,11.13,4.3,4481.0,19 HCPCS,J3490,"BUPIVACAINE 0.5 %-EPINEPHRINE BITARTRATE 1:200,000 INJECTION,CARTRIDGE",19.55,11.73,4.54,4481.0,19 HCPCS,J3490,"BUPIVACAINE-EPINEPHRINE (PF) 0.25 %-1:200,000 INJECTION SOLUTION",40.650000000000006,24.39,8.22,4481.0,38 HCPCS,J3490,"BUPIVACAINE-EPINEPHRINE (PF) 0.5 %-1:200,000 INJECTION SOLUTION",54.3,32.58,12.6,4481.0,19 HCPCS,J3490,"BUPIVACAINE-EPINEPHRINE (PF) 0.75 %-1:200,000 INJECTION SOLUTION",73.1,43.86,16.96,4481.0,19 HCPCS,J3490,BUPRENORPHINE 10 MCG/HOUR WEEKLY TRANSDERMAL PATCH,256.25,153.75,59.45,4481.0,19 HCPCS,J3490,BUPRENORPHINE 20 MCG/HOUR WEEKLY TRANSDERMAL PATCH,439.2,263.52,101.89,4481.0,19 HCPCS,J3490,BUPRENORPHINE 5 MCG/HOUR WEEKLY TRANSDERMAL PATCH,177.5,106.5,41.18,4481.0,19 HCPCS,J3490,BUPRENORPHINE HCL 150 MCG BUCCAL FILM,44.9,26.94,10.42,4481.0,19 HCPCS,J3490,BUPRENORPHINE HCL 2 MG SUBLINGUAL TABLET,22.15,13.29,5.14,4481.0,19 HCPCS,J3490,BUPRENORPHINE HCL 300 MCG BUCCAL FILM,57.95,34.77,13.44,4481.0,19 HCPCS,J3490,BUPRENORPHINE HCL 75 MCG BUCCAL FILM,44.9,26.94,10.42,4481.0,19 HCPCS,J3490,BUPRENORPHINE HCL 8 MG SUBLINGUAL TABLET,26.5,15.9,6.15,4481.0,19 HCPCS,J3490,BUPROPION HCL 100 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,BUPROPION HCL 75 MG TABLET,19.3,11.58,4.48,4481.0,19 HCPCS,J3490,"BUPROPION HCL SR 100 MG TABLET,12 HR SUSTAINED-RELEASE",18.4,11.04,4.27,4481.0,19 HCPCS,J3490,"BUPROPION HCL SR 150 MG TABLET,SUSTAINED-RELEASE (COMBINED) WRAPPER",17.85,10.71,4.14,4481.0,19 HCPCS,J3490,BUSPIRONE 10 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,BUSPIRONE 15 MG TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,BUSPIRONE 5 MG TABLET,16.35,9.81,3.79,4481.0,19 HCPCS,J3490,BUSPIRONE 7.5 MG TABLET,16.8,10.08,3.9,4481.0,19 HCPCS,J3490,BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50 MG-325 MG-40 MG TABLET,27.5,16.5,6.38,4481.0,19 HCPCS,J3490,CABERGOLINE 0.5 MG TABLET,156.4,93.84,36.28,4481.0,19 HCPCS,J3490,CAFFEINE CITRATE 20 MG/ML ORAL SOLUTION (COMPOUND),33.3,19.98,7.73,4481.0,19 HCPCS,J3490,CALCITONIN (SALMON) 200 UNIT/ACTUATION NASAL SPRAY,241.4,144.84,56.0,4481.0,19 HCPCS,J3490,CALCITRIOL 0.25 MCG CAPSULE,18.4,11.04,4.27,4481.0,19 HCPCS,J3490,CALCITRIOL 0.5 MCG CAPSULE,17.3,10.38,4.01,4481.0,19 HCPCS,J3490,CALCITRIOL 1 MCG/ML ORAL SOLUTION,36.05,21.63,8.36,4481.0,19 HCPCS,J3490,CALCIUM 200 MG (AS CALCIUM CARBONATE 500 MG) CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,CALCIUM 200 MG (AS CALCIUM CITRATE 950 MG) TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,"CALCIUM 500 MG/5 ML (AS CALCIUM CARB 1,250 MG/5 ML) ORAL SUSPENSION",4.325,2.595,0.3016,4481.0,38 HCPCS,J3490,"CALCIUM 600 MG (AS CALCIUM CARBONATE 1,500 MG) TABLET",1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,CALCIUM ACETATE(PHOSPHATE BINDERS) 667 MG CAPSULE,20.2,12.12,4.69,4481.0,19 HCPCS,J3490,CALCIUM GLUCONATE 2.5 % TOPICAL GEL,8.25,4.95,1.91,4481.0,19 HCPCS,J3490,CANDIDA ALBICANS SKIN TEST FDA STANDARD INTRADERMAL,141.6,84.96,32.85,4481.0,19 HCPCS,J3490,CANNABIDIOL 100 MG/ML ORAL SOLUTION,5146.0,3087.6,1193.87,4481.0,19 HCPCS,J3490,CAPSAICIN 0.025 % TOPICAL CREAM,11.8,7.08,2.74,4481.0,19 HCPCS,J3490,CAPTOPRIL 12.5 MG TABLET,20.25,12.15,4.7,4481.0,19 HCPCS,J3490,CAPTOPRIL 25 MG TABLET,20.65,12.39,4.79,4481.0,19 HCPCS,J3490,CARBACHOL 0.01 % INTRAOCULAR SOLUTION,62.65,37.59,14.53,4481.0,19 HCPCS,J3490,CARBAMAZEPINE 100 MG CHEWABLE TABLET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,CARBAMAZEPINE 100 MG/5 ML ORAL SUSPENSION,22.65,13.59,5.25,4481.0,19 HCPCS,J3490,CARBAMAZEPINE 200 MG TABLET,18.7,11.22,4.34,4481.0,19 HCPCS,J3490,"CARBAMAZEPINE ER 100 MG CAPSULE,EXTENDED RELEASE 12HR",25.3,15.18,5.87,4481.0,19 HCPCS,J3490,"CARBAMAZEPINE ER 100 MG TABLET,EXTENDED RELEASE,12 HR",17.35,10.41,4.03,4481.0,19 HCPCS,J3490,"CARBAMAZEPINE ER 200 MG TABLET,EXTENDED RELEASE,12 HR",18.4,11.04,4.27,4481.0,19 HCPCS,J3490,"CARBAMAZEPINE ER 300 MG CAPSULE,EXTENDED RELEASE 12HR",26.4,15.84,6.12,4481.0,19 HCPCS,J3490,CARBIDOPA 10 MG-LEVODOPA 100 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,CARBIDOPA 25 MG-LEVODOPA 100 MG TABLET,17.1,10.26,3.97,4481.0,19 HCPCS,J3490,CARBIDOPA-LEVODOPA 1.25-5 MG/1 ML ORAL SUSPENSION,32.5,19.5,7.54,4481.0,19 HCPCS,J3490,CARBOXYMETHYLCELLULOSE SODIUM 0.25 % EYE DROPS,15.475000000000001,9.285,3.11,4481.0,38 HCPCS,J3490,CARBOXYMETHYLCELLULOSE SODIUM 1 % EYE GEL IN A DROPPERETTE,1.5,0.9,0.348,4481.0,19 HCPCS,J3490,CARDIOPLEGIC PERFUSION (PLEGISOL) 10 MEQ/L (LOW K),340.95,204.57,79.1,4481.0,19 HCPCS,J3490,CARDIOPLEGIC PERFUSION (PLEGISOL) 80 MEQ/L (HIGH K),340.95,204.57,79.1,4481.0,19 HCPCS,J3490,CARDIOPLEGIC SOLUTION 16 MEQ/L (POTASSIUM) FOR PERFUSION,340.95,204.57,79.1,4481.0,19 HCPCS,J3490,CARGLUMIC ACID 200 MG DISPERSIBLE TABLET,677.75,406.65,157.24,4481.0,19 HCPCS,J3490,CARIPRAZINE 1.5 MG CAPSULE,167.9,100.74,38.95,4481.0,19 HCPCS,J3490,CARIPRAZINE 3 MG CAPSULE,167.9,100.74,38.95,4481.0,19 HCPCS,J3490,CARVEDILOL 1.67 MG/ML ORAL SUSP,23.2,13.92,5.38,4481.0,19 HCPCS,J3490,CARVEDILOL 12.5 MG TABLET,16.15,9.69,3.75,4481.0,19 HCPCS,J3490,CARVEDILOL 3.125 MG TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,CASTOR OIL 100 % ORAL,7.025,4.215,1.58,4481.0,38 HCPCS,J3490,CEFDINIR 250 MG/5 ML ORAL SUSPENSION,91.0,54.6,21.11,4481.0,19 HCPCS,J3490,CEFDINIR 300 MG CAPSULE,19.65,11.79,4.56,4481.0,19 HCPCS,J3490,CEFTAZIDIME 5% (50 MG/ML) OPHTHALMIC SOLUTION,43.9,26.34,10.18,4481.0,19 HCPCS,J3490,CEFUROXIME AXETIL 250 MG TABLET,27.35,16.41,6.35,4481.0,19 HCPCS,J3490,CEFUROXIME AXETIL 500 MG TABLET,20.15,12.09,4.67,4481.0,19 HCPCS,J3490,CELECOXIB 10 MG/ML ORAL SUSPENSION,18.4,11.04,4.27,4481.0,19 HCPCS,J3490,CELECOXIB 100 MG CAPSULE,20.35,12.21,4.72,4481.0,19 HCPCS,J3490,CELECOXIB 200 MG CAPSULE,22.1,13.26,5.13,4481.0,19 HCPCS,J3490,CENOBAMATE 200 MG TABLET,145.2,87.12,33.69,4481.0,19 HCPCS,J3490,CENOBAMATE 50 MG TABLET,145.2,87.12,33.69,4481.0,19 HCPCS,J3490,CEPHALEXIN 250 MG CAPSULE,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,CEPHALEXIN 250 MG/5 ML ORAL SUSPENSION,575.5,345.3,19.72,4481.0,38 HCPCS,J3490,CEPHALEXIN 500 MG CAPSULE,17.1,10.26,3.97,4481.0,19 HCPCS,J3490,CETIRIZINE 1 MG/ML ORAL SOLUTION,1.2,0.72,0.2784,4481.0,19 HCPCS,J3490,CETIRIZINE 10 MG TABLET,1.25,0.75,0.29,4481.0,19 HCPCS,J3490,CETIRIZINE 5 MG TABLET,1.25,0.75,0.29,4481.0,19 HCPCS,J3490,CETIRIZINE 5 MG/5 ML ORAL SOLUTION (UNIT DOSE CUPS/SYRINGES),3.25,1.95,0.754,4481.0,19 HCPCS,J3490,CHLORAL HYDRATE 500 MG/5 ML ORAL SYRUP,436.75,262.05,101.33,4481.0,19 HCPCS,J3490,CHLORAMBUCIL 2 MG TABLET,2335.3,1401.18,541.79,4481.0,19 HCPCS,J3490,CHLORDIAZEPOXIDE 25 MG CAPSULE,23.65,14.19,5.49,4481.0,19 HCPCS,J3490,CHLORHEXIDINE GLUCONATE 0.02% OPHTHALMIC SOLUTION,626.8,376.08,145.42,4481.0,19 HCPCS,J3490,CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASH,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,CHLOROTHIAZIDE 250 MG/5 ML ORAL SUSPENSION,243.55,146.13,56.5,4481.0,19 HCPCS,J3490,CHLORPROMAZINE 10 MG TABLET,28.9,17.34,6.7,4481.0,19 HCPCS,J3490,CHLORPROMAZINE 100 MG TABLET,22.8,13.68,5.29,4481.0,19 HCPCS,J3490,CHLORPROMAZINE 25 MG TABLET,18.6,11.16,4.32,4481.0,19 HCPCS,J3490,CHLORTHALIDONE 25 MG TABLET,21.75,13.05,5.05,4481.0,19 HCPCS,J3490,"CHOLECALCIFEROL (VITAMIN D3) 1,250 MCG (50,000 UNIT) TABLET",1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,CHOLECALCIFEROL (VITAMIN D3) 10 MCG (400 UNIT) TABLET,1.4,0.84,0.3248,4481.0,19 HCPCS,J3490,CHOLECALCIFEROL (VITAMIN D3) 10 MCG/ML (400 UNIT/ML) ORAL DROPS,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,"CHOLECALCIFEROL (VITAMIN D3) 125 MCG (5,000 UNIT) TABLET",1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,"CHOLECALCIFEROL (VITAMIN D3) 25 MCG (1,000 UNIT) TABLET",1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,CHOLESTYRAMINE (WITH SUGAR) 4 GRAM POWDER FOR SUSP IN A PACKET,19.0,11.4,4.41,4481.0,19 HCPCS,J3490,CHOLESTYRAMINE 20% IN AQUAPHOR OINTMENT,108.1,64.86,25.08,4481.0,19 HCPCS,J3490,CHROMIUM CHLORIDE 4 MCG/ML INTRAVENOUS SOLUTION,87.35,52.41,20.27,4481.0,19 HCPCS,J3490,CIDOFOVIR 1% TOPICAL GEL,289.15,173.49,67.08,4481.0,19 HCPCS,J3490,CINACALCET 1 MG/ML ORAL SUSP,76.3,45.78,17.7,4481.0,19 HCPCS,J3490,CINACALCET 30 MG TABLET,96.7,58.02,22.43,4481.0,19 HCPCS,J3490,CINACALCET 60 MG TABLET,18.7,11.22,4.34,4481.0,19 HCPCS,J3490,CINACALCET 90 MG TABLET,19.9,11.94,4.62,4481.0,19 HCPCS,J3490,CIPROFLOXACIN 0.3 % EYE DROPS,58.15,34.89,13.49,4481.0,19 HCPCS,J3490,CIPROFLOXACIN 250 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,CIPROFLOXACIN 500 MG/5 ML ORAL SUSPENSION,472.9,283.74,109.71,4481.0,19 HCPCS,J3490,CISATRACURIUM (NIMBEX) 0.5 MG/ML PEDIATRIC BOLUS FROM BAG,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,CISATRACURIUM (NIMBEX) 2 MG/ML PEDIATRIC BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,CISATRACURIUM 2 MG/ML CONTINUOUS INFUSION (2 MG/ML VIALS) (CSAC),1088.5,653.1,252.53,4481.0,19 HCPCS,J3490,CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTION,49.15,29.490000000000002,10.05,4481.0,38 HCPCS,J3490,CISATRACURIUM 2 MG/ML PEDIATRIC INFUSION (CSAC),473.2,283.92,109.78,4481.0,19 HCPCS,J3490,CISATRACURIUM CONCENTRATE 10 MG/ML (ICU USE ONLY) INTRAVENOUS SOLUTION,665.75,399.45,154.45,4481.0,19 HCPCS,J3490,CITALOPRAM 20 MG TABLET,16.2,9.72,3.76,4481.0,19 HCPCS,J3490,CITALOPRAM 40 MG TABLET,16.2,9.72,3.76,4481.0,19 HCPCS,J3490,CITRULLINE 5 GRAM POWDER FOR ORAL SOLN,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,CLARITHROMYCIN 250 MG/5 ML ORAL SUSPENSION,539.5,323.7,125.16,4481.0,19 HCPCS,J3490,CLARITHROMYCIN 500 MG TABLET,30.95,18.57,7.18,4481.0,19 HCPCS,J3490,CLINDAMYCIN 0.9 MG/ML ORAL IRRIGATION,79.45,47.67,18.43,4481.0,19 HCPCS,J3490,CLINDAMYCIN 1 % LOTION,305.55,183.33,70.89,4481.0,19 HCPCS,J3490,CLINDAMYCIN 1 % TOPICAL GEL,76.25,45.75,17.69,4481.0,19 HCPCS,J3490,CLINDAMYCIN HCL 150 MG CAPSULE,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,CLINDAMYCIN PHOSPHATE 1 % TOPICAL SOLUTION,124.4,74.64,28.86,4481.0,19 HCPCS,J3490,CLOBAZAM 10 MG TABLET,26.0,15.6,6.03,4481.0,19 HCPCS,J3490,CLOBAZAM 2.5 MG SPLIT TABLET,23.0,13.8,5.34,4481.0,19 HCPCS,J3490,CLOBAZAM 2.5 MG/ML ORAL SUSPENSION,51.525000000000006,30.915,9.59,4481.0,38 HCPCS,J3490,CLOBAZAM 5 MG SPLIT TABLET,24.0,14.4,5.57,4481.0,19 HCPCS,J3490,CLOBETASOL 0.05 % TOPICAL OINTMENT,259.3,155.58,60.16,4481.0,19 HCPCS,J3490,CLOMIPRAMINE 50 MG CAPSULE,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,CLONAZEPAM 0.1 MG/ML ORAL SUSP,22.15,13.29,5.14,4481.0,19 HCPCS,J3490,CLONAZEPAM 0.125 MG DISINTEGRATING TABLET,24.85,14.91,5.77,4481.0,19 HCPCS,J3490,CLONAZEPAM 0.25 MG DISINTEGRATING TABLET,24.85,14.91,5.77,4481.0,19 HCPCS,J3490,CLONAZEPAM 1 MG TABLET,23.45,14.07,5.44,4481.0,19 HCPCS,J3490,CLONIDINE 0.2 MG/24 HR WEEKLY TRANSDERMAL PATCH,149.85,89.91,34.77,4481.0,19 HCPCS,J3490,CLONIDINE 20 MCG/ML ORAL SOLN,17.65,10.59,4.09,4481.0,19 HCPCS,J3490,CLONIDINE HCL 0.1 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,CLONIDINE HCL 0.2 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,CLONIDINE HCL 0.3 MG TABLET,16.2,9.72,3.76,4481.0,19 HCPCS,J3490,CLOPIDOGREL 300 MG TABLET,58.85,35.31,13.65,4481.0,19 HCPCS,J3490,CLOPIDOGREL 5 MG/ML ORAL SUSPENSION,113.2,67.92,26.26,4481.0,19 HCPCS,J3490,CLORAZEPATE DIPOTASSIUM 7.5 MG TABLET,26.25,15.75,6.09,4481.0,19 HCPCS,J3490,CLOTRIMAZOLE 1 % TOPICAL CREAM,8.05,4.83,1.87,4481.0,19 HCPCS,J3490,CLOTRIMAZOLE 10 MG TROCHE,24.25,14.55,5.63,4481.0,19 HCPCS,J3490,CLOZAPINE 100 MG TABLET,21.05,12.63,4.88,4481.0,19 HCPCS,J3490,CLOZAPINE 25 MG TABLET,18.0,10.8,4.18,4481.0,19 HCPCS,J3490,COBICISTAT 150 MG TABLET,47.5,28.5,11.02,4481.0,19 HCPCS,J3490,COLCHICINE 0.3 MG SPLIT TABLET,43.9,26.34,10.18,4481.0,19 HCPCS,J3490,COLCHICINE 0.6 MG TABLET,43.9,26.34,10.18,4481.0,19 HCPCS,J3490,COLESTIPOL 1 GRAM TABLET,19.2,11.52,4.45,4481.0,19 HCPCS,J3490,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 250 UNIT/GRAM TOPICAL OINTMENT,971.6,582.96,225.41,4481.0,19 HCPCS,J3490,COLLOIDAL OATMEAL TOPICAL PACKET,2.05,1.23,0.4756,4481.0,19 HCPCS,J3490,CONJUGATED ESTROGENS 0.3 MG TABLET,37.25,22.35,8.64,4481.0,19 HCPCS,J3490,CONJUGATED ESTROGENS 0.625 MG TABLET,37.25,22.35,8.64,4481.0,19 HCPCS,J3490,CONJUGATED ESTROGENS 0.9 MG TABLET,37.25,22.35,8.64,4481.0,19 HCPCS,J3490,CONJUGATED ESTROGENS 1.25 MG TABLET,37.25,22.35,8.64,4481.0,19 HCPCS,J3490,CRIZOTINIB 250 MG CAPSULE,1609.9,965.94,373.5,4481.0,19 HCPCS,J3490,CUPRIC CHLORIDE 0.4 MG/ML INTRAVENOUS SOLUTION,166.7,100.02,38.67,4481.0,19 HCPCS,J3490,CUPRIC CHLORIDE 40 MCG/ML INTRAVENOUS DILUTION,64.65,38.79,15.0,4481.0,19 HCPCS,J3490,"CYANOCOBALAMIN (VIT B-12) 1,000 MCG TABLET",1.35,0.81,0.3132,4481.0,19 HCPCS,J3490,CYCLOBENZAPRINE 10 MG TABLET,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,CYCLOBENZAPRINE 5 MG TABLET,24.1,14.46,5.59,4481.0,19 HCPCS,J3490,CYCLOPENTOLATE 0.5 % EYE DROPS,320.75,192.45,74.41,4481.0,19 HCPCS,J3490,CYCLOPENTOLATE 1 % EYE DROPS,111.475,66.885,23.27,4481.0,38 HCPCS,J3490,CYCLOPENTOLATE 1 % EYE DROPS (MULTI-PATIENT),17.75,10.65,4.12,4481.0,19 HCPCS,J3490,CYCLOPENTOLATE 2 % EYE DROPS,155.6,93.36,36.1,4481.0,19 HCPCS,J3490,CYCLOPENTOLATE-PHENYLEPHRINE 0.2 %-1 % EYE DROPS,169.625,101.775,29.57,4481.0,38 HCPCS,J3490,CYCLOSPORINE 0.05 % EYE DROPS IN A DROPPERETTE,48.3,28.98,11.21,4481.0,19 HCPCS,J3490,CYPROHEPTADINE 2 MG/5 ML ORAL SYRUP,176.35,105.81,40.91,4481.0,19 HCPCS,J3490,CYSTEINE (L-CYSTEINE) 50 MG/ML INTRAVENOUS SOLUTION,372.7,223.62,86.47,4481.0,19 HCPCS,J3490,DABIGATRAN ETEXILATE 150 MG CAPSULE,25.95,15.57,6.02,4481.0,19 HCPCS,J3490,DABIGATRAN ETEXILATE 75 MG CAPSULE,25.95,15.57,6.02,4481.0,19 HCPCS,J3490,DANAZOL 200 MG CAPSULE,37.6,22.56,8.72,4481.0,19 HCPCS,J3490,DANTROLENE 20 MG INTRAVENOUS SOLUTION,294.9,176.94,68.42,4481.0,19 HCPCS,J3490,DANTROLENE 25 MG CAPSULE,18.45,11.07,4.28,4481.0,19 HCPCS,J3490,DANTROLENE 250 MG INTRAVENOUS SUSPENSION,10901.0,6540.6,2529.03,8720.8,19 HCPCS,J3490,DAPSONE 100 MG TABLET,19.25,11.55,4.47,4481.0,19 HCPCS,J3490,DAPSONE 2 MG/ML ORAL SUSP,79.0,47.4,18.33,4481.0,19 HCPCS,J3490,DAROLUTAMIDE 300 MG TABLET,500.15,300.09,116.03,4481.0,19 HCPCS,J3490,DARUNAVIR 600 MG TABLET,20.95,12.57,4.86,4481.0,19 HCPCS,J3490,DARUNAVIR 800 MG TABLET,25.9,15.54,6.01,4481.0,19 HCPCS,J3490,DASATINIB 100 MG TABLET,2457.85,1474.71,570.22,4481.0,19 HCPCS,J3490,DASATINIB 70 MG TABLET,1374.85,824.91,318.97,4481.0,19 HCPCS,J3490,DEFERASIROX 180 MG TABLET,347.0,208.2,80.5,4481.0,19 HCPCS,J3490,DESIPRAMINE 10 MG TABLET,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,DESIPRAMINE 25 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,DESIPRAMINE 50 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,DESMOPRESSIN 0.1 MG TABLET,18.25,10.95,4.23,4481.0,19 HCPCS,J3490,DESMOPRESSIN 10 MCG/ML ORAL SOLN,1673.2,1003.92,388.18,4481.0,19 HCPCS,J3490,DESMOPRESSIN 10 MCG/SPRAY (0.1 ML) NASAL SPRAY (NON-REFRIGERATED),386.65,231.99,89.7,4481.0,19 HCPCS,J3490,DESMOPRESSIN 150 MCG/SPRAY (0.1 ML) NASAL SPRAY,1220.0,732.0,283.04,4481.0,19 HCPCS,J3490,DEXAMETHASONE 1 MG/ML SYRUP WITHOUT ALCOHOL,318.4,191.04,73.87,4481.0,19 HCPCS,J3490,DEXAMETHASONE 2 MG TABLET,17.9,10.74,4.15,4481.0,19 HCPCS,J3490,DEXAMETHASONE SODIUM PHOSPHATE 0.1 % EYE DROPS,178.25,106.95,41.35,4481.0,19 HCPCS,J3490,"DEXLANSOPRAZOLE 60 MG CAPSULE,BIPHASE DELAYED RELEASE",42.25,25.35,9.8,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 100 MCG/ML INTRAVENOUS SOLUTION,80.2,48.12,18.61,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 20 MCG/5 ML (4 MCG/ML) IN 0.9 % SODIUM CHLR IV SYRINGE,102.1,61.26,23.69,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 20 MCG/5 ML SYRINGE (OR),107.15,64.29,24.86,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 200 MCG/2 ML INTRANASAL SOLUTION,80.2,48.12,18.61,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 200 MCG/50 ML (4 MCG/ML) NS PEDIATRIC INFUSION,154.6,92.76,35.87,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 4 MCG/ML BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 400 MCG/100 ML (4 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,234.7,140.82,54.45,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 8 MCG/ 2 ML (4 MCG/ML) NS PEDIATRIC INFUSION,66.7,40.02,15.47,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 80 MCG/20 ML (4 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,148.05,88.83,34.35,4481.0,19 HCPCS,J3490,DEXMEDETOMIDINE 800 MCG/200 ML (4 MCG/ML) IN 0.9 % NS,429.25,257.55,99.59,4481.0,19 HCPCS,J3490,DEXMETHYLPHENIDATE 5 MG TABLET,23.0,13.8,5.34,4481.0,19 HCPCS,J3490,"DEXMETHYLPHENIDATE ER 10 MG CAPSULE,EXTENDED RELEASE BIPHASIC50-50",25.95,15.57,6.02,4481.0,19 HCPCS,J3490,"DEXMETHYLPHENIDATE ER 5 MG CAPSULE,EXTENDED RELEASE BIPHASIC50-50",25.95,15.57,6.02,4481.0,19 HCPCS,J3490,DEXTROAMPHETAMINE-AMPHETAMINE 10 MG TABLET,24.65,14.79,5.72,4481.0,19 HCPCS,J3490,DEXTROAMPHETAMINE-AMPHETAMINE 5 MG TABLET,24.65,14.79,5.72,4481.0,19 HCPCS,J3490,"DEXTROAMPHETAMINE-AMPHETAMINE ER 10 MG 24HR CAPSULE,EXTEND RELEASE",26.25,15.75,6.09,4481.0,19 HCPCS,J3490,"DEXTROAMPHETAMINE-AMPHETAMINE ER 5 MG 24HR CAPSULE,EXTEND RELEASE",43.7,26.22,10.14,4481.0,19 HCPCS,J3490,DEXTROMETHORPHAN POLISTIREX ER 30 MG/5 ML ORAL SUSP EXT.RELEASE 12HR,1.7,1.02,0.3944,4481.0,19 HCPCS,J3490,DEXTROMETHORPHAN-GUAIFENESIN 10 MG-100 MG/5 ML ORAL SYRUP,4.6,2.76,1.07,4481.0,19 HCPCS,J3490,DEXTROSE 10 % AND 0.45 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,90.0,54.0,20.88,4481.0,17 HCPCS,J3490,DEXTROSE 10 % IN WATER (D10W) INTRAVENOUS SOLUTION,87.0,52.2,20.18,4481.0,17 HCPCS,J3490,DEXTROSE 10 % IV BOLUS,69.0,41.4,16.01,4481.0,17 HCPCS,J3490,DEXTROSE 2.45 GRAM-SOD CITRATE 2.2 GRAM-CITRIC AC 730 MG/100 ML SOLN,153.0,91.8,35.5,4481.0,19 HCPCS,J3490,DEXTROSE 2.45 GRAM-SOD CITRATE 2.2 GRAM-CITRIC AC 800 MG/100 ML SOLN,78.75,47.25,18.27,4481.0,19 HCPCS,J3490,DEXTROSE 20 % IN WATER (D20W) INTRAVENOUS SOLUTION,106.5,63.9,24.71,4481.0,17 HCPCS,J3490,DEXTROSE 20 % IN WATER (FOR ORAL USE) INTRAVENOUS SOLUTION,24.35,14.61,5.65,4481.0,17 HCPCS,J3490,DEXTROSE 40 % ORAL GEL,4.4,2.64,1.02,4481.0,19 HCPCS,J3490,DEXTROSE 5 % AND 0.2 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,81.0,48.6,18.79,4481.0,17 HCPCS,J3490,DEXTROSE 5 % AND 0.45 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,78.75,47.25,17.75,4481.0,34 HCPCS,J3490,DEXTROSE 5 % IN WATER (D5W) IV EXCEL,70.35,42.21,16.32,4481.0,17 HCPCS,J3490,DEXTROSE 5 % IV BOLUS,104.25,62.55,19.14,4481.0,51 HCPCS,J3490,DEXTROSE 5% WATER (D5W) NON-PVC,72.375,43.425,16.36,4481.0,34 HCPCS,J3490,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SOLUTION,36.3,21.78,8.42,4481.0,17 HCPCS,J3490,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SYRINGE,55.5,33.3,12.88,4481.0,19 HCPCS,J3490,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SYRINGE/VIAL WRAPPER,54.45,32.67,12.63,4481.0,19 HCPCS,J3490,DEXTROSE 70 % IN WATER (D70W) INTRAVENOUS SOLUTION,78.0,46.8,18.1,4481.0,17 HCPCS,J3490,DIAZEPAM 10 MG TABLET,22.25,13.35,5.16,4481.0,19 HCPCS,J3490,DIAZEPAM 2 MG TABLET,22.2,13.32,5.15,4481.0,19 HCPCS,J3490,DIAZEPAM 5 MG TABLET,22.25,13.35,5.16,4481.0,19 HCPCS,J3490,DIAZEPAM 5 MG/5 ML (1 MG/ML) ORAL SOLUTION,198.35,119.01,46.02,4481.0,19 HCPCS,J3490,"DIAZEPAM 5 MG/5 ML (1 MG/ML, 5 ML) ORAL SOLUTION",22.65,13.59,5.25,4481.0,19 HCPCS,J3490,DIAZOXIDE 50 MG/ML ORAL SUSPENSION,1475.8,885.48,342.39,4481.0,19 HCPCS,J3490,DIBUCAINE 1 % TOPICAL OINTMENT,5.95,3.57,1.38,4481.0,19 HCPCS,J3490,DICLOFENAC 0.1 % EYE DROPS,58.15,34.89,13.49,4481.0,19 HCPCS,J3490,DICLOXACILLIN 250 MG CAPSULE,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,DICYCLOMINE 10 MG CAPSULE,17.65,10.59,4.09,4481.0,19 HCPCS,J3490,DICYCLOMINE 10 MG/5 ML ORAL SOLUTION,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,DICYCLOMINE 20 MG TABLET,17.4,10.44,4.04,4481.0,19 HCPCS,J3490,DIGOXIN 125 MCG (0.125 MG) TABLET,20.05,12.03,4.65,4481.0,19 HCPCS,J3490,DIGOXIN 50 MCG/ML (0.05 MG/ML) ORAL SOLUTION,435.95,261.57,101.14,4481.0,19 HCPCS,J3490,DILTIAZEM 100 MCG/ML IN NS,63.05,37.83,14.63,4481.0,19 HCPCS,J3490,DILTIAZEM 12 MG/ML ORAL SUSP,102.4,61.44,23.76,4481.0,19 HCPCS,J3490,DILTIAZEM 30 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,DILTIAZEM 60 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,DILTIAZEM 90 MG TABLET,21.4,12.84,4.96,4481.0,19 HCPCS,J3490,"DILTIAZEM CD 120 MG CAPSULE,EXTENDED RELEASE 24 HR",18.45,11.07,4.28,4481.0,19 HCPCS,J3490,"DILTIAZEM CD 180 MG CAPSULE,EXTENDED RELEASE 24 HR",18.45,11.07,4.28,4481.0,19 HCPCS,J3490,"DILTIAZEM CD 240 MG CAPSULE,EXTENDED RELEASE 24 HR",17.85,10.71,4.14,4481.0,19 HCPCS,J3490,"DILTIAZEM CD 300 MG CAPSULE,EXTENDED RELEASE 24 HR",20.8,12.48,4.83,4481.0,19 HCPCS,J3490,DILUENT FOR CAPLACIZUMAB-YHDP (STERILE WATER) 1 ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,DILUENT FOR MITOMYCIN INTRA-PYELOCALYCEAL SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,DIMETHICONE 1.2 %-COLLOIDAL OATMEAL LOTION,5.2,3.12,1.21,4481.0,19 HCPCS,J3490,DIPHENHYDRAMINE 12.5 MG/5 ML ORAL ELIXIR,7.45,4.47,1.73,4481.0,19 HCPCS,J3490,DIPHENOXYLATE-ATROPINE 2.5 MG-0.025 MG TABLET,23.45,14.07,5.44,4481.0,19 HCPCS,J3490,DIPYRIDAMOLE 10 MG/ML ORAL SUSP,149.2,89.52,34.61,4481.0,19 HCPCS,J3490,DIPYRIDAMOLE 25 MG TABLET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,DIPYRIDAMOLE 50 MG TABLET,21.75,13.05,5.05,4481.0,19 HCPCS,J3490,DIPYRIDAMOLE 75 MG TABLET,19.25,11.55,4.47,4481.0,19 HCPCS,J3490,DISOPYRAMIDE PHOSPHATE 100 MG CAPSULE,22.0,13.2,5.1,4481.0,19 HCPCS,J3490,DISULFIRAM 250 MG TABLET,24.5,14.7,5.68,4481.0,19 HCPCS,J3490,"DIVALPROEX 125 MG CAPSULE,DELAYED RELEASE SPRINKLE",18.55,11.13,4.3,4481.0,19 HCPCS,J3490,"DIVALPROEX ER 250 MG TABLET,EXTENDED RELEASE 24 HR",20.45,12.27,4.74,4481.0,19 HCPCS,J3490,DOCUSATE SODIUM 100 MG CAPSULE,1.3,0.78,0.3016,4481.0,19 HCPCS,J3490,DOCUSATE SODIUM 283 MG/5 ML ENEMA,2.75,1.65,0.638,4481.0,19 HCPCS,J3490,DOCUSATE SODIUM 50 MG CAPSULE,1.4,0.84,0.3248,4481.0,19 HCPCS,J3490,DOCUSATE SODIUM 50 MG/5 ML ORAL LIQUID,3.6,2.16,0.8352,4481.0,19 HCPCS,J3490,DOFETILIDE 125 MCG CAPSULE,20.8,12.48,4.83,4481.0,19 HCPCS,J3490,DOFETILIDE 250 MCG CAPSULE,20.0,12.0,4.64,4481.0,19 HCPCS,J3490,DOFETILIDE 500 MCG CAPSULE,17.0,10.2,3.94,4481.0,19 HCPCS,J3490,DOLUTEGRAVIR 50 MG TABLET,248.55,149.13,57.66,4481.0,19 HCPCS,J3490,DONEPEZIL 10 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,DONEPEZIL 5 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,DORAVIRINE 100 MG TABLET,200.0,120.0,46.4,4481.0,19 HCPCS,J3490,DORNASE ALFA 1 MG/ML SOLUTION FOR CHEST TUBE,818.65,491.19,189.93,4481.0,19 HCPCS,J3490,DORNASE ALFA 1 MG/ML SOLUTION FOR INHALATION,417.35,250.41,96.83,4481.0,19 HCPCS,J3490,DORZOLAMIDE 2 % EYE DROPS,91.25,54.75,21.17,4481.0,19 HCPCS,J3490,DORZOLAMIDE 22.3 MG-TIMOLOL 6.8 MG/ML EYE DROPS,166.5,99.9,38.63,4481.0,19 HCPCS,J3490,DOXEPIN 10 MG CAPSULE,17.6,10.56,4.08,4481.0,19 HCPCS,J3490,DOXEPIN 25 MG CAPSULE,18.45,11.07,4.28,4481.0,19 HCPCS,J3490,DOXEPIN 50 MG CAPSULE,18.95,11.37,4.4,4481.0,19 HCPCS,J3490,DOXYCYCLINE HYCLATE 100 MG TABLET,27.5,16.5,6.38,4481.0,19 HCPCS,J3490,DOXYCYCLINE MONOHYDRATE 25 MG/5 ML ORAL SUSPENSION,25.15,15.09,5.83,4481.0,19 HCPCS,J3490,DOXYLAMINE SUCCINATE 25 MG TABLET,1.3,0.78,0.3016,4481.0,19 HCPCS,J3490,DRONABINOL 2.5 MG CAPSULE,28.3,16.98,6.57,4481.0,19 HCPCS,J3490,DRONABINOL 5 MG CAPSULE,74.3,44.58,17.24,4481.0,19 HCPCS,J3490,DRONEDARONE 400 MG TABLET,55.9,33.54,12.97,4481.0,19 HCPCS,J3490,DROXIDOPA 100 MG CAPSULE,19.35,11.61,4.49,4481.0,19 HCPCS,J3490,DROXIDOPA 300 MG CAPSULE,190.9,114.54,44.29,4481.0,19 HCPCS,J3490,ECONAZOLE NITRATE 1 % TOPICAL CREAM,166.75,100.05,38.69,4481.0,19 HCPCS,J3490,EFAVIRENZ 600 MG TABLET,24.05,14.43,5.58,4481.0,19 HCPCS,J3490,ELECTROLYTE-A INTRAVENOUS SOLUTION,114.0,68.4,26.45,4481.0,19 HCPCS,J3490,ELECTROLYTE-R IN DEXTROSE 5 % INTRAVENOUS SOLUTION,102.0,61.2,23.66,4481.0,19 HCPCS,J3490,ELTROMBOPAG OLAMINE 25 MG TABLET,798.65,479.19,185.29,4481.0,19 HCPCS,J3490,ELVITEG 150 MG-COB 150 MG-EMTRICIT 200 MG-TENOFO ALAFENAM 10 MG TABLET,437.65,262.59,101.53,4481.0,19 HCPCS,J3490,EMPAGLIFLOZIN 10 MG TABLET,78.95,47.37,18.32,4481.0,19 HCPCS,J3490,EMPAGLIFLOZIN 25 MG TABLET,78.95,47.37,18.32,4481.0,19 HCPCS,J3490,ENALAPRIL MALEATE 1 MG/ML ORAL SOLUTION,49.95,29.97,11.59,4481.0,19 HCPCS,J3490,ENALAPRIL MALEATE 10 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,ENALAPRIL MALEATE 20 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,ENALAPRILAT 1.25 MG/ML INTRAVENOUS SOLUTION,94.05,56.43,21.82,4481.0,19 HCPCS,J3490,ENALAPRILAT 125 MCG/ML IV SYRINGE NEONATAL,72.15,43.29,16.74,4481.0,19 HCPCS,J3490,ENCORAFENIB 75 MG CAPSULE,389.15,233.49,90.28,4481.0,19 HCPCS,J3490,ENTACAPONE 200 MG TABLET,28.4,17.04,6.59,4481.0,19 HCPCS,J3490,ENTECAVIR 0.05 MG/ML ORAL SOLUTION,153.25,91.95,35.55,4481.0,19 HCPCS,J3490,ENTECAVIR 0.5 MG TABLET,20.0,12.0,4.64,4481.0,19 HCPCS,J3490,ENTRECTINIB 100 MG CAPSULE,960.35,576.21,222.8,4481.0,19 HCPCS,J3490,ENTRECTINIB 200 MG CAPSULE,960.35,576.21,222.8,4481.0,19 HCPCS,J3490,ENZALUTAMIDE 40 MG TABLET,521.9,313.14,121.08,4481.0,19 HCPCS,J3490,ENZALUTAMIDE 80 MG TABLET,1018.75,611.25,236.35,4481.0,19 HCPCS,J3490,EPHEDRINE (PF) 25 MG/5 ML (5 MG/ML) IN 0.9% SODIUM CHLORIDE IV SYRINGE WRAPPER,64.2,38.52,14.89,4481.0,19 HCPCS,J3490,EPHEDRINE 50 MG/ML INJECTION WRAPPER,129.3,77.58,30.0,4481.0,19 HCPCS,J3490,EPHEDRINE SULFATE 50 MG/ML INTRAVENOUS SOLUTION,89.4,53.64,20.74,4481.0,19 HCPCS,J3490,EPINEPHRINE HCL 8 MG/250 ML (32 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS,271.6,162.96,63.01,4481.0,19 HCPCS,J3490,EPLERENONE 25 MG TABLET,20.2,12.12,4.69,4481.0,19 HCPCS,J3490,EPLERENONE 50 MG TABLET,20.2,12.12,4.69,4481.0,19 HCPCS,J3490,"ERGOCALCIFEROL (VITAMIN D2) 1,250 MCG (50,000 UNIT) CAPSULE",1.35,0.81,0.3132,4481.0,19 HCPCS,J3490,"ERGOCALCIFEROL (VITAMIN D2) 200 MCG/ML (8,000 UNIT/ML) ORAL DROPS",1.2999999999999998,0.78,0.2784,4481.0,57 HCPCS,J3490,ERLOTINIB 10 MG/ML ORAL SUSPENSION (SUGAR FREE),720.6,432.36,167.18,4481.0,19 HCPCS,J3490,ERLOTINIB 50 MG/ML ORAL SUSPENSION,720.6,432.36,167.18,4481.0,19 HCPCS,J3490,ERYTHROMYCIN 250 MG TABLET,35.85,21.51,8.32,4481.0,19 HCPCS,J3490,ERYTHROMYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT,49.75,29.85,11.54,4481.0,19 HCPCS,J3490,ERYTHROMYCIN ETHYLSUCCINATE 400 MG/5 ML ORAL POWDER FOR SUSPENSION,115.25,69.15,26.74,4481.0,19 HCPCS,J3490,ESCITALOPRAM 10 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,ESCITALOPRAM 20 MG TABLET,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,ESCITALOPRAM 5 MG TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,ESCITALOPRAM 5 MG/5 ML ORAL SOLUTION,22.6,13.56,5.24,4481.0,19 HCPCS,J3490,ESOMEPRAZOLE MAGNESIUM DR 10 MG GRANULES DELAYED RELEASE FOR SUSP,44.75,26.85,10.38,4481.0,19 HCPCS,J3490,ESOMEPRAZOLE MAGNESIUM DR 2.5 MG GRANULES DELAYED RELEASE FOR SUSP,44.75,26.85,10.38,4481.0,19 HCPCS,J3490,ESOMEPRAZOLE MAGNESIUM DR 20 MG GRANULES DELAYED RELEASE FOR SUSP,39.45,23.67,9.15,4481.0,19 HCPCS,J3490,ESOMEPRAZOLE MAGNESIUM DR 40 MG GRANULES DELAYED RELEASE FOR SUSP,39.45,23.67,9.15,4481.0,19 HCPCS,J3490,ESTRADIOL 0.01% (0.1 MG/GRAM) VAGINAL CREAM,1053.75,632.25,244.47,4481.0,19 HCPCS,J3490,ESTRADIOL 0.05 MG/24 HR WEEKLY TRANSDERMAL PATCH,71.7,43.02,16.63,4481.0,19 HCPCS,J3490,ESTRADIOL 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,71.7,43.02,16.63,4481.0,19 HCPCS,J3490,ESTRADIOL 0.5 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,ESTRADIOL 1 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,ESTRADIOL 2 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,ETHACRYNIC ACID 25 MG TABLET,23.5,14.1,5.45,4481.0,19 HCPCS,J3490,ETHAMBUTOL 100 MG TABLET,17.4,10.44,4.04,4481.0,19 HCPCS,J3490,ETHAMBUTOL 400 MG TABLET,19.25,11.55,4.47,4481.0,19 HCPCS,J3490,ETHOSUXIMIDE 250 MG CAPSULE,17.3,10.38,4.01,4481.0,19 HCPCS,J3490,ETHOSUXIMIDE 250 MG/5 ML ORAL SOLUTION,185.25,111.15,42.98,4481.0,19 HCPCS,J3490,ETHYL ALCOHOL 99 % INTRA-ARTERIAL SOLUTION,3896.5,2337.9,903.99,4481.0,19 HCPCS,J3490,ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTION,81.0,48.6,18.79,4481.0,19 HCPCS,J3490,ETRAVIRINE 200 MG TABLET,90.9,54.54,21.09,4481.0,19 HCPCS,J3490,EVEROLIMUS (ANTINEOPLASTIC) 10 MG TABLET,2758.5,1655.1,639.97,4481.0,19 HCPCS,J3490,EVEROLIMUS (ANTINEOPLASTIC) 2.5 MG TABLET,2638.45,1583.07,612.12,4481.0,19 HCPCS,J3490,EVEROLIMUS (ANTINEOPLASTIC) 5 MG TABLET,2758.6,1655.16,640.0,4481.0,19 HCPCS,J3490,EVEROLIMUS (ANTINEOPLASTIC) 7.5 MG TABLET,2758.65,1655.19,640.01,4481.0,19 HCPCS,J3490,EXEMESTANE 25 MG TABLET,178.5,107.1,41.41,4481.0,19 HCPCS,J3490,EZETIMIBE 10 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,FAMOTIDINE 10 MG TABLET,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,FAMOTIDINE 20 MG TABLET,1.35,0.81,0.3132,4481.0,19 HCPCS,J3490,FAMOTIDINE 40 MG TABLET,16.85,10.11,3.91,4481.0,19 HCPCS,J3490,FAMOTIDINE 40 MG/5 ML (8 MG/ML) ORAL SUSPENSION,47.5,28.5,11.02,4481.0,19 HCPCS,J3490,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 200 ML INFUSION (PEDS),747.75,448.65,173.48,4481.0,19 HCPCS,J3490,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 300 ML INFUSION (PEDS),1090.15,654.09,252.91,4481.0,19 HCPCS,J3490,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 400 ML INFUSION (PEDS),1432.5,859.5,332.34,4481.0,19 HCPCS,J3490,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 50 ML INFUSION (PEDS),302.9,181.74,70.27,4481.0,19 HCPCS,J3490,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 500 ML INFUSION (PEDS),1774.85,1064.91,411.77,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (200 ML),268.0,160.8,62.18,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (300 ML),370.5,222.3,85.96,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (400 ML),473.0,283.8,109.74,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (500 ML),575.45,345.27,133.5,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (600 ML),677.95,406.77,157.28,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (700 ML),780.45,468.27,181.06,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (800 ML),882.95,529.77,204.84,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (900 ML),985.45,591.27,228.62,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 24 ML SYRINGE (PEDS),41.2,24.72,9.56,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 50 ML SYRINGE (PEDS),68.5,41.1,15.89,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 8 ML SYRINGE (PEDS),24.4,14.64,5.66,4481.0,19 HCPCS,J3490,FAT EMULSION 20 % INTRAVENOUS,247.8,148.68,57.49,4481.0,19 HCPCS,J3490,FAT EMULSION SMOFLIPID 20 % (1000 ML) INFUSION,334.475,200.685,39.81,4481.0,38 HCPCS,J3490,FAT EMULSION SMOFLIPID 20 % (500 ML) INFUSION,171.6,102.96,39.81,4481.0,19 HCPCS,J3490,FAT EMULSION SMOFLIPID 20 % (750 ML) INFUSION,280.2,168.12,39.81,4481.0,38 HCPCS,J3490,FAT EMULSION SMOFLIPID 20 % INFUSION 24 ML SYRINGE (PEDS),26.7,16.02,6.19,4481.0,19 HCPCS,J3490,FAT EMULSION SMOFLIPID 20 % INFUSION 50 ML SYRINGE (PEDS),38.25,22.95,8.87,4481.0,19 HCPCS,J3490,FAT EMULSION SMOFLIPID 20 % INFUSION 8 ML SYRINGE (PEDS),19.6,11.76,4.55,4481.0,19 HCPCS,J3490,FAT EMULSION-SOYBEAN OIL-MCT-OLIVE OIL-FISH OIL 20 % INTRAVENOUS,171.6,102.96,39.81,4481.0,19 HCPCS,J3490,FATTY ACID NO.6-FISH OIL-GLYCERIN 10 % IV EMULSION,405.4,243.24,94.05,4481.0,19 HCPCS,J3490,FEBUXOSTAT 40 MG TABLET,49.05,29.43,11.38,4481.0,19 HCPCS,J3490,FEBUXOSTAT 80 MG TABLET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,FELBAMATE 400 MG TABLET,20.2,12.12,4.69,4481.0,19 HCPCS,J3490,FELBAMATE 600 MG/5 ML ORAL SUSPENSION,1540.4,924.24,357.37,4481.0,19 HCPCS,J3490,FENFLURAMINE 2.2 MG/ML ORAL SOLUTION,3032.325,1819.395,121.51,48182.6,76 HCPCS,J3490,FENOFIBRATE NANOCRYSTALLIZED 145 MG TABLET,25.9,15.54,6.01,4481.0,19 HCPCS,J3490,FENOFIBRATE NANOCRYSTALLIZED 48 MG TABLET,19.75,11.85,4.58,4481.0,19 HCPCS,J3490,FENTANYL (PF) 2 MCG/ML-BUPIVACAINE 0.0625 %-NACL INJECTION SOLUTION,81.45,48.87,18.9,4481.0,19 HCPCS,J3490,FENTANYL 100 MCG/HR TRANSDERMAL PATCH,61.55,36.93,14.28,4481.0,19 HCPCS,J3490,FENTANYL 12 MCG/HR TRANSDERMAL PATCH,71.4,42.84,16.56,4481.0,19 HCPCS,J3490,"FENTANYL 12.5 MCG, BUPIVACAINE 0.2% (1.25 ML SYRINGE) CSE",22.65,13.59,5.25,4481.0,19 HCPCS,J3490,FENTANYL 25 MCG/HR TRANSDERMAL PATCH,43.7,26.22,10.14,4481.0,19 HCPCS,J3490,FENTANYL 50 MCG/HR TRANSDERMAL PATCH,60.55,36.33,14.05,4481.0,19 HCPCS,J3490,FENTANYL 75 MCG/HR TRANSDERMAL PATCH,82.9,49.74,19.23,4481.0,19 HCPCS,J3490,FERRIC SUBSULFATE (BULK) 20 TO 22 GRAM/100 ML SOLUTION,3.35,2.01,0.7772,4481.0,19 HCPCS,J3490,FERROUS SULFATE 300 MG (60 MG IRON)/5 ML ORAL LIQUID,6.3,3.78,1.46,4481.0,19 HCPCS,J3490,FERROUS SULFATE 325 MG (65 MG IRON) TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,FIDAXOMICIN 200 MG TABLET,796.75,478.05,184.85,4481.0,19 HCPCS,J3490,FIDAXOMICIN 40 MG/ML ORAL SUSPENSION,15631.0,9378.6,3626.39,12504.8,19 HCPCS,J3490,FINASTERIDE 5 MG TABLET,18.7,11.22,4.34,4481.0,19 HCPCS,J3490,FLECAINIDE 100 MG TABLET,18.7,11.22,4.34,4481.0,19 HCPCS,J3490,FLECAINIDE 20 MG/ML ORAL SUSPENSION,17.65,10.59,4.09,4481.0,19 HCPCS,J3490,FLECAINIDE 50 MG TABLET,17.75,10.65,4.12,4481.0,19 HCPCS,J3490,FLUCONAZOLE 100 MG TABLET,21.65,12.99,5.02,4481.0,19 HCPCS,J3490,FLUCONAZOLE 150 MG TABLET,22.05,13.23,5.12,4481.0,19 HCPCS,J3490,FLUCONAZOLE 200 MG TABLET,24.1,14.46,5.59,4481.0,19 HCPCS,J3490,FLUCONAZOLE 40 MG/ML ORAL SUSPENSION,192.55,115.53,44.67,4481.0,19 HCPCS,J3490,FLUCONAZOLE 50 MG TABLET,19.4,11.64,4.5,4481.0,19 HCPCS,J3490,FLUCYTOSINE 250 MG CAPSULE,261.6,156.96,60.69,4481.0,19 HCPCS,J3490,FLUCYTOSINE 50 MG/ML ORAL SUSPENSION,2881.25,1728.75,668.45,4481.0,19 HCPCS,J3490,FLUCYTOSINE 500 MG CAPSULE,486.05,291.63,112.76,4481.0,19 HCPCS,J3490,FLUDROCORTISONE 0.1 MG TABLET,18.55,11.13,4.3,4481.0,19 HCPCS,J3490,FLUMAZENIL 0.1 MG/ML INTRAVENOUS SOLUTION,95.875,57.525,20.0,4481.0,38 HCPCS,J3490,FLUOCINOLONE 0.025 % TOPICAL OINTMENT,270.15,162.09,62.67,4481.0,19 HCPCS,J3490,FLUOCINONIDE 0.05 % TOPICAL OINTMENT,94.05,56.43,21.82,4481.0,19 HCPCS,J3490,FLUOCINONIDE 0.05 % TOPICAL SOLUTION,76.15,45.69,17.67,4481.0,19 HCPCS,J3490,FLUORESCEIN 0.25 %-BENOXINATE 0.4 % EYE DROPS,128.9,77.34,29.9,4481.0,19 HCPCS,J3490,FLUORIDE 0.5 MG (1.1 MG SODIUM FLUORIDE)/ML ORAL DROPS,1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,"FLUOROMETHOLONE 0.1 % EYE DROPS,SUSPENSION",249.1,149.46,57.79,4481.0,19 HCPCS,J3490,FLUOROURACIL 5 % TOPICAL CREAM,325.95,195.57,75.62,4481.0,19 HCPCS,J3490,FLUOXETINE 20 MG CAPSULE,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,FLUOXETINE 20 MG/5 ML (4 MG/ML) ORAL SOLUTION,19.15,11.49,4.44,4481.0,19 HCPCS,J3490,FLUPHENAZINE 1 MG TABLET,18.1,10.86,4.2,4481.0,19 HCPCS,J3490,FLUPHENAZINE 5 MG TABLET,29.7,17.82,6.89,4481.0,19 HCPCS,J3490,FLURBIPROFEN 0.03 % EYE DROPS,124.4,74.64,28.86,4481.0,19 HCPCS,J3490,FLUTICASONE FUROATE 100 MCG-VILANTEROL 25 MCG/DOSE INHALATION POWDER,488.25,292.95,113.27,4481.0,19 HCPCS,J3490,FLUTICASONE FUROATE 100 MCG/ACTUATION BLISTER POWDER FOR INHALATION,308.85,185.31,71.65,4481.0,19 HCPCS,J3490,FLUTICASONE FUROATE 200 MCG-VILANTEROL 25 MCG/DOSE INHALATION POWDER,488.25,292.95,113.27,4481.0,19 HCPCS,J3490,FLUTICASONE FUROATE 200 MCG/ACTUATION BLISTER POWDER FOR INHALATION,408.1,244.86,94.68,4481.0,19 HCPCS,J3490,FLUTICASONE PROPIONATE 110 MCG/ACTUATION HFA AEROSOL INHALER,551.8,331.08,128.02,4481.0,19 HCPCS,J3490,FLUTICASONE PROPIONATE 44 MCG/ACTUATION HFA AEROSOL INHALER,416.2,249.72,96.56,4481.0,19 HCPCS,J3490,"FLUTICASONE PROPIONATE 50 MCG/ACTUATION NASAL SPRAY,SUSPENSION",30.049999999999997,18.03,6.7,4481.0,38 HCPCS,J3490,FLUVOXAMINE 50 MG TABLET,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,FOLIC ACID 1 MG TABLET,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,FOLIC ACID 1 MG/ML ORAL SOLN,70.3,42.18,16.31,4481.0,19 HCPCS,J3490,FORMALDEHYDE (FORMALIN) 4 % IN SWFI 300 ML,186.6,111.96,43.29,4481.0,19 HCPCS,J3490,FORMOTEROL FUMARATE 20 MCG/2 ML SOLUTION FOR NEBULIZATION,77.5,46.5,17.98,4481.0,19 HCPCS,J3490,FOSFOMYCIN TROMETHAMINE 3 GRAM ORAL PACKET,257.0,154.2,59.62,4481.0,19 HCPCS,J3490,FUROSEMIDE 10 MG/ML ORAL SOLUTION,36.2,21.72,8.4,4481.0,19 HCPCS,J3490,FUROSEMIDE 20 MG TABLET,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,GABAPENTIN 100 MG CAPSULE,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,GABAPENTIN 250 MG/5 ML ORAL SOLUTION,295.2,177.12,68.49,4481.0,19 HCPCS,J3490,GABAPENTIN 300 MG CAPSULE,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,GABAPENTIN 300 MG/6 ML (6 ML) ORAL SOLUTION,27.25,16.35,6.32,4481.0,19 HCPCS,J3490,GABAPENTIN 400 MG CAPSULE,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,GELATIN ABSORBABLE EYE FILM,5972.8,3583.68,1385.69,4778.24,19 HCPCS,J3490,GEMFIBROZIL 600 MG TABLET,16.8,10.08,3.9,4481.0,19 HCPCS,J3490,GENTAMICIN 0.1 % TOPICAL CREAM,134.9,80.94,31.3,4481.0,19 HCPCS,J3490,"GENTAMICIN 1 MG/ML, SODIUM CITRATE 4% (2.4 ML) INTRA-CATHETER SYRINGE",23.2,13.92,5.38,4481.0,19 HCPCS,J3490,GENTAMICIN 30 MG/ML BUFFERED STERILE SOLUTION (ENT),101.1,60.66,23.46,4481.0,19 HCPCS,J3490,GENTIAN VIOLET 1 % TOPICAL SOLUTION,1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,GILTERITINIB 40 MG TABLET,1313.0,787.8,304.62,4481.0,19 HCPCS,J3490,GLIPIZIDE 10 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,GLIPIZIDE 5 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,GLUCOSE 4 GRAM CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,GLUTAMINE 15 GRAM ORAL POWDER PACKET,3.95,2.37,0.9164,4481.0,19 HCPCS,J3490,GLUTAMINE 250 MG/ML ORAL SUSPENSION,2.85,1.71,0.6612,4481.0,19 HCPCS,J3490,GLYBURIDE 1 MG/ML ORAL SUSPENSION,20.8,12.48,4.83,4481.0,19 HCPCS,J3490,GLYBURIDE 2.5 MG TABLET,16.65,9.99,3.86,4481.0,19 HCPCS,J3490,GLYBURIDE 5 MG TABLET,16.8,10.08,3.9,4481.0,19 HCPCS,J3490,GLYCERIN (ADULT) RECTAL SUPPOSITORY,1.25,0.75,0.29,4481.0,19 HCPCS,J3490,GLYCERIN (CHILD) RECTAL SUPPOSITORY,1.6,0.96,0.3712,4481.0,19 HCPCS,J3490,GLYCEROL PHENYLBUTYRATE 1.1 GRAM/ML ORAL LIQUID,17758.0,10654.8,4119.86,14206.4,19 HCPCS,J3490,GLYCINE DILUENT INTRAVENOUS SOLUTION,104.4,62.64,24.22,4481.0,19 HCPCS,J3490,GLYCOPYRROLATE 1 MG TABLET,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,GLYCOPYRROLATE 1 MG/5 ML (0.2 MG/ML) ORAL SOLUTION,1514.5,908.7,351.36,4481.0,19 HCPCS,J3490,GRANISETRON HCL 1 MG TABLET,46.0,27.6,10.67,4481.0,19 HCPCS,J3490,GRISEOFULVIN MICROSIZE 125 MG/5 ML ORAL SUSPENSION,161.45,96.87,37.46,4481.0,19 HCPCS,J3490,GRISEOFULVIN ULTRAMICROSIZE 125 MG TABLET,28.0,16.8,6.5,4481.0,19 HCPCS,J3490,GRISEOFULVIN ULTRAMICROSIZE 250 MG TABLET,31.3,18.78,7.26,4481.0,19 HCPCS,J3490,GUAIFENESIN 100 MG/5 ML ORAL LIQUID,2.25,1.35,0.522,4481.0,19 HCPCS,J3490,GUAIFENESIN 400 MG TABLET,1.55,0.93,0.3596,4481.0,19 HCPCS,J3490,GUANFACINE 1 MG TABLET,16.65,9.99,3.86,4481.0,19 HCPCS,J3490,"GUANFACINE ER 1 MG TABLET,EXTENDED RELEASE 24 HR",18.25,10.95,4.23,4481.0,19 HCPCS,J3490,"GUANFACINE ER 2 MG TABLET,EXTENDED RELEASE 24 HR",18.25,10.95,4.23,4481.0,19 HCPCS,J3490,GUAR GUM ORAL PACKET,1.75,1.05,0.406,4481.0,19 HCPCS,J3490,HALOPERIDOL 0.5 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,HALOPERIDOL 1 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,HALOPERIDOL 2 MG TABLET,17.7,10.62,4.11,4481.0,19 HCPCS,J3490,HALOPERIDOL 5 MG TABLET,18.75,11.25,4.35,4481.0,19 HCPCS,J3490,HALOPERIDOL LACTATE 2 MG/ML ORAL CONCENTRATE,17.4,10.44,3.87,4481.0,38 HCPCS,J3490,HISTAMINE 1 MG/ML (2.75 MG/ML) PERCUTANEOUS SOLUTION,127.75,76.65,29.64,4481.0,19 HCPCS,J3490,HYDRALAZINE 10 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,HYDRALAZINE 4 MG/ML ORAL SOLN,803.5,482.1,186.41,4481.0,19 HCPCS,J3490,HYDROCHLORIC ACID 0.2N SOLUTION,108.4,65.04,25.15,4481.0,19 HCPCS,J3490,HYDROCHLOROTHIAZIDE 12.5 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,HYDROCHLOROTHIAZIDE 25 MG TABLET,16.65,9.99,3.86,4481.0,19 HCPCS,J3490,HYDROCHLOROTHIAZIDE 5 MG/ML ORAL SUSPENSION,20.65,12.39,4.79,4481.0,19 HCPCS,J3490,HYDROCODONE 5 MG-ACETAMINOPHEN 325 MG TABLET,23.9,14.34,5.54,4481.0,19 HCPCS,J3490,HYDROCODONE-HOMATROPINE 5 MG-1.5 MG/5 ML (5 ML) ORAL SOLUTION,24.25,14.55,5.63,4481.0,19 HCPCS,J3490,HYDROCORTISONE 1 % TOPICAL CREAM,4.3,2.58,0.9976,4481.0,19 HCPCS,J3490,HYDROCORTISONE 1 % TOPICAL OINTMENT,4.3,2.58,0.9976,4481.0,19 HCPCS,J3490,HYDROCORTISONE 1 %-PRAMOXINE 1 % RECTAL FOAM,601.1,360.66,139.46,4481.0,19 HCPCS,J3490,HYDROCORTISONE 10 MG TABLET,21.05,12.63,4.88,4481.0,19 HCPCS,J3490,HYDROCORTISONE 100 MG/60 ML ENEMA,80.5,48.3,18.68,4481.0,19 HCPCS,J3490,HYDROCORTISONE 2 MG/ML ORAL SUSPENSION,16.35,9.81,3.79,4481.0,19 HCPCS,J3490,HYDROCORTISONE 2.5 % TOPICAL CREAM,24.75,14.85,5.74,4481.0,19 HCPCS,J3490,HYDROCORTISONE 2.5 % TOPICAL OINTMENT,25.9,15.54,6.01,4481.0,19 HCPCS,J3490,HYDROCORTISONE 20 MG TABLET,17.55,10.53,4.07,4481.0,19 HCPCS,J3490,HYDROCORTISONE ACETATE 25 MG RECTAL SUPPOSITORY,50.5,30.3,11.72,4481.0,19 HCPCS,J3490,HYDROCORTISONE-ACETIC ACID 1 %-2 % EAR DROPS,423.75,254.25,98.31,4481.0,19 HCPCS,J3490,HYDROGEN PEROXIDE 3 % SOLUTION,3.2,1.92,0.7424,4481.0,19 HCPCS,J3490,HYDROMORPHONE (PF) 10 MCG/ML-BUPIVACAINE 0.125 % IN 0.9 %NACL EPIDURAL,52.1,31.26,12.09,4481.0,19 HCPCS,J3490,HYDROMORPHONE 2 MG TABLET,22.6,13.56,5.24,4481.0,19 HCPCS,J3490,HYDROMORPHONE 4 MG TABLET,22.7,13.62,5.27,4481.0,19 HCPCS,J3490,"HYDROMORPHONE ER 12 MG TABLET,EXTENDED RELEASE 24 HR",57.0,34.2,13.22,4481.0,19 HCPCS,J3490,"HYDROMORPHONE ER 16 MG TABLET,EXTENDED RELEASE 24 HR",68.65,41.19,15.93,4481.0,19 HCPCS,J3490,"HYDROMORPHONE ER 8 MG TABLET,EXTENDED RELEASE 24 HR",45.45,27.27,10.54,4481.0,19 HCPCS,J3490,HYDROXYCHLOROQUINE 200 MG TABLET,21.85,13.11,5.07,4481.0,19 HCPCS,J3490,HYDROXYCHLOROQUINE 25 MG/ML ORAL SUSP,64.9,38.94,15.06,4481.0,19 HCPCS,J3490,HYDROXYUREA (SICKLE CELL) 100 MG/ML ORAL SOLUTION,2295.95,1377.57,532.66,4481.0,19 HCPCS,J3490,HYDROXYUREA 100 MG/ML ORAL SUSP,511.0,306.6,118.55,4481.0,19 HCPCS,J3490,HYDROXYUREA 500 MG CAPSULE,28.7,17.22,6.66,4481.0,19 HCPCS,J3490,HYDROXYZINE HCL 10 MG/5 ML ORAL SOLUTION,18.6,11.16,4.32,4481.0,19 HCPCS,J3490,HYDROXYZINE HCL 25 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,HYOSCYAMINE SULFATE 0.125 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,IBUPROFEN 100 MG/5 ML ORAL SUSPENSION,5.199999999999999,3.12,0.522,4481.0,76 HCPCS,J3490,IBUPROFEN 200 MG TABLET,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,IBUPROFEN 400 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,IBUPROFEN 600 MG TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,IBUPROFEN 800 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,IBUPROFEN LYSINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION,1554.95,932.97,360.75,4481.0,19 HCPCS,J3490,ILOPROST 10 MCG/ML SOLUTION FOR NEBULIZATION,128.45,77.07,29.8,4481.0,19 HCPCS,J3490,IMATINIB 100 MG TABLET,399.6,239.76,92.71,4481.0,19 HCPCS,J3490,IMATINIB 40 MG/ML ORAL SUSPENSION,443.0,265.8,102.78,4481.0,19 HCPCS,J3490,IMATINIB 50 MG SPLIT TABLET,27.45,16.47,6.37,4481.0,19 HCPCS,J3490,IMIPRAMINE 10 MG TABLET,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,IMIPRAMINE 25 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,IMIPRAMINE 50 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,INDOMETHACIN 1 MG INTRAVENOUS SOLUTION,1792.65,1075.59,415.89,4481.0,19 HCPCS,J3490,INDOMETHACIN 25 MG CAPSULE,17.1,10.26,3.97,4481.0,19 HCPCS,J3490,INDOMETHACIN 50 MG RECTAL SUPPOSITORY,1047.45,628.47,243.01,4481.0,19 HCPCS,J3490,IODINE STRONG (LUGOLS) 5 % ORAL SOLUTION,18.1,10.86,4.2,4481.0,19 HCPCS,J3490,IPRATROPIUM 0.5 MG-ALBUTEROL 3 MG (2.5 MG BASE)/3 ML NEBULIZATION SOLN,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,IPRATROPIUM 20 MCG-ALBUTEROL 100 MCG/ACTUATION MIST FOR INHALATION,1533.15,919.89,355.69,4481.0,19 HCPCS,J3490,IPRATROPIUM BROMIDE 0.02 % SOLN FOR CONTINUOUS NEBULIZATION,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,IPRATROPIUM BROMIDE 0.02 % SOLUTION FOR INHALATION,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,ISAVUCONAZONIUM SULFATE 186 MG CAPSULE,363.25,217.95,84.27,4481.0,19 HCPCS,J3490,ISOFLURANE 99.9 % INHALATION LIQUID,182.0,109.2,42.22,4481.0,19 HCPCS,J3490,ISONIAZID 50 MG/5 ML ORAL SOLUTION,1023.5,614.1,237.45,4481.0,19 HCPCS,J3490,ISOPROTERENOL 0.2 MG/ML INJECTION SOLUTION,649.75,389.85,116.81,4481.0,38 HCPCS,J3490,ISOSORBIDE DINITRATE 10 MG TABLET,18.8,11.28,4.36,4481.0,19 HCPCS,J3490,ISOSORBIDE DINITRATE 20 MG TABLET,18.75,11.25,4.35,4481.0,19 HCPCS,J3490,ISOSORBIDE DINITRATE 40 MG TABLET,56.1,33.66,13.02,4481.0,19 HCPCS,J3490,ISOSORBIDE DINITRATE 5 MG TABLET,18.7,11.22,4.34,4481.0,19 HCPCS,J3490,"ISOSORBIDE MONONITRATE ER 120 MG TABLET,EXTENDED RELEASE 24 HR",16.35,9.81,3.79,4481.0,19 HCPCS,J3490,"ISOSORBIDE MONONITRATE ER 30 MG TABLET,EXTENDED RELEASE 24 HR",17.15,10.29,3.98,4481.0,19 HCPCS,J3490,"ISOSORBIDE MONONITRATE ER 60 MG TABLET,EXTENDED RELEASE 24 HR",17.25,10.35,4.0,4481.0,19 HCPCS,J3490,ISRADIPINE 1 MG/ML ORAL SUSPENSION,77.8,46.68,18.05,4481.0,19 HCPCS,J3490,ISRADIPINE 2.5 MG CAPSULE,26.1,15.66,6.06,4481.0,19 HCPCS,J3490,ITRACONAZOLE 100 MG CAPSULE,26.0,15.6,6.03,4481.0,19 HCPCS,J3490,IVABRADINE 5 MG TABLET,47.3,28.38,10.97,4481.0,19 HCPCS,J3490,IVABRADINE 7.5 MG TABLET,47.3,28.38,10.97,4481.0,19 HCPCS,J3490,IVERMECTIN 3 MG TABLET,28.45,17.07,6.6,4481.0,19 HCPCS,J3490,KETAMINE 10 MG/ML INJECTION SOLUTION,80.1,48.06,18.58,4481.0,19 HCPCS,J3490,KETAMINE 10 MG/ML INJECTION SYRINGE WRAPPER,46.85,28.11,8.42,4481.0,57 HCPCS,J3490,KETAMINE 10 MG/ML INTRANASAL SOLUTION,81.55,48.93,18.92,4481.0,19 HCPCS,J3490,KETAMINE 100 MG/ML INJECTION SOLUTION,47.05,28.23,10.92,4481.0,19 HCPCS,J3490,KETAMINE 100 MG/ML INTRANASAL SOLUTION,47.05,28.23,10.92,4481.0,19 HCPCS,J3490,KETAMINE 50 MG/ML INJECTION SOLUTION,41.3,24.78,9.58,4481.0,19 HCPCS,J3490,KETAMINE 50 MG/ML ORAL SOLUTION,26.825000000000003,16.095,5.36,4481.0,38 HCPCS,J3490,KETOCONAZOLE 2 % SHAMPOO,82.5,49.5,19.14,4481.0,19 HCPCS,J3490,KETOCONAZOLE 2 % TOPICAL CREAM,130.55,78.33,30.29,4481.0,19 HCPCS,J3490,KETOCONAZOLE 20 MG/ML ORAL SUSP,19.0,11.4,4.41,4481.0,19 HCPCS,J3490,KETOCONAZOLE 200 MG TABLET,22.65,13.59,5.25,4481.0,19 HCPCS,J3490,KETOROLAC 0.5 % EYE DROPS,100.3,60.18,23.27,4481.0,19 HCPCS,J3490,KETOTIFEN 0.025 % (0.035 %) EYE DROPS,17.45,10.47,4.05,4481.0,19 HCPCS,J3490,LABETALOL 100 MG TABLET,17.4,10.44,4.04,4481.0,19 HCPCS,J3490,LABETALOL 200 MG TABLET,17.75,10.65,4.12,4481.0,19 HCPCS,J3490,LABETALOL 40 MG/ML ORAL SUSP,25.0,15.0,5.8,4481.0,19 HCPCS,J3490,LACOSAMIDE 10 MG/ML ORAL SOLUTION,74.0,44.4,11.87,4481.0,38 HCPCS,J3490,LACOSAMIDE 100 MG TABLET,31.35,18.81,7.27,4481.0,19 HCPCS,J3490,LACOSAMIDE 50 MG TABLET,25.75,15.45,5.97,4481.0,19 HCPCS,J3490,"LACTASE 3,000 UNIT TABLET",1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,LACTATED RINGERS IRRIGATION SOLUTION,90.0,54.0,20.88,4481.0,17 HCPCS,J3490,LACTULOSE 10 GRAM/15 ML ORAL SOLUTION,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,LACTULOSE 20 GRAM ORAL PACKET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,LACTULOSE ENEMA 200 G/300 ML,78.7,47.22,18.26,4481.0,19 HCPCS,J3490,LAMIVUDINE 10 MG/ML ORAL SOLUTION,348.65,209.19,80.89,4481.0,19 HCPCS,J3490,LAMIVUDINE 100 MG TABLET,51.2,30.72,11.88,4481.0,19 HCPCS,J3490,LAMIVUDINE 150 MG TABLET,38.5,23.1,8.93,4481.0,19 HCPCS,J3490,LAMIVUDINE 300 MG TABLET,20.0,12.0,4.64,4481.0,19 HCPCS,J3490,LAMOTRIGINE 1 MG/ML ORAL SOLN,19.0,11.4,4.41,4481.0,19 HCPCS,J3490,LAMOTRIGINE 100 MG TABLET,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,LAMOTRIGINE 25 MG CHEWABLE DISPERSIBLE TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,LAMOTRIGINE 25 MG TABLET,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,LAMOTRIGINE 5 MG CHEWABLE DISPERSIBLE TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,LANOLIN ALCOHOLS-MINERAL OIL-W.PETROLATUM-CERESIN TOPICAL CREAM,1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,"LANTHANUM 1,000 MG CHEWABLE TABLET",32.7,19.62,7.59,4481.0,19 HCPCS,J3490,LANTHANUM 750 MG CHEWABLE TABLET,48.4,29.04,11.23,4481.0,19 HCPCS,J3490,LAPATINIB 250 MG TABLET,296.4,177.84,68.76,4481.0,19 HCPCS,J3490,LATANOPROST 0.005 % EYE DROPS,30.9,18.54,7.17,4481.0,19 HCPCS,J3490,LCD 10% IN AQUAPHOR,306.25,183.75,71.05,4481.0,19 HCPCS,J3490,LCD-SALICYLIC ACID 10%-2% IN UNIBASE/AQUAPHOR,37.4,22.44,8.68,4481.0,19 HCPCS,J3490,LEECH,66.35,39.81,15.39,4481.0,19 HCPCS,J3490,LEFLUNOMIDE 10 MG TABLET,19.3,11.58,4.48,4481.0,19 HCPCS,J3490,LEFLUNOMIDE 20 MG TABLET,19.3,11.58,4.48,4481.0,19 HCPCS,J3490,LENACAPAVIR 300 MG TABLET,2453.5,1472.1,569.21,4481.0,19 HCPCS,J3490,LENALIDOMIDE (0.025 MG/ML) DESENSITIZATION ORAL SUSPENSION,25.6,15.36,5.94,4481.0,19 HCPCS,J3490,LENALIDOMIDE (1 MG/ML) DESENSITIZATION ORAL SUSPENSION,84.75,50.85,19.66,4481.0,19 HCPCS,J3490,LENALIDOMIDE (2.5 MICROGRAM/ML) DESENSITIZATION ORAL SUSPENSION,25.1,15.06,5.82,4481.0,19 HCPCS,J3490,LENALIDOMIDE 10 MG CAPSULE,3591.2,2154.72,833.16,4481.0,19 HCPCS,J3490,LENALIDOMIDE 15 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 HCPCS,J3490,LENALIDOMIDE 2.5 MG CAPSULE,3591.2,2154.72,833.16,4481.0,19 HCPCS,J3490,LENALIDOMIDE 25 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 HCPCS,J3490,LENALIDOMIDE 5 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 HCPCS,J3490,LETERMOVIR 120 MG ORAL PELLETS IN PACKET,221.8,133.08,51.46,4481.0,19 HCPCS,J3490,LETERMOVIR 20 MG ORAL PELLETS IN PACKET,50.3,30.18,11.67,4481.0,19 HCPCS,J3490,LETERMOVIR 480 MG TABLET,839.2,503.52,194.69,4481.0,19 HCPCS,J3490,LETERMOVIR 480 MG/24 ML INTRAVENOUS SOLUTION,1303.8,782.28,302.48,4481.0,19 HCPCS,J3490,LETROZOLE 1.25 MG/ML ORAL SUSPENSION,26.8,16.08,6.22,4481.0,19 HCPCS,J3490,LETROZOLE 2.5 MG TABLET,133.65,80.19,31.01,4481.0,19 HCPCS,J3490,LEUCOVORIN CALCIUM 25 MG TABLET,49.9,29.94,11.58,4481.0,19 HCPCS,J3490,LEUCOVORIN CALCIUM 5 MG TABLET,23.9,14.34,5.54,4481.0,19 HCPCS,J3490,LEVALBUTEROL 0.31 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 HCPCS,J3490,LEVALBUTEROL 0.63 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 HCPCS,J3490,LEVALBUTEROL 1.25 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 HCPCS,J3490,LEVETIRACETAM 100 MG/ML ORAL SOLUTION,105.4,63.24,24.45,4481.0,19 HCPCS,J3490,LEVETIRACETAM 250 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,LEVETIRACETAM 500 MG TABLET,16.65,9.99,3.86,4481.0,19 HCPCS,J3490,LEVETIRACETAM 500 MG/5 ML (5 ML) ORAL SOLUTION,33.4,20.04,7.75,4481.0,19 HCPCS,J3490,LEVETIRACETAM 750 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,LEVOCARNITINE (WITH SUGAR) 100 MG/ML ORAL SOLUTION,127.2,76.32,29.51,4481.0,19 HCPCS,J3490,LEVOCARNITINE 330 MG TABLET,2.4,1.44,0.5568,4481.0,19 HCPCS,J3490,LEVOFLOXACIN 250 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,LEVOFLOXACIN 250 MG/10 ML ORAL SOLUTION,1607.2,964.32,372.87,4481.0,19 HCPCS,J3490,LEVOFLOXACIN 500 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,LEVOFLOXACIN 750 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 100 MCG TABLET,17.85,10.71,4.14,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 112 MCG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 125 MCG TABLET,18.15,10.89,4.21,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 150 MCG TABLET,18.2,10.92,4.22,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 200 MCG TABLET,19.0,11.4,4.41,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 25 MCG TABLET,17.4,10.44,4.04,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 50 MCG TABLET,17.45,10.47,4.05,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 75 MCG TABLET,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,LEVOTHYROXINE 88 MCG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,LIDOCAINE (PF) 10 MG/ML (1 %) FOR NEBULIZATION,25.25,15.15,5.14,4481.0,57 HCPCS,J3490,LIDOCAINE 0.9 % BUFFERED WITH 8.4 % SODIUM BICARB (1 ML) INJ SYRINGE,16.15,9.69,3.75,4481.0,19 HCPCS,J3490,LIDOCAINE 1% IN SODIUM CHLORIDE 0.9% TOPICAL SOLN (MULTIPLE PATIENTS),16.2,9.72,3.76,4481.0,19 HCPCS,J3490,LIDOCAINE 2 % MUCOSAL JELLY IN APPLICATOR,23.7,14.22,5.5,4481.0,19 HCPCS,J3490,LIDOCAINE 4 % TOPICAL CREAM,11.85,7.11,2.75,4481.0,19 HCPCS,J3490,LIDOCAINE 4 % TOPICAL PATCH,2.7,1.62,0.6264,4481.0,19 HCPCS,J3490,"LIDOCAINE 4 %-EPINEPHRINE BITA 1:1,000-TETRACAINE 0.5 % TOP.SOLN(BULK)",30.6,18.36,7.1,4481.0,19 HCPCS,J3490,LIDOCAINE 4 %-RACEPINEPHRINE 0.05 %-TETRACAINE 0.5 % TOPICAL GEL,39.85,23.91,9.25,4481.0,19 HCPCS,J3490,LIDOCAINE 5 % TOPICAL OINTMENT,61.15,36.69,14.19,4481.0,19 HCPCS,J3490,LIDOCAINE HCL 2 % MUCOSAL SOLUTION,16.8,10.08,3.79,4481.0,38 HCPCS,J3490,LIDOCAINE HCL 4 % LARYNGOTRACHEAL SOLUTION,106.95,64.17,24.81,4481.0,19 HCPCS,J3490,LIDOCAINE-PRILOCAINE 2.5 %-2.5 % TOPICAL CREAM,61.45,36.87,14.26,4481.0,19 HCPCS,J3490,LIDOCAINE-XYLOMETAZOLINE 4%-0.1% NASAL SOLUTION,32.5,19.5,7.54,4481.0,19 HCPCS,J3490,LINACLOTIDE 145 MCG CAPSULE,72.8,43.68,16.89,4481.0,19 HCPCS,J3490,LINACLOTIDE 72 MCG CAPSULE,72.8,43.68,16.89,4481.0,19 HCPCS,J3490,LINEZOLID 100 MG/5 ML ORAL SUSPENSION,1026.25,615.75,238.09,4481.0,19 HCPCS,J3490,LINEZOLID 600 MG TABLET,34.55,20.73,8.02,4481.0,19 HCPCS,J3490,LIOTHYRONINE 10 MCG/ML INTRAVENOUS SOLUTION,1446.25,867.75,335.53,4481.0,19 HCPCS,J3490,LIOTHYRONINE 25 MCG TABLET,18.65,11.19,4.33,4481.0,19 HCPCS,J3490,LIOTHYRONINE 5 MCG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLAS(PORK)24,000-76,000-120,000 UNIT CAPSULE,DEL REL",2567.2,1540.32,595.59,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLASE (PORCINE) 20,880-78,300-78,300 UNIT TABLET",41.05,24.63,9.52,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLASE (PORK) 20,000-63,000-84K UNIT CAPSULE, DEL REL",2491.9,1495.14,578.12,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLASE (PORK) 25,000-79,000-105K UNIT CAPSULE,DEL REL",3079.9,1847.94,714.54,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLASE (PORK) 3,000-10,000-14K UNIT CAPSULE,DEL REL",685.3,411.18,158.99,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLASE 24,000-76,000-120,000 UNIT CAPSULE,DELAYED REL (TUBE DECLOG)",41.55,24.93,9.64,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLASE(PORK) 40,000-126,000-168K UNIT CAPSULE,DEL REL",64.9,38.94,15.06,4481.0,19 HCPCS,J3490,"LIPASE-PROTEASE-AMYLASE(PORK)10,000-32,000-42,000 UNIT CAPSULE,DEL REL",1278.1,766.86,296.52,4481.0,19 HCPCS,J3490,LISDEXAMFETAMINE 20 MG CAPSULE,34.55,20.73,8.02,4481.0,19 HCPCS,J3490,LISDEXAMFETAMINE 30 MG CAPSULE,34.55,20.73,8.02,4481.0,19 HCPCS,J3490,LISINOPRIL 1 MG/ML ORAL SOLUTION,2064.4,1238.64,478.94,4481.0,19 HCPCS,J3490,LISINOPRIL 10 MG TABLET,16.2,9.72,3.76,4481.0,19 HCPCS,J3490,LISINOPRIL 2.5 MG TABLET,16.1,9.66,3.74,4481.0,19 HCPCS,J3490,LISINOPRIL 20 MG TABLET,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,LISINOPRIL 40 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,LISINOPRIL 5 MG TABLET,16.2,9.72,3.76,4481.0,19 HCPCS,J3490,LITHIUM CARBONATE 300 MG TABLET,16.85,10.11,3.91,4481.0,19 HCPCS,J3490,"LITHIUM CARBONATE ER 300 MG TABLET,EXTENDED RELEASE",17.25,10.35,4.0,4481.0,19 HCPCS,J3490,LITHIUM CITRATE 8 MEQ/5 ML ORAL SOLUTION,796.0,477.6,184.67,4481.0,19 HCPCS,J3490,LOMUSTINE 40 MG CAPSULE,1968.8,1181.28,456.76,4481.0,19 HCPCS,J3490,LOPERAMIDE 1 MG/7.5 ML ORAL LIQUID,5.1,3.06,1.18,4481.0,19 HCPCS,J3490,LOPERAMIDE 2 MG CAPSULE,2.35,1.41,0.5452,4481.0,19 HCPCS,J3490,LOPINAVIR-RITONAVIR 200 MG-50 MG TABLET,38.15,22.89,8.85,4481.0,19 HCPCS,J3490,LORATADINE 10 MG TABLET,1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,LORATADINE 5 MG/5 ML ORAL SOLUTION,1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,LORAZEPAM 2 MG/ML ORAL CONCENTRATE,70.775,42.464999999999996,5.48,4481.0,38 HCPCS,J3490,LORLATINIB 100 MG TABLET,2872.95,1723.77,666.52,4481.0,19 HCPCS,J3490,LORLATINIB 25 MG TABLET,974.35,584.61,226.05,4481.0,19 HCPCS,J3490,LOSARTAN 100 MG TABLET,18.1,10.86,4.2,4481.0,19 HCPCS,J3490,LOSARTAN 2.5 MG/ML ORAL SUSP,70.0,42.0,16.24,4481.0,19 HCPCS,J3490,LOSARTAN 25 MG TABLET,17.55,10.53,4.07,4481.0,19 HCPCS,J3490,LOSARTAN 50 MG TABLET,17.85,10.71,4.14,4481.0,19 HCPCS,J3490,LOXAPINE SUCCINATE 25 MG CAPSULE,19.3,11.58,4.48,4481.0,19 HCPCS,J3490,LOXAPINE SUCCINATE 5 MG CAPSULE,17.65,10.59,4.09,4481.0,19 HCPCS,J3490,LUBIPROSTONE 8 MCG CAPSULE,34.6,20.76,8.03,4481.0,19 HCPCS,J3490,LURASIDONE 20 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,LURASIDONE 40 MG TABLET,19.65,11.79,4.56,4481.0,19 HCPCS,J3490,LURASIDONE 60 MG TABLET,157.9,94.74,36.63,4481.0,19 HCPCS,J3490,MACITENTAN 10 MG TABLET,1311.5,786.9,304.27,4481.0,19 HCPCS,J3490,MAFENIDE 85 MG/G TOPICAL CREAM,233.95,140.37,54.28,4481.0,19 HCPCS,J3490,"MAGIC MOUTHWASH ORAL SUSPENSION (DIPHENHYDRAMINE, NYSTATIN)",16.2,9.72,3.76,4481.0,19 HCPCS,J3490,MAGNESIUM CARBONATE 54 MG/5 ML ORAL LIQUID,42.65,25.59,9.89,4481.0,19 HCPCS,J3490,MAGNESIUM CITRATE ORAL SOLUTION,28.95,17.37,6.72,4481.0,19 HCPCS,J3490,MAGNESIUM HYDROXIDE 400 MG/5 ML ORAL SUSPENSION,1.55,0.93,0.3596,4481.0,19 HCPCS,J3490,MAGNESIUM OXIDE 400 MG (241.3 MG MAGNESIUM) TABLET,1.2,0.72,0.2784,4481.0,19 HCPCS,J3490,MAGNESIUM OXIDE-MAGNESIUM AMINO ACID CHELATE 133 MG TABLET,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,MECLIZINE 12.5 MG TABLET,1.8,1.08,0.4176,4481.0,19 HCPCS,J3490,MEDIUM CHAIN TRIGLYCERIDES (MCT) 7.7 KCAL/ML ORAL OIL,100.75,60.45,23.37,4481.0,19 HCPCS,J3490,MEDROXYPROGESTERONE 10 MG TABLET,20.2,12.12,4.69,4481.0,19 HCPCS,J3490,MEDROXYPROGESTERONE 2.5 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,MEGESTROL 20 MG TABLET,25.8,15.48,5.99,4481.0,19 HCPCS,J3490,MEGESTROL 400 MG/10 ML (10 ML) ORAL SUSPENSION,41.75,25.05,9.69,4481.0,19 HCPCS,J3490,MEGESTROL 400 MG/10 ML (40 MG/ML) ORAL SUSPENSION,169.0,101.4,39.21,4481.0,19 HCPCS,J3490,MELATONIN 3 MG TABLET,1.2,0.72,0.2784,4481.0,19 HCPCS,J3490,MELOXICAM 15 MG TABLET,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,MELOXICAM 7.5 MG TABLET,16.5,9.9,3.83,4481.0,19 HCPCS,J3490,MEMANTINE 10 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,MEMANTINE 5 MG TABLET,17.3,10.38,4.01,4481.0,19 HCPCS,J3490,MENTHOL LOZENGES WRAPPER,1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,MERCAPTOPURINE 20 MG/ML ORAL SUSPENSION,5252.2,3151.32,1218.51,4481.0,19 HCPCS,J3490,MERCAPTOPURINE 25 MG (ONCOLOGY) SPLIT TAB,20.8,12.48,4.83,4481.0,19 HCPCS,J3490,MERCAPTOPURINE 25 MG SPLIT TAB,25.55,15.33,5.93,4481.0,19 HCPCS,J3490,MERCAPTOPURINE 50 MG (ONCOLOGY) TABLET,37.7,22.62,8.75,4481.0,19 HCPCS,J3490,MERCAPTOPURINE 50 MG TABLET,37.7,22.62,8.75,4481.0,19 HCPCS,J3490,"MESALAMINE 1.2 GRAM TABLET,DELAYED RELEASE",29.35,17.61,6.81,4481.0,19 HCPCS,J3490,MESALAMINE 4 GRAM/60 ML ENEMA,55.4,33.24,12.85,4481.0,19 HCPCS,J3490,MESNA 400 MG TABLET,339.4,203.64,78.74,4481.0,19 HCPCS,J3490,"METFORMIN 1,000 MG TABLET",16.55,9.93,3.84,4481.0,19 HCPCS,J3490,METFORMIN 500 MG TABLET,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,METFORMIN 850 MG TABLET,16.65,9.99,3.86,4481.0,19 HCPCS,J3490,"METFORMIN ER 500 MG TABLET,EXTENDED RELEASE 24 HR",17.5,10.5,4.06,4481.0,19 HCPCS,J3490,"METFORMIN ER 750 MG TABLET,EXTENDED RELEASE 24 HR",17.3,10.38,4.01,4481.0,19 HCPCS,J3490,METHADONE 10 MG/ML ORAL CONCENTRATE,26.85,16.11,6.23,4481.0,19 HCPCS,J3490,METHADONE 5 MG TABLET,23.25,13.95,5.39,4481.0,19 HCPCS,J3490,METHADONE 5 MG/5 ML ORAL SOLUTION,28.15,16.89,6.53,4481.0,19 HCPCS,J3490,METHENAMINE HIPPURATE 1 GRAM TABLET,23.4,14.04,5.43,4481.0,19 HCPCS,J3490,METHIMAZOLE 10 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,METHIMAZOLE 2.5 MG SPLIT TABLET,16.15,9.69,3.75,4481.0,19 HCPCS,J3490,METHIMAZOLE 5 MG TABLET,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,METHOCARBAMOL 500 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,METHOHEXITAL 100 MG/10 ML (10 MG/ML) IN STERILE WATER (PF) IV SYRINGE,113.75,68.25,26.39,4481.0,19 HCPCS,J3490,METHOHEXITAL 500 MG SOLUTION FOR INJECTION,357.75,214.65,83.0,4481.0,19 HCPCS,J3490,METHOTREXATE 2.5 MG/ML (ONCOLOGY) ORAL SOLUTION,10026.8,6016.08,2326.22,8021.44,19 HCPCS,J3490,METHYLERGONOVINE 0.2 MG TABLET,65.5,39.3,15.2,4481.0,19 HCPCS,J3490,METHYLPHENIDATE 10 MG TABLET,22.9,13.74,5.31,4481.0,19 HCPCS,J3490,METHYLPHENIDATE 5 MG TABLET,22.6,13.56,5.24,4481.0,19 HCPCS,J3490,"METHYLPHENIDATE 5 MG/ML (25 MG/5 ML) ORAL SUSP,EXTENDED RELEASE 24 HR",45.15,27.09,10.47,4481.0,19 HCPCS,J3490,"METHYLPHENIDATE ER 18 MG TABLET,EXTENDED RELEASE 24 HR",61.25,36.75,14.21,4481.0,19 HCPCS,J3490,"METHYLPHENIDATE ER 27 MG TABLET,EXTENDED RELEASE 24 HR",62.2,37.32,14.43,4481.0,19 HCPCS,J3490,"METHYLPHENIDATE ER 36 MG TABLET,EXTENDED RELEASE 24 HR",28.3,16.98,6.57,4481.0,19 HCPCS,J3490,METOCLOPRAMIDE 10 MG TABLET,18.4,11.04,4.27,4481.0,19 HCPCS,J3490,METOLAZONE 1 MG/ML ORAL SUSP,34.0,20.4,7.89,4481.0,19 HCPCS,J3490,METOLAZONE 10 MG TABLET,18.7,11.22,4.34,4481.0,19 HCPCS,J3490,METOLAZONE 2.5 MG TABLET,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,METOLAZONE 5 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,"METOPROLOL SUCCINATE ER 100 MG TABLET,EXTENDED RELEASE 24 HR",20.2,12.12,4.69,4481.0,19 HCPCS,J3490,"METOPROLOL SUCCINATE ER 200 MG TABLET,EXTENDED RELEASE 24 HR",17.1,10.26,3.97,4481.0,19 HCPCS,J3490,"METOPROLOL SUCCINATE ER 25 MG TABLET,EXTENDED RELEASE 24 HR",18.95,11.37,4.4,4481.0,19 HCPCS,J3490,"METOPROLOL SUCCINATE ER 50 MG TABLET,EXTENDED RELEASE 24 HR",18.95,11.37,4.4,4481.0,19 HCPCS,J3490,METOPROLOL TARTRATE 10 MG/ML ORAL SOLN,59.2,35.52,13.73,4481.0,19 HCPCS,J3490,METOPROLOL TARTRATE 100 MG TABLET,16.85,10.11,3.91,4481.0,19 HCPCS,J3490,METOPROLOL TARTRATE 25 MG TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,METOPROLOL TARTRATE 50 MG TABLET,16.35,9.81,3.79,4481.0,19 HCPCS,J3490,METOPROLOL TARTRATE 6.25 MG SPLIT QUARTER TABLET,16.05,9.63,3.72,4481.0,19 HCPCS,J3490,METRONIDAZOLE 0.75 % (37.5 MG/5 GRAM) VAGINAL GEL,76.3,45.78,17.7,4481.0,19 HCPCS,J3490,METRONIDAZOLE 250 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,METRONIDAZOLE 50 MG/ML ORAL SUSP,79.05,47.43,18.34,4481.0,19 HCPCS,J3490,METRONIDAZOLE 500 MG TABLET,18.25,10.95,4.23,4481.0,19 HCPCS,J3490,MEXILETINE 10 MG/ML ORAL SUSP,52.0,31.2,12.06,4481.0,19 HCPCS,J3490,MEXILETINE 150 MG CAPSULE,18.35,11.01,4.26,4481.0,19 HCPCS,J3490,MEXILETINE 200 MG CAPSULE,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,MEXILETINE 250 MG CAPSULE,21.55,12.93,5.0,4481.0,19 HCPCS,J3490,MICONAZOLE NITRATE 2 % TOPICAL CREAM,7.8,4.68,1.81,4481.0,19 HCPCS,J3490,MICONAZOLE NITRATE 2 % VAGINAL CREAM,10.25,6.15,2.38,4481.0,19 HCPCS,J3490,MIDAZOLAM 10 MG/5 ML (2 MG/ML) ORAL SYRUP,40.6,24.36,9.42,4481.0,19 HCPCS,J3490,MIDAZOLAM 2 MG/ML ORAL LIQUID WRAPPER,130.15,78.09,9.42,4481.0,38 HCPCS,J3490,MIDODRINE 10 MG TABLET,20.25,12.15,4.7,4481.0,19 HCPCS,J3490,MIDODRINE 2.5 MG TABLET,18.95,11.37,4.4,4481.0,19 HCPCS,J3490,MIDODRINE 5 MG TABLET,18.25,10.95,4.23,4481.0,19 HCPCS,J3490,MIDOSTAURIN 25 MG CAPSULE,896.7,538.02,208.03,4481.0,19 HCPCS,J3490,MIFEPRISTONE 200 MG TABLET,145.0,87.0,33.64,4481.0,19 HCPCS,J3490,MILTEFOSINE 50 MG CAPSULE,1730.3,1038.18,401.43,4481.0,19 HCPCS,J3490,"MINERAL OIL, LIGHT STERILE",84.35,50.61,19.57,4481.0,19 HCPCS,J3490,MINOCYCLINE 100 MG CAPSULE,19.3,11.58,4.48,4481.0,19 HCPCS,J3490,MINOCYCLINE 50 MG CAPSULE,16.8,10.08,3.9,4481.0,19 HCPCS,J3490,MINOXIDIL 10 MG TABLET,17.95,10.77,4.16,4481.0,19 HCPCS,J3490,MINOXIDIL 2.5 MG TABLET,17.6,10.56,4.08,4481.0,19 HCPCS,J3490,"MIRABEGRON ER 25 MG TABLET,EXTENDED RELEASE 24 HR",62.05,37.23,14.4,4481.0,19 HCPCS,J3490,MIRTAZAPINE 15 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,MIRTAZAPINE 30 MG TABLET,17.05,10.23,3.96,4481.0,19 HCPCS,J3490,MIRTAZAPINE 45 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,MISOPROSTOL 200 MCG TABLET,22.85,13.71,5.3,4481.0,19 HCPCS,J3490,MISOPROSTOL 25 MCG SPLIT TABLET,16.5,9.9,3.83,4481.0,19 HCPCS,J3490,MONTELUKAST 10 MG TABLET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,MONTELUKAST 4 MG CHEWABLE TABLET,19.15,11.49,4.44,4481.0,19 HCPCS,J3490,MONTELUKAST 5 MG CHEWABLE TABLET,18.85,11.31,4.37,4481.0,19 HCPCS,J3490,MORPHINE (PF) 100 MG/100 ML(1 MG/ML) IN 0.9% SOD.CHLORIDE IV PUMP RESV,52.45,31.47,12.17,4481.0,19 HCPCS,J3490,MORPHINE 0.4 MG/ML ORAL SOLUTION (NEONATAL),22.15,13.29,5.14,4481.0,19 HCPCS,J3490,MORPHINE 10 MG/5 ML ORAL SOLUTION,36.55,21.93,5.43,4481.0,38 HCPCS,J3490,MORPHINE 15 MG IMMEDIATE RELEASE TABLET,24.35,14.61,5.65,4481.0,19 HCPCS,J3490,MORPHINE CONCENTRATE 20 MG/ML ORAL SOLUTION WRAPPER,22.85,13.71,5.3,4481.0,19 HCPCS,J3490,"MORPHINE ER 100 MG TABLET,EXTENDED RELEASE",38.65,23.19,8.97,4481.0,19 HCPCS,J3490,"MORPHINE ER 15 MG TABLET,EXTENDED RELEASE",24.8,14.88,5.75,4481.0,19 HCPCS,J3490,"MORPHINE ER 30 MG TABLET,EXTENDED RELEASE",26.85,16.11,6.23,4481.0,19 HCPCS,J3490,"MORPHINE ER 60 MG TABLET,EXTENDED RELEASE",24.7,14.82,5.73,4481.0,19 HCPCS,J3490,MOXIFLOXACIN 0.5 % EYE DROPS,61.15,36.69,14.19,4481.0,19 HCPCS,J3490,MOXIFLOXACIN 20 MG/ML ORAL SUSPENSION,124.0,74.4,28.77,4481.0,19 HCPCS,J3490,MULTIVIT AND MINERALS-FERROUS GLUCONATE 9 MG IRON/15 ML ORAL LIQUID,1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,MULTIVIT-MINS-FERROUS GLUCONATE 9 MG IRON/15 ML (15 ML) ORAL LIQUID,5.1,3.06,1.18,4481.0,19 HCPCS,J3490,MULTIVITAMIN-IRON 9 MG-FOLIC ACID 400 MCG-CALCIUM AND MINERALS TABLET,1.25,0.75,0.29,4481.0,19 HCPCS,J3490,MUPIROCIN 2 % TOPICAL OINTMENT,43.1,25.86,10.0,4481.0,19 HCPCS,J3490,MUPIROCIN 440 MG/1000 ML NASAL IRRIGATION,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,"MVI, PEDI NO.1 WITH VIT K 80 MG-400 UNIT-200 MCG/5 ML INTRAVENOUS SOLN",645.85,387.51,149.84,4481.0,19 HCPCS,J3490,"MVI,ADULT NO.4 WITH VIT K 3300 UNIT-150 MCG/10 ML INTRAVENOUS SOLUTION",71.45,42.870000000000005,15.52,4481.0,38 HCPCS,J3490,NALOXEGOL 12.5 MG TABLET,59.65,35.79,13.84,4481.0,19 HCPCS,J3490,NALOXEGOL 25 MG TABLET,59.65,35.79,13.84,4481.0,19 HCPCS,J3490,NALTREXONE 50 MG TABLET,24.7,14.82,5.73,4481.0,19 HCPCS,J3490,NAPROXEN 250 MG TABLET,16.8,10.08,3.9,4481.0,19 HCPCS,J3490,NAPROXEN 500 MG TABLET,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,"NEOMYCIN 3.5 MG/G-POLYMYXIN B 10,000 UNIT/G-DEXAMETH 0.1 % EYE OINT",70.2,42.12,16.29,4481.0,19 HCPCS,J3490,NEOMYCIN SULFATE (BULK) POWDER,194.25,116.55,45.07,4481.0,19 HCPCS,J3490,"NEOMYCIN-BACITRACN ZN-POLYMYXN 3.5 MG-400 UNIT-5,000 UNIT TOP OINT PKT",1.25,0.75,0.29,4481.0,19 HCPCS,J3490,"NEOMYCIN-COLIST-HC-THONZONM 3.3 MG-3 MG-10 MG-0.5 MG/ML EAR DROPS,SUSP",713.3,427.98,165.49,4481.0,19 HCPCS,J3490,"NEOMYCIN-POLYMYXIN-DEXAMETH 3.5 MG/ML-10,000 UNIT/ML-0.1% EYE DROPS",70.2,42.12,16.29,4481.0,19 HCPCS,J3490,"NEOMYCIN-POLYMYXIN-HYDROCORT 3.5 MG-10,000 UNIT/ML-1 % EAR DROPS,SUSP",268.55,161.13,62.3,4481.0,19 HCPCS,J3490,"NEOMYCIN-POLYMYXIN-HYDROCORT 3.5 MG/ML-10,000 UNIT/ML-1 % EAR SOLUTION",268.55,161.13,62.3,4481.0,19 HCPCS,J3490,NEONATAL AA 2.5%/HEPARIN 0.5 UNIT/ML DEXTROSE 10% WATER,539.25,323.55,125.11,4481.0,19 HCPCS,J3490,NEONATAL AA ISOTONIC 3.6%/HEPARIN 1 UNIT/ML,118.65,71.19,27.53,4481.0,19 HCPCS,J3490,NEVIRAPINE 50 MG/5 ML ORAL SUSPENSION,53.9,32.34,12.5,4481.0,19 HCPCS,J3490,NICOTINE (POLACRILEX) 2 MG BUCCAL LOZENGE,1.6,0.96,0.3712,4481.0,19 HCPCS,J3490,NICOTINE (POLACRILEX) 2 MG GUM,1.35,0.81,0.3132,4481.0,19 HCPCS,J3490,NICOTINE (POLACRILEX) 4 MG BUCCAL LOZENGE,1.6,0.96,0.3712,4481.0,19 HCPCS,J3490,NICOTINE (POLACRILEX) 4 MG GUM,1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,NICOTINE 14 MG/24 HR DAILY TRANSDERMAL PATCH,3.7,2.22,0.8584,4481.0,19 HCPCS,J3490,NICOTINE 21 MG/24 HR DAILY TRANSDERMAL PATCH,3.7,2.22,0.8584,4481.0,19 HCPCS,J3490,NICOTINE 7 MG/24 HR DAILY TRANSDERMAL PATCH,3.9,2.34,0.9048,4481.0,19 HCPCS,J3490,NIFEDIPINE 0.3%-LIDOCAINE 1.5% IN PETROLATUM,40.8,24.48,9.47,4481.0,19 HCPCS,J3490,NIFEDIPINE 10 MG CAPSULE,18.6,11.16,4.32,4481.0,19 HCPCS,J3490,"NIFEDIPINE ER 30 MG TABLET,EXTENDED RELEASE 24 HR",20.5,12.3,4.76,4481.0,19 HCPCS,J3490,"NIFEDIPINE ER 60 MG TABLET,EXTENDED RELEASE 24 HR",16.85,10.11,3.91,4481.0,19 HCPCS,J3490,NILOTINIB HCL 150 MG CAPSULE,798.05,478.83,185.15,4481.0,19 HCPCS,J3490,NILOTINIB HCL 200 MG CAPSULE,798.05,478.83,185.15,4481.0,19 HCPCS,J3490,NIMODIPINE 30 MG CAPSULE,24.65,14.79,5.72,4481.0,19 HCPCS,J3490,NIMODIPINE 30 MG/5 ML ORAL SYRINGE (FOR ORAL USE ONLY),176.25,105.75,40.89,4481.0,19 HCPCS,J3490,NIMODIPINE 60 MG/10 ML ORAL SOLUTION,180.5,108.3,41.88,4481.0,19 HCPCS,J3490,NITAZOXANIDE 500 MG TABLET,191.65,114.99,44.46,4481.0,19 HCPCS,J3490,NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS 100 MG CAPSULE,20.7,12.42,4.8,4481.0,19 HCPCS,J3490,NITROGLYCERIN 0.2 MG/HR TRANSDERMAL 24 HOUR PATCH,18.15,10.89,4.21,4481.0,19 HCPCS,J3490,NITROGLYCERIN 0.4 MG SUBLINGUAL TABLET,23.8,14.28,5.52,4481.0,19 HCPCS,J3490,NITROGLYCERIN 0.4 MG/HR TRANSDERMAL 24 HOUR PATCH,18.45,11.07,4.28,4481.0,19 HCPCS,J3490,NITROGLYCERIN 0.6 MG/HR TRANSDERMAL 24 HOUR PATCH,19.15,11.49,4.44,4481.0,19 HCPCS,J3490,NITROGLYCERIN 2 % TRANSDERMAL OINTMENT,23.3,13.98,5.41,4481.0,19 HCPCS,J3490,NITROGLYCERIN 400 MCG/SPRAY TRANSLINGUAL,579.1,347.46,134.35,4481.0,19 HCPCS,J3490,NITROPRUSSIDE 50 MG/100 ML (0.5 MG/ML) IN 0.9% SODIUM CHLORIDE IV SOLN,242.85,145.71,56.34,4481.0,19 HCPCS,J3490,NOREPINEPHRINE BITARTRATE 1 MG/ML INTRAVENOUS SOLUTION,79.35,47.61,18.41,4481.0,19 HCPCS,J3490,NOREPINEPHRINE BITARTRATE 8 MG/250 ML (32 MCG/ML) IN DEXTROSE 5 % IV,189.7,113.82,44.01,4481.0,19 HCPCS,J3490,NORETHINDRONE ACETATE 1 MG-ETHINYL ESTRADIOL 5 MCG TABLET,23.55,14.13,5.46,4481.0,19 HCPCS,J3490,NORETHINDRONE ACETATE 5 MG TABLET,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,NORGESTIMATE 0.25 MG-ETHINYL ESTRADIOL 0.035 MG TABLET,81.2,48.72,18.84,4481.0,19 HCPCS,J3490,NORTRIPTYLINE 10 MG CAPSULE,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,NORTRIPTYLINE 10 MG/5 ML ORAL SOLUTION,585.05,351.03,135.73,4481.0,19 HCPCS,J3490,NORTRIPTYLINE 50 MG CAPSULE,17.0,10.2,3.94,4481.0,19 HCPCS,J3490,NXSTAGE RFP 400 (+/- BB) - CONTAINS 2 MEQ/L POTASSIUM,243.0,145.8,56.38,4481.0,19 HCPCS,J3490,NXSTAGE RFP 402 - CONTAINS NO POTASSIUM,243.0,145.8,56.38,4481.0,19 HCPCS,J3490,NXSTAGE RFP 404 - CONTAINS 4 MEQ/L POTASSIUM,243.0,145.8,56.38,4481.0,19 HCPCS,J3490,NXSTAGE RFP 453 - CONTAINS POTASSIUM 2 MEQ/L (CALCIUM FREE),291.6,174.96,67.65,4481.0,19 HCPCS,J3490,NXSTAGE RFP 454 - CONTAINS POTASSIUM 4 MEQ/L (CALCIUM FREE),291.6,174.96,67.65,4481.0,19 HCPCS,J3490,NXSTAGE/MULTIBIC RFP 401 (+/- BB) - CONTAINS 4 MEQ/L POTASSIUM,291.6,174.96,67.65,4481.0,19 HCPCS,J3490,"NYSTATIN 100,000 UNIT/GRAM TOPICAL CREAM",55.1,33.06,12.78,4481.0,19 HCPCS,J3490,"NYSTATIN 100,000 UNIT/GRAM TOPICAL OINTMENT",58.15,34.89,13.49,4481.0,19 HCPCS,J3490,"NYSTATIN 100,000 UNIT/GRAM TOPICAL POWDER",37.1,22.26,8.61,4481.0,19 HCPCS,J3490,"NYSTATIN 100,000 UNIT/ML ORAL SUSPENSION",16.875,10.125,3.85,4481.0,38 HCPCS,J3490,OFLOXACIN 0.3 % EAR DROPS,18.75,11.25,4.35,4481.0,19 HCPCS,J3490,OFLOXACIN 0.3 % EYE DROPS,61.15,36.69,14.19,4481.0,19 HCPCS,J3490,OLANZAPINE 10 MG DISINTEGRATING TABLET,19.8,11.88,4.59,4481.0,19 HCPCS,J3490,OLANZAPINE 10 MG TABLET,17.05,10.23,3.96,4481.0,19 HCPCS,J3490,OLANZAPINE 20 MG DISINTEGRATING TABLET,23.4,14.04,5.43,4481.0,19 HCPCS,J3490,OLANZAPINE 20 MG TABLET,18.85,11.31,4.37,4481.0,19 HCPCS,J3490,OLANZAPINE 5 MG DISINTEGRATING TABLET,18.6,11.16,4.32,4481.0,19 HCPCS,J3490,OLANZAPINE 5 MG TABLET,17.5,10.5,4.06,4481.0,19 HCPCS,J3490,ONDANSETRON 4 MG DISINTEGRATING TABLET,18.1,10.86,4.2,4481.0,19 HCPCS,J3490,ONDANSETRON HCL 4 MG/5 ML ORAL SOLUTION,23.6,14.16,4.32,4481.0,38 HCPCS,J3490,ONDANSETRON HCL 8 MG TABLET,17.85,10.71,4.14,4481.0,19 HCPCS,J3490,OPIUM TINCTURE 10 MG/ML (MORPHINE) ORAL,25.5,15.3,5.92,4481.0,19 HCPCS,J3490,OSELTAMIVIR 30 MG CAPSULE,21.8,13.08,5.06,4481.0,19 HCPCS,J3490,OSELTAMIVIR 6 MG/ML ORAL SUSPENSION,226.6,135.96,52.57,4481.0,19 HCPCS,J3490,OSELTAMIVIR 75 MG CAPSULE,23.8,14.28,5.52,4481.0,19 HCPCS,J3490,OSIMERTINIB 40 MG TABLET,2375.8,1425.48,551.19,4481.0,19 HCPCS,J3490,OSIMERTINIB 80 MG TABLET,2375.8,1425.48,551.19,4481.0,19 HCPCS,J3490,OXCARBAZEPINE 150 MG TABLET,17.65,10.59,4.09,4481.0,19 HCPCS,J3490,OXCARBAZEPINE 300 MG TABLET,18.65,11.19,4.33,4481.0,19 HCPCS,J3490,OXCARBAZEPINE 300 MG/5 ML (60 MG/ML) ORAL SUSPENSION,25.95,15.57,6.02,4481.0,19 HCPCS,J3490,OXYBUTYNIN CHLORIDE 5 MG/5 ML ORAL SYRUP,23.95,14.37,5.56,4481.0,19 HCPCS,J3490,OXYCODONE 20 MG TABLET,23.3,13.98,5.41,4481.0,19 HCPCS,J3490,OXYCODONE 5 MG TABLET,23.4,14.04,5.43,4481.0,19 HCPCS,J3490,"OXYCODONE ER 10 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",39.7,23.82,9.21,4481.0,19 HCPCS,J3490,"OXYCODONE ER 20 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",54.95,32.97,12.75,4481.0,19 HCPCS,J3490,"OXYCODONE ER 30 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",66.7,40.02,15.47,4481.0,19 HCPCS,J3490,"OXYCODONE ER 40 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",78.4,47.04,18.19,4481.0,19 HCPCS,J3490,"OXYCODONE ER 60 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",99.9,59.94,23.18,4481.0,19 HCPCS,J3490,OXYCODONE-ACETAMINOPHEN 5 MG-325 MG TABLET,23.75,14.25,5.51,4481.0,19 HCPCS,J3490,OXYMETAZOLINE 0.05 % NASAL MIST,4.35,2.61,1.01,4481.0,19 HCPCS,J3490,OXYMETAZOLINE 0.05 % NASAL SPRAY,4.3,2.58,0.9976,4481.0,19 HCPCS,J3490,OXYMETAZOLINE 0.05 % NASAL SPRAY (MULTIPLE PATIENTS),1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,PALBOCICLIB 100 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 HCPCS,J3490,PALBOCICLIB 125 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 HCPCS,J3490,PALBOCICLIB 75 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 HCPCS,J3490,"PALIPERIDONE ER 1.5 MG TABLET,EXTENDED RELEASE 24 HR",22.55,13.53,5.23,4481.0,19 HCPCS,J3490,"PALIPERIDONE ER 3 MG TABLET,EXTENDED RELEASE 24 HR",22.55,13.53,5.23,4481.0,19 HCPCS,J3490,PANTOPRAZOLE 2 MG/ML ORAL SUSPENSION,77.8,46.68,18.05,4481.0,19 HCPCS,J3490,PANTOPRAZOLE 4 MG/ML NS PEDIATRIC INJECTION,66.1,39.66,15.34,4481.0,19 HCPCS,J3490,"PANTOPRAZOLE 40 MG TABLET,DELAYED RELEASE",16.55,9.93,3.84,4481.0,19 HCPCS,J3490,PANTOPRAZOLE 40 MG/50 ML NS PEDIATRIC INFUSION,81.5,48.9,18.91,4481.0,19 HCPCS,J3490,PANTOPRAZOLE 80 MG/100 ML NS PEDIATRIC DILUTION,100.0,60.0,23.2,4481.0,19 HCPCS,J3490,PAPAVARINE 16.7 MG/PHENTOLAMINE 0.56 MG/PROSTOGLANDIN,133.6,80.16,31.0,4481.0,19 HCPCS,J3490,PARENTERAL AMINO ACID 10 % COMBINATION NO.7 INTRAVENOUS SOLUTION,314.8,188.88,55.59,4481.0,38 HCPCS,J3490,PARENTERAL AMINO ACID 15 % COMBINATION NO.5 INTRAVENOUS SOLUTION,565.95,339.57,131.3,4481.0,19 HCPCS,J3490,PARENTERAL AMINO ACID 15 % COMBINATION NO.6 INTRAVENOUS SOLUTION,215.4,129.24,49.97,4481.0,19 HCPCS,J3490,PAROXETINE 10 MG TABLET,18.0,10.8,4.18,4481.0,19 HCPCS,J3490,PAROXETINE 20 MG TABLET,17.0,10.2,3.94,4481.0,19 HCPCS,J3490,PAROXETINE 30 MG TABLET,17.4,10.44,4.04,4481.0,19 HCPCS,J3490,PEDI MULTIVIT NO.77-VIT D3 750 UNIT-VIT K 500 MCG/0.5 ML ORAL DROPS,1.75,1.05,0.406,4481.0,19 HCPCS,J3490,PEDIATRIC MULTIVITAMIN NO.192 250 MCG-50 MG-10 MCG/ML ORAL DROPS,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 1,500 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 HCPCS,J3490,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 3,000 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 HCPCS,J3490,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 5,000 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 HCPCS,J3490,PEDIATRIC MULTIVITAMIN ORAL DROPS WRAPPER,2.05,1.23,0.2552,4481.0,38 HCPCS,J3490,PEDIATRIC MULTIVITAMIN-FERROUS SULFATE 11 MG/ML ORAL DROPS WRAPPER,7.425,4.455,0.2552,4481.0,57 HCPCS,J3490,PEG 3350-ELECTROLYTES 236 GRAM-22.74 GRAM-6.74 GRAM-5.86 GRAM SOLUTION,88.25,52.95,20.47,4481.0,19 HCPCS,J3490,PEG 400-HYPROMELLOSE-GLYCERIN 1 %-0.2 %-0.2 % EYE DROPS,3.65,2.19,0.8468,4481.0,19 HCPCS,J3490,PEG-ELECTROLYTE ORAL SOLUTION WRAPPER,88.25,52.95,20.47,4481.0,19 HCPCS,J3490,PEG-ELECTROLYTE SOLUTION 420 GRAM ORAL SOLUTION,100.3,60.18,23.27,4481.0,19 HCPCS,J3490,PENICILLAMINE 250 MG CAPSULE,48.4,29.04,11.23,4481.0,19 HCPCS,J3490,PENICILLIN G SODIUM 5 MILLION UNIT SOLUTION FOR INJECTION,195.75,117.45,45.41,4481.0,19 HCPCS,J3490,PENICILLIN V POTASSIUM 250 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,PENICILLIN V POTASSIUM 250 MG/5 ML ORAL SOLUTION,42.7,25.62,9.91,4481.0,19 HCPCS,J3490,PENICILLIN V POTASSIUM 500 MG TABLET,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,PENTAMIDINE 300 MG SOLUTION FOR INHALATION,518.35,311.01,120.26,4481.0,19 HCPCS,J3490,PENTAMIDINE 300 MG SOLUTION FOR INJECTION,367.0,220.2,85.14,4481.0,19 HCPCS,J3490,"PENTOXIFYLLINE ER 400 MG TABLET,EXTENDED RELEASE",17.3,10.38,4.01,4481.0,19 HCPCS,J3490,PERITON. DIALYSIS SOLN 19-1.5 % DEXTROSE CALC 3.5 MEQ/L-MAG 1.5 MEQ/L,93.5,56.1,19.93,4481.0,57 HCPCS,J3490,PERMETHRIN 1 % TOPICAL LIQUID,13.75,8.25,3.19,4481.0,19 HCPCS,J3490,PERMETHRIN 5 % TOPICAL CREAM,16.8,10.08,3.9,4481.0,19 HCPCS,J3490,PERPHENAZINE 2 MG TABLET,19.0,11.4,4.41,4481.0,19 HCPCS,J3490,PERPHENAZINE 8 MG TABLET,22.35,13.41,5.19,4481.0,19 HCPCS,J3490,PHENAZOPYRIDINE 10 MG/ML ORAL SUSP,3.0,1.8,0.696,4481.0,19 HCPCS,J3490,PHENAZOPYRIDINE 100 MG TABLET,17.0,10.2,3.94,4481.0,19 HCPCS,J3490,PHENAZOPYRIDINE 200 MG TABLET,17.45,10.47,4.05,4481.0,19 HCPCS,J3490,PHENELZINE 15 MG TABLET,18.0,10.8,4.18,4481.0,19 HCPCS,J3490,PHENOBARBITAL 16.2 MG TABLET,17.3,10.38,4.01,4481.0,19 HCPCS,J3490,PHENOBARBITAL 20 MG/5 ML (4 MG/ML) ORAL ELIXIR,35.6,21.36,8.26,4481.0,19 HCPCS,J3490,PHENOBARBITAL 32.4 MG TABLET,23.2,13.92,5.38,4481.0,19 HCPCS,J3490,PHENOBARBITAL 64.8 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,PHENOBARBITAL 97.2 MG TABLET,24.9,14.94,5.78,4481.0,19 HCPCS,J3490,PHENOL 1.4 % MUCOSAL AEROSOL SPRAY,4.85,2.91,1.13,4481.0,19 HCPCS,J3490,PHENYLEPHRINE 0.25 % NASAL SPRAY,6.4,3.84,1.48,4481.0,19 HCPCS,J3490,PHENYLEPHRINE 0.5 % NASAL SPRAY,6.4,3.84,1.48,4481.0,19 HCPCS,J3490,PHENYLEPHRINE 10 % EYE DROPS,136.4,81.84,31.64,4481.0,19 HCPCS,J3490,PHENYLEPHRINE 10 % EYE DROPS (MULTI-PATIENT),17.0,10.2,3.94,4481.0,19 HCPCS,J3490,PHENYLEPHRINE 2.5 % EYE DROPS,113.85,68.31,26.41,4481.0,19 HCPCS,J3490,PHENYLEPHRINE 2.5 % EYE DROPS (MULTI-PATIENT),16.95,10.17,3.93,4481.0,19 HCPCS,J3490,PHENYTOIN 100 MG/4 ML ORAL SUSPENSION,36.1,21.66,8.38,4481.0,19 HCPCS,J3490,PHENYTOIN 125 MG/5 ML ORAL SUSPENSION,17.4,10.44,4.04,4481.0,19 HCPCS,J3490,PHENYTOIN 50 MG CHEWABLE TABLET,20.5,12.3,4.76,4481.0,19 HCPCS,J3490,PHYTONADIONE (VITAMIN K1) 100 MCG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,PHYTONADIONE (VITAMIN K1) 5 MG TABLET,218.15,130.89,50.61,4481.0,19 HCPCS,J3490,PHYTONADIONE 1 MG/ML ORAL SUSPENSION,104.3,62.58,24.2,4481.0,19 HCPCS,J3490,PILOCARPINE 1 % EYE DROPS,253.4,152.04,58.79,4481.0,19 HCPCS,J3490,PILOCARPINE 2 % EYE DROPS,258.8,155.28,60.04,4481.0,19 HCPCS,J3490,PILOCARPINE 4 % EYE DROPS,270.55,162.33,62.77,4481.0,19 HCPCS,J3490,PILOCARPINE 5 MG TABLET,22.85,13.71,5.3,4481.0,19 HCPCS,J3490,PIOGLITAZONE 15 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,PIOGLITAZONE 30 MG TABLET,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,PIOGLITAZONE 45 MG TABLET,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,POLIDOCANOL 1 % (20 MG/2 ML) INTRAVENOUS SOLUTION,66.7,40.02,15.47,4481.0,19 HCPCS,J3490,POLIDOCANOL 1 % INTRAVENOUS FOAM,1223.85,734.31,283.93,4481.0,19 HCPCS,J3490,POLYETHYLENE GLYCOL 3350 17 GRAM ORAL POWDER PACKET,3.3,1.98,0.7656,4481.0,19 HCPCS,J3490,POLYETHYLENE GLYCOL 3350 17 GRAM/DOSE ORAL POWDER,13.55,8.13,3.14,4481.0,19 HCPCS,J3490,POLYETHYLENE GLYCOL 3350 ORAL POWDER FOR LARGE DOSE,42.55,25.53,9.87,4481.0,19 HCPCS,J3490,"POLYMYXIN B SULFATE 10,000 UNIT-TRIMETHOPRIM 1 MG/ML EYE DROPS",47.2,28.32,10.95,4481.0,19 HCPCS,J3490,"POLYMYXIN B SULFATE 500,000 UNIT SOLUTION FOR INJECTION",55.0,33.0,12.76,4481.0,19 HCPCS,J3490,POLYMYXIN/GENTAMICIN (DAB SOLUTION) FOR IRRIGATION (OR),90.1,54.06,20.9,4481.0,19 HCPCS,J3490,POLYSACCHARIDE IRON COMPLEX 150 MG IRON CAPSULE,1.2,0.72,0.2784,4481.0,19 HCPCS,J3490,PONATINIB 15 MG TABLET,3134.35,1880.61,727.17,4481.0,19 HCPCS,J3490,PORACTANT ALFA 120 MG/1.5 ML INTRATRACHEAL SUSPENSION,2351.95,1411.17,545.65,4481.0,19 HCPCS,J3490,PORACTANT ALFA 240 MG/3 ML INTRATRACHEAL SUSPENSION,4622.25,2773.35,1072.36,4481.0,19 HCPCS,J3490,POSACONAZOLE 200 MG/5 ML (40 MG/ML) ORAL SUSPENSION,118.85,71.31,27.57,4481.0,19 HCPCS,J3490,POSACONAZOLE 300 MG/16.7 ML INTRAVENOUS SOLUTION,1797.55,1078.53,417.03,4481.0,19 HCPCS,J3490,POTAS AND SOD CITRATE-CITRIC ACID 550 MG-500 MG-334 MG/5 ML ORAL SOLN,31.8,19.08,7.38,4481.0,19 HCPCS,J3490,POTASSIUM ACETATE 2 MEQ/ML INTRAVENOUS SOLUTION,80.7,48.42,18.72,4481.0,19 HCPCS,J3490,POTASSIUM CHLORIDE 20 MEQ ORAL PACKET,20.6,12.36,4.78,4481.0,19 HCPCS,J3490,POTASSIUM CHLORIDE 20 MEQ/15 ML ORAL LIQUID,189.15,113.49,43.88,4481.0,19 HCPCS,J3490,"POTASSIUM CHLORIDE ER 10 MEQ TABLET,EXTENDED RELEASE(PART/CRYST)",17.5,10.5,4.06,4481.0,19 HCPCS,J3490,"POTASSIUM CHLORIDE ER 20 MEQ TABLET,EXTENDED RELEASE(PART/CRYST)",17.55,10.53,4.07,4481.0,19 HCPCS,J3490,"POTASSIUM CITRATE ER 10 MEQ (1,080 MG) TABLET,EXTENDED RELEASE",23.25,13.95,5.39,4481.0,19 HCPCS,J3490,POTASSIUM IODIDE 1 GRAM/ML ORAL SOLUTION,30.25,18.15,7.02,4481.0,19 HCPCS,J3490,POTASSIUM PHOSPHATE 3 MMOL/ML ORAL SOLN,19.45,11.67,4.51,4481.0,19 HCPCS,J3490,"POTASSIUM PHOSPHATE, MONOBASIC 500 MG SOLUBLE TABLET",1.8,1.08,0.4176,4481.0,19 HCPCS,J3490,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION,159.9,95.94,20.4,4481.0,57 HCPCS,J3490,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION WRAPPER,87.95,52.77,14.01,4481.0,57 HCPCS,J3490,"POTASSIUM, SODIUM PHOSPHATES 280 MG-160 MG-250 MG ORAL POWDER PACKET",1.85,1.11,0.4292,4481.0,19 HCPCS,J3490,POVIDONE-IODINE 10 % TOPICAL LIQUID PACKET,2.55,1.53,0.5916,4481.0,19 HCPCS,J3490,POVIDONE-IODINE 5 % EYE SOLUTION,69.5,41.7,16.12,4481.0,19 HCPCS,J3490,PRAMIPEXOLE 0.125 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,PRAMIPEXOLE 0.25 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,PRAMIPEXOLE 0.5 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,PRAMIPEXOLE 1 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,PRASUGREL HCL 10 MG TABLET,18.5,11.1,4.29,4481.0,19 HCPCS,J3490,PRASUGREL HCL 5 MG TABLET,18.5,11.1,4.29,4481.0,19 HCPCS,J3490,PRAVASTATIN 10 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,PRAVASTATIN 80 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,PRAZIQUANTEL 600 MG TABLET,215.3,129.18,49.95,4481.0,19 HCPCS,J3490,PRAZOSIN 1 MG CAPSULE,17.3,10.38,4.01,4481.0,19 HCPCS,J3490,PRAZOSIN 2 MG CAPSULE,17.95,10.77,4.16,4481.0,19 HCPCS,J3490,PRAZOSIN 5 MG CAPSULE,26.3,15.78,6.1,4481.0,19 HCPCS,J3490,"PREDNISOLONE ACETATE 0.12 % EYE DROPS,SUSPENSION",498.85,299.31,115.73,4481.0,19 HCPCS,J3490,"PREDNISOLONE ACETATE 1 % EYE DROPS,SUSPENSION",280.9,168.54,34.61,4481.0,57 HCPCS,J3490,PREDNISOLONE SODIUM PHOSPHATE 1 % EYE DROPS,174.7,104.82,40.53,4481.0,19 HCPCS,J3490,PREGABALIN 100 MG CAPSULE,26.1,15.66,6.06,4481.0,19 HCPCS,J3490,PREGABALIN 150 MG CAPSULE,24.9,14.94,5.78,4481.0,19 HCPCS,J3490,PREGABALIN 25 MG CAPSULE,26.1,15.66,6.06,4481.0,19 HCPCS,J3490,PREGABALIN 50 MG CAPSULE,26.1,15.66,6.06,4481.0,19 HCPCS,J3490,PREGABALIN 75 MG CAPSULE,26.1,15.66,6.06,4481.0,19 HCPCS,J3490,PRENATAL VITAMINS WITH CALCIUM NO.72-IRON 27 MG-FOLIC ACID 1 MG TABLET,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,PRIMAQUINE 15 MG TABLET,22.15,13.29,5.14,4481.0,19 HCPCS,J3490,PRIMIDONE 250 MG TABLET,17.1,10.26,3.97,4481.0,19 HCPCS,J3490,PRIMIDONE 50 MG TABLET,18.45,11.07,4.28,4481.0,19 HCPCS,J3490,PROBENECID 500 MG TABLET,22.05,13.23,5.12,4481.0,19 HCPCS,J3490,PROCARBAZINE 50 MG CAPSULE,619.1,371.46,143.63,4481.0,19 HCPCS,J3490,PROCARBAZINE ORAL SUSPENSION (10 MG/ML),4192.0,2515.2,972.54,4481.0,19 HCPCS,J3490,PROCHLORPERAZINE 25 MG RECTAL SUPPOSITORY,42.15,25.29,9.78,4481.0,19 HCPCS,J3490,PROCHLORPERAZINE MALEATE 10 MG TABLET,17.6,10.56,4.08,4481.0,19 HCPCS,J3490,PROCHLORPERAZINE MALEATE 5 MG TABLET,19.35,11.61,4.49,4481.0,19 HCPCS,J3490,PROGESTERONE MICRONIZED 200 MG CAPSULE,111.05,66.63,25.76,4481.0,19 HCPCS,J3490,PROGESTERONE MICRONIZED 8 % VAGINAL GEL,110.45,66.27,25.62,4481.0,19 HCPCS,J3490,PROMETHAZINE 12.5 MG RECTAL SUPPOSITORY,45.25,27.15,10.5,4481.0,19 HCPCS,J3490,PROMETHAZINE 12.5 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,PROMETHAZINE 25 MG RECTAL SUPPOSITORY,45.25,27.15,10.5,4481.0,19 HCPCS,J3490,PROPAFENONE 150 MG TABLET,16.85,10.11,3.91,4481.0,19 HCPCS,J3490,PROPAFENONE 20 MG/ML ORAL SUSP,3.0,1.8,0.696,4481.0,19 HCPCS,J3490,PROPARACAINE 0.5 % EYE DROPS,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,PROPRANOLOL 10 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,PROPRANOLOL 20 MG TABLET,17.4,10.44,4.04,4481.0,19 HCPCS,J3490,PROPRANOLOL 20 MG/5 ML (4 MG/ML) ORAL SOLUTION,161.5,96.9,37.47,4481.0,19 HCPCS,J3490,PROPRANOLOL 40 MG TABLET,17.45,10.47,4.05,4481.0,19 HCPCS,J3490,PROPRANOLOL 80 MG TABLET,17.15,10.29,3.98,4481.0,19 HCPCS,J3490,PROPYLTHIOURACIL 5 MG/ML ORAL SUSP,92.2,55.32,21.39,4481.0,19 HCPCS,J3490,PROPYLTHIOURACIL 50 MG TABLET,24.4,14.64,5.66,4481.0,19 HCPCS,J3490,PRUCALOPRIDE 2 MG TABLET,71.75,43.05,16.65,4481.0,19 HCPCS,J3490,PSEUDOEPHEDRINE 30 MG TABLET,1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,PSYLLIUM HUSK 3.4 GRAM ORAL POWDER PACKET,1.5,0.9,0.348,4481.0,19 HCPCS,J3490,PYRAZINAMIDE 100 MG/ML ORAL SUSP,7.3,4.38,1.69,4481.0,19 HCPCS,J3490,PYRAZINAMIDE 500 MG TABLET,29.3,17.58,6.8,4481.0,19 HCPCS,J3490,PYRIDOSTIGMINE BROMIDE 5 MG/ML INJECTION SOLUTION,29.2,17.52,6.77,4481.0,19 HCPCS,J3490,PYRIDOSTIGMINE BROMIDE 60 MG TABLET,20.2,12.12,4.69,4481.0,19 HCPCS,J3490,PYRIDOSTIGMINE BROMIDE 60 MG/5 ML ORAL SYRUP,5284.75,3170.85,1226.06,4481.0,19 HCPCS,J3490,PYRIDOXINE (VITAMIN B6) 50 MG TABLET,1.4,0.84,0.3248,4481.0,19 HCPCS,J3490,PYRIMETHAMINE 2 MG/ML ORAL SUSPENSION,29.2,17.52,6.77,4481.0,19 HCPCS,J3490,QUETIAPINE 100 MG TABLET,17.6,10.56,4.08,4481.0,19 HCPCS,J3490,QUETIAPINE 200 MG TABLET,19.15,11.49,4.44,4481.0,19 HCPCS,J3490,QUETIAPINE 25 MG TABLET,17.0,10.2,3.94,4481.0,19 HCPCS,J3490,QUETIAPINE 300 MG TABLET,18.05,10.83,4.19,4481.0,19 HCPCS,J3490,QUIZARTINIB 17.7 MG TABLET,2362.1,1417.26,548.01,4481.0,19 HCPCS,J3490,QUIZARTINIB 26.5 MG TABLET,2362.1,1417.26,548.01,4481.0,19 HCPCS,J3490,RACEPINEPHRINE 2.25 % SOLUTION FOR NEBULIZATION,4.1,2.46,0.9512,4481.0,19 HCPCS,J3490,RALTEGRAVIR 400 MG TABLET,120.2,72.12,27.89,4481.0,19 HCPCS,J3490,REMIFENTANIL 1 MG INTRAVENOUS SOLUTION,206.4,123.84,47.88,4481.0,19 HCPCS,J3490,REMIFENTANIL 100 MCG/2 ML (50 MCG/ML) IN 0.9 % NACL IV SYRINGE,26.65,15.99,6.18,4481.0,19 HCPCS,J3490,REVUMENIB 110 MG TABLET,2658.35,1595.01,616.74,4481.0,19 HCPCS,J3490,REVUMENIB 160 MG TABLET,2658.35,1595.01,616.74,4481.0,19 HCPCS,J3490,REVUMENIB 25 MG TABLET,1358.35,815.01,315.14,4481.0,19 HCPCS,J3490,RIBAVIRIN 200 MG TABLET,17.85,10.71,4.14,4481.0,19 HCPCS,J3490,RIBOFLAVIN (VITAMIN B2) 100 MG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,RIFABUTIN 150 MG CAPSULE,58.0,34.8,13.46,4481.0,19 HCPCS,J3490,RIFAMPIN 150 MG CAPSULE,25.6,15.36,5.94,4481.0,19 HCPCS,J3490,RIFAMPIN 25 MG/ML ORAL SUSPENSION,88.0,52.8,20.42,4481.0,19 HCPCS,J3490,RIFAMPIN 300 MG CAPSULE,21.6,12.96,5.01,4481.0,19 HCPCS,J3490,RIFAXIMIN 20 MG/ML ORAL SUSPENSION,113.1,67.86,26.24,4481.0,19 HCPCS,J3490,RIFAXIMIN 200 MG TABLET,49.7,29.82,11.53,4481.0,19 HCPCS,J3490,RIFAXIMIN 550 MG TABLET,189.2,113.52,43.89,4481.0,19 HCPCS,J3490,RILPIVIRINE HCL 25 MG TABLET,164.35,98.61,38.13,4481.0,19 HCPCS,J3490,RILUZOLE 50 MG TABLET,18.0,10.8,4.18,4481.0,19 HCPCS,J3490,RIOCIGUAT 0.5 MG TABLET,486.35,291.81,112.83,4481.0,19 HCPCS,J3490,RIOCIGUAT 1 MG TABLET,486.35,291.81,112.83,4481.0,19 HCPCS,J3490,RIOCIGUAT 2.5 MG TABLET,486.35,291.81,112.83,4481.0,19 HCPCS,J3490,RISPERIDONE 0.25 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,RISPERIDONE 0.5 MG DISINTEGRATING TABLET,21.0,12.6,4.87,4481.0,19 HCPCS,J3490,RISPERIDONE 1 MG DISINTEGRATING TABLET,28.3,16.98,6.57,4481.0,19 HCPCS,J3490,RISPERIDONE 1 MG TABLET,17.3,10.38,4.01,4481.0,19 HCPCS,J3490,RISPERIDONE 1 MG/ML ORAL SOLUTION,106.0,63.6,24.59,4481.0,19 HCPCS,J3490,RISPERIDONE 2 MG DISINTEGRATING TABLET,35.95,21.57,8.34,4481.0,19 HCPCS,J3490,RITONAVIR 100 MG TABLET,44.15,26.49,10.24,4481.0,19 HCPCS,J3490,RIVAROXABAN 1 MG/ML ORAL SUSPENSION,1810.0,1086.0,419.92,4481.0,19 HCPCS,J3490,RIVAROXABAN 10 MG TABLET,75.85,45.51,17.6,4481.0,19 HCPCS,J3490,RIVAROXABAN 15 MG TABLET,75.85,45.51,17.6,4481.0,19 HCPCS,J3490,RIVAROXABAN 2.5 MG TABLET,45.95,27.57,10.66,4481.0,19 HCPCS,J3490,RIVAROXABAN 20 MG TABLET,75.85,45.51,17.6,4481.0,19 HCPCS,J3490,RIVASTIGMINE 1.5 MG CAPSULE,17.75,10.65,4.12,4481.0,19 HCPCS,J3490,RIZATRIPTAN 5 MG DISINTEGRATING TABLET,22.15,13.29,5.14,4481.0,19 HCPCS,J3490,ROCURONIUM 10 MG/ML INFUSION CSAC,184.5,110.7,42.8,4481.0,19 HCPCS,J3490,ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTION,75.15,45.09,17.43,4481.0,19 HCPCS,J3490,ROCURONIUM 10 MG/ML PEDIATRIC INFUSION 4 ML,72.75,43.65,16.88,4481.0,19 HCPCS,J3490,ROCURONIUM 10 MG/ML PEDIATRIC INFUSION 50 ML,184.5,110.7,42.8,4481.0,19 HCPCS,J3490,ROCURONIUM 10 MG/ML PEDIATRIC INFUSION 8 ML,82.45,49.47,19.13,4481.0,19 HCPCS,J3490,ROPINIROLE 0.25 MG TABLET,17.65,10.59,4.09,4481.0,19 HCPCS,J3490,ROPINIROLE 0.5 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,ROPINIROLE 1 MG TABLET,17.75,10.65,4.12,4481.0,19 HCPCS,J3490,ROPINIROLE 2 MG TABLET,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,ROTIGOTINE 8 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH,102.4,61.44,23.76,4481.0,19 HCPCS,J3490,RUFINAMIDE 40 MG/ML ORAL SUSPENSION,5293.15,3175.89,1228.01,4481.0,19 HCPCS,J3490,RUFINAMIDE 400 MG TABLET,95.2,57.12,22.09,4481.0,19 HCPCS,J3490,RUXOLITINIB 10 MG TABLET,1198.35,719.01,278.02,4481.0,19 HCPCS,J3490,RUXOLITINIB 5 MG TABLET,565.0,339.0,131.08,4481.0,19 HCPCS,J3490,SACUBITRIL 24 MG-VALSARTAN 26 MG TABLET,51.3,30.78,11.9,4481.0,19 HCPCS,J3490,SACUBITRIL 49 MG-VALSARTAN 51 MG TABLET,51.3,30.78,11.9,4481.0,19 HCPCS,J3490,SACUBITRIL 97 MG-VALSARTAN 103 MG TABLET,51.3,30.78,11.9,4481.0,19 HCPCS,J3490,SALIVA STIMULANT COMBINATION NO.3 ORAL MUCOSAL SPRAY,9.75,5.85,2.26,4481.0,19 HCPCS,J3490,SALSALATE 500 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,SCOPOLAMINE 1 MG OVER 3 DAYS TRANSDERMAL PATCH,44.5,26.7,10.32,4481.0,19 HCPCS,J3490,SELEGILINE 5 MG CAPSULE,21.05,12.63,4.88,4481.0,19 HCPCS,J3490,SELENIUM 10 MCG/ML DILUTION,292.6,175.56,67.88,4481.0,19 HCPCS,J3490,SELENIUM 12 MCG/ML DILUTION,1360.75,816.45,315.69,4481.0,19 HCPCS,J3490,SELENIUM 200 MCG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,SELENIUM 40 MCG/ML INTRAVENOUS SOLUTION,85.15,51.09,19.75,4481.0,19 HCPCS,J3490,SELENIUM 60 MCG/ML INTRAVENOUS SOLUTION,1400.6,840.36,324.94,4481.0,19 HCPCS,J3490,SELENIUM 60 MCG/ML ORAL SOLN,51.0,30.6,11.83,4481.0,19 HCPCS,J3490,SELENIUM SULFIDE 2.5 % LOTION,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,SELEXIPAG 200 MCG TABLET,783.45,470.07,181.76,4481.0,19 HCPCS,J3490,SELEXIPAG 800 MCG TABLET,1209.5,725.7,280.6,4481.0,19 HCPCS,J3490,SENNOSIDES 8.6 MG TABLET,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,SENNOSIDES 8.8 MG/5 ML ORAL SYRUP,1.15,0.69,0.2668,4481.0,19 HCPCS,J3490,SERTRALINE 100 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,SERTRALINE 25 MG TABLET,17.15,10.29,3.98,4481.0,19 HCPCS,J3490,SERTRALINE 50 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,SEVELAMER 50 MG/ML ORAL SOLN,376.0,225.6,87.23,4481.0,19 HCPCS,J3490,SEVELAMER CARBONATE 0.8 GRAM ORAL POWDER PACKET,44.4,26.64,10.3,4481.0,19 HCPCS,J3490,SEVELAMER CARBONATE 2.4 GRAM ORAL POWDER PACKET,21.7,13.02,5.03,4481.0,19 HCPCS,J3490,SEVELAMER CARBONATE 800 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,SILDENAFIL (PULMONARY HYPERTENSION) 10 MG/12.5 ML INTRAVENOUS SOLUTION,737.5,442.5,171.1,4481.0,19 HCPCS,J3490,SILDENAFIL (PULMONARY HYPERTENSION) 10 MG/ML ORAL POWDR FOR SUSPENSION,346.0,207.6,80.27,4481.0,19 HCPCS,J3490,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 2 ML,159.8,95.88,37.07,4481.0,19 HCPCS,J3490,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 50 ML,2482.8,1489.68,576.01,4481.0,19 HCPCS,J3490,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 8 ML,450.2,270.12,104.45,4481.0,19 HCPCS,J3490,SILDENAFIL PEDIATRIC LOADING DOSE INFUSION,667.95,400.77,154.96,4481.0,19 HCPCS,J3490,SILVER NITRATE 0.5 % TOPICAL SOLUTION,226.7,136.02,52.59,4481.0,19 HCPCS,J3490,SILVER SULFADIAZINE 1 % TOPICAL CREAM,164.1,98.46,38.07,4481.0,19 HCPCS,J3490,SILVER SULFADIAZINE-NYSTATIN TOPICAL CREAM,303.95,182.37,70.52,4481.0,19 HCPCS,J3490,SILVER SULFADIAZINE-NYSTATIN-BACITRACIN TOPICAL CREAM,88.5,53.1,20.53,4481.0,19 HCPCS,J3490,"SIMETHICONE 40 MG/0.6 ML ORAL DROPS,SUSPENSION",1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,SIMETHICONE 80 MG CHEWABLE TABLET,1.4,0.84,0.3248,4481.0,19 HCPCS,J3490,SMOG ENEMA 240ML,2.9,1.74,0.6728,4481.0,19 HCPCS,J3490,SODIUM ACETATE 2 MEQ/ML INTRAVENOUS SOLUTION,59.7,35.82,13.85,4481.0,19 HCPCS,J3490,SODIUM ACETATE 2 MEQ/ML ORAL SOLN,16.1,9.66,3.74,4481.0,19 HCPCS,J3490,SODIUM ACETATE 4 MEQ/ML INTRAVENOUS SOLUTION,91.8,55.08,21.3,4481.0,19 HCPCS,J3490,SODIUM BENZOATE 166.6 MG/ML ORAL SOLN,301.0,180.6,69.83,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 0.5 MEQ/ML INJ SOLUTION (PEDIATRIC),239.75,143.85,55.62,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1 MEQ/ML (8.4 %) INJECTION (COMBINED) WRAPPER,77.35,46.41,17.95,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1 MEQ/ML (8.4 %) INTRAVENOUS SOLUTION,77.35,46.41,17.95,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1 MEQ/ML INJ SOLUTION (PEDIATRIC),77.35,46.41,17.95,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1 MEQ/ML INJ SOLUTION WRAPPER (MULTI-VIAL SIZE),77.35,46.41,17.95,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1 MEQ/ML ORAL SOLN,3.0,1.8,0.696,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 150 MEQ/1000 ML IN DEXTROSE 5 % CONT INFUSION PREMIX,161.7,97.02,37.51,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 100 ML INFUSION,126.8,76.08,29.42,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 200ML INFUSION,190.55,114.33,44.21,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 50ML INFUSION,94.9,56.94,22.02,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 4.2 % (0.5 MEQ/ML) INTRAVENOUS SYRINGE,102.3,61.38,23.73,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 4.2 % INTRAVENOUS SOLUTION,76.35,45.81,10.42,4481.0,38 HCPCS,J3490,SODIUM BICARBONATE 50 MEQ/50 ML (8.4 %) INTRAVENOUS SYRINGE,92.85,55.71,21.54,4481.0,19 HCPCS,J3490,SODIUM BICARBONATE 650 MG TABLET,1.25,0.75,0.29,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 0.65 % NASAL SPRAY AEROSOL,2.45,1.47,0.5684,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 0.9 % FOR NEBULIZATION,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 0.9 % INJECTION SOLUTION,20.55,12.33,4.36,4481.0,57 HCPCS,J3490,SODIUM CHLORIDE 0.9 % INTRAVENOUS PIGGYBACK,84.9,50.94,19.7,4481.0,17 HCPCS,J3490,SODIUM CHLORIDE 0.9 % IRRIGATION SOLUTION,85.5,51.3,18.1,4481.0,76 HCPCS,J3490,SODIUM CHLORIDE 0.9% IV BOLUS,101.25,60.75,19.84,4481.0,51 HCPCS,J3490,SODIUM CHLORIDE 0.9% IVPB SOLN,71.4,42.84,16.39,4481.0,51 HCPCS,J3490,SODIUM CHLORIDE 0.9% SOLUTION FOR PCN TESTING,16.15,9.69,3.75,4481.0,38 HCPCS,J3490,SODIUM CHLORIDE 0.9% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),66.3,39.78,15.38,4481.0,19 HCPCS,J3490,"SODIUM CHLORIDE 1,000 MG SOLUBLE TABLET",1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 10 % FOR NEBULIZATION,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 3 % FOR NEBULIZATION,17.9,10.74,4.15,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 4 MEQ/ML ORAL SOLN,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 5 % EYE DROPS,1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 5 % EYE OINTMENT,27.05,16.23,6.28,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE 7 % FOR NEBULIZATION,17.9,10.74,4.15,4481.0,19 HCPCS,J3490,"SODIUM CHLORIDE, SODIUM BICARB-NASAL RINSE SQUEEZE BOTTLE WITH PACKET",14.95,8.97,3.47,4481.0,19 HCPCS,J3490,SODIUM CHLORIDE-HYPOCHLOROUS ACID 0.033 % IRRIGATION SOLUTION,38.325,22.994999999999997,6.44,4481.0,38 HCPCS,J3490,SODIUM CITRATE 4 % (3 ML) INTRA-CATHETER INJECTION SYRINGE,51.8,31.08,12.02,4481.0,19 HCPCS,J3490,SODIUM CITRATE 4 % (5 ML) INTRA-CATHETER INJECTION SYRINGE,22.65,13.59,5.25,4481.0,19 HCPCS,J3490,SODIUM CITRATE 4 GRAM/100 ML (4 %) SOLUTION,101.1,60.66,23.46,4481.0,19 HCPCS,J3490,SODIUM CITRATE-CITRIC ACID 500 MG-334 MG/5 ML ORAL SOLUTION,15.95,9.57,2.06,4481.0,38 HCPCS,J3490,SODIUM DI- AND MONOPHOSPHATE-POTASSIUM PHOS MONOBASIC 250 MG TABLET,1.55,0.93,0.3596,4481.0,19 HCPCS,J3490,SODIUM FLUORIDE 1.1 % DENTAL GEL,73.0,43.8,16.94,4481.0,19 HCPCS,J3490,SODIUM HYDROXIDE (BULK) 10 % SOLUTION,50.1,30.06,4.69,4481.0,38 HCPCS,J3490,SODIUM HYPOCHLORITE 0.125 % SOLUTION,23.0,13.8,5.34,4481.0,19 HCPCS,J3490,SODIUM HYPOCHLORITE 0.25 % SOLUTION,23.0,13.8,5.34,4481.0,19 HCPCS,J3490,SODIUM NITROPRUSSIDE 25 MG/ML INTRAVENOUS SOLUTION,128.4,77.04,29.79,4481.0,19 HCPCS,J3490,SODIUM PHENYLBUTYRATE 0.94 GRAM/GRAM ORAL POWDER,13560.0,8136.0,3145.92,10848.0,19 HCPCS,J3490,SODIUM PHENYLBUTYRATE 100 MG/ML ORAL SOLN,980.5,588.3,227.48,4481.0,19 HCPCS,J3490,SODIUM PHOSPHATE 3 MMOL/ML INTRAVENOUS SOLUTION,105.45,63.269999999999996,17.23,4481.0,38 HCPCS,J3490,SODIUM PHOSPHATE 3 MMOL/ML ORAL SOLUTION,19.6,11.76,4.13,4481.0,38 HCPCS,J3490,SODIUM POLYSTYRENE SULFONATE 15 GRAM-SORBITOL 20 GRAM/60 ML ORAL SUSP,90.35,54.21,20.96,4481.0,19 HCPCS,J3490,SODIUM POLYSTYRENE SULFONATE 15 GRAM/60 ML ORAL COMBINED WRAPPER,90.35,54.21,20.96,4481.0,19 HCPCS,J3490,SODIUM TETRADECYL SULFATE 1 % (10 MG/ML) INTRAVENOUS SOLUTION,126.9,76.14,29.44,4481.0,19 HCPCS,J3490,SODIUM TETRADECYL SULFATE 3 % (30 MG/ML) INTRAVENOUS SOLUTION,126.9,76.14,29.44,4481.0,19 HCPCS,J3490,SODIUM ZIRCONIUM CYCLOSILICATE 10 GRAM ORAL POWDER PACKET,102.2,61.32,23.71,4481.0,19 HCPCS,J3490,"SODIUM,POTASSIUM,MAG SULFATES 17.5 GRAM-3.13 GRAM-1.6 GRAM ORAL SOLN",277.3,166.38,64.33,4481.0,19 HCPCS,J3490,SOLIFENACIN 5 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,SOTALOL 120 MG TABLET,17.15,10.29,3.98,4481.0,19 HCPCS,J3490,SOTALOL 5 MG/ML ORAL SOLUTION,1780.0,1068.0,412.96,4481.0,19 HCPCS,J3490,SOTALOL 80 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,SPIRONOLACTONE 100 MG TABLET,18.2,10.92,4.22,4481.0,19 HCPCS,J3490,SPIRONOLACTONE 12.5 MG SPLIT TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,SPIRONOLACTONE 25 MG TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,SPIRONOLACTONE 25 MG/5 ML ORAL SUSPENSION,1312.75,787.65,304.56,4481.0,19 HCPCS,J3490,SQUARIC ACID 2 % IN ACETONE,78.7,47.22,18.26,4481.0,19 HCPCS,J3490,SQUARIC ACID 5 % IN ACETONE,164.5,98.7,38.16,4481.0,19 HCPCS,J3490,STUDY 021FSGS16010 DUPLEX SPARSENTAN 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 024-00 FTC-TAF/PLACEBO 200-25 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 024-00 FTC-TDF/PLACEBO 200-300 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 024-00 ISL/PLACEBO 60 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 101EP201 NATALIZUMAB 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 101EP201 NATALIZUMAB/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 1042-EAP-3005 GANAXOLONE 50 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 1346-0013 BI 425809/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 14-2797 MEDICATION A 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 14-2797 MEDICATION A 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 1937 INFLIXIMAB/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 20203331 APIXABAN/PLACEBO 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 20230151 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION INHALER,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2040 AZITHROMYCIN 500 MG /PLACEBO,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2072 BTX-A-HAC (DYSPORT)/PLACECO 0/1000/1500 UN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2073 BTX-A-HAC (DYSPORT),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2075 BMS-936557 (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2076 LY2127399/PLACEBO 120 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2111 BTX-A-HAC (DYSPORT)/PLACEBO 0 UNITS/500 UNITS/1000 UNITS,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2117 MIND-USA STUDY MEDICATION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 21177 FINERENONE 10 MG / 20 MG / PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2163 LIDOCAINE/PLACEBO 2%,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 217-PPD-301 SAGE-217/PLACEBO 40 MG KIT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 217-PPD-301 SAGE-217/PLACEBO 50 MG KIT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2176 BTX-A-HAC (DYSPORT) 1000 UNITS/ 1500 UNITS,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2184 QUADRIVALENT HPV VACCINE/ PLACEBO 0.5 ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 22-SRC-03-GIRDLER ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 22-SRC-03-GIRDLER PROGESTERONE MICRONIZED 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2214 BMS-936557 (MAINTENANCE) 0/7.5/15 MG/KG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2214 BMS-936557 0/10/20/MG/KG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2214 BMS-936557 250 MG VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 222291 GSK4532990 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 222291 GSK4532990 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 222291 GSK4532990 25 MG / 100 MG / 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 222291 GSK4532990 25 MG / 100 MG / 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2249 PF-00547659/PLACEBO SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2277 LY2127399 O/120 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2290 PF-04236921 0/10/50/200 MG PER DOSE SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2301 DRCR AFL-BEV-RAN STUDY,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2305 TOLVAPTAN/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 230LE305 BIIB059 (LITIFILIMAB) 225 MG PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2320 AA4500 0.9 MG / 0.39 ML VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2320 PAPAVARINE 16.7 MG/PHENTOLAMINE 0.56 MG/PROSTOGLE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2323 NNC0109-0012/PLACEBO 25MG/50MG/100 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2326 N6022/PLACEBO 1 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2333 DILUENT (PLACEBO SOLUTION),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2333 RAD-IFN 5 X 10E11 PARITCLES PER ML,0.2,0.12,0.0464,4481.0,34 HCPCS,J3490,STUDY 2333 SYN 3 (POLYAMIDE SURFACTANT),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2346 ART-123/ PLACEBO 6 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2358 BMS-188667 ABATACEPT/PLACEBO 250 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2369 PF-00547659/PLACEBO SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2377 BELIMUMAB/PLACEBO 80MG/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 24-1476 DEXTROSE 20% INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2403 H.P. ACTHAR GEL/PLACEBO 80 UNITS/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2404 BELIMUMAB/PLACEBO 80MG/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2414 CROTALIDAE POLYVALENT IMMUNE FAB (OVINE)/PLACEBO,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2418 CALCIPOTRIENE/PLACEBO FOAM 0.005%,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2423 ETANERCEPT/PLACEBO 25 MG/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2424 MEDI8968/PLACEBO 150 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2425 SELG1/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2430 NICOTINAMIDE 500 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2445 PDA-002 100 MILLION CELLS IN 5ML SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2445 PDA-002 30 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2445 PDA-002 10 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2445 PDA-002 3 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2452 BELIMUMAB/PLACEBO 80 MG/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2467 NKA (NEO-KIDNEY AUGMENT),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2473 EXENATIDE 250 MCG/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2474 ULARITIDE/PLACEBO 2.5 MG/5ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2477 APLIGRAF TOPICAL GEL,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2496 OXYCODONE ORAL SOLUTION 1 MG/1ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2504 DFA-02/PLACEBO,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 252BN201 BIIB093/PLACEBO 1 MG/ML IV SOLN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2536 SERELAXIN/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2538 DAPSONE/PLACEBO GEL 7.5%,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2545 ECULIZUMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2546 USL261(MIDAZOLAM)/PLACEBO,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2628 TREPROSTINIL/PLACEBO 2.9 ML SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2637 PEG ELECTROLYTE ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2665 VPI-2690B 30 MG/ML BLUE LABEL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2665 VPI-2690B 30 MG/ML WHITE LABEL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2691 FLUCONAZOLE 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2691 MICAFUNGIN 10 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2691 SCY-078 250 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 2819-CL-0202 FIDAXOMICIN 40 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2819-CL-0202 FIDAXOMICIN TABLET 200 MG,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2819-CL-0202 VANCOMYCIN 25 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2819-CL-0202 VANCOMYCIN CAPSULE 125 MG,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 2826 GEN-003 + MATRIX -M2 OR PLACEBO 0.8 ML VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 3265 MIDAZOLAM/PLACEBO 2 MG/ML ORAL SOLUTION (ROUND 0.1 ML),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 3265 MIDAZOLAM/PLACEBO 2 MG/ML ORAL SOLUTION (ROUND 0.2 ML),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY 70033093AFL3002 APIXABAN/PLACEBO 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 70033093AFL3002 APIXABAN/PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 70033093AFL3002 JNJ-70033093 (MILVEXIAN)/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 77242113UCO2001 JNJ-77242113 100 MG / 200 MG / PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY 80202135EBF3001 NIPOCALIMAB OR PLACEBO INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A011-12 SOTERIA SOTATERCEPT/PLACEBO 50 MG/ML (0.3 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY A011-12 SOTERIA SOTATERCEPT/PLACEBO 50 MG/ML (0.7 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY A011-13 HYPERION SOTATERCEPT/PLACEBO 50 MG/ML (0.3 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY A011-13 HYPERION SOTATERCEPT/PLACEBO 50 MG/ML (0.7 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY A032103-CIRB RELATLIMAB (BMS-986016) 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY A35-004 AMX0035/PLACEBO 4 G SACHET (TAURURSODIOL 1 G-PB 3 G),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5332 PITAVASTATIN/PLACEBO 4 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5355 CMV-MVA TRIPLEX/PLACEBO 5.2 X 10E8 PFU/ML INJECTION SOLUTION CYTOMEGALOVIRUS VACCINE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5355 CMV-MVA TRIPLEX/PLACEBO 8 X 10E8 PFU/ML INJECTION SOLUTION CYTOMEGALOVIRUS VACCINE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5357 CABOTEGRAVIR 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5357 VRC07-523LS 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5359 CABOTEGRAVIR LA 200 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,34 HCPCS,J3490,STUDY A5359 RILPIVIRINE LA 300 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,34 HCPCS,J3490,STUDY A5377 SAR441236 25 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5386 10-1074-LS (GS-2872) 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5386 N-803 2 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5386 VRC07-523LS 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5391 DORAVIRINE 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY A5404 MRNA-1273 100 MCG/0.5 ML INJECTION SOLUTION COVID 19 VACCINE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AAAU4206 ETRUMADENANT 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AAAU4206 ETRUMADENANT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AAAU4206 ETRUMADENANT 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ABT-CIP-10305 ASPIRIN/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACCL1931 LEVOCARNITINE 100 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ACCL1931 LEVOCARNITINE 330 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ACETAMINOPHEN 160 MG/5 ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ACETAMINOPHEN 325 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ACETAMINOPHEN 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ACETAMINOPHEN 500 MG/15 ML ORAL LIQUID,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ACNS2031 SODIUM THIOSULFATE (STS) ANHYDROUS 80 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTG A5326 BMS-963559/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTG A5342 VRC01/PLACEBO 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTG A5378 VRC07-523LS 100 MG/ML VIAL,0.2,0.12,0.0464,4481.0,34 HCPCS,J3490,STUDY ACTIV-1 IM REMDESIVIR 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2/A5401 AEROGEN ULTRA NEBULIZER DEVICE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2/A5401 C135-LS 100 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2/A5401 C144-LS 100 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2/A5401 CASIRIVIMAB 120 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2/A5401 CASIRIVIMAB 60 MG-IMDEVIMAB 60 MG/ML INTRAVENOUS SOLUTION (CO-FORMULATED),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2/A5401 IMDEVIMAB 120 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2/A5401 INTERFERON-B1A (SNG001) 12 MIU/ML NEBULIZED INHALATION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,"STUDY ACTIV-2/A5401 SAB-185 38,753 UNITS/ML IV SOLN",0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-2B/A5405 RITONAVIR/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-4D FOSTAMATINIB/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-4D FOSTAMATINIB/PLACEBO 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-4D TRV027/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACTIV-4D TXA127/PLACEBO 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACV01 MRNA (12YR UP) (PFIZER) (PF) 30 MCG/0.3 ML IM SUSPENSION (GRAY),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACV01 MRNA (12YR UP) (PFIZER) (PF) 30 MCG/0.3 ML IM SUSPENSION (PURPLE),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ACV01 MRNA (5-11YR) (PFIZER) (PF) 10 MCG/0.2 ML IM SUSPENSION (ORANGE),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ADRN-12 IRB# 22-1668 HYDROCORTISONE 2.5 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ADRN-12 IRB# 22-1668 TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AEROCHAMBER DEVICE ADULT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AEZS-130-P02 DETECT ARGININE HCL (L-ARGININE) 10 % INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AEZS-130-P02 DETECT CLONIDINE 0.75 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AEZS-130-P02 DETECT MACIMORELIN 0.5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AFT-66 (CAMBRIA-2) CAMIZESTRANT 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AK-US-001-0106 EFRUXIFERMIN/PLACEBO 50 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AK002-003X IN 0.9% SODIUM CHLORIDE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AK002-014 AK002 15 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AK002-016X AK002 15 MG/ML IV SOLN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AK117-205 AK117 (LIGUFALIMAB) / PLACEBO 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AK117-205 AK117 (LIGUFALIMAB) / PLACEBO 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AL001-3 AL001 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AL001-3 AL001/PLACEBO 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ALBUTEROL SULFATE 2.5 MG/3 ML (0.083 %) SOLUTION FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ALBUTEROL SULFATE HFA 90 MCG / ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ALE10 (DIVERT) VOCLOSPORIN/PLACEBO 7.9 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ALS-8176-503 ALS-008176/PLACEBO 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ALS-8176-503 ALS-008176/PLACEBO 9.1 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ALXN2220-ATTRCM-301 ALXN2220/PLACEBO 50 MG/ML IVPB,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AMG 569 20230070 IRB# 24-0683 AVACOPAN 10 MG GELATIN CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AMG 569 20230070 IRB# 24-0683 AVACOPAN 3 MG/ML ORAL LIQUID,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AMT-101-201 (PHASE 2) AMT-101 3 MG/10 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AMT-101-201 (PHASE 3) AMT-101/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY AMT-101-201 (PHASE 3) AMT-101/PLACEBO 3 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY APVO436-5201 APVO436 1.06 MCG/ML IV SOLUTION (DILUTION),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY APVO436-5201 APVO436 10.3 MCG/ML IV SOLUTION (DILUTION),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ARGX-113-1602 ARGX-113/PLACEBO 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ARGX-113-1704 ARGX-113/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ARGX-113-2308 ARGX-113 (EFGARTIGIMOD) 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ARGX-113-2308 ARGX-113 (EFGARTIGIMOD)/PLACEBO 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ARGX-117-2002 ARGX-113/PLACEBO 120 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ASPIRE APIXABAN/PLACEBO 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ASPIRE APIXABAN/PLACEBO 5 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ASPIRE ASPIRIN/PLACEBO 81 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ATROPINE 0.1 MG/ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AZ D5134C00001 (SOCRATES) ASPIRIN/PLACEBO 100 MG TABLETS,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AZ D5134C00001 (SOCRATES) TICAGRELOR/PLACEBO 90MG TABLETS,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY AZ D5985C00006 HFO/HFA MDI INHALER,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY B0401016 PF-04447943/PLACEBO 5 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY B0401016 PF-04447943/PLACEBO 5 MG/15 MG TABLETS,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY B7981041 RITLECITINIB/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY B7981041 RITLECITINIB/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY BACTERIOSTATIC WATER INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BAY-73-4506 REGORAFENIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY BAY-73-4506 REGORAFENIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY BAYER BAY 59-7939/17454 ASPIRIN 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BDTX-1535-101 BDTX-1535 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BDTX-1535-101 BDTX-1535 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,"STUDY BEST TRIAL UNC IRB# 21-3271 DULOXETINE 30 MG CAPSULE, DELAYED RELEASE",0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY BHV7000-303 BVH-7000 50 MG / 25 MG / PLACEBO EXTENDED RELEASE TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BI 1293.10 BI655064 0/120/180 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BLADE-VG2 CALCIUM SULFATE CARRIER POWDER,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BLADE-VG2 HEMISPHERICAL BEADS 3 MM USING MOLD MAT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BO45217 SOTORASIB 120 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY BP-ARDS-P2-001 BEVACIZUMAB/PLACEBO 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BP-ARDS-P2-001 PARIDIPRUBART/PLACEBO 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BP-ARDS-P2-001 VILOBELIMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BP41674 RO7248824 (IDDP) 35 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BP41674 RO7248824 20 ML DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BP41674 RO7248824 50 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BRE18-360 OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BRE18-360 OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY BRIMONIDINE 0.2% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY BUL-8/EEA BUDESONIDE/PLACEBO 1 MG/2 MG ORODISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY C15009 MLN4924 INTRAVENOUS SOLUTION 10 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY C4671026 NIRMATRELVIR 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY C4671026 RITONAVIR 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CA-ALT-803-01-14 ALT-803 1 MG/ML INTRAVESICAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CA-ALT-803-01-16 ALT-803 1 MG/ML INTRAVESICAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CAEL101-302 CAEL-101 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CAEL101-302 CAEL-101/PLACEBO 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CBGJ398XUS04 BGJ398 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CBGJ398XUS04 BGJ398 CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CBYL719F12201 ALPELISIB (BYL719) 125 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CBYL719F12201 ALPELISIB (BYL719) 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CBYL719F12201 ALPELISIB (BYL719) 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CBYL719F12201 ALPELISIB (BYL719)/PLACEBO 125 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CBYL719F12201 ALPELISIB (BYL719)/PLACEBO 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CC-93538-EE-001 CC-93538/PLACEBO 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CC-93538-EE-002 CC-93538 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CC-93538-EE-002 CC-93538 360 MG/2 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 200 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 50 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CHAP LABETOLOL 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CHAP NIIFEDIPINE EXTENDED RELEASE (ER) 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CHUGAI SA309JG SA237 120 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CHUGAI SA309JG SA237/PLACEBO 120 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CISATRACURIUM CONCENTRATE 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CJWT629A12301 AZITHROMYCIN/PLACEBO 250 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CJWT629A12301 HYDROXYCHLOROQUINE/PLACEBO 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3127),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3204),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3735),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CLEE011XUS03 LEE011 200 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CLEE011XUS03 LEE011 50 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CLINPRT-6 MBP091 (EAP) 50 MG/ML CONCENTRATE VIAL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CLN-PXT3003-06 PXT3003/PLACEBO ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CNS7056-008 REMIMAZOLAM/PLACEBO 2.5 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CNS7056-008 REMIMAZOLAM/PLACEBO 2.5 MG/ML TOP-UP DOSE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CNTO1959CRD3001 USTEKINUMAB/PLACEBO 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CNTO1959UCO3001 GUSELKUMAB/PLACEBO 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CO43613 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY COG AOST 1322 ERIBULIN 0.5 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CPI-IFE-008 IFETROBAN/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CRLX030A2209 SERELAXIN/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CV010-031 BMS-986177 25 MG / 100 MG / PLACEBO CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY CV013-011 BMS-986231/PLACEBO INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY CV013-011 BMS-986231/PLACEBO WITH POTASSIUM ACETATE IN 120 ML D5W IVPB,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY D0816C00010 OLAPARIB TABLET 100 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY D0816C00010 OLAPARIB TABLET 150 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY D1690C00078 DAPAGLIFLOZIN/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY D3258C00001 BENRALIZUMAB 30 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY D3258C00001 BENRALIZUMAB/PLACEBO 30 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY D3461C00007 ANIFROLUMAB/PLACEBO 150 MG INTRAVENOUS SOLUTION FOR 1ST 3 MONTHS,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY D5551C00002 EXENATIDE/PLACEBO 2 MG DUAL CHAMBER PREFILLED PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY D5551C00002 EXENATIDE/PLACEBO 2 MG POWDER FOR INJECTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY D798KC00001 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY D9090C00008 AZD5462 20 MG/40 MG/180 MG/PLACEBO TABLET (BLUE LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY D9090C00008 AZD5462 20 MG/40 MG/180 MG/PLACEBO TABLET (WHITE LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY D9470C00001 STABILIZER SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY DB-1303-O-3002 DB-1303 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY DEXAMETHASONE 0.1% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DEXAMETHASONE 0.1% OPHTHALMIC SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DEXAMETHASONE 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DEXAMETHASONE 1.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DEXAMETHASONE 2 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DEXAMETHASONE 4 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DEXAMETHASONE 6 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DEXTROSE 5% IN WATER (D5W) INTRAVENOUS SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DFCI 13-559 PALBOCICLIB 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DFCI 13-559 PALBOCICLIB CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DICTATE-AHF DAPAGLIFLOZIN 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DIPHENHYDRAMINE 25 MG CAPSULE/TABLET WRAPPER,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DMID 21-0018 CEFIXIME 400 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DMID 21-0018 CIPROFLOXACIN 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DMID 21-0018 MENINGOCOCCAL B VACCINE / INFLUENZA VACCINE / TETANUS DIPTHERIA VACCINE 0.5 ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY DNLI-E-0002 DNL310 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY DNLI-E-0007 DNL310 30 MG/ML INTRAVENOUS SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY DNLI-E-0007 DNL310 OR IDURSULFASE IVPB,0.2,0.12,0.0464,4481.0,51 HCPCS,J3490,STUDY DNLI-I-0001 DNL126 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY DRCR AF FENOFIBRATE/PLACEBO 160 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DRCR AF FENOFIBRATE/PLACEBO 54 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DU176B-D-U312 EDOXABAN 6 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY DV0013 ZILUCOPLAN 40 MG/ML (16.6 MG/0.416 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DV0013 ZILUCOPLAN 40 MG/ML (23.0 MG/0.574 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY DV0013 ZILUCOPLAN 40 MG/ML (32.4 MG/0.810 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ECU-MG-302 ECULIZUMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY EDGE EG-01-1962-03 EG-1962/PLACEBO 600 MG SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY EDOXABAN 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY EIND 31920 PSA1/PSA16/AFR22/KEN13 BACTERIOPHAGE FOR INFUSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,"STUDY EPINEPHRINE 0.3MG/0.3 ML (1:1,000) IM PEN INJECTOR",0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY EVADE MEDI3902 200 MG (50 MG/ML) OR PLACEBO VIAL,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY EX6018-4758 ZILTIVEKIMAB C 30 MG/ML OR PLACEBO PFS 0.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY EX6018-4915 ZILTIVEKIMAB B/PLACEBO 15 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY EX6018-4979 ZILTIVEKIMAB C/PLACEBO 15 MG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 14 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 3 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 7 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY EXPANDED ACCESS ABBV-8E12 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY FAMOTIDINE 10 MG/ML INJ SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,"STUDY FBF-001-001 ELLIOTTS B SOLUTION, BUFFERED INTRATHECAL ELECTROLYTE/DEXTROSE SOLUTION FOR INJECTION",0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY FBF-001-001 FBF-001 20 MG/ML STERILE SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY FLUMAZENIL 0.1 MG/ML IV,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY FMGX-CS-301 FLUCONAZOLE/PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY FP2CLI004 BEXMARILIMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY FPA-AS-30094 ALBUTEROL SULFATE 2.5 MG/3 ML (0.083%) SOLUTION FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY FPA-AS-30094 ALBUTEROL SULFATE MDI 90 MCG/ACTUATION INHALER,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY GA28950 ETROLIZUMAB/PLACEBO 105 MG 0.7 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GB002-3101 DRY POWDER INHALER DEVICE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GB002-3101 SERALUTINIB/PLACEBO 15 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GB002-3102 DRY POWDER INHALER DEVICE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GB002-3102 SERALUTINIB 15 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GBT440-041 VOXELOTOR 100 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY GBT440-041 VOXELOTOR 300 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY GCT1046-01 CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY GCT1046-01 GEN1046 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GILEAD GS-US-200-4334 GS-6207 450 MG/1.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GILEAD GS-US-326-1100 GS-5745/PLACEBO 150 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-528-6020 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY GS-US-528-6020 LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-528-9023 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG/PLACEBO TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY GS-US-528-9023 LENACAPAVIR 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-528-9023 LENACAPAVIR/PLACEBO 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-528-9023 LENACAPAVIR/PLACEBO 309 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-546-5857 MAGROLIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-563-6041 IRB# 21-2334 BICTEGRAVIR 50 MG/EMTRICITABINE 200 MG/TENOFOVIR 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-563-6041 IRB# 21-2334 ISLATRAVIR 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-563-6041 IRB# 21-2334 LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-721-7286 (PURPOSE 365) LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GS-US-721-7286 (PURPOSE 365) LENACAPAVIR 500 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GSK 201023 OSELTAMIVIR SUSPENSION 6 MG/ML,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY GT-031 BELAPECTIN/PLACEBO 27 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY GTX-102-CL301 GTX-102 2 MG/ML INTRATHECAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,"STUDY GTX-102-CL301 GTX/UX DILUENT AND FLUSH SOLUTION, BUFFERED (INTRATHECAL USE)",0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 0.75 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 1.5 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 3.0 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 4.5 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HAL-MPE1/PLACEBO 0.1 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HAL-MPE1/PLACEBO 1 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HAL-MPE1/PLACEBO 2 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HAL-MPE1/PLACEBO 20 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HAL-MPE1/PLACEBO 375 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HAL-MPE1/PLACEBO 40 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HAL-MPE1/PLACEBO 750 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HAZ COVID AZITHROMYCIN/PLACEBO 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HAZ COVID HYDROXYCHLOROQUINE/PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HEAT BIOLOGICS HS410-101 BCG LIVE VACCINE INTRAVESICAL SUSPENSIN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HM-TRIA-201 HM15211 2 MG / 4 MG / 6 MG / PLACEBO PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HOFFMAN-LAROCHE GA29145 ETROLIZUMAB PREFILLED SYRINGE 105MG/0.,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HPTN 083 CABOTEGRAVIR (GSK1265744) 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HPTN 083 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HPTN 106 EMTRICITABINE 200 MG-TENOFOVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HPTN 106 SUPPLEMENTAL SUPPLIES,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HPTN 106 TENOFOVIR (TFV) RECTAL DOUCHE SACHET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HQP1351CG301-POLARIS-2 OLVEREMBATINIB 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HS0005 BIMEKIZUMAB 160 MG/ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HVTN 704/HPTN 085 VRC01/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY HYDROCORTISONE 1 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HYDROCORTISONE 2.5% OINTMENT,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY HYDROCORTISONE 2.5% TOPICAL CREAM,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY I4V-MC-JAIR BARICITINIB/PLACEBO 2 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I4V-MC-JAIR BARICITINIB/PLACEBO 4 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHK(A) TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHL TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHM TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 10 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 12.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 15 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 2.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 7.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IA-001 FLU-IGIV/PLACEBO IN 0.9% SODIUM CHLORIDE IVPB,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IBUPROFEN 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IGHID 11525 ZANAMIVIR 10 MG/ML PEDIATRIC SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IGHID 11525 ZANAMIVIR 10 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IGHID 12430/DELIVER-02 MGD020 4 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IGHID 12430/DELIVER-02 MGV002 VEHICLE INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IGHID 12430/DELIVER-02 VOR 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IM011127 BMS-986165 6 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IM011127 BMS-986165/PLACEBO 12 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IM128027 BMS-931699/PLACEBO SYRINGE 1.25 MG/5 MG/12.5MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IMVT-1401-2401 BATOCLIMAB 340 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IMVT-1401-2401 BATOCLIMAB/PLACEBO 340 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IMVT-1401-3201 BATOCLIMAB/PLACEBO 340 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IMVT-1402-3101 300 MG/2 ML INJECTOR PEN OR PLACEBO,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND 116002 CEFEPIME-ZIDEBACTAM 3 GRAM INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND 172688 CLOFAZIMINE 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND 178958 CLOFAZIMINE 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND CASIRIVIMAB-IMDEVIMAB 60 MG-60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND DSP-0509 0.3 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND EXEBACASE (CF-301) 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND GANAXOLONE 1 MG/ML BOLUS FROM BAG (PEDIATRIC),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND GANAXOLONE 1 MG/ML INTRAVENOUS SOLUTION (PEDIATRIC),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND INOTUZUMAB OZOGAMICIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND IRB# 21-1333 AT-007 ORA-PLUS COMPOUNDING VEHICLE SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IND JZP150 IRB# 22-3339 JZP150 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND LOXO-305 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND MAGROLIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IND NIROGACESTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY INTREPID ASPIRIN 81 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY INTREPID TICAGRELOR 90 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,"STUDY IOBP PIVOTAL INUSLIN ASPART (FIASP) ""FASTER ASPART"" 100 UNITS/ML INJECTION CARTRIDGE",0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IOBP PIVOTAL INUSLIN ASPART (NOVOLOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IOBP PIVOTAL INUSLIN LISPRO (HUMALOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IOBP2X INSULIN ASPART (NOVOLOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IOBP2X INSULIN LISPRO (HUMALOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ION582-CS1 ION582 20 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ION582-CS1 ION582 DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ION582-CS2 ION582 40 MG / 80 MG / PLACEBO INTRATHECAL SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ION582-CS2 ION582 40 MG INTRATHECAL SYRINGE (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ION582-CS2 ION582 80 MG INTRATHECAL SYRINGE (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IPRATROPIUM BROMIDE 0.02 % SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB #15-2770 D3-CREATINE 4 MG/ML IN 20% HEAVY WATER (D20),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB #15-2770 D3-CREATINE 7.5 MG/ML IN 20% HEAVY WATER (D2O),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB 14-1455 APIXABAN 5 MG TABLETS,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB 15-2865 POLYETHYLENE GLYCOL-ELECTROLYTE SOLUTION 4000,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB 16-0739 FMT UPPER DELIVERY MICROBIOTA PREPARATIONN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB 20-2267 TRANEXAMIC ACID/PLACEBO 100 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB# 17-1500 PYRIDOXINE/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB# 18-0431 MEPOLIZUMAB / PLACEBO 100 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB# 19-2343 PROGESTERONE 200 MG / ESTRADIOL 2 MG / PLACEBO CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB# 20-0052 DORAVIRINE 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB# 20-1112 GABAPENTIN 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB# 20-3016 LIRAGLUTIDE/PLACEBO 6 MG/ML (18 MG/3 ML) INJECTION PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB# 21-2453 GOS/HGOS/PLACEBO 5 G SACHET KIT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB# 21-2453 GOS/HGOS/PLACEBO 7.5 G SACHET KIT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB# 21-3111 MINOCYCLINE/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB# 22-1421 PSILOCYBIN 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB# 22-1987 IND JZP150 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRB# 23-0632 DEXTROSE 20% INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB# 24-2210 AZITHROMYCIN/PLACEBO IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY IRB# 24-2276 KETOROLAC/PLACEBO 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,"STUDY IRB#22-1310 ERGOCALCIFEROL/PLACEBO 50,000 IU CAPSULE",0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY IRC 003 OSELTAMIVIR/RIBAVIRIN/AMANTIDINE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ISLEND-1 BICTEGRAVIR 50 MG / EMTRICITABINE 200 MG / TENOFOVIR 25 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ISLEND-1 ISLATRAVIR (MK-8591) 0.5 MG / LENACAPAVIR (GS-6207-02) 300 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ISLEND-1 ISLATRAVIR (MK-8591) 2 MG / LENACAPAVIR (GS-6207-02) 300 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY J1I-MC-GZQA RETATRUTIDE/PLACEBO 2 MG / 4 MG / 6 MG / 9 MG / 12 MG SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY J2L-MC-EZBB LY3461767/PLACEBO 10 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY J2L-MC-EZBB LY3461767/PLACEBO 8.7 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LAIV IN COPD FLU VACC QV LIVE 2022-2023 10E6.5-7.5 FF UNIT/0.2 ML NASAL SPRAY,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LBS-SS201 LB1148/PLACEBO RECONSTITUTED SOLUTION 700 ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LCCC1915 PERFLUTREN LIPID MICROSPHERES INTRAVENOUS SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LCCC2037 OLANZAPINE / PLACEBO 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LCCC2037 OLANZAPINE / PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LCCC2220 ERLOTINIB 25 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LCCC2425 MEMANTINE/PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LIDOCAINE 1% INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LIDOCAINE-PRILOCAINE 2.5 %-2.5 % TOPICAL CREAM,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LILLY I6T-MC-AMAN MIRIKIZUMAB (LY3074828)/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828)/PLACEBO 100 MG/ML PREFILLED SYRINGE #1 OF 2,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828)/PLACEBO 100 MG/ML PREFILLED SYRINGE #2 OF 2,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LORATADINE 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LOXO-FG3-22001 LOXO-435 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LOXO-FG3-22001 LOXO-435 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LOXO-FG3-22001 LOXO-435 20 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LOXO-FG3-22001 LOXO-435 6 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LOXO-RAS-20001 CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY LT3001-203 LT3001/PLACEBO 4 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LTI-401 TREPROSTINIL 106 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LTI-401 TREPROSTINIL 26.5 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LTI-401 TREPROSTINIL 53 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY LTI-401 TREPROSTINIL 79.5 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M13-741 ABT-981/PLACEBO 25/100/200 MG/ 2ML INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-327 UPADACITINIB ER 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-327 UPADACITINIB ER 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-671 UPADACITINIB 0.5 MG/ML / 1.0 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-671 UPADACITINIB 1.0 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-671 UPADACITINIB ER 15 MG / 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-671 UPADACITINIB ER 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-671 UPADACITINIB ER 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M14-671 UPADACITINIB ER 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY M22-574 SELINEXOR 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY M22-574 SELINEXOR 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY M22-574 SELINEXOR 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY M22-574 SELINEXOR 60 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY MAST MST-188-01 MST-188/PLACEBO 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MEK-NF-201 PD-0325901 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MEK-NF-201 PD-0325901 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MG0011 BEXSERO 0.5 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MG0011 MENVEO 0.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (16.6 MG/0.416 ML) PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (23 MG/0.574 ML) PRE-FILLE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (32.4 MG/0.810 ML) PRE-FIE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK-5475-007 DRY POWDER INHALER TRAINING DEVICE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK-5475-007 MK-5475 32 MCG/INH OR 100 MCG/INH OR 380 MCG/INH OR PLACEBO DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-001-01 MK-7240 (TULISOKIBART) 100 MG/ML SOLUTION FOR INFUSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 1000 MG/500 MG IV INFUSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 200 MG/ML AUTO-INJECTOR,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 500 MG/250 MG IV INFUSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-008-00 TULISOKIBART 100 MG/ML INTRAVENOUS SOLUTION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 1000 MG OR 500 MG IVPB IN 275 ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,"STUDY MK7240-008-00 TULISOKIBART/PLACEBO 200 MG/ML, 1.2 ML AUTOINJECTOR",0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 500 MG OR 250 MG IVPB IN 275 ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MK8527-011 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG (EQ 245 MG TD) OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY MK8527-011 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (EQ 245 MG TD),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY MK8527-011 MK-8527/PLACEBO 11 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MKC-CI-002 MKND-101 (CLOFAZIMINE) 80 MG / 50 MG / PLACEBO INHALATION SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MKC-CI-002 MNKD-101 (CLOFAZIMINE) 50 MG INHALATION SUSPENSION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MKC-CI-002 MNKD-101 (CLOFAZIMINE) 80 MG INHALATION SUSPENSION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MLN0002-2003 VEDOLIZUMAB 100/200 MG IVPB,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY MLN0002-2003 VEDOLIZUMAB 150/300 MG IVPB,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY MS200527_0082 EVOBRUTINIB 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MS200527_0082 EVOBRUTINIB/PLACEBO 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MS200527_0082 TERIFLUNOMIDE/PLACEBO 14 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MT-12 DESLORATADINE 0.5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MT-12 LORATADINE 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY MT-12 MOMETASONE FUROATE 50 MCG/ACTUATION NASAL SPRAY,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY MT-12 OLOPATADINE 0.1% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NAB-BC-3781-1202 LEFAMULIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NBTX-1100 NBTXR3 54.2 G/L,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NCI-10553-CIRB DAROLUTAMIDE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NCI10596-CIRB SNDX-5613 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NCI10596-CIRB SNDX-5613 113 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NCI10596-CIRB SNDX-5613 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NCI10596-CIRB SNDX-5613 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NCI10596-CIRB SNDX-5613 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NCI10596-CIRB SNDX-5613 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NCT01954056 HYDROCORTISONE/PLACEBO INTRAMUSCULAR,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NCT01954056 HYDROCORTISONE/PLACEBO INTRAVENOUS,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NCT01954056 HYDROCORTISONE/PLACEBO ORAL,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NEU-411-PD201 NEU-411/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NEU-411-PD201 NEU-411/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NHLBI-2019-SIL SILDENAFIL/PLACEBO 10 MG/12.5 ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NICHD MFMU PRAVASTATIN/PLACEBO 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NICHD NRN INS-3 INOSITOL/PLACEBO 50 MG/ML INTRAVENOUSNS,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NICHD NRN INS-3 INOSITOL/PLACEBO 50MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NICHD PROSPECT PROGESTERONE/PLACEBO 200 MG MICRONIZED CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 10 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NICHD-2023-MON01 MONTELUKAST/PLACEBO 4 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NICHD-NRN-0064 (BIB) BUDESONIDE/PLACEBO 0.5 MG/2 ML SUSPENSION (NEONATAL),0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 1 MG/ML + SEMAGLUTIDE 0.5 MG/ML (CAGRISEMA) (DOSE 0.25 MG/0.25 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 1 MG/ML + SEMAGLUTIDE 0.5 MG/ML (CAGRISEMA)/PLACEBO (DOSE 0.25 MG/0.25 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 2 MG/ML + SEMAGLUTIDE 1 MG/ML (CAGRISEMA) (DOSE 0.5 MG/0.5 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 2 MG/ML + SEMAGLUTIDE 1 MG/ML (CAGRISEMA)/PLACEBO (DOSE 0.5 MG/0.5 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 4 MG/ML + SEMAGLUTIDE 2 MG/ML (CAGRISEMA) (DOSE 1 MG/1 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 4 MG/ML + SEMAGLUTIDE 2 MG/ML (CAGRISEMA)/PLACEBO (DOSE 1 MG/1 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 6.8 MG/ML + SEMAGLUTIDE 3.4 MG/ML (CAGRISEMA) (DOSE 1.7 MG/1.7 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 6.8 MG/ML + SEMAGLUTIDE 3.4 MG/ML (CAGRISEMA)/PLACEBO (DOSE 1.7 MG/1.7 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 9.6 MG/ML + SEMAGLUTIDE 4.8 MG/ML (CAGRISEMA) (DOSE 2.4 MG/2.4 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NN9838-8484 CAGRILINTIDE 9.6 MG/ML + SEMAGLUTIDE 4.8 MG/ML (CAGRISEMA)/PLACEBO (DOSE 2.4 MG/2.4 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NOVAVAX 2019NCOV-301 SARS-COV-2 RS WITH MATRIX-M1 VACCINE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NRG-BN011-CIRB LOMUSTINE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NRG-BN011-CIRB LOMUSTINE 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NRG-BN011-CIRB LOMUSTINE 40 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NRG-GU010-CIRB DAROLUTAMIDE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY NRG-GY028-CIRB IPATASERTIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY NRG-GY028-CIRB IPATASERTIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ONDANSETRON 4 MG DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ONDANSETRON HCL 8 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY OSU-23199 SNDX-5613 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY OSU-23199 SNDX-5613 113 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY OSU-23199 SNDX-5613 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY OSU-23199 SNDX-5613 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY OSU-23199 SNDX-5613 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY OSU-23199 SNDX-5613 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PACIRA 402-C-331 BUPIVICAINE (PF) 0.5 % (5 MG/ML) INJECTION SOL,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PALV-09 IRB# 24-0156 PTX-022 3.9% W/W TOPICAL GEL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PEAK-1 CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PEAK-1 CABOZANTINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PEAK-1 CABOZANTINIB 60 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PEAK-1 CASDATIFAN / PLACEBO 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PEDIATRIC AEROSOL CHAMBER DEVICE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PEEPS UNC IRB# 21-2230 ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PEEPS UNC IRB# 21-2230 PROGESTERONE 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PIKASO METFORMIN/PLACEBO 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PROMETHAZINE 25 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PROPOFOL 10 MG/ML IV,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PROTEON PRT-201-320 VONAPANITASE (PRT-201)/PLACEBO 0012 MG/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PRT7732-01 PRT7732 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PRT7732-01 PRT7732 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PS-D202 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PS-D202 SODIUM CHLORIDE 7 % FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY PT-01 PEANUT 4320 DU SLIT-TABLET (PHASE 3 ONLY),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY PT-01 PEANUT SLIT-TABLET/PLACEBO,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R2222-RSV-1332 REGN2222/PLACEBO 150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R5458-ONC-2012 NIROGACESTAT 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R5458-ONC-2012 NIROGACESTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R668-EE-1324.01 DUPILUMAB/PLACEBO 150 MG/ML LOADING DOSE-600MG- 2 KITS,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R668-EE-1324.01 DUPILUMAB/PLACEBO 150 MG/ML MAINTENANCE DOSE 300 MG = 1 KIT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 100 MG / 200 MG / 300 MG / PLACEBO,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 200 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 300 MG,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RA101495-02.301 ZILUCOPLAN OR PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY RA101495-02.302 ZILUCOPLAN PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY RAD-IFN-CS-003 DILUENT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RAD-IFN-CS-003 RAD-IFN (INSTILADRIN) 3X10E11 VPS/ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RAD-IFN-CS-003 SYN 3 (POLYAMIDE SURFACTANT),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RC48G001 DISITAMAB VEDOTIN 7.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RE104-201-PPD ONDANSETRON 4 MG ODT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RE104-201-PPD RISPERIDONE 1 MG TABLET ODT,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY REGEN-004 RENAL AUTOLOGOUS CELL THERAPY 100X10E6 CELLS/ML PERCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY REGEN-006 RENAL AUTOLOGOUS CELL THERAPY 100X10E6 CELLS/ML PERCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY REM-PH-418 GLYCINE DILUENT INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY REM-PH-418 TREPROSTINIL 1 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY REM-PH-418 TREPROSTINIL 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY REM-PH-418 TREPROSTINIL 2.5 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RESEARCH EMERGENCY MEDICATION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RM-493-034 SETMELANOTIDE 10 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RM-493-034 SETMELANOTIDE/PLACEBO 10 MG/ML SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RM-493-035 SETMELANOTIDE/PLACEBO 10 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RNLC3132 IRB# 23-1481 RIFAXIMIN/PLACEBO 40 MG SDD-IR TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ROCHE CP40617 BALOXAVIR 2 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ROCHE CP40617 BALOXAVIR/PLACEBO 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ROCHE CP40617 OSELTAMIVIR 6 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY RP1-104 VUSOLIMOGENE ODERPAREPVEC 1 X 10E6 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RP1-104 VUSOLIMOGENE ODERPAREPVEC 1 X 10E7 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RPC02-201 RPC4046 150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RPC02-201 RPC4046/PLACEBO 75/150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RPL-003-19 RP1 (VUSOLIMOGENE ODERPAREPVEC) 1 X 10E6 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RPL-003-19 RP1 (VUSOLIMOGENE ODERPAREPVEC) 1 X 10E7 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RPL554-NCFB-220 ENSIFENTRINE/PLACEBO 3 MG INHALATION SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RRP-001 INO-3107 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RT234-PAH-CL202 AXIAL OSCILLATING SPHERE DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RT234-PAH-CL202 VARDENAFIL HYDROCHLORIDE 0.5 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RTRX-RE021-201 SPARSENTAN 80 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RUGONERSEN EAP/COMPASSIONATE USE PROGRAM RUGONERSEN 24 MG/ML INTRATHECAL INJECTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RVT-1201-2002 RODATRISTAT ETHYL 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY RVT-1201-2002 RODATRISTAT ETHYL/PLACEBO 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SAATELLITE MEDI4893 50 MG/ML OR PLACEBO VIAL,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SC9-GBM-03 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,38 HCPCS,J3490,STUDY SC9-GBM-03 PERFLUTREN LIPID MICROSPHERES IV SUSPENSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SELCLAX SELINEXOR 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SELCLAX VENETOCLAX 10 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SELCLAX VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SELCLAX VENETOCLAX 100 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SELCLAX VENETOCLAX 25 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SELCLAX VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SER-155-01 SER-155 / PLACEBO PART 1 (6.9 X 10E6 CFU) CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SER-155-01 SER-155 / PLACEBO PART 2 (3.1 X 10E7 CFU) CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SER-155-01 VANCOMYCIN / PLACEBO 125 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SGNTV-001 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SHIRE HGT-SAN-093 HGT-1410 (RECOMBINANT HUMAN HEPARAN N SULFATASE) 45 MG/3 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SHIRE SHP-610-201 HGT-1410 (RECOMBINANT HUMAN HEPARAN N SULFATASE) 45 MG/3 ML SY,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SHP620 MARIBAVIR 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY SOBI003-EA SOBI003 20 MG/ML INTRAVENOUS SOLN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY SP-624-202 SP-624/PLACEBO 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY STK-001-DS-301 ZOREVUNERSEN (STK-001)/SHAM 45 MG INTRATHECAL SYRINGE 10 ML,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY STK-001-DS-301 ZOREVUNERSEN (STK-001)/SHAM 70 MG INTRATHECAL SYRINGE 10 ML (LOADING DOSE),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TAK-079-2001 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AERSOL INH,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY TBCRC-065 TUCATINIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY TBCRC-065 TUCATINIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY THE NEXIS TRIAL PARENTERAL AMINO ACID 15% IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY THE NEXIS TRIAL PARENTERAL AMINO ACID 7.5% IV INFUSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TL-895-201 TL-895 100 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TL-895-201 TL-895 150 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TL-895-201 TL-895 25 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TL-895-201 TL-895 50 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TL-895-201 TL-895 75 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TPN-101-C9-201 TPN-101 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TPN-101-C9-201 TPN-101/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TTP399-302 TTP399/PLACEBO 400 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY U44-MNLT-01 MOON101 1 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY U44-MNLT-01 MOON101 10 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY U44-MNLT-01 MOON101 25 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY U44-MNLT-01 MOON101 50 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY U44-MNLT-01 MOON101 PLACEBO MN STAMP,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY UMI21-05-01 OBETICHOLIC ACID/PLACEBO 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY UNC IRB# 24-1715 ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY UNC IRB# 24-1715 PROGESTERONE MICRONIZED/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY UX143-CL314 DEXTROSE 5% FLUSH SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY V712-305 ORAL FOOD CHALLENGE KIT,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY V712-305 VIASKIN (DBV712) 250 MCG EPICUTANEOUS PATCH,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY V712-306 VITESSE DBV712 (VIASKIN) 250 MICROGRAM PATCH,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY V712-306 VITESSE DBV712 (VIASKIN)/PLACEBO 250 MICROGRAM PATCH,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY VAL-10-001 VAL-413 IRINOTECAN HCL 5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VERSATILE-003 PDS0101 (R-DOTAP/HPVMIX) 0.5 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VERSATILE002 PDS0101 (R-DOTAP/HPVMIX) 0.5 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX17-445-105 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX17-445-105 VX-445 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX19-445-107 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX19-445-107 IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX19-445-107 VX-445 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX19-445-107 VX-445 50 MG-TEZ 25 MG-IVA 37.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 ELX 100 MG-TEZ 50 MG-IVA 75 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 ELX 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 ELX 50 MG-TEZ 25 MG-IVA 37.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 ELX 80 MG-TEZ 40 MG-IVA 60 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 IVA 59.5 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 IVA 75 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX20-445-112 IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX21-147-301 VX-147/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX21-147-301 VX-147/PLACEBO 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY VX24-147-202 VX-147 (INAXAPLIN) 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY WARFARIN 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,STUDY ZX008-2103 FENFLURAMINE HCL (ZX008) 1.25 MG/ML OR 2.5 MG/ML OR 5 MG/ML OR PLACEBO ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ZX008-2103 FENFLURAMINE HCL (ZX008) 5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,STUDY ZYN2-CL-033 ZYN002/PLACEBO 4.2% TRANSDERMAL GEL,0.2,0.12,0.0464,4481.0,17 HCPCS,J3490,SUCCIMER 100 MG CAPSULE,82.15,49.29,19.06,4481.0,19 HCPCS,J3490,SUCRALFATE 1 GRAM TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,SUCRALFATE 100 MG/ML ORAL SUSPENSION,31.4,18.84,7.28,4481.0,19 HCPCS,J3490,SUFENTANIL CITRATE 50 MCG/ML INTRAVENOUS SOLUTION,29.9,17.94,6.94,4481.0,19 HCPCS,J3490,SUGAMMADEX 100 MG/ML INTRAVENOUS SOLUTION,546.95,328.17,126.89,4481.0,19 HCPCS,J3490,SULFADIAZINE 100 MG/ML ORAL SUSP,27.1,16.26,6.29,4481.0,19 HCPCS,J3490,SULFADIAZINE 500 MG TABLET,64.1,38.46,14.87,4481.0,19 HCPCS,J3490,SULFAMETHOXAZOLE 200 MG-TRIMETHOPRIM 40 MG/5 ML ORAL SUSPENSION,145.15,87.09,33.67,4481.0,19 HCPCS,J3490,SULFAMETHOXAZOLE 800 MG-TRIMETHOPRIM 160 MG TABLET,16.8,10.08,3.9,4481.0,19 HCPCS,J3490,SULFASALAZINE 100 MG/ML ORAL SUSP,128.9,77.34,29.9,4481.0,19 HCPCS,J3490,SULFASALAZINE 500 MG TABLET,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,SULINDAC 150 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,SULINDAC 200 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,SUMATRIPTAN 25 MG TABLET,17.0,10.2,3.94,4481.0,19 HCPCS,J3490,SUMATRIPTAN 50 MG TABLET,17.35,10.41,4.03,4481.0,19 HCPCS,J3490,SUNITINIB MALATE 25 MG CAPSULE,1869.7,1121.82,433.77,4481.0,19 HCPCS,J3490,SUNITINIB MALATE 37.5 MG CAPSULE,2792.05,1675.23,647.76,4481.0,19 HCPCS,J3490,SUNITINIB MALATE 50 MG CAPSULE,3236.4,1941.84,750.84,4481.0,19 HCPCS,J3490,TACROLIMUS 0.1 % TOPICAL OINTMENT,423.65,254.19,98.29,4481.0,19 HCPCS,J3490,TADALAFIL 20 MG TABLET (PULMONARY HYPERTENSION),224.5,134.7,52.08,4481.0,19 HCPCS,J3490,TAMOXIFEN 10 MG TABLET,26.95,16.17,6.25,4481.0,19 HCPCS,J3490,TAMSULOSIN 0.4 MG CAPSULE,17.8,10.68,4.13,4481.0,19 HCPCS,J3490,TAPENTADOL 50 MG TABLET,59.05,35.43,13.7,4481.0,19 HCPCS,J3490,TAPENTADOL 75 MG TABLET,49.3,29.58,11.44,4481.0,19 HCPCS,J3490,"TAPENTADOL ER 100 MG TABLET,EXTENDED RELEASE,12 HR",93.65,56.19,21.73,4481.0,19 HCPCS,J3490,"TAPENTADOL ER 250 MG TABLET,EXTENDED RELEASE,12 HR",168.8,101.28,39.16,4481.0,19 HCPCS,J3490,"TAPENTADOL ER 50 MG TABLET,EXTENDED RELEASE,12 HR",60.75,36.45,14.09,4481.0,19 HCPCS,J3490,TEDIZOLID 200 MG TABLET,1411.25,846.75,327.41,4481.0,19 HCPCS,J3490,TEMAZEPAM 15 MG CAPSULE,22.3,13.38,5.17,4481.0,19 HCPCS,J3490,TENOFOVIR ALAFENAMIDE 25 MG TABLET,168.7,101.22,39.14,4481.0,19 HCPCS,J3490,TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,23.1,13.86,5.36,4481.0,19 HCPCS,J3490,TEPOTINIB 225 MG TABLET,1742.8,1045.68,404.33,4481.0,19 HCPCS,J3490,TERAZOSIN 1 MG CAPSULE,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,TERAZOSIN 10 MG CAPSULE,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,TERAZOSIN 2 MG CAPSULE,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,TERAZOSIN 5 MG CAPSULE,16.55,9.93,3.84,4481.0,19 HCPCS,J3490,TERBINAFINE HCL 250 MG TABLET,16.75,10.05,3.89,4481.0,19 HCPCS,J3490,TERBUTALINE 2.5 MG TABLET,29.1,17.46,6.75,4481.0,19 HCPCS,J3490,TESTOSTERONE 50 MG/5 GRAM (1 %) TRANSDERMAL GEL,82.0,49.2,19.02,4481.0,19 HCPCS,J3490,TESTOSTERONE 75 MG IMPLANT PELLET,350.9,210.54,81.41,4481.0,19 HCPCS,J3490,TETRABENAZINE 12.5 MG TABLET,55.25,33.15,12.82,4481.0,19 HCPCS,J3490,TETRACAINE HCL (PF) 0.5 % EYE DROPS,57.8,34.68,13.41,4481.0,19 HCPCS,J3490,TETRACYCLINE 500 MG CAPSULE,21.1,12.66,4.9,4481.0,19 HCPCS,J3490,TETRAHYDROZOLINE 0.05 % EYE DROPS,6.25,3.75,1.45,4481.0,19 HCPCS,J3490,"THEOPHYLLINE ER 300 MG TABLET,EXTENDED RELEASE,12 HR",19.9,11.94,4.62,4481.0,19 HCPCS,J3490,"THEOPHYLLINE ER 400 MG TABLET,EXTENDED RELEASE 24 HR",20.05,12.03,4.65,4481.0,19 HCPCS,J3490,THIAMINE MONONITRATE (VITAMIN B1) 100 MG TABLET,1.3,0.78,0.3016,4481.0,19 HCPCS,J3490,THIOGUANINE 20 MG/ML ORAL SUSP,32.85,19.71,7.62,4481.0,19 HCPCS,J3490,THIOGUANINE 40 MG TABLET,1954.65,1172.79,453.48,4481.0,19 HCPCS,J3490,THIOTHIXENE 1 MG CAPSULE,18.85,11.31,4.37,4481.0,19 HCPCS,J3490,THIOTHIXENE 5 MG CAPSULE,21.75,13.05,5.05,4481.0,19 HCPCS,J3490,THYROID (PORK) 30 MG TABLET,18.1,10.86,4.2,4481.0,19 HCPCS,J3490,THYROID (PORK) 90 MG TABLET,19.6,11.76,4.55,4481.0,19 HCPCS,J3490,TIAGABINE 4 MG TABLET,35.05,21.03,8.13,4481.0,19 HCPCS,J3490,TICAGRELOR 90 MG TABLET,39.25,23.55,9.11,4481.0,19 HCPCS,J3490,TIMOLOL MALEATE 0.25 % EYE DROPS,31.6,18.96,7.33,4481.0,19 HCPCS,J3490,TIMOLOL MALEATE 0.5 % EYE DROPS,51.9,31.14,10.45,4481.0,38 HCPCS,J3490,TIMOLOL MALEATE 0.5 % EYE DROPS WRAPPER,45.625,27.375,7.54,4481.0,38 HCPCS,J3490,TIZANIDINE 2 MG TABLET,19.25,11.55,4.47,4481.0,19 HCPCS,J3490,TIZANIDINE 4 MG TABLET,17.95,10.77,4.16,4481.0,19 HCPCS,J3490,TOBRAMYCIN 0.3 % EYE DROPS,62.7,37.62,14.55,4481.0,19 HCPCS,J3490,"TOBRAMYCIN 0.3 %-DEXAMETHASONE 0.1 % EYE DROPS,SUSPENSION",18.3,10.98,4.25,4481.0,19 HCPCS,J3490,TOBRAMYCIN 1.4% OPHTHALMIC SOLN,116.65,69.99,27.06,4481.0,19 HCPCS,J3490,TOBRAMYCIN 300 MG/5 ML IN 0.225 % SODIUM CHLORIDE FOR NEBULIZATION,51.25,30.75,11.89,4481.0,19 HCPCS,J3490,TOBRAMYCIN-DEXAMETHASONE 0.3 %-0.1 % EYE OINTMENT,913.3,547.98,211.89,4481.0,19 HCPCS,J3490,TOCOPHERSOLAN (VITAMIN E TPGS) 75 UNIT/ML ORAL DROPS,66.1,39.66,15.34,4481.0,19 HCPCS,J3490,TOFACITINIB 10 MG TABLET,319.7,191.82,74.17,4481.0,19 HCPCS,J3490,TOLUIDINE BLUE 1 % SOLUTION,24.35,14.61,5.65,4481.0,19 HCPCS,J3490,TOLVAPTAN 15 MG TABLET,196.0,117.6,45.47,4481.0,19 HCPCS,J3490,TOLVAPTAN 30 MG TABLET,379.15,227.49,87.96,4481.0,19 HCPCS,J3490,TOPIRAMATE 100 MG TABLET,17.45,10.47,4.05,4481.0,19 HCPCS,J3490,TOPIRAMATE 25 MG TABLET,16.9,10.14,3.92,4481.0,19 HCPCS,J3490,TOPIRAMATE 25 MG/ML ORAL SOLUTION,1017.2,610.32,235.99,4481.0,19 HCPCS,J3490,TORSEMIDE 10 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,TORSEMIDE 100 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,TORSEMIDE 20 MG TABLET,17.05,10.23,3.96,4481.0,19 HCPCS,J3490,TRACE ELEMENTS (ADDAMEL) #1 5.33 MCG-0.34 MG-0.54 MG/ML INTRAVENOUS SOLUTION,78.4,47.04,18.19,4481.0,19 HCPCS,J3490,TRACE ELEMENTS CR-CU-MN-ZN 10 MCG-1 MG-0.5 MG-5 MG/ML INTRAVENOUS SOLN,63.8,38.28,14.8,4481.0,19 HCPCS,J3490,TRACE ELEMENTS PED CR-CU-MN-ZN 1 MCG-0.1 MG-30 MCG-0.5 MG/ML IV SOLN,43.3,25.98,10.05,4481.0,19 HCPCS,J3490,TRACE ELEMENTS ZN 3 MG-CU 0.3 MG-MN 55 MCG-SE 60 MCG/ML IV SOLUTION,125.95,75.57,29.22,4481.0,19 HCPCS,J3490,TRAMADOL 50 MG TABLET,22.45,13.47,5.21,4481.0,19 HCPCS,J3490,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) INTRAVENOUS SOLUTION",81.0,48.6,18.79,4481.0,19 HCPCS,J3490,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) INTRAVENOUS SOLUTION (PED)",128.4,77.04,29.79,4481.0,19 HCPCS,J3490,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) TOPICAL OR INHALATION SOLUTION",94.0,56.4,21.81,4481.0,19 HCPCS,J3490,"TRANEXAMIC ACID 2,000 MG/20 ML (100 MG/ML) INFUSION (PED)",193.7,116.22,44.94,4481.0,19 HCPCS,J3490,TRANEXAMIC ACID 650 MG TABLET,24.05,14.43,5.58,4481.0,19 HCPCS,J3490,TRAZODONE 100 MG TABLET,16.6,9.96,3.85,4481.0,19 HCPCS,J3490,TRAZODONE 150 MG TABLET,17.75,10.65,4.12,4481.0,19 HCPCS,J3490,TRAZODONE 50 MG TABLET,16.4,9.84,3.8,4481.0,19 HCPCS,J3490,TREPROSTINIL 32 MCG CARTRIDGE WITH INHALER,1139.75,683.85,264.42,4481.0,19 HCPCS,J3490,TREPROSTINIL 48 MCG CARTRIDGE WITH INHALER,1139.75,683.85,264.42,4481.0,19 HCPCS,J3490,TREPROSTINIL 64 MCG CARTRIDGE WITH INHALER,2635.0,1581.0,611.32,4481.0,19 HCPCS,J3490,"TREPROSTINIL DIOLAMINE ER 0.25 MG TABLET,EXTENDED RELEASE",60.55,36.33,14.05,4481.0,19 HCPCS,J3490,"TREPROSTINIL DIOLAMINE ER 1 MG TABLET,EXTENDED RELEASE",194.2,116.52,45.05,4481.0,19 HCPCS,J3490,"TREPROSTINIL DIOLAMINE ER 2.5 MG TABLET,EXTENDED RELEASE",461.4,276.84,107.04,4481.0,19 HCPCS,J3490,TRETINOIN (ANTINEOPLASTIC) 10 MG CAPSULE,132.6,79.56,30.76,4481.0,19 HCPCS,J3490,TRETINOIN (CHEMOTHERAPY) 10 MG/1 ML ORAL SUSPENSION,6857.0,4114.2,1590.82,5485.6,19 HCPCS,J3490,TRETINOIN 0.025 % TOPICAL CREAM,22.3,13.38,5.17,4481.0,19 HCPCS,J3490,TRETINOIN 0.05 % TOPICAL CREAM,298.6,179.16,69.28,4481.0,19 HCPCS,J3490,TRETINOIN 0.1 % TOPICAL CREAM,345.8,207.48,80.23,4481.0,19 HCPCS,J3490,TRIAMCINOLONE 0.05% IN MODIFIED EUCERIN CREAM,115.75,69.45,26.85,4481.0,19 HCPCS,J3490,TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL OINTMENT,40.6,24.36,9.42,4481.0,19 HCPCS,J3490,TRIAMCINOLONE ACETONIDE 0.1 % DENTAL PASTE,210.1,126.06,48.74,4481.0,19 HCPCS,J3490,TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAM,26.85,16.11,6.23,4481.0,19 HCPCS,J3490,TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENT,29.6,17.76,6.87,4481.0,19 HCPCS,J3490,TRIAMTERENE 37.5 MG-HYDROCHLOROTHIAZIDE 25 MG TABLET,18.5,11.1,4.29,4481.0,19 HCPCS,J3490,TRICHLOROACETIC ACID 40% (W/V) TOPICAL SOLUTION,21.3,12.78,4.94,4481.0,19 HCPCS,J3490,TRICHLOROACETIC ACID 85% (W/V) TOPICAL SOLUTION,72.45,43.47,16.81,4481.0,19 HCPCS,J3490,TRIFLURIDINE 1 % EYE DROPS,606.0,363.6,140.59,4481.0,19 HCPCS,J3490,TRIFLURIDINE 15 MG-TIPIRACIL 6.14 MG TABLET,897.2,538.32,208.15,4481.0,19 HCPCS,J3490,TRIFLURIDINE 20 MG-TIPIRACIL 8.19 MG TABLET,1187.9,712.74,275.59,4481.0,19 HCPCS,J3490,TRIHEXYPHENIDYL 2 MG TABLET,16.45,9.87,3.82,4481.0,19 HCPCS,J3490,TRIHEXYPHENIDYL 5 MG TABLET,16.7,10.02,3.87,4481.0,19 HCPCS,J3490,TRIMETHOPRIM 100 MG TABLET,21.55,12.93,5.0,4481.0,19 HCPCS,J3490,TROPICAMIDE 1 % EYE DROPS (MULTI-PATIENT),16.1,9.66,3.74,4481.0,19 HCPCS,J3490,TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL INJECTION SOLUTION,52.925,31.755,11.39,4481.0,57 HCPCS,J3490,ULIPRISTAL 30 MG TABLET,132.25,79.35,30.68,4481.0,19 HCPCS,J3490,UMECLIDINIUM 62.5 MCG-VILANTEROL 25 MCG/ACTUATION POWDR FOR INHALATION,369.85,221.91,85.81,4481.0,19 HCPCS,J3490,UMECLIDINIUM 62.5 MCG/ACTUATION BLISTER POWDER FOR INHALATION,241.9,145.14,56.12,4481.0,19 HCPCS,J3490,"UPADACITINIB ER 45 MG TABLET,EXTENDED RELEASE 24 HR",1366.55,819.93,317.04,4481.0,19 HCPCS,J3490,UREA 15 GRAM ORAL POWDER PACKET,6.65,3.99,1.54,4481.0,19 HCPCS,J3490,URSODIOL 300 MG CAPSULE,33.9,20.34,7.86,4481.0,19 HCPCS,J3490,URSODIOL 60 MG/ML ORAL SUSPENSION,204.3,122.58,47.4,4481.0,19 HCPCS,J3490,VALACYCLOVIR 500 MG TABLET,25.6,15.36,5.94,4481.0,19 HCPCS,J3490,VALACYCLOVIR 50MG/ML ORAL SUSPENSION,113.8,68.28,26.4,4481.0,19 HCPCS,J3490,VALGANCICLOVIR 450 MG TABLET,28.55,17.13,6.62,4481.0,19 HCPCS,J3490,VALPROATE SODIUM 500 MG/5 ML (100 MG/ML) INTRAVENOUS SOLUTION,85.9,51.54,19.93,4481.0,19 HCPCS,J3490,VALPROIC ACID (AS SODIUM SALT) 250 MG/5 ML (5 ML) ORAL SOLUTION,20.15,12.09,4.67,4481.0,19 HCPCS,J3490,VALSARTAN 160 MG TABLET,19.65,11.79,4.56,4481.0,19 HCPCS,J3490,VALSARTAN 40 MG TABLET,18.5,11.1,4.29,4481.0,19 HCPCS,J3490,VALSARTAN 80 MG TABLET,19.25,11.55,4.47,4481.0,19 HCPCS,J3490,VANCOMYCIN 50 MG/ML ORAL SOLUTION,23.45,14.07,5.44,4481.0,19 HCPCS,J3490,VARENICLINE TARTRATE 0.5 MG TABLET,18.95,11.37,4.4,4481.0,19 HCPCS,J3490,VARENICLINE TARTRATE 1 MG TABLET,55.1,33.06,12.78,4481.0,19 HCPCS,J3490,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 2 ML,64.7,38.82,15.01,4481.0,19 HCPCS,J3490,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 4 ML,66.4,39.84,15.4,4481.0,19 HCPCS,J3490,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 40ML,96.9,58.14,22.48,4481.0,19 HCPCS,J3490,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSON 100ML,147.7,88.62,34.27,4481.0,19 HCPCS,J3490,VECURONIUM 1 MG/ML PEDIATRIC BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3490,VECURONIUM BROMIDE 10 MG INTRAVENOUS SOLUTION,81.65,48.99,18.94,4481.0,19 HCPCS,J3490,VECURONIUM BROMIDE 20 MG INTRAVENOUS SOLUTION,92.45,55.47,21.45,4481.0,19 HCPCS,J3490,VENETOCLAX 10 MG (14)-50 MG (7)-100 MG (21) TABLETS IN A DOSE PACK,13510.9,8106.54,3134.53,10808.72,19 HCPCS,J3490,VENETOCLAX 10 MG TABLET,77.05,46.23,17.88,4481.0,19 HCPCS,J3490,VENETOCLAX 100 MG TABLET,545.6,327.36,126.58,4481.0,19 HCPCS,J3490,VENETOCLAX 50 MG TABLET,285.4,171.24,66.21,4481.0,19 HCPCS,J3490,VENLAFAXINE 25 MG TABLET,17.0,10.2,3.94,4481.0,19 HCPCS,J3490,VENLAFAXINE 37.5 MG TABLET,18.6,11.16,4.32,4481.0,19 HCPCS,J3490,VENLAFAXINE 75 MG TABLET,18.85,11.31,4.37,4481.0,19 HCPCS,J3490,"VENLAFAXINE ER 150 MG CAPSULE,EXTENDED RELEASE 24 HR",17.9,10.74,4.15,4481.0,19 HCPCS,J3490,"VENLAFAXINE ER 37.5 MG CAPSULE,EXTENDED RELEASE 24 HR",17.5,10.5,4.06,4481.0,19 HCPCS,J3490,"VENLAFAXINE ER 75 MG CAPSULE,EXTENDED RELEASE 24 HR",17.65,10.59,4.09,4481.0,19 HCPCS,J3490,VERAPAMIL 120 MG TABLET,16.25,9.75,3.77,4481.0,19 HCPCS,J3490,VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTION,87.02499999999999,52.215,7.41,4481.0,38 HCPCS,J3490,VERAPAMIL 80 MG TABLET,16.95,10.17,3.93,4481.0,19 HCPCS,J3490,"VERAPAMIL ER (SR) 180 MG TABLET,EXTENDED RELEASE",16.75,10.05,3.89,4481.0,19 HCPCS,J3490,VIGABATRIN 500 MG ORAL POWDER PACKET,34.0,20.4,7.89,4481.0,19 HCPCS,J3490,VILAZODONE 40 MG TABLET,52.5,31.5,12.18,4481.0,19 HCPCS,J3490,"VITAMIN A CAPSULE 3,000 MCG RAE (10000 UNITS)",1.1,0.66,0.2552,4481.0,19 HCPCS,J3490,VITAMIN A ORAL SOLUTION 2500 MCG RAE/ML,2.25,1.35,0.522,4481.0,19 HCPCS,J3490,"VITAMIN A PALMITATE 15,000 MCG RAE/ML (50,000 UNIT/ML) INTRAMUSCULAR SOLUTION",1417.6,850.56,328.88,4481.0,19 HCPCS,J3490,VITAMIN B COMPLEX-FOLIC ACID 0.4 MG TABLET,1.45,0.87,0.3364,4481.0,19 HCPCS,J3490,"VITAMIN E (DL, ACETATE) 180 MG (400 UNIT) CAPSULE",1.4,0.84,0.3248,4481.0,19 HCPCS,J3490,VITAMIN-BIOTIN 5 MG/ML ORAL SUSPENSION,1.35,0.81,0.3132,4481.0,19 HCPCS,J3490,VOCLOSPORIN 7.9 MG CAPSULE,280.25,168.15,65.02,4481.0,19 HCPCS,J3490,VORICONAZOLE 200 MG/5 ML (40 MG/ML) ORAL SUSPENSION,1857.85,1114.71,431.02,4481.0,19 HCPCS,J3490,VORTIOXETINE 10 MG TABLET,67.45,40.47,15.65,4481.0,19 HCPCS,J3490,VORTIOXETINE 20 MG TABLET,67.45,40.47,15.65,4481.0,19 HCPCS,J3490,VORTIOXETINE 5 MG TABLET,67.45,40.47,15.65,4481.0,19 HCPCS,J3490,WARFARIN 0.5 MG SPLIT TABLET,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,WARFARIN 1 MG TABLET,17.15,10.29,3.98,4481.0,19 HCPCS,J3490,WARFARIN 1 MG/ML ORAL SUSPENSION,16.3,9.78,3.78,4481.0,19 HCPCS,J3490,WARFARIN 2 MG TABLET,17.15,10.29,3.98,4481.0,19 HCPCS,J3490,WARFARIN 2.5 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,WARFARIN 2.5MG TABLET (SPLITTABLE),17.2,10.32,3.99,4481.0,19 HCPCS,J3490,WARFARIN 3 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,WARFARIN 4 MG TABLET,17.2,10.32,3.99,4481.0,19 HCPCS,J3490,WARFARIN 5 MG TABLET,17.25,10.35,4.0,4481.0,19 HCPCS,J3490,WARFARIN 7.5 MG TABLET,17.75,10.65,4.12,4481.0,19 HCPCS,J3490,WATER FOR INJECT BACT PARABENS INJECTION SOLUTION,23.4,14.04,5.43,4481.0,19 HCPCS,J3490,"WATER FOR INJECTION, BACTERIOSTATIC INJECTION SOLUTION",40.5,24.3,9.4,4481.0,19 HCPCS,J3490,"WATER FOR INJECTION, STERILE INJECTION SOLUTION",29.15,17.49,6.76,4481.0,19 HCPCS,J3490,"WATER FOR INJECTION, STERILE INTRAVENOUS SOLUTION",87.0,52.2,18.79,4481.0,38 HCPCS,J3490,"WATER FOR IRRIGATION, STERILE SOLUTION",75.75,45.45,16.36,4481.0,76 HCPCS,J3490,WHITE PETROLATUM 41 % TOPICAL OINTMENT,21.3,12.78,4.94,4481.0,19 HCPCS,J3490,WHITE PETROLATUM 42 % TOPICAL OINTMENT,9.85,5.91,2.29,4481.0,19 HCPCS,J3490,WHITE PETROLATUM-MINERAL OIL 57.3 %-42.5 % EYE OINTMENT,14.3,8.58,3.32,4481.0,19 HCPCS,J3490,WHITE PETROLATUM-MINERAL OIL 80 %-20 % EYE OINTMENT,12.4,7.44,2.88,4481.0,19 HCPCS,J3490,WHITE PETROLATUM-MINERAL OIL-LANOLIN TOPICAL CREAM WRAPPER,12.4,7.44,2.88,4481.0,19 HCPCS,J3490,ZIDOVUDINE 10 MG/ML ORAL SYRUP,20.5,12.3,4.76,4481.0,19 HCPCS,J3490,ZIDOVUDINE 300 MG TABLET,18.25,10.95,4.23,4481.0,19 HCPCS,J3490,ZINC ACETATE 10 MG ELEMENTAL ZINC/ML ORAL SOLN,1.05,0.63,0.2436,4481.0,19 HCPCS,J3490,ZINC CHLORIDE 0.5 MG/ML INTRAVENOUS DILUTION,200.9,120.54,46.61,4481.0,19 HCPCS,J3490,ZINC CHLORIDE 1 MG/ML INTRAVENOUS SOLUTION,53.0,31.8,12.3,4481.0,19 HCPCS,J3490,ZINC OXIDE 12.8 % TOPICAL OINTMENT,11.2,6.72,2.6,4481.0,19 HCPCS,J3490,ZINC OXIDE 13 % TOPICAL CREAM,7.05,4.23,1.64,4481.0,19 HCPCS,J3490,ZINC OXIDE-COD LIVER OIL 40 % TOPICAL PASTE,10.85,6.51,2.52,4481.0,19 HCPCS,J3490,ZINC SULFATE 50 MG ZINC (220 MG) CAPSULE,1.4,0.84,0.3248,4481.0,19 HCPCS,J3490,ZIPRASIDONE 20 MG CAPSULE,24.35,14.61,5.65,4481.0,19 HCPCS,J3490,ZIPRASIDONE 40 MG CAPSULE,24.35,14.61,5.65,4481.0,19 HCPCS,J3490,ZOLPIDEM 10 MG TABLET,22.35,13.41,5.19,4481.0,19 HCPCS,J3490,ZOLPIDEM 5 MG TABLET,22.3,13.38,5.17,4481.0,19 HCPCS,J3490,ZONISAMIDE 100 MG CAPSULE,17.7,10.62,4.11,4481.0,19 HCPCS,J3490,ZONISAMIDE 100 MG/5 ML ORAL SUSPENSION,1274.65,764.79,295.72,4481.0,19 HCPCS,J3490,ZONISAMIDE 25 MG CAPSULE,16.65,9.99,3.86,4481.0,19 HCPCS,J3590,DEFIBROTIDE 80 MG/ML INTRAVENOUS SOLUTION,3970.65,2382.39,921.19,4481.0,19 HCPCS,J3590,IDARUCIZUMAB 2.5 GRAM/50 ML INTRAVENOUS SOLUTION,8405.45,5043.27,1950.06,6724.36,19 HCPCS,J3590,SEMAGLUTIDE (NON-DIABETES) 1.7 MG/0.75 ML SUBCUTANEOUS PEN INJECTOR,1331.3,798.78,308.86,4481.0,19 HCPCS,J3590,SEMAGLUTIDE 1 MG/DOSE (4 MG/3 ML) SUBCUTANEOUS PEN INJECTOR,3906.6,2343.96,906.33,4481.0,19 HCPCS,J3590,STUDY A22-203 ROPEGINTERFERON ALFA-2B-NJFT 500 MCG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY A22-301 ROPEGINTERFERON ALFA-2B-NJFT 500 MCG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY CABL001AUS08 ASCIMINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY CEGIR 7810 DEGAS UNC IRB#21-0025 DUPILUMAB 150 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY CELLULAR THERAPY PRODUCT INFUSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3590,STUDY EFC15804 BOREAS UNC IDS#19-0049 DUPILUMAB 300 MG/PLACEBO INJECTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY GENE THERAPY PRODUCT INFUSION,0.2,0.12,0.0464,4481.0,17 HCPCS,J3590,STUDY IRB# 21-1548 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY IRB# 21-1548 SEMAGLUTIDE/PLACEBO 2 MG/3 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY IRB# 21-1689 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J3590,STUDY IRB# 21-1689 SEMAGLUTIDE/PLACEBO 2 MG/3 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 HCPCS,J7030,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION,78.0,46.8,4.39,4481.0,21 HCPCS,J7030,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION NON-PVC,72.0,43.2,4.39,4481.0,21 HCPCS,J7030,SODIUM CHLORIDE 0.9% INTRAVENOUS SOLUTION FOR DIALYSIS,78.0,46.8,4.39,4481.0,21 HCPCS,J7030,SODIUM CHLORIDE 0.9% IVPB SOLN,78.0,46.8,4.39,4481.0,21 HCPCS,J7030,SODIUM CHLORIDE 0.9% NON-PVC,72.0,43.2,4.39,4481.0,21 HCPCS,J7040,SODIUM CHLORIDE 0.45 % INTRAVENOUS SOLUTION,78.75,47.25,2.83,4481.0,42 HCPCS,J7040,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION FOR PRESSURE LINES,75.0,45.0,2.83,4481.0,21 HCPCS,J7040,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION NON-PVC,73.5,44.1,2.83,4481.0,21 HCPCS,J7040,"SODIUM CHLORIDE 0.9 %, BACTERIOSTATIC INJECTION SOLUTION",33.2,19.92,2.83,4481.0,23 HCPCS,J7040,SODIUM CHLORIDE 0.9% IV BOLUS,69.0,41.4,2.83,4481.0,21 HCPCS,J7040,SODIUM CHLORIDE 0.9% IVPB SOLN,75.0,45.0,2.83,4481.0,21 HCPCS,J7040,SODIUM CHLORIDE 0.9% NON-PVC,73.5,44.1,2.83,4481.0,21 HCPCS,J7042,DEXTROSE 5 % AND 0.45 % NACL IV BOLUS,66.0,39.6,3.17,4481.0,21 HCPCS,J7042,DEXTROSE 5 % AND 0.9 % NACL IV BOLUS,67.5,40.5,3.17,4481.0,21 HCPCS,J7042,DEXTROSE 5 % AND 0.9 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,81.0,48.6,3.17,4481.0,21 HCPCS,J7050,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION NON-PVC,71.25,42.75,1.46,4481.0,21 HCPCS,J7050,SODIUM CHLORIDE 0.9% IV BOLUS,75.75,45.45,1.46,4481.0,21 HCPCS,J7050,SODIUM CHLORIDE 0.9% IVPB SOLN,75.75,45.45,1.46,4481.0,21 HCPCS,J7050,STUDY GSK 201023 SODIUM CHLORIDE 0.9% (NS) INFUSION,0.2,0.12,0.0464,4481.0,21 HCPCS,J7060,DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS PIGGYBACK,82.95,49.77,4.07,4481.0,21 HCPCS,J7060,DEXTROSE 5 % IN WATER IV FLUSH,16.5,9.9,3.83,4481.0,21 HCPCS,J7060,DEXTROSE 5 % IV BOLUS,69.75,41.85,4.07,4481.0,21 HCPCS,J7060,DEXTROSE 5% IVPB SOLN,70.65,42.39,4.07,4481.0,21 HCPCS,J7060,DEXTROSE 5% WATER (D5W) NON-PVC,75.0,45.0,4.07,4481.0,21 HCPCS,J7070,DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION,81.0,48.6,7.0,4481.0,21 HCPCS,J7070,DEXTROSE 5 % IV BOLUS,67.5,40.5,7.0,4481.0,21 HCPCS,J7070,DEXTROSE 5% WATER (D5W) NON-PVC,75.0,45.0,7.0,4481.0,21 HCPCS,J7100,DEXTRAN 40 10 % IN 5 % DEXTROSE INTRAVENOUS,316.4,189.84,73.4,4481.0,21 HCPCS,J7120,LACTATED RINGERS INTRAVENOUS SOLUTION,78.0,46.8,5.42,4481.0,21 HCPCS,J7120,LACTATED RINGERS IRRIGATING INTRACRANIAL CATHETER,78.0,46.8,5.42,4481.0,21 HCPCS,J7120,LACTATED RINGERS IV BOLUS,66.75,40.05,5.42,4481.0,21 HCPCS,J7121,DEXTROSE 5 % AND LACTATED RINGERS INTRAVENOUS SOLUTION,81.0,48.6,18.32,4481.0,21 HCPCS,J7121,DEXTROSE 5 % IN LACTATED RINGERS IV BOLUS,72.0,43.2,16.7,4481.0,21 HCPCS,J7131,SODIUM CHLORIDE 23.4% (4 MEQ/ML) INTRAVENOUS SOLUTION,84.175,50.504999999999995,0.2805,4481.0,48 HCPCS,J7131,SODIUM CHLORIDE 3 % HYPERTONIC INTRAVENOUS INJECTION SOLUTION,82.5,49.5,0.2805,4481.0,24 HCPCS,J7131,SODIUM CHLORIDE 3 % INTRAVENOUS BOLUS SOLUTION,79.5,47.7,0.2805,4481.0,24 HCPCS,J7131,STUDY SODIUM CHLORIDE 0.9% BACTERIOSTATIC INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J7168,HUM PROTHROMBIN CPLX(PCC)4FACT 500 UNIT/20 ML IV KIT,87.25,52.35,2.08,4481.0,35 HCPCS,J7168,"HUM PROTHROMBIN CPLX, 4-FACTOR 1,000 UNIT (800-1,240 UNIT) IV SOLUTION",87.25,52.35,2.08,4481.0,35 HCPCS,J7168,"HUMAN PROTHROMBIN COMPLEX,4-FACTOR 500 UNIT (400-620 UNIT) IV SOLUTION",87.25,52.35,2.08,4481.0,35 HCPCS,J7169,"FACTOR XA,INACTIVATED-ZHZO (RECOMBINANT) 200 MG INTRAVENOUS BOLUS",8672.0,5203.2,127.44,7502.15,35 HCPCS,J7169,"FACTOR XA,INACTIVATED-ZHZO (RECOMBINANT) 200 MG INTRAVENOUS SOLUTION",8672.0,5203.2,127.44,7502.15,35 HCPCS,J7170,STUDY AHAEMI EMICIZUMAB 150 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J7175,COAGULATION FACTOR X 500 (+/-) UNIT RANGE INTRAVENOUS SOLUTION,116.15,69.69,9.49,4481.0,35 HCPCS,J7177,"FIBRINOGEN 1 GRAM (700 MG-1,300 MG) INTRAVENOUS SOLUTION",80.8,48.48,1.19,4481.0,35 HCPCS,J7185,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 1,000 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 HCPCS,J7185,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 250 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 HCPCS,J7185,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 500 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 HCPCS,J7185,"ANTIHEMOPHILIC FVIII,REC B-DOMAIN DELETED 1,000 (+/-) UNIT IV SYRINGE",83.6,50.16,1.62,4481.0,35 HCPCS,J7186,"ANTIHEMOPHILIC FACTOR-VWF 1,000 (400 VWF) UNIT/10 ML INTRAVENOUS SOLN",81.75,49.05,1.21,4481.0,35 HCPCS,J7186,"ANTIHEMOPHILIC FACTOR-VWF 2,000 (800 VWF) UNIT/10 ML INTRAVENOUS SOLN",81.75,49.05,1.21,4481.0,35 HCPCS,J7187,"(FVIII DOSING) ANTIHEMOPHILIC FACTOR-VWF 1,000 UNIT-2,400 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 HCPCS,J7187,"(VWF DOSING) ANTIHEMOPHILIC FACTOR-VWF 1,000 UNIT-2,400 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 HCPCS,J7187,ANTIHEMOPHILIC FACTOR-VWF 250 UNIT-600 UNIT INTRAVENOUS SOLUTION,82.7,49.62,1.45,4481.0,35 HCPCS,J7187,"ANTIHEMOPHILIC FACTOR-VWF 500 UNIT-1,200 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 HCPCS,J7188,"ANTIHEMOPHILIC FACTOR VIII,PORCINE REC 500(+/-) UNIT RANGE IV SOLUTION",87.15,52.29,3.13,4481.0,35 HCPCS,J7189,"COAGULATION FACTOR VIIA RECOMB 1 MG (1,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 HCPCS,J7189,"COAGULATION FACTOR VIIA RECOMB 2 MG (2,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 HCPCS,J7189,"COAGULATION FACTOR VIIA RECOMB 5 MG (5,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 HCPCS,J7189,FACTOR VIIA RECOMB (NOVOSEVEN) INTERMITTENT INFUSION,86.7,52.02,2.58,4481.0,35 HCPCS,J7190,"ANTIHEMOPHILIC FACTOR 1,000 (+/-) UNIT INTRAVENOUS POWDER FOR SOLUTION",82.0,49.2,1.06,4481.0,35 HCPCS,J7190,"ANTIHEMOPHILIC FACTOR 1,501 UNIT-2,000 UNIT INTRAVENOUS POWDR FOR SOLN",82.7,49.62,1.06,4481.0,35 HCPCS,J7190,ANTIHEMOPHILIC FACTOR 220 UNIT-400 UNIT INTRAVENOUS POWDR FOR SOLUTION,82.7,49.62,1.06,4481.0,35 HCPCS,J7190,"ANTIHEMOPHILIC FACTOR 801 UNIT-1,500 UNIT INTRAVENOUS POWDER FOR SOLN",82.7,49.62,1.06,4481.0,35 HCPCS,J7192,"ANTIHEMOPHILIC FACTOR (RECOMB) 1,000 (+/-) UNIT INTRAVENOUS SOLUTION",83.75,50.25,1.56,4481.0,35 HCPCS,J7192,"ANTIHEMOPHILIC FACTOR VIII, FULL LENGTH 500 (+/-) UNIT IV SOLUTION",83.75,50.25,1.56,4481.0,35 HCPCS,J7194,"FACTOR IX COMPLEX NO.4, 3-FACTOR 1,000 (+/-) UNIT INTRAVENOUS SOLUTION",82.1,49.26,1.65,4481.0,35 HCPCS,J7194,"FACTOR IX COMPLEX NO.4, 3-FACTOR 500 (+/-) UNIT INTRAVENOUS SOLUTION",82.1,49.26,1.65,4481.0,35 HCPCS,J7195,"COAGULATION FACTOR IX (RECOMB) 1,000 UNIT INTRAVENOUS SOLUTION",83.0,49.8,1.79,4481.0,35 HCPCS,J7195,COAGULATION FACTOR IX (RECOMB) 250 UNIT INTRAVENOUS SOLUTION,83.0,49.8,1.79,4481.0,35 HCPCS,J7195,COAGULATION FACTOR IX (RECOMB) 500 UNIT INTRAVENOUS SOLUTION,83.0,49.8,1.79,4481.0,35 HCPCS,J7197,ANTITHROMBIN III (HUMAN) 500 (+/-) UNIT INTRAVENOUS SOLUTION,92.35,55.41,3.98,4481.0,35 HCPCS,J7198,"ANTI-INHIBITOR COAGULANT COMPLEX 700 UNIT-1,300 UNIT INTRAVENOUS SOLN",86.3,51.78,2.34,4481.0,35 HCPCS,J7296,LEVONORGESTREL 17.5 MCG/24 HOUR (5 YEARS) INTRAUTERINE DEVICE,4649.2,2789.52,1078.61,184236.57,24 HCPCS,J7297,LEVONORGESTREL 20.4 MCG/24 HR (UP TO 8 YRS) 52 MG INTRAUTERINE DEVICE,3748.95,2249.37,869.76,141324.33,24 HCPCS,J7300,COPPER 380 SQUARE MM INTRAUTERINE DEVICE,4578.0,2746.8,1062.1,170749.32,24 HCPCS,J7301,LEVONORGESTREL 14 MCG/24 HR (UP TO 3 YRS) 13.5 MG INTRAUTERINE DEVICE,4067.55,2440.53,943.67,165907.14,24 HCPCS,J7307,ETONOGESTREL 68 MG SUBDERMAL IMPLANT,4880.55,2928.33,1132.29,164995.74,24 HCPCS,J7312,DEXAMETHASONE 0.7 MG INTRAVITREAL IMPLANT,5514.0,3308.4,198.47,4770.16,35 HCPCS,J7314,FLUOCINOLONE 0.18 MG INTRAVITREAL IMPLANT,36546.0,21927.6,513.99,85862.7,35 HCPCS,J7315,MITOMYCIN 0.2 MG OPHTHALMIC KIT,1463.3,877.98,339.49,4481.0,23 HCPCS,J7321,SODIUM HYALURONATE 10 MG/ML INTRA-ARTICULAR SYRINGE,941.7,565.02,160.92,11176.41,48 HCPCS,J7324,SODIUM HYALURONATE 30 MG/2 ML INTRA-ARTICULAR SYRINGE,1880.2,1128.12,111.1,19812.66,35 HCPCS,J7325,HYLAN G-F 20 48 MG/6 ML INTRA-ARTICULAR SYRINGE,5357.55,3214.53,7.71,4481.0,35 HCPCS,J7325,HYLAN G-F 20 16 MG/2 ML INTRA-ARTICULAR SYRINGE,1796.55,1077.93,7.71,4481.0,35 HCPCS,J7330,MEMBRANE 2 AUTOLOGOUS CULTURED CHONDROCYTES,156650.0,93990.0,4481.0,215040.47,24 HCPCS,J7330,MEMBRANE AUTOLOGOUS CULTURED CHONDROCYTES,95031.72,57019.03,4481.0,215040.47,24 HCPCS,J7336,CAPSAICIN-SKIN CLEANSER 8 % TOPICAL KIT,2750.45,1650.27,3.32,4481.0,35 HCPCS,J7355,TRAVOPROST 75 MCG INTRACAMERAL IMPLANT,54421.0,32652.6,189.85,43536.8,35 HCPCS,J7500,AZATHIOPRINE 25 MG SPLIT TAB,17.05,10.23,0.135,4481.0,24 HCPCS,J7500,AZATHIOPRINE 50 MG TABLET,18.05,10.83,0.135,4481.0,24 HCPCS,J7500,AZATHIOPRINE 50 MG/ML ORAL SUSPENSION,520.0,312.0,0.135,4481.0,24 HCPCS,J7501,AZATHIOPRINE 100 MG SOLUTION FOR INJECTION,991.0,594.6,246.45,4481.0,35 HCPCS,J7502,CYCLOSPORINE 100 MG CAPSULE,65.65,39.39,4.59,4481.0,24 HCPCS,J7502,CYCLOSPORINE MODIFIED 100 MG CAPSULE,29.2,17.52,4.59,4481.0,24 HCPCS,J7502,CYCLOSPORINE MODIFIED 100 MG/ML ORAL SOLUTION,1938.85,1163.31,4.59,4481.0,24 HCPCS,J7503,"STUDY TACROLIMUS XR 0.75 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 HCPCS,J7503,"STUDY TACROLIMUS XR 1 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 HCPCS,J7503,"STUDY TACROLIMUS XR 4 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 HCPCS,J7503,"TACROLIMUS XR 0.75 MG TABLET,EXTENDED RELEASE 24 HR",31.95,19.17,4.12,4481.0,24 HCPCS,J7503,"TACROLIMUS XR 1 MG TABLET,EXTENDED RELEASE 24 HR",37.25,22.35,4.12,4481.0,24 HCPCS,J7503,"TACROLIMUS XR 4 MG TABLET,EXTENDED RELEASE 24 HR",100.9,60.54,4.12,4481.0,24 HCPCS,J7504,"LYMPHOCYTE,ANTI-THYMO IMMUNE GLOBULIN 50 MG/ML INTRAVENOUS SOLUTION",18424.25,11054.55,4481.0,679563.36,35 HCPCS,J7507,"TACROLIMUS 0.5 MG CAPSULE, IMMEDIATE-RELEASE",21.95,13.17,0.3825,4481.0,24 HCPCS,J7507,"TACROLIMUS 1 MG CAPSULE, IMMEDIATE-RELEASE",20.5,12.3,0.3825,4481.0,24 HCPCS,J7507,TACROLIMUS 1 MG/ML ORAL SUSPENSION,405.05,243.03,0.3825,4481.0,24 HCPCS,J7507,"TACROLIMUS 5 MG CAPSULE, IMMEDIATE-RELEASE",51.9,31.14,0.3825,4481.0,24 HCPCS,J7508,"STUDY TACROLIMUS XL 0.5 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 HCPCS,J7508,"STUDY TACROLIMUS XL 1 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 HCPCS,J7508,"STUDY TACROLIMUS XL 5 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 HCPCS,J7508,"TACROLIMUS XL 1 MG CAPSULE,EXTENDED RELEASE 24 HR",33.35,20.01,1.33,4481.0,24 HCPCS,J7508,"TACROLIMUS XL 5 MG CAPSULE,EXTENDED RELEASE 24 HR",102.7,61.62,1.33,4481.0,24 HCPCS,J7509,METHYLPREDNISOLONE 16 MG TABLET,23.5,14.1,0.2475,4481.0,24 HCPCS,J7509,METHYLPREDNISOLONE 4 MG TABLET,21.05,12.63,0.2475,4481.0,24 HCPCS,J7510,PREDNISOLONE SODIUM PHOSPHATE 15 MG/5 ML (3 MG/ML) ORAL SOLUTION,19.3,11.58,0.5175,4481.0,24 HCPCS,J7511,ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG INTRAVENOUS SOLUTION,4135.1,2481.06,969.39,145865.16,35 HCPCS,J7511,STUDY BMT-CTN-2207 THYMOGLOBULIN (RABBIT ATG) 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,145865.16,35 HCPCS,J7512,PREDNISONE 1 MG TABLET,16.7,10.02,0.0225,4481.0,24 HCPCS,J7512,PREDNISONE 10 MG TABLET,16.65,9.99,0.0225,4481.0,24 HCPCS,J7512,PREDNISONE 20 MG TABLET,16.6,9.96,0.0225,4481.0,24 HCPCS,J7512,PREDNISONE 5 MG TABLET,16.55,9.93,0.0225,4481.0,24 HCPCS,J7512,PREDNISONE 5 MG/5 ML ORAL SOLUTION,946.0,567.6,0.0225,4481.0,24 HCPCS,J7512,PREDNISONE 50 MG TABLET,17.05,10.23,0.0225,4481.0,24 HCPCS,J7512,STUDY 1042-SE-3003 GANAXOLONE 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY 1042-SE-3003 GANAXOLONE 1 MG/ML OR PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY 218672 GSK4532990 100 MG/200 MG OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY 230LE301 BIIB059/PLACEBO 150 MG/ML SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY A5374 CHADOX1.HIVCONSV62 2.5 X 10E10 VP OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY A5374 CHADOX1.THIVCONSV1 2.5 X 10E10 VP OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY A5374 MVA.THIVCONSV3 1 X 10E8 PFU OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY A5374 MVA.THIVCONSV4 0.9 X 10E8 PFU OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY A5374 VES OR PLACEBO 2 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY A5415 CENICRIVIROC MESYLATE (CVC)/PLACEBO 150 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY ABX NAIL IRB# 23-0204 GENTAMICIN 80 MG/2 ML VIAL,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY ABX NAIL IRB# 23-0204 VANCOMYCIN 1 GRAM VIAL,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 1,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 2,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 3,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 4,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AK002-016 PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AP-SA02-101 5X10E10 (2.5X10E10 PFU/PHAGE) OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AP-SA02-101 HIGH DOSE 1X10E10 PFU/DOSE OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AP-SA02-101 HIGH DOSE 4X10E10 PFU (2X10E10 PFU/PHAGE) OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY AP-SA02-101 LOW DOSE 1X10E9 PFU/DOSE OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY B7981040 RITLECITINIB 50 MG/PLACEBO CAPSULES,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY BP41315 ALOGABAT 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY BP41315 ALOGABAT 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY BP41315 ALOGABAT 3 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY BP41315 ALOGABAT 4 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY C0221002 PF-06730512 120 MG/ML INJ,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY CETIRIZINE 1 MG/ML ORAL SOLUTION,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY CNTO1959CRD3001 GUSELKUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY CNTO1959CRD3001 GUSELKUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY CNTO1959CRD3001 GUSELKUMAB/PLACEBO 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY CNTO1959CRD3001 USTEKINUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY CV010-031 ASPIRIN 100 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY CV010-031 CLOPIDOGREL 75 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY EIND 167902 V-073 (POCAPAVIR) GRANULATED POWDER,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY EIP21-NFD-504 NEFLAMAPIMOD/PLACEBO 40 MG CAPSULE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY F901318/0041 OLOROFIM (F901318) 30 MG FILM COATED TABLET,0.2,0.12,0.0225,4481.0,21 HCPCS,J7512,STUDY ICI-M 1201 ABATACEPT/PLACEBO 25 MG/ML INJECTION,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY IRB 18-2650 ANAKINRA/PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY J3E-MC-EZDB LY3540378 20 MG/ML OR PLACEBO SYRINGE/VIAL,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY M20-259 USTEKINUMAB 90 MG/ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY MGT-AQP1-201 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY MGT-AQP1-202 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,23 HCPCS,J7512,STUDY PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY PROCLAIM MISOPROSTOL/PLACEBO 100 MCG CAPSULE,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY PTK0796-NTM-20203 OMADACYCLINE (PTK 0796) 150 MG/PLACEBO TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY R1979-HM-2298 PREDNISONE 50 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 1 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 5 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7512,STUDY TAK-079-2001 TAK-079 100 MG/ML OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,72 HCPCS,J7512,STUDY TBCRC-058 MIFEPRISTONE 300 MG TABLET,0.2,0.12,0.0225,4481.0,24 HCPCS,J7515,CYCLOSPORINE 25 MG CAPSULE,30.4,18.24,1.8,4481.0,24 HCPCS,J7515,CYCLOSPORINE MODIFIED 25 MG CAPSULE,19.3,11.58,1.8,4481.0,24 HCPCS,J7516,CYCLOSPORINE 1 MG/ML NS AVIVA INFUSION,88.05,52.83,20.43,10791.27,24 HCPCS,J7516,CYCLOSPORINE 1 MG/ML NS AVIVA IV,193.8,116.28,44.96,10791.27,24 HCPCS,J7516,CYCLOSPORINE 1 MG/ML NS AVIVA IVPB,193.8,116.28,44.96,10791.27,24 HCPCS,J7516,CYCLOSPORINE 250 MG/5 ML INTRAVENOUS SOLUTION,295.8,177.48,68.63,10791.27,24 HCPCS,J7517,MYCOPHENOLATE MOFETIL 200 MG/ML ORAL POWDER FOR SUSPENSION,48.4,29.04,0.36,4481.0,24 HCPCS,J7517,MYCOPHENOLATE MOFETIL 500 MG TABLET,19.3,11.58,0.36,4481.0,24 HCPCS,J7517,STUDY ALE10 (DIVERT) MYCOPHENOLATE MOFETIL (MMF)/PLACEBO 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 HCPCS,J7517,STUDY D798KC00001 MYCOPHENOLATE MOFETIL 500 MG TABLET,0.2,0.12,0.0464,4481.0,24 HCPCS,J7518,"MYCOPHENOLATE SODIUM 180 MG TABLET,DELAYED RELEASE",16.55,9.93,0.765,4481.0,24 HCPCS,J7518,"MYCOPHENOLATE SODIUM 360 MG TABLET,DELAYED RELEASE",17.15,10.29,0.765,4481.0,24 HCPCS,J7519,MYCOPHENOLATE 500 MG INTRAVENOUS SOLUTION,416.1,249.66,0.81,4481.0,24 HCPCS,J7520,SIROLIMUS 0.5 MG TABLET,32.4,19.44,1.96,4481.0,23 HCPCS,J7520,SIROLIMUS 1 MG TABLET,57.65,34.59,1.96,4481.0,24 HCPCS,J7520,SIROLIMUS 2 MG TABLET,38.5,23.1,1.96,4481.0,24 HCPCS,J7525,TACROLIMUS 0.01 MG/ML IV SYRINGE,236.35,141.81,59.8,4481.0,35 HCPCS,J7525,TACROLIMUS 5 MG/ML INTRAVENOUS SOLUTION,64.35,38.61,16.28,4481.0,35 HCPCS,J7525,TACROLIMUS INFUSION 0.01 MG/ML (50 ML SYRINGE),236.35,141.81,59.8,4481.0,35 HCPCS,J7527,EVEROLIMUS (IMMUNOSUPPRESSIVE) 0.25 MG TABLET,68.9,41.34,3.08,4481.0,24 HCPCS,J7527,EVEROLIMUS (IMMUNOSUPPRESSIVE) 0.5 MG TABLET,112.9,67.74,3.08,4481.0,24 HCPCS,J7527,EVEROLIMUS (IMMUNOSUPPRESSIVE) 0.75 MG TABLET,156.75,94.05,3.08,4481.0,24 HCPCS,J7686,TREPROSTINIL 1.74 MG/2.9 ML (0.6 MG/ML) SOLUTION FOR NEBULIZATION,2396.0,1437.6,555.87,4481.0,23 HCPCS,J7999,MITOMYCIN 0.04% (400 MCG/1 ML) OPHTHALMIC SOLUTION,130.0,78.0,30.16,4481.0,19 HCPCS,J8501,APREPITANT 125 MG CAPSULE,780.15,468.09,6.14,4481.0,24 HCPCS,J8501,APREPITANT 20 MG/ML ORAL SUSPENSION,505.5,303.3,6.14,4481.0,24 HCPCS,J8501,APREPITANT 40 MG CAPSULE,279.85,167.91,6.14,4481.0,24 HCPCS,J8501,APREPITANT 80 MG CAPSULE,505.1,303.06,6.14,4481.0,24 HCPCS,J8510,BUSULFAN 2MG/ML ORAL SUSPENSION,1337.0,802.2,81.68,4481.0,35 HCPCS,J8530,CYCLOPHOSPHAMIDE 25 MG CAPSULE,55.0,33.0,2.48,4481.0,24 HCPCS,J8530,CYCLOPHOSPHAMIDE 50 MG CAPSULE,80.0,48.0,2.48,4481.0,24 HCPCS,J8540,DEXAMETHASONE 0.5 MG TABLET,16.55,9.93,0.045,4481.0,24 HCPCS,J8540,DEXAMETHASONE 0.5 MG/5 ML ORAL SOLUTION,168.65,101.19,0.045,4481.0,24 HCPCS,J8540,DEXAMETHASONE 4 MG TABLET,19.05,11.43,0.045,4481.0,24 HCPCS,J8610,METHOTREXATE SODIUM 2.5 MG (ONCOLOGY) TABLET,32.1,19.26,0.4275,4481.0,24 HCPCS,J8610,METHOTREXATE SODIUM 2.5 MG TABLET,37.2,22.32,0.4275,4481.0,24 HCPCS,J8612,METHOTREXATE 2.5 MG/ML ORAL SOLUTION,10026.8,6016.08,22.0,8674.18,35 HCPCS,J8700,TEMOZOLOMIDE 10 MG/ML ORAL SUSPENSION,15105.0,9063.0,0.9735,13067.34,24 HCPCS,J8700,TEMOZOLOMIDE 20 MG CAPSULE,49.55,29.73,0.9735,4481.0,24 HCPCS,J8999,AFATINIB 20 MG TABLET,1597.25,958.35,370.56,4481.0,22 HCPCS,J8999,AFATINIB 30 MG TABLET,1597.25,958.35,370.56,4481.0,22 HCPCS,J8999,AFATINIB 40 MG TABLET,1597.25,958.35,370.56,4481.0,22 HCPCS,J8999,LOMUSTINE 10 MG CAPSULE,511.0,306.6,118.55,4481.0,22 HCPCS,J8999,MOMELOTINIB 100 MG TABLET,3873.9,2324.34,898.74,4481.0,22 HCPCS,J8999,MOMELOTINIB 200 MG TABLET,3873.9,2324.34,898.74,4481.0,22 HCPCS,J8999,PACRITINIB 100 MG CAPSULE,663.05,397.83,153.83,4481.0,22 HCPCS,J8999,STUDY (PUMA-ALI-1201) ALISERTIB ENTERIC-COATED 10 MG TABLET,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY 56021927PCR3011 APALUTAMIDE 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A041702-CIRB IBRUTINIB 140 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A041702-CIRB VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A041702-CIRB VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A041702-CIRB VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A051901-CIRB LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A051901-CIRB LENALIDOMIDE 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A052101-CIRB ZANUBRUTINIB 80 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A071701-CIRB ABEMACICLIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A071701-CIRB ENTRECTINIB 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY A071701-CIRB PAXALISIB (GDC-0084) 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY A092105-CIRB CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY ACCL2031 MEMANTINE / PLACEBO 2 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY AFT-41 LENALIDOMIDE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY AFT-41 LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY ANBL1531 LORLATINIB 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY ANBL1531 LORLATINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY BGB-11417-301 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BGB-11417-301 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BGB-11417-301 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BGB-11417-301 ZANUBRUTINIB 80 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BGB-11417-303 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BGB-11417-303 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BGB-11417-303 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BMT-CTN-2203 RUXOLITINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY BO45217 ADAGRASIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY CC-5013-AML-002 LENALIDOMIDE 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY CC-5013-AML-002 LENALIDOMIDE 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY CRAD001A2433 EVEROLIMUS TABLET 0.25 MG,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY CRAD001A2433 EVEROLIMUS TABLET 0.5 MG,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY CRAD001A2433 EVEROLIMUS TABLET 0.75 MG,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY CRAD001A2433 EVEROLIMUS TABLET 1 MG,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY GOG-3007 EVEROLIMUS 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY GOG-3007 EVEROLIMUS 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY GOG-3007 EVEROLIMUS 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY INCB57643-103 RUXOLITINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY IND DABRAFENIB 10 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY IND TRAMETINIB 0.05 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY LCCC2047 OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY LCCC2047 OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY M20-356 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M20-356 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M20-356 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M22-574 POMALIDOMIDE 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M22-574 POMALIDOMIDE 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M22-574 POMALIDOMIDE 3 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M22-574 POMALIDOMIDE 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M24-147 SORAFENIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M25-059 LENALIDOMIDE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M25-059 LENALIDOMIDE 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M25-059 LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M25-059 LENALIDOMIDE 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M25-059 LENALIDOMIDE 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY M25-059 LENALIDOMIDE 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY MM1OA-EA02 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY MM1OA-EA02 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY MM1OA-EA02 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10434-CIRB POMALIDOMIDE 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10434-CIRB POMALIDOMIDE 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10440-CIRB VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10440-CIRB VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10440-CIRB VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10464-CIRB OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY NCI-10464-CIRB OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY NCI-10538 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10538 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY NCI-10538 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY PROFFI FISETIN / PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 HCPCS,J8999,STUDY PUMA-ALI-1201 ANASTROZOLE 1 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY PUMA-ALI-1201 EXEMESTANE 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY PUMA-ALI-1201 LETROZOLE 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY PUMA-ALI-1201 TAMOXIFEN 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY S095031-178 IVOSIDENIB 250 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY S1925 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY S1925 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY S1925 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY TAPUR TALAZOPARIB 0.25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY TAPUR TALAZOPARIB 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY TBCRC-058 ENZALUTAMIDE 40 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 HCPCS,J8999,STUDY TBCRC-059 ABEMACICLIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 HCPCS,J9000,DOXORUBICIN (ADRIAMYCIN) 25 MG/ML INJECTION,309.0,185.4,6.79,4481.0,24 HCPCS,J9000,DOXORUBICIN 2 MG/ML INTRAVENOUS SOLUTION,672.2,403.32,6.79,4481.0,24 HCPCS,J9000,DOXORUBICIN 50 MG INTRAVENOUS SOLUTION,1145.65,687.39,6.79,4481.0,24 HCPCS,J9000,STUDY R1979-HM-2298 DOXORUBICIN 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9011,DATOPOTAMAB DERUXTECAN-DLNK 100 MG INTRAVENOUS SOLUTION,16464.45,9878.67,50.01,14243.4,35 HCPCS,J9011,STUDY DS3201-324 DS-1062A (DATO-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9011,STUDY LCCC2215 DATOPOTAMAB-DERUXTECAN (DATO-DXD) 100 MG POWDER FOR SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9011,STUDY TBCRC-064 DATOPOTAMAB DERUXTECAN (DATO-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9015,STUDY IMA203-301 ALDESLEUKIN 3.6 MILLION UNITS/ML SOLUTION,0.2,0.12,0.0506,327745.32,35 HCPCS,J9017,ARSENIC TRIOXIDE 1 MG/ML INTRAVENOUS SOLUTION,2241.15,1344.69,7.91,4481.0,35 HCPCS,J9017,ARSENIC TRIOXIDE 2 MG/ML INTRAVENOUS SOLUTION,4499.5,2699.7,7.91,4481.0,35 HCPCS,J9021,ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION,17851.1,10710.66,53.81,14280.88,35 HCPCS,J9021,ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION SPLIT SYRINGES,17851.1,10710.66,53.81,14280.88,35 HCPCS,J9022,ATEZOLIZUMAB (TECENTRIQ) 60 MG/ML INJECTION SOLUTION WRAPPER,32881.7,19729.02,88.6,30908.64,70 HCPCS,J9022,"ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION",38635.8,23181.48,88.6,30908.64,35 HCPCS,J9022,ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION,27127.6,16276.56,88.6,21702.08,35 HCPCS,J9022,STUDY CO43613 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 HCPCS,J9022,STUDY CO44668 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 HCPCS,J9022,STUDY CO44668 TIRAGOLUMAB / PLACEBO 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 HCPCS,J9022,STUDY DFHCC-23-429 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 HCPCS,J9022,STUDY LCCC2036 ATEZOLIZUMAB 60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,14630.91,70 HCPCS,J9022,STUDY RTOG-1216 ATEZOLIZUMAB (MPCL3280A) 60 MG /ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 HCPCS,J9022,STUDY YL201-INT-101-01 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 HCPCS,J9023,AVELUMAB 20 MG/ML INTRAVENOUS SOLUTION,7206.25,4323.75,97.09,15899.52,35 HCPCS,J9023,STUDY TBCRC-047 AVELUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,15899.52,35 HCPCS,J9024,"ATEZOLIZUMAB 1,875 MG-HYALURONIDASE-TQJS 30,000 UNIT/15 ML SUBCUT SOLN",38635.8,23181.48,30.63,30908.64,35 HCPCS,J9025,AZACITIDINE (VIDAZA) SYRINGE 25 MG/ML,2212.15,1327.29,0.5775,4481.0,24 HCPCS,J9025,STUDY AK117-205 AZACITIDINE 25 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9025,STUDY S095031-178 AZACITIDINE 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9025,STUDY S095031-178 AZACITIDINE 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9026,STUDY 20200469 TARLATAMAB 0.9 MG/ML INTRAVENOUS SOLUTION (1 MG VIAL),0.2,0.12,0.0506,257101.53,35 HCPCS,J9026,STUDY 20200469 TARLATAMAB 2.4 MG/ML INTRAVENOUS SOLUTION (10 MG VIAL),0.2,0.12,0.0506,257101.53,35 HCPCS,J9026,STUDY 20200469 TARLATAMAB 4.8 MG/ML INTRAVENOUS SOLUTION (25 MG VIAL),0.2,0.12,0.0506,257101.53,35 HCPCS,J9026,STUDY IND TARLATAMAB 0.9 MG/ML INTRAVENOUS SOLUTION (1 MG VIAL),0.2,0.12,0.0506,257101.53,35 HCPCS,J9026,STUDY IND TARLATAMAB 2.4 MG/ML INTRAVENOUS SOLUTION (10 MG VIAL),0.2,0.12,0.0506,257101.53,35 HCPCS,J9026,TARLATAMAB-DLLE 1 MG INTRAVENOUS SOLUTION,5637.25,3382.35,1426.22,257101.53,35 HCPCS,J9026,TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION,49925.0,29955.0,1517.7,257101.53,35 HCPCS,J9028,NOGAPENDEKIN ALFA INBAKICEPT-PMLN 400 MCG/0.4 ML INTRAVESICAL SOLUTION,118773.0,71263.8,91.82,95018.4,35 HCPCS,J9029,NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION,51341.7,30805.02,4481.0,10350356.73,35 HCPCS,J9030,BCG LIVE 50 MG INTRAVESICAL SUSPENSION,859.8,515.88,7.33,4481.0,24 HCPCS,J9030,STUDY CA-ALT-803-01-14 BCG 50 MG INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9030,STUDY CA-ALT-803-01-16 BCG 50 MG INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9030,STUDY S1602 BCG TOKYO-172 STRAIN 0.5 MG/ML INTRADERMAL INJECTION,0.2,0.12,0.0464,4481.0,23 HCPCS,J9030,STUDY S1602 BCG TOKYO-172 STRAIN 40 MG/ML INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,23 HCPCS,J9032,BELINOSTAT 500 MG INTRAVENOUS SOLUTION,8650.25,5190.15,50.9,7907.13,35 HCPCS,J9034,BENDAMUSTINE (BENDEKA) 25 MG/ML INTRAVENOUS SOLUTION,8463.3,5077.98,13.09,6770.64,35 HCPCS,J9034,STUDY R1979-HM-2298 BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9035,BEVACIZUMAB (AVASTIN) 25 MG/ML,308.0,184.8,71.0,10991.19,35 HCPCS,J9035,STUDY CHS-388-202 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,35 HCPCS,J9035,STUDY CO44668 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,35 HCPCS,J9035,STUDY EMERALD-Y90 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,70 HCPCS,J9037,STUDY GSK-209626-DREAMM12 BELANTAMAB MAFODOTIN 50 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 HCPCS,J9037,STUDY GSK-218670 BELANTAMAB 75 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 HCPCS,J9037,STUDY GSK-218670 BELANTAMAB MAFODOTIN 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 HCPCS,J9038,AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION,26672.625,16003.575,53.98,30265.2,70 HCPCS,J9039,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 24-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 48-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 7-DAY INFUSION)",18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 72-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 96-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (5 MCG/M2/DAY, 24-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (5 MCG/M2/DAY, 48-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,BLINATUMOMAB 35 MCG INTRAVENOUS KIT,18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,BLINATUMOMAB 35 MCG INTRAVENOUS SOLUTION,18667.95,11200.77,159.32,24925.32,35 HCPCS,J9039,STUDY A041703-CIRB BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 HCPCS,J9039,STUDY AALL1821 BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 HCPCS,J9039,STUDY AALL2321 BLINATUMOMAB 12.5 MCG/ML IV SOLUTION,0.2,0.12,0.0506,24925.32,35 HCPCS,J9039,STUDY EA9181-CIRB BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 HCPCS,J9040,BLEOMYCIN (BLENOXANE) SYRINGE 15 UNITS/ML,331.6,198.96,48.42,4481.0,24 HCPCS,J9040,BLEOMYCIN 15 UNIT SOLUTION FOR INJECTION,442.05,265.23,48.42,4481.0,24 HCPCS,J9040,BLEOMYCIN FOR WARTS SYRINGE,464.35,278.61,48.42,4481.0,24 HCPCS,J9040,BLEOMYCIN INTRALESIONAL SYRINGE 1 UNIT/ML,442.05,265.23,48.42,4481.0,24 HCPCS,J9040,BLEOMYCIN INTRALESIONAL SYRINGE 2 UNITS/ML,442.05,265.23,48.42,4481.0,24 HCPCS,J9040,BLEOMYCIN INTRALESIONAL SYRINGE 3 UNITS/ML,442.05,265.23,48.42,4481.0,24 HCPCS,J9040,BLEOMYCIN INTRALESIONAL SYRINGE 4 UNITS/ML,442.05,265.23,48.42,4481.0,24 HCPCS,J9040,BLEOMYCIN INTRALESIONAL SYRINGE 5 UNITS/ML,442.05,265.23,48.42,4481.0,24 HCPCS,J9041,BORTEZOMIB (VELCADE) IV SYRINGE 1 MG/ML,5580.95,3348.57,4.32,4481.0,24 HCPCS,J9041,BORTEZOMIB (VELCADE) SUBCUTANEOUS SYRINGE 2.5 MG/ML,5580.95,3348.57,4.32,4481.0,24 HCPCS,J9041,STUDY 1966 BORTEZOMIB IV SYRINGE 1 MG/ML,0.2,0.12,0.0464,4481.0,24 HCPCS,J9041,STUDY 1966 BORTEZOMIB SUBCUTANEOUS SYRINGE 2.5 MG/ML,0.2,0.12,0.0464,4481.0,24 HCPCS,J9041,STUDY M22-574 BORTEZOMIB 1 MG/ML IV SYRINGE,0.2,0.12,0.0464,4481.0,24 HCPCS,J9041,STUDY M22-574 BORTEZOMIB 2.5 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,24 HCPCS,J9042,BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION,42231.9,25339.14,250.88,37621.71,35 HCPCS,J9042,STUDY AHOD2131 BRENTUXIMAB VEDOTIN 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,37621.71,35 HCPCS,J9043,CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION,45834.25,27500.55,220.46,36667.4,35 HCPCS,J9045,CARBOPLATIN (PARAPLATIN) 10 MG/ML IVPB (BY AUC),479.0,287.4,5.56,4481.0,24 HCPCS,J9045,CARBOPLATIN (PARAPLATIN) 10 MG/ML IVPB (BY MG/M2),479.0,287.4,5.56,4481.0,24 HCPCS,J9045,CARBOPLATIN 0.1 MG/ML INJECTION,308.1,184.86,5.56,4481.0,24 HCPCS,J9045,CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,479.0,287.4,5.56,4481.0,24 HCPCS,J9045,STUDY J3M-MC-JZQB CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9047,CARFILZOMIB (KYPROLIS) IVPB 2 MG/ML,11983.1,7189.86,53.98,9586.48,35 HCPCS,J9047,CARFILZOMIB 60 MG INTRAVENOUS SOLUTION,11983.1,7189.86,53.98,9586.48,35 HCPCS,J9047,STUDY M22-574 CARFILZOMIB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,7908.6,35 HCPCS,J9047,STUDY M25-059 CARFILZOMIB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,7908.6,35 HCPCS,J9050,CARMUSTINE 100 MG INTRAVENOUS SOLUTION,9004.8,5402.88,231.31,22004.43,35 HCPCS,J9050,CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT,17751.8,10651.08,231.31,22004.43,35 HCPCS,J9055,CETUXIMAB 100 MG/50 ML IV,3043.85,1826.31,76.02,11827.62,35 HCPCS,J9055,CETUXIMAB 200 MG/100 ML INTRAVENOUS SOLUTION,5812.65,3487.59,76.02,11827.62,35 HCPCS,J9055,CETUXIMAB IVPB OVER 1 HOUR,4428.25,2656.95,76.02,11827.62,70 HCPCS,J9055,CETUXIMAB IVPB OVER 2 HOURS,4428.25,2656.95,76.02,11827.62,70 HCPCS,J9055,CETUXIMAB IVPB OVER 3 HOURS,4428.25,2656.95,76.02,11827.62,70 HCPCS,J9055,STUDY 61186372COR3001 CETUXIMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,11827.62,35 HCPCS,J9055,STUDY 849-001 CETUXIMAB 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11827.62,35 HCPCS,J9055,STUDY LOXO-RAS-20001 CETUXIMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,11827.62,35 HCPCS,J9055,STUDY NANORAY312 CETUXIMAB 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11827.62,35 HCPCS,J9057,COPANLISIB 60 MG INTRAVENOUS SOLUTION,17664.45,10598.67,200.95,14131.56,23 HCPCS,J9060,CISPLATIN (PLATINOL) 0.1 MG/ML INJECTION,275.1,165.06,5.15,4481.0,24 HCPCS,J9060,CISPLATIN (PLATINOL) IVPB 1 MG/ML,391.35,234.81,5.15,4481.0,48 HCPCS,J9060,CISPLATIN (POWDER) 1 MG/ML IVPB,1930.0,1158.0,5.15,4481.0,24 HCPCS,J9060,CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,392.85,235.71,5.15,4481.0,48 HCPCS,J9060,CISPLATIN 50 MG INTRAVENOUS POWDER FOR SOLUTION,1930.0,1158.0,5.15,4481.0,24 HCPCS,J9060,CISPLATIN SKIN TEST PERCUTANEOUS,278.35,167.01,5.15,4481.0,48 HCPCS,J9060,STUDY GCT1046-01 CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9060,STUDY J3M-MC-JZQB CISPLATIN 1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9060,STUDY LOXO-RAS-20001 CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9061,AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION,12875.15,7725.09,21.86,10300.12,35 HCPCS,J9061,STUDY 61186372COR3001 AMIVANTAMAB 160 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J9061,STUDY 61186372HNC2002 AMIVANTAMAB 160 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.05544,4481.0,62 HCPCS,J9063,MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION,22724.65,13634.79,67.41,18179.72,35 HCPCS,J9063,STUDY GOG-3078-GLORIOSA MIRVETUXIMAB SORAVTANSINE 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,11142.6,35 HCPCS,J9063,STUDY GOG-3115/M25-231 MIRVETUXIMAB SORAVTANSINE 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,11142.6,35 HCPCS,J9065,CLADRIBINE 10 MG/10 ML INTRAVENOUS SOLUTION,1714.85,1028.91,10.36,4481.0,35 HCPCS,J9070,STUDY CAB-201-001 (23-2231) CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 HCPCS,J9070,STUDY CRSP-AID-500 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 HCPCS,J9070,STUDY IMA203-301 CYCLOPHOSPHAMIDE 1 GM,0.2,0.12,0.0464,4481.0,25 HCPCS,J9070,STUDY R1979-HM-2298 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 HCPCS,J9073,STUDY CA0611001 (23-1564) CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9075,CYCLOPHOSPHAMIDE (CYTOXAN) 1 GM INJECTION,2129.8,1277.88,0.4656,4481.0,35 HCPCS,J9075,CYCLOPHOSPHAMIDE (POWDER) (CYTOXAN) 20 MG/ML IVPB,2129.8,1277.88,0.4656,4481.0,35 HCPCS,J9075,CYCLOPHOSPHAMIDE 2 GRAM INTRAVENOUS POWDER FOR SOLUTION,3984.65,2390.79,0.4656,4481.0,35 HCPCS,J9075,CYCLOPHOSPHAMIDE 500 MG INTRAVENOUS POWDER FOR SOLUTION,1202.45,721.47,0.4656,4481.0,35 HCPCS,J9075,STUDY TSCAN-002 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9100,CYTARABINE (PF) 100 MG/ML INJECTION,344.2,206.52,1.87,4481.0,24 HCPCS,J9118,CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION,96384.6,57830.76,79.62,77107.68,34 HCPCS,J9119,CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION,36436.65,21861.99,28.41,29149.32,35 HCPCS,J9119,STUDY LCCC2255 CEMIPLIMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4733.4,35 HCPCS,J9119,STUDY NRG-HN014 CEMIPLIMAB (REGN2810) 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4733.4,35 HCPCS,J9120,DACTINOMYCIN (COSMEGEN) SYRINGE 0.5 MG/ML,9240.3,5544.18,318.49,43645.77,35 HCPCS,J9130,DACARBAZINE 200 MG INTRAVENOUS SOLUTION,314.75,188.85,7.76,4481.0,24 HCPCS,J9144,"DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN",35267.9,21160.74,53.9,28214.32,35 HCPCS,J9144,STUDY 54767414MMY3021 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9144,STUDY 64407564MMY3002 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9144,STUDY AFT-41 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9144,STUDY EAA173CIRB DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9144,STUDY M25-059 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9144,STUDY M25-275 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9144,STUDY MSK-22-424 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9144,STUDY S1803-CIRB DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 HCPCS,J9145,STUDY AFT-41 DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11069.1,35 HCPCS,J9145,STUDY EAA173CIRB DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11069.1,35 HCPCS,J9150,DAUNORUBICIN (CERUBIDINE) SYRINGE 5 MG/ML,719.05,431.43,21.05,4481.0,35 HCPCS,J9153,DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION,36618.8,21971.28,248.41,40760.16,35 HCPCS,J9155,DEGARELIX 120 MG SUBCUTANEOUS SOLUTION,2797.55,1678.53,4.32,4481.0,35 HCPCS,J9155,DEGARELIX 80 MG SUBCUTANEOUS SOLUTION,1891.8,1135.08,4.32,4481.0,35 HCPCS,J9155,STUDY TBCRC-059 DEGARELIX 120 MG SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9155,STUDY TBCRC-059 DEGARELIX 80 MG SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9171,DOCETAXEL (TAXOTERE) 10 MG/ML INJECTION WRAPPER,1599.0,959.4,1.04,4481.0,24 HCPCS,J9171,DOCETAXEL (TAXOTERE) 20 MG/ML INJECTION WRAPPER,490.15,294.09,1.04,4481.0,24 HCPCS,J9171,DOCETAXEL 160 MG/16 ML (10 MG/ML) INTRAVENOUS SOLUTION,1334.2,800.52,1.04,4481.0,24 HCPCS,J9171,DOCETAXEL 20 MG/2 ML (10 MG/ML) INTRAVENOUS SOLUTION,407.4,244.44,1.04,4481.0,24 HCPCS,J9171,DOCETAXEL 80 MG/8 ML (10 MG/ML) INTRAVENOUS SOLUTION,1109.35,665.61,1.04,4481.0,24 HCPCS,J9171,STUDY RMC-6236-301 DOCETAXEL 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9171,STUDY RMC-6236-301 DOCETAXEL 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9173,DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION,9088.525,5453.115,82.57,13726.86,70 HCPCS,J9173,STUDY 20200469 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 HCPCS,J9173,STUDY BRE18-360 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9173,STUDY EMERALD-Y90 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 HCPCS,J9173,STUDY NCI-10464-CIRB DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 HCPCS,J9176,ELOTUZUMAB 400 MG INTRAVENOUS SOLUTION,10519.0,6311.4,7.65,8415.2,35 HCPCS,J9176,STUDY M22-574 ELOTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9177,ENFORTUMAB VEDOTIN-EJFV 20 MG INTRAVENOUS SOLUTION,9572.8,5743.68,35.64,7658.24,35 HCPCS,J9177,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION,14221.7,8533.02,35.64,11377.36,35 HCPCS,J9177,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 100 MG),14221.7,8533.02,35.64,11377.36,35 HCPCS,J9177,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 50 MG),14221.7,8533.02,35.64,11377.36,35 HCPCS,J9177,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 75 MG),14221.7,8533.02,35.64,11377.36,35 HCPCS,J9178,EPIRUBICIN 200 MG/100 ML INTRAVENOUS SOLUTION,1050.25,630.15,4.32,4481.0,24 HCPCS,J9178,EPIRUBICIN 50 MG/25 ML INTRAVENOUS SOLUTION,434.25,260.55,4.32,4481.0,24 HCPCS,J9179,ERIBULIN (HALAVEN) SYRINGE 0.5 MG/ML,4942.1,2965.26,86.66,17947.23,35 HCPCS,J9181,ETOPOSIDE 0.02 MG/ML INTRAVENOUS SOLUTION,275.2,165.12,2.12,4481.0,24 HCPCS,J9181,ETOPOSIDE 0.2 MG/ML INTRAVENOUS SOLUTION,275.2,165.12,2.12,4481.0,24 HCPCS,J9181,ETOPOSIDE 10 MG/ML SUSPENSION,595.75,357.45,2.12,4481.0,24 HCPCS,J9181,ETOPOSIDE 20 MG/ML INTRAVENOUS SOLUTION,480.9,288.54,2.12,4481.0,72 HCPCS,J9181,ETOPOSIDE PHOSPHATE 100 MG INTRAVENOUS SOLUTION,838.9,503.34,2.12,4481.0,24 HCPCS,J9185,FLUDARABINE (FLUDARA) 50 MG INJECTION WRAPPER,1174.95,704.97,66.15,9659.37,35 HCPCS,J9185,FLUDARABINE 50 MG INTRAVENOUS SOLUTION,587.8,352.68,66.15,9659.37,35 HCPCS,J9185,STUDY CA0611001 (23-1564) FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 HCPCS,J9185,STUDY CAB-201-001 (23-2231) FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 HCPCS,J9185,STUDY CRSP-AID-500 FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 HCPCS,J9185,STUDY IMA203-301 FLUDARABINE 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9659.37,35 HCPCS,J9185,STUDY TSCAN-002 FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 HCPCS,J9190,FLUOROURACIL (ADRUCIL) 50 MG/ML IV SOLUTION WRAPPER,286.35,171.81,4.48,4481.0,24 HCPCS,J9190,FLUOROURACIL (ADRUCIL) 50 MG/ML IV SOLUTION WRAPPER (UNC HOMECARE),372.0,223.2,4.48,4481.0,24 HCPCS,J9190,FLUOROURACIL 500 MG/10 ML INTRAVENOUS SOLUTION,286.35,171.81,4.48,4481.0,24 HCPCS,J9190,FLUOROURACIL INFUSION (CADD),286.35,171.81,4.48,4481.0,24 HCPCS,J9200,FLOXURIDINE 0.5 GRAM SOLUTION FOR INJECTION,13634.2,8180.52,3449.45,619321.29,35 HCPCS,J9201,GEMCITABINE 1 GRAM INTRAVENOUS SOLUTION,413.65,248.19,7.04,4481.0,24 HCPCS,J9201,GEMCITABINE 2 GRAM INTRAVENOUS SOLUTION,650.65,390.39,7.04,4481.0,24 HCPCS,J9201,GEMCITABINE 2 GRAM/52.6 ML (38 MG/ML) INTRAVENOUS SOLUTION,359.2,215.52,7.04,4481.0,24 HCPCS,J9201,GEMCITABINE 200 MG INTRAVENOUS SOLUTION,315.05,189.03,7.04,4481.0,24 HCPCS,J9201,GEMCITABINE 38 MG/ML INJECTABLE SOLUTION WRAPPER,574.85,344.91,7.04,4481.0,24 HCPCS,J9201,GEMCITABINE BLADDER INSTILLATION (38 MG/ML),424.95,254.97,7.04,4481.0,24 HCPCS,J9202,GOSERELIN 3.6 MG SUBCUTANEOUS IMPLANT,3995.3,2397.18,711.66,110495.49,35 HCPCS,J9203,GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN,34022.75,20413.65,229.52,38155.32,35 HCPCS,J9204,MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION,16104.75,9662.85,241.04,39876.69,35 HCPCS,J9205,IRINOTECAN LIPOSOMAL 4.3 MG/ML INTRAVENOUS,10135.5,6081.3,64.02,10683.96,35 HCPCS,J9206,IRINOTECAN 100 MG/5 ML INTRAVENOUS SOLUTION,347.75,208.65,3.81,4481.0,24 HCPCS,J9206,IRINOTECAN 20 MG/ML ORAL SOLUTION,93.7,56.22,3.81,4481.0,24 HCPCS,J9206,STUDY VAL-10-001 IRN-IVPO IRINOTECAN HCL 20 MG/ML INJ FOR ORAL USE,0.2,0.12,0.0464,4481.0,24 HCPCS,J9207,IXABEPILONE 45 MG INTRAVENOUS SOLUTION,20279.6,12167.76,135.03,21536.97,35 HCPCS,J9208,IFOSFAMIDE 3 GRAM INTRAVENOUS SOLUTION,631.0,378.6,56.7,4481.0,24 HCPCS,J9209,MESNA 100 MG/ML INTRAVENOUS SOLUTION,494.5,296.7,3.61,4481.0,24 HCPCS,J9210,EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION,35689.025,21413.415,373.3,62444.13,68 HCPCS,J9217,LEUPROLIDE 30 MG (4 MONTH) SUBCUTANEOUS SYRINGE,6255.4,3753.24,171.16,26039.58,35 HCPCS,J9217,LEUPROLIDE 7.5 MG (1 MONTH) SUBCUTANEOUS SYRINGE,1770.1,1062.06,171.16,26039.58,35 HCPCS,J9217,LEUPROLIDE 7.5 MG INTRAMUSCULAR SYRINGE KIT,7379.3,4427.58,171.16,26039.58,35 HCPCS,J9217,LEUPROLIDE ACETATE 22.5 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT,21587.7,12952.62,171.16,26039.58,35 HCPCS,J9217,LEUPROLIDE ACETATE 22.5 MG (3 MONTH) SUBCUTANEOUS SYRINGE,4760.3,2856.18,171.16,26039.58,35 HCPCS,J9217,LEUPROLIDE ACETATE 45 MG (6 MONTH) SUBCUTANEOUS SYRINGE,9245.55,5547.33,171.16,26039.58,35 HCPCS,J9217,STUDY 56021927PCR3011 LEUPROLIDE 22.5 MG INTRAMUSCULAR INJECTION,0.2,0.12,0.0506,26039.58,35 HCPCS,J9217,STUDY 56021927PCR3011 LEUPROLIDE 22.5 MG SUBCUTANEOUS INJECTION,0.2,0.12,0.0506,26039.58,35 HCPCS,J9223,LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION,27582.5,16549.5,200.92,33560.1,35 HCPCS,J9227,ISATUXIMAB-IRFC 20 MG/ML INTRAVENOUS SOLUTION,8913.325,5347.995,79.44,12906.6,70 HCPCS,J9227,STUDY LCCC1944 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,70 HCPCS,J9227,STUDY LCCC2119 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,70 HCPCS,J9228,IPILIMUMAB (YERVOY) 5 MG/ML INJECTION WRAPPER,75202.85,45121.71,177.98,96127.6,70 HCPCS,J9228,IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION,120159.5,72095.7,177.98,96127.6,35 HCPCS,J9228,IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION,30246.2,18147.72,177.98,27236.16,35 HCPCS,J9228,STUDY A092105-CIRB IPILIMUMAB 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,27236.16,35 HCPCS,J9229,INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN,79436.8,47662.08,2617.11,435080.31,35 HCPCS,J9229,STUDY A041703-CIRB INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,435080.31,35 HCPCS,J9229,STUDY AALL1732 INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,435080.31,35 HCPCS,J9229,STUDY IND INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.05544,6070.61,31 HCPCS,J9245,MELPHALAN (ALKERAN) IVPB,1930.0,1158.0,93.02,24394.65,35 HCPCS,J9245,MELPHALAN (ALKERAN) SYRINGE,1930.0,1158.0,93.02,24394.65,35 HCPCS,J9248,MELPHALAN HCL 50 MG INTRA-ARTERIAL SOLUTION,124400.0,74640.0,771.15,107618.44,35 HCPCS,J9260,METHOTREXATE 400 MCG/0.1 ML OPHTHALMIC INJECTION,276.25,165.75,6.15,4481.0,24 HCPCS,J9260,METHOTREXATE INJECTION (PF) 25 MG/ML (NON-ONCOLOGY),397.65,238.59,6.15,4481.0,24 HCPCS,J9260,METHOTREXATE SODIUM (CONTAINS PRESERVATIVES) 25 MG/ML INJECTION SOLUTION,342.65,205.59,6.15,4481.0,48 HCPCS,J9260,METHOTREXATE SODIUM (PF) 2.5 MG/ML INJECTION,277.05,166.23,6.15,4481.0,24 HCPCS,J9260,METHOTREXATE SODIUM (PF) 25 MG/ML INJECTION SOLUTION,396.55,237.93,6.15,4481.0,24 HCPCS,J9260,METHOTREXATE SODIUM (PF) 25 MG/ML INJECTION SOLUTION FOR INTRATHECAL,396.55,237.93,6.15,4481.0,24 HCPCS,J9261,NELARABINE (ARRANON) IVPB,2462.95,1477.77,77.46,10867.71,35 HCPCS,J9263,OXALIPLATIN (ELOXATIN) 0.05 MG/ML INJECTION,275.3,165.18,0.18,4481.0,24 HCPCS,J9264,PACLITAXEL-PROTEIN BOUND (ABRAXANE) INTRAVENOUS SUSPENSION,5505.0,3303.0,10.22,4481.0,35 HCPCS,J9264,STUDY CAAA614A12101 NAB-PACLITAXEL 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9264,STUDY GCT1046-01 NAB-PACLITAXEL 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9266,PEGASPARGASE (ONCASPAR) SYRINGE,89033.15,53419.89,4481.0,5480505.45,35 HCPCS,J9267,"PACLITAXEL 6 MG/ML CONCENTRATE,INTRAVENOUS",511.05,306.63,0.297,4481.0,24 HCPCS,J9267,STUDY CO43613 PACLITAXEL 6 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9267,STUDY GCT1046-01 PACLITAXEL 6 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9267,STUDY NX-1607-101 PACLITAXEL 6 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9268,PENTOSTATIN (NIPENT) SYRINGE,10043.75,6026.25,2529.92,404039.79,35 HCPCS,J9269,STUDY HCRN-AML20-472 TAGRAXOFUSP 100 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,55411.65,35 HCPCS,J9269,"TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION",84777.15,50866.29,346.22,67821.72,35 HCPCS,J9269,TAGRAXOFUSP-ERZS 100 MCG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION,84777.15,50866.29,346.22,67821.72,35 HCPCS,J9271,PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,20186.95,12112.17,58.48,16149.56,35 HCPCS,J9271,STUDY 21820 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY A031803-CIRB PEMBROLIZUMAB (MK-3475) 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY A092205-CIRB PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY DF-HCC-20-166 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY GCT1046-01 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY J3M-MC-JZQB PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY LCCC2047 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY LOXO-FG3-22001 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY LOXO-RAS-20001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY MK7902-010-WIRB PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY NRG-GU014 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY NX-1607-101 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY PBI-MST-01 CIVO GLO RED 400 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9271,STUDY PBI-MST-01 CIVO GLO YELLOW 400 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9271,STUDY PBI-MST-01 MK-0482 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9271,STUDY PBI-MST-01 MK-4830 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9271,STUDY PBI-MST-01 PEMBROLIZUMAB 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY PBI-MST-01 RILVEGOSTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9271,STUDY PBI-MST-01 SABESTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9271,STUDY PBI-MST-01 VOLRUSTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 HCPCS,J9271,STUDY TBCRC-053 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY VERSATILE-003 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9271,STUDY VERSATILE002 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 HCPCS,J9272,DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION,40095.2,24057.12,236.4,39304.86,35 HCPCS,J9273,STUDY SGNTV-001 TISOTUMAB VEDOTIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,30877.35,35 HCPCS,J9273,TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION,24771.65,14862.99,183.1,30877.35,35 HCPCS,J9274,TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION,69751.9,41851.14,210.58,55801.52,35 HCPCS,J9276,STUDY JZP598-303 ZANIDATAMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9280,MITOMYCIN 20 MG INTRAVENOUS SOLUTION,2366.9,1420.14,19.74,4481.0,35 HCPCS,J9280,MITOMYCIN 40 MG INTRAVENOUS SOLUTION,4458.75,2675.25,19.74,4481.0,35 HCPCS,J9280,MITOMYCIN 5 MG INTRAVENOUS SOLUTION,1080.25,648.15,19.74,4481.0,35 HCPCS,J9280,MITOMYCIN BLADDER INSTILLATION (1 MG/ML; 20 MG VIAL),2366.9,1420.14,19.74,4481.0,35 HCPCS,J9280,MITOMYCIN BLADDER INSTILLATION (1 MG/ML; 40 MG VIAL),4458.75,2675.25,19.74,4481.0,35 HCPCS,J9280,MITOMYCIN BLADDER INSTILLATION (2 MG/ML; 20 MG VIAL),2366.9,1420.14,19.74,4481.0,35 HCPCS,J9280,MITOMYCIN BLADDER INSTILLATION (2 MG/ML; 40 MG VIAL),4458.75,2675.25,19.74,4481.0,35 HCPCS,J9281,MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT,82842.95,49705.77,308.97,66274.36,35 HCPCS,J9286,GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION,9246.2,5547.72,2339.29,453849.27,70 HCPCS,J9286,STUDY DFHCC-23-429 GLOFITAMAB 1 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 HCPCS,J9286,STUDY DFHCC-23-429 GLOFITAMAB 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 HCPCS,J9286,STUDY GO44145-SKYGLO GLOFITAMAB 1 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 HCPCS,J9286,STUDY IND GLOFITAMAB 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,453849.27,35 HCPCS,J9289,"NIVOLUMAB 600 MG-HYALURONIDASE-NVHY 10,000 UNIT/5 ML SUBCUT SOLUTION",26566.6,15939.96,26.54,21253.28,35 HCPCS,J9293,MITOXANTRONE (NOVANTRONE) INJECTION,989.0,593.4,23.16,4481.0,35 HCPCS,J9298,NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION,51321.8,30793.08,191.9,41057.44,35 HCPCS,J9299,NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION,11229.8,6737.88,31.97,8983.84,35 HCPCS,J9299,NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION,26566.65,15939.99,31.97,21253.32,35 HCPCS,J9299,NIVOLUMAB 40 MG/4 ML INTRAVENOUS SOLUTION,4657.0,2794.2,31.97,5024.46,35 HCPCS,J9299,STUDY A032103-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5024.46,35 HCPCS,J9299,STUDY A092105-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 HCPCS,J9299,STUDY AHOD2131 NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 HCPCS,J9299,STUDY ETCTN10186-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 HCPCS,J9299,STUDY RP1-104 NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5024.46,35 HCPCS,J9301,"OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION",30065.95,18039.57,76.63,24052.76,35 HCPCS,J9301,STUDY A041702-CIRB OBINUTUZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11677.68,35 HCPCS,J9301,STUDY BGB-11417-301 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 HCPCS,J9301,STUDY BGB-11417-303 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 HCPCS,J9301,STUDY DFHCC-23-429 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 HCPCS,J9301,STUDY IND OBINUTUZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11677.68,35 HCPCS,J9301,STUDY M20-356 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 HCPCS,J9301,STUDY S1925 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 HCPCS,J9302,OFATUMUMAB (ARZERRA) 20 MG/ML INJECTION WRAPPER,11259.375,6755.625,60.36,16197.24,70 HCPCS,J9302,"OFATUMUMAB 1,000 MG/50 ML INTRAVENOUS SOLUTION",19793.2,11875.92,60.36,15834.56,35 HCPCS,J9302,OFATUMUMAB 100 MG/5 ML INTRAVENOUS SOLUTION,2272.2,1363.32,60.36,10203.27,35 HCPCS,J9303,PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION,6271.6,3762.96,167.84,24925.32,35 HCPCS,J9303,PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION,24261.25,14556.75,167.84,24925.32,35 HCPCS,J9305,PEMETREXED DISODIUM 500 MG INTRAVENOUS POWDER FOR SOLUTION,771.5,462.9,4.23,4481.0,35 HCPCS,J9305,STUDY D798KC00001 PEMETREXED 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9305,STUDY GCT1046-01 PEMETREXED 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9305,STUDY J3M-MC-JZQB PEMETREXED 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9305,STUDY LOXO-RAS-20001 PEMETREXED 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9306,PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION,22850.85,13710.51,16.51,18280.68,35 HCPCS,J9308,RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION,25113.1,15067.86,72.13,20090.48,35 HCPCS,J9309,POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION,61878.8,37127.28,132.57,49503.04,35 HCPCS,J9309,POLATUZUMAB VEDOTIN-PIIQ 30 MG INTRAVENOUS SOLUTION,13475.85,8085.51,132.57,21723.66,35 HCPCS,J9309,STUDY DFHCC-23-429 POLATUZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,21723.66,35 HCPCS,J9309,STUDY GO44145-SKYGLO POLATUZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,21723.66,35 HCPCS,J9311,"RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN",22043.5,13226.1,35.59,17634.8,35 HCPCS,J9311,"RITUXIMAB 1,600 MG/13.4 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN",25153.25,15091.95,35.59,20122.6,35 HCPCS,J9311,"STUDY R1979-HM-2298 RITUXIMAB 1400 MG-HYALURONIDASE 23,400 UNITS/11.7N",0.2,0.12,0.0506,6141.66,35 HCPCS,J9312,RITUXIMAB (RITUXAN) SYRINGE 10 MG/ML OPHTHALMIC INTRAVITREAL,306.1,183.66,72.96,4481.0,31 HCPCS,J9312,"RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS",9604.475,5762.6849999999995,72.96,12659.28,70 HCPCS,J9312,RITUXIMAB 10 MG/ML INTRALESIONAL SOLUTION,586.0,351.6,72.96,12511.17,70 HCPCS,J9312,STUDY 2458 RITUXIMAB 10 MG/ML,0.2,0.12,0.05544,4481.0,31 HCPCS,J9312,STUDY ITN080AI (REBOOT) RITUXIMAB 10 MG/ML IV SOLN,0.2,0.12,0.0506,12511.17,35 HCPCS,J9316,"PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN",46338.75,27803.25,60.24,37071.0,35 HCPCS,J9316,PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN,30982.95,18589.77,60.24,24786.36,35 HCPCS,J9316,"STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURONIDASE 30,000 UNITS/15 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 HCPCS,J9316,"STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONIDASE 20,000 UNITS/10 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 HCPCS,J9316,"STUDY NRG-GY026-CIRB PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURONIDASE-ZZXF 30,000 UNITS/15 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 HCPCS,J9316,"STUDY NRG-GY026-CIRB PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONIDASE-ZZXF 20,000 UNITS/10 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 HCPCS,J9317,SACITUZUMAB GOVITECAN-HZIY 180 MG INTRAVENOUS SOLUTION,8760.2,5256.12,35.19,7008.16,35 HCPCS,J9317,STUDY DF-HCC-20-166 SACITUZUMAB GOVITECAN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5859.42,35 HCPCS,J9317,STUDY GS-US-595-6184 SACITUZUMAB GOVITECAN-HZIY 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5859.42,35 HCPCS,J9317,STUDY TBCRC-047 SACITUZUMAB GOVITECAN 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5859.42,35 HCPCS,J9319,ROMIDEPSIN 10 MG/2 ML INTRAVENOUS POWDER FOR SOLUTION,10862.55,6517.53,29.86,8690.04,35 HCPCS,J9319,STUDY ACTG A5315 ROMIDEPSIN/PLACEBO 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5162.64,35 HCPCS,J9321,EPCORITAMAB-BYSP 0.16 MG/ML SUBCUTANEOUS SOLUTION DILUTION B,456.85,274.11,54.16,8980.23,35 HCPCS,J9321,EPCORITAMAB-BYSP 0.8 MG/ML SUBCUTANEOUS SOLUTION DILUTION A,1184.2,710.52,54.16,8980.23,35 HCPCS,J9321,EPCORITAMAB-BYSP 4 MG/0.8 ML SUBCUTANEOUS SOLUTION,3684.4,2210.64,54.16,8980.23,35 HCPCS,J9321,EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION,54824.8,32894.88,54.16,43859.84,35 HCPCS,J9321,STUDY ACCRU-LY-2201 EPCORITAMAB 0.16 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 HCPCS,J9321,STUDY ACCRU-LY-2201 EPCORITAMAB 0.8 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 HCPCS,J9321,STUDY ACCRU-LY-2201 EPCORITAMAB 60 MG/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8980.23,35 HCPCS,J9321,STUDY DF-HCC24-121 EPCORITAMAB 0.16 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 HCPCS,J9321,STUDY DF-HCC24-121 EPCORITAMAB 0.8 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 HCPCS,J9321,STUDY DF-HCC24-121 EPCORITAMAB 5 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8980.23,35 HCPCS,J9321,STUDY DF-HCC24-121 EPCORITAMAB 60 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8980.23,35 HCPCS,J9325,TALIMOGENE LAHERPAREPVEC 10EXP6 (1 MILLION) PFU/ML SUSP FOR INJECTION,506.3,303.78,71.72,11518.92,35 HCPCS,J9325,TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION,23398.0,14038.8,71.72,18718.4,35 HCPCS,J9328,TEMOZOLOMIDE IVPB,3595.3,2157.18,10.08,4481.0,35 HCPCS,J9330,STUDY ARST1431 TEMSIROLIMUS 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4581.99,35 HCPCS,J9330,STUDY COG AHEP0731 TEMSIROLIMUS 10MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4581.99,35 HCPCS,J9330,TEMSIROLIMUS 30 MG/3 ML (10 MG/ML) (FIRST DILUTION) INTRAVENOUS SOLN,6896.1,4137.66,25.91,5516.88,35 HCPCS,J9331,SIROLIMUS-PROTEIN BOUND 100 MG INTRAVENOUS SUSPENSION,27476.25,16485.75,82.03,21981.0,35 HCPCS,J9332,EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION,20305.55,12183.33,31.19,16244.44,35 HCPCS,J9332,STUDY ARGX-113-1802 EFGARTIGIMOD PH20 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 HCPCS,J9332,STUDY ARGX-113-1802 EFGARTIGIMOD PH20/PLACEBO 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 HCPCS,J9332,STUDY ARGX-113-2001 EFGARTIGIMOD 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5299.35,35 HCPCS,J9332,STUDY ARGX-113-2001 EFGARTIGIMOD PH20 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 HCPCS,J9333,ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION,30484.8,18290.88,22.47,24387.84,35 HCPCS,J9334,"EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN",52672.3,31603.38,32.87,42137.84,35 HCPCS,J9342,THIOTEPA (TEPADINA) 15 MG SOLUTION FOR INJECTION,2721.7,1633.02,10.22,4481.0,35 HCPCS,J9342,THIOTEPA 100 MG SOLUTION FOR INJECTION,6233.0,3739.8,10.22,5392.17,35 HCPCS,J9342,THIOTEPA 15 MG SOLUTION FOR INJECTION,2757.5,1654.5,10.22,4481.0,35 HCPCS,J9345,RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION,49074.35,29444.61,29.64,39259.48,35 HCPCS,J9347,TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION,74478.7,44687.22,136.67,109813.12,70 HCPCS,J9348,NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION,323818.0,194290.8,665.42,259054.4,35 HCPCS,J9349,STUDY IND TAFASITAMAB 40 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9349,STUDY OSU-22114 TAFASITAMAB 40 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 HCPCS,J9349,TAFASITAMAB-CXIX 200 MG INTRAVENOUS SOLUTION,4895.35,2937.21,13.88,4481.0,35 HCPCS,J9350,MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION,32302.425000000003,19381.454999999998,592.35,104912.43,70 HCPCS,J9351,TOPOTECAN 4 MG INTRAVENOUS SOLUTION,738.4,443.04,3.65,4481.0,24 HCPCS,J9351,TOPOTECAN 4 MG/4 ML (1 MG/ML) INTRAVENOUS SOLUTION,738.4,443.04,3.65,4481.0,24 HCPCS,J9352,TRABECTEDIN 1 MG INTRAVENOUS SOLUTION,12486.75,7492.05,379.34,59552.64,35 HCPCS,J9354,ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION,13480.7,8088.42,40.9,10784.56,35 HCPCS,J9354,ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION,21404.1,12842.46,40.9,17123.28,35 HCPCS,J9354,STUDY DS3201-324 TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 HCPCS,J9354,STUDY GOG-3112/DS8201-772 FAM-TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 HCPCS,J9354,STUDY TBCRC-064 TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 HCPCS,J9355,STUDY DF-HCC-20-347-ADEPT TRASTUZUMAB 21 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11339.58,35 HCPCS,J9355,TRASTUZUMAB 150 MG INTRAVENOUS SOLUTION,5433.45,3260.07,72.78,11339.58,35 HCPCS,J9356,"STUDY DF-HCC-20-347-ADEPT TRASTUZUMAB 600 MG-HYALURONIDASE 10,000 UNITS/5 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10297.35,35 HCPCS,J9356,"STUDY NRG-GY026-CIRB TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNITS/5 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10297.35,35 HCPCS,J9356,"TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION",15750.05,9450.03,59.6,12600.04,35 HCPCS,J9357,VALRUBICIN 40 MG/ML INTRAVESICAL SOLUTION,6399.35,3839.61,1283.65,218317.05,35 HCPCS,J9358,FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION,10491.25,6294.75,29.08,8393.0,35 HCPCS,J9359,LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION,94019.95,56411.97,210.39,75215.96,35 HCPCS,J9360,VINBLASTINE 1 MG/ML INTRAVENOUS SOLUTION,452.95,271.77,11.93,4481.0,24 HCPCS,J9370,STUDY R1979-HM-2298 VINCRISTINE 1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,J9370,VINCRISTINE 1 MG/ML INTRAVENOUS SOLUTION (2 MG MAX DOSE),326.0,195.6,18.5,4481.0,24 HCPCS,J9370,VINCRISTINE 1 MG/ML INTRAVENOUS SOLUTION (>2 MG MAX DOSE),326.0,195.6,18.5,4481.0,24 HCPCS,J9380,TECLISTAMAB-CQYV 10 MG/ML SUBCUTANEOUS SOLUTION,7055.65,4233.39,32.57,5644.52,35 HCPCS,J9380,TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION,34856.4,20913.84,32.57,27885.12,35 HCPCS,J9381,TEPLIZUMAB-MZWV 1 MG/ML INTRAVENOUS SOLUTION,48129.3,28877.58,36.53,38503.44,35 HCPCS,J9382,ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION,78887.5,47332.5,31.92,68245.58,35 HCPCS,J9390,VINORELBINE 10 MG/ML INTRAVENOUS SOLUTION,357.75,214.65,5.33,4481.0,24 HCPCS,J9390,VINORELBINE 50 MG/5 ML INTRAVENOUS SOLUTION,572.9,343.74,5.33,4481.0,24 HCPCS,J9395,STUDY PUMA-ALI-1201 FULVESTRANT 250 MG/5 ML INTRAMUSCULAR,0.2,0.12,0.0506,4481.0,35 HCPCS,J9395,STUDY TBCRC-037 FULVESTRANT 250 MG/5 ML INTRAMUSCULAR SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,J9400,ZIV-AFLIBERCEPT 100 MG/4 ML (25 MG/ML) INTRAVENOUS SOLUTION,5571.0,3342.6,7.64,4481.0,35 HCPCS,J9600,PORFIMER 75 MG INTRAVENOUS SOLUTION,77474.15,46484.49,4481.0,466585.35,35 HCPCS,J9999,STUDY 20230238 XALURITAMIG (AMG 509) 0.09 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY 20230238 XALURITAMIG (AMG 509) 0.46 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY 21820 BAY 3375968 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY A031702-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY A031704-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY A051901-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY AAAU4206 QUEMLICLUSTAT 12.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY AAAU4206 ZIMBERELIMAB 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY BIPAVE-001 AI-081 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY CHS-388-202 CASDOZOKITUG 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY D3251C00014 RESOLUTE BENRALIZUMAB/PLACEBO 100 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY D3253C00001 BENRALIZUMAB 30 MG/ML OR PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY D798KC00001 VOLRUSTOMIG 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY GFH009X2101 GFH009 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY GSK MHE 112562 MEPOLIZUMAB 100 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY INBRX106-01-201 INBRX-106 0.1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY INBRX106-01-201 INBRX-106/PLACEBO 0.1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY IND BELANTAMAB MAFODOTIN 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY IND MIFAMURTIDE 0.08 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY JZP598-303 TRASTUZUMAB-PKRB 21 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY LCCC2060-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY LCCC2115-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY LCCC2128-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY LCCC2152-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY LCCC2223-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY M24-064 TELISOTUZUMAB ADIZUTECAN (ABBV-400) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY M24-533 TELISOTUZUMAB ADIZUTECAN (ABBV-400) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY MCLA-158-CL02 PETOSEMTAMAB (MCLA-158) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY NRG-HN005-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY P-CD19CD20-ALLO1-001 RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY PRESERVE-006 ONC-392 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY RC48G001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY RRP-331 INO-3107 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY RRP-331 INO-3107/PLACEBO 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY SCCC-03121 CDX-301 2500 MCG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,J9999,STUDY SGNTV-001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY VRC-HIVMAB075-00-AB (VRC07-523LS) 100 MG/ML INJ,0.2,0.12,0.0464,4481.0,19 HCPCS,J9999,STUDY YL201-INT-101-01 YL201 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 HCPCS,M0076,HC PROLOTHERAPY,456.0,273.6,105.79,4481.0,22 HCPCS,P9041,STUDY R1979-HM-2298 ALBUMIN HUMAN 5% IV SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,P9045,"ALBUMIN, HUMAN 5 % INTRAVENOUS SOLUTION",245.6,147.36,51.49,4481.0,35 HCPCS,P9047,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION",566.375,339.825,93.55,4481.0,48 HCPCS,P9047,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION WRAPPER",566.375,339.825,93.55,4481.0,48 HCPCS,P9047,"ALBUMIN, HUMAN-KJDA 25 % INTRAVENOUS SOLUTION",330.75,198.45,76.73,4481.0,48 HCPCS,Q0138,FERUMOXYTOL 510 MG/17 ML (30 MG/ML) INTRAVENOUS SOLUTION,3966.15,2379.69,0.3104,4481.0,36 HCPCS,Q0224,PEMIVIBART 125 MG/ML INTRAVENOUS SOLUTION (EUA),20827.55,12496.53,4481.0,23978.46,25 HCPCS,Q2009,FOSPHENYTOIN 100 MG PE/2 ML INJECTION SOLUTION,173.7,104.22,5.89,4481.0,24 HCPCS,Q2009,FOSPHENYTOIN 500 MG PE/10 ML INJECTION SOLUTION,116.05,69.63,5.89,4481.0,24 HCPCS,Q2009,FOSPHENYTOIN IV 500 MG PE NS 50 ML INFUSION (TOTAL VOLUME 67 ML),231.05,138.63,5.89,4481.0,24 HCPCS,Q2043,SIPULEUCEL-T (PROVENGE) IVPB,207489.3,124493.58,4481.0,9332515.5,36 HCPCS,Q2050,"DOXORUBICIN, PEGYLATED LIPOSOMAL 2 MG/ML INTRAVENOUS SUSPENSION",3088.5,1853.1,105.22,22320.48,70 HCPCS,Q3027,INTERFERON BETA-1A 30 MCG/0.5 ML INTRAMUSCULAR SYRINGE KIT,28866.15,17319.69,57.13,24972.11,35 HCPCS,Q3027,STUDY CHARGE BG9418 INTERFERON BETA-1A (AVONEX) TITRATION DEVICE KIT,0.2,0.12,0.05544,4481.0,31 HCPCS,Q3027,STUDY CHARGE BG9418 INTERFERON BETA-1A 30 MCG/0.5 ML (AVONEX) INTRAMUSCULAR PEN/SYRINGE,0.2,0.12,0.0506,4481.0,35 HCPCS,Q4100,HC Actigraft Autologous Whole Blood Matrix,513.0,307.8,119.02,4481.0,24 HCPCS,Q4100,HC Biodesign 28 Sq Cm 4 X 7 per Sq Cm,44.0,26.4,10.21,4481.0,24 HCPCS,Q4100,HC Biodesign 6 Sq Cm 2 X 3 per Sq Cm,85.0,51.0,19.72,4481.0,24 HCPCS,Q4100,HC Epicel 60 Sq Cm 10 X 6 per Sq Cm,169.0,101.4,39.21,4481.0,24 HCPCS,Q4100,HC Fresh Skin 1 Square Cm,7.0,4.2,1.62,4481.0,24 HCPCS,Q4100,HC Maxxeus Cryopreserved Non Mesh Matrix 232 Sq Cm per Sq Cm,5.0,3.0,1.16,4481.0,24 HCPCS,Q4100,HC Maxxeus Cryopreserved Non Mesh Matrix 464 Sq Cm per Sq Cm,5.0,3.0,1.16,4481.0,24 HCPCS,Q4100,HC Skin 1 Square Cm,6.0,3.6,1.39,4481.0,24 HCPCS,Q4101,HC Apligraf per Sq Cm,106.0,63.6,24.59,4481.0,25 HCPCS,Q4101,HC Discarded Apligraf per Sq Cm,106.0,63.6,24.59,4481.0,24 HCPCS,Q4102,HC Discarded Oasis per Sq Cm,6.0,3.6,1.39,4481.0,24 HCPCS,Q4102,HC Oasis Wound Matrix per Sq Cm,5.0,3.0,1.16,4481.0,25 HCPCS,Q4104,HC Integra Bilayer Matrix Wound Dressing 125 Sqcm 10 X 12.5 per Sq Cm,96.0,57.6,22.27,4481.0,25 HCPCS,Q4104,HC Integra Bilayer Matrix Wound Dressing 500 Sq Cm 20 X 25 per Sq Cm,65.0,39.0,15.08,4481.0,25 HCPCS,Q4104,HC Integra Bilayer Wound Matrix 250 Sq Cm 10 X 25 per Sq Cm,75.0,45.0,17.4,4481.0,25 HCPCS,Q4105,HC Discarded Integra Omnigraft 4x4 per Sq Cm,253.0,151.8,58.7,4481.0,24 HCPCS,Q4105,HC Integra Meshed Dermal Regeneration 125 Sq Cm 4x5 per Sq Cm,74.0,44.4,17.17,4481.0,25 HCPCS,Q4105,HC Integra Omnigraft 4x4 per Sq Cm,253.0,151.8,58.7,4481.0,25 HCPCS,Q4106,HC Dermagraft per Sq Cm,129.0,77.4,29.93,4481.0,25 HCPCS,Q4106,HC Discarded Dermagraft per Sq Cm,129.0,77.4,29.93,4481.0,24 HCPCS,Q4112,HC Cymetra 2cc Syringe per 1cc,960.0,576.0,222.72,4481.0,24 HCPCS,Q4118,HC Matristem Micromatrix 1000mg per 1 Mg,5.0,3.0,1.16,4481.0,25 HCPCS,Q4118,HC Matristem Micromatrix 100mg per 1 Mg,6.0,3.6,1.39,4481.0,25 HCPCS,Q4118,HC Matristem Micromatrix 200mg per 1 Mg,6.0,3.6,1.39,4481.0,25 HCPCS,Q4118,HC Matristem Micromatrix 500mg per 1 Mg,5.0,3.0,1.16,4481.0,25 HCPCS,Q4121,HC Discarded Theraskin 2.5x2.5 per Sq Cm,546.0,327.6,118.69,4481.0,24 HCPCS,Q4121,HC Discarded Theraskin 4.0 X 6.5 per Sq Cm,81.0,48.6,18.79,4481.0,24 HCPCS,Q4121,HC Discarded Theraskin 5.1x7.6 per Sq Cm,123.0,73.8,28.54,4481.0,24 HCPCS,Q4121,HC Discarded Theraskin 6 Sqcm 2x3 per Sq Cm,299.0,179.4,69.37,4481.0,24 HCPCS,Q4121,HC Discarded Theraskin 7.6 X 15.2 per Sq Cm,58.0,34.8,13.46,4481.0,24 HCPCS,Q4121,HC Discarded Theraskin Wound Ctr 12.75 Sq Cm 2.5cm X 5.1cm per Sq Cm,281.0,168.6,65.19,4481.0,24 HCPCS,Q4121,HC Theraskin 116 Sq Cm 7.6 X 15.24 per Sq Cm,59.0,35.4,13.69,4481.0,25 HCPCS,Q4121,HC Theraskin 39 Sq Cm 5.1 X 7.6 per Sq Cm,65.0,39.0,15.08,4481.0,25 HCPCS,Q4121,HC Theraskin 4.0cm X 6.5cm per Sq Cm,81.0,48.6,18.79,4481.0,25 HCPCS,Q4121,HC Theraskin 6sqcm 2x3 per Sq Cm,299.0,179.4,69.37,4481.0,25 HCPCS,Q4121,HC Theraskin 7.6cm X 15.2cm per Sq Cm,58.0,34.8,13.46,4481.0,25 HCPCS,Q4121,HC Theraskin Wound Ctr 12.75 Sq Cm 2.5cm X 5.1cm per Sq Cm,281.0,168.6,65.19,4481.0,25 HCPCS,Q4121,HC Theraskin Wound Ctr 6.25 Sq Cm 2.5 X 2.5 per Sq Cm,546.0,327.6,118.69,4481.0,25 HCPCS,Q4121,HC Theraskin or 12.75 Sq Cm 2.5cm X 5.1cm per Sq Cm,165.0,99.0,38.28,4481.0,25 HCPCS,Q4121,HC Theraskin or 6.25 Sq Cm 2.5cm X 2.5cm per Sq Cm,296.0,177.6,68.67,4481.0,25 HCPCS,Q4124,HC Discarded Oasis Ultra Tri Layer Matrix 3x3.5 Cm Pad per Sq Cm,52.0,31.2,5.6,4481.0,24 HCPCS,Q4124,HC Discarded Oasis Ultra Tri Layer Matrix 3x7 Cm Pad per Sq Cm,48.0,28.8,5.6,4481.0,24 HCPCS,Q4124,HC Discarded Oasis Ultra Tri Layer Matrix 5x7 Cm Pad per Sq Cm,31.0,18.6,5.6,4481.0,24 HCPCS,Q4124,HC Oasis Ultra Tri Layer Matrix 3x3.5 Cm Pad,52.0,31.2,5.6,4481.0,25 HCPCS,Q4124,HC Oasis Ultra Tri Layer Matrix 3x7 Cm Pad,48.0,28.8,5.6,4481.0,25 HCPCS,Q4124,HC Oasis Ultra Tri Layer Matrix 5x7 Cm Pad,31.0,18.6,5.6,4481.0,25 HCPCS,Q4132,HC Grafix Core 1.5x2 per Sq Cm,950.0,570.0,220.4,4481.0,25 HCPCS,Q4132,HC Grafix Core 2x3 per Sqcm,685.0,411.0,158.92,4481.0,25 HCPCS,Q4132,HC Grafix Core 3x4 per Sq Cm,402.0,241.2,93.26,4481.0,25 HCPCS,Q4132,HC Grafix Core 5x5 per Sqcm,398.0,238.8,92.34,4481.0,25 HCPCS,Q4133,HC Discarded Grafix Prime 3x4 per Sq Cm,402.0,241.2,93.26,4481.0,24 HCPCS,Q4133,HC Discarded Grafix Prime 5x5 per Sqcm,398.0,238.8,92.34,4481.0,24 HCPCS,Q4133,HC Grafix Pl 16 Mm Disc,990.0,594.0,229.68,4481.0,25 HCPCS,Q4133,HC Grafix Prime 1.5x2 per Sq Cm,950.0,570.0,220.4,4481.0,25 HCPCS,Q4133,HC Grafix Prime 14mm Disc per Sq Cm,802.0,481.2,186.06,4481.0,25 HCPCS,Q4133,HC Grafix Prime 16 Mm Disc per Sq Cm,8020.0,4812.0,312.17,6938.1,25 HCPCS,Q4133,HC Grafix Prime 2x3 per Sqcm,685.0,411.0,158.92,4481.0,25 HCPCS,Q4133,HC Grafix Prime 3x4 per Sq Cm,402.0,241.2,93.26,4481.0,25 HCPCS,Q4133,HC Grafix Prime 5x5 per Sqcm,398.0,238.8,92.34,4481.0,25 HCPCS,Q4133,SKIN GRAFT SOFT TISS 2X4CM STRAVIX,5273.99,3164.39,312.17,4562.53,25 HCPCS,Q4133,SKIN GRAFT SOFT TISS 3X6CM STRAVIX,6895.01,4137.01,312.17,5964.87,25 HCPCS,Q4158,HC Kerecis Marigen 10.5 Sq Cm 3x3.5 per Sq Cm,149.0,89.4,34.57,4481.0,25 HCPCS,Q4158,HC Kerecis Surgibind Fenestrated 70 Sq Cm 7 X 10 per Sq Cm,89.0,53.4,20.65,4481.0,25 HCPCS,Q4158,HC Kerecis Surgiclose 70 Sq Cm 7 X 10 per Sq Cm,98.0,58.8,22.74,4481.0,25 HCPCS,Q4159,HC Affinity 6.25 Sq Cm 2.5 X 2.5 per Sq Cm,346.0,207.6,80.27,4481.0,25 HCPCS,Q4159,HC Discarded Affinity 6.25 Sq Cm 2.5 X 2.5 per Sq Cm,346.0,207.6,80.27,4481.0,24 HCPCS,Q4160,HC Discarded Nushield 2x3 per Sq Cm,289.0,173.4,67.05,6264.85,24 HCPCS,Q4160,HC Discarded Nushield 2x4 per Sq Cm,259.0,155.4,60.09,6264.85,24 HCPCS,Q4160,HC Discarded Nushield 3x4 per Sq Cm,254.0,152.4,58.93,6264.85,24 HCPCS,Q4160,HC Discarded Nushield 4x4 per Sq Cm,254.0,152.4,58.93,6264.85,24 HCPCS,Q4160,HC Discarded Nushield 4x6 per Sq Cm,237.0,142.2,54.98,6264.85,24 HCPCS,Q4160,HC Discarded Nushield 6x6 per Sq Cm,215.0,129.0,49.88,6264.85,24 HCPCS,Q4160,HC Discarded Nushield Disc 1.6 per Sq Cm,538.0,322.8,124.82,6264.85,24 HCPCS,Q4160,HC Nushield 2x3 per Sq Cm,289.0,173.4,67.05,6264.85,25 HCPCS,Q4160,HC Nushield 2x4 per Sq Cm,259.0,155.4,60.09,6264.85,25 HCPCS,Q4160,HC Nushield 3x4 per Sq Cm,254.0,152.4,58.93,6264.85,25 HCPCS,Q4160,HC Nushield 4x4 per Sq Cm,254.0,152.4,58.93,6264.85,25 HCPCS,Q4160,HC Nushield 4x6 per Sq Cm,237.0,142.2,54.98,6264.85,25 HCPCS,Q4160,HC Nushield 6x6 per Sq Cm,215.0,129.0,49.88,6264.85,25 HCPCS,Q4160,HC Nushield Disc 1.6 per Sq Cm,538.0,322.8,124.82,6264.85,25 HCPCS,Q4166,HC Cytal 1 Layer Wound Matrix 150 Sq Cm 10 X 15 per Sq Cm,9.0,5.4,2.09,4481.0,25 HCPCS,Q4166,HC Cytal 1 Layer Wound Matrix 70 Sq Cm 7 X 10 per Sq Cm,9.0,5.4,2.09,4481.0,25 HCPCS,Q4166,HC Cytal 3 Layer Wound Matrix 150 Sq Cm 10 X 15 per Sq Cm,46.0,27.6,10.67,4481.0,25 HCPCS,Q4166,HC Cytal 3 Layer Wound Matrix 70 Sq Cm 7 X 10 per Sq Cm,57.0,34.2,13.22,4481.0,25 HCPCS,Q4166,HC Cytal Burn Matrix 150 Sq Cm 10 X 15 per Sq Cm,27.0,16.2,6.26,4481.0,25 HCPCS,Q4166,HC Cytal Burn Matrix 70 Sq Cm 7 X 10 per Sq Cm,32.0,19.2,7.42,4481.0,25 HCPCS,Q4166,HC Cytal Wound Matrix 10.5 Sq Cm 3.5 X 3 per Sq Cm,18.0,10.8,4.18,4481.0,25 HCPCS,Q4166,HC Cytal Wound Matrix 25 Sq Cm 5 X 5 per Sq Cm,72.0,43.2,16.7,4481.0,25 HCPCS,Q4166,HC Cytal Wound Matrix 400 Sq Cm 16 X 25 per Sq Cm,33.0,19.8,7.66,4481.0,25 HCPCS,Q4166,HC Cytal Wound Matrix 560 Sq Cm 16 X 35 per Sq Cm,29.0,17.4,6.73,4481.0,25 HCPCS,Q4186,HC Discarded Epifix 2x4 per Sq Cm,191.0,114.6,44.31,4481.0,24 HCPCS,Q4186,HC Discarded Epifix Mesh 12.25sqcm 3.5x3.5 per Sq Cm,200.0,120.0,46.4,4481.0,24 HCPCS,Q4186,HC Discarded Epifix Mesh 4cmx4.5cm,148.0,88.8,34.34,4481.0,24 HCPCS,Q4186,HC Epifix 18mm Disc,1404.0,842.4,325.73,4481.0,25 HCPCS,Q4186,HC Epifix 2x4 per Sq Cm,191.0,114.6,44.31,4481.0,25 HCPCS,Q4186,HC Epifix Mesh 12.25sqcm 3.5x3.5 per Sq Cm,200.0,120.0,46.4,4481.0,25 HCPCS,Q4186,HC Epifix Mesh 4cmx4.5cm,148.0,88.8,34.34,4481.0,25 HCPCS,Q4196,HC Discarded Puraply Am 25sqcm 5x5 per Sq Cm,400.0,240.0,92.8,4481.0,24 HCPCS,Q4196,HC Discarded Puraply Am 4sqcm 2x2 per Sq Cm,505.0,303.0,117.16,4481.0,24 HCPCS,Q4196,HC Discarded Puraply Am 8sqcm 2x4 per Sq Cm,400.0,240.0,92.8,4481.0,24 HCPCS,Q4196,HC Puraply Am 25sqcm 5x5 per Sq Cm,400.0,240.0,92.8,4481.0,25 HCPCS,Q4196,HC Puraply Am 4sqcm 2x2 per Sq Cm,528.0,316.8,122.5,4481.0,25 HCPCS,Q4196,HC Puraply Am 8sqcm 2x4 per Sq Cm,400.0,240.0,92.8,4481.0,25 HCPCS,Q5101,FILGRASTIM-SNDZ 300 MCG/0.5 ML INJECTION SYRINGE,1086.05,651.63,0.4462,4481.0,35 HCPCS,Q5101,FILGRASTIM-SNDZ 480 MCG/0.8 ML INJECTION SYRINGE,1728.05,1036.83,0.4462,4481.0,35 HCPCS,Q5103,INFLIXIMAB-DYYB 100 MG INTRAVENOUS SOLUTION,3157.35,1894.41,19.39,4481.0,35 HCPCS,Q5104,INFLIXIMAB-ABDA 100 MG INTRAVENOUS SOLUTION,2526.6,1515.96,26.19,4481.0,35 HCPCS,Q5106,"EPOETIN ALFA EPBX (RETACRIT) 1,000 UNIT/ML INJECTION (PEDIATRICS DILUTION) SYRINGE",188.55,113.13,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA EPBX (RETACRIT) 10,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",446.2,267.72,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA EPBX (RETACRIT) 40,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",1736.7,1042.02,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA-EPBX (RETACRIT) 4,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",188.1,112.86,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA-EPBX 10,000 UNIT/ML INJECTION SOLUTION",446.2,267.72,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA-EPBX 2,000 UNIT/ML INJECTION SOLUTION",102.05,61.23,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA-EPBX 20,000 UNIT/ML INJECTION SOLUTION",876.35,525.81,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA-EPBX 3,000 UNIT/ML INJECTION SOLUTION",145.1,87.06,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA-EPBX 4,000 UNIT/ML INJECTION SOLUTION",188.1,112.86,7.61,4481.0,33 HCPCS,Q5106,"EPOETIN ALFA-EPBX 40,000 UNIT/ML INJECTION SOLUTION",1736.7,1042.02,7.61,4481.0,33 HCPCS,Q5107,BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION,6048.7,3629.22,27.02,7610.32,70 HCPCS,Q5108,PEGFILGRASTIM-JMDB 6 MG/0.6 ML SUBCUTANEOUS SYRINGE,8157.3,4894.38,96.16,18477.9,35 HCPCS,Q5110,FILGRASTIM-AAFI 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,870.1,522.06,0.291,4481.0,35 HCPCS,Q5110,FILGRASTIM-AAFI 300 MCG/ML INJECTION SOLUTION,870.1,522.06,0.291,4481.0,35 HCPCS,Q5110,FILGRASTIM-AAFI 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,1382.6,829.56,0.291,4481.0,35 HCPCS,Q5110,FILGRASTIM-AAFI 480 MCG/1.6 ML INJECTION SOLUTION,1382.6,829.56,0.291,4481.0,35 HCPCS,Q5111,PEGFILGRASTIM-CBQV 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUT INJECTOR,16298.5,9779.1,103.14,26777.52,35 HCPCS,Q5111,PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE,16298.5,9779.1,103.14,26777.52,35 HCPCS,Q5115,RITUXIMAB-ABBS 10 MG/ML INTRALESIONAL SOLUTION,554.9,332.94,28.5,5030.34,35 HCPCS,Q5115,RITUXIMAB-ABBS 10 MG/ML INTRAVENOUS SOLUTION,8671.35,5202.81,28.5,11415.12,70 HCPCS,Q5115,STUDY BGB-11417-303 RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,70 HCPCS,Q5115,STUDY GO44145-SKYGLO RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 HCPCS,Q5115,STUDY MB-105-201 RITUXIMAB-ABBS 10 MG/ML INTRAVENOUS SOLN,0.2,0.12,0.0506,5030.34,35 HCPCS,Q5115,STUDY R1979-HM-2298 RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 HCPCS,Q5116,TRASTUZUMAB-QYYP 150 MG INTRAVENOUS SOLUTION,4283.8,2570.28,27.15,4481.0,35 HCPCS,Q5116,TRASTUZUMAB-QYYP 420 MG INTRAVENOUS SOLUTION,11499.5,6899.7,27.15,9199.6,35 HCPCS,Q5118,BEVACIZUMAB-BVZR 25 MG/ML INTRAVENOUS SOLUTION,5350.925,3210.555,25.0,6717.16,70 HCPCS,Q5119,RITUXIMAB-PVVR 10 MG/ML INTRAVENOUS SOLUTION,7392.849999999999,4435.71,27.01,9710.44,70 HCPCS,Q5121,INFLIXIMAB-AXXQ 100 MG INTRAVENOUS SOLUTION,1698.0,1018.8,19.8,4481.0,35 HCPCS,Q5125,FILGRASTIM-AYOW 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,636.1,381.66,0.3686,4481.0,35 HCPCS,Q5125,FILGRASTIM-AYOW 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,1008.2,604.92,0.3686,4481.0,35 HCPCS,Q5135,TOCILIZUMAB-AAZG (FOR COVID-19) 20 MG/ML INJECTION (EUA) WRAPPER,3265.0,1959.0,4.29,5173.6,105 HCPCS,Q5135,TOCILIZUMAB-AAZG (TYENNE) 20 MG/ML INJECTION WRAPPER,3265.0,1959.0,4.29,5173.6,105 HCPCS,Q5151,ECULIZUMAB-AAGH 300 MG/30 ML INTRAVENOUS SOLUTION,14993.85,8996.31,30.41,11995.08,35 HCPCS,Q9950,SULFUR HEXAFLUORIDE MICROSPHERES 25 MG INTRAVENOUS SUSPENSION,169.0,101.4,39.21,4481.0,23 HCPCS,Q9956,PERFLUTREN PROTEIN-TYPE A MICROSPHERES 0.22 MG/ML INTRAVENOUS SUSP,163.85,98.31,38.01,4481.0,23 HCPCS,Q9957,PERFLUTREN LIPID MICROSPHERES 1.1 MG/ML INTRAVENOUS SUSPENSION,265.05,159.03,61.49,4481.0,23 HCPCS,Q9957,STUDY BT015 PERFLUTREN (DEFINITY) VIAL,0.2,0.12,0.0464,4481.0,23 HCPCS,Q9957,STUDY CEUS VKD PERFLUTREN (DEFINITY) SYRINGE,0.2,0.12,0.0464,4481.0,23 HCPCS,Q9957,STUDY CEUS VKD PERFLUTREN (DEFINITY) VIAL,0.2,0.12,0.0464,4481.0,23 HCPCS,Q9957,STUDY DRI17476 FREXALIMAB/PLACEBO 150 MG/ML VIAL/SYRINGE,0.2,0.12,0.0464,4481.0,21 HCPCS,Q9957,STUDY IFX-1-P2.4 IFX-1 10 MG/ML VIAL,0.2,0.12,0.0464,4481.0,23 HCPCS,Q9957,STUDY IFX-1-P2.4 IFX-1/PLACEBO 10 MG/ML VIAL,0.2,0.12,0.0464,4481.0,23 HCPCS,Q9957,STUDY IFX-1-P2.4 IFX-1/PLACEBO 400/800/1200 MG IN 0.9% SODIUM CHLORIDE IVPB,0.2,0.12,0.0464,4481.0,23 HCPCS,Q9957,STUDY LCCC1824 PERFLUTREN LIPID MICROSPHERES INJECTION,0.2,0.12,0.0464,4481.0,24 HCPCS,Q9958,DIATRIZOATE MEGLUMINE 30 % URETHRAL SOLUTION,67.55,40.53,0.18,4481.0,25 HCPCS,Q9963,DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM 66 %-10 % ORAL SOLUTION (37% ORGANICALLY BOUND IODINE),292.85,175.71,0.495,4481.0,24 HCPCS,Q9966,IOHEXOL 240 MG IODINE/ML INTRAVENOUS SOLUTION,49.45,29.67,1.01,4481.0,24 HCPCS,Q9966,STUDY 2471 IOHEXOL IODINE (OMNIPAQUE) 300 MG/ML,0.2,0.12,0.0464,4481.0,25 HCPCS,Q9967,IOHEXOL 300 MG IODINE/ML INTRAVENOUS SOLUTION,56.5,33.9,0.3375,4481.0,24 HCPCS,Q9967,IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION,57.95,34.769999999999996,0.3375,4481.0,48 HCPCS,Q9967,STUDY LCCC2139 IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 HCPCS,Q9968,ISOSULFAN BLUE 1 % SUBCUTANEOUS SOLUTION,489.55,293.73,6.19,4481.0,36 HCPCS,Q9968,METHYLENE BLUE (ANTIDOTE) 1 % (10 MG/ML) INTRAVENOUS SOLUTION,40.4,24.24,6.19,4481.0,36 HCPCS,Q9968,METHYLENE BLUE (ANTIDOTE) 5 MG/ML INTRAVENOUS SOLUTION,930.15,558.09,6.19,4481.0,36 HCPCS,Q9974,MORPHINE 0.1 MG/ML (NCCC COOLING PROTOCOL) BOLUS,0.2,0.12,0.0464,4481.0,26 HCPCS,Q9974,MORPHINE 1 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,26 HCPCS,Q9974,MORPHINE 5 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,26 HCPCS,S0013,ESKETAMINE 56 MG (28 MG X 2) NASAL SPRAY,1290.0,774.0,34.2,4481.0,23 HCPCS,S0013,ESKETAMINE 84 MG (28 MG X 3) NASAL SPRAY,1290.0,774.0,34.2,4481.0,23 HCPCS,j3490,TREPROSTINIL 16 MCG CARTRIDGE WITH INHALER,2635.0,1581.0,611.32,4481.0,24 HCPCS,j9042,STUDY AHOD1331 BRENTUXIMAB VEDOTIN (SGN-35) 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,26 ICD,F50.00,Eating Disorder - Inpatient,,,2390.0,4481.0,2 ICD,F50.01,Eating Disorder - Inpatient,,,2390.0,4481.0,2 ICD,F50.02,Eating Disorder - Inpatient,,,2390.0,4481.0,2 ICD,F50.2,Eating Disorder - Inpatient,,,2390.0,4481.0,2 ICD,F50.81,Eating Disorder - Inpatient,,,2390.0,4481.0,2 ICD,F50.82,Eating Disorder - Inpatient,,,2390.0,4481.0,2 ICD,F50.89,Eating Disorder - Inpatient,,,2390.0,4481.0,2 ICD,F50.9,Eating Disorder - Inpatient,,,2390.0,4481.0,2 LOCAL,181,Swing Bed,,,4481.0,4481.0,1 LOCAL,182,Swing Bed,,,4481.0,4481.0,1 LOCAL,183,Swing Bed,,,4481.0,4481.0,1 LOCAL,184,Swing Bed,,,4481.0,4481.0,1 LOCAL,187,Swing Bed,,,4481.0,4481.0,1 LOCAL,188,Swing Bed,,,4481.0,4481.0,1 LOCAL,211,SNF Bill Type,,,948.0,4481.0,3 LOCAL,212,SNF Bill Type,,,948.0,4481.0,3 LOCAL,213,SNF Bill Type,,,948.0,4481.0,3 LOCAL,214,SNF Bill Type,,,948.0,4481.0,3 LOCAL,215,SNF Bill Type,,,948.0,4481.0,3 LOCAL,216,SNF Bill Type,,,948.0,4481.0,3 LOCAL,217,SNF Bill Type,,,948.0,4481.0,3 LOCAL,218,SNF Bill Type,,,948.0,4481.0,3 LOCAL,219,SNF Bill Type,,,948.0,4481.0,3 LOCAL,280,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,280,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,281,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,281,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,282,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,282,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,283,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,283,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,284,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,284,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,285,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,285,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,286,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,286,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,287,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,287,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,288,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,288,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,289,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,289,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,660,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,660,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,661,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,661,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,662,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,662,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,663,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,663,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,664,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,664,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,665,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,665,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,666,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,666,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,667,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,667,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,668,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,668,Swing Bed Bill Type,,,4481.0,4481.0,1 LOCAL,669,SNF Bill Type,,,4481.0,4481.0,1 LOCAL,669,Swing Bed Bill Type,,,4481.0,4481.0,1 MS-DRG,001,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,001,Durable Heart VAD,,,,,0 MS-DRG,001,Durable Heart VAD - IP Stay,,,178221.0,178221.0,1 MS-DRG,001,HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM WITH MCC,,,4481.0,291323.91,20 MS-DRG,001,Heart-Lung Transplant,,,295000.0,295000.0,2 MS-DRG,001,MS-DRG 32.00:HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM W MCC,,,4481.0,4481.0,1 MS-DRG,001,MS-DRG 42.00: HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM WITH MCC,,,4481.0,396282.81,11 MS-DRG,002,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,002,Durable Heart VAD,,,,,0 MS-DRG,002,Durable Heart VAD - IP Stay,,,178221.0,178221.0,1 MS-DRG,002,HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM WITHOUT MCC,,,4481.0,243261.28,20 MS-DRG,002,Heart-Lung Transplant,,,295000.0,295000.0,2 MS-DRG,002,MS-DRG 32.00:HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM W/O MCC,,,4481.0,4481.0,1 MS-DRG,002,MS-DRG 42.00: HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM WITHOUT MCC,,,4481.0,136761.84,11 MS-DRG,003,"ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURES",,,4481.0,389928.15,17 MS-DRG,003,"MS-DRG 32.00:ECMO OR TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W MAJ O.R.",,,4481.0,4481.0,1 MS-DRG,003,"MS-DRG 42.00: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURES",,,4481.0,199252.32,10 MS-DRG,004,"MS-DRG 32.00:TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R.",,,4481.0,4481.0,1 MS-DRG,004,"MS-DRG 42.00: TRACHEOSTOMY WITH MV >96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURES",,,4481.0,177472.3,10 MS-DRG,004,"TRACHEOSTOMY WITH MV >96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURES",,,4481.0,254464.07,17 MS-DRG,005,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,005,Kidney-Liver Transplant,,,220496.0,262854.0,3 MS-DRG,005,LIVER TRANSPLANT WITH MCC OR INTESTINAL TRANSPLANT,,,79566.13,216233.05,18 MS-DRG,005,Liver (CAD) Transplant,,,130000.0,172263.0,2 MS-DRG,005,MS-DRG 32.00:LIVER TRANSPLANT W MCC OR INTESTINAL TRANSPLANT,,,4481.0,4481.0,1 MS-DRG,005,MS-DRG 42.00: LIVER TRANSPLANT WITH MCC OR INTESTINAL TRANSPLANT,,,4481.0,191616.92,11 MS-DRG,006,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,006,Kidney-Liver Transplant,,,220496.0,262854.0,3 MS-DRG,006,LIVER TRANSPLANT WITHOUT MCC,,,35783.73,216233.05,18 MS-DRG,006,Liver (CAD) Transplant,,,130000.0,172263.0,2 MS-DRG,006,MS-DRG 32.00:LIVER TRANSPLANT W/O MCC,,,4481.0,4481.0,1 MS-DRG,006,MS-DRG 42.00: LIVER TRANSPLANT WITHOUT MCC,,,4481.0,72220.18,11 MS-DRG,007,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,007,Double Lung Transplant - 1 donor,,,150000.0,150000.0,1 MS-DRG,007,Heart-Lung Transplant,,,295000.0,295000.0,2 MS-DRG,007,LUNG TRANSPLANT,,,99936.69,360500.0,21 MS-DRG,007,MS-DRG 32.00:LUNG TRANSPLANT,,,4481.0,4481.0,1 MS-DRG,007,MS-DRG 42.00: LUNG TRANSPLANT,,,4481.0,157960.81,11 MS-DRG,007,Single Lung Transplant - 1 donor,,,130000.0,130000.0,1 MS-DRG,008,MS-DRG 32.00:SIMULTANEOUS PANCREAS/KIDNEY TRANSPLANT,,,4481.0,4481.0,1 MS-DRG,008,MS-DRG 42.00: SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANT,,,4481.0,84305.52,11 MS-DRG,008,SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANT,,,43250.7,163000.0,19 MS-DRG,010,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,010,MS-DRG 32.00:PANCREAS TRANSPLANT,,,4481.0,4481.0,1 MS-DRG,010,MS-DRG 42.00: PANCREAS TRANSPLANT,,,4481.0,86637.81,11 MS-DRG,010,PANCREAS TRANSPLANT,,,4481.0,114089.0,19 MS-DRG,011,"MS-DRG 32.00:TRACHEOSTOMY FOR FACE,MOUTH & NECK DIAGNOSES W MCC",,,4481.0,4481.0,1 MS-DRG,011,"MS-DRG 42.00: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH MCC",,,4481.0,45230.45,10 MS-DRG,011,"TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH MCC",,,4481.0,100197.27,17 MS-DRG,012,"MS-DRG 32.00:TRACHEOSTOMY FOR FACE,MOUTH & NECK DIAGNOSES W CC",,,4481.0,4481.0,1 MS-DRG,012,"MS-DRG 42.00: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH CC",,,4481.0,33489.97,10 MS-DRG,012,"TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH CC",,,4481.0,77452.14,17 MS-DRG,013,"MS-DRG 32.00:TRACHEOSTOMY FOR FACE,MOUTH & NECK DIAGNOSES W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,013,"MS-DRG 42.00: TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITHOUT CC/MCC",,,4481.0,22155.41,10 MS-DRG,013,"TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITHOUT CC/MCC",,,4481.0,52941.55,17 MS-DRG,014,ALLOGENEIC BONE MARROW TRANSPLANT,,,4481.0,186325.52,17 MS-DRG,014,Allo Cord Blood (Single Unit) Transplant,,,192425.0,225271.0,2 MS-DRG,014,Allo Unrelated (double cord blood) Transplant,,,275486.0,275486.0,1 MS-DRG,014,Allo-Related Transplant,,,92000.0,182445.96,6 MS-DRG,014,Allo-Unrelated Transplant,,,192425.0,245964.0,4 MS-DRG,014,Allo/Auto Related Transplant,,,291570.0,291570.0,1 MS-DRG,014,Allo/Auto Unrelated Transplant,,,303393.0,303393.0,1 MS-DRG,014,Allogeneic Blood/Marrow Matched/Mismatched Double Cord Blood,,,307928.8,307928.8,1 MS-DRG,014,Auto/Allo Cord Blood (Single Unit) Transplant,,,303393.0,303393.0,1 MS-DRG,014,MS-DRG 32.00:ALLOGENEIC BONE MARROW TRANSPLANT,,,4481.0,4481.0,1 MS-DRG,014,MS-DRG 42.00: ALLOGENEIC BONE MARROW TRANSPLANT,,,4481.0,216973.06,11 MS-DRG,014,"Tandem Transplant (Auto/Auto, Allo/Auto)",,,103385.22,110968.0,2 MS-DRG,016,AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC,,,45759.49,124041.0,20 MS-DRG,016,Allo/Auto Related Transplant,,,291570.0,291570.0,1 MS-DRG,016,Allo/Auto Unrelated Transplant,,,303393.0,303393.0,1 MS-DRG,016,Auto/Auto Transplant,,,110968.0,223275.0,3 MS-DRG,016,MS-DRG 32.00:AUTOLOGOUS BONE MARROW TRANSPLANT W CC/MCC,,,4481.0,4481.0,1 MS-DRG,016,MS-DRG 42.00: AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC,,,4481.0,37193.61,11 MS-DRG,016,"Tandem Transplant (Auto/Auto, Allo/Auto)",,,103385.22,110968.0,2 MS-DRG,017,AUTOLOGOUS BONE MARROW TRANSPLANT WITHOUT CC/MCC,,,37337.16,124041.0,20 MS-DRG,017,Allo/Auto Related Transplant,,,291570.0,291570.0,1 MS-DRG,017,Allo/Auto Unrelated Transplant,,,303393.0,303393.0,1 MS-DRG,017,Auto/Auto Transplant,,,110968.0,223275.0,3 MS-DRG,017,MS-DRG 32.00:AUTOLOGOUS BONE MARROW TRANSPLANT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,017,MS-DRG 42.00: AUTOLOGOUS BONE MARROW TRANSPLANT WITHOUT CC/MCC,,,4481.0,37193.61,11 MS-DRG,017,"Tandem Transplant (Auto/Auto, Allo/Auto)",,,103385.22,110968.0,2 MS-DRG,018,CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES,,,4481.0,669506.13,16 MS-DRG,018,MS-DRG 42.00: CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES,,,4481.0,250445.96,11 MS-DRG,019,MS-DRG 42.00: SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANT WITH HEMODIALYSIS,,,4481.0,86139.38,11 MS-DRG,019,SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANT WITH HEMODIALYSIS,,,4481.0,163000.0,18 MS-DRG,020,INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITH MCC,,,4481.0,144557.72,18 MS-DRG,020,MS-DRG 32.00:INTRACRANIAL VASCULAR PROCEDURES W PDX HEMORRHAGE W MCC,,,4481.0,4481.0,1 MS-DRG,020,MS-DRG 42.00: INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITH MCC,,,4481.0,72715.91,10 MS-DRG,021,INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITH CC,,,4481.0,97252.4,18 MS-DRG,021,MS-DRG 32.00:INTRACRANIAL VASCULAR PROCEDURES W PDX HEMORRHAGE W CC,,,4481.0,4481.0,1 MS-DRG,021,MS-DRG 42.00: INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITH CC,,,4481.0,52602.71,10 MS-DRG,022,INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITHOUT CC/MCC,,,4481.0,56492.66,18 MS-DRG,022,MS-DRG 32.00:INTRACRANIAL VASCULAR PROCEDURES W PDX HEMORRHAGE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,022,MS-DRG 42.00: INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITHOUT CC/MCC,,,4481.0,32134.78,10 MS-DRG,023,CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITH MCC OR ANTINEOPLASTIC IMPLANT OR EPILEPSY WITH NEUROSTIMULATOR,,,4481.0,105271.34,18 MS-DRG,023,MS-DRG 32.00:CRANIO W MAJOR DEV IMPL/ACUTE COMPLEX CNS PDX W MCC OR CHEMO IMPLANT,,,4481.0,4481.0,1 MS-DRG,023,MS-DRG 42.00: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITH MCC OR CHEMOTHERAPY IMPLANT OR EPILEPSY WITH NEUROSTIMULATOR,,,4481.0,66464.44,10 MS-DRG,024,CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITHOUT MCC,,,4481.0,71865.51,18 MS-DRG,024,MS-DRG 32.00:CRANIO W MAJOR DEV IMPL/ACUTE COMPLEX CNS PDX W/O MCC,,,4481.0,4481.0,1 MS-DRG,024,MS-DRG 42.00: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITHOUT MCC,,,4481.0,42054.87,10 MS-DRG,025,CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC,,,4481.0,83527.43,18 MS-DRG,025,MS-DRG 32.00:CRANIOTOMY & ENDOVASCULAR INTRACRANIAL PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,025,MS-DRG 42.00: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC,,,4481.0,44364.71,10 MS-DRG,026,CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH CC,,,4481.0,57119.11,18 MS-DRG,026,MS-DRG 32.00:CRANIOTOMY & ENDOVASCULAR INTRACRANIAL PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,026,MS-DRG 42.00: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH CC,,,4481.0,27568.98,10 MS-DRG,027,CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT CC/MCC,,,4481.0,46348.2,18 MS-DRG,027,MS-DRG 32.00:CRANIOTOMY & ENDOVASCULAR INTRACRANIAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,027,MS-DRG 42.00: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT CC/MCC,,,4481.0,21824.02,10 MS-DRG,028,MS-DRG 32.00:SPINAL PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,028,MS-DRG 42.00: SPINAL PROCEDURES WITH MCC,,,4481.0,39868.07,10 MS-DRG,028,SPINAL PROCEDURES WITH MCC,,,4481.0,110378.48,18 MS-DRG,029,MS-DRG 32.00:SPINAL PROCEDURES W CC OR SPINAL NEUROSTIMULATORS,,,4481.0,4481.0,1 MS-DRG,029,MS-DRG 42.00: SPINAL PROCEDURES WITH CC OR SPINAL NEUROSTIMULATORS,,,4481.0,21039.11,10 MS-DRG,029,SPINAL PROCEDURES WITH CC OR SPINAL NEUROSTIMULATORS,,,4481.0,62674.5,18 MS-DRG,030,MS-DRG 32.00:SPINAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,030,MS-DRG 42.00: SPINAL PROCEDURES WITHOUT CC/MCC,,,4481.0,12977.13,10 MS-DRG,030,SPINAL PROCEDURES WITHOUT CC/MCC,,,4481.0,40328.02,18 MS-DRG,031,MS-DRG 32.00:VENTRICULAR SHUNT PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,031,MS-DRG 42.00: VENTRICULAR SHUNT PROCEDURES WITH MCC,,,4481.0,23790.8,10 MS-DRG,031,VENTRICULAR SHUNT PROCEDURES WITH MCC,,,4481.0,82311.27,18 MS-DRG,032,MS-DRG 32.00:VENTRICULAR SHUNT PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,032,MS-DRG 42.00: VENTRICULAR SHUNT PROCEDURES WITH CC,,,4481.0,12846.91,10 MS-DRG,032,VENTRICULAR SHUNT PROCEDURES WITH CC,,,4481.0,39148.6,18 MS-DRG,033,MS-DRG 32.00:VENTRICULAR SHUNT PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,033,MS-DRG 42.00: VENTRICULAR SHUNT PROCEDURES WITHOUT CC/MCC,,,4481.0,12820.86,10 MS-DRG,033,VENTRICULAR SHUNT PROCEDURES WITHOUT CC/MCC,,,4481.0,30549.14,18 MS-DRG,034,CAROTID ARTERY STENT PROCEDURES WITH MCC,,,4481.0,71108.63,18 MS-DRG,034,MS-DRG 32.00:CAROTID ARTERY STENT PROCEDURE W MCC,,,4481.0,4481.0,1 MS-DRG,034,MS-DRG 42.00: CAROTID ARTERY STENT PROCEDURES WITH MCC,,,4481.0,31769.26,10 MS-DRG,035,CAROTID ARTERY STENT PROCEDURES WITH CC,,,4481.0,43915.88,18 MS-DRG,035,MS-DRG 32.00:CAROTID ARTERY STENT PROCEDURE W CC,,,4481.0,4481.0,1 MS-DRG,035,MS-DRG 42.00: CAROTID ARTERY STENT PROCEDURES WITH CC,,,4481.0,25692.02,10 MS-DRG,036,CAROTID ARTERY STENT PROCEDURES WITHOUT CC/MCC,,,4481.0,35691.18,18 MS-DRG,036,MS-DRG 32.00:CAROTID ARTERY STENT PROCEDURE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,036,MS-DRG 42.00: CAROTID ARTERY STENT PROCEDURES WITHOUT CC/MCC,,,4481.0,15140.58,10 MS-DRG,037,EXTRACRANIAL PROCEDURES WITH MCC,,,4481.0,60479.17,18 MS-DRG,037,MS-DRG 32.00:EXTRACRANIAL PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,037,MS-DRG 42.00: EXTRACRANIAL PROCEDURES WITH MCC,,,4481.0,63075.12,10 MS-DRG,038,EXTRACRANIAL PROCEDURES WITH CC,,,4481.0,29808.78,18 MS-DRG,038,MS-DRG 32.00:EXTRACRANIAL PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,038,MS-DRG 42.00: EXTRACRANIAL PROCEDURES WITH CC,,,4481.0,18954.69,10 MS-DRG,039,EXTRACRANIAL PROCEDURES WITHOUT CC/MCC,,,4481.0,21595.11,18 MS-DRG,039,MS-DRG 32.00:EXTRACRANIAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,039,MS-DRG 42.00: EXTRACRANIAL PROCEDURES WITHOUT CC/MCC,,,4481.0,11294.14,10 MS-DRG,040,MS-DRG 32.00:PERIPH/CRANIAL NERVE & OTHER NERV SYST PROC W MCC,,,4481.0,4481.0,1 MS-DRG,040,"MS-DRG 42.00: PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH MCC",,,4481.0,24880.16,10 MS-DRG,040,"PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH MCC",,,4481.0,70934.11,18 MS-DRG,041,MS-DRG 32.00:PERIPH/CRANIAL NERVE & OTHER NERV SYST PROC W CC OR PERIPH NEUROSTIM,,,4481.0,4481.0,1 MS-DRG,041,"MS-DRG 42.00: PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH CC OR PERIPHERAL NEUROSTIMULATOR",,,4481.0,15656.97,10 MS-DRG,041,"PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH CC OR PERIPHERAL NEUROSTIMULATOR",,,4481.0,40392.32,18 MS-DRG,042,MS-DRG 32.00:PERIPH/CRANIAL NERVE & OTHER NERV SYST PROC W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,042,"MS-DRG 42.00: PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITHOUT CC/MCC",,,4481.0,12949.29,10 MS-DRG,042,"PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITHOUT CC/MCC",,,4481.0,31739.58,18 MS-DRG,052,MS-DRG 32.00:SPINAL DISORDERS & INJURIES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,052,MS-DRG 42.00: SPINAL DISORDERS AND INJURIES WITH CC/MCC,,,4481.0,29136.12,10 MS-DRG,052,SPINAL DISORDERS AND INJURIES WITH CC/MCC,,,4481.0,32715.08,18 MS-DRG,053,MS-DRG 32.00:SPINAL DISORDERS & INJURIES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,053,MS-DRG 42.00: SPINAL DISORDERS AND INJURIES WITHOUT CC/MCC,,,4481.0,10554.13,10 MS-DRG,053,SPINAL DISORDERS AND INJURIES WITHOUT CC/MCC,,,4481.0,17988.88,18 MS-DRG,054,MS-DRG 32.00:NERVOUS SYSTEM NEOPLASMS W MCC,,,4481.0,4481.0,1 MS-DRG,054,MS-DRG 42.00: NERVOUS SYSTEM NEOPLASMS WITH MCC,,,4481.0,13432.45,10 MS-DRG,054,NERVOUS SYSTEM NEOPLASMS WITH MCC,,,4481.0,28050.68,18 MS-DRG,055,MS-DRG 32.00:NERVOUS SYSTEM NEOPLASMS W/O MCC,,,4481.0,4481.0,1 MS-DRG,055,MS-DRG 42.00: NERVOUS SYSTEM NEOPLASMS WITHOUT MCC,,,4481.0,9154.04,10 MS-DRG,055,NERVOUS SYSTEM NEOPLASMS WITHOUT MCC,,,4481.0,18731.07,18 MS-DRG,056,DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC,,,4481.0,42677.67,18 MS-DRG,056,MS-DRG 32.00:DEGENERATIVE NERVOUS SYSTEM DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,056,MS-DRG 42.00: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC,,,4481.0,33040.03,10 MS-DRG,057,DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC,,,4481.0,23801.47,18 MS-DRG,057,MS-DRG 32.00:DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC,,,4481.0,4481.0,1 MS-DRG,057,MS-DRG 42.00: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC,,,4481.0,23128.92,10 MS-DRG,058,MS-DRG 32.00:MULTIPLE SCLEROSIS & CEREBELLAR ATAXIA W MCC,,,4481.0,4481.0,1 MS-DRG,058,MS-DRG 42.00: MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITH MCC,,,4481.0,11372.27,10 MS-DRG,058,MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITH MCC,,,4481.0,31405.22,18 MS-DRG,059,MS-DRG 32.00:MULTIPLE SCLEROSIS & CEREBELLAR ATAXIA W CC,,,4481.0,4481.0,1 MS-DRG,059,MS-DRG 42.00: MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITH CC,,,4481.0,10415.83,10 MS-DRG,059,MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITH CC,,,4481.0,22796.57,18 MS-DRG,060,MS-DRG 32.00:MULTIPLE SCLEROSIS & CEREBELLAR ATAXIA W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,060,MS-DRG 42.00: MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITHOUT CC/MCC,,,4481.0,8159.87,10 MS-DRG,060,MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITHOUT CC/MCC,,,4481.0,16897.65,18 MS-DRG,061,"ISCHEMIC STROKE, PRECEREBRAL OCCLUSION OR TRANSIENT ISCHEMIA WITH THROMBOLYTIC AGENT WITH MCC",,,4481.0,50650.68,18 MS-DRG,061,MS-DRG 32.00:ACUTE ISCHEMIC STROKE W USE OF THROMBOLYTIC AGENT W MCC,,,4481.0,4481.0,1 MS-DRG,061,"MS-DRG 42.00: ISCHEMIC STROKE, PRECEREBRAL OCCLUSION OR TRANSIENT ISCHEMIA WITH THROMBOLYTIC AGENT WITH MCC",,,4481.0,21142.39,10 MS-DRG,062,"ISCHEMIC STROKE, PRECEREBRAL OCCLUSION OR TRANSIENT ISCHEMIA WITH THROMBOLYTIC AGENT WITH CC",,,4481.0,32281.52,18 MS-DRG,062,MS-DRG 32.00:ACUTE ISCHEMIC STROKE W USE OF THROMBOLYTIC AGENT W CC,,,4481.0,4481.0,1 MS-DRG,062,"MS-DRG 42.00: ISCHEMIC STROKE, PRECEREBRAL OCCLUSION OR TRANSIENT ISCHEMIA WITH THROMBOLYTIC AGENT WITH CC",,,4481.0,16469.72,10 MS-DRG,063,"ISCHEMIC STROKE, PRECEREBRAL OCCLUSION OR TRANSIENT ISCHEMIA WITH THROMBOLYTIC AGENT WITHOUT CC/MCC",,,4481.0,25789.21,18 MS-DRG,063,MS-DRG 32.00:ACUTE ISCHEMIC STROKE W USE OF THROMBOLYTIC AGENT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,063,"MS-DRG 42.00: ISCHEMIC STROKE, PRECEREBRAL OCCLUSION OR TRANSIENT ISCHEMIA WITH THROMBOLYTIC AGENT WITHOUT CC/MCC",,,4481.0,16325.13,10 MS-DRG,064,INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC,,,4481.0,36944.08,18 MS-DRG,064,MS-DRG 32.00:INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION W MCC,,,4481.0,4481.0,1 MS-DRG,064,MS-DRG 42.00: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC,,,4481.0,32318.88,10 MS-DRG,065,INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS,,,4481.0,18560.22,18 MS-DRG,065,MS-DRG 32.00:INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION W CC OR TPA IN 24 HRS,,,4481.0,4481.0,1 MS-DRG,065,MS-DRG 42.00: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS,,,4481.0,13242.06,10 MS-DRG,066,INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT CC/MCC,,,4481.0,12573.11,18 MS-DRG,066,MS-DRG 32.00:INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,066,MS-DRG 42.00: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT CC/MCC,,,4481.0,7791.66,10 MS-DRG,067,MS-DRG 32.00:NONSPECIFIC CVA & PRECEREBRAL OCCLUSION W/O INFARCT W MCC,,,4481.0,4481.0,1 MS-DRG,067,MS-DRG 42.00: NONSPECIFIC CVA AND PRECEREBRAL OCCLUSION WITHOUT INFARCTION WITH MCC,,,4481.0,9353.41,10 MS-DRG,067,PRECEREBRAL OCCLUSION WITHOUT INFARCTION WITH MCC,,,4481.0,26981.49,18 MS-DRG,068,MS-DRG 32.00:NONSPECIFIC CVA & PRECEREBRAL OCCLUSION W/O INFARCT W/O MCC,,,4481.0,4481.0,1 MS-DRG,068,MS-DRG 42.00: NONSPECIFIC CVA AND PRECEREBRAL OCCLUSION WITHOUT INFARCTION WITHOUT MCC,,,4481.0,7233.06,10 MS-DRG,068,PRECEREBRAL OCCLUSION WITHOUT INFARCTION WITHOUT MCC,,,4481.0,15879.89,18 MS-DRG,069,MS-DRG 32.00:TRANSIENT ISCHEMIA,,,4481.0,4481.0,1 MS-DRG,069,MS-DRG 42.00: TRANSIENT ISCHEMIA WITHOUT THROMBOLYTIC,,,4481.0,7113.62,10 MS-DRG,069,TRANSIENT ISCHEMIA WITHOUT THROMBOLYTIC,,,4481.0,14674.75,18 MS-DRG,070,MS-DRG 32.00:NONSPECIFIC CEREBROVASCULAR DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,070,MS-DRG 42.00: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MCC,,,4481.0,20877.46,10 MS-DRG,070,OTHER CEREBROVASCULAR DISORDERS WITH MCC,,,4481.0,30584.04,18 MS-DRG,071,MS-DRG 32.00:NONSPECIFIC CEREBROVASCULAR DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,071,MS-DRG 42.00: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH CC,,,4481.0,11656.96,10 MS-DRG,071,OTHER CEREBROVASCULAR DISORDERS WITH CC,,,4481.0,18848.65,18 MS-DRG,072,MS-DRG 32.00:NONSPECIFIC CEREBROVASCULAR DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,072,MS-DRG 42.00: NONSPECIFIC CEREBROVASCULAR DISORDERS WITHOUT CC/MCC,,,4481.0,6538.85,10 MS-DRG,072,OTHER CEREBROVASCULAR DISORDERS WITHOUT CC/MCC,,,4481.0,13892.15,18 MS-DRG,073,CRANIAL AND PERIPHERAL NERVE DISORDERS WITH MCC,,,4481.0,29472.6,18 MS-DRG,073,MS-DRG 32.00:CRANIAL & PERIPHERAL NERVE DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,073,MS-DRG 42.00: CRANIAL AND PERIPHERAL NERVE DISORDERS WITH MCC,,,4481.0,9960.51,10 MS-DRG,074,CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MCC,,,4481.0,18936.83,18 MS-DRG,074,MS-DRG 32.00:CRANIAL & PERIPHERAL NERVE DISORDERS W/O MCC,,,4481.0,4481.0,1 MS-DRG,074,MS-DRG 42.00: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MCC,,,4481.0,9960.51,10 MS-DRG,075,MS-DRG 32.00:VIRAL MENINGITIS W CC/MCC,,,4481.0,4481.0,1 MS-DRG,075,MS-DRG 42.00: VIRAL MENINGITIS WITH CC/MCC,,,4481.0,8367.33,10 MS-DRG,075,VIRAL MENINGITIS WITH CC/MCC,,,4481.0,35226.39,18 MS-DRG,076,MS-DRG 32.00:VIRAL MENINGITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,076,MS-DRG 42.00: VIRAL MENINGITIS WITHOUT CC/MCC,,,4481.0,6176.93,10 MS-DRG,076,VIRAL MENINGITIS WITHOUT CC/MCC,,,4481.0,13756.2,18 MS-DRG,077,MS-DRG 32.00:HYPERTENSIVE ENCEPHALOPATHY W MCC,,,4481.0,4481.0,1 MS-DRG,077,MS-DRG 42.00: HYPERTENSIVE ENCEPHALOPATHY WITH MCC,,,4481.0,10743.62,10 MS-DRG,078,MS-DRG 32.00:HYPERTENSIVE ENCEPHALOPATHY W CC,,,4481.0,4481.0,1 MS-DRG,078,MS-DRG 42.00: HYPERTENSIVE ENCEPHALOPATHY WITH CC,,,4481.0,7395.61,10 MS-DRG,079,MS-DRG 32.00:HYPERTENSIVE ENCEPHALOPATHY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,079,MS-DRG 42.00: HYPERTENSIVE ENCEPHALOPATHY WITHOUT CC/MCC,,,4481.0,4869.34,10 MS-DRG,080,MS-DRG 32.00:NONTRAUMATIC STUPOR & COMA W MCC,,,4481.0,4481.0,1 MS-DRG,080,MS-DRG 42.00: NONTRAUMATIC STUPOR AND COMA WITH MCC,,,4481.0,11365.99,10 MS-DRG,080,NONTRAUMATIC STUPOR AND COMA WITH MCC,,,4481.0,33251.51,18 MS-DRG,081,MS-DRG 32.00:NONTRAUMATIC STUPOR & COMA W/O MCC,,,4481.0,4481.0,1 MS-DRG,081,MS-DRG 42.00: NONTRAUMATIC STUPOR AND COMA WITHOUT MCC,,,4481.0,6500.24,10 MS-DRG,081,NONTRAUMATIC STUPOR AND COMA WITHOUT MCC,,,4481.0,16453.07,18 MS-DRG,082,"MS-DRG 32.00:TRAUMATIC STUPOR & COMA, COMA >1 HR W MCC",,,4481.0,4481.0,1 MS-DRG,082,MS-DRG 42.00: TRAUMATIC STUPOR AND COMA >1 HOUR WITH MCC,,,4481.0,21747.69,10 MS-DRG,082,TRAUMATIC STUPOR AND COMA >1 HOUR WITH MCC,,,4481.0,41988.76,18 MS-DRG,083,"MS-DRG 32.00:TRAUMATIC STUPOR & COMA, COMA >1 HR W CC",,,4481.0,4481.0,1 MS-DRG,083,MS-DRG 42.00: TRAUMATIC STUPOR AND COMA >1 HOUR WITH CC,,,4481.0,15016.65,10 MS-DRG,083,TRAUMATIC STUPOR AND COMA >1 HOUR WITH CC,,,4481.0,25642.24,18 MS-DRG,084,"MS-DRG 32.00:TRAUMATIC STUPOR & COMA, COMA >1 HR W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,084,MS-DRG 42.00: TRAUMATIC STUPOR AND COMA >1 HOUR WITHOUT CC/MCC,,,4481.0,7732.39,10 MS-DRG,084,TRAUMATIC STUPOR AND COMA >1 HOUR WITHOUT CC/MCC,,,4481.0,17559.0,18 MS-DRG,085,"MS-DRG 32.00:TRAUMATIC STUPOR & COMA, COMA <1 HR W MCC",,,4481.0,4481.0,1 MS-DRG,085,MS-DRG 42.00: TRAUMATIC STUPOR AND COMA <1 HOUR WITH MCC,,,4481.0,13864.42,10 MS-DRG,085,TRAUMATIC STUPOR AND COMA <1 HOUR WITH MCC,,,4481.0,41737.07,18 MS-DRG,086,"MS-DRG 32.00:TRAUMATIC STUPOR & COMA, COMA <1 HR W CC",,,4481.0,4481.0,1 MS-DRG,086,MS-DRG 42.00: TRAUMATIC STUPOR AND COMA <1 HOUR WITH CC,,,4481.0,9469.26,10 MS-DRG,086,TRAUMATIC STUPOR AND COMA <1 HOUR WITH CC,,,4481.0,23931.9,18 MS-DRG,087,"MS-DRG 32.00:TRAUMATIC STUPOR & COMA, COMA <1 HR W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,087,MS-DRG 42.00: TRAUMATIC STUPOR AND COMA <1 HOUR WITHOUT CC/MCC,,,4198.27,4481.0,10 MS-DRG,087,TRAUMATIC STUPOR AND COMA <1 HOUR WITHOUT CC/MCC,,,4481.0,16803.95,18 MS-DRG,088,CONCUSSION WITH MCC,,,4481.0,24833.92,18 MS-DRG,088,MS-DRG 32.00:CONCUSSION W MCC,,,4481.0,4481.0,1 MS-DRG,088,MS-DRG 42.00: CONCUSSION WITH MCC,,,4481.0,11166.61,10 MS-DRG,089,CONCUSSION WITH CC,,,4481.0,20182.38,18 MS-DRG,089,MS-DRG 32.00:CONCUSSION W CC,,,4481.0,4481.0,1 MS-DRG,089,MS-DRG 42.00: CONCUSSION WITH CC,,,4481.0,8317.04,10 MS-DRG,090,CONCUSSION WITHOUT CC/MCC,,,4481.0,15123.01,18 MS-DRG,090,MS-DRG 32.00:CONCUSSION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,090,MS-DRG 42.00: CONCUSSION WITHOUT CC/MCC,,,4481.0,7100.15,10 MS-DRG,091,MS-DRG 32.00:OTHER DISORDERS OF NERVOUS SYSTEM W MCC,,,4481.0,4481.0,1 MS-DRG,091,MS-DRG 42.00: OTHER DISORDERS OF NERVOUS SYSTEM WITH MCC,,,4481.0,21610.28,10 MS-DRG,091,OTHER DISORDERS OF NERVOUS SYSTEM WITH MCC,,,4481.0,32263.15,18 MS-DRG,092,MS-DRG 32.00:OTHER DISORDERS OF NERVOUS SYSTEM W CC,,,4481.0,4481.0,1 MS-DRG,092,MS-DRG 42.00: OTHER DISORDERS OF NERVOUS SYSTEM WITH CC,,,4481.0,13484.54,10 MS-DRG,092,OTHER DISORDERS OF NERVOUS SYSTEM WITH CC,,,4481.0,18793.53,18 MS-DRG,093,MS-DRG 32.00:OTHER DISORDERS OF NERVOUS SYSTEM W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,093,MS-DRG 42.00: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT CC/MCC,,,4481.0,8051.21,10 MS-DRG,093,OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT CC/MCC,,,4481.0,14628.83,18 MS-DRG,094,BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH MCC,,,4481.0,64654.9,18 MS-DRG,094,MS-DRG 32.00:BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W MCC,,,4481.0,4481.0,1 MS-DRG,094,MS-DRG 42.00: BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH MCC,,,4481.0,38804.75,10 MS-DRG,095,BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH CC,,,4481.0,47382.48,18 MS-DRG,095,MS-DRG 32.00:BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W CC,,,4481.0,4481.0,1 MS-DRG,095,MS-DRG 42.00: BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH CC,,,4481.0,21489.94,10 MS-DRG,096,BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITHOUT CC/MCC,,,4481.0,47382.48,18 MS-DRG,096,MS-DRG 32.00:BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,096,MS-DRG 42.00: BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITHOUT CC/MCC,,,4481.0,21489.94,10 MS-DRG,097,MS-DRG 32.00:NON-BACTERIAL INFECT OF NERVOUS SYS EXC VIRAL MENINGITIS W MCC,,,4481.0,4481.0,1 MS-DRG,097,MS-DRG 42.00: NON-BACTERIAL INFECTION OF NERVOUS SYSTEM EXCEPT VIRAL MENINGITIS WITH MCC,,,4481.0,26471.54,10 MS-DRG,097,NON-BACTERIAL INFECTION OF NERVOUS SYSTEM EXCEPT VIRAL MENINGITIS WITH MCC,,,4481.0,66352.38,18 MS-DRG,098,MS-DRG 32.00:NON-BACTERIAL INFECT OF NERVOUS SYS EXC VIRAL MENINGITIS W CC,,,4481.0,4481.0,1 MS-DRG,098,MS-DRG 42.00: NON-BACTERIAL INFECTION OF NERVOUS SYSTEM EXCEPT VIRAL MENINGITIS WITH CC,,,4481.0,15957.82,10 MS-DRG,098,NON-BACTERIAL INFECTION OF NERVOUS SYSTEM EXCEPT VIRAL MENINGITIS WITH CC,,,4481.0,42159.61,18 MS-DRG,099,MS-DRG 32.00:NON-BACTERIAL INFECT OF NERVOUS SYS EXC VIRAL MENINGITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,099,MS-DRG 42.00: NON-BACTERIAL INFECTION OF NERVOUS SYSTEM EXCEPT VIRAL MENINGITIS WITHOUT CC/MCC,,,4481.0,10636.75,10 MS-DRG,099,NON-BACTERIAL INFECTION OF NERVOUS SYSTEM EXCEPT VIRAL MENINGITIS WITHOUT CC/MCC,,,4481.0,25028.65,18 MS-DRG,100,MS-DRG 32.00:SEIZURES W MCC,,,4481.0,4481.0,1 MS-DRG,100,MS-DRG 42.00: SEIZURES WITH MCC,,,4481.0,17276.19,10 MS-DRG,100,SEIZURES WITH MCC,,,4481.0,35580.95,18 MS-DRG,101,MS-DRG 32.00:SEIZURES W/O MCC,,,4481.0,4481.0,1 MS-DRG,101,MS-DRG 42.00: SEIZURES WITHOUT MCC,,,4481.0,6731.04,10 MS-DRG,101,SEIZURES WITHOUT MCC,,,4481.0,18954.0,18 MS-DRG,102,HEADACHES WITH MCC,,,4481.0,20592.05,18 MS-DRG,102,MS-DRG 32.00:HEADACHES W MCC,,,4481.0,4481.0,1 MS-DRG,102,MS-DRG 42.00: HEADACHES WITH MCC,,,4481.0,9025.61,10 MS-DRG,103,HEADACHES WITHOUT MCC,,,4481.0,15363.67,18 MS-DRG,103,MS-DRG 32.00:HEADACHES W/O MCC,,,4481.0,4481.0,1 MS-DRG,103,MS-DRG 42.00: HEADACHES WITHOUT MCC,,,4481.0,7239.35,10 MS-DRG,113,MS-DRG 32.00:ORBITAL PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,113,MS-DRG 42.00: ORBITAL PROCEDURES WITH CC/MCC,,,4481.0,20779.57,10 MS-DRG,113,ORBITAL PROCEDURES WITH CC/MCC,,,4481.0,43192.06,18 MS-DRG,114,MS-DRG 32.00:ORBITAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,114,MS-DRG 42.00: ORBITAL PROCEDURES WITHOUT CC/MCC,,,4481.0,10247.89,10 MS-DRG,114,ORBITAL PROCEDURES WITHOUT CC/MCC,,,4481.0,24855.96,18 MS-DRG,115,EXTRAOCULAR PROCEDURES EXCEPT ORBIT,,,4481.0,28197.65,18 MS-DRG,115,MS-DRG 32.00:EXTRAOCULAR PROCEDURES EXCEPT ORBIT,,,4481.0,4481.0,1 MS-DRG,115,MS-DRG 42.00: EXTRAOCULAR PROCEDURES EXCEPT ORBIT,,,4481.0,11674.92,10 MS-DRG,116,INTRAOCULAR PROCEDURES WITH CC/MCC,,,4481.0,33216.61,18 MS-DRG,116,MS-DRG 32.00:INTRAOCULAR PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,116,MS-DRG 42.00: INTRAOCULAR PROCEDURES WITH CC/MCC,,,4481.0,16519.12,10 MS-DRG,117,INTRAOCULAR PROCEDURES WITHOUT CC/MCC,,,4481.0,19930.7,18 MS-DRG,117,MS-DRG 32.00:INTRAOCULAR PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,117,MS-DRG 42.00: INTRAOCULAR PROCEDURES WITHOUT CC/MCC,,,4481.0,9980.26,10 MS-DRG,121,ACUTE MAJOR EYE INFECTIONS WITH CC/MCC,,,4481.0,21370.98,18 MS-DRG,121,MS-DRG 32.00:ACUTE MAJOR EYE INFECTIONS W CC/MCC,,,4481.0,4481.0,1 MS-DRG,121,MS-DRG 42.00: ACUTE MAJOR EYE INFECTIONS WITH CC/MCC,,,4481.0,6193.1,10 MS-DRG,122,ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC,,,4481.0,14435.93,18 MS-DRG,122,MS-DRG 32.00:ACUTE MAJOR EYE INFECTIONS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,122,MS-DRG 42.00: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC,,,4481.0,6085.33,10 MS-DRG,123,MS-DRG 32.00:NEUROLOGICAL EYE DISORDERS,,,4481.0,4481.0,1 MS-DRG,123,MS-DRG 42.00: NEUROLOGICAL EYE DISORDERS,,,4481.0,9535.72,10 MS-DRG,123,NEUROLOGICAL EYE DISORDERS,,,4481.0,14671.08,18 MS-DRG,124,MS-DRG 32.00:OTHER DISORDERS OF THE EYE W MCC,,,4481.0,4481.0,1 MS-DRG,124,MS-DRG 42.00: OTHER DISORDERS OF THE EYE WITH MCC OR THROMBOLYTIC AGENT,,,4481.0,11557.28,10 MS-DRG,124,OTHER DISORDERS OF THE EYE WITH MCC OR THROMBOLYTIC AGENT,,,4481.0,24306.67,18 MS-DRG,125,MS-DRG 32.00:OTHER DISORDERS OF THE EYE W/O MCC,,,4481.0,4481.0,1 MS-DRG,125,MS-DRG 42.00: OTHER DISORDERS OF THE EYE WITHOUT MCC,,,4481.0,5969.48,10 MS-DRG,125,OTHER DISORDERS OF THE EYE WITHOUT MCC,,,4481.0,14105.25,18 MS-DRG,129,MS-DRG 32.00:MAJOR HEAD & NECK PROCEDURES W CC/MCC OR MAJOR DEVICE,,,4481.0,4481.0,1 MS-DRG,130,MS-DRG 32.00:MAJOR HEAD & NECK PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,131,MS-DRG 32.00:CRANIAL/FACIAL PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,132,MS-DRG 32.00:CRANIAL/FACIAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,133,"MS-DRG 32.00:OTHER EAR, NOSE, MOUTH & THROAT O.R. PROCEDURES W CC/MCC",,,4481.0,4481.0,1 MS-DRG,134,"MS-DRG 32.00:OTHER EAR, NOSE, MOUTH & THROAT O.R. PROCEDURES W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,135,MS-DRG 32.00:SINUS & MASTOID PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,135,MS-DRG 42.00: SINUS AND MASTOID PROCEDURES WITH CC/MCC,,,4481.0,15975.79,10 MS-DRG,135,SINUS AND MASTOID PROCEDURES WITH CC/MCC,,,4481.0,38858.34,18 MS-DRG,136,MS-DRG 32.00:SINUS & MASTOID PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,136,MS-DRG 42.00: SINUS AND MASTOID PROCEDURES WITHOUT CC/MCC,,,4481.0,10630.47,10 MS-DRG,136,SINUS AND MASTOID PROCEDURES WITHOUT CC/MCC,,,4481.0,18652.08,18 MS-DRG,137,MOUTH PROCEDURES WITH CC/MCC,,,4481.0,27431.58,18 MS-DRG,137,MS-DRG 32.00:MOUTH PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,137,MS-DRG 42.00: MOUTH PROCEDURES WITH CC/MCC,,,4481.0,9120.81,10 MS-DRG,138,MOUTH PROCEDURES WITHOUT CC/MCC,,,4481.0,16280.38,18 MS-DRG,138,MS-DRG 32.00:MOUTH PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,138,MS-DRG 42.00: MOUTH PROCEDURES WITHOUT CC/MCC,,,4481.0,5336.34,10 MS-DRG,139,MS-DRG 32.00:SALIVARY GLAND PROCEDURES,,,4481.0,4481.0,1 MS-DRG,139,MS-DRG 42.00: SALIVARY GLAND PROCEDURES,,,4481.0,10723.87,10 MS-DRG,139,SALIVARY GLAND PROCEDURES,,,4481.0,22203.19,18 MS-DRG,140,MAJOR HEAD AND NECK PROCEDURES WITH MCC,,,4481.0,78357.83,18 MS-DRG,140,MS-DRG 42.00: MAJOR HEAD AND NECK PROCEDURES WITH MCC,,,4481.0,31665.98,10 MS-DRG,141,MAJOR HEAD AND NECK PROCEDURES WITH CC,,,4481.0,40068.99,18 MS-DRG,141,MS-DRG 42.00: MAJOR HEAD AND NECK PROCEDURES WITH CC,,,4481.0,19323.79,10 MS-DRG,142,MAJOR HEAD AND NECK PROCEDURES WITHOUT CC/MCC,,,4481.0,29327.46,18 MS-DRG,142,MS-DRG 42.00: MAJOR HEAD AND NECK PROCEDURES WITHOUT CC/MCC,,,4481.0,16095.23,10 MS-DRG,143,"MS-DRG 42.00: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH MCC",,,4481.0,23189.09,10 MS-DRG,143,"OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH MCC",,,4481.0,68828.79,18 MS-DRG,144,"MS-DRG 42.00: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH CC",,,4481.0,13934.47,10 MS-DRG,144,"OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH CC",,,4481.0,31835.11,18 MS-DRG,145,"MS-DRG 42.00: OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITHOUT CC/MCC",,,4481.0,8102.4,10 MS-DRG,145,"OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITHOUT CC/MCC",,,4481.0,22087.45,18 MS-DRG,146,"EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC",,,4481.0,38898.76,18 MS-DRG,146,"MS-DRG 32.00:EAR, NOSE, MOUTH & THROAT MALIGNANCY W MCC",,,4481.0,4481.0,1 MS-DRG,146,"MS-DRG 42.00: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC",,,4481.0,16485.89,10 MS-DRG,147,"EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC",,,4481.0,23358.73,18 MS-DRG,147,"MS-DRG 32.00:EAR, NOSE, MOUTH & THROAT MALIGNANCY W CC",,,4481.0,4481.0,1 MS-DRG,147,"MS-DRG 42.00: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC",,,4481.0,7968.58,10 MS-DRG,148,"EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC",,,4481.0,14643.52,18 MS-DRG,148,"MS-DRG 32.00:EAR, NOSE, MOUTH & THROAT MALIGNANCY W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,148,"MS-DRG 42.00: EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC",,,4481.0,6568.49,10 MS-DRG,149,DYSEQUILIBRIUM,,,4481.0,13807.64,18 MS-DRG,149,MS-DRG 32.00:DYSEQUILIBRIUM,,,4481.0,4481.0,1 MS-DRG,149,MS-DRG 42.00: DYSEQUILIBRIUM,,,4481.0,8950.18,10 MS-DRG,150,EPISTAXIS WITH MCC,,,4481.0,24460.99,18 MS-DRG,150,MS-DRG 32.00:EPISTAXIS W MCC,,,4481.0,4481.0,1 MS-DRG,150,MS-DRG 42.00: EPISTAXIS WITH MCC,,,4481.0,15019.34,10 MS-DRG,151,EPISTAXIS WITHOUT MCC,,,4481.0,13484.31,18 MS-DRG,151,MS-DRG 32.00:EPISTAXIS W/O MCC,,,4481.0,4481.0,1 MS-DRG,151,MS-DRG 42.00: EPISTAXIS WITHOUT MCC,,,4481.0,5566.24,10 MS-DRG,152,MS-DRG 32.00:OTITIS MEDIA & URI W MCC,,,4481.0,4481.0,1 MS-DRG,152,MS-DRG 42.00: OTITIS MEDIA AND URI WITH MCC,,,4481.0,6702.3,10 MS-DRG,152,OTITIS MEDIA AND URI WITH MCC,,,4481.0,21718.2,18 MS-DRG,153,MS-DRG 32.00:OTITIS MEDIA & URI W/O MCC,,,4481.0,4481.0,1 MS-DRG,153,MS-DRG 42.00: OTITIS MEDIA AND URI WITHOUT MCC,,,4481.0,4623.27,10 MS-DRG,153,OTITIS MEDIA AND URI WITHOUT MCC,,,4481.0,13561.47,18 MS-DRG,154,"MS-DRG 32.00:OTHER EAR, NOSE, MOUTH & THROAT DIAGNOSES W MCC",,,4481.0,4481.0,1 MS-DRG,154,"MS-DRG 42.00: OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITH MCC",,,4481.0,12379.91,10 MS-DRG,154,"OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITH MCC",,,4481.0,28723.06,18 MS-DRG,155,"MS-DRG 32.00:OTHER EAR, NOSE, MOUTH & THROAT DIAGNOSES W CC",,,4481.0,4481.0,1 MS-DRG,155,"MS-DRG 42.00: OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITH CC",,,4481.0,8207.47,10 MS-DRG,155,"OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITH CC",,,4481.0,16837.02,18 MS-DRG,156,"MS-DRG 32.00:OTHER EAR, NOSE, MOUTH & THROAT DIAGNOSES W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,156,"MS-DRG 42.00: OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITHOUT CC/MCC",,,4481.0,4679.85,10 MS-DRG,156,"OTHER EAR, NOSE, MOUTH AND THROAT DIAGNOSES WITHOUT CC/MCC",,,4481.0,12696.2,18 MS-DRG,157,DENTAL AND ORAL DISEASES WITH MCC,,,4481.0,31539.33,18 MS-DRG,157,MS-DRG 32.00:DENTAL & ORAL DISEASES W MCC,,,4481.0,4481.0,1 MS-DRG,157,MS-DRG 42.00: DENTAL AND ORAL DISEASES WITH MCC,,,4481.0,11427.06,10 MS-DRG,158,DENTAL AND ORAL DISEASES WITH CC,,,4481.0,16713.94,18 MS-DRG,158,MS-DRG 32.00:DENTAL & ORAL DISEASES W CC,,,4481.0,4481.0,1 MS-DRG,158,MS-DRG 42.00: DENTAL AND ORAL DISEASES WITH CC,,,4481.0,7633.6,10 MS-DRG,159,DENTAL AND ORAL DISEASES WITHOUT CC/MCC,,,4481.0,13015.85,18 MS-DRG,159,MS-DRG 32.00:DENTAL & ORAL DISEASES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,159,MS-DRG 42.00: DENTAL AND ORAL DISEASES WITHOUT CC/MCC,,,4481.0,5764.72,10 MS-DRG,163,MAJOR CHEST PROCEDURES WITH MCC,,,4481.0,82335.15,18 MS-DRG,163,MS-DRG 32.00:MAJOR CHEST PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,163,MS-DRG 42.00: MAJOR CHEST PROCEDURES WITH MCC,,,4481.0,41470.22,10 MS-DRG,164,MAJOR CHEST PROCEDURES WITH CC,,,4481.0,46368.4,18 MS-DRG,164,MS-DRG 32.00:MAJOR CHEST PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,164,MS-DRG 42.00: MAJOR CHEST PROCEDURES WITH CC,,,4481.0,21390.26,10 MS-DRG,165,MAJOR CHEST PROCEDURES WITHOUT CC/MCC,,,4481.0,35165.77,18 MS-DRG,165,MS-DRG 32.00:MAJOR CHEST PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,165,MS-DRG 42.00: MAJOR CHEST PROCEDURES WITHOUT CC/MCC,,,4481.0,18368.25,10 MS-DRG,166,MS-DRG 32.00:OTHER RESP SYSTEM O.R. PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,166,MS-DRG 42.00: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MCC,,,4481.0,30230.87,10 MS-DRG,166,OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MCC,,,4481.0,68665.29,18 MS-DRG,167,MS-DRG 32.00:OTHER RESP SYSTEM O.R. PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,167,MS-DRG 42.00: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH CC,,,4481.0,16861.28,10 MS-DRG,167,OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH CC,,,4481.0,33130.26,18 MS-DRG,168,MS-DRG 32.00:OTHER RESP SYSTEM O.R. PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,168,MS-DRG 42.00: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,15806.05,10 MS-DRG,168,OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,25102.13,18 MS-DRG,173,MS-DRG 42.00: ULTRASOUND ACCELERATED AND OTHER THROMBOLYSIS WITH PRINCIPAL DIAGNOSIS PULMONARY EMBOLISM,,,4481.0,22526.31,10 MS-DRG,173,ULTRASOUND ACCELERATED AND OTHER THROMBOLYSIS WITH PRINCIPAL DIAGNOSIS PULMONARY EMBOLISM,,,4481.0,54679.44,18 MS-DRG,175,MS-DRG 32.00:PULMONARY EMBOLISM W MCC,,,4481.0,4481.0,1 MS-DRG,175,MS-DRG 42.00: PULMONARY EMBOLISM WITH MCC OR ACUTE COR PULMONALE,,,4481.0,16164.38,10 MS-DRG,175,PULMONARY EMBOLISM WITH MCC OR ACUTE COR PULMONALE,,,4481.0,25234.41,18 MS-DRG,176,MS-DRG 32.00:PULMONARY EMBOLISM W/O MCC,,,4481.0,4481.0,1 MS-DRG,176,MS-DRG 42.00: PULMONARY EMBOLISM WITHOUT MCC,,,4481.0,8402.35,10 MS-DRG,176,PULMONARY EMBOLISM WITHOUT MCC,,,4481.0,14788.66,18 MS-DRG,177,MS-DRG 32.00:RESPIRATORY INFECTIONS & INFLAMMATIONS W MCC,,,4481.0,4481.0,1 MS-DRG,177,MS-DRG 42.00: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC,,,4481.0,15214.22,10 MS-DRG,177,RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC,,,4481.0,28708.36,18 MS-DRG,178,MS-DRG 32.00:RESPIRATORY INFECTIONS & INFLAMMATIONS W CC,,,4481.0,4481.0,1 MS-DRG,178,MS-DRG 42.00: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH CC,,,4481.0,10285.61,10 MS-DRG,178,RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH CC,,,4481.0,17930.1,18 MS-DRG,179,MS-DRG 32.00:RESPIRATORY INFECTIONS & INFLAMMATIONS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,179,MS-DRG 42.00: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITHOUT CC/MCC,,,4481.0,5383.04,10 MS-DRG,179,RESPIRATORY INFECTIONS AND INFLAMMATIONS WITHOUT CC/MCC,,,4481.0,13870.1,18 MS-DRG,180,MS-DRG 32.00:RESPIRATORY NEOPLASMS W MCC,,,4481.0,4481.0,1 MS-DRG,180,MS-DRG 42.00: RESPIRATORY NEOPLASMS WITH MCC,,,4481.0,19271.71,10 MS-DRG,180,RESPIRATORY NEOPLASMS WITH MCC,,,4481.0,32443.19,18 MS-DRG,181,MS-DRG 32.00:RESPIRATORY NEOPLASMS W CC,,,4481.0,4481.0,1 MS-DRG,181,MS-DRG 42.00: RESPIRATORY NEOPLASMS WITH CC,,,4481.0,8133.83,10 MS-DRG,181,RESPIRATORY NEOPLASMS WITH CC,,,4481.0,19675.34,18 MS-DRG,182,MS-DRG 32.00:RESPIRATORY NEOPLASMS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,182,MS-DRG 42.00: RESPIRATORY NEOPLASMS WITHOUT CC/MCC,,,4481.0,5464.76,10 MS-DRG,182,RESPIRATORY NEOPLASMS WITHOUT CC/MCC,,,4481.0,13668.02,18 MS-DRG,183,MAJOR CHEST TRAUMA WITH MCC,,,4481.0,28105.79,18 MS-DRG,183,MS-DRG 32.00:MAJOR CHEST TRAUMA W MCC,,,4481.0,4481.0,1 MS-DRG,183,MS-DRG 42.00: MAJOR CHEST TRAUMA WITH MCC,,,4481.0,11022.92,10 MS-DRG,184,MAJOR CHEST TRAUMA WITH CC,,,4481.0,19548.58,18 MS-DRG,184,MS-DRG 32.00:MAJOR CHEST TRAUMA W CC,,,4481.0,4481.0,1 MS-DRG,184,MS-DRG 42.00: MAJOR CHEST TRAUMA WITH CC,,,4481.0,8279.32,10 MS-DRG,185,MAJOR CHEST TRAUMA WITHOUT CC/MCC,,,4481.0,14448.79,18 MS-DRG,185,MS-DRG 32.00:MAJOR CHEST TRAUMA W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,185,MS-DRG 42.00: MAJOR CHEST TRAUMA WITHOUT CC/MCC,,,4481.0,5685.69,10 MS-DRG,186,MS-DRG 32.00:PLEURAL EFFUSION W MCC,,,4481.0,4481.0,1 MS-DRG,186,MS-DRG 42.00: PLEURAL EFFUSION WITH MCC,,,4481.0,16776.86,10 MS-DRG,186,PLEURAL EFFUSION WITH MCC,,,4481.0,28631.2,18 MS-DRG,187,MS-DRG 32.00:PLEURAL EFFUSION W CC,,,4481.0,4481.0,1 MS-DRG,187,MS-DRG 42.00: PLEURAL EFFUSION WITH CC,,,4481.0,8720.27,10 MS-DRG,187,PLEURAL EFFUSION WITH CC,,,4481.0,18170.76,18 MS-DRG,188,MS-DRG 32.00:PLEURAL EFFUSION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,188,MS-DRG 42.00: PLEURAL EFFUSION WITHOUT CC/MCC,,,4481.0,6732.84,10 MS-DRG,188,PLEURAL EFFUSION WITHOUT CC/MCC,,,4481.0,13175.68,18 MS-DRG,189,MS-DRG 32.00:PULMONARY EDEMA & RESPIRATORY FAILURE,,,4481.0,4481.0,1 MS-DRG,189,MS-DRG 42.00: PULMONARY EDEMA AND RESPIRATORY FAILURE,,,4481.0,11521.35,10 MS-DRG,189,PULMONARY EDEMA AND RESPIRATORY FAILURE,,,4481.0,22695.53,18 MS-DRG,190,CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC,,,4481.0,20349.56,18 MS-DRG,190,MS-DRG 32.00:CHRONIC OBSTRUCTIVE PULMONARY DISEASE W MCC,,,4481.0,4481.0,1 MS-DRG,190,MS-DRG 42.00: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC,,,4481.0,10360.15,10 MS-DRG,191,CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CC,,,4481.0,15486.75,18 MS-DRG,191,MS-DRG 32.00:CHRONIC OBSTRUCTIVE PULMONARY DISEASE W CC,,,4481.0,4481.0,1 MS-DRG,191,MS-DRG 42.00: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CC,,,4481.0,8674.47,10 MS-DRG,192,CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT CC/MCC,,,4481.0,11794.18,18 MS-DRG,192,MS-DRG 32.00:CHRONIC OBSTRUCTIVE PULMONARY DISEASE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,192,MS-DRG 42.00: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT CC/MCC,,,4481.0,6548.73,10 MS-DRG,193,MS-DRG 32.00:SIMPLE PNEUMONIA & PLEURISY W MCC,,,4481.0,4481.0,1 MS-DRG,193,MS-DRG 42.00: SIMPLE PNEUMONIA AND PLEURISY WITH MCC,,,4481.0,11432.44,10 MS-DRG,193,SIMPLE PNEUMONIA AND PLEURISY WITH MCC,,,4481.0,24146.84,18 MS-DRG,194,MS-DRG 32.00:SIMPLE PNEUMONIA & PLEURISY W CC,,,4481.0,4481.0,1 MS-DRG,194,MS-DRG 42.00: SIMPLE PNEUMONIA AND PLEURISY WITH CC,,,4481.0,7792.56,10 MS-DRG,194,SIMPLE PNEUMONIA AND PLEURISY WITH CC,,,4481.0,14805.19,18 MS-DRG,195,MS-DRG 32.00:SIMPLE PNEUMONIA & PLEURISY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,195,MS-DRG 42.00: SIMPLE PNEUMONIA AND PLEURISY WITHOUT CC/MCC,,,4481.0,4747.2,10 MS-DRG,195,SIMPLE PNEUMONIA AND PLEURISY WITHOUT CC/MCC,,,4481.0,11546.17,18 MS-DRG,196,INTERSTITIAL LUNG DISEASE WITH MCC,,,4481.0,34669.75,18 MS-DRG,196,MS-DRG 32.00:INTERSTITIAL LUNG DISEASE W MCC,,,4481.0,4481.0,1 MS-DRG,196,MS-DRG 42.00: INTERSTITIAL LUNG DISEASE WITH MCC,,,4481.0,10721.17,10 MS-DRG,197,INTERSTITIAL LUNG DISEASE WITH CC,,,4481.0,17435.92,18 MS-DRG,197,MS-DRG 32.00:INTERSTITIAL LUNG DISEASE W CC,,,4481.0,4481.0,1 MS-DRG,197,MS-DRG 42.00: INTERSTITIAL LUNG DISEASE WITH CC,,,4481.0,7205.22,10 MS-DRG,198,INTERSTITIAL LUNG DISEASE WITHOUT CC/MCC,,,4481.0,13157.31,18 MS-DRG,198,MS-DRG 32.00:INTERSTITIAL LUNG DISEASE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,198,MS-DRG 42.00: INTERSTITIAL LUNG DISEASE WITHOUT CC/MCC,,,4481.0,6012.59,10 MS-DRG,199,MS-DRG 32.00:PNEUMOTHORAX W MCC,,,4481.0,4481.0,1 MS-DRG,199,MS-DRG 42.00: PNEUMOTHORAX WITH MCC,,,4481.0,16182.34,10 MS-DRG,199,PNEUMOTHORAX WITH MCC,,,4481.0,32408.28,18 MS-DRG,200,MS-DRG 32.00:PNEUMOTHORAX W CC,,,4481.0,4481.0,1 MS-DRG,200,MS-DRG 42.00: PNEUMOTHORAX WITH CC,,,4481.0,8546.94,10 MS-DRG,200,PNEUMOTHORAX WITH CC,,,4481.0,20195.24,18 MS-DRG,201,MS-DRG 32.00:PNEUMOTHORAX W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,201,MS-DRG 42.00: PNEUMOTHORAX WITHOUT CC/MCC,,,4481.0,5841.95,10 MS-DRG,201,PNEUMOTHORAX WITHOUT CC/MCC,,,4481.0,13137.1,18 MS-DRG,202,BRONCHITIS AND ASTHMA WITH CC/MCC,,,4481.0,17841.92,18 MS-DRG,202,MS-DRG 32.00:BRONCHITIS & ASTHMA W CC/MCC,,,4481.0,4481.0,1 MS-DRG,202,MS-DRG 42.00: BRONCHITIS AND ASTHMA WITH CC/MCC,,,4481.0,7859.02,10 MS-DRG,203,BRONCHITIS AND ASTHMA WITHOUT CC/MCC,,,4481.0,12308.57,18 MS-DRG,203,MS-DRG 32.00:BRONCHITIS & ASTHMA W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,203,MS-DRG 42.00: BRONCHITIS AND ASTHMA WITHOUT CC/MCC,,,4481.0,4644.82,10 MS-DRG,204,MS-DRG 32.00:RESPIRATORY SIGNS & SYMPTOMS,,,4481.0,4481.0,1 MS-DRG,204,MS-DRG 42.00: RESPIRATORY SIGNS AND SYMPTOMS,,,4481.0,6475.99,10 MS-DRG,204,RESPIRATORY SIGNS AND SYMPTOMS,,,4481.0,14832.75,18 MS-DRG,205,MS-DRG 32.00:OTHER RESPIRATORY SYSTEM DIAGNOSES W MCC,,,4481.0,4481.0,1 MS-DRG,205,MS-DRG 42.00: OTHER RESPIRATORY SYSTEM DIAGNOSES WITH MCC,,,4481.0,11133.39,10 MS-DRG,205,OTHER RESPIRATORY SYSTEM DIAGNOSES WITH MCC,,,4481.0,33637.3,18 MS-DRG,206,MS-DRG 32.00:OTHER RESPIRATORY SYSTEM DIAGNOSES W/O MCC,,,4481.0,4481.0,1 MS-DRG,206,MS-DRG 42.00: OTHER RESPIRATORY SYSTEM DIAGNOSES WITHOUT MCC,,,4481.0,7936.25,10 MS-DRG,206,OTHER RESPIRATORY SYSTEM DIAGNOSES WITHOUT MCC,,,4481.0,17288.95,18 MS-DRG,207,MS-DRG 32.00:RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT 96+ HOURS,,,4481.0,4481.0,1 MS-DRG,207,MS-DRG 42.00: RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT >96 HOURS,,,4481.0,61495.41,10 MS-DRG,207,RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT >96 HOURS,,,4481.0,118211.87,18 MS-DRG,208,MS-DRG 32.00:RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <96 HOURS,,,4481.0,4481.0,1 MS-DRG,208,MS-DRG 42.00: RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT <=96 HOURS,,,4481.0,22079.08,10 MS-DRG,208,RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT <=96 HOURS,,,4481.0,50496.37,18 MS-DRG,209,COMPLEX AORTIC ARCH PROCEDURES,,,4481.0,207937.67,18 MS-DRG,212,CONCOMITANT AORTIC AND MITRAL VALVE PROCEDURES,,,4481.0,199768.09,18 MS-DRG,212,MS-DRG 42.00: CONCOMITANT AORTIC AND MITRAL VALVE PROCEDURES,,,4481.0,83106.59,10 MS-DRG,213,ENDOVASCULAR ABDOMINAL AORTA WITH ILIAC BRANCH PROCEDURES,,,4481.0,104841.46,18 MS-DRG,215,MS-DRG 32.00:OTHER HEART ASSIST SYSTEM IMPLANT,,,4481.0,4481.0,1 MS-DRG,215,MS-DRG 42.00: OTHER HEART ASSIST SYSTEM IMPLANT,,,4481.0,72335.13,10 MS-DRG,215,OTHER HEART ASSIST SYSTEM IMPLANT,,,4481.0,106357.4,12 MS-DRG,216,CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITH MCC,,,4481.0,179719.82,19 MS-DRG,216,MS-DRG 32.00:CARDIAC VALVE & OTH MAJ CARDIOTHORACIC PROC W CARD CATH W MCC,,,4481.0,4481.0,1 MS-DRG,216,MS-DRG 42.00: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITH MCC,,,4481.0,104375.61,10 MS-DRG,217,CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITH CC,,,4481.0,134550.0,19 MS-DRG,217,MS-DRG 32.00:CARDIAC VALVE & OTH MAJ CARDIOTHORACIC PROC W CARD CATH W CC,,,4481.0,4481.0,1 MS-DRG,217,MS-DRG 42.00: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITH CC,,,4481.0,51912.99,10 MS-DRG,218,CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITHOUT CC/MCC,,,4481.0,134550.0,19 MS-DRG,218,MS-DRG 32.00:CARDIAC VALVE & OTH MAJ CARDIOTHORACIC PROC W CARD CATH W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,218,MS-DRG 42.00: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITHOUT CC/MCC,,,4481.0,51912.99,10 MS-DRG,219,CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MCC,,,4481.0,141058.05,19 MS-DRG,219,MS-DRG 32.00:CARDIAC VALVE & OTH MAJ CARDIOTHORACIC PROC W/O CARD CATH W MCC,,,4481.0,4481.0,1 MS-DRG,219,MS-DRG 42.00: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MCC,,,4481.0,62503.95,10 MS-DRG,220,CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH CC,,,4481.0,110024.0,19 MS-DRG,220,MS-DRG 32.00:CARDIAC VALVE & OTH MAJ CARDIOTHORACIC PROC W/O CARD CATH W CC,,,4481.0,4481.0,1 MS-DRG,220,MS-DRG 42.00: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH CC,,,4481.0,42748.18,10 MS-DRG,221,CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITHOUT CC/MCC,,,4481.0,110024.0,19 MS-DRG,221,MS-DRG 32.00:CARDIAC VALVE & OTH MAJ CARDIOTHORACIC PROC W/O CARD CATH W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,221,MS-DRG 42.00: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITHOUT CC/MCC,,,4481.0,38606.28,10 MS-DRG,222,MS-DRG 32.00:CARDIAC DEFIB IMPLANT W CARDIAC CATH W AMI/HF/SHOCK W MCC,,,4481.0,4481.0,1 MS-DRG,223,MS-DRG 32.00:CARDIAC DEFIB IMPLANT W CARDIAC CATH W AMI/HF/SHOCK W/O MCC,,,4481.0,4481.0,1 MS-DRG,224,MS-DRG 32.00:CARDIAC DEFIB IMPLANT W CARDIAC CATH W/O AMI/HF/SHOCK W MCC,,,4481.0,4481.0,1 MS-DRG,225,MS-DRG 32.00:CARDIAC DEFIB IMPLANT W CARDIAC CATH W/O AMI/HF/SHOCK W/O MCC,,,4481.0,4481.0,1 MS-DRG,226,MS-DRG 32.00:CARDIAC DEFIBRILLATOR IMPLANT W/O CARDIAC CATH W MCC,,,4481.0,4481.0,1 MS-DRG,227,MS-DRG 32.00:CARDIAC DEFIBRILLATOR IMPLANT W/O CARDIAC CATH W/O MCC,,,4481.0,4481.0,1 MS-DRG,228,MS-DRG 32.00:OTHER CARDIOTHORACIC PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,228,MS-DRG 42.00: OTHER CARDIOTHORACIC PROCEDURES WITH MCC,,,4481.0,70687.17,10 MS-DRG,228,OTHER CARDIOTHORACIC PROCEDURES WITH MCC,,,4481.0,90888.69,18 MS-DRG,229,MS-DRG 32.00:OTHER CARDIOTHORACIC PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,229,MS-DRG 42.00: OTHER CARDIOTHORACIC PROCEDURES WITHOUT MCC,,,4481.0,33056.2,10 MS-DRG,229,OTHER CARDIOTHORACIC PROCEDURES WITHOUT MCC,,,4481.0,57859.46,18 MS-DRG,230,MS-DRG 32.00:OTHER CARDIOTHORACIC PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,231,CORONARY BYPASS WITH PTCA WITH MCC,,,4481.0,154865.69,19 MS-DRG,231,MS-DRG 32.00:CORONARY BYPASS W PTCA W MCC,,,4481.0,4481.0,1 MS-DRG,231,MS-DRG 42.00: CORONARY BYPASS WITH PTCA WITH MCC,,,4481.0,69675.04,10 MS-DRG,232,CORONARY BYPASS WITH PTCA WITHOUT MCC,,,4481.0,128489.0,19 MS-DRG,232,MS-DRG 32.00:CORONARY BYPASS W PTCA W/O MCC,,,4481.0,4481.0,1 MS-DRG,232,MS-DRG 42.00: CORONARY BYPASS WITH PTCA WITHOUT MCC,,,4481.0,49159.51,10 MS-DRG,233,CORONARY BYPASS WITH CARDIAC CATHETERIZATION OR OPEN ABLATION WITH MCC,,,4481.0,140449.97,19 MS-DRG,233,MS-DRG 32.00:CORONARY BYPASS W CARDIAC CATH W MCC,,,4481.0,4481.0,1 MS-DRG,233,MS-DRG 42.00: CORONARY BYPASS WITH CARDIAC CATHETERIZATION OR OPEN ABLATION WITH MCC,,,4481.0,63886.97,10 MS-DRG,234,CORONARY BYPASS WITH CARDIAC CATHETERIZATION OR OPEN ABLATION WITHOUT MCC,,,4481.0,105306.0,19 MS-DRG,234,MS-DRG 32.00:CORONARY BYPASS W CARDIAC CATH W/O MCC,,,4481.0,4481.0,1 MS-DRG,234,MS-DRG 42.00: CORONARY BYPASS WITH CARDIAC CATHETERIZATION OR OPEN ABLATION WITHOUT MCC,,,4481.0,48738.31,10 MS-DRG,235,CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MCC,,,4481.0,107812.05,19 MS-DRG,235,MS-DRG 32.00:CORONARY BYPASS W/O CARDIAC CATH W MCC,,,4481.0,4481.0,1 MS-DRG,235,MS-DRG 42.00: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MCC,,,4481.0,45846.52,10 MS-DRG,236,CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MCC,,,4481.0,89542.0,19 MS-DRG,236,MS-DRG 32.00:CORONARY BYPASS W/O CARDIAC CATH W/O MCC,,,4481.0,4481.0,1 MS-DRG,236,MS-DRG 42.00: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MCC,,,4481.0,36784.99,10 MS-DRG,237,MS-DRG 32.00:MAJOR CARDIOVASC PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,238,MS-DRG 32.00:MAJOR CARDIOVASC PROCEDURES W/O MCC,,,4481.0,4481.0,1 MS-DRG,239,AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH MCC,,,4481.0,90416.55,18 MS-DRG,239,MS-DRG 32.00:AMPUTATION FOR CIRC SYS DISORDERS EXC UPPER LIMB & TOE W MCC,,,4481.0,4481.0,1 MS-DRG,239,MS-DRG 42.00: AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH MCC,,,4481.0,40820.92,10 MS-DRG,240,AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH CC,,,4481.0,52366.54,18 MS-DRG,240,MS-DRG 32.00:AMPUTATION FOR CIRC SYS DISORDERS EXC UPPER LIMB & TOE W CC,,,4481.0,4481.0,1 MS-DRG,240,MS-DRG 42.00: AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH CC,,,4481.0,28879.27,10 MS-DRG,241,AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITHOUT CC/MCC,,,4481.0,25432.81,18 MS-DRG,241,MS-DRG 32.00:AMPUTATION FOR CIRC SYS DISORDERS EXC UPPER LIMB & TOE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,241,MS-DRG 42.00: AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITHOUT CC/MCC,,,4481.0,10903.48,10 MS-DRG,242,MS-DRG 32.00:PERMANENT CARDIAC PACEMAKER IMPLANT W MCC,,,4481.0,4481.0,1 MS-DRG,242,MS-DRG 42.00: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MCC,,,4481.0,24609.84,10 MS-DRG,242,PERMANENT CARDIAC PACEMAKER IMPLANT WITH MCC,,,4481.0,74600.0,19 MS-DRG,243,MS-DRG 32.00:PERMANENT CARDIAC PACEMAKER IMPLANT W CC,,,4481.0,4481.0,1 MS-DRG,243,MS-DRG 42.00: PERMANENT CARDIAC PACEMAKER IMPLANT WITH CC,,,4481.0,21670.45,10 MS-DRG,243,PERMANENT CARDIAC PACEMAKER IMPLANT WITH CC,,,4481.0,74600.0,19 MS-DRG,244,MS-DRG 32.00:PERMANENT CARDIAC PACEMAKER IMPLANT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,244,MS-DRG 42.00: PERMANENT CARDIAC PACEMAKER IMPLANT WITHOUT CC/MCC,,,4481.0,16904.39,10 MS-DRG,244,PERMANENT CARDIAC PACEMAKER IMPLANT WITHOUT CC/MCC,,,4481.0,48341.0,19 MS-DRG,245,AICD GENERATOR PROCEDURES,,,4481.0,83815.85,19 MS-DRG,245,MS-DRG 32.00:AICD GENERATOR PROCEDURES,,,4481.0,4481.0,1 MS-DRG,245,MS-DRG 42.00: AICD GENERATOR PROCEDURES,,,4481.0,35526.79,10 MS-DRG,246,MS-DRG 32.00:PERC CARDIOVASC PROC W DRUG-ELUTING STENT W MCC OR 4+ VESSELS/STENTS,,,4481.0,4481.0,1 MS-DRG,247,MS-DRG 32.00:PERC CARDIOVASC PROC W DRUG-ELUTING STENT W/O MCC,,,4481.0,4481.0,1 MS-DRG,248,MS-DRG 32.00:PERC CARDIOVASC PROC W NON-DRUG-ELUTING STENT W MCC OR 4+ VES/STENTS,,,4481.0,4481.0,1 MS-DRG,249,MS-DRG 32.00:PERC CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MCC,,,4481.0,4481.0,1 MS-DRG,250,MS-DRG 32.00:PERC CARDIOVASC PROC W/O CORONARY ARTERY STENT W MCC,,,4481.0,4481.0,1 MS-DRG,250,MS-DRG 42.00: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITHOUT INTRALUMINAL DEVICE WITH MCC,,,4481.0,15023.83,10 MS-DRG,250,PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITHOUT INTRALUMINAL DEVICE WITH MCC,,,4481.0,40094.71,19 MS-DRG,251,MS-DRG 32.00:PERC CARDIOVASC PROC W/O CORONARY ARTERY STENT W/O MCC,,,4481.0,4481.0,1 MS-DRG,251,MS-DRG 42.00: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITHOUT INTRALUMINAL DEVICE WITHOUT MCC,,,4481.0,14404.16,10 MS-DRG,251,PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITHOUT INTRALUMINAL DEVICE WITHOUT MCC,,,4481.0,37364.0,19 MS-DRG,252,MS-DRG 32.00:OTHER VASCULAR PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,252,MS-DRG 42.00: OTHER VASCULAR PROCEDURES WITH MCC,,,4481.0,37477.4,10 MS-DRG,252,OTHER VASCULAR PROCEDURES WITH MCC,,,4481.0,64083.56,18 MS-DRG,253,MS-DRG 32.00:OTHER VASCULAR PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,253,MS-DRG 42.00: OTHER VASCULAR PROCEDURES WITH CC,,,4481.0,24640.37,10 MS-DRG,253,OTHER VASCULAR PROCEDURES WITH CC,,,4481.0,47683.77,18 MS-DRG,254,MS-DRG 32.00:OTHER VASCULAR PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,254,MS-DRG 42.00: OTHER VASCULAR PROCEDURES WITHOUT CC/MCC,,,4481.0,16766.09,10 MS-DRG,254,OTHER VASCULAR PROCEDURES WITHOUT CC/MCC,,,4481.0,32731.61,18 MS-DRG,255,MS-DRG 32.00:UPPER LIMB & TOE AMPUTATION FOR CIRC SYSTEM DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,255,MS-DRG 42.00: UPPER LIMB AND TOE AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS WITH MCC,,,4481.0,14315.25,10 MS-DRG,255,UPPER LIMB AND TOE AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS WITH MCC,,,4481.0,49553.94,18 MS-DRG,256,MS-DRG 32.00:UPPER LIMB & TOE AMPUTATION FOR CIRC SYSTEM DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,256,MS-DRG 42.00: UPPER LIMB AND TOE AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS WITH CC,,,4481.0,9311.2,10 MS-DRG,256,UPPER LIMB AND TOE AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS WITH CC,,,4481.0,31192.12,18 MS-DRG,257,MS-DRG 32.00:UPPER LIMB & TOE AMPUTATION FOR CIRC SYSTEM DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,257,MS-DRG 42.00: UPPER LIMB AND TOE AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS WITHOUT CC/MCC,,,4481.0,9311.2,10 MS-DRG,257,UPPER LIMB AND TOE AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS WITHOUT CC/MCC,,,4481.0,20064.81,18 MS-DRG,258,CARDIAC PACEMAKER DEVICE REPLACEMENT WITH MCC,,,4481.0,57723.52,19 MS-DRG,258,MS-DRG 32.00:CARDIAC PACEMAKER DEVICE REPLACEMENT W MCC,,,4481.0,4481.0,1 MS-DRG,258,MS-DRG 42.00: CARDIAC PACEMAKER DEVICE REPLACEMENT WITH MCC,,,4481.0,28784.07,10 MS-DRG,259,CARDIAC PACEMAKER DEVICE REPLACEMENT WITHOUT MCC,,,4481.0,40063.0,19 MS-DRG,259,MS-DRG 32.00:CARDIAC PACEMAKER DEVICE REPLACEMENT W/O MCC,,,4481.0,4481.0,1 MS-DRG,259,MS-DRG 42.00: CARDIAC PACEMAKER DEVICE REPLACEMENT WITHOUT MCC,,,4481.0,17917.41,10 MS-DRG,260,CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT WITH MCC,,,4481.0,59757.19,19 MS-DRG,260,MS-DRG 32.00:CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT W MCC,,,4481.0,4481.0,1 MS-DRG,260,MS-DRG 42.00: CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT WITH MCC,,,4481.0,23648.01,10 MS-DRG,261,CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT WITH CC,,,4481.0,37419.0,19 MS-DRG,261,MS-DRG 32.00:CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT W CC,,,4481.0,4481.0,1 MS-DRG,261,MS-DRG 42.00: CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT WITH CC,,,4481.0,18765.19,10 MS-DRG,262,CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT WITHOUT CC/MCC,,,4481.0,37419.0,19 MS-DRG,262,MS-DRG 32.00:CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,262,MS-DRG 42.00: CARDIAC PACEMAKER REVISION EXCEPT DEVICE REPLACEMENT WITHOUT CC/MCC,,,4481.0,11568.05,10 MS-DRG,263,MS-DRG 32.00:VEIN LIGATION & STRIPPING,,,4481.0,4481.0,1 MS-DRG,263,MS-DRG 42.00: VEIN LIGATION AND STRIPPING,,,4481.0,29144.2,10 MS-DRG,263,VEIN LIGATION AND STRIPPING,,,4481.0,56167.5,18 MS-DRG,264,MS-DRG 32.00:OTHER CIRCULATORY SYSTEM O.R. PROCEDURES,,,4481.0,4481.0,1 MS-DRG,264,MS-DRG 42.00: OTHER CIRCULATORY SYSTEM O.R. PROCEDURES,,,4481.0,41972.25,10 MS-DRG,264,OTHER CIRCULATORY SYSTEM O.R. PROCEDURES,,,4481.0,61370.16,18 MS-DRG,265,AICD LEAD PROCEDURES,,,4481.0,66469.95,18 MS-DRG,265,MS-DRG 32.00:AICD LEAD PROCEDURES,,,4481.0,4481.0,1 MS-DRG,265,MS-DRG 42.00: AICD LEAD PROCEDURES,,,4481.0,27768.36,10 MS-DRG,266,ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH MCC,,,4481.0,112584.84,18 MS-DRG,266,MS-DRG 32.00:ENDOVASCULAR CARDIAC VALVE REPLACEMENT W MCC,,,4481.0,4481.0,1 MS-DRG,266,MS-DRG 42.00: ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH MCC,,,4481.0,59931.87,10 MS-DRG,267,ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC,,,4481.0,87460.66,18 MS-DRG,267,MS-DRG 32.00:ENDOVASCULAR CARDIAC VALVE REPLACEMENT W/O MCC,,,4481.0,4481.0,1 MS-DRG,267,MS-DRG 42.00: ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC,,,4481.0,40385.35,10 MS-DRG,268,AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON WITH MCC,,,4481.0,126353.9,18 MS-DRG,268,MS-DRG 42.00: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON WITH MCC,,,4481.0,50961.04,10 MS-DRG,269,AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON WITHOUT MCC,,,4481.0,77584.41,18 MS-DRG,269,MS-DRG 42.00: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON WITHOUT MCC,,,4481.0,29108.28,10 MS-DRG,270,MS-DRG 42.00: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH MCC,,,4481.0,54928.72,10 MS-DRG,270,OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH MCC,,,4481.0,96930.91,18 MS-DRG,271,MS-DRG 42.00: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH CC,,,4481.0,34228.18,10 MS-DRG,271,OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH CC,,,4481.0,65332.79,18 MS-DRG,272,MS-DRG 42.00: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC,,,4481.0,26954.7,10 MS-DRG,272,OTHER MAJOR CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC,,,4481.0,46901.16,18 MS-DRG,273,MS-DRG 42.00: PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITH MCC,,,4481.0,31322.02,10 MS-DRG,273,PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITH MCC,,,4481.0,75789.56,19 MS-DRG,274,MS-DRG 42.00: PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC,,,4481.0,27796.2,10 MS-DRG,274,PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC,,,4481.0,60471.82,19 MS-DRG,275,CARDIAC DEFIBRILLATOR IMPLANT WITH CARDIAC CATHETERIZATION AND MCC,,,4481.0,148177.0,19 MS-DRG,275,MS-DRG 42.00: CARDIAC DEFIBRILLATOR IMPLANT WITH CARDIAC CATHETERIZATION AND MCC,,,4481.0,68566.82,10 MS-DRG,276,CARDIAC DEFIBRILLATOR IMPLANT WITH MCC OR CAROTID SINUS NEUROSTIMULATOR,,,4481.0,110347.25,19 MS-DRG,276,MS-DRG 42.00: CARDIAC DEFIBRILLATOR IMPLANT WITH MCC OR CAROTID SINUS NEUROSTIMULATOR,,,4481.0,51735.18,10 MS-DRG,277,CARDIAC DEFIBRILLATOR IMPLANT WITHOUT MCC,,,4481.0,114048.0,19 MS-DRG,277,MS-DRG 42.00: CARDIAC DEFIBRILLATOR IMPLANT WITHOUT MCC,,,4481.0,42571.26,10 MS-DRG,278,MS-DRG 42.00: ULTRASOUND ACCELERATED AND OTHER THROMBOLYSIS OF PERIPHERAL VASCULAR STRUCTURES WITH MCC,,,4481.0,37551.94,10 MS-DRG,278,ULTRASOUND ACCELERATED AND OTHER THROMBOLYSIS OF PERIPHERAL VASCULAR STRUCTURES WITH MCC,,,4481.0,102256.66,18 MS-DRG,279,MS-DRG 42.00: ULTRASOUND ACCELERATED AND OTHER THROMBOLYSIS OF PERIPHERAL VASCULAR STRUCTURES WITHOUT MCC,,,4481.0,28462.56,10 MS-DRG,279,ULTRASOUND ACCELERATED AND OTHER THROMBOLYSIS OF PERIPHERAL VASCULAR STRUCTURES WITHOUT MCC,,,4481.0,66253.17,18 MS-DRG,280,"ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC",,,4481.0,29468.92,18 MS-DRG,280,"MS-DRG 32.00:ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W MCC",,,4481.0,4481.0,1 MS-DRG,280,"MS-DRG 42.00: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC",,,4481.0,15515.07,10 MS-DRG,281,"ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH CC",,,4481.0,16884.79,18 MS-DRG,281,"MS-DRG 32.00:ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W CC",,,4481.0,4481.0,1 MS-DRG,281,"MS-DRG 42.00: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH CC",,,4481.0,9973.98,10 MS-DRG,282,"ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITHOUT CC/MCC",,,4481.0,13284.07,18 MS-DRG,282,"MS-DRG 32.00:ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,282,"MS-DRG 42.00: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITHOUT CC/MCC",,,4481.0,7763.82,10 MS-DRG,283,"ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH MCC",,,4481.0,36389.28,18 MS-DRG,283,"MS-DRG 32.00:ACUTE MYOCARDIAL INFARCTION, EXPIRED W MCC",,,4481.0,4481.0,1 MS-DRG,283,"MS-DRG 42.00: ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH MCC",,,4481.0,12453.55,10 MS-DRG,284,"ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH CC",,,4481.0,12716.41,18 MS-DRG,284,"MS-DRG 32.00:ACUTE MYOCARDIAL INFARCTION, EXPIRED W CC",,,4481.0,4481.0,1 MS-DRG,284,"MS-DRG 42.00: ACUTE MYOCARDIAL INFARCTION, EXPIRED WITH CC",,,4481.0,5943.43,10 MS-DRG,285,"ACUTE MYOCARDIAL INFARCTION, EXPIRED WITHOUT CC/MCC",,,4481.0,11002.39,18 MS-DRG,285,"MS-DRG 32.00:ACUTE MYOCARDIAL INFARCTION, EXPIRED W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,285,"MS-DRG 42.00: ACUTE MYOCARDIAL INFARCTION, EXPIRED WITHOUT CC/MCC",,,4481.0,5943.43,10 MS-DRG,286,"CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITH MCC",,,4481.0,40651.35,19 MS-DRG,286,"MS-DRG 32.00:CIRCULATORY DISORDERS EXCEPT AMI, W CARD CATH W MCC",,,4481.0,4481.0,1 MS-DRG,286,"MS-DRG 42.00: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITH MCC",,,4481.0,24854.11,10 MS-DRG,287,"CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITHOUT MCC",,,4481.0,30115.0,19 MS-DRG,287,"MS-DRG 32.00:CIRCULATORY DISORDERS EXCEPT AMI, W CARD CATH W/O MCC",,,4481.0,4481.0,1 MS-DRG,287,"MS-DRG 42.00: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITHOUT MCC",,,4481.0,11266.3,10 MS-DRG,288,ACUTE AND SUBACUTE ENDOCARDITIS WITH MCC,,,4481.0,49715.6,18 MS-DRG,288,MS-DRG 32.00:ACUTE & SUBACUTE ENDOCARDITIS W MCC,,,4481.0,4481.0,1 MS-DRG,288,MS-DRG 42.00: ACUTE AND SUBACUTE ENDOCARDITIS WITH MCC,,,4481.0,18760.7,10 MS-DRG,289,ACUTE AND SUBACUTE ENDOCARDITIS WITH CC,,,4481.0,31357.46,18 MS-DRG,289,MS-DRG 32.00:ACUTE & SUBACUTE ENDOCARDITIS W CC,,,4481.0,4481.0,1 MS-DRG,289,MS-DRG 42.00: ACUTE AND SUBACUTE ENDOCARDITIS WITH CC,,,4481.0,13963.21,10 MS-DRG,290,ACUTE AND SUBACUTE ENDOCARDITIS WITHOUT CC/MCC,,,4481.0,17079.52,18 MS-DRG,290,MS-DRG 32.00:ACUTE & SUBACUTE ENDOCARDITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,290,MS-DRG 42.00: ACUTE AND SUBACUTE ENDOCARDITIS WITHOUT CC/MCC,,,4481.0,10638.55,10 MS-DRG,291,HEART FAILURE AND SHOCK WITH MCC,,,4481.0,23584.69,18 MS-DRG,291,MS-DRG 32.00:HEART FAILURE & SHOCK W MCC,,,4481.0,4481.0,1 MS-DRG,291,MS-DRG 42.00: HEART FAILURE AND SHOCK WITH MCC,,,4481.0,13406.4,10 MS-DRG,292,HEART FAILURE AND SHOCK WITH CC,,,4481.0,15596.98,18 MS-DRG,292,MS-DRG 32.00:HEART FAILURE & SHOCK W CC,,,4481.0,4481.0,1 MS-DRG,292,MS-DRG 42.00: HEART FAILURE AND SHOCK WITH CC,,,4481.0,11227.68,10 MS-DRG,293,HEART FAILURE AND SHOCK WITHOUT CC/MCC,,,4481.0,10397.99,18 MS-DRG,293,MS-DRG 32.00:HEART FAILURE & SHOCK W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,293,MS-DRG 42.00: HEART FAILURE AND SHOCK WITHOUT CC/MCC,,,3991.62,4481.0,10 MS-DRG,294,MS-DRG 32.00:DEEP VEIN THROMBOPHLEBITIS W CC/MCC,,,4481.0,4481.0,1 MS-DRG,294,MS-DRG 42.00: DEEP VEIN THROMBOPHLEBITIS WITH CC/MCC,,,4481.0,13343.54,10 MS-DRG,295,MS-DRG 32.00:DEEP VEIN THROMBOPHLEBITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,295,MS-DRG 42.00: DEEP VEIN THROMBOPHLEBITIS WITHOUT CC/MCC,,,4481.0,8582.86,10 MS-DRG,296,"CARDIAC ARREST, UNEXPLAINED WITH MCC",,,4481.0,28693.66,18 MS-DRG,296,"MS-DRG 32.00:CARDIAC ARREST, UNEXPLAINED W MCC",,,4481.0,4481.0,1 MS-DRG,296,"MS-DRG 42.00: CARDIAC ARREST, UNEXPLAINED WITH MCC",,,4481.0,16445.48,10 MS-DRG,297,"CARDIAC ARREST, UNEXPLAINED WITH CC",,,4481.0,11454.32,18 MS-DRG,297,"MS-DRG 32.00:CARDIAC ARREST, UNEXPLAINED W CC",,,4481.0,4481.0,1 MS-DRG,297,"MS-DRG 42.00: CARDIAC ARREST, UNEXPLAINED WITH CC",,,4481.0,7654.26,10 MS-DRG,298,"CARDIAC ARREST, UNEXPLAINED WITHOUT CC/MCC",,,4088.62,9078.23,18 MS-DRG,298,"MS-DRG 32.00:CARDIAC ARREST, UNEXPLAINED W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,298,"MS-DRG 42.00: CARDIAC ARREST, UNEXPLAINED WITHOUT CC/MCC",,,4481.0,4799.29,10 MS-DRG,299,MS-DRG 32.00:PERIPHERAL VASCULAR DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,299,MS-DRG 42.00: PERIPHERAL VASCULAR DISORDERS WITH MCC,,,4481.0,11357.01,10 MS-DRG,299,PERIPHERAL VASCULAR DISORDERS WITH MCC,,,4481.0,29994.33,18 MS-DRG,300,MS-DRG 32.00:PERIPHERAL VASCULAR DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,300,MS-DRG 42.00: PERIPHERAL VASCULAR DISORDERS WITH CC,,,4481.0,11357.01,10 MS-DRG,300,PERIPHERAL VASCULAR DISORDERS WITH CC,,,4481.0,19611.04,18 MS-DRG,301,MS-DRG 32.00:PERIPHERAL VASCULAR DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,301,MS-DRG 42.00: PERIPHERAL VASCULAR DISORDERS WITHOUT CC/MCC,,,4481.0,6334.99,10 MS-DRG,301,PERIPHERAL VASCULAR DISORDERS WITHOUT CC/MCC,,,4481.0,13221.61,18 MS-DRG,302,ATHEROSCLEROSIS WITH MCC,,,4481.0,21982.74,18 MS-DRG,302,MS-DRG 32.00:ATHEROSCLEROSIS W MCC,,,4481.0,4481.0,1 MS-DRG,302,MS-DRG 42.00: ATHEROSCLEROSIS WITH MCC,,,4481.0,7066.92,10 MS-DRG,303,ATHEROSCLEROSIS WITHOUT MCC,,,4481.0,12367.36,18 MS-DRG,303,MS-DRG 32.00:ATHEROSCLEROSIS W/O MCC,,,4481.0,4481.0,1 MS-DRG,303,MS-DRG 42.00: ATHEROSCLEROSIS WITHOUT MCC,,,4481.0,6204.77,10 MS-DRG,304,HYPERTENSION WITH MCC,,,4481.0,21861.49,18 MS-DRG,304,MS-DRG 32.00:HYPERTENSION W MCC,,,4481.0,4481.0,1 MS-DRG,304,MS-DRG 42.00: HYPERTENSION WITH MCC,,,4481.0,12585.57,10 MS-DRG,305,HYPERTENSION WITHOUT MCC,,,4481.0,13871.94,18 MS-DRG,305,MS-DRG 32.00:HYPERTENSION W/O MCC,,,4481.0,4481.0,1 MS-DRG,305,MS-DRG 42.00: HYPERTENSION WITHOUT MCC,,,4481.0,7903.02,10 MS-DRG,306,CARDIAC CONGENITAL AND VALVULAR DISORDERS WITH MCC,,,4481.0,28949.02,18 MS-DRG,306,MS-DRG 32.00:CARDIAC CONGENITAL & VALVULAR DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,306,MS-DRG 42.00: CARDIAC CONGENITAL AND VALVULAR DISORDERS WITH MCC,,,4481.0,10863.07,10 MS-DRG,307,CARDIAC CONGENITAL AND VALVULAR DISORDERS WITHOUT MCC,,,4481.0,16776.4,18 MS-DRG,307,MS-DRG 32.00:CARDIAC CONGENITAL & VALVULAR DISORDERS W/O MCC,,,4481.0,4481.0,1 MS-DRG,307,MS-DRG 42.00: CARDIAC CONGENITAL AND VALVULAR DISORDERS WITHOUT MCC,,,4481.0,5843.75,10 MS-DRG,308,CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MCC,,,4481.0,22118.68,18 MS-DRG,308,MS-DRG 32.00:CARDIAC ARRHYTHMIA & CONDUCTION DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,308,MS-DRG 42.00: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MCC,,,4481.0,16762.5,10 MS-DRG,309,CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC,,,4481.0,13515.54,18 MS-DRG,309,MS-DRG 32.00:CARDIAC ARRHYTHMIA & CONDUCTION DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,309,MS-DRG 42.00: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC,,,4481.0,8304.46,10 MS-DRG,310,CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC,,,4481.0,10399.82,18 MS-DRG,310,MS-DRG 32.00:CARDIAC ARRHYTHMIA & CONDUCTION DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,310,MS-DRG 42.00: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC,,,4481.0,5566.24,10 MS-DRG,311,ANGINA PECTORIS,,,4481.0,12894.6,18 MS-DRG,311,MS-DRG 32.00:ANGINA PECTORIS,,,4481.0,4481.0,1 MS-DRG,311,MS-DRG 42.00: ANGINA PECTORIS,,,4481.0,5124.39,10 MS-DRG,312,MS-DRG 32.00:SYNCOPE & COLLAPSE,,,4481.0,4481.0,1 MS-DRG,312,MS-DRG 42.00: SYNCOPE AND COLLAPSE,,,4481.0,7954.21,10 MS-DRG,312,SYNCOPE AND COLLAPSE,,,4481.0,16012.16,18 MS-DRG,313,CHEST PAIN,,,4481.0,13227.12,18 MS-DRG,313,MS-DRG 32.00:CHEST PAIN,,,4481.0,4481.0,1 MS-DRG,313,MS-DRG 42.00: CHEST PAIN,,,4481.0,7522.24,10 MS-DRG,314,MS-DRG 32.00:OTHER CIRCULATORY SYSTEM DIAGNOSES W MCC,,,4481.0,4481.0,1 MS-DRG,314,MS-DRG 42.00: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MCC,,,4481.0,23992.86,10 MS-DRG,314,OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MCC,,,4481.0,38307.21,18 MS-DRG,315,MS-DRG 32.00:OTHER CIRCULATORY SYSTEM DIAGNOSES W CC,,,4481.0,4481.0,1 MS-DRG,315,MS-DRG 42.00: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH CC,,,4481.0,13573.45,10 MS-DRG,315,OTHER CIRCULATORY SYSTEM DIAGNOSES WITH CC,,,4481.0,17696.78,18 MS-DRG,316,MS-DRG 32.00:OTHER CIRCULATORY SYSTEM DIAGNOSES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,316,MS-DRG 42.00: OTHER CIRCULATORY SYSTEM DIAGNOSES WITHOUT CC/MCC,,,4481.0,7530.33,10 MS-DRG,316,OTHER CIRCULATORY SYSTEM DIAGNOSES WITHOUT CC/MCC,,,4481.0,12530.86,18 MS-DRG,317,CONCOMITANT LEFT ATRIAL APPENDAGE CLOSURE AND CARDIAC ABLATION,,,4481.0,122837.69,18 MS-DRG,317,MS-DRG 42.00: CONCOMITANT LEFT ATRIAL APPENDAGE CLOSURE AND CARDIAC ABLATION,,,4481.0,67223.31,10 MS-DRG,318,PERCUTANEOUS CORONARY ATHERECTOMY WITHOUT INTRALUMINAL DEVICE,,,4481.0,44498.24,18 MS-DRG,319,MS-DRG 42.00: OTHER ENDOVASCULAR CARDIAC VALVE PROCEDURES WITH MCC,,,4481.0,31403.75,10 MS-DRG,319,OTHER ENDOVASCULAR CARDIAC VALVE PROCEDURES WITH MCC,,,4481.0,81987.94,18 MS-DRG,320,MS-DRG 42.00: OTHER ENDOVASCULAR CARDIAC VALVE PROCEDURES WITHOUT MCC,,,4481.0,25152.27,10 MS-DRG,320,OTHER ENDOVASCULAR CARDIAC VALVE PROCEDURES WITHOUT MCC,,,4481.0,44187.77,18 MS-DRG,321,MS-DRG 42.00: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITH MCC OR 4+ ARTERIES/INTRALUMINAL DEVICES,,,4481.0,27844.69,10 MS-DRG,321,PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITH MCC OR 4+ ARTERIES/INTRALUMINAL DEVICES,,,4481.0,66396.0,19 MS-DRG,322,MS-DRG 42.00: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITHOUT MCC,,,4481.0,16729.27,10 MS-DRG,322,PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITHOUT MCC,,,4481.0,55371.0,19 MS-DRG,323,CORONARY INTRAVASCULAR LITHOTRIPSY WITH INTRALUMINAL DEVICE WITH MCC,,,4481.0,79498.67,18 MS-DRG,323,MS-DRG 42.00: CORONARY INTRAVASCULAR LITHOTRIPSY WITH INTRALUMINAL DEVICE WITH MCC,,,4481.0,34587.41,10 MS-DRG,324,CORONARY INTRAVASCULAR LITHOTRIPSY WITH INTRALUMINAL DEVICE WITHOUT MCC,,,4481.0,57887.02,18 MS-DRG,324,MS-DRG 42.00: CORONARY INTRAVASCULAR LITHOTRIPSY WITH INTRALUMINAL DEVICE WITHOUT MCC,,,4481.0,31581.56,10 MS-DRG,325,CORONARY INTRAVASCULAR LITHOTRIPSY WITHOUT INTRALUMINAL DEVICE,,,4481.0,58978.26,18 MS-DRG,325,MS-DRG 42.00: CORONARY INTRAVASCULAR LITHOTRIPSY WITHOUT INTRALUMINAL DEVICE,,,4481.0,26063.82,10 MS-DRG,326,"MS-DRG 32.00:STOMACH, ESOPHAGEAL & DUODENAL PROC W MCC",,,4481.0,4481.0,1 MS-DRG,326,"MS-DRG 42.00: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MCC",,,4481.0,41547.46,10 MS-DRG,326,"STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MCC",,,4481.0,91623.53,18 MS-DRG,327,"MS-DRG 32.00:STOMACH, ESOPHAGEAL & DUODENAL PROC W CC",,,4481.0,4481.0,1 MS-DRG,327,"MS-DRG 42.00: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH CC",,,4481.0,19376.78,10 MS-DRG,327,"STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH CC",,,4481.0,44902.4,18 MS-DRG,328,"MS-DRG 32.00:STOMACH, ESOPHAGEAL & DUODENAL PROC W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,328,"MS-DRG 42.00: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITHOUT CC/MCC",,,4481.0,9381.25,10 MS-DRG,328,"STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITHOUT CC/MCC",,,4481.0,29435.85,18 MS-DRG,329,MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC,,,4481.0,84442.3,18 MS-DRG,329,MS-DRG 32.00:MAJOR SMALL & LARGE BOWEL PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,329,MS-DRG 42.00: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC,,,4481.0,47811.5,10 MS-DRG,330,MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC,,,4481.0,44038.96,18 MS-DRG,330,MS-DRG 32.00:MAJOR SMALL & LARGE BOWEL PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,330,MS-DRG 42.00: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC,,,4481.0,21022.94,10 MS-DRG,331,MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC,,,4481.0,30916.56,18 MS-DRG,331,MS-DRG 32.00:MAJOR SMALL & LARGE BOWEL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,331,MS-DRG 42.00: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC,,,4481.0,14502.05,10 MS-DRG,332,MS-DRG 32.00:RECTAL RESECTION W MCC,,,4481.0,4481.0,1 MS-DRG,332,MS-DRG 42.00: RECTAL RESECTION WITH MCC,,,4481.0,37692.04,10 MS-DRG,332,RECTAL RESECTION WITH MCC,,,4481.0,66515.88,18 MS-DRG,333,MS-DRG 32.00:RECTAL RESECTION W CC,,,4481.0,4481.0,1 MS-DRG,333,MS-DRG 42.00: RECTAL RESECTION WITH CC,,,4481.0,18372.74,10 MS-DRG,333,RECTAL RESECTION WITH CC,,,4481.0,43028.56,18 MS-DRG,334,MS-DRG 32.00:RECTAL RESECTION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,334,MS-DRG 42.00: RECTAL RESECTION WITHOUT CC/MCC,,,4481.0,18372.74,10 MS-DRG,334,RECTAL RESECTION WITHOUT CC/MCC,,,4481.0,30089.86,18 MS-DRG,335,MS-DRG 32.00:PERITONEAL ADHESIOLYSIS W MCC,,,4481.0,4481.0,1 MS-DRG,335,MS-DRG 42.00: PERITONEAL ADHESIOLYSIS WITH MCC,,,4481.0,22706.83,10 MS-DRG,335,PERITONEAL ADHESIOLYSIS WITH MCC,,,4481.0,65601.0,18 MS-DRG,336,MS-DRG 32.00:PERITONEAL ADHESIOLYSIS W CC,,,4481.0,4481.0,1 MS-DRG,336,MS-DRG 42.00: PERITONEAL ADHESIOLYSIS WITH CC,,,4481.0,19330.98,10 MS-DRG,336,PERITONEAL ADHESIOLYSIS WITH CC,,,4481.0,38738.93,18 MS-DRG,337,MS-DRG 32.00:PERITONEAL ADHESIOLYSIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,337,MS-DRG 42.00: PERITONEAL ADHESIOLYSIS WITHOUT CC/MCC,,,4481.0,11686.6,10 MS-DRG,337,PERITONEAL ADHESIOLYSIS WITHOUT CC/MCC,,,4481.0,28199.49,18 MS-DRG,338,MS-DRG 32.00:APPENDECTOMY W COMPLICATED PRINCIPAL DIAG W MCC,,,4481.0,4481.0,1 MS-DRG,339,MS-DRG 32.00:APPENDECTOMY W COMPLICATED PRINCIPAL DIAG W CC,,,4481.0,4481.0,1 MS-DRG,340,MS-DRG 32.00:APPENDECTOMY W COMPLICATED PRINCIPAL DIAG W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,341,MS-DRG 32.00:APPENDECTOMY W/O COMPLICATED PRINCIPAL DIAG W MCC,,,4481.0,4481.0,1 MS-DRG,342,MS-DRG 32.00:APPENDECTOMY W/O COMPLICATED PRINCIPAL DIAG W CC,,,4481.0,4481.0,1 MS-DRG,343,MS-DRG 32.00:APPENDECTOMY W/O COMPLICATED PRINCIPAL DIAG W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,344,MINOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC,,,4481.0,47448.62,18 MS-DRG,344,MS-DRG 32.00:MINOR SMALL & LARGE BOWEL PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,344,MS-DRG 42.00: MINOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC,,,4481.0,17048.98,10 MS-DRG,345,MINOR SMALL AND LARGE BOWEL PROCEDURES WITH CC,,,4481.0,27642.84,18 MS-DRG,345,MS-DRG 32.00:MINOR SMALL & LARGE BOWEL PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,345,MS-DRG 42.00: MINOR SMALL AND LARGE BOWEL PROCEDURES WITH CC,,,4481.0,13026.52,10 MS-DRG,346,MINOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC,,,4481.0,21791.68,18 MS-DRG,346,MS-DRG 32.00:MINOR SMALL & LARGE BOWEL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,346,MS-DRG 42.00: MINOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC,,,4481.0,13026.52,10 MS-DRG,347,ANAL AND STOMAL PROCEDURES WITH MCC,,,4481.0,42172.47,18 MS-DRG,347,MS-DRG 32.00:ANAL & STOMAL PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,347,MS-DRG 42.00: ANAL AND STOMAL PROCEDURES WITH MCC,,,4481.0,16618.8,10 MS-DRG,348,ANAL AND STOMAL PROCEDURES WITH CC,,,4481.0,24043.96,18 MS-DRG,348,MS-DRG 32.00:ANAL & STOMAL PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,348,MS-DRG 42.00: ANAL AND STOMAL PROCEDURES WITH CC,,,4481.0,9256.42,10 MS-DRG,349,ANAL AND STOMAL PROCEDURES WITHOUT CC/MCC,,,4481.0,15993.79,18 MS-DRG,349,MS-DRG 32.00:ANAL & STOMAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,349,MS-DRG 42.00: ANAL AND STOMAL PROCEDURES WITHOUT CC/MCC,,,4481.0,7663.24,10 MS-DRG,350,INGUINAL AND FEMORAL HERNIA PROCEDURES WITH MCC,,,4481.0,45778.69,18 MS-DRG,350,MS-DRG 32.00:INGUINAL & FEMORAL HERNIA PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,350,MS-DRG 42.00: INGUINAL AND FEMORAL HERNIA PROCEDURES WITH MCC,,,4481.0,17558.19,10 MS-DRG,351,INGUINAL AND FEMORAL HERNIA PROCEDURES WITH CC,,,4481.0,28006.59,18 MS-DRG,351,MS-DRG 32.00:INGUINAL & FEMORAL HERNIA PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,351,MS-DRG 42.00: INGUINAL AND FEMORAL HERNIA PROCEDURES WITH CC,,,4481.0,12062.89,10 MS-DRG,352,INGUINAL AND FEMORAL HERNIA PROCEDURES WITHOUT CC/MCC,,,4481.0,21453.65,18 MS-DRG,352,MS-DRG 32.00:INGUINAL & FEMORAL HERNIA PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,352,MS-DRG 42.00: INGUINAL AND FEMORAL HERNIA PROCEDURES WITHOUT CC/MCC,,,4481.0,7503.38,10 MS-DRG,353,HERNIA PROCEDURES EXCEPT INGUINAL AND FEMORAL WITH MCC,,,4481.0,53312.64,18 MS-DRG,353,MS-DRG 32.00:HERNIA PROCEDURES EXCEPT INGUINAL & FEMORAL W MCC,,,4481.0,4481.0,1 MS-DRG,353,MS-DRG 42.00: HERNIA PROCEDURES EXCEPT INGUINAL AND FEMORAL WITH MCC,,,4481.0,19058.86,10 MS-DRG,354,HERNIA PROCEDURES EXCEPT INGUINAL AND FEMORAL WITH CC,,,4481.0,30907.37,18 MS-DRG,354,MS-DRG 32.00:HERNIA PROCEDURES EXCEPT INGUINAL & FEMORAL W CC,,,4481.0,4481.0,1 MS-DRG,354,MS-DRG 42.00: HERNIA PROCEDURES EXCEPT INGUINAL AND FEMORAL WITH CC,,,4481.0,11919.2,10 MS-DRG,355,HERNIA PROCEDURES EXCEPT INGUINAL AND FEMORAL WITHOUT CC/MCC,,,4481.0,24708.99,18 MS-DRG,355,MS-DRG 32.00:HERNIA PROCEDURES EXCEPT INGUINAL & FEMORAL W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,355,MS-DRG 42.00: HERNIA PROCEDURES EXCEPT INGUINAL AND FEMORAL WITHOUT CC/MCC,,,4481.0,11919.2,10 MS-DRG,356,MS-DRG 32.00:OTHER DIGESTIVE SYSTEM O.R. PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,356,MS-DRG 42.00: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH MCC,,,4481.0,44755.37,10 MS-DRG,356,OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH MCC,,,4481.0,80700.13,18 MS-DRG,357,MS-DRG 32.00:OTHER DIGESTIVE SYSTEM O.R. PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,357,MS-DRG 42.00: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH CC,,,4481.0,18591.87,10 MS-DRG,357,OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH CC,,,4481.0,42721.76,18 MS-DRG,358,MS-DRG 32.00:OTHER DIGESTIVE SYSTEM O.R. PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,358,MS-DRG 42.00: OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,10577.48,10 MS-DRG,358,OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,25680.82,18 MS-DRG,359,PERCUTANEOUS CORONARY ATHERECTOMY WITH INTRALUMINAL DEVICE WITH MCC,,,4481.0,63170.52,18 MS-DRG,360,PERCUTANEOUS CORONARY ATHERECTOMY WITH INTRALUMINAL DEVICE WITHOUT MCC,,,4481.0,44353.11,18 MS-DRG,368,MAJOR ESOPHAGEAL DISORDERS WITH MCC,,,4481.0,29244.79,18 MS-DRG,368,MS-DRG 32.00:MAJOR ESOPHAGEAL DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,368,MS-DRG 42.00: MAJOR ESOPHAGEAL DISORDERS WITH MCC,,,4481.0,16889.12,10 MS-DRG,369,MAJOR ESOPHAGEAL DISORDERS WITH CC,,,4481.0,18374.67,18 MS-DRG,369,MS-DRG 32.00:MAJOR ESOPHAGEAL DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,369,MS-DRG 42.00: MAJOR ESOPHAGEAL DISORDERS WITH CC,,,4481.0,7218.69,10 MS-DRG,370,MAJOR ESOPHAGEAL DISORDERS WITHOUT CC/MCC,,,4481.0,12874.4,18 MS-DRG,370,MS-DRG 32.00:MAJOR ESOPHAGEAL DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,370,MS-DRG 42.00: MAJOR ESOPHAGEAL DISORDERS WITHOUT CC/MCC,,,4481.0,5819.5,10 MS-DRG,371,MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MCC,,,4481.0,32573.62,18 MS-DRG,371,MS-DRG 32.00:MAJOR GASTROINTESTINAL DISORDERS & PERITONEAL INFECTIONS W MCC,,,4481.0,4481.0,1 MS-DRG,371,MS-DRG 42.00: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MCC,,,4481.0,14269.45,10 MS-DRG,372,MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH CC,,,4481.0,18756.79,18 MS-DRG,372,MS-DRG 32.00:MAJOR GASTROINTESTINAL DISORDERS & PERITONEAL INFECTIONS W CC,,,4481.0,4481.0,1 MS-DRG,372,MS-DRG 42.00: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH CC,,,4481.0,9276.18,10 MS-DRG,373,MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITHOUT CC/MCC,,,4481.0,13363.07,18 MS-DRG,373,MS-DRG 32.00:MAJOR GASTROINTESTINAL DISORDERS & PERITONEAL INFECTIONS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,373,MS-DRG 42.00: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITHOUT CC/MCC,,,4481.0,6334.99,10 MS-DRG,374,DIGESTIVE MALIGNANCY WITH MCC,,,4481.0,39290.06,18 MS-DRG,374,MS-DRG 32.00:DIGESTIVE MALIGNANCY W MCC,,,4481.0,4481.0,1 MS-DRG,374,MS-DRG 42.00: DIGESTIVE MALIGNANCY WITH MCC,,,4481.0,21851.86,10 MS-DRG,375,DIGESTIVE MALIGNANCY WITH CC,,,4481.0,22221.56,18 MS-DRG,375,MS-DRG 32.00:DIGESTIVE MALIGNANCY W CC,,,4481.0,4481.0,1 MS-DRG,375,MS-DRG 42.00: DIGESTIVE MALIGNANCY WITH CC,,,4481.0,11168.41,10 MS-DRG,376,DIGESTIVE MALIGNANCY WITHOUT CC/MCC,,,4481.0,16980.32,18 MS-DRG,376,MS-DRG 32.00:DIGESTIVE MALIGNANCY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,376,MS-DRG 42.00: DIGESTIVE MALIGNANCY WITHOUT CC/MCC,,,4481.0,7464.77,10 MS-DRG,377,GASTROINTESTINAL HEMORRHAGE WITH MCC,,,4481.0,33582.19,18 MS-DRG,377,MS-DRG 32.00:G.I. HEMORRHAGE W MCC,,,4481.0,4481.0,1 MS-DRG,377,MS-DRG 42.00: GASTROINTESTINAL HEMORRHAGE WITH MCC,,,4481.0,18038.65,10 MS-DRG,378,GASTROINTESTINAL HEMORRHAGE WITH CC,,,4481.0,18016.44,18 MS-DRG,378,MS-DRG 32.00:G.I. HEMORRHAGE W CC,,,4481.0,4481.0,1 MS-DRG,378,MS-DRG 42.00: GASTROINTESTINAL HEMORRHAGE WITH CC,,,4481.0,10451.75,10 MS-DRG,379,GASTROINTESTINAL HEMORRHAGE WITHOUT CC/MCC,,,4481.0,11581.08,18 MS-DRG,379,MS-DRG 32.00:G.I. HEMORRHAGE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,379,MS-DRG 42.00: GASTROINTESTINAL HEMORRHAGE WITHOUT CC/MCC,,,4481.0,7154.03,10 MS-DRG,380,COMPLICATED PEPTIC ULCER WITH MCC,,,4481.0,36047.58,18 MS-DRG,380,MS-DRG 32.00:COMPLICATED PEPTIC ULCER W MCC,,,4481.0,4481.0,1 MS-DRG,380,MS-DRG 42.00: COMPLICATED PEPTIC ULCER WITH MCC,,,4481.0,11705.46,10 MS-DRG,381,COMPLICATED PEPTIC ULCER WITH CC,,,4481.0,19904.98,18 MS-DRG,381,MS-DRG 32.00:COMPLICATED PEPTIC ULCER W CC,,,4481.0,4481.0,1 MS-DRG,381,MS-DRG 42.00: COMPLICATED PEPTIC ULCER WITH CC,,,4481.0,11101.95,10 MS-DRG,382,COMPLICATED PEPTIC ULCER WITHOUT CC/MCC,,,4481.0,14707.82,18 MS-DRG,382,MS-DRG 32.00:COMPLICATED PEPTIC ULCER W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,382,MS-DRG 42.00: COMPLICATED PEPTIC ULCER WITHOUT CC/MCC,,,4481.0,5855.42,10 MS-DRG,383,MS-DRG 32.00:UNCOMPLICATED PEPTIC ULCER W MCC,,,4481.0,4481.0,1 MS-DRG,383,MS-DRG 42.00: UNCOMPLICATED PEPTIC ULCER WITH MCC,,,4481.0,8251.48,10 MS-DRG,383,UNCOMPLICATED PEPTIC ULCER WITH MCC,,,4481.0,25364.84,18 MS-DRG,384,MS-DRG 32.00:UNCOMPLICATED PEPTIC ULCER W/O MCC,,,4481.0,4481.0,1 MS-DRG,384,MS-DRG 42.00: UNCOMPLICATED PEPTIC ULCER WITHOUT MCC,,,4481.0,6865.75,10 MS-DRG,384,UNCOMPLICATED PEPTIC ULCER WITHOUT MCC,,,4481.0,15703.53,18 MS-DRG,385,INFLAMMATORY BOWEL DISEASE WITH MCC,,,4481.0,29068.43,18 MS-DRG,385,MS-DRG 32.00:INFLAMMATORY BOWEL DISEASE W MCC,,,4481.0,4481.0,1 MS-DRG,385,MS-DRG 42.00: INFLAMMATORY BOWEL DISEASE WITH MCC,,,4481.0,13885.08,10 MS-DRG,386,INFLAMMATORY BOWEL DISEASE WITH CC,,,4481.0,17935.61,18 MS-DRG,386,MS-DRG 32.00:INFLAMMATORY BOWEL DISEASE W CC,,,4481.0,4481.0,1 MS-DRG,386,MS-DRG 42.00: INFLAMMATORY BOWEL DISEASE WITH CC,,,4481.0,8584.66,10 MS-DRG,387,INFLAMMATORY BOWEL DISEASE WITHOUT CC/MCC,,,4481.0,12516.16,18 MS-DRG,387,MS-DRG 32.00:INFLAMMATORY BOWEL DISEASE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,387,MS-DRG 42.00: INFLAMMATORY BOWEL DISEASE WITHOUT CC/MCC,,,4481.0,7786.28,10 MS-DRG,388,GASTROINTESTINAL OBSTRUCTION WITH MCC,,,4481.0,27130.29,18 MS-DRG,388,MS-DRG 32.00:G.I. OBSTRUCTION W MCC,,,4481.0,4481.0,1 MS-DRG,388,MS-DRG 42.00: GASTROINTESTINAL OBSTRUCTION WITH MCC,,,4481.0,13506.99,10 MS-DRG,389,GASTROINTESTINAL OBSTRUCTION WITH CC,,,4481.0,14509.42,18 MS-DRG,389,MS-DRG 32.00:G.I. OBSTRUCTION W CC,,,4481.0,4481.0,1 MS-DRG,389,MS-DRG 42.00: GASTROINTESTINAL OBSTRUCTION WITH CC,,,4481.0,6277.52,10 MS-DRG,390,GASTROINTESTINAL OBSTRUCTION WITHOUT CC/MCC,,,4481.0,9993.82,18 MS-DRG,390,MS-DRG 32.00:G.I. OBSTRUCTION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,390,MS-DRG 42.00: GASTROINTESTINAL OBSTRUCTION WITHOUT CC/MCC,,,4481.0,5246.53,10 MS-DRG,391,"ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MCC",,,4481.0,23299.94,18 MS-DRG,391,"MS-DRG 32.00:ESOPHAGITIS, GASTROENT & MISC DIGEST DISORDERS W MCC",,,4481.0,4481.0,1 MS-DRG,391,"MS-DRG 42.00: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MCC",,,4481.0,11797.06,10 MS-DRG,392,"ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC",,,4481.0,14322.03,18 MS-DRG,392,"MS-DRG 32.00:ESOPHAGITIS, GASTROENT & MISC DIGEST DISORDERS W/O MCC",,,4481.0,4481.0,1 MS-DRG,392,"MS-DRG 42.00: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC",,,4481.0,6934.9,10 MS-DRG,393,MS-DRG 32.00:OTHER DIGESTIVE SYSTEM DIAGNOSES W MCC,,,4481.0,4481.0,1 MS-DRG,393,MS-DRG 42.00: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MCC,,,4481.0,10439.18,10 MS-DRG,393,OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MCC,,,4481.0,29380.74,18 MS-DRG,394,MS-DRG 32.00:OTHER DIGESTIVE SYSTEM DIAGNOSES W CC,,,4481.0,4481.0,1 MS-DRG,394,MS-DRG 42.00: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH CC,,,4481.0,9910.21,10 MS-DRG,394,OTHER DIGESTIVE SYSTEM DIAGNOSES WITH CC,,,4481.0,17189.74,18 MS-DRG,395,MS-DRG 32.00:OTHER DIGESTIVE SYSTEM DIAGNOSES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,395,MS-DRG 42.00: OTHER DIGESTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC,,,4481.0,5814.11,10 MS-DRG,395,OTHER DIGESTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC,,,4481.0,11922.78,18 MS-DRG,397,APPENDIX PROCEDURES WITH MCC,,,4481.0,43996.71,18 MS-DRG,397,MS-DRG 42.00: APPENDIX PROCEDURES WITH MCC,,,4481.0,14793.03,10 MS-DRG,398,APPENDIX PROCEDURES WITH CC,,,4481.0,27806.35,18 MS-DRG,398,MS-DRG 42.00: APPENDIX PROCEDURES WITH CC,,,4481.0,13878.79,10 MS-DRG,399,APPENDIX PROCEDURES WITHOUT CC/MCC,,,4481.0,21029.28,18 MS-DRG,399,MS-DRG 42.00: APPENDIX PROCEDURES WITHOUT CC/MCC,,,4481.0,9318.38,10 MS-DRG,402,MS-DRG 42.00: SINGLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL,,,4481.0,33287.0,10 MS-DRG,402,SINGLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL,,,4481.0,73860.61,18 MS-DRG,405,"MS-DRG 32.00:PANCREAS, LIVER & SHUNT PROCEDURES W MCC",,,4481.0,4481.0,1 MS-DRG,405,"MS-DRG 42.00: PANCREAS, LIVER AND SHUNT PROCEDURES WITH MCC",,,4481.0,39195.41,10 MS-DRG,405,"PANCREAS, LIVER AND SHUNT PROCEDURES WITH MCC",,,4481.0,100498.56,18 MS-DRG,406,"MS-DRG 32.00:PANCREAS, LIVER & SHUNT PROCEDURES W CC",,,4481.0,4481.0,1 MS-DRG,406,"MS-DRG 42.00: PANCREAS, LIVER AND SHUNT PROCEDURES WITH CC",,,4481.0,25668.67,10 MS-DRG,406,"PANCREAS, LIVER AND SHUNT PROCEDURES WITH CC",,,4481.0,53279.57,18 MS-DRG,407,"MS-DRG 32.00:PANCREAS, LIVER & SHUNT PROCEDURES W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,407,"MS-DRG 42.00: PANCREAS, LIVER AND SHUNT PROCEDURES WITHOUT CC/MCC",,,4481.0,21722.54,10 MS-DRG,407,"PANCREAS, LIVER AND SHUNT PROCEDURES WITHOUT CC/MCC",,,4481.0,40776.27,18 MS-DRG,408,BILIARY TRACT PROCEDURES EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITH MCC,,,4481.0,65503.64,18 MS-DRG,408,MS-DRG 32.00:BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O C.D.E. W MCC,,,4481.0,4481.0,1 MS-DRG,408,MS-DRG 42.00: BILIARY TRACT PROCEDURES EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITH MCC,,,4481.0,26399.7,10 MS-DRG,409,BILIARY TRACT PROCEDURES EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITH CC,,,4481.0,39999.18,18 MS-DRG,409,MS-DRG 32.00:BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O C.D.E. W CC,,,4481.0,4481.0,1 MS-DRG,409,MS-DRG 42.00: BILIARY TRACT PROCEDURES EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITH CC,,,4481.0,17762.05,10 MS-DRG,410,BILIARY TRACT PROCEDURES EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITHOUT CC/MCC,,,4481.0,29167.64,18 MS-DRG,410,MS-DRG 32.00:BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O C.D.E. W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,410,MS-DRG 42.00: BILIARY TRACT PROCEDURES EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITHOUT CC/MCC,,,4481.0,17762.05,10 MS-DRG,411,CHOLECYSTECTOMY WITH C.D.E. WITH MCC,,,4481.0,60684.92,18 MS-DRG,411,MS-DRG 32.00:CHOLECYSTECTOMY W C.D.E. W MCC,,,4481.0,4481.0,1 MS-DRG,411,MS-DRG 42.00: CHOLECYSTECTOMY WITH C.D.E. WITH MCC,,,4481.0,28638.59,10 MS-DRG,412,CHOLECYSTECTOMY WITH C.D.E. WITH CC,,,4481.0,38625.03,18 MS-DRG,412,MS-DRG 32.00:CHOLECYSTECTOMY W C.D.E. W CC,,,4481.0,4481.0,1 MS-DRG,412,MS-DRG 42.00: CHOLECYSTECTOMY WITH C.D.E. WITH CC,,,4481.0,17544.72,10 MS-DRG,413,CHOLECYSTECTOMY WITH C.D.E. WITHOUT CC/MCC,,,4481.0,30505.05,18 MS-DRG,413,MS-DRG 32.00:CHOLECYSTECTOMY W C.D.E. W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,413,MS-DRG 42.00: CHOLECYSTECTOMY WITH C.D.E. WITHOUT CC/MCC,,,4481.0,17544.72,10 MS-DRG,414,CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITH MCC,,,4481.0,65448.52,18 MS-DRG,414,MS-DRG 32.00:CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE W/O C.D.E. W MCC,,,4481.0,4481.0,1 MS-DRG,414,MS-DRG 42.00: CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITH MCC,,,4481.0,22933.14,10 MS-DRG,415,CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITH CC,,,4481.0,37967.35,18 MS-DRG,415,MS-DRG 32.00:CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE W/O C.D.E. W CC,,,4481.0,4481.0,1 MS-DRG,415,MS-DRG 42.00: CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITH CC,,,4481.0,17364.2,10 MS-DRG,416,CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITHOUT CC/MCC,,,4481.0,25045.18,18 MS-DRG,416,MS-DRG 32.00:CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE W/O C.D.E. W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,416,MS-DRG 42.00: CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITHOUT CC/MCC,,,4481.0,11180.98,10 MS-DRG,417,LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH MCC,,,4481.0,43840.55,18 MS-DRG,417,MS-DRG 32.00:LAPAROSCOPIC CHOLECYSTECTOMY W/O C.D.E. W MCC,,,4481.0,4481.0,1 MS-DRG,417,MS-DRG 42.00: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH MCC,,,4481.0,19218.72,10 MS-DRG,418,LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH CC,,,4481.0,31076.38,18 MS-DRG,418,MS-DRG 32.00:LAPAROSCOPIC CHOLECYSTECTOMY W/O C.D.E. W CC,,,4481.0,4481.0,1 MS-DRG,418,MS-DRG 42.00: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH CC,,,4481.0,13820.41,10 MS-DRG,419,LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITHOUT CC/MCC,,,4481.0,25091.11,18 MS-DRG,419,MS-DRG 32.00:LAPAROSCOPIC CHOLECYSTECTOMY W/O C.D.E. W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,419,MS-DRG 42.00: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITHOUT CC/MCC,,,4481.0,12208.38,10 MS-DRG,420,HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH MCC,,,4481.0,62591.83,18 MS-DRG,420,MS-DRG 32.00:HEPATOBILIARY DIAGNOSTIC PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,420,MS-DRG 42.00: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH MCC,,,4481.0,21450.43,10 MS-DRG,421,HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH CC,,,4481.0,31919.61,18 MS-DRG,421,MS-DRG 32.00:HEPATOBILIARY DIAGNOSTIC PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,421,MS-DRG 42.00: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH CC,,,4481.0,13416.28,10 MS-DRG,422,HEPATOBILIARY DIAGNOSTIC PROCEDURES WITHOUT CC/MCC,,,4481.0,25710.21,18 MS-DRG,422,MS-DRG 32.00:HEPATOBILIARY DIAGNOSTIC PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,422,MS-DRG 42.00: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITHOUT CC/MCC,,,4481.0,10374.52,10 MS-DRG,423,MS-DRG 32.00:OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,423,MS-DRG 42.00: OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITH MCC,,,4481.0,28780.48,10 MS-DRG,423,OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITH MCC,,,4481.0,76294.76,18 MS-DRG,424,MS-DRG 32.00:OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,424,MS-DRG 42.00: OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITH CC,,,4481.0,16580.19,10 MS-DRG,424,OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITH CC,,,4481.0,40193.91,18 MS-DRG,425,MS-DRG 32.00:OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,425,MS-DRG 42.00: OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,16580.19,10 MS-DRG,425,OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,27562.01,18 MS-DRG,426,MS-DRG 42.00: MULTIPLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL WITH MCC OR CUSTOM-MADE ANATOMICALLY DESIGNED INTERBODY FUSION DEVICE,,,4481.0,71283.49,10 MS-DRG,426,MULTIPLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL WITH MCC OR CUSTOM-MADE ANATOMICALLY DESIGNED INTERBODY FUSION DEVICE,,,4481.0,202470.47,18 MS-DRG,427,MS-DRG 42.00: MULTIPLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL WITH CC,,,4481.0,55594.19,10 MS-DRG,427,MULTIPLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL WITH CC,,,4481.0,132612.9,18 MS-DRG,428,MS-DRG 42.00: MULTIPLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL WITHOUT CC/MCC,,,4481.0,43745.04,10 MS-DRG,428,MULTIPLE LEVEL COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION EXCEPT CERVICAL WITHOUT CC/MCC,,,4481.0,103281.76,18 MS-DRG,429,COMBINED ANTERIOR AND POSTERIOR CERVICAL SPINAL FUSION WITH MCC,,,4481.0,165515.36,18 MS-DRG,429,MS-DRG 42.00: COMBINED ANTERIOR AND POSTERIOR CERVICAL SPINAL FUSION WITH MCC,,,4481.0,90630.63,10 MS-DRG,430,COMBINED ANTERIOR AND POSTERIOR CERVICAL SPINAL FUSION WITHOUT MCC,,,4481.0,105947.39,18 MS-DRG,430,MS-DRG 42.00: COMBINED ANTERIOR AND POSTERIOR CERVICAL SPINAL FUSION WITHOUT MCC,,,4481.0,41949.79,10 MS-DRG,432,CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MCC,,,4481.0,36157.8,18 MS-DRG,432,MS-DRG 32.00:CIRRHOSIS & ALCOHOLIC HEPATITIS W MCC,,,4481.0,4481.0,1 MS-DRG,432,MS-DRG 42.00: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MCC,,,4481.0,20713.11,10 MS-DRG,433,CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH CC,,,4481.0,19403.45,18 MS-DRG,433,MS-DRG 32.00:CIRRHOSIS & ALCOHOLIC HEPATITIS W CC,,,4481.0,4481.0,1 MS-DRG,433,MS-DRG 42.00: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH CC,,,4481.0,10032.35,10 MS-DRG,434,CIRRHOSIS AND ALCOHOLIC HEPATITIS WITHOUT CC/MCC,,,4481.0,13089.34,18 MS-DRG,434,MS-DRG 32.00:CIRRHOSIS & ALCOHOLIC HEPATITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,434,MS-DRG 42.00: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITHOUT CC/MCC,,,4481.0,5127.99,10 MS-DRG,435,MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC,,,4481.0,33742.02,18 MS-DRG,435,MS-DRG 32.00:MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS W MCC,,,4481.0,4481.0,1 MS-DRG,435,MS-DRG 42.00: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC,,,4481.0,17272.6,10 MS-DRG,436,MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC,,,4481.0,20779.44,18 MS-DRG,436,MS-DRG 32.00:MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS W CC,,,4481.0,4481.0,1 MS-DRG,436,MS-DRG 42.00: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC,,,4481.0,8240.7,10 MS-DRG,437,MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC,,,4481.0,15675.97,18 MS-DRG,437,MS-DRG 32.00:MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,437,MS-DRG 42.00: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC,,,4481.0,8055.7,10 MS-DRG,438,DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH MCC,,,4481.0,29948.4,18 MS-DRG,438,MS-DRG 32.00:DISORDERS OF PANCREAS EXCEPT MALIGNANCY W MCC,,,4481.0,4481.0,1 MS-DRG,438,MS-DRG 42.00: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH MCC,,,4481.0,15515.07,10 MS-DRG,439,DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH CC,,,4481.0,15453.69,18 MS-DRG,439,MS-DRG 32.00:DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC,,,4481.0,4481.0,1 MS-DRG,439,MS-DRG 42.00: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH CC,,,4481.0,8188.61,10 MS-DRG,440,DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC,,,4481.0,11415.74,18 MS-DRG,440,MS-DRG 32.00:DISORDERS OF PANCREAS EXCEPT MALIGNANCY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,440,MS-DRG 42.00: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC,,,4481.0,6560.41,10 MS-DRG,441,"DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MCC",,,4481.0,32970.43,18 MS-DRG,441,"MS-DRG 32.00:DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W MCC",,,4481.0,4481.0,1 MS-DRG,441,"MS-DRG 42.00: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MCC",,,4481.0,19227.7,10 MS-DRG,442,"DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH CC",,,4481.0,17733.53,18 MS-DRG,442,"MS-DRG 32.00:DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC",,,4481.0,4481.0,1 MS-DRG,442,"MS-DRG 42.00: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH CC",,,4481.0,9858.13,10 MS-DRG,443,"DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITHOUT CC/MCC",,,4481.0,12854.19,18 MS-DRG,443,"MS-DRG 32.00:DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,443,"MS-DRG 42.00: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITHOUT CC/MCC",,,4481.0,7308.5,10 MS-DRG,444,DISORDERS OF THE BILIARY TRACT WITH MCC,,,4481.0,30696.1,18 MS-DRG,444,MS-DRG 32.00:DISORDERS OF THE BILIARY TRACT W MCC,,,4481.0,4481.0,1 MS-DRG,444,MS-DRG 42.00: DISORDERS OF THE BILIARY TRACT WITH MCC,,,4481.0,15809.64,10 MS-DRG,445,DISORDERS OF THE BILIARY TRACT WITH CC,,,4481.0,20105.22,18 MS-DRG,445,MS-DRG 32.00:DISORDERS OF THE BILIARY TRACT W CC,,,4481.0,4481.0,1 MS-DRG,445,MS-DRG 42.00: DISORDERS OF THE BILIARY TRACT WITH CC,,,4481.0,10835.23,10 MS-DRG,446,DISORDERS OF THE BILIARY TRACT WITHOUT CC/MCC,,,4481.0,15198.33,18 MS-DRG,446,MS-DRG 32.00:DISORDERS OF THE BILIARY TRACT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,446,MS-DRG 42.00: DISORDERS OF THE BILIARY TRACT WITHOUT CC/MCC,,,4481.0,6644.83,10 MS-DRG,447,MS-DRG 42.00: MULTIPLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITH MCC OR CUSTOM-MADE ANATOMICALLY DESIGNED INTERBODY FUSION DEVICE,,,4481.0,52285.69,10 MS-DRG,447,MULTIPLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITH MCC OR CUSTOM-MADE ANATOMICALLY DESIGNED INTERBODY FUSION DEVICE,,,4481.0,122747.67,18 MS-DRG,448,MS-DRG 42.00: MULTIPLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITHOUT MCC,,,4481.0,39049.03,10 MS-DRG,448,MULTIPLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITHOUT MCC,,,4481.0,77907.74,18 MS-DRG,450,MS-DRG 42.00: SINGLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITH MCC OR CUSTOM-MADE ANATOMICALLY DESIGNED INTERBODY FUSION DEVICE,,,4481.0,55962.4,10 MS-DRG,450,SINGLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITH MCC OR CUSTOM-MADE ANATOMICALLY DESIGNED INTERBODY FUSION DEVICE,,,4481.0,97910.08,18 MS-DRG,451,MS-DRG 42.00: SINGLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITHOUT MCC,,,4481.0,32619.73,10 MS-DRG,451,SINGLE LEVEL SPINAL FUSION EXCEPT CERVICAL WITHOUT MCC,,,4481.0,59345.68,18 MS-DRG,453,MS-DRG 32.00:COMBINED ANTERIOR/POSTERIOR SPINAL FUSION W MCC,,,4481.0,4481.0,1 MS-DRG,454,MS-DRG 32.00:COMBINED ANTERIOR/POSTERIOR SPINAL FUSION W CC,,,4481.0,4481.0,1 MS-DRG,455,MS-DRG 32.00:COMBINED ANTERIOR/POSTERIOR SPINAL FUSION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,456,MS-DRG 32.00:SPINAL FUS EXC CERV W SPINAL CURV/MALIG/INFEC OR 9+ FUS W MCC,,,4481.0,4481.0,1 MS-DRG,456,"MS-DRG 42.00: SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE, MALIGNANCY, INFECTION OR EXTENSIVE FUSIONS WITH MCC",,,4481.0,68440.19,10 MS-DRG,456,"SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE, MALIGNANCY, INFECTION OR EXTENSIVE FUSIONS WITH MCC",,,4481.0,154378.86,18 MS-DRG,457,MS-DRG 32.00:SPINAL FUS EXC CERV W SPINAL CURV/MALIG/INFEC OR 9+ FUS W CC,,,4481.0,4481.0,1 MS-DRG,457,"MS-DRG 42.00: SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE, MALIGNANCY, INFECTION OR EXTENSIVE FUSIONS WITH CC",,,4481.0,56294.68,10 MS-DRG,457,"SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE, MALIGNANCY, INFECTION OR EXTENSIVE FUSIONS WITH CC",,,4481.0,109548.11,18 MS-DRG,458,MS-DRG 32.00:SPINAL FUS EXC CERV W SPINAL CURV/MALIG/INFEC OR 9+ FUS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,458,"MS-DRG 42.00: SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE, MALIGNANCY, INFECTION OR EXTENSIVE FUSIONS WITHOUT CC/MCC",,,4481.0,39657.02,10 MS-DRG,458,"SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE, MALIGNANCY, INFECTION OR EXTENSIVE FUSIONS WITHOUT CC/MCC",,,4481.0,76654.83,18 MS-DRG,459,MS-DRG 32.00:SPINAL FUSION EXCEPT CERVICAL W MCC,,,4481.0,4481.0,1 MS-DRG,460,MS-DRG 32.00:SPINAL FUSION EXCEPT CERVICAL W/O MCC,,,4481.0,4481.0,1 MS-DRG,461,BILATERAL OR MULTIPLE MAJOR JOINT PROCEDURES OF LOWER EXTREMITY WITH MCC,,,4481.0,98479.58,18 MS-DRG,461,MS-DRG 32.00:BILATERAL OR MULTIPLE MAJOR JOINT PROCS OF LOWER EXTREMITY W MCC,,,4481.0,4481.0,1 MS-DRG,461,MS-DRG 42.00: BILATERAL OR MULTIPLE MAJOR JOINT PROCEDURES OF LOWER EXTREMITY WITH MCC,,,4481.0,66688.06,10 MS-DRG,462,BILATERAL OR MULTIPLE MAJOR JOINT PROCEDURES OF LOWER EXTREMITY WITHOUT MCC,,,4481.0,48866.86,18 MS-DRG,462,MS-DRG 32.00:BILATERAL OR MULTIPLE MAJOR JOINT PROCS OF LOWER EXTREMITY W/O MCC,,,4481.0,4481.0,1 MS-DRG,462,MS-DRG 42.00: BILATERAL OR MULTIPLE MAJOR JOINT PROCEDURES OF LOWER EXTREMITY WITHOUT MCC,,,4481.0,29992.88,10 MS-DRG,463,"MS-DRG 32.00:WND DEBRID & SKN GRFT EXC HAND, FOR MUSCULO-CONN TISS DIS W MCC",,,4481.0,4481.0,1 MS-DRG,463,MS-DRG 42.00: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS WITH MCC,,,4481.0,45670.5,10 MS-DRG,463,WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS WITH MCC,,,4481.0,104705.51,18 MS-DRG,464,"MS-DRG 32.00:WND DEBRID & SKN GRFT EXC HAND, FOR MUSCULO-CONN TISS DIS W CC",,,4481.0,4481.0,1 MS-DRG,464,MS-DRG 42.00: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS WITH CC,,,4481.0,25363.32,10 MS-DRG,464,WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS WITH CC,,,4481.0,57220.15,18 MS-DRG,465,"MS-DRG 32.00:WND DEBRID & SKN GRFT EXC HAND, FOR MUSCULO-CONN TISS DIS W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,465,MS-DRG 42.00: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC,,,4481.0,16267.66,10 MS-DRG,465,WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC,,,4481.0,33503.19,18 MS-DRG,466,MS-DRG 32.00:REVISION OF HIP OR KNEE REPLACEMENT W MCC,,,4481.0,4481.0,1 MS-DRG,466,MS-DRG 42.00: REVISION OF HIP OR KNEE REPLACEMENT WITH MCC,,,4481.0,34987.95,10 MS-DRG,466,REVISION OF HIP OR KNEE REPLACEMENT WITH MCC,,,4481.0,95628.4,19 MS-DRG,467,MS-DRG 32.00:REVISION OF HIP OR KNEE REPLACEMENT W CC,,,4481.0,4481.0,1 MS-DRG,467,MS-DRG 42.00: REVISION OF HIP OR KNEE REPLACEMENT WITH CC,,,4481.0,31175.64,10 MS-DRG,467,REVISION OF HIP OR KNEE REPLACEMENT WITH CC,,,4481.0,64787.17,19 MS-DRG,468,MS-DRG 32.00:REVISION OF HIP OR KNEE REPLACEMENT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,468,MS-DRG 42.00: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT CC/MCC,,,4481.0,29093.91,10 MS-DRG,468,REVISION OF HIP OR KNEE REPLACEMENT WITHOUT CC/MCC,,,4481.0,50483.51,19 MS-DRG,469,MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MCC OR TOTAL ANKLE REPLACEMENT,,,4481.0,55722.92,19 MS-DRG,469,MS-DRG 32.00:MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY W MCC,,,4481.0,4481.0,1 MS-DRG,469,MS-DRG 42.00: MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MCC OR TOTAL ANKLE REPLACEMENT,,,4481.0,30889.15,10 MS-DRG,470,MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC,,,4481.0,69457.76,19 MS-DRG,470,MS-DRG 32.00:MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY W/O MCC,,,4481.0,4481.0,1 MS-DRG,470,MS-DRG 42.00: MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC,,,4481.0,19679.43,10 MS-DRG,471,CERVICAL SPINAL FUSION WITH MCC,,,4481.0,88708.05,18 MS-DRG,471,MS-DRG 32.00:CERVICAL SPINAL FUSION W MCC,,,4481.0,4481.0,1 MS-DRG,471,MS-DRG 42.00: CERVICAL SPINAL FUSION WITH MCC,,,4481.0,32562.26,10 MS-DRG,472,CERVICAL SPINAL FUSION WITH CC,,,4481.0,54122.8,18 MS-DRG,472,MS-DRG 32.00:CERVICAL SPINAL FUSION W CC,,,4481.0,4481.0,1 MS-DRG,472,MS-DRG 42.00: CERVICAL SPINAL FUSION WITH CC,,,4481.0,26490.4,10 MS-DRG,473,CERVICAL SPINAL FUSION WITHOUT CC/MCC,,,4481.0,44849.12,18 MS-DRG,473,MS-DRG 32.00:CERVICAL SPINAL FUSION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,473,MS-DRG 42.00: CERVICAL SPINAL FUSION WITHOUT CC/MCC,,,4481.0,21582.44,10 MS-DRG,474,AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH MCC,,,4481.0,78864.87,18 MS-DRG,474,MS-DRG 32.00:AMPUTATION FOR MUSCULOSKELETAL SYS & CONN TISSUE DIS W MCC,,,4481.0,4481.0,1 MS-DRG,474,MS-DRG 42.00: AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH MCC,,,4481.0,21970.41,10 MS-DRG,475,AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH CC,,,4481.0,41806.88,18 MS-DRG,475,MS-DRG 32.00:AMPUTATION FOR MUSCULOSKELETAL SYS & CONN TISSUE DIS W CC,,,4481.0,4481.0,1 MS-DRG,475,MS-DRG 42.00: AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH CC,,,4481.0,18812.79,10 MS-DRG,476,AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC,,,4481.0,21681.45,18 MS-DRG,476,MS-DRG 32.00:AMPUTATION FOR MUSCULOSKELETAL SYS & CONN TISSUE DIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,476,MS-DRG 42.00: AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC,,,4481.0,11657.86,10 MS-DRG,477,BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC,,,4481.0,63464.46,18 MS-DRG,477,MS-DRG 32.00:BIOPSIES OF MUSCULOSKELETAL SYSTEM & CONNECTIVE TISSUE W MCC,,,4481.0,4481.0,1 MS-DRG,477,MS-DRG 42.00: BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC,,,4481.0,20097.93,10 MS-DRG,478,BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC,,,4481.0,45177.96,18 MS-DRG,478,MS-DRG 32.00:BIOPSIES OF MUSCULOSKELETAL SYSTEM & CONNECTIVE TISSUE W CC,,,4481.0,4481.0,1 MS-DRG,478,MS-DRG 42.00: BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC,,,4481.0,15283.37,10 MS-DRG,479,BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC,,,4481.0,34149.85,18 MS-DRG,479,MS-DRG 32.00:BIOPSIES OF MUSCULOSKELETAL SYSTEM & CONNECTIVE TISSUE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,479,MS-DRG 42.00: BIOPSIES OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC,,,4481.0,11524.05,10 MS-DRG,480,HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MCC,,,4481.0,53501.86,18 MS-DRG,480,MS-DRG 32.00:HIP & FEMUR PROCEDURES EXCEPT MAJOR JOINT W MCC,,,4481.0,4481.0,1 MS-DRG,480,MS-DRG 42.00: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MCC,,,4481.0,25427.08,10 MS-DRG,481,HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH CC,,,4481.0,38478.06,18 MS-DRG,481,MS-DRG 32.00:HIP & FEMUR PROCEDURES EXCEPT MAJOR JOINT W CC,,,4481.0,4481.0,1 MS-DRG,481,MS-DRG 42.00: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH CC,,,4481.0,18607.13,10 MS-DRG,482,HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT CC/MCC,,,4481.0,29963.1,18 MS-DRG,482,MS-DRG 32.00:HIP & FEMUR PROCEDURES EXCEPT MAJOR JOINT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,482,MS-DRG 42.00: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT CC/MCC,,,4481.0,13357.91,10 MS-DRG,483,MAJOR JOINT OR LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITIES,,,4481.0,50922.57,18 MS-DRG,483,MS-DRG 32.00:MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES,,,4481.0,4481.0,1 MS-DRG,483,MS-DRG 42.00: MAJOR JOINT OR LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITIES,,,4481.0,23599.51,10 MS-DRG,485,KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITH MCC,,,4481.0,59285.05,18 MS-DRG,485,MS-DRG 32.00:KNEE PROCEDURES W PDX OF INFECTION W MCC,,,4481.0,4481.0,1 MS-DRG,485,MS-DRG 42.00: KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITH MCC,,,4481.0,23967.72,10 MS-DRG,486,KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITH CC,,,4481.0,38415.6,18 MS-DRG,486,MS-DRG 32.00:KNEE PROCEDURES W PDX OF INFECTION W CC,,,4481.0,4481.0,1 MS-DRG,486,MS-DRG 42.00: KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITH CC,,,4481.0,23163.05,10 MS-DRG,487,KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITHOUT CC/MCC,,,4481.0,28772.66,18 MS-DRG,487,MS-DRG 32.00:KNEE PROCEDURES W PDX OF INFECTION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,487,MS-DRG 42.00: KNEE PROCEDURES WITH PRINCIPAL DIAGNOSIS OF INFECTION WITHOUT CC/MCC,,,4481.0,12634.96,10 MS-DRG,488,KNEE PROCEDURES WITHOUT PRINCIPAL DIAGNOSIS OF INFECTION WITH CC/MCC,,,4481.0,27990.06,18 MS-DRG,488,MS-DRG 32.00:KNEE PROCEDURES W/O PDX OF INFECTION W CC/MCC,,,4481.0,4481.0,1 MS-DRG,488,MS-DRG 42.00: KNEE PROCEDURES WITHOUT PRINCIPAL DIAGNOSIS OF INFECTION WITH CC/MCC,,,4481.0,16694.24,10 MS-DRG,489,KNEE PROCEDURES WITHOUT PRINCIPAL DIAGNOSIS OF INFECTION WITHOUT CC/MCC,,,4481.0,20516.73,18 MS-DRG,489,MS-DRG 32.00:KNEE PROCEDURES W/O PDX OF INFECTION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,489,MS-DRG 42.00: KNEE PROCEDURES WITHOUT PRINCIPAL DIAGNOSIS OF INFECTION WITHOUT CC/MCC,,,4481.0,11374.97,10 MS-DRG,492,"LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH MCC",,,4481.0,67450.96,18 MS-DRG,492,"MS-DRG 32.00:LOWER EXTREM & HUMER PROC EXCEPT HIP,FOOT,FEMUR W MCC",,,4481.0,4481.0,1 MS-DRG,492,"MS-DRG 42.00: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH MCC",,,4481.0,25453.13,10 MS-DRG,493,"LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH CC",,,4481.0,46590.69,18 MS-DRG,493,"MS-DRG 32.00:LOWER EXTREM & HUMER PROC EXCEPT HIP,FOOT,FEMUR W CC",,,4481.0,4481.0,1 MS-DRG,493,"MS-DRG 42.00: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH CC",,,4481.0,19965.02,10 MS-DRG,494,"LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITHOUT CC/MCC",,,4481.0,36861.41,18 MS-DRG,494,"MS-DRG 32.00:LOWER EXTREM & HUMER PROC EXCEPT HIP,FOOT,FEMUR W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,494,"MS-DRG 42.00: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITHOUT CC/MCC",,,4481.0,13227.69,10 MS-DRG,495,LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITH MCC,,,4481.0,66607.73,18 MS-DRG,495,MS-DRG 32.00:LOCAL EXCISION & REMOVAL INT FIX DEVICES EXC HIP & FEMUR W MCC,,,4481.0,4481.0,1 MS-DRG,495,MS-DRG 42.00: LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITH MCC,,,4481.0,24819.99,10 MS-DRG,496,LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITH CC,,,4481.0,33139.45,18 MS-DRG,496,MS-DRG 32.00:LOCAL EXCISION & REMOVAL INT FIX DEVICES EXC HIP & FEMUR W CC,,,4481.0,4481.0,1 MS-DRG,496,MS-DRG 42.00: LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITH CC,,,4481.0,14846.91,10 MS-DRG,497,LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITHOUT CC/MCC,,,4481.0,21157.88,18 MS-DRG,497,MS-DRG 32.00:LOCAL EXCISION & REMOVAL INT FIX DEVICES EXC HIP & FEMUR W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,497,MS-DRG 42.00: LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES EXCEPT HIP AND FEMUR WITHOUT CC/MCC,,,4481.0,12408.65,10 MS-DRG,498,LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES OF HIP AND FEMUR WITH CC/MCC,,,4481.0,55421.63,18 MS-DRG,498,MS-DRG 32.00:LOCAL EXCISION & REMOVAL INT FIX DEVICES OF HIP & FEMUR W CC/MCC,,,4481.0,4481.0,1 MS-DRG,498,MS-DRG 42.00: LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES OF HIP AND FEMUR WITH CC/MCC,,,4481.0,15298.64,10 MS-DRG,499,LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES OF HIP AND FEMUR WITHOUT CC/MCC,,,4481.0,37013.89,18 MS-DRG,499,MS-DRG 32.00:LOCAL EXCISION & REMOVAL INT FIX DEVICES OF HIP & FEMUR W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,499,MS-DRG 42.00: LOCAL EXCISION AND REMOVAL OF INTERNAL FIXATION DEVICES OF HIP AND FEMUR WITHOUT CC/MCC,,,4481.0,11439.63,10 MS-DRG,500,MS-DRG 32.00:SOFT TISSUE PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,500,MS-DRG 42.00: SOFT TISSUE PROCEDURES WITH MCC,,,4481.0,22485.0,10 MS-DRG,500,SOFT TISSUE PROCEDURES WITH MCC,,,4481.0,58140.54,18 MS-DRG,501,MS-DRG 32.00:SOFT TISSUE PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,501,MS-DRG 42.00: SOFT TISSUE PROCEDURES WITH CC,,,4481.0,15141.48,10 MS-DRG,501,SOFT TISSUE PROCEDURES WITH CC,,,4481.0,32114.35,18 MS-DRG,502,MS-DRG 32.00:SOFT TISSUE PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,502,MS-DRG 42.00: SOFT TISSUE PROCEDURES WITHOUT CC/MCC,,,4481.0,8896.29,10 MS-DRG,502,SOFT TISSUE PROCEDURES WITHOUT CC/MCC,,,4481.0,24725.53,18 MS-DRG,503,FOOT PROCEDURES WITH MCC,,,4481.0,51275.3,18 MS-DRG,503,MS-DRG 32.00:FOOT PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,503,MS-DRG 42.00: FOOT PROCEDURES WITH MCC,,,4481.0,20160.8,10 MS-DRG,504,FOOT PROCEDURES WITH CC,,,4481.0,34339.07,18 MS-DRG,504,MS-DRG 32.00:FOOT PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,504,MS-DRG 42.00: FOOT PROCEDURES WITH CC,,,4481.0,16915.17,10 MS-DRG,505,FOOT PROCEDURES WITHOUT CC/MCC,,,4481.0,32935.53,18 MS-DRG,505,MS-DRG 32.00:FOOT PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,505,MS-DRG 42.00: FOOT PROCEDURES WITHOUT CC/MCC,,,4481.0,13109.14,10 MS-DRG,506,MAJOR THUMB OR JOINT PROCEDURES,,,4481.0,22037.85,18 MS-DRG,506,MS-DRG 32.00:MAJOR THUMB OR JOINT PROCEDURES,,,4481.0,4481.0,1 MS-DRG,506,MS-DRG 42.00: MAJOR THUMB OR JOINT PROCEDURES,,,4481.0,10947.49,10 MS-DRG,507,MAJOR SHOULDER OR ELBOW JOINT PROCEDURES WITH CC/MCC,,,4481.0,33185.37,18 MS-DRG,507,MS-DRG 32.00:MAJOR SHOULDER OR ELBOW JOINT PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,507,MS-DRG 42.00: MAJOR SHOULDER OR ELBOW JOINT PROCEDURES WITH CC/MCC,,,4481.0,13676.72,10 MS-DRG,508,MAJOR SHOULDER OR ELBOW JOINT PROCEDURES WITHOUT CC/MCC,,,4481.0,27821.04,18 MS-DRG,508,MS-DRG 32.00:MAJOR SHOULDER OR ELBOW JOINT PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,508,MS-DRG 42.00: MAJOR SHOULDER OR ELBOW JOINT PROCEDURES WITHOUT CC/MCC,,,4481.0,11037.29,10 MS-DRG,509,MS-DRG 32.00:ARTHROSCOPY,,,4481.0,4481.0,1 MS-DRG,509,MS-DRG 42.00: ARTHROSCOPY,,,4481.0,19087.6,10 MS-DRG,510,"MS-DRG 32.00:SHOULDER,ELBOW OR FOREARM PROC,EXC MAJOR JOINT PROC W MCC",,,4481.0,4481.0,1 MS-DRG,510,"MS-DRG 42.00: SHOULDER, ELBOW OR FOREARM PROCEDURES, EXCEPT MAJOR JOINT PROCEDURES WITH MCC",,,4481.0,24745.45,10 MS-DRG,510,"SHOULDER, ELBOW OR FOREARM PROCEDURES, EXCEPT MAJOR JOINT PROCEDURES WITH MCC",,,4481.0,55489.61,18 MS-DRG,511,"MS-DRG 32.00:SHOULDER,ELBOW OR FOREARM PROC,EXC MAJOR JOINT PROC W CC",,,4481.0,4481.0,1 MS-DRG,511,"MS-DRG 42.00: SHOULDER, ELBOW OR FOREARM PROCEDURES, EXCEPT MAJOR JOINT PROCEDURES WITH CC",,,4481.0,17700.08,10 MS-DRG,511,"SHOULDER, ELBOW OR FOREARM PROCEDURES, EXCEPT MAJOR JOINT PROCEDURES WITH CC",,,4481.0,38200.66,18 MS-DRG,512,"MS-DRG 32.00:SHOULDER,ELBOW OR FOREARM PROC,EXC MAJOR JOINT PROC W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,512,"MS-DRG 42.00: SHOULDER, ELBOW OR FOREARM PROCEDURES, EXCEPT MAJOR JOINT PROCEDURES WITHOUT CC/MCC",,,4481.0,10766.08,10 MS-DRG,512,"SHOULDER, ELBOW OR FOREARM PROCEDURES, EXCEPT MAJOR JOINT PROCEDURES WITHOUT CC/MCC",,,4481.0,30411.35,18 MS-DRG,513,"HAND OR WRIST PROCEDURES, EXCEPT MAJOR THUMB OR JOINT PROCEDURES WITH CC/MCC",,,4481.0,28921.47,18 MS-DRG,513,"MS-DRG 32.00:HAND OR WRIST PROC, EXCEPT MAJOR THUMB OR JOINT PROC W CC/MCC",,,4481.0,4481.0,1 MS-DRG,513,"MS-DRG 42.00: HAND OR WRIST PROCEDURES, EXCEPT MAJOR THUMB OR JOINT PROCEDURES WITH CC/MCC",,,4481.0,15254.63,10 MS-DRG,514,"HAND OR WRIST PROCEDURES, EXCEPT MAJOR THUMB OR JOINT PROCEDURES WITHOUT CC/MCC",,,4481.0,18780.67,18 MS-DRG,514,"MS-DRG 32.00:HAND OR WRIST PROC, EXCEPT MAJOR THUMB OR JOINT PROC W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,514,"MS-DRG 42.00: HAND OR WRIST PROCEDURES, EXCEPT MAJOR THUMB OR JOINT PROCEDURES WITHOUT CC/MCC",,,4481.0,15254.63,10 MS-DRG,515,MS-DRG 32.00:OTHER MUSCULOSKELET SYS & CONN TISS O.R. PROC W MCC,,,4481.0,4481.0,1 MS-DRG,515,MS-DRG 42.00: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH MCC,,,4481.0,27174.73,10 MS-DRG,515,OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH MCC,,,4481.0,58546.54,18 MS-DRG,516,MS-DRG 32.00:OTHER MUSCULOSKELET SYS & CONN TISS O.R. PROC W CC,,,4481.0,4481.0,1 MS-DRG,516,MS-DRG 42.00: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH CC,,,4481.0,21067.85,10 MS-DRG,516,OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH CC,,,4481.0,38176.78,18 MS-DRG,517,MS-DRG 32.00:OTHER MUSCULOSKELET SYS & CONN TISS O.R. PROC W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,517,MS-DRG 42.00: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,15885.08,10 MS-DRG,517,OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,28230.72,18 MS-DRG,518,BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITH MCC OR DISC DEVICE OR NEUROSTIMULATOR,,,4481.0,68657.94,18 MS-DRG,518,MS-DRG 32.00:BACK & NECK PROC EXC SPINAL FUSION W MCC OR DISC DEVICE/NEUROSTIM,,,4481.0,4481.0,1 MS-DRG,518,MS-DRG 42.00: BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITH MCC OR DISC DEVICE OR NEUROSTIMULATOR,,,4481.0,28886.45,10 MS-DRG,519,BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITH CC,,,4481.0,36745.67,18 MS-DRG,519,MS-DRG 32.00:BACK & NECK PROC EXC SPINAL FUSION W CC,,,4481.0,4481.0,1 MS-DRG,519,MS-DRG 42.00: BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITH CC,,,4481.0,19576.15,10 MS-DRG,520,BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITHOUT CC/MCC,,,4481.0,27444.44,18 MS-DRG,520,MS-DRG 32.00:BACK & NECK PROC EXC SPINAL FUSION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,520,MS-DRG 42.00: BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITHOUT CC/MCC,,,4481.0,13037.3,10 MS-DRG,521,HIP REPLACEMENT WITH PRINCIPAL DIAGNOSIS OF HIP FRACTURE WITH MCC,,,4481.0,52728.44,18 MS-DRG,521,MS-DRG 42.00: HIP REPLACEMENT WITH PRINCIPAL DIAGNOSIS OF HIP FRACTURE WITH MCC,,,4481.0,22788.55,10 MS-DRG,522,HIP REPLACEMENT WITH PRINCIPAL DIAGNOSIS OF HIP FRACTURE WITHOUT MCC,,,4481.0,38904.27,18 MS-DRG,522,MS-DRG 42.00: HIP REPLACEMENT WITH PRINCIPAL DIAGNOSIS OF HIP FRACTURE WITHOUT MCC,,,4481.0,22788.55,10 MS-DRG,533,FRACTURES OF FEMUR WITH MCC,,,4481.0,28800.22,18 MS-DRG,533,MS-DRG 32.00:FRACTURES OF FEMUR W MCC,,,4481.0,4481.0,1 MS-DRG,533,MS-DRG 42.00: FRACTURES OF FEMUR WITH MCC,,,4481.0,9516.86,10 MS-DRG,534,FRACTURES OF FEMUR WITHOUT MCC,,,4481.0,14808.86,18 MS-DRG,534,MS-DRG 32.00:FRACTURES OF FEMUR W/O MCC,,,4481.0,4481.0,1 MS-DRG,534,MS-DRG 42.00: FRACTURES OF FEMUR WITHOUT MCC,,,4011.68,4481.0,10 MS-DRG,535,FRACTURES OF HIP AND PELVIS WITH MCC,,,4481.0,23551.62,18 MS-DRG,535,MS-DRG 32.00:FRACTURES OF HIP & PELVIS W MCC,,,4481.0,4481.0,1 MS-DRG,535,MS-DRG 42.00: FRACTURES OF HIP AND PELVIS WITH MCC,,,4481.0,8521.8,10 MS-DRG,536,FRACTURES OF HIP AND PELVIS WITHOUT MCC,,,4481.0,14836.42,18 MS-DRG,536,MS-DRG 32.00:FRACTURES OF HIP & PELVIS W/O MCC,,,4481.0,4481.0,1 MS-DRG,536,MS-DRG 42.00: FRACTURES OF HIP AND PELVIS WITHOUT MCC,,,4481.0,8521.8,10 MS-DRG,537,"MS-DRG 32.00:SPRAINS, STRAINS, & DISLOCATIONS OF HIP, PELVIS & THIGH W CC/MCC",,,4481.0,4481.0,1 MS-DRG,537,"MS-DRG 42.00: SPRAINS, STRAINS, AND DISLOCATIONS OF HIP, PELVIS AND THIGH WITH CC/MCC",,,4481.0,6540.65,10 MS-DRG,537,"SPRAINS, STRAINS, AND DISLOCATIONS OF HIP, PELVIS AND THIGH WITH CC/MCC",,,4481.0,17531.45,18 MS-DRG,538,"MS-DRG 32.00:SPRAINS, STRAINS, & DISLOCATIONS OF HIP, PELVIS & THIGH W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,538,"MS-DRG 42.00: SPRAINS, STRAINS, AND DISLOCATIONS OF HIP, PELVIS AND THIGH WITHOUT CC/MCC",,,4481.0,6540.65,10 MS-DRG,538,"SPRAINS, STRAINS, AND DISLOCATIONS OF HIP, PELVIS AND THIGH WITHOUT CC/MCC",,,4481.0,13232.63,18 MS-DRG,539,MS-DRG 32.00:OSTEOMYELITIS W MCC,,,4481.0,4481.0,1 MS-DRG,539,MS-DRG 42.00: OSTEOMYELITIS WITH MCC,,,4481.0,15172.01,10 MS-DRG,539,OSTEOMYELITIS WITH MCC,,,4481.0,36185.36,18 MS-DRG,540,MS-DRG 32.00:OSTEOMYELITIS W CC,,,4481.0,4481.0,1 MS-DRG,540,MS-DRG 42.00: OSTEOMYELITIS WITH CC,,,4481.0,13141.47,10 MS-DRG,540,OSTEOMYELITIS WITH CC,,,4481.0,23814.33,18 MS-DRG,541,MS-DRG 32.00:OSTEOMYELITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,541,MS-DRG 42.00: OSTEOMYELITIS WITHOUT CC/MCC,,,4481.0,8503.83,10 MS-DRG,541,OSTEOMYELITIS WITHOUT CC/MCC,,,4481.0,14173.23,18 MS-DRG,542,MS-DRG 32.00:PATHOLOGICAL FRACTURES & MUSCULOSKELET & CONN TISS MALIG W MCC,,,4481.0,4481.0,1 MS-DRG,542,MS-DRG 42.00: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MCC,,,4481.0,19541.13,10 MS-DRG,542,PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MCC,,,4481.0,32452.37,18 MS-DRG,543,MS-DRG 32.00:PATHOLOGICAL FRACTURES & MUSCULOSKELET & CONN TISS MALIG W CC,,,4481.0,4481.0,1 MS-DRG,543,MS-DRG 42.00: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH CC,,,4481.0,10893.6,10 MS-DRG,543,PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH CC,,,4481.0,18885.39,18 MS-DRG,544,MS-DRG 32.00:PATHOLOGICAL FRACTURES & MUSCULOSKELET & CONN TISS MALIG W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,544,MS-DRG 42.00: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITHOUT CC/MCC,,,4481.0,5733.29,10 MS-DRG,544,PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITHOUT CC/MCC,,,4481.0,13862.76,18 MS-DRG,545,CONNECTIVE TISSUE DISORDERS WITH MCC,,,4481.0,45591.31,18 MS-DRG,545,MS-DRG 32.00:CONNECTIVE TISSUE DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,545,MS-DRG 42.00: CONNECTIVE TISSUE DISORDERS WITH MCC,,,4481.0,26083.57,10 MS-DRG,546,CONNECTIVE TISSUE DISORDERS WITH CC,,,4481.0,21189.11,18 MS-DRG,546,MS-DRG 32.00:CONNECTIVE TISSUE DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,546,MS-DRG 42.00: CONNECTIVE TISSUE DISORDERS WITH CC,,,4481.0,13227.69,10 MS-DRG,547,CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC,,,4481.0,15361.83,18 MS-DRG,547,MS-DRG 32.00:CONNECTIVE TISSUE DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,547,MS-DRG 42.00: CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC,,,4481.0,9070.52,10 MS-DRG,548,MS-DRG 32.00:SEPTIC ARTHRITIS W MCC,,,4481.0,4481.0,1 MS-DRG,548,MS-DRG 42.00: SEPTIC ARTHRITIS WITH MCC,,,4481.0,15357.01,10 MS-DRG,548,SEPTIC ARTHRITIS WITH MCC,,,4481.0,35472.56,18 MS-DRG,549,MS-DRG 32.00:SEPTIC ARTHRITIS W CC,,,4481.0,4481.0,1 MS-DRG,549,MS-DRG 42.00: SEPTIC ARTHRITIS WITH CC,,,4481.0,9174.69,10 MS-DRG,549,SEPTIC ARTHRITIS WITH CC,,,4481.0,22177.47,18 MS-DRG,550,MS-DRG 32.00:SEPTIC ARTHRITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,550,MS-DRG 42.00: SEPTIC ARTHRITIS WITHOUT CC/MCC,,,4481.0,6459.82,10 MS-DRG,550,SEPTIC ARTHRITIS WITHOUT CC/MCC,,,4481.0,16058.09,18 MS-DRG,551,MEDICAL BACK PROBLEMS WITH MCC,,,4481.0,30791.63,18 MS-DRG,551,MS-DRG 32.00:MEDICAL BACK PROBLEMS W MCC,,,4481.0,4481.0,1 MS-DRG,551,MS-DRG 42.00: MEDICAL BACK PROBLEMS WITH MCC,,,4481.0,11537.52,10 MS-DRG,552,MEDICAL BACK PROBLEMS WITHOUT MCC,,,4481.0,17660.04,18 MS-DRG,552,MS-DRG 32.00:MEDICAL BACK PROBLEMS W/O MCC,,,4481.0,4481.0,1 MS-DRG,552,MS-DRG 42.00: MEDICAL BACK PROBLEMS WITHOUT MCC,,,4481.0,10564.91,10 MS-DRG,553,BONE DISEASES AND ARTHROPATHIES WITH MCC,,,4481.0,23814.33,18 MS-DRG,553,MS-DRG 32.00:BONE DISEASES & ARTHROPATHIES W MCC,,,4481.0,4481.0,1 MS-DRG,553,MS-DRG 42.00: BONE DISEASES AND ARTHROPATHIES WITH MCC,,,4481.0,10183.23,10 MS-DRG,554,BONE DISEASES AND ARTHROPATHIES WITHOUT MCC,,,4481.0,15249.77,18 MS-DRG,554,MS-DRG 32.00:BONE DISEASES & ARTHROPATHIES W/O MCC,,,4481.0,4481.0,1 MS-DRG,554,MS-DRG 42.00: BONE DISEASES AND ARTHROPATHIES WITHOUT MCC,,,4481.0,10183.23,10 MS-DRG,555,MS-DRG 32.00:SIGNS & SYMPTOMS OF MUSCULOSKELETAL SYSTEM & CONN TISSUE W MCC,,,4481.0,4481.0,1 MS-DRG,555,MS-DRG 42.00: SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC,,,4481.0,9409.99,10 MS-DRG,555,SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC,,,4481.0,24282.79,18 MS-DRG,556,MS-DRG 32.00:SIGNS & SYMPTOMS OF MUSCULOSKELETAL SYSTEM & CONN TISSUE W/O MCC,,,4481.0,4481.0,1 MS-DRG,556,MS-DRG 42.00: SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT MCC,,,4481.0,8945.69,10 MS-DRG,556,SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT MCC,,,4481.0,15258.95,18 MS-DRG,557,"MS-DRG 32.00:TENDONITIS, MYOSITIS & BURSITIS W MCC",,,4481.0,4481.0,1 MS-DRG,557,"MS-DRG 42.00: TENDONITIS, MYOSITIS AND BURSITIS WITH MCC",,,4481.0,9466.57,10 MS-DRG,557,"TENDONITIS, MYOSITIS AND BURSITIS WITH MCC",,,4481.0,27315.84,18 MS-DRG,558,"MS-DRG 32.00:TENDONITIS, MYOSITIS & BURSITIS W/O MCC",,,4481.0,4481.0,1 MS-DRG,558,"MS-DRG 42.00: TENDONITIS, MYOSITIS AND BURSITIS WITHOUT MCC",,,4481.0,8404.15,10 MS-DRG,558,"TENDONITIS, MYOSITIS AND BURSITIS WITHOUT MCC",,,4481.0,16408.98,18 MS-DRG,559,"AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC",,,4481.0,34260.08,18 MS-DRG,559,"MS-DRG 32.00:AFTERCARE, MUSCULOSKELETAL SYSTEM & CONNECTIVE TISSUE W MCC",,,4481.0,4481.0,1 MS-DRG,559,"MS-DRG 42.00: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC",,,4481.0,25621.07,10 MS-DRG,560,"AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC",,,4481.0,20687.58,18 MS-DRG,560,"MS-DRG 32.00:AFTERCARE, MUSCULOSKELETAL SYSTEM & CONNECTIVE TISSUE W CC",,,4481.0,4481.0,1 MS-DRG,560,"MS-DRG 42.00: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC",,,4481.0,20581.09,10 MS-DRG,561,"AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC",,,4481.0,14768.45,18 MS-DRG,561,"MS-DRG 32.00:AFTERCARE, MUSCULOSKELETAL SYSTEM & CONNECTIVE TISSUE W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,561,"MS-DRG 42.00: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC",,,4481.0,17674.94,10 MS-DRG,562,"FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITH MCC",,,4481.0,26175.0,18 MS-DRG,562,"MS-DRG 32.00:FX, SPRN, STRN & DISL EXCEPT FEMUR, HIP, PELVIS & THIGH W MCC",,,4481.0,4481.0,1 MS-DRG,562,"MS-DRG 42.00: FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITH MCC",,,4481.0,9292.34,10 MS-DRG,563,"FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MCC",,,4481.0,16451.23,18 MS-DRG,563,"MS-DRG 32.00:FX, SPRN, STRN & DISL EXCEPT FEMUR, HIP, PELVIS & THIGH W/O MCC",,,4481.0,4481.0,1 MS-DRG,563,"MS-DRG 42.00: FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MCC",,,4481.0,6188.61,10 MS-DRG,564,MS-DRG 32.00:OTHER MUSCULOSKELETAL SYS & CONNECTIVE TISSUE DIAGNOSES W MCC,,,4481.0,4481.0,1 MS-DRG,564,MS-DRG 42.00: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITH MCC,,,4481.0,11028.31,10 MS-DRG,564,OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITH MCC,,,4481.0,28357.48,18 MS-DRG,565,MS-DRG 32.00:OTHER MUSCULOSKELETAL SYS & CONNECTIVE TISSUE DIAGNOSES W CC,,,4481.0,4481.0,1 MS-DRG,565,MS-DRG 42.00: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITH CC,,,4481.0,11028.31,10 MS-DRG,565,OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITH CC,,,4481.0,17900.7,18 MS-DRG,566,MS-DRG 32.00:OTHER MUSCULOSKELETAL SYS & CONNECTIVE TISSUE DIAGNOSES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,566,MS-DRG 42.00: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITHOUT CC/MCC,,,4481.0,6018.87,10 MS-DRG,566,OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITHOUT CC/MCC,,,4481.0,13765.39,18 MS-DRG,570,MS-DRG 32.00:SKIN DEBRIDEMENT W MCC,,,4481.0,4481.0,1 MS-DRG,570,MS-DRG 42.00: SKIN DEBRIDEMENT WITH MCC,,,4481.0,22867.58,10 MS-DRG,570,SKIN DEBRIDEMENT WITH MCC,,,4481.0,54030.95,18 MS-DRG,571,MS-DRG 32.00:SKIN DEBRIDEMENT W CC,,,4481.0,4481.0,1 MS-DRG,571,MS-DRG 42.00: SKIN DEBRIDEMENT WITH CC,,,4481.0,17791.68,10 MS-DRG,571,SKIN DEBRIDEMENT WITH CC,,,4481.0,31037.8,18 MS-DRG,572,MS-DRG 32.00:SKIN DEBRIDEMENT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,572,MS-DRG 42.00: SKIN DEBRIDEMENT WITHOUT CC/MCC,,,4481.0,11152.25,10 MS-DRG,572,SKIN DEBRIDEMENT WITHOUT CC/MCC,,,4481.0,21058.68,18 MS-DRG,573,MS-DRG 32.00:SKIN GRAFT FOR SKIN ULCER OR CELLULITIS W MCC,,,4481.0,4481.0,1 MS-DRG,573,MS-DRG 42.00: SKIN GRAFT FOR SKIN ULCER OR CELLULITIS WITH MCC,,,4481.0,29963.24,10 MS-DRG,573,SKIN GRAFT FOR SKIN ULCER OR CELLULITIS WITH MCC,,,4481.0,120355.77,18 MS-DRG,574,MS-DRG 32.00:SKIN GRAFT FOR SKIN ULCER OR CELLULITIS W CC,,,4481.0,4481.0,1 MS-DRG,574,MS-DRG 42.00: SKIN GRAFT FOR SKIN ULCER OR CELLULITIS WITH CC,,,4481.0,21864.44,10 MS-DRG,574,SKIN GRAFT FOR SKIN ULCER OR CELLULITIS WITH CC,,,4481.0,63773.09,18 MS-DRG,575,MS-DRG 32.00:SKIN GRAFT FOR SKIN ULCER OR CELLULITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,575,MS-DRG 42.00: SKIN GRAFT FOR SKIN ULCER OR CELLULITIS WITHOUT CC/MCC,,,4481.0,21696.5,10 MS-DRG,575,SKIN GRAFT FOR SKIN ULCER OR CELLULITIS WITHOUT CC/MCC,,,4481.0,30010.87,18 MS-DRG,576,MS-DRG 32.00:SKIN GRAFT EXC FOR SKIN ULCER OR CELLULITIS W MCC,,,4481.0,4481.0,1 MS-DRG,576,MS-DRG 42.00: SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITH MCC,,,4481.0,58626.97,10 MS-DRG,576,SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITH MCC,,,4481.0,90039.95,18 MS-DRG,577,MS-DRG 32.00:SKIN GRAFT EXC FOR SKIN ULCER OR CELLULITIS W CC,,,4481.0,4481.0,1 MS-DRG,577,MS-DRG 42.00: SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITH CC,,,4481.0,23938.08,10 MS-DRG,577,SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITH CC,,,4481.0,48696.01,18 MS-DRG,578,MS-DRG 32.00:SKIN GRAFT EXC FOR SKIN ULCER OR CELLULITIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,578,MS-DRG 42.00: SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITHOUT CC/MCC,,,4481.0,14252.39,10 MS-DRG,578,SKIN GRAFT EXCEPT FOR SKIN ULCER OR CELLULITIS WITHOUT CC/MCC,,,4481.0,29511.17,18 MS-DRG,579,"MS-DRG 32.00:OTHER SKIN, SUBCUT TISS & BREAST PROC W MCC",,,4481.0,4481.0,1 MS-DRG,579,"MS-DRG 42.00: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH MCC",,,4481.0,20960.08,10 MS-DRG,579,"OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH MCC",,,4481.0,59494.48,18 MS-DRG,580,"MS-DRG 32.00:OTHER SKIN, SUBCUT TISS & BREAST PROC W CC",,,4481.0,4481.0,1 MS-DRG,580,"MS-DRG 42.00: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH CC",,,4481.0,16666.4,10 MS-DRG,580,"OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH CC",,,4481.0,31745.09,18 MS-DRG,581,"MS-DRG 32.00:OTHER SKIN, SUBCUT TISS & BREAST PROC W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,581,"MS-DRG 42.00: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITHOUT CC/MCC",,,4481.0,10431.99,10 MS-DRG,581,"OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITHOUT CC/MCC",,,4481.0,26511.19,18 MS-DRG,582,MASTECTOMY FOR MALIGNANCY WITH CC/MCC,,,4481.0,35393.57,18 MS-DRG,582,MS-DRG 32.00:MASTECTOMY FOR MALIGNANCY W CC/MCC,,,4481.0,4481.0,1 MS-DRG,582,MS-DRG 42.00: MASTECTOMY FOR MALIGNANCY WITH CC/MCC,,,4481.0,22618.82,10 MS-DRG,583,MASTECTOMY FOR MALIGNANCY WITHOUT CC/MCC,,,4481.0,31678.95,18 MS-DRG,583,MS-DRG 32.00:MASTECTOMY FOR MALIGNANCY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,583,MS-DRG 42.00: MASTECTOMY FOR MALIGNANCY WITHOUT CC/MCC,,,4481.0,22618.82,10 MS-DRG,584,"BREAST BIOPSY, LOCAL EXCISION AND OTHER BREAST PROCEDURES WITH CC/MCC",,,4481.0,39326.8,18 MS-DRG,584,"MS-DRG 32.00:BREAST BIOPSY, LOCAL EXCISION & OTHER BREAST PROCEDURES W CC/MCC",,,4481.0,4481.0,1 MS-DRG,584,"MS-DRG 42.00: BREAST BIOPSY, LOCAL EXCISION AND OTHER BREAST PROCEDURES WITH CC/MCC",,,4481.0,21287.87,10 MS-DRG,585,"BREAST BIOPSY, LOCAL EXCISION AND OTHER BREAST PROCEDURES WITHOUT CC/MCC",,,4481.0,35439.5,18 MS-DRG,585,"MS-DRG 32.00:BREAST BIOPSY, LOCAL EXCISION & OTHER BREAST PROCEDURES W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,585,"MS-DRG 42.00: BREAST BIOPSY, LOCAL EXCISION AND OTHER BREAST PROCEDURES WITHOUT CC/MCC",,,4481.0,21287.87,10 MS-DRG,592,MS-DRG 32.00:SKIN ULCERS W MCC,,,4481.0,4481.0,1 MS-DRG,592,MS-DRG 42.00: SKIN ULCERS WITH MCC,,,4481.0,12616.1,10 MS-DRG,592,SKIN ULCERS WITH MCC,,,4481.0,35553.4,18 MS-DRG,593,MS-DRG 32.00:SKIN ULCERS W CC,,,4481.0,4481.0,1 MS-DRG,593,MS-DRG 42.00: SKIN ULCERS WITH CC,,,4481.0,8120.36,10 MS-DRG,593,SKIN ULCERS WITH CC,,,4481.0,21793.52,18 MS-DRG,594,MS-DRG 32.00:SKIN ULCERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,594,MS-DRG 42.00: SKIN ULCERS WITHOUT CC/MCC,,,4481.0,8120.36,10 MS-DRG,594,SKIN ULCERS WITHOUT CC/MCC,,,4481.0,15923.98,18 MS-DRG,595,MAJOR SKIN DISORDERS WITH MCC,,,4481.0,38959.38,18 MS-DRG,595,MS-DRG 32.00:MAJOR SKIN DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,595,MS-DRG 42.00: MAJOR SKIN DISORDERS WITH MCC,,,4481.0,11959.61,10 MS-DRG,596,MAJOR SKIN DISORDERS WITHOUT MCC,,,4481.0,19886.61,18 MS-DRG,596,MS-DRG 32.00:MAJOR SKIN DISORDERS W/O MCC,,,4481.0,4481.0,1 MS-DRG,596,MS-DRG 42.00: MAJOR SKIN DISORDERS WITHOUT MCC,,,4481.0,6321.52,10 MS-DRG,597,MALIGNANT BREAST DISORDERS WITH MCC,,,4481.0,30626.29,18 MS-DRG,597,MS-DRG 32.00:MALIGNANT BREAST DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,597,MS-DRG 42.00: MALIGNANT BREAST DISORDERS WITH MCC,,,4481.0,11813.23,10 MS-DRG,598,MALIGNANT BREAST DISORDERS WITH CC,,,4481.0,20783.11,18 MS-DRG,598,MS-DRG 32.00:MALIGNANT BREAST DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,598,MS-DRG 42.00: MALIGNANT BREAST DISORDERS WITH CC,,,4481.0,7975.77,10 MS-DRG,599,MALIGNANT BREAST DISORDERS WITHOUT CC/MCC,,,4481.0,13469.62,18 MS-DRG,599,MS-DRG 32.00:MALIGNANT BREAST DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,599,MS-DRG 42.00: MALIGNANT BREAST DISORDERS WITHOUT CC/MCC,,,4481.0,7975.77,10 MS-DRG,600,MS-DRG 32.00:NON-MALIGNANT BREAST DISORDERS W CC/MCC,,,4481.0,4481.0,1 MS-DRG,600,MS-DRG 42.00: NON-MALIGNANT BREAST DISORDERS WITH CC/MCC,,,4481.0,5106.43,10 MS-DRG,600,NON-MALIGNANT BREAST DISORDERS WITH CC/MCC,,,4481.0,19135.23,18 MS-DRG,601,MS-DRG 32.00:NON-MALIGNANT BREAST DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,601,MS-DRG 42.00: NON-MALIGNANT BREAST DISORDERS WITHOUT CC/MCC,,,4481.0,5013.93,10 MS-DRG,601,NON-MALIGNANT BREAST DISORDERS WITHOUT CC/MCC,,,4481.0,11114.45,18 MS-DRG,602,CELLULITIS WITH MCC,,,4481.0,26110.7,18 MS-DRG,602,MS-DRG 32.00:CELLULITIS W MCC,,,4481.0,4481.0,1 MS-DRG,602,MS-DRG 42.00: CELLULITIS WITH MCC,,,4481.0,12143.72,10 MS-DRG,603,CELLULITIS WITHOUT MCC,,,4481.0,15999.3,18 MS-DRG,603,MS-DRG 32.00:CELLULITIS W/O MCC,,,4481.0,4481.0,1 MS-DRG,603,MS-DRG 42.00: CELLULITIS WITHOUT MCC,,,4481.0,7462.07,10 MS-DRG,604,"MS-DRG 32.00:TRAUMA TO THE SKIN, SUBCUT TISS & BREAST W MCC",,,4481.0,4481.0,1 MS-DRG,604,"MS-DRG 42.00: TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITH MCC",,,4481.0,10008.1,10 MS-DRG,604,"TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITH MCC",,,4481.0,27043.95,18 MS-DRG,605,"MS-DRG 32.00:TRAUMA TO THE SKIN, SUBCUT TISS & BREAST W/O MCC",,,4481.0,4481.0,1 MS-DRG,605,"MS-DRG 42.00: TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITHOUT MCC",,,4481.0,7343.53,10 MS-DRG,605,"TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITHOUT MCC",,,4481.0,16827.84,18 MS-DRG,606,MINOR SKIN DISORDERS WITH MCC,,,4481.0,27799.0,18 MS-DRG,606,MS-DRG 32.00:MINOR SKIN DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,606,MS-DRG 42.00: MINOR SKIN DISORDERS WITH MCC,,,4481.0,8316.14,10 MS-DRG,607,MINOR SKIN DISORDERS WITHOUT MCC,,,4481.0,16651.47,18 MS-DRG,607,MS-DRG 32.00:MINOR SKIN DISORDERS W/O MCC,,,4481.0,4481.0,1 MS-DRG,607,MS-DRG 42.00: MINOR SKIN DISORDERS WITHOUT MCC,,,4481.0,7577.92,10 MS-DRG,614,ADRENAL AND PITUITARY PROCEDURES WITH CC/MCC,,,4481.0,40265.56,18 MS-DRG,614,MS-DRG 32.00:ADRENAL & PITUITARY PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,614,MS-DRG 42.00: ADRENAL AND PITUITARY PROCEDURES WITH CC/MCC,,,4481.0,19634.53,10 MS-DRG,615,ADRENAL AND PITUITARY PROCEDURES WITHOUT CC/MCC,,,4481.0,25706.54,18 MS-DRG,615,MS-DRG 32.00:ADRENAL & PITUITARY PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,615,MS-DRG 42.00: ADRENAL AND PITUITARY PROCEDURES WITHOUT CC/MCC,,,4481.0,16807.4,10 MS-DRG,616,"AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH MCC",,,4481.0,64067.03,18 MS-DRG,616,"MS-DRG 32.00:AMPUTAT OF LOWER LIMB FOR ENDOCRINE,NUTRIT,& METABOL DIS W MCC",,,4481.0,4481.0,1 MS-DRG,616,"MS-DRG 42.00: AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH MCC",,,4481.0,23265.43,10 MS-DRG,617,"AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC",,,4481.0,34359.28,18 MS-DRG,617,"MS-DRG 32.00:AMPUTAT OF LOWER LIMB FOR ENDOCRINE,NUTRIT,& METABOL DIS W CC",,,4481.0,4481.0,1 MS-DRG,617,"MS-DRG 42.00: AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC",,,4481.0,19126.22,10 MS-DRG,618,"AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITHOUT CC/MCC",,,4481.0,26055.59,18 MS-DRG,618,"MS-DRG 32.00:AMPUTAT OF LOWER LIMB FOR ENDOCRINE,NUTRIT,& METABOL DIS W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,618,"MS-DRG 42.00: AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITHOUT CC/MCC",,,4481.0,13529.44,10 MS-DRG,619,MS-DRG 32.00:O.R. PROCEDURES FOR OBESITY W MCC,,,4481.0,4481.0,1 MS-DRG,619,MS-DRG 42.00: O.R. PROCEDURES FOR OBESITY WITH MCC,,,4481.0,18638.57,10 MS-DRG,619,O.R. PROCEDURES FOR OBESITY WITH MCC,,,4481.0,53044.43,19 MS-DRG,620,MS-DRG 32.00:O.R. PROCEDURES FOR OBESITY W CC,,,4481.0,4481.0,1 MS-DRG,620,MS-DRG 42.00: O.R. PROCEDURES FOR OBESITY WITH CC,,,4481.0,15894.06,10 MS-DRG,620,O.R. PROCEDURES FOR OBESITY WITH CC,,,4481.0,34302.0,19 MS-DRG,621,MS-DRG 32.00:O.R. PROCEDURES FOR OBESITY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,621,MS-DRG 42.00: O.R. PROCEDURES FOR OBESITY WITHOUT CC/MCC,,,4481.0,12962.76,10 MS-DRG,621,O.R. PROCEDURES FOR OBESITY WITHOUT CC/MCC,,,4481.0,34302.0,19 MS-DRG,622,"MS-DRG 32.00:SKIN GRAFTS & WOUND DEBRID FOR ENDOC, NUTRIT & METAB DIS W MCC",,,4481.0,4481.0,1 MS-DRG,622,"MS-DRG 42.00: SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH MCC",,,4481.0,20856.8,10 MS-DRG,622,"SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH MCC",,,4481.0,65386.06,18 MS-DRG,623,"MS-DRG 32.00:SKIN GRAFTS & WOUND DEBRID FOR ENDOC, NUTRIT & METAB DIS W CC",,,4481.0,4481.0,1 MS-DRG,623,"MS-DRG 42.00: SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC",,,4481.0,19814.14,10 MS-DRG,623,"SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH CC",,,4481.0,32955.74,18 MS-DRG,624,"MS-DRG 32.00:SKIN GRAFTS & WOUND DEBRID FOR ENDOC, NUTRIT & METAB DIS W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,624,"MS-DRG 42.00: SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITHOUT CC/MCC",,,4481.0,10899.89,10 MS-DRG,624,"SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITHOUT CC/MCC",,,4481.0,22998.65,18 MS-DRG,625,"MS-DRG 32.00:THYROID, PARATHYROID & THYROGLOSSAL PROCEDURES W MCC",,,4481.0,4481.0,1 MS-DRG,625,"MS-DRG 42.00: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH MCC",,,4481.0,19054.37,10 MS-DRG,625,"THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH MCC",,,4481.0,55482.26,18 MS-DRG,626,"MS-DRG 32.00:THYROID, PARATHYROID & THYROGLOSSAL PROCEDURES W CC",,,4481.0,4481.0,1 MS-DRG,626,"MS-DRG 42.00: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH CC",,,4481.0,14859.48,10 MS-DRG,626,"THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITH CC",,,4481.0,27545.48,18 MS-DRG,627,"MS-DRG 32.00:THYROID, PARATHYROID & THYROGLOSSAL PROCEDURES W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,627,"MS-DRG 42.00: THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITHOUT CC/MCC",,,4481.0,9669.53,10 MS-DRG,627,"THYROID, PARATHYROID AND THYROGLOSSAL PROCEDURES WITHOUT CC/MCC",,,4481.0,24402.2,18 MS-DRG,628,"MS-DRG 32.00:OTHER ENDOCRINE, NUTRIT & METAB O.R. PROC W MCC",,,4481.0,4481.0,1 MS-DRG,628,"MS-DRG 42.00: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH MCC",,,4481.0,25609.39,10 MS-DRG,628,"OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH MCC",,,4481.0,68465.04,18 MS-DRG,629,"MS-DRG 32.00:OTHER ENDOCRINE, NUTRIT & METAB O.R. PROC W CC",,,4481.0,4481.0,1 MS-DRG,629,"MS-DRG 42.00: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC",,,4481.0,19504.31,10 MS-DRG,629,"OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH CC",,,4481.0,40026.73,18 MS-DRG,630,"MS-DRG 32.00:OTHER ENDOCRINE, NUTRIT & METAB O.R. PROC W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,630,"MS-DRG 42.00: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITHOUT CC/MCC",,,4481.0,15226.79,10 MS-DRG,630,"OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITHOUT CC/MCC",,,4481.0,26812.47,18 MS-DRG,637,DIABETES WITH MCC,,,4481.0,26393.62,18 MS-DRG,637,MS-DRG 32.00:DIABETES W MCC,,,4481.0,4481.0,1 MS-DRG,637,MS-DRG 42.00: DIABETES WITH MCC,,,4481.0,13801.56,10 MS-DRG,638,DIABETES WITH CC,,,4481.0,16464.09,18 MS-DRG,638,MS-DRG 32.00:DIABETES W CC,,,4481.0,4481.0,1 MS-DRG,638,MS-DRG 42.00: DIABETES WITH CC,,,4481.0,7867.1,10 MS-DRG,639,DIABETES WITHOUT CC/MCC,,,4481.0,11412.07,18 MS-DRG,639,MS-DRG 32.00:DIABETES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,639,MS-DRG 42.00: DIABETES WITHOUT CC/MCC,,,4481.0,5751.25,10 MS-DRG,640,"MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC",,,4481.0,24536.31,18 MS-DRG,640,"MS-DRG 32.00:MISC DISORDERS OF NUTRITION,METABOLISM,FLUIDS/ELECTROLYTES W MCC",,,4481.0,4481.0,1 MS-DRG,640,"MS-DRG 42.00: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC",,,4481.0,14378.12,10 MS-DRG,641,"MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC",,,4481.0,14296.31,18 MS-DRG,641,"MS-DRG 32.00:MISC DISORDERS OF NUTRITION,METABOLISM,FLUIDS/ELECTROLYTES W/O MCC",,,4481.0,4481.0,1 MS-DRG,641,"MS-DRG 42.00: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC",,,4481.0,7386.63,10 MS-DRG,642,INBORN AND OTHER DISORDERS OF METABOLISM,,,4481.0,26125.4,18 MS-DRG,642,MS-DRG 32.00:INBORN AND OTHER DISORDERS OF METABOLISM,,,4481.0,4481.0,1 MS-DRG,642,MS-DRG 42.00: INBORN AND OTHER DISORDERS OF METABOLISM,,,4481.0,12483.19,10 MS-DRG,643,ENDOCRINE DISORDERS WITH MCC,,,4481.0,30240.5,18 MS-DRG,643,MS-DRG 32.00:ENDOCRINE DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,643,MS-DRG 42.00: ENDOCRINE DISORDERS WITH MCC,,,4481.0,16371.83,10 MS-DRG,644,ENDOCRINE DISORDERS WITH CC,,,4481.0,18830.28,18 MS-DRG,644,MS-DRG 32.00:ENDOCRINE DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,644,MS-DRG 42.00: ENDOCRINE DISORDERS WITH CC,,,4481.0,8346.67,10 MS-DRG,645,ENDOCRINE DISORDERS WITHOUT CC/MCC,,,4481.0,14114.44,18 MS-DRG,645,MS-DRG 32.00:ENDOCRINE DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,645,MS-DRG 42.00: ENDOCRINE DISORDERS WITHOUT CC/MCC,,,4481.0,5966.78,10 MS-DRG,650,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,650,KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC,,,4481.0,112717.02,18 MS-DRG,650,Kidney (CAD) Transplant,,,55000.0,109671.0,3 MS-DRG,650,Kidney (LRD) Transplant,,,109671.0,109671.0,1 MS-DRG,650,Kidney (Living) Transplant,,,104080.0,104080.0,1 MS-DRG,650,Kidney-Liver Transplant,,,220496.0,262854.0,3 MS-DRG,650,MS-DRG 42.00: KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC,,,4481.0,54199.48,11 MS-DRG,651,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,651,KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC,,,4481.0,112717.02,18 MS-DRG,651,Kidney (CAD) Transplant,,,55000.0,109671.0,3 MS-DRG,651,Kidney (LRD) Transplant,,,109671.0,109671.0,1 MS-DRG,651,Kidney (Living) Transplant,,,104080.0,104080.0,1 MS-DRG,651,Kidney-Liver Transplant,,,220496.0,262854.0,3 MS-DRG,651,MS-DRG 42.00: KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC,,,4481.0,53029.3,11 MS-DRG,652,Combination Transplant (any combination of solid organ besides kidney/pancreas),,,,,0 MS-DRG,652,KIDNEY TRANSPLANT,,,24922.05,112717.02,19 MS-DRG,652,Kidney (CAD) Transplant,,,55000.0,109671.0,3 MS-DRG,652,Kidney (LRD) Transplant,,,109671.0,109671.0,1 MS-DRG,652,Kidney (Living) Transplant,,,104080.0,104080.0,1 MS-DRG,652,Kidney-Liver Transplant,,,220496.0,262854.0,3 MS-DRG,652,MS-DRG 32.00:KIDNEY TRANSPLANT,,,4481.0,4481.0,1 MS-DRG,652,MS-DRG 42.00: KIDNEY TRANSPLANT,,,4481.0,120947.71,11 MS-DRG,653,MAJOR BLADDER PROCEDURES WITH MCC,,,4481.0,95463.06,18 MS-DRG,653,MS-DRG 32.00:MAJOR BLADDER PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,653,MS-DRG 42.00: MAJOR BLADDER PROCEDURES WITH MCC,,,4481.0,33333.7,10 MS-DRG,654,MAJOR BLADDER PROCEDURES WITH CC,,,4481.0,51425.94,18 MS-DRG,654,MS-DRG 32.00:MAJOR BLADDER PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,654,MS-DRG 42.00: MAJOR BLADDER PROCEDURES WITH CC,,,4481.0,18746.33,10 MS-DRG,655,MAJOR BLADDER PROCEDURES WITHOUT CC/MCC,,,4481.0,38884.06,18 MS-DRG,655,MS-DRG 32.00:MAJOR BLADDER PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,655,MS-DRG 42.00: MAJOR BLADDER PROCEDURES WITHOUT CC/MCC,,,4481.0,18746.33,10 MS-DRG,656,KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC,,,4481.0,58489.59,18 MS-DRG,656,MS-DRG 32.00:KIDNEY & URETER PROCEDURES FOR NEOPLASM W MCC,,,4481.0,4481.0,1 MS-DRG,656,MS-DRG 42.00: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC,,,4481.0,24724.79,10 MS-DRG,657,KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC,,,4481.0,33618.93,18 MS-DRG,657,MS-DRG 32.00:KIDNEY & URETER PROCEDURES FOR NEOPLASM W CC,,,4481.0,4481.0,1 MS-DRG,657,MS-DRG 42.00: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC,,,4481.0,17617.46,10 MS-DRG,658,KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC,,,4481.0,28508.12,18 MS-DRG,658,MS-DRG 32.00:KIDNEY & URETER PROCEDURES FOR NEOPLASM W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,658,MS-DRG 42.00: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC,,,4481.0,13436.04,10 MS-DRG,659,KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC,,,4481.0,46678.87,18 MS-DRG,659,MS-DRG 32.00:KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC,,,4481.0,4481.0,1 MS-DRG,659,MS-DRG 42.00: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC,,,4481.0,17136.99,10 MS-DRG,660,KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC,,,4481.0,24280.95,18 MS-DRG,660,MS-DRG 32.00:KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC,,,4481.0,4481.0,1 MS-DRG,660,MS-DRG 42.00: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC,,,4481.0,11171.11,10 MS-DRG,661,KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC,,,4481.0,19021.33,18 MS-DRG,661,MS-DRG 32.00:KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,661,MS-DRG 42.00: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC,,,4481.0,9013.04,10 MS-DRG,662,MINOR BLADDER PROCEDURES WITH MCC,,,4481.0,56242.82,18 MS-DRG,662,MS-DRG 32.00:MINOR BLADDER PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,662,MS-DRG 42.00: MINOR BLADDER PROCEDURES WITH MCC,,,4481.0,17449.52,10 MS-DRG,663,MINOR BLADDER PROCEDURES WITH CC,,,4481.0,27927.59,18 MS-DRG,663,MS-DRG 32.00:MINOR BLADDER PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,663,MS-DRG 42.00: MINOR BLADDER PROCEDURES WITH CC,,,4481.0,11109.14,10 MS-DRG,664,MINOR BLADDER PROCEDURES WITHOUT CC/MCC,,,4481.0,19232.6,18 MS-DRG,664,MS-DRG 32.00:MINOR BLADDER PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,664,MS-DRG 42.00: MINOR BLADDER PROCEDURES WITHOUT CC/MCC,,,4481.0,7441.42,10 MS-DRG,665,MS-DRG 32.00:PROSTATECTOMY W MCC,,,4481.0,4481.0,1 MS-DRG,665,MS-DRG 42.00: PROSTATECTOMY WITH MCC,,,4481.0,37310.36,10 MS-DRG,665,PROSTATECTOMY WITH MCC,,,4481.0,57339.57,18 MS-DRG,666,MS-DRG 32.00:PROSTATECTOMY W CC,,,4481.0,4481.0,1 MS-DRG,666,MS-DRG 42.00: PROSTATECTOMY WITH CC,,,4481.0,10456.24,10 MS-DRG,666,PROSTATECTOMY WITH CC,,,4481.0,32136.39,18 MS-DRG,667,MS-DRG 32.00:PROSTATECTOMY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,667,MS-DRG 42.00: PROSTATECTOMY WITHOUT CC/MCC,,,4481.0,10456.24,10 MS-DRG,667,PROSTATECTOMY WITHOUT CC/MCC,,,4481.0,20322.0,18 MS-DRG,668,MS-DRG 32.00:TRANSURETHRAL PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,668,MS-DRG 42.00: TRANSURETHRAL PROCEDURES WITH MCC,,,4481.0,18249.7,10 MS-DRG,668,TRANSURETHRAL PROCEDURES WITH MCC,,,4481.0,53643.32,18 MS-DRG,669,MS-DRG 32.00:TRANSURETHRAL PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,669,MS-DRG 42.00: TRANSURETHRAL PROCEDURES WITH CC,,,4481.0,12264.96,10 MS-DRG,669,TRANSURETHRAL PROCEDURES WITH CC,,,4481.0,28511.79,18 MS-DRG,670,MS-DRG 32.00:TRANSURETHRAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,670,MS-DRG 42.00: TRANSURETHRAL PROCEDURES WITHOUT CC/MCC,,,4481.0,8542.45,10 MS-DRG,670,TRANSURETHRAL PROCEDURES WITHOUT CC/MCC,,,4481.0,17953.98,18 MS-DRG,671,MS-DRG 32.00:URETHRAL PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,671,MS-DRG 42.00: URETHRAL PROCEDURES WITH CC/MCC,,,4481.0,17531.24,10 MS-DRG,671,URETHRAL PROCEDURES WITH CC/MCC,,,4481.0,32975.94,18 MS-DRG,672,MS-DRG 32.00:URETHRAL PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,672,MS-DRG 42.00: URETHRAL PROCEDURES WITHOUT CC/MCC,,,4481.0,11891.36,10 MS-DRG,672,URETHRAL PROCEDURES WITHOUT CC/MCC,,,4481.0,19831.49,18 MS-DRG,673,MS-DRG 32.00:OTHER KIDNEY & URINARY TRACT PROCEDURES W MCC,,,4481.0,4481.0,1 MS-DRG,673,MS-DRG 42.00: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC,,,4481.0,40832.59,10 MS-DRG,673,OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC,,,4481.0,77187.59,18 MS-DRG,674,MS-DRG 32.00:OTHER KIDNEY & URINARY TRACT PROCEDURES W CC,,,4481.0,4481.0,1 MS-DRG,674,MS-DRG 42.00: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC,,,4481.0,21783.61,10 MS-DRG,674,OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC,,,4481.0,42962.42,18 MS-DRG,675,MS-DRG 32.00:OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,675,MS-DRG 42.00: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC,,,4481.0,16138.34,10 MS-DRG,675,OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC,,,4481.0,30154.16,18 MS-DRG,682,MS-DRG 32.00:RENAL FAILURE W MCC,,,4481.0,4481.0,1 MS-DRG,682,MS-DRG 42.00: RENAL FAILURE WITH MCC,,,4481.0,18531.7,10 MS-DRG,682,RENAL FAILURE WITH MCC,,,4481.0,27207.45,18 MS-DRG,683,MS-DRG 32.00:RENAL FAILURE W CC,,,4481.0,4481.0,1 MS-DRG,683,MS-DRG 42.00: RENAL FAILURE WITH CC,,,4481.0,8885.51,10 MS-DRG,683,RENAL FAILURE WITH CC,,,4481.0,16089.32,18 MS-DRG,684,MS-DRG 32.00:RENAL FAILURE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,684,MS-DRG 42.00: RENAL FAILURE WITHOUT CC/MCC,,,4481.0,6049.41,10 MS-DRG,684,RENAL FAILURE WITHOUT CC/MCC,,,4481.0,11028.11,18 MS-DRG,685,MS-DRG 32.00:ADMIT FOR RENAL DIALYSIS,,,4481.0,4481.0,1 MS-DRG,686,KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC,,,4481.0,33135.77,18 MS-DRG,686,MS-DRG 32.00:KIDNEY & URINARY TRACT NEOPLASMS W MCC,,,4481.0,4481.0,1 MS-DRG,686,MS-DRG 42.00: KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC,,,4481.0,11357.01,10 MS-DRG,687,KIDNEY AND URINARY TRACT NEOPLASMS WITH CC,,,4481.0,19249.13,18 MS-DRG,687,MS-DRG 32.00:KIDNEY & URINARY TRACT NEOPLASMS W CC,,,4481.0,4481.0,1 MS-DRG,687,MS-DRG 42.00: KIDNEY AND URINARY TRACT NEOPLASMS WITH CC,,,4481.0,7545.59,10 MS-DRG,688,KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC,,,4481.0,14518.6,18 MS-DRG,688,MS-DRG 32.00:KIDNEY & URINARY TRACT NEOPLASMS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,688,MS-DRG 42.00: KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC,,,4481.0,7545.59,10 MS-DRG,689,KIDNEY AND URINARY TRACT INFECTIONS WITH MCC,,,4481.0,21315.87,18 MS-DRG,689,MS-DRG 32.00:KIDNEY & URINARY TRACT INFECTIONS W MCC,,,4481.0,4481.0,1 MS-DRG,689,MS-DRG 42.00: KIDNEY AND URINARY TRACT INFECTIONS WITH MCC,,,4481.0,11069.62,10 MS-DRG,690,KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC,,,4481.0,14871.32,18 MS-DRG,690,MS-DRG 32.00:KIDNEY & URINARY TRACT INFECTIONS W/O MCC,,,4481.0,4481.0,1 MS-DRG,690,MS-DRG 42.00: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC,,,4481.0,6605.31,10 MS-DRG,691,MS-DRG 32.00:URINARY STONES W ESW LITHOTRIPSY W CC/MCC,,,4481.0,4481.0,1 MS-DRG,692,MS-DRG 32.00:URINARY STONES W ESW LITHOTRIPSY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,693,MS-DRG 32.00:URINARY STONES W/O ESW LITHOTRIPSY W MCC,,,4481.0,4481.0,1 MS-DRG,693,MS-DRG 42.00: URINARY STONES WITH MCC,,,4481.0,8767.87,10 MS-DRG,693,URINARY STONES WITH MCC,,,4481.0,24699.81,18 MS-DRG,694,MS-DRG 32.00:URINARY STONES W/O ESW LITHOTRIPSY W/O MCC,,,4481.0,4481.0,1 MS-DRG,694,MS-DRG 42.00: URINARY STONES WITHOUT MCC,,,4481.0,6254.17,10 MS-DRG,694,URINARY STONES WITHOUT MCC,,,4481.0,14360.61,18 MS-DRG,695,KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC,,,4481.0,21012.75,18 MS-DRG,695,MS-DRG 32.00:KIDNEY & URINARY TRACT SIGNS & SYMPTOMS W MCC,,,4481.0,4481.0,1 MS-DRG,695,MS-DRG 42.00: KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC,,,4481.0,5603.06,10 MS-DRG,696,KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC,,,4481.0,12657.62,18 MS-DRG,696,MS-DRG 32.00:KIDNEY & URINARY TRACT SIGNS & SYMPTOMS W/O MCC,,,4481.0,4481.0,1 MS-DRG,696,MS-DRG 42.00: KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC,,,4198.27,4481.0,10 MS-DRG,697,MS-DRG 32.00:URETHRAL STRICTURE,,,4481.0,4481.0,1 MS-DRG,697,MS-DRG 42.00: URETHRAL STRICTURE,,,4481.0,10886.42,10 MS-DRG,697,URETHRAL STRICTURE,,,4481.0,19800.26,18 MS-DRG,698,MS-DRG 32.00:OTHER KIDNEY & URINARY TRACT DIAGNOSES W MCC,,,4481.0,4481.0,1 MS-DRG,698,MS-DRG 42.00: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC,,,4481.0,18538.88,10 MS-DRG,698,OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC,,,4481.0,30392.98,18 MS-DRG,699,MS-DRG 32.00:OTHER KIDNEY & URINARY TRACT DIAGNOSES W CC,,,4481.0,4481.0,1 MS-DRG,699,MS-DRG 42.00: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC,,,4481.0,10637.65,10 MS-DRG,699,OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC,,,4481.0,18646.56,18 MS-DRG,700,MS-DRG 32.00:OTHER KIDNEY & URINARY TRACT DIAGNOSES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,700,MS-DRG 42.00: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC,,,4481.0,6007.2,10 MS-DRG,700,OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC,,,4481.0,12674.15,18 MS-DRG,707,MAJOR MALE PELVIC PROCEDURES WITH CC/MCC,,,4481.0,36747.51,18 MS-DRG,707,MS-DRG 32.00:MAJOR MALE PELVIC PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,707,MS-DRG 42.00: MAJOR MALE PELVIC PROCEDURES WITH CC/MCC,,,4481.0,14562.22,10 MS-DRG,708,MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC,,,4481.0,28184.79,18 MS-DRG,708,MS-DRG 32.00:MAJOR MALE PELVIC PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,708,MS-DRG 42.00: MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC,,,4481.0,13236.67,10 MS-DRG,709,MS-DRG 32.00:PENIS PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,709,MS-DRG 42.00: PENIS PROCEDURES WITH CC/MCC,,,4481.0,24418.55,10 MS-DRG,709,PENIS PROCEDURES WITH CC/MCC,,,4481.0,42751.15,18 MS-DRG,710,MS-DRG 32.00:PENIS PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,710,MS-DRG 42.00: PENIS PROCEDURES WITHOUT CC/MCC,,,4481.0,16314.36,10 MS-DRG,710,PENIS PROCEDURES WITHOUT CC/MCC,,,4481.0,25741.45,18 MS-DRG,711,MS-DRG 32.00:TESTES PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,711,MS-DRG 42.00: TESTES PROCEDURES WITH CC/MCC,,,4481.0,14834.34,10 MS-DRG,711,TESTES PROCEDURES WITH CC/MCC,,,4481.0,38281.49,18 MS-DRG,712,MS-DRG 32.00:TESTES PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,712,MS-DRG 42.00: TESTES PROCEDURES WITHOUT CC/MCC,,,4481.0,7260.9,10 MS-DRG,712,TESTES PROCEDURES WITHOUT CC/MCC,,,4481.0,20202.59,18 MS-DRG,713,MS-DRG 32.00:TRANSURETHRAL PROSTATECTOMY W CC/MCC,,,4481.0,4481.0,1 MS-DRG,713,MS-DRG 42.00: TRANSURETHRAL PROSTATECTOMY WITH CC/MCC,,,4481.0,10277.52,10 MS-DRG,713,TRANSURETHRAL PROSTATECTOMY WITH CC/MCC,,,4481.0,27618.96,18 MS-DRG,714,MS-DRG 32.00:TRANSURETHRAL PROSTATECTOMY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,714,MS-DRG 42.00: TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC,,,4481.0,7604.87,10 MS-DRG,714,TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC,,,4481.0,19425.5,18 MS-DRG,715,MS-DRG 32.00:OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC FOR MALIGNANCY W CC/MCC,,,4481.0,4481.0,1 MS-DRG,715,MS-DRG 42.00: OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC,,,4481.0,12650.23,10 MS-DRG,715,OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC,,,4481.0,41101.44,18 MS-DRG,716,MS-DRG 32.00:OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC FOR MALIGNANCY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,716,MS-DRG 42.00: OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC,,,4481.0,12650.23,10 MS-DRG,716,OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC,,,4481.0,27023.74,18 MS-DRG,717,MS-DRG 32.00:OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC EXC MALIGNANCY W CC/MCC,,,4481.0,4481.0,1 MS-DRG,717,MS-DRG 42.00: OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC,,,4481.0,11221.4,10 MS-DRG,717,OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC,,,4481.0,34730.38,18 MS-DRG,718,MS-DRG 32.00:OTHER MALE REPRODUCTIVE SYSTEM O.R. PROC EXC MALIGNANCY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,718,MS-DRG 42.00: OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC,,,4481.0,7746.76,10 MS-DRG,718,OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC,,,4481.0,24674.09,18 MS-DRG,722,"MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC",,,4481.0,33246.0,18 MS-DRG,722,"MS-DRG 32.00:MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC",,,4481.0,4481.0,1 MS-DRG,722,"MS-DRG 42.00: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC",,,4481.0,9418.07,10 MS-DRG,723,"MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC",,,4481.0,20992.54,18 MS-DRG,723,"MS-DRG 32.00:MALIGNANCY, MALE REPRODUCTIVE SYSTEM W CC",,,4481.0,4481.0,1 MS-DRG,723,"MS-DRG 42.00: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC",,,4481.0,7934.46,10 MS-DRG,724,"MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC",,,4481.0,11237.54,18 MS-DRG,724,"MS-DRG 32.00:MALIGNANCY, MALE REPRODUCTIVE SYSTEM W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,724,"MS-DRG 42.00: MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC",,,4481.0,7917.39,10 MS-DRG,725,BENIGN PROSTATIC HYPERTROPHY WITH MCC,,,4481.0,21497.74,18 MS-DRG,725,MS-DRG 32.00:BENIGN PROSTATIC HYPERTROPHY W MCC,,,4481.0,4481.0,1 MS-DRG,725,MS-DRG 42.00: BENIGN PROSTATIC HYPERTROPHY WITH MCC,,,4481.0,7661.44,10 MS-DRG,726,BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC,,,4481.0,13263.86,18 MS-DRG,726,MS-DRG 32.00:BENIGN PROSTATIC HYPERTROPHY W/O MCC,,,4481.0,4481.0,1 MS-DRG,726,MS-DRG 42.00: BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC,,,4481.0,5165.7,10 MS-DRG,727,INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC,,,4481.0,27242.36,18 MS-DRG,727,MS-DRG 32.00:INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM W MCC,,,4481.0,4481.0,1 MS-DRG,727,MS-DRG 42.00: INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC,,,4481.0,10438.28,10 MS-DRG,728,INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC,,,4481.0,14902.56,18 MS-DRG,728,MS-DRG 32.00:INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM W/O MCC,,,4481.0,4481.0,1 MS-DRG,728,MS-DRG 42.00: INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC,,,4481.0,7401.9,10 MS-DRG,729,MS-DRG 32.00:OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,729,MS-DRG 42.00: OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC,,,4481.0,5713.53,10 MS-DRG,729,OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC,,,4481.0,19449.38,18 MS-DRG,730,MS-DRG 32.00:OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,730,MS-DRG 42.00: OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC,,,4481.0,5713.53,10 MS-DRG,730,OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC,,,4481.0,12345.31,18 MS-DRG,734,"MS-DRG 32.00:PELVIC EVISCERATION, RAD HYSTERECTOMY & RAD VULVECTOMY W CC/MCC",,,4481.0,4481.0,1 MS-DRG,734,"MS-DRG 42.00: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC",,,4481.0,14934.02,10 MS-DRG,734,"PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC",,,4481.0,39130.23,18 MS-DRG,735,"MS-DRG 32.00:PELVIC EVISCERATION, RAD HYSTERECTOMY & RAD VULVECTOMY W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,735,"MS-DRG 42.00: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC",,,4481.0,11162.12,10 MS-DRG,735,"PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC",,,4481.0,24718.18,18 MS-DRG,736,MS-DRG 32.00:UTERINE & ADNEXA PROC FOR OVARIAN OR ADNEXAL MALIGNANCY W MCC,,,4481.0,4481.0,1 MS-DRG,736,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC,,,4481.0,29725.25,10 MS-DRG,736,UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC,,,4481.0,65667.14,18 MS-DRG,737,MS-DRG 32.00:UTERINE & ADNEXA PROC FOR OVARIAN OR ADNEXAL MALIGNANCY W CC,,,4481.0,4481.0,1 MS-DRG,737,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC,,,4481.0,16552.35,10 MS-DRG,737,UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC,,,4481.0,37855.28,18 MS-DRG,738,MS-DRG 32.00:UTERINE & ADNEXA PROC FOR OVARIAN OR ADNEXAL MALIGNANCY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,738,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC,,,4481.0,12265.85,10 MS-DRG,738,UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC,,,4481.0,26977.81,18 MS-DRG,739,"MS-DRG 32.00:UTERINE,ADNEXA PROC FOR NON-OVARIAN/ADNEXAL MALIG W MCC",,,4481.0,4481.0,1 MS-DRG,739,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC,,,4481.0,24528.12,10 MS-DRG,739,UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC,,,4481.0,64781.66,18 MS-DRG,740,"MS-DRG 32.00:UTERINE,ADNEXA PROC FOR NON-OVARIAN/ADNEXAL MALIG W CC",,,4481.0,4481.0,1 MS-DRG,740,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC,,,4481.0,16295.5,10 MS-DRG,740,UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC,,,4481.0,33244.16,18 MS-DRG,741,"MS-DRG 32.00:UTERINE,ADNEXA PROC FOR NON-OVARIAN/ADNEXAL MALIG W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,741,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC,,,4481.0,13740.49,10 MS-DRG,741,UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC,,,4481.0,26198.88,18 MS-DRG,742,MS-DRG 32.00:UTERINE & ADNEXA PROC FOR NON-MALIGNANCY W CC/MCC,,,4481.0,4481.0,1 MS-DRG,742,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC,,,4481.0,14401.47,10 MS-DRG,742,UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC,,,4481.0,33707.11,18 MS-DRG,743,MS-DRG 32.00:UTERINE & ADNEXA PROC FOR NON-MALIGNANCY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,743,MS-DRG 42.00: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC,,,4481.0,9099.26,10 MS-DRG,743,UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC,,,4481.0,22792.9,18 MS-DRG,744,"D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC",,,4481.0,37644.02,18 MS-DRG,744,"MS-DRG 32.00:D&C, CONIZATION, LAPAROSCOPY & TUBAL INTERRUPTION W CC/MCC",,,4481.0,4481.0,1 MS-DRG,744,"MS-DRG 42.00: D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC",,,4481.0,11584.22,10 MS-DRG,745,"D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC",,,4481.0,20897.01,18 MS-DRG,745,"MS-DRG 32.00:D&C, CONIZATION, LAPAROSCOPY & TUBAL INTERRUPTION W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,745,"MS-DRG 42.00: D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC",,,4481.0,7810.52,10 MS-DRG,746,"MS-DRG 32.00:VAGINA, CERVIX & VULVA PROCEDURES W CC/MCC",,,4481.0,4481.0,1 MS-DRG,746,"MS-DRG 42.00: VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC",,,4481.0,10839.72,10 MS-DRG,746,"VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC",,,4481.0,31912.26,18 MS-DRG,747,"MS-DRG 32.00:VAGINA, CERVIX & VULVA PROCEDURES W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,747,"MS-DRG 42.00: VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC",,,4481.0,7779.99,10 MS-DRG,747,"VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC",,,4481.0,15422.45,18 MS-DRG,748,FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES,,,4481.0,25486.09,18 MS-DRG,748,MS-DRG 32.00:FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES,,,4481.0,4481.0,1 MS-DRG,748,MS-DRG 42.00: FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES,,,4481.0,9918.3,10 MS-DRG,749,MS-DRG 32.00:OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,749,MS-DRG 42.00: OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC,,,4481.0,17637.22,10 MS-DRG,749,OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC,,,4481.0,47169.38,18 MS-DRG,750,MS-DRG 32.00:OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,750,MS-DRG 42.00: OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,11426.16,10 MS-DRG,750,OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,27111.92,18 MS-DRG,754,"MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC",,,4481.0,33833.87,18 MS-DRG,754,"MS-DRG 32.00:MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W MCC",,,4481.0,4481.0,1 MS-DRG,754,"MS-DRG 42.00: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC",,,4481.0,11259.12,10 MS-DRG,755,"MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC",,,4481.0,19983.97,18 MS-DRG,755,"MS-DRG 32.00:MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC",,,4481.0,4481.0,1 MS-DRG,755,"MS-DRG 42.00: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC",,,4481.0,7602.17,10 MS-DRG,756,"MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC",,,4481.0,17645.35,18 MS-DRG,756,"MS-DRG 32.00:MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,756,"MS-DRG 42.00: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC",,,4481.0,7602.17,10 MS-DRG,757,"INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC",,,4481.0,26305.43,18 MS-DRG,757,"MS-DRG 32.00:INFECTIONS, FEMALE REPRODUCTIVE SYSTEM W MCC",,,4481.0,4481.0,1 MS-DRG,757,"MS-DRG 42.00: INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC",,,4481.0,10866.66,10 MS-DRG,758,"INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC",,,4481.0,17985.21,18 MS-DRG,758,"MS-DRG 32.00:INFECTIONS, FEMALE REPRODUCTIVE SYSTEM W CC",,,4481.0,4481.0,1 MS-DRG,758,"MS-DRG 42.00: INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC",,,4481.0,6103.29,10 MS-DRG,759,"INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC",,,4481.0,12191.0,18 MS-DRG,759,"MS-DRG 32.00:INFECTIONS, FEMALE REPRODUCTIVE SYSTEM W/O CC/MCC",,,4481.0,4481.0,1 MS-DRG,759,"MS-DRG 42.00: INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC",,,4481.0,5307.6,10 MS-DRG,760,MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC,,,4481.0,18508.78,18 MS-DRG,760,MS-DRG 32.00:MENSTRUAL & OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS W CC/MCC,,,4481.0,4481.0,1 MS-DRG,760,MS-DRG 42.00: MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC,,,4481.0,9077.7,10 MS-DRG,761,MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC,,,4395.6,10464.12,18 MS-DRG,761,MS-DRG 32.00:MENSTRUAL & OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,761,MS-DRG 42.00: MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC,,,4481.0,5825.79,10 MS-DRG,765,MS-DRG 32.00:CESAREAN SECTION W CC/MCC,,,4481.0,4481.0,1 MS-DRG,766,MS-DRG 32.00:CESAREAN SECTION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,767,MS-DRG 32.00:VAGINAL DELIVERY W STERILIZATION &/OR D&C,,,4481.0,4481.0,1 MS-DRG,768,MS-DRG 32.00:VAGINAL DELIVERY W O.R. PROC EXCEPT STERIL &/OR D&C,,,4481.0,4481.0,1 MS-DRG,768,MS-DRG 42.00: VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C,,,4481.0,7821.3,10 MS-DRG,768,VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C,,,3652.0,15389.88,19 MS-DRG,769,MS-DRG 32.00:POSTPARTUM & POST ABORTION DIAGNOSES W O.R. PROCEDURE,,,4481.0,4481.0,1 MS-DRG,769,MS-DRG 42.00: POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES,,,4481.0,10726.56,10 MS-DRG,769,POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES,,,4481.0,31043.32,18 MS-DRG,770,"ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY",,,4481.0,18420.6,18 MS-DRG,770,"MS-DRG 32.00:ABORTION W D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY",,,4481.0,4481.0,1 MS-DRG,770,"MS-DRG 42.00: ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY",,,4481.0,7395.61,10 MS-DRG,774,MS-DRG 32.00:VAGINAL DELIVERY W COMPLICATING DIAGNOSES,,,4481.0,4481.0,1 MS-DRG,775,MS-DRG 32.00:VAGINAL DELIVERY W/O COMPLICATING DIAGNOSES,,,4481.0,4481.0,1 MS-DRG,776,MS-DRG 32.00:POSTPARTUM & POST ABORTION DIAGNOSES W/O O.R. PROCEDURE,,,4481.0,4481.0,1 MS-DRG,776,MS-DRG 42.00: POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES,,,4481.0,5048.06,10 MS-DRG,776,POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES,,,4481.0,12027.49,18 MS-DRG,777,MS-DRG 32.00:ECTOPIC PREGNANCY,,,4481.0,4481.0,1 MS-DRG,778,MS-DRG 32.00:THREATENED ABORTION,,,4481.0,4481.0,1 MS-DRG,779,ABORTION WITHOUT D&C,,,4481.0,13100.36,18 MS-DRG,779,MS-DRG 32.00:ABORTION W/O D&C,,,4481.0,4481.0,1 MS-DRG,779,MS-DRG 42.00: ABORTION WITHOUT D&C,,,4481.0,4914.24,10 MS-DRG,780,MS-DRG 32.00:FALSE LABOR,,,4481.0,4481.0,1 MS-DRG,781,MS-DRG 32.00:OTHER ANTEPARTUM DIAGNOSES W MEDICAL COMPLICATIONS,,,4481.0,4481.0,1 MS-DRG,782,MS-DRG 32.00:OTHER ANTEPARTUM DIAGNOSES W/O MEDICAL COMPLICATIONS,,,4481.0,4481.0,1 MS-DRG,783,CESAREAN SECTION WITH STERILIZATION WITH MCC,,,4481.0,29553.98,19 MS-DRG,783,MS-DRG 42.00: CESAREAN SECTION WITH STERILIZATION WITH MCC,,,4481.0,10443.67,10 MS-DRG,784,CESAREAN SECTION WITH STERILIZATION WITH CC,,,4481.0,16018.0,19 MS-DRG,784,MS-DRG 42.00: CESAREAN SECTION WITH STERILIZATION WITH CC,,,4481.0,8357.45,10 MS-DRG,785,CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC,,,4481.0,16018.0,19 MS-DRG,785,MS-DRG 42.00: CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC,,,4481.0,7409.98,10 MS-DRG,786,CESAREAN SECTION WITHOUT STERILIZATION WITH MCC,,,4481.0,21306.35,19 MS-DRG,786,MS-DRG 42.00: CESAREAN SECTION WITHOUT STERILIZATION WITH MCC,,,4481.0,11083.09,10 MS-DRG,787,CESAREAN SECTION WITHOUT STERILIZATION WITH CC,,,4481.0,16018.0,19 MS-DRG,787,MS-DRG 42.00: CESAREAN SECTION WITHOUT STERILIZATION WITH CC,,,4481.0,9164.81,10 MS-DRG,788,CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC,,,4481.0,16018.0,19 MS-DRG,788,MS-DRG 42.00: CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC,,,4481.0,8150.89,10 MS-DRG,789,"MS-DRG 32.00:NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY",,,4481.0,4481.0,1 MS-DRG,789,"MS-DRG 42.00: NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY",,,4481.0,19418.99,10 MS-DRG,789,"NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY",,,4481.0,33108.22,18 MS-DRG,790,"EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE",,,4481.0,109188.04,18 MS-DRG,790,"MS-DRG 32.00:EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE",,,4481.0,4481.0,1 MS-DRG,790,"MS-DRG 42.00: EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE",,,4481.0,76911.7,10 MS-DRG,791,MS-DRG 32.00:PREMATURITY W MAJOR PROBLEMS,,,4481.0,4481.0,1 MS-DRG,791,MS-DRG 42.00: PREMATURITY WITH MAJOR PROBLEMS,,,4481.0,23877.01,10 MS-DRG,791,PREMATURITY WITH MAJOR PROBLEMS,,,4481.0,74567.89,18 MS-DRG,792,MS-DRG 32.00:PREMATURITY W/O MAJOR PROBLEMS,,,4481.0,4481.0,1 MS-DRG,792,MS-DRG 42.00: PREMATURITY WITHOUT MAJOR PROBLEMS,,,4481.0,8462.52,10 MS-DRG,792,PREMATURITY WITHOUT MAJOR PROBLEMS,,,1833.0,44994.25,18 MS-DRG,793,FULL TERM NEONATE WITH MAJOR PROBLEMS,,,1833.0,76599.72,18 MS-DRG,793,MS-DRG 32.00:FULL TERM NEONATE W MAJOR PROBLEMS,,,4481.0,4481.0,1 MS-DRG,793,MS-DRG 42.00: FULL TERM NEONATE WITH MAJOR PROBLEMS,,,4481.0,10709.5,10 MS-DRG,794,MS-DRG 32.00:NEONATE W OTHER SIGNIFICANT PROBLEMS,,,4481.0,4481.0,1 MS-DRG,794,MS-DRG 42.00: NEONATE WITH OTHER SIGNIFICANT PROBLEMS,,,2904.35,4481.0,10 MS-DRG,794,NEONATE WITH OTHER SIGNIFICANT PROBLEMS,,,1833.0,27113.76,18 MS-DRG,795,MS-DRG 32.00:NORMAL NEWBORN,,,4481.0,4481.0,1 MS-DRG,795,MS-DRG 42.00: NORMAL NEWBORN,,,2076.9,4481.0,10 MS-DRG,795,NORMAL NEWBORN,,,457.0,6464.49,18 MS-DRG,796,MS-DRG 42.00: VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC,,,4481.0,11429.75,10 MS-DRG,796,VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC,,,3652.0,16366.57,19 MS-DRG,797,MS-DRG 42.00: VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC,,,4481.0,8251.48,10 MS-DRG,797,VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC,,,3652.0,14660.93,19 MS-DRG,798,MS-DRG 42.00: VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC,,,4481.0,8022.47,10 MS-DRG,798,VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC,,,3652.0,14217.65,19 MS-DRG,799,MS-DRG 32.00:SPLENECTOMY W MCC,,,4481.0,4481.0,1 MS-DRG,799,MS-DRG 42.00: SPLENIC PROCEDURES WITH MCC,,,4481.0,31790.82,10 MS-DRG,799,SPLENIC PROCEDURES WITH MCC,,,4481.0,83200.42,18 MS-DRG,800,MS-DRG 32.00:SPLENECTOMY W CC,,,4481.0,4481.0,1 MS-DRG,800,MS-DRG 42.00: SPLENIC PROCEDURES WITH CC,,,4481.0,15285.17,10 MS-DRG,800,SPLENIC PROCEDURES WITH CC,,,4481.0,51611.49,18 MS-DRG,801,MS-DRG 32.00:SPLENECTOMY W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,801,MS-DRG 42.00: SPLENIC PROCEDURES WITHOUT CC/MCC,,,4481.0,10795.71,10 MS-DRG,801,SPLENIC PROCEDURES WITHOUT CC/MCC,,,4481.0,35068.4,18 MS-DRG,802,MS-DRG 32.00:OTHER O.R. PROC OF THE BLOOD & BLOOD FORMING ORGANS W MCC,,,4481.0,4481.0,1 MS-DRG,802,MS-DRG 42.00: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC,,,4481.0,38953.83,10 MS-DRG,802,OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC,,,4481.0,73191.9,18 MS-DRG,803,MS-DRG 32.00:OTHER O.R. PROC OF THE BLOOD & BLOOD FORMING ORGANS W CC,,,4481.0,4481.0,1 MS-DRG,803,MS-DRG 42.00: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC,,,4481.0,14286.51,10 MS-DRG,803,OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC,,,4481.0,34149.85,18 MS-DRG,804,MS-DRG 32.00:OTHER O.R. PROC OF THE BLOOD & BLOOD FORMING ORGANS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,804,MS-DRG 42.00: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC,,,4481.0,13539.32,10 MS-DRG,804,OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC,,,4481.0,24911.08,18 MS-DRG,805,MS-DRG 42.00: VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC,,,4481.0,7478.24,10 MS-DRG,805,VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC,,,3652.0,15467.69,19 MS-DRG,806,MS-DRG 42.00: VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC,,,4481.0,6638.54,10 MS-DRG,806,VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC,,,3652.0,12138.31,19 MS-DRG,807,MS-DRG 42.00: VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC,,,4481.0,6058.39,10 MS-DRG,807,VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC,,,3652.0,11321.36,19 MS-DRG,808,MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC,,,4481.0,40561.33,18 MS-DRG,808,MS-DRG 32.00:MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W MCC,,,4481.0,4481.0,1 MS-DRG,808,MS-DRG 42.00: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC,,,4481.0,17604.89,10 MS-DRG,809,MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC,,,4481.0,23255.85,18 MS-DRG,809,MS-DRG 32.00:MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W CC,,,4481.0,4481.0,1 MS-DRG,809,MS-DRG 42.00: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC,,,4481.0,10333.2,10 MS-DRG,810,MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC,,,4481.0,19227.09,18 MS-DRG,810,MS-DRG 32.00:MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,810,MS-DRG 42.00: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC,,,4481.0,7677.61,10 MS-DRG,811,MS-DRG 32.00:RED BLOOD CELL DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,811,MS-DRG 42.00: RED BLOOD CELL DISORDERS WITH MCC,,,4481.0,14375.42,10 MS-DRG,811,RED BLOOD CELL DISORDERS WITH MCC,,,4481.0,25798.4,18 MS-DRG,812,MS-DRG 32.00:RED BLOOD CELL DISORDERS W/O MCC,,,4481.0,4481.0,1 MS-DRG,812,MS-DRG 42.00: RED BLOOD CELL DISORDERS WITHOUT MCC,,,4481.0,8231.72,10 MS-DRG,812,RED BLOOD CELL DISORDERS WITHOUT MCC,,,4481.0,16868.25,18 MS-DRG,813,COAGULATION DISORDERS,,,4481.0,28021.29,18 MS-DRG,813,MS-DRG 32.00:COAGULATION DISORDERS,,,4481.0,4481.0,1 MS-DRG,813,MS-DRG 42.00: COAGULATION DISORDERS,,,4481.0,17427.07,10 MS-DRG,814,MS-DRG 32.00:RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC,,,4481.0,4481.0,1 MS-DRG,814,MS-DRG 42.00: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC,,,4481.0,14741.84,10 MS-DRG,814,RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC,,,4481.0,39069.61,18 MS-DRG,815,MS-DRG 32.00:RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC,,,4481.0,4481.0,1 MS-DRG,815,MS-DRG 42.00: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC,,,4481.0,8002.71,10 MS-DRG,815,RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC,,,4481.0,18628.19,18 MS-DRG,816,MS-DRG 32.00:RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,816,MS-DRG 42.00: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC,,,4481.0,4821.74,10 MS-DRG,816,RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC,,,4481.0,11610.47,18 MS-DRG,817,MS-DRG 42.00: OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC,,,4481.0,11796.16,10 MS-DRG,817,OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC,,,4481.0,31010.25,18 MS-DRG,818,MS-DRG 42.00: OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC,,,4481.0,9929.07,10 MS-DRG,818,OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC,,,4481.0,19366.71,18 MS-DRG,819,MS-DRG 42.00: OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,7034.59,10 MS-DRG,819,OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,15797.22,18 MS-DRG,820,LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC,,,4481.0,107742.24,18 MS-DRG,820,MS-DRG 32.00:LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC,,,4481.0,4481.0,1 MS-DRG,820,MS-DRG 42.00: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC,,,4481.0,59088.58,10 MS-DRG,821,LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC,,,4481.0,41125.32,18 MS-DRG,821,MS-DRG 32.00:LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC,,,4481.0,4481.0,1 MS-DRG,821,MS-DRG 42.00: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC,,,4481.0,18968.16,10 MS-DRG,822,LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,22118.68,18 MS-DRG,822,MS-DRG 32.00:LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,822,MS-DRG 42.00: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,10535.27,10 MS-DRG,823,LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC,,,4481.0,84227.36,18 MS-DRG,823,MS-DRG 32.00:LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC,,,4481.0,4481.0,1 MS-DRG,823,MS-DRG 42.00: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC,,,4481.0,34847.85,10 MS-DRG,824,LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC,,,4481.0,41621.34,18 MS-DRG,824,MS-DRG 32.00:LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC,,,4481.0,4481.0,1 MS-DRG,824,MS-DRG 42.00: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC,,,4481.0,20641.26,10 MS-DRG,825,LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC,,,4481.0,24789.83,18 MS-DRG,825,MS-DRG 32.00:LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,825,MS-DRG 42.00: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC,,,4481.0,14887.32,10 MS-DRG,826,MS-DRG 32.00:MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC,,,4481.0,4481.0,1 MS-DRG,826,MS-DRG 42.00: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC,,,4481.0,34046.77,10 MS-DRG,826,MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC,,,4481.0,85935.86,18 MS-DRG,827,MS-DRG 32.00:MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC,,,4481.0,4481.0,1 MS-DRG,827,MS-DRG 42.00: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC,,,4481.0,21696.5,10 MS-DRG,827,MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC,,,4481.0,42459.06,15 MS-DRG,828,MS-DRG 32.00:MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,828,MS-DRG 42.00: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,15360.61,10 MS-DRG,828,MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,31300.51,15 MS-DRG,829,MS-DRG 32.00:MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC,,,4481.0,4481.0,1 MS-DRG,829,MS-DRG 42.00: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC,,,4481.0,24458.07,10 MS-DRG,829,MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC,,,4481.0,58052.36,15 MS-DRG,830,MS-DRG 32.00:MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,830,MS-DRG 42.00: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC,,,4481.0,12942.1,10 MS-DRG,830,MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC,,,4481.0,27648.35,15 MS-DRG,831,MS-DRG 42.00: OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC,,,4481.0,7895.84,10 MS-DRG,831,OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC,,,4481.0,22091.13,15 MS-DRG,832,MS-DRG 42.00: OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC,,,4481.0,5467.46,10 MS-DRG,832,OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC,,,4481.0,13256.51,15 MS-DRG,833,MS-DRG 42.00: OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,4962.74,10 MS-DRG,833,OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,9772.36,15 MS-DRG,834,ACUTE LEUKEMIA WITH MCC,,,4481.0,100854.95,15 MS-DRG,834,MS-DRG 32.00:ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC,,,4481.0,4481.0,1 MS-DRG,834,MS-DRG 42.00: ACUTE LEUKEMIA WITH MCC,,,4481.0,84591.1,10 MS-DRG,835,ACUTE LEUKEMIA WITH CC,,,4481.0,38318.23,15 MS-DRG,835,MS-DRG 32.00:ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC,,,4481.0,4481.0,1 MS-DRG,835,MS-DRG 42.00: ACUTE LEUKEMIA WITH CC,,,4481.0,28717.62,10 MS-DRG,836,ACUTE LEUKEMIA WITHOUT CC/MCC,,,4481.0,22403.43,15 MS-DRG,836,MS-DRG 32.00:ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,836,MS-DRG 42.00: ACUTE LEUKEMIA WITHOUT CC/MCC,,,4481.0,13808.74,10 MS-DRG,837,CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC,,,4481.0,88259.8,14 MS-DRG,837,MS-DRG 32.00:CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC,,,4481.0,4481.0,1 MS-DRG,837,MS-DRG 42.00: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC,,,4481.0,37616.6,10 MS-DRG,838,CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT,,,4481.0,38347.63,14 MS-DRG,838,MS-DRG 32.00:CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT,,,4481.0,4481.0,1 MS-DRG,838,MS-DRG 42.00: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT,,,4481.0,12356.56,10 MS-DRG,839,CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC,,,4481.0,26525.89,14 MS-DRG,839,MS-DRG 32.00:CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,839,MS-DRG 42.00: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC,,,4481.0,8360.14,10 MS-DRG,840,LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC,,,4481.0,59428.35,18 MS-DRG,840,MS-DRG 32.00:LYMPHOMA & NON-ACUTE LEUKEMIA W MCC,,,4481.0,4481.0,1 MS-DRG,840,MS-DRG 42.00: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC,,,4481.0,22816.39,10 MS-DRG,841,LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC,,,4481.0,29970.45,18 MS-DRG,841,MS-DRG 32.00:LYMPHOMA & NON-ACUTE LEUKEMIA W CC,,,4481.0,4481.0,1 MS-DRG,841,MS-DRG 42.00: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC,,,4481.0,15261.82,10 MS-DRG,842,LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC,,,4481.0,18562.06,18 MS-DRG,842,MS-DRG 32.00:LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,842,MS-DRG 42.00: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC,,,4481.0,9109.13,10 MS-DRG,843,MS-DRG 32.00:OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC,,,4481.0,4481.0,1 MS-DRG,843,MS-DRG 42.00: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC,,,4481.0,13350.72,10 MS-DRG,843,OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC,,,4481.0,36646.47,18 MS-DRG,844,MS-DRG 32.00:OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC,,,4481.0,4481.0,1 MS-DRG,844,MS-DRG 42.00: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC,,,4481.0,7555.47,10 MS-DRG,844,OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC,,,4481.0,22364.86,18 MS-DRG,845,MS-DRG 32.00:OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,845,MS-DRG 42.00: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC,,,4481.0,7555.47,10 MS-DRG,845,OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC,,,4481.0,15644.74,18 MS-DRG,846,CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC,,,4481.0,47626.82,14 MS-DRG,846,MS-DRG 32.00:CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC,,,4481.0,4481.0,1 MS-DRG,846,MS-DRG 42.00: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC,,,4481.0,10271.24,10 MS-DRG,847,CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC,,,4481.0,24032.94,14 MS-DRG,847,MS-DRG 32.00:CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC,,,4481.0,4481.0,1 MS-DRG,847,MS-DRG 42.00: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC,,,4481.0,10271.24,10 MS-DRG,848,CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC,,,4481.0,15604.33,14 MS-DRG,848,MS-DRG 32.00:CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,848,MS-DRG 42.00: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC,,,3978.54,4481.0,10 MS-DRG,849,MS-DRG 32.00:RADIOTHERAPY,,,4481.0,4481.0,1 MS-DRG,849,MS-DRG 42.00: RADIOTHERAPY,,,4481.0,29024.76,10 MS-DRG,849,RADIOTHERAPY,,,4481.0,49776.22,18 MS-DRG,850,ACUTE LEUKEMIA WITH OTHER PROCEDURES,,,4481.0,159083.67,18 MS-DRG,850,MS-DRG 42.00: ACUTE LEUKEMIA WITH OTHER PROCEDURES,,,4481.0,100098.99,10 MS-DRG,853,INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC,,,4481.0,90727.02,18 MS-DRG,853,MS-DRG 32.00:INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC,,,4481.0,4481.0,1 MS-DRG,853,MS-DRG 42.00: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC,,,4481.0,55516.95,10 MS-DRG,854,INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC,,,4481.0,36707.1,18 MS-DRG,854,MS-DRG 32.00:INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC,,,4481.0,4481.0,1 MS-DRG,854,MS-DRG 42.00: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC,,,4481.0,19489.94,10 MS-DRG,855,INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,27505.06,18 MS-DRG,855,MS-DRG 32.00:INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,855,MS-DRG 42.00: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,12388.89,10 MS-DRG,856,MS-DRG 32.00:POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC,,,4481.0,4481.0,1 MS-DRG,856,MS-DRG 42.00: POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC,,,4481.0,38566.76,10 MS-DRG,856,POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC,,,4481.0,83564.17,18 MS-DRG,857,MS-DRG 32.00:POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC,,,4481.0,4481.0,1 MS-DRG,857,MS-DRG 42.00: POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC,,,4481.0,17187.28,10 MS-DRG,857,POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC,,,4481.0,39341.5,18 MS-DRG,858,MS-DRG 32.00:POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,858,MS-DRG 42.00: POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,9066.03,10 MS-DRG,858,POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC,,,4481.0,25588.97,18 MS-DRG,862,MS-DRG 32.00:POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC,,,4481.0,4481.0,1 MS-DRG,862,MS-DRG 42.00: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC,,,4481.0,12666.39,10 MS-DRG,862,POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC,,,4481.0,33503.19,18 MS-DRG,863,MS-DRG 32.00:POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC,,,4481.0,4481.0,1 MS-DRG,863,MS-DRG 42.00: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC,,,4481.0,9215.11,10 MS-DRG,863,POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC,,,4481.0,18332.42,18 MS-DRG,864,FEVER AND INFLAMMATORY CONDITIONS,,,4481.0,16307.94,18 MS-DRG,864,MS-DRG 32.00:FEVER,,,4481.0,4481.0,1 MS-DRG,864,MS-DRG 42.00: FEVER AND INFLAMMATORY CONDITIONS,,,4481.0,6898.98,10 MS-DRG,865,MS-DRG 32.00:VIRAL ILLNESS W MCC,,,4481.0,4481.0,1 MS-DRG,865,MS-DRG 42.00: VIRAL ILLNESS WITH MCC,,,4481.0,10538.86,10 MS-DRG,865,VIRAL ILLNESS WITH MCC,,,4481.0,27525.27,18 MS-DRG,866,MS-DRG 32.00:VIRAL ILLNESS W/O MCC,,,4481.0,4481.0,1 MS-DRG,866,MS-DRG 42.00: VIRAL ILLNESS WITHOUT MCC,,,4481.0,4922.33,10 MS-DRG,866,VIRAL ILLNESS WITHOUT MCC,,,4481.0,15975.42,18 MS-DRG,867,MS-DRG 32.00:OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC,,,4481.0,4481.0,1 MS-DRG,867,MS-DRG 42.00: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC,,,4481.0,15536.63,10 MS-DRG,867,OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC,,,4481.0,38454.18,18 MS-DRG,868,MS-DRG 32.00:OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC,,,4481.0,4481.0,1 MS-DRG,868,MS-DRG 42.00: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC,,,4481.0,7480.93,10 MS-DRG,868,OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC,,,4481.0,18942.34,18 MS-DRG,869,MS-DRG 32.00:OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,869,MS-DRG 42.00: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC,,,4481.0,7480.93,10 MS-DRG,869,OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC,,,4481.0,13405.32,18 MS-DRG,870,MS-DRG 32.00:SEPTICEMIA OR SEVERE SEPSIS W MV 96+ HOURS,,,4481.0,4481.0,1 MS-DRG,870,MS-DRG 42.00: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS,,,4481.0,66131.25,10 MS-DRG,870,SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS,,,4481.0,126976.68,18 MS-DRG,871,MS-DRG 32.00:SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W MCC,,,4481.0,4481.0,1 MS-DRG,871,MS-DRG 42.00: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC,,,4481.0,19012.16,10 MS-DRG,871,SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC,,,4481.0,35685.67,18 MS-DRG,872,MS-DRG 32.00:SEPTICEMIA OR SEVERE SEPSIS W/O MV 96+ HOURS W/O MCC,,,4481.0,4481.0,1 MS-DRG,872,MS-DRG 42.00: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC,,,4481.0,8846.9,10 MS-DRG,872,SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC,,,4481.0,18799.04,18 MS-DRG,876,MS-DRG 32.00:O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS,,,4481.0,4481.0,1 MS-DRG,876,MS-DRG 42.00: O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS,,,4481.0,4481.0,1 MS-DRG,876,O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS,,,1331.99,71002.08,27 MS-DRG,880,ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION,,,1096.0,17639.83,28 MS-DRG,880,MS-DRG 32.00:ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION,,,4481.0,4481.0,1 MS-DRG,880,MS-DRG 42.00: ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION,,,4481.0,4481.0,1 MS-DRG,881,DEPRESSIVE NEUROSES,,,1096.0,17285.27,28 MS-DRG,881,MS-DRG 32.00:DEPRESSIVE NEUROSES,,,4481.0,4481.0,1 MS-DRG,881,MS-DRG 42.00: DEPRESSIVE NEUROSES,,,4481.0,4481.0,1 MS-DRG,882,MS-DRG 32.00:NEUROSES EXCEPT DEPRESSIVE,,,4481.0,4481.0,1 MS-DRG,882,MS-DRG 42.00: NEUROSES EXCEPT DEPRESSIVE,,,4481.0,4481.0,1 MS-DRG,882,NEUROSES EXCEPT DEPRESSIVE,,,1096.0,19726.78,28 MS-DRG,883,DISORDERS OF PERSONALITY AND IMPULSE CONTROL,,,1096.0,36122.9,28 MS-DRG,883,MS-DRG 32.00:DISORDERS OF PERSONALITY & IMPULSE CONTROL,,,4481.0,4481.0,1 MS-DRG,883,MS-DRG 42.00: DISORDERS OF PERSONALITY AND IMPULSE CONTROL,,,4481.0,4481.0,1 MS-DRG,884,MS-DRG 32.00:ORGANIC DISTURBANCES & MENTAL RETARDATION,,,4481.0,4481.0,1 MS-DRG,884,MS-DRG 42.00: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY,,,4481.0,4481.0,1 MS-DRG,884,ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY,,,1096.0,29557.1,28 MS-DRG,885,MS-DRG 32.00:PSYCHOSES,,,4481.0,4481.0,1 MS-DRG,885,MS-DRG 42.00: PSYCHOSES,,,4481.0,4481.0,1 MS-DRG,885,PSYCHOSES,,,1096.0,25660.61,28 MS-DRG,886,BEHAVIORAL AND DEVELOPMENTAL DISORDERS,,,1096.0,38125.34,28 MS-DRG,886,MS-DRG 32.00:BEHAVIORAL & DEVELOPMENTAL DISORDERS,,,4481.0,4481.0,1 MS-DRG,886,MS-DRG 42.00: BEHAVIORAL AND DEVELOPMENTAL DISORDERS,,,4481.0,4481.0,1 MS-DRG,887,MS-DRG 32.00:OTHER MENTAL DISORDER DIAGNOSES,,,4481.0,4481.0,1 MS-DRG,887,MS-DRG 42.00: OTHER MENTAL DISORDER DIAGNOSES,,,4481.0,4481.0,1 MS-DRG,887,OTHER MENTAL DISORDER DIAGNOSES,,,1096.0,19673.5,28 MS-DRG,894,"ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA",,,1096.0,11333.07,28 MS-DRG,894,"MS-DRG 32.00:ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA",,,4481.0,4481.0,1 MS-DRG,894,"MS-DRG 42.00: ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA",,,4481.0,4481.0,1 MS-DRG,895,"ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY",,,1096.0,26005.99,28 MS-DRG,895,MS-DRG 32.00:ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY,,,4481.0,4481.0,1 MS-DRG,895,"MS-DRG 42.00: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY",,,4481.0,4481.0,1 MS-DRG,896,"ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC",,,1096.0,32059.23,28 MS-DRG,896,MS-DRG 32.00:ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC,,,4481.0,4481.0,1 MS-DRG,896,"MS-DRG 42.00: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC",,,4481.0,4481.0,1 MS-DRG,897,"ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC",,,1096.0,16217.92,28 MS-DRG,897,MS-DRG 32.00:ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC,,,4481.0,4481.0,1 MS-DRG,897,"MS-DRG 42.00: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC",,,4481.0,4481.0,1 MS-DRG,901,MS-DRG 32.00:WOUND DEBRIDEMENTS FOR INJURIES W MCC,,,4481.0,4481.0,1 MS-DRG,901,MS-DRG 42.00: WOUND DEBRIDEMENTS FOR INJURIES WITH MCC,,,4481.0,30088.07,10 MS-DRG,901,WOUND DEBRIDEMENTS FOR INJURIES WITH MCC,,,4481.0,77095.74,18 MS-DRG,902,MS-DRG 32.00:WOUND DEBRIDEMENTS FOR INJURIES W CC,,,4481.0,4481.0,1 MS-DRG,902,MS-DRG 42.00: WOUND DEBRIDEMENTS FOR INJURIES WITH CC,,,4481.0,13577.04,10 MS-DRG,902,WOUND DEBRIDEMENTS FOR INJURIES WITH CC,,,4481.0,35171.28,18 MS-DRG,903,MS-DRG 32.00:WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,903,MS-DRG 42.00: WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC,,,4481.0,8035.94,10 MS-DRG,903,WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC,,,4481.0,21486.72,18 MS-DRG,904,MS-DRG 32.00:SKIN GRAFTS FOR INJURIES W CC/MCC,,,4481.0,4481.0,1 MS-DRG,904,MS-DRG 42.00: SKIN GRAFTS FOR INJURIES WITH CC/MCC,,,4481.0,32418.57,10 MS-DRG,904,SKIN GRAFTS FOR INJURIES WITH CC/MCC,,,4481.0,67478.52,18 MS-DRG,905,MS-DRG 32.00:SKIN GRAFTS FOR INJURIES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,905,MS-DRG 42.00: SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC,,,4481.0,10339.49,10 MS-DRG,905,SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC,,,4481.0,26303.6,18 MS-DRG,906,HAND PROCEDURES FOR INJURIES,,,4481.0,32377.05,18 MS-DRG,906,MS-DRG 32.00:HAND PROCEDURES FOR INJURIES,,,4481.0,4481.0,1 MS-DRG,906,MS-DRG 42.00: HAND PROCEDURES FOR INJURIES,,,4481.0,11219.6,10 MS-DRG,907,MS-DRG 32.00:OTHER O.R. PROCEDURES FOR INJURIES W MCC,,,4481.0,4481.0,1 MS-DRG,907,MS-DRG 42.00: OTHER O.R. PROCEDURES FOR INJURIES WITH MCC,,,4481.0,37465.73,10 MS-DRG,907,OTHER O.R. PROCEDURES FOR INJURIES WITH MCC,,,4481.0,70531.78,18 MS-DRG,908,MS-DRG 32.00:OTHER O.R. PROCEDURES FOR INJURIES W CC,,,4481.0,4481.0,1 MS-DRG,908,MS-DRG 42.00: OTHER O.R. PROCEDURES FOR INJURIES WITH CC,,,4481.0,17253.74,10 MS-DRG,908,OTHER O.R. PROCEDURES FOR INJURIES WITH CC,,,4481.0,36653.82,18 MS-DRG,909,MS-DRG 32.00:OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,909,MS-DRG 42.00: OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC,,,4481.0,10807.39,10 MS-DRG,909,OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC,,,4481.0,24115.61,18 MS-DRG,913,MS-DRG 32.00:TRAUMATIC INJURY W MCC,,,4481.0,4481.0,1 MS-DRG,913,MS-DRG 42.00: TRAUMATIC INJURY WITH MCC,,,4481.0,8776.85,10 MS-DRG,913,TRAUMATIC INJURY WITH MCC,,,4481.0,30029.24,18 MS-DRG,914,MS-DRG 32.00:TRAUMATIC INJURY W/O MCC,,,4481.0,4481.0,1 MS-DRG,914,MS-DRG 42.00: TRAUMATIC INJURY WITHOUT MCC,,,4481.0,6694.22,10 MS-DRG,914,TRAUMATIC INJURY WITHOUT MCC,,,4481.0,16267.52,18 MS-DRG,915,ALLERGIC REACTIONS WITH MCC,,,4481.0,30892.67,18 MS-DRG,915,MS-DRG 32.00:ALLERGIC REACTIONS W MCC,,,4481.0,4481.0,1 MS-DRG,915,MS-DRG 42.00: ALLERGIC REACTIONS WITH MCC,,,4481.0,11506.98,10 MS-DRG,916,ALLERGIC REACTIONS WITHOUT MCC,,,4481.0,12240.6,18 MS-DRG,916,MS-DRG 32.00:ALLERGIC REACTIONS W/O MCC,,,4481.0,4481.0,1 MS-DRG,916,MS-DRG 42.00: ALLERGIC REACTIONS WITHOUT MCC,,,4481.0,6471.5,10 MS-DRG,917,MS-DRG 32.00:POISONING & TOXIC EFFECTS OF DRUGS W MCC,,,4481.0,4481.0,1 MS-DRG,917,MS-DRG 42.00: POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC,,,4481.0,15031.01,10 MS-DRG,917,POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC,,,4481.0,28813.08,18 MS-DRG,918,MS-DRG 32.00:POISONING & TOXIC EFFECTS OF DRUGS W/O MCC,,,4481.0,4481.0,1 MS-DRG,918,MS-DRG 42.00: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC,,,4481.0,6916.94,10 MS-DRG,918,POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC,,,4481.0,15745.78,18 MS-DRG,919,COMPLICATIONS OF TREATMENT WITH MCC,,,4481.0,33633.63,18 MS-DRG,919,MS-DRG 32.00:COMPLICATIONS OF TREATMENT W MCC,,,4481.0,4481.0,1 MS-DRG,919,MS-DRG 42.00: COMPLICATIONS OF TREATMENT WITH MCC,,,4481.0,13353.42,10 MS-DRG,920,COMPLICATIONS OF TREATMENT WITH CC,,,4481.0,18413.25,18 MS-DRG,920,MS-DRG 32.00:COMPLICATIONS OF TREATMENT W CC,,,4481.0,4481.0,1 MS-DRG,920,MS-DRG 42.00: COMPLICATIONS OF TREATMENT WITH CC,,,4481.0,11345.33,10 MS-DRG,921,COMPLICATIONS OF TREATMENT WITHOUT CC/MCC,,,4481.0,12646.6,18 MS-DRG,921,MS-DRG 32.00:COMPLICATIONS OF TREATMENT W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,921,MS-DRG 42.00: COMPLICATIONS OF TREATMENT WITHOUT CC/MCC,,,4481.0,6324.22,10 MS-DRG,922,"MS-DRG 32.00:OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC",,,4481.0,4481.0,1 MS-DRG,922,"MS-DRG 42.00: OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC",,,4481.0,13184.58,10 MS-DRG,922,"OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC",,,4481.0,32138.23,18 MS-DRG,923,"MS-DRG 32.00:OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC",,,4481.0,4481.0,1 MS-DRG,923,"MS-DRG 42.00: OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC",,,4481.0,7973.97,10 MS-DRG,923,"OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC",,,4481.0,18696.17,18 MS-DRG,927,EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT,,,4481.0,223002.55,12 MS-DRG,927,MS-DRG 32.00:EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT,,,4481.0,4481.0,1 MS-DRG,927,MS-DRG 42.00: EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT,,,4481.0,113181.19,10 MS-DRG,928,FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC,,,4481.0,77852.13,12 MS-DRG,928,MS-DRG 32.00:FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC,,,4481.0,4481.0,1 MS-DRG,928,MS-DRG 42.00: FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC,,,4481.0,44030.62,10 MS-DRG,929,FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC,,,4481.0,37393.1,12 MS-DRG,929,MS-DRG 32.00:FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,929,MS-DRG 42.00: FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC,,,4481.0,16255.98,10 MS-DRG,933,EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT,,,4481.0,44287.29,12 MS-DRG,933,MS-DRG 32.00:EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT,,,4481.0,4481.0,1 MS-DRG,933,MS-DRG 42.00: EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT,,,4481.0,47018.51,10 MS-DRG,934,FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY,,,4481.0,27050.8,12 MS-DRG,934,MS-DRG 32.00:FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ,,,4481.0,4481.0,1 MS-DRG,934,MS-DRG 42.00: FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY,,,4481.0,5903.02,10 MS-DRG,935,MS-DRG 32.00:NON-EXTENSIVE BURNS,,,4481.0,4481.0,1 MS-DRG,935,MS-DRG 42.00: NON-EXTENSIVE BURNS,,,4481.0,10919.65,10 MS-DRG,935,NON-EXTENSIVE BURNS,,,4481.0,25509.0,12 MS-DRG,939,MS-DRG 32.00:O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC,,,4481.0,4481.0,1 MS-DRG,939,MS-DRG 42.00: O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC,,,4481.0,31861.76,10 MS-DRG,939,O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC,,,4481.0,66659.17,18 MS-DRG,940,MS-DRG 32.00:O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC,,,4481.0,4481.0,1 MS-DRG,940,MS-DRG 42.00: O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC,,,4481.0,16581.08,10 MS-DRG,940,O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC,,,4481.0,42931.19,18 MS-DRG,941,MS-DRG 32.00:O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,941,MS-DRG 42.00: O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC,,,4481.0,13922.79,10 MS-DRG,941,O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC,,,4481.0,37250.88,18 MS-DRG,945,MS-DRG 32.00:REHABILITATION W CC/MCC,,,4481.0,4481.0,1 MS-DRG,945,MS-DRG 42.00: REHABILITATION WITH CC/MCC,,,4481.0,4481.0,1 MS-DRG,945,REHABILITATION WITH CC/MCC,,,1790.36,28449.33,27 MS-DRG,946,MS-DRG 32.00:REHABILITATION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,946,MS-DRG 42.00: REHABILITATION WITHOUT CC/MCC,,,4481.0,4481.0,1 MS-DRG,946,REHABILITATION WITHOUT CC/MCC,,,1790.36,21067.86,27 MS-DRG,947,MS-DRG 32.00:SIGNS & SYMPTOMS W MCC,,,4481.0,4481.0,1 MS-DRG,947,MS-DRG 42.00: SIGNS AND SYMPTOMS WITH MCC,,,4481.0,16935.82,10 MS-DRG,947,SIGNS AND SYMPTOMS WITH MCC,,,4481.0,23320.15,18 MS-DRG,948,MS-DRG 32.00:SIGNS & SYMPTOMS W/O MCC,,,4481.0,4481.0,1 MS-DRG,948,MS-DRG 42.00: SIGNS AND SYMPTOMS WITHOUT MCC,,,4481.0,9277.07,10 MS-DRG,948,SIGNS AND SYMPTOMS WITHOUT MCC,,,4481.0,14705.99,18 MS-DRG,949,AFTERCARE WITH CC/MCC,,,4481.0,21855.98,18 MS-DRG,949,MS-DRG 32.00:AFTERCARE W CC/MCC,,,4481.0,4481.0,1 MS-DRG,949,MS-DRG 42.00: AFTERCARE WITH CC/MCC,,,4481.0,40423.07,10 MS-DRG,950,AFTERCARE WITHOUT CC/MCC,,,4481.0,11531.48,18 MS-DRG,950,MS-DRG 32.00:AFTERCARE W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,950,MS-DRG 42.00: AFTERCARE WITHOUT CC/MCC,,,4481.0,15262.72,10 MS-DRG,951,MS-DRG 32.00:OTHER FACTORS INFLUENCING HEALTH STATUS,,,4481.0,4481.0,1 MS-DRG,951,MS-DRG 42.00: OTHER FACTORS INFLUENCING HEALTH STATUS,,,4481.0,6274.82,10 MS-DRG,951,OTHER FACTORS INFLUENCING HEALTH STATUS,,,4481.0,10214.28,18 MS-DRG,955,CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA,,,4481.0,123657.04,18 MS-DRG,955,MS-DRG 32.00:CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA,,,4481.0,4481.0,1 MS-DRG,955,MS-DRG 42.00: CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA,,,4481.0,71755.87,10 MS-DRG,956,"LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA",,,4481.0,69130.07,18 MS-DRG,956,"MS-DRG 32.00:LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA",,,4481.0,4481.0,1 MS-DRG,956,"MS-DRG 42.00: LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA",,,4481.0,46449.13,10 MS-DRG,957,MS-DRG 32.00:OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC,,,4481.0,4481.0,1 MS-DRG,957,MS-DRG 42.00: OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC,,,4481.0,68238.13,10 MS-DRG,957,OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC,,,4481.0,139985.18,18 MS-DRG,958,MS-DRG 32.00:OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC,,,4481.0,4481.0,1 MS-DRG,958,MS-DRG 42.00: OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC,,,4481.0,32837.07,10 MS-DRG,958,OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC,,,4481.0,77413.56,18 MS-DRG,959,MS-DRG 32.00:OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,959,MS-DRG 42.00: OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC,,,4481.0,17627.34,10 MS-DRG,959,OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC,,,4481.0,54086.06,18 MS-DRG,963,MS-DRG 32.00:OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC,,,4481.0,4481.0,1 MS-DRG,963,MS-DRG 42.00: OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC,,,4481.0,19624.65,10 MS-DRG,963,OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC,,,4481.0,50222.64,18 MS-DRG,964,MS-DRG 32.00:OTHER MULTIPLE SIGNIFICANT TRAUMA W CC,,,4481.0,4481.0,1 MS-DRG,964,MS-DRG 42.00: OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC,,,4481.0,12617.0,10 MS-DRG,964,OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC,,,4481.0,28155.39,18 MS-DRG,965,MS-DRG 32.00:OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,965,MS-DRG 42.00: OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC,,,4481.0,8575.68,10 MS-DRG,965,OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC,,,4481.0,17277.93,18 MS-DRG,969,HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC,,,4481.0,112454.4,18 MS-DRG,969,MS-DRG 32.00:HIV W EXTENSIVE O.R. PROCEDURE W MCC,,,4481.0,4481.0,1 MS-DRG,969,MS-DRG 42.00: HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC,,,4481.0,46751.78,10 MS-DRG,970,HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC,,,4481.0,48451.68,18 MS-DRG,970,MS-DRG 32.00:HIV W EXTENSIVE O.R. PROCEDURE W/O MCC,,,4481.0,4481.0,1 MS-DRG,970,MS-DRG 42.00: HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC,,,4481.0,28832.57,10 MS-DRG,974,HIV WITH MAJOR RELATED CONDITION WITH MCC,,,4481.0,53018.71,18 MS-DRG,974,MS-DRG 32.00:HIV W MAJOR RELATED CONDITION W MCC,,,4481.0,4481.0,1 MS-DRG,974,MS-DRG 42.00: HIV WITH MAJOR RELATED CONDITION WITH MCC,,,4481.0,36906.23,10 MS-DRG,975,HIV WITH MAJOR RELATED CONDITION WITH CC,,,4481.0,23790.44,18 MS-DRG,975,MS-DRG 32.00:HIV W MAJOR RELATED CONDITION W CC,,,4481.0,4481.0,1 MS-DRG,975,MS-DRG 42.00: HIV WITH MAJOR RELATED CONDITION WITH CC,,,4481.0,11859.03,10 MS-DRG,976,HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC,,,4481.0,16432.86,18 MS-DRG,976,MS-DRG 32.00:HIV W MAJOR RELATED CONDITION W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,976,MS-DRG 42.00: HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC,,,4481.0,5892.24,10 MS-DRG,977,HIV WITH OR WITHOUT OTHER RELATED CONDITION,,,4481.0,23287.08,18 MS-DRG,977,MS-DRG 32.00:HIV W OR W/O OTHER RELATED CONDITION,,,4481.0,4481.0,1 MS-DRG,977,MS-DRG 42.00: HIV WITH OR WITHOUT OTHER RELATED CONDITION,,,4481.0,14502.05,10 MS-DRG,981,EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC,,,4481.0,86193.06,18 MS-DRG,981,MS-DRG 32.00:EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC,,,4481.0,4481.0,1 MS-DRG,981,MS-DRG 42.00: EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC,,,4481.0,57714.53,10 MS-DRG,982,EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC,,,4481.0,45165.1,18 MS-DRG,982,MS-DRG 32.00:EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC,,,4481.0,4481.0,1 MS-DRG,982,MS-DRG 42.00: EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC,,,4481.0,17679.43,10 MS-DRG,983,EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC,,,4481.0,31487.89,18 MS-DRG,983,MS-DRG 32.00:EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,983,MS-DRG 42.00: EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC,,,4481.0,12317.94,10 MS-DRG,984,MS-DRG 32.00:PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC,,,4481.0,4481.0,1 MS-DRG,985,MS-DRG 32.00:PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC,,,4481.0,4481.0,1 MS-DRG,986,MS-DRG 32.00:PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,987,MS-DRG 32.00:NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC,,,4481.0,4481.0,1 MS-DRG,987,MS-DRG 42.00: NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC,,,4481.0,40115.93,10 MS-DRG,987,NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC,,,4481.0,62983.14,18 MS-DRG,988,MS-DRG 32.00:NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC,,,4481.0,4481.0,1 MS-DRG,988,MS-DRG 42.00: NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC,,,4481.0,17286.97,10 MS-DRG,988,NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC,,,4481.0,30194.58,18 MS-DRG,989,MS-DRG 32.00:NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC,,,4481.0,4481.0,1 MS-DRG,989,MS-DRG 42.00: NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC,,,4481.0,9109.13,10 MS-DRG,989,NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC,,,4481.0,22030.5,18 MS-DRG,998,MS-DRG 32.00:PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS,,,4481.0,4481.0,1 MS-DRG,998,MS-DRG 42.00: PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS,,,4481.0,4481.0,1 MS-DRG,998,PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS,,,4481.0,4481.0,1 MS-DRG,999,MS-DRG 32.00:UNGROUPABLE,,,4481.0,4481.0,1 MS-DRG,999,MS-DRG 42.00: UNGROUPABLE,,,4481.0,4481.0,1 MS-DRG,999,UNGROUPABLE,,,4481.0,4481.0,1 NDC,00000000003,TACROLIMUS 1 MG/ML ORAL SUSPENSION,405.05,243.03,0.3825,4481.0,24 NDC,00000000004,BUSULFAN 2MG/ML ORAL SUSPENSION,1337.0,802.2,81.68,4481.0,35 NDC,00000000006,ACETAZOLAMIDE 25 MG/ML ORAL SUSPENSION,155.0,93.0,35.96,4481.0,19 NDC,00000000007,ALLOPURINOL 20MG/ML ORAL SUSPENSION,18.55,11.13,4.3,4481.0,19 NDC,00000000008,AMIODARONE 5 MG/ML ORAL SUSPENSION,23.2,13.92,5.38,4481.0,19 NDC,00000000009,AMILORIDE 1 MG/ML ORAL SUSPENSION,24.4,14.64,5.66,4481.0,19 NDC,00000000010,AMITRIPTYLINE 1 MG/ML ORAL SUSPENSION,18.4,11.04,4.27,4481.0,19 NDC,00000000014,AZATHIOPRINE 50 MG/ML ORAL SUSPENSION,520.0,312.0,0.135,4481.0,24 NDC,00000000016,BETHANECHOL 1 MG/ML ORAL SUSPENSION,25.0,15.0,5.8,4481.0,19 NDC,00000000022,CARVEDILOL 1.67 MG/ML ORAL SUSP,23.2,13.92,5.38,4481.0,19 NDC,00000000024,CINACALCET 1 MG/ML ORAL SUSP,76.3,45.78,17.7,4481.0,19 NDC,00000000030,CLOPIDOGREL 5 MG/ML ORAL SUSPENSION,113.2,67.92,26.26,4481.0,19 NDC,00000000033,DAPSONE 2 MG/ML ORAL SUSP,79.0,47.4,18.33,4481.0,19 NDC,00000000034,DESMOPRESSIN 10 MCG/ML ORAL SOLN,1673.2,1003.92,388.18,4481.0,19 NDC,00000000037,DILTIAZEM 12 MG/ML ORAL SUSP,102.4,61.44,23.76,4481.0,19 NDC,00000000038,DIPYRIDAMOLE 10 MG/ML ORAL SUSP,149.2,89.52,34.61,4481.0,19 NDC,00000000045,FOLIC ACID 1 MG/ML ORAL SOLN,70.3,42.18,16.31,4481.0,19 NDC,00000000048,HYDRALAZINE 4 MG/ML ORAL SOLN,803.5,482.1,186.41,4481.0,19 NDC,00000000050,HYDROXYCHLOROQUINE 25 MG/ML ORAL SUSP,64.9,38.94,15.06,4481.0,19 NDC,00000000051,HYDROXYUREA 100 MG/ML ORAL SUSP,511.0,306.6,118.55,4481.0,19 NDC,00000000055,KETOCONAZOLE 20 MG/ML ORAL SUSP,19.0,11.4,4.41,4481.0,19 NDC,00000000056,LABETALOL 40 MG/ML ORAL SUSP,25.0,15.0,5.8,4481.0,19 NDC,00000000058,LAMOTRIGINE 1 MG/ML ORAL SOLN,19.0,11.4,4.41,4481.0,19 NDC,00000000061,DECITABINE (DACOGEN) SYRINGE 10 MG/ML,5357.05,3214.23,2.75,4634.38,24 NDC,00000000062,LOSARTAN 2.5 MG/ML ORAL SUSP,70.0,42.0,16.24,4481.0,19 NDC,00000000064,"MAGIC MOUTHWASH ORAL SUSPENSION (DIPHENHYDRAMINE, NYSTATIN)",16.2,9.72,3.76,4481.0,19 NDC,00000000069,METOLAZONE 1 MG/ML ORAL SUSP,34.0,20.4,7.89,4481.0,19 NDC,00000000070,METOPROLOL TARTRATE 10 MG/ML ORAL SOLN,59.2,35.52,13.73,4481.0,19 NDC,00000000071,METRONIDAZOLE 50 MG/ML ORAL SUSP,79.05,47.43,18.34,4481.0,19 NDC,00000000072,MEXILETINE 10 MG/ML ORAL SUSP,52.0,31.2,12.06,4481.0,19 NDC,00000000078,PHENAZOPYRIDINE 10 MG/ML ORAL SUSP,3.0,1.8,0.696,4481.0,19 NDC,00000000080,POTASSIUM PHOSPHATE 3 MMOL/ML ORAL SOLN,19.45,11.67,4.51,4481.0,19 NDC,00000000082,PROPAFENONE 20 MG/ML ORAL SUSP,3.0,1.8,0.696,4481.0,19 NDC,00000000085,PROPYLTHIOURACIL 5 MG/ML ORAL SUSP,92.2,55.32,21.39,4481.0,19 NDC,00000000086,PYRAZINAMIDE 100 MG/ML ORAL SUSP,7.3,4.38,1.69,4481.0,19 NDC,00000000090,BLEOMYCIN (BLENOXANE) SYRINGE 15 UNITS/ML,331.6,198.96,48.42,4481.0,24 NDC,00000000092,SELENIUM 60 MCG/ML ORAL SOLN,51.0,30.6,11.83,4481.0,19 NDC,00000000093,SEVELAMER 50 MG/ML ORAL SOLN,376.0,225.6,87.23,4481.0,19 NDC,00000000097,SODIUM ACETATE 2 MEQ/ML ORAL SOLN,16.1,9.66,3.74,4481.0,19 NDC,00000000099,SODIUM BENZOATE 166.6 MG/ML ORAL SOLN,301.0,180.6,69.83,4481.0,19 NDC,00000000100,SODIUM BICARBONATE 1 MEQ/ML ORAL SOLN,3.0,1.8,0.696,4481.0,19 NDC,00000000101,SODIUM CHLORIDE 4 MEQ/ML ORAL SOLN,16.45,9.87,3.82,4481.0,19 NDC,00000000103,DOXORUBICIN (ADRIAMYCIN) 25 MG/ML INJECTION,309.0,185.4,6.79,4481.0,24 NDC,00000000111,SULFASALAZINE 100 MG/ML ORAL SUSP,128.9,77.34,29.9,4481.0,19 NDC,00000000113,SULFADIAZINE 100 MG/ML ORAL SUSP,27.1,16.26,6.29,4481.0,19 NDC,00000000115,THIOGUANINE 20 MG/ML ORAL SUSP,32.85,19.71,7.62,4481.0,19 NDC,00000000122,PEDIATRIC MULTIVITAMIN ORAL DROPS WRAPPER,3.0,1.8,0.696,4481.0,19 NDC,00000000123,PEDIATRIC MULTIVITAMIN ORAL DROPS WRAPPER,1.1,0.66,0.2552,4481.0,19 NDC,00000000124,ZINC ACETATE 10 MG ELEMENTAL ZINC/ML ORAL SOLN,1.05,0.63,0.2436,4481.0,19 NDC,00000000129,CIDOFOVIR 1% TOPICAL GEL,289.15,173.49,67.08,4481.0,19 NDC,00000000136,LCD 10% IN AQUAPHOR,306.25,183.75,71.05,4481.0,19 NDC,00000000138,LCD-SALICYLIC ACID 10%-2% IN UNIBASE/AQUAPHOR,37.4,22.44,8.68,4481.0,19 NDC,00000000139,LEECH,66.35,39.81,15.39,4481.0,19 NDC,00000000140,"LIDOCAINE 4 %-EPINEPHRINE BITA 1:1,000-TETRACAINE 0.5 % TOP.SOLN(BULK)",30.6,18.36,7.1,4481.0,19 NDC,00000000145,SILVER SULFADIAZINE-NYSTATIN-BACITRACIN TOPICAL CREAM,88.5,53.1,20.53,4481.0,19 NDC,00000000146,SILVER SULFADIAZINE-NYSTATIN TOPICAL CREAM,303.95,182.37,70.52,4481.0,19 NDC,00000000153,TRIAMCINOLONE 0.05% IN MODIFIED EUCERIN CREAM,115.75,69.45,26.85,4481.0,19 NDC,00000000155,CARBOPLATIN 0.1 MG/ML INJECTION,308.1,184.86,5.56,4481.0,24 NDC,00000000157,ALTEPLASE 250 MCG/ML INTRAOCULAR INJECTION,174498.9,104699.34,91.62,150959.0,35 NDC,00000000160,AMIKACIN 2% OPHTHALMIC SOLN,40.15,24.09,1.42,4481.0,24 NDC,00000000163,AMPHOTERICIN B 0.15% OPHTHALMIC SOLN,113.5,68.1,26.33,4481.0,24 NDC,00000000164,AMPHOTERICIN B 0.3% OPHTHALMIC SOLN,28.65,17.19,6.65,4481.0,24 NDC,00000000166,AZATHIOPRINE 25 MG SPLIT TAB,17.05,10.23,0.135,4481.0,24 NDC,00000000170,GENTAMICIN 2% OPHTHALMIC SOLN,22.0,13.2,4.97,4481.0,24 NDC,00000000173,BLOOD CARDIO - COLD INDUCTION,134.95,80.97,31.31,4481.0,19 NDC,00000000174,BLOOD CARDIO. - MAINTENANCE,240.6,144.36,55.82,4481.0,19 NDC,00000000175,BLOOD CARDIO. - REPERFUSION,517.55,310.53,120.07,4481.0,19 NDC,00000000179,CEFTAZIDIME (FORTAZ) 10 MG/0.5 ML INTRAOCULAR SYRINGE,63.05,37.83,3.53,4481.0,24 NDC,00000000185,OXALIPLATIN (ELOXATIN) 0.05 MG/ML INJECTION,275.3,165.18,0.18,4481.0,24 NDC,00000000190,CISPLATIN (PLATINOL) 0.1 MG/ML INJECTION,275.1,165.06,5.15,4481.0,24 NDC,00000000197,ALEMTUZUMAB (CAMPATH) SYRINGE 10 MG/ML (ONCOLOGY),0.2,0.12,0.0506,379123.29,35 NDC,00000000201,MERCAPTOPURINE 25 MG (ONCOLOGY) SPLIT TAB,20.8,12.48,4.83,4481.0,19 NDC,00000000206,CIPROFLOXACIN DESENSITIZATION 0.1 MG/ML,63.0,37.8,6.32,4481.0,24 NDC,00000000207,CIPROFLOXACIN DESENSITIZATION 1 MG/ML,63.0,37.8,6.32,4481.0,24 NDC,00000000208,CIPROFLOXACIN DESENSITIZATION 2MG/ML,114.7,68.82,6.32,4481.0,24 NDC,00000000209,COLISTIMETHATE DESENSITIZATION 10 MG/ML,97.8,58.68,22.69,4481.0,24 NDC,00000000211,COLISTIMETHATE DESENSITIZATION 0.1 MG/ML,63.0,37.8,14.62,4481.0,24 NDC,00000000212,COLISTIMETHATE DESENSITIZATION 0.01 MG/ML,63.0,37.8,14.62,4481.0,24 NDC,00000000213,COLISTIMETHATE DESENSITIZATION 0.001 MG/ML,63.0,37.8,14.62,4481.0,24 NDC,00000000227,HYDROCHLORIC ACID 0.2N SOLUTION,108.4,65.04,25.15,4481.0,19 NDC,00000000253,CEFAZOLIN DESENSITIZATION 0.001 MG/ML,63.0,37.8,1.8,4481.0,24 NDC,00000000255,CEFAZOLIN DESENSITIZATION 0.01 MG/ML,63.0,37.8,1.8,4481.0,24 NDC,00000000257,CEFAZOLIN DESENSITIZATION 0.1 MG/ML,63.0,37.8,1.8,4481.0,24 NDC,00000000260,CEFAZOLIN DESENSITIZATION 10 MG/ML,63.0,37.8,1.8,4481.0,24 NDC,00000000261,CEFAZOLIN DESENSITIZATION 100 MG/ML,65.45,39.27,1.8,4481.0,24 NDC,00000000271,CITRULLINE 5 GRAM POWDER FOR ORAL SOLN,1.1,0.66,0.2552,4481.0,19 NDC,00000000272,DEXAMETHASONE 1 MG/ML SYRUP WITHOUT ALCOHOL,318.4,191.04,73.87,4481.0,19 NDC,00000000276,ARGININE (L) 5 GRAM POWDER (100 MG/ML) FOR ORAL SOLN,23.35,14.01,5.42,4481.0,19 NDC,00000000279,VANCOMYCIN 5% OPHTHALMIC SOLN,31.5,18.9,0.0675,4481.0,24 NDC,00000000288,VORICONAZOLE 1% OPHTHALMIC SOLN,3.0,1.8,0.696,4481.0,24 NDC,00000000295,TOBRAMYCIN 1.4% OPHTHALMIC SOLN,116.65,69.99,27.06,4481.0,19 NDC,00000000298,GANCICLOVIR 2 MG/0.1 ML OPHTHALMIC INJECTION,74.3,44.58,17.24,4849.53,24 NDC,00000000300,AMPICILLIN (0.001 MG/ML) DESENSITIZATION DILUTION,63.05,37.83,1.24,4481.0,24 NDC,00000000301,AMPICILLIN (0.01 MG/ML) DESENSITIZATION DILUTION,63.05,37.83,1.24,4481.0,24 NDC,00000000302,AMPICILLIN (0.1 MG/ML) DESENSITIZATION DILUTION,63.05,37.83,1.24,4481.0,24 NDC,00000000303,AMPICILLIN (1 MG/ML) DESENSITIZATION DILUTION,63.2,37.92,1.24,4481.0,24 NDC,00000000304,AMPICILLIN (10 MG/ML) DESENSITIZATION DILUTION,64.8,38.88,1.24,4481.0,24 NDC,00000000305,METHOTREXATE SODIUM (PF) 2.5 MG/ML INJECTION,277.05,166.23,6.15,4481.0,24 NDC,00000000307,NEONATAL AA 2.5%/HEPARIN 0.5 UNIT/ML DEXTROSE 10% WATER,539.25,323.55,125.11,4481.0,19 NDC,00000000311,SENNOSIDES 8.8 MG/5 ML ORAL SYRUP,1.15,0.69,0.2668,4481.0,19 NDC,00000000312,SODIUM PHOSPHATE 3 MMOL/ML ORAL SOLUTION,17.8,10.68,4.13,4481.0,19 NDC,00000000318,SELENIUM 10 MCG/ML DILUTION,292.6,175.56,67.88,4481.0,19 NDC,00000000330,LIDOCAINE (PF) 8 MG/ML IN DEXTROSE 5% 50 ML PEDIATRIC INFUSION,64.5,38.7,0.0225,4481.0,24 NDC,00000000331,HEPARIN 100 UNITS/ML IN SODIUM CHLORIDE 0.45% 50 ML PEDIATRIC,72.35,43.41,0.4725,4481.0,24 NDC,00000000332,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) PEDIATRIC 10 ML INFUSION,123.7,74.22,0.0675,4481.0,24 NDC,00000000333,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) PEDIATRIC 30 ML INFUSION,245.0,147.0,0.0675,4481.0,24 NDC,00000000334,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) 50 ML PEDIATRIC INFUSION,366.3,219.78,0.0675,4481.0,24 NDC,00000000335,MILRINONE 200 MCG/ML IN DEXTROSE 5% 8 ML PEDIATRIC,67.2,40.32,3.26,4481.0,24 NDC,00000000336,MILRINONE 200 MCG/ML IN DEXTROSE 5% 50 ML PEDIATRIC,89.2,53.52,3.26,4481.0,24 NDC,00000000338,NITROGLYCERIN 400MCG/ML IN D5W 8 ML PEDIATRIC INFUSION,65.6,39.36,3.35,4481.0,24 NDC,00000000339,NITROGLYCERIN 400MCG/ML IN D5W 50ML PEDIATRIC INFUSIO,79.05,47.43,3.35,4481.0,24 NDC,00000000342,PENTOBARBITAL 50MG/ML PEDIATRIC INFUSION 100 ML,13609.15,8165.49,121.21,11773.28,24 NDC,00000000343,ROCURONIUM 10 MG/ML PEDIATRIC INFUSION 4 ML,72.75,43.65,16.88,4481.0,19 NDC,00000000346,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 40ML,96.9,58.14,22.48,4481.0,19 NDC,00000000347,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSON 100ML,147.7,88.62,34.27,4481.0,19 NDC,00000000348,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 50ML INFUSION,94.9,56.94,22.02,4481.0,19 NDC,00000000349,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 200ML INFUSION,190.55,114.33,44.21,4481.0,19 NDC,00000000353,FAMOTIDINE 2 MG/ML PEDIATRIC DILUTION,147.05,88.23,0.0225,4481.0,24 NDC,00000000354,SODIUM BICARBONATE 1MEQ/ML PEDIATRIC 100 ML INFUSION,126.8,76.08,29.42,4481.0,19 NDC,00000000359,CYCLOSPORINE 1 MG/ML NS AVIVA INFUSION,88.05,52.83,20.43,10791.27,24 NDC,00000000360,GENTAMICIN SULFATE 10 MG/ML PEDIATRIC DILUTION,99.65,59.79,4.97,4481.0,24 NDC,00000000385,EPINEPHRINE (PED) 250 MCG/250 ML NS SUBCUTANEOUS (OR),81.0,48.6,1.08,4481.0,24 NDC,00000000387,POLYMYXIN/GENTAMICIN (DAB SOLUTION) FOR IRRIGATION (OR),90.1,54.06,20.9,4481.0,19 NDC,00000000397,BUPIVACAINE (PF) 0.5 % (5 MG/ML) PAIN BALL 270 ML,141.6,84.96,0.0225,4481.0,24 NDC,00000000412,STUDY 1966 BORTEZOMIB IV SYRINGE 1 MG/ML,0.2,0.12,0.0464,4481.0,24 NDC,00000000494,STUDY 1903 IDURSULFASE 2 MG/ML,0.2,0.12,0.0506,81999.54,35 NDC,00000000495,STUDY 1937 INFLIXIMAB/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,19 NDC,00000000496,STUDY 1937 INFLIXIMAB 10 MG/ML,0.2,0.12,0.0506,4783.38,35 NDC,00000000497,STUDY 1903 IDURSULFASE (INTRATHECAL) 10MG/1ML VIAL,0.2,0.12,0.0506,81999.54,35 NDC,00000000511,STUDY 2369 PF-00547659/PLACEBO SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,00000000512,STUDY 2072 BTX-A-HAC (DYSPORT)/PLACECO 0/1000/1500 UN,0.2,0.12,0.0464,4481.0,19 NDC,00000000513,STUDY 2073 BTX-A-HAC (DYSPORT),0.2,0.12,0.0464,4481.0,19 NDC,00000000517,STUDY 2075 BMS-936557 (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,00000000521,STUDY 2076 LY2127399/PLACEBO 120 MG/ML,0.2,0.12,0.0464,4481.0,17 NDC,00000000532,STUDY 2111 BTX-A-HAC (DYSPORT)/PLACEBO 0 UNITS/500 UNITS/1000 UNITS,0.2,0.12,0.0464,4481.0,19 NDC,00000000537,STUDY 2163 LIDOCAINE/PLACEBO 2%,0.2,0.12,0.0464,4481.0,19 NDC,00000000541,STUDY 2184 QUADRIVALENT HPV VACCINE/ PLACEBO 0.5 ML,0.2,0.12,0.0464,4481.0,19 NDC,00000000545,STUDY 2208 OMALIZUMAB (XOLAIR) 150MG/ 1.2 ML,0.2,0.12,0.0506,6119.61,35 NDC,00000000546,STUDY 2208 OMALIZUMAB (XOLAIR) 300MG/ 2.4 ML,0.2,0.12,0.0506,6119.61,35 NDC,00000000550,STUDY 2214 BMS-936557 0/10/20/MG/KG,0.2,0.12,0.0464,4481.0,17 NDC,00000000551,STUDY 2214 BMS-936557 (MAINTENANCE) 0/7.5/15 MG/KG,0.2,0.12,0.0464,4481.0,17 NDC,00000000566,STUDY 2277 LY2127399 O/120 MG/ML,0.2,0.12,0.0464,4481.0,17 NDC,00000000570,STUDY 2320 AA4500 0.9 MG / 0.39 ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,00000000571,STUDY 2320 PAPAVARINE 16.7 MG/PHENTOLAMINE 0.56 MG/PROSTOGLE,0.2,0.12,0.0464,4481.0,19 NDC,00000000574,STUDY 2326 N6022/PLACEBO 1 MG/ML,0.2,0.12,0.0464,4481.0,17 NDC,00000000575,STUDY 2333 RAD-IFN 5 X 10E11 PARITCLES PER ML,0.2,0.12,0.0464,4481.0,17 NDC,00000000576,STUDY 2333 SYN 3 (POLYAMIDE SURFACTANT),0.2,0.12,0.0464,4481.0,17 NDC,00000000577,STUDY 2333 DILUENT (PLACEBO SOLUTION),0.2,0.12,0.0464,4481.0,19 NDC,00000000578,STUDY PROPOFOL 10 MG/ML IV,0.2,0.12,0.0464,4481.0,19 NDC,00000000579,STUDY FLUMAZENIL 0.1 MG/ML IV,0.2,0.12,0.0464,4481.0,19 NDC,00000000581,STUDY 2339 ECULIZUMAB 10 MG/ML,0.2,0.12,0.0506,7333.83,35 NDC,00000000582,STUDY MIDAZOLAM 5 MG/ML IV INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,00000000585,STUDY 2346 ART-123/ PLACEBO 6 MG/ML,0.2,0.12,0.0464,4481.0,17 NDC,00000000588,STUDY 2377 BELIMUMAB/PLACEBO 80MG/ML,0.2,0.12,0.0464,4481.0,19 NDC,00000000592,STUDY 2404 BELIMUMAB/PLACEBO 80MG/ML,0.2,0.12,0.0464,4481.0,19 NDC,00000000601,STUDY 1090 BELATACEPT 25 MG/ML,0.2,0.12,0.0506,4481.0,35 NDC,00000000613,STUDY DIPHENHYDRAMINE 25 MG CAPSULE/TABLET WRAPPER,0.2,0.12,0.0464,4481.0,19 NDC,00000000614,STUDY MEDROXYPROGESTERONE 150 MG/ML IM SUSP,0.2,0.12,0.0464,4481.0,24 NDC,00000000615,STUDY TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL,0.2,0.12,0.0464,4481.0,19 NDC,00000000616,"STUDY EPINEPHRINE 0.3MG/0.3 ML (1:1,000) IM PEN INJECTOR",0.2,0.12,0.0464,4481.0,19 NDC,00000000617,STUDY LORATADINE 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,00000000618,STUDY ALBUTEROL SULFATE HFA 90 MCG / ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 NDC,00000000619,STUDY AEROCHAMBER DEVICE ADULT,0.2,0.12,0.0464,4481.0,17 NDC,00000000620,"STUDY EPINEPHRINE 1 MG/ML (1:1,000) (1ML) INJECTION",0.2,0.12,0.0464,4481.0,24 NDC,00000000622,STUDY ONDANSETRON 4 MG DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,19 NDC,00000000623,STUDY ONDANSETRON HCL 2 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,00000000624,STUDY DIPHENHYDRAMINE 50 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,00000000625,STUDY METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/2ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,4481.0,35 NDC,00000000627,STUDY 2290 PF-04236921 0/10/50/200 MG PER DOSE SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,00000000628,STUDY 1966 BORTEZOMIB SUBCUTANEOUS SYRINGE 2.5 MG/ML,0.2,0.12,0.0464,4481.0,24 NDC,00000000629,STUDY LPS-13649 METHYLPREDNISOLONE 1000 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,00000000634,STUDY 2305 TOLVAPTAN/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,00000000635,STUDY 2347 BELIMUMAB 80 MG/ML,0.2,0.12,0.0506,8308.44,35 NDC,00000000659,STUDY 2323 NNC0109-0012/PLACEBO 25MG/50MG/100 MG,0.2,0.12,0.0464,4481.0,17 NDC,00000000685,LEUCOVORIN CALCIUM 500 MG SOL FOR INJ (10 MG/ML),288.45,173.07,7.25,4481.0,24 NDC,00000000686,ALEMTUZUMAB (CAMPATH) SYRINGE 3 MG/ML (ONCOLOGY),0.2,0.12,0.0506,379123.29,35 NDC,00000000687,THIOTEPA (TEPADINA) 15 MG SOLUTION FOR INJECTION,2721.7,1633.02,10.22,4481.0,35 NDC,00000000694,METHOTREXATE 400 MCG/0.1 ML OPHTHALMIC INJECTION,276.25,165.75,6.15,4481.0,24 NDC,00000000698,BLEOMYCIN FOR WARTS SYRINGE,464.35,278.61,48.42,4481.0,24 NDC,00000000700,ETOPOSIDE 0.2 MG/ML INTRAVENOUS SOLUTION,275.2,165.12,2.12,4481.0,24 NDC,00000000701,ETOPOSIDE 0.02 MG/ML INTRAVENOUS SOLUTION,275.2,165.12,2.12,4481.0,24 NDC,00000000702,STUDY RPC02-201 RPC4046 150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,00000000717,SODIUM CITRATE 4 % (5 ML) INTRA-CATHETER INJECTION SYRINGE,22.65,13.59,5.25,4481.0,19 NDC,00000000718,"GENTAMICIN 1 MG/ML, SODIUM CITRATE 4% (2.4 ML) INTRA-CATHETER SYRINGE",23.2,13.92,5.38,4481.0,19 NDC,00000000721,OXYMETAZOLINE 0.05 % NASAL SPRAY (MULTIPLE PATIENTS),1.05,0.63,0.2436,4481.0,19 NDC,00000000722,LIDOCAINE 1% IN SODIUM CHLORIDE 0.9% TOPICAL SOLN (MULTIPLE PATIENTS),16.2,9.72,3.76,4481.0,19 NDC,00000000723,CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION,45834.25,27500.55,220.46,36667.4,35 NDC,00000000724,TEMOZOLOMIDE 10 MG/ML ORAL SUSPENSION,15105.0,9063.0,0.9735,13067.34,24 NDC,00000000725,IMATINIB 40 MG/ML ORAL SUSPENSION,443.0,265.8,102.78,4481.0,19 NDC,00000000726,LENALIDOMIDE (2.5 MICROGRAM/ML) DESENSITIZATION ORAL SUSPENSION,25.1,15.06,5.82,4481.0,19 NDC,00000000727,LENALIDOMIDE (0.025 MG/ML) DESENSITIZATION ORAL SUSPENSION,25.6,15.36,5.94,4481.0,19 NDC,00000000728,LENALIDOMIDE (1 MG/ML) DESENSITIZATION ORAL SUSPENSION,84.75,50.85,19.66,4481.0,19 NDC,00000000730,ERLOTINIB 50 MG/ML ORAL SUSPENSION,720.6,432.36,167.18,4481.0,19 NDC,00000000731,LETROZOLE 1.25 MG/ML ORAL SUSPENSION,26.8,16.08,6.22,4481.0,19 NDC,00000000735,ETOPOSIDE 10 MG/ML SUSPENSION,595.75,357.45,2.12,4481.0,24 NDC,00000000748,AMINO ACID 5 % (L-ARGININE 25 G/L & L-LYSINE 25 G/L) INTRAVENOUS SOLUTION,291.6,174.96,67.65,4481.0,19 NDC,00000000749,IMATINIB 50 MG SPLIT TABLET,27.45,16.47,6.37,4481.0,19 NDC,00000000750,TAGRAXOFUSP-ERZS 100 MCG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION,84777.15,50866.29,346.22,67821.72,35 NDC,00000000758,ERLOTINIB 10 MG/ML ORAL SUSPENSION (SUGAR FREE),720.6,432.36,167.18,4481.0,19 NDC,00000000765,NIRSEVIMAB-ALIP (STATE SUPPLIED) 50 MG/0.5 ML INTRAMUSCULAR SYRINGE,0.2,0.12,0.0464,88292.61,25 NDC,00000000769,NATIONAL MARROW DONOR PROGRAM SUPPLIED FILGRASTIM-AYOW (RELEUKO) 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,00000000770,NATIONAL MARROW DONOR PROGRAM SUPPLIED FILGRASTIM-AYOW (RELEUKO) 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,00002418230,BARICITINIB 2 MG TABLET,292.75,175.65,67.92,4481.0,19 NDC,00002534060,SELPERCATINIB 40 MG TABLET,552.3,331.38,128.13,4481.0,26 NDC,00002556260,SELPERCATINIB 160 MG TABLET,1606.85,964.11,372.79,4481.0,26 NDC,00002608260,SELPERCATINIB 80 MG TABLET,815.95,489.57,189.3,4481.0,26 NDC,00002612060,SELPERCATINIB 120 MG TABLET,1606.85,964.11,372.79,4481.0,26 NDC,00002751001,INSULIN LISPRO (U-100) 100 UNIT/ML SUBCUTANEOUS SOLUTION,275.0,165.0,0.5175,4481.0,24 NDC,00002751001,INSULIN LISPRO 100 UNIT/ML PERCENTAGE MEAL EATEN ADULT,275.0,165.0,0.5175,4481.0,24 NDC,00002757501,MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION,31432.85,18859.71,41.76,25146.28,35 NDC,00002767801,RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION,25113.1,15067.86,72.13,20090.48,35 NDC,00002821501,INSULIN REGULAR 100 UNIT/ML CORRECTION SCALE ADULT,190.0,114.0,0.5175,4481.0,24 NDC,00002821501,INSULIN REGULAR 100 UNIT/ML PERCENTAGE MEAL EATEN ADULT,190.0,114.0,0.5175,4481.0,24 NDC,00002821501,INSULIN REGULAR HUMAN 100 UNIT/ML INJECTION (IV USE),208.9,125.34,0.5175,4481.0,24 NDC,00002821501,INSULIN U-100 REGULAR HUMAN 100 UNIT/ML INJECTION SOLUTION,190.0,114.0,0.5175,4481.0,24 NDC,00002831501,INSULIN NPH ISOPHANE U-100 HUMAN 100 UNIT/ML SUBCUTANEOUS SUSPENSION,190.0,114.0,0.5175,4481.0,24 NDC,00002871501,INSULIN HUMAN U-100 NPH-REGULR 70-30 MIX 100 UNIT/ML SUBCUTANEOUS SUSP,190.0,114.0,0.5175,4481.0,24 NDC,00002882427,INSULIN REGULAR HUMAN U-500 (CONCENTRATE) 500 UNIT/ML(3 ML) SUBCUT PEN,880.2,528.12,0.5175,4481.0,24 NDC,00002940101,DONANEMAB-AZBT 17.5 MG/ML INTRAVENOUS SOLUTION,2366.3,1419.78,4.01,4481.0,35 NDC,00003029305,TRIAMCINOLONE ACETONIDE - FOR INTRAPERICARDIAL USE ONLY,52.55,31.53,1.89,4481.0,24 NDC,00003029305,TRIAMCINOLONE ACETONIDE 40 MG/ML SUSPENSION FOR INJECTION,52.55,31.53,1.89,4481.0,24 NDC,00003029320,TRIAMCINOLONE ACETONIDE - FOR INTRAPERICARDIAL USE ONLY,201.3,120.78,1.89,4481.0,24 NDC,00003037113,BELATACEPT 250 MG INTRAVENOUS SOLUTION,3234.55,1940.73,3.77,4481.0,35 NDC,00003049420,TRIAMCINOLONE ACETONIDE 10 MG/ML SUSPENSION FOR INJECTION,18.4,11.04,1.89,4481.0,24 NDC,00003052411,DASATINIB 70 MG TABLET,1374.85,824.91,318.97,4481.0,19 NDC,00003085222,DASATINIB 100 MG TABLET,2457.85,1474.71,570.22,4481.0,19 NDC,00003089321,APIXABAN 2.5 MG TABLET,46.35,27.81,10.75,4481.0,19 NDC,00003089431,APIXABAN 5 MG TABLET,46.35,27.81,10.75,4481.0,19 NDC,00003161412,ENTECAVIR 0.05 MG/ML ORAL SOLUTION,153.25,91.95,35.55,4481.0,19 NDC,00003218713,ABATACEPT (WITH MALTOSE) 250 MG INTRAVENOUS SOLUTION,5131.5,3078.9,42.79,6554.73,35 NDC,00003232711,IPILIMUMAB (YERVOY) 5 MG/ML INJECTION WRAPPER,30246.2,18147.72,177.98,27236.16,35 NDC,00003232711,IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION,30246.2,18147.72,177.98,27236.16,35 NDC,00003232822,IPILIMUMAB (YERVOY) 5 MG/ML INJECTION WRAPPER,120159.5,72095.7,177.98,96127.6,35 NDC,00003232822,IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION,120159.5,72095.7,177.98,96127.6,35 NDC,00003373413,NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION,26566.65,15939.99,31.97,21253.32,35 NDC,00003377211,NIVOLUMAB 40 MG/4 ML INTRAVENOUS SOLUTION,4657.0,2794.2,31.97,5024.46,35 NDC,00003377412,NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION,11229.8,6737.88,31.97,8983.84,35 NDC,00003452211,ELOTUZUMAB 400 MG INTRAVENOUS SOLUTION,10519.0,6311.4,7.65,8415.2,35 NDC,00003612001,"NIVOLUMAB 600 MG-HYALURONIDASE-NVHY 10,000 UNIT/5 ML SUBCUT SOLUTION",26566.6,15939.96,26.54,21253.28,35 NDC,00003712511,NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION,51321.8,30793.08,191.9,41057.44,35 NDC,00004026129,MYCOPHENOLATE MOFETIL 200 MG/ML ORAL POWDER FOR SUSPENSION,48.4,29.04,0.36,4481.0,24 NDC,00004029809,MYCOPHENOLATE 500 MG INTRAVENOUS SOLUTION,416.1,249.66,0.81,4481.0,24 NDC,00005200010,PNEUMOCOCCAL 20-VALENT CONJ VACCINE-DIP CRM (PF) 0.5 ML IM SYRINGE,843.6,506.16,195.72,4481.0,26 NDC,00006022761,RALTEGRAVIR 400 MG TABLET,120.2,72.12,27.89,4481.0,19 NDC,00006302501,BEZLOTOXUMAB 25 MG/ML INTRAVENOUS SOLUTION,12489.0,7493.4,38.64,10804.23,35 NDC,00006302602,PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,20186.95,12112.17,58.48,16149.56,35 NDC,00006306901,DORAVIRINE 100 MG TABLET,200.0,120.0,46.4,4481.0,19 NDC,00006307604,LETERMOVIR 480 MG TABLET,839.2,503.52,194.69,4481.0,19 NDC,00006308399,"PEMBROLIZUMAB 395 MG-BERAHYALURONID-PMPH 4,800 UNIT/2.4 ML SUBCUT SOLN",40098.85,24059.31,4481.0,32079.08,22 NDC,00006351659,IMIPENEM-CILASTATIN 500 MG INTRAVENOUS SOLUTION,169.8,101.88,18.98,4481.0,24 NDC,00006385601,IMIPENEM-CILASTATIN-RELEBACTAM 1.25 GRAM INTRAVENOUS SOLUTION,1096.8,658.08,2.53,4481.0,35 NDC,00006404701,"ROTAVIRUS VACCINE LIVE, PENTAVALENT 2 ML ORAL SOLUTION",328.0,196.8,76.1,4481.0,25 NDC,00006409301,HEPATITIS B VACC RECMB(PF) 0.5 ML IM WRAPPER,107.55,64.53,24.95,4481.0,26 NDC,00006409502,HEPATITIS A VIRUS VACCINE (PF) 25 UNIT/0.5 ML INTRAMUSCULAR SYRINGE,139.75,83.85,32.42,4481.0,25 NDC,00006412102,"HUMAN PAPILLOMAVIRUS VACCINE,9-VALENT(PF) 0.5 ML INTRAMUSCULAR SYRINGE",1007.05,604.23,233.64,4481.0,25 NDC,00006434702,PNEUMOCOCCAL 21-VALENT CONJ VACCINE-DIP CRM (PF) 0.5 ML IM SYRINGE,926.05,555.63,214.84,4481.0,26 NDC,00006468100,"MEASLES,MUMPS,RUBELLA VACCINE LIVE(PF)1,000-12,500TCID50/0.5 ML SUBCUT",309.25,185.55,71.75,4481.0,25 NDC,00006482701,"VARICELLA VIRUS VACCINE LIVE (PF) 1,350 UNIT/0.5 ML SUBCUTANEOUS SUSP",596.1,357.66,138.3,4481.0,25 NDC,00006483141,HEPATITIS A VIRUS VACCINE (PF) 25 UNIT/0.5 ML INTRAMUSCULAR SUSPENSION,139.75,83.85,32.42,4481.0,25 NDC,00006489700,HAEMOPH B POLYSAC CONJ-MENING (PF) 7.5 MCG/0.5 ML INTRAMUSCULAR SOLN,114.2,68.52,26.49,4481.0,25 NDC,00006500401,LETERMOVIR 480 MG/24 ML INTRAVENOUS SOLUTION,1303.8,782.28,302.48,4481.0,19 NDC,00006508399,"PEMBROLIZUMAB 790 MG-BERAHYALURONID-PMPH 9,600 UNIT/4.8 ML SUBCUT SOLN",79922.65,47953.59,4481.0,63938.12,22 NDC,00006508599,LETERMOVIR 120 MG ORAL PELLETS IN PACKET,221.8,133.08,51.46,4481.0,19 NDC,00006508601,LETERMOVIR 20 MG ORAL PELLETS IN PACKET,50.3,30.18,11.67,4481.0,19 NDC,00006542302,SUGAMMADEX 100 MG/ML INTRAVENOUS SOLUTION,546.95,328.17,126.89,4481.0,19 NDC,00006542402,"ANTIVENIN LATRODECTUS MACTANS 6,000 UNIT SOLUTION FOR INJECTION",124.1,74.46,28.79,4481.0,19 NDC,00008010001,INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN,79436.8,47662.08,2617.11,435080.31,35 NDC,00008092351,PANTOPRAZOLE 40 MG INTRAVENOUS SOLUTION,79.6,47.76,4.34,4481.0,24 NDC,00008117901,TEMSIROLIMUS 30 MG/3 ML (10 MG/ML) (FIRST DILUTION) INTRAVENOUS SOLN,6896.1,4137.66,25.91,5516.88,35 NDC,00008451001,GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN,34022.75,20413.65,229.52,38155.32,35 NDC,00009001103,HYDROCORTISONE SOD SUCCINATE (PF) 100 MG/2 ML SOLUTION FOR INJECTION,109.9,65.94,25.5,4481.0,24 NDC,00009001305,HYDROCORTISONE SOD SUCCINATE (PF) 250 MG/2 ML SOLUTION FOR INJECTION,189.7,113.82,44.01,4481.0,24 NDC,00009003928,METHYLPREDNISOLONE SOD SUCC 40 MG/ML SOLUTION FOR INJECTION WRAPPER,41.25,24.75,0.2037,4481.0,35 NDC,00009003930,METHYLPREDNISOLONE SOD SUCC (PF) 40 MG/ML SOLUTION FOR INJECTION,41.25,24.75,0.2037,4481.0,35 NDC,00009003930,STUDY METHYLPREDNISOLONE SOD SUCC (PF) 40 MG/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,4481.0,35 NDC,00009004722,METHYLPREDNISOLONE SOD SUCC 125 MG/2 ML SOLUTION FOR INJECTION WRAPPER,56.65,33.99,0.2037,4481.0,35 NDC,00009004725,METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/2 ML SOLUTION FOR INJECTION,56.65,33.99,0.2037,4481.0,35 NDC,00009029703,GELATIN ABSORBABLE EYE FILM,5972.8,3583.68,1385.69,4778.24,19 NDC,00009030602,METHYLPREDNISOLONE ACETATE 80 MG/ML SUSPENSION FOR INJECTION,93.0,55.8,0.1164,4481.0,35 NDC,00009043601,ARGININE HCL (L-ARGININE) 0.1 G/ML (METABOLIC DIS) BOLUS,223.05,133.83,51.75,4481.0,19 NDC,00009043601,ARGININE HCL (L-ARGININE) 0.1 G/ML (METABOLIC DIS) INFUSION,200.35,120.21,46.48,4481.0,19 NDC,00009043601,ARGININE HCL (L-ARGININE) 10 % INTRAVENOUS SOLUTION,223.05,133.83,51.75,4481.0,19 NDC,00009069801,METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/ML PED-CARD SURGERY,206.85,124.11,0.2037,4481.0,35 NDC,00009069801,METHYLPREDNISOLONE SOD SUCC 62.5 MG/ML IV PEDIATRIC,206.85,124.11,0.2037,4481.0,35 NDC,00009069801,"METHYLPREDNISOLONE SODIUM SUCCINATE 1,000 MG INTRAVENOUS SOLUTION",206.85,124.11,0.2037,4481.0,35 NDC,00009072809,CLINDAMYCIN 150 MG/ML INJECTION SOLUTION,111.75,67.05,4.12,4481.0,24 NDC,00009074630,MEDROXYPROGESTERONE 150 MG/ML INTRAMUSCULAR COMBINED WRAPPER,221.3,132.78,1.28,4481.0,24 NDC,00009077526,CLINDAMYCIN 150 MG/ML INJECTION SOLUTION,27.5,16.5,4.12,4481.0,24 NDC,00009082501,HYDROCORTISONE SOD SUCCINATE (PF) 100 MG/2 ML SOLUTION INJ ACTOVIAL/VIAL WRAPPER,90.7,54.42,21.04,4481.0,24 NDC,00009082501,HYDROCORTISONE SOD SUCCINATE (PF) 50 MG/ML PEDIATRIC,90.7,54.42,21.04,4481.0,24 NDC,00009085001,METHYLPREDNISOLONE SODIUM SUCCINATE 2 GRAM INTRAVENOUS SOLUTION,419.0,251.4,0.2037,4481.0,35 NDC,00009085608,CARBOPROST TROMETHAMINE 250 MCG/ML INTRAMUSCULAR SOLUTION,562.0,337.2,49.52,4481.0,35 NDC,00009087026,CLINDAMYCIN 150 MG/ML INJECTION SOLUTION,25.75,15.45,4.12,4481.0,24 NDC,00009316906,ALPROSTADIL 500 MCG/ML INJECTION SOLUTION,676.45,405.87,1.3,4481.0,24 NDC,00009379401,IBUTILIDE FUMARATE 0.1 MG/ML INTRAVENOUS SOLUTION,1893.65,1136.19,167.14,4481.0,35 NDC,00009509101,EPIRUBICIN 50 MG/25 ML INTRAVENOUS SOLUTION,434.25,260.55,4.32,4481.0,24 NDC,00009509301,EPIRUBICIN 200 MG/100 ML INTRAVENOUS SOLUTION,1050.25,630.15,4.32,4481.0,24 NDC,00009518201,ALPROSTADIL 20 MCG INTRACAVERNOSAL KIT,428.75,257.25,1.3,4481.0,24 NDC,00009722402,"LYMPHOCYTE,ANTI-THYMO IMMUNE GLOBULIN 50 MG/ML INTRAVENOUS SOLUTION",18424.25,11054.55,4481.0,679563.36,35 NDC,00009766304,EXEMESTANE 25 MG TABLET,178.5,107.1,41.41,4481.0,19 NDC,0000\000612,STUDY ACETAMINOPHEN 325 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,00013264902,SOMATROPIN 0.2 MG/0.25 ML SUBCUTANEOUS SYRINGE,137.25,82.35,34.72,4481.0,35 NDC,00023066704,WHITE PETROLATUM-MINERAL OIL 57.3 %-42.5 % EYE OINTMENT,14.3,8.58,3.32,4481.0,19 NDC,00023114501,ONABOTULINUMTOXINA 100 UNIT SOLUTION FOR INJECTION,2554.9,1532.94,6.3,4481.0,35 NDC,00023334807,DEXAMETHASONE 0.7 MG INTRAVITREAL IMPLANT,5514.0,3308.4,198.47,4770.16,35 NDC,00023391950,ONABOTULINUMTOXINA 50 UNIT INTRAMUSCULAR SOLUTION,1427.8,856.68,6.3,4481.0,35 NDC,00023585801,LEVONORGESTREL 20.4 MCG/24 HR (UP TO 8 YRS) 52 MG INTRAUTERINE DEVICE,3748.95,2249.37,869.76,141324.33,24 NDC,00023608210,IRON DEXTRAN 50 MG/ML INJECTION SOLUTION,52.4,31.44,13.26,4517.31,35 NDC,00023615109,PROGESTERONE MICRONIZED 8 % VAGINAL GEL,110.45,66.27,25.62,4481.0,19 NDC,00023916360,CYCLOSPORINE 0.05 % EYE DROPS IN A DROPPERETTE,48.3,28.98,11.21,4481.0,19 NDC,00024065401,ISATUXIMAB-IRFC 20 MG/ML INTRAVENOUS SOLUTION,3154.45,1892.67,79.44,12906.6,35 NDC,00024065601,ISATUXIMAB-IRFC 20 MG/ML INTRAVENOUS SOLUTION,14672.2,8803.32,79.44,12906.6,35 NDC,00024159601,PRIMAQUINE 15 MG TABLET,22.15,13.29,5.14,4481.0,19 NDC,00024414206,DRONEDARONE 400 MG TABLET,55.9,33.54,12.97,4481.0,19 NDC,00024515011,RASBURICASE 1.5 MG INTRAVENOUS SOLUTION,3682.9,2209.74,366.19,55987.89,35 NDC,00024584001,ZIV-AFLIBERCEPT 100 MG/4 ML (25 MG/ML) INTRAVENOUS SOLUTION,5571.0,3342.6,7.64,4481.0,35 NDC,00024586201,PLERIXAFOR 24 MG/1.2 ML (20 MG/ML) SUBCUTANEOUS SOLUTION,38891.5,23334.9,24.57,31113.2,35 NDC,00032263601,"LIPASE-PROTEASE-AMYLASE 24,000-76,000-120,000 UNIT CAPSULE,DELAYED REL (TUBE DECLOG)",41.55,24.93,9.64,4481.0,19 NDC,00037682210,HYDROCORTISONE 1 %-PRAMOXINE 1 % RECTAL FOAM,601.1,360.66,139.46,4481.0,19 NDC,00046074905,CONJUGATED ESTROGENS 25 MG SOLUTION FOR INJECTION,1485.85,891.51,375.92,4481.0,35 NDC,00046110081,CONJUGATED ESTROGENS 0.3 MG TABLET,37.25,22.35,8.64,4481.0,19 NDC,00046110281,CONJUGATED ESTROGENS 0.625 MG TABLET,37.25,22.35,8.64,4481.0,19 NDC,00046110381,CONJUGATED ESTROGENS 0.9 MG TABLET,37.25,22.35,8.64,4481.0,19 NDC,00046110481,CONJUGATED ESTROGENS 1.25 MG TABLET,37.25,22.35,8.64,4481.0,19 NDC,00049001381,AMPICILLIN-SULBACTAM 1.5 GRAM MBP/ADV WRAPPER,46.1,27.66,3.13,4481.0,24 NDC,00049001381,AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION,46.1,27.66,3.13,4481.0,24 NDC,00049001481,AMPICILLIN-SULBACTAM 3 GRAM MBP/ADV WRAPPER,72.8,43.68,3.13,4481.0,24 NDC,00049001481,AMPICILLIN-SULBACTAM 3 GRAM SOLUTION FOR INJECTION,72.8,43.68,3.13,4481.0,24 NDC,00049052084,PENICILLIN G POTASSIUM 5 MILLION UNIT SOLUTION FOR INJECTION,65.65,39.39,1.78,4481.0,24 NDC,00049053028,PENICILLIN G POTASSIUM 20 MILLION UNIT SOLUTION FOR INJECTION,214.45,128.67,1.78,4481.0,24 NDC,00049316044,VORICONAZOLE 200 MG/5 ML (40 MG/ML) ORAL SUSPENSION,1857.85,1114.71,431.02,4481.0,19 NDC,00052060201,BCG LIVE 50 MG INTRAVESICAL SUSPENSION,859.8,515.88,7.33,4481.0,24 NDC,00054001020,FLECAINIDE 50 MG TABLET,17.75,10.65,4.12,4481.0,19 NDC,00054001720,PREDNISONE 10 MG TABLET,16.65,9.99,0.0225,4481.0,24 NDC,00054001920,PREDNISONE 50 MG TABLET,17.05,10.23,0.0225,4481.0,24 NDC,00054005746,DIGOXIN 50 MCG/ML (0.05 MG/ML) ORAL SOLUTION,435.95,261.57,101.14,4481.0,19 NDC,00054006344,RISPERIDONE 1 MG/ML ORAL SOLUTION,106.0,63.6,24.59,4481.0,19 NDC,00054023524,MORPHINE 15 MG IMMEDIATE RELEASE TABLET,24.35,14.61,5.65,4481.0,19 NDC,00054023749,MORPHINE 10 MG/5 ML ORAL SOLUTION,49.7,29.82,11.53,4481.0,19 NDC,00054038225,CYCLOPHOSPHAMIDE 25 MG CAPSULE,55.0,33.0,2.48,4481.0,24 NDC,00054038325,CYCLOPHOSPHAMIDE 50 MG CAPSULE,80.0,48.0,2.48,4481.0,24 NDC,00054087949,MERCAPTOPURINE 20 MG/ML ORAL SUSPENSION,5252.2,3151.32,1218.51,4481.0,19 NDC,00054317757,DEXAMETHASONE 0.5 MG/5 ML ORAL SOLUTION,168.65,101.19,0.045,4481.0,24 NDC,00054318863,DIAZEPAM 5 MG/5 ML (1 MG/ML) ORAL SOLUTION,198.35,119.01,46.02,4481.0,19 NDC,00054329446,FUROSEMIDE 10 MG/ML ORAL SOLUTION,36.2,21.72,8.4,4481.0,19 NDC,00054353244,LORAZEPAM 2 MG/ML ORAL CONCENTRATE,117.95,70.77,27.36,4481.0,19 NDC,00054372263,PREDNISONE 5 MG/5 ML ORAL SOLUTION,946.0,567.6,0.0225,4481.0,24 NDC,00054372763,PROPRANOLOL 20 MG/5 ML (4 MG/ML) ORAL SOLUTION,161.5,96.9,37.47,4481.0,19 NDC,00054449911,LEUCOVORIN CALCIUM 25 MG TABLET,49.9,29.94,11.58,4481.0,19 NDC,00054455025,METHOTREXATE SODIUM 2.5 MG (ONCOLOGY) TABLET,32.1,19.26,0.4275,4481.0,24 NDC,00054458111,MERCAPTOPURINE 50 MG (ONCOLOGY) TABLET,37.7,22.62,8.75,4481.0,19 NDC,00054458111,MERCAPTOPURINE 50 MG TABLET,37.7,22.62,8.75,4481.0,19 NDC,00054814622,CLOTRIMAZOLE 10 MG TROCHE,24.25,14.55,5.63,4481.0,19 NDC,00054817525,DEXAMETHASONE 4 MG TABLET,19.05,11.43,0.045,4481.0,24 NDC,00054817625,DEXAMETHASONE 2 MG TABLET,17.9,10.74,4.15,4481.0,19 NDC,00054817925,DEXAMETHASONE 0.5 MG TABLET,16.55,9.93,0.045,4481.0,24 NDC,00054829725,FUROSEMIDE 20 MG TABLET,16.55,9.93,3.84,4481.0,19 NDC,00054852825,LITHIUM CARBONATE 300 MG TABLET,16.85,10.11,3.91,4481.0,19 NDC,00054855025,METHOTREXATE SODIUM 2.5 MG TABLET,37.2,22.32,0.4275,4481.0,24 NDC,00054873925,PREDNISONE 1 MG TABLET,16.7,10.02,0.0225,4481.0,24 NDC,00065002315,CARBACHOL 0.01 % INTRAOCULAR SOLUTION,62.65,37.59,14.53,4481.0,19 NDC,00065009265,FLUORESCEIN 500 MG/5 ML (10 %) INTRAVENOUS SOLUTION,250.85,150.51,0.855,4481.0,26 NDC,00065035902,CYCLOPENTOLATE-PHENYLEPHRINE 0.2 %-1 % EYE DROPS,127.45,76.47,29.57,4481.0,19 NDC,00065035905,CYCLOPENTOLATE-PHENYLEPHRINE 0.2 %-1 % EYE DROPS,211.8,127.08,49.14,4481.0,19 NDC,00065039515,CYCLOPENTOLATE 0.5 % EYE DROPS,320.75,192.45,74.41,4481.0,19 NDC,00065039602,CYCLOPENTOLATE 1 % EYE DROPS,122.65,73.59,28.45,4481.0,19 NDC,00065039702,CYCLOPENTOLATE 2 % EYE DROPS,155.6,93.36,36.1,4481.0,19 NDC,00065041130,POVIDONE-IODINE 5 % EYE SOLUTION,69.5,41.7,16.12,4481.0,19 NDC,00065074114,TETRACAINE HCL (PF) 0.5 % EYE DROPS,57.8,34.68,13.41,4481.0,19 NDC,00065079515,BALANCED SALT IRRIGATION SOLUTION (BSS PLAIN),100.95,60.57,23.42,4481.0,19 NDC,00065079550,BALANCED SALT IRRIGATION INTRAOCULAR SOLUTION 500ML,178.5,107.1,41.41,4481.0,19 NDC,00065080050,BALANCED SALT IRRIGATION INTRAOCULAR SOLUTION COMBINATION NO.1,373.5,224.1,86.65,4481.0,19 NDC,00065806401,ARTIFICIAL TEARS (HYPROMELLOSE) 0.3 % EYE GEL,11.1,6.66,2.58,4481.0,19 NDC,00068059701,RIFAMPIN 600 MG INTRAVENOUS SOLUTION,646.9,388.14,0.315,4481.0,24 NDC,00069004302,"HEPARIN, PORCINE (PF) 1,000 UNIT/ML INJECTION SOLUTION",62.75,37.65,6.77,4481.0,24 NDC,00069014501,AXITINIB 1 MG TABLET,495.3,297.18,114.91,4481.0,19 NDC,00069015111,AXITINIB 5 MG TABLET,1435.8,861.48,333.11,4481.0,19 NDC,00069018721,PALBOCICLIB 75 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 NDC,00069018821,PALBOCICLIB 100 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 NDC,00069018921,PALBOCICLIB 125 MG CAPSULE,3160.65,1896.39,733.27,4481.0,19 NDC,00069021701,"DALTEPARIN (PORCINE) 10,000 ANTI-XA UNIT/ML SUBCUTANEOUS SYRINGE",510.55,306.33,37.22,4481.0,24 NDC,00069022001,"DALTEPARIN (PORCINE) 12,500 ANTI-XA UNIT/0.5 ML SUBCUTANEOUS SYRINGE",634.25,380.55,37.22,4481.0,24 NDC,00069022301,"DALTEPARIN (PORCINE) 15,000 ANTI-XA UNIT/0.6 ML SUBCUTANEOUS SYRINGE",757.85,454.71,37.22,4481.0,24 NDC,00069022701,LORLATINIB 25 MG TABLET,974.35,584.61,226.05,4481.0,19 NDC,00069022801,"DALTEPARIN (PORCINE) 18,000 ANTI-XA UNIT/0.72 ML SUBCUTANEOUS SYRINGE",757.85,454.71,37.22,4481.0,24 NDC,00069023101,LORLATINIB 100 MG TABLET,2872.95,1723.77,666.52,4481.0,19 NDC,00069023801,RITUXIMAB-PVVR 10 MG/ML INTRAVENOUS SOLUTION,2647.65,1588.59,27.01,4481.0,35 NDC,00069024901,RITUXIMAB-PVVR 10 MG/ML INTRAVENOUS SOLUTION,12138.05,7282.83,27.01,9710.44,35 NDC,00069029101,FILGRASTIM-AAFI 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,870.1,522.06,0.291,4481.0,35 NDC,00069029201,FILGRASTIM-AAFI 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,1382.6,829.56,0.291,4481.0,35 NDC,00069029301,FILGRASTIM-AAFI 300 MCG/ML INJECTION SOLUTION,870.1,522.06,0.291,4481.0,35 NDC,00069029301,FILGRASTIM-AAFI 300 MCG/ML SUBCUTANEOUS SOLUTION (COMPOUNDED SYRINGE),870.1,522.06,0.2716,4481.0,35 NDC,00069029401,FILGRASTIM-AAFI 480 MCG/1.6 ML INJECTION SOLUTION,1382.6,829.56,0.291,4481.0,35 NDC,00069030601,TRASTUZUMAB-QYYP 420 MG INTRAVENOUS SOLUTION,11499.5,6899.7,27.15,9199.6,35 NDC,00069030801,TRASTUZUMAB-QYYP 150 MG INTRAVENOUS SOLUTION,4283.8,2570.28,27.15,4481.0,35 NDC,00069031501,BEVACIZUMAB-BVZR 25 MG/ML INTRAVENOUS SOLUTION,2305.4,1383.24,25.0,4481.0,35 NDC,00069034201,BEVACIZUMAB-BVZR 25 MG/ML INTRAVENOUS SOLUTION,8396.45,5037.87,25.0,6717.16,35 NDC,00069077038,SUNITINIB MALATE 25 MG CAPSULE,1869.7,1121.82,433.77,4481.0,19 NDC,00069080901,INFLIXIMAB-DYYB 100 MG INTRAVENOUS SOLUTION,3157.35,1894.41,19.39,4481.0,35 NDC,00069083038,SUNITINIB MALATE 37.5 MG CAPSULE,2792.05,1675.23,647.76,4481.0,19 NDC,00069098038,SUNITINIB MALATE 50 MG CAPSULE,3236.4,1941.84,750.84,4481.0,19 NDC,00069100201,TOFACITINIB 10 MG TABLET,319.7,191.82,74.17,4481.0,19 NDC,00069130510,"EPOETIN ALFA-EPBX 2,000 UNIT/ML INJECTION SOLUTION",102.05,61.23,7.61,4481.0,33 NDC,00069130601,"EPOETIN ALFA-EPBX 3,000 UNIT/ML INJECTION SOLUTION",145.1,87.06,7.61,4481.0,33 NDC,00069130701,"EPOETIN ALFA-EPBX 4,000 UNIT/ML INJECTION SOLUTION",188.1,112.86,7.61,4481.0,33 NDC,00069130810,"EPOETIN ALFA-EPBX 10,000 UNIT/ML INJECTION SOLUTION",446.2,267.72,7.61,4481.0,33 NDC,00069130904,"EPOETIN ALFA-EPBX 40,000 UNIT/ML INJECTION SOLUTION",1736.7,1042.02,7.61,4481.0,33 NDC,00069131110,"EPOETIN ALFA-EPBX 20,000 UNIT/ML INJECTION SOLUTION",876.35,525.81,7.61,4481.0,33 NDC,00069252202,ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION,7741.4,4644.84,178.55,29949.78,35 NDC,00069252801,COVID VACC 2025-2026 (12 YRS UP) (PFIZER)(PF) 30 MCG/0.3 ML IM SYRINGE,465.1,279.06,107.9,4481.0,26 NDC,00069449402,ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION,7741.4,4644.84,178.55,29949.78,35 NDC,00069600125,FOSPHENYTOIN 100 MG PE/2 ML INJECTION SOLUTION,173.7,104.22,5.89,4481.0,24 NDC,00069814020,CRIZOTINIB 250 MG CAPSULE,1609.9,965.94,373.5,4481.0,19 NDC,00074056111,VENETOCLAX 10 MG TABLET,77.05,46.23,17.88,4481.0,19 NDC,00074056611,VENETOCLAX 50 MG TABLET,285.4,171.24,66.21,4481.0,19 NDC,00074057611,VENETOCLAX 100 MG TABLET,545.6,327.36,126.58,4481.0,19 NDC,00074057928,VENETOCLAX 10 MG (14)-50 MG (7)-100 MG (21) TABLETS IN A DOSE PACK,13510.9,8106.54,3134.53,10808.72,19 NDC,00074104328,"UPADACITINIB ER 45 MG TABLET,EXTENDED RELEASE 24 HR",1366.55,819.93,317.04,4481.0,19 NDC,00074104401,TELISOTUZUMAB VEDOTIN-TLLV 20 MG INTRAVENOUS SOLUTION,9529.8,5717.88,139.67,8244.23,35 NDC,00074105501,TELISOTUZUMAB VEDOTIN-TLLV 100 MG INTRAVENOUS SOLUTION,46548.8,27929.28,139.67,40269.37,35 NDC,00074165801,PARICALCITOL 5 MCG/ML INTRAVENOUS SOLUTION,112.55,67.53,1.83,4481.0,24 NDC,00074334603,LEUPROLIDE ACETATE 22.5 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT,21587.7,12952.62,171.16,26039.58,35 NDC,00074364103,LEUPROLIDE 3.75 MG INTRAMUSCULAR SYRINGE KIT,6236.7,3742.02,1577.89,252434.28,35 NDC,00074364203,LEUPROLIDE 7.5 MG INTRAMUSCULAR SYRINGE KIT,7379.3,4427.58,171.16,26039.58,35 NDC,00074366303,LEUPROLIDE ACETATE 11.25 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT,18160.2,10896.12,1678.41,252434.28,35 NDC,00074379902,ADALIMUMAB 40 MG/0.8 ML SUBCUTANEOUS SYRINGE KIT,13515.15,8109.09,88.98,11691.96,34 NDC,00074433902,ADALIMUMAB 40 MG/0.8 ML SUBCUTANEOUS PEN KIT,13515.15,8109.09,88.98,11691.96,34 NDC,00074463701,PARICALCITOL 2 MCG/ML INTRAVENOUS SOLUTION,82.85,49.71,1.83,4481.0,24 NDC,00074501501,RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION,34829.75,20897.85,14.49,27863.8,35 NDC,00075291201,ENOXAPARIN 120 MG/0.8 ML SUBCUTANEOUS SYRINGE,132.3,79.38,1.33,4481.0,24 NDC,00078010961,CYCLOSPORINE 250 MG/5 ML INTRAVENOUS SOLUTION,295.8,177.48,68.63,10791.27,24 NDC,00078024915,LETROZOLE 2.5 MG TABLET,133.65,80.19,31.01,4481.0,19 NDC,00078027422,CYCLOSPORINE MODIFIED 100 MG/ML ORAL SOLUTION,1938.85,1163.31,4.59,4481.0,24 NDC,00078033184,BASILIXIMAB 20 MG INTRAVENOUS SOLUTION,15269.65,9161.79,3863.22,727914.6,35 NDC,00078040134,IMATINIB 100 MG TABLET,399.6,239.76,92.71,4481.0,19 NDC,00078041461,EVEROLIMUS (IMMUNOSUPPRESSIVE) 0.5 MG TABLET,112.9,67.74,3.08,4481.0,24 NDC,00078041561,EVEROLIMUS (IMMUNOSUPPRESSIVE) 0.75 MG TABLET,156.75,94.05,3.08,4481.0,24 NDC,00078041720,EVEROLIMUS (IMMUNOSUPPRESSIVE) 0.25 MG TABLET,68.9,41.34,3.08,4481.0,24 NDC,00078046791,DEFEROXAMINE 500 MG SOLUTION FOR INJECTION,151.45,90.87,20.27,4481.0,24 NDC,00078050883,CARBAMAZEPINE 100 MG/5 ML ORAL SUSPENSION,22.65,13.59,5.25,4481.0,19 NDC,00078052651,NILOTINIB HCL 200 MG CAPSULE,798.05,478.83,185.15,4481.0,19 NDC,00078056651,EVEROLIMUS (ANTINEOPLASTIC) 5 MG TABLET,2758.6,1655.16,640.0,4481.0,19 NDC,00078056761,EVEROLIMUS (ANTINEOPLASTIC) 10 MG TABLET,2758.5,1655.1,639.97,4481.0,19 NDC,00078056845,ARTEMETHER-LUMEFANTRINE 20 MG-120 MG TABLET,32.85,19.71,7.62,4481.0,19 NDC,00078059251,NILOTINIB HCL 150 MG CAPSULE,798.05,478.83,185.15,4481.0,19 NDC,00078059451,EVEROLIMUS (ANTINEOPLASTIC) 2.5 MG TABLET,2638.45,1583.07,612.12,4481.0,19 NDC,00078062061,EVEROLIMUS (ANTINEOPLASTIC) 7.5 MG TABLET,2758.65,1655.19,640.01,4481.0,19 NDC,00078065515,DEFERASIROX 180 MG TABLET,347.0,208.2,80.5,4481.0,19 NDC,00078065920,SACUBITRIL 24 MG-VALSARTAN 26 MG TABLET,51.3,30.78,11.9,4481.0,19 NDC,00078066913,OFATUMUMAB (ARZERRA) 20 MG/ML INJECTION WRAPPER,2272.2,1363.32,60.36,10203.27,35 NDC,00078066913,OFATUMUMAB 100 MG/5 ML INTRAVENOUS SOLUTION,2272.2,1363.32,60.36,10203.27,35 NDC,00078067119,LAPATINIB 250 MG TABLET,296.4,177.84,68.76,4481.0,19 NDC,00078068515,ELTROMBOPAG OLAMINE 25 MG TABLET,798.65,479.19,185.29,4481.0,19 NDC,00078069061,OFATUMUMAB (ARZERRA) 20 MG/ML INJECTION WRAPPER,20246.55,12147.93,60.36,16197.24,35 NDC,00078069061,"OFATUMUMAB 1,000 MG/50 ML INTRAVENOUS SOLUTION",19793.2,11875.92,60.36,15834.56,35 NDC,00078069620,SACUBITRIL 97 MG-VALSARTAN 103 MG TABLET,51.3,30.78,11.9,4481.0,19 NDC,00078069899,MIDOSTAURIN 25 MG CAPSULE,896.7,538.02,208.03,4481.0,19 NDC,00078073461,CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION,69989.85,41993.91,137.35,55991.88,35 NDC,00078077720,SACUBITRIL 49 MG-VALSARTAN 51 MG TABLET,51.3,30.78,11.9,4481.0,19 NDC,00078081181,"OCTREOTIDE,MICROSPHERES ER 10 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",13757.4,8254.44,197.47,30919.98,35 NDC,00078081881,"OCTREOTIDE,MICROSPHERES ER 20 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",18019.6,10811.76,197.47,30919.98,35 NDC,00078082581,"OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE",26975.0,16185.0,197.47,30919.98,35 NDC,00078087601,TOBRAMYCIN-DEXAMETHASONE 0.3 %-0.1 % EYE OINTMENT,913.3,547.98,211.89,4481.0,19 NDC,00078088361,CRIZANLIZUMAB-TMCA 10 MG/ML INTRAVENOUS SOLUTION,8084.15,4850.49,125.6,21195.93,35 NDC,00078100060,INCLISIRAN 284 MG/1.5 ML SUBCUTANEOUS SYRINGE,14008.15,8404.89,11.95,11206.52,35 NDC,00078116861,SECUKINUMAB 25 MG/ML INTRAVENOUS SOLUTION,7259.2,4355.52,17.3,5807.36,35 NDC,00085132801,POSACONAZOLE 200 MG/5 ML (40 MG/ML) ORAL SUSPENSION,118.85,71.31,27.57,4481.0,19 NDC,00085138101,TEMOZOLOMIDE IVPB,3595.3,2157.18,10.08,4481.0,35 NDC,00085433101,POSACONAZOLE 300 MG/16.7 ML INTRAVENOUS SOLUTION,1797.55,1078.53,417.03,4481.0,19 NDC,00087040501,PEDIATRIC MULTIVITAMIN-FERROUS SULFATE 11 MG/ML ORAL DROPS WRAPPER,13.75,8.25,3.19,4481.0,19 NDC,00088222033,INSULIN GLARGINE (U-100) 100 UNIT/ML SUBCUTANEOUS SOLUTION,266.65,159.99,0.5175,4481.0,24 NDC,00093106001,SOTALOL 120 MG TABLET,17.15,10.29,3.98,4481.0,19 NDC,00093312301,DICLOXACILLIN 250 MG CAPSULE,18.05,10.83,4.19,4481.0,19 NDC,00093312701,DISOPYRAMIDE PHOSPHATE 100 MG CAPSULE,22.0,13.2,5.1,4481.0,19 NDC,00093406701,PRAZOSIN 1 MG CAPSULE,17.3,10.38,4.01,4481.0,19 NDC,00093406801,PRAZOSIN 2 MG CAPSULE,17.95,10.77,4.16,4481.0,19 NDC,00093412773,PENICILLIN V POTASSIUM 250 MG/5 ML ORAL SOLUTION,42.7,25.62,9.91,4481.0,19 NDC,00093417773,CEPHALEXIN 250 MG/5 ML ORAL SUSPENSION,85.0,51.0,19.72,4481.0,19 NDC,00093555001,"DEXMETHYLPHENIDATE ER 5 MG CAPSULE,EXTENDED RELEASE BIPHASIC50-50",25.95,15.57,6.02,4481.0,19 NDC,00093555101,"DEXMETHYLPHENIDATE ER 10 MG CAPSULE,EXTENDED RELEASE BIPHASIC50-50",25.95,15.57,6.02,4481.0,19 NDC,00093557156,ERYTHROMYCIN 250 MG TABLET,35.85,21.51,8.32,4481.0,19 NDC,00093598519,"EPINEPHRINE (JR) 0.15 MG/0.3 ML INJECTION,AUTO-INJECTOR",601.0,360.6,1.08,4481.0,24 NDC,00093834401,GLYBURIDE 5 MG TABLET,16.8,10.08,3.9,4481.0,19 NDC,00093874101,MEXILETINE 250 MG CAPSULE,21.55,12.93,5.0,4481.0,19 NDC,00093901865,CYCLOSPORINE MODIFIED 25 MG CAPSULE,19.3,11.58,1.8,4481.0,24 NDC,00093902019,CYCLOSPORINE MODIFIED 100 MG CAPSULE,29.2,17.52,4.59,4481.0,24 NDC,00093943301,GLYBURIDE 2.5 MG TABLET,16.65,9.99,3.86,4481.0,19 NDC,00093970101,CARBIDOPA 10 MG-LEVODOPA 100 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,00115107001,DIPYRIDAMOLE 25 MG TABLET,17.5,10.5,4.06,4481.0,19 NDC,00115107201,DIPYRIDAMOLE 75 MG TABLET,19.25,11.55,4.47,4481.0,19 NDC,00115172501,GRISEOFULVIN ULTRAMICROSIZE 250 MG TABLET,31.3,18.78,7.26,4481.0,19 NDC,00115441101,DANTROLENE 25 MG CAPSULE,18.45,11.07,4.28,4481.0,19 NDC,00121053005,FERROUS SULFATE 300 MG (60 MG IRON)/5 ML ORAL LIQUID,6.3,3.78,1.46,4481.0,19 NDC,00121058104,HALOPERIDOL LACTATE 2 MG/ML ORAL CONCENTRATE,16.7,10.02,3.87,4481.0,19 NDC,00121058105,HALOPERIDOL LACTATE 2 MG/ML ORAL CONCENTRATE,18.1,10.86,4.2,4481.0,19 NDC,00121059516,SODIUM CITRATE-CITRIC ACID 500 MG-334 MG/5 ML ORAL SOLUTION,23.0,13.8,5.34,4481.0,19 NDC,00121064610,AMANTADINE HCL 50 MG/5 ML ORAL SOLUTION,27.85,16.71,6.46,4481.0,19 NDC,00121065705,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL LIQUID WRAPPER,3.55,2.13,0.8236,4481.0,19 NDC,00121065705,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL SOLUTION,3.55,2.13,0.8236,4481.0,19 NDC,00121067716,POTAS AND SOD CITRATE-CITRIC ACID 550 MG-500 MG-334 MG/5 ML ORAL SOLN,31.8,19.08,7.38,4481.0,19 NDC,00121067816,NORTRIPTYLINE 10 MG/5 ML ORAL SOLUTION,585.05,351.03,135.73,4481.0,19 NDC,00121076616,"CALCIUM 500 MG/5 ML (AS CALCIUM CARB 1,250 MG/5 ML) ORAL SUSPENSION",1.3,0.78,0.3016,4481.0,19 NDC,00121086805,"NYSTATIN 100,000 UNIT/ML ORAL SUSPENSION",17.15,10.29,3.98,4481.0,19 NDC,00121089315,CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASH,17.8,10.68,4.13,4481.0,19 NDC,00121094510,MEGESTROL 400 MG/10 ML (10 ML) ORAL SUSPENSION,41.75,25.05,9.69,4481.0,19 NDC,00121097810,DIPHENHYDRAMINE 12.5 MG/5 ML ORAL ELIXIR,7.45,4.47,1.73,4481.0,19 NDC,00121119030,SODIUM CITRATE-CITRIC ACID 500 MG-334 MG/5 ML ORAL SOLUTION,8.9,5.34,2.06,4481.0,19 NDC,00121127610,DEXTROMETHORPHAN-GUAIFENESIN 10 MG-100 MG/5 ML ORAL SYRUP,4.6,2.76,1.07,4481.0,19 NDC,00121174405,GUAIFENESIN 100 MG/5 ML ORAL LIQUID,2.25,1.35,0.522,4481.0,19 NDC,00121176230,ALUMINUM-MAG HYDROXIDE-SIMETHICONE 400 MG-400 MG-40 MG/5 ML ORAL SUSP,3.95,2.37,0.9164,4481.0,19 NDC,00121202410,LACOSAMIDE 10 MG/ML ORAL SOLUTION,96.85,58.11,22.47,4481.0,19 NDC,00121467505,VALPROIC ACID (AS SODIUM SALT) 250 MG/5 ML (5 ML) ORAL SOLUTION,20.15,12.09,4.67,4481.0,19 NDC,00121476605,"CALCIUM 500 MG/5 ML (AS CALCIUM CARB 1,250 MG/5 ML) ORAL SUSPENSION",7.35,4.41,1.71,4481.0,19 NDC,00121495040,LIDOCAINE HCL 2 % MUCOSAL SOLUTION,17.25,10.35,4.0,4481.0,19 NDC,00126028802,SODIUM FLUORIDE 1.1 % DENTAL GEL,73.0,43.8,16.94,4481.0,19 NDC,00131181067,LACOSAMIDE 200 MG/20 ML INTRAVENOUS SOLUTION,96.6,57.96,0.45,4481.0,23 NDC,00131541072,LACOSAMIDE 10 MG/ML ORAL SOLUTION,51.15,30.69,11.87,4481.0,19 NDC,00132070336,BISACODYL 10 MG/30 ML ENEMA,4.05,2.43,0.9396,4481.0,19 NDC,00135009826,ALUMINUM HYDROX-MAGNESIUM CARB 160 MG-105 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 NDC,00135057603,"FLUTICASONE PROPIONATE 50 MCG/ACTUATION NASAL SPRAY,SUSPENSION",31.2,18.72,7.24,4481.0,19 NDC,00143920401,DOCETAXEL (TAXOTERE) 20 MG/ML INJECTION WRAPPER,490.15,294.09,1.04,4481.0,24 NDC,00143924510,DACARBAZINE 200 MG INTRAVENOUS SOLUTION,314.75,188.85,7.76,4481.0,24 NDC,00143924701,DEXRAZOXANE HCL 250 MG INTRAVENOUS SOLUTION,1085.65,651.39,61.17,12799.29,35 NDC,00143924801,DEXRAZOXANE HCL 500 MG INTRAVENOUS SOLUTION,2155.2,1293.12,61.17,12799.29,35 NDC,00143929201,THIOTEPA 100 MG SOLUTION FOR INJECTION,6233.0,3739.8,10.22,5392.17,35 NDC,00143929701,DANTROLENE 20 MG INTRAVENOUS SOLUTION,294.9,176.94,68.42,4481.0,19 NDC,00143937801,DAPTOMYCIN 500 MG SOLUTION FOR IV PUSH,177.45,106.47,0.0675,4481.0,24 NDC,00143938001,MIDAZOLAM (PF) 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,112.3,67.38,0.45,4481.0,24 NDC,00143939110,REMIFENTANIL 1 MG INTRAVENOUS SOLUTION,206.4,123.84,47.88,4481.0,19 NDC,00143950801,KETAMINE 50 MG/ML INJECTION SOLUTION,41.3,24.78,9.58,4481.0,19 NDC,00143951425,DROPERIDOL 2.5 MG/ML INJECTION SOLUTION,25.45,15.27,5.9,4481.0,24 NDC,00143955110,DAUNORUBICIN (CERUBIDINE) SYRINGE 5 MG/ML,719.05,431.43,21.05,4481.0,35 NDC,00143956401,PHENTOLAMINE 5 MG INJECTION SOLUTION,1926.9,1156.14,419.06,4481.0,35 NDC,00143956501,THIOTEPA 15 MG SOLUTION FOR INJECTION,2757.5,1654.5,10.22,4481.0,35 NDC,00143956601,AZATHIOPRINE 100 MG SOLUTION FOR INJECTION,991.0,594.6,246.45,4481.0,35 NDC,00143956701,CEFUROXIME SODIUM 1.5 GRAM SOLUTION FOR IV PUSH,33.55,20.13,4.16,4481.0,24 NDC,00143956801,CEFUROXIME SODIUM 750 MG SOLUTION FOR IV PUSH,24.9,14.94,4.16,4481.0,24 NDC,00143957010,SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE 62.5 MG/5 ML INTRAVENOUS,167.0,100.2,4.54,4481.0,24 NDC,00143967401,ARGATROBAN 100 MG/ML INTRAVENOUS SOLUTION,684.3,410.58,0.776,4481.0,35 NDC,00143970901,MILRINONE 1 MG/ML INTRAVENOUS SOLUTION,93.05,55.83,3.26,4481.0,24 NDC,00143971010,MILRINONE 1 MG/ML INTRAVENOUS SOLUTION,83.45,50.07,3.26,4481.0,24 NDC,00143971801,MILRINONE 40 MG/200 ML(200 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS PIGGYBK,184.95,110.97,3.26,4481.0,24 NDC,00143972001,LEVOFLOXACIN 750 MG/150 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,87.05,52.23,5.33,4481.0,24 NDC,00143972101,LEVOFLOXACIN 500 MG/100 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,86.25,51.75,5.33,4481.0,24 NDC,00143972201,LEVOFLOXACIN 250 MG/50 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,85.9,51.54,5.33,4481.0,24 NDC,00143972501,PROGESTERONE 50 MG/ML INTRAMUSCULAR OIL,17.35,10.41,1.57,4481.0,24 NDC,00143978310,FLUMAZENIL 0.1 MG/ML INTRAVENOUS SOLUTION,105.55,63.33,24.49,4481.0,19 NDC,00143978510,VALPROATE SODIUM 500 MG/5 ML (100 MG/ML) INTRAVENOUS SOLUTION,85.9,51.54,19.93,4481.0,19 NDC,00143978601,ENALAPRILAT 1.25 MG/ML INTRAVENOUS SOLUTION,94.05,56.43,21.82,4481.0,19 NDC,00143983701,PENICILLIN V POTASSIUM 250 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,00143987501,AMIODARONE 50 MG/ML INTRAVENOUS SOLUTION,69.55,41.73,0.9675,4481.0,24 NDC,00143988901,AMOXICILLIN 250 MG/5 ML ORAL SUSPENSION,16.45,9.87,3.82,4481.0,19 NDC,00143988915,AMOXICILLIN 250 MG/5 ML ORAL SUSPENSION,16.5,9.9,3.83,4481.0,19 NDC,00143992490,CEFAZOLIN (ANCEF) 100 MG/ML SYRINGE (PEDIATRIC),65.25,39.15,1.8,4481.0,24 NDC,00143992490,CEFAZOLIN 1 GRAM SOLUTION FOR INJECTION,67.5,40.5,1.8,4481.0,24 NDC,00143992701,CIPROFLOXACIN 250 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,00143997722,CEFUROXIME 1.5 GRAM (COMBINED) INJECTION WRAPPER,38.8,23.28,4.16,4481.0,24 NDC,00143997790,CEFUROXIME (ZINACEF) 90 MG/ML SYRINGE (PEDIATRIC),82.15,49.29,4.16,4481.0,24 NDC,00143997790,CEFUROXIME SODIUM 1.5 GRAM INTRAVENOUS SOLUTION,38.85,23.31,4.16,4481.0,23 NDC,00143997922,CEFUROXIME SODIUM 750 MG INJ SOLR IM,27.4,16.44,4.16,4481.0,24 NDC,00143997990,CEFUROXIME SODIUM 750 MG SOLUTION FOR INJECTION,27.4,16.44,4.16,4481.0,24 NDC,00143998201,AMOXICILLIN 400 MG-POTASSIUM CLAVULANATE 57 MG/5 ML ORAL SUSPENSION,59.8,35.88,13.87,4481.0,19 NDC,00143998391,CEFAZOLIN 10 GRAM SOLUTION FOR INJECTION,59.1,35.46,1.8,4481.0,24 NDC,00168006460,FLUOCINOLONE 0.025 % TOPICAL OINTMENT,270.15,162.09,62.67,4481.0,19 NDC,00168014630,HYDROCORTISONE 2.5 % TOPICAL OINTMENT,25.9,15.54,6.01,4481.0,19 NDC,00168020160,CLINDAMYCIN PHOSPHATE 1 % TOPICAL SOLUTION,124.4,74.64,28.86,4481.0,19 NDC,00168041630,TACROLIMUS 0.1 % TOPICAL OINTMENT,423.65,254.19,98.29,4481.0,19 NDC,00169413013,SEMAGLUTIDE 1 MG/DOSE (4 MG/3 ML) SUBCUTANEOUS PEN INJECTOR,3906.6,2343.96,906.33,4481.0,19 NDC,00169451714,SEMAGLUTIDE (NON-DIABETES) 1.7 MG/0.75 ML SUBCUTANEOUS PEN INJECTOR,1331.3,798.78,308.86,4481.0,19 NDC,00169720101,"COAGULATION FACTOR VIIA RECOMB 1 MG (1,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 NDC,00169720101,FACTOR VIIA RECOMB (NOVOSEVEN) INTERMITTENT INFUSION,86.7,52.02,2.58,4481.0,35 NDC,00169720201,"COAGULATION FACTOR VIIA RECOMB 2 MG (2,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 NDC,00169720501,"COAGULATION FACTOR VIIA RECOMB 5 MG (5,000 MCG) INTRAVENOUS SOLUTION",86.7,52.02,2.58,4481.0,35 NDC,00173054700,ATOVAQUONE 750 MG/5 ML ORAL SUSPENSION,115.5,69.3,26.8,4481.0,19 NDC,00173068224,ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,84.4,50.64,19.58,4481.0,19 NDC,00173085914,FLUTICASONE FUROATE 100 MCG-VILANTEROL 25 MCG/DOSE INHALATION POWDER,488.25,292.95,113.27,4481.0,19 NDC,00173086906,UMECLIDINIUM 62.5 MCG-VILANTEROL 25 MCG/ACTUATION POWDR FOR INHALATION,369.85,221.91,85.81,4481.0,19 NDC,00173087306,UMECLIDINIUM 62.5 MCG/ACTUATION BLISTER POWDER FOR INHALATION,241.9,145.14,56.12,4481.0,19 NDC,00173087414,FLUTICASONE FUROATE 100 MCG/ACTUATION BLISTER POWDER FOR INHALATION,308.85,185.31,71.65,4481.0,19 NDC,00173087614,FLUTICASONE FUROATE 200 MCG/ACTUATION BLISTER POWDER FOR INHALATION,408.1,244.86,94.68,4481.0,19 NDC,00173088101,MEPOLIZUMAB 100 MG SUBCUTANEOUS SOLUTION,14067.0,8440.2,30.33,11253.6,35 NDC,00173088214,FLUTICASONE FUROATE 200 MCG-VILANTEROL 25 MCG/DOSE INHALATION POWDER,488.25,292.95,113.27,4481.0,19 NDC,00173089803,DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION,40095.2,24057.12,236.4,39304.86,35 NDC,00185005501,METOLAZONE 5 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,00185013001,BUMETANIDE 2 MG TABLET,18.55,11.13,4.3,4481.0,19 NDC,00185505001,METOLAZONE 2.5 MG TABLET,17.8,10.68,4.13,4481.0,19 NDC,00186037028,BUDESONIDE-FORMOTEROL HFA 160 MCG-4.5 MCG/ACTUATION AEROSOL INHALER,495.2,297.12,114.89,4481.0,19 NDC,00186037228,BUDESONIDE-FORMOTEROL HFA 80 MCG-4.5 MCG/ACTUATION AEROSOL INHALER,432.6,259.56,100.36,4481.0,19 NDC,00186077739,TICAGRELOR 90 MG TABLET,39.25,23.55,9.11,4481.0,19 NDC,00186198804,BUDESONIDE 0.25 MG/2 ML SUSPENSION FOR NEBULIZATION,42.15,25.29,9.78,4481.0,19 NDC,00186198904,BUDESONIDE 0.5 MG/2 ML SLURRY FOR ORAL USE,31.4,18.84,7.28,4481.0,19 NDC,00186401001,ESOMEPRAZOLE MAGNESIUM DR 10 MG GRANULES DELAYED RELEASE FOR SUSP,44.75,26.85,10.38,4481.0,19 NDC,00186402501,ESOMEPRAZOLE MAGNESIUM DR 2.5 MG GRANULES DELAYED RELEASE FOR SUSP,44.75,26.85,10.38,4481.0,19 NDC,00187301220,PYRIDOSTIGMINE BROMIDE 60 MG/5 ML ORAL SYRUP,5284.75,3170.85,1226.06,4481.0,19 NDC,00187560015,VERTEPORFIN 15 MG INTRAVENOUS SOLUTION,5653.8,3392.28,11.19,4523.04,35 NDC,00225080047,PHENYLEPHRINE 0.25 % NASAL SPRAY,6.4,3.84,1.48,4481.0,19 NDC,00225080547,PHENYLEPHRINE 0.5 % NASAL SPRAY,6.4,3.84,1.48,4481.0,19 NDC,00228202710,ALPRAZOLAM 0.25 MG TABLET,22.15,13.29,5.14,4481.0,19 NDC,00228207610,TEMAZEPAM 15 MG CAPSULE,22.3,13.38,5.17,4481.0,19 NDC,00228285011,"GUANFACINE ER 1 MG TABLET,EXTENDED RELEASE 24 HR",18.25,10.95,4.23,4481.0,19 NDC,00228285111,"GUANFACINE ER 2 MG TABLET,EXTENDED RELEASE 24 HR",18.25,10.95,4.23,4481.0,19 NDC,00245036089,POTASSIUM CHLORIDE 20 MEQ ORAL PACKET,20.6,12.36,4.78,4481.0,19 NDC,00245531789,"POTASSIUM CHLORIDE ER 10 MEQ TABLET,EXTENDED RELEASE(PART/CRYST)",17.5,10.5,4.06,4481.0,19 NDC,00245531915,"POTASSIUM CHLORIDE ER 20 MEQ TABLET,EXTENDED RELEASE(PART/CRYST)",17.55,10.53,4.07,4481.0,19 NDC,00259050116,GLYCOPYRROLATE 1 MG/5 ML (0.2 MG/ML) ORAL SOLUTION,1514.5,908.7,351.36,4481.0,19 NDC,00259160501,INCOBOTULINUMTOXINA 50 UNIT INTRAMUSCULAR SOLUTION,1061.2,636.72,5.4,4481.0,35 NDC,00259161001,INCOBOTULINUMTOXINA 100 UNIT INTRAMUSCULAR SOLUTION,2008.9,1205.34,5.4,4481.0,35 NDC,00264151031,DEXTROSE 5 % IN WATER (D5W) IV EXCEL,70.35,42.21,16.32,4481.0,17 NDC,00264151032,DEXTROSE 5% WATER (D5W) NON-PVC,70.5,42.3,16.36,4481.0,17 NDC,00264193310,AMINO ACID 10 % INTRAVENOUS SOLUTION,208.55,125.13,48.38,4481.0,19 NDC,00264310311,CEFAZOLIN 1 GRAM/50 ML IN DEXTROSE (ISO-OSMOTIC) INTRAVENOUS PIGGYBACK,112.95,67.77,1.8,4481.0,24 NDC,00264310511,CEFAZOLIN 2 GRAM/50 ML IN DEXTROSE (ISO-OSMOTIC) INTRAVENOUS PIGGYBACK,119.25,71.55,1.8,4481.0,24 NDC,00264310511,CEFAZOLIN 2 GRAM/50 ML IN DEXTROSE WRAPPER,119.25,71.55,1.8,4481.0,24 NDC,00264450000,PARENTERAL AMINO ACID 15 % COMBINATION NO.6 INTRAVENOUS SOLUTION,215.4,129.24,49.97,4481.0,19 NDC,00264553532,METRONIDAZOLE 500 MG/100 ML IN SODIUM CHLOR(ISO) INTRAVENOUS PIGGYBACK,75.2,45.12,0.0675,4481.0,24 NDC,00264751000,DEXTROSE 5% WATER (D5W) NON-PVC,75.0,45.0,7.0,4481.0,21 NDC,00264751010,DEXTROSE 5% WATER (D5W) NON-PVC,75.0,45.0,4.07,4481.0,21 NDC,00264751020,DEXTROSE 5% WATER (D5W) NON-PVC,74.25,44.55,17.23,4481.0,17 NDC,00264780000,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION NON-PVC,72.0,43.2,4.39,4481.0,21 NDC,00264780000,SODIUM CHLORIDE 0.9% NON-PVC,72.0,43.2,4.39,4481.0,21 NDC,00264780010,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION NON-PVC,73.5,44.1,2.83,4481.0,21 NDC,00264780010,SODIUM CHLORIDE 0.9% NON-PVC,73.5,44.1,2.83,4481.0,21 NDC,00264780020,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION NON-PVC,71.25,42.75,1.46,4481.0,21 NDC,00264780510,SODIUM CHLORIDE 3 % INTRAVENOUS BOLUS SOLUTION,79.5,47.7,0.2805,4481.0,24 NDC,00270014957,DIATRIZOATE MEGLUMINE 30 % URETHRAL SOLUTION,67.55,40.53,0.18,4481.0,25 NDC,00270044535,DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM 66 %-10 % ORAL SOLUTION (37% ORGANICALLY BOUND IODINE),292.85,175.71,0.495,4481.0,24 NDC,00270055615,SINCALIDE 5 MCG SOLUTION FOR INJECTION,524.85,314.91,121.77,4481.0,24 NDC,00270709916,SULFUR HEXAFLUORIDE MICROSPHERES 25 MG INTRAVENOUS SUSPENSION,169.0,101.4,39.21,4481.0,23 NDC,00281032608,NITROGLYCERIN 2 % TRANSDERMAL OINTMENT,23.3,13.98,5.41,4481.0,19 NDC,00283067902,BENZOCAINE 20 % MUCOSAL AEROSOL SPRAY,1.85,1.11,0.4292,4481.0,19 NDC,00283067902,BENZOCAINE 20 % MUCOSAL SPRAY WRAPPER,48.4,29.04,11.23,4481.0,19 NDC,00283087102,BENZOCAINE 20 % MUCOSAL GEL,10.05,6.03,2.33,4481.0,19 NDC,00310111001,SODIUM ZIRCONIUM CYCLOSILICATE 10 GRAM ORAL POWDER PACKET,102.2,61.32,23.71,4481.0,19 NDC,00310134930,OSIMERTINIB 40 MG TABLET,2375.8,1425.48,551.19,4481.0,19 NDC,00310135030,OSIMERTINIB 80 MG TABLET,2375.8,1425.48,551.19,4481.0,19 NDC,00310173030,BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE,22819.5,13691.7,159.65,26729.01,35 NDC,00310304000,ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION,17853.9,10712.34,17.54,14283.12,35 NDC,00310450012,DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION,3686.7,2212.02,82.57,13726.86,35 NDC,00310450525,TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION,11691.0,7014.6,136.67,22627.71,35 NDC,00310453530,TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION,137266.4,82359.84,136.67,109813.12,35 NDC,00310461150,DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION,14490.35,8694.21,82.57,13726.86,35 NDC,00338000344,"WATER FOR IRRIGATION, STERILE SOLUTION",75.0,45.0,17.4,4481.0,19 NDC,00338000347,"WATER FOR IRRIGATION, STERILE SOLUTION",70.5,42.3,16.36,4481.0,19 NDC,00338000402,"WATER FOR IRRIGATION, STERILE SOLUTION",94.5,56.7,21.92,4481.0,19 NDC,00338000403,"WATER FOR IRRIGATION, STERILE SOLUTION",76.5,45.9,17.75,4481.0,19 NDC,00338001304,"WATER FOR INJECTION, STERILE INTRAVENOUS SOLUTION",93.0,55.8,21.58,4481.0,19 NDC,00338001306,"WATER FOR INJECTION, STERILE INTRAVENOUS SOLUTION",81.0,48.6,18.79,4481.0,19 NDC,00338001703,DEXTROSE 5 % IV BOLUS,69.75,41.85,4.07,4481.0,21 NDC,00338001704,DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION,81.0,48.6,7.0,4481.0,21 NDC,00338001704,DEXTROSE 5 % IV BOLUS,67.5,40.5,7.0,4481.0,21 NDC,00338001710,DEXTROSE 5 % IV BOLUS,150.0,90.0,34.8,4481.0,17 NDC,00338001711,DEXTROSE 5 % IV BOLUS,104.25,62.55,24.19,4481.0,17 NDC,00338001731,DEXTROSE 5% IVPB SOLN,70.65,42.39,4.07,4481.0,21 NDC,00338001738,DEXTROSE 5 % IV BOLUS,82.5,49.5,19.14,4481.0,17 NDC,00338002304,DEXTROSE 10 % IN WATER (D10W) INTRAVENOUS SOLUTION,87.0,52.2,20.18,4481.0,17 NDC,00338002304,DEXTROSE 10 % IV BOLUS,69.0,41.4,16.01,4481.0,17 NDC,00338004303,SODIUM CHLORIDE 0.45 % INTRAVENOUS SOLUTION,76.5,45.9,2.83,4481.0,21 NDC,00338004304,SODIUM CHLORIDE 0.45 % INTRAVENOUS SOLUTION,81.0,48.6,2.83,4481.0,21 NDC,00338004727,SODIUM CHLORIDE 0.9 % IRRIGATION SOLUTION,81.0,48.6,18.79,4481.0,19 NDC,00338004802,SODIUM CHLORIDE 0.9 % IRRIGATION SOLUTION,120.0,72.0,27.84,4481.0,19 NDC,00338004803,SODIUM CHLORIDE 0.9 % IRRIGATION SOLUTION,90.0,54.0,20.88,4481.0,19 NDC,00338004804,SODIUM CHLORIDE 0.9 % IRRIGATION SOLUTION,78.0,46.8,18.1,4481.0,19 NDC,00338004902,SODIUM CHLORIDE 0.9% IV BOLUS,75.75,45.45,1.46,4481.0,21 NDC,00338004902,SODIUM CHLORIDE 0.9% IVPB SOLN,75.75,45.45,1.46,4481.0,21 NDC,00338004903,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION FOR PRESSURE LINES,75.0,45.0,2.83,4481.0,21 NDC,00338004903,SODIUM CHLORIDE 0.9% IV BOLUS,69.0,41.4,2.83,4481.0,21 NDC,00338004903,SODIUM CHLORIDE 0.9% IVPB SOLN,75.0,45.0,2.83,4481.0,21 NDC,00338004904,SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION,78.0,46.8,4.39,4481.0,21 NDC,00338004904,SODIUM CHLORIDE 0.9% INTRAVENOUS SOLUTION FOR DIALYSIS,78.0,46.8,4.39,4481.0,21 NDC,00338004904,SODIUM CHLORIDE 0.9% IVPB SOLN,78.0,46.8,4.39,4481.0,21 NDC,00338004910,SODIUM CHLORIDE 0.9% IV BOLUS,147.0,88.2,34.1,4481.0,17 NDC,00338004910,SODIUM CHLORIDE 0.9% IVPB SOLN,71.4,42.84,16.56,4481.0,17 NDC,00338004941,SODIUM CHLORIDE 0.9% IV BOLUS,101.25,60.75,23.49,4481.0,17 NDC,00338004941,SODIUM CHLORIDE 0.9% IVPB SOLN,70.65,42.39,16.39,4481.0,17 NDC,00338004948,SODIUM CHLORIDE 0.9% IV BOLUS,85.5,51.3,19.84,4481.0,17 NDC,00338004948,SODIUM CHLORIDE 0.9% IVPB SOLN,72.0,43.2,16.7,4481.0,17 NDC,00338005403,SODIUM CHLORIDE 3 % HYPERTONIC INTRAVENOUS INJECTION SOLUTION,82.5,49.5,0.2805,4481.0,24 NDC,00338007704,DEXTROSE 5 % AND 0.2 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,81.0,48.6,18.79,4481.0,17 NDC,00338008503,DEXTROSE 5 % AND 0.45 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,76.5,45.9,17.75,4481.0,17 NDC,00338008504,DEXTROSE 5 % AND 0.45 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,81.0,48.6,18.79,4481.0,17 NDC,00338008904,DEXTROSE 5 % AND 0.9 % NACL IV BOLUS,67.5,40.5,3.17,4481.0,21 NDC,00338008904,DEXTROSE 5 % AND 0.9 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,81.0,48.6,3.17,4481.0,21 NDC,00338010820,NOREPINEPHRINE BITARTRATE 8 MG/250 ML (32 MCG/ML) IN DEXTROSE 5 % IV,189.7,113.82,44.01,4481.0,19 NDC,00338011404,LACTATED RINGERS IRRIGATION SOLUTION,90.0,54.0,20.88,4481.0,17 NDC,00338011704,LACTATED RINGERS INTRAVENOUS SOLUTION,78.0,46.8,5.42,4481.0,21 NDC,00338011704,LACTATED RINGERS IRRIGATING INTRACRANIAL CATHETER,78.0,46.8,5.42,4481.0,21 NDC,00338011704,LACTATED RINGERS IV BOLUS,66.75,40.05,5.42,4481.0,21 NDC,00338012204,VANCOMYCIN 1250 MG/250 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,236.4,141.84,0.0675,4481.0,24 NDC,00338012404,VANCOMYCIN 1500 MG/300 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,241.35,144.81,0.0675,4481.0,24 NDC,00338012504,DEXTROSE 5 % AND LACTATED RINGERS INTRAVENOUS SOLUTION,81.0,48.6,18.32,4481.0,21 NDC,00338012504,DEXTROSE 5 % IN LACTATED RINGERS IV BOLUS,72.0,43.2,16.7,4481.0,21 NDC,00338012612,INSULIN REGULAR 100 UNIT/100 ML (1 UNIT/ML) IN 0.9 % NACL IV SOLUTION,196.35,117.81,0.5175,4481.0,24 NDC,00338018001,AMINO ACID 8 % IN DEXTROSE 14 % WATER INTRAVENOUS SOLUTION,299.25,179.55,69.43,4481.0,17 NDC,00338018801,AMINO ACID 8 % IN DEXTROSE 10% WATER INTRAVENOUS SOLUTION,264.95,158.97,61.47,4481.0,17 NDC,00338019801,AMINO ACID 6 % IN DEXTROSE 5 % WATER INTRAVENOUS SOLUTION,264.95,158.97,61.47,4481.0,17 NDC,00338020201,AMINO ACIDS 8 %-DEXTROSE 14 %-ELECTROLYTES INTRAVENOUS SOLUTION,303.05,181.83,70.31,4481.0,17 NDC,00338021001,AMINO ACIDS 8 %-DEXTROSE 10 %-ELECTROLYTES INTRAVENOUS SOLUTION,314.5,188.7,72.96,4481.0,17 NDC,00338022104,ELECTROLYTE-A INTRAVENOUS SOLUTION,114.0,68.4,26.45,4481.0,19 NDC,00338035703,MANNITOL 20 % INTRAVENOUS SOLUTION,78.4,47.04,0.135,4481.0,21 NDC,00338041102,LIDOCAINE (PF) 8 MG/ML (0.8 %) IN 5 % DEXTROSE INTRAVENOUS SOLUTION,92.55,55.53,0.0225,4481.0,24 NDC,00338042418,"HEPARIN (PORCINE) (PF) 1,000 UNIT/500 ML IN 0.9 % SODIUM CHLORIDE IV",82.05,49.23,0.4725,4481.0,24 NDC,00338042418,"HEPARIN (PORCINE) 1,000 UNIT/500 ML IN 0.9% SODIUM CHLORIDE IV (COMBINED)",82.05,49.23,0.4725,4481.0,24 NDC,00338050206,PARENTERAL AMINO ACID 15 % COMBINATION NO.5 INTRAVENOUS SOLUTION,565.95,339.57,131.3,4481.0,19 NDC,00338055111,DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS PIGGYBACK,82.95,49.77,4.07,4481.0,21 NDC,00338055318,SODIUM CHLORIDE 0.9 % INTRAVENOUS PIGGYBACK,84.9,50.94,19.7,4481.0,17 NDC,00338064406,PARENTERAL AMINO ACID 10 % COMBINATION NO.6 INTRAVENOUS SOLUTION,276.4,165.84,64.12,4481.0,24 NDC,00338066304,POTASSIUM CHLORIDE 20 MEQ/L IN DEXTROSE 5 %-0.2 % SODIUM CHLORIDE IV,97.3,58.38,0.2475,4481.0,24 NDC,00338066904,POTASSIUM CHLORIDE 10 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,93.0,55.8,0.2475,4481.0,21 NDC,00338067104,POTASSIUM CHLORIDE 20 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,85.9,51.54,0.2475,4481.0,24 NDC,00338067304,POTASSIUM CHLORIDE 30 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,101.1,60.66,0.2475,4481.0,24 NDC,00338067504,POTASSIUM CHLORIDE 40 MEQ/L IN DEXTROSE 5 %-0.45 % SODIUM CHLORIDE IV,101.1,60.66,0.2475,4481.0,24 NDC,00338069104,POTASSIUM CHLORIDE 20 MEQ/L IN 0.9 % SODIUM CHLORIDE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 NDC,00338069504,POTASSIUM CHLORIDE 40 MEQ/L IN 0.9 % SODIUM CHLORIDE INTRAVENOUS,108.75,65.25,0.2475,4481.0,24 NDC,00338070548,POTASSIUM CHLORIDE 20 MEQ/100ML IN STERILE WATER INTRAVENOUS PIGGYBACK,78.65,47.19,0.2475,4481.0,24 NDC,00338070948,POTASSIUM CHLORIDE 10 MEQ/100ML IN STERILE WATER INTRAVENOUS PIGGYBACK,77.9,46.74,0.2475,4481.0,21 NDC,00338071906,DEXTROSE 70 % IN WATER (D70W) INTRAVENOUS SOLUTION,78.0,46.8,18.1,4481.0,17 NDC,00338080304,POTASSIUM CHLORIDE 20 MEQ/L IN D5-0.9 % SODIUM CHLORIDE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 NDC,00338081104,POTASSIUM CHLORIDE 20 MEQ/L-LACTATED RINGERS-5 % DEXTROSE INTRAVENOUS,104.95,62.97,0.2475,4481.0,24 NDC,00338100702,"DOPAMINE 400 MG/250 ML (1,600 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS SOLN",117.3,70.38,1.8,4481.0,24 NDC,00338102341,PENICILLIN G POT 2 MILLION UNIT/50 ML-DEXTROSE INTRAVENOUS PIGGYBACK,102.45,61.47,1.78,4481.0,24 NDC,00338102541,PENICILLIN G POT 3 MILLION UNIT/50 ML-DEXTROSE INTRAVENOUS PIGGYBACK,104.0,62.4,1.78,4481.0,24 NDC,00338104902,NITROGLYCERIN 200 MCG/ML BOLUS INJECTION (VIR/CATH),63.2,37.92,3.35,4481.0,24 NDC,00338104902,NITROGLYCERIN 50 MG/250 ML (200 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS,148.75,89.25,3.35,4481.0,24 NDC,00338105102,NITROGLYCERIN 400 MCG/ML BOLUS INJECTION (VIR/CATH),63.1,37.86,3.35,4481.0,24 NDC,00338113003,PARENTERAL AMINO ACID 10 % COMBINATION NO.7 INTRAVENOUS SOLUTION,239.6,143.76,55.59,4481.0,19 NDC,00338113004,PARENTERAL AMINO ACID 10 % COMBINATION NO.7 INTRAVENOUS SOLUTION,390.0,234.0,90.48,4481.0,19 NDC,00338355248,VANCOMYCIN 1000 MG/200 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,165.9,99.54,0.0675,4481.0,24 NDC,00338358048,VANCOMYCIN 750 MG/150 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,109.3,65.58,0.0675,4481.0,24 NDC,00338361250,CLINDAMYCIN 600 MG/50 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,103.8,62.28,4.12,4481.0,24 NDC,00338381424,CLINDAMYCIN 18 MG/ML SYRINGE PEDIATRIC,105.7,63.42,4.12,4481.0,24 NDC,00338850301,THROMBIN(HUM PLAS)-FIBRIN-APROT-CA 2.5 TO 6.5 UNIT/ML(2ML) TOPICAL SYR,986.9,592.14,137.63,4481.0,34 NDC,00338850303,THROMBIN(HUM PLAS)-FIBRIN-APROT-CA 2.5 TO 6.5 UNIT/ML(4ML) TOPICAL SYR,1665.3,999.18,137.63,4481.0,36 NDC,00338954550,CLINDAMYCIN 300 MG/50 ML IN 0.9% SODIUM CHLORIDE INTRAVENOUS PIGGYBACK,90.1,54.06,4.69,4481.0,24 NDC,00338954950,CLINDAMYCIN 600 MG/50 ML IN 0.9% SODIUM CHLORIDE INTRAVENOUS PIGGYBACK,103.8,62.28,4.69,4481.0,24 NDC,00338963801,PIPERACILLIN-TAZOBACTAM 4.5 GRAM/100 ML DEXTROSE(ISO-OSM) IV PIGGYBACK,159.8,95.88,2.41,4481.0,24 NDC,00338964101,THROMBIN(HM PLAS)-FIBRIN-APROT-CA 2.5 TO 6.5 UNIT/ML(10ML) TOPICAL SYR,3699.8,2219.88,137.63,4481.0,36 NDC,00362901150,"BUPIVACAINE 0.5 %-EPINEPHRINE BITARTRATE 1:200,000 INJECTION,CARTRIDGE",19.55,11.73,4.54,4481.0,19 NDC,00363087143,HYDROGEN PEROXIDE 3 % SOLUTION,3.2,1.92,0.7424,4481.0,19 NDC,00378335016,ESTRADIOL 0.05 MG/24 HR WEEKLY TRANSDERMAL PATCH,71.7,43.02,16.63,4481.0,19 NDC,00378335299,ESTRADIOL 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,71.7,43.02,16.63,4481.0,19 NDC,00378354752,MERCAPTOPURINE 25 MG SPLIT TAB,25.55,15.33,5.93,4481.0,19 NDC,00378363501,CETIRIZINE 5 MG TABLET,1.25,0.75,0.29,4481.0,19 NDC,00378699889,SODIUM CHLORIDE 10 % FOR NEBULIZATION,16.75,10.05,3.89,4481.0,19 NDC,00378808220,TRETINOIN 0.025 % TOPICAL CREAM,22.3,13.38,5.17,4481.0,19 NDC,00378910416,NITROGLYCERIN 0.2 MG/HR TRANSDERMAL 24 HOUR PATCH,18.15,10.89,4.21,4481.0,19 NDC,00378911216,NITROGLYCERIN 0.4 MG/HR TRANSDERMAL 24 HOUR PATCH,18.45,11.07,4.28,4481.0,19 NDC,00378911616,NITROGLYCERIN 0.6 MG/HR TRANSDERMAL 24 HOUR PATCH,19.15,11.49,4.44,4481.0,19 NDC,00378912216,FENTANYL 50 MCG/HR TRANSDERMAL PATCH,60.55,36.33,14.05,4481.0,19 NDC,00395051592,CASTOR OIL 100 % ORAL,7.25,4.35,1.68,4481.0,19 NDC,00406012362,HYDROCODONE 5 MG-ACETAMINOPHEN 325 MG TABLET,23.9,14.34,5.54,4481.0,19 NDC,00406051262,OXYCODONE-ACETAMINOPHEN 5 MG-325 MG TABLET,23.75,14.25,5.51,4481.0,19 NDC,00406114201,METHYLPHENIDATE 5 MG TABLET,22.6,13.56,5.24,4481.0,19 NDC,00406114401,METHYLPHENIDATE 10 MG TABLET,22.9,13.74,5.31,4481.0,19 NDC,00406324301,HYDROMORPHONE 2 MG TABLET,22.6,13.56,5.24,4481.0,19 NDC,00406575562,METHADONE 5 MG TABLET,23.25,13.95,5.39,4481.0,19 NDC,00406831562,"MORPHINE ER 15 MG TABLET,EXTENDED RELEASE",24.8,14.88,5.75,4481.0,19 NDC,00406833023,"MORPHINE ER 30 MG TABLET,EXTENDED RELEASE",26.85,16.11,6.23,4481.0,19 NDC,00406839062,"MORPHINE ER 100 MG TABLET,EXTENDED RELEASE",38.65,23.19,8.97,4481.0,19 NDC,00406907576,FENTANYL 75 MCG/HR TRANSDERMAL PATCH,82.9,49.74,19.23,4481.0,19 NDC,00406911276,FENTANYL 12 MCG/HR TRANSDERMAL PATCH,71.4,42.84,16.56,4481.0,19 NDC,00406912576,FENTANYL 25 MCG/HR TRANSDERMAL PATCH,43.7,26.22,10.14,4481.0,19 NDC,00407141230,IOHEXOL 240 MG IODINE/ML INTRAVENOUS SOLUTION,49.45,29.67,1.01,4481.0,24 NDC,00407141363,IOHEXOL 300 MG IODINE/ML INTRAVENOUS SOLUTION,56.5,33.9,0.3375,4481.0,24 NDC,00407141472,IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION,53.7,32.22,0.3375,4481.0,24 NDC,00407141491,IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION,62.2,37.32,0.3375,4481.0,24 NDC,00407270718,PERFLUTREN PROTEIN-TYPE A MICROSPHERES 0.22 MG/ML INTRAVENOUS SUSP,163.85,98.31,38.01,4481.0,23 NDC,00409012501,LABETALOL 5 MG/ML INTRAVENOUS SOLUTION,75.95,45.57,0.765,4481.0,24 NDC,00409018201,GEMCITABINE 2 GRAM/52.6 ML (38 MG/ML) INTRAVENOUS SOLUTION,359.2,215.52,7.04,4481.0,24 NDC,00409018201,GEMCITABINE 38 MG/ML INJECTABLE SOLUTION WRAPPER,574.85,344.91,7.04,4481.0,24 NDC,00409018201,GEMCITABINE BLADDER INSTILLATION (38 MG/ML),424.95,254.97,7.04,4481.0,24 NDC,00409018701,GEMCITABINE 2 GRAM INTRAVENOUS SOLUTION,650.65,390.39,7.04,4481.0,24 NDC,00409020110,DOCETAXEL 80 MG/8 ML (10 MG/ML) INTRAVENOUS SOLUTION,1109.35,665.61,1.04,4481.0,24 NDC,00409080101,PENTOSTATIN (NIPENT) SYRINGE,10043.75,6026.25,2529.92,404039.79,35 NDC,00409082911,AZTREONAM 1 GRAM SOLUTION FOR INJECTION,148.6,89.16,5.69,4481.0,24 NDC,00409083011,AZTREONAM 2 GRAM SOLUTION FOR INJECTION,277.15,166.29,5.69,4481.0,24 NDC,00409110502,ATRACURIUM 10 MG/ML INTRAVENOUS SOLUTION,70.9,42.54,16.45,4481.0,19 NDC,00409114402,VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTION,142.1,85.26,32.97,4481.0,19 NDC,00409115918,BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION,25.25,15.15,0.0225,4481.0,24 NDC,00409115919,BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION,25.5,15.3,0.0225,4481.0,24 NDC,00409116218,BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION,26.85,16.11,0.0225,4481.0,24 NDC,00409116519,BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) INJECTION SOLUTION,34.75,20.85,0.0225,4481.0,24 NDC,00409117630,MEPERIDINE (PF) 25 MG/ML INJECTION SYRINGE,40.2,24.12,9.33,4481.0,24 NDC,00409117630,MEPERIDINE (PF) 25 MG/ML INJECTION WRAPPER,40.2,24.12,9.33,4481.0,24 NDC,00409117830,MEPERIDINE (PF) 50 MG/ML INJECTION SYRINGE,44.75,26.85,10.38,4481.0,24 NDC,00409117930,MEPERIDINE (PF) 75 MG/ML INJECTION SYRINGE,41.3,24.78,9.58,4481.0,24 NDC,00409118069,MEPERIDINE (PF) 100 MG/ML INJECTION SYRINGE,36.45,21.87,8.46,4481.0,24 NDC,00409127303,DIAZEPAM 5 MG/ML INJECTION SYRINGE,123.35,74.01,16.54,4481.0,24 NDC,00409128331,HYDROMORPHONE 1 MG/ML INJECTION WRAPPER,29.85,17.91,0.2025,4481.0,24 NDC,00409131230,HYDROMORPHONE 2 MG/ML INJECTION SYRINGE,32.15,19.29,0.2025,4481.0,24 NDC,00409131230,HYDROMORPHONE 2 MG/ML INJECTION WRAPPER,23.05,13.83,0.2025,4481.0,24 NDC,00409131901,VANCOMYCIN 10 GRAM INTRAVENOUS SOLUTION,98.55,59.13,0.0675,4481.0,24 NDC,00409140212,"HEPARIN (PORCINE) 5,000 UNIT/ML (1 ML) INJECTION CARTRIDGE",29.7,17.82,0.4725,4481.0,24 NDC,00409140212,"HEPARIN (PORCINE) 5,000 UNIT/ML INJ SOLUTION (MULTI-VIAL SIZE WRAPPER)",29.7,17.82,0.4725,4481.0,24 NDC,00409146301,NALBUPHINE 10 MG/ML INJECTION SOLUTION,33.4,20.04,7.75,4481.0,24 NDC,00409163140,CALCIUM CHLORIDE 100 MG/ML (CENTRAL) IV PEDIATRIC,104.3,62.58,0.0675,4481.0,24 NDC,00409174929,"BUPIVACAINE-EPINEPHRINE (PF) 0.5 %-1:200,000 INJECTION SOLUTION",54.3,32.58,12.6,4481.0,19 NDC,00409176105,BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) IN 8.25 % DEXTROSE INJECTION,41.65,24.99,0.0225,4481.0,24 NDC,00409178269,NALOXONE 0.4 MG/ML INJECTION SYRINGE,76.25,45.75,0.18,4481.0,24 NDC,00409188622,LEVETIRACETAM 500 MG/5 ML INTRAVENOUS SOLUTION,75.75,45.45,0.09,4481.0,24 NDC,00409189003,MORPHINE 2 MG/ML INJECTION PF WRAPPER,25.25,15.15,4.91,4481.0,24 NDC,00409189003,MORPHINE 2 MG/ML INTRAVENOUS SYRINGE,28.45,17.07,4.91,4481.0,24 NDC,00409189103,MORPHINE 4 MG/ML INJECTION WRAPPER,24.95,14.97,4.91,4481.0,24 NDC,00409190211,PROCAINAMIDE 100 MG/ML INJECTION SOLUTION,175.85,105.51,44.49,4481.0,35 NDC,00409196602,STUDY SODIUM CHLORIDE 0.9% BACTERIOSTATIC INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,00409198530,LORAZEPAM 2 MG/ML INJECTION SYRINGE,24.7,14.82,3.1,4481.0,24 NDC,00409202201,MORPHINE 50 MG/ML INTRAVENOUS SOLUTION,185.75,111.45,4.91,4481.0,24 NDC,00409205105,KETAMINE 100 MG/ML INJECTION SOLUTION,47.05,28.23,10.92,4481.0,19 NDC,00409205105,KETAMINE 100 MG/ML INTRANASAL SOLUTION,47.05,28.23,10.92,4481.0,19 NDC,00409230504,MIDAZOLAM (PF) 1 MG/ML INJECTION SOLUTION,22.35,13.41,0.3375,4481.0,24 NDC,00409230801,MIDAZOLAM 5 MG/ML (COMBINED) INTRANASAL SOLUTION WRAPPER,25.5,15.3,0.3375,4481.0,24 NDC,00409230802,MIDAZOLAM (PF) 5 MG/ML INJECTION SOLUTION,26.1,15.66,0.3375,4481.0,24 NDC,00409230802,MIDAZOLAM 5 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,26.1,15.66,0.3375,4481.0,24 NDC,00409230802,MIDAZOLAM 5 MG/ML (COMBINED) INTRANASAL SOLUTION WRAPPER,26.1,15.66,0.3375,4481.0,24 NDC,00409230821,MIDAZOLAM (PF) 5 MG/ML INJECTION SOLUTION,25.5,15.3,0.3375,4481.0,24 NDC,00409230821,MIDAZOLAM 5 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,25.5,15.3,0.3375,4481.0,24 NDC,00409234401,DOBUTAMINE 250 MG/20 ML (12.5 MG/ML) INTRAVENOUS SOLUTION,88.35,53.01,15.93,4481.0,24 NDC,00409263405,HYDROMORPHONE (PF) 10 MG/ML INJECTION SOLUTION,67.95,40.77,0.2025,4481.0,24 NDC,00409263450,HYDROMORPHONE (PF) 10 MG/ML INJECTION SOLUTION,519.75,311.85,0.2025,4481.0,24 NDC,00409263450,HYDROMORPHONE (PF) 10 MG/ML INJECTION SOLUTION FOR PEDS PCA COMPONENT,519.75,311.85,0.2025,4481.0,24 NDC,00409272101,"HEPARIN (PORCINE) 10,000 UNIT/ML INJECTION SOLUTION",28.85,17.31,0.4725,4481.0,24 NDC,00409272330,"HEPARIN (PORCINE) 5,000 UNIT/ML INJECTION SOLUTION",23.9,14.34,0.4725,4481.0,24 NDC,00409317716,"LIDOCAINE-EPINEPHRINE 0.5 %-1:200,000 INJECTION SOLUTION",16.35,9.81,0.0225,4481.0,24 NDC,00409318202,"LIDOCAINE 20 MG/ML (2 %)-EPINEPHRINE 1:100,000 INJECTION SOLUTION",16.7,10.02,0.0225,4481.0,24 NDC,00409318910,ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTION,75.15,45.09,17.43,4481.0,19 NDC,00409321312,DIAZEPAM 5 MG/ML INJECTION SOLUTION,196.2,117.72,16.54,4481.0,24 NDC,00409338221,SUFENTANIL CITRATE 50 MCG/ML INTRAVENOUS SOLUTION,29.9,17.94,6.94,4481.0,19 NDC,00409359501,CEFOTAXIME 1 GRAM SOLUTION FOR INJECTION,35.65,21.39,8.27,4481.0,24 NDC,00409379619,KETOROLAC 60 MG/2 ML INTRAMUSCULAR SOLUTION,28.8,17.28,0.2813,4481.0,34 NDC,00409381412,MORPHINE (PF) 0.5 MG/ML INJECTION SOLUTION,28.4,17.04,6.59,4481.0,24 NDC,00409381412,MORPHINE (PF) 0.5 MG/ML INJECTION SOLUTION WRAPPER,28.4,17.04,6.59,4481.0,24 NDC,00409381511,MORPHINE (PF) 1 MG/ML INJECTION SOLUTION,28.35,17.01,6.58,4481.0,24 NDC,00409397701,"WATER FOR INJECTION, BACTERIOSTATIC INJECTION SOLUTION",40.5,24.3,9.4,4481.0,19 NDC,00409403101,MANNITOL 25 % INTRAVENOUS INFUSION,39.8,23.88,0.135,4481.0,21 NDC,00409409011,ZINC CHLORIDE 1 MG/ML INTRAVENOUS SOLUTION,53.0,31.8,12.3,4481.0,19 NDC,00409409211,CUPRIC CHLORIDE 0.4 MG/ML INTRAVENOUS SOLUTION,166.7,100.02,38.67,4481.0,19 NDC,00409409311,CHROMIUM CHLORIDE 4 MCG/ML INTRAVENOUS SOLUTION,87.35,52.41,20.27,4481.0,19 NDC,00409427501,LIDOCAINE HCL 5 MG/ML (0.5 %) INJECTION SOLUTION,34.55,20.73,0.0225,4481.0,24 NDC,00409427701,LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION,31.55,18.93,0.0225,4481.0,24 NDC,00409428212,LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION,44.2,26.52,0.0225,4481.0,24 NDC,00409428301,LIDOCAINE (PF) 40 MG/ML (4 %) INJECTION SOLUTION,34.9,20.94,0.0225,4481.0,24 NDC,00409471342,LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,21.05,12.63,0.0225,4481.0,24 NDC,00409488803,SODIUM CHLORIDE 0.9% SOLUTION FOR PCN TESTING,16.15,9.69,3.75,4481.0,19 NDC,00409488820,SODIUM CHLORIDE 0.9 % INJECTION SOLUTION,20.7,12.42,4.8,4481.0,19 NDC,00409488850,SODIUM CHLORIDE 0.9 % INJECTION SOLUTION,18.8,11.28,4.36,4481.0,19 NDC,00409491134,ATROPINE 0.1 MG/ML INJECTION (PEDIATRIC),123.4,74.04,0.198,4481.0,24 NDC,00409553424,SODIUM BICARBONATE 4.2 % (0.5 MEQ/ML) INTRAVENOUS SYRINGE,102.3,61.38,23.73,4481.0,19 NDC,00409582001,DOPAMINE 200 MG/5 ML (40 MG/ML) INTRAVENOUS SOLUTION,76.1,45.66,1.8,4481.0,24 NDC,00409592201,AMINOPHYLLINE 25 MG/ML PEDIATRIC INJECTION,105.1,63.06,22.61,4481.0,24 NDC,00409592216,AMINOPHYLLINE 500 MG/20 ML INTRAVENOUS SOLUTION,66.2,39.72,15.36,4481.0,24 NDC,00409610218,FUROSEMIDE 10 MG/ML INJECTION SOLUTION,27.45,16.47,0.045,4481.0,24 NDC,00409610219,FUROSEMIDE 10 MG/ML INJECTION SOLUTION,32.35,19.41,0.045,4481.0,24 NDC,00409610220,FUROSEMIDE 10 MG/ML INJECTION SOLUTION,38.8,23.28,0.045,4481.0,24 NDC,00409647644,ERYTHROMYCIN LACTOBIONATE 500 MG INTRAVENOUS SOLUTION,339.45,203.67,78.75,4481.0,24 NDC,00409650901,VANCOMYCIN 5 GRAM INTRAVENOUS SOLUTION,358.2,214.92,0.0675,4481.0,24 NDC,00409653311,"VANCOMYCIN 1,000 MG INTRAVENOUS INJECTION",116.25,69.75,0.0675,4481.0,24 NDC,00409664816,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SOLUTION,36.3,21.78,8.42,4481.0,17 NDC,00409672924,MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) INTRAVENOUS PIGGYBACK WRAPPER,124.75,74.85,1.08,4481.0,24 NDC,00409729501,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION WRAPPER,60.4,36.24,14.01,4481.0,19 NDC,00409729983,SODIUM ACETATE 2 MEQ/ML INTRAVENOUS SOLUTION,59.7,35.82,13.85,4481.0,19 NDC,00409733211,CEFTRIAXONE 1 GRAM SOLUTION FOR INJECTION,21.95,13.17,0.9675,4481.0,24 NDC,00409733211,CEFTRIAXONE 1 GRAM SOLUTION FOR IV PUSH,21.95,13.17,0.9675,4481.0,24 NDC,00409733513,CEFTRIAXONE 2 GRAM SOLUTION FOR INJECTION,27.3,16.38,0.9675,4481.0,24 NDC,00409733513,CEFTRIAXONE IM PEDIATRIC SYRINGE,72.5,43.5,0.9675,4481.0,24 NDC,00409733701,CEFTRIAXONE 250 MG INJ SOLR IM,19.0,11.4,0.9675,4481.0,24 NDC,00409733711,CEFTRIAXONE 250 MG SOLUTION FOR INJECTION,19.0,11.4,0.9675,4481.0,24 NDC,00409733811,CEFTRIAXONE 500 MG SOLUTION FOR INJECTION,19.8,11.88,0.9675,4481.0,24 NDC,00409741813,DEXTRAN 40 10 % IN 5 % DEXTROSE INTRAVENOUS,316.4,189.84,73.4,4481.0,21 NDC,00409751716,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SYRINGE/VIAL WRAPPER,54.45,32.67,12.63,4481.0,19 NDC,00409796905,CARDIOPLEGIC SOLUTION 16 MEQ/L (POTASSIUM) FOR PERFUSION,340.95,204.57,79.1,4481.0,19 NDC,00409818301,POTASSIUM ACETATE 2 MEQ/ML INTRAVENOUS SOLUTION,80.7,48.42,18.72,4481.0,19 NDC,00409904217,"BUPIVACAINE-EPINEPHRINE (PF) 0.25 %-1:200,000 INJECTION SOLUTION",35.45,21.27,8.22,4481.0,19 NDC,00409909412,FENTANYL 50 MCG/ML INTRANASAL SOLUTION,30.5,18.3,2.48,4481.0,24 NDC,00409909425,FENTANYL 50 MCG/ML INTRANASAL SOLUTION,32.3,19.38,2.48,4481.0,24 NDC,00409909428,FENTANYL (PF) 50 MCG/ML INJECTION SOLUTION,42.5,25.5,2.48,4481.0,24 NDC,00409909428,FENTANYL 50 MCG/ML INTRANASAL SOLUTION,42.5,25.5,2.48,4481.0,24 NDC,00409910420,DOPAMINE 400 MG/10 ML (40 MG/ML) INTRAVENOUS SOLUTION,82.1,49.26,1.8,4481.0,24 NDC,00409973501,CEFEPIME 2 GRAM SOLUTION FOR INJECTION,55.2,33.12,2.75,4481.0,24 NDC,00430375414,ESTRADIOL 0.01% (0.1 MG/GRAM) VAGINAL CREAM,1053.75,632.25,244.47,4481.0,19 NDC,00436067216,SODIUM HYPOCHLORITE 0.125 % SOLUTION,23.0,13.8,5.34,4481.0,19 NDC,00436093616,SODIUM HYPOCHLORITE 0.25 % SOLUTION,23.0,13.8,5.34,4481.0,19 NDC,00456060001,CEFTAROLINE FOSAMIL 0.001 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 NDC,00456060001,CEFTAROLINE FOSAMIL 0.01 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 NDC,00456060001,CEFTAROLINE FOSAMIL 0.1 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 NDC,00456060001,CEFTAROLINE FOSAMIL 1 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 NDC,00456060001,CEFTAROLINE FOSAMIL 10 MG/ML DESENSITIZATION SOLUTION,904.9,542.94,4.1,4481.0,35 NDC,00456060001,CEFTAROLINE FOSAMIL 600 MG INTRAVENOUS SOLUTION,904.9,542.94,4.1,4481.0,35 NDC,00456060001,CEFTAROLINE FOSAMIL 600 MG/20ML IV WETTED VIAL,904.9,542.94,4.1,4481.0,35 NDC,00456114030,VILAZODONE 40 MG TABLET,52.5,31.5,12.18,4481.0,19 NDC,00456120130,LINACLOTIDE 145 MCG CAPSULE,72.8,43.68,16.89,4481.0,19 NDC,00456120330,LINACLOTIDE 72 MCG CAPSULE,72.8,43.68,16.89,4481.0,19 NDC,00456270010,CEFTAZIDIME-AVIBACTAM 2.5 GRAM INTRAVENOUS SOLUTION,1421.25,852.75,101.59,4481.0,35 NDC,00469052002,ISAVUCONAZONIUM SULFATE 186 MG CAPSULE,363.25,217.95,84.27,4481.0,19 NDC,00469062599,ENZALUTAMIDE 40 MG TABLET,521.9,313.14,121.08,4481.0,19 NDC,00469067773,"TACROLIMUS XL 1 MG CAPSULE,EXTENDED RELEASE 24 HR",33.35,20.01,1.33,4481.0,24 NDC,00469068773,"TACROLIMUS XL 5 MG CAPSULE,EXTENDED RELEASE 24 HR",102.7,61.62,1.33,4481.0,24 NDC,00469072560,ENZALUTAMIDE 80 MG TABLET,1018.75,611.25,236.35,4481.0,19 NDC,00469142590,GILTERITINIB 40 MG TABLET,1313.0,787.8,304.62,4481.0,19 NDC,00469260130,"MIRABEGRON ER 25 MG TABLET,EXTENDED RELEASE 24 HR",62.05,37.23,14.4,4481.0,19 NDC,00469301601,TACROLIMUS 5 MG/ML INTRAVENOUS SOLUTION,64.35,38.61,16.28,4481.0,35 NDC,00469342510,ZOLBETUXIMAB-CLZB 100 MG INTRAVENOUS SOLUTION,5571.0,3342.6,31.74,5080.32,35 NDC,00469650189,REGADENOSON 0.4 MG/5 ML INTRAVENOUS SYRINGE,1021.3,612.78,6.79,4481.0,24 NDC,00472001304,GRISEOFULVIN MICROSIZE 125 MG/5 ML ORAL SUSPENSION,161.45,96.87,37.46,4481.0,19 NDC,00472008216,ACYCLOVIR 200 MG/5 ML ORAL SUSPENSION,1084.55,650.73,251.62,4481.0,19 NDC,00472016615,"NYSTATIN 100,000 UNIT/GRAM TOPICAL OINTMENT",58.15,34.89,13.49,4481.0,19 NDC,00480356601,LISDEXAMFETAMINE 20 MG CAPSULE,34.55,20.73,8.02,4481.0,19 NDC,00480356701,LISDEXAMFETAMINE 30 MG CAPSULE,34.55,20.73,8.02,4481.0,19 NDC,00486111101,"POTASSIUM PHOSPHATE, MONOBASIC 500 MG SOLUBLE TABLET",1.8,1.08,0.4176,4481.0,19 NDC,00487590199,RACEPINEPHRINE 2.25 % SOLUTION FOR NEBULIZATION,4.1,2.46,0.9512,4481.0,19 NDC,00487930133,SODIUM CHLORIDE 0.9 % FOR NEBULIZATION,16.9,10.14,3.92,4481.0,19 NDC,00487990130,ALBUTEROL SULFATE CONCENTRATE 2.5 MG/0.5 ML SOLUTION FOR NEBULIZATION,17.5,10.5,4.06,4481.0,19 NDC,00496088206,LIDOCAINE 4 % TOPICAL CREAM,11.85,7.11,2.75,4481.0,19 NDC,00517030110,METHYLENE BLUE (ANTIDOTE) 1 % (10 MG/ML) INTRAVENOUS SOLUTION,40.4,24.24,6.19,4481.0,36 NDC,00517071001,FOMEPIZOLE 1 GRAM/ML INTRAVENOUS SOLUTION,5725.4,3435.24,6.09,4953.04,35 NDC,00517072001,BETAMETHASONE ACETATE AND SODIUM PHOS 6 MG/ML SUSPENSION FOR INJECTION,230.65,138.39,15.66,4481.0,24 NDC,00517074020,METHYLERGONOVINE 0.2 MG/ML (1 ML) INJECTION SOLUTION,138.0,82.8,32.02,4481.0,24 NDC,00517090101,HYDRALAZINE 20 MG/ML INJECTION SOLUTION,74.5,44.7,12.6,4481.0,24 NDC,00517100401,ATROPINE 0.4 MG/ML INJECTION WRAPPER,59.8,35.88,0.315,4481.0,25 NDC,00517190525,DOPAMINE 400 MG/5 ML (80 MG/ML) INTRAVENOUS SOLUTION,73.7,44.22,1.8,4481.0,24 NDC,00517231005,IRON SUCROSE 200 MG IRON/10 ML INTRAVENOUS SOLUTION,275.4,165.24,0.5175,4481.0,24 NDC,00517234010,IRON SUCROSE 100 MG IRON/5 ML INTRAVENOUS SOLUTION,275.4,165.24,0.5175,4481.0,24 NDC,00517250501,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION,372.1,223.26,86.33,4481.0,19 NDC,00517250501,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION WRAPPER,372.1,223.26,86.33,4481.0,19 NDC,00517420125,HYDROXYZINE HCL 25 MG/ML INTRAMUSCULAR SOLUTION,135.25,81.15,31.38,4481.0,24 NDC,00517460125,GLYCOPYRROLATE 0.2 MG/ML INJECTION SOLUTION,66.7,40.02,0.4462,4481.0,35 NDC,00517481001,NITROGLYCERIN 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION,113.85,68.31,3.35,4481.0,24 NDC,00517560125,HYDROXYZINE HCL 50 MG/ML INTRAMUSCULAR SOLUTION,147.5,88.5,34.22,4481.0,24 NDC,00517651025,SELENIUM 40 MCG/ML INTRAVENOUS SOLUTION,85.15,51.09,19.75,4481.0,19 NDC,00517656005,SELENIUM 60 MCG/ML INTRAVENOUS SOLUTION,1400.6,840.36,324.94,4481.0,19 NDC,00517671010,CALCIUM CHLORIDE 100 MG/ML (10 %) INTRAVENOUS SOLUTION,129.15,77.49,0.0675,4481.0,24 NDC,00517720125,TRACE ELEMENTS CR-CU-MN-ZN 10 MCG-1 MG-0.5 MG-5 MG/ML INTRAVENOUS SOLN,63.8,38.28,14.8,4481.0,19 NDC,00517912001,AMINOCAPROIC ACID 250 MG/ML INTRAVENOUS SOLUTION,24.05,14.43,3.85,4481.0,24 NDC,00517930501,TRACE ELEMENTS ZN 3 MG-CU 0.3 MG-MN 55 MCG-SE 60 MCG/ML IV SOLUTION,125.95,75.57,29.22,4481.0,19 NDC,00517931025,TRACE ELEMENTS PED CR-CU-MN-ZN 1 MCG-0.1 MG-30 MCG-0.5 MG/ML IV SOLN,43.3,25.98,10.05,4481.0,19 NDC,00527131801,TERBUTALINE 2.5 MG TABLET,29.1,17.46,6.75,4481.0,19 NDC,00527136701,PROBENECID 500 MG TABLET,22.05,13.23,5.12,4481.0,19 NDC,00527136906,DANAZOL 200 MG CAPSULE,37.6,22.56,8.72,4481.0,19 NDC,00527139401,LOXAPINE SUCCINATE 5 MG CAPSULE,17.65,10.59,4.09,4481.0,19 NDC,00527139601,LOXAPINE SUCCINATE 25 MG CAPSULE,19.3,11.58,4.48,4481.0,19 NDC,00527410737,MEXILETINE 150 MG CAPSULE,18.35,11.01,4.26,4481.0,19 NDC,00536105556,BENZOYL PEROXIDE 5 % TOPICAL GEL,6.6,3.96,1.53,4481.0,23 NDC,00536105656,BENZOYL PEROXIDE 10 % TOPICAL GEL,6.95,4.17,1.61,4481.0,19 NDC,00536110888,NICOTINE 21 MG/24 HR DAILY TRANSDERMAL PATCH,3.7,2.22,0.8584,4481.0,19 NDC,00536114397,WHITE PETROLATUM 42 % TOPICAL OINTMENT,9.85,5.91,2.29,4481.0,19 NDC,00536120207,LIDOCAINE 4 % TOPICAL PATCH,2.7,1.62,0.6264,4481.0,19 NDC,00536125240,KETOTIFEN 0.025 % (0.035 %) EYE DROPS,17.45,10.47,4.05,4481.0,19 NDC,00536128636,BISMUTH SUBSALICYLATE 262 MG/15 ML ORAL SUSPENSION,1.65,0.99,0.3828,4481.0,19 NDC,00536137575,MICONAZOLE NITRATE 2 % TOPICAL CREAM,7.8,4.68,1.81,4481.0,19 NDC,00536252525,CAPSAICIN 0.025 % TOPICAL CREAM,11.8,7.08,2.74,4481.0,19 NDC,00536302923,NICOTINE (POLACRILEX) 2 MG GUM,1.35,0.81,0.3132,4481.0,19 NDC,00536303023,NICOTINE (POLACRILEX) 4 MG GUM,1.45,0.87,0.3364,4481.0,19 NDC,00536589588,NICOTINE 14 MG/24 HR DAILY TRANSDERMAL PATCH,3.7,2.22,0.8584,4481.0,19 NDC,00548560300,ENOXAPARIN 60 MG/0.6 ML SUBCUTANEOUS SYRINGE,51.1,30.66,1.33,4481.0,24 NDC,00548590000,COSYNTROPIN 0.25 MG SOLUTION FOR INJECTION,431.7,259.02,57.08,4481.0,24 NDC,00548950200,ISOPROTERENOL 0.2 MG/ML INJECTION SOLUTION,796.0,477.6,184.67,4481.0,19 NDC,00555087202,MEDROXYPROGESTERONE 2.5 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,00555088602,ESTRADIOL 1 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,00555097102,DEXTROAMPHETAMINE-AMPHETAMINE 5 MG TABLET,24.65,14.79,5.72,4481.0,19 NDC,00555097202,DEXTROAMPHETAMINE-AMPHETAMINE 10 MG TABLET,24.65,14.79,5.72,4481.0,19 NDC,00555901658,NORGESTIMATE 0.25 MG-ETHINYL ESTRADIOL 0.035 MG TABLET,81.2,48.72,18.84,4481.0,19 NDC,00574006924,DEXTROSE 40 % ORAL GEL,4.4,2.64,1.02,4481.0,19 NDC,00574010601,BROMOCRIPTINE 2.5 MG TABLET,25.05,15.03,5.81,4481.0,19 NDC,00574015004,MIDAZOLAM 2 MG/ML ORAL LIQUID WRAPPER,219.7,131.82,50.97,4481.0,19 NDC,00574029201,AMILORIDE 5 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,00574052076,ACTIVATED CHARCOAL-SORBITOL 50 GRAM/240 ML ORAL SUSPENSION,15.7,9.42,3.64,4481.0,19 NDC,00574052174,ACTIVATED CHARCOAL 25 GRAM/120 ML ORAL SUSPENSION,21.65,12.99,5.02,4481.0,19 NDC,00574052176,ACTIVATED CHARCOAL 50 GRAM/240 ML ORAL SUSPENSION,15.7,9.42,3.64,4481.0,19 NDC,00574082001,TESTOSTERONE CYPIONATE 200 MG/ML INTRAMUSCULAR OIL,36.0,21.6,0.0675,4481.0,24 NDC,00574200815,"NYSTATIN 100,000 UNIT/GRAM TOPICAL POWDER",37.1,22.26,8.61,4481.0,19 NDC,00574204230,LIDOCAINE-PRILOCAINE 2.5 %-2.5 % TOPICAL CREAM,61.45,36.87,14.26,4481.0,19 NDC,00574703412,ASPIRIN 300 MG RECTAL SUPPOSITORY,2.85,1.71,0.6612,4481.0,19 NDC,00574704012,BELLADONNA ALKALOIDS-OPIUM 16.2 MG-60 MG RECTAL SUPPOSITORY,103.4,62.04,23.99,4481.0,19 NDC,00574705012,BISACODYL 10 MG RECTAL SUPPOSITORY,1.55,0.93,0.3596,4481.0,19 NDC,00574985510,"BUDESONIDE DR - ER 3 MG CAPSULE,DELAYED,EXTENDED RELEASE",19.0,11.4,4.41,4481.0,19 NDC,00575620030,DIAZOXIDE 50 MG/ML ORAL SUSPENSION,1475.8,885.48,342.39,4481.0,19 NDC,00591034510,VERAPAMIL 120 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,00591040501,LISINOPRIL 2.5 MG TABLET,16.1,9.66,3.74,4481.0,19 NDC,00591044401,GUANFACINE 1 MG TABLET,16.65,9.99,3.86,4481.0,19 NDC,00591231245,ALVIMOPAN 12 MG CAPSULE,487.35,292.41,113.07,4481.0,19 NDC,00591288830,"HYDROXOCOBALAMIN 1,000 MCG/ML INTRAMUSCULAR SOLUTION",113.5,68.1,0.0097,4481.0,35 NDC,00591350954,CLONIDINE 0.2 MG/24 HR WEEKLY TRANSDERMAL PATCH,149.85,89.91,34.77,4481.0,19 NDC,00591387045,MEMANTINE 5 MG TABLET,17.3,10.38,4.01,4481.0,19 NDC,00591532101,PRIMIDONE 250 MG TABLET,17.1,10.26,3.97,4481.0,19 NDC,00591533501,TRIHEXYPHENIDYL 2 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,00591555601,PROPRANOLOL 40 MG TABLET,17.45,10.47,4.05,4481.0,19 NDC,00591566001,SULINDAC 200 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,00591566101,SULINDAC 150 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,00597002402,IPRATROPIUM 20 MCG-ALBUTEROL 100 MCG/ACTUATION MIST FOR INHALATION,1533.15,919.89,355.69,4481.0,19 NDC,00597003510,SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION,91306.75,54784.05,63.76,73045.4,35 NDC,00597013730,AFATINIB 30 MG TABLET,1597.25,958.35,370.56,4481.0,22 NDC,00597013830,AFATINIB 40 MG TABLET,1597.25,958.35,370.56,4481.0,22 NDC,00597014130,AFATINIB 20 MG TABLET,1597.25,958.35,370.56,4481.0,22 NDC,00597015237,EMPAGLIFLOZIN 10 MG TABLET,78.95,47.37,18.32,4481.0,19 NDC,00597015337,EMPAGLIFLOZIN 25 MG TABLET,78.95,47.37,18.32,4481.0,19 NDC,00597019705,IDARUCIZUMAB 2.5 GRAM/50 ML INTRAVENOUS SOLUTION,8405.45,5043.27,1950.06,6724.36,19 NDC,00597035556,DABIGATRAN ETEXILATE 75 MG CAPSULE,25.95,15.57,6.02,4481.0,19 NDC,00597036082,DABIGATRAN ETEXILATE 150 MG CAPSULE,25.95,15.57,6.02,4481.0,19 NDC,00603116158,DICYCLOMINE 10 MG/5 ML ORAL SOLUTION,16.75,10.05,3.89,4481.0,19 NDC,00603516521,PHENOBARBITAL 16.2 MG TABLET,17.3,10.38,4.01,4481.0,19 NDC,00603516721,PHENOBARBITAL 64.8 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,00641037621,DIPHENHYDRAMINE 50 MG VIAL/SYRINGE WRAPPER,17.15,10.29,1.71,4481.0,24 NDC,00641037621,DIPHENHYDRAMINE 50 MG/ML INJECTION SOLUTION,20.6,12.36,1.71,4481.0,24 NDC,00641047625,PHENOBARBITAL SODIUM 65 MG/ML INJECTION SOLUTION,101.35,60.81,23.51,4481.0,24 NDC,00641047725,PHENOBARBITAL SODIUM 130 MG/ML INJECTION SOLUTION,227.9,136.74,52.87,4481.0,24 NDC,00641049321,PHENYTOIN SODIUM 50 MG/ML INTRAVENOUS SOLUTION,21.45,12.87,1.01,4481.0,24 NDC,00641092825,PROMETHAZINE 25 MG/ML INJECTION SOLUTION,23.25,13.95,5.39,4481.0,24 NDC,00641139731,CHLORPROMAZINE 25 MG/ML INJECTION SOLUTION,128.7,77.22,29.86,4481.0,24 NDC,00641139831,CHLORPROMAZINE 25 MG/ML INJECTION SOLUTION,145.1,87.06,33.66,4481.0,24 NDC,00641141035,DIGOXIN 250 MCG/ML (0.25 MG/ML) INJECTION SOLUTION,21.4,12.84,4.96,4481.0,24 NDC,00641600125,LORAZEPAM 2 MG/ML INJECTION SOLUTION,23.45,14.07,3.1,4481.0,24 NDC,00641600125,LORAZEPAM 2 MG/ML INJECTION WRAPPER,23.45,14.07,3.1,4481.0,24 NDC,00641600801,BUMETANIDE 0.25 MG/ML INJECTION SOLUTION,27.8,16.68,0.3589,4481.0,35 NDC,00641601301,DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTION,65.25,39.15,0.0675,4481.0,24 NDC,00641601401,DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTION,65.05,39.03,0.0675,4481.0,24 NDC,00641601510,DILTIAZEM 5 MG/ML INTRAVENOUS SOLUTION,64.2,38.52,0.0675,4481.0,24 NDC,00641603901,MORPHINE (PF) 10 MG/ML INJECTION SOLUTION,648.1,388.86,27.11,4481.0,24 NDC,00641604001,MORPHINE (PF) 25 MG/ML INJECTION SOLUTION,1086.55,651.93,27.11,4481.0,24 NDC,00641605325,MEPERIDINE (PF) 50 MG/ML INJECTION SOLUTION,30.0,18.0,6.96,4481.0,24 NDC,00641605325,MEPERIDINE (PF) 50 MG/ML INJECTION WRAPPER,30.0,18.0,6.96,4481.0,24 NDC,00641606001,MIDAZOLAM 5 MG/ML (COMBINED) INTRANASAL SOLUTION WRAPPER,42.8,25.68,0.3375,4481.0,24 NDC,00641606001,MIDAZOLAM 5 MG/ML INJECTION SOLUTION,42.8,25.68,0.3375,4481.0,24 NDC,00641606010,MIDAZOLAM 5 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,42.8,25.68,0.3375,4481.0,24 NDC,00641608025,ONDANSETRON HCL (PF) 4 MG/2 ML INJECTION SOLUTION,18.35,11.01,0.2475,4481.0,24 NDC,00641608025,ONDANSETRON HCL 2 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER,18.35,11.01,0.2475,4481.0,24 NDC,00641612701,MORPHINE 10 MG/ML INJ COMBINED WRAPPER,25.85,15.51,4.91,4481.0,24 NDC,00641614201,PHENYLEPHRINE 10 MG/ML INJECTION SOLUTION,31.6,18.96,0.0225,4481.0,24 NDC,00641614901,NEOSTIGMINE METHYLSULFATE 1 MG/ML INTRAVENOUS SOLUTION,51.1,30.66,1.73,4481.0,24 NDC,00641617410,OCTREOTIDE ACETATE 50 MCG/ML INJECTION SOLUTION,24.8,14.88,1.37,4481.0,24 NDC,00703011301,HYDROMORPHONE (PF) 10 MG/ML INJECTION SOLUTION FOR PEDS PCA COMPONENT,50.4,30.24,0.2025,4481.0,24 NDC,00703574711,CISPLATIN (PLATINOL) IVPB 1 MG/ML,374.3,224.58,5.15,4481.0,24 NDC,00703574711,CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,374.3,224.58,5.15,4481.0,24 NDC,00703574711,CISPLATIN SKIN TEST PERCUTANEOUS,279.0,167.4,5.15,4481.0,24 NDC,00703574811,CISPLATIN (PLATINOL) IVPB 1 MG/ML,408.4,245.04,5.15,4481.0,24 NDC,00703574811,CISPLATIN SKIN TEST PERCUTANEOUS,277.7,166.62,5.15,4481.0,24 NDC,00703951403,SULFAMETHOXAZOLE 400 MG-TRIMETHOPRIM 80 MG/5 ML INTRAVENOUS SOLUTION,104.05,62.43,0.1125,4481.0,24 NDC,00713013506,PROCHLORPERAZINE 25 MG RECTAL SUPPOSITORY,42.15,25.29,9.78,4481.0,19 NDC,00713050306,HYDROCORTISONE ACETATE 25 MG RECTAL SUPPOSITORY,50.5,30.3,11.72,4481.0,19 NDC,00713052612,PROMETHAZINE 25 MG RECTAL SUPPOSITORY,45.25,27.15,10.5,4481.0,19 NDC,00713053612,PROMETHAZINE 12.5 MG RECTAL SUPPOSITORY,45.25,27.15,10.5,4481.0,19 NDC,00713065660,CLOBETASOL 0.05 % TOPICAL OINTMENT,259.3,155.58,60.16,4481.0,19 NDC,00713067815,"NYSTATIN 100,000 UNIT/GRAM TOPICAL CREAM",55.1,33.06,12.78,4481.0,19 NDC,00781149001,AMITRIPTYLINE 100 MG TABLET,19.45,11.67,4.51,4481.0,19 NDC,00781202001,AMOXICILLIN 250 MG CAPSULE,16.35,9.81,3.79,4481.0,19 NDC,00781232206,APREPITANT 80 MG CAPSULE,505.1,303.06,6.14,4481.0,24 NDC,00781232306,APREPITANT 125 MG CAPSULE,780.15,468.09,6.14,4481.0,24 NDC,00781304072,PYRIDOSTIGMINE BROMIDE 5 MG/ML INJECTION SOLUTION,29.2,17.52,6.77,4481.0,19 NDC,00781311090,PIPERACILLIN-TAZOBACTAM 2.25 GRAM INTRAVENOUS SOLUTION,74.25,44.55,2.41,4481.0,24 NDC,00781311491,PIPERACILLIN-TAZOBACTAM 4.5 GRAM INTRAVENOUS SOLUTION,85.45,51.27,2.41,4481.0,24 NDC,00781315606,"ACETAMINOPHEN 1,000 MG/100 ML (10 MG/ML) INTRAVENOUS SOLUTION",104.15,62.49,0.132,4481.0,24 NDC,00781320885,CEFTRIAXONE 1 GRAM INJ SOLR IM,29.65,17.79,0.9675,4481.0,24 NDC,00781321046,CEFTRIAXONE 10 GRAM SOLUTION FOR INJECTION,172.45,103.47,0.9675,4481.0,24 NDC,00781323394,CYCLOPHOSPHAMIDE 500 MG INTRAVENOUS POWDER FOR SOLUTION,1202.45,721.47,0.4656,4481.0,35 NDC,00781324494,CYCLOPHOSPHAMIDE (CYTOXAN) 1 GM INJECTION,2129.8,1277.88,0.4656,4481.0,35 NDC,00781324494,CYCLOPHOSPHAMIDE (POWDER) (CYTOXAN) 20 MG/ML IVPB,2129.8,1277.88,0.4656,4481.0,35 NDC,00781324602,ENOXAPARIN 40 MG/0.4 ML SUBCUTANEOUS SYRINGE,30.4,18.24,1.33,4481.0,24 NDC,00781325594,CYCLOPHOSPHAMIDE 2 GRAM INTRAVENOUS POWDER FOR SOLUTION,3984.65,2390.79,0.4656,4481.0,35 NDC,00781340278,AMPICILLIN 250 MG SOLUTION FOR INJECTION,26.45,15.87,1.24,4481.0,24 NDC,00781340278,AMPICILLIN SODIUM 250 MG INJ SOLR IM,26.45,15.87,1.24,4481.0,24 NDC,00781340485,AMPICILLIN SODIUM 1 GRAM INJ SOLR IM,37.6,22.56,1.24,4481.0,24 NDC,00781340795,AMPICILLIN 500 MG SOLUTION FOR INJECTION,27.0,16.2,1.24,4481.0,24 NDC,00781340795,AMPICILLIN SODIUM 500 MG INJ SOLR IM,27.0,16.2,1.24,4481.0,24 NDC,00781340895,AMPICILLIN SODIUM 2 GRAM INJ SOLR IM,43.75,26.25,1.24,4481.0,24 NDC,00781345875,PHENYLEPHRINE 10 MG/ML INJECTION SOLUTION,80.35,48.21,0.0225,4481.0,24 NDC,00781349380,DEXMEDETOMIDINE 80 MCG/20 ML (4 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,148.05,88.83,34.35,4481.0,19 NDC,00781582701,GRISEOFULVIN ULTRAMICROSIZE 125 MG TABLET,28.0,16.8,6.5,4481.0,19 NDC,00781602346,CLARITHROMYCIN 250 MG/5 ML ORAL SUSPENSION,539.5,323.7,125.16,4481.0,19 NDC,00781615395,PENICILLIN G SODIUM 5 MILLION UNIT SOLUTION FOR INJECTION,195.75,117.45,45.41,4481.0,19 NDC,00832121189,WARFARIN 1 MG TABLET,17.15,10.29,3.98,4481.0,19 NDC,00832121289,WARFARIN 2 MG TABLET,17.15,10.29,3.98,4481.0,19 NDC,00832121301,WARFARIN 2.5MG TABLET (SPLITTABLE),17.2,10.32,3.99,4481.0,19 NDC,00832121389,WARFARIN 2.5 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,00832121489,WARFARIN 3 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,00832121589,WARFARIN 4 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,00832121689,WARFARIN 5 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,00832121889,WARFARIN 7.5 MG TABLET,17.75,10.65,4.12,4481.0,19 NDC,00832601800,CHLORPROMAZINE 25 MG TABLET,18.6,11.16,4.32,4481.0,19 NDC,00832602211,"CARBAMAZEPINE ER 100 MG TABLET,EXTENDED RELEASE,12 HR",17.35,10.41,4.03,4481.0,19 NDC,00832602311,"CARBAMAZEPINE ER 200 MG TABLET,EXTENDED RELEASE,12 HR",18.4,11.04,4.27,4481.0,19 NDC,00904052361,ASCORBIC ACID (VITAMIN C) 500 MG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,00904208560,"VITAMIN A CAPSULE 3,000 MCG RAE (10000 UNITS)",1.1,0.66,0.2552,4481.0,19 NDC,00904386575,SODIUM CHLORIDE 0.65 % NASAL SPRAY AEROSOL,2.45,1.47,0.5684,4481.0,19 NDC,00904505359,PSEUDOEPHEDRINE 30 MG TABLET,1.05,0.63,0.2436,4481.0,19 NDC,00904522452,"LACTASE 3,000 UNIT TABLET",1.15,0.69,0.2668,4481.0,19 NDC,00904530920,IBUPROFEN 100 MG/5 ML ORAL SUSPENSION,7.35,4.41,1.71,4481.0,19 NDC,00904539561,POLYSACCHARIDE IRON COMPLEX 150 MG IRON CAPSULE,1.2,0.72,0.2784,4481.0,19 NDC,00904579146,ACETAMINOPHEN 80 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 NDC,00904585361,IBUPROFEN 400 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,00904585461,IBUPROFEN 600 MG TABLET,16.3,9.78,3.78,4481.0,19 NDC,00904585561,IBUPROFEN 800 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,00904589161,PRAVASTATIN 10 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,00904592161,DIGOXIN 125 MCG (0.125 MG) TABLET,20.05,12.03,4.65,4481.0,19 NDC,00904608261,ZOLPIDEM 5 MG TABLET,22.3,13.38,5.17,4481.0,19 NDC,00904608561,CITALOPRAM 20 MG TABLET,16.2,9.72,3.76,4481.0,19 NDC,00904617261,CARBAMAZEPINE 200 MG TABLET,18.7,11.22,4.34,4481.0,19 NDC,00904629161,ATORVASTATIN 20 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,00904630521,PHENOL 1.4 % MUCOSAL AEROSOL SPRAY,4.85,2.91,1.13,4481.0,19 NDC,00904635161,LEVOFLOXACIN 250 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,00904635261,LEVOFLOXACIN 500 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,00904635361,LEVOFLOXACIN 750 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,00904636961,AMLODIPINE 2.5 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,00904637061,AMLODIPINE 5 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,00904640761,"BISACODYL 5 MG TABLET,DELAYED RELEASE",1.05,0.63,0.2436,4481.0,19 NDC,00904642761,ESCITALOPRAM 20 MG TABLET,16.55,9.93,3.84,4481.0,19 NDC,00904644961,"ISOSORBIDE MONONITRATE ER 30 MG TABLET,EXTENDED RELEASE 24 HR",17.15,10.29,3.98,4481.0,19 NDC,00904645061,"ISOSORBIDE MONONITRATE ER 60 MG TABLET,EXTENDED RELEASE 24 HR",17.25,10.35,4.0,4481.0,19 NDC,00904657561,PHENOBARBITAL 32.4 MG TABLET,23.2,13.92,5.38,4481.0,19 NDC,00904659961,PERPHENAZINE 2 MG TABLET,19.0,11.4,4.41,4481.0,19 NDC,00904673061,ACETAMINOPHEN 500 MG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,00904676520,CETIRIZINE 1 MG/ML ORAL SOLUTION,1.2,0.72,0.2784,4481.0,19 NDC,00904677361,ACETAMINOPHEN 325 MG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,00904679761,LISINOPRIL 5 MG TABLET,16.2,9.72,3.76,4481.0,19 NDC,00904679861,LISINOPRIL 10 MG TABLET,16.2,9.72,3.76,4481.0,19 NDC,00904693806,BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50 MG-325 MG-40 MG TABLET,27.5,16.5,6.38,4481.0,19 NDC,00904700261,PREGABALIN 150 MG CAPSULE,24.9,14.94,5.78,4481.0,19 NDC,00904705361,DOXEPIN 25 MG CAPSULE,18.45,11.07,4.28,4481.0,19 NDC,00904712461,LEVETIRACETAM 500 MG TABLET,16.65,9.99,3.86,4481.0,19 NDC,00904714504,DRONABINOL 5 MG CAPSULE,74.3,44.58,17.24,4481.0,19 NDC,00904716361,METFORMIN 850 MG TABLET,16.65,9.99,3.86,4481.0,19 NDC,00904720061,LISINOPRIL 40 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,00904724468,LACOSAMIDE 50 MG TABLET,25.75,15.45,5.97,4481.0,19 NDC,00904725261,SENNOSIDES 8.6 MG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,00904730561,CARVEDILOL 3.125 MG TABLET,16.3,9.78,3.78,4481.0,19 NDC,00904734661,FLUOXETINE 20 MG CAPSULE,16.3,9.78,3.78,4481.0,19 NDC,00904739489,DROXIDOPA 300 MG CAPSULE,190.9,114.54,44.29,4481.0,19 NDC,00904759161,FERROUS SULFATE 325 MG (65 MG IRON) TABLET,1.1,0.66,0.2552,4481.0,19 NDC,00904775127,LANOLIN ALCOHOLS-MINERAL OIL-W.PETROLATUM-CERESIN TOPICAL CREAM,1.05,0.63,0.2436,4481.0,19 NDC,00904791461,IBUPROFEN 200 MG TABLET,1.15,0.69,0.2668,4481.0,19 NDC,00904880567,"NEOMYCIN-BACITRACN ZN-POLYMYXN 3.5 MG-400 UNIT-5,000 UNIT TOP OINT PKT",1.25,0.75,0.29,4481.0,19 NDC,00941040901,PERITON.DIALYSIS SOLN 6-1.5 % DEXTROS LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,223.05,133.83,51.75,4481.0,23 NDC,00941040905,PERITON.DIALYSIS SOLN 6-1.5 % DEXTROS LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,200.2,120.12,46.45,4481.0,23 NDC,00941040906,PERITON.DIALYSIS SOLN 6-1.5 % DEXTROS LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,63.0,37.8,14.62,4481.0,23 NDC,00941040907,PERITON.DIALYSIS SOLN 6-1.5 % DEXTROS LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,63.0,37.8,14.62,4481.0,23 NDC,00941041104,PERITONEAL DIALYSIS SOLN 4-1.5 % DEXTR CA+ 3.5 MEQ/L-LOW MAG 0.5 MEQ/L,188.75,113.25,43.79,4481.0,23 NDC,00941041105,PERITONEAL DIALYSIS SOLN 4-1.5 % DEXTR CA+ 3.5 MEQ/L-LOW MAG 0.5 MEQ/L,74.45,44.67,17.27,4481.0,23 NDC,00941041106,PERITONEAL DIALYSIS SOLN 4-1.5 % DEXTR CA+ 3.5 MEQ/L-LOW MAG 0.5 MEQ/L,139.2,83.52,32.29,4481.0,23 NDC,00941041107,PERITONEAL DIALYSIS SOLN 4-1.5 % DEXTR CA+ 3.5 MEQ/L-LOW MAG 0.5 MEQ/L,196.35,117.81,45.55,4481.0,23 NDC,00941041111,PERITONEAL DIALYSIS SOLN 4-1.5 % DEXTR CA+ 3.5 MEQ/L-LOW MAG 0.5 MEQ/L,268.75,161.25,62.35,4481.0,23 NDC,00941041501,PERITON. DIALYSIS SOLN 3-4.25 % DEXTROSE CALC 3.5 MEQ/L-MAG 0.5 MEQ/L,245.9,147.54,57.05,4481.0,23 NDC,00941041505,PERITON. DIALYSIS SOLN 3-4.25 % DEXTROSE CALC 3.5 MEQ/L-MAG 0.5 MEQ/L,181.15,108.69,42.03,4481.0,23 NDC,00941041506,PERITON. DIALYSIS SOLN 3-4.25 % DEXTROSE CALC 3.5 MEQ/L-MAG 0.5 MEQ/L,70.65,42.39,16.39,4481.0,23 NDC,00941041507,PERITON. DIALYSIS SOLN 3-4.25 % DEXTROSE CALC 3.5 MEQ/L-MAG 0.5 MEQ/L,63.0,37.8,14.62,4481.0,23 NDC,00941042451,PERITON.DIALYSIS SOLN 6-1.5 % DEXTROS LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,200.25,120.15,46.46,4481.0,23 NDC,00941043052,PERITONEAL DIALYSIS SOLN 7-2.5 % DEXT.LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,206.15,123.69,47.83,4481.0,23 NDC,00941043055,PERITONEAL DIALYSIS SOLN 7-2.5 % DEXT.LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,223.95,134.37,51.96,4481.0,23 NDC,00941043351,PERITON. DIALYSIS SOLN 8-4.25 % DEXTROSE CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,205.1,123.06,47.58,4481.0,23 NDC,00941043352,PERITON. DIALYSIS SOLN 8-4.25 % DEXTROSE CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,207.4,124.44,48.12,4481.0,23 NDC,00941043353,PERITON. DIALYSIS SOLN 8-4.25 % DEXTROSE CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,212.55,127.53,49.31,4481.0,23 NDC,00941043355,PERITON. DIALYSIS SOLN 8-4.25 % DEXTROSE CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,228.85,137.31,53.09,4481.0,23 NDC,00941045701,PERITONEAL DIALYSIS SOLN 7-2.5 % DEXT.LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,245.9,147.54,57.05,4481.0,23 NDC,00941045705,PERITONEAL DIALYSIS SOLN 7-2.5 % DEXT.LOW CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,63.0,37.8,14.62,4481.0,23 NDC,00941045905,PERITON. DIALYSIS SOLN 8-4.25 % DEXTROSE CALC 2.5 MEQ/L-MAG 0.5 MEQ/L,215.4,129.24,49.97,4481.0,23 NDC,00942064104,DEXTROSE 2.45 GRAM-SOD CITRATE 2.2 GRAM-CITRIC AC 730 MG/100 ML SOLN,153.0,91.8,35.5,4481.0,19 NDC,00942950625,SODIUM CITRATE 4 GRAM/100 ML (4 %) SOLUTION,101.1,60.66,23.46,4481.0,19 NDC,00944265603,"IMMUNE GLOB,GAMMA(IGG) 5 GRAM-GLY-GLUC-IGA 0 TO 50 MCG/ML IV SOLUTION",4202.65,2521.59,76.44,12694.92,35 NDC,00944265804,"IMMUNE GLOB,GAMMA(IGG) 10 GRAM-GLY-GLUC-IGA 0 TO 50 MCG/ML IV SOLUTION",8328.25,4996.95,76.44,12694.92,35 NDC,00944284310,"ANTIHEMOPHILIC FACTOR (RECOMB) 1,000 (+/-) UNIT INTRAVENOUS SOLUTION",83.75,50.25,1.56,4481.0,35 NDC,00944305202,"ANTIHEMOPHILIC FACTOR VIII, FULL LENGTH 500 (+/-) UNIT IV SOLUTION",83.75,50.25,1.56,4481.0,35 NDC,00944394002,ANTIHEMOPHILIC FACTOR 220 UNIT-400 UNIT INTRAVENOUS POWDR FOR SOLUTION,82.7,49.62,1.06,4481.0,35 NDC,00944394402,"ANTIHEMOPHILIC FACTOR 801 UNIT-1,500 UNIT INTRAVENOUS POWDER FOR SOLN",82.7,49.62,1.06,4481.0,35 NDC,00944394602,"ANTIHEMOPHILIC FACTOR 1,501 UNIT-2,000 UNIT INTRAVENOUS POWDR FOR SOLN",82.7,49.62,1.06,4481.0,35 NDC,00944500101,"ANTIHEMOPHILIC FACTOR VIII,PORCINE REC 500(+/-) UNIT RANGE IV SOLUTION",87.15,52.29,3.13,4481.0,35 NDC,00990614309,ACETIC ACID 0.25 % IRRIGATION SOLUTION,78.0,46.8,18.1,4481.0,19 NDC,00990793519,DEXTROSE 20 % IN WATER (D20W) INTRAVENOUS SOLUTION,106.5,63.9,24.71,4481.0,17 NDC,00990796809,ELECTROLYTE-R IN DEXTROSE 5 % INTRAVENOUS SOLUTION,102.0,61.2,23.66,4481.0,19 NDC,02420850912,MAGNESIUM CARBONATE 54 MG/5 ML ORAL LIQUID,42.65,25.59,9.89,4481.0,19 NDC,0487990130B,ALBUTEROL SULFATE CONCENTRATE 5 MG/ML(0.5 %) SOLUTION FOR NEBULIZATION,84.4,50.64,19.58,4481.0,19 NDC,05928000100,"SODIUM CHLORIDE, SODIUM BICARB-NASAL RINSE SQUEEZE BOTTLE WITH PACKET",14.95,8.97,3.47,4481.0,19 NDC,08137003640,COLLOIDAL OATMEAL TOPICAL PACKET,2.05,1.23,0.4756,4481.0,19 NDC,09990009943,"ERGOCALCIFEROL (VITAMIN D2) 200 MCG/ML (8,000 UNIT/ML) ORAL DROPS",1.2,0.72,0.2784,4481.0,19 NDC,09990011664,WARFARIN 1 MG/ML ORAL SUSPENSION,16.3,9.78,3.78,4481.0,19 NDC,09990038488,FLUOXETINE 20 MG/5 ML (4 MG/ML) ORAL SOLUTION,19.15,11.49,4.44,4481.0,19 NDC,09991009943,"ERGOCALCIFEROL (VITAMIN D2) 200 MCG/ML (8,000 UNIT/ML) ORAL DROPS",1.2,0.72,0.2784,4481.0,19 NDC,09998728001,ISRADIPINE 1 MG/ML ORAL SUSPENSION,77.8,46.68,18.05,4481.0,19 NDC,09999000370,OPIUM TINCTURE 10 MG/ML (MORPHINE) ORAL,25.5,15.3,5.92,4481.0,19 NDC,09999000377,MULTIVIT AND MINERALS-FERROUS GLUCONATE 9 MG IRON/15 ML ORAL LIQUID,1.45,0.87,0.3364,4481.0,19 NDC,09999000400,NXSTAGE RFP 402 - CONTAINS NO POTASSIUM,243.0,145.8,56.38,4481.0,19 NDC,09999000404,LORAZEPAM 2 MG/ML ORAL CONCENTRATE,23.6,14.16,5.48,4481.0,19 NDC,09999000738,FLUCONAZOLE 2 MG/ML (ODD DOSE) IN SODIUM CHLORIDE 0.9% IVPB (60MIN ADMIN),131.05,78.63,5.08,4481.0,24 NDC,09999000819,PEDIATRIC MULTIVITAMIN-FERROUS SULFATE 11 MG/ML ORAL DROPS WRAPPER,1.1,0.66,0.2552,4481.0,19 NDC,09999000882,ONDANSETRON HCL 4 MG/5 ML ORAL SOLUTION,28.6,17.16,6.64,4481.0,19 NDC,09999001015,ROCURONIUM 10 MG/ML INFUSION CSAC,184.5,110.7,42.8,4481.0,19 NDC,09999001241,NXSTAGE RFP 400 (+/- BB) - CONTAINS 2 MEQ/L POTASSIUM,243.0,145.8,56.38,4481.0,19 NDC,09999001243,STUDY LBS-SS201 LB1148/PLACEBO RECONSTITUTED SOLUTION 700 ML,0.2,0.12,0.0464,4481.0,17 NDC,09999001249,STUDY ONDANSETRON HCL 8 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999001253,STUDY IRB 14-1455 APIXABAN 5 MG TABLETS,0.2,0.12,0.0464,4481.0,19 NDC,09999001254,STUDY IM128027 BMS-931699/PLACEBO SYRINGE 1.25 MG/5 MG/12.5MG,0.2,0.12,0.0464,4481.0,17 NDC,09999001291,STUDY GOG-3007 EVEROLIMUS 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999001292,STUDY GOG-3007 EVEROLIMUS 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999001298,STUDY GOG-3007 EVEROLIMUS 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999001308,MISOPROSTOL 25 MCG SPLIT TABLET,16.5,9.9,3.83,4481.0,19 NDC,09999001313,STUDY CC-5013-AML-002 LENALIDOMIDE 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 NDC,09999001314,STUDY CC-5013-AML-002 LENALIDOMIDE 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 NDC,09999001336,STUDY 2826 GEN-003 + MATRIX -M2 OR PLACEBO 0.8 ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999001337,STUDY NICHD PROSPECT PROGESTERONE/PLACEBO 200 MG MICRONIZED CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999001348,MORPHINE 10 MG/5 ML ORAL SOLUTION,23.4,14.04,5.43,4481.0,19 NDC,09999001381,STUDY BAYER BAY 59-7939/17454 ASPIRIN 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999001390,STUDY IND INOTUZUMAB OZOGAMICIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001420,STUDY R2222-RSV-1332 REGN2222/PLACEBO 150 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001421,STUDY IGHID 11525 ZANAMIVIR 10 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999001445,STUDY GILEAD GS-US-326-1100 GS-5745/PLACEBO 150 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999001474,PHENYTOIN 125 MG/5 ML ORAL SUSPENSION,17.4,10.44,4.04,4481.0,19 NDC,09999001481,PEDIATRIC MULTIVITAMIN-FERROUS SULFATE 11 MG/ML ORAL DROPS WRAPPER,1.1,0.66,0.2552,4481.0,19 NDC,09999001507,MORPHINE 0.4 MG/ML ORAL SOLUTION (NEONATAL),22.15,13.29,5.14,4481.0,19 NDC,09999001509,STUDY INTREPID TICAGRELOR 90 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999001510,STUDY INTREPID ASPIRIN 81 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999001513,STUDY ALS-8176-503 ALS-008176/PLACEBO 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001514,STUDY ALS-8176-503 ALS-008176/PLACEBO 9.1 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001555,STUDY BAYER BAY 59-7939/16573 RIVAROXABAN/PLACEBO 15 MG TABLETT,0.2,0.12,0.0464,4481.0,23 NDC,09999001557,STUDY SHIRE SHP621-301 COSYNTROPIN 0.25 MG SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,09999001558,STUDY IRB #15-2770 D3-CREATINE 4 MG/ML IN 20% HEAVY WATER (D20),0.2,0.12,0.0464,4481.0,17 NDC,09999001559,STUDY IRB #15-2770 D3-CREATINE 7.5 MG/ML IN 20% HEAVY WATER (D2O),0.2,0.12,0.0464,4481.0,17 NDC,09999001561,STUDY ABLYNX ALX0681-C301 CAPLACIZUMAB/PLACEBO 12.5 MG/ML,0.2,0.12,0.0464,4481.0,21 NDC,09999001562,STUDY ABLYNX ALX0681-C301 CAPLACIZUMAB 12.5 MG/ML,0.2,0.12,0.0464,4481.0,21 NDC,09999001571,STUDY PACIRA 402-C-331 BUPIVICAINE (PF) 0.5 % (5 MG/ML) INJECTION SOL,0.2,0.12,0.0464,4481.0,19 NDC,09999001572,STUDY PACIRA 402-C-331 BUPIVACAINE LIPOSOME/PLACEBO (PF) 266 MG/20 ML (13.3 M,0.2,0.12,0.0506,4481.0,34 NDC,09999001574,STUDY IRB 15-2865 BISACODYL TABLETS 5 MG,0.2,0.12,0.0464,4481.0,23 NDC,09999001577,STUDY IRB 15-2865 POLYETHYLENE GLYCOL-ELECTROLYTE SOLUTION 4000,0.2,0.12,0.0464,4481.0,19 NDC,09999001578,STUDY CRFB002H2301 RANIBIZUMAB 0.5 MG/0.05 ML INTRAVITREAL SOLUTION FOR INJECTION,0.2,0.12,0.0506,14039.97,35 NDC,09999001579,STUDY MLN0002-3026 VEDOLIZUMAB/PLACEBO 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999001580,STUDY MLN0002-3026 ADALIMUMAB/PLACEBO 40 MG PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,30 NDC,09999001581,STUDY HVTN 704/HPTN 085 VRC01/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001583,STUDY 39039039 RIVAROXABAN 15 MG (42)-20 MG (9) TABLETS IN A DOSE PACK,0.2,0.12,0.0464,4481.0,24 NDC,09999001585,STUDY B0401016 PF-04447943/PLACEBO 5 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999001586,STUDY A-TREAT TRANEXAMIC ACID/PLACEBO TABLET 650 MG,0.2,0.12,0.0464,4481.0,23 NDC,09999001603,STUDY 39039039 RIVAROXABAN 15 MG (42)-20 MG (9) TABLETS IN A DOSE PACK,0.2,0.12,0.0464,4481.0,24 NDC,09999001604,STUDY B5201002 RIVIPANSEL/PLACEBO 30 MG/ML INTRAVENOUS SOLN,0.2,0.12,0.0464,4481.0,22 NDC,09999001605,STUDY PROTEON PRT-201-320 VONAPANITASE (PRT-201)/PLACEBO 0012 MG/ML,0.2,0.12,0.0464,4481.0,17 NDC,09999001607,STUDY IRB 16-0739 FMT UPPER DELIVERY MICROBIOTA PREPARATIONN,0.2,0.12,0.0464,4481.0,17 NDC,09999001656,STUDY ML29966 OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTI,0.2,0.12,0.0506,9460.92,35 NDC,09999001657,STUDY ML29966 OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTI,0.2,0.12,0.0506,9460.92,35 NDC,09999001664,STUDY EXPANDED ACCESS ABBV-8E12 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001665,NXSTAGE RFP 404 - CONTAINS 4 MEQ/L POTASSIUM,243.0,145.8,56.38,4481.0,19 NDC,09999001679,STUDY EDGE EG-01-1962-03 EG-1962/PLACEBO 600 MG SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999001680,STUDY EDGE EG-01-1962-03 NIMODIPINE/PLACEBO CAPSULE 30 MG,0.2,0.12,0.0464,4481.0,23 NDC,09999001684,STUDY IMMUPHARM IPP-201101/005 IPP-201101/PLACEBO SUBCUTANEOUS SOLUTION 200 MG/ML,0.2,0.12,0.0464,4481.0,22 NDC,09999001685,STUDY 2819-CL-0202 FIDAXOMICIN TABLET 200 MG,0.2,0.12,0.0464,4481.0,19 NDC,09999001686,STUDY 2819-CL-0202 FIDAXOMICIN 40 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,09999001687,STUDY 2819-CL-0202 VANCOMYCIN CAPSULE 125 MG,0.2,0.12,0.0464,4481.0,19 NDC,09999001688,STUDY 2819-CL-0202 VANCOMYCIN 25 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999001694,STUDY TBCRC-037 FULVESTRANT 250 MG/5 ML INTRAMUSCULAR SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999001704,PEDIATRIC MULTIVITAMIN NO.192 250 MCG-50 MG-10 MCG/ML ORAL DROPS,1.1,0.66,0.2552,4481.0,19 NDC,09999001727,STUDY 20130295 AMG EVOLOCUMAB 140 MG/ML SUBCUTANEOUS AUTOINJECTOR,0.2,0.12,0.0464,4481.0,24 NDC,09999001728,STUDY RAD-IFN-CS-003 RAD-IFN (INSTILADRIN) 3X10E11 VPS/ML,0.2,0.12,0.0464,4481.0,17 NDC,09999001729,STUDY RAD-IFN-CS-003 SYN 3 (POLYAMIDE SURFACTANT),0.2,0.12,0.0464,4481.0,17 NDC,09999001730,STUDY RAD-IFN-CS-003 DILUENT,0.2,0.12,0.0464,4481.0,17 NDC,09999001731,STUDY BI 1293.10 METHYLPREDNISOLONE SODIUM SUCC 500 MG INTRAVENOUS SON,0.2,0.12,0.0506,4481.0,35 NDC,09999001732,STUDY BI 1293.10 BI655064 0/120/180 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999001737,STUDY IRB 16-0129 IBUTILIDE 0.1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999001738,STUDY IRB 16-0129 MAGNESIUM SULFATE 2 GM IN 50 ML DEXTROSE 5% INFUSIN,0.2,0.12,0.0464,4481.0,24 NDC,09999001739,STUDY IRB 16-2363 FLU VACCINE QUADRIVALENT 15 MCG/STRAIN (QUIV) OR HIGH-DOSE TRIVALENT 60 MCG/STRAIN (TIV),0.2,0.12,0.0464,4481.0,26 NDC,09999001792,STUDY IND INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.05544,6070.61,31 NDC,09999001812,STUDY GA28950 ETROLIZUMAB/PLACEBO 105 MG 0.7 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999001813,STUDY C0168IBD4020 ADAPT INFLIXIMAB INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4783.38,35 NDC,09999001825,STUDY D3461C00007 ANIFROLUMAB/PLACEBO 150 MG INTRAVENOUS SOLUTION FOR 1ST 3 MONTHS,0.2,0.12,0.0464,4481.0,17 NDC,09999001828,STUDY D3461C00007 ANIFROLUMAB/PLACEBO 150 MG INTRAVENOUS SOLUTION MAINTENANCE,0.2,0.12,0.0464,4481.0,22 NDC,09999001834,STUDY XENCOR XMAB5871-04 METHYLPREDNISOLONE ACETATE 80 MG/ML INJECTION,0.2,0.12,0.0506,4481.0,35 NDC,09999001835,STUDY XENCOR XMAB5871/PLACEBO INFUSION,0.2,0.12,0.0464,4481.0,22 NDC,09999001836,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 10 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999001837,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.045,4481.0,24 NDC,09999001838,STUDY GSK 201023 DANIRIXIN/PLACEBO 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999001839,STUDY GSK 201023 OSELTAMIVIR 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,23 NDC,09999001843,STUDY GSK 201023 SODIUM CHLORIDE 0.9% (NS) INFUSION,0.2,0.12,0.0464,4481.0,21 NDC,09999001845,STUDY HAL-MPE1/PLACEBO 0.1 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001846,STUDY HAL-MPE1/PLACEBO 1 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001847,STUDY HAL-MPE1/PLACEBO 2 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001848,STUDY HAL-MPE1/PLACEBO 20 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001849,STUDY HAL-MPE1/PLACEBO 40 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001850,STUDY HAL-MPE1/PLACEBO 375 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001892,STUDY S1602 BCG TOKYO-172 STRAIN 40 MG/ML INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,23 NDC,09999001893,STUDY S1602 BCG TOKYO-172 STRAIN 0.5 MG/ML INTRADERMAL INJECTION,0.2,0.12,0.0464,4481.0,23 NDC,09999001909,STUDY HAL-MPE1/PLACEBO 750 MCG/ML DILUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001910,STUDY GSK 201023 OSELTAMIVIR SUSPENSION 6 MG/ML,0.2,0.12,0.0464,4481.0,19 NDC,09999001912,STUDY NICHD-2014-FUR01 FUROSEMIDE/PLACEBO 2 MG/ML INJECTION SOLUTION,0.2,0.12,0.045,4481.0,24 NDC,09999001913,STUDY MLN0002SC-3031 VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999001914,STUDY MLN0002SC-3031 VEDOLIZUMAB/PLACEBO 108 MG/0.68 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999001925,STUDY ACTG A5315 ROMIDEPSIN/PLACEBO 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5162.64,35 NDC,09999001927,STUDY ARGX-113-1602 ARGX-113/PLACEBO 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999001929,STUDY DEXAMETHASONE 4 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999001980,STUDY D5551C00002 EXENATIDE/PLACEBO 2 MG POWDER FOR INJECTION,0.2,0.12,0.0464,4481.0,19 NDC,09999006000,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION (SYRINGE) PEDS,80.5,48.3,0.0675,4481.0,24 NDC,09999006985,KETAMINE 50 MG/ML ORAL SOLUTION,30.55,18.33,7.09,4481.0,19 NDC,09999006991,STUDY D9090C00008 AZD5462 20 MG/40 MG/180 MG/PLACEBO TABLET (WHITE LABEL),0.2,0.12,0.0464,4481.0,17 NDC,09999006992,STUDY D9090C00008 AZD5462 20 MG/40 MG/180 MG/PLACEBO TABLET (BLUE LABEL),0.2,0.12,0.0464,4481.0,17 NDC,09999007008,STUDY IRB# 24-2210 AZITHROMYCIN/PLACEBO IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999007131,KETAMINE 50 MG/ML ORAL SOLUTION,23.1,13.86,5.36,4481.0,19 NDC,09999007203,LABETALOL 5 MG/ML PEDIATRIC SYRINGE,75.95,45.57,0.765,4481.0,24 NDC,09999007209,TREPROSTINIL 1.74 MG/2.9 ML (0.6 MG/ML) SOLUTION FOR NEBULIZATION,2396.0,1437.6,555.87,4481.0,23 NDC,09999007214,SQUARIC ACID 5 % IN ACETONE,164.5,98.7,38.16,4481.0,19 NDC,09999007714,"HEPARIN (PORCINE) 10,000 UNIT/1,000 ML IN NS (UNCH CUPID)",154.45,92.67,0.4725,4481.0,24 NDC,09999007726,"HEPARIN (PORCINE) 10,000 UNIT/1,000 ML IN 0.9 % SOD. CHLORIDE IV SOLN",85.9,51.54,0.4725,4481.0,24 NDC,09999007739,AMPHOTERICIN B CONVENTIONAL 1.5 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 NDC,09999007893,STUDY ARST1431 TEMSIROLIMUS 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4581.99,35 NDC,09999007903,HYDROCHLOROTHIAZIDE 5 MG/ML ORAL SUSPENSION,20.65,12.39,4.79,4481.0,19 NDC,09999007913,(TAKE HOME) SULFAMETHOXAZOLE 800 MG-TRIMETHOPRIM 160 MG TABLET,27.05,16.23,6.28,4481.0,19 NDC,09999007914,(TAKE HOME) NALOXONE 1 MG/ML INJECTION SYRINGE,144.7,86.82,0.18,4481.0,24 NDC,09999007918,(TAKE HOME) EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,612.1,367.26,142.01,4481.0,19 NDC,09999007920,(TAKE HOME) RALTEGRAVIR 400 MG TABLET,641.0,384.6,148.71,4481.0,19 NDC,09999007924,DOPAMINE 3200 MCG/ML IN DEXTROSE 5% 2 ML PEDIATRIC,63.55,38.13,1.8,4481.0,24 NDC,09999007925,DOPAMINE 3200 MCG/ML IN DEXTROSE 5% 8 ML PEDIATRIC,65.1,39.06,1.8,4481.0,24 NDC,09999007926,DOPAMINE 3200 MCG/ML IN DEXTROSE 5% 50 ML PEDIATRIC,75.95,45.57,1.8,4481.0,24 NDC,09999007991,(TAKE HOME) CIPROFLOXACIN 0.3 % EYE DROPS,58.15,34.89,13.49,4481.0,19 NDC,09999007992,(TAKE HOME) ERYTHROMYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT,61.8,37.08,14.34,4481.0,19 NDC,09999007994,(TAKE HOME) CLINDAMYCIN HCL 150 MG CAPSULE,17.35,10.41,4.03,4481.0,19 NDC,09999007998,PANTOPRAZOLE 2 MG/ML ORAL SUSPENSION,77.8,46.68,18.05,4481.0,19 NDC,09999008047,STUDY NRG-GI004-CIRB ATEZOLIZUMAB 60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999008204,STUDY 101EP201 NATALIZUMAB/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999008205,STUDY 101EP201 NATALIZUMAB 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999008246,STUDY D5551C00002 EXENATIDE/PLACEBO 2 MG DUAL CHAMBER PREFILLED PEN,0.2,0.12,0.0464,4481.0,19 NDC,09999008264,GLUTAMINE 250 MG/ML ORAL SUSPENSION,2.85,1.71,0.6612,4481.0,19 NDC,09999008276,STUDY IFX-1-P2.4 IFX-1/PLACEBO 10 MG/ML VIAL,0.2,0.12,0.0464,4481.0,23 NDC,09999008277,STUDY IFX-1-P2.4 IFX-1 10 MG/ML VIAL,0.2,0.12,0.0464,4481.0,23 NDC,09999008278,STUDY IFX-1-P2.4 IFX-1/PLACEBO 400/800/1200 MG IN 0.9% SODIUM CHLORIDE IVPB,0.2,0.12,0.0464,4481.0,23 NDC,09999008289,STUDY DU176B-D-U312 ENOXAPARIN 10 MG/0.1 ML SYRINGE,0.2,0.12,0.0464,4481.0,24 NDC,09999008290,STUDY WARFARIN 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999008294,STUDY DU176B-D-U312 ENOXAPARIN 10 MG/0.1 ML SYRINGE,0.2,0.12,0.0464,4481.0,24 NDC,09999008295,STUDY DU176B-D-U312 ENOXAPARIN 10 MG/0.1 ML SYRINGE,0.2,0.12,0.0464,4481.0,24 NDC,09999008316,STUDY CA-ALT-803-01-16 BCG 50 MG INTRAVESICAL SUSPENSION,0.2,0.12,0.0464,4481.0,24 NDC,09999008341,STUDY LIDOCAINE-PRILOCAINE 2.5 %-2.5 % TOPICAL CREAM,0.2,0.12,0.0464,4481.0,19 NDC,09999008342,STUDY VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999008343,"STUDY EPINEPHRINE 0.15 MG/0.3 ML INJECTION, AUTO-INJECTOR",0.2,0.12,0.0464,4481.0,24 NDC,09999008344,STUDY MLN0002-2003 VEDOLIZUMAB 150/300 MG IVPB,0.2,0.12,0.0464,4481.0,19 NDC,09999008345,STUDY MLN0002-2003 VEDOLIZUMAB 100/200 MG IVPB,0.2,0.12,0.0464,4481.0,19 NDC,09999008346,STUDY ACETAMINOPHEN 160 MG/5 ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,09999008359,STUDY LILLY I6T-MC-AMAN MIRIKIZUMAB (LY3074828)/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,19 NDC,09999008361,STUDY CV013-011 BMS-986231/PLACEBO INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999008464,STUDY ARGX-113-1704 ARGX-113/PLACEBO 20 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999008465,AMPICILLIN (10 MG/ML) DILUTION (PCN TESTING),63.35,38.01,1.24,4481.0,24 NDC,09999008473,STUDY ACETAMINOPHEN 500 MG/15 ML ORAL LIQUID,0.2,0.12,0.0464,4481.0,19 NDC,09999008474,STUDY IA-001 FLU-IGIV/PLACEBO IN 0.9% SODIUM CHLORIDE IVPB,0.2,0.12,0.0464,4481.0,19 NDC,09999008487,STUDY NANT17-01/MIBG-D DINUTUXIMAB 3.5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999008500,STUDY AK002-003X IN 0.9% SODIUM CHLORIDE,0.2,0.12,0.0464,4481.0,19 NDC,09999008501,STUDY CV013-011 BMS-986231/PLACEBO WITH POTASSIUM ACETATE IN 120 ML D5W IVPB,0.2,0.12,0.0464,4481.0,17 NDC,09999008508,STUDY ACTG A5378 VRC07-523LS 100 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999008509,STUDY ACTG A5378 VRC07-523LS 100 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999008511,STUDY HAEMOPH B POLYSAC CONJ-MENING (PF) 7.5 MCG/0.5 ML IIM SOLN,0.2,0.12,0.0464,4481.0,25 NDC,09999008526,"STUDY MENINGOC VAC A,C,Y,W-135 DIP (PF) 4 MCG/0.5 ML IM SOLUTION",0.2,0.12,0.0464,4481.0,25 NDC,09999008527,"STUDY MENNGOCOCCAL B VAC,4-CMP 50 MCG-50 MCG-50 MCG-25 MCG/0.5 ML IM E",0.2,0.12,0.0464,4481.0,25 NDC,09999008528,STUDY PNEUMOCOCCAL 13-VAL CONJ VACCINE-DIP CRM (PF) 0.5 ML IM SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999008529,STUDY HAEMOPHILUS B POLYSACCHARID CONJ-TETANUS TOX (PF) (ACTHIB) IM SOLN,0.2,0.12,0.0464,4481.0,25 NDC,09999008530,STUDY GILEAD GS-US-420-3902 GS-9722/PLACEBO 50 MG/ML VIAL,0.2,0.12,0.0464,4481.0,22 NDC,09999008531,STUDY IRB# 18-0431 MEPOLIZUMAB / PLACEBO 100 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999008554,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828)/PLACEBO 100 MG/ML PREFILLED SYRINGE #1 OF 2,0.2,0.12,0.0464,4481.0,19 NDC,09999008555,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 100 MG/ML PREFILLED SYRINGE #1 OF 2,0.2,0.12,0.0506,7785.12,35 NDC,09999008556,STUDY LILLY I6T-MC-AMBG MIRIKIZUMAB (LY3074828) 20 MG/ML VIAL,0.2,0.12,0.0506,7785.12,35 NDC,09999008557,STUDY ROCHE CP40617 BALOXAVIR/PLACEBO 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999008558,STUDY ROCHE CP40617 BALOXAVIR 2 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,09999008559,STUDY ROCHE CP40617 OSELTAMIVIR 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,23 NDC,09999008560,STUDY ROCHE CP40617 OSELTAMIVIR 6 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,09999008561,STUDY A041702-CIRB IBRUTINIB 140 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999008563,STUDY A041702-CIRB VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999008564,STUDY A041702-CIRB VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999008565,STUDY A041702-CIRB VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999008566,STUDY A041702-CIRB OBINUTUZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11677.68,35 NDC,09999008568,STUDY CA-ALT-803-01-16 ALT-803 1 MG/ML INTRAVESICAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999008570,STUDY SGNTV-001 TISOTUMAB VEDOTIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,30877.35,35 NDC,09999008596,STUDY ETCTN10186-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 NDC,09999008599,STUDY IND LOXO-305 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999008617,STUDY GSK MHE 112562 MEPOLIZUMAB 100 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999008643,STUDY A5377 SAR441236 25 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 NDC,09999008645,STUDY TAK-079-2001 TAK-079 100 MG/ML OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999008682,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 200 MG,0.2,0.12,0.0464,4481.0,17 NDC,09999008683,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 300 MG,0.2,0.12,0.0464,4481.0,17 NDC,09999008702,STUDY COFAR-11 OMALIZUMAB OR PLACEBO PREFILLED SYRINGE 150 MG/ML,0.2,0.12,0.0506,6119.61,35 NDC,09999008703,STUDY COFAR-11 OMALIZUMAB OR PLACEBO PREFILLED SYRINGE 75 MG/0.5 ML,0.2,0.12,0.0506,6119.61,35 NDC,09999008707,STUDY CAFFEINE CITRATE 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999008708,STUDY NWU2015-09-02 HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999008710,STUDY ALXN1210-MG-306 MENINGOCOCCAL CONJUGATE (MENACTRA) VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999008711,STUDY ALXN1210-MG-306 MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999008712,STUDY IND LOXO-305 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999008727,STUDY 54767414MMY3021 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 NDC,09999008732,STUDY A031702-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999008733,STUDY EAA173CIRB DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11069.1,35 NDC,09999008737,STUDY A031704-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999008749,STUDY 56021927PCR3011 LEUPROLIDE 22.5 MG INTRAMUSCULAR INJECTION,0.2,0.12,0.0506,26039.58,35 NDC,09999008750,STUDY 56021927PCR3011 LEUPROLIDE 22.5 MG SUBCUTANEOUS INJECTION,0.2,0.12,0.0506,26039.58,35 NDC,09999008901,NXSTAGE RFP 453 - CONTAINS POTASSIUM 2 MEQ/L (CALCIUM FREE),291.6,174.96,67.65,4481.0,19 NDC,09999008902,NXSTAGE RFP 454 - CONTAINS POTASSIUM 4 MEQ/L (CALCIUM FREE),291.6,174.96,67.65,4481.0,19 NDC,09999008903,STUDY ALXN1210-MG-306 RAVULIZUMAB/PLACEBO 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999008904,STUDY ALXN1210-MG-306 RAVULIUMAB 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999008917,STUDY PNEU-PED V114 VACCINE,0.2,0.12,0.0464,4481.0,26 NDC,09999008918,STUDY IBUPROFEN 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999008922,STUDY LCCC1824 PERFLUTREN LIPID MICROSPHERES INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,09999008927,STUDY MEK-NF-201 PD-0325901 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999008935,STUDY I6T-MC-AMAP MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 NDC,09999008943,STUDY MEK-NF-201 PD-0325901 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999008954,STUDY RA101495-02.301 ZILUCOPLAN OR PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999008955,STUDY RA101495-02.301 MENINGOCOCCAL QUADRIVALENT CONJUGATE (MENACTRA)),0.2,0.12,0.0464,4481.0,25 NDC,09999008956,STUDY RA101495-02.301 MENINGOCOCCAL GROUP B (BEXSERO) INJECTION,0.2,0.12,0.0464,4481.0,25 NDC,09999008957,STUDY IRB 18-2650 ANAKINRA/PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999008966,STUDY A041703-CIRB INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,435080.31,35 NDC,09999008967,STUDY A041703-CIRB BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 NDC,09999008971,STUDY S1803-CIRB DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 NDC,09999008984,STUDY MK7902-010-WIRB PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999008985,STUDY AALL1732 INOTUZUMAB OZOGAMICIN 0.25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,435080.31,35 NDC,09999008992,STUDY MEDI8897/PLACEBO 100 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999008995,STUDY EFC15804 BOREAS UNC IDS#19-0049 DUPILUMAB 300 MG/PLACEBO INJECTION,0.2,0.12,0.0464,4481.0,19 NDC,09999008996,"EPOETIN ALFA EPBX (RETACRIT) 1,000 UNIT/ML INJECTION (PEDIATRICS DILUTION) SYRINGE",188.55,113.13,7.61,4481.0,33 NDC,09999008997,STUDY A071701-CIRB ABEMACICLIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999008998,STUDY A071701-CIRB ENTRECTINIB 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999008999,STUDY A071701-CIRB PAXALISIB (GDC-0084) 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 NDC,09999009004,STUDY 252BN201 BIIB093/PLACEBO 1 MG/ML IV SOLN,0.2,0.12,0.0464,4481.0,17 NDC,09999009008,STUDY ITN080AI (REBOOT) BELIMUMAB/PLACEBO 200 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,8308.44,35 NDC,09999009009,STUDY ITN080AI (REBOOT) RITUXIMAB 10 MG/ML IV SOLN,0.2,0.12,0.0506,12511.17,35 NDC,09999009051,URSODIOL 60 MG/ML ORAL SUSPENSION,204.3,122.58,47.4,4481.0,19 NDC,09999009054,STUDY VRC-HIVMAB075-00-AB (VRC07-523LS) 100 MG/ML INJ,0.2,0.12,0.0464,4481.0,19 NDC,09999009056,STUDY LIMIT-JIA ABATACEPT (ORENCIA) 125 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009057,STUDY LIMIT-JIA ABATACEPT (ORENCIA) 50 MG/0.4 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009058,STUDY LIMIT-JIA ABATACEPT (ORENCIA) 87.5 MG/0.7 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009060,STUDY D3253C00001 MEPOLIZUMAB 100 MG/ML OR PLACEBO VIAL,0.2,0.12,0.0506,4999.47,35 NDC,09999009061,STUDY D3253C00001 BENRALIZUMAB 30 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0506,26729.01,35 NDC,09999009062,STUDY D3253C00001 BENRALIZUMAB 30 MG/ML OR PLACEBO PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999009070,STUDY RA101495-02.302 ZILUCOPLAN PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999009071,STUDY RA101495-02.302 MENINGOCOCCAL QUADRIVALENT CONJUGATE (MENACTRA) INJECTION,0.2,0.12,0.0464,4481.0,25 NDC,09999009072,STUDY RA101495-02.302 MENINGOCOCCAL GROUP B (BEXSERO) INJECTION,0.2,0.12,0.0464,4481.0,25 NDC,09999009073,STUDY GILEAD GS-US-200-4334 GS-6207 450 MG/1.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999009076,STUDY IRB# 19-2343 LEUPROLIDE DEPOT 3.75 MG INJECTION,0.2,0.12,0.0506,252434.28,35 NDC,09999009090,STUDY 849-001 CETUXIMAB 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11827.62,35 NDC,09999009100,STUDY ACTG A5379 HEPATITIS B VACCINE 20 MCG/0.5 ML-ADJUVANT CPG 1018 (PF) IM SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999009106,STUDY NICHD MFMU PRAVASTATIN/PLACEBO 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999009107,STUDY CNTO1959CRD3001 USTEKINUMAB/PLACEBO 130 MG/26 ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999009108,STUDY CNTO1959CRD3001 USTEKINUMAB/PLACEBO 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999009109,STUDY HAZ COVID HYDROXYCHLOROQUINE/PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999009110,STUDY HAZ COVID AZITHROMYCIN/PLACEBO 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999009123,STUDY IND TAFASITAMAB 40 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999009126,STUDY LCCC2037 OLANZAPINE / PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999009127,STUDY LCCC2037 OLANZAPINE / PLACEBO 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999009141,GENTAMCIN 1 MG/ML (5 ML) LOCK IN NS,26.35,15.81,4.97,4481.0,24 NDC,09999009144,STUDY CX-280-202 CB-280/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999009145,STUDY CX-280-202 CB-280/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999009146,STUDY CX-280-202 COSYNTROPIN 0.25 MG/ML 0.9% SODIUM CHLORIDE INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,09999009147,STUDY HPTN 083 CABOTEGRAVIR (GSK1265744) 200 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999009148,STUDY HPTN 083 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999009149,STUDY 20170625 VESALIUS EVOLOCUMAB/PLACEBO 140 MG/ML INJECTION PEN,0.2,0.12,0.0464,4481.0,24 NDC,09999009401,STUDY 20170625 VESALIUS PLACEBO INJECTION PEN,0.2,0.12,0.0464,4481.0,24 NDC,09999009406,STUDY VIS649-201 0/2/4/8 MG/KG IN 0.9% SODIUM CHLORIDE (NS) IVPB,0.2,0.12,0.0464,4481.0,22 NDC,09999009407,STUDY R10933-10987-COV-2066 REGN10933+REGN10987/PLACEBO 0/2.4/8.0 G IVPB,0.2,0.12,0.0464,4481.0,22 NDC,09999009408,STUDY IM011074 BMS-98616501/PLACEBO 0/3/6/12 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009411,STUDY ALXN1210-NMO-307 RAVULIZUMAB 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999009420,STUDY INCB57643-103 INCB057643 2 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009421,STUDY INCB57643-103 INCB057643 4 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009439,STUDY AFT-41 LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999009488,STUDY IRB 19-3149 DROSPIRENONE 3 MG-ETHINYL ESTRADIOL 0.03 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999009490,STUDY AK002-016 AK002/PLACEBO 15 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999009491,STUDY AK002-016 PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999009493,STUDY ACP-2566-003 TROFINETIDE/PLACEBO 1 G/5 ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999009497,STUDY PATH HHT 133646-2 IRB# 19-3071 POMALIDOMIDE/PLACEBO 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999009498,STUDY PATH HHT 133646-2 IRB# 19-3071 POMALIDOMIDE/PLACEBO 3 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999009499,STUDY PATH HHT 133646-2 IRB# 19-3071 POMALIDOMIDE/PLACEBO 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999009504,STUDY TAK-079-2001 TAK-079 100 MG/ML OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999009505,STUDY TAK-079-2001 TAK-079 100 MG/ML OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999009506,STUDY TAK-079-2001 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AERSOL INH,0.2,0.12,0.0464,4481.0,19 NDC,09999009511,STUDY ACTIV-1 IM REMDESIVIR 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999009512,STUDY ACTIV-1 IM INFLIXIMAB/PLACEBO 10 MG/ML SOLUTION,0.2,0.12,0.0506,4783.38,35 NDC,09999009513,STUDY ACTIV-1 IM ABATACEPT/PLACEBO 250 MG INTRAVENOUS SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999009514,STUDY ACTIV-1 IM CENICRIVIROC (CVC)/PLACEBO 150 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009515,STUDY ACTIV-1 IM CENICRIVIROC (CVC)/PLACEBO 7.5 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 NDC,09999009519,STUDY COFAR-11 OMALIZUMAB PREFILLED SYRINGE 150 MG/ML,0.2,0.12,0.0506,6119.61,35 NDC,09999009520,STUDY COFAR-11 OMALIZUMAB PREFILLED SYRINGE 75 MG/0.5 ML,0.2,0.12,0.0506,6119.61,35 NDC,09999009521,STUDY ECU-NMO-303 ECULIZUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,7333.83,35 NDC,09999009522,STUDY INCB 54707-204 INCB054707/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009523,STUDY INCB 54707-204 INCB054707 15 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009542,STUDY AALL1821 BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 NDC,09999009545,STUDY GSK-209626-DREAMM12 BELANTAMAB MAFODOTIN 50 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999009571,STUDY ARMOR (C20-0155) IRB# 19-2850 ARAMCHOL 300 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009574,STUDY PNEUMOCOCCAL 23 POLYVALENT VACCINE 25 MCG/0.5 ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999009593,NAFCILLIN DESENSITIZATION DILUTION 0.001 MG/ML,101.3,60.78,0.1125,4481.0,24 NDC,09999009726,STUDY IRB# 19-2343 PROGESTERONE 200 MG / ESTRADIOL 2 MG / PLACEBO CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999009731,STUDY FLOW/NN9535-4321 SEMAGLUTIDE 2 MG/1.5 ML OR PLACEBO SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,24 NDC,09999009736,STUDY DF-HCC-20-166 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999009737,STUDY DF-HCC-20-166 SACITUZUMAB GOVITECAN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5859.42,35 NDC,09999009744,STUDY A031801-CIRB CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,26 NDC,09999009745,STUDY A031801-CIRB CABOZANTINIB 60 MG TABLET,0.2,0.12,0.0464,4481.0,26 NDC,09999009758,STUDY EAA173CIRB DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION,0.2,0.12,0.0506,8673.0,35 NDC,09999009765,STUDY GS-US-546-5857 MAGROLIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999009781,STUDY ION-682884-CS3 ISIS 420915 (INOTERSEN) SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009782,STUDY ION-682884-CS3 ION-682884 150 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009811,STUDY COFAR-11 OPEN OFC ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009812,STUDY COFAR-11 IDE RESCUE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009813,STUDY COFAR-11 BUILD-UP/MAINTENANCE RESCUE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009814,STUDY COFAR-11 BLINDED DBPCFC ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009815,STUDY COFAR-11 BLINDED IDE ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009816,STUDY COFAR-11 BLINDED BUILD-UP/MAINTENANCE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009819,STUDY COFAR-11 MAINTENANCE ONLY RESCUE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009820,STUDY COFAR-11 BLINDED MAINTENANCE OIT ALLERGEN KITS,0.2,0.12,0.0464,4481.0,22 NDC,09999009823,STUDY ION-682884-CS2 (CARDIO-TTRANSFORM) ION-682884/PLACEBO SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009824,"STUDY ION-682884-CS2 (CARDIO-TTRANSFORM) VITAMIN A 3,000 MCG (10,000 IU) CAPSULE",0.2,0.12,0.0464,4481.0,24 NDC,09999009826,STUDY ALXN1210-NEPH-202 RAVULIZUMAB (ALXN1210)/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,36062.04,35 NDC,09999009827,STUDY ALXN1210-NEPH-202 MENINGOCOCCAL CONJUGATE (MENACTRA) INTRAMUSCULAR SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999009828,STUDY ALXN1210-NEPH-202 MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999009829,STUDY ALXN1210-NEPH-202 PNEUMOCOCCAL 13-VAL CONJ VACCINE,0.2,0.12,0.0464,4481.0,26 NDC,09999009837,STUDY ALXN1210-NEPH-202 HAEMOPHILUS B POLYSACCHARID CONJ-TETANUS TOX VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999009841,STUDY RPC-1063-MS-001 OZANIMOD 0.25 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999009842,STUDY RPC-1063-MS-001 OZANIMOD 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999009843,STUDY D3251C00014 RESOLUTE BENRALIZUMAB/PLACEBO 100 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999009851,COLCHICINE 0.3 MG SPLIT TABLET,43.9,26.34,10.18,4481.0,19 NDC,09999009853,METHIMAZOLE 2.5 MG SPLIT TABLET,16.15,9.69,3.75,4481.0,19 NDC,09999009854,STUDY IND IRB# 21-1333 AT-007 200 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 NDC,09999009855,STUDY C3671008 RESPIRATORY SYNCYTIAL VIRUS (RSV)/PLACEBO VACCINE,0.2,0.12,0.0464,4481.0,22 NDC,09999009860,STUDY IND IRB# 21-1333 AT-007 ORA-PLUS COMPOUNDING VEHICLE SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,09999009861,STUDY SB2640-CLIN-007 TVB-2640 25 MG/50 MG/PLACEBO TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009864,STUDY CEGIR 7810 DEGAS UNC IRB#21-0025 DUPILUMAB/PLACEBO 150 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009865,STUDY CEGIR 7810 DEGAS UNC IRB#21-0025 DUPILUMAB 150 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999009867,HYDROCODONE-HOMATROPINE 5 MG-1.5 MG/5 ML (5 ML) ORAL SOLUTION,24.25,14.55,5.63,4481.0,19 NDC,09999009868,STUDY CQGE031G12301 LIGELIZUMAB/PLACEBO 120 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999009869,"HYALURONIDASE, HUMAN RECOMBINANT 15 UNIT/ML (DILUTION) INJECTION",59.55,35.73,0.81,4481.0,24 NDC,09999009871,STUDY ALXN1210-NEPH-202 PNEUMOCOCCAL 23 POLYVALENT VACCINE,0.2,0.12,0.0464,4481.0,26 NDC,09999009877,STUDY NOVAVAX 2019NCOV-301 SARS-COV-2 RS WITH MATRIX-M1 VACCINE,0.2,0.12,0.0464,4481.0,17 NDC,09999009878,STUDY IRB# 21-1548 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 NDC,09999009879,STUDY IRB# 21-1689 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 NDC,09999009884,STUDY LCCC1944 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,35 NDC,09999009885,STUDY LCCC1944 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,35 NDC,09999009890,STUDY NCI-10434-CIRB POMALIDOMIDE 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999009891,STUDY NCI-10434-CIRB POMALIDOMIDE 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999009898,STUDY LP-118-US-I01 LP-118 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009899,STUDY LP-118-US-I01 LP-118 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009911,STUDY LCCC2047 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999009912,STUDY LCCC2047 OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,20 NDC,09999009913,STUDY LCCC2047 OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,20 NDC,09999009916,STUDY IND OBINUTUZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11677.68,35 NDC,09999009917,STUDY IND GLOFITAMAB 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,453849.27,35 NDC,09999009919,STUDY LCCC1915 PERFLUTREN LIPID MICROSPHERES INTRAVENOUS SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,09999009920,STUDY R5458-ONC-2012 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999009921,STUDY R5458-ONC-2012 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999009926,STUDY TBCRC-053 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999009927,STUDY HCRN-AML20-472 TAGRAXOFUSP 100 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,55411.65,35 NDC,09999009929,STUDY A051902-CIRB CC-486 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009930,STUDY A051902-CIRB CC-486 150 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009932,STUDY A051902-CIRB DUVELISIB 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999009933,STUDY A051902-CIRB DUVELISIB 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999009934,STUDY AFT-41 LENALIDOMIDE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999009935,STUDY AFT-41 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8673.0,35 NDC,09999009936,STUDY 56021927PCR3011 APALUTAMIDE 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009937,STUDY LCCC2117 TRILACICLIB 15 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999009938,STUDY LCCC2036 ONC201 125 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999009939,STUDY LCCC2036 ATEZOLIZUMAB 60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999009940,STUDY LCCC2036 ATEZOLIZUMAB 60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999009941,STUDY LOXO-NGR-21001 LOXO-260 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999009942,STUDY LOXO-NGR-21001 LOXO-260 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999009946,STUDY 20200469 TARLATAMAB 0.9 MG/ML INTRAVENOUS SOLUTION (1 MG VIAL),0.2,0.12,0.0506,257101.53,35 NDC,09999009948,STUDY 20200469 TARLATAMAB 2.4 MG/ML INTRAVENOUS SOLUTION (10 MG VIAL),0.2,0.12,0.0506,257101.53,35 NDC,09999009949,STUDY 20200469 TARLATAMAB 4.8 MG/ML INTRAVENOUS SOLUTION (25 MG VIAL),0.2,0.12,0.0506,257101.53,35 NDC,09999009951,STUDY DSP-5336-101 DSP-5336 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999009952,STUDY INCB57643-103 RUXOLITINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010000,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION PEDS 100 ML,98.0,58.8,0.0675,4481.0,24 NDC,09999010022,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 100 ML,98.0,58.8,0.0675,4481.0,24 NDC,09999010432,STUDY NN9389-4606 UNC IRB#21-2634 SEMAGLUTIDE/PLACEBO 2 MG/1.5 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 NDC,09999010433,STUDY NN9389-4606 UNC IRB#21-2634 SEMAGLUTIDE/PLACEBO 3.0 MG/ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 NDC,09999010434,STUDY NN9389-4606 UNC IRB#21-2634 NNC0480-0389/PLACEBO 10 MG/ML CARTRIDGE,0.2,0.12,0.0464,4481.0,26 NDC,09999010435,STUDY NN9389-4606 UNC IRB#21-2634 NNC0480-0389/PLACEBO 30 MG/ML CARTRIDGE,0.2,0.12,0.0464,4481.0,26 NDC,09999010436,STUDY PEEPS UNC IRB# 21-2230 ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 NDC,09999010437,STUDY PEEPS UNC IRB# 21-2230 PROGESTERONE 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999010443,STUDY IND TECOVIRIMAT SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999010447,METHIMAZOLE 3 MG/ML ORAL SUSPENSION,25.3,15.18,5.87,4481.0,24 NDC,09999010450,STUDY ARC008 IDE AR101 PEANUT PROTEIN KIT,0.2,0.12,0.0464,4481.0,22 NDC,09999010451,STUDY ARC008 MAINTENANCE AR101 PEANUT PROTEIN KIT,0.2,0.12,0.0464,4481.0,22 NDC,09999010452,STUDY ARC008 DOSE BUILD-UP AR101 PEANUT PROTEIN KIT,0.2,0.12,0.0464,4481.0,22 NDC,09999010453,STUDY ARC008 OLFC PEANUT FLOUR PACKET,0.2,0.12,0.0464,4481.0,22 NDC,09999010454,STUDY ARC008 DBPCFC PEANUT/PLACEBO PACKET,0.2,0.12,0.0464,4481.0,22 NDC,09999010459,CLOBAZAM 5 MG SPLIT TABLET,24.0,14.4,5.57,4481.0,19 NDC,09999010460,CLOBAZAM 2.5 MG SPLIT TABLET,23.0,13.8,5.34,4481.0,19 NDC,09999010461,STUDY RM-493-035 SETMELANOTIDE/PLACEBO 10 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999010462,STUDY SP-1011-004 APT-1011 3 MG ORALLY DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010469,STUDY ALXN2050-MG-201 ALXN2050/PLACEBO 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010470,STUDY ALXN2050-MG-201 ALXN2050 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010471,STUDY ALXN2050-MG-201 MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999010472,STUDY ALXN2050-MG-201 MENINGOCOCCAL CONJUGATE (MENACTRA) VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999010476,STUDY 64407564MMY3002 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 NDC,09999010477,STUDY 64407564MMY3002 TALQUETAMAB 2 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,11455.71,35 NDC,09999010482,STUDY NANORAY312 CETUXIMAB 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11827.62,35 NDC,09999010484,STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010485,STUDY DF-HCC-20-347-ADEPT TRASTUZUMAB 21 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,11339.58,35 NDC,09999010486,"STUDY DF-HCC-20-347-ADEPT TRASTUZUMAB 600 MG-HYALURONIDASE 10,000 UNITS/5 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10297.35,35 NDC,09999010487,"STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURONIDASE 30,000 UNITS/15 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 NDC,09999010488,"STUDY DF-HCC-20-347-ADEPT PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONIDASE 20,000 UNITS/10 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 NDC,09999010489,STUDY GCT1046-01 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999010492,STUDY 64407564MMY3002 TALQUETAMAB 40 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,11455.71,35 NDC,09999010493,STUDY IND MAGROLIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999010520,"STUDY NRG-GY026-CIRB TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNITS/5 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10297.35,35 NDC,09999010521,"STUDY NRG-GY026-CIRB PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURONIDASE-ZZXF 30,000 UNITS/15 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 NDC,09999010522,"STUDY NRG-GY026-CIRB PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONIDASE-ZZXF 20,000 UNITS/10 ML SUBCUTANEOUS SOLUTION",0.2,0.12,0.0506,10310.58,35 NDC,09999010523,STUDY IND DSP-0509 0.3 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999010550,STUDY NN9535-4984 SEMAMAX SEMAGLUTIDE B/PLACEBO 9.6 MG/ML CARTRIDGE,0.2,0.12,0.0464,4481.0,24 NDC,09999010551,STUDY 6058-SCD-101 FTX-6058 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999010552,STUDY 6058-SCD-101 FTX-6058 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999010553,STUDY INFLAMMATION AND SOCIAL BEHAVIOR IRB# 22-1024 FLU VACCINE/PLACEBO (QS 2023-24 6 MO UP),0.2,0.12,0.0464,4481.0,26 NDC,09999010554,STUDY SKOAP IRB# 22-1526 BUPIVACAINE LIPSOME(PF) 1.3 % (13.3 MG/ML) SUSPENSION,0.2,0.12,0.0506,4481.0,34 NDC,09999010557,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 1 MG/ML + 0.5 MG/ML, CAGRILINTIDE 1 MG/ML, SEMAGLUTIDE 0.5 MG/ML OR PLACEBO PEN",0.2,0.12,0.0464,4481.0,22 NDC,09999010558,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 2 MG/ML + 1 MG/ML, CAGRILINTIDE 2 MG/ML, SEMAGLUTIDE 1 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 NDC,09999010559,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 4 MG/ML + 2 MG/ML, CAGRILINTIDE 4 MG/ML, SEMAGLUTIDE 2 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 NDC,09999010560,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 9.6 MG/ML + 4.8 MG/ML, CAGRILINTIDE 9.6 MG/ML, SEMAGLUTIDE 4.8 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 NDC,09999010561,"STUDY NN9838-4608 IRB# 22-1990 CAGRISEMA 6.8 MG/ML + 3.4 MG/ML, CAGRILINTIDE 6.8 MG/ML, SEMAGLUTIDE 3.4 MG/ML OR PLACEBO",0.2,0.12,0.0464,4481.0,22 NDC,09999010562,STUDY IM011134 IRB# 22-2162 DEUCRAVACITINIB/PLACEBO 6 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999010563,STUDY PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010564,STUDY M21-471 IRB# 22-0783 ONABOTULINUMTOXINA/PLACEBO 50 UNIT/ML SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999010596,STUDY CC-93538-EE-002 CC-93538 360 MG/2 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999010597,STUDY LIDOCAINE 1% INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010598,STUDY I6T-MC-AMAX MIRIKIZUMAB 300 MG/3 ML PRE-FILLED SYRINGE KIT,0.2,0.12,0.0506,7785.12,35 NDC,09999010599,STUDY AEZS-130-P02 DETECT CLONIDINE 0.75 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010600,STUDY AEZS-130-P02 DETECT ARGININE HCL (L-ARGININE) 10 % INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010602,STUDY AEZS-130-P02 DETECT MACIMORELIN 0.5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010603,STUDY MENINGOCOCCAL CONJUGATE (MENVEO) VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999010604,STUDY ADRN-12 IRB# 22-1668 VANICREAM MOISTURIZER,0.2,0.12,0.0464,4481.0,24 NDC,09999010605,STUDY ADRN-12 IRB# 22-1668 HYDROCORTISONE 2.5 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 NDC,09999010606,STUDY ADRN-12 IRB# 22-1668 TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 NDC,09999010607,STUDY ADRN-12 IRB# 22-1668 DUPILUMAB 300 MG/2 ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999010608,STUDY ADRN-12 IRB# 22-1668 DUPILUMAB 200 MG/1.14 ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999010610,STUDY 718-CIH-201 IRB# 22-0706 SAGE-718/PLACEBO 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999010611,STUDY 718-CIH-201 IRB# 22-0706 SAGE-718/PLACEBO 0.9 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999010612,STUDY 718-CIH-201 IRB# 22-0706 SAGE-718/PLACEBO 1.2 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999010614,STUDY LYR-220-2021-001 BEACON IRB# 22-0807 LYR-220-16 SYSTEM (MOMETASONE FUROATE/PLACEBO),0.2,0.12,0.0464,4481.0,22 NDC,09999010615,STUDY LCCC2119 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,35 NDC,09999010616,STUDY LCCC2119 ISATUXIMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,12906.6,35 NDC,09999010622,STUDY NRG-HN005-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010623,STUDY PBI-MST-01 PEMBROLIZUMAB 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999010624,STUDY PBI-MST-01 MK-0482 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999010625,STUDY PBI-MST-01 MK-4830 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999010626,STUDY PBI-MST-01 CIVO GLO YELLOW 400 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999010627,STUDY PBI-MST-01 CIVO GLO RED 400 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999010628,STUDY TBCRC-047 SACITUZUMAB GOVITECAN 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5859.42,35 NDC,09999010629,STUDY 20200469 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 NDC,09999010632,STUDY NX-1607-101 NX-1607 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999010633,STUDY NX-1607-101 NX-1607 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999010634,STUDY GOG-3078-GLORIOSA MIRVETUXIMAB SORAVTANSINE 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,11142.6,35 NDC,09999010645,STUDY S1925 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 NDC,09999010646,STUDY S1925 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010647,STUDY S1925 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010648,STUDY S1925 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010649,STUDY LCCC2115-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999010651,STUDY A051901-CIRB LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999010652,STUDY A051901-CIRB LENALIDOMIDE 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999010653,STUDY A051901-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010656,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010657,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 5 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010658,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 1 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010659,STUDY R668-BP-1902 IRB# 22-1408 PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010660,STUDY R668-BP-1902 IRB# 22-1408 DUPILUMAB/PLACEBO 300 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999010662,STUDY EVOLVE-MI IRB# 22-1820 EVOLOCUMAB 140 MG/ML SUBCUTANEOUS PEN INJECTOR,0.2,0.12,0.0464,4481.0,26 NDC,09999010665,STUDY HBS-101-CL IRB# PITOLISANT 4.45 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999010666,STUDY HBS-101-CL-005 IRB# PITOLISANT 17.8 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999010671,STUDY GS-US-563-6041 IRB# 21-2334 LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999010672,STUDY GS-US-563-6041 IRB# 21-2334 ISLATRAVIR 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999010673,STUDY GS-US-563-6041 IRB# 21-2334 BICTEGRAVIR 50 MG/EMTRICITABINE 200 MG/TENOFOVIR 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999010674,STUDY CS1-003 CS1 (SODIUM VALPROATE) 160 MG DELAYED-RELEASE CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999010677,STUDY HBS-101-CL-005 IRB# PITOLISANT/PLACEBO TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999010679,STUDY INCB 18424-220 IRB# 22-2205 RUXOLITINIB 1.5%/PLACEBO CREAM,0.2,0.12,0.0464,4481.0,24 NDC,09999010682,STUDY HMI-203-101 IRB# 22-0517 HMI-203 VECTOR GENOMES (+/-) INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999010683,"STUDY TACROLIMUS XL 0.5 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 NDC,09999010684,"STUDY TACROLIMUS XL 1 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 NDC,09999010685,"STUDY TACROLIMUS XL 5 MG CAPSULE, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 NDC,09999010686,"STUDY TACROLIMUS XR 0.75 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 NDC,09999010687,"STUDY TACROLIMUS XR 1 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 NDC,09999010688,"STUDY TACROLIMUS XR 4 MG TABLET, EXTENDED RELEASE 24 HR",0.2,0.12,0.0464,4481.0,24 NDC,09999010689,STUDY INCB 18424-220 IRB# 22-2205 RUXOLITINIB 1.5% CREAM,0.2,0.12,0.0464,4481.0,24 NDC,09999010690,STUDY A011-13 HYPERION SOTATERCEPT/PLACEBO 50 MG/ML (0.3 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010691,STUDY A011-13 HYPERION SOTATERCEPT/PLACEBO 50 MG/ML (0.7 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010692,STUDY DEXAMETHASONE 6 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010693,STUDY DEXAMETHASONE 4 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010694,STUDY DEXAMETHASONE 2 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010695,STUDY DEXAMETHASONE 1.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010696,STUDY DEXAMETHASONE 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010697,STUDY ARGX-117-2002 ARGX-113/PLACEBO 120 MG/ML VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999010698,STUDY MENINGOCOCCAL B (BEXSERO) VACCINE,0.2,0.12,0.0464,4481.0,25 NDC,09999010699,STUDY D5244C00001 TEZEPELUMAB/PLACEBO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999010700,STUDY D5244C00001 TEZEPELUMAB 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999010701,STUDY C4671026 PF-07321332 (NIRMATRELVIR) 150 MG/RITONAVIR 100 MG POWDER,0.2,0.12,0.0464,4481.0,22 NDC,09999010726,HYDROMORPHONE 500MG/50 ML (10MG/ML) PCA CADD,283.9,170.34,0.2025,4481.0,24 NDC,09999010731,STUDY 1042-SE-3003 GANAXOLONE 1 MG/ML OR PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0225,4481.0,24 NDC,09999010734,STUDY ABX NAIL IRB# 23-0204 VANCOMYCIN 1 GRAM VIAL,0.2,0.12,0.0225,4481.0,24 NDC,09999010735,STUDY ABX NAIL IRB# 23-0204 GENTAMICIN 80 MG/2 ML VIAL,0.2,0.12,0.0225,4481.0,24 NDC,09999010744,STUDY AL001-3 AL001 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999010745,STUDY SEXTANT IRB# 22-2127 VANCOMYCIN 1000 MG POWDER,0.2,0.12,0.0464,4481.0,24 NDC,09999010746,STUDY SEXTANT IRB# 22-2127 TOBRAMYCIN 1.2 GRAM POWDER,0.2,0.12,0.0464,4481.0,24 NDC,09999010748,STUDY NCI-10464-CIRB OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,20 NDC,09999010749,STUDY NCI-10464-CIRB OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,20 NDC,09999010753,STUDY CO43613 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999010755,STUDY CO43613 PACLITAXEL 6 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999010756,STUDY CO43613 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010759,STUDY EA9181-CIRB BLINATUMOMAB 12.5 MCG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,24925.32,35 NDC,09999010768,STUDY IND TARLATAMAB 0.9 MG/ML INTRAVENOUS SOLUTION (1 MG VIAL),0.2,0.12,0.0506,257101.53,35 NDC,09999010769,STUDY IND TARLATAMAB 2.4 MG/ML INTRAVENOUS SOLUTION (10 MG VIAL),0.2,0.12,0.0506,257101.53,35 NDC,09999010771,STUDY IND NIROGACESTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999010774,STUDY M24-108 ETENTAMIG (ABBV-383) 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999010776,STUDY FLUTE-3 SP-1011-005 APT-1011 3 MG ORALLY DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010777,STUDY FLUTE-3 SP-1011-005 APT-1011/PLACEBO 3 MG ORALLY DISINTEGRATING TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010779,STUDY DRCR AF FENOFIBRATE/PLACEBO 160 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010780,STUDY DRCR AF FENOFIBRATE/PLACEBO 54 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010781,STUDY LCCC2139 IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999010782,STUDY BAYER 22186 EFFEKTOR FINERENONE BAY 94-8862/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010785,STUDY IND JZP150 IRB# 22-3339 JZP150 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999010787,STUDY FLUTE-3 SP-1011-005 COSYNTROPIN 0.25 MG/ML INJECTION VIAL,0.2,0.12,0.0464,4481.0,24 NDC,09999010814,STUDY A011-12 SOTERIA SOTATERCEPT/PLACEBO 50 MG/ML (0.3 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010815,STUDY A011-12 SOTERIA SOTATERCEPT/PLACEBO 50 MG/ML (0.7 MG/KG) INJECTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010816,STUDY ALE10 (DIVERT) VOCLOSPORIN/PLACEBO 7.9 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999010817,STUDY ALE10 (DIVERT) MYCOPHENOLATE MOFETIL (MMF)/PLACEBO 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999010819,STUDY ALE10 (DIVERT) METHYLPREDNISOLONE ACETATE 80 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0506,4481.0,35 NDC,09999010820,STUDY ALE10 (DIVERT) TRIAMCINOLONE ACETONIDE 40 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0464,4481.0,24 NDC,09999010834,STUDY 1042-TSC-3002 GANAXOLONE 50 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 NDC,09999010844,STUDY CABL001AUS08 ASCIMINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999010857,STUDY GCT1046-01 CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010858,STUDY GCT1046-01 CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999010859,STUDY GCT1046-01 PEMETREXED 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999010861,STUDY GCT1046-01 NAB-PACLITAXEL 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999010862,STUDY GCT1046-01 PACLITAXEL 6 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999010864,STUDY NCI10522-CIRB CA-4948 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010867,STUDY SGNTV-001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010868,STUDY SGNTV-001 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010869,STUDY R5458-ONC-2012 REGN5458 (LINVOSELTAMAB) 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999010870,STUDY R5458-ONC-2012 NIROGACESTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999010871,STUDY AZ D5985C00006 HFO/HFA MDI INHALER,0.2,0.12,0.0464,4481.0,19 NDC,09999010874,STUDY V712-306 VITESSE DBV712 (VIASKIN)/PLACEBO 250 MICROGRAM PATCH,0.2,0.12,0.0464,4481.0,19 NDC,09999010875,STUDY HYDROCORTISONE 2.5% OINTMENT,0.2,0.12,0.0464,4481.0,19 NDC,09999010877,"STUDY BEST TRIAL UNC IRB# 21-3271 DULOXETINE 30 MG CAPSULE, DELAYED RELEASE",0.2,0.12,0.0464,4481.0,19 NDC,09999010880,STUDY A5415 CENICRIVIROC MESYLATE (CVC)/PLACEBO 150 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010885,STUDY J3E-MC-EZDB LY3540378 20 MG/ML OR PLACEBO SYRINGE/VIAL,0.2,0.12,0.0225,4481.0,24 NDC,09999010889,STUDY ICI-M 1201 ABATACEPT/PLACEBO 25 MG/ML INJECTION,0.2,0.12,0.0225,4481.0,24 NDC,09999010890,STUDY BP41315 ALOGABAT 3 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010891,STUDY BP41315 ALOGABAT 4 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010892,STUDY BP41315 ALOGABAT 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010893,STUDY BP41315 ALOGABAT 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010894,STUDY 230LE301 BIIB059/PLACEBO 150 MG/ML SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010901,STUDY EIND 167902 V-073 (POCAPAVIR) GRANULATED POWDER,0.2,0.12,0.0225,4481.0,24 NDC,09999010904,STUDY B7981040 RITLECITINIB 50 MG/PLACEBO CAPSULES,0.2,0.12,0.0225,4481.0,24 NDC,09999010910,STUDY EIP21-NFD-504 NEFLAMAPIMOD/PLACEBO 40 MG CAPSULE,0.2,0.12,0.0225,4481.0,24 NDC,09999010911,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 1,0.2,0.12,0.0225,4481.0,24 NDC,09999010912,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 2,0.2,0.12,0.0225,4481.0,24 NDC,09999010913,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 3,0.2,0.12,0.0225,4481.0,24 NDC,09999010914,STUDY AGLE-102-102 AGLE-102 NANOPARTICLE SUSPENSION WOUND 4,0.2,0.12,0.0225,4481.0,24 NDC,09999010915,STUDY AP-SA02-101 LOW DOSE 1X10E9 PFU/DOSE OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010916,STUDY AP-SA02-101 HIGH DOSE 1X10E10 PFU/DOSE OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010918,STUDY EX6018-4758 ZILTIVEKIMAB C 30 MG/ML OR PLACEBO PFS 0.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999010922,STUDY PTK0796-NTM-20203 OMADACYCLINE (PTK 0796) 150 MG/PLACEBO TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010923,STUDY 218672 GSK4532990 100 MG/200 MG OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010924,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (16.6 MG/0.416 ML) PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999010925,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (23 MG/0.574 ML) PRE-FILLE,0.2,0.12,0.0464,4481.0,17 NDC,09999010926,STUDY MG0011 ZILUCOPLAN (RA101495) 40 MG/ML (32.4 MG/0.810 ML) PRE-FIE,0.2,0.12,0.0464,4481.0,17 NDC,09999010927,STUDY MG0011 MENVEO 0.5 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999010928,STUDY MG0011 BEXSERO 0.5 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999010929,STUDY IRB# 23-0632 DEXTROSE 20% INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999010931,STUDY 1346-0014 BI 425809 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010932,STUDY EXE A841790 EXE-346 1500 X 10^9 CFU SACHET,0.2,0.12,0.0464,4481.0,22 NDC,09999010934,STUDY 19-0021 CRS3123 200 MG/400 MG/VANCOMYCIN 125 MG/PLACEBO CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999010938,STUDY GBT021601-021 GBT021601 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010939,STUDY GBT021601-021 GBT021601 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010940,FOSPHENYTOIN IV 500 MG PE NS 50 ML INFUSION (TOTAL VOLUME 67 ML),231.05,138.63,5.89,4481.0,24 NDC,09999010943,STUDY TAK-609-5005 IDURSULFASE INTRATHECAL 10 MG/ML SYRINGE,0.2,0.12,0.0506,81999.54,35 NDC,09999010944,STUDY ALXN1210-MG-319 RAVULIZUMAB (ALXN1210) 100 MG/ML INJECTION SOLUTION,0.2,0.12,0.0506,81999.54,35 NDC,09999010945,STUDY A5374 CHADOX1.THIVCONSV1 2.5 X 10E10 VP OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010946,STUDY A5374 CHADOX1.HIVCONSV62 2.5 X 10E10 VP OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010947,STUDY A5374 MVA.THIVCONSV3 1 X 10E8 PFU OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010948,STUDY A5374 MVA.THIVCONSV4 0.9 X 10E8 PFU OR PLACEBO SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010949,STUDY A5374 VES OR PLACEBO 2 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999010951,STUDY A5374 GS-5423 150 MG/ML OR PLACEBO INJECTION,0.2,0.12,0.0506,81999.54,35 NDC,09999010952,STUDY A5374 GS-2872 150 MG/ML OR PLACEBO INJECTION,0.2,0.12,0.0506,81999.54,35 NDC,09999010963,STUDY AP-SA02-101 HIGH DOSE 4X10E10 PFU (2X10E10 PFU/PHAGE) OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999010964,STUDY IRB# 23-2111 RIFAXIMIN 550 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999010974,STUDY ION-682884-CS12 (CARDIO-TTRANSFORM) ION-682884 SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999010975,"STUDY ION-682884-CS12 (CARDIO-TTRANSFORM) VITAMIN A 3,000 MCG (10,000E",0.2,0.12,0.0464,4481.0,24 NDC,09999010976,STUDY ION-682884-CS12 (CARDIO-TTRANSFORM) ION-682884 AUTO-INJECTOR,0.2,0.12,0.0464,4481.0,22 NDC,09999011001,STUDY R5458-ONC-2012 NIROGACESTAT 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011004,STUDY NCI-10538 ASTX727 (CEDAZURIDINE 100 MG-DECITABINE 35 MG) TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011005,STUDY NCI-10538 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011006,STUDY NCI-10538 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011007,STUDY NCI-10538 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011008,STUDY FP2CLI004 BEXMARILIMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011009,STUDY MGT-AQP1-201 GLYCOPYRROLATE 0.2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011010,STUDY MGT-AQP1-201 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999011011,STUDY MGT-AQP1-201 TMN200P DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011012,STUDY MGT-AQP1-201 AAV2-HAQP1/TMN200P SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011013,STUDY FX-909-CLINPRO-1 FX-909 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011014,STUDY FX-909-CLINPRO-1 FX-909 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011015,STUDY CO44668 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999011016,STUDY CO44668 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,35 NDC,09999011017,STUDY CO44668 TIRAGOLUMAB / PLACEBO 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999011018,STUDY LOXO-RAS-20001 LY3537982 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011019,STUDY LOXO-RAS-20001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999011020,STUDY LCCC2032 SODIUM BUTYRATE/SODIUM PROPIONATE (SCFA) OR PLACEBO ORAL POWDER,0.2,0.12,0.0464,4481.0,22 NDC,09999011042,STUDY EX6018-4915 ZILTIVEKIMAB B/PLACEBO 15 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999011046,STUDY IRB# 21-1689 SEMAGLUTIDE/PLACEBO 2 MG/3 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 NDC,09999011047,STUDY IRB# 21-1548 SEMAGLUTIDE/PLACEBO 2 MG/3 ML (MULTI-DOSE) SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,19 NDC,09999011052,STUDY DNLI-E-0007 DNL310 OR IDURSULFASE IVPB,0.2,0.12,0.0464,4481.0,17 NDC,09999011061,STUDY 20604 BAY 2433334 ASUNDEXIAN/PLACEBO 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011067,STUDY ALE10 (DIVERT) TRIAMCINOLONE ACETONIDE 80 MG/ML SUSPENSION FOR INJ,0.2,0.12,0.0464,4481.0,24 NDC,09999011080,STUDY A032103-CIRB RELATLIMAB (BMS-986016) 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011081,STUDY A032103-CIRB NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5024.46,35 NDC,09999011088,STUDY PROFFI FISETIN / PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,20 NDC,09999011089,STUDY RC48G001 DISITAMAB VEDOTIN 7.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011090,STUDY RC48G001 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011095,STUDY BO45217 SOTORASIB 120 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011096,STUDY BO45217 ADAGRASIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011100,STUDY SER-155-01 VANCOMYCIN / PLACEBO 125 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999011102,STUDY SER-155-01 SER-155 / PLACEBO PART 2 (3.1 X 10E7 CFU) CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011105,STUDY PT217X1101 PT217 15 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011106,STUDY PT217X1101 PT217 0.5 MG/ML IV SYRINGE OR IVPB,0.2,0.12,0.0464,4481.0,22 NDC,09999011107,STUDY LCCC2060-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011110,STUDY A22-203 ROPEGINTERFERON ALFA-2B-NJFT 500 MCG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,09999011111,STUDY R1979-HM-2298 ODRONEXTAMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011112,STUDY R1979-HM-2298 ODRONEXTAMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011113,STUDY OSU-22114 TAFASITAMAB 40 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011114,STUDY TSCAN-002 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011115,STUDY TSCAN-002 FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 NDC,09999011119,STUDY EGFR-008-001 JANX008 0.05 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011120,STUDY P-CD19CD20-ALLO1-001 RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011121,STUDY EGFR-008-001 JANX008 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011122,STUDY CA0611001 (23-1564) FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 NDC,09999011123,STUDY CA0611001 (23-1564) CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011124,STUDY CA0611001 (23-1564) TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011127,STUDY LCCC2032 SODIUM BUTYRATE/SODIUM PROPIONATE (SCFA) ORAL POWDER,0.2,0.12,0.0464,4481.0,22 NDC,09999011128,STUDY LOXO-RAS-20001 PEMETREXED 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011129,STUDY LOXO-RAS-20001 CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011130,STUDY LOXO-RAS-20001 CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011131,STUDY CAB-201-001 (23-2231) FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 NDC,09999011132,STUDY CAB-201-001 (23-2231) CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999011133,STUDY CAB-201-001 (23-2231) TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011134,STUDY ISB2001-101 ISB 2001 77 MG/ML (77000 MCG/ML) SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011135,STUDY ISB2001-101 ISB 2001 9.6 MG/ML (9600 MCG/ML) SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011136,STUDY ISB2001-101 ISB 2001 1 MG/ML (1000 MCG/ML) SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011138,STUDY R1979-HM-2298 RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 NDC,09999011139,"STUDY R1979-HM-2298 RITUXIMAB 1400 MG-HYALURONIDASE 23,400 UNITS/11.7N",0.2,0.12,0.0506,6141.66,35 NDC,09999011140,STUDY R1979-HM-2298 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999011141,STUDY HYDROCORTISONE 1 % TOPICAL OINTMENT,0.2,0.12,0.0464,4481.0,19 NDC,09999011142,STUDY D5180C00016 TEZEPELUMAB/PLACEBO 110 MG/ML SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011144,STUDY RNLC3132 IRB# 23-1481 RIFAXIMIN/PLACEBO 40 MG SDD-IR TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011160,(TAKE HOME) DOLUTEGRAVIR 50 MG TABLET,713.55,428.13,165.54,4481.0,19 NDC,09999011162,STUDY J2L-MC-EZBB LY3461767/PLACEBO 10 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 NDC,09999011163,STUDY ARGX-113-2007 EFGARTIGIMOD PH20/PLACEBO SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011169,STUDY DNLI-I-0001 DNL126 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011201,STUDY REM-PH-418 GLYCINE DILUENT INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011210,STUDY R1979-HM-2298 DOXORUBICIN 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011211,STUDY R1979-HM-2298 VINCRISTINE 1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011212,STUDY R1979-HM-2298 PREDNISONE 50 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,09999011213,STUDY R1979-HM-2298 BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011214,STUDY R1979-HM-2298 ALBUMIN HUMAN 5% IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011215,STUDY R1979-HM-2298 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011216,STUDY A052101-CIRB ZANUBRUTINIB 80 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011217,STUDY IND VORASIDENIB 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011218,STUDY IND VORASIDENIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011219,STUDY EMERALD-Y90 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,35 NDC,09999011221,STUDY EMERALD-Y90 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,13726.86,35 NDC,09999011223,STUDY SC9-GBM-03 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011224,STUDY SC9-GBM-03 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011225,STUDY SC9-GBM-03 PERFLUTREN LIPID MICROSPHERES IV SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,09999011226,STUDY SCCC-03121 CDX-1140 3 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011227,STUDY SCCC-03121 CDX-301 2500 MCG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011228,STUDY PRESERVE-006 ONC-392 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011229,STUDY IND MIRDAMETINIB 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011230,STUDY IND MIRDAMETINIB 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011234,STUDY D9470C00001 AZD9829 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011235,STUDY D9470C00001 STABILIZER SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011238,STUDY LCCC2223-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011244,STUDY NCI10596-CIRB SNDX-5613 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011245,STUDY NCI10596-CIRB SNDX-5613 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011246,STUDY NCI10596-CIRB SNDX-5613 113 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011250,STUDY M24-147 LIVMONIPLIMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011253,STUDY MK7240-001-01 MK-7240 (TULISOKIBART) 100 MG/ML SOLUTION FOR INFUSION,0.2,0.12,0.0464,4481.0,17 NDC,09999011254,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 1000 MG/500 MG IV INFUSION,0.2,0.12,0.0464,4481.0,17 NDC,09999011255,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 500 MG/250 MG IV INFUSION,0.2,0.12,0.0464,4481.0,17 NDC,09999011256,STUDY MK7240-001-01 MK-7240 (TULISOKIBART)/PLACEBO 200 MG/ML AUTO-INJECTOR,0.2,0.12,0.0464,4481.0,17 NDC,09999011257,STUDY HEALEY ALS PLATFORM REGIMEN G DNL343/PLACEBO 100 MG STICK,0.2,0.12,0.0464,4481.0,22 NDC,09999011272,"(TAKE HOME) NIRMATRELVIR 300 MG (150 MG X2)-RITONAVIR 100 MG TABLET,DOSE PACK",16.1,9.66,3.74,4481.0,19 NDC,09999011283,(TAKE HOME) MOLNUPIRAVIR 200 MG CAPSULE (EUA),16.05,9.63,3.72,4481.0,19 NDC,09999011290,STUDY D6970C00002 BAXDROSTAT/PLACEBO 1 MG/2 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011291,STUDY D6970C00002 BAXDROSTAT 2 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011300,STUDY M24-147 BUDIGALIMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011301,STUDY M24-147 LENVATINIB 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011302,STUDY M24-147 SORAFENIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011303,STUDY PT217X1101 PT217 0.5 MG/ML IVPB OVER 2 HOURS (DL 1 AND 2; DOSE 25-50 MG),0.2,0.12,0.0464,4481.0,22 NDC,09999011304,STUDY AC676-001 AC676 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011305,STUDY AC676-001 AC676 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011307,STUDY MSK-22-424 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 NDC,09999011308,STUDY BGB-11417-301 SONROTOCLAX 1 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011309,STUDY BGB-11417-301 SONROTOCLAX 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011310,STUDY BGB-11417-301 SONROTOCLAX 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011311,STUDY BGB-11417-301 SONROTOCLAX 80 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011312,STUDY BGB-11417-301 ZANUBRUTINIB 80 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011313,STUDY BGB-11417-301 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011314,STUDY BGB-11417-301 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011315,STUDY BGB-11417-301 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011316,STUDY BGB-11417-301 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 NDC,09999011320,STUDY TAPUR FUTIBATINIB 4 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999011321,STUDY AK117-205 AK117 (LIGUFALIMAB) / PLACEBO 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011322,STUDY AK117-205 AZACITIDINE 25 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011325,STUDY LOXO-RAS-20001 CETUXIMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,11827.62,35 NDC,09999011326,STUDY DFHCC-23-429 GLOFITAMAB 1 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 NDC,09999011327,STUDY DFHCC-23-429 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 NDC,09999011328,STUDY DFHCC-23-429 POLATUZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,21723.66,35 NDC,09999011329,STUDY DFHCC-23-429 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999011330,STUDY DFHCC-23-429 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011331,STUDY 61186372HNC2002 AMIVANTAMAB 160 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999011332,STUDY 61186372HNC2002 AMIVANTAMAB 160 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999011333,STUDY DB-1303-O-3002 DB-1303 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011334,STUDY IMGN151-1001 IMGN151 12 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011335,STUDY M22-574 ETENTAMIG (ABBV-383) 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011339,STUDY GFH009X2101 GFH009 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011340,STUDY DS3201-324 TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 NDC,09999011349,STUDY M23-732 RISANKIZUMAB 150 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011350,STUDY M23-732 RISANKIZUMAB 55 MG/0.37 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011351,STUDY M23-732 ADALIMUMAB 20 MG/0.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,30 NDC,09999011352,STUDY M23-732 ADALIMUMAB 40 MG/0.4 ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,30 NDC,09999011353,STUDY IRB# 21-2453 GOS/HGOS/PLACEBO 5 G SACHET KIT,0.2,0.12,0.0464,4481.0,17 NDC,09999011354,STUDY R668-EGE-2213 IRB# 22-2246 DUPILUMAB/PLACEBO 300 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999011357,STUDY IRB# 21-2453 GOS/HGOS/PLACEBO 7.5 G SACHET KIT,0.2,0.12,0.0464,4481.0,17 NDC,09999011358,STUDY LPS17558 IRB# 23-1878 DUPILUMAB/PLACEBO 300 MG/2 ML INJECTION,0.2,0.12,0.0464,4481.0,26 NDC,09999011359,STUDY LPS17558 IRB# 23-1878 DUPILUMAB 300 MG/2 ML INJECTION,0.2,0.12,0.0464,4481.0,26 NDC,09999011362,STUDY EFC14771 IRB# 23-2814 DUPILUMAB 300 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999011364,STUDY F901318/0041 AMPHOTERICIN B LIPOSOME 50 MG INTRAVENOUS SUSPENSION,0.2,0.12,0.0506,4481.0,35 NDC,09999011365,STUDY F901318/0041 OLOROFIM (F901318) 30 MG FILM COATED TABLET,0.2,0.12,0.0225,4481.0,21 NDC,09999011366,STUDY VX21-147-301 VX-147/PLACEBO 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011368,STUDY 1042-SE-3003 GANAXOLONE 1 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0225,4481.0,24 NDC,09999011373,STUDY IND 072807/171784/IRB# 24-0781 MAT2203 (AMPHOTERICIN B LNC) 20 MG/ML ORAL SUSPENSION,0.2,0.12,0.05544,4481.0,31 NDC,09999011374,STUDY FPA-AS-30094 FP/ABS EMDPI 30/117 MCG OR FP/ABS EMDPI 55/117 MCG OR ABS EMDPI 117 MCG INHALER,0.2,0.12,0.0464,4481.0,24 NDC,09999011375,STUDY FPA-AS-30094 ALBUTEROL SALBUTAMOL (PROAIR RESPICLICK) 117 MCG INHALER,0.2,0.12,0.0464,4481.0,24 NDC,09999011377,STUDY FPA-AS-30094 ALBUTEROL SULFATE MDI 90 MCG/ACTUATION INHALER,0.2,0.12,0.0464,4481.0,19 NDC,09999011378,STUDY GS-US-528-6020 LENACAPAVIR 309 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011379,STUDY GS-US-528-6020 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011380,STUDY GS-US-528-6020 LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011383,STUDY PIKASO METFORMIN/PLACEBO 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011386,STUDY IRB# 24-0191 ANIFROLUMAB-FNIA 150 MG/ML INTRAVENOUS INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011388,STUDY AMG 569 20230070 IRB# 24-0683 AVACOPAN 10 MG GELATIN CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999011389,STUDY AMG 569 20230070 IRB# 24-0683 AVACOPAN 3 MG/ML ORAL LIQUID,0.2,0.12,0.0464,4481.0,19 NDC,09999011390,STUDY PT-01 PEANUT 4320 DU SLIT-TABLET (PHASE 3 ONLY),0.2,0.12,0.0464,4481.0,17 NDC,09999011391,STUDY M23-784 RISANKIZUMAB/PLACEBO 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011392,STUDY M23-784 RISANKIZUMAB 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011396,STUDY PALV-09 IRB# 24-0156 PTX-022 3.9% W/W TOPICAL GEL,0.2,0.12,0.0464,4481.0,17 NDC,09999011397,STUDY IND 172688 CLOFAZIMINE 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011398,STUDY 718-CIH-301 SAGE-718 0.9 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011399,STUDY DS3201-324 VALEMETOSTAT 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011401,STUDY DS3201-324 VALEMETOSTAT 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011402,STUDY RP1-104 VUSOLIMOGENE ODERPAREPVEC 1 X 10E6 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011403,STUDY RP1-104 VUSOLIMOGENE ODERPAREPVEC 1 X 10E7 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011404,STUDY RP1-104 NIVOLUMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5024.46,35 NDC,09999011405,STUDY DS3201-324 DS-1062A (DATO-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011407,STUDY A062102-CIRB IBERDOMIDE 0.45 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011408,STUDY A062102-CIRB IBERDOMIDE 0.6 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011409,STUDY A062102-CIRB IBERDOMIDE 0.75 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011410,STUDY A062102-CIRB IBERDOMIDE 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011411,STUDY AAAU4206 ZIMBERELIMAB 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011412,STUDY AAAU4206 QUEMLICLUSTAT 12.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011413,STUDY AAAU4206 ETRUMADENANT 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011414,STUDY NX-1607-101 PACLITAXEL 6 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011415,STUDY NX-1607-101 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999011416,STUDY BDTX-1535-101 BDTX-1535 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011417,STUDY BDTX-1535-101 BDTX-1535 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011418,STUDY BAML16-001 S21 ZE46-0134 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011421,ALTEPLASE 10 MG/10 ML SYRINGE FOR IRRIGATION,2764.4,1658.64,91.62,4481.0,35 NDC,09999011422,STUDY BO45217 DIVARASIB 400 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999011424,STUDY LCCC2128-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011425,STUDY LCCC2152-ATL RIMIDUCID 5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011430,STUDY FPA-AS-30094 ALBUTEROL SULFATE 2.5 MG/3 ML (0.083%) SOLUTION FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 NDC,09999011432,STUDY HPTN 106 TENOFOVIR (TFV) RECTAL DOUCHE SACHET,0.2,0.12,0.0464,4481.0,19 NDC,09999011433,STUDY HPTN 106 EMTRICITABINE 200 MG-TENOFOVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011434,STUDY HPTN 106 SUPPLEMENTAL SUPPLIES,0.2,0.12,0.0464,4481.0,19 NDC,09999011435,STUDY NCI-10440-CIRB IXAZOMIB 2.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999011436,STUDY NCI-10440-CIRB IXAZOMIB 3 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999011437,STUDY NCI-10440-CIRB IXAZOMIB 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999011438,STUDY NCI-10440-CIRB VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011439,STUDY NCI-10440-CIRB VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011440,STUDY NCI-10440-CIRB VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011441,STUDY SMT112-3003 IVONESCIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011442,STUDY SMT112-3003 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011443,STUDY 1719-001 MRTX1719 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011444,STUDY 1719-001 MRTX1719 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011445,STUDY 1719-001 MRTX1719 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011447,STUDY GO44145-SKYGLO GLOFITAMAB 1 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 NDC,09999011448,STUDY GO44145-SKYGLO POLATUZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,21723.66,35 NDC,09999011449,STUDY GO44145-SKYGLO RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 NDC,09999011450,STUDY GO44145-SKYGLO TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011451,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011452,STUDY R10597-ONC-22114 REGN10597 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011453,STUDY R10597-ONC-22114 REGN10597 1 MG/ML IV SOLUTION (INTERMEDIATE DILUTION),0.2,0.12,0.0464,4481.0,22 NDC,09999011454,STUDY R10597-ONC-22114 REGN10597 SOLUTION STABILIZER,0.2,0.12,0.0464,4481.0,22 NDC,09999011455,STUDY OSU-23199 SNDX-5613 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011456,STUDY OSU-23199 SNDX-5613 113 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011457,STUDY ACCRU-LY-2201 EPCORITAMAB 0.16 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 NDC,09999011458,STUDY ACCRU-LY-2201 EPCORITAMAB 0.8 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 NDC,09999011459,STUDY ACCRU-LY-2201 EPCORITAMAB 60 MG/ML SOLUTION FOR INJECTION,0.2,0.12,0.0506,8980.23,35 NDC,09999011460,STUDY CELLULAR THERAPY PRODUCT INFUSION,0.2,0.12,0.0464,4481.0,17 NDC,09999011461,STUDY GENE THERAPY PRODUCT INFUSION,0.2,0.12,0.0464,4481.0,17 NDC,09999011462,STUDY IND MIFAMURTIDE 0.08 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011463,STUDY PBI-MST-01 RILVEGOSTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999011464,STUDY PBI-MST-01 VOLRUSTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999011465,STUDY PBI-MST-01 SABESTOMIG 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,09999011467,STUDY DFHCC-23-429 GLOFITAMAB 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,453849.27,35 NDC,09999011468,STUDY D798KC00001 CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011469,STUDY IND BAY2927088 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011471,STUDY S22-11168 ROPIDOXURIDINE 120 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011490,STUDY IMVT-1401-2401 BATOCLIMAB/PLACEBO 340 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999011491,STUDY IMVT-1401-2401 BATOCLIMAB 340 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,09999011496,STUDY AP-SA02-101 5X10E10 (2.5X10E10 PFU/PHAGE) OR PLACEBO IV SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,09999011497,STUDY 70033093AFL3002 JNJ-70033093 (MILVEXIAN)/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011498,STUDY 70033093AFL3002 APIXABAN/PLACEBO 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011499,STUDY 70033093AFL3002 APIXABAN/PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011501,PROCARBAZINE ORAL SUSPENSION (10 MG/ML),4192.0,2515.2,972.54,4481.0,19 NDC,09999011513,STUDY ARGX-113-2011 EFGARTIGIMOD PH20 SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011514,STUDY BT015 PERFLUTREN (DEFINITY) VIAL,0.2,0.12,0.0464,4481.0,23 NDC,09999011530,STUDY AK117-205 AK117 (LIGUFALIMAB) / PLACEBO 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011531,STUDY J3M-MC-JZQB CARBOPLATIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011532,STUDY J3M-MC-JZQB CISPLATIN 1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011533,STUDY J3M-MC-JZQB PEMETREXED 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011534,STUDY J3M-MC-JZQB PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999011535,STUDY 1463-0001 BI 765179 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011537,STUDY D798KC00001 MYCOPHENOLATE MOFETIL 500 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999011538,STUDY M20-356 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 NDC,09999011539,STUDY M20-356 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011540,STUDY M20-356 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011541,STUDY M20-356 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011542,STUDY 20230238 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011543,STUDY CAAA614A12101 NAB-PACLITAXEL 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011544,STUDY LBS-007-CT01 LBS-007 0.5 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011545,STUDY CAEL101-302 CAEL-101 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011546,STUDY R10597-ONC-22114 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011547,STUDY SMT112-3007 IVONESCIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011548,STUDY SMT112-3007 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011549,STUDY OSU-23199 SNDX-5613 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011550,STUDY OSU-23199 SNDX-5613 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011551,STUDY OSU-23199 SNDX-5613 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011552,STUDY OSU-23199 SNDX-5613 40 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011553,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011554,STUDY BAML16-001 S17 SNDX-5613 (REVUMENIB) 160 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011555,STUDY AC220-168 QUIZARTINIB/PLACEBO 20 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999011556,STUDY AC220-168 QUIZARTINIB/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999011557,STUDY CPI-818-004 SOQUELITINIB (CPI-818) 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011558,STUDY J3M-MC-JZQB OLOMORASIB (LY3537982)/PLACEBO 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011559,STUDY J3M-MC-JZQB OLOMORASIB (LY3537982)/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011560,STUDY D798KC00001 VOLRUSTOMIG 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011561,STUDY M22-574 BORTEZOMIB 1 MG/ML IV SYRINGE,0.2,0.12,0.0464,4481.0,24 NDC,09999011562,STUDY M22-574 BORTEZOMIB 2.5 MG/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,24 NDC,09999011563,STUDY M22-574 CARFILZOMIB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,7908.6,35 NDC,09999011564,STUDY M22-574 ELOTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011565,STUDY M24-064 TELISOTUZUMAB ADIZUTECAN (ABBV-400) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011566,STUDY M22-574 POMALIDOMIDE 4 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011567,STUDY M22-574 POMALIDOMIDE 3 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011568,STUDY 24-1476 DEXTROSE 20% INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011569,STUDY V712-306 VITESSE DBV712 (VIASKIN) 250 MICROGRAM PATCH,0.2,0.12,0.0464,4481.0,19 NDC,09999011570,STUDY CLINPRT-6 MBP091 (EAP) 50 MG/ML CONCENTRATE VIAL,0.2,0.12,0.0464,4481.0,17 NDC,09999011571,STUDY M22-574 POMALIDOMIDE 2 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011572,STUDY M22-574 POMALIDOMIDE 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011573,STUDY M22-574 SELINEXOR 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011574,STUDY M22-574 SELINEXOR 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011575,STUDY M22-574 SELINEXOR 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011585,STUDY M22-574 SELINEXOR 60 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011586,STUDY INBRX106-01-201 INBRX-106 0.1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011587,STUDY INBRX106-01-201 INBRX-106/PLACEBO 0.1 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011588,STUDY JNJ-90301900NSC2001 JNJ-90301900 54.2 G/L INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011588,STUDY JNJ-90301900NSC2001 JNJ-90301900 54.2 G/L PRIMING SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011589,STUDY MCLA-158-CL02 PETOSEMTAMAB (MCLA-158) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011601,STUDY 21820 BAY 3375968 50 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011602,STUDY 21820 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999011603,STUDY RPL-003-19 RP1 (VUSOLIMOGENE ODERPAREPVEC) 1 X 10E6 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011604,STUDY RPL-003-19 RP1 (VUSOLIMOGENE ODERPAREPVEC) 1 X 10E7 PFU/ML INTRATUMORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011605,STUDY MGT-AQP1-202 AAV2-HAQP1/TMN200P SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011607,STUDY MGT-AQP1-202 GLYCOPYRROLATE 0.2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011608,STUDY MGT-AQP1-202 PREDNISONE 10 MG TABLET,0.2,0.12,0.0225,4481.0,23 NDC,09999011651,STUDY DRI17476 FREXALIMAB/PLACEBO 150 MG/ML VIAL/SYRINGE,0.2,0.12,0.0464,4481.0,21 NDC,09999011659,STUDY ISLEND-1 ISLATRAVIR (MK-8591) 2 MG / LENACAPAVIR (GS-6207-02) 300 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011660,STUDY ISLEND-1 ISLATRAVIR (MK-8591) 0.5 MG / LENACAPAVIR (GS-6207-02) 300 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011661,STUDY ISLEND-1 BICTEGRAVIR 50 MG / EMTRICITABINE 200 MG / TENOFOVIR 25 MG OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011666,STUDY APL2-C3G-801 PEGCETACOPLAN 1080 MG/20 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011668,STUDY 61186372COR3001 AMIVANTAMAB 160 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011669,STUDY 61186372COR3001 CETUXIMAB 2 MG/ML IV SOLUTION,0.2,0.12,0.0506,11827.62,35 NDC,09999011670,STUDY BMT-CTN-2207 THYMOGLOBULIN (RABBIT ATG) 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,145865.16,35 NDC,09999011671,STUDY RRP-331 INO-3107/PLACEBO 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011673,STUDY RRP-331 INO-3107 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011674,STUDY HQP1351CG301-POLARIS-2 OLVEREMBATINIB 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011677,STUDY UNC IRB# 24-1715 ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 NDC,09999011678,STUDY UNC IRB# 24-1715 PROGESTERONE MICRONIZED/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999011679,STUDY RE104-201-PPD RE104 1.5 MG/0.05 ML / 30 MG/ML SUBCUTAENOUS INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011682,STUDY RE104-201-PPD ONDANSETRON 4 MG ODT,0.2,0.12,0.0464,4481.0,17 NDC,09999011683,STUDY RE104-201-PPD RISPERIDONE 1 MG TABLET ODT,0.2,0.12,0.0464,4481.0,19 NDC,09999011684,STUDY FMGX-CS-301 CASPOFUNGIN/PLACEBO 50 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011685,STUDY FMGX-CS-301 CASPOFUNGIN/PLACEBO 70 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011686,STUDY FMGX-CS-301 FOSMANOGEPIX/PLACEBO 400 MG TABLET,0.2,0.12,0.0464,4481.0,21 NDC,09999011687,STUDY FMGX-CS-301 FLUCONAZOLE/PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999011688,STUDY FMGX-CS-301 FOSMANOGEPIX/PLACEBO 20 MG/ML SOLUTION VIAL,0.2,0.12,0.0464,4481.0,21 NDC,09999011690,STUDY ALAMERE SOLRIKITUG/PLACEBO 0/125/250/500 MG SUBCUTANEOUS INJECTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,22 NDC,09999011691,STUDY ALAMERE SOLRIKITUG/PLACEBO 0/125/250/500 MG SUBCUTANEOUS INJECTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,22 NDC,09999011692,STUDY ALAMERE SOLRIKITUG 250 MG SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011695,STUDY EAST-002 NECTERO EAST STABILIZER MIXTURE BOX,0.2,0.12,0.0464,4481.0,22 NDC,09999011705,STUDY M24-064 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999011706,STUDY DSC-08-2357-32 GIVINOSTAT 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011707,STUDY DSC-08-2357-32 GIVINOSTAT 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011708,STUDY DSC-08-2357-32 GIVINOSTAT 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011709,STUDY DSC-08-2357-32 HYDROXYUREA 500 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011710,STUDY A032102 VALEMETOSTAT 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011712,STUDY NMD670-02-0002 NMD670/PLACEBO 100 MG OR 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011713,STUDY NMD670-02-0002 NMD670/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011714,STUDY NMD670-02-0002 NMD670/PLACEBO 200 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011717,STUDY ION582-CS1 ION582 40 MG/15 ML INTRATHECAL INJECTION (21 ML DILUENT),0.2,0.12,0.0464,4481.0,22 NDC,09999011718,STUDY ION582-CS1 ION582 80 MG/15 ML INTRATHECAL INJECTION (21 ML DILUENT),0.2,0.12,0.0464,4481.0,22 NDC,09999011719,STUDY A032102 VALEMETOSTAT 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011720,STUDY LCCC2425 MEMANTINE/PLACEBO 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,09999011721,STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 125 MCG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 NDC,09999011722,STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 63 MCG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 NDC,09999011723,STUDY CHARGE BIIB017 PEGINTERFERON BETA-1A (PLEGRIDY) 94 MCG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,26 NDC,09999011724,STUDY CHARGE BG9418 INTERFERON BETA-1A 30 MCG/0.5 ML (AVONEX) INTRAMUSCULAR PEN/SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011725,STUDY CHARGE BG9418 INTERFERON BETA-1A (AVONEX) TITRATION DEVICE KIT,0.2,0.12,0.05544,4481.0,31 NDC,09999011729,STUDY LCCC2255 CEMIPLIMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4733.4,35 NDC,09999011730,STUDY LCCC2255 XL092 (ZANZALINTINIB) 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011731,STUDY LCCC2255 XL092 (ZANZALINTINIB) 40 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011732,STUDY LCCC2255 XL092 (ZANZALINTINIB) 60 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011733,STUDY LCCC2255 XL092 (ZANZALINTINIB) 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011734,STUDY YL201-INT-101-01 YL201 25 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011735,STUDY CHS-388-202 CASDOZOKITUG 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011736,STUDY CHS-388-202 TORIPALIMAB 40 MG/ML IV SOLUTION,0.2,0.12,0.0506,6398.91,35 NDC,09999011737,STUDY CHS-388-202 BEVACIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,10991.19,35 NDC,09999011751,STUDY A092205-CIRB PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999011752,STUDY TBCRC-064 TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 NDC,09999011753,STUDY TBCRC-064 DATOPOTAMAB DERUXTECAN (DATO-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011762,STUDY PT-01 PEANUT SLIT-TABLET/PLACEBO,0.2,0.12,0.0464,4481.0,17 NDC,09999011765,STUDY TN-31 ABROCITINIB/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,26 NDC,09999011766,STUDY TN-31 RITLECITINIB/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,26 NDC,09999011767,STUDY DS102A-10-RD2 EPELEUTON 500 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011776,STUDY S095031-178 IVOSIDENIB 250 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011777,STUDY S095031-178 AZACITIDINE 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011778,STUDY S095031-178 AZACITIDINE 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011779,STUDY IND BELANTAMAB MAFODOTIN 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011780,STUDY PRT7732-01 PRT7732 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011781,STUDY PRT7732-01 PRT7732 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011784,STUDY APVO436-5201 APVO436 1.06 MCG/ML IV SOLUTION (DILUTION),0.2,0.12,0.0464,4481.0,17 NDC,09999011785,STUDY APVO436-5201 APVO436 10.3 MCG/ML IV SOLUTION (DILUTION),0.2,0.12,0.0464,4481.0,17 NDC,09999011786,STUDY AUTX-703-001 AUTX-703 0.5 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011787,STUDY AUTX-703-001 AUTX-703 3 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011788,STUDY AUTX-703-001 AUTX-703 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011789,STUDY LCCC2415 TIRZEPATIDE 5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999011790,STUDY LCCC2415 TIRZEPATIDE 2.5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999011791,STUDY LCCC2502 TIRZEPATIDE 5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999011792,STUDY LCCC2502 TIRZEPATIDE 2.5 MG/0.5 ML SUBCUTANEOUS SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999011793,STUDY MK2140-011 ZILOVERTAMAB VEDOTIN 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011794,STUDY D798KC00001 INFLIXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,4783.38,35 NDC,09999011795,STUDY PT217X1101 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999011797,STUDY MM1OA-EA02 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011798,STUDY MM1OA-EA02 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011799,STUDY MM1OA-EA02 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011800,STUDY PALV-10 IRB# 25-0413 PTX-022 (SIROLIMUS) 3.9% TOPICAL GEL W/W DISPENSER,0.2,0.12,0.0464,4481.0,22 NDC,09999011801,STUDY BMT-CTN-2203 RUXOLITINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011802,STUDY D5180C00016 TEZEPELUMAB 110 MG/ML SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011803,STUDY PVT-2201-203 BREPOCITINIB/PLACEBO 0/15/45 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011804,STUDY RCT2100-101 RCT2100 5 MG/5 ML DISPERSION SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,24 NDC,09999011805,STUDY TBCRC-065 TUCATINIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011806,STUDY TBCRC-065 TUCATINIB 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011811,STUDY RCT2100-101 RCT2100/PLACEBO 5 MG/5 ML DISPERSION SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,24 NDC,09999011812,STUDY IRB# 24-2214 MIRIKIZUMAB-MRKZ 100 MG/ML PRE-FILLED SYRINGE/PEN,0.2,0.12,0.0506,7785.12,35 NDC,09999011813,STUDY IRB# 24-2214 MIRIKIZUMAB-MRKZ 20 MG/ML VIAL,0.2,0.12,0.0506,7785.12,35 NDC,09999011818,STUDY BIPAVE-001 AI-081 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011819,STUDY A032201-CIRB TIVOZANIB 1.34 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011820,STUDY A032201-CIRB TIVOZANIB 0.89 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011822,STUDY ZE50-0134-0002 ZE50-0134 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011823,STUDY ZE50-0134-0002 ZE50-0134 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011824,STUDY ZE50-0134-0002 ZE50-0134 250 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011826,STUDY GB45429 GDC-6988/PLACEBO 7 MG CAPSULE FOR DPI INHALATION,0.2,0.12,0.0464,4481.0,24 NDC,09999011828,STUDY GOG-3112/DS8201-772 FAM-TRASTUZUMAB DERUXTECAN (T-DXD) 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,6728.19,35 NDC,09999011836,STUDY OWED-T IRB 25-0864 OMALIZUMAB 150 MG SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,6119.61,35 NDC,09999011837,STUDY OWED-T IRB 25-0864 OMALIZUMAB 150 MG/ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0506,6119.61,35 NDC,09999011838,STUDY OWED-T IRB 25-0864 OMALIZUMAB 75 MG/0.5 ML SUBCUTANEOUS PREFILLED SYRINGE,0.2,0.12,0.0506,6119.61,35 NDC,09999011840,STUDY B7981094 RITLECITINIB/PLACEBO 100 MG CAPSULE (WHITE LABEL),0.2,0.12,0.0464,4481.0,26 NDC,09999011841,STUDY B7981094 RITLECITINIB/PLACEBO 50 MG CAPSULE (YELLOW LABEL),0.2,0.12,0.0464,4481.0,26 NDC,09999011843,STUDY GB002-3102 SERALUTINIB 15 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999011844,STUDY CA088-1000 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011845,STUDY GB002-3102 DRY POWDER INHALER DEVICE,0.2,0.12,0.0464,4481.0,17 NDC,09999011847,STUDY LCCC2220 ERLOTINIB 25 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011848,STUDY R668-EGE-2213 IRB# 22-2246 DUPILUMAB 300 MG/2 ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999011851,STUDY M14-671 UPADACITINIB 0.5 MG/ML / 1.0 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011852,STUDY M14-671 UPADACITINIB 1.0 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011853,STUDY M14-671 UPADACITINIB ER 15 MG / 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011854,STUDY M14-671 UPADACITINIB ER 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011855,STUDY M14-671 UPADACITINIB ER 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011856,STUDY M14-671 UPADACITINIB ER 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011901,STUDY MM1OA-EA02 GILTERITINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,26 NDC,09999011902,STUDY LOXO-FG3-22001 LOXO-435 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011903,STUDY ALTE2131 TRIPTORELIN 22.5 MG INTRAMUSCULAR SUSPENSION,0.2,0.12,0.0464,4481.0,26 NDC,09999011904,STUDY GSK-218670 BELANTAMAB MAFODOTIN 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999011905,STUDY GSK-218670 BELANTAMAB 75 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999011909,STUDY TAPUR TALAZOPARIB 0.25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011910,STUDY TAPUR TALAZOPARIB 1 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011911,STUDY RMC-6236-301 RMC-6236 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011912,STUDY RMC-6236-301 RMC-6236 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011913,STUDY RMC-6236-301 DOCETAXEL 10 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011914,STUDY RMC-6236-301 DOCETAXEL 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,09999011916,STUDY NCI10596-CIRB SNDX-5613 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011917,STUDY NCI10596-CIRB SNDX-5613 110 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011920,STUDY 1719-001 MRTX1719 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011921,STUDY MK2140-011 PEGFILGRASTIM 6 MG/0.6 ML WEARABLE SUBCUTANEOUS INJECTOR,0.2,0.12,0.0464,4481.0,25 NDC,09999011922,STUDY PUL-042-207 PAM2CSK4 / ODN M362 OR PLACEBO 5 ML INHALATION SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011923,STUDY M25-059 ETENTAMIG (ABBV-383) 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011924,STUDY M25-059 LENALIDOMIDE 2.5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011925,STUDY M25-059 LENALIDOMIDE 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011926,STUDY M25-059 LENALIDOMIDE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011927,STUDY M25-059 LENALIDOMIDE 15 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011928,STUDY M25-059 LENALIDOMIDE 20 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011929,STUDY M25-059 LENALIDOMIDE 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011930,STUDY LOXO-RAS-20001 LY3537982 5 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999011933,STUDY BUL-8/EEA BUDESONIDE/PLACEBO 1 MG/2 MG ORODISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011934,STUDY J4Z-MC-GIDI TIRZEPATIDE/PLACEBO 2.5 MG/5 MG/7.5 MG/10 MG/12.5 MG/15 MG PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999011935,STUDY J4Z-MC-GIDI BIMAGRUMAB/PLACEBO 150 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011936,STUDY VERSATILE-003 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999011937,STUDY VERSATILE-003 PDS0101 (R-DOTAP/HPVMIX) 0.5 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011938,STUDY M24-533 TELISOTUZUMAB ADIZUTECAN (ABBV-400) 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999011939,STUDY NRG-GU014 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,09999011942,STUDY GOG-3115/M25-231 MIRVETUXIMAB SORAVTANSINE 5 MG/ML IV SOLUTION,0.2,0.12,0.0506,11142.6,35 NDC,09999011943,STUDY 8951-CL-0305 ZOLBETUXIMAB/PLACEBO 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,09999011946,STUDY DF-HCC24-121 EPCORITAMAB 60 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8980.23,35 NDC,09999011947,STUDY DF-HCC24-121 EPCORITAMAB 5 MG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8980.23,35 NDC,09999011948,STUDY DF-HCC24-121 EPCORITAMAB 0.16 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 NDC,09999011949,STUDY DF-HCC24-121 EPCORITAMAB 0.8 MG/ML SOLUTION FOR INJECTION (DILUTION),0.2,0.12,0.0506,8980.23,35 NDC,09999011951,STUDY RTOG-1216 ATEZOLIZUMAB (MPCL3280A) 60 MG /ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999011953,STUDY LCCC2215 DATOPOTAMAB-DERUXTECAN (DATO-DXD) 100 MG POWDER FOR SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011954,STUDY MIDAS MILRINONE/PLACEBO 1 MG/ML INTRAVENOUS SOLUTION VIAL,0.2,0.12,0.0464,4481.0,24 NDC,09999011958,STUDY TAK-279-PSO-3004 ZASOCITINIB (TAK-279)/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,24 NDC,09999011959,STUDY TAK-279-PSO-3004 DEUCRAVACITINIB/PLACEBO 6 MG CAPSULE,0.2,0.12,0.0464,4481.0,24 NDC,09999011961,STUDY ARGX-113-2315 EFGARTIGIMOD PH20/PLACEBO 200 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999011962,STUDY ARGX-113-2315 EFGARTIGIMOD PH20 200 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999011963,STUDY AAAU4206 ETRUMADENANT 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011964,STUDY AAAU4206 ETRUMADENANT 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999011965,STUDY M25-059 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 NDC,09999011967,STUDY EG-70-101 EG-70 0.8 MG/ML INTRAVESICAL SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999011968,STUDY TNG462-C102 TNG462 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011969,STUDY TNG462-C102 TNG462 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011970,STUDY TNG462-C102 TNG462 150 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011971,STUDY TNG462-C102 RMC-6236 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011972,STUDY TNG462-C102 RMC-6236 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011973,STUDY TNG462-C102 RMC-9805 300 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011974,STUDY BGB-11417-303 SONROTOCLAX 1 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011975,STUDY BGB-11417-303 SONROTOCLAX 5 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011976,STUDY CRSP-AID-500 FLUDARABINE 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9659.37,35 NDC,09999011977,STUDY CRSP-AID-500 CYCLOPHOSPHAMIDE 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,09999011978,STUDY CRSP-AID-500 TOCILIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011979,STUDY BGB-11417-303 SONROTOCLAX 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011980,STUDY BGB-11417-303 SONROTOCLAX 80 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999011981,STUDY EIND 31920 PSA1/PSA16/AFR22/KEN13 BACTERIOPHAGE FOR INFUSION,0.2,0.12,0.0464,4481.0,17 NDC,09999011990,STUDY JZP598-303 TRASTUZUMAB-PKRB 21 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,09999011991,STUDY JZP598-303 ZANIDATAMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,09999011992,STUDY DOC-GBM2 FILGRASTIM (NEUPOGEN) 300 MCG/0.5 ML INJECTION SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011993,STUDY DOC-GBM2 FILGRASTIM (NEUPOGEN) 480 MCG/0.8 ML INJECTION SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,09999011994,STUDY DOC-GBM2 PEGINTERFERON ALFA-2A (PIFN) 180 MCG/0.5 ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,26 NDC,09999011996,STUDY MK8527-011 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG (EQ 245 MG TD) OR PLACEBO TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999011997,STUDY MK8527-011 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (EQ 245 MG TD),0.2,0.12,0.0464,4481.0,19 NDC,09999011998,STUDY MK8527-011 MK-8527/PLACEBO 11 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999012003,STUDY BGB-11417-303 VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999012004,STUDY BGB-11417-303 VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999012005,STUDY BGB-11417-303 VENETOCLAX 100 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999012006,STUDY BGB-11417-303 OBINUTUZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,11677.68,35 NDC,09999012007,STUDY BGB-11417-303 RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 NDC,09999012008,STUDY BGB-11417-303 RITUXIMAB 10 MG/ML IV SOLUTION,0.2,0.12,0.0506,5030.34,35 NDC,09999012009,STUDY M25-275 ABBV-453 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999012010,STUDY M25-275 ABBV-453 80 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,09999012011,STUDY M25-275 DARATUMUMAB 120 MG/ML + RHUPH20 2000 U/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0506,8673.0,35 NDC,09999012015,STUDY KO-MEN-017 ZIFTOMENIB / PLACEBO 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,22 NDC,09999012016,STUDY AALL2321 BLINATUMOMAB 12.5 MCG/ML IV SOLUTION,0.2,0.12,0.0506,24925.32,35 NDC,09999012022,STUDY APVO436-5201 APVO436 2 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999012023,STUDY SLV-324-01TX SLV-324 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,09999012028,STUDY 20230238 XALURITAMIG (AMG 509) 0.09 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999012029,STUDY 20230238 XALURITAMIG (AMG 509) 0.46 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,09999012031,STUDY 20230151 AMG691/PLACEBO 140 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,09999012032,STUDY 20230151 ALBUTEROL SULFATE HFA 90 MCG/ACTUATION INHALER,0.2,0.12,0.0464,4481.0,19 NDC,09999012033,STUDY 20230151 INHALATION SPACER,0.2,0.12,0.0464,4481.0,24 NDC,09999012034,STUDY U44-MNLT-01 MOON101 1 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 NDC,09999012035,STUDY U44-MNLT-01 MOON101 10 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 NDC,09999012036,STUDY U44-MNLT-01 MOON101 25 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 NDC,09999012037,STUDY U44-MNLT-01 MOON101 50 MICROGRAM MN STAMP,0.2,0.12,0.0464,4481.0,19 NDC,09999012038,STUDY U44-MNLT-01 MOON101 PLACEBO MN STAMP,0.2,0.12,0.0464,4481.0,19 NDC,09999012045,STUDY PEAK-1 CASDATIFAN / PLACEBO 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,09999012046,STUDY PEAK-1 CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999012047,STUDY PEAK-1 CABOZANTINIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999012048,STUDY PEAK-1 CABOZANTINIB 60 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,09999012051,STUDY RUGONERSEN EAP/COMPASSIONATE USE PROGRAM RUGONERSEN 24 MG/ML INTRATHECAL INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,09999012052,STUDY NRG-HN014 CEMIPLIMAB (REGN2810) 50 MG/ML IV SOLUTION,0.2,0.12,0.0506,4733.4,35 NDC,09999012053,STUDY YL201-INT-101-01 ATEZOLIZUMAB 60 MG/ML IV SOLUTION,0.2,0.12,0.0506,14630.91,35 NDC,09999012054,STUDY IMVT-1402-3101 300 MG/2 ML INJECTOR PEN OR PLACEBO,0.2,0.12,0.0464,4481.0,17 NDC,09999012055,STUDY TAK-881-3003 RHUPH20 SYRINGE FOR INFUSION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012056,STUDY TAK-881-3003 IGSC (TAK-881) 20% INFUSION SOLUTION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012057,STUDY TAK-881-3003 IGI (HYQVIA) 10% INFUSION SOLUTION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012058,STUDY TAK-881-3003 RHUPH20 SYRINGE FOR INFUSION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012059,STUDY TAK-881-3003 IGSC (TAK-881) 20% INFUSION SOLUTION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012060,STUDY TAK-881-3003 IGI (HYQVIA) 10% INFUSION SOLUTION (PT WT >/= 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012063,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 0.75 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 NDC,09999012064,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 1.5 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 NDC,09999012065,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 3.0 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 NDC,09999012066,STUDY H9X-MC-GBGS DULAGLUTIDE (LY2189265) 4.5 MG/0.5 ML PEN INJECTOR,0.2,0.12,0.0464,4481.0,19 NDC,09999012100,STUDY GB45429 SMART DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,24 NDC,09999012106,STUDY TAK-881-3003 RHUPH20 SYRINGE FOR INFUSION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012107,STUDY TAK-881-3003 RHUPH20 SYRINGE FOR INFUSION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012108,STUDY TAK-881-3003 IGI (HYQVIA) 10% INFUSION SOLUTION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012109,STUDY TAK-881-3003 IGI (HYQVIA) 10% INFUSION SOLUTION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012110,STUDY TAK-881-3003 IGSC (TAK-881) 20% INFUSION SOLUTION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012111,STUDY TAK-881-3003 IGSC (TAK-881) 20% INFUSION SOLUTION (PT WT < 40 KG),0.2,0.12,0.0464,4481.0,22 NDC,09999012119,STUDY IND 178958 CLOFAZIMINE 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,09999017739,AMPHOTERICIN B CONVENTIONAL 1 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 NDC,09999020000,VANCOMYCIN 10 MG/ML (CENTRAL) CONTINUOUS INFUSION PEDS 200 ML,203.0,121.8,0.0675,4481.0,24 NDC,09999020022,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 200 ML,133.0,79.8,0.0675,4481.0,24 NDC,09999026854,MOXIFLOXACIN 20 MG/ML ORAL SUSPENSION,124.0,74.4,28.77,4481.0,19 NDC,09999040022,VANCOMYCIN 5 MG/ML CONTINUOUS INFUSION PEDS 400 ML,203.0,121.8,0.0675,4481.0,24 NDC,09999041606,BLOOD CARDIOPLEGIA (DEL NIDO),287.8,172.68,66.77,4481.0,19 NDC,09999052885,"HEPARIN 5,000 UNIT/ML NEBULIZATION",28.15,16.89,6.53,4481.0,26 NDC,09999077195,LEVETIRACETAM 10 MG/ML IV PEDIATRIC,133.35,80.01,0.09,4481.0,24 NDC,09999077411,CAFFEINE CITRATE 20 MG/ML ORAL SOLUTION (COMPOUND),33.3,19.98,7.73,4481.0,19 NDC,09999098036,"LIPASE-PROTEASE-AMYLAS(PORK)24,000-76,000-120,000 UNIT CAPSULE,DEL REL",2567.2,1540.32,595.59,4481.0,19 NDC,09999099510,SPIRONOLACTONE 12.5 MG SPLIT TABLET,16.3,9.78,3.78,4481.0,19 NDC,09999108021,ACETAMINOPHEN (OFIRMEV) 10 MG/ML INJECTION,94.4,56.64,0.132,4481.0,24 NDC,09999125480,"BUPIVACAINE (PF) 0.1 % (1,000 MCG/ML) IN 0.9% SODIUM CHLORIDE EPIDURAL",25.75,15.45,0.0225,4481.0,24 NDC,09999130136,MORPHINE (PF) 1 MG/ML INJECTION SOLUTION,28.35,17.01,6.58,4481.0,24 NDC,09999152401,ALTEPLASE 1 MG/ML 2 ML PEDIATRIC INFUSION,668.5,401.1,91.62,4481.0,35 NDC,09999184834,"EPOETIN ALFA-EPBX (RETACRIT) 4,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",188.1,112.86,7.61,4481.0,33 NDC,09999184835,"EPOETIN ALFA EPBX (RETACRIT) 10,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",446.2,267.72,7.61,4481.0,33 NDC,09999187102,FENFLURAMINE 2.2 MG/ML ORAL SOLUTION,523.75,314.25,121.51,4481.0,19 NDC,09999189603,FENFLURAMINE 2.2 MG/ML ORAL SOLUTION,1025.45,615.27,237.9,4481.0,19 NDC,09999194836,"EPOETIN ALFA EPBX (RETACRIT) 40,000 UNIT/ML INJECTION (PEDIATRICS) SYRINGE",1736.7,1042.02,7.61,4481.0,33 NDC,09999197603,"SIMETHICONE 40 MG/0.6 ML ORAL DROPS,SUSPENSION",1.05,0.63,0.2436,4481.0,19 NDC,09999197618,SELENIUM 12 MCG/ML DILUTION,1360.75,816.45,315.69,4481.0,19 NDC,09999197620,REMIFENTANIL 100 MCG/2 ML (50 MCG/ML) IN 0.9 % NACL IV SYRINGE,26.65,15.99,6.18,4481.0,19 NDC,09999197622,METHADONE 10 MG/ML ORAL CONCENTRATE,26.85,16.11,6.23,4481.0,19 NDC,09999197626,NXSTAGE/MULTIBIC RFP 401 (+/- BB) - CONTAINS 4 MEQ/L POTASSIUM,291.6,174.96,67.65,4481.0,19 NDC,09999197807,BOSENTAN 6.25 MG/ML ORAL SUSPENSION,307.4,184.44,71.32,4481.0,19 NDC,09999197815,MEROPENEM-VABORBACTAM DILUTION 8 MG OF MEROPENEM/ML PEDIATRIC INJECTION,602.55,361.53,2.11,4481.0,35 NDC,09999197825,GLUCOSE 4 GRAM CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 NDC,09999197828,BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION,16.6,9.96,0.0225,4481.0,24 NDC,09999197829,BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION,17.5,10.5,0.0225,4481.0,24 NDC,09999197853,METRONIDAZOLE 5 MG/ML IN SODIUM CHLORIDE (ODD DOSE),71.05,42.63,0.0675,4481.0,24 NDC,09999197855,ATROPINE 1% SUBLINGUAL SYRINGE,17.25,10.35,4.0,4481.0,19 NDC,09999197868,FLUCONAZOLE 2 MG/ML (ODD DOSE) IN SODIUM CHLORIDE 0.9% IVPB (120MIN ADMIN),131.05,78.63,5.08,4481.0,24 NDC,09999197872,SODIUM BICARBONATE 150 MEQ/1000 ML IN DEXTROSE 5 % CONT INFUSION PREMIX,161.7,97.02,37.51,4481.0,19 NDC,09999199004,EPINEPHRINE (PEDIATRIC PITKIN) 0.8 MG IN 500 ML SODIUM CHLORIDE 0.9 %,126.8,76.08,1.08,4481.0,23 NDC,09999199005,EPINEPHRINE (PEDIATRIC) 30 MG/1000 ML NS IRRIGATION,174.2,104.52,1.08,4481.0,24 NDC,09999199007,FAT EMULSION SMOFLIPID 20 % INFUSION 8 ML SYRINGE (PEDS),19.6,11.76,4.55,4481.0,19 NDC,09999199008,FAT EMULSION SMOFLIPID 20 % INFUSION 24 ML SYRINGE (PEDS),26.7,16.02,6.19,4481.0,19 NDC,09999199009,FAT EMULSION SMOFLIPID 20 % INFUSION 50 ML SYRINGE (PEDS),38.25,22.95,8.87,4481.0,19 NDC,09999199011,FAT EMULSION SMOFLIPID 20 % (750 ML) INFUSION,388.8,233.28,90.2,4481.0,19 NDC,09999199012,FAT EMULSION SMOFLIPID 20 % (1000 ML) INFUSION,497.35,298.41,115.39,4481.0,19 NDC,09999199013,FUROSEMIDE 10 MG/ML PEDIATRIC SYRINGE,32.1,19.26,0.045,4481.0,24 NDC,09999199028,PROMETHAZINE 1 MG/ML PEDIATRIC DILUTION INJECTION (20 MIN),21.8,13.08,5.06,4481.0,24 NDC,09999199029,HYDRALAZINE 20 MG/ML IV,798.75,479.25,12.6,4481.0,24 NDC,09999199030,KETOROLAC 15 MG/ML IV PEDIATRIC,75.3,45.18,0.2813,4481.0,34 NDC,09999199040,PANTOPRAZOLE 4 MG/ML NS PEDIATRIC INJECTION,66.1,39.66,15.34,4481.0,19 NDC,09999199041,PANTOPRAZOLE 40 MG/50 ML NS PEDIATRIC INFUSION,81.5,48.9,18.91,4481.0,19 NDC,09999199042,PANTOPRAZOLE 80 MG/100 ML NS PEDIATRIC DILUTION,100.0,60.0,23.2,4481.0,19 NDC,09999199043,FLUCYTOSINE 50 MG/ML ORAL SUSPENSION,2881.25,1728.75,668.45,4481.0,19 NDC,09999199051,"METHYLPHENIDATE 5 MG/ML (25 MG/5 ML) ORAL SUSP,EXTENDED RELEASE 24 HR",45.15,27.09,10.47,4481.0,19 NDC,09999199054,EPINEPHRINE HCL 100 MCG/10 ML(10 MCG/ML) IN 0.9 % SOD CHLOR IV SYRINGE,43.15,25.89,3.06,4481.0,24 NDC,09999199056,VANCOMYCIN 10 GRAM INTRAVENOUS SOLUTION,98.0,58.8,0.0675,4481.0,24 NDC,09999199058,VANCOMYCIN 10 MG/ML (CENTRAL) PEDIATRIC DILUTION,762.8,457.68,0.0675,4481.0,24 NDC,09999199072,GENTAMICIN 40 MG/ML INJ SOLN FOR ORAL USE,116.0,69.6,4.97,4481.0,24 NDC,09999199075,BUMETANIDE 0.25 MG/ML ORAL SOLUTION,25.85,15.51,6.0,4481.0,19 NDC,09999199078,CISATRACURIUM 2 MG/ML PEDIATRIC INFUSION (CSAC),473.2,283.92,109.78,4481.0,19 NDC,09999199094,ALKALINE SALINE 2% MOUTH RINSE,1.05,0.63,0.2436,4481.0,19 NDC,09999199096,ALKALINE SALINE 2% MOUTH RINSE,1.15,0.69,0.2668,4481.0,19 NDC,09999199097,NAFCILLIN 20 MG/ML PEDIATRIC DILUTION,427.65,256.59,0.1125,4481.0,24 NDC,09999199101,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 2 ML,159.8,95.88,37.07,4481.0,19 NDC,09999199102,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 8 ML,450.2,270.12,104.45,4481.0,19 NDC,09999199103,SILDENAFIL PEDIATRIC CONTINUOUS INFUSION 50 ML,2482.8,1489.68,576.01,4481.0,19 NDC,09999199122,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 4 ML,66.4,39.84,15.4,4481.0,19 NDC,09999199133,DEXMEDETOMIDINE 8 MCG/ 2 ML (4 MCG/ML) NS PEDIATRIC INFUSION,66.7,40.02,15.47,4481.0,19 NDC,09999199135,CEFTOLOZANE-TAZOBACTAM (20 MG OF CEFTOLOZANE/ML) PEDIATRIC INJECTION,471.75,283.05,109.45,4481.0,26 NDC,09999199138,VANCOMYCIN-HEPARIN (2.5 MG-10 UNITS/ML) IN NS NEONATAL LOCK SOLUTION,63.25,37.95,0.0675,4481.0,24 NDC,09999199149,PENTOBARBITAL 50MG/ML PEDIATRIC INFUSION 10 ML,1843.4,1106.04,121.21,4481.0,24 NDC,09999199161,SODIUM PHOSPHATE 3 MMOL/ML INTRAVENOUS SOLUTION,136.65,81.99,31.7,4481.0,19 NDC,09999199165,SODIUM BICARBONATE 0.5 MEQ/ML INJ SOLUTION (PEDIATRIC),239.75,143.85,55.62,4481.0,19 NDC,09999199167,SODIUM PHOSPHATE 3 MMOL/ML ORAL SOLUTION,21.4,12.84,4.96,4481.0,19 NDC,09999199176,SOMATROPIN (1 MG/ML) SUBCUTANEOUS PEDIATRIC DILUTION,252.7,151.62,47.45,4481.0,35 NDC,09999199177,DEXTROSE 20 % IN WATER (FOR ORAL USE) INTRAVENOUS SOLUTION,24.35,14.61,5.65,4481.0,17 NDC,09999199189,NEONATAL AA ISOTONIC 3.6%/HEPARIN 1 UNIT/ML,118.65,71.19,27.53,4481.0,19 NDC,09999199194,GLYBURIDE 1 MG/ML ORAL SUSPENSION,20.8,12.48,4.83,4481.0,19 NDC,09999226301,ALTEPLASE 1 MG/ML INTRATHECAL INJECTION,365.75,219.45,91.62,4481.0,35 NDC,09999500000,WARFARIN 0.5 MG SPLIT TABLET,16.3,9.78,3.78,4481.0,19 NDC,09999508256,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION FOR STROKE,32375.35,19425.21,167.05,28007.92,35 NDC,09999508639,VITAMIN A ORAL SOLUTION 2500 MCG RAE/ML,2.25,1.35,0.522,4481.0,19 NDC,09999777707,SODIUM FERRIC GLUCONATE 250 MG IN 100 ML PREMIX (SSC),478.95,287.37,4.54,4481.0,24 NDC,09999910546,METHADONE 10 MG/ML INJECTION SOLUTION,57.4,34.44,13.32,4481.0,24 NDC,10019092602,IFOSFAMIDE 3 GRAM INTRAVENOUS SOLUTION,631.0,378.6,56.7,4481.0,24 NDC,10119002239,WHITE PETROLATUM-MINERAL OIL 80 %-20 % EYE OINTMENT,12.4,7.44,2.88,4481.0,19 NDC,10122018001,VELMANASE ALFA-TYCV 10 MG INTRAVENOUS SOLUTION,14415.05,8649.03,451.27,72834.09,35 NDC,10122051001,PORACTANT ALFA 120 MG/1.5 ML INTRATRACHEAL SUSPENSION,2351.95,1411.17,545.65,4481.0,19 NDC,10122051003,PORACTANT ALFA 240 MG/3 ML INTRATRACHEAL SUSPENSION,4622.25,2773.35,1072.36,4481.0,19 NDC,10122061010,CLEVIDIPINE 25 MG/50 ML INTRAVENOUS EMULSION,351.3,210.78,2.76,4481.0,35 NDC,10122061101,CLEVIDIPINE 50 MG/100 ML INTRAVENOUS EMULSION,703.6,422.16,2.76,4481.0,35 NDC,10122062001,CANGRELOR 50 MG INTRAVENOUS SOLUTION,3920.7,2352.42,19.38,4481.0,35 NDC,10370026801,TRETINOIN (ANTINEOPLASTIC) 10 MG CAPSULE,132.6,79.56,30.76,4481.0,19 NDC,10454071110,"RIMABOTULINUMTOXINB 5,000 UNIT/ML INTRAMUSCULAR SOLUTION",1254.45,752.67,12.89,4481.0,35 NDC,10481300601,SODIUM HYDROXIDE (BULK) 10 % SOLUTION,80.0,48.0,18.56,4481.0,19 NDC,10511300102,HEXAMINOLEVULINATE 100 MG INTRAVESICAL SOLUTION,2744.45,1646.67,636.71,4481.0,24 NDC,10542010008,"CHOLECALCIFEROL (VITAMIN D3) 1,250 MCG (50,000 UNIT) TABLET",1.45,0.87,0.3364,4481.0,19 NDC,10572001201,"SODIUM,POTASSIUM,MAG SULFATES 17.5 GRAM-3.13 GRAM-1.6 GRAM ORAL SOLN",277.3,166.38,64.33,4481.0,19 NDC,10572030201,PEG-ELECTROLYTE SOLUTION 420 GRAM ORAL SOLUTION,100.3,60.18,23.27,4481.0,19 NDC,10572030201,STUDY 2637 PEG ELECTROLYTE ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,11523723403,POLYETHYLENE GLYCOL 3350 ORAL POWDER FOR LARGE DOSE,42.55,25.53,9.87,4481.0,19 NDC,11845007791,PHYTONADIONE (VITAMIN K1) 100 MCG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,11980017405,"PREDNISOLONE ACETATE 0.12 % EYE DROPS,SUSPENSION",498.85,299.31,115.73,4481.0,19 NDC,11994001104,PERFLUTREN LIPID MICROSPHERES 1.1 MG/ML INTRAVENOUS SUSPENSION,265.05,159.03,61.49,4481.0,23 NDC,12496120203,BUPRENORPHINE 2 MG-NALOXONE 0.5 MG SUBLINGUAL FILM,37.25,22.35,8.64,4481.0,22 NDC,13107028301,CLORAZEPATE DIPOTASSIUM 7.5 MG TABLET,26.25,15.75,6.09,4481.0,19 NDC,13533031805,RABIES IMMUNE GLOBULIN (PF) 300 UNIT/ML INTRAMUSCULAR - 5 ML VIALS,12411.0,7446.6,271.45,10736.76,36 NDC,13533033504,"IMMUNE GLOB,GAMMA(IGG) 15 %-18 % RANGE-GLYCINE INTRAMUSCULAR SOLUTION",454.15,272.49,47.56,4481.0,35 NDC,13533033512,"IMMUNE GLOB,GAMMA(IGG) 15 %-18 % RANGE-GLYCINE INTRAMUSCULAR SOLUTION",1800.3,1080.18,47.56,4481.0,35 NDC,13533060250,ANTITHROMBIN III (HUMAN) 500 (+/-) UNIT INTRAVENOUS SOLUTION,92.35,55.41,3.98,4481.0,35 NDC,13533063402,TETANUS IMMUNE GLOBULIN (PF) 250 UNIT/ML INTRAMUSCULAR SYRINGE,2430.25,1458.15,575.21,4481.0,35 NDC,13533063630,HEPATITIS B IMMUNE GLOBULIN 110 UNIT/0.5 ML INTRAMUSCULAR SYRINGE,397.65,238.59,100.61,4481.0,36 NDC,13533070511,"ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 1,000 MG (+/-) IV SOLN WRAPPER",65.0,39.0,5.3,4481.0,35 NDC,13533080012,IMMUNE GLOBU G 1 GRAM/10 ML(10 %)-GLY-IGA AVE 46 MCG/ML INFUSION SOLN,616.2,369.72,47.49,7576.38,35 NDC,13533080024,IMMUNE GLOB G 20 GRAM/200 ML(10%)-GLY-IGA AVE 46 MCG/ML INFUSION SOLN,10860.65,6516.39,47.49,8688.52,35 NDC,13533080071,IMMUNE GLOB G 10 GRAM/100 ML(10%)-GLY-IGA AVE 46 MCG/ML INFUSION SOLN,5468.85,3281.31,47.49,7576.38,35 NDC,13668001101,CITALOPRAM 40 MG TABLET,16.2,9.72,3.76,4481.0,19 NDC,13668009190,PRAMIPEXOLE 0.125 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,13668009290,PRAMIPEXOLE 0.25 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,13668009390,PRAMIPEXOLE 0.5 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,13668009490,PRAMIPEXOLE 1 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,13668045301,ANAGRELIDE 0.5 MG CAPSULE,18.5,11.1,4.29,4481.0,19 NDC,13668059181,APREPITANT 40 MG CAPSULE,279.85,167.91,6.14,4481.0,24 NDC,13811070310,"HYDROMORPHONE ER 16 MG TABLET,EXTENDED RELEASE 24 HR",68.65,41.19,15.93,4481.0,19 NDC,14537096775,DEXTROSE 2.45 GRAM-SOD CITRATE 2.2 GRAM-CITRIC AC 800 MG/100 ML SOLN,78.75,47.25,18.27,4481.0,19 NDC,14789090002,PROCAINAMIDE 500 MG/ML INJECTION SOLUTION,2356.0,1413.6,285.85,4481.0,35 NDC,15054004301,IRINOTECAN LIPOSOMAL 4.3 MG/ML INTRAVENOUS,10135.5,6081.3,64.02,10683.96,35 NDC,15054050001,ABOBOTULINUMTOXINA 500 UNIT INTRAMUSCULAR SOLUTION,3449.95,2069.97,8.49,4481.0,35 NDC,15054053006,ABOBOTULINUMTOXINA 300 UNIT INTRAMUSCULAR SOLUTION,2077.15,1246.29,8.49,4481.0,35 NDC,15054106004,LANREOTIDE 60 MG/0.2 ML SUBCUTANEOUS SYRINGE,23759.2,14255.52,33.03,19007.36,35 NDC,16500059920,PEDIATRIC MULTIVITAMIN NO.226-FERROUS SULFATE 18 MG CHEWABLE TABLET,1.2,0.72,0.2784,4481.0,24 NDC,16571072360,MAFENIDE 85 MG/G TOPICAL CREAM,233.95,140.37,54.28,4481.0,19 NDC,16571074309,GLYCOPYRROLATE 1 MG TABLET,16.4,9.84,3.8,4481.0,19 NDC,16571078501,LAMOTRIGINE 5 MG CHEWABLE DISPERSIBLE TABLET,16.9,10.14,3.92,4481.0,19 NDC,16571078601,LAMOTRIGINE 25 MG CHEWABLE DISPERSIBLE TABLET,16.95,10.17,3.93,4481.0,19 NDC,16729002310,BICALUTAMIDE 50 MG TABLET,28.05,16.83,6.51,4481.0,19 NDC,16729003510,ANASTROZOLE 1 MG TABLET,26.2,15.72,6.08,4481.0,19 NDC,16729004954,TEMOZOLOMIDE 20 MG CAPSULE,49.55,29.73,0.9735,4481.0,24 NDC,16729010811,MITOMYCIN 20 MG INTRAVENOUS SOLUTION,2366.9,1420.14,19.74,4481.0,35 NDC,16729010811,MITOMYCIN BLADDER INSTILLATION (1 MG/ML; 20 MG VIAL),2366.9,1420.14,19.74,4481.0,35 NDC,16729010811,MITOMYCIN BLADDER INSTILLATION (2 MG/ML; 20 MG VIAL),2366.9,1420.14,19.74,4481.0,35 NDC,16729011431,ETOPOSIDE 20 MG/ML INTRAVENOUS SOLUTION,309.1,185.46,2.12,4481.0,24 NDC,16729011505,MITOMYCIN 5 MG INTRAVENOUS SOLUTION,1080.25,648.15,19.74,4481.0,35 NDC,16729011638,MITOMYCIN 40 MG INTRAVENOUS SOLUTION,4458.75,2675.25,19.74,4481.0,35 NDC,16729011638,MITOMYCIN BLADDER INSTILLATION (1 MG/ML; 40 MG VIAL),4458.75,2675.25,19.74,4481.0,35 NDC,16729011638,MITOMYCIN BLADDER INSTILLATION (2 MG/ML; 40 MG VIAL),4458.75,2675.25,19.74,4481.0,35 NDC,16729015131,TOPOTECAN 4 MG INTRAVENOUS SOLUTION,738.4,443.04,3.65,4481.0,24 NDC,16729018929,"MYCOPHENOLATE SODIUM 360 MG TABLET,DELAYED RELEASE",17.15,10.29,0.765,4481.0,24 NDC,16729024331,TOPOTECAN 4 MG/4 ML (1 MG/ML) INTRAVENOUS SOLUTION,738.4,443.04,3.65,4481.0,24 NDC,16729026129,"MYCOPHENOLATE SODIUM 180 MG TABLET,DELAYED RELEASE",16.55,9.93,0.765,4481.0,24 NDC,16729027210,PRASUGREL HCL 5 MG TABLET,18.5,11.1,4.29,4481.0,19 NDC,16729027735,METHOTREXATE INJECTION (PF) 25 MG/ML (NON-ONCOLOGY),397.65,238.59,6.15,4481.0,24 NDC,16729029310,EPLERENONE 25 MG TABLET,20.2,12.12,4.69,4481.0,19 NDC,16729029410,EPLERENONE 50 MG TABLET,20.2,12.12,4.69,4481.0,19 NDC,16729029805,ONDANSETRON HCL 2 MG/ML INTRAVENOUS SOLUTION,63.9,38.34,0.2475,4481.0,24 NDC,16729034710,LURASIDONE 40 MG TABLET,19.65,11.79,4.56,4481.0,19 NDC,16729044210,CINACALCET 90 MG TABLET,19.9,11.94,4.62,4481.0,19 NDC,16864002101,ZINC OXIDE 12.8 % TOPICAL OINTMENT,11.2,6.72,2.6,4481.0,19 NDC,16864068003,BENZOCAINE 20 %-MENTHOL 0.5 % TOPICAL AEROSOL,10.0,6.0,2.32,4481.0,19 NDC,17433987600,DOCUSATE SODIUM 283 MG/5 ML ENEMA,2.75,1.65,0.638,4481.0,19 NDC,18657011704,"HYALURONIDASE, HUMAN RECOMBINANT 150 UNIT/ML INJECTION SOLUTION",233.65,140.19,0.81,4481.0,24 NDC,19515090452,FLU VACCINE TS 2025-26(6MOS UP)(PF) 45 MCG(15MCG X3)/0.5 ML IM SYRINGE,81.25,48.75,18.85,4481.0,26 NDC,20555000100,ASCORBIC ACID (VITAMIN C) 250 MG TABLET,1.05,0.63,0.2436,4481.0,19 NDC,20555003300,"CHOLECALCIFEROL (VITAMIN D3) 25 MCG (1,000 UNIT) TABLET",1.1,0.66,0.2552,4481.0,19 NDC,21586001102,CEFOTAXIME 1 GRAM INJ SOLR IM,54.25,32.55,12.59,4481.0,24 NDC,21922000101,FLUOCINONIDE 0.05 % TOPICAL SOLUTION,76.15,45.69,17.67,4481.0,19 NDC,21922002107,PERMETHRIN 5 % TOPICAL CREAM,16.8,10.08,3.9,4481.0,19 NDC,23155002601,VERAPAMIL 80 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,23155021631,CIDOFOVIR 75 MG/ML INTRAVENOUS SOLUTION,2482.8,1489.68,529.9,78865.5,35 NDC,23155026141,CARMUSTINE 100 MG INTRAVENOUS SOLUTION,9004.8,5402.88,231.31,22004.43,35 NDC,23155029041,AMIKACIN 250 MG/ML INJECTION SOLUTION WRAPPER,45.25,27.15,1.42,4481.0,24 NDC,23155076701,TETRACYCLINE 500 MG CAPSULE,21.1,12.66,4.9,4481.0,19 NDC,23155077131,FOSCARNET 24 MG/ML INTRAVENOUS SOLUTION,1434.6,860.76,15.6,4481.0,35 NDC,24201040002,CALCITONIN (SALMON) 200 UNIT/ML INJECTION SOLUTION,3136.0,1881.6,470.42,4481.0,35 NDC,24208004040,TRIAMCINOLONE ACETONIDE (PF) 40 MG/ML SUPRACHOROIDAL SUSPENSION,731.0,438.6,169.59,4481.0,26 NDC,24208027715,SODIUM CHLORIDE 5 % EYE DROPS,1.1,0.66,0.2552,4481.0,19 NDC,24208038555,SODIUM CHLORIDE 5 % EYE OINTMENT,27.05,16.23,6.28,4481.0,19 NDC,24208041105,BRIMONIDINE 0.2 % EYE DROPS,59.65,35.79,13.84,4481.0,19 NDC,24208041105,STUDY BRIMONIDINE 0.2% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,24208053920,ACETYLCHOLINE CHLORIDE 1 % (20 MG/2 ML) INTRAOCULAR KIT,409.05,245.43,94.9,4481.0,19 NDC,24208055555,"BACITRACIN-POLYMYXIN B 500 UNIT-10,000 UNIT/GRAM EYE OINTMENT",85.0,51.0,19.72,4481.0,19 NDC,24208063110,"NEOMYCIN-POLYMYXIN-HYDROCORT 3.5 MG/ML-10,000 UNIT/ML-1 % EAR SOLUTION",268.55,161.13,62.3,4481.0,19 NDC,24208063562,"NEOMYCIN-POLYMYXIN-HYDROCORT 3.5 MG-10,000 UNIT/ML-1 % EAR DROPS,SUSP",268.55,161.13,62.3,4481.0,19 NDC,24208071510,PREDNISOLONE SODIUM PHOSPHATE 1 % EYE DROPS,174.7,104.82,40.53,4481.0,19 NDC,24208072002,DEXAMETHASONE SODIUM PHOSPHATE 0.1 % EYE DROPS,178.25,106.95,41.35,4481.0,19 NDC,24208072002,STUDY DEXAMETHASONE 0.1% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,24208073006,PROPARACAINE 0.5 % EYE DROPS,16.4,9.84,3.8,4481.0,19 NDC,24338005008,CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT,17751.8,10651.08,231.31,22004.43,35 NDC,24338013013,ERYTHROMYCIN ETHYLSUCCINATE 400 MG/5 ML ORAL POWDER FOR SUSPENSION,115.25,69.15,26.74,4481.0,19 NDC,24338023015,NIMODIPINE 30 MG/5 ML ORAL SYRINGE (FOR ORAL USE ONLY),176.25,105.75,40.89,4481.0,19 NDC,24338026008,NIMODIPINE 60 MG/10 ML ORAL SOLUTION,180.5,108.3,41.88,4481.0,19 NDC,24338053025,SOTALOL 5 MG/ML ORAL SOLUTION,1780.0,1068.0,412.96,4481.0,19 NDC,24385044164,DOXYLAMINE SUCCINATE 25 MG TABLET,1.3,0.78,0.3016,4481.0,19 NDC,24385051530,CASTOR OIL 100 % ORAL,6.8,4.08,1.58,4481.0,19 NDC,24510005010,TAPENTADOL 50 MG TABLET,59.05,35.43,13.7,4481.0,19 NDC,24510005860,"TAPENTADOL ER 50 MG TABLET,EXTENDED RELEASE,12 HR",60.75,36.45,14.09,4481.0,19 NDC,24510011660,"TAPENTADOL ER 100 MG TABLET,EXTENDED RELEASE,12 HR",93.65,56.19,21.73,4481.0,19 NDC,24510029160,"TAPENTADOL ER 250 MG TABLET,EXTENDED RELEASE,12 HR",168.8,101.28,39.16,4481.0,19 NDC,24979000206,"DEXLANSOPRAZOLE 60 MG CAPSULE,BIPHASE DELAYED RELEASE",42.25,25.35,9.8,4481.0,19 NDC,25021011020,CEFOXITIN 2 GRAM INTRAVENOUS SOLUTION,95.7,57.42,10.76,4481.0,24 NDC,25021011487,CIPROFLOXACIN 400 MG/200 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,89.7,53.82,6.32,4481.0,24 NDC,25021011487,CIPROFLOXACIN 400 MG/200 ML IN D5W (ODD DOSE),89.7,53.82,6.32,4481.0,24 NDC,25021011506,CLINDAMYCIN 150 MG/ML INJECTION SOLUTION,37.3,22.38,4.12,4481.0,24 NDC,25021012120,CEFEPIME 1 GRAM SOLUTION FOR IV PUSH,39.4,23.64,2.75,4481.0,24 NDC,25021012250,CEFEPIME 2 GRAM SOLUTION FOR IV PUSH',55.0,33.0,2.75,4481.0,24 NDC,25021016430,PIPERACILLIN-TAZO 200 MG/ML DESENS SOL'N #1,72.8,43.68,2.41,4481.0,24 NDC,25021018482,FLUCONAZOLE 200 MG/100 ML IN SOD. CHLORIDE (ISO) INTRAVENOUS PIGGYBACK,97.3,58.38,5.08,4481.0,24 NDC,25021018487,FLUCONAZOLE 400 MG/200 ML IN SOD. CHLORIDE(ISO) INTRAVENOUS PIGGYBACK,116.35,69.81,5.08,4481.0,24 NDC,25021019010,MICAFUNGIN 50 MG INTRAVENOUS SOLUTION,368.75,221.25,0.585,4481.0,24 NDC,25021020401,VINORELBINE 10 MG/ML INTRAVENOUS SOLUTION,357.75,214.65,5.33,4481.0,24 NDC,25021020405,VINORELBINE 50 MG/5 ML INTRAVENOUS SOLUTION,572.9,343.74,5.33,4481.0,24 NDC,25021023002,IRINOTECAN 20 MG/ML ORAL SOLUTION,93.7,56.22,3.81,4481.0,24 NDC,25021030520,CHLOROTHIAZIDE SODIUM 500 MG INTRAVENOUS SOLUTION,259.2,155.52,60.13,4481.0,24 NDC,25021040030,"HEPARIN (PORCINE) 1,000 UNIT/ML INJECTION SOLUTION",42.6,25.56,0.4725,4481.0,24 NDC,25021060103,CAFFEINE CITRATE 20 MG/ML (FOR ORAL USE) INJECTION SOLUTION,76.05,45.63,2.77,4481.0,23 NDC,25021067620,PENTOBARBITAL SODIUM 50 MG/ML INJECTION SOLUTION,3664.1,2198.46,121.21,4481.0,24 NDC,25021081230,ACETYLCYSTEINE 200 MG/ML (20 %) INTRAVENOUS SOLUTION,79.4,47.64,0.855,4481.0,24 NDC,25021081310,LEUCOVORIN CALCIUM 50 MG SOLUTION FOR INJECTION,304.15,182.49,7.25,4481.0,24 NDC,25021081430,LEUCOVORIN CALCIUM 100 MG SOLUTION FOR INJECTION,94.0,56.4,7.25,4481.0,24 NDC,25021081630,LEUCOVORIN CALCIUM 350 MG SOLUTION FOR INJECTION,506.7,304.02,7.25,4481.0,24 NDC,25021083082,ZOLEDRONIC ACID 5 MG/100 ML IN MANNITOL 5 %-WATER INTRAVENOUS PIGGYBCK,1207.5,724.5,11.38,4481.0,24 NDC,25357010001,TRAVOPROST 75 MCG INTRACAMERAL IMPLANT,54421.0,32652.6,189.85,43536.8,35 NDC,25682000101,ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION,21393.2,12835.92,43.48,17114.56,35 NDC,25682000701,SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION,33449.7,20069.82,523.71,77433.72,35 NDC,25682002501,RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION,21422.95,12853.77,218.36,36062.04,35 NDC,25682002801,RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION,78382.65,47029.59,218.36,62706.12,35 NDC,25767073545,CARDIOPLEGIC-ORGAN PRESERVATION SOLUTION NO.1 9 MMOL-198 MMOL-2 MMOL/L,855.5,513.3,198.48,4481.0,24 NDC,27808022201,"PALIPERIDONE ER 1.5 MG TABLET,EXTENDED RELEASE 24 HR",22.55,13.53,5.23,4481.0,19 NDC,27808022301,"PALIPERIDONE ER 3 MG TABLET,EXTENDED RELEASE 24 HR",22.55,13.53,5.23,4481.0,19 NDC,28595012049,NITROGLYCERIN 400 MCG/SPRAY TRANSLINGUAL,579.1,347.46,134.35,4481.0,19 NDC,30237890006,SIPULEUCEL-T (PROVENGE) IVPB,207489.3,124493.58,4481.0,9332515.5,36 NDC,31722011901,"HYDROMORPHONE ER 8 MG TABLET,EXTENDED RELEASE 24 HR",45.45,27.27,10.54,4481.0,19 NDC,31722012001,"HYDROMORPHONE ER 12 MG TABLET,EXTENDED RELEASE 24 HR",57.0,34.2,13.22,4481.0,19 NDC,31722030801,OLANZAPINE 10 MG INTRAMUSCULAR SOLUTION,94.0,56.4,1.96,4481.0,24 NDC,31722050430,EFAVIRENZ 600 MG TABLET,24.05,14.43,5.58,4481.0,19 NDC,31722050960,ZIDOVUDINE 300 MG TABLET,18.25,10.95,4.23,4481.0,19 NDC,31722055612,LOPINAVIR-RITONAVIR 200 MG-50 MG TABLET,38.15,22.89,8.85,4481.0,19 NDC,31722056860,DARUNAVIR 600 MG TABLET,20.95,12.57,4.86,4481.0,19 NDC,31722057447,LEVETIRACETAM 100 MG/ML ORAL SOLUTION,105.4,63.24,24.45,4481.0,19 NDC,31722083260,VALGANCICLOVIR 450 MG TABLET,28.55,17.13,6.62,4481.0,19 NDC,31722083330,ENTECAVIR 0.5 MG TABLET,20.0,12.0,4.64,4481.0,19 NDC,31722086831,TOLVAPTAN 15 MG TABLET,196.0,117.6,45.47,4481.0,19 NDC,31722093502,ALBENDAZOLE 200 MG TABLET,106.0,63.6,24.59,4481.0,19 NDC,33342005507,PIOGLITAZONE 30 MG TABLET,16.55,9.93,3.84,4481.0,19 NDC,33342005607,PIOGLITAZONE 45 MG TABLET,16.6,9.96,3.85,4481.0,19 NDC,33342025666,OSELTAMIVIR 30 MG CAPSULE,21.8,13.08,5.06,4481.0,19 NDC,33342032915,TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAM,26.85,16.11,6.23,4481.0,19 NDC,33342044711,PYRAZINAMIDE 500 MG TABLET,29.3,17.58,6.8,4481.0,19 NDC,35046000155,CALCIUM 200 MG (AS CALCIUM CITRATE 950 MG) TABLET,1.1,0.66,0.2552,4481.0,19 NDC,36000003310,METOPROLOL TARTRATE 5 MG/5 ML INTRAVENOUS SOLUTION,19.9,11.94,0.27,4481.0,24 NDC,36000014801,FLUMAZENIL 0.1 MG/ML INTRAVENOUS SOLUTION,86.2,51.72,20.0,4481.0,19 NDC,37000002410,PSYLLIUM HUSK 3.4 GRAM ORAL POWDER PACKET,1.5,0.9,0.348,4481.0,19 NDC,37000003202,BISMUTH SUBSALICYLATE 262 MG/15 ML ORAL SUSPENSION,1.75,1.05,0.406,4481.0,19 NDC,38779034801,NEOMYCIN SULFATE (BULK) POWDER,194.25,116.55,45.07,4481.0,19 NDC,39822015101,LIOTHYRONINE 10 MCG/ML INTRAVENOUS SOLUTION,1446.25,867.75,335.53,4481.0,19 NDC,39822019001,ACETAZOLAMIDE 500 MG SOLUTION FOR INJECTION,138.85,83.31,32.21,4481.0,24 NDC,39822041201,TOBRAMYCIN 1.2 GRAM POWDER (OSM),328.0,196.8,5.33,4481.0,24 NDC,39822041201,TOBRAMYCIN 1.2 GRAM SOLUTION FOR INJECTION,328.0,196.8,5.33,4481.0,24 NDC,39822105505,AMPHOTERICIN B 50 MG SOLUTION FOR INJECTION,203.2,121.92,47.14,4481.0,24 NDC,39822105505,AMPHOTERICIN B CONVENTIONAL 5 MG/ML NASAL IRRIGATION,220.0,132.0,51.04,4481.0,24 NDC,39822105505,AMPHOTERICIN B CONVENTIONAL SOLUTION FOR INHALATION,220.0,132.0,51.04,4481.0,24 NDC,39822200001,"CLONIDINE (PF) 1,000 MCG/10 ML (100 MCG/ML) EPIDURAL SOLUTION",75.3,45.18,17.47,4481.0,24 NDC,39822305001,PENTAMIDINE 300 MG SOLUTION FOR INJECTION,367.0,220.2,85.14,4481.0,19 NDC,40093010196,SELENIUM 200 MCG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,41679036513,MEDIUM CHAIN TRIGLYCERIDES (MCT) 7.7 KCAL/ML ORAL OIL,100.75,60.45,23.37,4481.0,19 NDC,42023010501,METHOHEXITAL 500 MG SOLUTION FOR INJECTION,357.75,214.65,83.0,4481.0,19 NDC,42023011310,KETAMINE 10 MG/ML INTRANASAL SOLUTION,81.55,48.93,18.92,4481.0,19 NDC,42023015925,EPINEPHRINE 1 MG/ML (1 ML) INJECTION SOLUTION,21.85,13.11,3.06,4481.0,24 NDC,42023016401,VASOPRESSIN 20 UNIT/ML INTRAVENOUS SOLUTION,35.5,21.3,2.09,4481.0,24 NDC,42023019001,VASOPRESSIN 20 UNIT/ML INJECTION SOLUTION WRAPPER,35.5,21.3,2.09,4481.0,24 NDC,42023019001,VASOPRESSIN 20 UNIT/ML INTRAVENOUS SOLUTION,35.5,21.3,2.09,4481.0,24 NDC,42023021601,EPHEDRINE 50 MG/ML INJECTION WRAPPER,129.3,77.58,30.0,4481.0,19 NDC,42023023710,VASOPRESSIN 0.2 UNIT/ML INTRAVENOUS SOLUTION,226.5,135.9,2.09,4481.0,24 NDC,42192032901,THYROID (PORK) 30 MG TABLET,18.1,10.86,4.2,4481.0,19 NDC,42192033101,THYROID (PORK) 90 MG TABLET,19.6,11.76,4.55,4481.0,19 NDC,42192034001,HYOSCYAMINE SULFATE 0.125 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,42192060806,GABAPENTIN 300 MG/6 ML (6 ML) ORAL SOLUTION,27.25,16.35,6.32,4481.0,19 NDC,42192060816,GABAPENTIN 250 MG/5 ML ORAL SOLUTION,295.2,177.12,68.49,4481.0,19 NDC,42192061405,PHENYTOIN SODIUM 50 MG/ML INTRAVENOUS SOLUTION,35.45,21.27,1.01,4481.0,24 NDC,42291006830,ATOMOXETINE 60 MG CAPSULE,20.2,12.12,4.69,4481.0,19 NDC,42292005401,COLCHICINE 0.6 MG TABLET,43.9,26.34,10.18,4481.0,19 NDC,42367054032,DANTROLENE 250 MG INTRAVENOUS SUSPENSION,10901.0,6540.6,2529.03,8720.8,19 NDC,42571014726,DORZOLAMIDE 22.3 MG-TIMOLOL 6.8 MG/ML EYE DROPS,166.5,99.9,38.63,4481.0,19 NDC,42571016201,AMOXICILLIN 875 MG-POTASSIUM CLAVULANATE 125 MG TABLET,17.8,10.68,4.13,4481.0,19 NDC,42571024301,"ACETAZOLAMIDE ER 500 MG CAPSULE,EXTENDED RELEASE",18.25,10.95,4.23,4481.0,19 NDC,42747076101,MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION,16104.75,9662.85,241.04,39876.69,35 NDC,42794001812,LIOTHYRONINE 5 MCG TABLET,18.05,10.83,4.19,4481.0,19 NDC,42794001912,LIOTHYRONINE 25 MCG TABLET,18.65,11.19,4.33,4481.0,19 NDC,42794008614,SODIUM PHENYLBUTYRATE 0.94 GRAM/GRAM ORAL POWDER,13560.0,8136.0,3145.92,10848.0,19 NDC,42799011901,BUMETANIDE 0.5 MG TABLET,17.05,10.23,3.96,4481.0,19 NDC,42799040501,ETHACRYNIC ACID 25 MG TABLET,23.5,14.1,5.45,4481.0,19 NDC,42799080601,IVERMECTIN 3 MG TABLET,28.45,17.07,6.6,4481.0,19 NDC,42806008701,ESTRADIOL 0.5 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,42806026698,CHOLESTYRAMINE (WITH SUGAR) 4 GRAM POWDER FOR SUSP IN A PACKET,19.0,11.4,4.41,4481.0,19 NDC,42806075760,SULFADIAZINE 500 MG TABLET,64.1,38.46,14.87,4481.0,19 NDC,42858000401,OXYCODONE 20 MG TABLET,23.3,13.98,5.41,4481.0,19 NDC,42858030225,HYDROMORPHONE 4 MG TABLET,22.7,13.62,5.27,4481.0,19 NDC,42858080301,"MORPHINE ER 60 MG TABLET,EXTENDED RELEASE",24.7,14.82,5.73,4481.0,19 NDC,42858086706,DRONABINOL 2.5 MG CAPSULE,28.3,16.98,6.57,4481.0,19 NDC,43066001610,NICARDIPINE 40 MG/200 ML(0.2 MG/ML) IN SOD CHLOR(ISO) INTRAVENOUS SOLN,324.6,194.76,0.1575,4481.0,24 NDC,43066002301,ROPIVACAINE (PF) 5 MG/ML (0.5 %) INJECTION SOLUTION,31.65,18.99,0.1125,4481.0,24 NDC,43066003101,VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTION,31.95,19.17,7.41,4481.0,19 NDC,43066015010,"AMIODARONE 150 MG/100 ML (1.5 MG/ML) IN DEXTROSE, ISO-OSMOTIC IV",195.25,117.15,5.87,4481.0,24 NDC,43066036020,"AMIODARONE 360 MG/200 ML (1.8 MG/ML) IN DEXTROSE, ISO-OSMOTIC IV",239.05,143.43,5.87,4481.0,24 NDC,43066099524,CLINDAMYCIN 900 MG/50 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK,112.75,67.65,4.12,4481.0,24 NDC,43066099710,NOREPINEPHRINE BITARTRATE 1 MG/ML INTRAVENOUS SOLUTION,79.35,47.61,18.41,4481.0,19 NDC,43376032230,FENFLURAMINE 2.2 MG/ML ORAL SOLUTION,5039.2,3023.52,1169.09,4481.0,19 NDC,43376032236,FENFLURAMINE 2.2 MG/ML ORAL SOLUTION,60228.25,36136.95,4481.0,48182.6,19 NDC,43386031208,POLYETHYLENE GLYCOL 3350 17 GRAM/DOSE ORAL POWDER,13.55,8.13,3.14,4481.0,19 NDC,43528000305,HEPATITIS B VACCINE 20 MCG/0.5 ML-ADJUVANT CPG 1018 (PF) IM SYRINGE,489.25,293.55,113.51,4481.0,26 NDC,43547054710,ENALAPRIL MALEATE 10 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,43547054810,ENALAPRIL MALEATE 20 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,43598012745,METHYLPREDNISOLONE SODIUM SUCCINATE 40 MG SOLUTION FOR INJECTION,34.75,20.85,0.2037,4481.0,35 NDC,43598012811,METHYLPREDNISOLONE SODIUM SUCCINATE 500 MG INTRAVENOUS SOLUTION,134.95,80.97,0.2037,4481.0,35 NDC,43598012925,METHYLPREDNISOLONE SODIUM SUCCINATE 125 MG SOLUTION FOR INJECTION,45.65,27.39,0.2037,4481.0,35 NDC,43598044001,"METHYLPHENIDATE ER 36 MG TABLET,EXTENDED RELEASE 24 HR",28.3,16.98,6.57,4481.0,19 NDC,43598047801,SEVELAMER CARBONATE 0.8 GRAM ORAL POWDER PACKET,44.4,26.64,10.3,4481.0,19 NDC,43598048624,NICOTINE (POLACRILEX) 2 MG BUCCAL LOZENGE,1.6,0.96,0.3712,4481.0,19 NDC,43598048724,NICOTINE (POLACRILEX) 4 MG BUCCAL LOZENGE,1.6,0.96,0.3712,4481.0,19 NDC,43598054125,"DOXORUBICIN, PEGYLATED LIPOSOMAL 2 MG/ML INTRAVENOUS SUSPENSION",4412.5,2647.5,105.22,22320.48,35 NDC,43598063552,LEVETIRACETAM 500 MG/100 ML IN SODIUM CHLORIDE (ISO-OSM) IV PIGGYBACK,133.5,80.1,0.09,4481.0,24 NDC,43598084811,ZIPRASIDONE 20 MG/ML (FINAL CONCENTRATION) INTRAMUSCULAR SOLUTION,199.3,119.58,8.55,4481.0,24 NDC,43825020001,TERLIPRESSIN 0.85 MG INTRAVENOUS POWDER FOR SOLUTION,3293.8,1976.28,764.16,4481.0,22 NDC,43900028300,GLUTAMINE 15 GRAM ORAL POWDER PACKET,3.95,2.37,0.9164,4481.0,19 NDC,43900097647,GUAR GUM ORAL PACKET,1.75,1.05,0.406,4481.0,19 NDC,43975033210,"DEXTROAMPHETAMINE-AMPHETAMINE ER 10 MG 24HR CAPSULE,EXTEND RELEASE",26.25,15.75,6.09,4481.0,19 NDC,44087353501,AVELUMAB 20 MG/ML INTRAVENOUS SOLUTION,7206.25,4323.75,97.09,15899.52,35 NDC,44087500003,TEPOTINIB 225 MG TABLET,1742.8,1045.68,404.33,4481.0,19 NDC,44206025105,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION",403.25,241.95,93.55,4481.0,24 NDC,44206025105,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION WRAPPER",403.25,241.95,93.55,4481.0,24 NDC,44206025110,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION",729.5,437.7,103.28,4481.0,24 NDC,44206025110,"ALBUMIN, HUMAN 25 % INTRAVENOUS SOLUTION WRAPPER",729.5,437.7,103.28,4481.0,24 NDC,44206030001,"RHO(D) IMMUNE GLOBULIN 1,500 UNIT (300 MCG)/2 ML INJECTION SYRINGE",693.8,416.28,10.94,4481.0,24 NDC,44206043605,ORAL HUMAN IMMUNE GLOBULIN FOR NOROVIRUS (OFF-LABEL USE),1468.0,880.8,49.22,7707.21,35 NDC,44206043710,ORAL HUMAN IMMUNE GLOBULIN FOR NOROVIRUS (OFF-LABEL USE),1468.0,880.8,49.22,7707.21,35 NDC,44206043820,"IMMUNE GLOB,GAMM(IGG) 10 %-PRO-IGA 0 TO 50 MCG/ML INTRAVENOUS SOLUTION",13986.85,8392.11,49.22,11189.48,35 NDC,44206043820,ORAL HUMAN IMMUNE GLOBULIN FOR NOROVIRUS (OFF-LABEL USE),1468.0,880.8,49.22,7707.21,35 NDC,44567022110,NAFCILLIN 1 GRAM SOLUTION FOR INJECTION,99.0,59.4,0.1125,4481.0,24 NDC,44567022210,NAFCILLIN 2 GRAM INJ SOLR IM,134.95,80.97,0.1125,4481.0,24 NDC,44567022210,NAFCILLIN 2 GRAM SOLUTION FOR INJECTION,134.95,80.97,0.1125,4481.0,24 NDC,44567023525,CEFTAZIDIME 1 GRAM INJ SOLR IM,33.55,20.13,3.53,4481.0,24 NDC,44567023525,CEFTAZIDIME 1 GRAM INJECTION COMBINED WRAPPER,33.55,20.13,3.53,4481.0,24 NDC,44567023525,CEFTAZIDIME 1 GRAM SOLUTION FOR INJECTION,33.55,20.13,3.53,4481.0,24 NDC,44567023610,CEFTAZIDIME 2 GRAM INJECTION COMBINED WRAPPER,55.0,33.0,3.53,4481.0,24 NDC,44567023610,CEFTAZIDIME 2 GRAM SOLUTION FOR INJECTION,55.0,33.0,3.53,4481.0,24 NDC,44567024525,CEFOXITIN 1 GRAM INTRAVENOUS SOLUTION,95.55,57.33,10.76,4481.0,24 NDC,44567045001,"ESMOLOL 2,500 MG/250 ML (10 MG/ML) IN SODIUM CHLORIDE (ISO-OSMOTIC) IV",367.15,220.29,0.495,4481.0,24 NDC,44567050201,"LEVETIRACETAM 1,000 MG/100 ML IN SODIUM CHLORIDE(ISO-OSM) IV PIGGYBACK",105.3,63.18,0.09,4481.0,24 NDC,44567050301,"LEVETIRACETAM 1,500 MG/100 ML IN SODIUM CHLORIDE(ISO-OSM) IV PIGGYBACK",120.95,72.57,0.09,4481.0,24 NDC,44567053001,CISPLATIN (POWDER) 1 MG/ML IVPB,1930.0,1158.0,5.15,4481.0,24 NDC,44567053001,CISPLATIN 50 MG INTRAVENOUS POWDER FOR SOLUTION,1930.0,1158.0,5.15,4481.0,24 NDC,44567061101,MIDAZOLAM 1 MG/ML INFUSION WRAPPER,112.3,67.38,0.3375,4481.0,24 NDC,44567062001,"CALCIUM GLUCONATE 1 GRAM/50 ML IN SODIUM CHLORIDE, ISO-OSM IV SOLUTION",138.25,82.95,0.2025,4481.0,24 NDC,44567062101,"CALCIUM GLUCONATE 2 GRAM/100 ML IN SODIUM CHLORIDE,ISO-OSM IV SOLUTION",213.5,128.1,0.2025,4481.0,24 NDC,44946103208,FLUORIDE 0.5 MG (1.1 MG SODIUM FLUORIDE)/ML ORAL DROPS,1.05,0.63,0.2436,4481.0,19 NDC,45802004064,SELENIUM SULFIDE 2.5 % LOTION,16.45,9.87,3.82,4481.0,19 NDC,45802005436,TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL OINTMENT,40.6,24.36,9.42,4481.0,19 NDC,45802005535,TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENT,29.6,17.76,6.87,4481.0,19 NDC,45802005635,GENTAMICIN 0.1 % TOPICAL CREAM,134.9,80.94,31.3,4481.0,19 NDC,45802006070,BACITRACIN 500 UNIT/GRAM TOPICAL PACKET,1.25,0.75,0.29,4481.0,19 NDC,45802009846,MESALAMINE 4 GRAM/60 ML ENEMA,55.4,33.24,12.85,4481.0,19 NDC,45802013970,METRONIDAZOLE 0.75 % (37.5 MG/5 GRAM) VAGINAL GEL,76.3,45.78,17.7,4481.0,19 NDC,45802027603,HYDROCORTISONE 1 % TOPICAL OINTMENT,4.3,2.58,0.9976,4481.0,19 NDC,45802041059,OXYMETAZOLINE 0.05 % NASAL SPRAY,4.3,2.58,0.9976,4481.0,19 NDC,45802043803,HYDROCORTISONE 1 % TOPICAL CREAM,4.3,2.58,0.9976,4481.0,19 NDC,45802046564,KETOCONAZOLE 2 % SHAMPOO,82.5,49.5,19.14,4481.0,19 NDC,45802046611,ECONAZOLE NITRATE 1 % TOPICAL CREAM,166.75,100.05,38.69,4481.0,19 NDC,45802052555,AMMONIUM LACTATE 12 % LOTION,16.15,9.69,3.75,4481.0,19 NDC,45802058001,SCOPOLAMINE 1 MG OVER 3 DAYS TRANSDERMAL PATCH,44.5,26.7,10.32,4481.0,19 NDC,45802073000,ACETAMINOPHEN 650 MG RECTAL SUPPOSITORY,1.45,0.87,0.3364,4481.0,19 NDC,45802073200,ACETAMINOPHEN 120 MG RECTAL SUPPOSITORY,1.5,0.9,0.348,4481.0,19 NDC,45802095243,IBUPROFEN 100 MG/5 ML ORAL SUSPENSION,39.9,23.94,9.26,4481.0,19 NDC,45963043864,LACTULOSE 10 GRAM/15 ML ORAL SOLUTION,16.7,10.02,3.87,4481.0,19 NDC,45963060955,FLUDARABINE 50 MG INTRAVENOUS SOLUTION,587.8,352.68,66.15,9659.37,35 NDC,46122043240,ALUMINUM-MAG HYDROXIDE-SIMETHICONE 400 MG-400 MG-40 MG/5 ML ORAL SUSP,1.35,0.81,0.3132,4481.0,19 NDC,46122059602,"ASPIRIN 325 MG TABLET,DELAYED RELEASE",1.05,0.63,0.2436,4481.0,19 NDC,46122070165,BISMUTH SUBSALICYLATE 262 MG CHEWABLE TABLET,1.15,0.69,0.2668,4481.0,19 NDC,46287000660,SODIUM POLYSTYRENE SULFONATE 15 GRAM-SORBITOL 20 GRAM/60 ML ORAL SUSP,90.35,54.21,20.96,4481.0,19 NDC,46287000660,SODIUM POLYSTYRENE SULFONATE 15 GRAM/60 ML ORAL COMBINED WRAPPER,90.35,54.21,20.96,4481.0,19 NDC,46287000901,ISONIAZID 50 MG/5 ML ORAL SOLUTION,1023.5,614.1,237.45,4481.0,19 NDC,46287002004,SPIRONOLACTONE 25 MG/5 ML ORAL SUSPENSION,1312.75,787.65,304.56,4481.0,19 NDC,47335004940,"DOXORUBICIN, PEGYLATED LIPOSOMAL 2 MG/ML INTRAVENOUS SUSPENSION",1764.5,1058.7,105.22,22320.48,35 NDC,47335006186,DOFETILIDE 125 MCG CAPSULE,20.8,12.48,4.83,4481.0,19 NDC,47335017148,TOBRAMYCIN 300 MG/5 ML IN 0.225 % SODIUM CHLORIDE FOR NEBULIZATION,51.25,30.75,11.89,4481.0,19 NDC,47335023783,AMBRISENTAN 10 MG TABLET,131.25,78.75,30.45,4481.0,19 NDC,47335033040,CHLOROTHIAZIDE SODIUM 28 MG/ML,389.4,233.64,88.76,4481.0,24 NDC,47335033040,CHLOROTHIAZIDE SODIUM 28 MG/ML (PEDIATRIC),389.4,233.64,88.76,4481.0,24 NDC,47335057883,LURASIDONE 20 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,47426030102,BUPIVACAINE-MELOXICAM ER 400 MG-12 MG/14 ML SURGICAL SITE INSTILL SOLN,165.0,99.0,0.7566,4481.0,35 NDC,47426030301,BUPIVACAINE-MELOXICAM ER 200 MG-6 MG/7 ML SURGICAL SITE INSTILL SOLN,170.7,102.42,0.7566,4481.0,35 NDC,47781035711,BUPRENORPHINE 8 MG-NALOXONE 2 MG SUBLINGUAL FILM,30.6,18.36,7.1,4481.0,22 NDC,47781060730,DISULFIRAM 250 MG TABLET,24.5,14.7,5.68,4481.0,19 NDC,47781064726,"ERGOCALCIFEROL (VITAMIN D2) 200 MCG/ML (8,000 UNIT/ML) ORAL DROPS",1.4,0.84,0.3248,4481.0,19 NDC,48433022040,DOCUSATE SODIUM 50 MG/5 ML ORAL LIQUID,3.6,2.16,0.8352,4481.0,19 NDC,48433023015,IODINE STRONG (LUGOLS) 5 % ORAL SOLUTION,18.1,10.86,4.2,4481.0,19 NDC,48582000155,SALIVA STIMULANT COMBINATION NO.3 ORAL MUCOSAL SPRAY,9.75,5.85,2.26,4481.0,19 NDC,49230018820,PERITON. DIALYSIS SOLN 19-1.5 % DEXTROSE CALC 3.5 MEQ/L-MAG 1.5 MEQ/L,93.5,56.1,21.69,4481.0,19 NDC,49230018830,PERITON. DIALYSIS SOLN 19-1.5 % DEXTROSE CALC 3.5 MEQ/L-MAG 1.5 MEQ/L,85.9,51.54,19.93,4481.0,19 NDC,49230018850,PERITON. DIALYSIS SOLN 19-1.5 % DEXTROSE CALC 3.5 MEQ/L-MAG 1.5 MEQ/L,120.15,72.09,27.87,4481.0,19 NDC,49281021558,TETANUS AND DIPHTHERIA TOX (PF) 5 LF UNIT-2 LF UNIT/0.5 ML IM SUSP,144.25,86.55,33.47,4481.0,25 NDC,49281054503,HAEMOPHILUS B POLYSACCHARID CONJ-TETANUS TOX(PF) 10 MCG/0.5 ML IM SOLN,60.0,36.0,13.92,4481.0,25 NDC,49281057488,NIRSEVIMAB-ALIP 100 MG/ML INTRAMUSCULAR SYRINGE,2184.95,1310.97,506.91,88292.61,25 NDC,49281057515,NIRSEVIMAB-ALIP 50 MG/0.5 ML INTRAMUSCULAR SYRINGE,2184.95,1310.97,506.91,88292.61,25 NDC,49281075221,TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL INJECTION SOLUTION,56.75,34.05,13.17,4481.0,19 NDC,49281075222,TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL INJECTION SOLUTION,49.1,29.46,11.39,4481.0,19 NDC,49281086010,POLIOVIRUS VACCINE 40 UNIT-8 UNIT-32 UNIT/0.5 ML INJECTION SUSPENSION,153.95,92.37,35.72,4481.0,25 NDC,49401010101,BELIMUMAB 120 MG INTRAVENOUS SOLUTION,2180.2,1308.12,54.39,8308.44,35 NDC,49401010201,BELIMUMAB 400 MG INTRAVENOUS SOLUTION,7119.7,4271.82,54.39,8308.44,35 NDC,49411005208,AMINOCAPROIC ACID 250 MG/ML (25 %) ORAL SOLUTION,8400.9,5040.54,1949.01,6720.72,19 NDC,49471000105,BENZYLPENICILLOYL POLYLYSINE 0.25 ML INTRADERMAL INJECTION SOLUTION,43.75,26.25,10.15,4481.0,19 NDC,49502010201,"EPINEPHRINE 0.3 MG/0.3 ML INJECTION, AUTO-INJECTOR",601.0,360.6,1.08,4481.0,24 NDC,49502060595,FORMOTEROL FUMARATE 20 MCG/2 ML SOLUTION FOR NEBULIZATION,77.5,46.5,17.98,4481.0,19 NDC,49591005151,HEPATITIS B IMMUNE GLOBULIN-MALTOSE (HEPAGAM B) >312 UNIT/ML (5 ML) INJECTION SOLN,3303.05,1981.83,64.64,4481.0,35 NDC,49591005251,HEPATITIS B IMMUNE GLOBULIN-MALTOSE (HEPAGAM B) >312 UNIT/ML (1 ML) INJECTION SOLUTION,814.15,488.49,64.64,4481.0,35 NDC,49591053250,CYTOMEGALOVIRUS IMMUNE GLOBULIN 50 MG/ML INTRAVENOUS SOLUTION,6445.6,3867.36,1630.74,321716.85,35 NDC,49702020548,LAMIVUDINE 10 MG/ML ORAL SOLUTION,348.65,209.19,80.89,4481.0,19 NDC,49702021326,ZIDOVUDINE 10 MG/ML INTRAVENOUS SOLUTION,158.5,95.1,3.4,4481.0,24 NDC,49702022813,DOLUTEGRAVIR 50 MG TABLET,248.55,149.13,57.66,4481.0,19 NDC,49702024015,"CABOTEGRAVIR ER 600 MG/3 ML-RILPIVIRINE ER 900 MG/3ML IM SUSPENSION,ER",27156.1,16293.66,22.94,21724.88,35 NDC,49702025315,"CABOTEGRAVIR ER 400 MG/2 ML-RILPIVIRINE ER 600 MG/2ML IM SUSPENSION,ER",18109.4,10865.64,22.94,14487.52,35 NDC,49702026423,"CABOTEGRAVIR ER 600 MG/3 ML (200 MG/ML) IM SUSPENSION,EXTENDED RELEASE",16106.85,9664.11,6.81,12885.48,35 NDC,49771000201,MITOMYCIN 0.2 MG OPHTHALMIC KIT,1463.3,877.98,339.49,4481.0,23 NDC,49884015576,VARENICLINE TARTRATE 0.5 MG TABLET,18.95,11.37,4.4,4481.0,19 NDC,49884023183,PRAZIQUANTEL 600 MG TABLET,215.3,129.18,49.95,4481.0,19 NDC,49884030602,CLONAZEPAM 0.125 MG DISINTEGRATING TABLET,24.85,14.91,5.77,4481.0,19 NDC,49884030702,CLONAZEPAM 0.25 MG DISINTEGRATING TABLET,24.85,14.91,5.77,4481.0,19 NDC,49884031552,RISPERIDONE 1 MG DISINTEGRATING TABLET,28.3,16.98,6.57,4481.0,19 NDC,49884040152,RISPERIDONE 2 MG DISINTEGRATING TABLET,35.95,21.57,8.34,4481.0,19 NDC,50190014123,SODIUM CHLORIDE 7 % FOR NEBULIZATION,17.9,10.74,4.15,4481.0,19 NDC,50190014263,SODIUM CHLORIDE 3 % FOR NEBULIZATION,17.9,10.74,4.15,4481.0,19 NDC,50228048201,DILTIAZEM 60 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,50242001403,TENECTEPLASE 25 MG INTRAVENOUS SOLUTION FOR STROKE,32375.35,19425.21,167.05,28007.92,35 NDC,50242004062,OMALIZUMAB 150 MG SUBCUTANEOUS SOLUTION,4878.95,2927.37,43.26,6119.61,35 NDC,50242004164,ALTEPLASE 2 MG INTRA-CATHETER SOLUTION,738.2,442.92,91.62,4481.0,35 NDC,50242004406,ALTEPLASE 50 MG INTRAVENOUS SOLUTION,17176.75,10306.05,91.62,14859.61,35 NDC,50242005121,RITUXIMAB (RITUXAN) SYRINGE 10 MG/ML OPHTHALMIC INTRAVITREAL,306.1,183.66,72.96,4481.0,31 NDC,50242005121,"RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS",3384.85,2030.91,72.96,12511.17,35 NDC,50242005121,RITUXIMAB 10 MG/ML INTRALESIONAL SOLUTION,586.0,351.6,72.96,12511.17,35 NDC,50242005306,"RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS",15824.1,9494.46,72.96,12659.28,35 NDC,50242005306,RITUXIMAB 10 MG/ML INTRALESIONAL SOLUTION,586.0,351.6,72.96,12511.17,35 NDC,50242006101,BEVACIZUMAB (AVASTIN) 25 MG/ML,308.0,184.8,71.0,10991.19,35 NDC,50242007001,"OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION",30065.95,18039.57,76.63,24052.76,35 NDC,50242007701,"TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION",15750.05,9450.03,59.6,12600.04,35 NDC,50242008525,ALTEPLASE 1 MG/ML 100 ML PEDIATRIC INFUSION,28840.2,17304.12,91.62,24949.66,35 NDC,50242008525,ALTEPLASE 100 MG INTRAVENOUS SOLUTION,34337.45,20602.47,91.62,29705.33,35 NDC,50242008525,ALTEPLASE STEMI INFUSION,34337.45,20602.47,91.62,29705.33,35 NDC,50242008527,ALTEPLASE 15 MG STEMI BOLUS,34337.45,20602.47,91.62,29705.33,35 NDC,50242008701,ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION,21404.1,12842.46,40.9,17123.28,35 NDC,50242008801,ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION,13480.7,8088.42,40.9,10784.56,35 NDC,50242009130,ENTRECTINIB 100 MG CAPSULE,960.35,576.21,222.8,4481.0,19 NDC,50242009490,ENTRECTINIB 200 MG CAPSULE,960.35,576.21,222.8,4481.0,19 NDC,50242009601,FARICIMAB-SVOA 6 MG/0.05 ML INTRAVITREAL INJ WRAPPER,9168.9,5501.34,32.86,7335.12,35 NDC,50242010040,DORNASE ALFA 1 MG/ML SOLUTION FOR CHEST TUBE,818.65,491.19,189.93,4481.0,19 NDC,50242010040,DORNASE ALFA 1 MG/ML SOLUTION FOR INHALATION,417.35,250.41,96.83,4481.0,19 NDC,50242010301,POLATUZUMAB VEDOTIN-PIIQ 30 MG INTRAVENOUS SOLUTION,13475.85,8085.51,132.57,21723.66,35 NDC,50242010501,POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION,61878.8,37127.28,132.57,49503.04,35 NDC,50242010801,"RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN",22043.5,13226.1,35.59,17634.8,35 NDC,50242010901,"RITUXIMAB 1,600 MG/13.4 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN",25153.25,15091.95,35.59,20122.6,35 NDC,50242012047,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION FOR MI,32375.35,19425.21,167.05,28007.92,35 NDC,50242012047,TENECTEPLASE 50 MG INTRAVENOUS SOLUTION WRAPPER FOR MI,32375.35,19425.21,167.05,28007.92,35 NDC,50242012501,GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION,9246.2,5547.72,2339.29,453849.27,35 NDC,50242012701,GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION,9246.2,5547.72,2339.29,453849.27,35 NDC,50242013001,ALECTINIB 150 MG CAPSULE,349.45,209.67,81.07,4481.0,19 NDC,50242013201,TRASTUZUMAB 150 MG INTRAVENOUS SOLUTION,5433.45,3260.07,72.78,11339.58,35 NDC,50242013501,TOCILIZUMAB (ACTEMRA) 20 MG/ML INJECTION WRAPPER,1799.9,1079.94,5.54,4481.0,35 NDC,50242013501,TOCILIZUMAB 80 MG/4 ML (20 MG/ML) INTRAVENOUS SOLUTION,1799.9,1079.94,5.54,4481.0,35 NDC,50242013601,TOCILIZUMAB (ACTEMRA) 20 MG/ML INJECTION WRAPPER,4405.3,2643.18,5.54,4481.0,35 NDC,50242013601,TOCILIZUMAB 200 MG/10 ML (20 MG/ML) INTRAVENOUS SOLUTION,4405.3,2643.18,5.54,4481.0,35 NDC,50242013701,TOCILIZUMAB (ACTEMRA) 20 MG/ML INJECTION WRAPPER,8747.55,5248.53,5.54,6998.04,35 NDC,50242013701,TOCILIZUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION,8747.55,5248.53,5.54,6998.04,35 NDC,50242014201,MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION,62263.55,37358.13,634.99,104912.43,35 NDC,50242014501,PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION,22850.85,13710.51,16.51,18280.68,35 NDC,50242015001,OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION,67558.95,40535.37,57.63,54047.16,35 NDC,50242015901,MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION,2341.3,1404.78,592.35,104912.43,35 NDC,50242021401,OMALIZUMAB 75 MG/0.5 ML SUBCUTANEOUS SYRINGE,2887.9,1732.74,43.26,6119.61,35 NDC,50242021501,OMALIZUMAB 150 MG/ML SUBCUTANEOUS SYRINGE,5759.8,3455.88,43.26,6119.61,35 NDC,50242022701,OMALIZUMAB 300 MG/2 ML SUBCUTANEOUS SYRINGE,11503.6,6902.16,43.26,9202.88,35 NDC,50242024501,"PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN",46338.75,27803.25,60.24,37071.0,35 NDC,50242026001,PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN,30982.95,18589.77,60.24,24786.36,35 NDC,50242055401,"OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN",161015.5,96609.3,45.81,128812.4,35 NDC,50242086001,BALOXAVIR MARBOXIL 40 MG TABLET,522.5,313.5,121.22,4481.0,19 NDC,50242087701,BALOXAVIR MARBOXIL 80 MG TABLET,522.5,313.5,121.22,4481.0,19 NDC,50242091701,ATEZOLIZUMAB (TECENTRIQ) 60 MG/ML INJECTION SOLUTION WRAPPER,38635.8,23181.48,88.6,30908.64,35 NDC,50242091701,"ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION",38635.8,23181.48,88.6,30908.64,35 NDC,50242091801,ATEZOLIZUMAB (TECENTRIQ) 60 MG/ML INJECTION SOLUTION WRAPPER,27127.6,16276.56,88.6,21702.08,35 NDC,50242091801,ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION,27127.6,16276.56,88.6,21702.08,35 NDC,50242093301,"ATEZOLIZUMAB 1,875 MG-HYALURONIDASE-TQJS 30,000 UNIT/15 ML SUBCUT SOLN",38635.8,23181.48,30.63,30908.64,35 NDC,50268003711,AMITRIPTYLINE 10 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,50268006911,AMANTADINE HCL 100 MG CAPSULE,22.0,13.2,5.1,4481.0,19 NDC,50268010611,BACLOFEN 10 MG TABLET,17.6,10.56,4.08,4481.0,19 NDC,50268014411,BUPRENORPHINE 2 MG-NALOXONE 0.5 MG SUBLINGUAL TABLET,33.85,20.31,7.85,4481.0,23 NDC,50268014511,BUPRENORPHINE 8 MG-NALOXONE 2 MG SUBLINGUAL TABLET,37.3,22.38,8.65,4481.0,23 NDC,50268015111,CEPHALEXIN 250 MG CAPSULE,17.25,10.35,4.0,4481.0,19 NDC,50268017011,"CARBAMAZEPINE ER 100 MG CAPSULE,EXTENDED RELEASE 12HR",25.3,15.18,5.87,4481.0,19 NDC,50268017211,"CARBAMAZEPINE ER 300 MG CAPSULE,EXTENDED RELEASE 12HR",26.4,15.84,6.12,4481.0,19 NDC,50268017415,CLONAZEPAM 1 MG TABLET,23.45,14.07,5.44,4481.0,19 NDC,50268019015,CYCLOBENZAPRINE 5 MG TABLET,24.1,14.46,5.59,4481.0,19 NDC,50268032111,FLECAINIDE 100 MG TABLET,18.7,11.22,4.34,4481.0,19 NDC,50268036115,GLIPIZIDE 5 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,50268036811,FLUPHENAZINE 5 MG TABLET,29.7,17.82,6.89,4481.0,19 NDC,50268043011,INDOMETHACIN 25 MG CAPSULE,17.1,10.26,3.97,4481.0,19 NDC,50268044711,ISOSORBIDE DINITRATE 5 MG TABLET,18.7,11.22,4.34,4481.0,19 NDC,50268052411,MELATONIN 3 MG TABLET,1.2,0.72,0.2784,4481.0,19 NDC,50268052511,MELOXICAM 7.5 MG TABLET,16.5,9.9,3.83,4481.0,19 NDC,50268052611,MELOXICAM 15 MG TABLET,16.6,9.96,3.85,4481.0,19 NDC,50268055011,"METFORMIN ER 500 MG TABLET,EXTENDED RELEASE 24 HR",17.5,10.5,4.06,4481.0,19 NDC,50268055115,"METFORMIN ER 750 MG TABLET,EXTENDED RELEASE 24 HR",17.3,10.38,4.01,4481.0,19 NDC,50268057311,MONTELUKAST 4 MG CHEWABLE TABLET,19.15,11.49,4.44,4481.0,19 NDC,50268057411,MONTELUKAST 5 MG CHEWABLE TABLET,18.85,11.31,4.37,4481.0,19 NDC,50268059411,NAPROXEN 250 MG TABLET,16.8,10.08,3.9,4481.0,19 NDC,50268062215,ONDANSETRON HCL 8 MG TABLET,17.85,10.71,4.14,4481.0,19 NDC,50268063911,"PANTOPRAZOLE 40 MG TABLET,DELAYED RELEASE",16.55,9.93,3.84,4481.0,19 NDC,50268064011,PAROXETINE 10 MG TABLET,18.0,10.8,4.18,4481.0,19 NDC,50268064211,PAROXETINE 30 MG TABLET,17.4,10.44,4.04,4481.0,19 NDC,50268068411,PROCHLORPERAZINE MALEATE 5 MG TABLET,19.35,11.61,4.49,4481.0,19 NDC,50268072411,SOTALOL 80 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,50268074211,ROPINIROLE 0.5 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,50268075511,TORSEMIDE 10 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,50268075611,TORSEMIDE 20 MG TABLET,17.05,10.23,3.96,4481.0,19 NDC,50268075711,TORSEMIDE 100 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,50268075811,TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,23.1,13.86,5.36,4481.0,19 NDC,50268085715,VITAMIN B COMPLEX-FOLIC ACID 0.4 MG TABLET,1.45,0.87,0.3364,4481.0,19 NDC,50268085811,PYRIDOXINE (VITAMIN B6) 50 MG TABLET,1.4,0.84,0.3248,4481.0,19 NDC,50268086611,"CHOLECALCIFEROL (VITAMIN D3) 125 MCG (5,000 UNIT) TABLET",1.45,0.87,0.3364,4481.0,19 NDC,50383028616,LEVOFLOXACIN 250 MG/10 ML ORAL SOLUTION,1607.2,964.32,372.87,4481.0,19 NDC,50419025091,RIOCIGUAT 0.5 MG TABLET,486.35,291.81,112.83,4481.0,19 NDC,50419025191,RIOCIGUAT 1 MG TABLET,486.35,291.81,112.83,4481.0,19 NDC,50419025491,RIOCIGUAT 2.5 MG TABLET,486.35,291.81,112.83,4481.0,19 NDC,50419038501,COPANLISIB 60 MG INTRAVENOUS SOLUTION,17664.45,10598.67,200.95,14131.56,23 NDC,50419039501,DAROLUTAMIDE 300 MG TABLET,500.15,300.09,116.03,4481.0,19 NDC,50419042201,LEVONORGESTREL 14 MCG/24 HR (UP TO 3 YRS) 13.5 MG INTRAUTERINE DEVICE,4067.55,2440.53,943.67,165907.14,24 NDC,50419042408,LEVONORGESTREL 17.5 MCG/24 HOUR (5 YEARS) INTRAUTERINE DEVICE,4649.2,2789.52,1078.61,184236.57,24 NDC,50419077501,CIPROFLOXACIN 500 MG/5 ML ORAL SUSPENSION,472.9,283.74,109.71,4481.0,19 NDC,50458002802,ESKETAMINE 56 MG (28 MG X 2) NASAL SPRAY,1290.0,774.0,34.2,4481.0,23 NDC,50458002803,ESKETAMINE 84 MG (28 MG X 3) NASAL SPRAY,1290.0,774.0,34.2,4481.0,23 NDC,50458056001,PALIPERIDONE PALMITATE 39 MG/0.25 ML INTRAMUSCULAR SYRINGE,2335.8,1401.48,14.66,4481.0,35 NDC,50458056101,PALIPERIDONE PALMITATE 78 MG/0.5 ML INTRAMUSCULAR SYRINGE,4655.8,2793.48,14.66,4481.0,35 NDC,50458056201,PALIPERIDONE PALMITATE 117 MG/0.75 ML INTRAMUSCULAR SYRINGE,6975.75,4185.45,14.66,5580.6,35 NDC,50458056301,PALIPERIDONE PALMITATE 156 MG/ML INTRAMUSCULAR SYRINGE,9296.05,5577.63,14.66,7436.84,35 NDC,50458056401,PALIPERIDONE PALMITATE 234 MG/1.5 ML INTRAMUSCULAR SYRINGE,13935.7,8361.42,14.66,11148.56,35 NDC,50458057501,RIVAROXABAN 1 MG/ML ORAL SUSPENSION,1810.0,1086.0,419.92,4481.0,19 NDC,50458057701,RIVAROXABAN 2.5 MG TABLET,45.95,27.57,10.66,4481.0,19 NDC,50458057801,RIVAROXABAN 15 MG TABLET,75.85,45.51,17.6,4481.0,19 NDC,50458057901,RIVAROXABAN 20 MG TABLET,75.85,45.51,17.6,4481.0,19 NDC,50458058001,RIVAROXABAN 10 MG TABLET,75.85,45.51,17.6,4481.0,19 NDC,50458058501,"METHYLPHENIDATE ER 18 MG TABLET,EXTENDED RELEASE 24 HR",61.25,36.75,14.21,4481.0,19 NDC,50458058801,"METHYLPHENIDATE ER 27 MG TABLET,EXTENDED RELEASE 24 HR",62.2,37.32,14.43,4481.0,19 NDC,50458083002,TAPENTADOL 75 MG TABLET,49.3,29.58,11.44,4481.0,19 NDC,50474057066,BRIVARACETAM 50 MG TABLET,96.65,57.99,22.42,4481.0,19 NDC,50474071079,CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT,19681.15,11808.69,3.79,15744.92,35 NDC,50474077009,BRIVARACETAM 100 MG TABLET,96.65,57.99,22.42,4481.0,19 NDC,50474080603,ROTIGOTINE 8 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH,102.4,61.44,23.76,4481.0,19 NDC,50474097075,BRIVARACETAM 50 MG/5 ML INTRAVENOUS SOLUTION,212.05,127.23,49.2,4481.0,19 NDC,50474098079,ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION,30484.8,18290.88,22.47,24387.84,35 NDC,50484001030,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 250 UNIT/GRAM TOPICAL OINTMENT,971.6,582.96,225.41,4481.0,19 NDC,50632000102,"SMALLPOX,MPOX LIVE VACCINE(PF) 0.5X TO 3.95X 10EXP8/0.5 ML SUBCUT SUSP",0.2,0.12,0.0097,4481.0,36 NDC,50632001001,"RABIES VACCINE, PURIFIED CHICKEN EMBRYO CELL (PF) 2.5 UNIT IM SUSP",1325.85,795.51,304.27,4481.0,36 NDC,50633011012,CROTALIDAE POLYVAL IMMUNE FAB SOLUTION FOR INJECTION,11669.75,7001.85,1773.86,10095.5,35 NDC,50633012011,DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION,18107.75,10864.65,4481.0,16457.93,35 NDC,50633021011,GLUCARPIDASE (VORAXAZE) SYRINGE,141434.95,84860.97,992.21,122355.38,23 NDC,50633031011,HYDROXOCOBALAMIN 5 GRAM INTRAVENOUS SOLUTION,3490.0,2094.0,5.03,4481.0,35 NDC,50742011201,DESIPRAMINE 10 MG TABLET,16.4,9.84,3.8,4481.0,19 NDC,50742011301,DESIPRAMINE 25 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,50742011401,DESIPRAMINE 50 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,50742017701,"ISOSORBIDE MONONITRATE ER 120 MG TABLET,EXTENDED RELEASE 24 HR",16.35,9.81,3.79,4481.0,19 NDC,50742024001,MEXILETINE 200 MG CAPSULE,17.5,10.5,4.06,4481.0,19 NDC,50742026101,"NIFEDIPINE ER 60 MG TABLET,EXTENDED RELEASE 24 HR",16.85,10.11,3.91,4481.0,19 NDC,50742055605,FENTANYL 100 MCG/HR TRANSDERMAL PATCH,61.55,36.93,14.28,4481.0,19 NDC,50881000560,RUXOLITINIB 5 MG TABLET,565.0,339.0,131.08,4481.0,19 NDC,50881000603,RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION,49074.35,29444.61,29.64,39259.48,35 NDC,50881001060,RUXOLITINIB 10 MG TABLET,1198.35,719.01,278.02,4481.0,19 NDC,50881002311,AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION,37831.5,22698.9,53.98,30265.2,35 NDC,50881003412,AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION,15513.75,9308.25,53.98,12411.0,35 NDC,51079007401,HYDRALAZINE 10 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,51079008801,MIRTAZAPINE 45 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,51079014101,CHLORDIAZEPOXIDE 25 MG CAPSULE,23.65,14.19,5.49,4481.0,19 NDC,51079028420,DIAZEPAM 2 MG TABLET,22.2,13.32,5.15,4481.0,19 NDC,51079028520,DIAZEPAM 5 MG TABLET,22.25,13.35,5.16,4481.0,19 NDC,51079028601,DIAZEPAM 10 MG TABLET,22.25,13.35,5.16,4481.0,19 NDC,51079043601,DOXEPIN 10 MG CAPSULE,17.6,10.56,4.08,4481.0,19 NDC,51079043801,DOXEPIN 50 MG CAPSULE,18.95,11.37,4.4,4481.0,19 NDC,51079058101,LEUCOVORIN CALCIUM 5 MG TABLET,23.9,14.34,5.54,4481.0,19 NDC,51079059701,CETIRIZINE 10 MG TABLET,1.25,0.75,0.29,4481.0,19 NDC,51079068401,ATENOLOL 50 MG TABLET,16.3,9.78,3.78,4481.0,19 NDC,51079068501,ATENOLOL 100 MG TABLET,16.65,9.99,3.86,4481.0,19 NDC,51079072501,ZOLPIDEM 10 MG TABLET,22.35,13.41,5.19,4481.0,19 NDC,51079073301,HALOPERIDOL 0.5 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,51079073420,HALOPERIDOL 1 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,51079073501,HALOPERIDOL 2 MG TABLET,17.7,10.62,4.11,4481.0,19 NDC,51079075301,SUCRALFATE 1 GRAM TABLET,16.95,10.17,3.93,4481.0,19 NDC,51079075901,ATENOLOL 25 MG TABLET,16.55,9.93,3.84,4481.0,19 NDC,51079088820,METOCLOPRAMIDE 10 MG TABLET,18.4,11.04,4.27,4481.0,19 NDC,51079098501,BUSPIRONE 5 MG TABLET,16.35,9.81,3.79,4481.0,19 NDC,51079098601,BUSPIRONE 10 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,51144000301,TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION,24771.65,14862.99,183.1,30877.35,35 NDC,51144002001,ENFORTUMAB VEDOTIN-EJFV 20 MG INTRAVENOUS SOLUTION,9572.8,5743.68,35.64,7658.24,35 NDC,51144003001,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION,14221.7,8533.02,35.64,11377.36,35 NDC,51144003001,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 100 MG),14221.7,8533.02,35.64,11377.36,35 NDC,51144003001,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 50 MG),14221.7,8533.02,35.64,11377.36,35 NDC,51144003001,ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION (MAX DOSE 75 MG),14221.7,8533.02,35.64,11377.36,35 NDC,51144005001,BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION,42231.9,25339.14,250.88,37621.71,35 NDC,51293062801,PHENOBARBITAL 97.2 MG TABLET,24.9,14.94,5.78,4481.0,19 NDC,51383000313,SODIUM CHLORIDE-HYPOCHLOROUS ACID 0.033 % IRRIGATION SOLUTION,27.75,16.65,6.44,4481.0,19 NDC,51383000314,SODIUM CHLORIDE-HYPOCHLOROUS ACID 0.033 % IRRIGATION SOLUTION,48.9,29.34,11.34,4481.0,19 NDC,51407073801,TRIMETHOPRIM 100 MG TABLET,21.55,12.93,5.0,4481.0,19 NDC,51525044208,FELBAMATE 600 MG/5 ML ORAL SUSPENSION,1540.4,924.24,357.37,4481.0,19 NDC,51672126402,FLUOCINONIDE 0.05 % TOPICAL OINTMENT,94.05,56.43,21.82,4481.0,19 NDC,51672126705,TRIAMCINOLONE ACETONIDE 0.1 % DENTAL PASTE,210.1,126.06,48.74,4481.0,19 NDC,51672129802,KETOCONAZOLE 2 % TOPICAL CREAM,130.55,78.33,30.29,4481.0,19 NDC,51672139400,TRETINOIN 0.05 % TOPICAL CREAM,298.6,179.16,69.28,4481.0,19 NDC,51672139500,TRETINOIN 0.1 % TOPICAL CREAM,345.8,207.48,80.23,4481.0,19 NDC,51672139902,CLINDAMYCIN 1 % TOPICAL GEL,76.25,45.75,17.69,4481.0,19 NDC,51672211600,ACETAMINOPHEN 325 MG RECTAL SUPPOSITORY,2.6,1.56,0.6032,4481.0,19 NDC,51672300302,HYDROCORTISONE 2.5 % TOPICAL CREAM,24.75,14.85,5.74,4481.0,19 NDC,51672300701,HYDROCORTISONE-ACETIC ACID 1 %-2 % EAR DROPS,423.75,254.25,98.31,4481.0,19 NDC,51672400101,NORTRIPTYLINE 10 MG CAPSULE,16.6,9.96,3.85,4481.0,19 NDC,51672400301,NORTRIPTYLINE 50 MG CAPSULE,17.0,10.2,3.94,4481.0,19 NDC,51672401206,CLOMIPRAMINE 50 MG CAPSULE,18.05,10.83,4.19,4481.0,19 NDC,51672402301,ACETAZOLAMIDE 250 MG TABLET,17.05,10.23,3.96,4481.0,19 NDC,51672402601,KETOCONAZOLE 200 MG TABLET,22.65,13.59,5.25,4481.0,19 NDC,51672409103,ONDANSETRON HCL 4 MG/5 ML ORAL SOLUTION,18.6,11.16,4.32,4481.0,19 NDC,51672411806,FLUOROURACIL 5 % TOPICAL CREAM,325.95,195.57,75.62,4481.0,19 NDC,51754050001,CAFFEINE CITRATE 60 MG/3 ML (20 MG/ML) INTRAVENOUS SOLUTION,102.25,61.35,2.77,4481.0,24 NDC,51754100601,NITROPRUSSIDE 50 MG/100 ML (0.5 MG/ML) IN 0.9% SODIUM CHLORIDE IV SOLN,242.85,145.71,56.34,4481.0,19 NDC,51754100701,CYSTEINE (L-CYSTEINE) 50 MG/ML INTRAVENOUS SOLUTION,372.7,223.62,86.47,4481.0,19 NDC,51754425003,EPHEDRINE (PF) 25 MG/5 ML (5 MG/ML) IN 0.9% SODIUM CHLORIDE IV SYRINGE WRAPPER,64.2,38.52,14.89,4481.0,19 NDC,51754500101,SODIUM BICARBONATE 1 MEQ/ML (8.4 %) INJECTION (COMBINED) WRAPPER,77.35,46.41,17.95,4481.0,19 NDC,51754500101,SODIUM BICARBONATE 1 MEQ/ML (8.4 %) INTRAVENOUS SOLUTION,77.35,46.41,17.95,4481.0,19 NDC,51754500101,SODIUM BICARBONATE 1 MEQ/ML INJ SOLUTION (PEDIATRIC),77.35,46.41,17.95,4481.0,19 NDC,51754500101,SODIUM BICARBONATE 1 MEQ/ML INJ SOLUTION WRAPPER (MULTI-VIAL SIZE),77.35,46.41,17.95,4481.0,19 NDC,51754501201,SODIUM BICARBONATE 4.2 % INTRAVENOUS SOLUTION,44.9,26.94,10.42,4481.0,19 NDC,51754601303,GLYCOPYRROLATE 0.2 MG/ML SYRINGE WRAPPER,55.0,33.0,0.4462,4481.0,35 NDC,51759020813,ECULIZUMAB-AAGH 300 MG/30 ML INTRAVENOUS SOLUTION,14993.85,8996.31,30.41,11995.08,35 NDC,51862033401,ESTRADIOL 2 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,51991036060,ASENAPINE 10 MG SUBLINGUAL TABLET,31.3,18.78,7.26,4481.0,19 NDC,51991073532,GRANISETRON HCL 1 MG TABLET,46.0,27.6,10.67,4481.0,19 NDC,51991097401,PENICILLAMINE 250 MG CAPSULE,48.4,29.04,11.23,4481.0,19 NDC,52015008001,FIDAXOMICIN 200 MG TABLET,796.75,478.05,184.85,4481.0,19 NDC,52015070022,FIDAXOMICIN 40 MG/ML ORAL SUSPENSION,15631.0,9378.6,3626.39,12504.8,19 NDC,52268010001,PEG 3350-ELECTROLYTES 236 GRAM-22.74 GRAM-6.74 GRAM-5.86 GRAM SOLUTION,88.25,52.95,20.47,4481.0,19 NDC,52268010001,PEG-ELECTROLYTE ORAL SOLUTION WRAPPER,88.25,52.95,20.47,4481.0,19 NDC,52276031260,CARGLUMIC ACID 200 MG DISPERSIBLE TABLET,677.75,406.65,157.24,4481.0,19 NDC,52380001103,POVIDONE-IODINE 10 % TOPICAL LIQUID PACKET,2.55,1.53,0.5916,4481.0,19 NDC,52536010605,VANCOMYCIN 50 MG/ML ORAL SOLUTION,23.45,14.07,5.44,4481.0,19 NDC,52609450506,DEFEROXAMINE 500 MG SOLUTION FOR IV ADMIXTURE USE,66.6,39.96,15.45,4481.0,24 NDC,52652200101,METHOTREXATE 2.5 MG/ML (ONCOLOGY) ORAL SOLUTION,10026.8,6016.08,2326.22,8021.44,19 NDC,52652200101,METHOTREXATE 2.5 MG/ML ORAL SOLUTION,10026.8,6016.08,22.0,8674.18,35 NDC,52652300101,LISINOPRIL 1 MG/ML ORAL SOLUTION,2064.4,1238.64,478.94,4481.0,19 NDC,52652400101,ENALAPRIL MALEATE 1 MG/ML ORAL SOLUTION,49.95,29.97,11.59,4481.0,19 NDC,52652500101,AMLODIPINE BENZOATE 1 MG/ML ORAL SUSPENSION,48.0,28.8,11.14,4481.0,19 NDC,52652600101,BACLOFEN 25 MG/5 ML (5 MG/ML) ORAL SUSPENSION,34.15,20.49,7.92,4481.0,19 NDC,52652800101,ZONISAMIDE 100 MG/5 ML ORAL SUSPENSION,1274.65,764.79,295.72,4481.0,19 NDC,52652900103,TOPIRAMATE 25 MG/ML ORAL SOLUTION,1017.2,610.32,235.99,4481.0,19 NDC,54092038101,"DEXTROAMPHETAMINE-AMPHETAMINE ER 5 MG 24HR CAPSULE,EXTEND RELEASE",43.7,26.22,10.14,4481.0,19 NDC,54092054701,PRUCALOPRIDE 2 MG TABLET,71.75,43.05,16.65,4481.0,19 NDC,54092070001,IDURSULFASE 6 MG/3 ML INTRAVENOUS SOLUTION,10624.8,6374.88,541.71,81999.54,35 NDC,54092070104,VELAGLUCERASE ALFA 400 UNIT INTRAVENOUS SOLUTION,4531.05,2718.63,369.92,55023.57,35 NDC,54288010301,EPINEPHRINE HCL (PF) 1 MG/ML (1 ML) INJECTION SOLUTION,20.3,12.18,2.38,4481.0,24 NDC,54288010502,ETHYL ALCOHOL 99 % INTRA-ARTERIAL SOLUTION,3896.5,2337.9,903.99,4481.0,19 NDC,54288012001,EPINEPHRINE 1 MG/ML INJECTION SOLUTION,308.5,185.1,2.38,4481.0,24 NDC,54288012001,EPINEPHRINE 1 MG/ML INJECTION WRAPPER,308.5,185.1,2.38,4481.0,24 NDC,54288014210,PAPAVERINE 30 MG/ML INJECTION SOLUTION,142.75,85.65,33.12,4481.0,24 NDC,54482005401,PROCARBAZINE 50 MG CAPSULE,619.1,371.46,143.63,4481.0,19 NDC,54482014701,LEVOCARNITINE 200 MG/ML INTRAVENOUS SOLUTION,167.65,100.59,38.89,4481.0,24 NDC,54643564700,"MVI, PEDI NO.1 WITH VIT K 80 MG-400 UNIT-200 MCG/5 ML INTRAVENOUS SOLN",645.85,387.51,149.84,4481.0,19 NDC,54643564901,"MVI,ADULT NO.4 WITH VIT K 3300 UNIT-150 MCG/10 ML INTRAVENOUS SOLUTION",76.0,45.6,17.63,4481.0,19 NDC,54643901502,"MVI,ADULT NO.4 WITH VIT K 3300 UNIT-150 MCG/10 ML INTRAVENOUS SOLUTION",66.9,40.14,15.52,4481.0,19 NDC,54838050280,HYDROXYZINE HCL 10 MG/5 ML ORAL SOLUTION,18.6,11.16,4.32,4481.0,19 NDC,55111051930,ATOMOXETINE 10 MG CAPSULE,20.9,12.54,4.85,4481.0,19 NDC,55111052030,ATOMOXETINE 18 MG CAPSULE,20.9,12.54,4.85,4481.0,19 NDC,55111052830,ATOMOXETINE 25 MG CAPSULE,20.9,12.54,4.85,4481.0,19 NDC,55111055610,DECITABINE 50 MG INTRAVENOUS SOLUTION,2261.0,1356.6,2.75,4481.0,24 NDC,55111065401,SIROLIMUS 2 MG TABLET,38.5,23.1,1.96,4481.0,24 NDC,55111067811,FONDAPARINUX 2.5 MG/0.5 ML SUBCUTANEOUS SOLUTION SYRINGE,106.05,63.63,1.62,4481.0,24 NDC,55111067911,FONDAPARINUX 5 MG/0.4 ML SUBCUTANEOUS SOLUTION SYRINGE,227.85,136.71,1.62,4481.0,24 NDC,55111068011,FONDAPARINUX 7.5 MG/0.6 ML SUBCUTANEOUS SOLUTION SYRINGE,227.85,136.71,1.62,4481.0,24 NDC,55111068507,ZOLEDRONIC ACID 4 MG/5 ML INTRAVENOUS SOLUTION,308.25,184.95,11.38,4481.0,24 NDC,55135013201,SACITUZUMAB GOVITECAN-HZIY 180 MG INTRAVENOUS SOLUTION,8760.2,5256.12,35.19,7008.16,35 NDC,55150011310,AMPICILLIN 1 GRAM INJ COMBINED WRAPPER,34.9,20.94,1.24,4481.0,24 NDC,55150011310,AMPICILLIN 1 GRAM SOLUTION FOR INJECTION,34.9,20.94,1.24,4481.0,24 NDC,55150011420,AMPICILLIN 2 GRAM INJ COMBINED WRAPPER,43.75,26.25,1.24,4481.0,24 NDC,55150011420,AMPICILLIN 2 GRAM SOLUTION FOR INJECTION,43.75,26.25,1.24,4481.0,24 NDC,55150011899,AMPICILLIN-SULBACTAM 15 GRAM SOLUTION FOR INJECTION,272.65,163.59,3.13,4481.0,24 NDC,55150012030,PIPERACILLIN-TAZOBACTAM 3.375 GRAM INTRAVENOUS SOLUTION,81.0,48.6,2.41,4481.0,24 NDC,55150012215,NAFCILLIN 1 GRAM INJ COMBINED WRAPPER,101.3,60.78,0.1125,4481.0,24 NDC,55150012215,NAFCILLIN 1 GRAM INJ SOLR IM,101.3,60.78,0.1125,4481.0,24 NDC,55150012315,NAFCILLIN 2 GRAM INJ COMBINED WRAPPER,103.9,62.34,0.1125,4481.0,24 NDC,55150012409,NAFCILLIN 10 GRAM SOLUTION FOR INJECTION,122.1,73.26,0.1125,4481.0,24 NDC,55150016102,LIDOCAINE (PF) 10 MG/ML (1 %) FOR NEBULIZATION,33.35,20.01,7.74,4481.0,19 NDC,55150016205,LIDOCAINE (PF) 10 MG/ML (1 %) FOR NEBULIZATION,25.25,15.15,5.86,4481.0,19 NDC,55150016205,LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,27.55,16.53,0.0225,4481.0,24 NDC,55150016330,LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,28.45,17.07,0.0225,4481.0,24 NDC,55150016402,LIDOCAINE (PF) 20 MG/ML (2 %) INECTION SOLUTION WRAPPER,29.05,17.43,0.0225,4481.0,24 NDC,55150016505,LIDOCAINE (PF) 20 MG/ML (2 %) INECTION SOLUTION WRAPPER,26.4,15.84,0.0225,4481.0,24 NDC,55150016505,LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION,26.4,15.84,0.0225,4481.0,24 NDC,55150016613,SILDENAFIL (PULMONARY HYPERTENSION) 10 MG/12.5 ML INTRAVENOUS SOLUTION,737.5,442.5,171.1,4481.0,19 NDC,55150016613,SILDENAFIL PEDIATRIC LOADING DOSE INFUSION,667.95,400.77,154.96,4481.0,19 NDC,55150017110,BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) INJECTION SOLUTION,26.25,15.75,0.0225,4481.0,24 NDC,55150017301,SUMATRIPTAN 6 MG/0.5 ML SUBCUTANEOUS SOLUTION,58.9,35.34,13.66,4481.0,24 NDC,55150018301,NICARDIPINE 25 MG/10 ML INTRAVENOUS SOLUTION,132.5,79.5,0.1575,4481.0,24 NDC,55150019301,ADENOSINE (DIAGNOSTIC) 3 MG/ML INTRAVENOUS SOLUTION,573.75,344.25,1.25,4481.0,24 NDC,55150019410,ESMOLOL 100 MG/10 ML (10 MG/ML) INTRAVENOUS SOLUTION,77.4,46.44,0.495,4481.0,24 NDC,55150023410,"POLYMYXIN B SULFATE 500,000 UNIT SOLUTION FOR INJECTION",55.0,33.0,12.76,4481.0,19 NDC,55150023601,VECURONIUM BROMIDE 20 MG INTRAVENOUS SOLUTION,92.45,55.47,21.45,4481.0,19 NDC,55150026705,FLUPHENAZINE DECANOATE 25 MG/ML INJECTION SOLUTION,62.8,37.68,14.57,4481.0,24 NDC,55150028220,ERTAPENEM 1 GRAM IM INJECTION,250.0,150.0,22.18,4481.0,24 NDC,55150028220,ERTAPENEM 1 GRAM SOLUTION FOR INJECTION,250.0,150.0,22.18,4481.0,24 NDC,55150029701,DEXMEDETOMIDINE 400 MCG/100 ML (4 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,234.7,140.82,54.45,4481.0,19 NDC,55150030401,DEXAMETHASONE SODIUM PHOSPHATE (PF) 10 MG/ML INJECTION SOLUTION,33.2,19.92,0.2025,4481.0,24 NDC,55150043801,KETAMINE 10 MG/ML INJECTION SOLUTION,80.1,48.06,18.58,4481.0,19 NDC,55292013901,PASIREOTIDE PAMOATE 10 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 NDC,55292014001,PASIREOTIDE PAMOATE 20 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 NDC,55292014101,PASIREOTIDE PAMOATE 30 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 NDC,55292014201,PASIREOTIDE PAMOATE 40 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 NDC,55292014301,PASIREOTIDE PAMOATE 60 MG IM SUSPENSION,81611.9,48967.14,555.77,86249.31,35 NDC,55292020111,SUCCIMER 100 MG CAPSULE,82.15,49.29,19.06,4481.0,19 NDC,55292070254,HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION,36661.3,21996.78,33.15,31715.69,35 NDC,55292081155,DACTINOMYCIN (COSMEGEN) SYRINGE 0.5 MG/ML,9240.3,5544.18,318.49,43645.77,35 NDC,55513000201,DARBEPOETIN ALFA 25 MCG/ML IN POLYSORBATE INJECTION,770.65,462.39,2.84,4481.0,35 NDC,55513000501,DARBEPOETIN ALFA 100 MCG/ML IN POLYSORBATE INJECTION,3034.6,1820.76,2.84,4481.0,35 NDC,55513002101,DARBEPOETIN ALFA 40 MCG/0.4 ML IN POLYSORBATE INJECTION SYRINGE,1223.45,734.07,2.84,4481.0,35 NDC,55513002301,DARBEPOETIN ALFA 60 MCG/0.3 ML IN POLYSORBATE INJECTION SYRINGE,1827.2,1096.32,2.84,4481.0,35 NDC,55513002501,DARBEPOETIN ALFA 100 MCG/0.5 ML IN POLYSORBATE INJECTION SYRINGE,3034.6,1820.76,2.84,4481.0,35 NDC,55513002701,DARBEPOETIN ALFA 150 MCG/0.3 ML IN POLYSORBATE INJECTION SYRINGE,4543.9,2726.34,2.84,4481.0,35 NDC,55513002801,DARBEPOETIN ALFA 200 MCG/0.4 ML IN POLYSORBATE INJECTION SYRINGE,6053.2,3631.92,2.84,4842.56,35 NDC,55513003201,DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE,4543.9,2726.34,2.84,4481.0,35 NDC,55513005701,DARBEPOETIN ALFA 25 MCG/0.42 ML IN POLYSORBATE INJECTION SYRINGE,770.65,462.39,2.84,4481.0,35 NDC,55513005901,TARLATAMAB-DLLE 1 MG INTRAVENOUS SOLUTION,5637.25,3382.35,1426.22,257101.53,35 NDC,55513007330,CINACALCET 30 MG TABLET,96.7,58.02,22.43,4481.0,19 NDC,55513007701,TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION,49925.0,29955.0,1517.7,257101.53,35 NDC,55513007801,TALIMOGENE LAHERPAREPVEC 10EXP6 (1 MILLION) PFU/ML SUSP FOR INJECTION,506.3,303.78,71.72,11518.92,35 NDC,55513007901,TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION,23398.0,14038.8,71.72,18718.4,35 NDC,55513011101,DARBEPOETIN ALFA 300 MCG/0.6 ML IN POLYSORBATE INJECTION SYRINGE,9071.8,5443.08,2.84,7257.44,35 NDC,55513011296,TEZEPELUMAB-EKKO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS SYRINGE,14184.7,8510.82,17.47,11347.76,35 NDC,55513012301,TEZEPELUMAB-EKKO 210 MG/1.91 ML (110 MG/ML) SUBCUTANEOUS PEN INJECTOR,18249.2,10949.52,17.47,14599.36,35 NDC,55513014410,"EPOETIN ALFA 10,000 UNIT/ML INJECTION SOLUTION",662.65,397.59,8.28,4481.0,33 NDC,55513014810,"EPOETIN ALFA 4,000 UNIT/ML INJECTION SOLUTION",274.65,164.79,8.28,4481.0,33 NDC,55513015001,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 24-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 NDC,55513015001,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 48-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 NDC,55513015001,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 7-DAY INFUSION)",18667.95,11200.77,159.32,24925.32,35 NDC,55513015001,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 72-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 NDC,55513015001,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (15 MCG/M2/DAY, 96-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 NDC,55513015001,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (5 MCG/M2/DAY, 24-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 NDC,55513015001,"BLINATUMOMAB 12.5 MCG/ML IV SOLN (5 MCG/M2/DAY, 48-HR INFUSION)",18667.95,11200.77,159.32,24925.32,35 NDC,55513015001,BLINATUMOMAB 35 MCG INTRAVENOUS SOLUTION,18667.95,11200.77,159.32,24925.32,35 NDC,55513016001,BLINATUMOMAB 35 MCG INTRAVENOUS KIT,18667.95,11200.77,159.32,24925.32,35 NDC,55513019201,PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR,25046.2,15027.72,86.66,20036.96,35 NDC,55513020601,BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION,2584.5,1550.7,27.02,4481.0,35 NDC,55513020701,BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION,9512.9,5707.74,27.02,7610.32,35 NDC,55513022101,ROMIPLOSTIM (NPLATE) SYRINGE 500 MCG/ML (250 MCG),10752.8,6451.68,10.68,8602.24,35 NDC,55513022201,ROMIPLOSTIM (NPLATE) INJECTION 500 MCG/ML (500 MCG),21489.5,12893.7,10.68,17191.6,35 NDC,55513022301,ROMIPLOSTIM 125 MCG SUBCUTANEOUS SOLUTION,5384.5,3230.7,10.68,4481.0,35 NDC,55513026710,"EPOETIN ALFA 3,000 UNIT/ML INJECTION SOLUTION",210.0,126.0,8.28,4481.0,33 NDC,55513067001,INFLIXIMAB-AXXQ 100 MG INTRAVENOUS SOLUTION,1698.0,1018.8,19.8,4481.0,35 NDC,55513071001,DENOSUMAB 60 MG/ML SUBCUTANEOUS SYRINGE,7330.2,4398.12,28.5,5864.16,35 NDC,55513073001,DENOSUMAB 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION,13470.0,8082.0,28.5,10776.0,35 NDC,55513080060,IVABRADINE 5 MG TABLET,47.3,28.38,10.97,4481.0,19 NDC,55513081060,IVABRADINE 7.5 MG TABLET,47.3,28.38,10.97,4481.0,19 NDC,55513088002,ROMOSOZUMAB-AQQG 210 MG/2.34 ML(105 MG/1.17 ML X2)SUBCUTANEOUS SYRINGE,10268.8,6161.28,11.71,8215.04,35 NDC,55513095401,PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION,6271.6,3762.96,167.84,24925.32,35 NDC,55513095601,PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION,24261.25,14556.75,167.84,24925.32,35 NDC,55566105000,NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION,51341.7,30805.02,4481.0,10350356.73,35 NDC,55566180101,SOMATROPIN 5 MG SUBCUTANEOUS SOLUTION,1147.0,688.2,47.45,4481.0,35 NDC,55566830301,DEGARELIX 80 MG SUBCUTANEOUS SOLUTION,1891.8,1135.08,4.32,4481.0,35 NDC,55566840301,DEGARELIX 120 MG SUBCUTANEOUS SOLUTION,2797.55,1678.53,4.32,4481.0,35 NDC,57237004101,PENICILLIN V POTASSIUM 500 MG TABLET,16.6,9.96,3.85,4481.0,19 NDC,57237021930,PIOGLITAZONE 15 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,57894003001,INFLIXIMAB 100 MG INTRAVENOUS SOLUTION,3881.8,2329.08,30.16,4783.38,35 NDC,57894005427,USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION,6994.3,4196.58,12.6,5595.44,35 NDC,57894006103,USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE,113706.7,68224.02,144.92,90965.36,35 NDC,57894022501,GEMCITABINE 225 MG INTRAVESICAL IMPLANT,228665.0,137199.0,4481.0,182932.0,22 NDC,57894035001,GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION,6600.4,3960.24,10.71,5280.32,35 NDC,57894044901,TECLISTAMAB-CQYV 10 MG/ML SUBCUTANEOUS SOLUTION,7055.65,4233.39,32.57,5644.52,35 NDC,57894045001,TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION,34856.4,20913.84,32.57,27885.12,35 NDC,57894046901,TALQUETAMAB-TGVS 2 MG/ML SUBCUTANEOUS SOLUTION,3143.05,1885.83,70.44,11455.71,35 NDC,57894047001,TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION,38515.55,23109.33,70.44,30812.44,35 NDC,57894047001,TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION (FOR 0.8 MG/KG DOSAGE),38515.55,23109.33,70.44,30812.44,35 NDC,57894050101,AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION,12875.15,7725.09,21.86,10300.12,35 NDC,57894050301,"DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN",35267.9,21160.74,53.9,28214.32,35 NDC,57894065002,GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION,47695.3,28617.18,73.69,38156.24,35 NDC,57896014509,BACITRACIN 500 UNIT/GRAM TOPICAL PACKET WRAPPER,1.15,0.69,0.2668,4481.0,19 NDC,57896018105,PEG 400-HYPROMELLOSE-GLYCERIN 1 %-0.2 %-0.2 % EYE DROPS,3.65,2.19,0.8468,4481.0,19 NDC,57970010001,DALBAVANCIN 500 MG INTRAVENOUS SOLUTION,6954.65,4172.79,15.14,6016.47,35 NDC,58160081052,"DIPH,PERTUS(ACEL),TET PED(PF) 25 LF UNIT-58 MCG-10 LF/0.5ML IM SYRINGE",104.05,62.43,24.14,4481.0,25 NDC,58160081152,HEP B-DP(A)T-POLIO VACC (PF) 10 MCG-25LF-25 MCG-10LF/0.5 ML IM SYRINGE,321.65,192.99,74.62,4481.0,25 NDC,58160081552,HEPATITIS A AND B VIRUS VACCINE(PF)720 ELISA UNIT-20 MCG/ML IM SYRINGE,414.8,248.88,96.23,4481.0,25 NDC,58160082311,"VARICELLA-ZOSTER GLYCOE VACC-AS01B ADJ(PF) 50 MCG/0.5 ML IM SUSP, KIT",668.55,401.13,155.1,4481.0,24 NDC,58160082643,"HEPATITIS A VACCINE (PF) 1,440 ELISA UNIT/ML INTRAMUSCULAR WRAPPER",278.25,166.95,64.55,4481.0,25 NDC,58160082652,"HEPATITIS A VACCINE (PF) 1,440 ELISA UNIT/ML INTRAMUSCULAR SYRINGE",278.25,166.95,64.55,4481.0,25 NDC,58160082730,"MENINGOCOCCAL VAC A,C,Y,W-135 DIP(PF) 10 MCG-5 MCG/0.5 ML IM SOLUTION",520.0,312.0,120.64,4481.0,25 NDC,58160082803,VARICELLA-ZOSTER GLYCOP E VACCINE (VIAL 2 OF 2) 50 MCG IM SUSPENSION,668.55,401.13,155.1,4481.0,24 NDC,58160082901,"ADJUVANT AS01B (PF), COMPONENT VIAL 1 OF 2 INTRAMUSCULAR SUSPENSION",454.6,272.76,105.47,4481.0,24 NDC,58160084252,"DIPHTH,PERTUSSIS(ACEL),TETANUS 2.5 LF UNIT-8 MCG-5 LF/0.5ML IM SYRINGE",161.5,96.9,37.47,4481.0,25 NDC,58160095509,"MENINGOC VAC A,C,Y,W-135 DIP(PF) 10 MCG-5 MCG/0.5 ML IM KIT (2 VIALS)",520.0,312.0,120.64,4481.0,25 NDC,58160097602,"MENINGOCOCCAL B VAC,4-CMP 50 MCG-50 MCG-50 MCG-25 MCG/0.5ML IM SYRINGE",731.15,438.69,169.63,4481.0,25 NDC,58181304005,LOMUSTINE 10 MG CAPSULE,511.0,306.6,118.55,4481.0,22 NDC,58181304105,LOMUSTINE 40 MG CAPSULE,1968.8,1181.28,456.76,4481.0,19 NDC,58204000400,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 1,500 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 NDC,58204000404,PEDI MULTIVIT NO.77-VIT D3 750 UNIT-VIT K 500 MCG/0.5 ML ORAL DROPS,1.75,1.05,0.406,4481.0,19 NDC,58204000406,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 3,000 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 NDC,58204000409,"PEDIATRIC MULTIVITAMIN NO.61-VIT D3 5,000 UNIT-VIT K 800 MCG CAPSULE",1.85,1.11,0.4292,4481.0,19 NDC,58394001201,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 250 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 NDC,58394001301,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 500 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 NDC,58394001401,"ANTIHEMOPHILIC FACTOR VIII,REC B-DOMAIN DELETED 1,000 (+/-) UNIT IV SOLN",83.6,50.16,1.62,4481.0,35 NDC,58394002403,"ANTIHEMOPHILIC FVIII,REC B-DOMAIN DELETED 1,000 (+/-) UNIT IV SYRINGE",83.6,50.16,1.62,4481.0,35 NDC,58394013303,COAGULATION FACTOR IX (RECOMB) 250 UNIT INTRAVENOUS SOLUTION,83.0,49.8,1.79,4481.0,35 NDC,58394013403,COAGULATION FACTOR IX (RECOMB) 500 UNIT INTRAVENOUS SOLUTION,83.0,49.8,1.79,4481.0,35 NDC,58394063503,"COAGULATION FACTOR IX (RECOMB) 1,000 UNIT INTRAVENOUS SOLUTION",83.0,49.8,1.79,4481.0,35 NDC,58406001004,ETANERCEPT 25 MG/0.5 ML (0.5 ML) SUBCUTANEOUS SYRINGE,7969.7,4781.82,1048.45,6894.59,35 NDC,58468003001,THYROTROPIN ALFA 0.9 MG INTRAMUSCULAR SOLUTION,7902.3,4741.38,1999.28,314159.58,35 NDC,58468004001,AGALSIDASE BETA 35 MG INTRAVENOUS SOLUTION,25658.85,15395.31,223.25,32754.54,35 NDC,58468005001,OLIPUDASE ALFA-RPCP 20 MG INTRAVENOUS SOLUTION,24837.3,14902.38,381.85,62401.5,35 NDC,58468007001,LARONIDASE 2.9 MG/5 ML INTRAVENOUS SOLUTION,3703.8,2222.28,38.67,6960.45,35 NDC,58468008001,ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG INTRAVENOUS SOLUTION,4135.1,2481.06,969.39,145865.16,35 NDC,58468009001,HYLAN G-F 20 16 MG/2 ML INTRA-ARTICULAR SYRINGE,1796.55,1077.93,7.71,4481.0,35 NDC,58468009003,HYLAN G-F 20 48 MG/6 ML INTRA-ARTICULAR SYRINGE,5357.55,3214.53,7.71,4481.0,35 NDC,58468016001,ALGLUCOSIDASE ALFA 50 MG INTRAVENOUS SOLUTION,3311.3,1986.78,200.39,30464.28,35 NDC,58468020001,ALEMTUZUMAB (LEMTRADA) 12 MG/1.2 ML INTRAVENOUS SOLUTION (NON-ONCOLOGY),97326.7,58396.02,2356.99,379123.29,35 NDC,58468022701,CAPLACIZUMAB-YHDP 11 MG SOLUTION FOR INJECTION,28092.4,16855.44,1788.37,24302.74,23 NDC,58468022901,DILUENT FOR CAPLACIZUMAB-YHDP (STERILE WATER) 1 ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,58468042601,AVALGLUCOSIDASE ALFA-NGPT 100 MG INTRAVENOUS SOLUTION,6431.0,3858.6,78.48,12737.55,35 NDC,58468466301,IMIGLUCERASE 400 UNIT INTRAVENOUS SOLUTION,5733.65,3440.19,41.89,6341.58,35 NDC,58790000115,CARBOXYMETHYLCELLULOSE SODIUM 0.25 % EYE DROPS,13.4,8.04,3.11,4481.0,19 NDC,58790000115,STUDY ARTIFICIAL TEARS (PF) OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,58790000130,CARBOXYMETHYLCELLULOSE SODIUM 0.25 % EYE DROPS,17.55,10.53,4.07,4481.0,19 NDC,58790000330,CARBOXYMETHYLCELLULOSE SODIUM 1 % EYE GEL IN A DROPPERETTE,1.5,0.9,0.348,4481.0,19 NDC,58980001205,"BACITRACIN ZINC 500 UNIT-POLYMYXIN B 10,000 UNIT/GRAM TOPICAL OINTMENT",6.75,4.05,1.57,4481.0,19 NDC,58980040925,GLYCERIN (CHILD) RECTAL SUPPOSITORY,1.6,0.96,0.3712,4481.0,19 NDC,59011041020,"OXYCODONE ER 10 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",39.7,23.82,9.21,4481.0,19 NDC,59011042020,"OXYCODONE ER 20 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",54.95,32.97,12.75,4481.0,19 NDC,59011043010,"OXYCODONE ER 30 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",66.7,40.02,15.47,4481.0,19 NDC,59011044020,"OXYCODONE ER 40 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",78.4,47.04,18.19,4481.0,19 NDC,59011046010,"OXYCODONE ER 60 MG TABLET,CRUSH RESISTANT,EXTENDED RELEASE 12 HR",99.9,59.94,23.18,4481.0,19 NDC,59011075004,BUPRENORPHINE 5 MCG/HOUR WEEKLY TRANSDERMAL PATCH,177.5,106.5,41.18,4481.0,19 NDC,59011075104,BUPRENORPHINE 10 MCG/HOUR WEEKLY TRANSDERMAL PATCH,256.25,153.75,59.45,4481.0,19 NDC,59011075204,BUPRENORPHINE 20 MCG/HOUR WEEKLY TRANSDERMAL PATCH,439.2,263.52,101.89,4481.0,19 NDC,59137023101,AMINOLEVULINIC ACID HCL 30 MG/ML ORAL SOLUTION,9604.0,5762.4,2228.13,7683.2,22 NDC,59137033501,TREOSULFAN 1 GRAM INTRAVENOUS SOLUTION,2294.1,1376.46,31.36,4481.0,35 NDC,59137036501,TREOSULFAN 5 GRAM INTRAVENOUS SOLUTION,10370.5,6222.3,31.36,8971.52,35 NDC,59137057001,TRIAMCINOLONE HEXACETONIDE 20 MG/ML SUSPENSION FOR INJECTION,269.5,161.7,18.65,4481.0,24 NDC,59148001971,"ARIPIPRAZOLE ER 400 MG INTRAMUSCULAR SUSPENSION,EXTENDED RELEASE",0.2,0.12,0.0506,4481.0,35 NDC,59148003713,BREXPIPRAZOLE 1 MG TABLET,167.6,100.56,38.88,4481.0,19 NDC,59148007091,BUSULFAN 60 MG/10 ML INTRAVENOUS SOLUTION,1930.0,1158.0,0.8536,4481.0,35 NDC,59338077501,FERUMOXYTOL 510 MG/17 ML (30 MG/ML) INTRAVENOUS SOLUTION,3966.15,2379.69,0.3104,4481.0,36 NDC,59365512801,COPPER 380 SQUARE MM INTRAUTERINE DEVICE,4578.0,2746.8,1062.1,170749.32,24 NDC,59385002101,BUPRENORPHINE HCL 75 MCG BUCCAL FILM,44.9,26.94,10.42,4481.0,19 NDC,59385002260,BUPRENORPHINE HCL 150 MCG BUCCAL FILM,44.9,26.94,10.42,4481.0,19 NDC,59385002360,BUPRENORPHINE HCL 300 MCG BUCCAL FILM,57.95,34.77,13.44,4481.0,19 NDC,59390021805,FLUORESCEIN 0.25 %-BENOXINATE 0.4 % EYE DROPS,128.9,77.34,29.9,4481.0,19 NDC,59572010201,AZACITIDINE (VIDAZA) SYRINGE 25 MG/ML,2212.15,1327.29,0.5775,4481.0,24 NDC,59572040228,LENALIDOMIDE 2.5 MG CAPSULE,3591.2,2154.72,833.16,4481.0,19 NDC,59572040500,LENALIDOMIDE 5 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 NDC,59572041028,LENALIDOMIDE 10 MG CAPSULE,3591.2,2154.72,833.16,4481.0,19 NDC,59572041521,LENALIDOMIDE 15 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 NDC,59572042500,LENALIDOMIDE 25 MG CAPSULE,3591.25,2154.75,833.17,4481.0,19 NDC,59572071101,LUSPATERCEPT-AAMT 25 MG SUBCUTANEOUS SOLUTION,13513.0,8107.8,40.72,10810.4,35 NDC,59572077501,LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION,40412.75,24247.65,40.72,32330.2,35 NDC,59572098401,ROMIDEPSIN 10 MG/2 ML INTRAVENOUS POWDER FOR SOLUTION,10862.55,6517.53,29.86,8690.04,35 NDC,59584013801,CANDIDA ALBICANS SKIN TEST FDA STANDARD INTRADERMAL,141.6,84.96,32.85,4481.0,19 NDC,59627022205,INTERFERON BETA-1A 30 MCG/0.5 ML INTRAMUSCULAR SYRINGE KIT,28866.15,17319.69,57.13,24972.11,35 NDC,59630026601,CEFIDEROCOL 1 GRAM INTRAVENOUS SOLUTION,824.4,494.64,2.35,4481.0,35 NDC,59651011960,DOFETILIDE 250 MCG CAPSULE,20.0,12.0,4.64,4481.0,19 NDC,59651036650,VIGABATRIN 500 MG ORAL POWDER PACKET,34.0,20.4,7.89,4481.0,19 NDC,59676027801,RILPIVIRINE HCL 25 MG TABLET,164.35,98.61,38.13,4481.0,19 NDC,59676030201,"EPOETIN ALFA 2,000 UNIT/ML INJECTION SOLUTION",224.5,134.7,8.28,4481.0,33 NDC,59676032004,"EPOETIN ALFA 20,000 UNIT/ML INJECTION SOLUTION",2100.55,1260.33,8.28,4481.0,33 NDC,59676034001,"EPOETIN ALFA 40,000 UNIT/ML INJECTION SOLUTION",4185.1,2511.06,8.28,4481.0,33 NDC,59676036001,SODIUM HYALURONATE 30 MG/2 ML INTRA-ARTICULAR SYRINGE,1880.2,1128.12,111.1,19812.66,35 NDC,59676057101,ETRAVIRINE 200 MG TABLET,90.9,54.54,21.09,4481.0,19 NDC,59676061001,TRABECTEDIN 1 MG INTRAVENOUS SOLUTION,12486.75,7492.05,379.34,59552.64,35 NDC,59746000314,METHYLPREDNISOLONE 16 MG TABLET,23.5,14.1,0.2475,4481.0,24 NDC,59746001032,RISPERIDONE 0.5 MG DISINTEGRATING TABLET,21.0,12.6,4.87,4481.0,19 NDC,59746011506,PROCHLORPERAZINE MALEATE 10 MG TABLET,17.6,10.56,4.08,4481.0,19 NDC,59746038306,TERAZOSIN 1 MG CAPSULE,16.55,9.93,3.84,4481.0,19 NDC,59746038406,TERAZOSIN 2 MG CAPSULE,16.55,9.93,3.84,4481.0,19 NDC,59746038506,TERAZOSIN 5 MG CAPSULE,16.55,9.93,3.84,4481.0,19 NDC,59746038606,TERAZOSIN 10 MG CAPSULE,16.55,9.93,3.84,4481.0,19 NDC,59762007501,HYDROCORTISONE 20 MG TABLET,17.55,10.53,4.07,4481.0,19 NDC,59762011901,PHENELZINE 15 MG TABLET,18.0,10.8,4.18,4481.0,19 NDC,59762045001,COLESTIPOL 1 GRAM TABLET,19.2,11.52,4.45,4481.0,19 NDC,59762100501,CABERGOLINE 0.5 MG TABLET,156.4,93.84,36.28,4481.0,19 NDC,59762135001,RIFABUTIN 150 MG CAPSULE,58.0,34.8,13.46,4481.0,19 NDC,59762235007,ETHOSUXIMIDE 250 MG/5 ML ORAL SOLUTION,185.25,111.15,42.98,4481.0,19 NDC,59762313001,AZITHROMYCIN 200 MG/5 ML ORAL SUSPENSION,76.05,45.63,17.64,4481.0,19 NDC,59762374401,CLINDAMYCIN 1 % LOTION,305.55,183.33,70.89,4481.0,19 NDC,59762500005,SULFASALAZINE 500 MG TABLET,16.6,9.96,3.85,4481.0,19 NDC,59762503001,FLUCONAZOLE 40 MG/ML ORAL SUSPENSION,192.55,115.53,44.67,4481.0,19 NDC,60219174903,ATROPINE 1 % EYE DROPS,147.85,88.71,34.3,4481.0,19 NDC,60219175008,ATROPINE 1 % EYE DROPS,388.65,233.19,90.17,4481.0,19 NDC,60258000615,"POTASSIUM, SODIUM PHOSPHATES 280 MG-160 MG-250 MG ORAL POWDER PACKET",1.85,1.11,0.4292,4481.0,19 NDC,60267070550,SODIUM THIOSULFATE 12.5 GRAM/50 ML (250 MG/ML) INTRAVENOUS SOLUTION,321.35,192.81,1.84,4481.0,24 NDC,60267081200,SODIUM NITRITE-SODIUM THIOSULFATE 300 MG/10 ML-12.5 GRAM/50 ML IV SOLN,566.65,339.99,2.16,4481.0,35 NDC,60505003306,"PENTOXIFYLLINE ER 400 MG TABLET,EXTENDED RELEASE",17.3,10.38,4.01,4481.0,19 NDC,60505005501,SELEGILINE 5 MG CAPSULE,21.05,12.63,4.88,4481.0,19 NDC,60505014200,GLIPIZIDE 10 MG TABLET,16.25,9.75,3.77,4481.0,19 NDC,60505025701,DESMOPRESSIN 0.1 MG TABLET,18.25,10.95,4.23,4481.0,19 NDC,60505081500,DESMOPRESSIN 10 MCG/SPRAY (0.1 ML) NASAL SPRAY (NON-REFRIGERATED),386.65,231.99,89.7,4481.0,19 NDC,60505082306,CALCITONIN (SALMON) 200 UNIT/ACTUATION NASAL SPRAY,241.4,144.84,56.0,4481.0,19 NDC,60505082901,"FLUTICASONE PROPIONATE 50 MCG/ACTUATION NASAL SPRAY,SUSPENSION",28.9,17.34,6.7,4481.0,19 NDC,60505083305,AZELASTINE 137 MCG (0.1 %) NASAL SPRAY,81.5,48.9,18.91,4481.0,19 NDC,60505132309,PRAVASTATIN 80 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,60505311300,OLANZAPINE 10 MG TABLET,17.05,10.23,3.96,4481.0,19 NDC,60505325006,LAMIVUDINE 100 MG TABLET,51.2,30.72,11.88,4481.0,19 NDC,60505327803,OLANZAPINE 20 MG DISINTEGRATING TABLET,23.4,14.04,5.43,4481.0,19 NDC,60505464303,PRASUGREL HCL 10 MG TABLET,18.5,11.1,4.29,4481.0,19 NDC,60505614600,CEFEPIME 1 GRAM SOLUTION FOR INJECTION,35.7,21.42,2.75,4481.0,24 NDC,60505614704,CEFEPIME 2 GRAM INJ COMBINED WRAPPER,71.15,42.69,2.75,4481.0,24 NDC,60505623100,CEFAZOLIN 2 GRAM SOLUTION FOR IVPB WRAPPER,82.15,49.29,1.8,4481.0,24 NDC,60505623105,CEFAZOLIN 2 GRAM SOLUTION FOR INJECTION,82.15,49.29,1.8,4481.0,24 NDC,60505626605,CEFAZOLIN 3 G IV VIAL FOR IVPB (WRAPPER),91.7,55.02,1.8,4481.0,24 NDC,60505706100,NICOTINE 7 MG/24 HR DAILY TRANSDERMAL PATCH,3.9,2.34,0.9048,4481.0,19 NDC,60635011801,POLIDOCANOL 1 % INTRAVENOUS FOAM,1223.85,734.31,283.93,4481.0,19 NDC,60687010011,URSODIOL 300 MG CAPSULE,33.9,20.34,7.86,4481.0,19 NDC,60687010511,MEDROXYPROGESTERONE 10 MG TABLET,20.2,12.12,4.69,4481.0,19 NDC,60687011311,CLONIDINE HCL 0.1 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,60687012211,PREDNISONE 5 MG TABLET,16.55,9.93,0.0225,4481.0,24 NDC,60687012411,CLONIDINE HCL 0.2 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,60687012911,DOCUSATE SODIUM 100 MG CAPSULE,1.3,0.78,0.3016,4481.0,19 NDC,60687014511,PREDNISONE 20 MG TABLET,16.6,9.96,0.0225,4481.0,24 NDC,60687015511,METFORMIN 500 MG TABLET,16.4,9.84,3.8,4481.0,19 NDC,60687015695,PHENYTOIN 50 MG CHEWABLE TABLET,20.5,12.3,4.76,4481.0,19 NDC,60687016111,HALOPERIDOL 5 MG TABLET,18.75,11.25,4.35,4481.0,19 NDC,60687016211,"METFORMIN 1,000 MG TABLET",16.55,9.93,3.84,4481.0,19 NDC,60687016311,CEPHALEXIN 500 MG CAPSULE,17.1,10.26,3.97,4481.0,19 NDC,60687017911,ARIPIPRAZOLE 10 MG TABLET,17.9,10.74,4.15,4481.0,19 NDC,60687018411,MEMANTINE 10 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,60687018811,ENTACAPONE 200 MG TABLET,28.4,17.04,6.59,4481.0,19 NDC,60687019111,ARIPIPRAZOLE 15 MG TABLET,21.55,12.93,5.0,4481.0,19 NDC,60687019511,"DILTIAZEM CD 120 MG CAPSULE,EXTENDED RELEASE 24 HR",18.45,11.07,4.28,4481.0,19 NDC,60687020611,"DILTIAZEM CD 180 MG CAPSULE,EXTENDED RELEASE 24 HR",18.45,11.07,4.28,4481.0,19 NDC,60687021711,"DILTIAZEM CD 240 MG CAPSULE,EXTENDED RELEASE 24 HR",17.85,10.71,4.14,4481.0,19 NDC,60687022411,GEMFIBROZIL 600 MG TABLET,16.8,10.08,3.9,4481.0,19 NDC,60687022811,"DILTIAZEM CD 300 MG CAPSULE,EXTENDED RELEASE 24 HR",20.8,12.48,4.83,4481.0,19 NDC,60687022911,LOPERAMIDE 2 MG CAPSULE,2.35,1.41,0.5452,4481.0,19 NDC,60687023011,ZONISAMIDE 100 MG CAPSULE,17.7,10.62,4.11,4481.0,19 NDC,60687023111,SERTRALINE 25 MG TABLET,17.15,10.29,3.98,4481.0,19 NDC,60687024211,SERTRALINE 50 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,60687024940,LEVETIRACETAM 500 MG/5 ML (5 ML) ORAL SOLUTION,33.4,20.04,7.75,4481.0,19 NDC,60687025311,SERTRALINE 100 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,60687027211,CEFUROXIME AXETIL 250 MG TABLET,27.35,16.41,6.35,4481.0,19 NDC,60687027562,PHENYTOIN 100 MG/4 ML ORAL SUSPENSION,36.1,21.66,8.38,4481.0,19 NDC,60687029211,DONEPEZIL 5 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,60687029995,ITRACONAZOLE 100 MG CAPSULE,26.0,15.6,6.03,4481.0,19 NDC,60687030311,DONEPEZIL 10 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,60687030411,CAPTOPRIL 12.5 MG TABLET,20.25,12.15,4.7,4481.0,19 NDC,60687030911,LINEZOLID 600 MG TABLET,34.55,20.73,8.02,4481.0,19 NDC,60687031511,CAPTOPRIL 25 MG TABLET,20.65,12.39,4.79,4481.0,19 NDC,60687031795,CHLORTHALIDONE 25 MG TABLET,21.75,13.05,5.05,4481.0,19 NDC,60687032695,ATOMOXETINE 40 MG CAPSULE,35.0,21.0,8.12,4481.0,19 NDC,60687032711,QUETIAPINE 25 MG TABLET,17.0,10.2,3.94,4481.0,19 NDC,60687033301,LISINOPRIL 20 MG TABLET,16.4,9.84,3.8,4481.0,19 NDC,60687033611,MINOCYCLINE 100 MG CAPSULE,19.3,11.58,4.48,4481.0,19 NDC,60687034011,BUPROPION HCL 75 MG TABLET,19.3,11.58,4.48,4481.0,19 NDC,60687034511,CALCITRIOL 0.25 MCG CAPSULE,18.4,11.04,4.27,4481.0,19 NDC,60687034911,QUETIAPINE 100 MG TABLET,17.6,10.56,4.08,4481.0,19 NDC,60687036011,QUETIAPINE 200 MG TABLET,19.15,11.49,4.44,4481.0,19 NDC,60687036911,DICYCLOMINE 10 MG CAPSULE,17.65,10.59,4.09,4481.0,19 NDC,60687037111,QUETIAPINE 300 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,60687038011,DICYCLOMINE 20 MG TABLET,17.4,10.44,4.04,4481.0,19 NDC,60687038111,PHYTONADIONE (VITAMIN K1) 5 MG TABLET,218.15,130.89,50.61,4481.0,19 NDC,60687038711,MIDODRINE 2.5 MG TABLET,18.95,11.37,4.4,4481.0,19 NDC,60687038801,ALPRAZOLAM 0.5 MG TABLET,23.15,13.89,5.37,4481.0,19 NDC,60687039011,"METOPROLOL SUCCINATE ER 25 MG TABLET,EXTENDED RELEASE 24 HR",18.95,11.37,4.4,4481.0,19 NDC,60687039579,ALBUTEROL SULFATE 2.5 MG/3 ML (0.083 %) SOLUTION FOR NEBULIZATION,16.9,10.14,3.92,4481.0,19 NDC,60687039811,MIDODRINE 5 MG TABLET,18.25,10.95,4.23,4481.0,19 NDC,60687040211,"METOPROLOL SUCCINATE ER 50 MG TABLET,EXTENDED RELEASE 24 HR",18.95,11.37,4.4,4481.0,19 NDC,60687040411,CLOZAPINE 25 MG TABLET,18.0,10.8,4.18,4481.0,19 NDC,60687040995,MIDODRINE 10 MG TABLET,20.25,12.15,4.7,4481.0,19 NDC,60687041311,"METOPROLOL SUCCINATE ER 100 MG TABLET,EXTENDED RELEASE 24 HR",20.2,12.12,4.69,4481.0,19 NDC,60687041511,CLOZAPINE 100 MG TABLET,21.05,12.63,4.88,4481.0,19 NDC,60687041911,CHLORPROMAZINE 10 MG TABLET,28.9,17.34,6.7,4481.0,19 NDC,60687042095,RITONAVIR 100 MG TABLET,44.15,26.49,10.24,4481.0,19 NDC,60687042811,FINASTERIDE 5 MG TABLET,18.7,11.22,4.34,4481.0,19 NDC,60687042945,MAGNESIUM HYDROXIDE 400 MG/5 ML ORAL SUSPENSION,1.55,0.93,0.3596,4481.0,19 NDC,60687043199,POLYETHYLENE GLYCOL 3350 17 GRAM ORAL POWDER PACKET,3.3,1.98,0.7656,4481.0,19 NDC,60687043211,TRAZODONE 150 MG TABLET,17.75,10.65,4.12,4481.0,19 NDC,60687043311,AMITRIPTYLINE 25 MG TABLET,17.3,10.38,4.01,4481.0,19 NDC,60687043511,CLARITHROMYCIN 500 MG TABLET,30.95,18.57,7.18,4481.0,19 NDC,60687043611,CELECOXIB 100 MG CAPSULE,20.35,12.21,4.72,4481.0,19 NDC,60687043711,AMIODARONE 200 MG TABLET,17.15,10.29,3.98,4481.0,19 NDC,60687043811,MYCOPHENOLATE MOFETIL 500 MG TABLET,19.3,11.58,0.36,4481.0,24 NDC,60687043911,LABETALOL 100 MG TABLET,17.4,10.44,4.04,4481.0,19 NDC,60687044311,TRAZODONE 50 MG TABLET,16.4,9.84,3.8,4481.0,19 NDC,60687044411,AMITRIPTYLINE 50 MG TABLET,17.75,10.65,4.12,4481.0,19 NDC,60687044711,CELECOXIB 200 MG CAPSULE,22.1,13.26,5.13,4481.0,19 NDC,60687045011,LABETALOL 200 MG TABLET,17.75,10.65,4.12,4481.0,19 NDC,60687045311,LEVOTHYROXINE 25 MCG TABLET,17.4,10.44,4.04,4481.0,19 NDC,60687045411,TRAZODONE 100 MG TABLET,16.6,9.96,3.85,4481.0,19 NDC,60687046411,LEVOTHYROXINE 50 MCG TABLET,17.45,10.47,4.05,4481.0,19 NDC,60687046511,SPIRONOLACTONE 25 MG TABLET,16.3,9.78,3.78,4481.0,19 NDC,60687047301,PREGABALIN 25 MG CAPSULE,26.1,15.66,6.06,4481.0,19 NDC,60687047511,LEVOTHYROXINE 75 MCG TABLET,17.8,10.68,4.13,4481.0,19 NDC,60687047911,CARBAMAZEPINE 100 MG CHEWABLE TABLET,17.5,10.5,4.06,4481.0,19 NDC,60687048111,BUPRENORPHINE HCL 2 MG SUBLINGUAL TABLET,22.15,13.29,5.14,4481.0,19 NDC,60687048411,PREGABALIN 50 MG CAPSULE,26.1,15.66,6.06,4481.0,19 NDC,60687048711,SPIRONOLACTONE 100 MG TABLET,18.2,10.92,4.22,4481.0,19 NDC,60687049211,BUPRENORPHINE HCL 8 MG SUBLINGUAL TABLET,26.5,15.9,6.15,4481.0,19 NDC,60687049511,PREGABALIN 75 MG CAPSULE,26.1,15.66,6.06,4481.0,19 NDC,60687049611,AMLODIPINE 10 MG TABLET,16.5,9.9,3.83,4481.0,19 NDC,60687049711,LEVOTHYROXINE 100 MCG TABLET,17.85,10.71,4.14,4481.0,19 NDC,60687050601,PREGABALIN 100 MG CAPSULE,26.1,15.66,6.06,4481.0,19 NDC,60687050811,LEVOTHYROXINE 112 MCG TABLET,18.05,10.83,4.19,4481.0,19 NDC,60687051911,LEVOTHYROXINE 125 MCG TABLET,18.15,10.89,4.21,4481.0,19 NDC,60687052479,BUDESONIDE 0.5 MG/2 ML SUSPENSION FOR NEBULIZATION,44.05,26.43,10.22,4481.0,19 NDC,60687052611,METRONIDAZOLE 250 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,60687053011,LEVOTHYROXINE 150 MCG TABLET,18.2,10.92,4.22,4481.0,19 NDC,60687055011,METRONIDAZOLE 500 MG TABLET,18.25,10.95,4.23,4481.0,19 NDC,60687055211,LEVOTHYROXINE 200 MCG TABLET,19.0,11.4,4.41,4481.0,19 NDC,60687055801,CYCLOBENZAPRINE 10 MG TABLET,16.55,9.93,3.84,4481.0,19 NDC,60687055911,METHOCARBAMOL 500 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,60687057233,PRAZOSIN 5 MG CAPSULE,26.3,15.78,6.1,4481.0,19 NDC,60687057511,RIFAMPIN 150 MG CAPSULE,25.6,15.36,5.94,4481.0,19 NDC,60687057711,ROPINIROLE 0.25 MG TABLET,17.65,10.59,4.09,4481.0,19 NDC,60687058011,GABAPENTIN 100 MG CAPSULE,16.4,9.84,3.8,4481.0,19 NDC,60687058211,HYDROCORTISONE 10 MG TABLET,21.05,12.63,4.88,4481.0,19 NDC,60687058611,RIFAMPIN 300 MG CAPSULE,21.6,12.96,5.01,4481.0,19 NDC,60687058711,PROPRANOLOL 10 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,60687058811,ROPINIROLE 1 MG TABLET,17.75,10.65,4.12,4481.0,19 NDC,60687059111,GABAPENTIN 300 MG CAPSULE,16.45,9.87,3.82,4481.0,19 NDC,60687059311,HYDROCHLOROTHIAZIDE 25 MG TABLET,16.65,9.99,3.86,4481.0,19 NDC,60687059511,FAMOTIDINE 20 MG TABLET,1.35,0.81,0.3132,4481.0,19 NDC,60687059811,PROPRANOLOL 20 MG TABLET,17.4,10.44,4.04,4481.0,19 NDC,60687059911,FLUCYTOSINE 250 MG CAPSULE,261.6,156.96,60.69,4481.0,19 NDC,60687060211,GABAPENTIN 400 MG CAPSULE,16.6,9.96,3.85,4481.0,19 NDC,60687061011,FLUCYTOSINE 500 MG CAPSULE,486.05,291.63,112.76,4481.0,19 NDC,60687061211,VALSARTAN 40 MG TABLET,18.5,11.1,4.29,4481.0,19 NDC,60687061411,SULFAMETHOXAZOLE 800 MG-TRIMETHOPRIM 160 MG TABLET,16.8,10.08,3.9,4481.0,19 NDC,60687061811,FENOFIBRATE NANOCRYSTALLIZED 48 MG TABLET,19.75,11.85,4.58,4481.0,19 NDC,60687062311,VALSARTAN 80 MG TABLET,19.25,11.55,4.47,4481.0,19 NDC,60687062911,FENOFIBRATE NANOCRYSTALLIZED 145 MG TABLET,25.9,15.54,6.01,4481.0,19 NDC,60687063411,VALSARTAN 160 MG TABLET,19.65,11.79,4.56,4481.0,19 NDC,60687064811,VARENICLINE TARTRATE 1 MG TABLET,55.1,33.06,12.78,4481.0,19 NDC,60687066011,PROMETHAZINE 12.5 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,60687066111,CARBIDOPA 25 MG-LEVODOPA 100 MG TABLET,17.1,10.26,3.97,4481.0,19 NDC,60687066911,METHIMAZOLE 5 MG TABLET,17.8,10.68,4.13,4481.0,19 NDC,60687067140,PHENOBARBITAL 20 MG/5 ML (4 MG/ML) ORAL ELIXIR,35.6,21.36,8.26,4481.0,19 NDC,60687067511,HYDROXYZINE HCL 25 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,60687067711,ALLOPURINOL 100 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,60687068111,FOLIC ACID 1 MG TABLET,16.55,9.93,3.84,4481.0,19 NDC,60687068711,LACOSAMIDE 100 MG TABLET,31.35,18.81,7.27,4481.0,19 NDC,60687068811,ALLOPURINOL 300 MG TABLET,18.25,10.95,4.23,4481.0,19 NDC,60687068911,BETHANECHOL CHLORIDE 10 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,60687069411,METHENAMINE HIPPURATE 1 GRAM TABLET,23.4,14.04,5.43,4481.0,19 NDC,60687070011,BETHANECHOL CHLORIDE 25 MG TABLET,18.8,11.28,4.36,4481.0,19 NDC,60687071111,OXCARBAZEPINE 150 MG TABLET,17.65,10.59,4.09,4481.0,19 NDC,60687071711,DILTIAZEM 30 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,60687072011,LAMIVUDINE 150 MG TABLET,38.5,23.1,8.93,4481.0,19 NDC,60687072211,OXCARBAZEPINE 300 MG TABLET,18.65,11.19,4.33,4481.0,19 NDC,60687073823,SUCRALFATE 100 MG/ML ORAL SUSPENSION,31.4,18.84,7.28,4481.0,19 NDC,60687074211,AZITHROMYCIN 250 MG TABLET,21.25,12.75,4.93,4481.0,19 NDC,60687074601,MISOPROSTOL 200 MCG TABLET,22.85,13.71,5.3,4481.0,19 NDC,60687075405,LINEZOLID 100 MG/5 ML ORAL SUSPENSION,1026.25,615.75,238.09,4481.0,19 NDC,60687077511,MECLIZINE 12.5 MG TABLET,1.8,1.08,0.4176,4481.0,19 NDC,60687079501,TRAMADOL 50 MG TABLET,22.45,13.47,5.21,4481.0,19 NDC,60758011910,"PREDNISOLONE ACETATE 1 % EYE DROPS,SUSPENSION",280.9,168.54,65.17,4481.0,19 NDC,60758011915,"PREDNISOLONE ACETATE 1 % EYE DROPS,SUSPENSION",413.35,248.01,95.9,4481.0,19 NDC,60758080105,TIMOLOL MALEATE 0.5 % EYE DROPS WRAPPER,32.5,19.5,7.54,4481.0,19 NDC,60758088005,"FLUOROMETHOLONE 0.1 % EYE DROPS,SUSPENSION",249.1,149.46,57.79,4481.0,19 NDC,60793070010,"PENICILLIN G BENZATHINE 600,000 UNIT/ML INTRAMUSCULAR SYRINGE",847.0,508.2,29.11,4481.0,35 NDC,60793070110,"PENICILLIN G BENZATHINE 1,200,000 UNIT/2 ML INTRAMUSCULAR SYRINGE",1455.25,873.15,29.11,4481.0,35 NDC,60793070210,"PENICILLIN G BENZATHINE 2,400,000 UNIT/4 ML INTRAMUSCULAR SYRINGE",2965.25,1779.15,29.11,4481.0,35 NDC,60977014127,PRALIDOXIME 1 GRAM SOLUTION FOR INJECTION,354.15,212.49,82.16,4481.0,24 NDC,61269041020,ETOPOSIDE PHOSPHATE 100 MG INTRAVENOUS SOLUTION,838.9,503.34,2.12,4481.0,24 NDC,61269073063,MICONAZOLE NITRATE 2 % VAGINAL CREAM,10.25,6.15,2.38,4481.0,19 NDC,61314001405,DICLOFENAC 0.1 % EYE DROPS,58.15,34.89,13.49,4481.0,19 NDC,61314001910,DORZOLAMIDE 2 % EYE DROPS,91.25,54.75,21.17,4481.0,19 NDC,61314004475,TRIFLURIDINE 1 % EYE DROPS,606.0,363.6,140.59,4481.0,19 NDC,61314012605,KETOROLAC 0.5 % EYE DROPS,100.3,60.18,23.27,4481.0,19 NDC,61314020315,PILOCARPINE 1 % EYE DROPS,253.4,152.04,58.79,4481.0,19 NDC,61314020415,PILOCARPINE 2 % EYE DROPS,258.8,155.28,60.04,4481.0,19 NDC,61314020615,PILOCARPINE 4 % EYE DROPS,270.55,162.33,62.77,4481.0,19 NDC,61314022605,TIMOLOL MALEATE 0.25 % EYE DROPS,31.6,18.96,7.33,4481.0,19 NDC,61314022705,TIMOLOL MALEATE 0.5 % EYE DROPS,45.05,27.03,10.45,4481.0,19 NDC,61314031805,FILGRASTIM-SNDZ 300 MCG/0.5 ML INJECTION SYRINGE,1086.05,651.63,0.4462,4481.0,35 NDC,61314032601,FILGRASTIM-SNDZ 480 MCG/0.8 ML INJECTION SYRINGE,1728.05,1036.83,0.4462,4481.0,35 NDC,61314039603,CYCLOPENTOLATE 1 % EYE DROPS,100.3,60.18,23.27,4481.0,19 NDC,61314062810,"POLYMYXIN B SULFATE 10,000 UNIT-TRIMETHOPRIM 1 MG/ML EYE DROPS",47.2,28.32,10.95,4481.0,19 NDC,61314063006,"NEOMYCIN-POLYMYXIN-DEXAMETH 3.5 MG/ML-10,000 UNIT/ML-0.1% EYE DROPS",70.2,42.12,16.29,4481.0,19 NDC,61314063136,"NEOMYCIN 3.5 MG/G-POLYMYXIN B 10,000 UNIT/G-DEXAMETH 0.1 % EYE OINT",70.2,42.12,16.29,4481.0,19 NDC,61314063705,"PREDNISOLONE ACETATE 1 % EYE DROPS,SUSPENSION",149.2,89.52,34.61,4481.0,19 NDC,61314064305,TOBRAMYCIN 0.3 % EYE DROPS,62.7,37.62,14.55,4481.0,19 NDC,61314064705,"TOBRAMYCIN 0.3 %-DEXAMETHASONE 0.1 % EYE DROPS,SUSPENSION",18.3,10.98,4.25,4481.0,19 NDC,61314065605,CIPROFLOXACIN 0.3 % EYE DROPS,58.15,34.89,13.49,4481.0,19 NDC,61314066505,APRACLONIDINE 0.5 % EYE DROPS,209.4,125.64,48.58,4481.0,19 NDC,61553011853,"FENTANYL (PF) 2,500 MCG/50 ML (50 MCG/ML) INTRAVENOUS PCA SYRINGE",75.6,45.36,2.48,4481.0,24 NDC,61553042459,FENTANYL (PF) 25 MCG/2.5 ML (10 MCG/ML) INFUSION SYRINGE,24.1,14.46,2.48,4481.0,24 NDC,61553042459,FENTANYL (PF) 25 MCG/2.5 ML (10 MCG/ML) INJECTION,24.1,14.46,2.48,4481.0,24 NDC,61570013140,SILVER SULFADIAZINE 1 % TOPICAL CREAM,164.1,98.46,38.07,4481.0,19 NDC,61703030916,VINCRISTINE 1 MG/ML INTRAVENOUS SOLUTION (2 MG MAX DOSE),326.0,195.6,18.5,4481.0,24 NDC,61703030916,VINCRISTINE 1 MG/ML INTRAVENOUS SOLUTION (>2 MG MAX DOSE),326.0,195.6,18.5,4481.0,24 NDC,61703032618,PAMIDRONATE 90 MG/10 ML (9 MG/ML) INTRAVENOUS SOLUTION,83.5,50.1,19.37,4481.0,24 NDC,61703033218,BLEOMYCIN 15 UNIT SOLUTION FOR INJECTION,442.05,265.23,48.42,4481.0,24 NDC,61703033218,BLEOMYCIN INTRALESIONAL SYRINGE 1 UNIT/ML,442.05,265.23,48.42,4481.0,24 NDC,61703033218,BLEOMYCIN INTRALESIONAL SYRINGE 2 UNITS/ML,442.05,265.23,48.42,4481.0,24 NDC,61703033218,BLEOMYCIN INTRALESIONAL SYRINGE 3 UNITS/ML,442.05,265.23,48.42,4481.0,24 NDC,61703033218,BLEOMYCIN INTRALESIONAL SYRINGE 4 UNITS/ML,442.05,265.23,48.42,4481.0,24 NDC,61703033218,BLEOMYCIN INTRALESIONAL SYRINGE 5 UNITS/ML,442.05,265.23,48.42,4481.0,24 NDC,61703034250,"PACLITAXEL 6 MG/ML CONCENTRATE,INTRAVENOUS",511.05,306.63,0.297,4481.0,24 NDC,61703034365,MITOXANTRONE (NOVANTRONE) INJECTION,989.0,593.4,23.16,4481.0,35 NDC,61703034909,IRINOTECAN 100 MG/5 ML INTRAVENOUS SOLUTION,347.75,208.65,3.81,4481.0,24 NDC,61703035038,METHOTREXATE SODIUM (CONTAINS PRESERVATIVES) 25 MG/ML INJECTION SOLUTION,299.1,179.46,6.15,4481.0,24 NDC,61703040841,METHOTREXATE SODIUM (PF) 25 MG/ML INJECTION SOLUTION,396.55,237.93,6.15,4481.0,24 NDC,61703040841,METHOTREXATE SODIUM (PF) 25 MG/ML INJECTION SOLUTION FOR INTRATHECAL,396.55,237.93,6.15,4481.0,24 NDC,61755000501,AFLIBERCEPT 2 MG/0.05 ML INTRAVITREAL SYRINGE,7591.1,4554.66,748.41,120279.81,35 NDC,61755000801,CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION,36436.65,21861.99,28.41,29149.32,35 NDC,61755001001,EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION,146386.0,87831.6,187.95,117108.8,35 NDC,61755001301,EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION,42130.9,25278.54,187.95,33704.72,35 NDC,61755005001,AFLIBERCEPT 8 MG/0.07 ML INTRAVITREAL SOLUTION FOR INJECTION,10667.1,6400.26,302.04,52571.61,35 NDC,61755005400,LINVOSELTAMAB-GCPT 2 MG/ML INTRAVENOUS SOLUTION,1830.7,1098.42,424.72,4481.0,22 NDC,61755005600,LINVOSELTAMAB-GCPT 20 MG/ML INTRAVENOUS SOLUTION,8053.5,4832.1,1868.41,6442.8,22 NDC,61874011511,CARIPRAZINE 1.5 MG CAPSULE,167.9,100.74,38.95,4481.0,19 NDC,61874013011,CARIPRAZINE 3 MG CAPSULE,167.9,100.74,38.95,4481.0,19 NDC,61958070101,EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,200.25,120.15,1.68,4481.0,35 NDC,61958080101,AMBRISENTAN 5 MG TABLET,1390.65,834.39,322.63,4481.0,19 NDC,61958140101,COBICISTAT 150 MG TABLET,47.5,28.5,11.02,4481.0,19 NDC,61958190101,ELVITEG 150 MG-COB 150 MG-EMTRICIT 200 MG-TENOFO ALAFENAM 10 MG TABLET,437.65,262.59,101.53,4481.0,19 NDC,61958230101,TENOFOVIR ALAFENAMIDE 25 MG TABLET,168.7,101.22,39.14,4481.0,19 NDC,61958250103,BICTEGRAVIR 50 MG-EMTRICITABINE 200 MG-TENOFOVIR ALAFENAM 25 MG TABLET,437.65,262.59,101.53,4481.0,19 NDC,61958290102,REMDESIVIR 100 MG INTRAVENOUS POWDER FOR SOLUTION,2023.05,1213.83,6.53,4481.0,35 NDC,61958290102,REMDESIVIR 100 MG INTRAVENOUS POWDER FOR SOLUTION (EUA),2023.05,1213.83,6.53,4481.0,35 NDC,61958300101,LENACAPAVIR 300 MG TABLET,2453.5,1472.1,569.21,4481.0,19 NDC,61958300401,LENACAPAVIR 309 MG/ML SUBCUTANEOUS SOLUTION,76066.0,45639.6,21.49,60852.8,35 NDC,62064012202,IBALIZUMAB-UIYK 200 MG/1.33 ML (150 MG/ML) INTRAVENOUS SOLUTION,49914.2,29948.52,76.88,39931.36,35 NDC,62135048149,CEPHALEXIN 250 MG/5 ML ORAL SUSPENSION,1066.0,639.6,247.31,4481.0,19 NDC,62135052047,OXYBUTYNIN CHLORIDE 5 MG/5 ML ORAL SYRUP,23.95,14.37,5.56,4481.0,19 NDC,62144551005,ARTIFICIAL TEARS (HYPROMELLOSE) (PF) 1.7 % EYE DROPS WITH APPLICATOR,39.75,23.85,9.22,4481.0,19 NDC,62225060000,PHENYLEPHRINE 1 %-KETOROLAC 0.3 % INTRAOCULAR CONCENTRATE FOR IRRIG,1856.8,1114.08,91.25,4481.0,34 NDC,62332003331,ROPINIROLE 2 MG TABLET,16.4,9.84,3.8,4481.0,19 NDC,62332006360,RIVASTIGMINE 1.5 MG CAPSULE,17.75,10.65,4.12,4481.0,19 NDC,62332009730,ARIPIPRAZOLE 2 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,62332009831,ARIPIPRAZOLE 5 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,62332019130,FEBUXOSTAT 80 MG TABLET,17.5,10.5,4.06,4481.0,19 NDC,62484001504,HYDROXYUREA (SICKLE CELL) 100 MG/ML ORAL SOLUTION,2295.95,1377.57,532.66,4481.0,19 NDC,62530000011,UREA 15 GRAM ORAL POWDER PACKET,6.65,3.99,1.54,4481.0,19 NDC,62559013807,HYDROCORTISONE 100 MG/60 ML ENEMA,80.5,48.3,18.68,4481.0,19 NDC,62559015901,FLUVOXAMINE 50 MG TABLET,17.8,10.68,4.13,4481.0,19 NDC,62559023001,PROPAFENONE 150 MG TABLET,16.85,10.11,3.91,4481.0,19 NDC,62559026530,TRANEXAMIC ACID 650 MG TABLET,24.05,14.43,5.58,4481.0,19 NDC,62584026511,METOPROLOL TARTRATE 25 MG TABLET,16.3,9.78,3.78,4481.0,19 NDC,62584026611,METOPROLOL TARTRATE 50 MG TABLET,16.35,9.81,3.79,4481.0,19 NDC,62584026711,METOPROLOL TARTRATE 100 MG TABLET,16.85,10.11,3.91,4481.0,19 NDC,62584069311,DOXYCYCLINE HYCLATE 100 MG TABLET,27.5,16.5,6.38,4481.0,19 NDC,62756023301,AMPHOTERICIN B LIPOSOME 50 MG INTRAVENOUS SUSPENSION,896.05,537.63,20.84,4481.0,35 NDC,62856021201,LECANEMAB-IRMB 100 MG/ML INTRAVENOUS SOLUTION,917.25,550.35,1.28,4481.0,35 NDC,62856021501,LECANEMAB-IRMB 100 MG/ML INTRAVENOUS SOLUTION,2198.6,1319.16,1.28,4481.0,35 NDC,62856038901,ERIBULIN (HALAVEN) SYRINGE 0.5 MG/ML,4942.1,2965.26,86.66,17947.23,35 NDC,62856058352,RUFINAMIDE 400 MG TABLET,95.2,57.12,22.09,4481.0,19 NDC,62856058446,RUFINAMIDE 40 MG/ML ORAL SUSPENSION,5293.15,3175.89,1228.01,4481.0,19 NDC,62935015350,LEUPROLIDE 45 MG (PEDIATRIC 6 MONTH) SUBCUTANEOUS SYRINGE,91111.6,54666.96,136.76,72889.28,35 NDC,62935022305,LEUPROLIDE ACETATE 22.5 MG (3 MONTH) SUBCUTANEOUS SYRINGE,4760.3,2856.18,171.16,26039.58,35 NDC,62935030330,LEUPROLIDE 30 MG (4 MONTH) SUBCUTANEOUS SYRINGE,6255.4,3753.24,171.16,26039.58,35 NDC,62935045345,LEUPROLIDE ACETATE 45 MG (6 MONTH) SUBCUTANEOUS SYRINGE,9245.55,5547.33,171.16,26039.58,35 NDC,62935075680,LEUPROLIDE 7.5 MG (1 MONTH) SUBCUTANEOUS SYRINGE,1770.1,1062.06,171.16,26039.58,35 NDC,63020004901,BORTEZOMIB (VELCADE) IV SYRINGE 1 MG/ML,5580.95,3348.57,4.32,4481.0,24 NDC,63020004901,BORTEZOMIB (VELCADE) SUBCUTANEOUS SYRINGE 2.5 MG/ML,5580.95,3348.57,4.32,4481.0,24 NDC,63020053530,PONATINIB 15 MG TABLET,3134.35,1880.61,727.17,4481.0,19 NDC,63304017513,"MESALAMINE 1.2 GRAM TABLET,DELAYED RELEASE",29.35,17.61,6.81,4481.0,19 NDC,63323001001,GENTAMICIN 40 MG/ML INJECTION SOLUTION,34.1,20.46,4.97,4481.0,24 NDC,63323001003,GENTAMICIN 40 MG/ML INJECTION SOLUTION,145.95,87.57,4.97,4481.0,24 NDC,63323001203,OXYTOCIN 10 UNIT/ML INJECTION SOLUTION,20.05,12.03,3.22,4481.0,24 NDC,63323001210,OXYTOCIN 10 UNIT/ML INJECTION SOLUTION,17.2,10.32,3.22,4481.0,24 NDC,63323001302,THIAMINE HCL (VITAMIN B1) 100 MG/ML INJECTION SOLUTION,21.85,13.11,4.09,4481.0,24 NDC,63323002425,MANNITOL 25 % INTRAVENOUS SOLUTION,27.8,16.68,0.135,4481.0,21 NDC,63323003200,SODIUM ACETATE 4 MEQ/ML INTRAVENOUS SOLUTION,91.8,55.08,21.3,4481.0,19 NDC,63323004400,"CYANOCOBALAMIN (VIT B-12) 1,000 MCG/ML INJECTION SOLUTION",17.35,10.41,2.25,4481.0,24 NDC,63323004701,"HEPARIN (PORCINE) 5,000 UNIT/ML INJECTION SOLUTION",22.8,13.68,0.4725,4481.0,24 NDC,63323004710,"HEPARIN (PORCINE) 5,000 UNIT/ML INJ SOLUTION (MULTI-VIAL SIZE WRAPPER)",22.8,13.68,0.4725,4481.0,24 NDC,63323006403,MAGNESIUM SULFATE 4 MEQ/ML (50 %) INJECTION WRAPPER,24.9,14.94,1.08,4481.0,24 NDC,63323006403,MAGNESIUM SULFATE 500 MG/ML (50 %) INJECTION SOLUTION,24.9,14.94,1.08,4481.0,24 NDC,63323008305,SODIUM BICARBONATE 4.2 % INTRAVENOUS SOLUTION,107.8,64.68,25.01,4481.0,19 NDC,63323009301,SODIUM CHLORIDE 23.4% (4 MEQ/ML) INTRAVENOUS SOLUTION,88.05,52.83,0.2805,4481.0,24 NDC,63323009502,SODIUM CHLORIDE 23.4% (4 MEQ/ML) INTRAVENOUS SOLUTION,80.3,48.18,0.2805,4481.0,24 NDC,63323010213,GEMCITABINE 200 MG INTRAVENOUS SOLUTION,315.05,189.03,7.04,4481.0,24 NDC,63323010365,CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION,411.4,246.84,5.15,4481.0,24 NDC,63323010425,ETOPOSIDE 20 MG/ML INTRAVENOUS SOLUTION,480.9,288.54,2.12,4481.0,24 NDC,63323010450,ETOPOSIDE 20 MG/ML INTRAVENOUS SOLUTION,686.8,412.08,2.12,4481.0,24 NDC,63323010602,MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK,112.0,67.2,1.08,4481.0,24 NDC,63323010615,MAGNESIUM SULFATE 20 GRAM/500 ML (4 %) IN WATER INTRAVENOUS SOLUTION,85.9,51.54,1.08,4481.0,24 NDC,63323010800,MAGNESIUM SULFATE 1 GRAM/100 ML IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK,98.45,59.07,1.08,4481.0,24 NDC,63323011710,FLUOROURACIL (ADRUCIL) 50 MG/ML IV SOLUTION WRAPPER,286.35,171.81,4.48,4481.0,24 NDC,63323011710,FLUOROURACIL 500 MG/10 ML INTRAVENOUS SOLUTION,286.35,171.81,4.48,4481.0,24 NDC,63323011710,FLUOROURACIL INFUSION (CADD),286.35,171.81,4.48,4481.0,24 NDC,63323011761,FLUOROURACIL (ADRUCIL) 50 MG/ML IV SOLUTION WRAPPER (UNC HOMECARE),372.0,223.2,4.48,4481.0,24 NDC,63323012020,CYTARABINE (PF) 100 MG/ML INJECTION,344.2,206.52,1.87,4481.0,24 NDC,63323012310,METHOTREXATE SODIUM (CONTAINS PRESERVATIVES) 25 MG/ML INJECTION SOLUTION,386.2,231.72,6.15,4481.0,24 NDC,63323012594,GEMCITABINE 1 GRAM INTRAVENOUS SOLUTION,413.65,248.19,7.04,4481.0,24 NDC,63323013002,DOXYCYCLINE HYCLATE 100 MG INTRAVENOUS POWDER FOR SOLUTION,149.1,89.46,0.2475,4481.0,24 NDC,63323014010,CLADRIBINE 10 MG/10 ML INTRAVENOUS SOLUTION,1714.85,1028.91,10.36,4481.0,35 NDC,63323014397,TRACE ELEMENTS (ADDAMEL) #1 5.33 MCG-0.34 MG-0.54 MG/ML INTRAVENOUS SOLUTION,78.4,47.04,18.19,4481.0,19 NDC,63323016100,KETOROLAC 15 MG/ML INJECTION SOLUTION,30.65,18.39,0.2813,4481.0,34 NDC,63323016100,KETOROLAC 15 MG/ML INJECTION SOLUTION WRAPPER,30.65,18.39,0.2813,4481.0,34 NDC,63323016201,KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION,38.25,22.95,0.2813,4481.0,34 NDC,63323016201,KETOROLAC 30 MG/ML INJECTION WRAPPER,38.25,22.95,0.2813,4481.0,34 NDC,63323017260,CARBOPLATIN (PARAPLATIN) 10 MG/ML IVPB (BY AUC),479.0,287.4,5.56,4481.0,24 NDC,63323017260,CARBOPLATIN (PARAPLATIN) 10 MG/ML IVPB (BY MG/M2),479.0,287.4,5.56,4481.0,24 NDC,63323017260,CARBOPLATIN 10 MG/ML INTRAVENOUS SOLUTION,479.0,287.4,5.56,4481.0,24 NDC,63323017301,GENTAMICIN SULFATE (PEDIATRIC) (PF) 20 MG/2 ML INJECTION SOLUTION,40.1,24.06,4.97,4481.0,24 NDC,63323017302,GENTAMICIN SULFATE (PF) 20 MG/2 ML INJ SOLN WRAPPER,40.1,24.06,4.97,4481.0,24 NDC,63323018000,PYRIDOXINE (VITAMIN B6) 100 MG/ML INJECTION SOLUTION,58.4,35.04,13.55,4481.0,24 NDC,63323018410,FOLIC ACID 5 MG/ML INJECTION SOLUTION,21.0,12.6,0.135,4481.0,24 NDC,63323018505,"WATER FOR INJECTION, STERILE INJECTION SOLUTION",29.15,17.49,6.76,4481.0,19 NDC,63323018520,"STUDY WATER FOR INJECTION, STERILE INTRAVENOUS SOLUTION",0.2,0.12,0.0464,4481.0,24 NDC,63323018601,SODIUM CHLORIDE 0.9 % INJECTION SOLUTION,20.55,12.33,4.77,4481.0,19 NDC,63323018601,SODIUM CHLORIDE 0.9% SOLUTION FOR PCN TESTING,16.15,9.69,3.75,4481.0,19 NDC,63323019202,FLUDARABINE (FLUDARA) 50 MG INJECTION WRAPPER,1174.95,704.97,66.15,9659.37,35 NDC,63323020103,LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION,26.4,15.84,0.0225,4481.0,24 NDC,63323020320,VANCOMYCIN 750 MG INTRAVENOUS SOLUTION,94.1,56.46,0.0675,4481.0,24 NDC,63323020521,FAT EMULSION 10 % FISH OIL-BASED (OMEGAVEN) 50 ML INFUSION (PEDS),302.9,181.74,70.27,4481.0,19 NDC,63323020531,FATTY ACID NO.6-FISH OIL-GLYCERIN 10 % IV EMULSION,405.4,243.24,94.05,4481.0,19 NDC,63323020805,LIDOCAINE (PF) 20 MG/ML (2 %) INTRAVENOUS SOLUTION,30.65,18.39,0.0225,4481.0,24 NDC,63323022921,PROTAMINE 10 MG/ML INTRAVENOUS SOLUTION,59.5,35.7,3.92,4481.0,24 NDC,63323022930,PROTAMINE 10 MG/ML INTRAVENOUS SOLUTION,222.35,133.41,3.92,4481.0,24 NDC,63323023710,CEFAZOLIN 1 GRAM INJ SOLR IM,22.8,13.68,1.8,4481.0,24 NDC,63323024930,WATER FOR INJECT BACT PARABENS INJECTION SOLUTION,23.4,14.04,5.43,4481.0,19 NDC,63323025410,"MINERAL OIL, LIGHT STERILE",84.35,50.61,19.57,4481.0,19 NDC,63323026001,MEPIVACAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,59.45,35.67,8.89,4481.0,24 NDC,63323026929,PROPOFOL 10 MG/ML INTRAVENOUS EMULSION,39.4,23.64,0.2025,4481.0,24 NDC,63323026965,PROPOFOL INFUSION 10 MG/ML,161.1,96.66,0.2025,4481.0,24 NDC,63323027810,VINBLASTINE 1 MG/ML INTRAVENOUS SOLUTION,452.95,271.77,11.93,4481.0,24 NDC,63323028110,FLUPHENAZINE 2.5 MG/ML INJECTION SOLUTION,53.5,32.1,7.12,4481.0,35 NDC,63323028507,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJECTION SOLUTION,59.1,35.46,0.1125,4481.0,24 NDC,63323028513,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJECTION SOLUTION,37.55,22.53,0.1125,4481.0,24 NDC,63323028561,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJECTION SOLUTION,166.55,99.93,0.1125,4481.0,24 NDC,63323028568,ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJ SOLN OSM,95.6,57.36,0.1125,4481.0,24 NDC,63323028807,ROPIVACAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION,82.4,49.44,0.1125,4481.0,24 NDC,63323029301,MEPIVACAINE (PF) 15 MG/ML (1.5 %) INJECTION SOLUTION,75.0,45.0,8.89,4481.0,24 NDC,63323029427,MEPIVACAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION,64.25,38.55,8.89,4481.0,24 NDC,63323030502,TOBRAMYCIN 10 MG/ML INJECTION SOLUTION,65.9,39.54,5.33,4481.0,24 NDC,63323030602,TOBRAMYCIN 40 MG/ML INJECTION SOLUTION,29.25,17.55,5.33,4481.0,24 NDC,63323030630,TOBRAMYCIN 40 MG/ML INJECTION SOLUTION,101.8,61.08,5.33,4481.0,24 NDC,63323031510,GANCICLOVIR SODIUM 500 MG INTRAVENOUS SOLUTION,381.1,228.66,88.42,4849.53,24 NDC,63323032225,IMIPENEM-CILASTATIN FOR INHALATION,161.05,96.63,18.98,4481.0,24 NDC,63323032620,CEFEPIME 1 GRAM INJ COMBINED WRAPPER,40.8,24.48,2.75,4481.0,24 NDC,63323032620,CEFEPIME 1 GRAM INJ SOLR IM,40.8,24.48,2.75,4481.0,24 NDC,63323034225,CEFOXITIN 100 MG/ML SYRINGE PEDIATRIC,108.65,65.19,10.76,4481.0,24 NDC,63323034901,IMIPENEM-CILASTATIN 250 MG INTRAVENOUS SOLUTION,118.9,71.34,18.98,4481.0,24 NDC,63323036001,CALCIUM GLUCONATE (PICU-UNC) 100 MG/ML PEDIATRIC BOLUS,95.8,57.48,0.09,4481.0,24 NDC,63323036001,CALCIUM GLUCONATE 100 MG/ML (10 %) INTRAVENOUS SOLUTION,79.4,47.64,0.09,4481.0,24 NDC,63323036820,AMPICILLIN-SULBACTAM 1.5 GRAM INJ SOLR IM,31.2,18.72,3.13,4481.0,24 NDC,63323037601,OCTREOTIDE ACETATE 100 MCG/ML INJECTION SOLUTION,45.1,27.06,1.37,4481.0,24 NDC,63323037700,OCTREOTIDE ACETATE 500 MCG/ML SYRINGE (PEDS),209.8,125.88,1.37,4481.0,24 NDC,63323037701,OCTREOTIDE ACETATE 500 MCG/ML INJECTION SOLUTION,209.8,125.88,1.37,4481.0,24 NDC,63323037805,OCTREOTIDE ACETATE 200 MCG/ML INJECTION SOLUTION,54.8,32.88,1.37,4481.0,24 NDC,63323037905,"OCTREOTIDE ACETATE 1,000 MCG/ML INJECTION SOLUTION",1953.85,1172.31,1.37,4481.0,24 NDC,63323040310,FOSPHENYTOIN 500 MG PE/10 ML INJECTION SOLUTION,116.05,69.63,5.89,4481.0,24 NDC,63323041115,MIDAZOLAM 1 MG/ML INJECTION SOLUTION,23.0,13.8,0.3375,4481.0,24 NDC,63323041218,MIDAZOLAM 5 MG/ML INJECTION SOLUTION,31.85,19.11,0.3375,4481.0,24 NDC,63323041820,CISATRACURIUM CONCENTRATE 10 MG/ML (ICU USE ONLY) INTRAVENOUS SOLUTION,665.75,399.45,154.45,4481.0,19 NDC,63323045100,MORPHINE 10 MG/ML INJECTION SOLUTION,26.6,15.96,6.17,4481.0,24 NDC,63323046037,"BUPIVACAINE-EPINEPHRINE (PF) 0.75 %-1:200,000 INJECTION SOLUTION",73.1,43.86,16.96,4481.0,19 NDC,63323046817,"BUPIVACAINE-EPINEPHRINE (PF) 0.25 %-1:200,000 INJECTION SOLUTION",45.85,27.51,10.64,4481.0,19 NDC,63323046901,HALOPERIDOL DECANOATE 50 MG/ML INTRAMUSCULAR SOLUTION,70.8,42.48,9.9,4481.0,24 NDC,63323047401,HALOPERIDOL LACTATE 5 MG/ML INJECTION WRAPPER,20.7,12.42,1.8,4481.0,24 NDC,63323047727,CHLOROPROCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION,110.8,66.48,0.09,4481.0,24 NDC,63323047801,CHLOROPROCAINE (PF) 30 MG/ML (3 %) INJECTION SOLUTION,103.3,61.98,0.09,4481.0,24 NDC,63323048203,"LIDOCAINE 1 %-EPINEPHRINE 1:100,000 INJECTION SOLUTION",17.1,10.26,0.0225,4481.0,24 NDC,63323048501,LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION,29.3,17.58,0.0225,4481.0,24 NDC,63323048657,LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION,43.9,26.34,0.0225,4481.0,24 NDC,63323048707,"LIDOCAINE-EPINEPHRINE (PF) 1 %-1:200,000 INJECTION SOLUTION",18.05,10.83,0.0225,4481.0,24 NDC,63323048807,"LIDOCAINE-EPINEPHRINE (PF) 1.5 %-1:200,000 INJECTION SOLUTION",18.35,11.01,0.0225,4481.0,24 NDC,63323048921,"LIDOCAINE-EPINEPHRINE (PF) 2 %-1:200,000 INJECTION SOLUTION",20.6,12.36,0.0225,4481.0,24 NDC,63323049157,LIDOCAINE (PF) 5 MG/ML (0.5 %) INJECTION SOLUTION,72.55,43.53,0.0225,4481.0,24 NDC,63323049237,LIDOCAINE (PF) 10 MG/ML (1 %) FOR NEBULIZATION,22.15,13.29,5.14,4481.0,19 NDC,63323049301,LIDOCAINE (PF) 15 MG/ML (1.5 %) INJECTION SOLUTION,69.55,41.73,0.0225,4481.0,24 NDC,63323049697,LIDOCAINE (PF) 20 MG/ML (2 %) INECTION SOLUTION WRAPPER,43.05,25.83,0.0225,4481.0,24 NDC,63323050701,MEROPENEM 500 MG INTRAVENOUS SOLUTION,72.85,43.71,0.945,4481.0,24 NDC,63323050801,MEROPENEM 1 GRAM INTRAVENOUS SOLUTION,82.3,49.38,0.945,4481.0,24 NDC,63323050830,MEROPENEM 50 MG/ML PEDIATRIC IV,82.3,49.38,0.945,4481.0,24 NDC,63323051774,"HEPARIN (PORCINE) 25,000 UNIT/250 ML IN 0.45 % SODIUM CHLORIDE IV SOLN",104.0,62.4,0.4725,4481.0,24 NDC,63323054003,"HEPARIN (PORCINE) 1,000 UNIT/ML INJECTION SOLUTION",31.1,18.66,0.4725,4481.0,24 NDC,63323054005,"HEPARIN (PORCINE) 1,000 UNIT/ML INJECTION SOLUTION",44.4,26.64,0.4725,4481.0,24 NDC,63323055921,ENOXAPARIN 30 MG/0.3 ML SUBCUTANEOUS SYRINGE,26.85,16.11,1.33,4481.0,24 NDC,63323056310,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) INTRAVENOUS SOLUTION (PED)",128.4,77.04,29.79,4481.0,19 NDC,63323056310,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) TOPICAL OR INHALATION SOLUTION",94.0,56.4,21.81,4481.0,19 NDC,63323058421,ENOXAPARIN 80 MG/0.8 ML SUBCUTANEOUS SYRINGE,44.9,26.94,1.33,4481.0,24 NDC,63323058621,ENOXAPARIN 100 MG/ML SUBCUTANEOUS SYRINGE,52.35,31.41,1.33,4481.0,24 NDC,63323058921,ENOXAPARIN 150 MG/ML SUBCUTANEOUS SYRINGE,70.45,42.27,1.33,4481.0,24 NDC,63323059303,GLUCAGON 1 MG SOLUTION FOR INJECTION (COMBINED VIALS) WRAPPER,1001.5,600.9,144.52,4481.0,35 NDC,63323059303,GLUCAGON HCL 1 MG/ML SOLUTION FOR INJECTION,1001.5,600.9,144.52,4481.0,35 NDC,63323060400,PROPRANOLOL 1 MG/ML INTRAVENOUS SOLUTION,60.8,36.48,14.11,4481.0,24 NDC,63323063703,ARSENIC TRIOXIDE 1 MG/ML INTRAVENOUS SOLUTION,2241.15,1344.69,7.91,4481.0,35 NDC,63323065903,INDOMETHACIN 1 MG INTRAVENOUS SOLUTION,1792.65,1075.59,415.89,4481.0,19 NDC,63323066501,TERBUTALINE 1 MG/ML SUBCUTANEOUS SOLUTION,92.85,55.71,7.46,4481.0,24 NDC,63323069404,ACETYLCYSTEINE 200 MG/ML (20 %) INHALATION SOLUTION,40.0,24.0,9.28,4481.0,19 NDC,63323069404,ACETYLCYSTEINE 200 MG/ML (20 %) SOLUTION,51.95,31.17,12.05,4481.0,19 NDC,63323071100,LEUCOVORIN CALCIUM 500 MG SOLUTION FOR INJECTION,560.3,336.18,7.25,4481.0,24 NDC,63323072901,MICAFUNGIN 100 MG INTRAVENOUS SOLUTION,220.0,132.0,0.585,4481.0,24 NDC,63323073311,MESNA 100 MG/ML INTRAVENOUS SOLUTION,494.5,296.7,3.61,4481.0,24 NDC,63323073809,FAMOTIDINE 10 MG/ML INJ SOLUTION (MULTI-VIAL SIZE),64.5,38.7,0.0225,4481.0,24 NDC,63323073912,FAMOTIDINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION,64.5,38.7,0.0225,4481.0,24 NDC,63323073912,FAMOTIDINE 10 MG/ML INJ SOLUTION (MULTI-VIAL SIZE),64.5,38.7,0.0225,4481.0,24 NDC,63323080611,FENTANYL 50 MCG/ML INTRANASAL SOLUTION,28.7,17.22,2.48,4481.0,24 NDC,63323080620,FENTANYL 50 MCG/ML INTRANASAL SOLUTION,47.6,28.56,2.48,4481.0,24 NDC,63323082004,FAT EMULSION SMOFLIPID 20 % (1000 ML) INFUSION,171.6,102.96,39.81,4481.0,19 NDC,63323082004,FAT EMULSION SMOFLIPID 20 % (500 ML) INFUSION,171.6,102.96,39.81,4481.0,19 NDC,63323082004,FAT EMULSION SMOFLIPID 20 % (750 ML) INFUSION,171.6,102.96,39.81,4481.0,19 NDC,63323082004,FAT EMULSION-SOYBEAN OIL-MCT-OLIVE OIL-FISH OIL 20 % INTRAVENOUS,171.6,102.96,39.81,4481.0,19 NDC,63323085110,HYDROMORPHONE (PF) 10 MG/ML INJECTION SOLUTION,22.15,13.29,0.2025,4481.0,24 NDC,63323085110,HYDROMORPHONE (PF) 10 MG/ML INJECTION SOLUTION FOR PEDS PCA COMPONENT,22.15,13.29,0.2025,4481.0,24 NDC,63323085203,HYDROMORPHONE (PF) 1 MG/ML INJECTION SOLUTION,24.65,14.79,0.2025,4481.0,24 NDC,63323085403,HYDROMORPHONE (PF) 4 MG/ML INJECTION SOLUTION,25.4,15.24,0.2025,4481.0,24 NDC,63323086910,DEXTROSE 5 % AND 0.45 % NACL IV BOLUS,66.0,39.6,3.17,4481.0,21 NDC,63323087715,PENTAMIDINE 300 MG SOLUTION FOR INHALATION,518.35,311.01,120.26,4481.0,19 NDC,63323088406,SODIUM PHOSPHATE 3 MMOL/ML INTRAVENOUS SOLUTION,74.25,44.55,17.23,4481.0,19 NDC,63323088514,LEVOTHYROXINE 20 MCG/ML INTRAVENOUS SOLUTION,308.25,184.95,6.63,4481.0,35 NDC,63323092430,"SODIUM CHLORIDE 0.9 %, BACTERIOSTATIC INJECTION SOLUTION",33.2,19.92,2.83,4481.0,23 NDC,63323096502,POTASSIUM CHLORIDE 2 MEQ/ML INTRAVENOUS SOLUTION,71.6,42.96,0.2475,4481.0,24 NDC,63323096520,POTASSIUM CHLORIDE FOR THERAPEUTIC ABORTION,71.6,42.96,0.2475,4481.0,24 NDC,63402030630,LURASIDONE 60 MG TABLET,157.9,94.74,36.63,4481.0,19 NDC,63459010310,RITUXIMAB-ABBS 10 MG/ML INTRALESIONAL SOLUTION,554.9,332.94,28.5,5030.34,35 NDC,63459010310,RITUXIMAB-ABBS 10 MG/ML INTRAVENOUS SOLUTION,3073.8,1844.28,28.5,5030.34,35 NDC,63459010450,RITUXIMAB-ABBS 10 MG/ML INTRAVENOUS SOLUTION,14268.9,8561.34,28.5,11415.12,35 NDC,63459034804,BENDAMUSTINE (BENDEKA) 25 MG/ML INTRAVENOUS SOLUTION,8463.3,5077.98,13.09,6770.64,35 NDC,63459060111,ARSENIC TRIOXIDE 2 MG/ML INTRAVENOUS SOLUTION,4499.5,2699.7,7.91,4481.0,35 NDC,63481052910,"NEOMYCIN-COLIST-HC-THONZONM 3.3 MG-3 MG-10 MG-0.5 MG/ML EAR DROPS,SUSP",713.3,427.98,165.49,4481.0,19 NDC,63736012002,PERMETHRIN 1 % TOPICAL LIQUID,13.75,8.25,3.19,4481.0,19 NDC,63739014310,TAMOXIFEN 10 MG TABLET,26.95,16.17,6.25,4481.0,19 NDC,63824017365,DEXTROMETHORPHAN POLISTIREX ER 30 MG/5 ML ORAL SUSP EXT.RELEASE 12HR,1.7,1.02,0.3944,4481.0,19 NDC,63833038602,HUM PROTHROMBIN CPLX(PCC)4FACT 500 UNIT/20 ML IV KIT,87.25,52.35,2.08,4481.0,35 NDC,63833038602,"HUMAN PROTHROMBIN COMPLEX,4-FACTOR 500 UNIT (400-620 UNIT) IV SOLUTION",87.25,52.35,2.08,4481.0,35 NDC,63833038702,"HUM PROTHROMBIN CPLX, 4-FACTOR 1,000 UNIT (800-1,240 UNIT) IV SOLUTION",87.25,52.35,2.08,4481.0,35 NDC,63833061502,ANTIHEMOPHILIC FACTOR-VWF 250 UNIT-600 UNIT INTRAVENOUS SOLUTION,82.7,49.62,1.45,4481.0,35 NDC,63833061602,"ANTIHEMOPHILIC FACTOR-VWF 500 UNIT-1,200 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 NDC,63833061702,"(FVIII DOSING) ANTIHEMOPHILIC FACTOR-VWF 1,000 UNIT-2,400 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 NDC,63833061702,"(VWF DOSING) ANTIHEMOPHILIC FACTOR-VWF 1,000 UNIT-2,400 UNIT INTRAVENOUS SOLUTION",82.7,49.62,1.45,4481.0,35 NDC,63833082502,C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS KIT,16675.3,10005.18,73.58,13340.24,35 NDC,63833083501,C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION,16675.3,10005.18,73.58,13340.24,35 NDC,64193042402,"ANTI-INHIBITOR COAGULANT COMPLEX 700 UNIT-1,300 UNIT INTRAVENOUS SOLN",86.3,51.78,2.34,4481.0,35 NDC,64208251203,"ALBUMIN, HUMAN-KJDA 25 % INTRAVENOUS SOLUTION",330.75,198.45,76.73,4481.0,24 NDC,64208251207,"ALBUMIN, HUMAN-KJDA 25 % INTRAVENOUS SOLUTION",330.75,198.45,76.73,4481.0,24 NDC,64208775601,COAGULATION FACTOR X 500 (+/-) UNIT RANGE INTRAVENOUS SOLUTION,116.15,69.69,9.49,4481.0,35 NDC,64253090091,CALCIUM CHLORIDE 100 MG/ML (10 %) INTRAVENOUS SYRINGE,55.0,33.0,0.0675,4481.0,24 NDC,64380015801,MEGESTROL 20 MG TABLET,25.8,15.48,5.99,4481.0,19 NDC,64380016001,MEGESTROL 400 MG/10 ML (40 MG/ML) ORAL SUSPENSION,169.0,101.4,39.21,4481.0,19 NDC,64380017201,OLANZAPINE 5 MG DISINTEGRATING TABLET,18.6,11.16,4.32,4481.0,19 NDC,64380017301,OLANZAPINE 10 MG DISINTEGRATING TABLET,19.8,11.88,4.59,4481.0,19 NDC,64380021301,METHIMAZOLE 10 MG TABLET,17.25,10.35,4.0,4481.0,19 NDC,64380071104,LAMIVUDINE 300 MG TABLET,20.0,12.0,4.64,4481.0,19 NDC,64380078706,BUSPIRONE 7.5 MG TABLET,16.8,10.08,3.9,4481.0,19 NDC,64380078932,LIDOCAINE 5 % TOPICAL OINTMENT,61.15,36.69,14.19,4481.0,19 NDC,64380087806,ETHOSUXIMIDE 250 MG CAPSULE,17.3,10.38,4.01,4481.0,19 NDC,64406000801,NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION,29098.05,17458.83,23.28,23278.44,35 NDC,64406005801,NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION,570581.95,342349.17,1241.84,456465.56,34 NDC,64764008060,LUBIPROSTONE 8 MCG CAPSULE,34.6,20.76,8.03,4481.0,19 NDC,64764030020,VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION,30669.95,18401.97,20.67,24535.96,35 NDC,64764072030,VORTIOXETINE 5 MG TABLET,67.45,40.47,15.65,4481.0,19 NDC,64764073030,VORTIOXETINE 10 MG TABLET,67.45,40.47,15.65,4481.0,19 NDC,64764075030,VORTIOXETINE 20 MG TABLET,67.45,40.47,15.65,4481.0,19 NDC,64764091830,FEBUXOSTAT 40 MG TABLET,49.05,29.43,11.38,4481.0,19 NDC,64842102001,TRIFLURIDINE 20 MG-TIPIRACIL 8.19 MG TABLET,1187.9,712.74,275.59,4481.0,19 NDC,64842102501,TRIFLURIDINE 15 MG-TIPIRACIL 6.14 MG TABLET,897.2,538.32,208.15,4481.0,19 NDC,64850091001,ISRADIPINE 2.5 MG CAPSULE,26.1,15.66,6.06,4481.0,19 NDC,64875000101,MIFEPRISTONE 200 MG TABLET,145.0,87.0,33.64,4481.0,19 NDC,64950036204,COCAINE 4 % SOLUTION WRAPPER,766.8,460.08,3.87,4481.0,23 NDC,64980010401,SODIUM DI- AND MONOPHOSPHATE-POTASSIUM PHOS MONOBASIC 250 MG TABLET,1.55,0.93,0.3596,4481.0,19 NDC,64980013401,DIPYRIDAMOLE 50 MG TABLET,21.75,13.05,5.05,4481.0,19 NDC,64980033990,MAGNESIUM OXIDE 400 MG (241.3 MG MAGNESIUM) TABLET,1.2,0.72,0.2784,4481.0,19 NDC,64980034214,ALENDRONATE 70 MG TABLET,17.9,10.74,4.15,4481.0,19 NDC,64980044715,CALCITRIOL 1 MCG/ML ORAL SOLUTION,36.05,21.63,8.36,4481.0,19 NDC,64980050312,LEVOCARNITINE (WITH SUGAR) 100 MG/ML ORAL SOLUTION,127.2,76.32,29.51,4481.0,19 NDC,64980050448,CYPROHEPTADINE 2 MG/5 ML ORAL SYRUP,176.35,105.81,40.91,4481.0,19 NDC,64980051401,TIMOLOL MALEATE 0.5 % EYE DROPS,58.75,35.25,13.63,4481.0,19 NDC,64980051401,TIMOLOL MALEATE 0.5 % EYE DROPS WRAPPER,58.75,35.25,13.63,4481.0,19 NDC,64980051505,OFLOXACIN 0.3 % EYE DROPS,61.15,36.69,14.19,4481.0,19 NDC,64980052621,NITAZOXANIDE 500 MG TABLET,191.65,114.99,44.46,4481.0,19 NDC,65162005827,SEVELAMER CARBONATE 800 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,65162051210,SALSALATE 500 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,65162059606,"ASPIRIN 25 MG-DIPYRIDAMOLE 200 MG CAPSULE,EXT.RELEASE 12 HR MULTIPHASE",19.0,11.4,4.41,4481.0,19 NDC,65162064978,OXCARBAZEPINE 300 MG/5 ML (60 MG/ML) ORAL SUSPENSION,25.95,15.57,6.02,4481.0,19 NDC,65162068110,PHENAZOPYRIDINE 100 MG TABLET,17.0,10.2,3.94,4481.0,19 NDC,65162068210,PHENAZOPYRIDINE 200 MG TABLET,17.45,10.47,4.05,4481.0,19 NDC,65162070588,ESCITALOPRAM 5 MG/5 ML ORAL SOLUTION,22.6,13.56,5.24,4481.0,19 NDC,65219005209,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION WRAPPER,87.95,52.77,20.4,4481.0,19 NDC,65219005229,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION,87.95,52.77,20.4,4481.0,19 NDC,65219005429,POTASSIUM PHOSPHATES-MBASIC AND DIBASIC 3 MMOL/ML INTRAVENOUS SOLUTION,159.9,95.94,37.1,4481.0,19 NDC,65219019030,VORICONAZOLE 200 MG INTRAVENOUS SOLUTION,259.2,155.52,1.73,4481.0,24 NDC,65219028100,GADOBUTROL 1 MMOL/ML INTRAVENOUS WRAPPER,11.75,7.05,0.6075,4481.0,23 NDC,65219028103,GADOBUTROL 1 MMOL/ML INTRAVENOUS WRAPPER,11.75,7.05,0.6075,4481.0,23 NDC,65219028105,GADOBUTROL 1 MMOL/ML INTRAVENOUS WRAPPER,11.75,7.05,0.6075,4481.0,23 NDC,65219028110,GADOBUTROL 1 MMOL/ML INTRAVENOUS WRAPPER,11.75,7.05,0.6075,4481.0,23 NDC,65219028710,GADOBUTROL 1 MMOL/ML INTRAVENOUS WRAPPER,11.75,7.05,0.6075,4481.0,23 NDC,65219028910,GADOBUTROL 1 MMOL/ML INTRAVENOUS WRAPPER,11.75,7.05,0.6075,4481.0,23 NDC,65219042950,ARGATROBAN 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS WRAPPER,456.9,274.14,0.776,4481.0,35 NDC,65219042950,ARGATROBAN CRRT REGIONAL CIRCUIT INFUSION (50 MG/50 ML),456.9,274.14,0.776,4481.0,35 NDC,65219044510,ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTION,81.0,48.6,18.79,4481.0,19 NDC,65219053301,FAT EMULSION 20 % INTRAVENOUS,247.8,148.68,57.49,4481.0,19 NDC,65219059004,TOCILIZUMAB-AAZG (FOR COVID-19) 20 MG/ML INJECTION (EUA) WRAPPER,1343.8,806.28,4.29,4481.0,35 NDC,65219059004,TOCILIZUMAB-AAZG (TYENNE) 20 MG/ML INJECTION WRAPPER,1343.8,806.28,4.29,4481.0,35 NDC,65219059210,TOCILIZUMAB-AAZG (FOR COVID-19) 20 MG/ML INJECTION (EUA) WRAPPER,3265.0,1959.0,4.29,4481.0,35 NDC,65219059210,TOCILIZUMAB-AAZG (TYENNE) 20 MG/ML INJECTION WRAPPER,3265.0,1959.0,4.29,4481.0,35 NDC,65219059420,TOCILIZUMAB-AAZG (FOR COVID-19) 20 MG/ML INJECTION (EUA) WRAPPER,6467.0,3880.2,4.29,5173.6,35 NDC,65219059420,TOCILIZUMAB-AAZG (TYENNE) 20 MG/ML INJECTION WRAPPER,6467.0,3880.2,4.29,5173.6,35 NDC,65250013309,BUPIVACAINE LIPOSOME(PF) 1.3 %(13.3 MG/ML) SUSPENSION FOR INFILTRATION,957.05,574.23,1.39,4481.0,34 NDC,65597040601,FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION,10491.25,6294.75,29.08,8393.0,35 NDC,65597050404,QUIZARTINIB 17.7 MG TABLET,2362.1,1417.26,548.01,4481.0,19 NDC,65597051104,QUIZARTINIB 26.5 MG TABLET,2362.1,1417.26,548.01,4481.0,19 NDC,65597080101,DATOPOTAMAB DERUXTECAN-DLNK 100 MG INTRAVENOUS SOLUTION,16464.45,9878.67,50.01,14243.4,35 NDC,65649030103,RIFAXIMIN 200 MG TABLET,49.7,29.82,11.53,4481.0,19 NDC,65649030303,RIFAXIMIN 550 MG TABLET,189.2,113.52,43.89,4481.0,19 NDC,65649031112,CHLOROTHIAZIDE 250 MG/5 ML ORAL SUSPENSION,243.55,146.13,56.5,4481.0,19 NDC,65649055102,METHYLNALTREXONE 12 MG/0.6 ML SUBCUTANEOUS SOLUTION,457.85,274.71,3.26,4481.0,24 NDC,65649055102,METHYLNALTREXONE 12 MG/0.6 ML SYRINGE (PEDIATRIC),457.85,274.71,3.26,4481.0,24 NDC,65757030001,"NALTREXONE ER 380 MG INTRAMUSCULAR SUSPENSION,EXTENDED RELEASE",6608.35,3965.01,4.11,5286.68,35 NDC,65862004824,ZIDOVUDINE 10 MG/ML ORAL SYRUP,20.5,12.3,4.76,4481.0,19 NDC,65862005724,NEVIRAPINE 50 MG/5 ML ORAL SUSPENSION,53.9,32.34,12.5,4481.0,19 NDC,65862007930,TERBINAFINE HCL 250 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,65862014636,SUMATRIPTAN 25 MG TABLET,17.0,10.2,3.94,4481.0,19 NDC,65862014736,SUMATRIPTAN 50 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,65862020768,RIBAVIRIN 200 MG TABLET,17.85,10.71,4.14,4481.0,19 NDC,65862020901,MINOCYCLINE 50 MG CAPSULE,16.8,10.08,3.9,4481.0,19 NDC,65862049647,SULFAMETHOXAZOLE 200 MG-TRIMETHOPRIM 40 MG/5 ML ORAL SUSPENSION,145.15,87.09,33.67,4481.0,19 NDC,65862050220,AMOXICILLIN 500 MG-POTASSIUM CLAVULANATE 125 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,65862062503,RIZATRIPTAN 5 MG DISINTEGRATING TABLET,22.15,13.29,5.14,4481.0,19 NDC,65862064230,AZITHROMYCIN 500 MG TABLET,19.85,11.91,4.61,4481.0,19 NDC,65862093108,SEVELAMER CARBONATE 2.4 GRAM ORAL POWDER PACKET,21.7,13.02,5.03,4481.0,19 NDC,66215010106,BOSENTAN 62.5 MG TABLET,686.7,412.02,159.31,4481.0,19 NDC,66215030200,ILOPROST 10 MCG/ML SOLUTION FOR NEBULIZATION,128.45,77.07,29.8,4481.0,19 NDC,66215040201,EPOPROSTENOL 1.5 MG INTRAVENOUS SOLUTION,243.75,146.25,36.45,4481.0,24 NDC,66215040301,EPOPROSTENOL 0.5 MG INTRAVENOUS SOLUTION,153.4,92.04,35.59,4481.0,24 NDC,66215050115,MACITENTAN 10 MG TABLET,1311.5,786.9,304.27,4481.0,19 NDC,66215060206,SELEXIPAG 200 MCG TABLET,783.45,470.07,181.76,4481.0,19 NDC,66215060806,SELEXIPAG 800 MCG TABLET,1209.5,725.7,280.6,4481.0,19 NDC,66220016010,CONIVAPTAN 20 MG/100 ML IN 5 % DEXTROSE IV,3458.9,2075.34,102.28,4481.0,23 NDC,66220031511,TELAVANCIN 750 MG INTRAVENOUS SOLUTION,2210.35,1326.21,6.9,4481.0,35 NDC,66220072901,LACTULOSE 20 GRAM ORAL PACKET,17.5,10.5,4.06,4481.0,19 NDC,66302001401,DINUTUXIMAB 3.5 MG/ML INTRAVENOUS SOLUTION,63321.5,37992.9,4481.0,54779.43,25 NDC,66302010101,TREPROSTINIL SODIUM 1 MG/ML INJECTION SOLUTION,4981.95,2989.17,53.07,8670.06,35 NDC,66302010201,TREPROSTINIL SODIUM 2.5 MG/ML INJECTION SOLUTION,12430.9,7458.54,53.07,9944.72,35 NDC,66302010501,TREPROSTINIL SODIUM 5 MG/ML INJECTION SOLUTION,24845.75,14907.45,53.07,19876.6,35 NDC,66302011001,TREPROSTINIL SODIUM 10 MG/ML INJECTION SOLUTION,49675.5,29805.3,53.07,39740.4,35 NDC,66302015050,GLYCINE DILUENT INTRAVENOUS SOLUTION,104.4,62.64,24.22,4481.0,19 NDC,66302030202,"TREPROSTINIL DIOLAMINE ER 0.25 MG TABLET,EXTENDED RELEASE",60.55,36.33,14.05,4481.0,19 NDC,66302031001,"TREPROSTINIL DIOLAMINE ER 1 MG TABLET,EXTENDED RELEASE",194.2,116.52,45.05,4481.0,19 NDC,66302032501,"TREPROSTINIL DIOLAMINE ER 2.5 MG TABLET,EXTENDED RELEASE",461.4,276.84,107.04,4481.0,19 NDC,66302046760,TADALAFIL 20 MG TABLET (PULMONARY HYPERTENSION),224.5,134.7,52.08,4481.0,19 NDC,66302061601,TREPROSTINIL 16 MCG CARTRIDGE WITH INHALER,2635.0,1581.0,611.32,4481.0,24 NDC,66302063201,TREPROSTINIL 32 MCG CARTRIDGE WITH INHALER,1139.75,683.85,264.42,4481.0,19 NDC,66302064801,TREPROSTINIL 48 MCG CARTRIDGE WITH INHALER,1139.75,683.85,264.42,4481.0,19 NDC,66302066401,TREPROSTINIL 64 MCG CARTRIDGE WITH INHALER,2635.0,1581.0,611.32,4481.0,19 NDC,66553000101,ASPIRIN 325 MG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,66553000201,ASPIRIN 81 MG CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 NDC,66553000401,CALCIUM 200 MG (AS CALCIUM CARBONATE 500 MG) CHEWABLE TABLET,1.1,0.66,0.2552,4481.0,19 NDC,66658023401,ANAKINRA (KINERET) IV SYRINGE,837.7,502.62,194.35,4481.0,19 NDC,66658023407,ANAKINRA 100 MG/0.67 ML SUBCUTANEOUS SYRINGE,837.7,502.62,194.35,4481.0,19 NDC,66658050101,EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION,11938.35,7163.01,373.3,62444.13,34 NDC,66658050501,EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION,59439.7,35663.82,373.3,62444.13,34 NDC,66733094823,CETUXIMAB 100 MG/50 ML IV,3043.85,1826.31,76.02,11827.62,35 NDC,66733094823,CETUXIMAB IVPB OVER 1 HOUR,3043.85,1826.31,76.02,11827.62,35 NDC,66733094823,CETUXIMAB IVPB OVER 2 HOURS,3043.85,1826.31,76.02,11827.62,35 NDC,66733094823,CETUXIMAB IVPB OVER 3 HOURS,3043.85,1826.31,76.02,11827.62,35 NDC,66733095823,CETUXIMAB 200 MG/100 ML INTRAVENOUS SOLUTION,5812.65,3487.59,76.02,11827.62,35 NDC,66733095823,CETUXIMAB IVPB OVER 1 HOUR,5812.65,3487.59,76.02,11827.62,35 NDC,66733095823,CETUXIMAB IVPB OVER 2 HOURS,5812.65,3487.59,76.02,11827.62,35 NDC,66733095823,CETUXIMAB IVPB OVER 3 HOURS,5812.65,3487.59,76.02,11827.62,35 NDC,66758005003,DOCETAXEL (TAXOTERE) 10 MG/ML INJECTION WRAPPER,1599.0,959.4,1.04,4481.0,24 NDC,66794001725,ISOFLURANE 99.9 % INHALATION LIQUID,182.0,109.2,42.22,4481.0,19 NDC,66794015101,BACLOFEN 50 MCG/ML (1 ML) INTRATHECAL SYRINGE,202.9,121.74,47.07,4481.0,24 NDC,66794015502,"BACLOFEN 10,000 MCG/20 ML (500 MCG/ML) INTRATHECAL SOLUTION",16.15,9.69,4.09,4481.0,35 NDC,66794015701,"BACLOFEN 40,000 MCG/20 ML (2,000 MCG/ML) INTRATHECAL SYRINGE",4337.55,2602.53,175.78,4481.0,35 NDC,66794015702,"BACLOFEN 40,000 MCG/20 ML (2,000 MCG/ML) INTRATHECAL SOLUTION",4033.8,2420.28,175.78,4481.0,35 NDC,66794021963,LINEZOLID IN 5% DEXTROSE IN WATER 600 MG/300 ML INTRAVENOUS PIGGYBACK,135.05,81.03,8.03,4481.0,24 NDC,66794023002,DEXMEDETOMIDINE 100 MCG/ML INTRAVENOUS SOLUTION,80.2,48.12,18.61,4481.0,19 NDC,66794023002,DEXMEDETOMIDINE 200 MCG/2 ML INTRANASAL SOLUTION,80.2,48.12,18.61,4481.0,19 NDC,66887000105,TESTOSTERONE 50 MG/5 GRAM (1 %) TRANSDERMAL GEL,82.0,49.2,19.02,4481.0,19 NDC,66887000301,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG SOLUTION FOR INJECTION,27737.3,16642.38,73.63,22189.84,35 NDC,66887000401,TESTOSTERONE 75 MG IMPLANT PELLET,350.9,210.54,81.41,4481.0,19 NDC,66993007896,FLUTICASONE PROPIONATE 44 MCG/ACTUATION HFA AEROSOL INHALER,416.2,249.72,96.56,4481.0,19 NDC,66993007996,FLUTICASONE PROPIONATE 110 MCG/ACTUATION HFA AEROSOL INHALER,551.8,331.08,128.02,4481.0,19 NDC,66993042353,LANTHANUM 750 MG CHEWABLE TABLET,48.4,29.04,11.23,4481.0,19 NDC,66993049036,IBUPROFEN LYSINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION,1554.95,932.97,360.75,4481.0,19 NDC,67066000501,SECRETIN (HUMAN) 16 MCG INTRAVENOUS SOLUTION,1779.75,1067.85,39.3,5400.78,35 NDC,67108356509,MESNA 400 MG TABLET,339.4,203.64,78.74,4481.0,19 NDC,67386013051,EPTINEZUMAB-JJMR 100 MG/ML INTRAVENOUS SOLUTION,6407.05,3844.23,19.37,5125.64,35 NDC,67386031321,CLOBAZAM 2.5 MG/ML ORAL SUSPENSION,61.7,37.02,14.31,4481.0,19 NDC,67386031401,CLOBAZAM 10 MG TABLET,26.0,15.6,6.03,4481.0,19 NDC,6738631321S,CLOBAZAM 2.5 MG/ML ORAL SUSPENSION,41.35,24.81,9.59,4481.0,19 NDC,67457015309,AMIODARONE 50 MG/ML INTRAVENOUS SOLUTION,72.7,43.62,0.9675,4481.0,24 NDC,67457016200,SODIUM TETRADECYL SULFATE 1 % (10 MG/ML) INTRAVENOUS SOLUTION,126.9,76.14,29.44,4481.0,19 NDC,67457016300,SODIUM TETRADECYL SULFATE 3 % (30 MG/ML) INTRAVENOUS SOLUTION,126.9,76.14,29.44,4481.0,19 NDC,67457017750,DIMETHYL SULFOXIDE 50 % INTRAVESICAL SOLUTION,2862.05,1717.23,724.1,4481.0,35 NDC,67457019501,MELPHALAN (ALKERAN) IVPB,1930.0,1158.0,93.02,24394.65,35 NDC,67457019501,MELPHALAN (ALKERAN) SYRINGE,1930.0,1158.0,93.02,24394.65,35 NDC,67457022000,ISOSULFAN BLUE 1 % SUBCUTANEOUS SOLUTION,489.55,293.73,6.19,4481.0,36 NDC,67457029200,NALOXONE 0.4 MG/ML INJ SOLUTION (COMBINED) WRAPPER,55.0,33.0,0.18,4481.0,24 NDC,67457029200,NALOXONE 0.4 MG/ML INJECTION SOLUTION,55.0,33.0,0.18,4481.0,24 NDC,67457032325,MOXIFLOXACIN 400 MG/250 ML-SODIUM CHLORIDE(ISO) INTRAVENOUS PIGGYBACK,230.65,138.39,20.27,4481.0,24 NDC,67457034000,VANCOMYCIN 1 G TOPICAL POWDER,64.15,38.49,0.0675,4481.0,24 NDC,67457034001,VANCOMYCIN 1 G TOPICAL POWDER (OPTIME),64.15,38.49,0.0675,4481.0,24 NDC,67457042300,DEXAMETHASONE SODIUM PHOSPHATE 4 MG/ML INJECTION SOLUTION,19.05,11.43,0.2025,4481.0,24 NDC,67457042600,HALOPERIDOL LACTATE 5 MG/ML INJECTION SOLUTION,17.4,10.44,1.8,4481.0,24 NDC,67457043010,PAMIDRONATE 30 MG/10 ML (3 MG/ML) INTRAVENOUS SOLUTION,107.15,64.29,21.69,4481.0,24 NDC,67457043650,DOXORUBICIN 50 MG INTRAVENOUS SOLUTION,1145.65,687.39,6.79,4481.0,24 NDC,67457043800,VECURONIUM BROMIDE 10 MG INTRAVENOUS SOLUTION,81.65,48.99,18.94,4481.0,19 NDC,67457044843,FAMOTIDINE 10 MG/ML INTRAVENOUS SOLUTION,64.5,38.7,0.0225,4481.0,24 NDC,67457045720,FAMOTIDINE 10 MG/ML INJ SOLUTION (MULTI-VIAL SIZE),64.5,38.7,0.0225,4481.0,24 NDC,67457045720,FAMOTIDINE 10 MG/ML INTRAVENOUS SOLUTION,64.5,38.7,0.0225,4481.0,24 NDC,67457052810,LEUCOVORIN CALCIUM 100 MG SOLN FOR INJ (10 MG/ML),94.0,56.4,7.25,4481.0,24 NDC,67457052920,LEUCOVORIN CALCIUM 200 MG SOLN FOR INJ (10 MG/ML),407.4,244.44,7.25,4481.0,24 NDC,67457052920,LEUCOVORIN CALCIUM 200 MG SOLUTION FOR INJECTION,172.0,103.2,7.25,4481.0,24 NDC,67457053102,DOCETAXEL 20 MG/2 ML (10 MG/ML) INTRAVENOUS SOLUTION,407.4,244.44,1.04,4481.0,24 NDC,67457053316,DOCETAXEL 160 MG/16 ML (10 MG/ML) INTRAVENOUS SOLUTION,1334.2,800.52,1.04,4481.0,24 NDC,67457058500,FONDAPARINUX 10 MG/0.8 ML SUBCUTANEOUS SOLUTION SYRINGE,244.15,146.49,1.62,4481.0,24 NDC,67457062910,EPTIFIBATIDE 2 MG/ML INTRAVENOUS SOLUTION,161.1,96.66,22.95,4481.0,24 NDC,67457063110,EPTIFIBATIDE 0.75 MG/ML BOLUS (CATH),390.0,234.0,22.95,4481.0,24 NDC,67457063110,EPTIFIBATIDE 0.75 MG/ML INTRAVENOUS SOLUTION,390.0,234.0,22.95,4481.0,24 NDC,67457081350,DAPTOMYCIN 500 MG INTRAVENOUS SOLUTION,161.1,96.66,0.0675,4481.0,24 NDC,67457085500,ADENOSINE 3 MG/ML INTRAVENOUS SOLUTION,27.7,16.62,1.25,4481.0,24 NDC,67457088910,FOSAPREPITANT 150 MG INTRAVENOUS POWDER FOR SOLUTION,331.75,199.05,0.225,4481.0,24 NDC,67618011128,DOCUSATE SODIUM 50 MG CAPSULE,1.4,0.84,0.3248,4481.0,19 NDC,67850014100,POLIDOCANOL 1 % (20 MG/2 ML) INTRAVENOUS SOLUTION,66.7,40.02,15.47,4481.0,19 NDC,67877021660,CEFUROXIME AXETIL 500 MG TABLET,20.15,12.09,4.67,4481.0,19 NDC,67877028660,RILUZOLE 50 MG TABLET,18.0,10.8,4.18,4481.0,19 NDC,67877049090,EZETIMIBE 10 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,67877050430,CINACALCET 60 MG TABLET,18.7,11.22,4.34,4481.0,19 NDC,67877052790,SOLIFENACIN 5 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,67877063633,TOLVAPTAN 30 MG TABLET,379.15,227.49,87.96,4481.0,19 NDC,67919003001,CEFTOLOZANE-TAZOBACTAM 1.5 GRAM INTRAVENOUS SOLUTION,696.05,417.63,8.8,4481.0,35 NDC,67919004099,TEDIZOLID 200 MG INTRAVENOUS SOLUTION,1274.5,764.7,1.9,4481.0,35 NDC,67919004104,TEDIZOLID 200 MG TABLET,1411.25,846.75,327.41,4481.0,19 NDC,67979000101,VALRUBICIN 40 MG/ML INTRAVESICAL SOLUTION,6399.35,3839.61,1283.65,218317.05,35 NDC,67979051143,TESTOSTERONE UNDECANOATE 750 MG/3 ML (250MG/ML) INTRAMUSCULAR SOLUTION,6260.2,3756.12,2.01,5415.7,35 NDC,68001015100,CARVEDILOL 12.5 MG TABLET,16.15,9.69,3.75,4481.0,19 NDC,68001015700,VENLAFAXINE 25 MG TABLET,17.0,10.2,3.94,4481.0,19 NDC,68001023900,CLONIDINE HCL 0.3 MG TABLET,16.2,9.72,3.76,4481.0,19 NDC,68001024200,ZONISAMIDE 25 MG CAPSULE,16.65,9.99,3.86,4481.0,19 NDC,68001024515,ATOVAQUONE 250 MG-PROGUANIL 100 MG TABLET,33.55,20.13,7.78,4481.0,19 NDC,68001024616,ONDANSETRON 4 MG DISINTEGRATING TABLET,18.1,10.86,4.2,4481.0,19 NDC,68001025104,FLUCONAZOLE 50 MG TABLET,19.4,11.64,4.5,4481.0,19 NDC,68001025344,FLUCONAZOLE 150 MG TABLET,22.05,13.23,5.12,4481.0,19 NDC,68001030900,BUPROPION HCL 100 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,68001036206,CEFDINIR 300 MG CAPSULE,19.65,11.79,4.56,4481.0,19 NDC,68001039800,FAMOTIDINE 40 MG TABLET,16.85,10.11,3.91,4481.0,19 NDC,68001047547,CLOTRIMAZOLE 1 % TOPICAL CREAM,8.05,4.83,1.87,4481.0,19 NDC,68001049404,FAMOTIDINE 10 MG TABLET,1.15,0.69,0.2668,4481.0,19 NDC,68001053146,BACITRACIN ZINC 500 UNIT/GRAM TOPICAL OINTMENT,8.25,4.95,1.91,4481.0,19 NDC,68001059100,ESCITALOPRAM 5 MG TABLET,16.3,9.78,3.78,4481.0,19 NDC,68001060600,NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS 100 MG CAPSULE,20.7,12.42,4.8,4481.0,19 NDC,68084002111,ABACAVIR 300 MG TABLET,42.5,25.5,9.86,4481.0,19 NDC,68084004511,PAROXETINE 20 MG TABLET,17.0,10.2,3.94,4481.0,19 NDC,68084008211,ISOSORBIDE DINITRATE 10 MG TABLET,18.8,11.28,4.36,4481.0,19 NDC,68084008311,ISOSORBIDE DINITRATE 20 MG TABLET,18.75,11.25,4.35,4481.0,19 NDC,68084009711,ATORVASTATIN 10 MG TABLET,17.15,10.29,3.98,4481.0,19 NDC,68084009911,ATORVASTATIN 40 MG TABLET,17.35,10.41,4.03,4481.0,19 NDC,68084010311,ZIPRASIDONE 20 MG CAPSULE,24.35,14.61,5.65,4481.0,19 NDC,68084010411,ZIPRASIDONE 40 MG CAPSULE,24.35,14.61,5.65,4481.0,19 NDC,68084011911,MIRTAZAPINE 15 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,68084012011,MIRTAZAPINE 30 MG TABLET,17.05,10.23,3.96,4481.0,19 NDC,68084014911,METHYLPREDNISOLONE 4 MG TABLET,21.05,12.63,0.2475,4481.0,24 NDC,68084020211,PRIMIDONE 50 MG TABLET,18.45,11.07,4.28,4481.0,19 NDC,68084020411,MINOXIDIL 2.5 MG TABLET,17.6,10.56,4.08,4481.0,19 NDC,68084020511,MINOXIDIL 10 MG TABLET,17.95,10.77,4.16,4481.0,19 NDC,68084021511,VALACYCLOVIR 500 MG TABLET,25.6,15.36,5.94,4481.0,19 NDC,68084022911,AZATHIOPRINE 50 MG TABLET,18.05,10.83,0.135,4481.0,24 NDC,68084024311,CLINDAMYCIN HCL 150 MG CAPSULE,17.35,10.41,4.03,4481.0,19 NDC,68084024811,LORATADINE 10 MG TABLET,1.45,0.87,0.3364,4481.0,19 NDC,68084026911,HYDROXYCHLOROQUINE 200 MG TABLET,21.85,13.11,5.07,4481.0,19 NDC,68084027011,RISPERIDONE 0.25 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,68084027211,RISPERIDONE 1 MG TABLET,17.3,10.38,4.01,4481.0,19 NDC,68084028011,ETHAMBUTOL 400 MG TABLET,19.25,11.55,4.47,4481.0,19 NDC,68084028411,HYDROXYUREA 500 MG CAPSULE,28.7,17.22,6.66,4481.0,19 NDC,68084028811,FLUDROCORTISONE 0.1 MG TABLET,18.55,11.13,4.3,4481.0,19 NDC,68084029111,NALTREXONE 50 MG TABLET,24.7,14.82,5.73,4481.0,19 NDC,68084029911,TAMSULOSIN 0.4 MG CAPSULE,17.8,10.68,4.13,4481.0,19 NDC,68084031011,"DIVALPROEX ER 250 MG TABLET,EXTENDED RELEASE 24 HR",20.45,12.27,4.74,4481.0,19 NDC,68084031311,"DIVALPROEX 125 MG CAPSULE,DELAYED RELEASE SPRINKLE",18.55,11.13,4.3,4481.0,19 NDC,68084031811,LAMOTRIGINE 25 MG TABLET,16.6,9.96,3.85,4481.0,19 NDC,68084031911,LAMOTRIGINE 100 MG TABLET,16.6,9.96,3.85,4481.0,19 NDC,68084034211,TOPIRAMATE 25 MG TABLET,16.9,10.14,3.92,4481.0,19 NDC,68084034411,TOPIRAMATE 100 MG TABLET,17.45,10.47,4.05,4481.0,19 NDC,68084034611,LOSARTAN 25 MG TABLET,17.55,10.53,4.07,4481.0,19 NDC,68084034711,LOSARTAN 50 MG TABLET,17.85,10.71,4.14,4481.0,19 NDC,68084034811,LOSARTAN 100 MG TABLET,18.1,10.86,4.2,4481.0,19 NDC,68084035411,OXYCODONE 5 MG TABLET,23.4,14.04,5.43,4481.0,19 NDC,68084038111,BENZTROPINE 0.5 MG TABLET,17.5,10.5,4.06,4481.0,19 NDC,68084038811,BENZTROPINE 1 MG TABLET,17.5,10.5,4.06,4481.0,19 NDC,68084038911,BENZTROPINE 2 MG TABLET,17.7,10.62,4.11,4481.0,19 NDC,68084044911,"TACROLIMUS 0.5 MG CAPSULE, IMMEDIATE-RELEASE",21.95,13.17,0.3825,4481.0,24 NDC,68084045011,"TACROLIMUS 1 MG CAPSULE, IMMEDIATE-RELEASE",20.5,12.3,0.3825,4481.0,24 NDC,68084045111,"TACROLIMUS 5 MG CAPSULE, IMMEDIATE-RELEASE",51.9,31.14,0.3825,4481.0,24 NDC,68084047911,CALCIUM ACETATE(PHOSPHATE BINDERS) 667 MG CAPSULE,20.2,12.12,4.69,4481.0,19 NDC,68084049411,PYRIDOSTIGMINE BROMIDE 60 MG TABLET,20.2,12.12,4.69,4481.0,19 NDC,68084052911,OLANZAPINE 20 MG TABLET,18.85,11.31,4.37,4481.0,19 NDC,68084059025,ATORVASTATIN 80 MG TABLET,18.05,10.83,4.19,4481.0,19 NDC,68084059711,"NIFEDIPINE ER 30 MG TABLET,EXTENDED RELEASE 24 HR",20.5,12.3,4.76,4481.0,19 NDC,68084060711,PERPHENAZINE 8 MG TABLET,22.35,13.41,5.19,4481.0,19 NDC,68084061711,ESCITALOPRAM 10 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,68084064011,"LITHIUM CARBONATE ER 300 MG TABLET,EXTENDED RELEASE",17.25,10.35,4.0,4481.0,19 NDC,68084064511,TIZANIDINE 4 MG TABLET,17.95,10.77,4.16,4481.0,19 NDC,68084069711,"BUPROPION HCL SR 100 MG TABLET,12 HR SUSTAINED-RELEASE",18.4,11.04,4.27,4481.0,19 NDC,68084069811,"VENLAFAXINE ER 37.5 MG CAPSULE,EXTENDED RELEASE 24 HR",17.5,10.5,4.06,4481.0,19 NDC,68084070895,"BUPROPION HCL SR 150 MG TABLET,SUSTAINED-RELEASE (COMBINED) WRAPPER",17.85,10.71,4.14,4481.0,19 NDC,68084070911,"VENLAFAXINE ER 75 MG CAPSULE,EXTENDED RELEASE 24 HR",17.65,10.59,4.09,4481.0,19 NDC,68084071311,"VENLAFAXINE ER 150 MG CAPSULE,EXTENDED RELEASE 24 HR",17.9,10.74,4.15,4481.0,19 NDC,68084072311,OLANZAPINE 5 MG TABLET,17.5,10.5,4.06,4481.0,19 NDC,68084072811,FLUCONAZOLE 100 MG TABLET,21.65,12.99,5.02,4481.0,19 NDC,68084073511,FLUCONAZOLE 200 MG TABLET,24.1,14.46,5.59,4481.0,19 NDC,68084075095,TRIAMTERENE 37.5 MG-HYDROCHLOROTHIAZIDE 25 MG TABLET,18.5,11.1,4.29,4481.0,19 NDC,68084075295,CLOPIDOGREL 300 MG TABLET,58.85,35.31,13.65,4481.0,19 NDC,68084077595,TIZANIDINE 2 MG TABLET,19.25,11.55,4.47,4481.0,19 NDC,68084084411,VENLAFAXINE 37.5 MG TABLET,18.6,11.16,4.32,4481.0,19 NDC,68084085033,"POTASSIUM CITRATE ER 10 MEQ (1,080 MG) TABLET,EXTENDED RELEASE",23.25,13.95,5.39,4481.0,19 NDC,68084085611,VENLAFAXINE 75 MG TABLET,18.85,11.31,4.37,4481.0,19 NDC,68084085911,LEVETIRACETAM 250 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,68084087511,MONTELUKAST 10 MG TABLET,17.5,10.5,4.06,4481.0,19 NDC,68084087995,CYCLOSPORINE 25 MG CAPSULE,30.4,18.24,1.8,4481.0,24 NDC,68084088211,LEVETIRACETAM 750 MG TABLET,17.2,10.32,3.99,4481.0,19 NDC,68084091595,SIROLIMUS 1 MG TABLET,57.65,34.59,1.96,4481.0,24 NDC,68084092195,CYCLOSPORINE 100 MG CAPSULE,65.65,39.39,4.59,4481.0,24 NDC,68084092895,PILOCARPINE 5 MG TABLET,22.85,13.71,5.3,4481.0,19 NDC,68084094995,ALBUTEROL SULFATE 2 MG TABLET,34.7,20.82,8.05,4481.0,19 NDC,68084096495,PROPYLTHIOURACIL 50 MG TABLET,24.4,14.64,5.66,4481.0,19 NDC,68094000462,CETIRIZINE 5 MG/5 ML ORAL SOLUTION (UNIT DOSE CUPS/SYRINGES),3.25,1.95,0.754,4481.0,19 NDC,68094003059,ACETAMINOPHEN 650 MG/20.3 ML ORAL LIQUID WRAPPER,3.85,2.31,0.8932,4481.0,19 NDC,68094003059,ACETAMINOPHEN 650 MG/20.3 ML ORAL SUSPENSION,3.85,2.31,0.8932,4481.0,19 NDC,68094003162,METHADONE 5 MG/5 ML ORAL SOLUTION,28.15,16.89,6.53,4481.0,19 NDC,68094012059,MULTIVIT-MINS-FERROUS GLUCONATE 9 MG IRON/15 ML (15 ML) ORAL LIQUID,5.1,3.06,1.18,4481.0,19 NDC,68094012959,LOPERAMIDE 1 MG/7.5 ML ORAL LIQUID,5.1,3.06,1.18,4481.0,19 NDC,68094023159,ACETAMINOPHEN 160 MG/5 ML (5 ML) ORAL SUSPENSION,2.4,1.44,0.5568,4481.0,19 NDC,68094049459,IBUPROFEN 100 MG/5 ML ORAL SUSPENSION,2.25,1.35,0.522,4481.0,19 NDC,68094050359,IBUPROFEN 100 MG/5 ML ORAL SUSPENSION,3.05,1.83,0.7076,4481.0,19 NDC,68094076462,MIDAZOLAM 10 MG/5 ML (2 MG/ML) ORAL SYRUP,40.6,24.36,9.42,4481.0,19 NDC,68094076462,MIDAZOLAM 2 MG/ML ORAL LIQUID WRAPPER,40.6,24.36,9.42,4481.0,19 NDC,68135002001,GALSULFASE 5 MG/5 ML INTRAVENOUS SOLUTION,8195.5,4917.3,1144.71,73279.5,24 NDC,68135010001,ELOSULFASE ALFA 5 MG/5 ML (1 MG/ML) INTRAVENOUS SOLUTION,4990.9,2994.54,299.42,48111.63,35 NDC,68135050000,CERLIPONASE ALFA 150 MG/5 ML INTRAVENTRICULAR SOLUTION,108816.7,65290.02,116.75,87053.36,33 NDC,68176000017,TOCOPHERSOLAN (VITAMIN E TPGS) 75 UNIT/ML ORAL DROPS,66.1,39.66,15.34,4481.0,19 NDC,68180015001,FAMOTIDINE 40 MG/5 ML (8 MG/ML) ORAL SUSPENSION,47.5,28.5,11.02,4481.0,19 NDC,68180028001,ETHAMBUTOL 100 MG TABLET,17.4,10.44,4.04,4481.0,19 NDC,68180034606,DARUNAVIR 800 MG TABLET,25.9,15.54,6.01,4481.0,19 NDC,68180042201,MOXIFLOXACIN 0.5 % EYE DROPS,61.15,36.69,14.19,4481.0,19 NDC,68180065701,DOXYCYCLINE MONOHYDRATE 25 MG/5 ML ORAL SUSPENSION,25.15,15.09,5.83,4481.0,19 NDC,68180067711,OSELTAMIVIR 75 MG CAPSULE,23.8,14.28,5.52,4481.0,19 NDC,68180072305,CEFDINIR 250 MG/5 ML ORAL SUSPENSION,91.0,54.6,21.11,4481.0,19 NDC,68180082110,"LANTHANUM 1,000 MG CHEWABLE TABLET",32.7,19.62,7.59,4481.0,19 NDC,68180082873,NORETHINDRONE ACETATE 1 MG-ETHINYL ESTRADIOL 5 MCG TABLET,23.55,14.13,5.46,4481.0,19 NDC,68382018201,BUSPIRONE 15 MG TABLET,16.3,9.78,3.78,4481.0,19 NDC,68382052001,SIROLIMUS 0.5 MG TABLET,32.4,19.44,1.96,4481.0,23 NDC,68382056701,"METOPROLOL SUCCINATE ER 200 MG TABLET,EXTENDED RELEASE 24 HR",17.1,10.26,3.97,4481.0,19 NDC,68462018022,MUPIROCIN 2 % TOPICAL OINTMENT,43.1,25.86,10.0,4481.0,19 NDC,68462019001,NAPROXEN 500 MG TABLET,16.4,9.84,3.8,4481.0,19 NDC,68462030450,NORETHINDRONE ACETATE 5 MG TABLET,17.8,10.68,4.13,4481.0,19 NDC,68462038001,"THEOPHYLLINE ER 400 MG TABLET,EXTENDED RELEASE 24 HR",20.05,12.03,4.65,4481.0,19 NDC,68462063925,NITROGLYCERIN 0.4 MG SUBLINGUAL TABLET,23.8,14.28,5.52,4481.0,19 NDC,68462072101,"THEOPHYLLINE ER 300 MG TABLET,EXTENDED RELEASE,12 HR",19.9,11.94,4.62,4481.0,19 NDC,68516320401,"FACTOR IX COMPLEX NO.4, 3-FACTOR 500 (+/-) UNIT INTRAVENOUS SOLUTION",82.1,49.26,1.65,4481.0,35 NDC,68516320502,"FACTOR IX COMPLEX NO.4, 3-FACTOR 1,000 (+/-) UNIT INTRAVENOUS SOLUTION",82.1,49.26,1.65,4481.0,35 NDC,68516460702,"ANTIHEMOPHILIC FACTOR-VWF 1,000 (400 VWF) UNIT/10 ML INTRAVENOUS SOLN",81.75,49.05,1.21,4481.0,35 NDC,68516461002,"ANTIHEMOPHILIC FACTOR-VWF 2,000 (800 VWF) UNIT/10 ML INTRAVENOUS SOLN",81.75,49.05,1.21,4481.0,35 NDC,68516521401,"ALBUMIN, HUMAN 5 % INTRAVENOUS SOLUTION",245.6,147.36,51.49,4481.0,35 NDC,68546031730,GLATIRAMER 20 MG/ML SUBCUTANEOUS SYRINGE,940.85,564.51,143.44,4481.0,35 NDC,68547000501,ANGIOTENSIN II 0.5 MG/ML INTRAVENOUS SOLUTION,1668.6,1001.16,67.01,4481.0,34 NDC,68547050102,ANGIOTENSIN II 2.5 MG/ML INTRAVENOUS SOLUTION,5834.55,3500.73,1353.62,5047.47,26 NDC,68682000810,DILTIAZEM 90 MG TABLET,21.4,12.84,4.96,4481.0,19 NDC,68682042112,TETRABENAZINE 12.5 MG TABLET,55.25,33.15,12.82,4481.0,19 NDC,68727071201,LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION,27582.5,16549.5,200.92,33560.1,35 NDC,68727074501,DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION,36618.8,21971.28,248.41,40760.16,35 NDC,68727080002,DEFIBROTIDE 80 MG/ML INTRAVENOUS SOLUTION,3970.65,2382.39,921.19,4481.0,19 NDC,68727090001,ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION,17851.1,10710.66,53.81,14280.88,35 NDC,68727090001,ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION SPLIT SYRINGES,17851.1,10710.66,53.81,14280.88,35 NDC,68817013450,PACLITAXEL-PROTEIN BOUND (ABRAXANE) INTRAVENOUS SUSPENSION,5505.0,3303.0,10.22,4481.0,35 NDC,68982034901,"FIBRINOGEN 1 GRAM (700 MG-1,300 MG) INTRAVENOUS SOLUTION",80.8,48.48,1.19,4481.0,35 NDC,68992301003,"TACROLIMUS XR 1 MG TABLET,EXTENDED RELEASE 24 HR",37.25,22.35,4.12,4481.0,24 NDC,68992304003,"TACROLIMUS XR 4 MG TABLET,EXTENDED RELEASE 24 HR",100.9,60.54,4.12,4481.0,24 NDC,68992307503,"TACROLIMUS XR 0.75 MG TABLET,EXTENDED RELEASE 24 HR",31.95,19.17,4.12,4481.0,24 NDC,69051030001,MILTEFOSINE 50 MG CAPSULE,1730.3,1038.18,401.43,4481.0,19 NDC,69097016887,ARFORMOTEROL 15 MCG/2 ML SOLUTION FOR NEBULIZATION,23.5,14.1,5.45,4481.0,19 NDC,69097022316,ALENDRONATE 35 MG TABLET,18.65,11.19,4.33,4481.0,19 NDC,69097036202,ABACAVIR 600 MG-LAMIVUDINE 300 MG TABLET,26.0,15.6,6.03,4481.0,19 NDC,69097052834,ESOMEPRAZOLE MAGNESIUM DR 20 MG GRANULES DELAYED RELEASE FOR SUSP,39.45,23.67,9.15,4481.0,19 NDC,69097052934,ESOMEPRAZOLE MAGNESIUM DR 40 MG GRANULES DELAYED RELEASE FOR SUSP,39.45,23.67,9.15,4481.0,19 NDC,69097070831,PHYTONADIONE (VITAMIN K1) 10 MG/ML INJECTION SOLUTION,49.4,29.64,6.14,4481.0,24 NDC,69097070930,PHYTONADIONE (VITAMIN K1) 1 MG/0.5 ML INJECTION SOLUTION,39.4,23.64,6.14,4481.0,24 NDC,69097086707,NADOLOL 20 MG TABLET,16.5,9.9,3.83,4481.0,23 NDC,69097087067,LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE,34697.4,20818.44,28.94,27757.92,35 NDC,69238106001,CHLORPROMAZINE 100 MG TABLET,22.8,13.68,5.29,4481.0,19 NDC,69238145902,POTASSIUM CHLORIDE 20 MEQ/15 ML ORAL LIQUID,189.15,113.49,43.88,4481.0,19 NDC,69238160508,METHYLERGONOVINE 0.2 MG TABLET,65.5,39.3,15.2,4481.0,19 NDC,69238167801,FLUPHENAZINE 1 MG TABLET,18.1,10.86,4.2,4481.0,19 NDC,69238183301,LEVOTHYROXINE 88 MCG TABLET,16.9,10.14,3.92,4481.0,19 NDC,69238208101,PROPRANOLOL 80 MG TABLET,17.15,10.29,3.98,4481.0,19 NDC,69292072225,FLURBIPROFEN 0.03 % EYE DROPS,124.4,74.64,28.86,4481.0,19 NDC,69315013301,IMIPRAMINE 10 MG TABLET,16.55,9.93,3.84,4481.0,19 NDC,69315013401,IMIPRAMINE 25 MG TABLET,16.75,10.05,3.89,4481.0,19 NDC,69315013501,IMIPRAMINE 50 MG TABLET,16.95,10.17,3.93,4481.0,19 NDC,69315015501,HYDROCHLOROTHIAZIDE 12.5 MG TABLET,16.45,9.87,3.82,4481.0,19 NDC,69315021101,NIFEDIPINE 10 MG CAPSULE,18.6,11.16,4.32,4481.0,19 NDC,69315050460,"NYSTATIN 100,000 UNIT/ML ORAL SUSPENSION",16.6,9.96,3.85,4481.0,19 NDC,69315091001,DIPHENOXYLATE-ATROPINE 2.5 MG-0.025 MG TABLET,23.45,14.07,5.44,4481.0,19 NDC,69367026701,PRENATAL VITAMINS WITH CALCIUM NO.72-IRON 27 MG-FOLIC ACID 1 MG TABLET,1.15,0.69,0.2668,4481.0,19 NDC,69374031410,"MIDAZOLAM (PF) 1 MG/ML IN SODIUM CHLORIDE,ISO-OSM INTRAVENOUS SOLUTION",88.25,52.95,0.3375,4481.0,24 NDC,69374092510,EPINEPHRINE 0.1 MG/ML INJECTION SYRINGE WRAPPER,35.5,21.3,1.08,4481.0,24 NDC,69374092510,"EPINEPHRINE 1 MG/10 ML (100 MCG/ML) IN SODIUM CHLOR,ISO-OSM IV SYRINGE",35.5,21.3,1.08,4481.0,24 NDC,69374093503,ATROPINE 1.2 MG/3 ML (0.4 MG/ML) IN 0.9 % SODIUM CHLORIDE IV SYRINGE,65.05,39.03,0.198,4481.0,24 NDC,69374098810,ARGININE 25 MG/ML-LYSINE 25 MG/ML IN 0.9 % NACL INTRAVENOUS SOLUTION,444.0,266.4,103.01,4481.0,19 NDC,69452015120,"ERGOCALCIFEROL (VITAMIN D2) 1,250 MCG (50,000 UNIT) CAPSULE",1.35,0.81,0.3132,4481.0,19 NDC,69452020820,CALCITRIOL 0.5 MCG CAPSULE,17.3,10.38,4.01,4481.0,19 NDC,69452020907,NIMODIPINE 30 MG CAPSULE,24.65,14.79,5.72,4481.0,19 NDC,69452039098,MAGNESIUM CITRATE ORAL SOLUTION,28.95,17.37,6.72,4481.0,19 NDC,69618001854,ASCORBIC ACID (VITAMIN C) 500 MG/5 ML ORAL LIQUID,1.4,0.84,0.3248,4481.0,19 NDC,69618005051,OXYMETAZOLINE 0.05 % NASAL MIST,4.35,2.61,1.01,4481.0,19 NDC,69853010201,"FACTOR XA,INACTIVATED-ZHZO (RECOMBINANT) 200 MG INTRAVENOUS BOLUS",8672.0,5203.2,127.44,7502.15,35 NDC,69853010201,"FACTOR XA,INACTIVATED-ZHZO (RECOMBINANT) 200 MG INTRAVENOUS SOLUTION",8672.0,5203.2,127.44,7502.15,35 NDC,69918089910,DESMOPRESSIN 4 MCG/ML INJECTION SOLUTION,164.2,98.52,3.41,4481.0,35 NDC,69918090110,DESMOPRESSIN 4 MCG/ML INJECTION SOLUTION,1556.5,933.9,3.41,4481.0,35 NDC,69968006003,"BACITRACIN 500 UNIT-POLYMYXIN B 10,000 UNIT/GRAM TOPICAL OINTMENT (+/- ZINC) WRAPPER",7.1,4.26,1.65,4481.0,19 NDC,70020191101,IXABEPILONE 45 MG INTRAVENOUS SOLUTION,20279.6,12167.76,135.03,21536.97,35 NDC,70069002125,(ANES) DEXAMETHASONE (PF) 10 MG/ML INJECTION SOLUTION,32.95,19.77,0.2025,4481.0,24 NDC,70069010125,METHOCARBAMOL 100 MG/ML INJECTION SOLUTION,27.65,16.59,6.41,4481.0,24 NDC,70069030101,SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION,49.15,29.49,2.07,4481.0,24 NDC,70069042101,LATANOPROST 0.005 % EYE DROPS,30.9,18.54,7.17,4481.0,19 NDC,70069072801,CALCIUM GLUCONATE 100 MG/ML (10 %) INTRAVENOUS SOLUTION,71.85,43.11,0.09,4481.0,24 NDC,70092106807,OXYTOCIN 30 UNIT/500 ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS,85.9,51.54,3.22,4481.0,23 NDC,70092109844,FENTANYL (PF) 250 MCG/5 ML (50 MCG/ML) INTRAVENOUS SYRINGE,38.45,23.07,2.48,4481.0,24 NDC,70092111450,HYDROMORPHONE (PF) 10 MG/50 ML (0.2 MG/ML) IN NS IV PEDIATRIC SYRINGE,48.55,29.13,11.26,4481.0,25 NDC,70092111850,HYDROMORPHONE (PF) 50 MG/50 ML (1 MG/ML) IN 0.9 % NACL IV SYRINGE,64.15,38.49,0.2025,4481.0,24 NDC,70092113243,MORPHINE (PF) 0.5 MG/ML INJECTION SOLUTION WRAPPER,38.6,23.16,8.96,4481.0,24 NDC,70092113343,MORPHINE (PF) 2 MG/2 ML(1 MG/ML) IN 0.9% SODIUM CHLORIDE IV SYRINGE,36.25,21.75,8.41,4481.0,24 NDC,70092114843,SODIUM CITRATE 4 % (3 ML) INTRA-CATHETER INJECTION SYRINGE,51.8,31.08,12.02,4481.0,19 NDC,70092117343,ATROPINE 0.8 MG/2 ML (0.4 MG/ML) INTRAVENOUS SYRINGE,68.8,41.28,0.198,4481.0,24 NDC,70092126937,FENTANYL (PF) 2 MCG/ML-BUPIVACAINE 0.0625 %-NACL INJECTION SOLUTION,81.45,48.87,18.9,4481.0,19 NDC,70092129474,HYDROMORPHONE 50 MG/50 ML (1 MG/ML) IN 0.9 % SOD.CHLORIDE IV PUMP RESV,103.75,62.25,0.2025,4481.0,24 NDC,70092131046,METHOHEXITAL 100 MG/10 ML (10 MG/ML) IN STERILE WATER (PF) IV SYRINGE,113.75,68.25,26.39,4481.0,19 NDC,70092138036,MORPHINE 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS WRAPPER,56.65,33.99,13.14,4481.0,24 NDC,70092144343,LIDOCAINE 0.9 % BUFFERED WITH 8.4 % SODIUM BICARB (1 ML) INJ SYRINGE,16.15,9.69,3.75,4481.0,19 NDC,70092148646,PHENYLEPHRINE 0.8 MG/10 ML (80 MCG/ML) IN 0.9 %SOD.CHLORIDE IV SYRINGE,18.05,10.83,0.0225,4481.0,24 NDC,70092150935,FENTANYL (PF) 50 MCG/ML INTRAVENOUS SOLUTION,72.3,43.38,2.48,4481.0,24 NDC,70092151875,MORPHINE (PF) 100 MG/100 ML(1 MG/ML) IN 0.9% SOD.CHLORIDE IV PUMP RESV,52.45,31.47,12.17,4481.0,19 NDC,70092151875,MORPHINE 100 MG/100 ML IN NS PCA CADD WRAPPER,52.45,31.47,12.17,4481.0,24 NDC,70092154635,HYDROMORPHONE 1 MG/ML IN NS INFUSION WRAPPER,73.8,44.28,0.2025,4481.0,24 NDC,70092161144,LIDOCAINE 4 %-RACEPINEPHRINE 0.05 %-TETRACAINE 0.5 % TOPICAL GEL,39.85,23.91,9.25,4481.0,19 NDC,70092161746,EPINEPHRINE 100 MCG/10 ML (10 MCG/ML) IV SYRINGE WRAPPER,18.05,10.83,1.08,4481.0,24 NDC,70092956343,KETAMINE 10 MG/ML INJECTION SYRINGE WRAPPER,47.5,28.5,11.02,4481.0,19 NDC,70114010101,PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE,16298.5,9779.1,103.14,26777.52,35 NDC,70114013001,PEGFILGRASTIM-CBQV 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUT INJECTOR,16298.5,9779.1,103.14,26777.52,35 NDC,70114034001,TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION,31794.55,19076.73,38.23,25435.64,35 NDC,70121156801,FILGRASTIM-AYOW 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE,636.1,381.66,0.3686,4481.0,35 NDC,70121157001,FILGRASTIM-AYOW 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE,1008.2,604.92,0.3686,4481.0,35 NDC,70121157301,METHYLPREDNISOLONE ACETATE 40 MG/ML SUSPENSION FOR INJECTION,25.4,15.24,0.1164,4481.0,35 NDC,70121157401,METHYLPREDNISOLONE ACETATE 80 MG/ML SUSPENSION FOR INJECTION,79.65,47.79,0.1164,4481.0,35 NDC,70127010010,CANNABIDIOL 100 MG/ML ORAL SOLUTION,5146.0,3087.6,1193.87,4481.0,19 NDC,70199002611,"VITAMIN A PALMITATE 15,000 MCG RAE/ML (50,000 UNIT/ML) INTRAMUSCULAR SOLUTION",1417.6,850.56,328.88,4481.0,19 NDC,70255001002,BINIMETINIB 15 MG TABLET,382.25,229.35,88.68,4481.0,19 NDC,70255002501,ENCORAFENIB 75 MG CAPSULE,389.15,233.49,90.28,4481.0,19 NDC,70377010211,AMINOCAPROIC ACID 500 MG TABLET,51.05,30.63,11.84,4481.0,19 NDC,70461002503,FLU VACC 2025-26(65YR UP)-MF59C(PF) 45 MCG(15 MCGX3)/0.5 ML IM SYRINGE,278.45,167.07,64.6,4481.0,26 NDC,70515026210,DIGOXIN 100 MCG/ML (0.1 MG/ML) INJECTION SOLUTION,553.15,331.89,10.89,4481.0,24 NDC,70594002301,COLISTIN (COLISTIMETHATE SODIUM) 150 MG SOLUTION FOR INJECTION,125.2,75.12,29.05,4481.0,24 NDC,70700026894,FOSFOMYCIN TROMETHAMINE 3 GRAM ORAL PACKET,257.0,154.2,59.62,4481.0,19 NDC,70710115201,ISOSORBIDE DINITRATE 40 MG TABLET,56.1,33.66,13.02,4481.0,19 NDC,70710115703,LEFLUNOMIDE 10 MG TABLET,19.3,11.58,4.48,4481.0,19 NDC,70710115803,LEFLUNOMIDE 20 MG TABLET,19.3,11.58,4.48,4481.0,19 NDC,70710116506,OSELTAMIVIR 6 MG/ML ORAL SUSPENSION,226.6,135.96,52.57,4481.0,19 NDC,70710172601,NELARABINE (ARRANON) IVPB,2462.95,1477.77,77.46,10867.71,35 NDC,70710183801,METHYLENE BLUE (ANTIDOTE) 5 MG/ML INTRAVENOUS SOLUTION,930.15,558.09,6.19,4481.0,36 NDC,70710185207,INDOMETHACIN 50 MG RECTAL SUPPOSITORY,1047.45,628.47,243.01,4481.0,19 NDC,70720072010,ZICONOTIDE 100 MCG/ML INTRATHECAL SOLUTION,4794.1,2876.46,9.84,4481.0,35 NDC,70720095036,GOSERELIN 3.6 MG SUBCUTANEOUS IMPLANT,3995.3,2397.18,711.66,110495.49,35 NDC,70756060915,OFLOXACIN 0.3 % EAR DROPS,18.75,11.25,4.35,4481.0,19 NDC,70756061430,PHENYLEPHRINE 10 % EYE DROPS,136.4,81.84,31.64,4481.0,19 NDC,70756062925,PHENYLEPHRINE 2.5 % EYE DROPS,113.85,68.31,26.41,4481.0,19 NDC,70842012006,MEROPENEM-VABORBACTAM 2 GRAM INTRAVENOUS SOLUTION,790.6,474.36,2.11,4481.0,35 NDC,70842016001,MINOCYCLINE 100 MG INTRAVENOUS SOLUTION,908.3,544.98,2.59,4481.0,35 NDC,70842024001,REZAFUNGIN 200 MG INTRAVENOUS SOLUTION,6896.15,4137.69,10.31,5516.92,35 NDC,70860010041,AZITHROMYCIN 500 MG INTRAVENOUS SOLUTION,79.35,47.61,4.59,4481.0,24 NDC,70860011899,AMPICILLIN 10 GRAM SOLUTION FOR INJECTION,308.5,185.1,1.24,4481.0,24 NDC,70860020851,DOXORUBICIN 2 MG/ML INTRAVENOUS SOLUTION,672.2,403.32,6.79,4481.0,24 NDC,70860030602,ISOPROTERENOL 0.2 MG/ML INJECTION SOLUTION,503.5,302.1,116.81,4481.0,19 NDC,70860060105,MIDAZOLAM 5 MG/ML (COMBINED) INTRANASAL SOLUTION WRAPPER,38.6,23.16,0.3375,4481.0,24 NDC,70954001410,THIOTHIXENE 1 MG CAPSULE,18.85,11.31,4.37,4481.0,19 NDC,70954001610,THIOTHIXENE 5 MG CAPSULE,21.75,13.05,5.05,4481.0,19 NDC,70954013620,DAPSONE 100 MG TABLET,19.25,11.55,4.47,4481.0,19 NDC,70954016810,SILDENAFIL (PULMONARY HYPERTENSION) 10 MG/ML ORAL POWDR FOR SUSPENSION,346.0,207.6,80.27,4481.0,19 NDC,70954021110,TRIHEXYPHENIDYL 5 MG TABLET,16.7,10.02,3.87,4481.0,19 NDC,70954049210,LEVOCARNITINE 330 MG TABLET,2.4,1.44,0.5568,4481.0,19 NDC,71285604401,OXYTOCIN 30 UNIT/500 ML IN NS PMB BOLUS (OB 1 HR),101.1,60.66,3.22,4481.0,23 NDC,71285604401,OXYTOCIN 30 UNIT/500 ML IN NS PMB BOLUS (OB 4 HR),101.1,60.66,3.22,4481.0,23 NDC,71285701901,EPINEPHRINE HCL 8 MG/250 ML (32 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS,271.6,162.96,63.01,4481.0,19 NDC,71288016750,PEMETREXED DISODIUM 500 MG INTRAVENOUS POWDER FOR SOLUTION,771.5,462.9,4.23,4481.0,35 NDC,71288040405,"HEPARIN (PORCINE) 10,000 UNIT/ML INJECTION SOLUTION",49.9,29.94,0.4725,4481.0,24 NDC,71288040905,PALONOSETRON 0.25 MG/5 ML INTRAVENOUS SOLUTION,92.45,55.47,0.765,4481.0,24 NDC,71288042603,ENOXAPARIN 300 MG/3 ML SUBCUTANEOUS SOLUTION,140.85,84.51,1.33,4481.0,24 NDC,71288042710,BIVALIRUDIN 250 MG INTRAVENOUS POWDER FOR SOLUTION,289.0,173.4,0.3825,4481.0,24 NDC,71288070105,ATRACURIUM 10 MG/ML INTRAVENOUS SOLUTION,34.45,20.67,7.99,4481.0,19 NDC,71288071206,CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTION,43.3,25.98,10.05,4481.0,19 NDC,71288071411,CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTION,55.0,33.0,12.76,4481.0,19 NDC,71336100001,PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION,32059.95,19235.97,96.97,25647.96,35 NDC,71336100301,VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE,465484.9,279290.94,4481.0,811244.49,35 NDC,71390001111,REMIMAZOLAM 20 MG INTRAVENOUS SOLUTION,153.9,92.34,5.04,4481.0,24 NDC,71399282901,DIBUCAINE 1 % TOPICAL OINTMENT,5.95,3.57,1.38,4481.0,19 NDC,71399740105,CHOLECALCIFEROL (VITAMIN D3) 10 MCG/ML (400 UNIT/ML) ORAL DROPS,1.1,0.66,0.2552,4481.0,19 NDC,71449000115,PHENYLEPHRINE 1 MG/10 ML (100 MCG/ML) IN 0.9 % SOD.CHLORIDE IV WRAPPER,18.65,11.19,0.0225,4481.0,24 NDC,71449000115,PHENYLEPHRINE FOR PRIAPISM 100 MCG/ML VIAL/SYRINGE WRAPPER,42.15,25.29,0.0225,4481.0,24 NDC,71449006911,KETAMINE 10 MG/ML INJECTION SYRINGE WRAPPER,46.85,28.11,10.87,4481.0,19 NDC,71449007951,ROPIVACAINE(PF) 0.2 % 545 ML INFIL RATE ELAST PUMP WRAPPER,1682.65,1009.59,0.1125,4481.0,24 NDC,71449009199,BEVACIZUMAB 2.25 MG/0.09 ML INTRAVITREAL SYRINGE,251.95,151.17,1.78,4481.0,36 NDC,71449010811,DEXMEDETOMIDINE 20 MCG/5 ML SYRINGE (OR),107.15,64.29,24.86,4481.0,19 NDC,71699005030,CENOBAMATE 50 MG TABLET,145.2,87.12,33.69,4481.0,19 NDC,71699020030,CENOBAMATE 200 MG TABLET,145.2,87.12,33.69,4481.0,19 NDC,71715000102,OMADACYCLINE 100 MG INTRAVENOUS SOLUTION,1624.65,974.79,3.9,4481.0,35 NDC,71740011230,POTASSIUM IODIDE 1 GRAM/ML ORAL SOLUTION,30.25,18.15,7.02,4481.0,19 NDC,71837100001,ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION,78887.5,47332.5,31.92,68245.58,35 NDC,71837584301,SARGRAMOSTIM 250 MCG SOLUTION FOR INJECTION,1243.05,745.83,48.86,9552.06,35 NDC,71879013601,FLUOCINOLONE 0.18 MG INTRAVITREAL IMPLANT,36546.0,21927.6,513.99,85862.7,35 NDC,71894012002,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",6948813.05,4169287.83,4481.0,379707196.05,33 NDC,71894012103,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",5940704.2,3564422.52,4481.0,379707196.05,33 NDC,71894012203,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",5211625.5,3126975.3,4481.0,379707196.05,33 NDC,71894012303,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",4623223.3,2773933.98,4481.0,379707196.05,33 NDC,71894012404,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",4169313.0,2501587.8,4481.0,379707196.05,33 NDC,71894012504,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",3784035.8,2270421.48,4481.0,379707196.05,33 NDC,71894012604,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",3474438.0,2084662.8,4481.0,379707196.05,33 NDC,71894012705,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",3202699.2,1921619.52,4481.0,379707196.05,33 NDC,71894012805,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2978098.75,1786859.25,4481.0,379707196.05,33 NDC,71894012905,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2776198.0,1665718.8,4481.0,379707196.05,33 NDC,71894013006,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2605844.3,1563506.58,4481.0,379707196.05,33 NDC,71894013106,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2449942.85,1469965.71,4481.0,379707196.05,33 NDC,71894013206,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2316313.0,1389787.8,4481.0,379707196.05,33 NDC,71894013307,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2192307.3,1315384.38,4481.0,379707196.05,33 NDC,71894013407,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",2084688.0,1250812.8,4481.0,379707196.05,33 NDC,71894013507,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",1983702.75,1190221.65,4481.0,379707196.05,33 NDC,71894013608,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",1895176.65,1137105.99,4481.0,379707196.05,33 NDC,71894013708,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",1811348.55,1086809.13,4481.0,379707196.05,33 NDC,71894013808,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",1737250.5,1042350.3,4481.0,379707196.05,33 NDC,71894013909,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",1666551.05,999930.63,4481.0,379707196.05,33 NDC,71894014009,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",1603620.7,962172.42,4481.0,379707196.05,33 NDC,71894014109,"ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT",1543190.55,925914.33,4481.0,379707196.05,33 NDC,72140000022,WHITE PETROLATUM-MINERAL OIL-LANOLIN TOPICAL CREAM WRAPPER,12.4,7.44,2.88,4481.0,19 NDC,72140003147,WHITE PETROLATUM 41 % TOPICAL OINTMENT,21.3,12.78,4.94,4481.0,19 NDC,72162242601,DEXMETHYLPHENIDATE 5 MG TABLET,23.0,13.8,5.34,4481.0,19 NDC,72187040101,"TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION",84777.15,50866.29,346.22,67821.72,35 NDC,72205004160,DOFETILIDE 500 MCG CAPSULE,17.0,10.2,3.94,4481.0,19 NDC,72205007290,DROXIDOPA 100 MG CAPSULE,19.35,11.61,4.49,4481.0,19 NDC,72205008530,TIAGABINE 4 MG TABLET,35.05,21.03,8.13,4481.0,19 NDC,72482010012,PACRITINIB 100 MG CAPSULE,663.05,397.83,153.83,4481.0,22 NDC,72485010501,SODIUM NITROPRUSSIDE 25 MG/ML INTRAVENOUS SOLUTION,128.4,77.04,29.79,4481.0,19 NDC,72485067035,ERYTHROMYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT,49.75,29.85,11.54,4481.0,19 NDC,72493010220,DILUENT FOR MITOMYCIN INTRA-PYELOCALYCEAL SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,72493010303,MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT,82842.95,49705.77,308.97,66274.36,35 NDC,72512092801,CAPSAICIN-SKIN CLEANSER 8 % TOPICAL KIT,2750.45,1650.27,3.32,4481.0,35 NDC,72578005601,FELBAMATE 400 MG TABLET,20.2,12.12,4.69,4481.0,19 NDC,72603020301,EPHEDRINE SULFATE 50 MG/ML INTRAVENOUS SOLUTION,89.4,53.64,20.74,4481.0,19 NDC,72677055103,INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION,142853.05,85711.83,480.68,114282.44,35 NDC,72694051501,CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION,96384.6,57830.76,79.62,77107.68,34 NDC,72694095401,PEGASPARGASE (ONCASPAR) SYRINGE,89033.15,53419.89,4481.0,5480505.45,35 NDC,72769018103,PERAMIVIR (PF) 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION,1098.5,659.1,1.63,4481.0,35 NDC,72888012526,LIDOCAINE HCL 2 % MUCOSAL SOLUTION,16.35,9.81,3.79,4481.0,19 NDC,72888017246,LITHIUM CITRATE 8 MEQ/5 ML ORAL SOLUTION,796.0,477.6,184.67,4481.0,19 NDC,72893000201,BELINOSTAT 500 MG INTRAVENOUS SOLUTION,8650.25,5190.15,50.9,7907.13,35 NDC,72903085301,MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION,22724.65,13634.79,67.41,18179.72,35 NDC,72989037330,PROGESTERONE MICRONIZED 200 MG CAPSULE,111.05,66.63,25.76,4481.0,19 NDC,73042020101,NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION,323818.0,194290.8,665.42,259054.4,35 NDC,73077001001,SODIUM THIOSULFATE 12.5 GRAM/100 ML (125 MG/ML) INTRAVENOUS SOLUTION,37396.95,22438.17,92.26,29917.56,35 NDC,73090042001,SILTUXIMAB 100 MG INTRAVENOUS SOLUTION,5542.25,3325.35,160.86,26739.3,35 NDC,73090042101,SILTUXIMAB 400 MG INTRAVENOUS SOLUTION,21343.85,12806.31,160.86,26739.3,35 NDC,73150015006,UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION,36392.75,21835.65,68.63,29114.2,35 NDC,73177010106,KETAMINE 10 MG/ML INJECTION SYRINGE WRAPPER,36.3,21.78,8.42,4481.0,19 NDC,73177010201,FENTANYL (PF) 10 MCG/ML NEONATAL DILUTION INJECTION,40.05,24.03,2.48,4481.0,24 NDC,73177010605,"MIDAZOLAM (PF) 50 MG/50 ML (1 MG/ML) IN SOD CHLOR,ISO-OSM IV SYRINGE",85.25,51.15,19.78,4481.0,26 NDC,73177011415,DESMOPRESSIN 150 MCG/SPRAY (0.1 ML) NASAL SPRAY,1220.0,732.0,283.04,4481.0,19 NDC,73177012302,DEXMEDETOMIDINE 20 MCG/5 ML (4 MCG/ML) IN 0.9 % SODIUM CHLR IV SYRINGE,102.1,61.26,23.69,4481.0,19 NDC,73177012705,POTASSIUM CHLORIDE 100 MEQ/50 ML (2 MEQ/ML) IN WATER IV SYRINGE (CONC),64.65,38.79,15.0,4481.0,26 NDC,73177014633,ALBUTEROL SULFATE CONCENTRATE 5 MG/ML(0.5 %) SOLUTION FOR NEBULIZATION,766.0,459.6,177.71,4481.0,19 NDC,73177016143,"METHADONE 10 MG/ML IN SODIUM CHLORIDE,ISO-OSMOTIC INTRAVENOUS SYRINGE",148.45,89.07,34.44,4481.0,26 NDC,73302045601,ULIPRISTAL 30 MG TABLET,132.25,79.35,30.68,4481.0,19 NDC,73462010101,TRILACICLIB 300 MG INTRAVENOUS SOLUTION,5337.65,3202.59,5.3,4481.0,35 NDC,73475304105,EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION,20305.55,12183.33,31.19,16244.44,35 NDC,73475310203,"EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN",52672.3,31603.38,32.87,42137.84,35 NDC,73535020801,TAFASITAMAB-CXIX 200 MG INTRAVENOUS SOLUTION,4895.35,2937.21,13.88,4481.0,35 NDC,73555050000,REVUMENIB 25 MG TABLET,1358.35,815.01,315.14,4481.0,19 NDC,73555050100,REVUMENIB 110 MG TABLET,2658.35,1595.01,616.74,4481.0,19 NDC,73555050200,REVUMENIB 160 MG TABLET,2658.35,1595.01,616.74,4481.0,19 NDC,73556016802,AVACOPAN 10 MG CAPSULE,314.0,188.4,72.85,4481.0,19 NDC,73562011001,"LIPASE-PROTEASE-AMYLASE(PORK)10,000-32,000-42,000 UNIT CAPSULE,DEL REL",1278.1,766.86,296.52,4481.0,19 NDC,73562011201,"LIPASE-PROTEASE-AMYLASE (PORK) 20,000-63,000-84K UNIT CAPSULE, DEL REL",2491.9,1495.14,578.12,4481.0,19 NDC,73562011301,"LIPASE-PROTEASE-AMYLASE (PORK) 3,000-10,000-14K UNIT CAPSULE,DEL REL",685.3,411.18,158.99,4481.0,19 NDC,73562011401,"LIPASE-PROTEASE-AMYLASE(PORK) 40,000-126,000-168K UNIT CAPSULE,DEL REL",64.9,38.94,15.06,4481.0,19 NDC,73562011601,"LIPASE-PROTEASE-AMYLASE (PORK) 25,000-79,000-105K UNIT CAPSULE,DEL REL",3079.9,1847.94,714.54,4481.0,19 NDC,73562020810,"LIPASE-PROTEASE-AMYLASE (PORCINE) 20,880-78,300-78,300 UNIT TABLET",41.05,24.63,9.52,4481.0,19 NDC,73594931001,FERRIC DERISOMALTOSE 100 MG IRON/ML INTRAVENOUS SOLUTION,12005.65,7203.39,21.36,10386.09,35 NDC,73606001001,"PEGCETACOPLAN 1,080 MG/20 ML SUBCUTANEOUS SOLUTION",15952.1,9571.26,3700.89,12761.68,22 NDC,73607001111,ARTESUNATE 110 MG INTRAVENOUS SOLUTION,17650.7,10590.42,50.28,15269.62,35 NDC,73650031601,TEPLIZUMAB-MZWV 1 MG/ML INTRAVENOUS SOLUTION,48129.3,28877.58,36.53,38503.44,35 NDC,74300000071,ZINC OXIDE-COD LIVER OIL 40 % TOPICAL PASTE,10.85,6.51,2.52,4481.0,19 NDC,74300000300,ZINC OXIDE 13 % TOPICAL CREAM,7.05,4.23,1.64,4481.0,19 NDC,74312000640,RIBOFLAVIN (VITAMIN B2) 100 MG TABLET,1.1,0.66,0.2552,4481.0,19 NDC,75626000101,VOCLOSPORIN 7.9 MG CAPSULE,280.25,168.15,65.02,4481.0,19 NDC,75833080001,MELPHALAN HCL 50 MG INTRA-ARTERIAL SOLUTION,124400.0,74640.0,771.15,107618.44,35 NDC,75834015801,"VERAPAMIL ER (SR) 180 MG TABLET,EXTENDED RELEASE",16.75,10.05,3.89,4481.0,19 NDC,75987005006,GLYCEROL PHENYLBUTYRATE 1.1 GRAM/ML ORAL LIQUID,17758.0,10654.8,4119.86,14206.4,19 NDC,75987008010,PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION,100592.6,60355.56,3551.01,538834.38,35 NDC,75987013015,TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION,58985.0,35391.0,348.41,57707.79,35 NDC,76045000906,HYDROMORPHONE 0.5 MG/0.5 ML INJECTION SYRINGE WRAPPER,34.5,20.7,0.2025,4481.0,24 NDC,76045073701,HALOPERIDOL LACTATE 5 MG/ML INTRAMUSCULAR SYRINGE,22.25,13.35,1.8,4481.0,24 NDC,76075010101,CARFILZOMIB (KYPROLIS) IVPB 2 MG/ML,11983.1,7189.86,53.98,9586.48,35 NDC,76075010101,CARFILZOMIB 60 MG INTRAVENOUS SOLUTION,11983.1,7189.86,53.98,9586.48,35 NDC,76125067810,"ANTIHEMOPHILIC FACTOR 1,000 (+/-) UNIT INTRAVENOUS POWDER FOR SOLUTION",82.0,49.2,1.06,4481.0,35 NDC,76128015575,PORFIMER 75 MG INTRAVENOUS SOLUTION,77474.15,46484.49,4481.0,466585.35,35 NDC,76204010030,IPRATROPIUM BROMIDE 0.02 % SOLN FOR CONTINUOUS NEBULIZATION,16.95,10.17,3.93,4481.0,19 NDC,76204010030,IPRATROPIUM BROMIDE 0.02 % SOLUTION FOR INHALATION,16.95,10.17,3.93,4481.0,19 NDC,76204060030,IPRATROPIUM 0.5 MG-ALBUTEROL 3 MG (2.5 MG BASE)/3 ML NEBULIZATION SOLN,17.2,10.32,3.99,4481.0,19 NDC,76204070001,LEVALBUTEROL 0.31 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 NDC,76204080011,LEVALBUTEROL 0.63 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 NDC,76204090011,LEVALBUTEROL 1.25 MG/3 ML SOLUTION FOR NEBULIZATION,20.8,12.48,4.83,4481.0,19 NDC,76329124001,PHYTONADIONE 1 MG/0.5 ML INJ SOLUTION (MULTI-VIAL SIZE),112.45,67.47,6.14,4481.0,23 NDC,76329191201,MORPHINE (PF) 30 MG/30 ML (1 MG/ML) PCA INTRAVENOUS SOLUTION,64.2,38.52,14.89,4481.0,24 NDC,76329301505,LIDOCAINE 2 % MUCOSAL JELLY IN APPLICATOR,23.7,14.22,5.5,4481.0,19 NDC,76329330201,DEXTROSE 50 % IN WATER (D50W) INTRAVENOUS SYRINGE,55.5,33.3,12.88,4481.0,19 NDC,76329331801,EPINEPHRINE 0.1 MG/ML INJECTION SYRINGE,69.6,41.76,1.08,4481.0,24 NDC,76329334001,ATROPINE 0.1 MG/ML INJECTION SYRINGE,60.7,36.42,0.198,4481.0,24 NDC,76329335201,SODIUM BICARBONATE 50 MEQ/50 ML (8.4 %) INTRAVENOUS SYRINGE,92.85,55.71,21.54,4481.0,19 NDC,76329336901,NALOXONE 1 MG/ML INJECTION SYRINGE,144.7,86.82,0.18,4481.0,24 NDC,76329336901,NALOXONE 1 MG/ML INTRANASAL SOLUTION,144.7,86.82,0.18,4481.0,24 NDC,76329339001,LIDOCAINE (PF) 100 MG/5 ML (2 %) INTRAVENOUS SYRINGE,50.95,30.57,0.0225,4481.0,24 NDC,76329630005,LIDOCAINE HCL 4 % LARYNGOTRACHEAL SOLUTION,106.95,64.17,24.81,4481.0,19 NDC,76385013801,METOLAZONE 10 MG TABLET,18.7,11.22,4.34,4481.0,19 NDC,77333036025,GUAIFENESIN 400 MG TABLET,1.55,0.93,0.3596,4481.0,19 NDC,77333081225,SIMETHICONE 80 MG CHEWABLE TABLET,1.4,0.84,0.3248,4481.0,19 NDC,77333082725,SODIUM BICARBONATE 650 MG TABLET,1.25,0.75,0.29,4481.0,19 NDC,77333084410,"SODIUM CHLORIDE 1,000 MG SOLUBLE TABLET",1.45,0.87,0.3364,4481.0,19 NDC,77333086110,MULTIVITAMIN-IRON 9 MG-FOLIC ACID 400 MCG-CALCIUM AND MINERALS TABLET,1.25,0.75,0.29,4481.0,19 NDC,77333093425,THIAMINE MONONITRATE (VITAMIN B1) 100 MG TABLET,1.3,0.78,0.3016,4481.0,19 NDC,77333093825,"CYANOCOBALAMIN (VIT B-12) 1,000 MCG TABLET",1.35,0.81,0.3132,4481.0,19 NDC,77333094825,CHOLECALCIFEROL (VITAMIN D3) 10 MCG (400 UNIT) TABLET,1.4,0.84,0.3248,4481.0,19 NDC,77333095125,"VITAMIN E (DL, ACETATE) 180 MG (400 UNIT) CAPSULE",1.4,0.84,0.3248,4481.0,19 NDC,77333098325,ZINC SULFATE 50 MG ZINC (220 MG) CAPSULE,1.4,0.84,0.3248,4481.0,19 NDC,78206014501,ETONOGESTREL 68 MG SUBDERMAL IMPLANT,4880.55,2928.33,1132.29,164995.74,24 NDC,78206016201,INFLIXIMAB-ABDA 100 MG INTRAVENOUS SOLUTION,2526.6,1515.96,26.19,4481.0,35 NDC,79952011001,LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION,94019.95,56411.97,210.39,75215.96,35 NDC,80410000042,MENTHOL LOZENGES WRAPPER,1.05,0.63,0.2436,4481.0,19 NDC,80446040101,TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION,69751.9,41851.14,210.58,55801.52,35 NDC,80681000500,"CALCIUM 600 MG (AS CALCIUM CARBONATE 1,500 MG) TABLET",1.05,0.63,0.2436,4481.0,19 NDC,80725061025,CHLORAMBUCIL 2 MG TABLET,2335.3,1401.18,541.79,4481.0,19 NDC,80725063025,THIOGUANINE 40 MG TABLET,1954.65,1172.79,453.48,4481.0,19 NDC,80777011387,COVID VAC 2025-26 (6MO-11YR)(MODERNA) (PF) 25 MCG/0.25 ML IM SYRINGE,409.0,245.4,94.89,4481.0,26 NDC,80803015350,SIROLIMUS-PROTEIN BOUND 100 MG INTRAVENOUS SUSPENSION,27476.25,16485.75,82.03,21981.0,35 NDC,81052013810,PAFOLACIANINE 3.2 MG/1.6 ML INTRAVENOUS SOLUTION,13960.5,8376.3,304.81,12077.23,23 NDC,81284021301,PHENYLEPHRINE 10 MG/ML INJECTION SOLUTION,86.2,51.72,0.0225,4481.0,24 NDC,81284061100,"TRANEXAMIC ACID 1,000 MG/10 ML (100 MG/ML) INTRAVENOUS SOLUTION",81.0,48.6,18.79,4481.0,19 NDC,81370003602,DIMETHICONE 1.2 %-COLLOIDAL OATMEAL LOTION,5.2,3.12,1.21,4481.0,19 NDC,81481080301,NOGAPENDEKIN ALFA INBAKICEPT-PMLN 400 MCG/0.4 ML INTRAVESICAL SOLUTION,118773.0,71263.8,91.82,95018.4,35 NDC,81643927001,FLOXURIDINE 0.5 GRAM SOLUTION FOR INJECTION,13634.2,8180.52,3449.45,619321.29,35 NDC,81864010130,MOMELOTINIB 200 MG TABLET,3873.9,2324.34,898.74,4481.0,22 NDC,81864010330,MOMELOTINIB 100 MG TABLET,3873.9,2324.34,898.74,4481.0,22 NDC,81960003103,PEMIVIBART 125 MG/ML INTRAVENOUS SOLUTION (EUA),20827.55,12496.53,4481.0,23978.46,25 NDC,81964020501,AMOXICILLIN 500 MG CAPSULE,16.3,9.78,3.78,4481.0,19 NDC,82625880101,NALOXEGOL 12.5 MG TABLET,59.65,35.79,13.84,4481.0,19 NDC,82625880203,NALOXEGOL 25 MG TABLET,59.65,35.79,13.84,4481.0,19 NDC,82667060005,STUDY DEXAMETHASONE 0.1% OPHTHALMIC SUSPENSION,0.2,0.12,0.0464,4481.0,19 NDC,82705000201,EPCORITAMAB-BYSP 0.16 MG/ML SUBCUTANEOUS SOLUTION DILUTION B,456.85,274.11,54.16,8980.23,35 NDC,82705000201,EPCORITAMAB-BYSP 0.8 MG/ML SUBCUTANEOUS SOLUTION DILUTION A,1184.2,710.52,54.16,8980.23,35 NDC,82705000201,EPCORITAMAB-BYSP 4 MG/0.8 ML SUBCUTANEOUS SOLUTION,3684.4,2210.64,54.16,8980.23,35 NDC,82705001001,EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION,54824.8,32894.88,54.16,43859.84,35 NDC,82829000299,AVACINCAPTAD PEGOL (PF) 2 MG/0.1 ML INTRAVITREAL SOLUTION,8206.0,4923.6,101.97,17585.61,35 NDC,82950000116,TOVORAFENIB 400 MG/WEEK (100 MG X 4) TABLET,9240.0,5544.0,2143.68,7993.52,26 NDC,82950000120,TOVORAFENIB 500 MG/WEEK (100 MG X 5) TABLET,7397.0,4438.2,1716.1,6399.14,26 NDC,82950000124,TOVORAFENIB 600 MG/WEEK (100 MG X 6) TABLET,6168.35,3701.01,1431.06,5336.24,26 NDC,82950001201,TOVORAFENIB 25 MG/ML ORAL SUSPENSION,73744.85,44246.91,4481.0,63796.67,26 NDC,82959011101,IMETELSTAT 188 MG INTRAVENOUS SOLUTION,34102.35,20461.41,55.32,29501.94,35 NDC,82959011201,IMETELSTAT 47 MG INTRAVENOUS SOLUTION,8572.85,5143.71,55.32,7416.37,35 NDC,83257000541,PEGFILGRASTIM-JMDB 6 MG/0.6 ML SUBCUTANEOUS SYRINGE,8157.3,4894.38,96.16,18477.9,35 NDC,87701014975,TETRAHYDROZOLINE 0.05 % EYE DROPS,6.25,3.75,1.45,4481.0,19 NDC,87701040073,GENTIAN VIOLET 1 % TOPICAL SOLUTION,1.05,0.63,0.2436,4481.0,19 NDC,87701042510,GLYCERIN (ADULT) RECTAL SUPPOSITORY,1.25,0.75,0.29,4481.0,19 NDC,87701093206,LORATADINE 5 MG/5 ML ORAL SOLUTION,1.45,0.87,0.3364,4481.0,19 NDC,89122072420,SODIUM HYALURONATE 10 MG/ML INTRA-ARTICULAR SYRINGE,942.25,565.35,160.92,11176.41,24 NDC,89130444401,SODIUM HYALURONATE 10 MG/ML INTRA-ARTICULAR SYRINGE,941.15,564.69,160.92,11176.41,24 NDC,90999001161,CARDIOPLEGIC PERFUSION (PLEGISOL) 80 MEQ/L (HIGH K),340.95,204.57,79.1,4481.0,19 NDC,96974000002,MAGNESIUM OXIDE-MAGNESIUM AMINO ACID CHELATE 133 MG TABLET,1.15,0.69,0.2668,4481.0,19 NDC,99990000424,ACETYLCYSTEINE 20% (200 MG/ML) OPHTHALMIC SOLUTION,259.65,155.79,60.24,4481.0,19 NDC,99990000435,CEFTAZIDIME 2.25% (22.5 MG/ML) INTRAOCULAR SYRINGE,63.05,37.83,3.53,4481.0,24 NDC,99990000436,CEFTAZIDIME 5% (50 MG/ML) OPHTHALMIC SOLUTION,43.9,26.34,10.18,4481.0,19 NDC,99990000438,GENTAMICIN 1.5% (15 MG/ML) OPHTHALMIC SOLUTION,30.4,18.24,4.97,4481.0,24 NDC,99990000441,MITOMYCIN 0.04% (400 MCG/1 ML) OPHTHALMIC SOLUTION,130.0,78.0,30.16,4481.0,19 NDC,99990000461,STUDY 2422 USTEKINUMAB (STELARA) 90 MG SYRINGE,0.2,0.12,0.0506,23352.42,35 NDC,99990000462,STUDY 2420 LEUPROLIDE/PLACEBO 3.75 MG/ML SYRINGE,0.2,0.12,0.0506,252434.28,35 NDC,99990000463,STUDY 2423 ETANERCEPT/PLACEBO 25 MG/ML,0.2,0.12,0.0464,4481.0,19 NDC,99990000464,STUDY 2424 MEDI8968/PLACEBO 150 MG/ML,0.2,0.12,0.0464,4481.0,17 NDC,99990000465,STUDY 2425 SELG1/PLACEBO 10 MG/ML,0.2,0.12,0.0464,4481.0,17 NDC,99990000467,STUDY 2445 PDA-002 100 MILLION CELLS IN 5ML SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99990000468,STUDY 2445 PDA-002 10 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 NDC,99990000469,STUDY 2445 PDA-002 30 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 NDC,99990000470,STUDY 2445 PDA-002 3 MILLION CELLS IN 5 ML NS,0.2,0.12,0.0464,4481.0,17 NDC,99990000471,STUDY 2458 RITUXIMAB 10 MG/ML,0.2,0.12,0.05544,4481.0,31 NDC,99990000472,STUDY 2504 DFA-02/PLACEBO,0.2,0.12,0.0464,4481.0,17 NDC,99990000474,STUDY 2403 H.P. ACTHAR GEL/PLACEBO 80 UNITS/ML,0.2,0.12,0.0464,4481.0,19 NDC,99990000475,STUDY 2301 DRCR AFL-BEV-RAN STUDY,0.2,0.12,0.0464,4481.0,17 NDC,99990000478,STUDY 2414 CROTALIDAE POLYVALENT IMMUNE FAB (OVINE)/PLACEBO,0.2,0.12,0.0464,4481.0,19 NDC,99990000480,STUDY 2474 ULARITIDE/PLACEBO 2.5 MG/5ML,0.2,0.12,0.0464,4481.0,17 NDC,99990000483,STUDY 2418 CALCIPOTRIENE/PLACEBO FOAM 0.005%,0.2,0.12,0.0464,4481.0,19 NDC,99990000567,STUDY 2538 DAPSONE/PLACEBO GEL 7.5%,0.2,0.12,0.0464,4481.0,19 NDC,99990000580,STUDY RESEARCH EMERGENCY MEDICATION,0.2,0.12,0.0464,4481.0,17 NDC,99990000637,STUDY 2473 EXENATIDE 250 MCG/ML,0.2,0.12,0.0464,4481.0,19 NDC,99990000700,STUDY 2358 BMS-188667 ABATACEPT/PLACEBO 250 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99990000763,STUDY PROMETHAZINE 25 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,99990000764,STUDY PROMETHAZINE 25 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99990000772,STUDY 2330 PENTOBARBITAL 50 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,24 NDC,99990000775,STUDY 2330 MIDAZOLAM 5 MG/ML VIAL,0.2,0.12,0.0464,4481.0,24 NDC,99990000940,STUDY NICHD NRN INS-3 INOSITOL/PLACEBO 50 MG/ML INTRAVENOUSNS,0.2,0.12,0.0464,4481.0,17 NDC,99990000957,STUDY NICHD NRN INS-3 INOSITOL/PLACEBO 50MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99990000962,STUDY 1VIT13035 FERRIC CARBOXYMALTOSE 50 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,99990001012,STUDY CLEE011XUS03 LEE011 50 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001013,STUDY CLEE011XUS03 LEE011 200 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001014,STUDY ECU-MG-302 ECULIZUMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99990001016,STUDY ECU-MG-302 ECULIZUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,7333.83,35 NDC,99990001022,STUDY 2628 TREPROSTINIL/PLACEBO 2.9 ML SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,19 NDC,99990001043,STUDY BAY-73-4506 REGORAFENIB 40 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99990001044,STUDY BAY-73-4506 REGORAFENIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99990001048,STUDY MK-3475-045 PEMBROLIZUMAB INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,25 NDC,99990001074,STUDY NCT01954056 HYDROCORTISONE/PLACEBO INTRAVENOUS,0.2,0.12,0.0464,4481.0,19 NDC,99990001075,STUDY NCT01954056 HYDROCORTISONE/PLACEBO ORAL,0.2,0.12,0.0464,4481.0,19 NDC,99990001076,STUDY NCT01954056 HYDROCORTISONE/PLACEBO INTRAMUSCULAR,0.2,0.12,0.0464,4481.0,19 NDC,99990001077,STUDY M13-741 ABT-981/PLACEBO 25/100/200 MG/ 2ML INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,99990001079,STUDY AZ D5134C00001 (SOCRATES) ASPIRIN/PLACEBO 100 MG TABLETS,0.2,0.12,0.0464,4481.0,19 NDC,99990001080,STUDY AZ D5134C00001 (SOCRATES) TICAGRELOR/PLACEBO 90MG TABLETS,0.2,0.12,0.0464,4481.0,19 NDC,99990001081,STUDY IRC 003 OSELTAMIVIR/RIBAVIRIN/AMANTIDINE,0.2,0.12,0.0464,4481.0,19 NDC,99990001094,STUDY CRLX030A2209 SERELAXIN/PLACEBO INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99990001102,STUDY DFCI 13-559 PALBOCICLIB 75 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99990001109,STUDY DFCI 13-559 PALBOCICLIB CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,19 NDC,99990001115,STUDY 2691 SCY-078 250 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99990001116,STUDY 2691 FLUCONAZOLE 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99990001117,STUDY 2691 MICAFUNGIN 10 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,19 NDC,99990001118,STUDY ATROPINE 0.1 MG/ML INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,99990001119,STUDY FAMOTIDINE 10 MG/ML INJ SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99990001120,STUDY 2665 VPI-2690B 30 MG/ML WHITE LABEL,0.2,0.12,0.0464,4481.0,17 NDC,99990001123,STUDY 2665 VPI-2690B 30 MG/ML BLUE LABEL,0.2,0.12,0.0464,4481.0,17 NDC,99990001142,STUDY 14-2797 MEDICATION A 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99990001143,STUDY 14-2797 MEDICATION A 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,99990001144,STUDY CBGJ398XUS04 BGJ398 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99990001145,STUDY CBGJ398XUS04 BGJ398 CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001146,STUDY D0816C00010 OLAPARIB TABLET 100 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001147,STUDY D0816C00010 OLAPARIB TABLET 150 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001153,STUDY CRAD001A2433 EVEROLIMUS TABLET 0.75 MG,0.2,0.12,0.0464,4481.0,20 NDC,99990001154,STUDY CRAD001A2433 EVEROLIMUS TABLET 1 MG,0.2,0.12,0.0464,4481.0,20 NDC,99990001171,STUDY AHOD1331 BRENTUXIMAB VEDOTIN (SGN-35) 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,26 NDC,99990001172,STUDY R668-EE-1324.01 DUPILUMAB/PLACEBO 150 MG/ML LOADING DOSE-600MG- 2 KITS,0.2,0.12,0.0464,4481.0,17 NDC,99990001174,STUDY R668-EE-1324.01 DUPILUMAB/PLACEBO 150 MG/ML MAINTENANCE DOSE 300 MG = 1 KIT,0.2,0.12,0.0464,4481.0,17 NDC,99990001176,STUDY PS-D202 SODIUM CHLORIDE 7 % FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 NDC,99990001189,STUDY SHIRE SHP-609-302 IDURSULFASE INTRATHECAL 10 MG/ML SYRINGE,0.2,0.12,0.0506,81999.54,35 NDC,99990001195,STUDY MAST MST-188-01 MST-188/PLACEBO 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99990001200,STUDY CTRC 10-0742 NICARDIPINE 20 MG/200 ML IN SODIUM CHLORIDE(ISO) IB,0.2,0.12,0.0464,4481.0,24 NDC,99990001210,STUDY SHIRE HGT-SAN-093 HGT-1410 (RECOMBINANT HUMAN HEPARAN N SULFATASE) 45 MG/3 ML SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99990001214,STUDY ACTG A5342 VRC01/PLACEBO 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99990001216,STUDY CNS7056-008 REMIMAZOLAM/PLACEBO 2.5 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,17 NDC,99990001217,STUDY CNS7056-008 REMIMAZOLAM/PLACEBO 2.5 MG/ML TOP-UP DOSE,0.2,0.12,0.0464,4481.0,17 NDC,99990001218,STUDY CNS7056-008 MIDAZOLAM 1 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,24 NDC,99990001219,STUDY CNS7056-008 MIDAZOLAM 1 MG/ML TOP-UP DOSE,0.2,0.12,0.0464,4481.0,24 NDC,99990001220,STUDY CNS7056-008 FENTANYL 0.05 MG/ML INITIAL DOSE,0.2,0.12,0.0464,4481.0,24 NDC,99990001223,STUDY CNS7056-008 FENTANYL 0.05 MG/ML FOLLOW-UP DOSE,0.2,0.12,0.0464,4481.0,24 NDC,99990001225,STUDY ALBUTEROL SULFATE 2.5 MG/3 ML (0.083 %) SOLUTION FOR NEBULIZATION,0.2,0.12,0.0464,4481.0,19 NDC,99990001226,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 50 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001227,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 100 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001228,STUDY CEMPRA CE01-120 SOLITHROMYCIN CAPSULE 200 MG,0.2,0.12,0.0464,4481.0,17 NDC,99990001230,STUDY B0401016 PF-04447943/PLACEBO 5 MG/15 MG TABLETS,0.2,0.12,0.0464,4481.0,17 NDC,99990001232,STUDY HOFFMAN-LAROCHE GA29145 ETROLIZUMAB PREFILLED SYRINGE 105MG/0.,0.2,0.12,0.0464,4481.0,17 NDC,99990001233,STUDY CHAP LABETOLOL 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99990001234,STUDY CHAP NIIFEDIPINE EXTENDED RELEASE (ER) 30 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99990020767,TROPICAMIDE 1 % EYE DROPS (MULTI-PATIENT),16.1,9.66,3.74,4481.0,19 NDC,99990020768,PHENYLEPHRINE 2.5 % EYE DROPS (MULTI-PATIENT),16.95,10.17,3.93,4481.0,19 NDC,99990020769,CYCLOPENTOLATE 1 % EYE DROPS (MULTI-PATIENT),17.75,10.65,4.12,4481.0,19 NDC,99990077845,"TRANEXAMIC ACID 2,000 MG/20 ML (100 MG/ML) INFUSION (PED)",193.7,116.22,44.94,4481.0,19 NDC,99999000084,"FENTANYL 12.5 MCG, BUPIVACAINE 0.2% (1.25 ML SYRINGE) CSE",22.65,13.59,5.25,4481.0,19 NDC,99999000365,DIGOXIN 25 MCG/ML NEONATAL DILUTION,65.5,39.3,10.89,4481.0,24 NDC,99999000366,HYDRALAZINE 0.5 MG/ML PEDIATRIC DILUTION,65.95,39.57,12.6,4481.0,24 NDC,99999000369,CLONAZEPAM 0.1 MG/ML ORAL SUSP,22.15,13.29,5.14,4481.0,19 NDC,99999000375,TERBUTALINE (BRETHINE) 16 MG/16 ML PEDIATRIC INFUSION,1093.75,656.25,7.46,4481.0,24 NDC,99999000382,ALUMINUM HYDROXIDE GEL 320 MG/5 ML ORAL SUSPENSION,1.7,1.02,0.3944,4481.0,19 NDC,99999000403,FERRIC SUBSULFATE (BULK) 20 TO 22 GRAM/100 ML SOLUTION,3.35,2.01,0.7772,4481.0,19 NDC,99999000408,TUBERCULIN PPD 5 TUB. UNIT/0.1 ML INTRADERMAL INJECTION SOLUTION,56.75,34.05,13.17,4481.0,19 NDC,99999000421,ARGATROBAN 20 MG/20 ML (1 MG/ML) PEDIATRIC SYRINGE,359.95,215.97,0.776,4481.0,35 NDC,99999000423,TACROLIMUS 0.01 MG/ML IV SYRINGE,236.35,141.81,59.8,4481.0,35 NDC,99999000423,TACROLIMUS INFUSION 0.01 MG/ML (50 ML SYRINGE),236.35,141.81,59.8,4481.0,35 NDC,99999000431,GENTAMICIN 30 MG/ML BUFFERED STERILE SOLUTION (ENT),101.1,60.66,23.46,4481.0,19 NDC,99999000434,SODIUM HYDROXIDE (BULK) 10 % SOLUTION,20.2,12.12,4.69,4481.0,19 NDC,99999000437,CLINDAMYCIN 1% (10 MG/ML) INTRAOCULAR SYRINGE,16.1,9.66,3.74,4481.0,24 NDC,99999000444,TOLUIDINE BLUE 1 % SOLUTION,24.35,14.61,5.65,4481.0,19 NDC,99999000445,TRICHLOROACETIC ACID 85% (W/V) TOPICAL SOLUTION,72.45,43.47,16.81,4481.0,19 NDC,99999000447,TRICHLOROACETIC ACID 40% (W/V) TOPICAL SOLUTION,21.3,12.78,4.94,4481.0,19 NDC,99999000456,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 8 ML SYRINGE (PEDS),24.4,14.64,5.66,4481.0,19 NDC,99999000457,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 24 ML SYRINGE (PEDS),41.2,24.72,9.56,4481.0,19 NDC,99999000458,FAT EMULSION 20 % INTRALIPID INTRAVENOUS 50 ML SYRINGE (PEDS),68.5,41.1,15.89,4481.0,19 NDC,99999000497,(TAKE HOME) ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,84.4,50.64,19.58,4481.0,19 NDC,99999000515,HEPARIN 500 UNITS IN 500 ML NS (FOR VASCULAR SERVICE),87.55,52.53,0.4725,4481.0,24 NDC,99999000516,PHENYLEPHRINE (PITKIN) 10 MG IN LR 1000 ML IRRIGATION,69.55,41.73,0.0225,4481.0,24 NDC,99999000517,PHENYLEPHRINE 4 MG/50 ML (80 MCG/ML) IN 0.9% SODIUM CHLORIDE,69.55,41.73,0.0225,4481.0,24 NDC,99999000521,GENTAMICIN-VANCOMYCIN 40-500 MG IN NS IRRIGATION 500 ML,79.35,47.61,4.97,4481.0,24 NDC,99999000525,ENOXAPARIN 20 MG/ML DILUTION PEDIATRIC INJECTION,107.8,64.68,1.33,4481.0,24 NDC,99999000526,COSYNTROPIN 2.5 MCG/ML DILUTION INJECTION,63.8,38.28,14.8,4481.0,24 NDC,99999000535,MORPHINE CONCENTRATE 20 MG/ML ORAL SOLUTION WRAPPER,22.85,13.71,5.3,4481.0,19 NDC,99999000565,CALCIUM GLUCONATE 2.5 % TOPICAL GEL,8.25,4.95,1.91,4481.0,19 NDC,99999000570,DEXMEDETOMIDINE 200 MCG/50 ML (4 MCG/ML) NS PEDIATRIC INFUSION,154.6,92.76,35.87,4481.0,19 NDC,99999000574,INSULIN DILUTION (INSULIN REGULAR) TEN UNIT/ML INJECTION,549.25,329.55,0.5175,4481.0,24 NDC,99999000576,POTASSIUM CHLORIDE 0.2 MEQ/ML (CENTRAL LINE) IV PEDIATRIC,71.85,43.11,0.2475,4481.0,24 NDC,99999000577,POTASSIUM CHLORIDE 0.1 MEQ/ML (PERIPHERAL LINE) IV PEDIATRIC,79.05,47.43,0.2475,4481.0,21 NDC,99999000578,DEXMEDETOMIDINE 4 MCG/ML BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,19 NDC,99999000579,ESMOLOL 500 MG/50 ML NS SYRINGE,147.7,88.62,0.495,4481.0,24 NDC,99999000596,INSULIN REGULAR 0.5 UNIT/ML PEDIATRIC DILUTION,72.85,43.71,0.5175,4481.0,24 NDC,99999000597,INSULIN DILUTION (INSULIN REGULAR) ONE UNIT/ML INJECTION,63.2,37.92,0.5175,4481.0,24 NDC,99999000598,SMOG ENEMA 240ML,2.9,1.74,0.6728,4481.0,19 NDC,99999000599,PAPAVARINE 16.7 MG/PHENTOLAMINE 0.56 MG/PROSTOGLANDIN,133.6,80.16,31.0,4481.0,19 NDC,99999000600,CISATRACURIUM (NIMBEX) 0.5 MG/ML PEDIATRIC BOLUS FROM BAG,0.2,0.12,0.0464,4481.0,19 NDC,99999000602,CISATRACURIUM (NIMBEX) 2 MG/ML PEDIATRIC BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,19 NDC,99999000603,FENTANYL (PF) 50 MCG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,24 NDC,99999000604,FENTANYL (PF) 10 MCG/ML PEDIATRIC BOLUS FROM INFUSION (CSAC),0.2,0.12,0.0464,4481.0,24 NDC,99999000610,MORPHINE 1 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,26 NDC,99999000611,MORPHINE 5 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,26 NDC,99999000612,MORPHINE 0.1 MG/ML (NCCC COOLING PROTOCOL) BOLUS,0.2,0.12,0.0464,4481.0,26 NDC,99999000613,PENTOBARBITAL (NEMBUTAL) 50 MG/ML BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,24 NDC,99999000630,PYRIMETHAMINE 2 MG/ML ORAL SUSPENSION,29.2,17.52,6.77,4481.0,19 NDC,99999000639,CEFAZOLIN DESENSITIZATION 1 MG/ML,16.0,9.6,1.8,4481.0,24 NDC,99999000650,METHYLPREDNISOLONE SOD SUCC 4 MG/ML PEDIATRIC DILUTION,1403.7,842.22,0.2037,4481.0,35 NDC,99999000651,DEXAMETHASONE 0.1 MG/ML PEDIATRIC DILUTION,67.6,40.56,0.2025,4481.0,24 NDC,99999000661,CARBIDOPA-LEVODOPA 1.25-5 MG/1 ML ORAL SUSPENSION,32.5,19.5,7.54,4481.0,19 NDC,99999000669,LINEZOLID 2 MG/ML IV PEDIATRIC,252.35,151.41,8.03,4481.0,24 NDC,99999000670,LEVOFLOXACIN 5 MG/ML IN 5 % DEXTROSE PEDIATRIC,76.75,46.05,5.33,4481.0,24 NDC,99999000673,BUMETANIDE 0.25 MG/ML PEDIATRIC 18 ML INFUSION,82.7,49.62,0.3589,4481.0,35 NDC,99999000674,BUMETANIDE 0.25 MG/ML PEDIATRIC 8 ML INFUSION,76.95,46.17,0.3589,4481.0,35 NDC,99999000676,CELECOXIB 10 MG/ML ORAL SUSPENSION,18.4,11.04,4.27,4481.0,19 NDC,99999000681,VECURONIUM (NORCURON) 1 MG/ML PEDIATRIC INFUSION 2 ML,64.7,38.82,15.01,4481.0,19 NDC,99999000701,ASPIRIN ORAL DESENSITIZATION 1 MG/ML BULK SOLUTION,16.05,9.63,3.72,4481.0,19 NDC,99999000707,AMPHOTERICIN B LIPOSOME (AMBISOME) INHALATION,583.45,350.07,20.84,4481.0,35 NDC,99999000708,PENTOBARBITAL 2500MG/50 ML ADULT INFUSION,6815.6,4089.36,121.21,5896.18,24 NDC,99999000709,EPINEPHRINE 90 MG/1000 ML NS IRRIGATION,2531.85,1519.11,1.08,4481.0,24 NDC,99999000710,GENTAMICIN 100 MG IN LR 1000 ML (KIDNEY FLUSH),82.65,49.59,4.97,4481.0,24 NDC,99999000713,BUPIVACAINE 0.125% IN NS EPIDURAL SYRINGE FOR OR,28.8,17.28,0.0225,4481.0,24 NDC,99999000716,"HEPARIN 30,000 UNITS (CELL SAVER) IN 1000 ML NS",31.6,18.96,0.4725,4481.0,24 NDC,99999000718,TRIVEX TUMESCENT SOLUTION (LIDOCAINE500MG/EPINEPHRINE2MG/NS),141.5,84.9,0.0225,4481.0,24 NDC,99999000719,LIDOCAINE 2 G (LASER TUMESCENT) IN 1000 ML LR,367.15,220.29,0.0225,4481.0,24 NDC,99999000721,LEVOCARNITINE 25 MG/ML INTRAVENOUS DILUTION,155.2,93.12,36.01,4481.0,24 NDC,99999000722,ZINC CHLORIDE 0.5 MG/ML INTRAVENOUS DILUTION,200.9,120.54,46.61,4481.0,19 NDC,99999000723,MAGNESIUM SULFATE 2.03 MEQ/ML INJECTION DILUTION,45.65,27.39,1.08,4481.0,24 NDC,99999000724,CUPRIC CHLORIDE 40 MCG/ML INTRAVENOUS DILUTION,64.65,38.79,15.0,4481.0,19 NDC,99999000725,LIDOCAINE 300 MG-EPINEPHRINE 1 MG IN LR 1000 ML (PLASTICS-TUMESCENT),99.0,59.4,0.0225,4481.0,24 NDC,99999000727,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (200 ML),268.0,160.8,62.18,4481.0,19 NDC,99999000728,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (300 ML),370.5,222.3,85.96,4481.0,19 NDC,99999000729,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (400 ML),473.0,283.8,109.74,4481.0,19 NDC,99999000730,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (500 ML),575.45,345.27,133.5,4481.0,19 NDC,99999000731,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (600 ML),677.95,406.77,157.28,4481.0,19 NDC,99999000732,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (700 ML),780.45,468.27,181.06,4481.0,19 NDC,99999000733,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (800 ML),882.95,529.77,204.84,4481.0,19 NDC,99999000734,FAT EMULSION 20 % INTRALIPID INTRAVENOUS (900 ML),985.45,591.27,228.62,4481.0,19 NDC,99999000736,FLUCONAZOLE 800 MG/400 ML NS IVPB,199.05,119.43,5.08,4481.0,24 NDC,99999000737,BIVALIRUDIN 250 MG/50 ML INFUSION (CATH LAB),126.8,76.08,0.3825,4481.0,24 NDC,99999000739,BECLOMETHASONE 1 MG/ML IN CORN OIL EMULSION,16.2,9.72,3.76,4481.0,19 NDC,99999000742,ALTEPLASE 0.81 MG/KG STROKE INFUSION,34337.45,20602.47,91.62,29705.33,35 NDC,99999000744,IBUTILIDE FUMARATE 0.1 MG/ML (FOR OR USE) INTRAVENOUS SOLUTION,1893.65,1136.19,167.14,4481.0,35 NDC,99999000791,NITROGLYCERIN 12 MG/120 ML (100 MCG/ML) IN HEPARINIZED SALINE 120 ML,64.1,38.46,3.35,4481.0,24 NDC,99999000798,PREDNISOLONE SODIUM PHOSPHATE 15 MG/5 ML (3 MG/ML) ORAL SOLUTION,19.3,11.58,0.5175,4481.0,24 NDC,99999000838,TRETINOIN (CHEMOTHERAPY) 10 MG/1 ML ORAL SUSPENSION,6857.0,4114.2,1590.82,5485.6,19 NDC,99999000856,TERBUTALINE 200 MCG/ML (BOLUS FROM INFUSION),0.2,0.12,0.0464,4481.0,24 NDC,99999000857,CHLORHEXIDINE GLUCONATE 0.02% OPHTHALMIC SOLUTION,626.8,376.08,145.42,4481.0,19 NDC,99999000879,DOPAMINE 1600 MCG/ML IN DEXTROSE 5% 50 ML PEDIATRIC,70.55,42.33,1.8,4481.0,24 NDC,99999000888,GENTAMICIN 1 MG/ML (2 ML) LOCK IN NS,23.75,14.25,4.97,4481.0,24 NDC,99999000891,MAGNESIUM SULFATE 2 GRAM/50 ML (40MG/ML) PEDIATRIC INFUSION,116.0,69.6,1.08,4481.0,24 NDC,99999000892,MAGNESIUM SULFATE 40 MG/ML (PERIPHERAL) PEDIATRIC IV,116.0,69.6,1.08,4481.0,24 NDC,99999000907,MAGNESIUM SULFATE 100 MG/ML (CENTRAL) PEDIATRIC DILUTION,87.55,52.53,1.08,4481.0,24 NDC,99999000953,SODIUM ACETATE 0.45% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),69.25,41.55,0.4725,4481.0,24 NDC,99999000954,SODIUM ACETATE 0.9% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),72.35,43.41,0.4725,4481.0,24 NDC,99999000955,SODIUM CHLORIDE 0.45% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),66.3,39.78,0.4725,4481.0,24 NDC,99999000956,SODIUM CHLORIDE 0.9% WITH HEPARIN 1 UNIT/ML (NEONATAL/ARTERIAL),66.3,39.78,15.38,4481.0,19 NDC,99999000972,DEXTROSE 5 % IN WATER IV FLUSH,16.5,9.9,3.83,4481.0,21 NDC,99999001061,PHYTONADIONE 1 MG/ML ORAL SUSPENSION,104.3,62.58,24.2,4481.0,19 NDC,99999001063,VALACYCLOVIR 50MG/ML ORAL SUSPENSION,113.8,68.28,26.4,4481.0,19 NDC,99999001162,CARDIOPLEGIC PERFUSION (PLEGISOL) 10 MEQ/L (LOW K),340.95,204.57,79.1,4481.0,19 NDC,99999001180,RIFAXIMIN 20 MG/ML ORAL SUSPENSION,113.1,67.86,26.24,4481.0,19 NDC,99999001182,CLINDAMYCIN 0.9 MG/ML ORAL IRRIGATION,79.45,47.67,18.43,4481.0,19 NDC,99999001221,LACOSAMIDE 10 MG/1 ML INTRAVENOUS SOLUTION (PEDS),320.25,192.15,0.45,4481.0,23 NDC,99999001565,APREPITANT 20 MG/ML ORAL SUSPENSION,505.5,303.3,6.14,4481.0,24 NDC,99999001706,NITROGLYCERIN 100 MCG/ML BOLUS INJECTION (10 ML SYRINGE),63.1,37.86,3.35,4481.0,24 NDC,99999001711,BETHANECHOL 5 MG/ML ORAL SUSPENSION,34.0,20.4,7.89,4481.0,19 NDC,99999001712,RIFAMPIN 25 MG/ML ORAL SUSPENSION,88.0,52.8,20.42,4481.0,19 NDC,99999001727,INSULIN REGULAR 0.5 UNIT/ML NEONATAL 4 ML INFUSION,63.9,38.34,0.5175,4481.0,24 NDC,99999001805,METOCLOPRAMIDE 0.1 MG/ML IV SYRINGE NEONATAL,95.7,57.42,2.45,4481.0,24 NDC,99999001807,ONDANSETRON (PF) 4 MG/2 ML PEDIATRIC INJECTION,17.9,10.74,0.2475,4481.0,24 NDC,99999001808,ENALAPRILAT 125 MCG/ML IV SYRINGE NEONATAL,72.15,43.29,16.74,4481.0,19 NDC,99999001937,NICARDIPINE 0.2 MG/ML IN NS 50 ML PEDIATRIC INFUSION,229.3,137.58,0.1575,4481.0,24 NDC,99999003430,ACHS(CASH) OTIC INSUFFLATE CAPSULE,194.65,116.79,45.16,4481.0,19 NDC,99999006802,STUDY IRB# 20-3016 LIRAGLUTIDE/PLACEBO 6 MG/ML (18 MG/3 ML) INJECTION PEN,0.2,0.12,0.0464,4481.0,19 NDC,99999006805,STUDY D3258C00001 BENRALIZUMAB/PLACEBO 30 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,99999006806,STUDY I4V-MC-JAIR BARICITINIB/PLACEBO 2 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999006807,STUDY I4V-MC-JAIR BARICITINIB/PLACEBO 4 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999006810,STUDY D3258C00001 BENRALIZUMAB 30 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,99999006811,STUDY 21177 FINERENONE 10 MG / 20 MG / PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999006819,STUDY RTRX-RE021-201 SPARSENTAN 80 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999006820,STUDY TPN-101-C9-201 TPN-101/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999006821,STUDY TPN-101-C9-201 TPN-101 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999006836,"STUDY IRB#22-1310 ERGOCALCIFEROL/PLACEBO 50,000 IU CAPSULE",0.2,0.12,0.0464,4481.0,17 NDC,99999006837,STUDY 1346-0013 BI 425809/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999006859,STUDY REM-PH-418 TREPROSTINIL 1 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99999006860,STUDY REM-PH-418 TREPROSTINIL 2.5 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999006862,STUDY REM-PH-418 TREPROSTINIL 10 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999006932,STUDY IRB# 22-1421 PSILOCYBIN 25 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999007705,DILTIAZEM 100 MCG/ML IN NS,63.05,37.83,14.63,4481.0,19 NDC,99999007706,FOSCARNET 2.4 MG/0.1 ML INTRAVITREAL SOLUTION,63.55,38.13,15.6,4481.0,35 NDC,99999007711,VORICONAZOLE (VFEND) 0.1% (100 MCG/0.1 ML) INTRAOCULAR,64.25,38.55,1.73,4481.0,24 NDC,99999007712,VANCOMYCIN 1 MG/0.1 ML (1%) INTRAOCULAR SYRINGE,63.1,37.86,0.0675,4481.0,24 NDC,99999007715,AMINOPHYLLINE 300 MG IN 50 ML NS (CATH LAB OSM),377.6,226.56,22.61,4481.0,24 NDC,99999007718,CHLORAL HYDRATE 500 MG/5 ML ORAL SYRUP,436.75,262.05,101.33,4481.0,19 NDC,99999007719,ALTEPLASE 125 MCG/ML INTRAOCULAR INJECTION,18.85,11.31,4.77,4481.0,35 NDC,99999007721,AMPHOTERICIN B 50 MCG/ML INTRAOCULAR INJECTION,16.05,9.63,3.72,4481.0,24 NDC,99999007723,DEXTROSE 10 % AND 0.45 % SODIUM CHLORIDE INTRAVENOUS SOLUTION,90.0,54.0,20.88,4481.0,17 NDC,99999007724,EPINEPHRINE 1 MG IN LR 1000 ML (PLASTICS-TUMESCENT),72.85,43.71,3.06,4481.0,24 NDC,99999007730,VANCOMYCIN 2.5 MG/ML (2 ML) LOCK IN NS,22.3,13.38,0.0675,4481.0,24 NDC,99999007732,VANCOMYCIN 2.5 MG/ML (5 ML) LOCK IN NS,28.7,17.22,0.0675,4481.0,24 NDC,99999007733,VANCOMYCIN-GENTAMICIN 2.5-1 MG/ML (2 ML) LOCK IN NS,24.0,14.4,0.0675,4481.0,24 NDC,99999007734,VANCOMYCIN-GENTAMICIN 2.5-1 MG/ML (5 ML) LOCK IN NS,27.0,16.2,0.0675,4481.0,24 NDC,99999007735,DEXMEDETOMIDINE 800 MCG/200 ML (4 MCG/ML) IN 0.9 % NS,429.25,257.55,99.59,4481.0,19 NDC,99999007736,TOBRAMYCIN 5 MG/3 ML NS INTRATHECAL,79.65,47.79,5.33,4481.0,24 NDC,99999007739,AMPHOTERICIN B CONVENTIONAL 0.5 MG IN D5W 3 ML INTRATHECAL,64.25,38.55,14.91,4481.0,19 NDC,99999007762,STUDY IRB #15-1307 CEFTOLOZANE-TAZOBACTAM 1.5 GRAM INTRAVENOUS SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,99999007763,CEFTAZIDIME DESENSITIZATION 0.001 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 NDC,99999007764,CEFTAZIDIME DESENSITIZATION 0.01 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 NDC,99999007765,CEFTAZIDIME DESENSITIZATION 0.1 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 NDC,99999007766,CEFTAZIDIME DESENSITIZATION 1 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 NDC,99999007767,CEFTAZIDIME DESENSITIZATION 10 MG/ML SOLUTION,16.05,9.63,1.8,4481.0,24 NDC,99999007770,CEFUROXIME 1MG/0.1ML INTRACAMERAL INJECTION,63.05,37.83,4.16,4481.0,24 NDC,99999007771,FORMALDEHYDE (FORMALIN) 4 % IN SWFI 300 ML,186.6,111.96,43.29,4481.0,19 NDC,99999007772,AMPHOTERICIN B 100 MCG/ML INTRAOCULAR INJECTION,16.05,9.63,3.72,4481.0,24 NDC,99999007780,PIPERACILLIN-TAZO 100 MG/ML DESENS SOL'N #2,63.05,37.83,2.41,4481.0,24 NDC,99999007781,PIPERACILLIN-TAZO 10 MG/ML DESENS SOL'N #3,63.05,37.83,2.41,4481.0,24 NDC,99999007782,PIPERACILLIN-TAZO 1 MG/ML DESENS SOL'N #4,63.05,37.83,2.41,4481.0,24 NDC,99999007783,PIPERACILLIN-TAZO 0.1 MG/ML DESENS SOL'N #5,63.05,37.83,2.41,4481.0,24 NDC,99999007785,FENTANYL 50 MCG BUPIVACAINE 0.125% IN SODIUM CHLORIDE 0.9% (15 ML SYRINGE),24.85,14.91,2.48,4481.0,24 NDC,99999007786,TOBRAMYCIN SULFATE (PEDIATRIC) 10 MG/ML (PF),99.65,59.79,5.33,4481.0,24 NDC,99999007795,PHENYLEPHRINE 40 MCG/ML DILUTION,62.8,37.68,0.0225,4481.0,24 NDC,99999007798,CHOLESTYRAMINE 20% IN AQUAPHOR OINTMENT,108.1,64.86,25.08,4481.0,19 NDC,99999007807,STUDY ADARE SP-1011-002 COSYNTROPIN 0.25 MG/ML SYRINGE,0.2,0.12,0.0464,4481.0,21 NDC,99999007808,STUDY RESOLVE RSLV-132-03/PLACEBO 10 MG/ML (COMPONENT),0.2,0.12,0.0464,4481.0,22 NDC,99999007814,STUDY IPRATROPIUM BROMIDE 0.02 % SOLUTION FOR INHALATION,0.2,0.12,0.0464,4481.0,19 NDC,99999007815,STUDY PREDNISONE 20 MG TABLET,0.2,0.12,0.0225,4481.0,24 NDC,99999007864,HISTAMINE 1 MG/ML (2.75 MG/ML) PERCUTANEOUS SOLUTION,127.75,76.65,29.64,4481.0,19 NDC,99999007896,LIDOCAINE-XYLOMETAZOLINE 4%-0.1% NASAL SOLUTION,32.5,19.5,7.54,4481.0,19 NDC,99999007898,BUMETANIDE 0.25 MG/ML PEDIATRIC 2 ML INFUSION,66.5,39.9,0.3589,4481.0,35 NDC,99999007900,PHENYLEPHRINE 20 MG/250 ML (80 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV,121.3,72.78,0.0225,4481.0,24 NDC,99999007961,STUDY 3265 MIDAZOLAM/PLACEBO 2 MG/ML ORAL SOLUTION (ROUND 0.1 ML),0.2,0.12,0.0464,4481.0,19 NDC,99999007968,"STUDY VIOLET VITAMIN D3 EMULSION/PLACEBO 540,000 IU/5 ML ORAL",0.2,0.12,0.0464,4481.0,24 NDC,99999007971,STUDY DEXTROSE 5% IN WATER (D5W) INTRAVENOUS SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,99999007973,STUDY 3265 MIDAZOLAM/PLACEBO 2 MG/ML ORAL SOLUTION (ROUND 0.2 ML),0.2,0.12,0.0464,4481.0,19 NDC,99999007974,STUDY ACCRU-SC-1601 APIXABAN 2.5 MG OR 5 MG TABLET,0.2,0.12,0.0464,4481.0,23 NDC,99999007975,STUDY ACCRU-SC-1601 APIXABAN 5 MG TABLET,0.2,0.12,0.0464,4481.0,23 NDC,99999007976,STUDY SAATELLITE MEDI4893 50 MG/ML OR PLACEBO VIAL,0.2,0.12,0.0464,4481.0,19 NDC,99999007977,STUDY EVADE MEDI3902 200 MG (50 MG/ML) OR PLACEBO VIAL,0.2,0.12,0.0464,4481.0,19 NDC,99999007978,STUDY CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99999007979,STUDY CISATRACURIUM CONCENTRATE 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99999007983,STUDY CEUS VKD PERFLUTREN (DEFINITY) VIAL,0.2,0.12,0.0464,4481.0,23 NDC,99999007987,STUDY UX143-CL314 DEXTROSE 5% FLUSH SYRINGE,0.2,0.12,0.0464,4481.0,19 NDC,99999008061,STUDY CEUS VKD PERFLUTREN (DEFINITY) SYRINGE,0.2,0.12,0.0464,4481.0,23 NDC,99999008064,STUDY COSYNTROPIN 0.25 MG SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,24 NDC,99999008071,STUDY RAP-MD-20 RAPASTINEL 450 MG OR PLACEBO INJECTION SYRINGE,0.2,0.12,0.0464,4481.0,22 NDC,99999008076,STUDY MISLE MESENCHYMAL STEM CELLS/PLACEBO IV INFUSION,0.2,0.12,0.0464,4481.0,22 NDC,99999008079,PROPRANOLOL 0.05 MG/ML PEDIATRIC DILUTION,98.15,58.89,22.36,4481.0,24 NDC,99999008250,VITAMIN-BIOTIN 5 MG/ML ORAL SUSPENSION,1.35,0.81,0.3132,4481.0,19 NDC,99999008251,CLONIDINE 20 MCG/ML ORAL SOLN,17.65,10.59,4.09,4481.0,19 NDC,99999008254,FLECAINIDE 20 MG/ML ORAL SUSPENSION,17.65,10.59,4.09,4481.0,19 NDC,99999008257,HYDROCORTISONE 2 MG/ML ORAL SUSPENSION,16.35,9.81,3.79,4481.0,19 NDC,99999008262,SQUARIC ACID 2 % IN ACETONE,78.7,47.22,18.26,4481.0,19 NDC,99999008641,STUDY PROCLAIM MISOPROSTOL/PLACEBO 100 MCG CAPSULE,0.2,0.12,0.0225,4481.0,24 NDC,99999009014,STUDY ITN080AI (REBOOT) BELIMUMAB 200 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,8308.44,35 NDC,99999009015,STUDY TBCRC-047 AVELUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,15899.52,35 NDC,99999009016,STUDY TBCRC-047 BINIMETINIB 15 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,99999009028,STUDY CACZ885D2310 CANAKINUMAB (ACZ885)/PLACEBO 150 MG/ML IV SOLUTION,0.2,0.12,0.0506,20638.8,35 NDC,99999009029,STUDY CJWT629A12301 AZITHROMYCIN/PLACEBO 250 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999009031,STUDY CJWT629A12301 HYDROXYCHLOROQUINE/PLACEBO 200 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999009034,STUDY A031803-CIRB PEMBROLIZUMAB (MK-3475) 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,99999009039,STUDY THE NEXIS TRIAL PARENTERAL AMINO ACID 7.5% IV INFUSION,0.2,0.12,0.0464,4481.0,17 NDC,99999009046,STUDY VX17-445-105 VX-445 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009047,STUDY VX17-445-105 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009048,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3127),0.2,0.12,0.0464,4481.0,17 NDC,99999009152,STUDY D798KC00001 PEMETREXED 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,99999009167,STUDY DNLI-E-0002 DNL310 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009169,STUDY GCT1046-01 GEN1046 20 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009171,STUDY CAEL101-302 CAEL-101/PLACEBO 30 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009178,STUDY AMT-101-201 (PHASE 2) AMT-101 3 MG/10 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009179,STUDY AMT-101-201 (PHASE 3) AMT-101/PLACEBO 3 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009180,STUDY AMT-101-201 (PHASE 3) AMT-101/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009185,STUDY I6T-MC-AMAX MIRIKIZUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 NDC,99999009186,STUDY I6T-MC-AMAX MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 NDC,99999009187,STUDY I6T-MC-AMAX MIRIKIZUMAB 20 MG/ML IV SOLUTION,0.2,0.12,0.0506,7785.12,35 NDC,99999009188,STUDY ASPIRE APIXABAN/PLACEBO 5 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009189,STUDY ASPIRE APIXABAN/PLACEBO 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009190,STUDY ASPIRE ASPIRIN/PLACEBO 81 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009191,STUDY RRP-001 INO-3107 6.25 MG/ML INTRAMUSCURAL INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009198,STUDY VERSATILE002 PEMBROLIZUMAB 25 MG/ML IV SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,99999009199,STUDY VERSATILE002 PDS0101 (R-DOTAP/HPVMIX) 0.5 ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009205,STUDY CNTO1959CRD3001 GUSELKUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,99999009222,STUDY IRB# 20-1112 GABAPENTIN 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999009223,STUDY 217-PPD-301 SAGE-217/PLACEBO 40 MG KIT,0.2,0.12,0.0464,4481.0,17 NDC,99999009228,STUDY ACTIV-2/A5401 AEROGEN ULTRA NEBULIZER DEVICE,0.2,0.12,0.0464,4481.0,17 NDC,99999009233,STUDY MT-12 DESLORATADINE 0.5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009234,STUDY MT-12 LORATADINE 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999009235,STUDY MT-12 MOMETASONE FUROATE 50 MCG/ACTUATION NASAL SPRAY,0.2,0.12,0.0464,4481.0,17 NDC,99999009236,STUDY MT-12 OLOPATADINE 0.1% OPHTHALMIC SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009237,STUDY ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER,0.2,0.12,0.0464,4481.0,19 NDC,99999009238,STUDY PEDIATRIC AEROSOL CHAMBER DEVICE,0.2,0.12,0.0464,4481.0,17 NDC,99999009242,STUDY I8F-MC-GPHK(A) TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009247,STUDY IOBP PIVOTAL INUSLIN LISPRO (HUMALOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009248,STUDY IOBP PIVOTAL INUSLIN ASPART (NOVOLOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009249,"STUDY IOBP PIVOTAL INUSLIN ASPART (FIASP) ""FASTER ASPART"" 100 UNITS/ML INJECTION CARTRIDGE",0.2,0.12,0.0464,4481.0,17 NDC,99999009250,STUDY VX19-445-107 VX-445 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009251,STUDY VX19-445-107 VX-445 50 MG-TEZ 25 MG-IVA 37.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009252,STUDY VX19-445-107 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009253,STUDY VX19-445-107 IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009254,STUDY 20203331 APIXABAN/PLACEBO 2.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009256,STUDY 021FSGS16010 DUPLEX SPARSENTAN 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009259,STUDY ABT-CIP-10305 ASPIRIN/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009262,STUDY AK002-016X AK002 15 MG/ML IV SOLN,0.2,0.12,0.0464,4481.0,19 NDC,99999009263,STUDY COVID-19-004 MODERNA/PFIZER BIONTECH/PLACEBO COVID-19 VACCINE,0.2,0.12,0.0464,4481.0,22 NDC,99999009265,STUDY BP41674 RO7248824 50 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 NDC,99999009266,STUDY BP41674 RO7248824 (IDDP) 35 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 NDC,99999009267,STUDY BP41674 RO7248824 20 ML DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009268,STUDY R668-EE-1877 DUPILUMAB PRE-FILLED SYRINGE 100 MG / 200 MG / 300 MG / PLACEBO,0.2,0.12,0.0464,4481.0,17 NDC,99999009269,STUDY I8F-MC-GPHM TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009270,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009271,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 2.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009272,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009273,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 7.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009274,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 10 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009275,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 12.5 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009276,STUDY I8F-MC-GPHN TIRZEPATIDE (LY3298176) 15 MG/0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009277,STUDY BRE18-360 OLAPARIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009278,STUDY BRE18-360 OLAPARIB 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009279,STUDY BRE18-360 DURVALUMAB 50 MG/ML IV SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,99999009280,STUDY HPTN 083 CABOTEGRAVIR (GSK1265744) 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009281,STUDY M20-259 RISANKIZUMAB 90 MG/ML IV SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,99999009284,STUDY AL001-3 AL001/PLACEBO 50 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009289,STUDY CNTO1959UCO3001 GUSELKUMAB/PLACEBO 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999009290,STUDY A5391 DORAVIRINE 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009291,STUDY J2L-MC-EZBB LY3461767/PLACEBO 8.7 MG/ML INJECTION SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 NDC,99999009293,STUDY NHLBI-2019-SIL SILDENAFIL/PLACEBO 10 MG/12.5 ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009294,STUDY NHLBI-2019-SIL SILDENAFIL/PLACEBO 10 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,22 NDC,99999009302,STUDY THE NEXIS TRIAL PARENTERAL AMINO ACID 15% IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009307,STUDY A5404 MRNA-1273 100 MCG/0.5 ML INJECTION SOLUTION COVID 19 VACCINE,0.2,0.12,0.0464,4481.0,19 NDC,99999009309,STUDY M20-259 RISANKIZUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,31 NDC,99999009310,STUDY M20-259 USTEKINUMAB 90 MG/ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,99999009311,STUDY M20-259 USTEKINUMAB 130 MG/26 ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,99999009313,STUDY ACTIV-2B/A5405 RITONAVIR/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999009314,STUDY 024-00 ISL/PLACEBO 60 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009315,STUDY 024-00 FTC-TDF/PLACEBO 200-300 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009316,STUDY 024-00 FTC-TAF/PLACEBO 200-25 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009318,STUDY A5386 N-803 2 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009321,STUDY A5386 VRC07-523LS 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009324,STUDY A5355 CMV-MVA TRIPLEX/PLACEBO 5.2 X 10E8 PFU/ML INJECTION SOLUTION CYTOMEGALOVIRUS VACCINE,0.2,0.12,0.0464,4481.0,17 NDC,99999009325,STUDY A5355 CMV-MVA TRIPLEX/PLACEBO 8 X 10E8 PFU/ML INJECTION SOLUTION CYTOMEGALOVIRUS VACCINE,0.2,0.12,0.0464,4481.0,17 NDC,99999009328,STUDY SHP620 MARIBAVIR 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009333,STUDY IOBP2X INSULIN ASPART (NOVOLOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009334,STUDY IOBP2X INSULIN LISPRO (HUMALOG) 100 UNITS/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009339,STUDY IRB# 20-0052 DORAVIRINE 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009340,STUDY SOBI003-EA SOBI003 20 MG/ML INTRAVENOUS SOLN,0.2,0.12,0.0464,4481.0,19 NDC,99999009341,STUDY CC-93538-EE-001 CC-93538/PLACEBO 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999009342,STUDY ARGX-113-2001 EFGARTIGIMOD 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5299.35,35 NDC,99999009343,STUDY ARGX-113-2001 EFGARTIGIMOD PH20 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 NDC,99999009344,STUDY CBYL719F12201 ALPELISIB (BYL719)/PLACEBO 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009345,STUDY CBYL719F12201 ALPELISIB (BYL719)/PLACEBO 125 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009346,STUDY CBYL719F12201 ALPELISIB (BYL719) 50 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009347,STUDY CBYL719F12201 ALPELISIB (BYL719) 125 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009348,STUDY CBYL719F12201 ALPELISIB (BYL719) 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009350,STUDY CNTO1959CRD3001 GUSELKUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0225,4481.0,24 NDC,99999009351,STUDY ACTIV-2/A5401 INTERFERON-B1A (SNG001) 12 MIU/ML NEBULIZED INHALATION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009352,"STUDY ACTIV-2/A5401 SAB-185 38,753 UNITS/ML IV SOLN",0.2,0.12,0.0464,4481.0,17 NDC,99999009353,STUDY ACTIV-2/A5401 C135-LS 100 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 NDC,99999009354,STUDY ACTIV-2/A5401 C144-LS 100 MG/ML INJ SOLN,0.2,0.12,0.0464,4481.0,17 NDC,99999009355,STUDY ACTIV-2/A5401 CASIRIVIMAB 120 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009356,STUDY ACTIV-2/A5401 IMDEVIMAB 120 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009357,STUDY ACTIV-2/A5401 CASIRIVIMAB 60 MG-IMDEVIMAB 60 MG/ML INTRAVENOUS SOLUTION (CO-FORMULATED),0.2,0.12,0.0464,4481.0,17 NDC,99999009364,STUDY CLN-PXT3003-06 PXT3003/PLACEBO ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009365,STUDY D1690C00078 DAPAGLIFLOZIN/PLACEBO 10 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009366,STUDY HS0005 BIMEKIZUMAB 160 MG/ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999009376,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,7785.12,35 NDC,99999009377,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 100 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 NDC,99999009378,STUDY I6T-MC-AMAM-AA MIRIKIZUMAB 200 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0506,7785.12,35 NDC,99999009380,STUDY ACTIV-4D TRV027/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009381,STUDY ACTIV-4D TXA127/PLACEBO 30 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009383,STUDY ACTIV-4D FOSTAMATINIB/PLACEBO 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009384,STUDY 1042-EAP-3005 GANAXOLONE 50 MG/ML ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999009385,STUDY ACTIV-4D FOSTAMATINIB/PLACEBO 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009387,STUDY IND CASIRIVIMAB-IMDEVIMAB 60 MG-60 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009393,STUDY GS-US-528-9023 LENACAPAVIR/PLACEBO 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999009394,STUDY GS-US-528-9023 LENACAPAVIR/PLACEBO 309 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009395,STUDY GS-US-528-9023 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG/PLACEBO TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999009396,STUDY GS-US-528-9023 LENACAPAVIR 300 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999009397,STUDY GS-US-528-9023 LENACAPAVIR 309 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,99999009398,STUDY GS-US-528-9023 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMURATE 300 MG TABLET,0.2,0.12,0.0506,4481.0,35 NDC,99999009399,STUDY IRB# 21-2224 BREXANOLONE 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,21 NDC,99999009482,STUDY AK002-014 AK002/PLACEBO 15 MG/ML IV SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,99999009483,STUDY AK002-014 AK002 15 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99999009580,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 3 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009581,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 7 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009582,STUDY EX9924-4473 (SOUL) SEMAGLUTIDE/PLACEBO 14 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009583,STUDY A5332 PITAVASTATIN/PLACEBO 4 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009592,STUDY IRB 20-2267 TRANEXAMIC ACID/PLACEBO 100 MG/ML IV SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009594,NAFCILLIN DESENSITIZATION DILUTION 0.01 MG/ML,101.3,60.78,0.1125,4481.0,24 NDC,99999009595,NAFCILLIN DESENSITIZATION DILUTION 0.1 MG/ML,101.3,60.78,0.1125,4481.0,24 NDC,99999009596,NAFCILLIN DESENSITIZATION DILUTION 1 MG/ML,101.3,60.78,0.1125,4481.0,24 NDC,99999009597,NAFCILLIN DESENSITIZATION DILUTION 10 MG/ML,101.3,60.78,0.1125,4481.0,24 NDC,99999009604,STUDY ZUL-PPP-01 BREXANOLONE 5 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,21 NDC,99999009617,STUDY HM-TRIA-201 HM15211 2 MG / 4 MG / 6 MG / PLACEBO PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999009619,ACETYLCYSTEINE 10% (100 MG/ML) OPHTHALMIC SOLUTION,259.65,155.79,60.24,4481.0,19 NDC,99999009620,PROMETHAZINE 12.5 MG IN NS 50 ML IVPB PREMADE,100.0,60.0,6.64,4481.0,24 NDC,99999009710,STUDY I8F-MC-GPHL TIRZEPATIDE (LY3298176)/PLACEBO 0.5 ML INJECTION PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999009718,STUDY MS200527_0082 EVOBRUTINIB/PLACEBO 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009719,STUDY MS200527_0082 EVOBRUTINIB 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009720,STUDY MS200527_0082 TERIFLUNOMIDE/PLACEBO 14 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009846,STUDY IRB# 17-1500 PYRIDOXINE/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999009960,STUDY IND EXEBACASE (CF-301) 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009961,STUDY A35-004 AMX0035/PLACEBO 4 G SACHET (TAURURSODIOL 1 G-PB 3 G),0.2,0.12,0.0464,4481.0,17 NDC,99999009963,STUDY ARGX-113-1802 EFGARTIGIMOD PH20/PLACEBO 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 NDC,99999009964,STUDY ARGX-113-1802 EFGARTIGIMOD PH20 180 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,5299.35,35 NDC,99999009966,STUDY V712-305 VIASKIN (DBV712) 250 MCG EPICUTANEOUS PATCH,0.2,0.12,0.0464,4481.0,17 NDC,99999009967,STUDY V712-305 ORAL FOOD CHALLENGE KIT,0.2,0.12,0.0464,4481.0,17 NDC,99999009968,STUDY A5386 10-1074-LS (GS-2872) 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009969,STUDY HYDROCORTISONE 2.5% TOPICAL CREAM,0.2,0.12,0.0464,4481.0,19 NDC,99999009970,STUDY GT-031 BELAPECTIN 2 MG/KG LBM / 4 MG/KG LBM / PLACEBO IVPB,0.2,0.12,0.0464,4481.0,22 NDC,99999009971,STUDY GT-031 BELAPECTIN/PLACEBO 27 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999009972,STUDY ZYN2-CL-033 ZYN002/PLACEBO 4.2% TRANSDERMAL GEL,0.2,0.12,0.0464,4481.0,17 NDC,99999009984,STUDY VX20-445-112 ELX 100 MG-TEZ 50 MG-IVA 75 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 NDC,99999009985,STUDY VX20-445-112 IVA 75 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 NDC,99999009986,STUDY VX20-445-112 ELX 80 MG-TEZ 40 MG-IVA 60 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 NDC,99999009987,STUDY VX20-445-112 IVA 59.5 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 NDC,99999009988,STUDY VX20-445-112 ELX 100 MG-TEZ 50 MG-IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009989,STUDY VX20-445-112 IVA 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009990,STUDY DMID 21-0018 MENINGOCOCCAL B VACCINE / INFLUENZA VACCINE / TETANUS DIPTHERIA VACCINE 0.5 ML,0.2,0.12,0.0464,4481.0,17 NDC,99999009991,STUDY RVT-1201-2002 RODATRISTAT ETHYL/PLACEBO 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009992,STUDY RVT-1201-2002 RODATRISTAT ETHYL 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009993,STUDY DMID 21-0018 CEFTRIAXONE 250 MG IM INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,21 NDC,99999009994,STUDY DMID 21-0018 CEFIXIME 400 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999009995,STUDY DMID 21-0018 CIPROFLOXACIN 500 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999009996,STUDY VX20-445-112 ELX 50 MG-TEZ 25 MG-IVA 37.5 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999009997,STUDY VX20-445-112 IVA 75 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010005,STUDY A5357 CABOTEGRAVIR 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010007,STUDY A5357 CABOTEGRAVIR LA 200 MG/ML IM SUSPENSION,0.2,0.12,0.0506,4481.0,35 NDC,99999010009,STUDY A5357 VRC07-523LS 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010012,STUDY ION582-CS1 ION582 20 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010013,STUDY ION582-CS1 ION582 DILUENT SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010014,STUDY REGEN-004 RENAL AUTOLOGOUS CELL THERAPY 100X10E6 CELLS/ML PERCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010018,STUDY 022-00 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,0.2,0.12,0.0506,4481.0,35 NDC,99999010019,STUDY 024-00 EMTRICITABINE 200 MG-TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET,0.2,0.12,0.0506,4481.0,35 NDC,99999010020,STUDY 024-00 EMTRICITABINE 200 MG-TENOFOVIR ALAFENAMIDE 25 MG TABLET,0.2,0.12,0.0506,4481.0,35 NDC,99999010023,STUDY RM-493-034 SETMELANOTIDE 10 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010024,STUDY RM-493-034 SETMELANOTIDE/PLACEBO 10 MG/ML SUBCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010025,STUDY 22-SRC-03-GIRDLER ESTRADIOL/PLACEBO 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH,0.2,0.12,0.0464,4481.0,19 NDC,99999010026,STUDY 22-SRC-03-GIRDLER PROGESTERONE MICRONIZED 200 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999010029,STUDY C4671026 NIRMATRELVIR 150 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010031,STUDY C4671026 RITONAVIR 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010032,STUDY ZX008-2103 FENFLURAMINE HCL (ZX008) 1.25 MG/ML OR 2.5 MG/ML OR 5 MG/ML OR PLACEBO ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010035,STUDY ZX008-2103 FENFLURAMINE HCL (ZX008) 5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010038,STUDY NICHD-NRN-0064 (BIB) BUDESONIDE/PLACEBO 0.5 MG/2 ML SUSPENSION (NEONATAL),0.2,0.12,0.0464,4481.0,19 NDC,99999010039,STUDY MK-5475-007 DRY POWDER INHALER TRAINING DEVICE,0.2,0.12,0.0464,4481.0,17 NDC,99999010040,STUDY MK-5475-007 MK-5475 32 MCG/INH OR 100 MCG/INH OR 380 MCG/INH OR PLACEBO DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,17 NDC,99999010041,STUDY CC-93538-EE-002 CC-93538 180 MG/1.2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999010042,STUDY IRB# 21-3111 MINOCYCLINE/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999010043,STUDY IND GANAXOLONE 1 MG/ML INTRAVENOUS SOLUTION (PEDIATRIC),0.2,0.12,0.0464,4481.0,17 NDC,99999010044,STUDY IND GANAXOLONE 1 MG/ML BOLUS FROM BAG (PEDIATRIC),0.2,0.12,0.0464,4481.0,17 NDC,99999010049,STUDY ACV01 MRNA (12YR UP) (PFIZER) (PF) 30 MCG/0.3 ML IM SUSPENSION (GRAY),0.2,0.12,0.0464,4481.0,17 NDC,99999010050,STUDY ACV01 MRNA (12YR UP) (PFIZER) (PF) 30 MCG/0.3 ML IM SUSPENSION (PURPLE),0.2,0.12,0.0464,4481.0,17 NDC,99999010051,STUDY ACV01 MRNA (5-11YR) (PFIZER) (PF) 10 MCG/0.2 ML IM SUSPENSION (ORANGE),0.2,0.12,0.0464,4481.0,17 NDC,99999010053,STUDY NAB-BC-3781-1202 LEFAMULIN 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010056,STUDY DNLI-E-0007 DNL310 OR IDURSULFASE IVPB,0.2,0.12,0.0464,4481.0,17 NDC,99999010057,STUDY DNLI-E-0007 DNL310 OR IDURSULFASE IVPB,0.2,0.12,0.0464,4481.0,17 NDC,99999010058,STUDY DNLI-E-0007 DNL310 30 MG/ML INTRAVENOUS SOLUTION (RECONSTITUTED),0.2,0.12,0.0464,4481.0,17 NDC,99999010059,STUDY DNLI-E-0007 IDURSULFASE 2 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,81999.54,35 NDC,99999010061,STUDY REGEN-006 RENAL AUTOLOGOUS CELL THERAPY 100X10E6 CELLS/ML PERCUTANEOUS INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010063,STUDY VX21-147-301 VX-147/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010089,STUDY A5359 RILPIVIRINE LA 300 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999010090,STUDY A5359 RILPIVIRINE LA 300 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999010091,STUDY A5359 CABOTEGRAVIR LA 200 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999010092,STUDY A5359 CABOTEGRAVIR LA 200 MG/ML IM SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999010099,STUDY IRB# 22-1987 IND JZP150 0.3 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999010102,STUDY LAIV IN COPD FLU VACC QV LIVE 2022-2023 10E6.5-7.5 FF UNIT/0.2 ML NASAL SPRAY,0.2,0.12,0.0464,4481.0,17 NDC,99999010301,STUDY IM011127 BMS-986165/PLACEBO 12 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010302,STUDY IM011127 BMS-986165 6 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010307,STUDY CNTO1275JPA3001 USTEKINUMAB 45 MG/0.5 ML INJECTION SOLUTION,0.2,0.12,0.05544,4481.0,31 NDC,99999010308,STUDY CNTO1275JPA3001 USTEKINUMAB 90 MG/ML PRE-FILLED SYRINGE,0.2,0.12,0.05544,4481.0,31 NDC,99999010310,STUDY ANBL1531 LORLATINIB 25 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,99999010311,STUDY ANBL1531 LORLATINIB 5 MG TABLET,0.2,0.12,0.0464,4481.0,20 NDC,99999010319,STUDY VAL-10-001 VAL-413 IRINOTECAN HCL 5 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010320,STUDY VAL-10-001 IRN-IVPO IRINOTECAN HCL 20 MG/ML INJ FOR ORAL USE,0.2,0.12,0.0464,4481.0,24 NDC,99999010321,STUDY SELCLAX VENETOCLAX 10 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999010322,STUDY SELCLAX VENETOCLAX 50 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999010324,STUDY SELCLAX VENETOCLAX 25 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999010325,STUDY SELCLAX VENETOCLAX 100 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999010326,STUDY SELCLAX SELINEXOR 20 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999010334,STUDY IND DABRAFENIB 10 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,22 NDC,99999010335,STUDY LOXO-FG3-22001 PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,9215.43,35 NDC,99999010336,STUDY LOXO-FG3-22001 LOXO-435 6 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010337,STUDY LOXO-FG3-22001 LOXO-435 20 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010338,STUDY IND TRAMETINIB 0.05 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,99999010339,STUDY LOXO-FG3-22001 LOXO-435 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010347,STUDY ACNS2031 SODIUM THIOSULFATE (STS) ANHYDROUS 80 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999010351,STUDY ACCL2031 MEMANTINE / PLACEBO 2 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,22 NDC,99999010353,STUDY A22-301 ROPEGINTERFERON ALFA-2B-NJFT 500 MCG/ML SUBCUTANEOUS SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99999010362,STUDY AHOD2131 BRENTUXIMAB VEDOTIN 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,37621.71,35 NDC,99999010363,STUDY AHOD2131 NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 NDC,99999010370,STUDY NCI-10553-CIRB DAROLUTAMIDE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999010372,STUDY SELCLAX VENETOCLAX 10 MG POWDER FOR ORAL SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999010373,STUDY NRG-GU010-CIRB DAROLUTAMIDE 300 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999010374,STUDY NRG-GY028-CIRB IPATASERTIB 100 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010375,STUDY NRG-GY028-CIRB IPATASERTIB 200 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010378,STUDY ACCL1931 LEVOCARNITINE 330 MG TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999010379,STUDY ACCL1931 LEVOCARNITINE 100 MG/ML ORAL SOLUTION,0.2,0.12,0.0464,4481.0,19 NDC,99999010380,STUDY ACCL1931 LEVOCARNITINE 200 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,99999010381,STUDY GS-US-595-6184 SACITUZUMAB GOVITECAN-HZIY 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5859.42,35 NDC,99999010388,STUDY A092105-CIRB NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,5024.46,35 NDC,99999010389,STUDY A092105-CIRB IPILIMUMAB 5 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0506,27236.16,35 NDC,99999010390,STUDY A092105-CIRB CABOZANTINIB 20 MG TABLET,0.2,0.12,0.0464,4481.0,22 NDC,99999010391,STUDY NRG-BN011-CIRB LOMUSTINE 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999010392,STUDY NRG-BN011-CIRB LOMUSTINE 40 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999010393,STUDY NRG-BN011-CIRB LOMUSTINE 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999010397,STUDY 77242113UCO2001 JNJ-77242113 100 MG / 200 MG / PLACEBO TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999010398,STUDY IMVT-1401-3201 BATOCLIMAB/PLACEBO 340 MG/2 ML PRE-FILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999010399,STUDY GB002-3101 SERALUTINIB/PLACEBO 15 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999010516,METOPROLOL TARTRATE 6.25 MG SPLIT QUARTER TABLET,16.05,9.63,3.72,4481.0,19 NDC,99999011022,MEROPENEM DESENSITIZATION DILUTION 0.0001 MG/ML,63.2,37.92,0.945,4481.0,24 NDC,99999011023,MEROPENEM DESENSITIZATION DILUTION 0.001 MG/ML,63.2,37.92,0.945,4481.0,24 NDC,99999011024,MEROPENEM DESENSITIZATION DILUTION 0.01 MG/ML,63.2,37.92,0.945,4481.0,24 NDC,99999011025,MEROPENEM DESENSITIZATION DILUTION 0.1 MG/ML,63.25,37.95,0.945,4481.0,24 NDC,99999011026,MEROPENEM DESENSITIZATION DILUTION 1 MG/ML,63.85,38.31,0.945,4481.0,24 NDC,99999011027,MEROPENEM DESENSITIZATION DILUTION 10 MG/ML,69.75,41.85,0.945,4481.0,24 NDC,99999011043,FOSAPREPITANT 150 MG IN 0.9 % SODIUM CHLORIDE 100 ML IVPB PREMADE,145.75,87.45,0.225,4481.0,24 NDC,99999011053,VANCOMYCIN 750 MG/250 ML NS IVPB PREMADE (282.5 ML TOTAL VOLUME),188.65,113.19,0.0675,4481.0,24 NDC,99999011054,VANCOMYCIN 1250 MG/250 ML NS IVPB PREMADE (287.5 ML TOTAL VOLUME),229.45,137.67,0.0675,4481.0,24 NDC,99999011055,VANCOMYCIN 1500 MG/500 ML NS IVPB PREMADE (555 ML TOTAL VOLUME),246.3,147.78,0.0675,4481.0,24 NDC,99999011056,VANCOMYCIN 1750 MG/500 ML NS IVPB PREMADE (557.5 ML TOTAL VOLUME),199.75,119.85,0.0675,4481.0,24 NDC,99999011057,VANCOMYCIN 2000 MG/500 ML NS IVPB PREMADE (560 ML TOTAL VOLUME),216.85,130.11,0.0675,4481.0,24 NDC,99999011062,VANCOMYCIN 1000 MG/250 ML NS IVPB PREMADE (285 ML TOTAL VOLUME),145.05,87.03,0.0675,4481.0,24 NDC,99999011178,STUDY J1I-MC-GZQA RETATRUTIDE/PLACEBO 2 MG / 4 MG / 6 MG / 9 MG / 12 MG SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999011183,STUDY ALXN2220-ATTRCM-301 ALXN2220/PLACEBO 50 MG/ML IVPB,0.2,0.12,0.0464,4481.0,17 NDC,99999011185,STUDY GB002-3101 DRY POWDER INHALER DEVICE,0.2,0.12,0.0464,4481.0,17 NDC,99999011186,STUDY UMI21-05-01 OBETICHOLIC ACID/PLACEBO 25 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999011189,STUDY FBF-001-001 FBF-001 20 MG/ML STERILE SOLUTION FOR INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011190,"STUDY FBF-001-001 ELLIOTTS B SOLUTION, BUFFERED INTRATHECAL ELECTROLYTE/DEXTROSE SOLUTION FOR INJECTION",0.2,0.12,0.0464,4481.0,17 NDC,99999011191,STUDY SP-624-202 SP-624/PLACEBO 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011192,STUDY GBT440-041 VOXELOTOR 100 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999011193,STUDY GBT440-041 VOXELOTOR 300 MG DISPERSIBLE TABLET,0.2,0.12,0.0464,4481.0,19 NDC,99999011195,STUDY TTP399-302 TTP399/PLACEBO 400 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999011199,STUDY B7981041 RITLECITINIB/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999011472,STUDY B7981041 RITLECITINIB/PLACEBO 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,19 NDC,99999011474,STUDY EX6018-4979 ZILTIVEKIMAB C/PLACEBO 15 MG/0.5 ML SUBCUTANEOUS PEN,0.2,0.12,0.0464,4481.0,17 NDC,99999011475,STUDY BLADE-VG2 CALCIUM SULFATE CARRIER POWDER,0.2,0.12,0.0464,4481.0,17 NDC,99999011476,STUDY BLADE-VG2 VANCOMYCIN HYDROCHLORIDE 500 MG POWDER,0.2,0.12,0.0464,4481.0,24 NDC,99999011477,STUDY BLADE-VG2 GENTAMICIN SULFATE 80 MG/2 ML SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,99999011478,STUDY CKJX839A1US10 INCLISIRAN 284 MG/1.5 ML SUBCUTANEOUS PRE-FILLED SYRINGE,0.2,0.12,0.0506,4481.0,35 NDC,99999011480,STUDY LT3001-203 LT3001/PLACEBO 4 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011481,STUDY BLADE-VG2 HEMISPHERICAL BEADS 3 MM USING MOLD MAT,0.2,0.12,0.0464,4481.0,17 NDC,99999011482,STUDY RT234-PAH-CL202 VARDENAFIL HYDROCHLORIDE 0.5 MG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011483,STUDY RT234-PAH-CL202 AXIAL OSCILLATING SPHERE DRY POWDER INHALER,0.2,0.12,0.0464,4481.0,17 NDC,99999011484,STUDY AHAEMI EMICIZUMAB 150 MG/ML SUBCUTANEOUS INJECTION SOLUTION,0.2,0.12,0.0506,4481.0,35 NDC,99999011485,STUDY DV0013 ZILUCOPLAN 40 MG/ML (16.6 MG/0.416 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 NDC,99999011486,STUDY DV0013 ZILUCOPLAN 40 MG/ML (23.0 MG/0.574 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 NDC,99999011487,STUDY DV0013 ZILUCOPLAN 40 MG/ML (32.4 MG/0.810 ML) SUBCUTANEOUS INJECTION WITH AUTO-INJECTOR PEN,0.2,0.12,0.0464,4481.0,19 NDC,99999011488,STUDY LTI-401 TREPROSTINIL 26.5 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011489,STUDY LTI-401 TREPROSTINIL 53 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011609,STUDY LTI-401 TREPROSTINIL 79.5 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011610,STUDY LTI-401 TREPROSTINIL 106 MCG INHALATION CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011612,STUDY 230LE305 BIIB059 (LITIFILIMAB) 225 MG PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999011613,STUDY GTX-102-CL301 GTX-102 2 MG/ML INTRATHECAL SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011614,"STUDY GTX-102-CL301 GTX/UX DILUENT AND FLUSH SOLUTION, BUFFERED (INTRATHECAL USE)",0.2,0.12,0.0464,4481.0,17 NDC,99999011615,STUDY BHV7000-303 BVH-7000 50 MG / 25 MG / PLACEBO EXTENDED RELEASE TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999011617,"STUDY MK7240-008-00 TULISOKIBART/PLACEBO 200 MG/ML, 1.2 ML AUTOINJECTOR",0.2,0.12,0.0464,4481.0,17 NDC,99999011618,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 100 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011619,STUDY MK7240-008-00 TULISOKIBART 100 MG/ML INTRAVENOUS SOLUTION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011621,STUDY RPL554-NCFB-220 ENSIFENTRINE/PLACEBO 3 MG INHALATION SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999011622,STUDY NEU-411-PD201 NEU-411/PLACEBO 15 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999011623,STUDY IRB# 24-2276 KETOROLAC/PLACEBO 10 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011624,STUDY MKC-CI-002 MKND-101 (CLOFAZIMINE) 80 MG / 50 MG / PLACEBO INHALATION SUSPENSION,0.2,0.12,0.0464,4481.0,17 NDC,99999011625,STUDY MKC-CI-002 MNKD-101 (CLOFAZIMINE) 80 MG INHALATION SUSPENSION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011626,STUDY MKC-CI-002 MNKD-101 (CLOFAZIMINE) 50 MG INHALATION SUSPENSION (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011627,STUDY ION582-CS2 ION582 40 MG / 80 MG / PLACEBO INTRATHECAL SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999011630,STUDY NEU-411-PD201 NEU-411/PLACEBO 30 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999011631,STUDY ARRC AZITHROMYCIN/PLACEBO 500 MG INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,21 NDC,99999011632,STUDY ION582-CS2 ION582 40 MG INTRATHECAL SYRINGE (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011633,STUDY ION582-CS2 ION582 80 MG INTRATHECAL SYRINGE (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011634,STUDY NN9838-8484 CAGRILINTIDE 1 MG/ML + SEMAGLUTIDE 0.5 MG/ML (CAGRISEMA)/PLACEBO (DOSE 0.25 MG/0.25 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 NDC,99999011635,STUDY NN9838-8484 CAGRILINTIDE 2 MG/ML + SEMAGLUTIDE 1 MG/ML (CAGRISEMA)/PLACEBO (DOSE 0.5 MG/0.5 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 NDC,99999011636,STUDY NN9838-8484 CAGRILINTIDE 4 MG/ML + SEMAGLUTIDE 2 MG/ML (CAGRISEMA)/PLACEBO (DOSE 1 MG/1 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 NDC,99999011637,STUDY NN9838-8484 CAGRILINTIDE 6.8 MG/ML + SEMAGLUTIDE 3.4 MG/ML (CAGRISEMA)/PLACEBO (DOSE 1.7 MG/1.7 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 NDC,99999011638,STUDY NN9838-8484 CAGRILINTIDE 9.6 MG/ML + SEMAGLUTIDE 4.8 MG/ML (CAGRISEMA)/PLACEBO (DOSE 2.4 MG/2.4 MG) PEN INJECTOR,0.2,0.12,0.0464,4481.0,17 NDC,99999011639,STUDY NN9838-8484 CAGRILINTIDE 1 MG/ML + SEMAGLUTIDE 0.5 MG/ML (CAGRISEMA) (DOSE 0.25 MG/0.25 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011640,STUDY NN9838-8484 CAGRILINTIDE 2 MG/ML + SEMAGLUTIDE 1 MG/ML (CAGRISEMA) (DOSE 0.5 MG/0.5 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011641,STUDY NN9838-8484 CAGRILINTIDE 4 MG/ML + SEMAGLUTIDE 2 MG/ML (CAGRISEMA) (DOSE 1 MG/1 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011642,STUDY NN9838-8484 CAGRILINTIDE 6.8 MG/ML + SEMAGLUTIDE 3.4 MG/ML (CAGRISEMA) (DOSE 1.7 MG/1.7 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011643,STUDY NN9838-8484 CAGRILINTIDE 9.6 MG/ML + SEMAGLUTIDE 4.8 MG/ML (CAGRISEMA) (DOSE 2.4 MG/2.4 MG) PEN INJECTOR (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011644,STUDY TL-895-201 TL-895 25 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011645,STUDY TL-895-201 TL-895 50 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011646,STUDY TL-895-201 TL-895 75 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011647,STUDY TL-895-201 TL-895 100 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011648,STUDY TL-895-201 TL-895 150 MG TABLET (OPEN LABEL),0.2,0.12,0.0464,4481.0,17 NDC,99999011728,STUDY ARGX-113-2308 ARGX-113 (EFGARTIGIMOD)/PLACEBO 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011862,STUDY BP-ARDS-P2-001 VILOBELIMAB/PLACEBO 10 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011863,STUDY BP-ARDS-P2-001 PARIDIPRUBART/PLACEBO 150 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011864,STUDY BP-ARDS-P2-001 BEVACIZUMAB/PLACEBO 25 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011865,STUDY AK-US-001-0106 EFRUXIFERMIN/PLACEBO 50 MG/ML PREFILLED SYRINGE,0.2,0.12,0.0464,4481.0,17 NDC,99999011866,STUDY VX24-147-202 VX-147 (INAXAPLIN) 45 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999011867,STUDY GTX-102-CL301 DEXAMETHASONE 4 MG/ML INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,21 NDC,99999011868,STUDY NICHD-2023-MON01 MONTELUKAST/PLACEBO 4 MG ORAL GRANULES,0.2,0.12,0.0464,4481.0,17 NDC,99999011870,STUDY IND 116002 CEFEPIME-ZIDEBACTAM 3 GRAM INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011871,STUDY 222291 GSK4532990 25 MG / 100 MG / 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,17 NDC,99999011872,STUDY CPI-IFE-008 IFETROBAN/PLACEBO 50 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011873,STUDY STK-001-DS-301 ZOREVUNERSEN (STK-001)/SHAM 70 MG INTRATHECAL SYRINGE 10 ML (LOADING DOSE),0.2,0.12,0.0464,4481.0,17 NDC,99999011874,STUDY STK-001-DS-301 ZOREVUNERSEN (STK-001)/SHAM 45 MG INTRATHECAL SYRINGE 10 ML,0.2,0.12,0.0464,4481.0,17 NDC,99999011875,STUDY GS-US-721-7286 (PURPOSE 365) LENACAPAVIR 300 MG TABLET,0.2,0.12,0.0464,4481.0,17 NDC,99999011876,STUDY GS-US-721-7286 (PURPOSE 365) LENACAPAVIR 500 MG/ML INJECTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011877,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3204),0.2,0.12,0.0464,4481.0,17 NDC,99999011878,STUDY CLAM320B2002M CLOFAZIMINE 50 MG CAPSULE (IDS 3735),0.2,0.12,0.0464,4481.0,17 NDC,99999011879,STUDY IGHID 12430/DELIVER-02 MGD020 4 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011880,STUDY IGHID 12430/DELIVER-02 MGV002 VEHICLE INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999011882,STUDY IGHID 12430/DELIVER-02 VOR 100 MG CAPSULE,0.2,0.12,0.0464,4481.0,17 NDC,99999011885,STUDY 222291 GSK4532990 25 MG / 100 MG / 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,17 NDC,99999011886,STUDY 222291 GSK4532990 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 1),0.2,0.12,0.0464,4481.0,17 NDC,99999011889,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 1000 MG OR 500 MG IVPB IN 275 ML,0.2,0.12,0.0464,4481.0,17 NDC,99999011890,STUDY MK7240-008-00 TULISOKIBART/PLACEBO 500 MG OR 250 MG IVPB IN 275 ML,0.2,0.12,0.0464,4481.0,17 NDC,99999011891,STUDY 222291 GSK4532990 200 MG / PLACEBO INJECTION SOLUTION (SYRINGE 2),0.2,0.12,0.0464,4481.0,17 NDC,99999020703,STUDY JR-141-GS31 PABINAFUSP ALFA OR IDURSULFASE 10 MG INJECTION VIAL,0.2,0.12,0.0464,4481.0,22 NDC,99999020714,STUDY JR-141-GS32 PABINAFUSP ALFA 10 MG INJECTION VIAL,0.2,0.12,0.0464,4481.0,22 NDC,99999020715,STUDY ARGX-113-2308 ARGX-113 (EFGARTIGIMOD) 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999020771,PHENYLEPHRINE 10 % EYE DROPS (MULTI-PATIENT),17.0,10.2,3.94,4481.0,19 NDC,99999025727,STUDY LT3001-205 LT3001/PLACEBO,0.2,0.12,0.0464,4481.0,22 NDC,99999025728,STUDY 80202135EBF3001 NIPOCALIMAB OR PLACEBO INJECTION SOLUTION,0.2,0.12,0.0464,4481.0,17 NDC,99999025729,STUDY IND 143335 CAFFEINE CITRATE 20 MG/ML INTRAVENOUS SOLUTION,0.2,0.12,0.0464,4481.0,24 NDC,99999025731,STUDY 22-002587 DARATUMUMAB 120 MG/ML-RHUPH20 2000 UNITS/ML 15 ML INJECTION,0.2,0.12,0.0464,4481.0,22 NDC,99999077700,DESENSITIZATION DILUTION 0.0001 MG/ML,63.0,37.8,1.8,4481.0,24 NDC,99999077701,DESENSITIZATION DILUTION 0.001 MG/ML,16.0,9.6,1.8,4481.0,24 NDC,99999077702,DESENSITIZATION DILUTION 0.01 MG/ML,16.0,9.6,1.8,4481.0,24 NDC,99999077703,DESENSITIZATION DILUTION 0.1 MG/ML,16.0,9.6,1.8,4481.0,24 NDC,99999077704,DESENSITIZATION DILUTION 1 MG/ML,16.0,9.6,1.8,4481.0,24 NDC,99999077705,DESENSITIZATION DILUTION 10 MG/ML,16.0,9.6,1.8,4481.0,24 NDC,99999077709,"DOBUTAMINE 32 MG/8 ML (4,000 MCG/ML) IN 5 % DEXTROSE (8 ML)",66.1,39.66,15.34,4481.0,24 NDC,99999077710,"DOBUTAMINE 200 MG/50 ML (4,000 MCG/ML) IN 5 % DEXTROSE (50 ML)",79.35,47.61,15.93,4481.0,24 NDC,99999077711,HYDROMORPHONE 50 MG/50 ML (1 MG/ML) IN 0.9 % SOD.CHLORIDE IV PUMP RESV,329.05,197.43,0.2025,4481.0,24 NDC,99999077712,MORPHINE 100 MG/100 ML(1 MG/ML) IN 0.9% SODIUM CHLOR IV PUMP RESERVOIR,196.3,117.78,27.11,4481.0,24 NDC,99999077734,NITROGLYCERIN 200 MCG/ML IN D5W 8 ML PEDIATRIC INFUSION,64.1,38.46,3.35,4481.0,24 NDC,99999077744,AMPHOTERICIN B INTRATHECAL SOLUTION 0.25 MG/ML DILUTION,0.2,0.12,0.0464,4481.0,24 NDC,99999077746,FENTANYL (PF) 100 MCG/10 ML (10 MCG/ML) IN 0.9 % NACL IV SYRINGE,25.15,15.09,2.48,4481.0,24 NDC,99999077748,HYDROMORPHONE (PF) 10 MCG/ML-BUPIVACAINE 0.125 % IN 0.9 %NACL EPIDURAL,52.1,31.26,12.09,4481.0,19 NDC,99999077752,BUMETANIDE 20 MG/80 ML (0.25 MG/ML) INFUSION CSAC,148.85,89.31,0.3589,4481.0,35 NDC,99999077770,FENTANYL (PF) 50 MCG/ML INFUSION,156.4,93.84,2.48,4481.0,24 NDC,99999077778,TREPROSTINIL SODIUM 1 MG/ML INJECTION SOLUTION,760.9,456.54,53.07,8670.06,35 NDC,99999077780,"PENICILLIN G POTASSIUM 100,000 UNITS/ML IV (PED DILUTION)",17.0,10.2,1.78,4481.0,24 NDC,99999077781,TREPROSTINIL SODIUM 2.5 MG/ML INJECTION SOLUTION,1878.25,1126.95,53.07,8670.06,35 NDC,99999077782,TREPROSTINIL SODIUM 5 MG/ML INJECTION SOLUTION,3740.5,2244.3,53.07,8670.06,35 NDC,99999077783,TREPROSTINIL SODIUM 10 MG/ML INJECTION SOLUTION,7464.95,4478.97,53.07,8670.06,35 NDC,99999077786,CISATRACURIUM 2 MG/ML CONTINUOUS INFUSION (2 MG/ML VIALS) (CSAC),1088.5,653.1,252.53,4481.0,19 NDC,99999077788,THIAMINE IN NS (5 MG/ML) PEDIATRIC DILUTION,95.45,57.27,4.09,4481.0,24 NDC,99999077789,PYRIDOXINE IN NS (5 MG/ML) PEDIATRIC DILUTION,205.2,123.12,13.61,4481.0,24 NDC,99999077790,FOLIC ACID IN NS (500 MCG/ML) PEDIATRIC DILUTION,272.0,163.2,0.135,4481.0,24 NDC,99999077793,CEFTAZIDIME-AVIBACTAM 40 MG/ML PEDIATRIC DILUTION,1236.95,742.17,101.59,4481.0,35 NDC,99999077795,EPINEPHRINE 1000 MCG/100 ML (10 MCG/ML) NS SUBCUTANEOUS (OR),112.05,67.23,3.06,4481.0,24 NDC,99999077796,MIDAZOLAM 5 MG/ML INFUSION (MAXIMUM CONCENTRATION),248.4,149.04,0.3375,4481.0,24 NDC,9999909224,STUDY 217-PPD-301 SAGE-217/PLACEBO 50 MG KIT,0.2,0.12,0.0464,4481.0,17 NDC,99999197621,ALTEPLASE 1 MG/1 ML SOLUTION FOR INJECTION,314.5,188.7,79.57,4481.0,35 NDC,99999197801,VECURONIUM 1 MG/ML PEDIATRIC BOLUS FROM INFUSION,0.2,0.12,0.0464,4481.0,19 NDC,99999197805,SILVER NITRATE 0.5 % TOPICAL SOLUTION,226.7,136.02,52.59,4481.0,19 NDC,99999426027,CYCLOSPORINE 1 MG/ML NS AVIVA IVPB,193.8,116.28,44.96,10791.27,24 NDC,99999732101,DALBAVANCIN 0.1 MG/ML DESENSITIZATION SOLN-DILUTION 3,74.3,44.58,15.14,4481.0,35 NDC,99999732102,DALBAVANCIN 1 MG/ML DESENSITIZATION SOLN-DILUTION 2,289.0,173.4,15.14,4481.0,35 NDC,99999732103,DALBAVANCIN 20 MG/ML DESENSITIZATION SOLN-DILUTION 1,6752.5,4051.5,15.14,5841.59,35 NDC,99999777702,"PENICILLIN G POTASSIUM 100,000 UNITS/ML IM DILUTION",65.55,39.33,1.78,4481.0,24 NDC,99999777705,LIDOCAINE 1 G (LASER TUMESCENT) IN 500 ML LR,215.1,129.06,0.0225,4481.0,24 NDC,99999900002,SUCCINYLCHOLINE CHLORIDE 100 MG/5 ML (20 MG/ML) INTRAVENOUS SYRINGE,91.65,54.99,2.07,4481.0,24 NDC,99999900002,SUCCINYLCHOLINE CHLORIDE 20MG/ML SYRINGE/VIAL WRAPPER,50.2,30.12,2.07,4481.0,24 NDC,99999999358,CYCLOSPORINE 1 MG/ML NS AVIVA IV,193.8,116.28,44.96,10791.27,24 RC,360,"1-STAGE DISTAL HYPOSPADIAS REPAIR (WITH OR WITHOUT CHORDEE OR CIRCUMCISION); WITH EXTENSIVE DISSECTION TO CORRECT CHORDEE AND URETHROPLASTY WITH LOCAL SKIN FLAPS, SKIN GRAFT PATCH, AND/OR ISLAND FLAP",,,3247.35,15394.0,15 RC,360,"1-STAGE DISTAL HYPOSPADIAS REPAIR (WITH OR WITHOUT CHORDEE OR CIRCUMCISION); WITH SIMPLE MEATAL ADVANCEMENT (EG, MAGPI, V-FLAP)",,,3247.35,13194.0,15 RC,360,"1-STAGE DISTAL HYPOSPADIAS REPAIR (WITH OR WITHOUT CHORDEE OR CIRCUMCISION); WITH URETHROPLASTY BY LOCAL SKIN FLAPS (EG, FLIP-FLAP, PREPUCIAL FLAP)",,,3247.35,15394.0,15 RC,360,1-STAGE DISTAL HYPOSPADIAS REPAIR (WITH OR WITHOUT CHORDEE OR CIRCUMCISION); WITH URETHROPLASTY BY LOCAL SKIN FLAPS AND MOBILIZATION OF URETHRA,,,3247.35,13194.0,15 RC,360,1-STAGE PERINEAL HYPOSPADIAS REPAIR REQUIRING EXTENSIVE DISSECTION TO CORRECT CHORDEE AND URETHROPLASTY BY USE OF SKIN GRAFT TUBE AND/OR ISLAND FLAP,,,3247.35,15291.0,14 RC,360,1-STAGE PROXIMAL PENILE OR PENOSCROTAL HYPOSPADIAS REPAIR REQUIRING EXTENSIVE DISSECTION TO CORRECT CHORDEE AND URETHROPLASTY BY USE OF SKIN GRAFT TUBE AND/OR ISLAND FLAP,,,3247.35,13194.0,14 RC,360,ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITH IMAGING GUIDANCE,,,882.75,7278.0,15 RC,360,ABDOMINAL PARACENTESIS (DIAGNOSTIC OR THERAPEUTIC); WITHOUT IMAGING GUIDANCE,,,882.75,7278.0,15 RC,360,"ABLATION OF MALIGNANT PROSTATE TISSUE, TRANSRECTAL, WITH HIGH INTENSITY-FOCUSED ULTRASOUND (HIFU), INCLUDING ULTRASOUND GUIDANCE",,,5514.0,17457.0,15 RC,360,"ABLATION THERAPY FOR REDUCTION OR ERADICATION OF 1 OR MORE BONE TUMORS (EG, METASTASIS) INCLUDING ADJACENT SOFT TISSUE WHEN INVOLVED BY TUMOR EXTENSION, PERCUTANEOUS, INCLUDING IMAGING GUIDANCE WHEN P",,,5449.0,15394.0,14 RC,360,"ABLATION, SOFT TISSUE OF INFERIOR TURBINATES, UNILATERAL OR BILATERAL, ANY METHOD (EG, ELECTROCAUTERY, RADIOFREQUENCY ABLATION, OR TISSUE VOLUME REDUCTION); INTRAMURAL (IE, SUBMUCOSAL)",,,1394.69,5449.0,15 RC,360,"ABLATION, SOFT TISSUE OF INFERIOR TURBINATES, UNILATERAL OR BILATERAL, ANY METHOD (EG, ELECTROCAUTERY, RADIOFREQUENCY ABLATION, OR TISSUE VOLUME REDUCTION); SUPERFICIAL",,,1394.69,5449.0,15 RC,360,"ACROMIOPLASTY OR ACROMIONECTOMY, PARTIAL, WITH OR WITHOUT CORACOACROMIAL LIGAMENT RELEASE",,,3054.93,15394.0,15 RC,360,"ADENOIDECTOMY, PRIMARY; AGE 12 OR OVER",,,3053.48,10561.0,15 RC,360,"ADENOIDECTOMY, PRIMARY; YOUNGER THAN AGE 12",,,3053.48,10561.0,15 RC,360,"ADENOIDECTOMY, SECONDARY; AGE 12 OR OVER",,,3053.48,10561.0,15 RC,360,"ADENOIDECTOMY, SECONDARY; YOUNGER THAN AGE 12",,,3053.48,10561.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, ANY AREA; DEFECT 30.1 SQ CM TO 60.0 SQ CM",,,3446.95,17457.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, ANY AREA; EACH ADDITIONAL 30.0 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, EYELIDS, NOSE, EARS AND/OR LIPS; DEFECT 10 SQ CM OR LESS",,,1722.29,8413.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, EYELIDS, NOSE, EARS AND/OR LIPS; DEFECT 10.1 SQ CM TO 30.0 SQ CM",,,1722.29,8413.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS AND/OR FEET; DEFECT 10 SQ CM OR LESS",,,1722.29,7278.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS AND/OR FEET; DEFECT 10.1 SQ CM TO 30.0 SQ CM",,,1722.29,8413.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, SCALP, ARMS AND/OR LEGS; DEFECT 10 SQ CM OR LESS",,,1722.29,8413.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, SCALP, ARMS AND/OR LEGS; DEFECT 10.1 SQ CM TO 30.0 SQ CM",,,1722.29,8413.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, TRUNK; DEFECT 10 SQ CM OR LESS",,,1722.29,7278.0,15 RC,360,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, TRUNK; DEFECT 10.1 SQ CM TO 30.0 SQ CM",,,1722.29,8413.0,15 RC,360,ADJUNCTIVE BLUE LIGHT CYSTOSCOPY WITH FLUORESCENT IMAGING AGENT (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,5449.0,3 RC,360,"ALLOGRAFT, MORSELIZED, OR PLACEMENT OF OSTEOPROMOTIVE MATERIAL, FOR SPINE SURGERY ONLY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"ALLOGRAFT, STRUCTURAL, FOR SPINE SURGERY ONLY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"ALVEOLECTOMY, INCLUDING CURETTAGE OF OSTEITIS OR SEQUESTRECTOMY",,,3053.48,9324.0,14 RC,360,"ALVEOLOPLASTY, EACH QUADRANT (SPECIFY)",,,3012.0,5449.0,14 RC,360,AMPUTATION OF PENIS; COMPLETE,,,3012.0,7278.0,3 RC,360,AMPUTATION OF PENIS; PARTIAL,,,3247.35,13194.0,15 RC,360,"AMPUTATION, ARM THROUGH HUMERUS; SECONDARY CLOSURE OR SCAR REVISION",,,3054.93,9324.0,15 RC,360,"AMPUTATION, ARM THROUGH HUMERUS; WITH PRIMARY CLOSURE",,,13844.0,21454.0,2 RC,360,"AMPUTATION, FINGER OR THUMB, PRIMARY OR SECONDARY, ANY JOINT OR PHALANX, SINGLE, INCLUDING NEURECTOMIES; WITH DIRECT CLOSURE",,,3012.0,7278.0,15 RC,360,"AMPUTATION, FINGER OR THUMB, PRIMARY OR SECONDARY, ANY JOINT OR PHALANX, SINGLE, INCLUDING NEURECTOMIES; WITH LOCAL ADVANCEMENT FLAPS (V-Y, HOOD)",,,3012.0,10561.0,15 RC,360,"AMPUTATION, FOOT; TRANSMETATARSAL",,,3054.93,9324.0,14 RC,360,"AMPUTATION, LEG, THROUGH TIBIA AND FIBULA;",,,17956.0,30725.0,2 RC,360,"AMPUTATION, LEG, THROUGH TIBIA AND FIBULA; RE-AMPUTATION",,,13844.0,21454.0,2 RC,360,"AMPUTATION, METACARPAL, WITH FINGER OR THUMB (RAY AMPUTATION), SINGLE, WITH OR WITHOUT INTEROSSEOUS TRANSFER",,,3054.93,13194.0,15 RC,360,"AMPUTATION, METATARSAL, WITH TOE, SINGLE",,,3054.93,9324.0,15 RC,360,"AMPUTATION, THIGH, THROUGH FEMUR, ANY LEVEL; RE-AMPUTATION",,,13844.0,21454.0,2 RC,360,"AMPUTATION, TOE; INTERPHALANGEAL JOINT",,,3054.93,9324.0,15 RC,360,"AMPUTATION, TOE; METATARSOPHALANGEAL JOINT",,,3054.93,9324.0,15 RC,360,"ANESTHESIA FOR PROCEDURES ON THE INTEGUMENTARY SYSTEM ON THE EXTREMITIES, ANTERIOR TRUNK AND PERINEUM; RECONSTRUCTIVE PROCEDURES ON BREAST (EG, REDUCTION OR AUGMENTATION MAMMOPLASTY, MUSCLE FLAPS)",,,,,0 RC,360,"ANGIOGRAPHY, EXTREMITY, UNILATERAL, RADIOLOGICAL SUPERVISION AND INTERPRETATION",,,233.66,3238.46,12 RC,360,"ANORECTAL EXAM, SURGICAL, REQUIRING ANESTHESIA (GENERAL, SPINAL, OR EPIDURAL), DIAGNOSTIC",,,2582.07,7278.0,15 RC,360,"ANOSCOPY; WITH BIOPSY, SINGLE OR MULTIPLE",,,1110.16,5449.0,14 RC,360,"ANOSCOPY; WITH DILATION (EG, BALLOON, GUIDE WIRE, BOUGIE)",,,1110.16,5449.0,14 RC,360,"ANTERIOR COLPORRHAPHY, REPAIR OF CYSTOCELE WITH OR WITHOUT REPAIR OF URETHROCELE, INCLUDING CYSTOURETHROSCOPY, WHEN PERFORMED",,,4647.86,13194.0,15 RC,360,ANTERIOR INSTRUMENTATION; 2 TO 3 VERTEBRAL SEGMENTS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,5449.0,21454.0,3 RC,360,ANTERIOR INSTRUMENTATION; 4 TO 7 VERTEBRAL SEGMENTS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,5449.0,21454.0,3 RC,360,"ANTERIOR TIBIAL TUBERCLEPLASTY (EG, MAQUET TYPE PROCEDURE)",,,6649.0,15394.0,15 RC,360,APPENDECTOMY;,,,5874.98,13194.0,14 RC,360,APPENDECTOMY; WHEN DONE FOR INDICATED PURPOSE AT TIME OF OTHER MAJOR PROCEDURE (NOT AS SEPARATE PROCEDURE) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,1251.0,2 RC,360,"APPLICATION OF A MULTIPLANE (PINS OR WIRES IN MORE THAN 1 PLANE), UNILATERAL, EXTERNAL FIXATION SYSTEM (EG, ILIZAROV, MONTICELLI TYPE)",,,6649.0,13238.67,15 RC,360,"APPLICATION OF A UNIPLANE (PINS OR WIRES IN 1 PLANE), UNILATERAL, EXTERNAL FIXATION SYSTEM",,,5152.0,13194.0,15 RC,360,"APPLICATION OF CLUBFOOT CAST WITH MOLDING OR MANIPULATION, LONG OR SHORT LEG",,,148.57,1251.0,13 RC,360,"APPLICATION OF CRANIAL TONGS, CALIPER, OR STEREOTACTIC FRAME, INCLUDING REMOVAL (SEPARATE PROCEDURE)",,,1506.85,7278.0,14 RC,360,APPLICATION OF HIP SPICA CAST; 1 AND ONE-HALF SPICA OR BOTH LEGS,,,250.06,7278.0,14 RC,360,APPLICATION OF HIP SPICA CAST; 1 LEG,,,250.06,5449.0,14 RC,360,"APPLICATION OF INTERDENTAL FIXATION DEVICE FOR CONDITIONS OTHER THAN FRACTURE OR DISLOCATION, INCLUDES REMOVAL",,,1394.69,5449.0,15 RC,360,"APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 ",,,576.34,7278.0,17 RC,360,"APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; EACH ADDITIO",,,777.0,5449.0,3 RC,360,"APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; FIRST 25 SQ ",,,576.34,7278.0,14 RC,360,"APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; EACH ADDITIONAL 100 SQ CM WOUND SURFACE AREA, OR PART THEREOF, OR EACH ",,,777.0,5449.0,3 RC,360,"APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; FIRST 100 SQ CM WOUND SURFACE AREA, OR 1% OF BODY AREA OF INFANTS AND C",,,1722.29,7278.0,14 RC,360,"APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; EACH ADDITIONAL 25 SQ CM WOUND SURFACE AREA, OR PART THEREOF (LIST SEPARATELY IN ADDITION ",,,777.0,5449.0,3 RC,360,"APPLICATION OF LOW COST SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; FIRST 25 SQ CM OR LESS WOUND SURFACE AREA",,,576.34,7278.0,14 RC,360,"APPLICATION OF MULTIPLANE (PINS OR WIRES IN MORE THAN 1 PLANE), UNILATERAL, EXTERNAL FIXATION WITH STEREOTACTIC COMPUTER-ASSISTED ADJUSTMENT (EG, SPATIAL FRAME), INCLUDING IMAGING; INITIAL AND SUBSEQU",,,7444.0,18921.52,15 RC,360,"APPLICATION OF RIGHT AND LEFT PULMONARY ARTERY BANDS (EG, HYBRID APPROACH STAGE 1)",,,2533.0,4850.0,2 RC,360,"APPLICATION OF RISSER JACKET, LOCALIZER, BODY; ONLY",,,250.06,1251.0,13 RC,360,APPLICATION OF SHORT ARM SPLINT (FOREARM TO HAND); STATIC,,,121.37,1251.0,13 RC,360,"APPLICATION OF SKIN CELL SUSPENSION AUTOGRAFT TO WOUND AND DONOR SITES, INCLUDING APPLICATION OF PRIMARY DRESSING, TRUNK, ARMS, LEGS; FIRST 480 SQ CM OR LESS",,,1722.29,7278.0,14 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; EA",,,777.0,5449.0,3 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; FI",,,1722.29,7278.0,15 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; EACH ADDITIONAL 25 SQ",,,777.0,5449.0,3 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; FIRST 25 SQ CM OR LES",,,1722.29,7278.0,15 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; EACH ADDITIONAL 100 SQ CM WOUND SURFACE AREA, OR PART THEREOF, OR EACH ADDITIONA",,,777.0,5449.0,3 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; FIRST 100 SQ CM WOUND SURFACE AREA, OR 1% OF BODY AREA OF INFANTS AND CHILDREN",,,3446.95,13194.0,15 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; EACH ADDITIONAL 25 SQ CM WOUND SURFACE AREA, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE F",,,777.0,5449.0,3 RC,360,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; FIRST 25 SQ CM OR LESS WOUND SURFACE AREA",,,1722.29,7278.0,15 RC,360,"APPLICATION, CAST; FIGURE-OF-EIGHT",,,250.06,1251.0,13 RC,360,"AQUEOUS SHUNT TO EXTRAOCULAR EQUATORIAL PLATE RESERVOIR, EXTERNAL APPROACH; WITH GRAFT",,,4858.07,15394.0,15 RC,360,"ARREST, EPIPHYSEAL (EPIPHYSIODESIS), OPEN; DISTAL FIBULA",,,3054.93,13194.0,15 RC,360,"ARREST, EPIPHYSEAL (EPIPHYSIODESIS), OPEN; DISTAL TIBIA",,,3054.93,13194.0,15 RC,360,"ARREST, EPIPHYSEAL (EPIPHYSIODESIS), OPEN; DISTAL TIBIA AND FIBULA",,,3054.93,13194.0,15 RC,360,"ARREST, EPIPHYSEAL, ANY METHOD (EG, EPIPHYSIODESIS); COMBINED DISTAL FEMUR, PROXIMAL TIBIA AND FIBULA",,,6726.11,13194.0,14 RC,360,"ARREST, EPIPHYSEAL, ANY METHOD (EG, EPIPHYSIODESIS); DISTAL FEMUR",,,6726.11,13194.0,14 RC,360,"ARREST, EPIPHYSEAL, ANY METHOD (EG, EPIPHYSIODESIS); TIBIA AND FIBULA, PROXIMAL",,,6726.11,13194.0,14 RC,360,"ARREST, HEMIEPIPHYSEAL, DISTAL FEMUR OR PROXIMAL TIBIA OR FIBULA (EG, GENU VARUS OR VALGUS)",,,6726.11,13194.0,14 RC,360,"ARTERIAL CATHETERIZATION OR CANNULATION FOR SAMPLING, MONITORING OR TRANSFUSION (SEPARATE PROCEDURE); PERCUTANEOUS",,,777.0,5449.0,3 RC,360,"ARTERIOVENOUS ANASTOMOSIS, OPEN; BY FOREARM VEIN TRANSPOSITION",,,5089.69,21454.0,15 RC,360,"ARTERIOVENOUS ANASTOMOSIS, OPEN; BY UPPER ARM BASILIC VEIN TRANSPOSITION",,,5089.69,21454.0,15 RC,360,"ARTERIOVENOUS ANASTOMOSIS, OPEN; BY UPPER ARM CEPHALIC VEIN TRANSPOSITION",,,5089.69,21454.0,15 RC,360,"ARTERIOVENOUS ANASTOMOSIS, OPEN; DIRECT, ANY SITE (EG, CIMINO TYPE) (SEPARATE PROCEDURE)",,,2963.5,13194.0,15 RC,360,"ARTHROCENTESIS, ASPIRATION AND/OR INJECTION, INTERMEDIATE JOINT OR BURSA (EG, TEMPOROMANDIBULAR, ACROMIOCLAVICULAR, WRIST, ELBOW OR ANKLE, OLECRANON BURSA); WITHOUT ULTRASOUND GUIDANCE",,,277.93,5449.0,15 RC,360,"ARTHROCENTESIS, ASPIRATION AND/OR INJECTION, MAJOR JOINT OR BURSA (EG, SHOULDER, HIP, KNEE, SUBACROMIAL BURSA); WITHOUT ULTRASOUND GUIDANCE",,,277.93,5449.0,15 RC,360,"ARTHROCENTESIS, ASPIRATION AND/OR INJECTION, SMALL JOINT OR BURSA (EG, FINGERS, TOES); WITH ULTRASOUND GUIDANCE, WITH PERMANENT RECORDING AND REPORTING",,,277.93,5449.0,14 RC,360,"ARTHROCENTESIS, ASPIRATION AND/OR INJECTION, SMALL JOINT OR BURSA (EG, FINGERS, TOES); WITHOUT ULTRASOUND GUIDANCE",,,277.93,5449.0,15 RC,360,"ARTHRODESIS, ANKLE, OPEN",,,8213.0,21454.0,15 RC,360,"ARTHRODESIS, ANTERIOR INTERBODY TECHNIQUE, INCLUDING MINIMAL DISCECTOMY TO PREPARE INTERSPACE (OTHER THAN FOR DECOMPRESSION); CERVICAL BELOW C2",,,12114.63,21454.0,14 RC,360,"ARTHRODESIS, ANTERIOR INTERBODY TECHNIQUE, INCLUDING MINIMAL DISCECTOMY TO PREPARE INTERSPACE (OTHER THAN FOR DECOMPRESSION); EACH ADDITIONAL INTERSPACE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMAR",,,13844.0,21454.0,2 RC,360,"ARTHRODESIS, ANTERIOR INTERBODY TECHNIQUE, INCLUDING MINIMAL DISCECTOMY TO PREPARE INTERSPACE (OTHER THAN FOR DECOMPRESSION); LUMBAR",,,13764.0,30725.0,3 RC,360,"ARTHRODESIS, ANTERIOR INTERBODY, INCLUDING DISC SPACE PREPARATION, DISCECTOMY, OSTEOPHYTECTOMY AND DECOMPRESSION OF SPINAL CORD AND/OR NERVE ROOTS; CERVICAL BELOW C2",,,12114.63,21454.0,14 RC,360,"ARTHRODESIS, ANTERIOR INTERBODY, INCLUDING DISC SPACE PREPARATION, DISCECTOMY, OSTEOPHYTECTOMY AND DECOMPRESSION OF SPINAL CORD AND/OR NERVE ROOTS; CERVICAL BELOW C2, EACH ADDITIONAL INTERSPACE (LIST ",,,5449.0,15394.0,3 RC,360,"ARTHRODESIS, COMBINED POSTERIOR OR POSTEROLATERAL TECHNIQUE WITH POSTERIOR INTERBODY TECHNIQUE INCLUDING LAMINECTOMY AND/OR DISCECTOMY SUFFICIENT TO PREPARE INTERSPACE (OTHER THAN FOR DECOMPRESSION), ",,,13764.0,30351.0,14 RC,360,"ARTHRODESIS, DISTAL RADIOULNAR JOINT WITH SEGMENTAL RESECTION OF ULNA, WITH OR WITHOUT BONE GRAFT (EG, SAUVE-KAPANDJI PROCEDURE)",,,6726.11,15394.0,15 RC,360,"ARTHRODESIS, GREAT TOE; INTERPHALANGEAL JOINT",,,5514.0,10561.0,15 RC,360,"ARTHRODESIS, GREAT TOE; METATARSOPHALANGEAL JOINT",,,6726.11,21454.0,15 RC,360,"ARTHRODESIS, INTERPHALANGEAL JOINT, WITH OR WITHOUT INTERNAL FIXATION;",,,3054.93,13194.0,15 RC,360,"ARTHRODESIS, INTERPHALANGEAL JOINT, WITH OR WITHOUT INTERNAL FIXATION; WITH AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,3054.93,13194.0,15 RC,360,"ARTHRODESIS, KNEE, ANY TECHNIQUE",,,12615.0,21454.0,3 RC,360,"ARTHRODESIS, METACARPOPHALANGEAL JOINT, WITH OR WITHOUT INTERNAL FIXATION;",,,6726.11,13194.0,15 RC,360,"ARTHRODESIS, MIDTARSAL OR TARSOMETATARSAL, MULTIPLE OR TRANSVERSE;",,,8213.0,21454.0,15 RC,360,"ARTHRODESIS, MIDTARSAL OR TARSOMETATARSAL, MULTIPLE OR TRANSVERSE; WITH OSTEOTOMY (EG, FLATFOOT CORRECTION)",,,8213.0,21454.0,15 RC,360,"ARTHRODESIS, MIDTARSAL OR TARSOMETATARSAL, SINGLE JOINT",,,6726.11,21454.0,15 RC,360,"ARTHRODESIS, POSTERIOR INTERBODY TECHNIQUE, INCLUDING LAMINECTOMY AND/OR DISCECTOMY TO PREPARE INTERSPACE (OTHER THAN FOR DECOMPRESSION), SINGLE INTERSPACE, LUMBAR;",,,13764.0,30725.0,14 RC,360,"ARTHRODESIS, POSTERIOR OR POSTEROLATERAL TECHNIQUE, SINGLE INTERSPACE; CERVICAL BELOW C2 SEGMENT",,,13764.0,30725.0,3 RC,360,"ARTHRODESIS, POSTERIOR OR POSTEROLATERAL TECHNIQUE, SINGLE INTERSPACE; EACH ADDITIONAL INTERSPACE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"ARTHRODESIS, POSTERIOR OR POSTEROLATERAL TECHNIQUE, SINGLE INTERSPACE; LUMBAR (WITH LATERAL TRANSVERSE TECHNIQUE, WHEN PERFORMED)",,,13764.0,21454.0,14 RC,360,"ARTHRODESIS, POSTERIOR OR POSTEROLATERAL TECHNIQUE, SINGLE INTERSPACE; THORACIC (WITH LATERAL TRANSVERSE TECHNIQUE, WHEN PERFORMED)",,,13764.0,30725.0,3 RC,360,"ARTHRODESIS, POSTERIOR, FOR SPINAL DEFORMITY, WITH OR WITHOUT CAST; 13 OR MORE VERTEBRAL SEGMENTS",,,13764.0,30725.0,3 RC,360,"ARTHRODESIS, POSTERIOR, FOR SPINAL DEFORMITY, WITH OR WITHOUT CAST; 7 TO 12 VERTEBRAL SEGMENTS",,,13764.0,30725.0,3 RC,360,"ARTHRODESIS, WITH EXTENSOR HALLUCIS LONGUS TRANSFER TO FIRST METATARSAL NECK, GREAT TOE, INTERPHALANGEAL JOINT (EG, JONES TYPE PROCEDURE)",,,6726.11,21454.0,15 RC,360,"ARTHRODESIS, WITH TENDON LENGTHENING AND ADVANCEMENT, MIDTARSAL, TARSAL NAVICULAR-CUNEIFORM (EG, MILLER TYPE PROCEDURE)",,,9350.0,21454.0,15 RC,360,"ARTHRODESIS, WRIST; COMPLETE, WITHOUT BONE GRAFT (INCLUDES RADIOCARPAL AND/OR INTERCARPAL AND/OR CARPOMETACARPAL JOINTS)",,,6726.11,21454.0,15 RC,360,"ARTHRODESIS, WRIST; LIMITED, WITHOUT BONE GRAFT (EG, INTERCARPAL OR RADIOCARPAL)",,,6726.11,15394.0,15 RC,360,"ARTHRODESIS, WRIST; WITH AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,6726.11,21454.0,15 RC,360,"ARTHRODESIS, WRIST; WITH ILIAC OR OTHER AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,9350.0,21454.0,15 RC,360,ARTHRODESIS; PANTALAR,,,8213.0,21454.0,15 RC,360,ARTHRODESIS; SUBTALAR,,,8213.0,21454.0,15 RC,360,ARTHRODESIS; TRIPLE,,,8213.0,21454.0,15 RC,360,"ARTHROPLASTY, ACETABULAR AND PROXIMAL FEMORAL PROSTHETIC REPLACEMENT (TOTAL HIP ARTHROPLASTY), WITH OR WITHOUT AUTOGRAFT OR ALLOGRAFT",,,12114.63,30725.0,14 RC,360,"ARTHROPLASTY, ANKLE;",,,6726.11,15394.0,15 RC,360,"ARTHROPLASTY, ANKLE; REVISION, TOTAL ANKLE",,,13764.0,21454.0,3 RC,360,"ARTHROPLASTY, ANKLE; WITH IMPLANT (TOTAL ANKLE)",,,13764.0,21454.0,14 RC,360,"ARTHROPLASTY, GLENOHUMERAL JOINT; HEMIARTHROPLASTY",,,12114.63,30725.0,14 RC,360,"ARTHROPLASTY, GLENOHUMERAL JOINT; TOTAL SHOULDER (GLENOID AND PROXIMAL HUMERAL REPLACEMENT (EG, TOTAL SHOULDER))",,,12615.0,30725.0,14 RC,360,"ARTHROPLASTY, INTERCARPAL OR CARPOMETACARPAL JOINTS; INTERPOSITION (EG, TENDON)",,,3054.93,15394.0,15 RC,360,"ARTHROPLASTY, INTERCARPAL OR CARPOMETACARPAL JOINTS; SUSPENSION, INCLUDING TRANSFER OR TRANSPLANT OF TENDON, WITH INTERPOSITION, WHEN PERFORMED",,,3054.93,13194.0,14 RC,360,"ARTHROPLASTY, INTERPHALANGEAL JOINT; EACH JOINT",,,3054.93,15394.0,15 RC,360,"ARTHROPLASTY, INTERPHALANGEAL JOINT; WITH PROSTHETIC IMPLANT, EACH JOINT",,,6726.11,15394.0,15 RC,360,"ARTHROPLASTY, KNEE, CONDYLE AND PLATEAU; MEDIAL AND LATERAL COMPARTMENTS WITH OR WITHOUT PATELLA RESURFACING (TOTAL KNEE ARTHROPLASTY)",,,12114.63,30725.0,14 RC,360,"ARTHROPLASTY, KNEE, CONDYLE AND PLATEAU; MEDIAL OR LATERAL COMPARTMENT",,,12114.63,30725.0,14 RC,360,"ARTHROPLASTY, METACARPOPHALANGEAL JOINT; WITH PROSTHETIC IMPLANT, EACH JOINT",,,6726.11,15394.0,15 RC,360,"ARTHROPLASTY, RADIAL HEAD;",,,9350.0,15394.0,15 RC,360,"ARTHROPLASTY, RADIAL HEAD; WITH IMPLANT",,,12114.63,30725.0,14 RC,360,"ARTHROPLASTY, TEMPOROMANDIBULAR JOINT, WITH ALLOGRAFT",,,5569.83,15394.0,15 RC,360,"ARTHROPLASTY, TEMPOROMANDIBULAR JOINT, WITH OR WITHOUT AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,15 RC,360,"ARTHROPLASTY, TEMPOROMANDIBULAR JOINT, WITH PROSTHETIC JOINT REPLACEMENT",,,9350.0,18921.52,15 RC,360,"ARTHROPLASTY, WRIST, WITH OR WITHOUT INTERPOSITION, WITH OR WITHOUT EXTERNAL OR INTERNAL FIXATION",,,3054.93,15394.0,15 RC,360,ARTHROSCOPICALLY AIDED ANTERIOR CRUCIATE LIGAMENT REPAIR/AUGMENTATION OR RECONSTRUCTION,,,6649.0,21454.0,15 RC,360,ARTHROSCOPICALLY AIDED POSTERIOR CRUCIATE LIGAMENT REPAIR/AUGMENTATION OR RECONSTRUCTION,,,6649.0,21454.0,15 RC,360,"ARTHROSCOPICALLY AIDED REPAIR OF LARGE OSTEOCHONDRITIS DISSECANS LESION, TALAR DOME FRACTURE, OR TIBIAL PLAFOND FRACTURE, WITH OR WITHOUT INTERNAL FIXATION (INCLUDES ARTHROSCOPY)",,,6649.0,15394.0,15 RC,360,"ARTHROSCOPICALLY AIDED TREATMENT OF INTERCONDYLAR SPINE(S) AND/OR TUBEROSITY FRACTURE(S) OF THE KNEE, WITH OR WITHOUT MANIPULATION; WITH INTERNAL OR EXTERNAL FIXATION (INCLUDES ARTHROSCOPY)",,,1506.85,15394.0,15 RC,360,"ARTHROSCOPICALLY AIDED TREATMENT OF INTERCONDYLAR SPINE(S) AND/OR TUBEROSITY FRACTURE(S) OF THE KNEE, WITH OR WITHOUT MANIPULATION; WITHOUT INTERNAL OR EXTERNAL FIXATION (INCLUDES ARTHROSCOPY)",,,1506.85,13194.0,15 RC,360,"ARTHROSCOPICALLY AIDED TREATMENT OF TIBIAL FRACTURE, PROXIMAL (PLATEAU); UNICONDYLAR, INCLUDES INTERNAL FIXATION, WHEN PERFORMED (INCLUDES ARTHROSCOPY)",,,6726.11,21454.0,15 RC,360,"ARTHROSCOPY, ANKLE (TIBIOTALAR AND FIBULOTALAR JOINTS), SURGICAL; DEBRIDEMENT, EXTENSIVE",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, ANKLE (TIBIOTALAR AND FIBULOTALAR JOINTS), SURGICAL; DEBRIDEMENT, LIMITED",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, ANKLE (TIBIOTALAR AND FIBULOTALAR JOINTS), SURGICAL; SYNOVECTOMY, PARTIAL",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, ANKLE (TIBIOTALAR AND FIBULOTALAR JOINTS), SURGICAL; WITH REMOVAL OF LOOSE BODY OR FOREIGN BODY",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, ANKLE, SURGICAL, EXCISION OF OSTEOCHONDRAL DEFECT OF TALUS AND/OR TIBIA, INCLUDING DRILLING OF THE DEFECT",,,3054.93,21454.0,15 RC,360,"ARTHROSCOPY, ELBOW, SURGICAL; DEBRIDEMENT, EXTENSIVE",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, ELBOW, SURGICAL; SYNOVECTOMY, PARTIAL",,,3054.93,21454.0,15 RC,360,"ARTHROSCOPY, ELBOW, SURGICAL; WITH REMOVAL OF LOOSE BODY OR FOREIGN BODY",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, HIP, SURGICAL; WITH ACETABULOPLASTY (IE, TREATMENT OF PINCER LESION)",,,6726.11,21454.0,15 RC,360,"ARTHROSCOPY, HIP, SURGICAL; WITH DEBRIDEMENT/SHAVING OF ARTICULAR CARTILAGE (CHONDROPLASTY), ABRASION ARTHROPLASTY, AND/OR RESECTION OF LABRUM",,,6726.11,21454.0,15 RC,360,"ARTHROSCOPY, HIP, SURGICAL; WITH FEMOROPLASTY (IE, TREATMENT OF CAM LESION)",,,6726.11,21454.0,15 RC,360,"ARTHROSCOPY, HIP, SURGICAL; WITH LABRAL REPAIR",,,6726.11,21454.0,15 RC,360,"ARTHROSCOPY, KNEE, DIAGNOSTIC, WITH OR WITHOUT SYNOVIAL BIOPSY (SEPARATE PROCEDURE)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; ABRASION ARTHROPLASTY (INCLUDES CHONDROPLASTY WHERE NECESSARY) OR MULTIPLE DRILLING OR MICROFRACTURE",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; DEBRIDEMENT/SHAVING OF ARTICULAR CARTILAGE (CHONDROPLASTY)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; DRILLING FOR INTACT OSTEOCHONDRITIS DISSECANS LESION",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; DRILLING FOR INTACT OSTEOCHONDRITIS DISSECANS LESION WITH INTERNAL FIXATION",,,6649.0,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; FOR INFECTION, LAVAGE AND DRAINAGE",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; FOR REMOVAL OF LOOSE BODY OR FOREIGN BODY (EG, OSTEOCHONDRITIS DISSECANS FRAGMENTATION, CHONDRAL FRAGMENTATION)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; MENISCAL TRANSPLANTATION (INCLUDES ARTHROTOMY FOR MENISCAL INSERTION), MEDIAL OR LATERAL",,,6726.11,21454.0,14 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; OSTEOCHONDRAL ALLOGRAFT (EG, MOSAICPLASTY)",,,8413.0,21454.0,14 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; OSTEOCHONDRAL AUTOGRAFT(S) (EG, MOSAICPLASTY) (INCLUDES HARVESTING OF THE AUTOGRAFT[S])",,,6726.11,21454.0,14 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; SYNOVECTOMY, LIMITED (EG, PLICA OR SHELF RESECTION) (SEPARATE PROCEDURE)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; SYNOVECTOMY, MAJOR, 2 OR MORE COMPARTMENTS (EG, MEDIAL OR LATERAL)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; WITH LATERAL RELEASE",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; WITH LYSIS OF ADHESIONS, WITH OR WITHOUT MANIPULATION (SEPARATE PROCEDURE)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; WITH MENISCECTOMY (MEDIAL AND LATERAL, INCLUDING ANY MENISCAL SHAVING) INCLUDING DEBRIDEMENT/SHAVING OF ARTICULAR CARTILAGE (CHONDROPLASTY), SAME OR SEPARATE COMPARTMENT(S",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; WITH MENISCECTOMY (MEDIAL OR LATERAL, INCLUDING ANY MENISCAL SHAVING) INCLUDING DEBRIDEMENT/SHAVING OF ARTICULAR CARTILAGE (CHONDROPLASTY), SAME OR SEPARATE COMPARTMENT(S)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; WITH MENISCUS REPAIR (MEDIAL AND LATERAL)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, KNEE, SURGICAL; WITH MENISCUS REPAIR (MEDIAL OR LATERAL)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, SHOULDER, DIAGNOSTIC, WITH OR WITHOUT SYNOVIAL BIOPSY (SEPARATE PROCEDURE)",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; BICEPS TENODESIS",,,6726.11,21454.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; CAPSULORRHAPHY",,,6649.0,21454.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; DEBRIDEMENT, EXTENSIVE, 3 OR MORE DISCRETE STRUCTURES (EG, HUMERAL BONE, HUMERAL ARTICULAR CARTILAGE, GLENOID BONE, GLENOID ARTICULAR CARTILAGE, BICEPS TENDON, BICEPS ",,,3054.93,21454.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; DEBRIDEMENT, LIMITED, 1 OR 2 DISCRETE STRUCTURES (EG, HUMERAL BONE, HUMERAL ARTICULAR CARTILAGE, GLENOID BONE, GLENOID ARTICULAR CARTILAGE, BICEPS TENDON, BICEPS ANCHO",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; DECOMPRESSION OF SUBACROMIAL SPACE WITH PARTIAL ACROMIOPLASTY, WITH CORACOACROMIAL LIGAMENT (IE, ARCH) RELEASE, WHEN PERFORMED (LIST SEPARATELY IN ADDITION TO CODE FOR",,,777.0,8413.0,4 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; DISTAL CLAVICULECTOMY INCLUDING DISTAL ARTICULAR SURFACE (MUMFORD PROCEDURE)",,,3054.93,21454.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; REPAIR OF SLAP LESION",,,6649.0,21454.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; WITH LYSIS AND RESECTION OF ADHESIONS, WITH OR WITHOUT MANIPULATION",,,3054.93,21454.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; WITH REMOVAL OF LOOSE BODY OR FOREIGN BODY",,,3054.93,21454.0,15 RC,360,"ARTHROSCOPY, SHOULDER, SURGICAL; WITH ROTATOR CUFF REPAIR",,,6726.11,21454.0,15 RC,360,"ARTHROSCOPY, SUBTALAR JOINT, SURGICAL; WITH DEBRIDEMENT",,,3054.93,17457.0,15 RC,360,"ARTHROSCOPY, SUBTALAR JOINT, SURGICAL; WITH SYNOVECTOMY",,,6726.11,17457.0,15 RC,360,"ARTHROSCOPY, TEMPOROMANDIBULAR JOINT, SURGICAL",,,3054.93,13194.0,15 RC,360,"ARTHROSCOPY, WRIST, SURGICAL; EXCISION AND/OR REPAIR OF TRIANGULAR FIBROCARTILAGE AND/OR JOINT DEBRIDEMENT",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY WITH BIOPSY; INTERPHALANGEAL JOINT, EACH",,,1506.85,5449.0,15 RC,360,ARTHROTOMY WITH BIOPSY; INTERTARSAL OR TARSOMETATARSAL JOINT,,,3054.93,9324.0,15 RC,360,"ARTHROTOMY, ANKLE, WITH JOINT EXPLORATION, WITH OR WITHOUT BIOPSY, WITH OR WITHOUT REMOVAL OF LOOSE OR FOREIGN BODY",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY, ELBOW; WITH JOINT EXPLORATION, WITH OR WITHOUT BIOPSY, WITH OR WITHOUT REMOVAL OF LOOSE OR FOREIGN BODY",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY, GLENOHUMERAL JOINT, WITH JOINT EXPLORATION, WITH OR WITHOUT REMOVAL OF LOOSE OR FOREIGN BODY",,,6726.11,13194.0,15 RC,360,"ARTHROTOMY, HIP, INCLUDING EXPLORATION OR REMOVAL OF LOOSE OR FOREIGN BODY",,,6649.0,15394.0,15 RC,360,"ARTHROTOMY, KNEE, WITH EXPLORATION, DRAINAGE, OR REMOVAL OF FOREIGN BODY (EG, INFECTION)",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY, KNEE; INCLUDING JOINT EXPLORATION, BIOPSY, OR REMOVAL OF LOOSE OR FOREIGN BODIES",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY, POSTERIOR CAPSULAR RELEASE, ANKLE, WITH OR WITHOUT ACHILLES TENDON LENGTHENING",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY, WITH EXPLORATION, DRAINAGE, OR REMOVAL OF LOOSE OR FOREIGN BODY; INTERPHALANGEAL JOINT, EACH",,,1506.85,10561.0,15 RC,360,"ARTHROTOMY, WITH EXPLORATION, DRAINAGE, OR REMOVAL OF LOOSE OR FOREIGN BODY; METACARPOPHALANGEAL JOINT, EACH",,,3012.0,10561.0,15 RC,360,"ARTHROTOMY, WITH SYNOVECTOMY, KNEE; ANTERIOR OR POSTERIOR",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY, WRIST JOINT; WITH JOINT EXPLORATION, WITH OR WITHOUT BIOPSY, WITH OR WITHOUT REMOVAL OF LOOSE OR FOREIGN BODY",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY, WRIST JOINT; WITH SYNOVECTOMY",,,3054.93,13194.0,15 RC,360,"ARTHROTOMY; GLENOHUMERAL JOINT, WITH SYNOVECTOMY, WITH OR WITHOUT BIOPSY",,,6726.11,13194.0,15 RC,360,ASPIRATION AND INJECTION FOR TREATMENT OF BONE CYST,,,662.46,5449.0,14 RC,360,"ASPIRATION AND/OR INJECTION OF RENAL CYST OR PELVIS BY NEEDLE, PERCUTANEOUS",,,662.46,5449.0,15 RC,360,ASPIRATION OF BLADDER; WITH INSERTION OF SUPRAPUBIC CATHETER,,,1928.76,9324.0,15 RC,360,"ASPIRATION OR RELEASE OF VITREOUS, SUBRETINAL OR CHOROIDAL FLUID, PARS PLANA APPROACH (POSTERIOR SCLEROTOMY)",,,2147.4,9324.0,15 RC,360,"AUDITORY EVOKED POTENTIALS; FOR THRESHOLD ESTIMATION AT MULTIPLE FREQUENCIES, WITH INTERPRETATION AND REPORT",,,293.19,320.4,11 RC,360,"AUDITORY EVOKED POTENTIALS; NEURODIAGNOSTIC, WITH INTERPRETATION AND REPORT",,,293.19,320.4,11 RC,360,"AUTOGRAFT FOR SPINE SURGERY ONLY (INCLUDES HARVESTING THE GRAFT); LOCAL (EG, RIBS, SPINOUS PROCESS, OR LAMINAR FRAGMENTS) OBTAINED FROM SAME INCISION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY P",,,5449.0,13194.0,3 RC,360,AUTOGRAFT FOR SPINE SURGERY ONLY (INCLUDES HARVESTING THE GRAFT); MORSELIZED (THROUGH SEPARATE SKIN OR FASCIAL INCISION) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,5449.0,13194.0,3 RC,360,"AUTOLOGOUS CHONDROCYTE IMPLANTATION, KNEE",,,6726.11,21454.0,14 RC,360,"AVULSION OF NAIL PLATE, PARTIAL OR COMPLETE, SIMPLE; SINGLE",,,187.08,5449.0,14 RC,360,AXILLARY LYMPHADENECTOMY; COMPLETE,,,5493.28,21454.0,15 RC,360,AXILLARY LYMPHADENECTOMY; SUPERFICIAL,,,5152.0,21454.0,15 RC,360,"BACKBENCH STANDARD PREPARATION OF LIVING DONOR RENAL ALLOGRAFT (OPEN OR LAPAROSCOPIC) PRIOR TO TRANSPLANTATION, INCLUDING DISSECTION AND REMOVAL OF PERINEPHRIC FAT AND PREPARATION OF URETER(S), RENAL ",,,2533.0,4850.0,2 RC,360,"BALLOON DILATION, URETERAL STRICTURE, INCLUDING IMAGING GUIDANCE (EG, ULTRASOUND AND/OR FLUOROSCOPY) AND ALL ASSOCIATED RADIOLOGICAL SUPERVISION AND INTERPRETATION (LIST SEPARATELY IN ADDITION TO CODE",,,777.0,5449.0,3 RC,360,"BIOPSIES, PROSTATE, NEEDLE, TRANSPERINEAL, STEREOTACTIC TEMPLATE GUIDED SATURATION SAMPLING, INCLUDING IMAGING GUIDANCE",,,3012.0,7278.0,15 RC,360,BIOPSY EXTERNAL AUDITORY CANAL,,,1394.69,5239.0,13 RC,360,"BIOPSY OF ANORECTAL WALL, ANAL APPROACH (EG, CONGENITAL MEGACOLON)",,,2582.07,5449.0,15 RC,360,"BIOPSY OF BREAST; OPEN, INCISIONAL",,,3605.42,9324.0,15 RC,360,"BIOPSY OF CERVIX, SINGLE OR MULTIPLE, OR LOCAL EXCISION OF LESION, WITH OR WITHOUT FULGURATION (SEPARATE PROCEDURE)",,,819.83,5449.0,15 RC,360,BIOPSY OF CONJUNCTIVA,,,2196.57,6649.0,15 RC,360,BIOPSY OF FLOOR OF MOUTH,,,1525.52,5449.0,15 RC,360,BIOPSY OF LACRIMAL GLAND,,,2196.57,9324.0,15 RC,360,BIOPSY OF LIP,,,218.65,1251.0,13 RC,360,"BIOPSY OF LIVER, NEEDLE; PERCUTANEOUS",,,1525.52,5449.0,15 RC,360,"BIOPSY OF LIVER, NEEDLE; WHEN DONE FOR INDICATED PURPOSE AT TIME OF OTHER MAJOR PROCEDURE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"BIOPSY OF LIVER, WEDGE",,,5514.0,9324.0,2 RC,360,"BIOPSY OF NAIL UNIT (EG, PLATE, BED, MATRIX, HYPONYCHIUM, PROXIMAL AND LATERAL NAIL FOLDS) (SEPARATE PROCEDURE)",,,662.46,5449.0,15 RC,360,BIOPSY OF NERVE,,,1838.62,9324.0,15 RC,360,"BIOPSY OF PALATE, UVULA",,,1394.69,5449.0,15 RC,360,BIOPSY OF PENIS; (SEPARATE PROCEDURE),,,1525.52,5449.0,15 RC,360,BIOPSY OF PENIS; DEEP STRUCTURES,,,2694.74,9324.0,15 RC,360,BIOPSY OF SALIVARY GLAND; INCISIONAL,,,1394.69,7278.0,15 RC,360,BIOPSY OF SALIVARY GLAND; NEEDLE,,,662.46,5449.0,15 RC,360,"BIOPSY OF TESTIS, INCISIONAL (SEPARATE PROCEDURE)",,,3247.35,9324.0,15 RC,360,BIOPSY OF TONGUE; ANTERIOR TWO-THIRDS,,,479.48,5449.0,15 RC,360,BIOPSY OF URETHRA,,,1928.76,9324.0,15 RC,360,"BIOPSY OF VAGINAL MUCOSA; EXTENSIVE, REQUIRING SUTURE (INCLUDING CYSTS)",,,2993.65,9324.0,15 RC,360,BIOPSY OF VAGINAL MUCOSA; SIMPLE (SEPARATE PROCEDURE),,,819.83,5449.0,15 RC,360,BIOPSY OF VULVA OR PERINEUM (SEPARATE PROCEDURE); 1 LESION,,,819.83,5449.0,15 RC,360,BIOPSY OF VULVA OR PERINEUM (SEPARATE PROCEDURE); EACH SEPARATE ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,5449.0,3 RC,360,"BIOPSY OR EXCISION OF LYMPH NODE(S); BY NEEDLE, SUPERFICIAL (EG, CERVICAL, INGUINAL, AXILLARY)",,,1525.52,5449.0,15 RC,360,"BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, DEEP AXILLARY NODE(S)",,,3605.42,9324.0,15 RC,360,"BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, DEEP CERVICAL NODE(S)",,,3605.42,9324.0,15 RC,360,"BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, DEEP CERVICAL NODE(S) WITH EXCISION SCALENE FAT PAD",,,3605.42,9324.0,15 RC,360,"BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, INGUINOFEMORAL NODE(S)",,,3605.42,13194.0,14 RC,360,"BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, SUPERFICIAL",,,3605.42,9324.0,15 RC,360,"BIOPSY, BONE, OPEN; DEEP (EG, HUMERAL SHAFT, ISCHIUM, FEMORAL SHAFT)",,,2694.74,9324.0,15 RC,360,"BIOPSY, BONE, OPEN; SUPERFICIAL (EG, STERNUM, SPINOUS PROCESS, RIB, PATELLA, OLECRANON PROCESS, CALCANEUS, TARSAL, METATARSAL, CARPAL, METACARPAL, PHALANX)",,,2694.74,9324.0,15 RC,360,"BIOPSY, BONE, TROCAR, OR NEEDLE; DEEP (EG, VERTEBRAL BODY, FEMUR)",,,1525.52,7278.0,15 RC,360,"BIOPSY, BONE, TROCAR, OR NEEDLE; SUPERFICIAL (EG, ILIUM, STERNUM, SPINOUS PROCESS, RIBS)",,,1525.52,5449.0,15 RC,360,"BIOPSY, BREAST, WITH PLACEMENT OF BREAST LOCALIZATION DEVICE(S) (EG, CLIP, METALLIC PELLET), WHEN PERFORMED, AND IMAGING OF THE BIOPSY SPECIMEN, WHEN PERFORMED, PERCUTANEOUS; FIRST LESION, INCLUDING U",,,1525.52,7278.0,15 RC,360,"BIOPSY, INTRANASAL",,,1394.69,5449.0,15 RC,360,"BIOPSY, MUSCLE, PERCUTANEOUS NEEDLE",,,1525.52,5449.0,15 RC,360,"BIOPSY, MUSCLE; DEEP",,,2694.74,8413.0,15 RC,360,"BIOPSY, MUSCLE; SUPERFICIAL",,,1525.52,7278.0,15 RC,360,"BIOPSY, PROSTATE; NEEDLE OR PUNCH, SINGLE OR MULTIPLE, ANY APPROACH",,,1928.76,7278.0,15 RC,360,"BIOPSY, SOFT TISSUE OF LEG OR ANKLE AREA; DEEP (SUBFASCIAL OR INTRAMUSCULAR)",,,2694.74,9324.0,15 RC,360,"BIOPSY, SOFT TISSUE OF NECK OR THORAX",,,1525.52,5449.0,15 RC,360,"BIOPSY, SOFT TISSUE OF SHOULDER AREA; DEEP",,,2694.74,9324.0,15 RC,360,"BIOPSY, SOFT TISSUE OF UPPER ARM OR ELBOW AREA; DEEP (SUBFASCIAL OR INTRAMUSCULAR)",,,2694.74,7278.0,15 RC,360,"BIOPSY, SOFT TISSUE OF UPPER ARM OR ELBOW AREA; SUPERFICIAL",,,1525.52,5449.0,15 RC,360,"BIOPSY, VERTEBRAL BODY, OPEN; THORACIC",,,3054.93,13194.0,15 RC,360,"BIOPSY, VESTIBULE OF MOUTH",,,479.48,5449.0,14 RC,360,"BIOPSY; NASOPHARYNX, SURVEY FOR UNKNOWN PRIMARY LESION",,,3053.48,9324.0,15 RC,360,"BIOPSY; NASOPHARYNX, VISIBLE LESION, SIMPLE",,,3012.0,5449.0,15 RC,360,BIOPSY; OROPHARYNX,,,1394.69,5449.0,14 RC,360,BLADDER INSTILLATION OF ANTICARCINOGENIC AGENT (INCLUDING RETENTION TIME),,,628.45,5449.0,15 RC,360,"BLEPHAROPLASTY, LOWER EYELID;",,,1722.29,8413.0,15 RC,360,"BLEPHAROPLASTY, UPPER EYELID;",,,1722.29,8413.0,15 RC,360,"BLEPHAROPLASTY, UPPER EYELID; WITH EXCESSIVE SKIN WEIGHTING DOWN LID",,,1722.29,12615.0,15 RC,360,"BONE GRAFT, ANY DONOR AREA; MAJOR OR LARGE",,,6726.11,13194.0,15 RC,360,"BONE GRAFT, ANY DONOR AREA; MINOR OR SMALL (EG, DOWEL OR BUTTON)",,,6649.0,13194.0,15 RC,360,"BONE MARROW ASPIRATION FOR BONE GRAFTING, SPINE SURGERY ONLY, THROUGH SEPARATE SKIN OR FASCIAL INCISION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,BONE MARROW HARVESTING FOR TRANSPLANTATION; ALLOGENEIC,,,1543.44,12615.0,14 RC,360,BREAST AUGMENTATION WITH IMPLANT,,,8875.0,21454.0,15 RC,360,BREAST RECONSTRUCTION; WITH LATISSIMUS DORSI FLAP,,,2533.0,4850.0,2 RC,360,BREAST REDUCTION,,,6140.22,15394.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; DIAGNOSTIC, WITH CELL WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,1623.65,7278.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; EACH ADDITIONAL MAJOR BRONCHUS STENTED (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,4 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH BALLOON OCCLUSION, WHEN PERFORMED, ASSESSMENT OF AIR LEAK, AIRWAY SIZING, AND INSERTION OF BRONCHIAL VALVE(S), EA",,,777.0,12408.0,4 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH BALLOON OCCLUSION, WHEN PERFORMED, ASSESSMENT OF AIR LEAK, AIRWAY SIZING, AND INSERTION OF BRONCHIAL VALVE(S), IN",,,6517.78,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH BRONCHIAL ALVEOLAR LAVAGE",,,1623.65,7278.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH BRONCHIAL OR ENDOBRONCHIAL BIOPSY(S), SINGLE OR MULTIPLE SITES",,,1623.65,7278.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH BRUSHING OR PROTECTED BRUSHINGS",,,1623.65,7278.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH COMPUTER-ASSISTED, IMAGE-GUIDED NAVIGATION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE[S])",,,777.0,5449.0,3 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH DESTRUCTION OF TUMOR OR RELIEF OF STENOSIS BY ANY METHOD OTHER THAN EXCISION (EG, LASER THERAPY, CRYOTHERAPY)",,,3471.41,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH ENDOBRONCHIAL ULTRASOUND (EBUS) GUIDED TRANSTRACHEAL AND/OR TRANSBRONCHIAL SAMPLING (EG, ASPIRATION[S]/BIOPSY[IES",,,3471.41,17457.0,30 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH EXCISION OF TUMOR",,,3471.41,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH PLACEMENT OF BRONCHIAL STENT(S) (INCLUDES TRACHEAL/BRONCHIAL DILATION AS REQUIRED), INITIAL BRONCHUS",,,5152.0,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH PLACEMENT OF FIDUCIAL MARKERS, SINGLE OR MULTIPLE",,,6517.78,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH PLACEMENT OF TRACHEAL STENT(S) (INCLUDES TRACHEAL/BRONCHIAL DILATION AS REQUIRED)",,,5152.0,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH REMOVAL OF BRONCHIAL VALVE(S), EACH ADDITIONAL LOBE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,1623.65,6649.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH REMOVAL OF BRONCHIAL VALVE(S), INITIAL LOBE",,,3471.41,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH REMOVAL OF FOREIGN BODY",,,1623.65,7278.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH REVISION OF TRACHEAL OR BRONCHIAL STENT INSERTED AT PREVIOUS SESSION (INCLUDES TRACHEAL/BRONCHIAL DILATION AS REQ",,,5152.0,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH THERAPEUTIC ASPIRATION OF TRACHEOBRONCHIAL TREE, INITIAL",,,1623.65,7278.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH TRACHEAL/BRONCHIAL DILATION OR CLOSED REDUCTION OF FRACTURE",,,3471.41,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH TRANSBRONCHIAL LUNG BIOPSY(S), EACH ADDITIONAL LOBE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,7278.0,4 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH TRANSBRONCHIAL LUNG BIOPSY(S), SINGLE LOBE",,,3012.0,7278.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH TRANSBRONCHIAL NEEDLE ASPIRATION BIOPSY(S), EACH ADDITIONAL LOBE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY",,,777.0,7278.0,4 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH TRANSBRONCHIAL NEEDLE ASPIRATION BIOPSY(S), TRACHEA, MAIN STEM AND/OR LOBAR BRONCHUS(I)",,,3471.41,13194.0,15 RC,360,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH TRANSENDOSCOPIC ENDOBRONCHIAL ULTRASOUND (EBUS) DURING BRONCHOSCOPIC DIAGNOSTIC OR THERAPEUTIC INTERVENTION(S) FO",,,777.0,5449.0,4 RC,360,BURR HOLE(S) OR TREPHINE; WITH BIOPSY OF BRAIN OR INTRACRANIAL LESION,,,2533.0,4850.0,2 RC,360,"BURR HOLE(S) WITH EVACUATION AND/OR DRAINAGE OF HEMATOMA, EXTRADURAL OR SUBDURAL",,,2533.0,4850.0,2 RC,360,CANTHOPLASTY (RECONSTRUCTION OF CANTHUS),,,2196.57,9324.0,15 RC,360,CANTHOTOMY (SEPARATE PROCEDURE),,,2196.57,9324.0,15 RC,360,"CAPSULECTOMY OR CAPSULOTOMY, HIP, WITH OR WITHOUT EXCISION OF HETEROTOPIC BONE, WITH RELEASE OF HIP FLEXOR MUSCLES (IE, GLUTEUS MEDIUS, GLUTEUS MINIMUS, TENSOR FASCIA LATAE, RECTUS FEMORIS, SARTORIUS,",,,9974.0,15394.0,3 RC,360,"CAPSULECTOMY OR CAPSULOTOMY; INTERPHALANGEAL JOINT, EACH JOINT",,,1506.85,8413.0,15 RC,360,"CAPSULECTOMY OR CAPSULOTOMY; METACARPOPHALANGEAL JOINT, EACH JOINT",,,3012.0,8413.0,15 RC,360,"CAPSULODESIS, METACARPOPHALANGEAL JOINT; SINGLE DIGIT",,,3054.93,13194.0,15 RC,360,"CAPSULORRHAPHY OR RECONSTRUCTION, WRIST, OPEN (EG, CAPSULODESIS, LIGAMENT REPAIR, TENDON TRANSFER OR GRAFT) (INCLUDES SYNOVECTOMY, CAPSULOTOMY AND OPEN REDUCTION) FOR CARPAL INSTABILITY",,,6649.0,15394.0,15 RC,360,"CAPSULORRHAPHY, ANTERIOR, ANY TYPE; WITH BONE BLOCK",,,6726.11,21454.0,15 RC,360,"CAPSULORRHAPHY, ANTERIOR, ANY TYPE; WITH CORACOID PROCESS TRANSFER",,,6726.11,15394.0,15 RC,360,"CAPSULORRHAPHY, ANTERIOR; WITH LABRAL REPAIR (EG, BANKART PROCEDURE)",,,6726.11,21454.0,15 RC,360,"CAPSULOTOMY, MIDFOOT; EXTENSIVE, INCLUDING POSTERIOR TALOTIBIAL CAPSULOTOMY AND TENDON(S) LENGTHENING (EG, RESISTANT CLUBFOOT DEFORMITY)",,,5514.0,10561.0,15 RC,360,"CAPSULOTOMY, POSTERIOR CAPSULAR RELEASE, KNEE",,,3054.93,13194.0,15 RC,360,"CAPSULOTOMY, WRIST (EG, CONTRACTURE)",,,3054.93,9324.0,15 RC,360,"CAPSULOTOMY; INTERPHALANGEAL JOINT, EACH JOINT (SEPARATE PROCEDURE)",,,1506.85,9324.0,14 RC,360,"CAPSULOTOMY; METATARSOPHALANGEAL JOINT, WITH OR WITHOUT TENORRHAPHY, EACH JOINT (SEPARATE PROCEDURE)",,,3054.93,9324.0,15 RC,360,"CARDIOPULMONARY RESUSCITATION (EG, IN CARDIAC ARREST)",,,293.19,1251.0,13 RC,360,"CARDIOVERSION, ELECTIVE, ELECTRICAL CONVERSION OF ARRHYTHMIA; EXTERNAL",,,616.12,3517.0,13 RC,360,CARPECTOMY; 1 BONE,,,3054.93,13194.0,15 RC,360,CARPECTOMY; ALL BONES OF PROXIMAL ROW,,,3054.93,13194.0,15 RC,360,CARTILAGE GRAFT; COSTOCHONDRAL,,,576.34,8413.0,15 RC,360,CARTILAGE GRAFT; NASAL SEPTUM,,,3446.95,13194.0,15 RC,360,"CATHETERIZATION WITH REMOVAL OF TEMPORARY DEVICE FOR ISCHEMIC REMODELING (IE, PRESSURE NECROSIS) OF BLADDER NECK AND PROSTATE",,,228.99,5449.0,14 RC,360,CAUTERY OF CERVIX; ELECTRO OR THERMAL,,,2993.65,9324.0,14 RC,360,"CENTRALIZATION OF WRIST ON ULNA (EG, RADIAL CLUB HAND)",,,3054.93,15394.0,15 RC,360,"CERCLAGE OF CERVIX, DURING PREGNANCY; VAGINAL",,,2993.65,9324.0,15 RC,360,"CERCLAGE OF UTERINE CERVIX, NONOBSTETRICAL",,,2993.65,9324.0,15 RC,360,CERVICAL LYMPHADENECTOMY (COMPLETE),,,5514.0,10561.0,14 RC,360,CERVICAL LYMPHADENECTOMY (MODIFIED RADICAL NECK DISSECTION),,,5514.0,10561.0,3 RC,360,CESAREAN DELIVERY ONLY;,,,2533.0,4850.0,2 RC,360,CESAREAN DELIVERY ONLY; INCLUDING POSTPARTUM CARE,,,2533.0,12615.0,3 RC,360,CHANGE OF CYSTOSTOMY TUBE; COMPLICATED,,,628.45,5449.0,15 RC,360,CHANGE OF CYSTOSTOMY TUBE; SIMPLE,,,228.99,5449.0,15 RC,360,CHANGE OF URETEROSTOMY TUBE OR EXTERNALLY ACCESSIBLE URETERAL STENT VIA ILEAL CONDUIT,,,1928.76,5449.0,15 RC,360,"CHEMICAL CAUTERIZATION OF GRANULATION TISSUE (IE, PROUD FLESH)",,,187.08,5449.0,14 RC,360,CHEMODENERVATION OF EXTRAOCULAR MUSCLE,,,281.46,5449.0,15 RC,360,CHEMODENERVATION OF INTERNAL ANAL SPHINCTER,,,1110.16,5449.0,15 RC,360,"CHEMODENERVATION OF MUSCLE(S); LARYNX, UNILATERAL, PERCUTANEOUS (EG, FOR SPASMODIC DYSPHONIA), INCLUDES GUIDANCE BY NEEDLE ELECTROMYOGRAPHY, WHEN PERFORMED",,,652.03,5449.0,14 RC,360,"CHEMODENERVATION OF MUSCLE(S); MUSCLE(S) INNERVATED BY FACIAL NERVE, UNILATERAL (EG, FOR BLEPHAROSPASM, HEMIFACIAL SPASM)",,,277.93,5449.0,15 RC,360,"CHEMODENERVATION OF MUSCLE(S); NECK MUSCLE(S), EXCLUDING MUSCLES OF THE LARYNX, UNILATERAL (EG, FOR CERVICAL DYSTONIA, SPASMODIC TORTICOLLIS)",,,277.93,5449.0,14 RC,360,CHEMODENERVATION OF ONE EXTREMITY; 1-4 MUSCLE(S),,,652.03,5449.0,14 RC,360,CHEMODENERVATION OF ONE EXTREMITY; 5 OR MORE MUSCLES,,,652.03,5449.0,14 RC,360,"CHEMODENERVATION OF ONE EXTREMITY; EACH ADDITIONAL EXTREMITY, 1-4 MUSCLE(S) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"CHEMODENERVATION OF PAROTID AND SUBMANDIBULAR SALIVARY GLANDS, BILATERAL",,,277.93,5449.0,14 RC,360,CHEMODENERVATION OF TRUNK MUSCLE(S); 1-5 MUSCLE(S),,,652.03,5449.0,14 RC,360,CHEMODENERVATION OF TRUNK MUSCLE(S); 6 OR MORE MUSCLES,,,652.03,5449.0,14 RC,360,"CHEMOTHERAPY ADMINISTRATION, INTO CNS (EG, INTRATHECAL), REQUIRING AND INCLUDING SPINAL PUNCTURE",,,312.3,341.28,11 RC,360,"CHEMOTHERAPY ADMINISTRATION; INTRALESIONAL, UP TO AND INCLUDING 7 LESIONS",,,67.01,73.22,11 RC,360,"CHROMOTUBATION OF OVIDUCT, INCLUDING MATERIALS",,,4647.86,13194.0,15 RC,360,"CILIARY BODY DESTRUCTION; CYCLOPHOTOCOAGULATION, ENDOSCOPIC, WITHOUT CONCOMITANT REMOVAL OF CRYSTALLINE LENS",,,2147.4,9324.0,15 RC,360,"CILIARY BODY DESTRUCTION; CYCLOPHOTOCOAGULATION, TRANSSCLERAL",,,2196.57,9324.0,15 RC,360,"CIRCUMCISION, SURGICAL EXCISION OTHER THAN CLAMP, DEVICE, OR DORSAL SLIT; OLDER THAN 28 DAYS OF AGE",,,1928.76,9324.0,15 RC,360,"CIRCUMCISION, USING CLAMP OR OTHER DEVICE WITH REGIONAL DORSAL PENILE OR RING BLOCK",,,1928.76,9324.0,15 RC,360,CLAVICULECTOMY; PARTIAL,,,3054.93,13194.0,15 RC,360,CLITOROPLASTY FOR INTERSEX STATE,,,2993.65,9324.0,13 RC,360,"CLOSED TREATMENT OF ARTICULAR FRACTURE, INVOLVING METACARPOPHALANGEAL OR INTERPHALANGEAL JOINT; WITH MANIPULATION, EACH",,,777.0,7278.0,15 RC,360,"CLOSED TREATMENT OF BIMALLEOLAR ANKLE FRACTURE (EG, LATERAL AND MEDIAL MALLEOLI, OR LATERAL AND POSTERIOR MALLEOLI OR MEDIAL AND POSTERIOR MALLEOLI); WITH MANIPULATION",,,1506.85,5449.0,15 RC,360,"CLOSED TREATMENT OF CARPAL BONE FRACTURE (EXCLUDING CARPAL SCAPHOID [NAVICULAR]); WITH MANIPULATION, EACH BONE",,,777.0,5449.0,15 RC,360,"CLOSED TREATMENT OF CARPAL BONE FRACTURE (EXCLUDING CARPAL SCAPHOID [NAVICULAR]); WITHOUT MANIPULATION, EACH BONE",,,225.85,5449.0,14 RC,360,CLOSED TREATMENT OF CARPAL SCAPHOID (NAVICULAR) FRACTURE; WITHOUT MANIPULATION,,,225.85,1251.0,13 RC,360,CLOSED TREATMENT OF CLAVICULAR FRACTURE; WITHOUT MANIPULATION,,,225.85,5449.0,15 RC,360,"CLOSED TREATMENT OF DISTAL EXTENSOR TENDON INSERTION, WITH OR WITHOUT PERCUTANEOUS PINNING (EG, MALLET FINGER)",,,1506.85,8413.0,15 RC,360,CLOSED TREATMENT OF DISTAL FIBULAR FRACTURE (LATERAL MALLEOLUS); WITHOUT MANIPULATION,,,225.85,5449.0,15 RC,360,"CLOSED TREATMENT OF DISTAL PHALANGEAL FRACTURE, FINGER OR THUMB; WITH MANIPULATION, EACH",,,225.85,1251.0,13 RC,360,"CLOSED TREATMENT OF DISTAL RADIAL FRACTURE (EG, COLLES OR SMITH TYPE) OR EPIPHYSEAL SEPARATION, INCLUDES CLOSED TREATMENT OF FRACTURE OF ULNAR STYLOID, WHEN PERFORMED; WITH MANIPULATION",,,1506.85,8413.0,15 RC,360,"CLOSED TREATMENT OF FEMORAL FRACTURE, PROXIMAL END, NECK; WITH MANIPULATION, WITH OR WITHOUT SKELETAL TRACTION",,,3012.0,5449.0,3 RC,360,"CLOSED TREATMENT OF FEMORAL SHAFT FRACTURE, WITH MANIPULATION, WITH OR WITHOUT SKIN OR SKELETAL TRACTION",,,1506.85,7278.0,15 RC,360,"CLOSED TREATMENT OF FEMORAL SHAFT FRACTURE, WITHOUT MANIPULATION",,,225.85,5449.0,15 RC,360,"CLOSED TREATMENT OF FRACTURE, PHALANX OR PHALANGES, OTHER THAN GREAT TOE; WITHOUT MANIPULATION, EACH",,,225.85,5449.0,14 RC,360,"CLOSED TREATMENT OF HIP DISLOCATION, TRAUMATIC; REQUIRING ANESTHESIA",,,1506.85,7278.0,15 RC,360,"CLOSED TREATMENT OF HUMERAL EPICONDYLAR FRACTURE, MEDIAL OR LATERAL; WITH MANIPULATION",,,777.0,7278.0,15 RC,360,CLOSED TREATMENT OF MANDIBULAR FRACTURE WITH INTERDENTAL FIXATION,,,5569.83,15394.0,15 RC,360,CLOSED TREATMENT OF MANDIBULAR FRACTURE; WITH MANIPULATION,,,1394.69,10561.0,15 RC,360,CLOSED TREATMENT OF MANDIBULAR OR MAXILLARY ALVEOLAR RIDGE FRACTURE (SEPARATE PROCEDURE),,,3053.48,9324.0,15 RC,360,"CLOSED TREATMENT OF METACARPAL FRACTURE, SINGLE; WITH MANIPULATION, EACH BONE",,,225.85,7278.0,15 RC,360,"CLOSED TREATMENT OF METACARPAL FRACTURE, SINGLE; WITHOUT MANIPULATION, EACH BONE",,,225.85,1251.0,13 RC,360,"CLOSED TREATMENT OF METACARPAL FRACTURE, WITH MANIPULATION, WITH EXTERNAL FIXATION, EACH BONE",,,3012.0,7278.0,15 RC,360,"CLOSED TREATMENT OF METACARPOPHALANGEAL DISLOCATION, SINGLE, WITH MANIPULATION; REQUIRING ANESTHESIA",,,777.0,7278.0,15 RC,360,"CLOSED TREATMENT OF METATARSAL FRACTURE; WITH MANIPULATION, EACH",,,225.85,5449.0,14 RC,360,"CLOSED TREATMENT OF METATARSAL FRACTURE; WITHOUT MANIPULATION, EACH",,,225.85,5449.0,14 RC,360,CLOSED TREATMENT OF METATARSOPHALANGEAL JOINT DISLOCATION; REQUIRING ANESTHESIA,,,1506.85,5449.0,15 RC,360,CLOSED TREATMENT OF NASAL BONE FRACTURE WITH MANIPULATION; WITH STABILIZATION,,,3012.0,7278.0,15 RC,360,CLOSED TREATMENT OF NASAL BONE FRACTURE WITH MANIPULATION; WITHOUT STABILIZATION,,,1394.69,7278.0,15 RC,360,"CLOSED TREATMENT OF NASAL SEPTAL FRACTURE, WITH OR WITHOUT STABILIZATION",,,3012.0,7278.0,15 RC,360,CLOSED TREATMENT OF PATELLAR DISLOCATION; WITHOUT ANESTHESIA,,,225.85,5449.0,15 RC,360,"CLOSED TREATMENT OF PATELLAR FRACTURE, WITHOUT MANIPULATION",,,225.85,5449.0,15 RC,360,"CLOSED TREATMENT OF PHALANGEAL SHAFT FRACTURE, PROXIMAL OR MIDDLE PHALANX, FINGER OR THUMB; WITH MANIPULATION, WITH OR WITHOUT SKIN OR SKELETAL TRACTION, EACH",,,225.85,7278.0,14 RC,360,CLOSED TREATMENT OF POST HIP ARTHROPLASTY DISLOCATION; REQUIRING REGIONAL OR GENERAL ANESTHESIA,,,1506.85,7278.0,15 RC,360,CLOSED TREATMENT OF POSTERIOR MALLEOLUS FRACTURE; WITHOUT MANIPULATION,,,225.85,5449.0,15 RC,360,CLOSED TREATMENT OF RADIAL AND ULNAR SHAFT FRACTURES; WITH MANIPULATION,,,777.0,7278.0,15 RC,360,CLOSED TREATMENT OF RADIAL HEAD OR NECK FRACTURE; WITH MANIPULATION,,,777.0,5449.0,15 RC,360,"CLOSED TREATMENT OF RADIOCARPAL OR INTERCARPAL DISLOCATION, 1 OR MORE BONES, WITH MANIPULATION",,,225.85,5449.0,15 RC,360,"CLOSED TREATMENT OF SHOULDER DISLOCATION, WITH MANIPULATION; REQUIRING ANESTHESIA",,,1506.85,5449.0,15 RC,360,"CLOSED TREATMENT OF SUPRACONDYLAR OR TRANSCONDYLAR HUMERAL FRACTURE, WITH OR WITHOUT INTERCONDYLAR EXTENSION; WITH MANIPULATION, WITH OR WITHOUT SKIN OR SKELETAL TRACTION",,,777.0,5449.0,15 RC,360,CLOSED TREATMENT OF TALUS FRACTURE; WITHOUT MANIPULATION,,,225.85,5449.0,14 RC,360,"CLOSED TREATMENT OF TARSAL BONE DISLOCATION, OTHER THAN TALOTARSAL; WITHOUT ANESTHESIA",,,225.85,5449.0,14 RC,360,CLOSED TREATMENT OF TEMPOROMANDIBULAR DISLOCATION; INITIAL OR SUBSEQUENT,,,225.85,5449.0,15 RC,360,"CLOSED TREATMENT OF TIBIAL SHAFT FRACTURE (WITH OR WITHOUT FIBULAR FRACTURE); WITH MANIPULATION, WITH OR WITHOUT SKELETAL TRACTION",,,1506.85,5449.0,15 RC,360,CLOSED TREATMENT OF TRIMALLEOLAR ANKLE FRACTURE; WITH MANIPULATION,,,1506.85,5449.0,15 RC,360,CLOSED TREATMENT OF ULNAR SHAFT FRACTURE; WITH MANIPULATION,,,225.85,5449.0,15 RC,360,CLOSURE OF ANAL FISTULA WITH RECTAL ADVANCEMENT FLAP,,,2582.07,13194.0,15 RC,360,CLOSURE OF ENTEROENTERIC OR ENTEROCOLIC FISTULA,,,2533.0,4850.0,2 RC,360,"CLOSURE OF ENTEROSTOMY, LARGE OR SMALL INTESTINE;",,,2533.0,4850.0,2 RC,360,"CLOSURE OF ENTEROSTOMY, LARGE OR SMALL INTESTINE; WITH RESECTION AND COLORECTAL ANASTOMOSIS (EG, CLOSURE OF HARTMANN TYPE PROCEDURE)",,,2533.0,4850.0,2 RC,360,CLOSURE OF GASTROCOLIC FISTULA,,,2533.0,4850.0,2 RC,360,"CLOSURE OF GASTROSTOMY, SURGICAL",,,3582.12,9324.0,15 RC,360,"CLOSURE OF LACERATION, VESTIBULE OF MOUTH; 2.5 CM OR LESS",,,218.65,1251.0,13 RC,360,"CLOSURE OF LACERATION, VESTIBULE OF MOUTH; OVER 2.5 CM OR COMPLEX",,,479.48,5449.0,15 RC,360,CLOSURE OF RECTOVAGINAL FISTULA; VAGINAL OR TRANSANAL APPROACH,,,2993.65,9324.0,15 RC,360,"CLOSURE OF THE LACRIMAL PUNCTUM; BY PLUG, EACH",,,281.46,5449.0,14 RC,360,"CLOSURE OF THE LACRIMAL PUNCTUM; BY THERMOCAUTERIZATION, LIGATION, OR LASER SURGERY",,,281.46,5449.0,14 RC,360,"CLOSURE OF URETHROSTOMY OR URETHROCUTANEOUS FISTULA, MALE (SEPARATE PROCEDURE)",,,4786.44,13194.0,15 RC,360,CLOSURE OF URETHROVAGINAL FISTULA;,,,6649.0,15394.0,15 RC,360,"CLOSURE OF VESICOVAGINAL FISTULA, ABDOMINAL APPROACH",,,7444.0,13194.0,3 RC,360,CLOSURE OF VESICOVAGINAL FISTULA; VAGINAL APPROACH,,,4647.86,13194.0,15 RC,360,"COCCYGECTOMY, PRIMARY",,,3054.93,13194.0,15 RC,360,"COCHLEAR DEVICE IMPLANTATION, WITH OR WITHOUT MASTOIDECTOMY",,,12408.0,38950.0,15 RC,360,COLLECTION OF VENOUS BLOOD BY VENIPUNCTURE,,,6.83,9.64,12 RC,360,"COLONOSCOPY, FLEXIBLE; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,858.41,7278.0,15 RC,360,"COLONOSCOPY, FLEXIBLE; WITH BIOPSY, SINGLE OR MULTIPLE",,,1110.16,7278.0,15 RC,360,"COLONOSCOPY, FLEXIBLE; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,1110.16,7278.0,15 RC,360,"COLONOSCOPY, FLEXIBLE; WITH ENDOSCOPIC MUCOSAL RESECTION",,,2582.07,8213.0,15 RC,360,"COLONOSCOPY, FLEXIBLE; WITH REMOVAL OF FOREIGN BODY(S)",,,1110.16,7278.0,15 RC,360,"COLONOSCOPY, FLEXIBLE; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE",,,1110.16,7278.0,15 RC,360,COLPOCLEISIS (LE FORT TYPE),,,4647.86,13194.0,14 RC,360,"COLPOPEXY, VAGINAL; EXTRA-PERITONEAL APPROACH (SACROSPINOUS, ILIOCOCCYGEUS)",,,6962.51,15394.0,14 RC,360,"COLPOPEXY, VAGINAL; INTRA-PERITONEAL APPROACH (UTEROSACRAL, LEVATOR MYORRHAPHY)",,,6962.51,15394.0,14 RC,360,"COLPORRHAPHY, SUTURE OF INJURY OF VAGINA (NONOBSTETRICAL)",,,2993.65,9324.0,15 RC,360,COLPOSCOPY OF THE CERVIX INCLUDING UPPER/ADJACENT VAGINA;,,,189.41,7278.0,15 RC,360,COLPOSCOPY OF THE CERVIX INCLUDING UPPER/ADJACENT VAGINA; WITH BIOPSY(S) OF THE CERVIX,,,286.41,5449.0,15 RC,360,COLPOSCOPY OF THE CERVIX INCLUDING UPPER/ADJACENT VAGINA; WITH BIOPSY(S) OF THE CERVIX AND ENDOCERVICAL CURETTAGE,,,286.41,7278.0,15 RC,360,COLPOSCOPY OF THE CERVIX INCLUDING UPPER/ADJACENT VAGINA; WITH ENDOCERVICAL CURETTAGE,,,286.41,5449.0,15 RC,360,COLPOSCOPY OF THE CERVIX INCLUDING UPPER/ADJACENT VAGINA; WITH LOOP ELECTRODE BIOPSY(S) OF THE CERVIX,,,2993.65,9324.0,14 RC,360,COLPOSCOPY OF THE CERVIX INCLUDING UPPER/ADJACENT VAGINA; WITH LOOP ELECTRODE CONIZATION OF THE CERVIX,,,2993.65,9324.0,15 RC,360,"COLPOSCOPY OF THE ENTIRE VAGINA, WITH CERVIX IF PRESENT;",,,286.41,5449.0,15 RC,360,COLPOSCOPY OF THE VULVA; WITH BIOPSY(S),,,286.41,5449.0,15 RC,360,COLPOTOMY; WITH EXPLORATION,,,2993.65,9324.0,15 RC,360,"COMBINED ANTEROPOSTERIOR COLPORRHAPHY, INCLUDING CYSTOURETHROSCOPY, WHEN PERFORMED;",,,4647.86,13194.0,15 RC,360,"COMBINED ANTEROPOSTERIOR COLPORRHAPHY, INCLUDING CYSTOURETHROSCOPY, WHEN PERFORMED; WITH ENTEROCELE REPAIR",,,4647.86,15394.0,15 RC,360,"COMPLEX CYSTOMETROGRAM (IE, CALIBRATED ELECTRONIC EQUIPMENT);",,,228.99,5449.0,15 RC,360,"COMPLEX CYSTOMETROGRAM (IE, CALIBRATED ELECTRONIC EQUIPMENT); WITH VOIDING PRESSURE STUDIES (IE, BLADDER VOIDING PRESSURE), ANY TECHNIQUE",,,628.45,5449.0,14 RC,360,"COMPUTER-AIDED MAPPING OF CERVIX UTERI DURING COLPOSCOPY, INCLUDING OPTICAL DYNAMIC SPECTRAL IMAGING AND ALGORITHMIC QUANTIFICATION OF THE ACETOWHITENING EFFECT (LIST SEPARATELY IN ADDITION TO CODE FO",,,777.0,1251.0,2 RC,360,"COMPUTER-ASSISTED MUSCULOSKELETAL SURGICAL NAVIGATIONAL ORTHOPEDIC PROCEDURE, WITH IMAGE-GUIDANCE BASED ON FLUOROSCOPIC IMAGES (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"COMPUTER-ASSISTED SURGICAL NAVIGATIONAL PROCEDURE FOR MUSCULOSKELETAL PROCEDURES, IMAGE-LESS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"CONDYLECTOMY, TEMPOROMANDIBULAR JOINT (SEPARATE PROCEDURE)",,,5569.83,15394.0,15 RC,360,"CONIZATION OF CERVIX, WITH OR WITHOUT FULGURATION, WITH OR WITHOUT DILATION AND CURETTAGE, WITH OR WITHOUT REPAIR; COLD KNIFE OR LASER",,,2993.65,9324.0,15 RC,360,"CONIZATION OF CERVIX, WITH OR WITHOUT FULGURATION, WITH OR WITHOUT DILATION AND CURETTAGE, WITH OR WITHOUT REPAIR; LOOP ELECTRODE EXCISION",,,2993.65,9324.0,15 RC,360,CONJUNCTIVAL FLAP; BRIDGE OR PARTIAL (SEPARATE PROCEDURE),,,3550.55,13194.0,15 RC,360,"CONJUNCTIVOPLASTY, RECONSTRUCTION CUL-DE-SAC; WITH CONJUNCTIVAL GRAFT OR EXTENSIVE REARRANGEMENT",,,3550.55,13194.0,15 RC,360,CONJUNCTIVOPLASTY; WITH BUCCAL MUCOUS MEMBRANE GRAFT (INCLUDES OBTAINING GRAFT),,,3550.55,13194.0,15 RC,360,CONJUNCTIVOPLASTY; WITH CONJUNCTIVAL GRAFT OR EXTENSIVE REARRANGEMENT,,,2196.57,10561.0,15 RC,360,CONJUNCTIVORHINOSTOMY (FISTULIZATION OF CONJUNCTIVA TO NASAL CAVITY); WITH INSERTION OF TUBE OR STENT,,,3550.55,13194.0,15 RC,360,CONSTRUCTION OF ARTIFICIAL VAGINA; WITH GRAFT,,,4647.86,13194.0,14 RC,360,"CONSTRUCTION OF TRACHEOESOPHAGEAL FISTULA AND SUBSEQUENT INSERTION OF AN ALARYNGEAL SPEECH PROSTHESIS (EG, VOICE BUTTON, BLOM-SINGER PROSTHESIS)",,,3053.48,9324.0,15 RC,360,"CONTROL NASAL HEMORRHAGE, ANTERIOR, COMPLEX (EXTENSIVE CAUTERY AND/OR PACKING) ANY METHOD",,,121.37,5449.0,15 RC,360,"CONTROL NASAL HEMORRHAGE, ANTERIOR, SIMPLE (LIMITED CAUTERY AND/OR PACKING) ANY METHOD",,,121.37,5449.0,14 RC,360,"CONTROL OROPHARYNGEAL HEMORRHAGE, PRIMARY OR SECONDARY (EG, POST-TONSILLECTOMY); COMPLICATED, REQUIRING HOSPITALIZATION",,,5514.0,9324.0,2 RC,360,"CONTROL OROPHARYNGEAL HEMORRHAGE, PRIMARY OR SECONDARY (EG, POST-TONSILLECTOMY); SIMPLE",,,479.48,5449.0,15 RC,360,"CONVERSION OF PREVIOUS HIP SURGERY TO TOTAL HIP ARTHROPLASTY, WITH OR WITHOUT AUTOGRAFT OR ALLOGRAFT",,,13764.0,30725.0,3 RC,360,"CORE NEEDLE BIOPSY, LUNG OR MEDIASTINUM, PERCUTANEOUS, INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,1525.52,12408.0,15 RC,360,CORNEAL RELAXING INCISION FOR CORRECTION OF SURGICALLY INDUCED ASTIGMATISM,,,911.92,10561.0,15 RC,360,CORNEAL WEDGE RESECTION FOR CORRECTION OF SURGICALLY INDUCED ASTIGMATISM,,,2196.57,10561.0,15 RC,360,CORONOIDECTOMY (SEPARATE PROCEDURE),,,5569.83,15394.0,15 RC,360,CORRECTION OF INVERTED NIPPLES,,,3605.42,13194.0,15 RC,360,"CORRECTION OF LAGOPHTHALMOS, WITH IMPLANTATION OF UPPER EYELID LID LOAD (EG, GOLD WEIGHT)",,,2196.57,9324.0,15 RC,360,CORRECTION OF LID RETRACTION,,,2196.57,9324.0,15 RC,360,"CORRECTION OF TRICHIASIS; EPILATION BY OTHER THAN FORCEPS (EG, BY ELECTROSURGERY, CRYOTHERAPY, LASER SURGERY)",,,281.46,4121.0,14 RC,360,"CORRECTION, HALLUX VALGUS WITH BUNIONECTOMY, WITH SESAMOIDECTOMY WHEN PERFORMED; WITH DISTAL METATARSAL OSTEOTOMY, ANY METHOD",,,3054.93,13194.0,15 RC,360,"CORRECTION, HALLUX VALGUS WITH BUNIONECTOMY, WITH SESAMOIDECTOMY WHEN PERFORMED; WITH DOUBLE OSTEOTOMY, ANY METHOD",,,6726.11,13194.0,15 RC,360,"CORRECTION, HALLUX VALGUS WITH BUNIONECTOMY, WITH SESAMOIDECTOMY WHEN PERFORMED; WITH FIRST METATARSAL AND MEDIAL CUNEIFORM JOINT ARTHRODESIS, ANY METHOD",,,6649.0,13238.67,15 RC,360,"CORRECTION, HALLUX VALGUS WITH BUNIONECTOMY, WITH SESAMOIDECTOMY WHEN PERFORMED; WITH PROXIMAL METATARSAL OSTEOTOMY, ANY METHOD",,,3054.93,13194.0,15 RC,360,"CORRECTION, HALLUX VALGUS WITH BUNIONECTOMY, WITH SESAMOIDECTOMY WHEN PERFORMED; WITH PROXIMAL PHALANX OSTEOTOMY, ANY METHOD",,,6649.0,13194.0,15 RC,360,"CORRECTION, HALLUX VALGUS WITH BUNIONECTOMY, WITH SESAMOIDECTOMY WHEN PERFORMED; WITH RESECTION OF PROXIMAL PHALANX BASE, WHEN PERFORMED, ANY METHOD",,,3054.93,13194.0,15 RC,360,"CORRECTION, HAMMERTOE (EG, INTERPHALANGEAL FUSION, PARTIAL OR TOTAL PHALANGECTOMY)",,,3054.93,9324.0,15 RC,360,"CRANIECTOMY OR CRANIOTOMY FOR IMPLANTATION OF NEUROSTIMULATOR ELECTRODES, CEREBRAL, CORTICAL",,,2533.0,4850.0,2 RC,360,CRANIECTOMY; WITH EXCISION OF TUMOR OR OTHER BONE LESION OF SKULL,,,13844.0,21454.0,3 RC,360,"CRANIOFACIAL APPROACH TO ANTERIOR CRANIAL FOSSA; EXTRADURAL, INCLUDING LATERAL RHINOTOMY, ORBITAL EXENTERATION, ETHMOIDECTOMY, SPHENOIDECTOMY AND/OR MAXILLECTOMY",,,2533.0,4850.0,2 RC,360,CRANIOPLASTY FOR SKULL DEFECT; UP TO 5 CM DIAMETER,,,2533.0,4850.0,2 RC,360,"CRANIOTOMY FOR REPAIR OF ENCEPHALOCELE, SKULL BASE",,,2533.0,4850.0,2 RC,360,CREATION OF ARTERIOVENOUS FISTULA BY OTHER THAN DIRECT ARTERIOVENOUS ANASTOMOSIS (SEPARATE PROCEDURE); AUTOGENOUS GRAFT,,,5089.69,21454.0,15 RC,360,"CREATION OF ARTERIOVENOUS FISTULA BY OTHER THAN DIRECT ARTERIOVENOUS ANASTOMOSIS (SEPARATE PROCEDURE); NONAUTOGENOUS GRAFT (EG, BIOLOGICAL COLLAGEN, THERMOPLASTIC GRAFT)",,,5089.69,21454.0,15 RC,360,"CREATION OF LESION OF SPINAL CORD BY STEREOTACTIC METHOD, PERCUTANEOUS, ANY MODALITY (INCLUDING STIMULATION AND/OR RECORDING)",,,1838.62,9324.0,15 RC,360,"CREATION OF SHUNT, LUMBAR, SUBARACHNOID-PERITONEAL, -PLEURAL, OR OTHER; PERCUTANEOUS, NOT REQUIRING LAMINECTOMY",,,6029.68,15394.0,14 RC,360,"CREATION OF SHUNT; VENTRICULO-PERITONEAL, -PLEURAL, OTHER TERMINUS",,,2533.0,4850.0,2 RC,360,CRYOSURGICAL ABLATION OF THE PROSTATE (INCLUDES ULTRASONIC GUIDANCE AND MONITORING),,,8706.56,30725.0,15 RC,360,"CURETTAGE, POSTPARTUM",,,2993.65,9324.0,15 RC,360,CUTANEOUS VESICOSTOMY,,,5514.0,9324.0,2 RC,360,"CYSTECTOMY, PARTIAL; SIMPLE",,,2533.0,4850.0,2 RC,360,"CYSTOLITHOTOMY, CYSTOTOMY WITH REMOVAL OF CALCULUS, WITHOUT VESICAL NECK RESECTION",,,4786.44,10561.0,15 RC,360,"CYSTORRHAPHY, SUTURE OF BLADDER WOUND, INJURY OR RUPTURE; COMPLICATED",,,7444.0,13194.0,3 RC,360,"CYSTORRHAPHY, SUTURE OF BLADDER WOUND, INJURY OR RUPTURE; SIMPLE",,,5514.0,9514.39,14 RC,360,"CYSTOSTOMY, CYSTOTOMY WITH DRAINAGE",,,1928.76,10561.0,15 RC,360,"CYSTOTOMY FOR EXCISION, INCISION, OR REPAIR OF URETEROCELE",,,3247.35,9324.0,13 RC,360,"CYSTOTOMY, WITH CALCULUS BASKET EXTRACTION AND/OR ULTRASONIC OR ELECTROHYDRAULIC FRAGMENTATION OF URETERAL CALCULUS",,,3247.35,10561.0,15 RC,360,"CYSTOTOMY, WITH INSERTION OF URETERAL CATHETER OR STENT (SEPARATE PROCEDURE)",,,1928.76,10561.0,15 RC,360,"CYSTOURETHROSCOPY (INCLUDING URETERAL CATHETERIZATION); WITH MANIPULATION, WITHOUT REMOVAL OF URETERAL CALCULUS",,,3247.35,9324.0,15 RC,360,CYSTOURETHROSCOPY (INCLUDING URETERAL CATHETERIZATION); WITH SUBURETERIC INJECTION OF IMPLANT MATERIAL,,,4786.44,15394.0,15 RC,360,CYSTOURETHROSCOPY (SEPARATE PROCEDURE),,,628.45,5449.0,15 RC,360,CYSTOURETHROSCOPY WITH DIRECT VISION INTERNAL URETHROTOMY,,,1928.76,9324.0,15 RC,360,"CYSTOURETHROSCOPY WITH INCISION, FULGURATION, OR RESECTION OF CONGENITAL POSTERIOR URETHRAL VALVES, OR CONGENITAL OBSTRUCTIVE HYPERTROPHIC MUCOSAL FOLDS",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY WITH INSERTION OF TEMPORARY DEVICE FOR ISCHEMIC REMODELING (IE, PRESSURE NECROSIS) OF BLADDER NECK AND PROSTATE",,,5514.0,9514.39,14 RC,360,"CYSTOURETHROSCOPY WITH INSERTION OF URETERAL GUIDE WIRE THROUGH KIDNEY TO ESTABLISH A PERCUTANEOUS NEPHROSTOMY, RETROGRADE",,,3247.35,9324.0,15 RC,360,CYSTOURETHROSCOPY WITH IRRIGATION AND EVACUATION OF MULTIPLE OBSTRUCTING CLOTS,,,3012.0,7278.0,15 RC,360,"CYSTOURETHROSCOPY WITH TRANSURETHRAL ANTERIOR PROSTATE COMMISSUROTOMY AND DRUG DELIVERY, INCLUDING TRANSRECTAL ULTRASOUND AND FLUOROSCOPY, WHEN PERFORMED",,,5514.0,9514.39,14 RC,360,"CYSTOURETHROSCOPY WITH URETEROSCOPY; WITH TREATMENT OF INTRA-RENAL STRICTURE (EG, BALLOON DILATION, LASER, ELECTROCAUTERY, AND INCISION)",,,4786.44,9324.0,15 RC,360,"CYSTOURETHROSCOPY WITH URETEROSCOPY; WITH TREATMENT OF URETERAL STRICTURE (EG, BALLOON DILATION, LASER, ELECTROCAUTERY, AND INCISION)",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY WITH URETEROSCOPY; WITH TREATMENT OF URETEROPELVIC JUNCTION STRICTURE (EG, BALLOON DILATION, LASER, ELECTROCAUTERY, AND INCISION)",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH BIOPSY(S)",,,1928.76,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH CALIBRATION AND/OR DILATION OF URETHRAL STRICTURE OR STENOSIS, WITH OR WITHOUT MEATOTOMY, WITH OR WITHOUT INJECTION PROCEDURE FOR CYSTOGRAPHY, MALE OR FEMALE",,,1928.76,7278.0,15 RC,360,"CYSTOURETHROSCOPY, WITH DILATION OF BLADDER FOR INTERSTITIAL CYSTITIS; GENERAL OR CONDUCTION (SPINAL) ANESTHESIA",,,1928.76,7278.0,15 RC,360,"CYSTOURETHROSCOPY, WITH EJACULATORY DUCT CATHETERIZATION, WITH OR WITHOUT IRRIGATION, INSTILLATION, OR DUCT RADIOGRAPHY, EXCLUSIVE OF RADIOLOGIC SERVICE",,,628.45,7278.0,15 RC,360,"CYSTOURETHROSCOPY, WITH FULGURATION (INCLUDING CRYOSURGERY OR LASER SURGERY) AND/OR RESECTION OF; LARGE BLADDER TUMOR(S)",,,4786.44,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH FULGURATION (INCLUDING CRYOSURGERY OR LASER SURGERY) AND/OR RESECTION OF; MEDIUM BLADDER TUMOR(S) (2.0 TO 5.0 CM)",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH FULGURATION (INCLUDING CRYOSURGERY OR LASER SURGERY) AND/OR RESECTION OF; SMALL BLADDER TUMOR(S) (0.5 UP TO 2.0 CM)",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH FULGURATION (INCLUDING CRYOSURGERY OR LASER SURGERY) OF TRIGONE, BLADDER NECK, PROSTATIC FOSSA, URETHRA, OR PERIURETHRAL GLANDS",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH FULGURATION (INCLUDING CRYOSURGERY OR LASER SURGERY) OR TREATMENT OF MINOR (LESS THAN 0.5 CM) LESION(S) WITH OR WITHOUT BIOPSY",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH INJECTION(S) FOR CHEMODENERVATION OF THE BLADDER",,,1928.76,9350.0,15 RC,360,"CYSTOURETHROSCOPY, WITH INSERTION OF INDWELLING URETERAL STENT (EG, GIBBONS OR DOUBLE-J TYPE)",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH INSERTION OF PERMANENT URETHRAL STENT",,,3247.35,17457.0,15 RC,360,"CYSTOURETHROSCOPY, WITH INSERTION OF TEMPORARY PROSTATIC IMPLANT/STENT WITH FIXATION/ANCHOR AND INCISIONAL STRUTS",,,8413.0,8413.0,1 RC,360,"CYSTOURETHROSCOPY, WITH MECHANICAL URETHRAL DILATION AND URETHRAL THERAPEUTIC DRUG DELIVERY BY DRUG-COATED BALLOON CATHETER FOR URETHRAL STRICTURE OR STENOSIS, MALE, INCLUDING FLUOROSCOPY, WHEN PERFOR",,,4786.44,9324.0,14 RC,360,"CYSTOURETHROSCOPY, WITH REMOVAL OF FOREIGN BODY, CALCULUS, OR URETERAL STENT FROM URETHRA OR BLADDER (SEPARATE PROCEDURE); COMPLICATED",,,1928.76,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH REMOVAL OF FOREIGN BODY, CALCULUS, OR URETERAL STENT FROM URETHRA OR BLADDER (SEPARATE PROCEDURE); SIMPLE",,,1928.76,7278.0,15 RC,360,"CYSTOURETHROSCOPY, WITH STEROID INJECTION INTO STRICTURE",,,1928.76,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH URETERAL CATHETERIZATION, WITH OR WITHOUT IRRIGATION, INSTILLATION, OR URETEROPYELOGRAPHY, EXCLUSIVE OF RADIOLOGIC SERVICE;",,,1928.76,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH URETEROSCOPY AND/OR PYELOSCOPY, WITH LITHOTRIPSY, AND URETERAL CATHETERIZATION FOR STEERABLE VACUUM ASPIRATION OF THE KIDNEY, COLLECTING SYSTEM, URETER, BLADDER, AND URETHRA IF",,,5514.0,10561.0,14 RC,360,"CYSTOURETHROSCOPY, WITH URETEROSCOPY AND/OR PYELOSCOPY; DIAGNOSTIC",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY, WITH URETEROSCOPY AND/OR PYELOSCOPY; WITH BIOPSY AND/OR FULGURATION OF URETERAL OR RENAL PELVIC LESION",,,4786.44,10561.0,15 RC,360,"CYSTOURETHROSCOPY, WITH URETEROSCOPY AND/OR PYELOSCOPY; WITH LITHOTRIPSY (URETERAL CATHETERIZATION IS INCLUDED)",,,4786.44,15394.0,15 RC,360,"CYSTOURETHROSCOPY, WITH URETEROSCOPY AND/OR PYELOSCOPY; WITH LITHOTRIPSY INCLUDING INSERTION OF INDWELLING URETERAL STENT (EG, GIBBONS OR DOUBLE-J TYPE)",,,4786.44,17457.0,15 RC,360,"CYSTOURETHROSCOPY, WITH URETEROSCOPY AND/OR PYELOSCOPY; WITH REMOVAL OR MANIPULATION OF CALCULUS (URETERAL CATHETERIZATION IS INCLUDED)",,,3247.35,10561.0,15 RC,360,"CYSTOURETHROSCOPY, WITH URETEROSCOPY AND/OR PYELOSCOPY; WITH RESECTION OF URETERAL OR RENAL PELVIC TUMOR",,,4786.44,10561.0,15 RC,360,"CYSTOURETHROSCOPY; WITH INCISION OR RESECTION OF ORIFICE OF BLADDER DIVERTICULUM, SINGLE OR MULTIPLE",,,4786.44,9324.0,15 RC,360,"CYSTOURETHROSCOPY; WITH RESECTION OR FULGURATION OF ORTHOTOPIC URETEROCELE(S), UNILATERAL OR BILATERAL",,,3247.35,9324.0,15 RC,360,"CYSTOURETHROSCOPY; WITH TREATMENT OF URETERAL STRICTURE (EG, BALLOON DILATION, LASER, ELECTROCAUTERY, AND INCISION)",,,3247.35,9324.0,15 RC,360,DACRYOCYSTORHINOSTOMY (FISTULIZATION OF LACRIMAL SAC TO NASAL CAVITY),,,3550.55,13194.0,15 RC,360,"DEBRIDEMENT (EG, HIGH PRESSURE WATERJET WITH/WITHOUT SUCTION, SHARP SELECTIVE DEBRIDEMENT WITH SCISSORS, SCALPEL AND FORCEPS), OPEN WOUND, (EG, FIBRIN, DEVITALIZED EPIDERMIS AND/OR DERMIS, EXUDATE, DE",,,187.08,5449.0,14 RC,360,"DEBRIDEMENT INCLUDING REMOVAL OF FOREIGN MATERIAL AT THE SITE OF AN OPEN FRACTURE AND/OR AN OPEN DISLOCATION (EG, EXCISIONAL DEBRIDEMENT); SKIN AND SUBCUTANEOUS TISSUES",,,662.46,7278.0,15 RC,360,"DEBRIDEMENT INCLUDING REMOVAL OF FOREIGN MATERIAL AT THE SITE OF AN OPEN FRACTURE AND/OR AN OPEN DISLOCATION (EG, EXCISIONAL DEBRIDEMENT); SKIN, SUBCUTANEOUS TISSUE, MUSCLE FASCIA, AND MUSCLE",,,662.46,7278.0,15 RC,360,"DEBRIDEMENT INCLUDING REMOVAL OF FOREIGN MATERIAL AT THE SITE OF AN OPEN FRACTURE AND/OR AN OPEN DISLOCATION (EG, EXCISIONAL DEBRIDEMENT); SKIN, SUBCUTANEOUS TISSUE, MUSCLE FASCIA, MUSCLE, AND BONE",,,2246.0,7278.0,15 RC,360,DEBRIDEMENT OF EXTENSIVE ECZEMATOUS OR INFECTED SKIN; UP TO 10% OF BODY SURFACE,,,576.34,5449.0,14 RC,360,DEBRIDEMENT OF NAIL(S) BY ANY METHOD(S); 1 TO 5,,,55.93,5449.0,14 RC,360,"DEBRIDEMENT OF SKIN, SUBCUTANEOUS TISSUE, MUSCLE AND FASCIA FOR NECROTIZING SOFT TISSUE INFECTION; ABDOMINAL WALL, WITH OR WITHOUT FASCIAL CLOSURE",,,2533.0,4850.0,2 RC,360,"DEBRIDEMENT OF SKIN, SUBCUTANEOUS TISSUE, MUSCLE AND FASCIA FOR NECROTIZING SOFT TISSUE INFECTION; EXTERNAL GENITALIA AND PERINEUM",,,2533.0,4850.0,2 RC,360,"DEBRIDEMENT, BONE (INCLUDES EPIDERMIS, DERMIS, SUBCUTANEOUS TISSUE, MUSCLE AND/OR FASCIA, IF PERFORMED); EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROC",,,777.0,5449.0,3 RC,360,"DEBRIDEMENT, BONE (INCLUDES EPIDERMIS, DERMIS, SUBCUTANEOUS TISSUE, MUSCLE AND/OR FASCIA, IF PERFORMED); FIRST 20 SQ CM OR LESS",,,1525.52,7278.0,15 RC,360,"DEBRIDEMENT, MASTOIDECTOMY CAVITY, COMPLEX (EG, WITH ANESTHESIA OR MORE THAN ROUTINE CLEANING)",,,479.48,7278.0,14 RC,360,"DEBRIDEMENT, MASTOIDECTOMY CAVITY, SIMPLE (EG, ROUTINE CLEANING)",,,187.08,1251.0,13 RC,360,"DEBRIDEMENT, MUSCLE AND/OR FASCIA (INCLUDES EPIDERMIS, DERMIS, AND SUBCUTANEOUS TISSUE, IF PERFORMED); EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCED",,,777.0,5449.0,3 RC,360,"DEBRIDEMENT, MUSCLE AND/OR FASCIA (INCLUDES EPIDERMIS, DERMIS, AND SUBCUTANEOUS TISSUE, IF PERFORMED); FIRST 20 SQ CM OR LESS",,,576.34,7278.0,15 RC,360,"DEBRIDEMENT, SUBCUTANEOUS TISSUE (INCLUDES EPIDERMIS AND DERMIS, IF PERFORMED); EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"DEBRIDEMENT, SUBCUTANEOUS TISSUE (INCLUDES EPIDERMIS AND DERMIS, IF PERFORMED); FIRST 20 SQ CM OR LESS",,,376.18,7278.0,15 RC,360,"DECOMPRESSION FACIAL NERVE, INTRATEMPORAL; LATERAL TO GENICULATE GANGLION",,,5569.83,15394.0,15 RC,360,"DECOMPRESSION FASCIOTOMY, LEG; ANTERIOR AND/OR LATERAL COMPARTMENTS ONLY",,,3054.93,9324.0,15 RC,360,"DECOMPRESSION FASCIOTOMY, LEG; ANTERIOR AND/OR LATERAL, AND POSTERIOR COMPARTMENT(S)",,,3054.93,13194.0,15 RC,360,"DECOMPRESSION FASCIOTOMY, LEG; POSTERIOR COMPARTMENT(S) ONLY",,,3054.93,9324.0,15 RC,360,DECOMPRESSION INTERNAL AUDITORY CANAL,,,5569.83,15394.0,13 RC,360,DECOMPRESSION; UNSPECIFIED NERVE(S) (SPECIFY),,,1838.62,9324.0,15 RC,360,"DELAY OF FLAP OR SECTIONING OF FLAP (DIVISION AND INSET); AT EYELIDS, NOSE, EARS, OR LIPS",,,1722.29,8413.0,15 RC,360,"DELAY OF FLAP OR SECTIONING OF FLAP (DIVISION AND INSET); AT FOREHEAD, CHEEKS, CHIN, NECK, AXILLAE, GENITALIA, HANDS, OR FEET",,,1722.29,10561.0,15 RC,360,"DELAY OF FLAP OR SECTIONING OF FLAP (DIVISION AND INSET); AT SCALP, ARMS, OR LEGS",,,1722.29,9324.0,15 RC,360,"DESTRUCTION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), OF BENIGN LESIONS OTHER THAN SKIN TAGS OR CUTANEOUS VASCULAR PROLIFERATIVE LESIONS; 15 OR MORE LESIONS",,,187.08,5449.0,14 RC,360,"DESTRUCTION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), OF BENIGN LESIONS OTHER THAN SKIN TAGS OR CUTANEOUS VASCULAR PROLIFERATIVE LESIONS; UP TO 14 LESIONS",,,187.08,5449.0,14 RC,360,"DESTRUCTION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), PREMALIGNANT LESIONS (EG, ACTINIC KERATOSES), 15 OR MORE LESIONS",,,376.18,5449.0,15 RC,360,"DESTRUCTION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), PREMALIGNANT LESIONS (EG, ACTINIC KERATOSES); FIRST LESION",,,187.08,5449.0,14 RC,360,"DESTRUCTION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), PREMALIGNANT LESIONS (EG, ACTINIC KERATOSES); SECOND THROUGH 14 LESIONS, EACH (LIST SEPARATELY IN ADDI",,,777.0,5449.0,3 RC,360,"DESTRUCTION BY NEUROLYTIC AGENT, GENICULAR NERVE BRANCHES INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,1838.62,9324.0,15 RC,360,"DESTRUCTION BY NEUROLYTIC AGENT, PARAVERTEBRAL FACET JOINT NERVE(S), WITH IMAGING GUIDANCE (FLUOROSCOPY OR CT); CERVICAL OR THORACIC, SINGLE FACET JOINT",,,1838.62,9324.0,15 RC,360,DESTRUCTION BY NEUROLYTIC AGENT; OTHER PERIPHERAL NERVE OR BRANCH,,,838.24,5449.0,15 RC,360,"DESTRUCTION OF CUTANEOUS VASCULAR PROLIFERATIVE LESIONS (EG, LASER TECHNIQUE); 10.0 TO 50.0 SQ CM",,,576.34,5449.0,15 RC,360,"DESTRUCTION OF CUTANEOUS VASCULAR PROLIFERATIVE LESIONS (EG, LASER TECHNIQUE); LESS THAN 10 SQ CM",,,376.18,5449.0,15 RC,360,"DESTRUCTION OF CUTANEOUS VASCULAR PROLIFERATIVE LESIONS (EG, LASER TECHNIQUE); OVER 50.0 SQ CM",,,1722.29,5449.0,15 RC,360,"DESTRUCTION OF LESION OF CORNEA BY CRYOTHERAPY, PHOTOCOAGULATION OR THERMOCAUTERIZATION",,,281.46,5449.0,14 RC,360,"DESTRUCTION OF LESION OR SCAR OF VESTIBULE OF MOUTH BY PHYSICAL METHODS (EG, LASER, THERMAL, CRYO, CHEMICAL)",,,3012.0,5449.0,15 RC,360,"DESTRUCTION OF LESION(S), ANUS (EG, CONDYLOMA, PAPILLOMA, MOLLUSCUM CONTAGIOSUM, HERPETIC VESICLE), EXTENSIVE (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY)",,,2582.07,9324.0,15 RC,360,"DESTRUCTION OF LESION(S), ANUS (EG, CONDYLOMA, PAPILLOMA, MOLLUSCUM CONTAGIOSUM, HERPETIC VESICLE), SIMPLE; ELECTRODESICCATION",,,1722.29,7278.0,14 RC,360,"DESTRUCTION OF LESION(S), ANUS (EG, CONDYLOMA, PAPILLOMA, MOLLUSCUM CONTAGIOSUM, HERPETIC VESICLE), SIMPLE; LASER SURGERY",,,2582.07,9324.0,15 RC,360,"DESTRUCTION OF LESION(S), ANUS (EG, CONDYLOMA, PAPILLOMA, MOLLUSCUM CONTAGIOSUM, HERPETIC VESICLE), SIMPLE; SURGICAL EXCISION",,,2582.07,9324.0,15 RC,360,"DESTRUCTION OF LESION(S), PENIS (EG, CONDYLOMA, PAPILLOMA, MOLLUSCUM CONTAGIOSUM, HERPETIC VESICLE), EXTENSIVE (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY)",,,1722.29,5449.0,15 RC,360,"DESTRUCTION OF LESION(S), PENIS (EG, CONDYLOMA, PAPILLOMA, MOLLUSCUM CONTAGIOSUM, HERPETIC VESICLE), SIMPLE; LASER SURGERY",,,1722.29,5449.0,15 RC,360,"DESTRUCTION OF LESION(S), PENIS (EG, CONDYLOMA, PAPILLOMA, MOLLUSCUM CONTAGIOSUM, HERPETIC VESICLE), SIMPLE; SURGICAL EXCISION",,,1722.29,5449.0,15 RC,360,"DESTRUCTION OF LESION(S), VULVA; EXTENSIVE (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY)",,,1722.29,8413.0,15 RC,360,"DESTRUCTION OF LESION(S), VULVA; SIMPLE (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY)",,,1722.29,5449.0,14 RC,360,"DESTRUCTION OF LOCALIZED LESION OF RETINA (EG, MACULAR EDEMA, TUMORS), 1 OR MORE SESSIONS; RADIATION BY IMPLANTATION OF SOURCE (INCLUDES REMOVAL OF SOURCE)",,,3550.55,13194.0,15 RC,360,"DESTRUCTION OF VAGINAL LESION(S); EXTENSIVE (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY)",,,2993.65,9324.0,15 RC,360,"DESTRUCTION OF VAGINAL LESION(S); SIMPLE (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY)",,,2993.65,9324.0,14 RC,360,"DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.6 TO 1.0 CM",,,187.08,5449.0,14 RC,360,DIAGNOSTIC BONE MARROW; ASPIRATION(S),,,1525.52,5449.0,15 RC,360,DIAGNOSTIC BONE MARROW; BIOPSY(IES),,,1525.52,5449.0,15 RC,360,DIAGNOSTIC BONE MARROW; BIOPSY(IES) AND ASPIRATION(S),,,2694.74,5449.0,15 RC,360,"DILATION AND CATHETERIZATION OF SALIVARY DUCT, WITH OR WITHOUT INJECTION",,,479.48,5449.0,14 RC,360,DILATION AND CURETTAGE OF CERVICAL STUMP,,,2993.65,9324.0,15 RC,360,"DILATION AND CURETTAGE, DIAGNOSTIC AND/OR THERAPEUTIC (NONOBSTETRICAL)",,,2993.65,9324.0,15 RC,360,DILATION OF ANAL SPHINCTER (SEPARATE PROCEDURE) UNDER ANESTHESIA OTHER THAN LOCAL,,,1110.16,5449.0,15 RC,360,"DILATION OF ESOPHAGUS, BY UNGUIDED SOUND OR BOUGIE, SINGLE OR MULTIPLE PASSES",,,882.75,5449.0,15 RC,360,"DILATION OF ESOPHAGUS, OVER GUIDE WIRE",,,1786.09,5449.0,15 RC,360,"DILATION OF EXISTING TRACT, PERCUTANEOUS, FOR AN ENDOUROLOGIC PROCEDURE INCLUDING IMAGING GUIDANCE (EG, ULTRASOUND AND/OR FLUOROSCOPY) AND ALL ASSOCIATED RADIOLOGICAL SUPERVISION AND INTERPRETATION, W",,,3247.35,17457.0,29 RC,360,"DILATION OF LACRIMAL PUNCTUM, WITH OR WITHOUT IRRIGATION",,,375.71,1251.0,13 RC,360,DILATION OF RECTAL STRICTURE (SEPARATE PROCEDURE) UNDER ANESTHESIA OTHER THAN LOCAL,,,1110.16,5449.0,15 RC,360,"DILATION OF URETHRAL STRICTURE BY PASSAGE OF SOUND OR URETHRAL DILATOR, MALE; INITIAL",,,228.99,5449.0,15 RC,360,"DILATION OF URETHRAL STRICTURE BY PASSAGE OF SOUND OR URETHRAL DILATOR, MALE; SUBSEQUENT",,,121.37,5449.0,15 RC,360,"DILATION OF URETHRAL STRICTURE OR VESICAL NECK BY PASSAGE OF SOUND OR URETHRAL DILATOR, MALE, GENERAL OR CONDUCTION (SPINAL) ANESTHESIA",,,3012.0,7278.0,15 RC,360,DILATION OF VAGINA UNDER ANESTHESIA (OTHER THAN LOCAL),,,2993.65,9324.0,15 RC,360,DILATION SALIVARY DUCT,,,1394.69,5449.0,15 RC,360,"DIRECT REPAIR OF ANEURYSM, PSEUDOANEURYSM, OR EXCISION (PARTIAL OR TOTAL) AND GRAFT INSERTION, WITH OR WITHOUT PATCH GRAFT; FOR ANEURYSM AND ASSOCIATED OCCLUSIVE DISEASE, AXILLARY-BRACHIAL ARTERY, BY ",,,5089.69,21454.0,13 RC,360,"DIRECT REPAIR OF ANEURYSM, PSEUDOANEURYSM, OR EXCISION (PARTIAL OR TOTAL) AND GRAFT INSERTION, WITH OR WITHOUT PATCH GRAFT; FOR ANEURYSM, PSEUDOANEURYSM, AND ASSOCIATED OCCLUSIVE DISEASE, COMMON FEMOR",,,2533.0,4850.0,2 RC,360,"DIRECT REPAIR OF ANEURYSM, PSEUDOANEURYSM, OR EXCISION (PARTIAL OR TOTAL) AND GRAFT INSERTION, WITH OR WITHOUT PATCH GRAFT; FOR ANEURYSM, PSEUDOANEURYSM, AND ASSOCIATED OCCLUSIVE DISEASE, RADIAL OR UL",,,5089.69,21454.0,13 RC,360,"DIRECT REPAIR OF ANEURYSM, PSEUDOANEURYSM, OR EXCISION (PARTIAL OR TOTAL) AND GRAFT INSERTION, WITH OR WITHOUT PATCH GRAFT; FOR RUPTURED ANEURYSM, ABDOMINAL AORTA",,,2533.0,4850.0,2 RC,360,DISARTICULATION AT KNEE,,,13844.0,21454.0,2 RC,360,"DISCECTOMY, ANTERIOR, WITH DECOMPRESSION OF SPINAL CORD AND/OR NERVE ROOT(S), INCLUDING OSTEOPHYTECTOMY; CERVICAL, SINGLE INTERSPACE",,,6726.11,21454.0,14 RC,360,"DISSECTION, DEEP JUGULAR NODE(S)",,,5152.0,21454.0,15 RC,360,DIVISION OF ABERRANT VESSEL (VASCULAR RING);,,,2533.0,4850.0,2 RC,360,"DIVISION OF PLANTAR FASCIA AND MUSCLE (EG, STEINDLER STRIPPING) (SEPARATE PROCEDURE)",,,3054.93,9324.0,15 RC,360,DIVISION OF SCALENUS ANTICUS; WITH RESECTION OF CERVICAL RIB,,,12615.0,21454.0,3 RC,360,"DIVISION OF STERNOCLEIDOMASTOID FOR TORTICOLLIS, OPEN OPERATION; WITHOUT CAST APPLICATION",,,3054.93,9324.0,15 RC,360,"DRAINAGE EXTERNAL EAR, ABSCESS OR HEMATOMA; COMPLICATED",,,1525.52,5449.0,14 RC,360,"DRAINAGE OF ABSCESS, CYST, HEMATOMA, VESTIBULE OF MOUTH; COMPLICATED",,,479.48,7278.0,15 RC,360,"DRAINAGE OF ABSCESS, CYST, HEMATOMA, VESTIBULE OF MOUTH; SIMPLE",,,662.46,3517.0,13 RC,360,"DRAINAGE OF ABSCESS; PAROTID, COMPLICATED",,,3053.48,9324.0,15 RC,360,"DRAINAGE OF ABSCESS; SUBMAXILLARY OR SUBLINGUAL, INTRAORAL",,,479.48,5449.0,15 RC,360,DRAINAGE OF FINGER ABSCESS; SIMPLE,,,187.08,1251.0,13 RC,360,"DRAINAGE OF OVARIAN ABSCESS; VAGINAL APPROACH, OPEN",,,2993.65,9324.0,15 RC,360,"DRAINAGE OF OVARIAN CYST(S), UNILATERAL OR BILATERAL (SEPARATE PROCEDURE); ABDOMINAL APPROACH",,,2993.65,9324.0,14 RC,360,DRAINAGE OF PALMAR BURSA; MULTIPLE BURSA,,,3012.0,7278.0,15 RC,360,"DRAINAGE OF PERITONEAL ABSCESS OR LOCALIZED PERITONITIS, EXCLUSIVE OF APPENDICEAL ABSCESS, OPEN",,,2533.0,4850.0,2 RC,360,"DRAINAGE OF RETROPERITONEAL ABSCESS, OPEN",,,2533.0,4850.0,2 RC,360,DRAINAGE OF SCROTAL WALL ABSCESS,,,1525.52,5449.0,15 RC,360,"DRAINAGE OF TENDON SHEATH, DIGIT AND/OR PALM, EACH",,,3012.0,7278.0,15 RC,360,DRESSING CHANGE (FOR OTHER THAN BURNS) UNDER ANESTHESIA (OTHER THAN LOCAL),,,576.34,5449.0,14 RC,360,"DRESSINGS AND/OR DEBRIDEMENT OF PARTIAL-THICKNESS BURNS, INITIAL OR SUBSEQUENT; MEDIUM (EG, WHOLE FACE OR WHOLE EXTREMITY, OR 5% TO 10% TOTAL BODY SURFACE AREA)",,,187.08,7278.0,15 RC,360,"DRESSINGS AND/OR DEBRIDEMENT OF PARTIAL-THICKNESS BURNS, INITIAL OR SUBSEQUENT; SMALL (LESS THAN 5% TOTAL BODY SURFACE AREA)",,,187.08,5449.0,15 RC,360,"DRUG-INDUCED SLEEP ENDOSCOPY, WITH DYNAMIC EVALUATION OF VELUM, PHARYNX, TONGUE BASE, AND LARYNX FOR EVALUATION OF SLEEP-DISORDERED BREATHING, FLEXIBLE, DIAGNOSTIC",,,777.0,7278.0,14 RC,360,ELECTRICAL STIMULATION FOR GUIDANCE IN CONJUNCTION WITH CHEMODENERVATION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,,,0 RC,360,"ELECTROLYSIS EPILATION, EACH 30 MINUTES",,,576.34,1251.0,13 RC,360,"ELECTROMYOGRAPHY STUDIES (EMG) OF ANAL OR URETHRAL SPHINCTER, OTHER THAN NEEDLE, ANY TECHNIQUE",,,147.31,1251.0,13 RC,360,"EMBOLECTOMY OR THROMBECTOMY, WITH OR WITHOUT CATHETER; AXILLARY, BRACHIAL, INNOMINATE, SUBCLAVIAN ARTERY, BY ARM INCISION",,,5089.69,21454.0,15 RC,360,ENDOCERVICAL CURETTAGE (NOT DONE AS PART OF A DILATION AND CURETTAGE),,,819.83,5449.0,15 RC,360,ENDOLYMPHATIC SAC OPERATION; WITH SHUNT,,,5569.83,15394.0,15 RC,360,ENDOLYMPHATIC SAC OPERATION; WITHOUT SHUNT,,,5569.83,15394.0,15 RC,360,"ENDOMETRIAL ABLATION, THERMAL, WITHOUT HYSTEROSCOPIC GUIDANCE",,,4647.86,15291.0,15 RC,360,ENDOMETRIAL SAMPLING (BIOPSY) PERFORMED IN CONJUNCTION WITH COLPOSCOPY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,5449.0,3 RC,360,"ENDOMETRIAL SAMPLING (BIOPSY) WITH OR WITHOUT ENDOCERVICAL SAMPLING (BIOPSY), WITHOUT CERVICAL DILATION, ANY METHOD (SEPARATE PROCEDURE)",,,189.41,5449.0,14 RC,360,"ENDOSCOPIC EVALUATION OF SMALL INTESTINAL POUCH (EG, KOCK POUCH, ILEAL RESERVOIR [S OR J]); DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,858.41,5449.0,15 RC,360,"ENDOSCOPIC EVALUATION OF SMALL INTESTINAL POUCH (EG, KOCK POUCH, ILEAL RESERVOIR [S OR J]); WITH BIOPSY, SINGLE OR MULTIPLE",,,858.41,5449.0,15 RC,360,ENDOSCOPIC INJECTION OF IMPLANT MATERIAL INTO THE SUBMUCOSAL TISSUES OF THE URETHRA AND/OR BLADDER NECK,,,3247.35,13194.0,15 RC,360,ENDOSCOPIC PLANTAR FASCIOTOMY,,,3054.93,17457.0,15 RC,360,ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH REMOVAL OF CALCULI/DEBRIS FROM BILIARY/PANCREATIC DUCT(S),,,3582.12,9324.0,15 RC,360,"ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD), INCLUDING ENDOSCOPY OR COLONOSCOPY, MUCOSAL CLOSURE, WHEN PERFORMED",,,3582.12,9324.0,14 RC,360,"ENDOSCOPY, WRIST, SURGICAL, WITH RELEASE OF TRANSVERSE CARPAL LIGAMENT",,,1506.85,17457.0,15 RC,360,"ENDOVENOUS ABLATION THERAPY OF INCOMPETENT VEIN, EXTREMITY, INCLUSIVE OF ALL IMAGING GUIDANCE AND MONITORING, PERCUTANEOUS, LASER; FIRST VEIN TREATED",,,2963.5,17457.0,15 RC,360,"ENDOVENOUS ABLATION THERAPY OF INCOMPETENT VEIN, EXTREMITY, INCLUSIVE OF ALL IMAGING GUIDANCE AND MONITORING, PERCUTANEOUS, LASER; SUBSEQUENT VEIN(S) TREATED IN A SINGLE EXTREMITY, EACH THROUGH SEPARA",,,777.0,5449.0,3 RC,360,"ENDOVENOUS ABLATION THERAPY OF INCOMPETENT VEIN, EXTREMITY, INCLUSIVE OF ALL IMAGING GUIDANCE AND MONITORING, PERCUTANEOUS, RADIOFREQUENCY; FIRST VEIN TREATED",,,2963.5,17457.0,15 RC,360,"ENTERECTOMY, RESECTION OF SMALL INTESTINE; SINGLE RESECTION AND ANASTOMOSIS",,,2533.0,4850.0,2 RC,360,ENTEROLYSIS (FREEING OF INTESTINAL ADHESION) (SEPARATE PROCEDURE),,,2533.0,15291.0,3 RC,360,"ENUCLEATION OF EYE; WITH IMPLANT, MUSCLES ATTACHED TO IMPLANT",,,3550.55,13194.0,15 RC,360,ENUCLEATION OF EYE; WITHOUT IMPLANT,,,3550.55,13194.0,15 RC,360,EPIDIDYMECTOMY; BILATERAL,,,3247.35,10561.0,15 RC,360,"EPIPHYSEAL ARREST BY EPIPHYSIODESIS OR STAPLING, GREATER TROCHANTER OF FEMUR",,,12615.0,21454.0,3 RC,360,EPIPHYSEAL ARREST BY EPIPHYSIODESIS OR STAPLING; DISTAL RADIUS AND ULNA,,,3054.93,15394.0,15 RC,360,EPIPHYSEAL ARREST BY EPIPHYSIODESIS OR STAPLING; DISTAL RADIUS OR ULNA,,,3054.93,15394.0,15 RC,360,"EPISIOTOMY OR VAGINAL REPAIR, BY OTHER THAN ATTENDING",,,2993.65,9324.0,14 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,882.75,5449.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S) (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,1786.09,9350.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH BAND LIGATION OF ESOPHAGEAL/GASTRIC VARICES",,,1786.09,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH BIOPSY, SINGLE OR MULTIPLE",,,882.75,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DILATION OF ESOPHAGUS WITH BALLOON (30 MM DIAMETER OR LARGER) (INCLUDES FLUOROSCOPIC GUIDANCE, WHEN PERFORMED)",,,1786.09,9350.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DILATION OF GASTRIC/DUODENAL STRICTURE(S) (EG, BALLOON, BOUGIE)",,,1786.09,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DIRECTED PLACEMENT OF PERCUTANEOUS GASTROSTOMY TUBE",,,1786.09,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,882.75,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH ENDOSCOPIC MUCOSAL RESECTION",,,1786.09,8413.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH ENDOSCOPIC ULTRASOUND EXAMINATION, INCLUDING THE ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM OR A SURGICALLY ALTERED STOMACH WHERE THE JEJUNUM IS ",,,1786.09,8413.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH INSERTION OF GUIDE WIRE FOLLOWED BY PASSAGE OF DILATOR(S) THROUGH ESOPHAGUS OVER GUIDE WIRE",,,882.75,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH PLACEMENT OF ENDOSCOPIC STENT (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,5604.81,17457.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF FOREIGN BODY(S)",,,882.75,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE",,,1786.09,7278.0,15 RC,360,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC BALLOON DILATION OF ESOPHAGUS (LESS THAN 30 MM DIAMETER)",,,1786.09,7278.0,15 RC,360,"ESOPHAGOPLASTY (PLASTIC REPAIR OR RECONSTRUCTION), CERVICAL APPROACH; WITH REPAIR OF TRACHEOESOPHAGEAL FISTULA",,,2533.0,4850.0,2 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,882.75,5449.0,15 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH DILATION OF ESOPHAGUS WITH BALLOON (30 MM DIAMETER OR LARGER) (INCLUDES FLUOROSCOPIC GUIDANCE, WHEN PERFORMED)",,,1786.09,9350.0,15 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH DILATION OF ESOPHAGUS, BY BALLOON OR DILATOR, RETROGRADE (INCLUDES FLUOROSCOPIC GUIDANCE, WHEN PERFORMED)",,,1786.09,9350.0,15 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,1786.09,5449.0,15 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH INSERTION OF GUIDE WIRE FOLLOWED BY PASSAGE OF DILATOR(S) OVER GUIDE WIRE",,,1786.09,5449.0,15 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF FOREIGN BODY(S)",,,1786.09,5449.0,15 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC BALLOON DILATION (LESS THAN 30 MM DIAMETER)",,,1786.09,7278.0,15 RC,360,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC ULTRASOUND-GUIDED INTRAMURAL OR TRANSMURAL FINE NEEDLE ASPIRATION/BIOPSY(S)",,,1786.09,7278.0,15 RC,360,"ESOPHAGOSCOPY, RIGID, TRANSORAL WITH DIVERTICULECTOMY OF HYPOPHARYNX OR CERVICAL ESOPHAGUS (EG, ZENKER'S DIVERTICULUM), WITH CRICOPHARYNGEAL MYOTOMY, INCLUDES USE OF TELESCOPE OR OPERATING MICROSCOPE ",,,5514.0,17457.0,15 RC,360,"ESOPHAGOSCOPY, RIGID, TRANSORAL; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING WHEN PERFORMED (SEPARATE PROCEDURE)",,,1786.09,6649.0,15 RC,360,"ESOPHAGOSCOPY, RIGID, TRANSORAL; WITH BALLOON DILATION (LESS THAN 30 MM DIAMETER)",,,3012.0,9350.0,15 RC,360,"ESOPHAGOSCOPY, RIGID, TRANSORAL; WITH BIOPSY, SINGLE OR MULTIPLE",,,1786.09,9350.0,15 RC,360,"ESOPHAGOSCOPY, RIGID, TRANSORAL; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,1786.09,9350.0,15 RC,360,"ESOPHAGOSCOPY, RIGID, TRANSORAL; WITH INSERTION OF GUIDE WIRE FOLLOWED BY DILATION OVER GUIDE WIRE",,,1786.09,9350.0,15 RC,360,"ESOPHAGOSCOPY, RIGID, TRANSORAL; WITH REMOVAL OF FOREIGN BODY(S)",,,1786.09,9350.0,15 RC,360,"ETHMOIDECTOMY; INTRANASAL, ANTERIOR",,,5152.0,15394.0,15 RC,360,EVISCERATION OF OCULAR CONTENTS; WITH IMPLANT,,,3550.55,13194.0,15 RC,360,"EXCHANGE NEPHROSTOMY CATHETER, PERCUTANEOUS, INCLUDING DIAGNOSTIC NEPHROSTOGRAM AND/OR URETEROGRAM WHEN PERFORMED, IMAGING GUIDANCE (EG, ULTRASOUND AND/OR FLUOROSCOPY) AND ALL ASSOCIATED RADIOLOGICAL ",,,1928.76,6649.0,15 RC,360,EXCHANGE OF INTRAOCULAR LENS,,,2147.4,13764.0,15 RC,360,"EXCISION AND REPAIR OF EYELID, INVOLVING LID MARGIN, TARSUS, CONJUNCTIVA, CANTHUS, OR FULL THICKNESS, MAY INCLUDE PREPARATION FOR SKIN GRAFT OR PEDICLE FLAP WITH ADJACENT TISSUE TRANSFER OR REARRANGEM",,,2196.57,9324.0,30 RC,360,EXCISION AURAL GLOMUS TUMOR; EXTENDED (EXTRATEMPORAL),,,2533.0,4850.0,2 RC,360,EXCISION AURAL GLOMUS TUMOR; TRANSCANAL,,,5569.83,15394.0,15 RC,360,EXCISION AURAL GLOMUS TUMOR; TRANSMASTOID,,,5569.83,15394.0,15 RC,360,EXCISION AURAL POLYP,,,1394.69,7278.0,14 RC,360,"EXCISION BRANCHIAL CLEFT CYST OR VESTIGE, CONFINED TO SKIN AND SUBCUTANEOUS TISSUES",,,3053.48,9324.0,15 RC,360,"EXCISION BRANCHIAL CLEFT CYST, VESTIGE, OR FISTULA, EXTENDING BENEATH SUBCUTANEOUS TISSUES AND/OR INTO PHARYNX",,,5569.83,15394.0,15 RC,360,"EXCISION DERMOID CYST, NOSE; COMPLEX, UNDER BONE OR CARTILAGE",,,5152.0,15394.0,15 RC,360,"EXCISION DERMOID CYST, NOSE; SIMPLE, SKIN, SUBCUTANEOUS",,,1394.69,5449.0,15 RC,360,"EXCISION DISTAL ULNA PARTIAL OR COMPLETE (EG, DARRACH TYPE OR MATCHED RESECTION)",,,3054.93,13194.0,15 RC,360,"EXCISION EXTERNAL EAR; PARTIAL, SIMPLE REPAIR",,,2694.74,5449.0,15 RC,360,EXCISION FIRST AND/OR CERVICAL RIB;,,,12615.0,21454.0,3 RC,360,"EXCISION FLEXOR TENDON, WITH IMPLANTATION OF SYNTHETIC ROD FOR DELAYED TENDON GRAFT, HAND OR FINGER, EACH ROD",,,6726.11,13194.0,15 RC,360,"EXCISION INFERIOR TURBINATE, PARTIAL OR COMPLETE, ANY METHOD",,,3053.48,9324.0,15 RC,360,EXCISION OF BARTHOLIN'S GLAND OR CYST,,,2993.65,9324.0,15 RC,360,"EXCISION OF BENIGN TUMOR OR CYST OF MANDIBLE, BY ENUCLEATION AND/OR CURETTAGE",,,3053.48,9324.0,15 RC,360,"EXCISION OF BENIGN TUMOR OR CYST OF MANDIBLE; REQUIRING EXTRA-ORAL OSTEOTOMY AND PARTIAL MANDIBULECTOMY (EG, LOCALLY AGGRESSIVE OR DESTRUCTIVE LESION[S])",,,5152.0,15394.0,15 RC,360,"EXCISION OF BENIGN TUMOR OR CYST OF MANDIBLE; REQUIRING INTRA-ORAL OSTEOTOMY (EG, LOCALLY AGGRESSIVE OR DESTRUCTIVE LESION[S])",,,5152.0,15394.0,15 RC,360,EXCISION OF BENIGN TUMOR OR CYST OF MAXILLA OR ZYGOMA BY ENUCLEATION AND CURETTAGE,,,5514.0,9324.0,14 RC,360,"EXCISION OF BENIGN TUMOR OR CYST OF MAXILLA; REQUIRING EXTRA-ORAL OSTEOTOMY AND PARTIAL MAXILLECTOMY (EG, LOCALLY AGGRESSIVE OR DESTRUCTIVE LESION[S])",,,5569.83,15394.0,15 RC,360,"EXCISION OF BENIGN TUMOR OR CYST OF MAXILLA; REQUIRING INTRA-ORAL OSTEOTOMY (EG, LOCALLY AGGRESSIVE OR DESTRUCTIVE LESION[S])",,,5569.83,15394.0,15 RC,360,"EXCISION OF BONE (EG, FOR OSTEOMYELITIS OR BONE ABSCESS); FACIAL BONE(S)",,,5152.0,9324.0,15 RC,360,"EXCISION OF BONE (EG, FOR OSTEOMYELITIS OR BONE ABSCESS); MANDIBLE",,,5152.0,15394.0,15 RC,360,"EXCISION OF BREAST LESION IDENTIFIED BY PREOPERATIVE PLACEMENT OF RADIOLOGICAL MARKER, OPEN; SINGLE LESION",,,3605.42,9324.0,15 RC,360,EXCISION OF CAROTID BODY TUMOR; WITHOUT EXCISION OF CAROTID ARTERY,,,2533.0,4850.0,2 RC,360,"EXCISION OF CERVICAL STUMP, VAGINAL APPROACH;",,,4647.86,9324.0,15 RC,360,"EXCISION OF CHALAZION; MULTIPLE, DIFFERENT LIDS",,,281.46,5449.0,15 RC,360,EXCISION OF CHALAZION; SINGLE,,,281.46,5449.0,15 RC,360,"EXCISION OF CHALAZION; UNDER GENERAL ANESTHESIA AND/OR REQUIRING HOSPITALIZATION, SINGLE OR MULTIPLE",,,2196.57,9324.0,15 RC,360,EXCISION OF CHEST WALL TUMOR INCLUDING RIB(S),,,2694.74,12615.0,14 RC,360,"EXCISION OF CYST OR ADENOMA OF THYROID, OR TRANSECTION OF ISTHMUS",,,5152.0,21454.0,15 RC,360,"EXCISION OF CYST, FIBROADENOMA, OR OTHER BENIGN OR MALIGNANT TUMOR, ABERRANT BREAST TISSUE, DUCT LESION, NIPPLE OR AREOLAR LESION (EXCEPT 19300), OPEN, MALE OR FEMALE, 1 OR MORE LESIONS",,,3605.42,9324.0,15 RC,360,"EXCISION OF CYSTIC HYGROMA, AXILLARY OR CERVICAL; WITHOUT DEEP NEUROVASCULAR DISSECTION",,,3605.42,9324.0,15 RC,360,"EXCISION OF EPIPHYSEAL BAR, WITH OR WITHOUT AUTOGENOUS SOFT TISSUE GRAFT OBTAINED THROUGH SAME FASCIAL INCISION",,,3054.93,15394.0,13 RC,360,EXCISION OF EXTRAPARENCHYMAL LESION OF TESTIS,,,3247.35,9324.0,15 RC,360,"EXCISION OF FRENUM, LABIAL OR BUCCAL (FRENUMECTOMY, FRENULECTOMY, FRENECTOMY)",,,1394.69,5449.0,15 RC,360,"EXCISION OF GANGLION, WRIST (DORSAL OR VOLAR); PRIMARY",,,1506.85,9324.0,15 RC,360,"EXCISION OF GANGLION, WRIST (DORSAL OR VOLAR); RECURRENT",,,1506.85,10561.0,15 RC,360,"EXCISION OF HYDROCELE OF SPERMATIC CORD, UNILATERAL (SEPARATE PROCEDURE)",,,3247.35,13194.0,15 RC,360,EXCISION OF HYDROCELE; BILATERAL,,,3322.75,13194.0,15 RC,360,EXCISION OF HYDROCELE; UNILATERAL,,,3322.75,13194.0,15 RC,360,EXCISION OF INFECTED GRAFT; EXTREMITY,,,2963.5,13194.0,13 RC,360,EXCISION OF LACRIMAL SAC (DACRYOCYSTECTOMY),,,3550.55,13194.0,15 RC,360,EXCISION OF LESION OF EYELID (EXCEPT CHALAZION) WITHOUT CLOSURE OR WITH SIMPLE DIRECT CLOSURE,,,911.92,7278.0,15 RC,360,"EXCISION OF LESION OF MENISCUS OR CAPSULE (EG, CYST, GANGLION), KNEE",,,3054.93,10561.0,15 RC,360,"EXCISION OF LESION OF MUCOSA AND SUBMUCOSA, VESTIBULE OF MOUTH; COMPLEX, WITH EXCISION OF UNDERLYING MUSCLE",,,3053.48,9324.0,15 RC,360,"EXCISION OF LESION OF MUCOSA AND SUBMUCOSA, VESTIBULE OF MOUTH; WITH COMPLEX REPAIR",,,3053.48,9324.0,15 RC,360,"EXCISION OF LESION OF MUCOSA AND SUBMUCOSA, VESTIBULE OF MOUTH; WITH SIMPLE REPAIR",,,1394.69,5449.0,14 RC,360,"EXCISION OF LESION OF MUCOSA AND SUBMUCOSA, VESTIBULE OF MOUTH; WITHOUT REPAIR",,,3012.0,5449.0,14 RC,360,"EXCISION OF LESION OF PANCREAS (EG, CYST, ADENOMA)",,,2533.0,4850.0,2 RC,360,EXCISION OF LESION OF SPERMATIC CORD (SEPARATE PROCEDURE),,,3247.35,10561.0,15 RC,360,"EXCISION OF LESION OF TENDON SHEATH OR CAPSULE (EG, CYST OR GANGLION), LEG AND/OR ANKLE",,,3054.93,9324.0,15 RC,360,"EXCISION OF LESION OF TENDON SHEATH OR JOINT CAPSULE (EG, CYST, MUCOUS CYST, OR GANGLION), HAND OR FINGER",,,1506.85,8413.0,15 RC,360,EXCISION OF LESION OF TONGUE WITH CLOSURE; ANTERIOR TWO-THIRDS,,,3012.0,7278.0,15 RC,360,EXCISION OF LESION OF TONGUE WITH CLOSURE; POSTERIOR ONE-THIRD,,,3012.0,7278.0,15 RC,360,EXCISION OF LESION OF TONGUE WITHOUT CLOSURE,,,3012.0,5449.0,15 RC,360,"EXCISION OF LESION OR TUMOR (EXCEPT LISTED ABOVE), DENTOALVEOLAR STRUCTURES; WITH COMPLEX REPAIR",,,5152.0,15394.0,15 RC,360,"EXCISION OF LESION OR TUMOR (EXCEPT LISTED ABOVE), DENTOALVEOLAR STRUCTURES; WITH SIMPLE REPAIR",,,3053.48,9324.0,14 RC,360,"EXCISION OF LESION OR TUMOR (EXCEPT LISTED ABOVE), DENTOALVEOLAR STRUCTURES; WITHOUT REPAIR",,,3012.0,5449.0,14 RC,360,"EXCISION OF LESION, CONJUNCTIVA; OVER 1 CM",,,2196.57,9324.0,15 RC,360,"EXCISION OF LESION, CONJUNCTIVA; UP TO 1 CM",,,2196.57,9324.0,15 RC,360,"EXCISION OF LESION, CORNEA (KERATECTOMY, LAMELLAR, PARTIAL), EXCEPT PTERYGIUM",,,911.92,5449.0,15 RC,360,"EXCISION OF LESION, TENDON, TENDON SHEATH, OR CAPSULE (INCLUDING SYNOVECTOMY) (EG, CYST OR GANGLION); FOOT",,,1506.85,9324.0,15 RC,360,"EXCISION OF LESION, TENDON, TENDON SHEATH, OR CAPSULE (INCLUDING SYNOVECTOMY) (EG, CYST OR GANGLION); TOE(S), EACH",,,1506.85,9324.0,15 RC,360,EXCISION OF LINGUAL FRENUM (FRENECTOMY),,,1394.69,5449.0,15 RC,360,"EXCISION OF LIP; FULL THICKNESS, RECONSTRUCTION WITH CROSS LIP FLAP (ABBE-ESTLANDER)",,,5152.0,9324.0,15 RC,360,EXCISION OF LIP; TRANSVERSE WEDGE EXCISION WITH PRIMARY CLOSURE,,,3053.48,9324.0,15 RC,360,EXCISION OF LIP; V-EXCISION WITH PRIMARY DIRECT LINEAR CLOSURE,,,3012.0,7278.0,15 RC,360,EXCISION OF LOCAL LESION OF EPIDIDYMIS,,,3247.35,9324.0,15 RC,360,EXCISION OF MALIGNANT TUMOR OF MANDIBLE;,,,5152.0,15394.0,15 RC,360,EXCISION OF MAXILLARY TORUS PALATINUS,,,3053.48,9324.0,14 RC,360,EXCISION OF MUCOSA OF VESTIBULE OF MOUTH AS DONOR GRAFT,,,479.48,5449.0,15 RC,360,"EXCISION OF MULTIPLE EXTERNAL PAPILLAE OR TAGS, ANUS",,,2582.07,5449.0,15 RC,360,"EXCISION OF NAIL AND NAIL MATRIX, PARTIAL OR COMPLETE (EG, INGROWN OR DEFORMED NAIL), FOR PERMANENT REMOVAL",,,376.18,5449.0,15 RC,360,EXCISION OF NEUROFIBROMA OR NEUROLEMMOMA; CUTANEOUS NERVE,,,1838.62,9324.0,15 RC,360,EXCISION OF NEUROFIBROMA OR NEUROLEMMOMA; EXTENSIVE (INCLUDING MALIGNANT TYPE),,,6029.68,15394.0,15 RC,360,EXCISION OF NEUROFIBROMA OR NEUROLEMMOMA; MAJOR PERIPHERAL NERVE,,,1838.62,9324.0,15 RC,360,"EXCISION OF NEUROMA; CUTANEOUS NERVE, SURGICALLY IDENTIFIABLE",,,1838.62,9324.0,15 RC,360,"EXCISION OF NEUROMA; DIGITAL NERVE, 1 OR BOTH, SAME DIGIT",,,1838.62,9324.0,15 RC,360,"EXCISION OF NEUROMA; DIGITAL NERVE, EACH ADDITIONAL DIGIT (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,7278.0,3 RC,360,"EXCISION OF NEUROMA; MAJOR PERIPHERAL NERVE, EXCEPT SCIATIC",,,1838.62,9324.0,15 RC,360,EXCISION OF NEUROMA; SCIATIC NERVE,,,6029.68,15394.0,15 RC,360,"EXCISION OF OSSEOUS TUBEROSITIES, DENTOALVEOLAR STRUCTURES",,,5514.0,9324.0,14 RC,360,"EXCISION OF PAROTID TUMOR OR PAROTID GLAND; LATERAL LOBE, WITH DISSECTION AND PRESERVATION OF FACIAL NERVE",,,5569.83,15394.0,15 RC,360,"EXCISION OF PAROTID TUMOR OR PAROTID GLAND; LATERAL LOBE, WITHOUT NERVE DISSECTION",,,5569.83,15394.0,15 RC,360,"EXCISION OF PAROTID TUMOR OR PAROTID GLAND; TOTAL, EN BLOC REMOVAL WITH SACRIFICE OF FACIAL NERVE",,,5569.83,15394.0,15 RC,360,"EXCISION OF PAROTID TUMOR OR PAROTID GLAND; TOTAL, WITH DISSECTION AND PRESERVATION OF FACIAL NERVE",,,5569.83,15394.0,15 RC,360,EXCISION OF PENILE PLAQUE (PEYRONIE DISEASE); WITH GRAFT GREATER THAN 5 CM IN LENGTH,,,5152.0,15394.0,15 RC,360,EXCISION OF PILONIDAL CYST OR SINUS; COMPLICATED,,,2694.74,9324.0,15 RC,360,EXCISION OF PILONIDAL CYST OR SINUS; EXTENSIVE,,,2694.74,9324.0,15 RC,360,EXCISION OF PILONIDAL CYST OR SINUS; SIMPLE,,,2694.74,9324.0,15 RC,360,EXCISION OF PRESACRAL OR SACROCOCCYGEAL TUMOR,,,2533.0,4850.0,2 RC,360,"EXCISION OF RECTAL TUMOR, TRANSANAL APPROACH; INCLUDING MUSCULARIS PROPRIA (IE, FULL THICKNESS)",,,2582.07,17457.0,15 RC,360,"EXCISION OF RECTAL TUMOR, TRANSANAL APPROACH; NOT INCLUDING MUSCULARIS PROPRIA (IE, PARTIAL THICKNESS)",,,2582.07,9350.0,15 RC,360,"EXCISION OF RIB, PARTIAL",,,5152.0,13194.0,15 RC,360,"EXCISION OF SINGLE EXTERNAL PAPILLA OR TAG, ANUS",,,1110.16,5449.0,15 RC,360,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, AXILLARY; WITH COMPLEX REPAIR",,,2694.74,9324.0,15 RC,360,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, AXILLARY; WITH SIMPLE OR INTERMEDIATE REPAIR",,,2694.74,9324.0,15 RC,360,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, INGUINAL; WITH COMPLEX REPAIR",,,2694.74,9324.0,15 RC,360,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, INGUINAL; WITH SIMPLE OR INTERMEDIATE REPAIR",,,2694.74,9324.0,15 RC,360,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, PERIANAL, PERINEAL, OR UMBILICAL; WITH COMPLEX REPAIR",,,2694.74,9324.0,15 RC,360,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, PERIANAL, PERINEAL, OR UMBILICAL; WITH SIMPLE OR INTERMEDIATE REPAIR",,,2694.74,9324.0,15 RC,360,"EXCISION OF SPERMATOCELE, WITH OR WITHOUT EPIDIDYMECTOMY",,,1928.76,10561.0,15 RC,360,EXCISION OF SUBLINGUAL GLAND,,,5152.0,9324.0,15 RC,360,EXCISION OF SUBLINGUAL SALIVARY CYST (RANULA),,,3053.48,9324.0,15 RC,360,EXCISION OF SUBMANDIBULAR (SUBMAXILLARY) GLAND,,,5569.83,15394.0,15 RC,360,"EXCISION OF SYNOVIAL CYST OF POPLITEAL SPACE (EG, BAKER'S CYST)",,,3054.93,10561.0,15 RC,360,"EXCISION OF TENDON, FINGER, FLEXOR OR EXTENSOR, EACH TENDON",,,1506.85,8413.0,15 RC,360,"EXCISION OF TENDON, PALM, FLEXOR OR EXTENSOR, SINGLE, EACH TENDON",,,1506.85,8413.0,15 RC,360,"EXCISION OF THROMBOSED HEMORRHOID, EXTERNAL",,,1110.16,5449.0,15 RC,360,EXCISION OF THYROGLOSSAL DUCT CYST OR SINUS;,,,5493.28,21454.0,15 RC,360,EXCISION OF THYROGLOSSAL DUCT CYST OR SINUS; RECURRENT,,,5493.28,21454.0,15 RC,360,EXCISION OF TORUS MANDIBULARIS,,,3053.48,9324.0,14 RC,360,EXCISION OF TRACHEAL TUMOR OR CARCINOMA; CERVICAL,,,5514.0,10561.0,15 RC,360,"EXCISION OF URACHAL CYST OR SINUS, WITH OR WITHOUT UMBILICAL HERNIA REPAIR",,,5493.28,13194.0,15 RC,360,EXCISION OF URETHRAL DIVERTICULUM (SEPARATE PROCEDURE); FEMALE,,,4786.44,13194.0,15 RC,360,EXCISION OF URETHRAL DIVERTICULUM (SEPARATE PROCEDURE); MALE,,,4786.44,9324.0,15 RC,360,EXCISION OF VAGINAL CYST OR TUMOR,,,2993.65,9324.0,15 RC,360,EXCISION OF VAGINAL SEPTUM,,,2993.65,9324.0,15 RC,360,EXCISION OF VARICOCELE OR LIGATION OF SPERMATIC VEINS FOR VARICOCELE; (SEPARATE PROCEDURE),,,3247.35,10561.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF CARPAL BONES; WITH AUTOGRAFT (INCLUDES OBTAINING GRAFT),,,6649.0,13194.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF CLAVICLE OR SCAPULA;,,,3054.93,10561.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF CLAVICLE OR SCAPULA; WITH ALLOGRAFT,,,6726.11,13194.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF FEMUR;,,,3054.93,13194.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF FEMUR; WITH ALLOGRAFT,,,7444.0,13238.67,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF FEMUR; WITH INTERNAL FIXATION (LIST IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,12615.0,3 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF METACARPAL;,,,1506.85,7278.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF PROXIMAL HUMERUS;,,,3054.93,13194.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF PROXIMAL, MIDDLE, OR DISTAL PHALANX OF FINGER;",,,1506.85,7278.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF PROXIMAL, MIDDLE, OR DISTAL PHALANX OF FINGER; WITH AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,3012.0,8413.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF RADIUS OR ULNA (EXCLUDING HEAD OR NECK OF RADIUS AND OLECRANON PROCESS);,,,3054.93,13194.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF RADIUS OR ULNA (EXCLUDING HEAD OR NECK OF RADIUS AND OLECRANON PROCESS); WITH ALLOGRAFT,,,3054.93,13194.0,15 RC,360,EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR OF RADIUS OR ULNA (EXCLUDING HEAD OR NECK OF RADIUS AND OLECRANON PROCESS); WITH AUTOGRAFT (INCLUDES OBTAINING GRAFT),,,1506.85,9324.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, HUMERUS;",,,3054.93,9324.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, HUMERUS; WITH ALLOGRAFT",,,6649.0,13194.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, PHALANGES OF FOOT",,,1506.85,9324.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, TALUS OR CALCANEUS;",,,3054.93,9324.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, TALUS OR CALCANEUS; WITH ALLOGRAFT",,,6649.0,21454.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, TALUS OR CALCANEUS; WITH ILIAC OR OTHER AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,6649.0,21454.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, TARSAL OR METATARSAL, EXCEPT TALUS OR CALCANEUS;",,,3054.93,9324.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, TIBIA OR FIBULA;",,,3054.93,13194.0,15 RC,360,"EXCISION OR CURETTAGE OF BONE CYST OR BENIGN TUMOR, TIBIA OR FIBULA; WITH ALLOGRAFT",,,6649.0,13194.0,15 RC,360,"EXCISION OR DESTRUCTION (EG, LASER), INTRANASAL LESION; INTERNAL APPROACH",,,3012.0,8413.0,15 RC,360,"EXCISION OR DESTRUCTION LINGUAL TONSIL, ANY METHOD (SEPARATE PROCEDURE)",,,5514.0,9324.0,15 RC,360,"EXCISION OR DESTRUCTION OF LESION OF PHARYNX, ANY METHOD",,,3053.48,9324.0,15 RC,360,"EXCISION OR DESTRUCTION, OPEN, INTRA-ABDOMINAL (IE, PERITONEAL, MESENTERIC, RETROPERITONEAL), PRIMARY OR SECONDARY TUMOR(S) OR CYST(S), SUM OF THE MAXIMUM LENGTH OF TUMOR(S) OR CYST(S); 10.1 TO 20 CM",,,5514.0,9324.0,2 RC,360,"EXCISION OR DESTRUCTION, OPEN, INTRA-ABDOMINAL (IE, PERITONEAL, MESENTERIC, RETROPERITONEAL), PRIMARY OR SECONDARY TUMOR(S) OR CYST(S), SUM OF THE MAXIMUM LENGTH OF TUMOR(S) OR CYST(S); 5 CM OR LESS",,,5514.0,9324.0,2 RC,360,"EXCISION OR DESTRUCTION, OPEN, INTRA-ABDOMINAL (IE, PERITONEAL, MESENTERIC, RETROPERITONEAL), PRIMARY OR SECONDARY TUMOR(S) OR CYST(S), SUM OF THE MAXIMUM LENGTH OF TUMOR(S) OR CYST(S); 5.1 TO 10 CM",,,5514.0,9324.0,2 RC,360,"EXCISION OR DESTRUCTION, OPEN, INTRA-ABDOMINAL TUMORS, CYSTS OR ENDOMETRIOMAS, 1 OR MORE PERITONEAL, MESENTERIC, OR RETROPERITONEAL PRIMARY OR SECONDARY TUMORS; LARGEST TUMOR 5 CM DIAMETER OR LESS",,,,,0 RC,360,"EXCISION OR DESTRUCTION, OPEN, INTRA-ABDOMINAL TUMORS, CYSTS OR ENDOMETRIOMAS, 1 OR MORE PERITONEAL, MESENTERIC, OR RETROPERITONEAL PRIMARY OR SECONDARY TUMORS; LARGEST TUMOR 5.1-10.0 CM DIAMETER",,,,,0 RC,360,"EXCISION OR DESTRUCTION, OPEN, INTRA-ABDOMINAL TUMORS, CYSTS OR ENDOMETRIOMAS, 1 OR MORE PERITONEAL, MESENTERIC, OR RETROPERITONEAL PRIMARY OR SECONDARY TUMORS; LARGEST TUMOR GREATER THAN 10.0 CM DIAM",,,,,0 RC,360,EXCISION OR FULGURATION; URETHRAL CARUNCLE,,,1928.76,9324.0,15 RC,360,"EXCISION OR FULGURATION; URETHRAL POLYP(S), DISTAL URETHRA",,,3247.35,9324.0,15 RC,360,EXCISION OR SURGICAL PLANING OF SKIN OF NOSE FOR RHINOPHYMA,,,3053.48,9324.0,15 RC,360,EXCISION OR TRANSPOSITION OF PTERYGIUM; WITH GRAFT,,,2196.57,12615.0,15 RC,360,EXCISION OR TRANSPOSITION OF PTERYGIUM; WITHOUT GRAFT,,,2196.57,9324.0,15 RC,360,"EXCISION SOFT TISSUE LESION, EXTERNAL AUDITORY CANAL",,,2694.74,7278.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS",,,1525.52,7278.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,7278.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM",,,1525.52,5449.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,5449.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,5449.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM",,,376.18,5449.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,662.46,5449.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,5449.0,15 RC,360,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER OVER 4.0 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, EXCESSIVE SKIN AND SUBCUTANEOUS TISSUE (INCLUDES LIPECTOMY), ABDOMEN (EG, ABDOMINOPLASTY) (INCLUDES UMBILICAL TRANSPOSITION AND FASCIAL PLICATION) (LIST SEPARATELY IN ADDITION TO CODE FOR PR",,,777.0,8413.0,3 RC,360,"EXCISION, EXCESSIVE SKIN AND SUBCUTANEOUS TISSUE (INCLUDES LIPECTOMY); ABDOMEN, INFRAUMBILICAL PANNICULECTOMY",,,6140.22,15394.0,15 RC,360,"EXCISION, EXCESSIVE SKIN AND SUBCUTANEOUS TISSUE (INCLUDES LIPECTOMY); ARM",,,2694.74,8413.0,15 RC,360,"EXCISION, EXCESSIVE SKIN AND SUBCUTANEOUS TISSUE (INCLUDES LIPECTOMY); BUTTOCK",,,2694.74,9324.0,15 RC,360,"EXCISION, EXCESSIVE SKIN AND SUBCUTANEOUS TISSUE (INCLUDES LIPECTOMY); OTHER AREA",,,2694.74,8413.0,15 RC,360,"EXCISION, INTERDIGITAL (MORTON) NEUROMA, SINGLE, EACH",,,1506.85,9324.0,15 RC,360,"EXCISION, LESION OF FLOOR OF MOUTH",,,3053.48,9324.0,15 RC,360,"EXCISION, LESION OF PALATE, UVULA; WITH SIMPLE PRIMARY CLOSURE",,,3012.0,7278.0,15 RC,360,"EXCISION, LESION OF PALATE, UVULA; WITHOUT CLOSURE",,,3012.0,7278.0,15 RC,360,"EXCISION, LOCAL; MALIGNANT TUMOR OF STOMACH",,,2533.0,4850.0,2 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,7278.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,7278.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,7278.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,5449.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,5449.0,14 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,5449.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM",,,376.18,5449.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,662.46,5449.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,662.46,7278.0,15 RC,360,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, NASAL POLYP(S), EXTENSIVE",,,3053.48,9324.0,15 RC,360,"EXCISION, NASAL POLYP(S), SIMPLE",,,1394.69,5449.0,14 RC,360,"EXCISION, OLECRANON BURSA",,,3054.93,9324.0,15 RC,360,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,7278.0,15 RC,360,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,7278.0,15 RC,360,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,15 RC,360,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,5449.0,15 RC,360,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,5449.0,15 RC,360,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 RC,360,"EXCISION, TUMOR OR VASCULAR MALFORMATION, SOFT TISSUE OF HAND OR FINGER, SUBCUTANEOUS; 1.5 CM OR GREATER",,,1525.52,17457.0,15 RC,360,"EXCISION, TUMOR OR VASCULAR MALFORMATION, SOFT TISSUE OF HAND OR FINGER, SUBCUTANEOUS; LESS THAN 1.5 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF ABDOMINAL WALL, SUBCUTANEOUS; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF ABDOMINAL WALL, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,12408.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF ABDOMINAL WALL, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF ABDOMINAL WALL, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,10561.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF BACK OR FLANK, SUBCUTANEOUS; 3 CM OR GREATER",,,1525.52,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF BACK OR FLANK, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF BACK OR FLANK, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF BACK OR FLANK, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,12408.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FACE AND SCALP, SUBFASCIAL (EG, SUBGALEAL, INTRAMUSCULAR); 2 CM OR GREATER",,,2246.0,5449.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FACE AND SCALP, SUBFASCIAL (EG, SUBGALEAL, INTRAMUSCULAR); LESS THAN 2 CM",,,1525.52,5449.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FACE OR SCALP, SUBCUTANEOUS; 2 CM OR GREATER",,,1525.52,5449.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FACE OR SCALP, SUBCUTANEOUS; LESS THAN 2 CM",,,1525.52,5449.0,14 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOOT OR TOE, SUBCUTANEOUS; 1.5 CM OR GREATER",,,2694.74,9324.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOOT OR TOE, SUBCUTANEOUS; LESS THAN 1.5 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOOT OR TOE, SUBFASCIAL (EG, INTRAMUSCULAR); 1.5 CM OR GREATER",,,2694.74,9324.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOOT OR TOE, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 1.5 CM",,,2694.74,8413.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOREARM AND/OR WRIST AREA, SUBCUTANEOUS; 3 CM OR GREATER",,,1525.52,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOREARM AND/OR WRIST AREA, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOREARM AND/OR WRIST AREA, SUBFASCIAL (EG, INTRAMUSCULAR); 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF FOREARM AND/OR WRIST AREA, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 3 CM",,,1525.52,8413.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF LEG OR ANKLE AREA, SUBCUTANEOUS; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF LEG OR ANKLE AREA, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF LEG OR ANKLE AREA, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF LEG OR ANKLE AREA, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,8413.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF NECK OR ANTERIOR THORAX, SUBCUTANEOUS; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF NECK OR ANTERIOR THORAX, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF NECK OR ANTERIOR THORAX, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF NECK OR ANTERIOR THORAX, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,9324.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF PELVIS AND HIP AREA, SUBCUTANEOUS; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF PELVIS AND HIP AREA, SUBCUTANEOUS; LESS THAN 3 CM",,,2694.74,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF PELVIS AND HIP AREA, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF PELVIS AND HIP AREA, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,8413.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF SHOULDER AREA, SUBCUTANEOUS; 3 CM OR GREATER",,,1525.52,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF SHOULDER AREA, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF SHOULDER AREA, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF THIGH OR KNEE AREA, SUBCUTANEOUS; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF THIGH OR KNEE AREA, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,9324.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF THIGH OR KNEE AREA, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF THIGH OR KNEE AREA, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,8413.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF UPPER ARM OR ELBOW AREA, SUBCUTANEOUS; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF UPPER ARM OR ELBOW AREA, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF UPPER ARM OR ELBOW AREA, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE OF UPPER ARM OR ELBOW AREA, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,7278.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE, OR VASCULAR MALFORMATION, OF HAND OR FINGER, SUBFASCIAL (EG, INTRAMUSCULAR); 1.5 CM OR GREATER",,,1525.52,17457.0,15 RC,360,"EXCISION, TUMOR, SOFT TISSUE, OR VASCULAR MALFORMATION, OF HAND OR FINGER, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 1.5 CM",,,1525.52,7278.0,15 RC,360,"EXENTERATION OF ORBIT (DOES NOT INCLUDE SKIN GRAFT), REMOVAL OF ORBITAL CONTENTS; ONLY",,,3550.55,13194.0,15 RC,360,"EXPLORATION FOR POSTOPERATIVE HEMORRHAGE, THROMBOSIS OR INFECTION; NECK",,,12615.0,21454.0,3 RC,360,EXPLORATION FOR UNDESCENDED TESTIS (INGUINAL OR SCROTAL AREA),,,3322.75,13194.0,15 RC,360,EXPLORATION OF PENETRATING WOUND (SEPARATE PROCEDURE); ABDOMEN/FLANK/BACK,,,1722.29,5239.0,13 RC,360,EXPLORATION OF PENETRATING WOUND (SEPARATE PROCEDURE); EXTREMITY,,,1525.52,5449.0,15 RC,360,EXPLORATION OF SPINAL FUSION,,,10561.0,21454.0,3 RC,360,"EXPLORATION WITH REMOVAL OF DEEP FOREIGN BODY, FOREARM OR WRIST",,,1506.85,9324.0,15 RC,360,"EXPLORATORY LAPAROTOMY, EXPLORATORY CELIOTOMY WITH OR WITHOUT BIOPSY(S) (SEPARATE PROCEDURE)",,,7444.0,13194.0,3 RC,360,"EXTERNAL CEPHALIC VERSION, WITH OR WITHOUT TOCOLYSIS",,,2993.65,9324.0,14 RC,360,"EXTRACAPSULAR CATARACT REMOVAL WITH INSERTION OF INTRAOCULAR LENS PROSTHESIS (1 STAGE PROCEDURE), MANUAL OR MECHANICAL TECHNIQUE (EG, IRRIGATION AND ASPIRATION OR PHACOEMULSIFICATION); WITH ENDOSCOPIC",,,3787.69,17457.0,15 RC,360,"EXTRACAPSULAR CATARACT REMOVAL WITH INSERTION OF INTRAOCULAR LENS PROSTHESIS (1 STAGE PROCEDURE), MANUAL OR MECHANICAL TECHNIQUE (EG, IRRIGATION AND ASPIRATION OR PHACOEMULSIFICATION); WITH INSERTION ",,,4858.07,15394.0,15 RC,360,"EXTRACAPSULAR CATARACT REMOVAL WITH INSERTION OF INTRAOCULAR LENS PROSTHESIS (1 STAGE PROCEDURE), MANUAL OR MECHANICAL TECHNIQUE (EG, IRRIGATION AND ASPIRATION OR PHACOEMULSIFICATION); WITHOUT ENDOSCO",,,2147.4,12686.0,15 RC,360,"EXTRACAPSULAR CATARACT REMOVAL WITH INSERTION OF INTRAOCULAR LENS PROSTHESIS (1-STAGE PROCEDURE), MANUAL OR MECHANICAL TECHNIQUE (EG, IRRIGATION AND ASPIRATION OR PHACOEMULSIFICATION), COMPLEX, REQUIR",,,2147.4,17457.0,45 RC,360,"EXTRAORAL INCISION AND DRAINAGE OF ABSCESS, CYST, OR HEMATOMA OF FLOOR OF MOUTH; MASTICATOR SPACE",,,1394.69,5449.0,15 RC,360,"EXTRAORAL INCISION AND DRAINAGE OF ABSCESS, CYST, OR HEMATOMA OF FLOOR OF MOUTH; SUBLINGUAL",,,479.48,5449.0,15 RC,360,"EXTRAORAL INCISION AND DRAINAGE OF ABSCESS, CYST, OR HEMATOMA OF FLOOR OF MOUTH; SUBMANDIBULAR",,,3012.0,5449.0,15 RC,360,"EXTRAORAL INCISION AND DRAINAGE OF ABSCESS, CYST, OR HEMATOMA OF FLOOR OF MOUTH; SUBMENTAL",,,4121.0,9324.0,15 RC,360,"FASCIA LATA GRAFT; BY INCISION AND AREA EXPOSURE, COMPLEX OR SHEET",,,1722.29,9324.0,15 RC,360,"FASCIECTOMY, PALM ONLY, WITH OR WITHOUT Z-PLASTY, OTHER LOCAL TISSUE REARRANGEMENT, OR SKIN GRAFTING (INCLUDES OBTAINING GRAFT)",,,3054.93,13194.0,15 RC,360,"FASCIECTOMY, PARTIAL PALMAR WITH RELEASE OF SINGLE DIGIT INCLUDING PROXIMAL INTERPHALANGEAL JOINT, WITH OR WITHOUT Z-PLASTY, OTHER LOCAL TISSUE REARRANGEMENT, OR SKIN GRAFTING (INCLUDES OBTAINING GRAF",,,777.0,13194.0,18 RC,360,"FASCIECTOMY, PLANTAR FASCIA; RADICAL (SEPARATE PROCEDURE)",,,3054.93,9324.0,15 RC,360,"FASCIOTOMY, FOOT AND/OR TOE",,,3054.93,9324.0,15 RC,360,"FASCIOTOMY, ILIOTIBIAL (TENOTOMY), OPEN",,,3054.93,9324.0,15 RC,360,"FASCIOTOMY, PALMAR (EG, DUPUYTREN'S CONTRACTURE); PERCUTANEOUS",,,1506.85,10561.0,15 RC,360,"FETAL UMBILICAL CORD OCCLUSION, INCLUDING ULTRASOUND GUIDANCE",,,286.41,5449.0,15 RC,360,"FINE NEEDLE ASPIRATION BIOPSY, INCLUDING ULTRASOUND GUIDANCE; EACH ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"FINE NEEDLE ASPIRATION BIOPSY, INCLUDING ULTRASOUND GUIDANCE; FIRST LESION",,,662.46,5449.0,15 RC,360,"FINE NEEDLE ASPIRATION BIOPSY, WITHOUT IMAGING GUIDANCE; FIRST LESION",,,376.18,5449.0,14 RC,360,FINE NEEDLE ASPIRATION OF ORBITAL CONTENTS,,,2196.57,9324.0,15 RC,360,"FISSURECTOMY, INCLUDING SPHINCTEROTOMY, WHEN PERFORMED",,,2582.07,9324.0,15 RC,360,"FISTULIZATION OF SCLERA FOR GLAUCOMA; SCLERECTOMY WITH PUNCH OR SCISSORS, WITH IRIDECTOMY",,,2147.4,9324.0,15 RC,360,FISTULIZATION OF SCLERA FOR GLAUCOMA; TRABECULECTOMY AB EXTERNO IN ABSENCE OF PREVIOUS SURGERY,,,2147.4,10561.0,15 RC,360,FISTULIZATION OF SCLERA FOR GLAUCOMA; TRABECULECTOMY AB EXTERNO WITH SCARRING FROM PREVIOUS OCULAR SURGERY OR TRAUMA (INCLUDES INJECTION OF ANTIFIBROTIC AGENTS),,,2147.4,10561.0,15 RC,360,FITTING AND INSERTION OF PESSARY OR OTHER INTRAVAGINAL SUPPORT DEVICE,,,189.41,1251.0,13 RC,360,FIXATION OF CONTRALATERAL TESTIS (SEPARATE PROCEDURE),,,3247.35,9324.0,15 RC,360,FLAP; ISLAND PEDICLE REQUIRING IDENTIFICATION AND DISSECTION OF AN ANATOMICALLY NAMED AXIAL VESSEL,,,1722.29,7278.0,15 RC,360,"FOREHEAD FLAP WITH PRESERVATION OF VASCULAR PEDICLE (EG, AXIAL PATTERN FLAP, PARAMEDIAN FOREHEAD FLAP)",,,3446.95,13194.0,15 RC,360,FORESKIN MANIPULATION INCLUDING LYSIS OF PREPUTIAL ADHESIONS AND STRETCHING,,,228.99,5449.0,15 RC,360,"FORMATION OF DIRECT OR TUBED PEDICLE, WITH OR WITHOUT TRANSFER; EYELIDS, NOSE, EARS, LIPS, OR INTRAORAL",,,1722.29,8413.0,15 RC,360,"FORMATION OF DIRECT OR TUBED PEDICLE, WITH OR WITHOUT TRANSFER; FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS OR FEET",,,1722.29,8413.0,15 RC,360,"FRACTIONAL ABLATIVE LASER FENESTRATION OF BURN AND TRAUMATIC SCARS FOR FUNCTIONAL IMPROVEMENT; EACH ADDITIONAL 100 CM2, OR EACH ADDITIONAL 1% OF BODY SURFACE AREA OF INFANTS AND CHILDREN, OR PART THER",,,777.0,5449.0,3 RC,360,"FRACTIONAL ABLATIVE LASER FENESTRATION OF BURN AND TRAUMATIC SCARS FOR FUNCTIONAL IMPROVEMENT; FIRST 100 CM2 OR PART THEREOF, OR 1% OF BODY SURFACE AREA OF INFANTS AND CHILDREN",,,576.34,5449.0,14 RC,360,"FRACTURE NASAL INFERIOR TURBINATE(S), THERAPEUTIC",,,3053.48,10561.0,15 RC,360,FREE MUSCLE OR MYOCUTANEOUS FLAP WITH MICROVASCULAR ANASTOMOSIS,,,5514.0,9324.0,3 RC,360,"FRENOPLASTY (SURGICAL REVISION OF FRENUM, EG, WITH Z-PLASTY)",,,3053.48,15394.0,15 RC,360,FRENULOTOMY OF PENIS,,,1928.76,9324.0,15 RC,360,"FULL THICKNESS GRAFT, FREE, INCLUDING DIRECT CLOSURE OF DONOR SITE, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS, AND/OR FEET; 20 SQ CM OR LESS",,,1722.29,8413.0,15 RC,360,"FULL THICKNESS GRAFT, FREE, INCLUDING DIRECT CLOSURE OF DONOR SITE, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS, AND/OR FEET; EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARAT",,,777.0,8413.0,3 RC,360,"FULL THICKNESS GRAFT, FREE, INCLUDING DIRECT CLOSURE OF DONOR SITE, NOSE, EARS, EYELIDS, AND/OR LIPS; 20 SQ CM OR LESS",,,1722.29,7278.0,15 RC,360,"FULL THICKNESS GRAFT, FREE, INCLUDING DIRECT CLOSURE OF DONOR SITE, NOSE, EARS, EYELIDS, AND/OR LIPS; EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDU",,,777.0,7278.0,3 RC,360,"FULL THICKNESS GRAFT, FREE, INCLUDING DIRECT CLOSURE OF DONOR SITE, SCALP, ARMS, AND/OR LEGS; 20 SQ CM OR LESS",,,1722.29,7278.0,15 RC,360,"FULL THICKNESS GRAFT, FREE, INCLUDING DIRECT CLOSURE OF DONOR SITE, SCALP, ARMS, AND/OR LEGS; EACH ADDITIONAL 20 SQ CM, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,7278.0,3 RC,360,"FULL THICKNESS GRAFT, FREE, INCLUDING DIRECT CLOSURE OF DONOR SITE, TRUNK; 20 SQ CM OR LESS",,,1722.29,9324.0,15 RC,360,"FUSION IN OPPOSITION, THUMB, WITH AUTOGENOUS GRAFT (INCLUDES OBTAINING GRAFT)",,,6726.11,13194.0,15 RC,360,"GASTRECTOMY, PARTIAL, DISTAL; WITH GASTRODUODENOSTOMY",,,2533.0,4850.0,2 RC,360,"GASTRIC INTUBATION AND ASPIRATION, DIAGNOSTIC; COLLECTION OF MULTIPLE FRACTIONAL SPECIMENS WITH GASTRIC STIMULATION, SINGLE OR DOUBLE LUMEN TUBE (GASTRIC SECRETORY STUDY) (EG, HISTAMINE, INSULIN, PENT",,,147.31,5449.0,15 RC,360,"GASTROCNEMIUS RECESSION (EG, STRAYER PROCEDURE)",,,3054.93,13194.0,15 RC,360,"GASTROSTOMY, OPEN; WITHOUT CONSTRUCTION OF GASTRIC TUBE (EG, STAMM PROCEDURE) (SEPARATE PROCEDURE)",,,1786.09,9324.0,13 RC,360,"GENIOPLASTY; AUGMENTATION (AUTOGRAFT, ALLOGRAFT, PROSTHETIC MATERIAL)",,,5514.0,15291.0,15 RC,360,"GENIOPLASTY; SLIDING OSTEOTOMY, SINGLE PIECE",,,3053.48,15291.0,15 RC,360,"GENIOPLASTY; SLIDING, AUGMENTATION WITH INTERPOSITIONAL BONE GRAFTS (INCLUDES OBTAINING AUTOGRAFTS)",,,3053.48,15291.0,15 RC,360,"GINGIVECTOMY, EXCISION GINGIVA, EACH QUADRANT",,,3053.48,9324.0,15 RC,360,GLOSSECTOMY; LESS THAN ONE-HALF TONGUE,,,5569.83,15394.0,15 RC,360,GONIOTOMY,,,3787.69,9324.0,15 RC,360,GRAFT FOR FACIAL NERVE PARALYSIS; FREE FASCIA GRAFT (INCLUDING OBTAINING FASCIA),,,3446.95,13194.0,15 RC,360,GRAFT FOR FACIAL NERVE PARALYSIS; REGIONAL MUSCLE TRANSFER,,,3446.95,13194.0,15 RC,360,"GRAFT, BONE; MANDIBLE (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,15 RC,360,"GRAFT, BONE; NASAL, MAXILLARY OR MALAR AREAS (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,15 RC,360,"GRAFT; COMPOSITE (EG, FULL THICKNESS OF EXTERNAL EAR OR NASAL ALA), INCLUDING PRIMARY CLOSURE, DONOR AREA",,,1722.29,7278.0,15 RC,360,GRAFT; DERMA-FAT-FASCIA,,,3446.95,13194.0,15 RC,360,"GRAFT; EAR CARTILAGE, AUTOGENOUS, TO NOSE OR EAR (INCLUDES OBTAINING GRAFT)",,,3012.0,15291.0,15 RC,360,"GRAFT; RIB CARTILAGE, AUTOGENOUS, TO FACE, CHIN, NOSE OR EAR (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,15 RC,360,"GRAFTING OF AUTOLOGOUS FAT HARVESTED BY LIPOSUCTION TECHNIQUE TO FACE, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, AND/OR FEET; 25 CC OR LESS INJECTATE",,,1722.29,17457.0,15 RC,360,"GRAFTING OF AUTOLOGOUS FAT HARVESTED BY LIPOSUCTION TECHNIQUE TO FACE, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, AND/OR FEET; EACH ADDITIONAL 25 CC INJECTATE, OR PART THEREOF (LIST SEPARAT",,,777.0,5449.0,3 RC,360,"GRAFTING OF AUTOLOGOUS FAT HARVESTED BY LIPOSUCTION TECHNIQUE TO TRUNK, BREASTS, SCALP, ARMS, AND/OR LEGS; 50 CC OR LESS INJECTATE",,,3446.95,17457.0,15 RC,360,"GRAFTING OF AUTOLOGOUS FAT HARVESTED BY LIPOSUCTION TECHNIQUE TO TRUNK, BREASTS, SCALP, ARMS, AND/OR LEGS; EACH ADDITIONAL 50 CC INJECTATE, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRI",,,777.0,5449.0,3 RC,360,"GRAFTING OF AUTOLOGOUS SOFT TISSUE, OTHER, HARVESTED BY DIRECT EXCISION (EG, FAT, DERMIS, FASCIA)",,,3446.95,17457.0,15 RC,360,"HALLUX RIGIDUS CORRECTION WITH CHEILECTOMY, DEBRIDEMENT AND CAPSULAR RELEASE OF THE FIRST METATARSOPHALANGEAL JOINT; WITH IMPLANT",,,6726.11,21454.0,14 RC,360,"HALLUX RIGIDUS CORRECTION WITH CHEILECTOMY, DEBRIDEMENT AND CAPSULAR RELEASE OF THE FIRST METATARSOPHALANGEAL JOINT; WITHOUT IMPLANT",,,3054.93,9324.0,15 RC,360,HARVEST OF SKIN FOR SKIN CELL SUSPENSION AUTOGRAFT; FIRST 25 SQ CM OR LESS,,,1722.29,7278.0,14 RC,360,"HARVEST OF SKIN FOR TISSUE CULTURED SKIN AUTOGRAFT, 100 SQ CM OR LESS",,,1722.29,7278.0,15 RC,360,"HEMORRHOIDECTOMY, EXTERNAL, 2 OR MORE COLUMNS/GROUPS",,,2582.07,9324.0,15 RC,360,"HEMORRHOIDECTOMY, INTERNAL AND EXTERNAL, 2 OR MORE COLUMNS/GROUPS;",,,2582.07,9324.0,15 RC,360,"HEMORRHOIDECTOMY, INTERNAL AND EXTERNAL, SINGLE COLUMN/GROUP;",,,2582.07,9324.0,15 RC,360,"HEMORRHOIDECTOMY, INTERNAL AND EXTERNAL, SINGLE COLUMN/GROUP; WITH FISTULECTOMY, INCLUDING FISSURECTOMY, WHEN PERFORMED",,,2582.07,9324.0,15 RC,360,"HEMORRHOIDECTOMY, INTERNAL, BY LIGATION OTHER THAN RUBBER BAND; 2 OR MORE HEMORRHOID COLUMNS/GROUPS, WITHOUT IMAGING GUIDANCE",,,2582.07,9324.0,15 RC,360,"HEMORRHOIDECTOMY, INTERNAL, BY LIGATION OTHER THAN RUBBER BAND; SINGLE HEMORRHOID COLUMN/GROUP, WITHOUT IMAGING GUIDANCE",,,2582.07,9324.0,14 RC,360,"HEMORRHOIDECTOMY, INTERNAL, BY RUBBER BAND LIGATION(S)",,,858.41,5449.0,15 RC,360,"HYMENOTOMY, SIMPLE INCISION",,,2993.65,9324.0,15 RC,360,"HYSTEROSCOPY, DIAGNOSTIC (SEPARATE PROCEDURE)",,,2993.65,9324.0,15 RC,360,"HYSTEROSCOPY, SURGICAL; WITH DIVISION OR RESECTION OF INTRAUTERINE SEPTUM (ANY METHOD)",,,4647.86,13194.0,15 RC,360,"HYSTEROSCOPY, SURGICAL; WITH ENDOMETRIAL ABLATION (EG, ENDOMETRIAL RESECTION, ELECTROSURGICAL ABLATION, THERMOABLATION)",,,4647.86,17457.0,15 RC,360,"HYSTEROSCOPY, SURGICAL; WITH LYSIS OF INTRAUTERINE ADHESIONS (ANY METHOD)",,,4647.86,9324.0,15 RC,360,"HYSTEROSCOPY, SURGICAL; WITH REMOVAL OF IMPACTED FOREIGN BODY",,,2993.65,9324.0,15 RC,360,"HYSTEROSCOPY, SURGICAL; WITH REMOVAL OF LEIOMYOMATA",,,4647.86,13194.0,15 RC,360,"HYSTEROSCOPY, SURGICAL; WITH SAMPLING (BIOPSY) OF ENDOMETRIUM AND/OR POLYPECTOMY, WITH OR WITHOUT D & C",,,2993.65,9324.0,15 RC,360,"ILEOSCOPY, THROUGH STOMA; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,882.75,5449.0,15 RC,360,"ILEOSCOPY, THROUGH STOMA; WITH BIOPSY, SINGLE OR MULTIPLE",,,882.75,5449.0,15 RC,360,"IMAGE-GUIDED FLUID COLLECTION DRAINAGE BY CATHETER (EG, ABSCESS, HEMATOMA, SEROMA, LYMPHOCELE, CYST); PERITONEAL OR RETROPERITONEAL, PERCUTANEOUS",,,1525.52,17457.0,15 RC,360,"IMAGE-GUIDED FLUID COLLECTION DRAINAGE BY CATHETER (EG, ABSCESS, HEMATOMA, SEROMA, LYMPHOCELE, CYST); PERITONEAL OR RETROPERITONEAL, TRANSVAGINAL OR TRANSRECTAL",,,1525.52,8413.0,15 RC,360,"IMPLANTATION OF BIOLOGIC IMPLANT (EG, ACELLULAR DERMAL MATRIX) FOR SOFT TISSUE REINFORCEMENT (IE, BREAST, TRUNK) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,IMPLANTATION OF NERVE END INTO BONE OR MUSCLE (LIST SEPARATELY IN ADDITION TO NEUROMA EXCISION),,,777.0,7278.0,3 RC,360,"IMPLANTATION OR REPLACEMENT OF CAROTID SINUS BAROREFLEX ACTIVATION DEVICE; TOTAL SYSTEM (INCLUDES GENERATOR PLACEMENT, UNILATERAL OR BILATERAL LEAD PLACEMENT, INTRA-OPERATIVE INTERROGATION, PROGRAMMIN",,,18691.0,46301.0,13 RC,360,"IMPLANTATION OR REPLACEMENT OF DEVICE FOR INTRATHECAL OR EPIDURAL DRUG INFUSION; PROGRAMMABLE PUMP, INCLUDING PREPARATION OF PUMP, WITH OR WITHOUT PROGRAMMING",,,5152.0,30820.0,15 RC,360,IMPLANTATION OR REPLACEMENT OF DEVICE FOR INTRATHECAL OR EPIDURAL DRUG INFUSION; SUBCUTANEOUS RESERVOIR,,,5152.0,18184.89,15 RC,360,IMPLANTATION OR REPLACEMENT OF ELECTROMAGNETIC BONE CONDUCTION HEARING DEVICE IN TEMPORAL BONE,,,6649.0,15394.0,4 RC,360,"IMPLANTATION, OSSEOINTEGRATED IMPLANT, SKULL; WITH MAGNETIC TRANSCUTANEOUS ATTACHMENT TO EXTERNAL SPEECH PROCESSOR, OUTSIDE OF THE MASTOID AND RESULTING IN REMOVAL OF GREATER THAN OR EQUAL TO 100 SQ M",,,8875.0,21454.0,14 RC,360,"IMPLANTATION, OSSEOINTEGRATED IMPLANT, SKULL; WITH MAGNETIC TRANSCUTANEOUS ATTACHMENT TO EXTERNAL SPEECH PROCESSOR, WITHIN THE MASTOID AND/OR RESULTING IN REMOVAL OF LESS THAN 100 SQ MM SURFACE AREA O",,,8875.0,21454.0,14 RC,360,"IMPLANTATION, OSSEOINTEGRATED IMPLANT, SKULL; WITH PERCUTANEOUS ATTACHMENT TO EXTERNAL SPEECH PROCESSOR",,,8875.0,30725.0,14 RC,360,"IMPLANTATION, REVISION OR REPOSITIONING OF TUNNELED INTRATHECAL OR EPIDURAL CATHETER, FOR LONG-TERM MEDICATION ADMINISTRATION VIA AN EXTERNAL PUMP OR IMPLANTABLE RESERVOIR/INFUSION PUMP; WITHOUT LAMIN",,,5152.0,15394.0,15 RC,360,INCISION AND DRAINAGE ABSCESS; PERITONSILLAR,,,218.65,5449.0,15 RC,360,"INCISION AND DRAINAGE ABSCESS; RETROPHARYNGEAL OR PARAPHARYNGEAL, EXTERNAL APPROACH",,,5152.0,15394.0,15 RC,360,"INCISION AND DRAINAGE ABSCESS; RETROPHARYNGEAL OR PARAPHARYNGEAL, INTRAORAL APPROACH",,,3012.0,5449.0,15 RC,360,"INCISION AND DRAINAGE BELOW FASCIA, WITH OR WITHOUT TENDON SHEATH INVOLVEMENT, FOOT; MULTIPLE AREAS",,,3054.93,9324.0,15 RC,360,"INCISION AND DRAINAGE BELOW FASCIA, WITH OR WITHOUT TENDON SHEATH INVOLVEMENT, FOOT; SINGLE BURSAL SPACE",,,1506.85,9324.0,15 RC,360,"INCISION AND DRAINAGE OF ABSCESS (EG, CARBUNCLE, SUPPURATIVE HIDRADENITIS, CUTANEOUS OR SUBCUTANEOUS ABSCESS, CYST, FURUNCLE, OR PARONYCHIA); COMPLICATED OR MULTIPLE",,,376.18,5449.0,15 RC,360,"INCISION AND DRAINAGE OF ABSCESS (EG, CARBUNCLE, SUPPURATIVE HIDRADENITIS, CUTANEOUS OR SUBCUTANEOUS ABSCESS, CYST, FURUNCLE, OR PARONYCHIA); SIMPLE OR SINGLE",,,187.08,5449.0,14 RC,360,INCISION AND DRAINAGE OF BARTHOLIN'S GLAND ABSCESS,,,189.41,5449.0,15 RC,360,"INCISION AND DRAINAGE OF EPIDIDYMIS, TESTIS AND/OR SCROTAL SPACE (EG, ABSCESS OR HEMATOMA)",,,1928.76,9324.0,15 RC,360,"INCISION AND DRAINAGE OF HEMATOMA, SEROMA OR FLUID COLLECTION",,,1525.52,5449.0,14 RC,360,"INCISION AND DRAINAGE OF INTRAMURAL, INTRAMUSCULAR, OR SUBMUCOSAL ABSCESS, TRANSANAL, UNDER ANESTHESIA",,,2582.07,9324.0,15 RC,360,INCISION AND DRAINAGE OF ISCHIORECTAL AND/OR PERIRECTAL ABSCESS (SEPARATE PROCEDURE),,,1110.16,8413.0,15 RC,360,"INCISION AND DRAINAGE OF ISCHIORECTAL OR INTRAMURAL ABSCESS, WITH FISTULECTOMY OR FISTULOTOMY, SUBMUSCULAR, WITH OR WITHOUT PLACEMENT OF SETON",,,2582.07,7278.0,15 RC,360,INCISION AND DRAINAGE OF PILONIDAL CYST; COMPLICATED,,,662.46,5449.0,14 RC,360,INCISION AND DRAINAGE OF PILONIDAL CYST; SIMPLE,,,662.46,5449.0,14 RC,360,"INCISION AND DRAINAGE OF SUBMUCOSAL ABSCESS, RECTUM",,,1110.16,7278.0,15 RC,360,INCISION AND DRAINAGE OF VULVA OR PERINEAL ABSCESS,,,286.41,7278.0,15 RC,360,"INCISION AND DRAINAGE, BURSA, FOOT",,,1525.52,7278.0,14 RC,360,"INCISION AND DRAINAGE, COMPLEX, POSTOPERATIVE WOUND INFECTION",,,2694.74,9324.0,15 RC,360,"INCISION AND DRAINAGE, DEEP ABSCESS OR HEMATOMA, SOFT TISSUES OF NECK OR THORAX;",,,2694.74,9324.0,15 RC,360,"INCISION AND DRAINAGE, DEEP ABSCESS, BURSA, OR HEMATOMA, THIGH OR KNEE REGION",,,2694.74,9324.0,15 RC,360,"INCISION AND DRAINAGE, FOREARM AND/OR WRIST; DEEP ABSCESS OR HEMATOMA",,,3054.93,9324.0,15 RC,360,"INCISION AND DRAINAGE, LEG OR ANKLE; DEEP ABSCESS OR HEMATOMA",,,2694.74,9324.0,15 RC,360,"INCISION AND DRAINAGE, PERIANAL ABSCESS, SUPERFICIAL",,,858.41,5449.0,15 RC,360,"INCISION AND DRAINAGE, UPPER ARM OR ELBOW AREA; DEEP ABSCESS OR HEMATOMA",,,2694.74,9324.0,15 RC,360,"INCISION AND REMOVAL OF FOREIGN BODY, SUBCUTANEOUS TISSUES; COMPLICATED",,,1525.52,7278.0,15 RC,360,"INCISION AND REMOVAL OF FOREIGN BODY, SUBCUTANEOUS TISSUES; SIMPLE",,,376.18,5449.0,14 RC,360,INCISION OF LABIAL FRENUM (FRENOTOMY),,,479.48,5449.0,14 RC,360,INCISION OF LINGUAL FRENUM (FRENOTOMY),,,1394.69,5449.0,15 RC,360,"INCISION, BONE CORTEX (EG, OSTEOMYELITIS OR BONE ABSCESS), FOOT",,,3054.93,9324.0,15 RC,360,"INCISION, BONE CORTEX, HAND OR FINGER (EG, OSTEOMYELITIS OR BONE ABSCESS)",,,1506.85,7278.0,15 RC,360,"INCISION, EXTENSOR TENDON SHEATH, WRIST (EG, DE QUERVAINS DISEASE)",,,1506.85,9324.0,15 RC,360,"INCISIONAL BIOPSY OF SKIN (EG, WEDGE) (INCLUDING SIMPLE CLOSURE, WHEN PERFORMED); SINGLE LESION",,,576.34,5449.0,15 RC,360,"INDUCED ABORTION, BY 1 OR MORE VAGINAL SUPPOSITORIES (EG, PROSTAGLANDIN) WITH OR WITHOUT CERVICAL DILATION (EG, LAMINARIA), INCLUDING HOSPITAL ADMISSION AND VISITS, DELIVERY OF FETUS AND SECUNDINES; W",,,3012.0,7278.0,3 RC,360,"INDUCED ABORTION, BY DILATION AND CURETTAGE",,,2993.65,12615.0,15 RC,360,"INDUCED ABORTION, BY DILATION AND EVACUATION",,,2993.65,12615.0,15 RC,360,"INFRATEMPORAL POST-AURICULAR APPROACH TO MIDDLE CRANIAL FOSSA (INTERNAL AUDITORY MEATUS, PETROUS APEX, TENTORIUM, CAVERNOUS SINUS, PARASELLAR AREA, INFRATEMPORAL FOSSA) INCLUDING MASTOIDECTOMY, RESECT",,,2533.0,4850.0,2 RC,360,"INFRATEMPORAL PRE-AURICULAR APPROACH TO MIDDLE CRANIAL FOSSA (PARAPHARYNGEAL SPACE, INFRATEMPORAL AND MIDLINE SKULL BASE, NASOPHARYNX), WITH OR WITHOUT DISARTICULATION OF THE MANDIBLE, INCLUDING PAROT",,,2533.0,4850.0,2 RC,360,"INGUINOFEMORAL LYMPHADENECTOMY, SUPERFICIAL, IN CONTINUITY WITH PELVIC LYMPHADENECTOMY, INCLUDING EXTERNAL ILIAC, HYPOGASTRIC, AND OBTURATOR NODES (SEPARATE PROCEDURE)",,,2533.0,4850.0,2 RC,360,"INGUINOFEMORAL LYMPHADENECTOMY, SUPERFICIAL, INCLUDING CLOQUET'S NODE (SEPARATE PROCEDURE)",,,5152.0,9324.0,15 RC,360,"INITIAL TREATMENT, FIRST DEGREE BURN, WHEN NO MORE THAN LOCAL TREATMENT IS REQUIRED",,,187.08,1251.0,13 RC,360,"INJECTION OF CORPORA CAVERNOSA WITH PHARMACOLOGIC AGENT(S) (EG, PAPAVERINE, PHENTOLAMINE)",,,228.99,1251.0,13 RC,360,INJECTION OF MEDICATION OR OTHER SUBSTANCE INTO TENON'S CAPSULE,,,281.46,5449.0,15 RC,360,"INJECTION OF NON-COMPOUNDED FOAM SCLEROSANT WITH ULTRASOUND COMPRESSION MANEUVERS TO GUIDE DISPERSION OF THE INJECTATE, INCLUSIVE OF ALL IMAGING GUIDANCE AND MONITORING; MULTIPLE INCOMPETENT TRUNCAL V",,,1722.29,17457.0,15 RC,360,"INJECTION OF SCLEROSANT; MULTIPLE INCOMPETENT VEINS (OTHER THAN TELANGIECTASIA), SAME LEG",,,376.18,5449.0,14 RC,360,"INJECTION OF SCLEROSING SOLUTION, HEMORRHOIDS",,,858.41,3517.0,13 RC,360,INJECTION OF SINUS TRACT; DIAGNOSTIC (SINOGRAM),,,777.0,5449.0,3 RC,360,"INJECTION OF VITREOUS SUBSTITUTE, PARS PLANA OR LIMBAL APPROACH (FLUID-GAS EXCHANGE), WITH OR WITHOUT ASPIRATION (SEPARATE PROCEDURE)",,,2147.4,9324.0,15 RC,360,"INJECTION PROCEDURE FOR ANTEGRADE NEPHROSTOGRAM AND/OR URETEROGRAM, COMPLETE DIAGNOSTIC PROCEDURE INCLUDING IMAGING GUIDANCE (EG, ULTRASOUND AND FLUOROSCOPY) AND ALL ASSOCIATED RADIOLOGICAL SUPERVISIO",,,628.45,6649.0,30 RC,360,INJECTION PROCEDURE FOR CYSTOGRAPHY OR VOIDING URETHROCYSTOGRAPHY,,,777.0,1251.0,2 RC,360,INJECTION PROCEDURE FOR ELBOW ARTHROGRAPHY,,,777.0,5449.0,3 RC,360,INJECTION PROCEDURE FOR EXTREMITY VENOGRAPHY (INCLUDING INTRODUCTION OF NEEDLE OR INTRACATHETER),,,777.0,5449.0,3 RC,360,INJECTION PROCEDURE FOR HIP ARTHROGRAPHY; WITH ANESTHESIA,,,777.0,5449.0,3 RC,360,INJECTION PROCEDURE FOR PEYRONIE DISEASE;,,,228.99,4121.0,14 RC,360,INJECTION PROCEDURE FOR RETROGRADE URETHROCYSTOGRAPHY,,,777.0,1251.0,2 RC,360,INJECTION PROCEDURE FOR SHOULDER ARTHROGRAPHY OR ENHANCED CT/MRI SHOULDER ARTHROGRAPHY,,,777.0,5449.0,3 RC,360,"INJECTION PROCEDURE FOR VISUALIZATION OF ILEAL CONDUIT AND/OR URETEROPYELOGRAPHY, EXCLUSIVE OF RADIOLOGIC SERVICE",,,777.0,5449.0,3 RC,360,INJECTION PROCEDURE; RADIOACTIVE TRACER FOR IDENTIFICATION OF SENTINEL NODE,,,378.34,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; AXILLARY NERVE, INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,838.24,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; BRACHIAL PLEXUS, INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,838.24,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; FEMORAL NERVE, CONTINUOUS INFUSION BY CATHETER (INCLUDING CATHETER PLACEMENT), INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,838.24,4121.0,14 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; FEMORAL NERVE, INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,652.03,4121.0,14 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; GENICULAR NERVE BRANCHES, INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,652.03,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; GREATER OCCIPITAL NERVE",,,277.93,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; ILIOINGUINAL, ILIOHYPOGASTRIC NERVES",,,652.03,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; INTERCOSTAL NERVE, EACH ADDITIONAL LEVEL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,838.24,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; INTERCOSTAL NERVE, SINGLE LEVEL",,,652.03,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; OTHER PERIPHERAL NERVE OR BRANCH",,,652.03,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; PARACERVICAL (UTERINE) NERVE",,,652.03,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; PLANTAR COMMON DIGITAL NERVE(S) (EG, MORTON'S NEUROMA)",,,277.93,5449.0,14 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; PUDENDAL NERVE",,,838.24,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; SCIATIC NERVE, INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,652.03,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; SUPRASCAPULAR NERVE",,,652.03,5449.0,15 RC,360,"INJECTION(S), ANESTHETIC AGENT(S) AND/OR STEROID; TRIGEMINAL NERVE, EACH BRANCH (IE, OPHTHALMIC, MAXILLARY, MANDIBULAR)",,,277.93,5449.0,15 RC,360,"INJECTION(S), BONE-SUBSTITUTE MATERIAL (EG, CALCIUM PHOSPHATE) INTO SUBCHONDRAL BONE DEFECT (IE, BONE MARROW LESION, BONE BRUISE, STRESS INJURY, MICROTRABECULAR FRACTURE), INCLUDING IMAGING GUIDANCE A",,,3054.93,13194.0,14 RC,360,"INJECTION(S), INCLUDING INDWELLING CATHETER PLACEMENT, CONTINUOUS INFUSION OR INTERMITTENT BOLUS, OF DIAGNOSTIC OR THERAPEUTIC SUBSTANCE(S) (EG, ANESTHETIC, ANTISPASMODIC, OPIOID, STEROID, OTHER SOLUT",,,838.24,5449.0,30 RC,360,"INJECTION(S), OF DIAGNOSTIC OR THERAPEUTIC SUBSTANCE(S) (EG, ANESTHETIC, ANTISPASMODIC, OPIOID, STEROID, OTHER SOLUTION), NOT INCLUDING NEUROLYTIC SUBSTANCES, INCLUDING NEEDLE OR CATHETER PLACEMENT, I",,,652.03,5449.0,45 RC,360,"INJECTION(S); SINGLE OR MULTIPLE TRIGGER POINT(S), 1 OR 2 MUSCLE(S)",,,277.93,5449.0,15 RC,360,"INJECTION(S); SINGLE OR MULTIPLE TRIGGER POINT(S), 3 OR MORE MUSCLES",,,277.93,5449.0,15 RC,360,"INJECTION(S); SINGLE TENDON SHEATH, OR LIGAMENT, APONEUROSIS (EG, PLANTAR ""FASCIA"")",,,277.93,5449.0,15 RC,360,"INJECTION, ANESTHETIC AGENT; LUMBAR OR THORACIC (PARAVERTEBRAL SYMPATHETIC)",,,838.24,5449.0,15 RC,360,"INJECTION, ANESTHETIC AGENT; SUPERIOR HYPOGASTRIC PLEXUS",,,838.24,7278.0,15 RC,360,"INJECTION, ANTERIOR CHAMBER OF EYE (SEPARATE PROCEDURE); AIR OR LIQUID",,,2147.4,5449.0,15 RC,360,"INJECTION, ANTERIOR CHAMBER OF EYE (SEPARATE PROCEDURE); MEDICATION",,,2147.4,5449.0,15 RC,360,"INJECTION, EPIDURAL, OF BLOOD OR CLOT PATCH",,,652.03,5449.0,15 RC,360,"INJECTION, INTRALESIONAL; MORE THAN 7 LESIONS",,,187.08,5449.0,14 RC,360,"INJECTION, INTRALESIONAL; UP TO AND INCLUDING 7 LESIONS",,,187.08,5449.0,14 RC,360,"INSERTION OF A TEMPORARY PROSTATIC URETHRAL STENT, INCLUDING URETHRAL MEASUREMENT",,,1928.76,5449.0,14 RC,360,INSERTION OF A VAGINAL RADIATION AFTERLOADING APPARATUS FOR CLINICAL BRACHYTHERAPY,,,286.41,7278.0,15 RC,360,"INSERTION OF ANTERIOR SEGMENT AQUEOUS DRAINAGE DEVICE INTO THE TRABECULAR MESHWORK, WITHOUT EXTERNAL RESERVOIR, AND WITHOUT CONCOMITANT CATARACT REMOVAL, ONE OR MORE",,,4858.07,9324.0,14 RC,360,"INSERTION OF ANTERIOR SEGMENT AQUEOUS DRAINAGE DEVICE, WITHOUT EXTRAOCULAR RESERVOIR, EXTERNAL APPROACH",,,3787.69,17457.0,15 RC,360,"INSERTION OF AQUEOUS DRAINAGE DEVICE, WITHOUT EXTRAOCULAR RESERVOIR, INTERNAL APPROACH, INTO THE SUBCONJUNCTIVAL SPACE; INITIAL DEVICE",,,4858.07,15394.0,14 RC,360,"INSERTION OF BREAST IMPLANT ON SAME DAY OF MASTECTOMY (IE, IMMEDIATE)",,,5152.0,15394.0,15 RC,360,"INSERTION OF CERVICAL DILATOR (EG, LAMINARIA, PROSTAGLANDIN) (SEPARATE PROCEDURE)",,,286.41,5449.0,15 RC,360,"INSERTION OF DUODENOSTOMY OR JEJUNOSTOMY TUBE, PERCUTANEOUS, UNDER FLUOROSCOPIC GUIDANCE INCLUDING CONTRAST INJECTION(S), IMAGE DOCUMENTATION AND REPORT",,,1786.09,7278.0,15 RC,360,"INSERTION OF GASTROSTOMY TUBE, PERCUTANEOUS, UNDER FLUOROSCOPIC GUIDANCE INCLUDING CONTRAST INJECTION(S), IMAGE DOCUMENTATION AND REPORT",,,1786.09,7278.0,15 RC,360,INSERTION OF INDWELLING TUNNELED PLEURAL CATHETER WITH CUFF,,,3322.75,17457.0,15 RC,360,"INSERTION OF INFLATABLE URETHRAL/BLADDER NECK SPHINCTER, INCLUDING PLACEMENT OF PUMP, RESERVOIR, AND CUFF",,,4121.0,30351.0,15 RC,360,"INSERTION OF INTERBODY BIOMECHANICAL DEVICE(S) (EG, SYNTHETIC CAGE, MESH) WITH INTEGRAL ANTERIOR INSTRUMENTATION FOR DEVICE ANCHORING (EG, SCREWS, FLANGES), WHEN PERFORMED, TO INTERVERTEBRAL DISC SPAC",,,777.0,5449.0,3 RC,360,"INSERTION OF INTERVERTEBRAL BIOMECHANICAL DEVICE(S) (EG, SYNTHETIC CAGE, MESH) WITH INTEGRAL ANTERIOR INSTRUMENTATION FOR DEVICE ANCHORING (EG, SCREWS, FLANGES), WHEN PERFORMED, TO VERTEBRAL CORPECTOM",,,777.0,5449.0,3 RC,360,"INSERTION OF INTERVERTEBRAL BIOMECHANICAL DEVICE(S) (EG, SYNTHETIC CAGE, MESH, METHYLMETHACRYLATE) TO INTERVERTEBRAL DISC SPACE OR VERTEBRAL BODY DEFECT WITHOUT INTERBODY ARTHRODESIS, EACH CONTIGUOUS ",,,777.0,5449.0,3 RC,360,"INSERTION OF INTRAOCULAR LENS PROSTHESIS (SECONDARY IMPLANT), NOT ASSOCIATED WITH CONCURRENT CATARACT REMOVAL",,,2147.4,13764.0,15 RC,360,INSERTION OF INTRAUTERINE DEVICE (IUD),,,777.0,5449.0,3 RC,360,"INSERTION OF INTRAVASCULAR VENA CAVA FILTER, ENDOVASCULAR APPROACH INCLUDING VASCULAR ACCESS, VESSEL SELECTION, AND RADIOLOGICAL SUPERVISION AND INTERPRETATION, INTRAPROCEDURAL ROADMAPPING, AND IMAGIN",,,5089.69,21454.0,14 RC,360,"INSERTION OF MULTI-COMPONENT, INFLATABLE PENILE PROSTHESIS, INCLUDING PLACEMENT OF PUMP, CYLINDERS, AND RESERVOIR",,,6649.0,30351.0,15 RC,360,INSERTION OF NEW OR REPLACEMENT OF PERMANENT PACEMAKER WITH TRANSVENOUS ELECTRODE(S); ATRIAL AND VENTRICULAR,,,9853.53,30351.0,14 RC,360,INSERTION OF NEW OR REPLACEMENT OF PERMANENT PACEMAKER WITH TRANSVENOUS ELECTRODE(S); VENTRICULAR,,,9853.53,30725.0,14 RC,360,"INSERTION OF NON-INDWELLING BLADDER CATHETER (EG, STRAIGHT CATHETERIZATION FOR RESIDUAL URINE)",,,121.37,5449.0,14 RC,360,INSERTION OF NON-TUNNELED CENTRALLY INSERTED CENTRAL VENOUS CATHETER; AGE 5 YEARS OR OLDER,,,2246.0,5449.0,15 RC,360,INSERTION OF PENILE PROSTHESIS; NON-INFLATABLE (SEMI-RIGID),,,6649.0,30725.0,15 RC,360,"INSERTION OF PERIPHERALLY INSERTED CENTRAL VENOUS ACCESS DEVICE, WITH SUBCUTANEOUS PORT; AGE 5 YEARS OR OLDER",,,2963.5,13194.0,15 RC,360,"INSERTION OF PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER (PICC), WITHOUT SUBCUTANEOUS PORT OR PUMP, WITHOUT IMAGING GUIDANCE; AGE 5 YEARS OR OLDER",,,1462.62,5449.0,15 RC,360,INSERTION OF TANDEM CUFF (DUAL CUFF),,,5152.0,30725.0,15 RC,360,"INSERTION OF TEMPORARY INDWELLING BLADDER CATHETER; COMPLICATED (EG, ALTERED ANATOMY, FRACTURED CATHETER/BALLOON)",,,147.31,5449.0,15 RC,360,"INSERTION OF TEMPORARY INDWELLING BLADDER CATHETER; SIMPLE (EG, FOLEY)",,,121.37,5449.0,14 RC,360,INSERTION OF TESTICULAR PROSTHESIS (SEPARATE PROCEDURE),,,4786.44,9324.0,15 RC,360,"INSERTION OF TISSUE EXPANDER(S) FOR OTHER THAN BREAST, INCLUDING SUBSEQUENT EXPANSION",,,3446.95,13194.0,15 RC,360,"INSERTION OF TUNNELED CENTRALLY INSERTED CENTRAL VENOUS ACCESS DEVICE, WITH SUBCUTANEOUS PORT; AGE 5 YEARS OR OLDER",,,2963.5,13194.0,15 RC,360,"INSERTION OF TUNNELED CENTRALLY INSERTED CENTRAL VENOUS ACCESS DEVICE, WITH SUBCUTANEOUS PORT; YOUNGER THAN 5 YEARS OF AGE",,,2963.5,13194.0,15 RC,360,"INSERTION OF TUNNELED CENTRALLY INSERTED CENTRAL VENOUS CATHETER, WITHOUT SUBCUTANEOUS PORT OR PUMP; AGE 5 YEARS OR OLDER",,,2963.5,13194.0,15 RC,360,"INSERTION OF TUNNELED CENTRALLY INSERTED CENTRAL VENOUS CATHETER, WITHOUT SUBCUTANEOUS PORT OR PUMP; YOUNGER THAN 5 YEARS OF AGE",,,5089.69,21454.0,15 RC,360,"INSERTION OF TUNNELED INTRAPERITONEAL CATHETER FOR DIALYSIS, OPEN",,,3322.75,13194.0,15 RC,360,"INSERTION OF TUNNELED INTRAPERITONEAL CATHETER, WITH SUBCUTANEOUS PORT (IE, TOTALLY IMPLANTABLE)",,,4121.0,21454.0,15 RC,360,"INSERTION OF WIRE OR PIN WITH APPLICATION OF SKELETAL TRACTION, INCLUDING REMOVAL (SEPARATE PROCEDURE)",,,3054.93,13194.0,15 RC,360,INSERTION OR REPLACEMENT OF BREAST IMPLANT ON SEPARATE DAY FROM MASTECTOMY,,,6649.0,21454.0,15 RC,360,"INSERTION OR REPLACEMENT OF CRANIAL NEUROSTIMULATOR PULSE GENERATOR OR RECEIVER, DIRECT OR INDUCTIVE COUPLING; WITH CONNECTION TO 2 OR MORE ELECTRODE ARRAYS",,,6649.0,38950.0,15 RC,360,"INSERTION OR REPLACEMENT OF CRANIAL NEUROSTIMULATOR PULSE GENERATOR OR RECEIVER, DIRECT OR INDUCTIVE COUPLING; WITH CONNECTION TO A SINGLE ELECTRODE ARRAY",,,5152.0,30820.0,15 RC,360,"INSERTION OR REPLACEMENT OF PERIPHERAL, SACRAL, OR GASTRIC NEUROSTIMULATOR PULSE GENERATOR OR RECEIVER, REQUIRING POCKET CREATION AND CONNECTION BETWEEN ELECTRODE ARRAY AND PULSE GENERATOR OR RECEIVER",,,5152.0,30820.0,15 RC,360,"INSERTION OR REPLACEMENT OF PERMANENT IMPLANTABLE DEFIBRILLATOR SYSTEM, WITH TRANSVENOUS LEAD(S), SINGLE OR DUAL CHAMBER",,,15291.0,38950.0,14 RC,360,"INSERTION OR REPLACEMENT OF PERMANENT SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR SYSTEM, WITH SUBCUTANEOUS ELECTRODE, INCLUDING DEFIBRILLATION THRESHOLD EVALUATION, INDUCTION OF ARRHYTHMIA, EVALUATION OF ",,,8413.0,38950.0,14 RC,360,"INSERTION OR REPLACEMENT OF SPINAL NEUROSTIMULATOR PULSE GENERATOR OR RECEIVER, REQUIRING POCKET CREATION AND CONNECTION BETWEEN ELECTRODE ARRAY AND PULSE GENERATOR OR RECEIVER",,,5152.0,31354.26,15 RC,360,INSERTION OR REPLACEMENT OF TEMPORARY TRANSVENOUS SINGLE CHAMBER CARDIAC ELECTRODE OR PACEMAKER CATHETER (SEPARATE PROCEDURE),,,7792.17,21454.0,14 RC,360,"INSERTION, DRUG-DELIVERY IMPLANT (IE, BIORESORBABLE, BIODEGRADABLE, NON-BIODEGRADABLE)",,,121.37,5449.0,14 RC,360,"INTERNAL NEUROLYSIS, REQUIRING USE OF OPERATING MICROSCOPE (LIST SEPARATELY IN ADDITION TO CODE FOR NEUROPLASTY) (NEUROPLASTY INCLUDES EXTERNAL NEUROLYSIS)",,,777.0,5449.0,3 RC,360,INTERSEX SURGERY; FEMALE TO MALE,,,3247.35,3548.65,11 RC,360,INTERSEX SURGERY; MALE TO FEMALE,,,4647.86,5079.11,11 RC,360,"INTESTINAL STRICTUROPLASTY (ENTEROTOMY AND ENTERORRHAPHY) WITH OR WITHOUT DILATION, FOR INTESTINAL OBSTRUCTION",,,2533.0,4850.0,2 RC,360,"INTRAOPERATIVE IDENTIFICATION (EG, MAPPING) OF SENTINEL LYMPH NODE(S) INCLUDES INJECTION OF NON-RADIOACTIVE DYE, WHEN PERFORMED (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"INTRAOPERATIVE NEAR-INFRARED FLUORESCENCE IMAGING OF MAJOR EXTRA-HEPATIC BILE DUCT(S) (E.G., CYSTIC DUCT, COMMON BILE DUCT AND COMMON HEPATIC DUCT) WITH INTRAVENOUS ADMINISTRATION OF INDOCYANINE GREEN",,,,,0 RC,360,"INTRAORAL INCISION AND DRAINAGE OF ABSCESS, CYST, OR HEMATOMA OF TONGUE OR FLOOR OF MOUTH; LINGUAL",,,479.48,5449.0,15 RC,360,"INTRAORAL INCISION AND DRAINAGE OF ABSCESS, CYST, OR HEMATOMA OF TONGUE OR FLOOR OF MOUTH; MASTICATOR SPACE",,,479.48,5449.0,15 RC,360,"INTRAORAL INCISION AND DRAINAGE OF ABSCESS, CYST, OR HEMATOMA OF TONGUE OR FLOOR OF MOUTH; SUBMANDIBULAR SPACE",,,3012.0,5449.0,15 RC,360,"INTRAVASCULAR ULTRASOUND (NONCORONARY VESSEL) DURING DIAGNOSTIC EVALUATION AND/OR THERAPEUTIC INTERVENTION, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION; EACH ADDITIONAL NONCORONARY VESSEL (L",,,777.0,5449.0,3 RC,360,"INTRAVASCULAR ULTRASOUND (NONCORONARY VESSEL) DURING DIAGNOSTIC EVALUATION AND/OR THERAPEUTIC INTERVENTION, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION; INITIAL NONCORONARY VESSEL (LIST SEPA",,,777.0,5449.0,3 RC,360,"INTRAVENOUS INJECTION OF AGENT (EG, FLUORESCEIN) TO TEST VASCULAR FLOW IN FLAP OR GRAFT",,,375.71,5449.0,14 RC,360,INTRAVITREAL INJECTION OF A PHARMACOLOGIC AGENT (SEPARATE PROCEDURE),,,312.3,5449.0,15 RC,360,"INTRODUCTION OF CATHETER, SUPERIOR OR INFERIOR VENA CAVA",,,777.0,5449.0,3 RC,360,"INTRODUCTION OF NEEDLE(S) AND/OR CATHETER(S), DIALYSIS CIRCUIT, WITH DIAGNOSTIC ANGIOGRAPHY OF THE DIALYSIS CIRCUIT, INCLUDING ALL DIRECT PUNCTURE(S) AND CATHETER PLACEMENT(S), INJECTION(S) OF CONTRAS",,,1462.62,5449.0,14 RC,360,"INTUBATION, ENDOTRACHEAL, EMERGENCY PROCEDURE",,,218.65,5449.0,15 RC,360,"IRIDECTOMY, WITH CORNEOSCLERAL OR CORNEAL SECTION; PERIPHERAL FOR GLAUCOMA (SEPARATE PROCEDURE)",,,2147.4,8413.0,15 RC,360,IRIDOTOMY BY STAB INCISION (SEPARATE PROCEDURE); EXCEPT TRANSFIXION,,,777.0,5449.0,15 RC,360,IRIDOTOMY BY STAB INCISION (SEPARATE PROCEDURE); WITH TRANSFIXION AS FOR IRIS BOMBE,,,2147.4,5449.0,15 RC,360,"IRIDOTOMY/IRIDECTOMY BY LASER SURGERY (EG, FOR GLAUCOMA) (PER SESSION)",,,516.52,5449.0,15 RC,360,IRRIGATION OF CORPORA CAVERNOSA FOR PRIAPISM,,,228.99,5449.0,15 RC,360,KERATOMILEUSIS,,,5514.0,15291.0,3 RC,360,KERATOPLASTY (CORNEAL TRANSPLANT); ANTERIOR LAMELLAR,,,4858.07,15394.0,15 RC,360,KERATOPLASTY (CORNEAL TRANSPLANT); ENDOTHELIAL,,,3787.69,17457.0,15 RC,360,KERATOPLASTY (CORNEAL TRANSPLANT); PENETRATING (EXCEPT IN APHAKIA OR PSEUDOPHAKIA),,,3787.69,15394.0,15 RC,360,KERATOPLASTY (CORNEAL TRANSPLANT); PENETRATING (IN APHAKIA),,,4858.07,15394.0,15 RC,360,KERATOPLASTY (CORNEAL TRANSPLANT); PENETRATING (IN PSEUDOPHAKIA),,,3787.69,15394.0,15 RC,360,LABYRINTHECTOMY; WITH MASTOIDECTOMY,,,5569.83,15394.0,15 RC,360,"LAMINECTOMY FOR EXCISION OF INTRASPINAL LESION OTHER THAN NEOPLASM, INTRADURAL; LUMBAR",,,13652.0,30725.0,3 RC,360,"LAMINECTOMY FOR EXCISION OF INTRASPINAL LESION OTHER THAN NEOPLASM, INTRADURAL; THORACIC",,,2533.0,13652.0,3 RC,360,"LAMINECTOMY FOR EXCISION OR EVACUATION OF INTRASPINAL LESION OTHER THAN NEOPLASM, EXTRADURAL; LUMBAR",,,5514.0,13652.0,15 RC,360,"LAMINECTOMY FOR EXCISION OR EVACUATION OF INTRASPINAL LESION OTHER THAN NEOPLASM, EXTRADURAL; THORACIC",,,6726.11,21454.0,15 RC,360,LAMINECTOMY FOR EXCISION OR OCCLUSION OF ARTERIOVENOUS MALFORMATION OF SPINAL CORD; THORACOLUMBAR,,,13652.0,30725.0,3 RC,360,"LAMINECTOMY FOR IMPLANTATION OF NEUROSTIMULATOR ELECTRODES, PLATE/PADDLE, EPIDURAL",,,13652.0,30725.0,15 RC,360,"LAMINECTOMY, FACETECTOMY AND FORAMINOTOMY (UNILATERAL OR BILATERAL WITH DECOMPRESSION OF SPINAL CORD, CAUDA EQUINA AND/OR NERVE ROOT[S], [EG, SPINAL OR LATERAL RECESS STENOSIS]), SINGLE VERTEBRAL SEGM",,,777.0,21454.0,49 RC,360,"LAMINECTOMY, FACETECTOMY, OR FORAMINOTOMY (UNILATERAL OR BILATERAL WITH DECOMPRESSION OF SPINAL CORD, CAUDA EQUINA AND/OR NERVE ROOT[S] [EG, SPINAL OR LATERAL RECESS STENOSIS]), DURING POSTERIOR INTER",,,777.0,5449.0,3 RC,360,"LAMINECTOMY, WITH RELEASE OF TETHERED SPINAL CORD, LUMBAR",,,13652.0,30725.0,3 RC,360,"LAMINOPLASTY, CERVICAL, WITH DECOMPRESSION OF THE SPINAL CORD, 2 OR MORE VERTEBRAL SEGMENTS; WITH RECONSTRUCTION OF THE POSTERIOR BONY ELEMENTS (INCLUDING THE APPLICATION OF BRIDGING BONE GRAFT AND NO",,,2533.0,4850.0,2 RC,360,"LAMINOTOMY (HEMILAMINECTOMY), WITH DECOMPRESSION OF NERVE ROOT(S), INCLUDING PARTIAL FACETECTOMY, FORAMINOTOMY AND/OR EXCISION OF HERNIATED INTERVERTEBRAL DISC, REEXPLORATION, SINGLE INTERSPACE; LUMBA",,,6726.11,21454.0,15 RC,360,"LAMINOTOMY (HEMILAMINECTOMY), WITH DECOMPRESSION OF NERVE ROOT(S), INCLUDING PARTIAL FACETECTOMY, FORAMINOTOMY AND/OR EXCISION OF HERNIATED INTERVERTEBRAL DISC; 1 INTERSPACE, CERVICAL",,,6726.11,21454.0,15 RC,360,"LAMINOTOMY (HEMILAMINECTOMY), WITH DECOMPRESSION OF NERVE ROOT(S), INCLUDING PARTIAL FACETECTOMY, FORAMINOTOMY AND/OR EXCISION OF HERNIATED INTERVERTEBRAL DISC; 1 INTERSPACE, LUMBAR",,,6726.11,21454.0,15 RC,360,"LAMINOTOMY (HEMILAMINECTOMY), WITH DECOMPRESSION OF NERVE ROOT(S), INCLUDING PARTIAL FACETECTOMY, FORAMINOTOMY AND/OR EXCISION OF HERNIATED INTERVERTEBRAL DISC; EACH ADDITIONAL INTERSPACE, CERVICAL OR",,,777.0,13652.0,4 RC,360,LAPAROSCOPIC TREATMENT OF ECTOPIC PREGNANCY; WITH SALPINGECTOMY AND/OR OOPHORECTOMY,,,5493.28,21454.0,14 RC,360,LAPAROSCOPIC TREATMENT OF ECTOPIC PREGNANCY; WITHOUT SALPINGECTOMY AND/OR OOPHORECTOMY,,,5493.28,21454.0,14 RC,360,"LAPAROSCOPY, ABDOMEN, PERITONEUM, AND OMENTUM, DIAGNOSTIC, WITH OR WITHOUT COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING (SEPARATE PROCEDURE)",,,5493.28,15394.0,15 RC,360,"LAPAROSCOPY, SURGICAL PROSTATECTOMY, RETROPUBIC RADICAL, INCLUDING NERVE SPARING, INCLUDES ROBOTIC ASSISTANCE, WHEN PERFORMED",,,9802.58,30725.0,14 RC,360,"LAPAROSCOPY, SURGICAL PROSTATECTOMY, SIMPLE SUBTOTAL (INCLUDING CONTROL OF POSTOPERATIVE BLEEDING, VASECTOMY, MEATOTOMY, URETHRAL CALIBRATION AND/OR DILATION, AND INTERNAL URETHROTOMY), INCLUDES ROBOT",,,9802.58,21454.0,14 RC,360,"LAPAROSCOPY, SURGICAL, ABLATION OF 1 OR MORE LIVER TUMOR(S); RADIOFREQUENCY",,,9802.58,30725.0,14 RC,360,"LAPAROSCOPY, SURGICAL, APPENDECTOMY",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, CLOSURE OF ENTEROSTOMY, LARGE OR SMALL INTESTINE, WITH RESECTION AND ANASTOMOSIS",,,2533.0,8413.0,3 RC,360,"LAPAROSCOPY, SURGICAL, COLPOPEXY (SUSPENSION OF VAGINAL APEX)",,,9802.58,21454.0,14 RC,360,"LAPAROSCOPY, SURGICAL, ENTEROLYSIS (FREEING OF INTESTINAL ADHESION) (SEPARATE PROCEDURE)",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, ESOPHAGEAL LENGTHENING PROCEDURE (EG, COLLIS GASTROPLASTY OR WEDGE GASTROPLASTY) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,2533.0,4850.0,2 RC,360,"LAPAROSCOPY, SURGICAL, ESOPHAGOGASTRIC FUNDOPLASTY (EG, NISSEN, TOUPET PROCEDURES)",,,9350.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, ESOPHAGOMYOTOMY (HELLER TYPE), WITH FUNDOPLASTY, WHEN PERFORMED",,,13844.0,21454.0,2 RC,360,"LAPAROSCOPY, SURGICAL, GASTRIC RESTRICTIVE PROCEDURE; LONGITUDINAL GASTRECTOMY (IE, SLEEVE GASTRECTOMY)",,,13844.0,21454.0,2 RC,360,"LAPAROSCOPY, SURGICAL, GASTRIC RESTRICTIVE PROCEDURE; REMOVAL OF ADJUSTABLE GASTRIC RESTRICTIVE DEVICE AND SUBCUTANEOUS PORT COMPONENTS",,,3582.12,30725.0,14 RC,360,"LAPAROSCOPY, SURGICAL, GASTRIC RESTRICTIVE PROCEDURE; WITH GASTRIC BYPASS AND ROUX-EN-Y GASTROENTEROSTOMY (ROUX LIMB 150 CM OR LESS)",,,13844.0,21454.0,2 RC,360,"LAPAROSCOPY, SURGICAL, MYOMECTOMY, EXCISION; 1 TO 4 INTRAMURAL MYOMAS WITH TOTAL WEIGHT OF 250 G OR LESS AND/OR REMOVAL OF SURFACE MYOMAS",,,5493.28,17457.0,15 RC,360,"LAPAROSCOPY, SURGICAL, MYOMECTOMY, EXCISION; 5 OR MORE INTRAMURAL MYOMAS AND/OR INTRAMURAL MYOMAS WITH TOTAL WEIGHT GREATER THAN 250 G",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, REPAIR OF PARAESOPHAGEAL HERNIA, INCLUDES FUNDOPLASTY, WHEN PERFORMED; WITH IMPLANTATION OF MESH",,,9802.58,21454.0,14 RC,360,"LAPAROSCOPY, SURGICAL, REPAIR OF PARAESOPHAGEAL HERNIA, INCLUDES FUNDOPLASTY, WHEN PERFORMED; WITHOUT IMPLANTATION OF MESH",,,9802.58,21454.0,14 RC,360,"LAPAROSCOPY, SURGICAL, SPLENECTOMY",,,9350.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, SUPRACERVICAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS;",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, SUPRACERVICAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS; WITH REMOVAL OF TUBE(S) AND/OR OVARY(S)",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, SUPRACERVICAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G;",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, SUPRACERVICAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G; WITH REMOVAL OF TUBE(S) AND/OR OVARY(S)",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, TOTAL HYSTERECTOMY FOR RESECTION OF MALIGNANCY (TUMOR DEBULKING), WITH OMENTECTOMY INCLUDING SALPINGO-OOPHORECTOMY, UNILATERAL OR BILATERAL, WHEN PERFORMED",,,7444.0,13194.0,2 RC,360,"LAPAROSCOPY, SURGICAL, WITH ADRENALECTOMY, PARTIAL OR COMPLETE, OR EXPLORATION OF ADRENAL GLAND WITH OR WITHOUT BIOPSY, TRANSABDOMINAL, LUMBAR OR DORSAL",,,9974.0,15394.0,3 RC,360,"LAPAROSCOPY, SURGICAL, WITH LIGATION OF SPERMATIC VEINS FOR VARICOCELE",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH RADICAL HYSTERECTOMY, WITH BILATERAL TOTAL PELVIC LYMPHADENECTOMY AND PARA-AORTIC LYMPH NODE SAMPLING (BIOPSY), WITH REMOVAL OF TUBE(S) AND OVARY(S), IF PERFORMED",,,9974.0,15394.0,2 RC,360,"LAPAROSCOPY, SURGICAL, WITH TOTAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS;",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH TOTAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS; WITH REMOVAL OF TUBE(S) AND/OR OVARY(S)",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH TOTAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G;",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH TOTAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G; WITH REMOVAL OF TUBE(S) AND/OR OVARY(S)",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH VAGINAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS;",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH VAGINAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS; WITH REMOVAL OF TUBE(S) AND/OR OVARY(S)",,,9350.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH VAGINAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G;",,,9350.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL, WITH VAGINAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G; WITH REMOVAL OF TUBE(S) AND/OR OVARY(S)",,,9350.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; ABLATION OF RENAL CYSTS",,,9350.0,15394.0,15 RC,360,"LAPAROSCOPY, SURGICAL; CHOLECYSTECTOMY",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; CHOLECYSTECTOMY WITH CHOLANGIOGRAPHY",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; CHOLECYSTECTOMY WITH EXPLORATION OF COMMON DUCT",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; COLECTOMY, PARTIAL, WITH ANASTOMOSIS",,,9974.0,15394.0,2 RC,360,"LAPAROSCOPY, SURGICAL; COLECTOMY, PARTIAL, WITH REMOVAL OF TERMINAL ILEUM WITH ILEOCOLOSTOMY",,,2533.0,4850.0,2 RC,360,"LAPAROSCOPY, SURGICAL; COLECTOMY, TOTAL, ABDOMINAL, WITH PROCTECTOMY, WITH ILEOANAL ANASTOMOSIS, CREATION OF ILEAL RESERVOIR (S OR J), WITH LOOP ILEOSTOMY, INCLUDES RECTAL MUCOSECTOMY, WHEN PERFORMED",,,2533.0,4850.0,2 RC,360,"LAPAROSCOPY, SURGICAL; COLECTOMY, TOTAL, ABDOMINAL, WITH PROCTECTOMY, WITH ILEOSTOMY",,,2533.0,4850.0,2 RC,360,"LAPAROSCOPY, SURGICAL; DONOR NEPHRECTOMY (INCLUDING COLD PRESERVATION), FROM LIVING DONOR",,,2533.0,12615.0,3 RC,360,"LAPAROSCOPY, SURGICAL; GASTROSTOMY, WITHOUT CONSTRUCTION OF GASTRIC TUBE (EG, STAMM PROCEDURE) (SEPARATE PROCEDURE)",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; JEJUNOSTOMY (EG, FOR DECOMPRESSION OR FEEDING)",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; NEPHRECTOMY WITH TOTAL URETERECTOMY",,,2533.0,12615.0,3 RC,360,"LAPAROSCOPY, SURGICAL; NEPHRECTOMY, INCLUDING PARTIAL URETERECTOMY",,,2533.0,12615.0,3 RC,360,"LAPAROSCOPY, SURGICAL; ORCHIECTOMY",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; ORCHIOPEXY FOR INTRA-ABDOMINAL TESTIS",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; PARTIAL NEPHRECTOMY",,,9802.58,21454.0,14 RC,360,"LAPAROSCOPY, SURGICAL; PROCTOPEXY (FOR PROLAPSE)",,,7444.0,13194.0,3 RC,360,"LAPAROSCOPY, SURGICAL; PYELOPLASTY",,,9350.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; RADICAL NEPHRECTOMY (INCLUDES REMOVAL OF GEROTA'S FASCIA AND SURROUNDING FATTY TISSUE, REMOVAL OF REGIONAL LYMPH NODES, AND ADRENALECTOMY)",,,2533.0,4850.0,2 RC,360,"LAPAROSCOPY, SURGICAL; REPAIR INITIAL INGUINAL HERNIA",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; REPAIR RECURRENT INGUINAL HERNIA",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; URETERONEOCYSTOSTOMY WITH CYSTOSCOPY AND URETERAL STENT PLACEMENT",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; URETERONEOCYSTOSTOMY WITHOUT CYSTOSCOPY AND URETERAL STENT PLACEMENT",,,9802.58,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; URETHRAL SUSPENSION FOR STRESS INCONTINENCE",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH ASPIRATION OF CAVITY OR CYST (EG, OVARIAN CYST) (SINGLE OR MULTIPLE)",,,5493.28,15394.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH BILATERAL TOTAL PELVIC LYMPHADENECTOMY",,,8875.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH BILATERAL TOTAL PELVIC LYMPHADENECTOMY AND PERI-AORTIC LYMPH NODE SAMPLING (BIOPSY), SINGLE OR MULTIPLE",,,8875.0,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH BILATERAL TOTAL PELVIC LYMPHADENECTOMY AND PERI-AORTIC LYMPH NODE SAMPLING, PERITONEAL WASHINGS, PERITONEAL BIOPSY(IES), OMENTECTOMY, AND DIAPHRAGMATIC WASHINGS, INCLUDING ",,,9802.58,21454.0,14 RC,360,"LAPAROSCOPY, SURGICAL; WITH BIOPSY (SINGLE OR MULTIPLE)",,,5493.28,15394.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH FULGURATION OF OVIDUCTS (WITH OR WITHOUT TRANSECTION)",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH FULGURATION OR EXCISION OF LESIONS OF THE OVARY, PELVIC VISCERA, OR PERITONEAL SURFACE BY ANY METHOD",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH INSERTION OF TUNNELED INTRAPERITONEAL CATHETER",,,5493.28,17457.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH LYSIS OF ADHESIONS (SALPINGOLYSIS, OVARIOLYSIS) (SEPARATE PROCEDURE)",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH OMENTOPEXY (OMENTAL TACKING PROCEDURE) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,17457.0,4 RC,360,"LAPAROSCOPY, SURGICAL; WITH REMOVAL OF ADNEXAL STRUCTURES (PARTIAL OR TOTAL OOPHORECTOMY AND/OR SALPINGECTOMY)",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH RETROPERITONEAL LYMPH NODE SAMPLING (BIOPSY), SINGLE OR MULTIPLE",,,5493.28,21454.0,15 RC,360,"LAPAROSCOPY, SURGICAL; WITH REVISION OF PREVIOUSLY PLACED INTRAPERITONEAL CANNULA OR CATHETER, WITH REMOVAL OF INTRALUMINAL OBSTRUCTIVE MATERIAL IF PERFORMED",,,5493.28,17457.0,15 RC,360,"LAPAROTOMY, FOR STAGING OR RESTAGING OF OVARIAN, TUBAL, OR PRIMARY PERITONEAL MALIGNANCY (SECOND LOOK), WITH OR WITHOUT OMENTECTOMY, PERITONEAL WASHING, BIOPSY OF ABDOMINAL AND PELVIC PERITONEUM, DIAP",,,13844.0,21454.0,3 RC,360,"LARYNGOPLASTY, MEDIALIZATION, UNILATERAL",,,5569.83,15394.0,14 RC,360,"LARYNGOPLASTY; FOR LARYNGEAL STENOSIS, WITH GRAFT, WITH INDWELLING STENT PLACEMENT, YOUNGER THAN 12 YEARS OF AGE",,,5569.83,15394.0,14 RC,360,"LARYNGOSCOPY DIRECT, WITH OR WITHOUT TRACHEOSCOPY; DIAGNOSTIC, EXCEPT NEWBORN",,,1623.65,7278.0,15 RC,360,"LARYNGOSCOPY DIRECT, WITH OR WITHOUT TRACHEOSCOPY; DIAGNOSTIC, WITH OPERATING MICROSCOPE OR TELESCOPE",,,1623.65,7278.0,15 RC,360,"LARYNGOSCOPY DIRECT, WITH OR WITHOUT TRACHEOSCOPY; WITH DILATION, INITIAL",,,3471.41,9324.0,15 RC,360,"LARYNGOSCOPY DIRECT, WITH OR WITHOUT TRACHEOSCOPY; WITH DILATION, SUBSEQUENT",,,3471.41,9324.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH ARYTENOIDECTOMY;",,,6517.78,13194.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH ARYTENOIDECTOMY; WITH OPERATING MICROSCOPE OR TELESCOPE",,,5514.0,12615.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH BIOPSY;",,,3471.41,9324.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH BIOPSY; WITH OPERATING MICROSCOPE OR TELESCOPE",,,3471.41,9324.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH EXCISION OF TUMOR AND/OR STRIPPING OF VOCAL CORDS OR EPIGLOTTIS;",,,3471.41,9324.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH EXCISION OF TUMOR AND/OR STRIPPING OF VOCAL CORDS OR EPIGLOTTIS; WITH OPERATING MICROSCOPE OR TELESCOPE",,,3471.41,10561.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH FOREIGN BODY REMOVAL;",,,1623.65,7278.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH FOREIGN BODY REMOVAL; WITH OPERATING MICROSCOPE OR TELESCOPE",,,3012.0,8413.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH OPERATING MICROSCOPE OR TELESCOPE, WITH SUBMUCOSAL REMOVAL OF NON-NEOPLASTIC LESION(S) OF VOCAL CORD; RECONSTRUCTION WITH GRAFT(S) (INCLUDES OBTAINING AUTOGRAFT)",,,6517.78,13194.0,15 RC,360,"LARYNGOSCOPY, DIRECT, OPERATIVE, WITH OPERATING MICROSCOPE OR TELESCOPE, WITH SUBMUCOSAL REMOVAL OF NON-NEOPLASTIC LESION(S) OF VOCAL CORD; RECONSTRUCTION WITH LOCAL TISSUE FLAP(S)",,,3471.41,10561.0,15 RC,360,"LARYNGOSCOPY, DIRECT, WITH INJECTION INTO VOCAL CORD(S), THERAPEUTIC;",,,3012.0,7278.0,15 RC,360,"LARYNGOSCOPY, DIRECT, WITH INJECTION INTO VOCAL CORD(S), THERAPEUTIC; WITH OPERATING MICROSCOPE OR TELESCOPE",,,3471.41,9324.0,15 RC,360,"LARYNGOSCOPY, FLEXIBLE; DIAGNOSTIC",,,182.79,7278.0,14 RC,360,"LARYNGOSCOPY, FLEXIBLE; WITH ABLATION OR DESTRUCTION OF LESION(S) WITH LASER, UNILATERAL",,,3471.41,12408.0,15 RC,360,"LARYNGOSCOPY, FLEXIBLE; WITH REMOVAL OF LESION(S), NON-LASER",,,3012.0,7278.0,15 RC,360,"LARYNGOSCOPY, FLEXIBLE; WITH THERAPEUTIC INJECTION(S) (EG, CHEMODENERVATION AGENT OR CORTICOSTEROID, INJECTED PERCUTANEOUS, TRANSORAL, OR VIA ENDOSCOPE CHANNEL), UNILATERAL",,,1623.65,12408.0,15 RC,360,"LARYNGOSCOPY, INDIRECT; DIAGNOSTIC (SEPARATE PROCEDURE)",,,182.79,1251.0,13 RC,360,"LARYNGOTOMY (THYROTOMY, LARYNGOFISSURE), WITH REMOVAL OF TUMOR OR LARYNGOCELE, CORDECTOMY",,,3053.48,12615.0,15 RC,360,"LASER ENUCLEATION OF THE PROSTATE WITH MORCELLATION, INCLUDING CONTROL OF POSTOPERATIVE BLEEDING, COMPLETE (VASECTOMY, MEATOTOMY, CYSTOURETHROSCOPY, URETHRAL CALIBRATION AND/OR DILATION, INTERNAL URET",,,4786.44,17457.0,15 RC,360,"LASER INTERSTITIAL THERMAL THERAPY (LITT) OF LESION, INTRACRANIAL, INCLUDING BURR HOLE(S), WITH MAGNETIC RESONANCE IMAGING GUIDANCE, WHEN PERFORMED; SINGLE TRAJECTORY FOR 1 SIMPLE LESION",,,2533.0,4850.0,2 RC,360,"LASER VAPORIZATION OF PROSTATE, INCLUDING CONTROL OF POSTOPERATIVE BLEEDING, COMPLETE (VASECTOMY, MEATOTOMY, CYSTOURETHROSCOPY, URETHRAL CALIBRATION AND/OR DILATION, INTERNAL URETHROTOMY AND TRANSURET",,,4786.44,17457.0,15 RC,360,LATERAL CANTHOPEXY,,,3012.0,12615.0,15 RC,360,"LATERAL RETINACULAR RELEASE, OPEN",,,3054.93,15291.0,15 RC,360,"LENGTHENING OF HAMSTRING TENDON; MULTIPLE TENDONS, 1 LEG",,,6649.0,13194.0,15 RC,360,"LENGTHENING OF HAMSTRING TENDON; MULTIPLE TENDONS, BILATERAL",,,3054.93,15394.0,15 RC,360,"LENGTHENING OF PALATE, WITH ISLAND FLAP",,,5569.83,15394.0,13 RC,360,"LENGTHENING OF TENDON, FLEXOR, HAND OR FINGER, EACH TENDON",,,3012.0,5449.0,15 RC,360,"LENGTHENING OR SHORTENING OF FLEXOR OR EXTENSOR TENDON, FOREARM AND/OR WRIST, SINGLE, EACH TENDON",,,3054.93,13194.0,15 RC,360,"LENGTHENING OR SHORTENING OF TENDON, LEG OR ANKLE; MULTIPLE TENDONS (THROUGH SAME INCISION), EACH",,,3054.93,13194.0,15 RC,360,"LENGTHENING OR SHORTENING OF TENDON, LEG OR ANKLE; SINGLE TENDON (SEPARATE PROCEDURE)",,,3054.93,13194.0,15 RC,360,"LIGAMENTOUS RECONSTRUCTION (AUGMENTATION), KNEE; EXTRA-ARTICULAR",,,6649.0,21454.0,15 RC,360,"LIGAMENTOUS RECONSTRUCTION (AUGMENTATION), KNEE; INTRA-ARTICULAR (OPEN)",,,8213.0,21454.0,15 RC,360,"LIGATION AND DIVISION OF LONG SAPHENOUS VEIN AT SAPHENOFEMORAL JUNCTION, OR DISTAL INTERRUPTIONS",,,2963.5,13194.0,15 RC,360,LIGATION AND DIVISION OF SHORT SAPHENOUS VEIN AT SAPHENOPOPLITEAL JUNCTION (SEPARATE PROCEDURE),,,2246.0,8413.0,15 RC,360,LIGATION OR BANDING OF ANGIOACCESS ARTERIOVENOUS FISTULA,,,2963.5,13194.0,15 RC,360,"LIGATION OR BIOPSY, TEMPORAL ARTERY",,,1525.52,7278.0,15 RC,360,"LIGATION SALIVARY DUCT, INTRAORAL",,,3053.48,15291.0,15 RC,360,"LIGATION, DIVISION, AND STRIPPING, LONG (GREATER) SAPHENOUS VEINS FROM SAPHENOFEMORAL JUNCTION TO KNEE OR BELOW",,,2963.5,13194.0,15 RC,360,"LIGATION, DIVISION, AND STRIPPING, SHORT SAPHENOUS VEIN",,,2963.5,13194.0,15 RC,360,"LIGATION, DIVISION, AND/OR EXCISION OF VARICOSE VEIN CLUSTER(S), 1 LEG",,,2963.5,13194.0,15 RC,360,"LIGATION, INTERNAL JUGULAR VEIN",,,2246.0,3517.0,13 RC,360,"LIGATION, MAJOR ARTERY (EG, POST-TRAUMATIC, RUPTURE); EXTREMITY",,,2533.0,4850.0,2 RC,360,"LIGATION, MAJOR ARTERY (EG, POST-TRAUMATIC, RUPTURE); NECK",,,2246.0,3517.0,13 RC,360,LIGATION; EXTERNAL CAROTID ARTERY,,,2963.5,13194.0,13 RC,360,LIMITED LYMPHADENECTOMY FOR STAGING (SEPARATE PROCEDURE); PELVIC AND PARA-AORTIC,,,13844.0,21454.0,2 RC,360,LIMITED PHARYNGECTOMY,,,5569.83,15394.0,15 RC,360,LITHOLAPAXY: CRUSHING OR FRAGMENTATION OF CALCULUS BY ANY MEANS IN BLADDER AND REMOVAL OF FRAGMENTS; COMPLICATED OR LARGE (OVER 2.5 CM),,,3247.35,9324.0,15 RC,360,LITHOLAPAXY: CRUSHING OR FRAGMENTATION OF CALCULUS BY ANY MEANS IN BLADDER AND REMOVAL OF FRAGMENTS; SIMPLE OR SMALL (LESS THAN 2.5 CM),,,3247.35,9324.0,15 RC,360,"LITHOTRIPSY, EXTRACORPOREAL SHOCK WAVE",,,3247.35,21454.0,15 RC,360,"LOWER ESOPHAGEAL MYOTOMY, TRANSORAL (IE, PERORAL ENDOSCOPIC MYOTOMY [POEM])",,,5514.0,17457.0,15 RC,360,"LOWER EXTREMITY FASCIAL PLANE BLOCK, UNILATERAL; BY INJECTION(S), INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,777.0,5449.0,3 RC,360,LYMPHANGIOTOMY OR OTHER OPERATIONS ON LYMPHATIC CHANNELS,,,3605.42,9324.0,15 RC,360,LYSIS INTRANASAL SYNECHIA,,,479.48,7278.0,15 RC,360,LYSIS OF LABIAL ADHESIONS,,,2993.65,9324.0,15 RC,360,LYSIS OR EXCISION OF PENILE POST-CIRCUMCISION ADHESIONS,,,1928.76,9324.0,15 RC,360,"MALAR AUGMENTATION, PROSTHETIC MATERIAL",,,5569.83,15394.0,15 RC,360,"MANAGEMENT OF LIVER HEMORRHAGE; EXPLORATION OF HEPATIC WOUND, EXTENSIVE DEBRIDEMENT, COAGULATION AND/OR SUTURE, WITH OR WITHOUT PACKING OF LIVER",,,2533.0,4850.0,2 RC,360,MANIPULATION OF KNEE JOINT UNDER GENERAL ANESTHESIA (INCLUDES APPLICATION OF TRACTION OR OTHER FIXATION DEVICES),,,1506.85,5449.0,15 RC,360,"MANIPULATION OF SPINE REQUIRING ANESTHESIA, ANY REGION",,,1506.85,7278.0,15 RC,360,"MANIPULATION, ELBOW, UNDER ANESTHESIA",,,1506.85,8213.0,15 RC,360,MARSUPIALIZATION OF BARTHOLIN'S GLAND CYST,,,2993.65,9324.0,15 RC,360,MARSUPIALIZATION OF SUBLINGUAL SALIVARY CYST (RANULA),,,3053.48,9324.0,15 RC,360,MASTECTOMY FOR GYNECOMASTIA,,,3605.42,10561.0,15 RC,360,"MASTECTOMY, MODIFIED RADICAL, INCLUDING AXILLARY LYMPH NODES, WITH OR WITHOUT PECTORALIS MINOR MUSCLE, BUT EXCLUDING PECTORALIS MAJOR MUSCLE",,,6140.22,17457.0,15 RC,360,"MASTECTOMY, PARTIAL (EG, LUMPECTOMY, TYLECTOMY, QUADRANTECTOMY, SEGMENTECTOMY);",,,3605.42,9324.0,15 RC,360,"MASTECTOMY, PARTIAL (EG, LUMPECTOMY, TYLECTOMY, QUADRANTECTOMY, SEGMENTECTOMY); WITH AXILLARY LYMPHADENECTOMY",,,6140.22,15394.0,15 RC,360,"MASTECTOMY, RADICAL, INCLUDING PECTORAL MUSCLES, AXILLARY LYMPH NODES",,,2533.0,4850.0,2 RC,360,"MASTECTOMY, SIMPLE, COMPLETE",,,6140.22,13194.0,15 RC,360,MASTOIDECTOMY; COMPLETE,,,5514.0,15291.0,15 RC,360,MASTOIDECTOMY; RADICAL,,,5569.83,15394.0,15 RC,360,MASTOPEXY,,,6140.22,13194.0,15 RC,360,"MASTOTOMY WITH EXPLORATION OR DRAINAGE OF ABSCESS, DEEP",,,1525.52,9324.0,15 RC,360,MAXILLECTOMY; WITHOUT ORBITAL EXENTERATION,,,2533.0,4850.0,2 RC,360,"MEASUREMENT OF POST-VOIDING RESIDUAL URINE AND/OR BLADDER CAPACITY BY ULTRASOUND, NON-IMAGING",,,55.93,1251.0,13 RC,360,"MEATOTOMY, CUTTING OF MEATUS (SEPARATE PROCEDURE); EXCEPT INFANT",,,1928.76,9324.0,15 RC,360,"MECHANICAL REMOVAL OF OBSTRUCTIVE MATERIAL FROM GASTROSTOMY, DUODENOSTOMY, JEJUNOSTOMY, GASTRO-JEJUNOSTOMY, OR CECOSTOMY (OR OTHER COLONIC) TUBE, ANY METHOD, UNDER FLUOROSCOPIC GUIDANCE INCLUDING CONT",,,882.75,5449.0,15 RC,360,MEDIAL CANTHOPEXY (SEPARATE PROCEDURE),,,3053.48,15394.0,15 RC,360,"MEDIASTINOSCOPY; INCLUDES BIOPSY(IES) OF MEDIASTINAL MASS (EG, LYMPHOMA), WHEN PERFORMED",,,5493.28,15394.0,14 RC,360,"MEDIASTINOSCOPY; WITH LYMPH NODE BIOPSY(IES) (EG, LUNG CANCER STAGING)",,,5493.28,15394.0,14 RC,360,METATARSECTOMY,,,3054.93,9324.0,15 RC,360,"MICROSURGICAL TECHNIQUES, REQUIRING USE OF OPERATING MICROSCOPE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,MIDDLE EAR EXPLORATION THROUGH POSTAURICULAR OR EAR CANAL INCISION,,,3053.48,9324.0,15 RC,360,"MIDFACE FLAP (IE, ZYGOMATICOFACIAL FLAP) WITH PRESERVATION OF VASCULAR PEDICLE(S)",,,3446.95,17457.0,15 RC,360,"MUSCLE TRANSFER, ANY TYPE, SHOULDER OR UPPER ARM; SINGLE",,,6726.11,15394.0,15 RC,360,"MUSCLE, MYOCUTANEOUS, OR FASCIOCUTANEOUS FLAP; HEAD AND NECK WITH NAMED VASCULAR PEDICLE (IE, BUCCINATORS, GENIOGLOSSUS, TEMPORALIS, MASSETER, STERNOCLEIDOMASTOID, LEVATOR SCAPULAE)",,,3446.95,17457.0,15 RC,360,"MUSCLE, MYOCUTANEOUS, OR FASCIOCUTANEOUS FLAP; LOWER EXTREMITY",,,3446.95,13194.0,15 RC,360,"MUSCLE, MYOCUTANEOUS, OR FASCIOCUTANEOUS FLAP; TRUNK",,,3446.95,13194.0,15 RC,360,"MUSCLE, MYOCUTANEOUS, OR FASCIOCUTANEOUS FLAP; UPPER EXTREMITY",,,1722.29,8413.0,15 RC,360,"MYOMECTOMY, EXCISION OF FIBROID TUMOR(S) OF UTERUS, 1 TO 4 INTRAMURAL MYOMA(S) WITH TOTAL WEIGHT OF 250 G OR LESS AND/OR REMOVAL OF SURFACE MYOMAS; ABDOMINAL APPROACH",,,7444.0,15291.0,3 RC,360,"MYOMECTOMY, EXCISION OF FIBROID TUMOR(S) OF UTERUS, 1 TO 4 INTRAMURAL MYOMA(S) WITH TOTAL WEIGHT OF 250 G OR LESS AND/OR REMOVAL OF SURFACE MYOMAS; VAGINAL APPROACH",,,2993.65,12615.0,15 RC,360,"MYOMECTOMY, EXCISION OF FIBROID TUMOR(S) OF UTERUS, 5 OR MORE INTRAMURAL MYOMAS AND/OR INTRAMURAL MYOMAS WITH TOTAL WEIGHT GREATER THAN 250 G, ABDOMINAL APPROACH",,,7444.0,13194.0,2 RC,360,MYRINGOPLASTY (SURGERY CONFINED TO DRUMHEAD AND DONOR AREA),,,3053.48,9324.0,15 RC,360,MYRINGOTOMY INCLUDING ASPIRATION AND/OR EUSTACHIAN TUBE INFLATION,,,218.65,8413.0,15 RC,360,MYRINGOTOMY INCLUDING ASPIRATION AND/OR EUSTACHIAN TUBE INFLATION REQUIRING GENERAL ANESTHESIA,,,3012.0,8413.0,15 RC,360,"NASAL ENDOSCOPY, DIAGNOSTIC, UNILATERAL OR BILATERAL (SEPARATE PROCEDURE)",,,182.79,7278.0,14 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL WITH ETHMOIDECTOMY; PARTIAL (ANTERIOR)",,,5514.0,10561.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL WITH ETHMOIDECTOMY; TOTAL (ANTERIOR AND POSTERIOR)",,,6517.78,13194.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL WITH ETHMOIDECTOMY; TOTAL (ANTERIOR AND POSTERIOR), INCLUDING FRONTAL SINUS EXPLORATION, WITH REMOVAL OF TISSUE FROM FRONTAL SINUS, WHEN PERFORMED",,,6517.78,17457.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL WITH ETHMOIDECTOMY; TOTAL (ANTERIOR AND POSTERIOR), INCLUDING SPHENOIDOTOMY",,,6517.78,17457.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL WITH ETHMOIDECTOMY; TOTAL (ANTERIOR AND POSTERIOR), INCLUDING SPHENOIDOTOMY, WITH REMOVAL OF TISSUE FROM THE SPHENOID SINUS",,,6517.78,17457.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH DILATION (EG, BALLOON DILATION); FRONTAL SINUS OSTIUM",,,6517.78,17457.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH DILATION (EG, BALLOON DILATION); MAXILLARY SINUS OSTIUM, TRANSNASAL OR VIA CANINE FOSSA",,,6517.78,17457.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH DILATION (EG, BALLOON DILATION); SPHENOID SINUS OSTIUM",,,5514.0,17457.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH FRONTAL SINUS EXPLORATION, INCLUDING REMOVAL OF TISSUE FROM FRONTAL SINUS, WHEN PERFORMED",,,6517.78,13194.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH MAXILLARY ANTROSTOMY;",,,3471.41,9324.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH MAXILLARY ANTROSTOMY; WITH REMOVAL OF TISSUE FROM MAXILLARY SINUS",,,5514.0,9324.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH ORBITAL DECOMPRESSION; MEDIAL AND INFERIOR WALL",,,6517.78,13194.0,14 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH ORBITAL DECOMPRESSION; MEDIAL OR INFERIOR WALL",,,6517.78,13194.0,14 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH REPAIR OF CEREBROSPINAL FLUID LEAK; ETHMOID REGION",,,2533.0,8413.0,3 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH SPHENOIDOTOMY;",,,6517.78,13194.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL, WITH SPHENOIDOTOMY; WITH REMOVAL OF TISSUE FROM THE SPHENOID SINUS",,,6517.78,13194.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL; WITH BIOPSY, POLYPECTOMY OR DEBRIDEMENT (SEPARATE PROCEDURE)",,,1623.65,7278.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL; WITH CONCHA BULLOSA RESECTION",,,1623.65,9324.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL; WITH CONTROL OF NASAL HEMORRHAGE",,,1623.65,7278.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL; WITH DACRYOCYSTORHINOSTOMY",,,3471.41,10561.0,15 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL; WITH DESTRUCTION BY CRYOABLATION, POSTERIOR NASAL NERVE",,,5569.83,15394.0,14 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL; WITH DESTRUCTION BY RADIOFREQUENCY ABLATION, POSTERIOR NASAL NERVE",,,5569.83,15394.0,14 RC,360,"NASAL/SINUS ENDOSCOPY, SURGICAL; WITH LIGATION OF SPHENOPALATINE ARTERY",,,1623.65,9324.0,14 RC,360,"NASO- OR ORO-GASTRIC TUBE PLACEMENT, REQUIRING PHYSICIAN'S SKILL AND FLUOROSCOPIC GUIDANCE (INCLUDES FLUOROSCOPY, IMAGE DOCUMENTATION AND REPORT)",,,375.71,7278.0,14 RC,360,"NASOPHARYNGOSCOPY, SURGICAL, WITH DILATION OF EUSTACHIAN TUBE (IE, BALLOON DILATION); BILATERAL",,,5569.83,17457.0,15 RC,360,"NASOPHARYNGOSCOPY, SURGICAL, WITH DILATION OF EUSTACHIAN TUBE (IE, BALLOON DILATION); UNILATERAL",,,5449.0,17457.0,15 RC,360,"NEGATIVE PRESSURE WOUND THERAPY (EG, VACUUM ASSISTED DRAINAGE COLLECTION), UTILIZING DURABLE MEDICAL EQUIPMENT (DME), INCLUDING TOPICAL APPLICATION(S), WOUND ASSESSMENT, AND INSTRUCTION(S) FOR ONGOING",,,187.08,204.44,11 RC,360,NEPHRECTOMY WITH TOTAL URETERECTOMY AND BLADDER CUFF; THROUGH SAME INCISION,,,2533.0,4850.0,2 RC,360,"NEPHRECTOMY, PARTIAL",,,2533.0,4850.0,2 RC,360,"NERVE GRAFT (INCLUDES OBTAINING GRAFT), HEAD OR NECK; MORE THAN 4 CM LENGTH",,,5152.0,15394.0,15 RC,360,"NERVE GRAFT (INCLUDES OBTAINING GRAFT), HEAD OR NECK; UP TO 4 CM IN LENGTH",,,5152.0,15394.0,15 RC,360,"NERVE GRAFT (INCLUDES OBTAINING GRAFT), MULTIPLE STRANDS (CABLE), ARM OR LEG; UP TO 4 CM LENGTH",,,6029.68,15394.0,15 RC,360,"NERVE GRAFT (INCLUDES OBTAINING GRAFT), SINGLE STRAND, ARM OR LEG; UP TO 4 CM LENGTH",,,5152.0,15394.0,15 RC,360,"NERVE GRAFT (INCLUDES OBTAINING GRAFT), SINGLE STRAND, HAND OR FOOT; UP TO 4 CM LENGTH",,,5152.0,15394.0,15 RC,360,"NERVE GRAFT, EACH ADDITIONAL NERVE; MULTIPLE STRANDS (CABLE) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,7278.0,3 RC,360,"NERVE GRAFT, EACH ADDITIONAL NERVE; SINGLE STRAND (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,7278.0,3 RC,360,NERVE PEDICLE TRANSFER; FIRST STAGE,,,5152.0,15394.0,15 RC,360,"NERVE REPAIR; WITH NERVE ALLOGRAFT, EACH NERVE, FIRST STRAND (CABLE)",,,6029.68,15394.0,14 RC,360,"NERVE REPAIR; WITH SYNTHETIC CONDUIT OR VEIN ALLOGRAFT (EG, NERVE TUBE), EACH NERVE",,,6029.68,15394.0,15 RC,360,"NEURECTOMY, POPLITEAL (GASTROCNEMIUS)",,,1838.62,7278.0,15 RC,360,"NEUROENDOSCOPY, INTRACRANIAL; WITH EXCISION OF PITUITARY TUMOR, TRANSNASAL OR TRANS-SPHENOIDAL APPROACH",,,2533.0,4850.0,2 RC,360,NEUROPLASTY AND/OR TRANSPOSITION; CRANIAL NERVE (SPECIFY),,,1838.62,9324.0,15 RC,360,NEUROPLASTY AND/OR TRANSPOSITION; MEDIAN NERVE AT CARPAL TUNNEL,,,1838.62,9324.0,15 RC,360,NEUROPLASTY AND/OR TRANSPOSITION; ULNAR NERVE AT ELBOW,,,1838.62,9324.0,15 RC,360,NEUROPLASTY AND/OR TRANSPOSITION; ULNAR NERVE AT WRIST,,,1838.62,9324.0,15 RC,360,"NEUROPLASTY, MAJOR PERIPHERAL NERVE, ARM OR LEG, OPEN; BRACHIAL PLEXUS",,,1838.62,9324.0,15 RC,360,"NEUROPLASTY, MAJOR PERIPHERAL NERVE, ARM OR LEG, OPEN; LUMBAR PLEXUS",,,1838.62,9324.0,15 RC,360,"NEUROPLASTY, MAJOR PERIPHERAL NERVE, ARM OR LEG, OPEN; OTHER THAN SPECIFIED",,,1838.62,9324.0,15 RC,360,"NEUROPLASTY, MAJOR PERIPHERAL NERVE, ARM OR LEG, OPEN; SCIATIC NERVE",,,1838.62,9324.0,15 RC,360,"NEUROPLASTY; DIGITAL, 1 OR BOTH, SAME DIGIT",,,1838.62,9324.0,15 RC,360,NEUROPLASTY; NERVE OF HAND OR FOOT,,,1838.62,9324.0,15 RC,360,"NIPPLE EXPLORATION, WITH OR WITHOUT EXCISION OF A SOLITARY LACTIFEROUS DUCT OR A PAPILLOMA LACTIFEROUS DUCT",,,3605.42,9324.0,15 RC,360,NIPPLE/AREOLA RECONSTRUCTION,,,3605.42,10561.0,15 RC,360,"OCULAR SURFACE RECONSTRUCTION; AMNIOTIC MEMBRANE TRANSPLANTATION, MULTIPLE LAYERS",,,3550.55,13194.0,15 RC,360,OCULAR SURFACE RECONSTRUCTION; LIMBAL CONJUNCTIVAL AUTOGRAFT (INCLUDES OBTAINING GRAFT),,,3550.55,13194.0,15 RC,360,"OMENTAL FLAP, INTRA-ABDOMINAL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,9974.0,15394.0,2 RC,360,"OMENTECTOMY, EPIPLOECTOMY, RESECTION OF OMENTUM (SEPARATE PROCEDURE)",,,5514.0,10561.0,3 RC,360,"OOPHORECTOMY, PARTIAL OR TOTAL, UNILATERAL OR BILATERAL;",,,7444.0,13194.0,3 RC,360,"OPEN IMPLANTATION OF CRANIAL NERVE (EG, VAGUS NERVE) NEUROSTIMULATOR ELECTRODE ARRAY AND PULSE GENERATOR",,,7278.0,38950.0,14 RC,360,"OPEN IMPLANTATION OF HYPOGLOSSAL NERVE NEUROSTIMULATOR ARRAY, PULSE GENERATOR, AND DISTAL RESPIRATORY SENSOR ELECTRODE OR ELECTRODE ARRAY",,,7278.0,31354.26,14 RC,360,OPEN IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY; SACRAL NERVE (TRANSFORAMINAL PLACEMENT),,,6179.23,30725.0,15 RC,360,"OPEN OSTEOCHONDRAL AUTOGRAFT, TALUS (INCLUDES OBTAINING GRAFT[S])",,,6726.11,21454.0,15 RC,360,"OPEN TREATMENT AND/OR REDUCTION OF VERTEBRAL FRACTURE(S) AND/OR DISLOCATION(S), POSTERIOR APPROACH, 1 FRACTURED VERTEBRA OR DISLOCATED SEGMENT; EACH ADDITIONAL FRACTURED VERTEBRA OR DISLOCATED SEGMENT",,,777.0,5449.0,3 RC,360,"OPEN TREATMENT AND/OR REDUCTION OF VERTEBRAL FRACTURE(S) AND/OR DISLOCATION(S), POSTERIOR APPROACH, 1 FRACTURED VERTEBRA OR DISLOCATED SEGMENT; LUMBAR",,,13764.0,21454.0,3 RC,360,"OPEN TREATMENT AND/OR REDUCTION OF VERTEBRAL FRACTURE(S) AND/OR DISLOCATION(S), POSTERIOR APPROACH, 1 FRACTURED VERTEBRA OR DISLOCATED SEGMENT; THORACIC",,,13764.0,21454.0,3 RC,360,"OPEN TREATMENT OF ACROMIOCLAVICULAR DISLOCATION, ACUTE OR CHRONIC;",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF ACROMIOCLAVICULAR DISLOCATION, ACUTE OR CHRONIC; WITH FASCIAL GRAFT (INCLUDES OBTAINING GRAFT)",,,6726.11,21454.0,15 RC,360,OPEN TREATMENT OF ACUTE OR CHRONIC ELBOW DISLOCATION,,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF ARTICULAR FRACTURE, INVOLVING METACARPOPHALANGEAL OR INTERPHALANGEAL JOINT, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, EACH",,,3054.93,12615.0,15 RC,360,"OPEN TREATMENT OF BIMALLEOLAR ANKLE FRACTURE (EG, LATERAL AND MEDIAL MALLEOLI, OR LATERAL AND POSTERIOR MALLEOLI, OR MEDIAL AND POSTERIOR MALLEOLI), INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF CALCANEAL FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED;",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF CARPAL BONE FRACTURE (OTHER THAN CARPAL SCAPHOID [NAVICULAR]), EACH BONE",,,3054.93,21454.0,15 RC,360,"OPEN TREATMENT OF CARPAL SCAPHOID (NAVICULAR) FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF CARPOMETACARPAL DISLOCATION, OTHER THAN THUMB; INCLUDES INTERNAL FIXATION, WHEN PERFORMED, EACH JOINT",,,3054.93,9324.0,15 RC,360,"OPEN TREATMENT OF CARPOMETACARPAL FRACTURE DISLOCATION, THUMB (BENNETT FRACTURE), INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,3054.93,21454.0,15 RC,360,"OPEN TREATMENT OF CLAVICULAR FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF COMPLICATED (EG, COMMINUTED OR INVOLVING CRANIAL NERVE FORAMINA) FRACTURE(S) OF MALAR AREA, INCLUDING ZYGOMATIC ARCH AND MALAR TRIPOD; WITH BONE GRAFTING (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,14 RC,360,"OPEN TREATMENT OF COMPLICATED (EG, COMMINUTED OR INVOLVING CRANIAL NERVE FORAMINA) FRACTURE(S) OF MALAR AREA, INCLUDING ZYGOMATIC ARCH AND MALAR TRIPOD; WITH INTERNAL FIXATION AND MULTIPLE SURGICAL AP",,,5569.83,15394.0,15 RC,360,"OPEN TREATMENT OF COMPLICATED (EG, COMMINUTED OR INVOLVING POSTERIOR WALL) FRONTAL SINUS FRACTURE, VIA CORONAL OR MULTIPLE APPROACHES",,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF COMPLICATED MANDIBULAR FRACTURE BY MULTIPLE SURGICAL APPROACHES INCLUDING INTERNAL FIXATION, INTERDENTAL FIXATION, AND/OR WIRING OF DENTURES OR SPLINTS",,,5569.83,15394.0,15 RC,360,OPEN TREATMENT OF CRANIOFACIAL SEPARATION (LEFORT III TYPE); WITH WIRING AND/OR INTERNAL FIXATION,,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF DEPRESSED MALAR FRACTURE, INCLUDING ZYGOMATIC ARCH AND MALAR TRIPOD",,,5514.0,12408.0,15 RC,360,"OPEN TREATMENT OF DEPRESSED ZYGOMATIC ARCH FRACTURE (EG, GILLIES APPROACH)",,,5514.0,9324.0,15 RC,360,"OPEN TREATMENT OF DISTAL FIBULAR FRACTURE (LATERAL MALLEOLUS), INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF DISTAL PHALANGEAL FRACTURE, FINGER OR THUMB, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, EACH",,,3054.93,10561.0,15 RC,360,"OPEN TREATMENT OF DISTAL RADIAL EXTRA-ARTICULAR FRACTURE OR EPIPHYSEAL SEPARATION, WITH INTERNAL FIXATION",,,6726.11,21454.0,15 RC,360,OPEN TREATMENT OF DISTAL RADIAL INTRA-ARTICULAR FRACTURE OR EPIPHYSEAL SEPARATION; WITH INTERNAL FIXATION OF 2 FRAGMENTS,,,6726.11,21454.0,15 RC,360,OPEN TREATMENT OF DISTAL RADIAL INTRA-ARTICULAR FRACTURE OR EPIPHYSEAL SEPARATION; WITH INTERNAL FIXATION OF 3 OR MORE FRAGMENTS,,,6726.11,21454.0,15 RC,360,"OPEN TREATMENT OF DISTAL RADIOULNAR DISLOCATION, ACUTE OR CHRONIC",,,5152.0,9324.0,15 RC,360,"OPEN TREATMENT OF DISTAL TIBIOFIBULAR JOINT (SYNDESMOSIS) DISRUPTION, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,5152.0,21454.0,15 RC,360,"OPEN TREATMENT OF FEMORAL FRACTURE, DISTAL END, MEDIAL OR LATERAL CONDYLE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF FEMORAL SHAFT FRACTURE WITH PLATE/SCREWS, WITH OR WITHOUT CERCLAGE",,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF FEMORAL SHAFT FRACTURE, WITH OR WITHOUT EXTERNAL FIXATION, WITH INSERTION OF INTRAMEDULLARY IMPLANT, WITH OR WITHOUT CERCLAGE AND/OR LOCKING SCREWS",,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF FRACTURE OF ORBIT, EXCEPT BLOWOUT; WITH BONE GRAFTING (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,14 RC,360,"OPEN TREATMENT OF FRACTURE OF ORBIT, EXCEPT BLOWOUT; WITH IMPLANT",,,5569.83,15394.0,15 RC,360,"OPEN TREATMENT OF FRACTURE OF ORBIT, EXCEPT BLOWOUT; WITHOUT IMPLANT",,,5569.83,15394.0,15 RC,360,"OPEN TREATMENT OF FRACTURE OF WEIGHT BEARING ARTICULAR SURFACE/PORTION OF DISTAL TIBIA (EG, PILON OR TIBIAL PLAFOND), WITH INTERNAL FIXATION, WHEN PERFORMED; OF BOTH TIBIA AND FIBULA",,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF FRACTURE OF WEIGHT BEARING ARTICULAR SURFACE/PORTION OF DISTAL TIBIA (EG, PILON OR TIBIAL PLAFOND), WITH INTERNAL FIXATION, WHEN PERFORMED; OF TIBIA ONLY",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF FRACTURE, GREAT TOE, PHALANX OR PHALANGES, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,3054.93,9324.0,15 RC,360,"OPEN TREATMENT OF HUMERAL CONDYLAR FRACTURE, MEDIAL OR LATERAL, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF HUMERAL EPICONDYLAR FRACTURE, MEDIAL OR LATERAL, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF HUMERAL SHAFT FRACTURE WITH PLATE/SCREWS, WITH OR WITHOUT CERCLAGE",,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF HUMERAL SUPRACONDYLAR OR TRANSCONDYLAR FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED; WITH INTERCONDYLAR EXTENSION",,,9350.0,21454.0,15 RC,360,"OPEN TREATMENT OF HUMERAL SUPRACONDYLAR OR TRANSCONDYLAR FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED; WITHOUT INTERCONDYLAR EXTENSION",,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF INTERCONDYLAR SPINE(S) AND/OR TUBEROSITY FRACTURE(S) OF THE KNEE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF INTERPHALANGEAL JOINT DISLOCATION, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, SINGLE",,,3054.93,9324.0,15 RC,360,"OPEN TREATMENT OF KNEE DISLOCATION, INCLUDES INTERNAL FIXATION, WHEN PERFORMED; WITH PRIMARY LIGAMENTOUS REPAIR, WITH AUGMENTATION/RECONSTRUCTION",,,9974.0,15394.0,3 RC,360,OPEN TREATMENT OF MANDIBULAR CONDYLAR FRACTURE,,,5569.83,15394.0,15 RC,360,OPEN TREATMENT OF MANDIBULAR FRACTURE WITH EXTERNAL FIXATION,,,5514.0,12615.0,15 RC,360,OPEN TREATMENT OF MANDIBULAR FRACTURE; WITH INTERDENTAL FIXATION,,,5569.83,15394.0,15 RC,360,OPEN TREATMENT OF MANDIBULAR FRACTURE; WITHOUT INTERDENTAL FIXATION,,,5569.83,15394.0,15 RC,360,OPEN TREATMENT OF MANDIBULAR OR MAXILLARY ALVEOLAR RIDGE FRACTURE (SEPARATE PROCEDURE),,,5569.83,15394.0,15 RC,360,"OPEN TREATMENT OF MEDIAL MALLEOLUS FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF METACARPAL FRACTURE, SINGLE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, EACH BONE",,,3054.93,21454.0,15 RC,360,"OPEN TREATMENT OF METATARSAL FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, EACH",,,6726.11,21454.0,15 RC,360,"OPEN TREATMENT OF METATARSOPHALANGEAL JOINT DISLOCATION, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,3054.93,9324.0,15 RC,360,"OPEN TREATMENT OF MONTEGGIA TYPE OF FRACTURE DISLOCATION AT ELBOW (FRACTURE PROXIMAL END OF ULNA WITH DISLOCATION OF RADIAL HEAD), INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,OPEN TREATMENT OF NASAL FRACTURE; WITH CONCOMITANT OPEN TREATMENT OF FRACTURED SEPTUM,,,3053.48,15291.0,15 RC,360,OPEN TREATMENT OF NASOETHMOID FRACTURE; WITHOUT EXTERNAL FIXATION,,,5514.0,10561.0,15 RC,360,OPEN TREATMENT OF NASOMAXILLARY COMPLEX FRACTURE (LEFORT II TYPE); REQUIRING MULTIPLE OPEN APPROACHES,,,5569.83,15394.0,14 RC,360,OPEN TREATMENT OF NASOMAXILLARY COMPLEX FRACTURE (LEFORT II TYPE); WITH BONE GRAFTING (INCLUDES OBTAINING GRAFT),,,9974.0,15394.0,3 RC,360,OPEN TREATMENT OF ORBITAL FLOOR BLOWOUT FRACTURE; PERIORBITAL APPROACH,,,5569.83,15394.0,14 RC,360,OPEN TREATMENT OF ORBITAL FLOOR BLOWOUT FRACTURE; PERIORBITAL APPROACH WITH BONE GRAFT (INCLUDES OBTAINING GRAFT),,,5569.83,15394.0,14 RC,360,"OPEN TREATMENT OF ORBITAL FLOOR BLOWOUT FRACTURE; PERIORBITAL APPROACH, WITH ALLOPLASTIC OR OTHER IMPLANT",,,5569.83,15394.0,15 RC,360,OPEN TREATMENT OF ORBITAL FLOOR BLOWOUT FRACTURE; TRANSANTRAL APPROACH (CALDWELL-LUC TYPE OPERATION),,,5569.83,17457.0,15 RC,360,"OPEN TREATMENT OF PALATAL OR MAXILLARY FRACTURE (LEFORT I TYPE); COMPLICATED (COMMINUTED OR INVOLVING CRANIAL NERVE FORAMINA), MULTIPLE APPROACHES",,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF PATELLAR DISLOCATION, WITH OR WITHOUT PARTIAL OR TOTAL PATELLECTOMY",,,5152.0,21454.0,15 RC,360,"OPEN TREATMENT OF PATELLAR FRACTURE, WITH INTERNAL FIXATION AND/OR PARTIAL OR COMPLETE PATELLECTOMY AND SOFT TISSUE REPAIR",,,6649.0,21454.0,15 RC,360,OPEN TREATMENT OF PERIARTICULAR FRACTURE AND/OR DISLOCATION OF THE ELBOW (FRACTURE DISTAL HUMERUS AND PROXIMAL ULNA AND/OR PROXIMAL RADIUS);,,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF PHALANGEAL SHAFT FRACTURE, PROXIMAL OR MIDDLE PHALANX, FINGER OR THUMB, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, EACH",,,3054.93,10561.0,15 RC,360,"OPEN TREATMENT OF PROXIMAL FIBULA OR SHAFT FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF PROXIMAL HUMERAL (SURGICAL OR ANATOMICAL NECK) FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, INCLUDES REPAIR OF TUBEROSITY(S), WHEN PERFORMED;",,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF PROXIMAL HUMERAL (SURGICAL OR ANATOMICAL NECK) FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, INCLUDES REPAIR OF TUBEROSITY(S), WHEN PERFORMED; WITH PROXIMAL HUMERAL PROSTHETI",,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF RADIAL AND ULNAR SHAFT FRACTURES, WITH INTERNAL FIXATION, WHEN PERFORMED; OF RADIUS AND ULNA",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF RADIAL AND ULNAR SHAFT FRACTURES, WITH INTERNAL FIXATION, WHEN PERFORMED; OF RADIUS OR ULNA",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF RADIAL HEAD OR NECK FRACTURE, INCLUDES INTERNAL FIXATION OR RADIAL HEAD EXCISION, WHEN PERFORMED;",,,6726.11,21454.0,15 RC,360,"OPEN TREATMENT OF RADIAL HEAD OR NECK FRACTURE, INCLUDES INTERNAL FIXATION OR RADIAL HEAD EXCISION, WHEN PERFORMED; WITH RADIAL HEAD PROSTHETIC REPLACEMENT",,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF RADIAL SHAFT FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF RADIAL SHAFT FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, AND CLOSED TREATMENT OF DISTAL RADIOULNAR JOINT DISLOCATION (GALEAZZI FRACTURE/ DISLOCATION), INCLUDES PERCUTANEOUS",,,6726.11,21454.0,15 RC,360,"OPEN TREATMENT OF RADIOCARPAL OR INTERCARPAL DISLOCATION, 1 OR MORE BONES",,,5514.0,9324.0,15 RC,360,"OPEN TREATMENT OF RIB FRACTURE(S) WITH INTERNAL FIXATION, INCLUDES THORACOSCOPIC VISUALIZATION WHEN PERFORMED, UNILATERAL; 1-3 RIBS",,,5514.0,17457.0,15 RC,360,"OPEN TREATMENT OF SCAPULAR FRACTURE (BODY, GLENOID OR ACROMION) INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,OPEN TREATMENT OF SLIPPED FEMORAL EPIPHYSIS; CLOSED MANIPULATION WITH SINGLE OR MULTIPLE PINNING,,,12615.0,21454.0,3 RC,360,"OPEN TREATMENT OF TALUS FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF TARSAL BONE DISLOCATION, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,5152.0,21454.0,15 RC,360,"OPEN TREATMENT OF TARSAL BONE FRACTURE (EXCEPT TALUS AND CALCANEUS), INCLUDES INTERNAL FIXATION, WHEN PERFORMED, EACH",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF TARSOMETATARSAL JOINT DISLOCATION, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF TIBIAL FRACTURE, PROXIMAL (PLATEAU); BICONDYLAR, WITH OR WITHOUT INTERNAL FIXATION",,,9974.0,15394.0,3 RC,360,"OPEN TREATMENT OF TIBIAL FRACTURE, PROXIMAL (PLATEAU); UNICONDYLAR, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,8413.0,15394.0,3 RC,360,"OPEN TREATMENT OF TIBIAL SHAFT FRACTURE (WITH OR WITHOUT FIBULAR FRACTURE), WITH PLATE/SCREWS, WITH OR WITHOUT CERCLAGE",,,8213.0,21454.0,15 RC,360,"OPEN TREATMENT OF TRIMALLEOLAR ANKLE FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, MEDIAL AND/OR LATERAL MALLEOLUS; WITH FIXATION OF POSTERIOR LIP",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF TRIMALLEOLAR ANKLE FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED, MEDIAL AND/OR LATERAL MALLEOLUS; WITHOUT FIXATION OF POSTERIOR LIP",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF ULNAR FRACTURE, PROXIMAL END (EG, OLECRANON OR CORONOID PROCESS[ES]), INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,"OPEN TREATMENT OF ULNAR SHAFT FRACTURE, INCLUDES INTERNAL FIXATION, WHEN PERFORMED",,,6649.0,21454.0,15 RC,360,OPEN TREATMENT OF ULNAR STYLOID FRACTURE,,,6649.0,21454.0,15 RC,360,"OPHTHALMOLOGICAL EXAMINATION AND EVALUATION, UNDER GENERAL ANESTHESIA, WITH OR WITHOUT MANIPULATION OF GLOBE FOR PASSIVE RANGE OF MOTION OR OTHER MANIPULATION TO FACILITATE DIAGNOSTIC EXAMINATION; COM",,,2196.57,9324.0,13 RC,360,"OPHTHALMOLOGICAL EXAMINATION AND EVALUATION, UNDER GENERAL ANESTHESIA, WITH OR WITHOUT MANIPULATION OF GLOBE FOR PASSIVE RANGE OF MOTION OR OTHER MANIPULATION TO FACILITATE DIAGNOSTIC EXAMINATION; LIM",,,2196.57,9324.0,13 RC,360,OPPONENSPLASTY; HYPOTHENAR MUSCLE TRANSFER,,,3054.93,13194.0,15 RC,360,"OPPONENSPLASTY; SUPERFICIALIS TENDON TRANSFER TYPE, EACH TENDON",,,3054.93,13194.0,15 RC,360,"OPPONENSPLASTY; TENDON TRANSFER WITH GRAFT (INCLUDES OBTAINING GRAFT), EACH TENDON",,,3054.93,13194.0,15 RC,360,"OPTIC NERVE DECOMPRESSION (EG, INCISION OR FENESTRATION OF OPTIC NERVE SHEATH)",,,3550.55,13194.0,15 RC,360,ORBITAL IMPLANT (IMPLANT OUTSIDE MUSCLE CONE); REMOVAL OR REVISION,,,3550.55,13194.0,15 RC,360,"ORBITOTOMY WITH BONE FLAP OR WINDOW, LATERAL APPROACH (EG, KROENLEIN); FOR EXPLORATION, WITH OR WITHOUT BIOPSY",,,3550.55,13194.0,15 RC,360,"ORBITOTOMY WITH BONE FLAP OR WINDOW, LATERAL APPROACH (EG, KROENLEIN); WITH DRAINAGE",,,3550.55,13194.0,15 RC,360,"ORBITOTOMY WITH BONE FLAP OR WINDOW, LATERAL APPROACH (EG, KROENLEIN); WITH REMOVAL OF BONE FOR DECOMPRESSION",,,3550.55,13194.0,15 RC,360,"ORBITOTOMY WITH BONE FLAP OR WINDOW, LATERAL APPROACH (EG, KROENLEIN); WITH REMOVAL OF LESION",,,3550.55,13194.0,15 RC,360,"ORBITOTOMY WITHOUT BONE FLAP (FRONTAL OR TRANSCONJUNCTIVAL APPROACH); FOR EXPLORATION, WITH OR WITHOUT BIOPSY",,,3550.55,13194.0,15 RC,360,ORBITOTOMY WITHOUT BONE FLAP (FRONTAL OR TRANSCONJUNCTIVAL APPROACH); WITH REMOVAL OF BONE FOR DECOMPRESSION,,,3550.55,13194.0,14 RC,360,ORBITOTOMY WITHOUT BONE FLAP (FRONTAL OR TRANSCONJUNCTIVAL APPROACH); WITH REMOVAL OF FOREIGN BODY,,,2196.57,12615.0,15 RC,360,ORBITOTOMY WITHOUT BONE FLAP (FRONTAL OR TRANSCONJUNCTIVAL APPROACH); WITH REMOVAL OF LESION,,,2196.57,12615.0,15 RC,360,"ORCHIECTOMY, PARTIAL",,,3247.35,9324.0,15 RC,360,"ORCHIECTOMY, RADICAL, FOR TUMOR; INGUINAL APPROACH",,,3322.75,13194.0,15 RC,360,"ORCHIECTOMY, SIMPLE (INCLUDING SUBCAPSULAR), WITH OR WITHOUT TESTICULAR PROSTHESIS, SCROTAL OR INGUINAL APPROACH",,,3247.35,13194.0,15 RC,360,"ORCHIOPEXY, ABDOMINAL APPROACH, FOR INTRA-ABDOMINAL TESTIS (EG, FOWLER-STEPHENS)",,,3322.75,13194.0,14 RC,360,"ORCHIOPEXY, INGUINAL OR SCROTAL APPROACH",,,3322.75,13194.0,15 RC,360,"OSTECTOMY OF STERNUM, PARTIAL",,,9974.0,15394.0,3 RC,360,"OSTECTOMY, CALCANEUS;",,,3054.93,10561.0,15 RC,360,"OSTECTOMY, CALCANEUS; FOR SPUR, WITH OR WITHOUT PLANTAR FASCIAL RELEASE",,,3054.93,10561.0,15 RC,360,"OSTECTOMY, COMPLETE EXCISION; ALL METATARSAL HEADS, WITH PARTIAL PROXIMAL PHALANGECTOMY, EXCLUDING FIRST METATARSAL (EG, CLAYTON TYPE PROCEDURE)",,,3054.93,9324.0,15 RC,360,"OSTECTOMY, COMPLETE EXCISION; FIFTH METATARSAL HEAD",,,3054.93,9324.0,15 RC,360,"OSTECTOMY, COMPLETE EXCISION; OTHER METATARSAL HEAD (SECOND, THIRD OR FOURTH)",,,3054.93,9324.0,15 RC,360,"OSTECTOMY, EXCISION OF TARSAL COALITION",,,3054.93,9324.0,15 RC,360,"OSTECTOMY, PARTIAL EXCISION, FIFTH METATARSAL HEAD (BUNIONETTE) (SEPARATE PROCEDURE)",,,3054.93,9324.0,15 RC,360,"OSTECTOMY, PARTIAL, EXOSTECTOMY OR CONDYLECTOMY, METATARSAL HEAD, EACH METATARSAL HEAD",,,3054.93,9324.0,15 RC,360,"OSTEOCHONDRAL ALLOGRAFT, KNEE, OPEN",,,8413.0,21454.0,14 RC,360,"OSTEOCHONDRAL AUTOGRAFT(S), KNEE, OPEN (EG, MOSAICPLASTY) (INCLUDES HARVESTING OF AUTOGRAFT[S])",,,6726.11,17457.0,15 RC,360,"OSTEOPLASTY, FACIAL BONES; AUGMENTATION (AUTOGRAFT, ALLOGRAFT, OR PROSTHETIC IMPLANT)",,,5569.83,15394.0,15 RC,360,"OSTEOPLASTY, FACIAL BONES; REDUCTION",,,5569.83,15394.0,15 RC,360,"OSTEOPLASTY, RADIUS AND ULNA; LENGTHENING WITH AUTOGRAFT",,,6726.11,15394.0,15 RC,360,"OSTEOPLASTY, RADIUS OR ULNA; SHORTENING",,,6649.0,15394.0,15 RC,360,"OSTEOTOMY, CLAVICLE, WITH OR WITHOUT INTERNAL FIXATION; WITH BONE GRAFT FOR NONUNION OR MALUNION (INCLUDES OBTAINING GRAFT AND/OR NECESSARY FIXATION)",,,12114.63,21454.0,15 RC,360,"OSTEOTOMY, FEMUR, SHAFT OR SUPRACONDYLAR; WITH FIXATION",,,12615.0,21454.0,3 RC,360,"OSTEOTOMY, HUMERUS, WITH OR WITHOUT INTERNAL FIXATION",,,6726.11,15394.0,15 RC,360,"OSTEOTOMY, ILIAC, ACETABULAR OR INNOMINATE BONE;",,,12615.0,21454.0,3 RC,360,"OSTEOTOMY, INTERTROCHANTERIC OR SUBTROCHANTERIC INCLUDING INTERNAL OR EXTERNAL FIXATION AND/OR CAST",,,12615.0,21454.0,3 RC,360,"OSTEOTOMY, MANDIBLE, SEGMENTAL;",,,5514.0,9324.0,14 RC,360,"OSTEOTOMY, MANDIBLE, SEGMENTAL; WITH GENIOGLOSSUS ADVANCEMENT",,,5569.83,15394.0,14 RC,360,"OSTEOTOMY, PROXIMAL TIBIA, INCLUDING FIBULAR EXCISION OR OSTEOTOMY (INCLUDES CORRECTION OF GENU VARUS [BOWLEG] OR GENU VALGUS [KNOCK-KNEE]); AFTER EPIPHYSEAL CLOSURE",,,9974.0,15394.0,3 RC,360,"OSTEOTOMY, PROXIMAL TIBIA, INCLUDING FIBULAR EXCISION OR OSTEOTOMY (INCLUDES CORRECTION OF GENU VARUS [BOWLEG] OR GENU VALGUS [KNOCK-KNEE]); BEFORE EPIPHYSEAL CLOSURE",,,12615.0,21454.0,3 RC,360,"OSTEOTOMY, RADIUS; DISTAL THIRD",,,6649.0,15394.0,15 RC,360,"OSTEOTOMY, SHORTENING, ANGULAR OR ROTATIONAL CORRECTION; OTHER PHALANGES, ANY TOE",,,3054.93,9324.0,15 RC,360,"OSTEOTOMY, SHORTENING, ANGULAR OR ROTATIONAL CORRECTION; PROXIMAL PHALANX, FIRST TOE (SEPARATE PROCEDURE)",,,5514.0,9324.0,15 RC,360,"OSTEOTOMY, TARSAL BONES, OTHER THAN CALCANEUS OR TALUS;",,,5152.0,21454.0,15 RC,360,"OSTEOTOMY, WITH OR WITHOUT LENGTHENING, SHORTENING OR ANGULAR CORRECTION, METATARSAL; FIRST METATARSAL",,,5514.0,10561.0,15 RC,360,"OSTEOTOMY, WITH OR WITHOUT LENGTHENING, SHORTENING OR ANGULAR CORRECTION, METATARSAL; MULTIPLE (EG, SWANSON TYPE CAVUS FOOT PROCEDURE)",,,6726.11,21454.0,15 RC,360,"OSTEOTOMY, WITH OR WITHOUT LENGTHENING, SHORTENING OR ANGULAR CORRECTION, METATARSAL; OTHER THAN FIRST METATARSAL, EACH",,,3054.93,9324.0,15 RC,360,"OSTEOTOMY; CALCANEUS (EG, DWYER OR CHAMBERS TYPE PROCEDURE), WITH OR WITHOUT INTERNAL FIXATION",,,5152.0,21454.0,15 RC,360,OSTEOTOMY; FIBULA,,,3054.93,13194.0,15 RC,360,"OSTEOTOMY; METACARPAL, EACH",,,3054.93,13194.0,15 RC,360,"OSTEOTOMY; PHALANX OF FINGER, EACH",,,3054.93,13194.0,15 RC,360,OSTEOTOMY; RADIUS AND ULNA,,,6649.0,15394.0,15 RC,360,OSTEOTOMY; TIBIA,,,5152.0,15394.0,15 RC,360,OSTEOTOMY; TIBIA AND FIBULA,,,5152.0,13238.67,15 RC,360,OSTEOTOMY; ULNA,,,6649.0,15394.0,15 RC,360,OTOLARYNGOLOGIC EXAMINATION UNDER GENERAL ANESTHESIA,,,479.48,1251.0,13 RC,360,"OTOPLASTY, PROTRUDING EAR, WITH OR WITHOUT SIZE REDUCTION",,,3053.48,9324.0,15 RC,360,"OVARIAN CYSTECTOMY, UNILATERAL OR BILATERAL",,,4647.86,13194.0,14 RC,360,"PALATOPHARYNGOPLASTY (EG, UVULOPALATOPHARYNGOPLASTY, UVULOPHARYNGOPLASTY)",,,5514.0,12615.0,15 RC,360,"PALATOPLASTY FOR CLEFT PALATE, SOFT AND/OR HARD PALATE ONLY",,,5569.83,15394.0,15 RC,360,"PALATOPLASTY FOR CLEFT PALATE, WITH CLOSURE OF ALVEOLAR RIDGE; SOFT TISSUE ONLY",,,3053.48,15394.0,15 RC,360,"PALATOPLASTY FOR CLEFT PALATE, WITH CLOSURE OF ALVEOLAR RIDGE; WITH BONE GRAFT TO ALVEOLAR RIDGE (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,15 RC,360,PALATOPLASTY FOR CLEFT PALATE; ATTACHMENT PHARYNGEAL FLAP,,,5569.83,15394.0,15 RC,360,PALATOPLASTY FOR CLEFT PALATE; MAJOR REVISION,,,5569.83,15394.0,15 RC,360,PALATOPLASTY FOR CLEFT PALATE; SECONDARY LENGTHENING PROCEDURE,,,5569.83,15394.0,15 RC,360,PARACENTESIS OF ANTERIOR CHAMBER OF EYE (SEPARATE PROCEDURE); WITH REMOVAL OF AQUEOUS,,,777.0,5449.0,15 RC,360,"PARACENTESIS OF ANTERIOR CHAMBER OF EYE (SEPARATE PROCEDURE); WITH REMOVAL OF BLOOD, WITH OR WITHOUT IRRIGATION AND/OR AIR INJECTION",,,2147.4,9324.0,15 RC,360,PARATHYROID AUTOTRANSPLANTATION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,8413.0,3 RC,360,PARATHYROIDECTOMY OR EXPLORATION OF PARATHYROID(S);,,,5569.83,15394.0,14 RC,360,PARATHYROIDECTOMY OR EXPLORATION OF PARATHYROID(S); RE-EXPLORATION,,,5569.83,17457.0,15 RC,360,"PARAVERTEBRAL BLOCK (PVB) (PARASPINOUS BLOCK), THORACIC; CONTINUOUS INFUSION BY CATHETER (INCLUDES IMAGING GUIDANCE, WHEN PERFORMED)",,,652.03,5449.0,14 RC,360,"PARAVERTEBRAL BLOCK (PVB) (PARASPINOUS BLOCK), THORACIC; SECOND AND ANY ADDITIONAL INJECTION SITE(S) (INCLUDES IMAGING GUIDANCE, WHEN PERFORMED) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCED",,,777.0,5449.0,3 RC,360,"PARAVERTEBRAL BLOCK (PVB) (PARASPINOUS BLOCK), THORACIC; SINGLE INJECTION SITE (INCLUDES IMAGING GUIDANCE, WHEN PERFORMED)",,,652.03,5449.0,14 RC,360,"PARING OR CUTTING OF BENIGN HYPERKERATOTIC LESION (EG, CORN OR CALLUS); SINGLE LESION",,,187.08,5449.0,14 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, OR DIAPHYSECTOMY) BONE (EG, OSTEOMYELITIS); DISTAL PHALANX OF FINGER",,,1506.85,8413.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, OR DIAPHYSECTOMY) BONE (EG, OSTEOMYELITIS); METACARPAL",,,3012.0,15291.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, OR DIAPHYSECTOMY) BONE (EG, OSTEOMYELITIS); PROXIMAL OR MIDDLE PHALANX OF FINGER",,,1506.85,8413.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, OR DIAPHYSECTOMY) BONE, FEMUR, PROXIMAL TIBIA AND/OR FIBULA (EG, OSTEOMYELITIS OR BONE ABSCESS)",,,3054.93,13194.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, OR DIAPHYSECTOMY) OF BONE (EG, FOR OSTEOMYELITIS); RADIUS",,,3054.93,13194.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, OR DIAPHYSECTOMY), BONE (EG, OSTEOMYELITIS); FIBULA",,,3054.93,13194.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, OR DIAPHYSECTOMY), BONE (EG, OSTEOMYELITIS); TIBIA",,,3054.93,13194.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, SEQUESTRECTOMY, OR DIAPHYSECTOMY) BONE (EG, OSTEOMYELITIS OR BOSSING); PHALANX OF TOE",,,3054.93,9324.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, SEQUESTRECTOMY, OR DIAPHYSECTOMY) BONE (EG, OSTEOMYELITIS OR BOSSING); TALUS OR CALCANEUS",,,3054.93,15291.0,15 RC,360,"PARTIAL EXCISION (CRATERIZATION, SAUCERIZATION, SEQUESTRECTOMY, OR DIAPHYSECTOMY) BONE (EG, OSTEOMYELITIS OR BOSSING); TARSAL OR METATARSAL BONE, EXCEPT TALUS OR CALCANEUS",,,3054.93,9324.0,15 RC,360,"PARTIAL EXCISION, WING OF ILIUM, SYMPHYSIS PUBIS, OR GREATER TROCHANTER OF FEMUR, (CRATERIZATION, SAUCERIZATION) (EG, OSTEOMYELITIS OR BONE ABSCESS); DEEP (SUBFASCIAL OR INTRAMUSCULAR)",,,12615.0,21454.0,3 RC,360,PARTIAL HYMENECTOMY OR REVISION OF HYMENAL RING,,,2993.65,9324.0,15 RC,360,"PARTIAL THYROID LOBECTOMY, UNILATERAL; WITH CONTRALATERAL SUBTOTAL LOBECTOMY, INCLUDING ISTHMUSECTOMY",,,5493.28,21454.0,14 RC,360,"PARTIAL THYROID LOBECTOMY, UNILATERAL; WITH OR WITHOUT ISTHMUSECTOMY",,,5493.28,21454.0,14 RC,360,PELVIC EXAMINATION UNDER ANESTHESIA (OTHER THAN LOCAL),,,2993.65,9324.0,15 RC,360,"PELVIC LYMPHADENECTOMY, INCLUDING EXTERNAL ILIAC, HYPOGASTRIC, AND OBTURATOR NODES (SEPARATE PROCEDURE)",,,2533.0,4850.0,2 RC,360,"PERCUTANEOUS ARTERIOVENOUS FISTULA CREATION, UPPER EXTREMITY, SINGLE ACCESS OF BOTH THE PERIPHERAL ARTERY AND PERIPHERAL VEIN, INCLUDING FISTULA MATURATION PROCEDURES (EG, TRANSLUMINAL BALLOON ANGIOPL",,,15291.0,30725.0,14 RC,360,"PERCUTANEOUS IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY, EPIDURAL",,,6179.23,21454.0,15 RC,360,PERCUTANEOUS IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY; PERIPHERAL NERVE (EXCLUDES SACRAL NERVE),,,5449.0,21454.0,14 RC,360,"PERCUTANEOUS IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY; SACRAL NERVE (TRANSFORAMINAL PLACEMENT) INCLUDING IMAGE GUIDANCE, IF PERFORMED",,,6179.23,21454.0,15 RC,360,"PERCUTANEOUS LAMINOTOMY/LAMINECTOMY (INTERLAMINAR APPROACH) FOR DECOMPRESSION OF NEURAL ELEMENTS, (WITH OR WITHOUT LIGAMENTOUS RESECTION, DISCECTOMY, FACETECTOMY AND/OR FORAMINOTOMY), ANY METHOD, UNDE",,,6726.11,21454.0,14 RC,360,"PERCUTANEOUS NEPHROLITHOTOMY OR PYELOLITHOTOMY, LITHOTRIPSY, STONE EXTRACTION, ANTEGRADE URETEROSCOPY, ANTEGRADE STENT PLACEMENT AND NEPHROSTOMY TUBE PLACEMENT, WHEN PERFORMED, INCLUDING IMAGING GUIDA",,,8706.56,15394.0,28 RC,360,PERCUTANEOUS PORTAL VEIN CATHETERIZATION BY ANY METHOD,,,777.0,5449.0,3 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF CARPOMETACARPAL DISLOCATION, OTHER THAN THUMB, WITH MANIPULATION, EACH JOINT",,,3054.93,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF CARPOMETACARPAL FRACTURE DISLOCATION, THUMB (BENNETT FRACTURE), WITH MANIPULATION",,,3054.93,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF DISTAL PHALANGEAL FRACTURE, FINGER OR THUMB, EACH",,,3054.93,9324.0,15 RC,360,PERCUTANEOUS SKELETAL FIXATION OF DISTAL RADIAL FRACTURE OR EPIPHYSEAL SEPARATION,,,3054.93,9324.0,15 RC,360,PERCUTANEOUS SKELETAL FIXATION OF DISTAL RADIOULNAR DISLOCATION,,,3054.93,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF FEMORAL FRACTURE, PROXIMAL END, NECK",,,6726.11,13194.0,14 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF FRACTURE GREAT TOE, PHALANX OR PHALANGES, WITH MANIPULATION",,,3054.93,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF HUMERAL CONDYLAR FRACTURE, MEDIAL OR LATERAL, WITH MANIPULATION",,,5152.0,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF INTERPHALANGEAL JOINT DISLOCATION, SINGLE, WITH MANIPULATION",,,3054.93,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF METACARPAL FRACTURE, EACH BONE",,,3054.93,10561.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF METATARSAL FRACTURE, WITH MANIPULATION, EACH",,,3054.93,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF SUPRACONDYLAR OR TRANSCONDYLAR HUMERAL FRACTURE, WITH OR WITHOUT INTERCONDYLAR EXTENSION",,,5152.0,9324.0,15 RC,360,"PERCUTANEOUS SKELETAL FIXATION OF UNSTABLE PHALANGEAL SHAFT FRACTURE, PROXIMAL OR MIDDLE PHALANX, FINGER OR THUMB, WITH MANIPULATION, EACH",,,3054.93,15291.0,15 RC,360,"PERCUTANEOUS TRANSLUMINAL MECHANICAL THROMBECTOMY AND/OR INFUSION FOR THROMBOLYSIS, DIALYSIS CIRCUIT, ANY METHOD, INCLUDING ALL IMAGING AND RADIOLOGICAL SUPERVISION AND INTERPRETATION, DIAGNOSTIC ANGI",,,10677.6,30725.0,14 RC,360,"PERCUTANEOUS TRANSLUMINAL MECHANICAL THROMBECTOMY, VEIN(S), INCLUDING INTRAPROCEDURAL PHARMACOLOGICAL THROMBOLYTIC INJECTIONS AND FLUOROSCOPIC GUIDANCE",,,8875.0,21454.0,15 RC,360,"PERCUTANEOUS VERTEBRAL AUGMENTATION, INCLUDING CAVITY CREATION (FRACTURE REDUCTION AND BONE BIOPSY INCLUDED WHEN PERFORMED) USING MECHANICAL DEVICE (EG, KYPHOPLASTY), 1 VERTEBRAL BODY, UNILATERAL OR B",,,6726.11,21454.0,14 RC,360,"PERI-IMPLANT CAPSULECTOMY, BREAST, COMPLETE, INCLUDING REMOVAL OF ALL INTRACAPSULAR CONTENTS",,,3605.42,13194.0,15 RC,360,"PERINEOPLASTY, REPAIR OF PERINEUM, NONOBSTETRICAL (SEPARATE PROCEDURE)",,,2993.65,12615.0,15 RC,360,PERIRECTAL INJECTION OF SCLEROSING SOLUTION FOR PROLAPSE,,,858.41,5449.0,14 RC,360,"PERITONEAL LAVAGE, INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,882.75,7278.0,15 RC,360,PETROUS APICECTOMY INCLUDING RADICAL MASTOIDECTOMY,,,5569.83,15394.0,15 RC,360,PHARYNGOPLASTY (PLASTIC OR RECONSTRUCTIVE OPERATION ON PHARYNX),,,5152.0,9324.0,15 RC,360,"PINCH GRAFT, SINGLE OR MULTIPLE, TO COVER SMALL ULCER, TIP OF DIGIT, OR OTHER MINIMAL OPEN AREA (EXCEPT ON FACE), UP TO DEFECT SIZE 2 CM DIAMETER",,,576.34,7278.0,15 RC,360,"PLACEMENT OF ADJUSTABLE SUTURE(S) DURING STRABISMUS SURGERY, INCLUDING POSTOPERATIVE ADJUSTMENT(S) OF SUTURE(S) (LIST SEPARATELY IN ADDITION TO CODE FOR SPECIFIC STRABISMUS SURGERY)",,,777.0,10561.0,3 RC,360,"PLACEMENT OF AMNIOTIC MEMBRANE ON THE OCULAR SURFACE; SINGLE LAYER, SUTURED",,,3550.55,13194.0,15 RC,360,PLACEMENT OF AMNIOTIC MEMBRANE ON THE OCULAR SURFACE; WITHOUT SUTURES,,,911.92,5449.0,15 RC,360,"PLACEMENT OF BILIARY DRAINAGE CATHETER, PERCUTANEOUS, INCLUDING DIAGNOSTIC CHOLANGIOGRAPHY WHEN PERFORMED, IMAGING GUIDANCE (EG, ULTRASOUND AND/OR FLUOROSCOPY), AND ALL ASSOCIATED RADIOLOGICAL SUPERVI",,,3322.75,17457.0,15 RC,360,"PLACEMENT OF BREAST LOCALIZATION DEVICE(S) (EG, CLIP, METALLIC PELLET, WIRE/NEEDLE, RADIOACTIVE SEEDS), PERCUTANEOUS; FIRST LESION, INCLUDING ULTRASOUND GUIDANCE",,,662.46,7278.0,15 RC,360,"PLACEMENT OF INTERSTITIAL DEVICE(S) FOR RADIATION THERAPY GUIDANCE (EG, FIDUCIAL MARKERS, DOSIMETER), PERCUTANEOUS, INTRA-ABDOMINAL, INTRA-PELVIC (EXCEPT PROSTATE), AND/OR RETROPERITONEUM, SINGLE OR M",,,1288.28,5449.0,15 RC,360,"PLACEMENT OF INTERSTITIAL DEVICE(S) FOR RADIATION THERAPY GUIDANCE (EG, FIDUCIAL MARKERS, DOSIMETER), PROSTATE (VIA NEEDLE, ANY APPROACH), SINGLE OR MULTIPLE",,,1288.28,5449.0,15 RC,360,"PLACEMENT OF INTERSTITIAL DEVICE(S) FOR RADIATION THERAPY/SURGERY GUIDANCE (E.G., FIDUCIAL MARKERS, DOSIMETER), FOR OTHER THAN THE FOLLOWING SITES (ANY APPROACH): ABDOMEN, PELVIS, PROSTATE, RETROPERIT",,,1288.28,1407.81,11 RC,360,"PLACEMENT OF NEPHROSTOMY CATHETER, PERCUTANEOUS, INCLUDING DIAGNOSTIC NEPHROSTOGRAM AND/OR URETEROGRAM WHEN PERFORMED, IMAGING GUIDANCE (EG, ULTRASOUND AND/OR FLUOROSCOPY) AND ALL ASSOCIATED RADIOLOGI",,,1928.76,12408.0,15 RC,360,PLACEMENT OF SETON,,,2582.07,9324.0,15 RC,360,"PLACEMENT OF URETERAL STENT, PERCUTANEOUS, INCLUDING DIAGNOSTIC NEPHROSTOGRAM AND/OR URETEROGRAM WHEN PERFORMED, IMAGING GUIDANCE (EG, ULTRASOUND AND/OR FLUOROSCOPY), AND ALL ASSOCIATED RADIOLOGICAL S",,,3247.35,17457.0,15 RC,360,"PLASTIC OPERATION OF PENIS FOR STRAIGHTENING OF CHORDEE (EG, HYPOSPADIAS), WITH OR WITHOUT MOBILIZATION OF URETHRA",,,3247.35,15394.0,15 RC,360,PLASTIC OPERATION ON PENIS FOR CORRECTION OF CHORDEE OR FOR FIRST STAGE HYPOSPADIAS REPAIR WITH OR WITHOUT TRANSPLANTATION OF PREPUCE AND/OR SKIN FLAPS,,,3247.35,15394.0,15 RC,360,PLASTIC OPERATION ON PENIS FOR EPISPADIAS DISTAL TO EXTERNAL SPHINCTER;,,,1928.76,13194.0,15 RC,360,PLASTIC OPERATION ON PENIS TO CORRECT ANGULATION,,,3247.35,15394.0,15 RC,360,PLASTIC REPAIR OF CANALICULI,,,2196.57,9324.0,15 RC,360,"PLASTIC REPAIR OF CLEFT LIP/NASAL DEFORMITY; PRIMARY BILATERAL, 1 OF 2 STAGES",,,5569.83,15394.0,14 RC,360,"PLASTIC REPAIR OF CLEFT LIP/NASAL DEFORMITY; PRIMARY BILATERAL, 1-STAGE PROCEDURE",,,5569.83,15394.0,15 RC,360,"PLASTIC REPAIR OF CLEFT LIP/NASAL DEFORMITY; PRIMARY, PARTIAL OR COMPLETE, UNILATERAL",,,5569.83,15394.0,15 RC,360,"PLASTIC REPAIR OF CLEFT LIP/NASAL DEFORMITY; SECONDARY, BY RECREATION OF DEFECT AND RECLOSURE",,,3053.48,15394.0,15 RC,360,PLASTIC REPAIR OF INTROITUS,,,2993.65,9324.0,15 RC,360,"PLASTIC REPAIR OF SALIVARY DUCT, SIALODOCHOPLASTY; PRIMARY OR SIMPLE",,,5514.0,9324.0,15 RC,360,"PLASTIC REPAIR OF SALIVARY DUCT, SIALODOCHOPLASTY; SECONDARY OR COMPLICATED",,,5569.83,15394.0,15 RC,360,"PLEURAL DRAINAGE, PERCUTANEOUS, WITH INSERTION OF INDWELLING CATHETER; WITHOUT IMAGING GUIDANCE",,,1786.09,7278.0,15 RC,360,POLLICIZATION OF A DIGIT,,,3054.93,13194.0,15 RC,360,"POSTERIOR COLPORRHAPHY, REPAIR OF RECTOCELE WITH OR WITHOUT PERINEORRHAPHY",,,4647.86,13194.0,15 RC,360,"POSTERIOR NON-SEGMENTAL INSTRUMENTATION (EG, HARRINGTON ROD TECHNIQUE, PEDICLE FIXATION ACROSS 1 INTERSPACE, ATLANTOAXIAL TRANSARTICULAR SCREW FIXATION, SUBLAMINAR WIRING AT C1, FACET SCREW FIXATION) ",,,777.0,5449.0,3 RC,360,"POSTERIOR SEGMENTAL INSTRUMENTATION (EG, PEDICLE FIXATION, DUAL RODS WITH MULTIPLE HOOKS AND SUBLAMINAR WIRES); 13 OR MORE VERTEBRAL SEGMENTS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE",,,777.0,5449.0,3 RC,360,"POSTERIOR SEGMENTAL INSTRUMENTATION (EG, PEDICLE FIXATION, DUAL RODS WITH MULTIPLE HOOKS AND SUBLAMINAR WIRES); 3 TO 6 VERTEBRAL SEGMENTS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"POSTERIOR SEGMENTAL INSTRUMENTATION (EG, PEDICLE FIXATION, DUAL RODS WITH MULTIPLE HOOKS AND SUBLAMINAR WIRES); 7 TO 12 VERTEBRAL SEGMENTS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"POSTERIOR TIBIAL NEUROSTIMULATION, PERCUTANEOUS NEEDLE ELECTRODE, SINGLE TREATMENT, INCLUDES PROGRAMMING",,,277.93,5449.0,15 RC,360,"PREPARATION OF SKIN CELL SUSPENSION AUTOGRAFT, REQUIRING ENZYMATIC PROCESSING, MANUAL MECHANICAL DISAGGREGATION OF SKIN CELLS, AND FILTRATION; FIRST 25 SQ CM OR LESS OF HARVESTED SKIN",,,6826.64,21454.0,13 RC,360,"PRIMARY PERCUTANEOUS TRANSLUMINAL MECHANICAL THROMBECTOMY, NONCORONARY, NON-INTRACRANIAL, ARTERIAL OR ARTERIAL BYPASS GRAFT, INCLUDING FLUOROSCOPIC GUIDANCE AND INTRAPROCEDURAL PHARMACOLOGICAL THROMBO",,,777.0,21454.0,18 RC,360,"PROBING OF LACRIMAL CANALICULI, WITH OR WITHOUT IRRIGATION",,,281.46,5449.0,14 RC,360,"PROBING OF NASOLACRIMAL DUCT, WITH OR WITHOUT IRRIGATION;",,,281.46,5449.0,15 RC,360,"PROBING OF NASOLACRIMAL DUCT, WITH OR WITHOUT IRRIGATION; WITH INSERTION OF TUBE OR STENT",,,2196.57,9324.0,15 RC,360,"PROCTOSIGMOIDOSCOPY, RIGID; DIAGNOSTIC, WITH OR WITHOUT COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING (SEPARATE PROCEDURE)",,,858.41,5449.0,15 RC,360,"PROCTOSIGMOIDOSCOPY, RIGID; WITH BIOPSY, SINGLE OR MULTIPLE",,,1110.16,5449.0,15 RC,360,"PROPHYLACTIC TREATMENT (NAILING, PINNING, PLATING OR WIRING) WITH OR WITHOUT METHYLMETHACRYLATE, FEMORAL NECK AND PROXIMAL FEMUR",,,10561.0,21454.0,3 RC,360,"PROPHYLACTIC TREATMENT (NAILING, PINNING, PLATING OR WIRING) WITH OR WITHOUT METHYLMETHACRYLATE, TIBIA",,,6649.0,21454.0,15 RC,360,"PROPHYLACTIC TREATMENT (NAILING, PINNING, PLATING OR WIRING), WITH OR WITHOUT METHYLMETHACRYLATE, HUMERAL SHAFT",,,6649.0,21454.0,15 RC,360,"PROPHYLACTIC TREATMENT (NAILING, PINNING, PLATING, OR WIRING) WITH OR WITHOUT METHYLMETHACRYLATE, FEMUR",,,12615.0,21454.0,3 RC,360,"PROPHYLAXIS OF RETINAL DETACHMENT (EG, RETINAL BREAK, LATTICE DEGENERATION) WITHOUT DRAINAGE; PHOTOCOAGULATION",,,516.52,5449.0,15 RC,360,"PROSTATECTOMY, PERINEAL, SUBTOTAL (INCLUDING CONTROL OF POSTOPERATIVE BLEEDING, VASECTOMY, MEATOTOMY, URETHRAL CALIBRATION AND/OR DILATION, AND INTERNAL URETHROTOMY)",,,2533.0,4850.0,2 RC,360,"PROSTATECTOMY, RETROPUBIC RADICAL, WITH OR WITHOUT NERVE SPARING;",,,2533.0,4850.0,2 RC,360,"PTERYGOMAXILLARY FOSSA SURGERY, ANY APPROACH",,,5514.0,9324.0,13 RC,360,"PUNCH BIOPSY OF SKIN (INCLUDING SIMPLE CLOSURE, WHEN PERFORMED); EACH SEPARATE/ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"PUNCH BIOPSY OF SKIN (INCLUDING SIMPLE CLOSURE, WHEN PERFORMED); SINGLE LESION",,,376.18,5449.0,14 RC,360,"PUNCTURE ASPIRATION OF ABSCESS, HEMATOMA, BULLA, OR CYST",,,376.18,5449.0,14 RC,360,"PUNCTURE ASPIRATION OF HYDROCELE, TUNICA VAGINALIS, WITH OR WITHOUT INJECTION OF MEDICATION",,,662.46,3517.0,13 RC,360,PUNCTURE OF SHUNT TUBING OR RESERVOIR FOR ASPIRATION OR INJECTION PROCEDURE,,,652.03,5449.0,15 RC,360,"PYELOPLASTY (FOLEY Y-PYELOPLASTY), PLASTIC OPERATION ON RENAL PELVIS, WITH OR WITHOUT PLASTIC OPERATION ON URETER, NEPHROPEXY, NEPHROSTOMY, PYELOSTOMY, OR URETERAL SPLINTING; COMPLICATED (CONGENITAL K",,,7444.0,13194.0,2 RC,360,"PYELOTOMY; WITH REMOVAL OF CALCULUS (PYELOLITHOTOMY, PELVIOLITHOTOMY, INCLUDING COAGULUM PYELOLITHOTOMY)",,,2533.0,4850.0,2 RC,360,"PYLOROMYOTOMY, CUTTING OF PYLORIC MUSCLE (FREDET-RAMSTEDT TYPE OPERATION)",,,2533.0,4850.0,2 RC,360,"QUADRICEPSPLASTY (EG, BENNETT OR THOMPSON TYPE)",,,6726.11,15394.0,15 RC,360,RADICAL EXCISION EXTERNAL AUDITORY CANAL LESION; WITHOUT NECK DISSECTION,,,5514.0,9324.0,15 RC,360,"RADICAL EXCISION OF BURSA, SYNOVIA OF WRIST, OR FOREARM TENDON SHEATHS (EG, TENOSYNOVITIS, FUNGUS, TBC, OR OTHER GRANULOMAS, RHEUMATOID ARTHRITIS); EXTENSORS, WITH OR WITHOUT TRANSPOSITION OF DORSAL R",,,3054.93,10561.0,15 RC,360,"RADICAL EXCISION OF BURSA, SYNOVIA OF WRIST, OR FOREARM TENDON SHEATHS (EG, TENOSYNOVITIS, FUNGUS, TBC, OR OTHER GRANULOMAS, RHEUMATOID ARTHRITIS); FLEXORS",,,1506.85,10561.0,15 RC,360,"RADICAL RESECTION OF CAPSULE, SOFT TISSUE, AND HETEROTOPIC BONE, ELBOW, WITH CONTRACTURE RELEASE (SEPARATE PROCEDURE)",,,6726.11,13194.0,14 RC,360,"RADICAL RESECTION OF TONSIL, TONSILLAR PILLARS, AND/OR RETROMOLAR TRIGONE; CLOSURE WITH LOCAL FLAP (EG, TONGUE, BUCCAL)",,,5569.83,15394.0,13 RC,360,"RADICAL RESECTION OF TONSIL, TONSILLAR PILLARS, AND/OR RETROMOLAR TRIGONE; WITHOUT CLOSURE",,,5514.0,9324.0,13 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF ABDOMINAL WALL; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF ABDOMINAL WALL; LESS THAN 5 CM",,,2694.74,12408.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF BACK OR FLANK; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF BACK OR FLANK; LESS THAN 5 CM",,,2694.74,8413.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF FACE OR SCALP; 2 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF FACE OR SCALP; LESS THAN 2 CM",,,2694.74,8413.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF FOOT OR TOE; LESS THAN 3 CM",,,2694.74,8413.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF FOREARM AND/OR WRIST AREA; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF HAND OR FINGER; LESS THAN 3 CM",,,2694.74,8413.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF LEG OR ANKLE AREA; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF LEG OR ANKLE AREA; LESS THAN 5 CM",,,2694.74,8413.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF NECK OR ANTERIOR THORAX; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF NECK OR ANTERIOR THORAX; LESS THAN 5 CM",,,2694.74,7278.0,14 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF PELVIS AND HIP AREA; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF SHOULDER AREA; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF SHOULDER AREA; LESS THAN 5 CM",,,2694.74,8413.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF THIGH OR KNEE AREA; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF THIGH OR KNEE AREA; LESS THAN 5 CM",,,2694.74,10561.0,15 RC,360,"RADICAL RESECTION OF TUMOR (EG, SARCOMA), SOFT TISSUE OF UPPER ARM OR ELBOW AREA; 5 CM OR GREATER",,,2694.74,17457.0,15 RC,360,RADICAL RESECTION OF TUMOR; FIBULA,,,12615.0,21454.0,3 RC,360,"RADICAL RESECTION OF TUMOR; WING OF ILIUM, 1 PUBIC OR ISCHIAL RAMUS OR SYMPHYSIS PUBIS",,,12615.0,21454.0,3 RC,360,"RADICAL TRACHELECTOMY, WITH BILATERAL TOTAL PELVIC LYMPHADENECTOMY AND PARA-AORTIC LYMPH NODE SAMPLING BIOPSY, WITH OR WITHOUT REMOVAL OF TUBE(S), WITH OR WITHOUT REMOVAL OF OVARY(S)",,,2533.0,4850.0,2 RC,360,"REALIGNMENT OF EXTENSOR TENDON, HAND, EACH TENDON",,,3012.0,8413.0,15 RC,360,"RECONSTRUCTION (ADVANCEMENT), POSTERIOR TIBIAL TENDON WITH EXCISION OF ACCESSORY TARSAL NAVICULAR BONE (EG, KIDNER TYPE PROCEDURE)",,,6649.0,21454.0,15 RC,360,"RECONSTRUCTION EXTERNAL AUDITORY CANAL FOR CONGENITAL ATRESIA, SINGLE STAGE",,,5569.83,15394.0,15 RC,360,"RECONSTRUCTION FOR STABILIZATION OF UNSTABLE DISTAL ULNA OR DISTAL RADIOULNAR JOINT, SECONDARY BY SOFT TISSUE STABILIZATION (EG, TENDON TRANSFER, TENDON GRAFT OR WEAVE, OR TENODESIS) WITH OR WITHOUT O",,,6726.11,15394.0,15 RC,360,"RECONSTRUCTION MEDIAL COLLATERAL LIGAMENT, ELBOW, WITH TENDON GRAFT (INCLUDES HARVESTING OF GRAFT)",,,6649.0,15394.0,15 RC,360,"RECONSTRUCTION MIDFACE, LEFORT I; 2 PIECES, SEGMENT MOVEMENT IN ANY DIRECTION, REQUIRING BONE GRAFTS (INCLUDES OBTAINING AUTOGRAFTS) (EG, UNGRAFTED UNILATERAL ALVEOLAR CLEFT)",,,9974.0,15394.0,3 RC,360,"RECONSTRUCTION MIDFACE, LEFORT I; 2 PIECES, SEGMENT MOVEMENT IN ANY DIRECTION, WITHOUT BONE GRAFT",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION MIDFACE, LEFORT I; 3 OR MORE PIECES, SEGMENT MOVEMENT IN ANY DIRECTION, REQUIRING BONE GRAFTS (INCLUDES OBTAINING AUTOGRAFTS) (EG, UNGRAFTED BILATERAL ALVEOLAR CLEFT OR MULTIPLE OSTEOTO",,,9974.0,15394.0,3 RC,360,"RECONSTRUCTION MIDFACE, LEFORT I; 3 OR MORE PIECES, SEGMENT MOVEMENT IN ANY DIRECTION, WITHOUT BONE GRAFT",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION MIDFACE, LEFORT I; SINGLE PIECE, SEGMENT MOVEMENT IN ANY DIRECTION (EG, FOR LONG FACE SYNDROME), WITHOUT BONE GRAFT",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION MIDFACE, LEFORT I; SINGLE PIECE, SEGMENT MOVEMENT IN ANY DIRECTION, REQUIRING BONE GRAFTS (INCLUDES OBTAINING AUTOGRAFTS)",,,9974.0,15394.0,3 RC,360,"RECONSTRUCTION OF DISLOCATING PATELLA; WITH EXTENSOR REALIGNMENT AND/OR MUSCLE ADVANCEMENT OR RELEASE (EG, CAMPBELL, GOLDWAITE TYPE PROCEDURE)",,,6726.11,15394.0,15 RC,360,"RECONSTRUCTION OF EXTERNAL AUDITORY CANAL (MEATOPLASTY) (EG, FOR STENOSIS DUE TO INJURY, INFECTION) (SEPARATE PROCEDURE)",,,5569.83,15394.0,15 RC,360,"RECONSTRUCTION OF EYELID, FULL THICKNESS BY TRANSFER OF TARSOCONJUNCTIVAL FLAP FROM OPPOSING EYELID; SECOND STAGE",,,2196.57,9324.0,15 RC,360,"RECONSTRUCTION OF EYELID, FULL THICKNESS BY TRANSFER OF TARSOCONJUNCTIVAL FLAP FROM OPPOSING EYELID; TOTAL EYELID, LOWER, 1 STAGE OR FIRST STAGE",,,2196.57,9324.0,15 RC,360,"RECONSTRUCTION OF EYELID, FULL THICKNESS BY TRANSFER OF TARSOCONJUNCTIVAL FLAP FROM OPPOSING EYELID; UP TO TWO-THIRDS OF EYELID, 1 STAGE OR FIRST STAGE",,,2196.57,9324.0,15 RC,360,"RECONSTRUCTION OF MANDIBLE OR MAXILLA, ENDOSTEAL IMPLANT (EG, BLADE, CYLINDER); PARTIAL",,,5569.83,15394.0,15 RC,360,"RECONSTRUCTION OF MANDIBLE OR MAXILLA, SUBPERIOSTEAL IMPLANT; COMPLETE",,,5569.83,15394.0,15 RC,360,"RECONSTRUCTION OF MANDIBLE, EXTRAORAL, WITH TRANSOSTEAL BONE PLATE (EG, MANDIBULAR STAPLE BONE PLATE)",,,5569.83,15394.0,15 RC,360,"RECONSTRUCTION OF MANDIBULAR RAMI AND/OR BODY, SAGITTAL SPLIT; WITH INTERNAL RIGID FIXATION",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION OF MANDIBULAR RAMI AND/OR BODY, SAGITTAL SPLIT; WITHOUT INTERNAL RIGID FIXATION",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION OF MANDIBULAR RAMI, HORIZONTAL, VERTICAL, C, OR L OSTEOTOMY; WITH BONE GRAFT (INCLUDES OBTAINING GRAFT)",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION OF POLYDACTYLOUS DIGIT, SOFT TISSUE AND BONE",,,3012.0,12615.0,15 RC,360,"RECONSTRUCTION OF TENDON PULLEY, EACH TENDON; WITH LOCAL TISSUES (SEPARATE PROCEDURE)",,,3012.0,10561.0,15 RC,360,"RECONSTRUCTION SUPERIOR-LATERAL ORBITAL RIM AND LOWER FOREHEAD, ADVANCEMENT OR ALTERATION, WITH OR WITHOUT GRAFTS (INCLUDES OBTAINING AUTOGRAFTS)",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION, ANGULAR DEFORMITY OF TOE, SOFT TISSUE PROCEDURES ONLY (EG, OVERLAPPING SECOND TOE, FIFTH TOE, CURLY TOES)",,,3054.93,9324.0,15 RC,360,"RECONSTRUCTION, BIFRONTAL, SUPERIOR-LATERAL ORBITAL RIMS AND LOWER FOREHEAD, ADVANCEMENT OR ALTERATION (EG, PLAGIOCEPHALY, TRIGONOCEPHALY, BRACHYCEPHALY), WITH OR WITHOUT GRAFTS (INCLUDES OBTAINING AU",,,5569.83,15394.0,14 RC,360,"RECONSTRUCTION, COLLATERAL LIGAMENT, INTERPHALANGEAL JOINT, SINGLE, INCLUDING GRAFT, EACH JOINT",,,3054.93,13194.0,15 RC,360,"RECONSTRUCTION, COLLATERAL LIGAMENT, METACARPOPHALANGEAL JOINT, SINGLE; WITH TENDON OR FASCIAL GRAFT (INCLUDES OBTAINING GRAFT)",,,3054.93,15291.0,15 RC,360,"RECONSTRUCTION, ENTIRE OR MAJORITY OF FOREHEAD AND/OR SUPRAORBITAL RIMS; WITH GRAFTS (ALLOGRAFT OR PROSTHETIC MATERIAL)",,,9974.0,15394.0,3 RC,360,"RECONSTRUCTION, TOE(S); POLYDACTYLY",,,3054.93,10561.0,15 RC,360,"RECONSTRUCTION, TOE(S); SYNDACTYLY, WITH OR WITHOUT SKIN GRAFT(S), EACH WEB",,,1506.85,10561.0,15 RC,360,"RECONSTRUCTIVE REPAIR OF PECTUS EXCAVATUM OR CARINATUM; MINIMALLY INVASIVE APPROACH (NUSS PROCEDURE), WITH THORACOSCOPY",,,3054.93,15394.0,15 RC,360,RECONSTRUCTIVE REPAIR OF PECTUS EXCAVATUM OR CARINATUM; OPEN,,,10561.0,21454.0,3 RC,360,REDUCTION FOREHEAD; CONTOURING AND SETBACK OF ANTERIOR FRONTAL SINUS WALL,,,5569.83,15394.0,13 RC,360,REDUCTION OF OVERCORRECTION OF PTOSIS,,,2196.57,10561.0,15 RC,360,"REDUCTION OF TORSION OF TESTIS, SURGICAL, WITH OR WITHOUT FIXATION OF CONTRALATERAL TESTIS",,,3247.35,10561.0,15 RC,360,"REINSERTION OF RUPTURED BICEPS OR TRICEPS TENDON, DISTAL, WITH OR WITHOUT TENDON GRAFT",,,6649.0,15394.0,15 RC,360,REINSERTION OF SPINAL FIXATION DEVICE,,,13764.0,30725.0,3 RC,360,RELEASE OF EXTENSIVE SCAR TISSUE WITHOUT DETACHING EXTRAOCULAR MUSCLE (SEPARATE PROCEDURE),,,2196.57,15291.0,15 RC,360,"RELEASE OF THENAR MUSCLE(S) (EG, THUMB CONTRACTURE)",,,3012.0,8413.0,15 RC,360,"RELEASE, INTRINSIC MUSCLES OF HAND, EACH MUSCLE",,,3012.0,8413.0,15 RC,360,"RELEASE, TARSAL TUNNEL (POSTERIOR TIBIAL NERVE DECOMPRESSION)",,,1838.62,10561.0,15 RC,360,RELOCATION OF SKIN POCKET FOR PACEMAKER,,,1722.29,7278.0,15 RC,360,"REMOVAL (VIA SNARE/CAPTURE) OF INTERNALLY DWELLING URETERAL STENT VIA TRANSURETHRAL APPROACH, WITHOUT USE OF CYSTOSCOPY, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION",,,1928.76,9324.0,15 RC,360,"REMOVAL AND REPLACEMENT OF ALL COMPONENT(S) OF A MULTI-COMPONENT, INFLATABLE PENILE PROSTHESIS AT THE SAME OPERATIVE SESSION",,,6649.0,30351.0,15 RC,360,"REMOVAL AND REPLACEMENT OF EXTERNALLY ACCESSIBLE NEPHROURETERAL CATHETER (EG, EXTERNAL/INTERNAL STENT) REQUIRING FLUOROSCOPIC GUIDANCE, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION",,,1928.76,5449.0,15 RC,360,"REMOVAL AND REPLACEMENT OF INFLATABLE URETHRAL/BLADDER NECK SPHINCTER INCLUDING PUMP, RESERVOIR, AND CUFF AT THE SAME OPERATIVE SESSION",,,4121.0,30351.0,15 RC,360,REMOVAL AND REPLACEMENT OF NON-INFLATABLE (SEMI-RIGID) OR INFLATABLE (SELF-CONTAINED) PENILE PROSTHESIS AT THE SAME OPERATIVE SESSION,,,6649.0,30351.0,15 RC,360,"REMOVAL BY CONTOURING OF BENIGN TUMOR OF FACIAL BONE (EG, FIBROUS DYSPLASIA)",,,3053.48,9324.0,15 RC,360,"REMOVAL FOREIGN BODY FROM DEEP PENILE TISSUE (EG, PLASTIC IMPLANT)",,,2694.74,9324.0,15 RC,360,REMOVAL FOREIGN BODY FROM EXTERNAL AUDITORY CANAL; WITH GENERAL ANESTHESIA,,,1525.52,5449.0,15 RC,360,REMOVAL FOREIGN BODY FROM EXTERNAL AUDITORY CANAL; WITHOUT GENERAL ANESTHESIA,,,121.37,1251.0,13 RC,360,"REMOVAL FOREIGN BODY, INTRANASAL; REQUIRING GENERAL ANESTHESIA",,,3012.0,5449.0,15 RC,360,"REMOVAL IMPACTED CERUMEN REQUIRING INSTRUMENTATION, UNILATERAL",,,55.93,5449.0,14 RC,360,"REMOVAL IMPACTED CERUMEN USING IRRIGATION/LAVAGE, UNILATERAL",,,55.93,5449.0,14 RC,360,"REMOVAL OF ALL COMPONENTS OF A MULTI-COMPONENT, INFLATABLE PENILE PROSTHESIS WITHOUT REPLACEMENT OF PROSTHESIS",,,3247.35,13194.0,15 RC,360,"REMOVAL OF ANAL SETON, OTHER MARKER",,,1110.16,5449.0,15 RC,360,REMOVAL OF ANTERIOR INSTRUMENTATION,,,13764.0,21454.0,3 RC,360,"REMOVAL OF BLOOD CLOT, ANTERIOR SEGMENT OF EYE",,,2147.4,12615.0,15 RC,360,REMOVAL OF BONE FLAP OR PROSTHETIC PLATE OF SKULL,,,2533.0,4850.0,2 RC,360,REMOVAL OF CERCLAGE SUTURE UNDER ANESTHESIA (OTHER THAN LOCAL),,,2993.65,13194.0,15 RC,360,REMOVAL OF COMPLETE CEREBROSPINAL FLUID SHUNT SYSTEM; WITH REPLACEMENT BY SIMILAR OR OTHER SHUNT AT SAME OPERATION,,,2533.0,4850.0,2 RC,360,REMOVAL OF COMPLETE CEREBROSPINAL FLUID SHUNT SYSTEM; WITHOUT REPLACEMENT,,,3012.0,7278.0,3 RC,360,"REMOVAL OF CORNEAL EPITHELIUM; WITH APPLICATION OF CHELATING AGENT (EG, EDTA)",,,2196.57,9324.0,14 RC,360,"REMOVAL OF CORNEAL EPITHELIUM; WITH OR WITHOUT CHEMOCAUTERIZATION (ABRASION, CURETTAGE)",,,911.92,5449.0,15 RC,360,"REMOVAL OF CRANIAL NERVE (EG, VAGUS NERVE) NEUROSTIMULATOR ELECTRODE ARRAY AND PULSE GENERATOR",,,5449.0,21454.0,15 RC,360,REMOVAL OF EMBEDDED FOREIGN BODY FROM DENTOALVEOLAR STRUCTURES; SOFT TISSUES,,,1394.69,5449.0,15 RC,360,REMOVAL OF FECAL IMPACTION OR FOREIGN BODY (SEPARATE PROCEDURE) UNDER ANESTHESIA,,,1110.16,5449.0,15 RC,360,REMOVAL OF FOREIGN BODY IN MUSCLE OR TENDON SHEATH; DEEP OR COMPLICATED,,,2694.74,9324.0,15 RC,360,REMOVAL OF FOREIGN BODY IN SCROTUM,,,1928.76,9324.0,15 RC,360,"REMOVAL OF FOREIGN BODY OR DACRYOLITH, LACRIMAL PASSAGES",,,281.46,5449.0,14 RC,360,"REMOVAL OF FOREIGN BODY, DEEP, THIGH REGION OR KNEE AREA",,,2694.74,15291.0,15 RC,360,"REMOVAL OF FOREIGN BODY, EXTERNAL EYE; CONJUNCTIVAL EMBEDDED (INCLUDES CONCRETIONS), SUBCONJUNCTIVAL, OR SCLERAL NONPERFORATING",,,375.71,1251.0,13 RC,360,"REMOVAL OF FOREIGN BODY, FOOT; SUBCUTANEOUS",,,662.46,7278.0,15 RC,360,"REMOVAL OF FOREIGN BODY, INTRAOCULAR; FROM POSTERIOR SEGMENT, MAGNETIC EXTRACTION, ANTERIOR OR POSTERIOR ROUTE",,,777.0,8413.0,15 RC,360,"REMOVAL OF FOREIGN BODY, INTRAOCULAR; FROM POSTERIOR SEGMENT, NONMAGNETIC EXTRACTION",,,2147.4,10561.0,15 RC,360,"REMOVAL OF HYPOGLOSSAL NERVE NEUROSTIMULATOR ARRAY, PULSE GENERATOR, AND DISTAL RESPIRATORY SENSOR ELECTRODE OR ELECTRODE ARRAY",,,5449.0,21454.0,14 RC,360,REMOVAL OF IMPACTED VAGINAL FOREIGN BODY (SEPARATE PROCEDURE) UNDER ANESTHESIA (OTHER THAN LOCAL),,,2993.65,9324.0,15 RC,360,REMOVAL OF IMPLANT FROM FINGER OR HAND,,,1525.52,7278.0,15 RC,360,"REMOVAL OF IMPLANT; DEEP (EG, BURIED WIRE, PIN, SCREW, METAL BAND, NAIL, ROD OR PLATE)",,,2694.74,9324.0,15 RC,360,"REMOVAL OF IMPLANT; SUPERFICIAL (EG, BURIED WIRE, PIN OR ROD) (SEPARATE PROCEDURE)",,,1525.52,5449.0,15 RC,360,REMOVAL OF IMPLANTABLE DEFIBRILLATOR PULSE GENERATOR ONLY,,,3426.54,13194.0,14 RC,360,REMOVAL OF IMPLANTED INTRA-ARTERIAL INFUSION PUMP,,,3426.54,13194.0,15 RC,360,"REMOVAL OF IMPLANTED MATERIAL, ANTERIOR SEGMENT OF EYE",,,2147.4,15291.0,15 RC,360,"REMOVAL OF IMPLANTED MATERIAL, POSTERIOR SEGMENT; EXTRAOCULAR",,,2147.4,9324.0,15 RC,360,"REMOVAL OF IMPLANTED MATERIAL, POSTERIOR SEGMENT; INTRAOCULAR",,,2147.4,13194.0,15 RC,360,REMOVAL OF INDWELLING TUNNELED PLEURAL CATHETER WITH CUFF,,,582.12,5449.0,14 RC,360,"REMOVAL OF INFLATABLE URETHRAL/BLADDER NECK SPHINCTER, INCLUDING PUMP, RESERVOIR, AND CUFF",,,4121.0,21454.0,15 RC,360,REMOVAL OF INTACT BREAST IMPLANT,,,3605.42,13194.0,15 RC,360,REMOVAL OF INTRAUTERINE DEVICE (IUD),,,286.41,5449.0,15 RC,360,"REMOVAL OF LENS MATERIAL; ASPIRATION TECHNIQUE, 1 OR MORE STAGES",,,2147.4,10561.0,15 RC,360,REMOVAL OF LENS MATERIAL; INTRACAPSULAR,,,2147.4,10561.0,15 RC,360,"REMOVAL OF LENS MATERIAL; INTRACAPSULAR, FOR DISLOCATED LENS",,,3787.69,12615.0,15 RC,360,"REMOVAL OF LENS MATERIAL; PARS PLANA APPROACH, WITH OR WITHOUT VITRECTOMY",,,3787.69,15394.0,15 RC,360,"REMOVAL OF LENS MATERIAL; PHACOFRAGMENTATION TECHNIQUE (MECHANICAL OR ULTRASONIC) (EG, PHACOEMULSIFICATION), WITH ASPIRATION",,,2147.4,15291.0,15 RC,360,"REMOVAL OF LUNG, OTHER THAN PNEUMONECTOMY; SINGLE LOBE (LOBECTOMY)",,,2533.0,4850.0,2 RC,360,"REMOVAL OF NEPHROSTOMY TUBE, REQUIRING FLUOROSCOPIC GUIDANCE (EG, WITH CONCURRENT INDWELLING URETERAL STENT)",,,628.45,5449.0,15 RC,360,"REMOVAL OF NON-INFLATABLE (SEMI-RIGID) OR INFLATABLE (SELF-CONTAINED) PENILE PROSTHESIS, WITHOUT REPLACEMENT OF PROSTHESIS",,,3247.35,13194.0,15 RC,360,REMOVAL OF OCULAR IMPLANT,,,3550.55,13194.0,15 RC,360,REMOVAL OF PERMANENT PACEMAKER PULSE GENERATOR ONLY,,,5152.0,13194.0,15 RC,360,REMOVAL OF PERMANENT PACEMAKER PULSE GENERATOR WITH REPLACEMENT OF PACEMAKER PULSE GENERATOR; DUAL LEAD SYSTEM,,,8413.0,30725.0,14 RC,360,"REMOVAL OF POSTERIOR NONSEGMENTAL INSTRUMENTATION (EG, HARRINGTON ROD)",,,13764.0,21454.0,3 RC,360,REMOVAL OF POSTERIOR SEGMENTAL INSTRUMENTATION,,,13764.0,21454.0,3 RC,360,REMOVAL OF PREVIOUSLY IMPLANTED INTRATHECAL OR EPIDURAL CATHETER,,,1838.62,9324.0,15 RC,360,"REMOVAL OF PROSTHETIC MATERIAL OR MESH, ABDOMINAL WALL FOR INFECTION (EG, FOR CHRONIC OR RECURRENT MESH INFECTION OR NECROTIZING SOFT TISSUE INFECTION) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY",,,7444.0,13194.0,2 RC,360,"REMOVAL OF RUPTURED BREAST IMPLANT, INCLUDING IMPLANT CONTENTS (EG, SALINE, SILICONE GEL)",,,3605.42,13194.0,15 RC,360,"REMOVAL OF SECONDARY MEMBRANOUS CATARACT (OPACIFIED POSTERIOR LENS CAPSULE AND/OR ANTERIOR HYALOID) WITH CORNEO-SCLERAL SECTION, WITH OR WITHOUT IRIDECTOMY (IRIDOCAPSULOTOMY, IRIDOCAPSULECTOMY)",,,2147.4,10561.0,15 RC,360,REMOVAL OF SINGLE OR DUAL CHAMBER IMPLANTABLE DEFIBRILLATOR ELECTRODE(S); BY TRANSVENOUS EXTRACTION,,,3426.54,13194.0,14 RC,360,"REMOVAL OF SKIN TAGS, MULTIPLE FIBROCUTANEOUS TAGS, ANY AREA; UP TO AND INCLUDING 15 LESIONS",,,187.08,5449.0,14 RC,360,"REMOVAL OF SPINAL NEUROSTIMULATOR ELECTRODE PERCUTANEOUS ARRAY(S), INCLUDING FLUOROSCOPY, WHEN PERFORMED",,,1838.62,12408.0,15 RC,360,"REMOVAL OF SPINAL NEUROSTIMULATOR ELECTRODE PLATE/PADDLE(S) PLACED VIA LAMINOTOMY OR LAMINECTOMY, INCLUDING FLUOROSCOPY, WHEN PERFORMED",,,3237.97,13194.0,15 RC,360,REMOVAL OF SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR ELECTRODE,,,3426.54,13194.0,14 RC,360,"REMOVAL OF SUBCUTANEOUS RESERVOIR OR PUMP, PREVIOUSLY IMPLANTED FOR INTRATHECAL OR EPIDURAL INFUSION",,,5152.0,21454.0,15 RC,360,"REMOVAL OF SUTURES OR STAPLES REQUIRING ANESTHESIA (IE, GENERAL ANESTHESIA, MODERATE SEDATION)",,,1722.29,5449.0,15 RC,360,"REMOVAL OF SYNTHETIC ROD AND INSERTION OF FLEXOR TENDON GRAFT, HAND OR FINGER (INCLUDES OBTAINING GRAFT), EACH ROD",,,6649.0,13194.0,15 RC,360,REMOVAL OF TISSUE EXPANDER WITHOUT INSERTION OF IMPLANT,,,2694.74,9324.0,15 RC,360,"REMOVAL OF TOTAL OR NEAR TOTAL NON-INFECTED MESH OR OTHER PROSTHESIS AT THE TIME OF INITIAL OR RECURRENT ANTERIOR ABDOMINAL HERNIA REPAIR OR PARASTOMAL HERNIA REPAIR, ANY APPROACH (IE, OPEN, LAPAROSCO",,,777.0,5449.0,3 RC,360,REMOVAL OF TRANSVENOUS PACEMAKER ELECTRODE(S); DUAL LEAD SYSTEM,,,3426.54,13194.0,14 RC,360,"REMOVAL OF TRANSVENOUS PACEMAKER ELECTRODE(S); SINGLE LEAD SYSTEM, ATRIAL OR VENTRICULAR",,,3426.54,13194.0,14 RC,360,"REMOVAL OF TUMOR, TEMPORAL BONE",,,5569.83,15394.0,14 RC,360,"REMOVAL OF TUNNELED CENTRAL VENOUS ACCESS DEVICE, WITH SUBCUTANEOUS PORT OR PUMP, CENTRAL OR PERIPHERAL INSERTION",,,1462.62,5449.0,15 RC,360,"REMOVAL OF TUNNELED CENTRAL VENOUS CATHETER, WITHOUT SUBCUTANEOUS PORT OR PUMP",,,582.12,5449.0,15 RC,360,REMOVAL OF TUNNELED INTRAPERITONEAL CATHETER,,,2963.5,13194.0,15 RC,360,"REMOVAL OF VITREOUS, ANTERIOR APPROACH (OPEN SKY TECHNIQUE OR LIMBAL INCISION); PARTIAL REMOVAL",,,2147.4,10561.0,15 RC,360,"REMOVAL OF VITREOUS, ANTERIOR APPROACH (OPEN SKY TECHNIQUE OR LIMBAL INCISION); SUBTOTAL REMOVAL WITH MECHANICAL VITRECTOMY",,,2147.4,10561.0,15 RC,360,"REMOVAL OR REVISION OF SLING FOR STRESS INCONTINENCE (EG, FASCIA OR SYNTHETIC)",,,2993.65,13194.0,14 RC,360,"REMOVAL WITH REINSERTION, NON-BIODEGRADABLE DRUG DELIVERY IMPLANT",,,375.71,5449.0,14 RC,360,"REMOVAL, ENTIRE OSSEOINTEGRATED IMPLANT, SKULL; WITH MAGNETIC TRANSCUTANEOUS ATTACHMENT TO EXTERNAL SPEECH PROCESSOR, OUTSIDE THE MASTOID AND INVOLVING A BONY DEFECT GREATER THAN OR EQUAL TO 100 SQ MM",,,3054.93,13194.0,14 RC,360,"REMOVAL, ENTIRE OSSEOINTEGRATED IMPLANT, SKULL; WITH MAGNETIC TRANSCUTANEOUS ATTACHMENT TO EXTERNAL SPEECH PROCESSOR, WITHIN THE MASTOID AND/OR INVOLVING A BONY DEFECT LESS THAN 100 SQ MM SURFACE AREA",,,3054.93,13194.0,15 RC,360,"REMOVAL, IMPLANTABLE CONTRACEPTIVE CAPSULES",,,662.46,5449.0,15 RC,360,"REMOVAL, NON-BIODEGRADABLE DRUG DELIVERY IMPLANT",,,375.71,5449.0,14 RC,360,"REMOVAL, UNDER ANESTHESIA, OF EXTERNAL FIXATION SYSTEM",,,1506.85,5449.0,15 RC,360,"RENAL BIOPSY; PERCUTANEOUS, BY TROCAR OR NEEDLE",,,1525.52,5449.0,15 RC,360,"RENAL ENDOSCOPY THROUGH NEPHROTOMY OR PYELOTOMY, WITH OR WITHOUT IRRIGATION, INSTILLATION, OR URETEROPYELOGRAPHY, EXCLUSIVE OF RADIOLOGIC SERVICE; WITH ENDOPYELOTOMY (INCLUDES CYSTOSCOPY, URETEROSCOPY",,,4786.44,15394.0,13 RC,360,REOPENING OF RECENT LAPAROTOMY,,,2533.0,4850.0,2 RC,360,"REPAIR AND RECONSTRUCTION, FINGER, VOLAR PLATE, INTERPHALANGEAL JOINT",,,3054.93,13194.0,15 RC,360,REPAIR BLOOD VESSEL WITH GRAFT OTHER THAN VEIN; UPPER EXTREMITY,,,5089.69,21454.0,14 RC,360,REPAIR BLOOD VESSEL WITH VEIN GRAFT; UPPER EXTREMITY,,,5089.69,21454.0,14 RC,360,"REPAIR BLOOD VESSEL, DIRECT; LOWER EXTREMITY",,,662.46,10561.0,14 RC,360,"REPAIR BLOOD VESSEL, DIRECT; UPPER EXTREMITY",,,2963.5,13194.0,14 RC,360,REPAIR CHOANAL ATRESIA; INTRANASAL,,,5569.83,15394.0,15 RC,360,REPAIR CLEFT HAND,,,3012.0,12615.0,15 RC,360,REPAIR FISTULA; OROMAXILLARY (COMBINE WITH 31030 IF ANTROTOMY IS INCLUDED),,,5569.83,15394.0,15 RC,360,REPAIR FISTULA; ORONASAL,,,5569.83,15394.0,15 RC,360,REPAIR INCOMPLETE CIRCUMCISION,,,1928.76,9324.0,15 RC,360,"REPAIR INGUINAL HERNIA, SLIDING, ANY AGE",,,3322.75,13194.0,15 RC,360,"REPAIR INITIAL FEMORAL HERNIA, ANY AGE; REDUCIBLE",,,3322.75,13194.0,15 RC,360,"REPAIR INITIAL INGUINAL HERNIA, AGE 5 YEARS OR OLDER; INCARCERATED OR STRANGULATED",,,3322.75,17457.0,15 RC,360,"REPAIR INITIAL INGUINAL HERNIA, AGE 5 YEARS OR OLDER; REDUCIBLE",,,3322.75,13194.0,15 RC,360,"REPAIR INITIAL INGUINAL HERNIA, AGE 6 MONTHS TO YOUNGER THAN 5 YEARS, WITH OR WITHOUT HYDROCELECTOMY; INCARCERATED OR STRANGULATED",,,3322.75,17457.0,15 RC,360,"REPAIR INITIAL INGUINAL HERNIA, AGE 6 MONTHS TO YOUNGER THAN 5 YEARS, WITH OR WITHOUT HYDROCELECTOMY; REDUCIBLE",,,5874.98,13194.0,15 RC,360,"REPAIR LATERAL COLLATERAL LIGAMENT, ELBOW, WITH LOCAL TISSUE",,,3054.93,13194.0,15 RC,360,"REPAIR LIP, FULL THICKNESS; OVER ONE-HALF VERTICAL HEIGHT, OR COMPLEX",,,1394.69,8413.0,15 RC,360,"REPAIR LIP, FULL THICKNESS; UP TO HALF VERTICAL HEIGHT",,,479.48,8413.0,15 RC,360,REPAIR LUMBAR HERNIA,,,5152.0,13194.0,15 RC,360,"REPAIR MACRODACTYLIA, EACH DIGIT",,,1506.85,12615.0,15 RC,360,"REPAIR MEDIAL COLLATERAL LIGAMENT, ELBOW, WITH LOCAL TISSUE",,,5152.0,13194.0,15 RC,360,REPAIR NASAL SEPTAL PERFORATIONS,,,3053.48,15291.0,15 RC,360,"REPAIR NON-UNION, METACARPAL OR PHALANX (INCLUDES OBTAINING BONE GRAFT WITH OR WITHOUT EXTERNAL OR INTERNAL FIXATION)",,,6726.11,13194.0,15 RC,360,"REPAIR OF ANTERIOR ABDOMINAL HERNIA(S) (IE, EPIGASTRIC, INCISIONAL, VENTRAL, UMBILICAL, SPIGELIAN), ANY APPROACH (IE, OPEN, LAPAROSCOPIC, ROBOTIC), INITIAL, INCLUDING IMPLANTATION OF MESH OR OTHER PRO",,,3322.75,21454.0,73 RC,360,"REPAIR OF ANTERIOR ABDOMINAL HERNIA(S) (IE, EPIGASTRIC, INCISIONAL, VENTRAL, UMBILICAL, SPIGELIAN), ANY APPROACH (IE, OPEN, LAPAROSCOPIC, ROBOTIC), RECURRENT, INCLUDING IMPLANTATION OF MESH OR OTHER P",,,3322.75,21454.0,51 RC,360,"REPAIR OF ANTERIOR PALATE, INCLUDING VOMER FLAP",,,5569.83,15394.0,15 RC,360,"REPAIR OF BLEPHAROPTOSIS; (TARSO) LEVATOR RESECTION OR ADVANCEMENT, EXTERNAL APPROACH",,,2196.57,10561.0,15 RC,360,"REPAIR OF BLEPHAROPTOSIS; CONJUNCTIVO-TARSO-MULLER'S MUSCLE-LEVATOR RESECTION (EG, FASANELLA-SERVAT TYPE)",,,2196.57,10561.0,15 RC,360,REPAIR OF BLEPHAROPTOSIS; FRONTALIS MUSCLE TECHNIQUE WITH AUTOLOGOUS FASCIAL SLING (INCLUDES OBTAINING FASCIA),,,3550.55,13194.0,15 RC,360,"REPAIR OF BLEPHAROPTOSIS; FRONTALIS MUSCLE TECHNIQUE WITH SUTURE OR OTHER MATERIAL (EG, BANKED FASCIA)",,,2196.57,12615.0,15 RC,360,"REPAIR OF BROW PTOSIS (SUPRACILIARY, MID-FOREHEAD OR CORONAL APPROACH)",,,2196.57,10561.0,15 RC,360,"REPAIR OF COLLATERAL LIGAMENT, METACARPOPHALANGEAL OR INTERPHALANGEAL JOINT",,,3012.0,10561.0,15 RC,360,"REPAIR OF COMPLEX RETINAL DETACHMENT (EG, PROLIFERATIVE VITREORETINOPATHY, STAGE C-1 OR GREATER, DIABETIC TRACTION RETINAL DETACHMENT, RETINOPATHY OF PREMATURITY, RETINAL TEAR OF GREATER THAN 90 DEGRE",,,4858.07,17457.0,15 RC,360,"REPAIR OF COMPONENT(S) OF A MULTI-COMPONENT, INFLATABLE PENILE PROSTHESIS",,,4786.44,15394.0,15 RC,360,REPAIR OF ECTROPION; EXCISION TARSAL WEDGE,,,2196.57,10561.0,15 RC,360,"REPAIR OF ECTROPION; EXTENSIVE (EG, TARSAL STRIP OPERATIONS)",,,2196.57,10561.0,15 RC,360,"REPAIR OF ENCEPHALOCELE, SKULL VAULT, INCLUDING CRANIOPLASTY",,,2533.0,4850.0,2 RC,360,"REPAIR OF ENTEROCELE, VAGINAL APPROACH (SEPARATE PROCEDURE)",,,4647.86,9324.0,15 RC,360,"REPAIR OF ENTROPION; EXTENSIVE (EG, TARSAL STRIP OR CAPSULOPALPEBRAL FASCIA REPAIRS OPERATION)",,,2196.57,10561.0,15 RC,360,REPAIR OF ENTROPION; SUTURE,,,2196.57,9324.0,15 RC,360,"REPAIR OF EXTENSOR TENDON, CENTRAL SLIP, SECONDARY (EG, BOUTONNIERE DEFORMITY); USING LOCAL TISSUE(S), INCLUDING LATERAL BAND(S), EACH FINGER",,,3054.93,13194.0,15 RC,360,"REPAIR OF EXTENSOR TENDON, CENTRAL SLIP, SECONDARY (EG, BOUTONNIERE DEFORMITY); WITH FREE GRAFT (INCLUDES OBTAINING GRAFT), EACH FINGER",,,3054.93,13194.0,15 RC,360,"REPAIR OF EXTENSOR TENDON, DISTAL INSERTION, PRIMARY OR SECONDARY; WITHOUT GRAFT (EG, MALLET FINGER)",,,3012.0,8413.0,15 RC,360,REPAIR OF FIBULA NONUNION AND/OR MALUNION WITH INTERNAL FIXATION,,,6726.11,21454.0,15 RC,360,"REPAIR OF HYPOSPADIAS COMPLICATION(S) (IE, FISTULA, STRICTURE, DIVERTICULA); BY CLOSURE, INCISION, OR EXCISION, SIMPLE",,,3247.35,13194.0,15 RC,360,"REPAIR OF HYPOSPADIAS COMPLICATION(S) (IE, FISTULA, STRICTURE, DIVERTICULA); REQUIRING EXTENSIVE DISSECTION, AND URETHROPLASTY WITH FLAP, PATCH OR TUBED GRAFT (INCLUDING URINARY DIVERSION, WHEN PERFOR",,,4786.44,13194.0,15 RC,360,"REPAIR OF HYPOSPADIAS COMPLICATION(S) (IE, FISTULA, STRICTURE, DIVERTICULA); REQUIRING MOBILIZATION OF SKIN FLAPS AND URETHROPLASTY WITH FLAP OR PATCH GRAFT",,,6649.0,13194.0,15 RC,360,"REPAIR OF LACERATION; APPLICATION OF TISSUE GLUE, WOUNDS OF CORNEA AND/OR SCLERA",,,2147.4,7278.0,15 RC,360,"REPAIR OF LACERATION; CONJUNCTIVA, WITH OR WITHOUT NONPERFORATING LACERATION SCLERA, DIRECT CLOSURE",,,2196.57,9324.0,15 RC,360,"REPAIR OF LACERATION; CORNEA AND/OR SCLERA, PERFORATING, NOT INVOLVING UVEAL TISSUE",,,4858.07,10561.0,15 RC,360,"REPAIR OF LACERATION; CORNEA AND/OR SCLERA, PERFORATING, WITH REPOSITION OR RESECTION OF UVEAL TISSUE",,,4858.07,10561.0,15 RC,360,REPAIR OF LARGE OMPHALOCELE OR GASTROSCHISIS; WITH OR WITHOUT PROSTHESIS,,,2533.0,10561.0,3 RC,360,REPAIR OF MENINGOCELE; LESS THAN 5 CM DIAMETER,,,2533.0,4850.0,2 RC,360,REPAIR OF NAIL BED,,,576.34,5449.0,14 RC,360,"REPAIR OF NASAL VALVE COLLAPSE WITH LOW ENERGY, TEMPERATURE-CONTROLLED (IE, RADIOFREQUENCY) SUBCUTANEOUS/SUBMUCOSAL REMODELING",,,5569.83,15394.0,14 RC,360,REPAIR OF NASAL VALVE COLLAPSE WITH SUBCUTANEOUS/SUBMUCOSAL LATERAL WALL IMPLANT(S),,,5569.83,17457.0,15 RC,360,"REPAIR OF NASAL VESTIBULAR STENOSIS (EG, SPREADER GRAFTING, LATERAL NASAL WALL RECONSTRUCTION)",,,5569.83,17457.0,15 RC,360,"REPAIR OF NONUNION OR MALUNION, HUMERUS; WITH ILIAC OR OTHER AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,8213.0,21454.0,15 RC,360,"REPAIR OF NONUNION OR MALUNION, HUMERUS; WITHOUT GRAFT (EG, COMPRESSION TECHNIQUE)",,,6649.0,21454.0,15 RC,360,"REPAIR OF NONUNION OR MALUNION, RADIUS AND ULNA; WITH AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,6726.11,21454.0,15 RC,360,"REPAIR OF NONUNION OR MALUNION, RADIUS AND ULNA; WITHOUT GRAFT (EG, COMPRESSION TECHNIQUE)",,,6649.0,21454.0,15 RC,360,"REPAIR OF NONUNION OR MALUNION, RADIUS OR ULNA; WITH AUTOGRAFT (INCLUDES OBTAINING GRAFT)",,,6726.11,21454.0,15 RC,360,"REPAIR OF NONUNION OR MALUNION, RADIUS OR ULNA; WITHOUT GRAFT (EG, COMPRESSION TECHNIQUE)",,,6649.0,15394.0,15 RC,360,"REPAIR OF NONUNION OR MALUNION, TIBIA; WITHOUT GRAFT, (EG, COMPRESSION TECHNIQUE)",,,6726.11,21454.0,15 RC,360,"REPAIR OF NONUNION, SCAPHOID CARPAL (NAVICULAR) BONE, WITH OR WITHOUT RADIAL STYLOIDECTOMY (INCLUDES OBTAINING GRAFT AND NECESSARY FIXATION)",,,6726.11,15394.0,15 RC,360,"REPAIR OF RETINAL DETACHMENT, INCLUDING DRAINAGE OF SUBRETINAL FLUID WHEN PERFORMED; PHOTOCOAGULATION",,,516.52,12615.0,15 RC,360,"REPAIR OF RETINAL DETACHMENT; SCLERAL BUCKLING (SUCH AS LAMELLAR SCLERAL DISSECTION, IMBRICATION OR ENCIRCLING PROCEDURE), INCLUDING, WHEN PERFORMED, IMPLANT, CRYOTHERAPY, PHOTOCOAGULATION, AND DRAINA",,,3787.69,15394.0,15 RC,360,"REPAIR OF RETINAL DETACHMENT; WITH VITRECTOMY, ANY METHOD, INCLUDING, WHEN PERFORMED, AIR OR GAS TAMPONADE, FOCAL ENDOLASER PHOTOCOAGULATION, CRYOTHERAPY, DRAINAGE OF SUBRETINAL FLUID, SCLERAL BUCKLIN",,,3787.69,15394.0,15 RC,360,"REPAIR OF RUPTURED MUSCULOTENDINOUS CUFF (EG, ROTATOR CUFF) OPEN; ACUTE",,,6726.11,15394.0,15 RC,360,"REPAIR OF SYMBLEPHARON; CONJUNCTIVOPLASTY, WITHOUT GRAFT",,,2147.4,10561.0,15 RC,360,"REPAIR OF SYMBLEPHARON; DIVISION OF SYMBLEPHARON, WITH OR WITHOUT INSERTION OF CONFORMER OR CONTACT LENS",,,2196.57,10561.0,15 RC,360,REPAIR OF SYMBLEPHARON; WITH FREE GRAFT CONJUNCTIVA OR BUCCAL MUCOUS MEMBRANE (INCLUDES OBTAINING GRAFT),,,3550.55,13194.0,15 RC,360,"REPAIR OF SYNDACTYLY (WEB FINGER) EACH WEB SPACE; COMPLEX (EG, INVOLVING BONE, NAILS)",,,3054.93,13194.0,15 RC,360,REPAIR OF SYNDACTYLY (WEB FINGER) EACH WEB SPACE; WITH SKIN FLAPS,,,1506.85,7278.0,15 RC,360,REPAIR OF SYNDACTYLY (WEB FINGER) EACH WEB SPACE; WITH SKIN FLAPS AND GRAFTS,,,3054.93,13194.0,15 RC,360,REPAIR OF TUNICA VAGINALIS HYDROCELE (BOTTLE TYPE),,,3247.35,10561.0,15 RC,360,"REPAIR OR ADVANCEMENT OF PROFUNDUS TENDON, WITH INTACT SUPERFICIALIS TENDON; PRIMARY, EACH TENDON",,,3054.93,13194.0,15 RC,360,"REPAIR OR ADVANCEMENT, FLEXOR TENDON, IN ZONE 2 DIGITAL FLEXOR TENDON SHEATH (EG, NO MAN'S LAND); PRIMARY, WITHOUT FREE GRAFT, EACH TENDON",,,3054.93,13194.0,15 RC,360,"REPAIR OR ADVANCEMENT, FLEXOR TENDON, IN ZONE 2 DIGITAL FLEXOR TENDON SHEATH (EG, NO MAN'S LAND); SECONDARY, WITHOUT FREE GRAFT, EACH TENDON",,,3054.93,13194.0,15 RC,360,"REPAIR OR ADVANCEMENT, FLEXOR TENDON, NOT IN ZONE 2 DIGITAL FLEXOR TENDON SHEATH (EG, NO MAN'S LAND); PRIMARY OR SECONDARY WITHOUT FREE GRAFT, EACH TENDON",,,3054.93,13194.0,15 RC,360,"REPAIR OR ADVANCEMENT, FLEXOR TENDON, NOT IN ZONE 2 DIGITAL FLEXOR TENDON SHEATH (EG, NO MAN'S LAND); SECONDARY WITH FREE GRAFT (INCLUDES OBTAINING GRAFT), EACH TENDON",,,6726.11,13194.0,15 RC,360,REPAIR OVAL WINDOW FISTULA,,,3053.48,10561.0,15 RC,360,"REPAIR RECURRENT INGUINAL HERNIA, ANY AGE; INCARCERATED OR STRANGULATED",,,5874.98,17457.0,15 RC,360,"REPAIR RECURRENT INGUINAL HERNIA, ANY AGE; REDUCIBLE",,,3322.75,13194.0,15 RC,360,REPAIR ROUND WINDOW FISTULA,,,3053.48,10561.0,15 RC,360,"REPAIR, COMPLEX, EYELIDS, NOSE, EARS AND/OR LIPS; 1.1 CM TO 2.5 CM",,,576.34,8413.0,15 RC,360,"REPAIR, COMPLEX, EYELIDS, NOSE, EARS AND/OR LIPS; 2.6 CM TO 7.5 CM",,,576.34,8413.0,15 RC,360,"REPAIR, COMPLEX, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS AND/OR FEET; 1.1 CM TO 2.5 CM",,,376.18,7278.0,15 RC,360,"REPAIR, COMPLEX, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS AND/OR FEET; 2.6 CM TO 7.5 CM",,,576.34,8413.0,15 RC,360,"REPAIR, COMPLEX, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS AND/OR FEET; EACH ADDITIONAL 5 CM OR LESS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"REPAIR, COMPLEX, SCALP, ARMS, AND/OR LEGS; 1.1 CM TO 2.5 CM",,,576.34,7278.0,15 RC,360,"REPAIR, COMPLEX, SCALP, ARMS, AND/OR LEGS; 2.6 CM TO 7.5 CM",,,576.34,8413.0,15 RC,360,"REPAIR, COMPLEX, SCALP, ARMS, AND/OR LEGS; EACH ADDITIONAL 5 CM OR LESS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"REPAIR, COMPLEX, TRUNK; 1.1 CM TO 2.5 CM",,,576.34,7278.0,15 RC,360,"REPAIR, COMPLEX, TRUNK; 2.6 CM TO 7.5 CM",,,576.34,8413.0,15 RC,360,"REPAIR, COMPLEX, TRUNK; EACH ADDITIONAL 5 CM OR LESS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"REPAIR, CONGENITAL MALFORMATION OF FETUS, PROCEDURE PERFORMED IN UTERO, NOT OTHERWISE CLASSIFIED",,,,,0 RC,360,"REPAIR, DISLOCATING PERONEAL TENDONS; WITH FIBULAR OSTEOTOMY",,,6649.0,13194.0,15 RC,360,"REPAIR, DISLOCATING PERONEAL TENDONS; WITHOUT FIBULAR OSTEOTOMY",,,3054.93,9324.0,15 RC,360,"REPAIR, EXTENSOR TENDON, FINGER, PRIMARY OR SECONDARY; WITH FREE GRAFT (INCLUDES OBTAINING GRAFT) EACH TENDON",,,3054.93,13194.0,15 RC,360,"REPAIR, EXTENSOR TENDON, FINGER, PRIMARY OR SECONDARY; WITHOUT FREE GRAFT, EACH TENDON",,,1506.85,10561.0,15 RC,360,"REPAIR, EXTENSOR TENDON, HAND, PRIMARY OR SECONDARY; WITH FREE GRAFT (INCLUDES OBTAINING GRAFT), EACH TENDON",,,3054.93,13194.0,15 RC,360,"REPAIR, EXTENSOR TENDON, HAND, PRIMARY OR SECONDARY; WITHOUT FREE GRAFT, EACH TENDON",,,1506.85,8413.0,15 RC,360,"REPAIR, EXTENSOR TENDON, LEG; PRIMARY, WITHOUT GRAFT, EACH TENDON",,,5152.0,13194.0,15 RC,360,"REPAIR, FASCIAL DEFECT OF LEG",,,3054.93,9324.0,15 RC,360,"REPAIR, FLEXOR TENDON, LEG; PRIMARY, WITHOUT GRAFT, EACH TENDON",,,3054.93,9324.0,15 RC,360,"REPAIR, INITIAL INGUINAL HERNIA, FULL TERM INFANT YOUNGER THAN AGE 6 MONTHS, OR PRETERM INFANT OLDER THAN 50 WEEKS POSTCONCEPTION AGE AND YOUNGER THAN AGE 6 MONTHS AT THE TIME OF SURGERY, WITH OR WITH",,,3322.75,13194.0,15 RC,360,"REPAIR, INITIAL INGUINAL HERNIA, PRETERM INFANT (YOUNGER THAN 37 WEEKS GESTATION AT BIRTH), PERFORMED FROM BIRTH UP TO 50 WEEKS POSTCONCEPTION AGE, WITH OR WITHOUT HYDROCELECTOMY; REDUCIBLE",,,5493.28,13194.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 12.6 CM TO 20.0 CM",,,376.18,7278.0,15 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 2.5 CM OR LESS",,,376.18,5449.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 2.6 CM TO 5.0 CM",,,376.18,5449.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 5.1 CM TO 7.5 CM",,,376.18,5449.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 7.6 CM TO 12.5 CM",,,376.18,7278.0,15 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF NECK, HANDS, FEET AND/OR EXTERNAL GENITALIA; 2.5 CM OR LESS",,,376.18,5449.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF NECK, HANDS, FEET AND/OR EXTERNAL GENITALIA; 2.6 CM TO 7.5 CM",,,376.18,5449.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF NECK, HANDS, FEET AND/OR EXTERNAL GENITALIA; 20.1 CM TO 30.0 CM",,,576.34,7278.0,15 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF NECK, HANDS, FEET AND/OR EXTERNAL GENITALIA; 7.6 CM TO 12.5 CM",,,576.34,7278.0,15 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 12.6 CM TO 20.0 CM",,,376.18,7278.0,15 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 2.5 CM OR LESS",,,376.18,5449.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 2.6 CM TO 7.5 CM",,,376.18,5449.0,14 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 20.1 CM TO 30.0 CM",,,576.34,7278.0,15 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 7.6 CM TO 12.5 CM",,,376.18,7278.0,15 RC,360,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); OVER 30.0 CM",,,1722.29,7278.0,15 RC,360,"REPAIR, INTRINSIC MUSCLES OF HAND, EACH MUSCLE",,,3054.93,9324.0,15 RC,360,"REPAIR, LACERATION OF PALATE; OVER 2 CM OR COMPLEX",,,5152.0,9324.0,15 RC,360,"REPAIR, MYELOMENINGOCELE IN THE FETUS, PROCEDURE PERFORMED IN UTERO",,,,,0 RC,360,"REPAIR, NONUNION OR MALUNION, FEMUR, DISTAL TO HEAD AND NECK; WITH ILIAC OR OTHER AUTOGENOUS BONE GRAFT (INCLUDES OBTAINING GRAFT)",,,12615.0,21454.0,3 RC,360,"REPAIR, NONUNION OR MALUNION, FEMUR, DISTAL TO HEAD AND NECK; WITHOUT GRAFT (EG, COMPRESSION TECHNIQUE)",,,12615.0,21454.0,3 RC,360,"REPAIR, NONUNION OR MALUNION; METATARSAL, WITH OR WITHOUT BONE GRAFT (INCLUDES OBTAINING GRAFT)",,,5514.0,10561.0,15 RC,360,"REPAIR, NONUNION OR MALUNION; TARSAL BONES",,,8213.0,21454.0,15 RC,360,"REPAIR, PRIMARY, DISRUPTED LIGAMENT, ANKLE; BOTH COLLATERAL LIGAMENTS",,,5152.0,13194.0,15 RC,360,"REPAIR, PRIMARY, DISRUPTED LIGAMENT, ANKLE; COLLATERAL",,,5152.0,13194.0,15 RC,360,"REPAIR, PRIMARY, OPEN OR PERCUTANEOUS, RUPTURED ACHILLES TENDON;",,,6649.0,15394.0,15 RC,360,"REPAIR, PRIMARY, TORN LIGAMENT AND/OR CAPSULE, KNEE; COLLATERAL",,,6726.11,15394.0,15 RC,360,"REPAIR, PRIMARY, TORN LIGAMENT AND/OR CAPSULE, KNEE; COLLATERAL AND CRUCIATE LIGAMENTS",,,6726.11,15394.0,15 RC,360,"REPAIR, SECONDARY, ACHILLES TENDON, WITH OR WITHOUT GRAFT",,,6649.0,15394.0,15 RC,360,"REPAIR, SECONDARY, DISRUPTED LIGAMENT, ANKLE, COLLATERAL (EG, WATSON-JONES PROCEDURE)",,,5152.0,13194.0,15 RC,360,"REPAIR, TENDON OR MUSCLE, EXTENSOR, FOREARM AND/OR WRIST; PRIMARY, SINGLE, EACH TENDON OR MUSCLE",,,3054.93,13194.0,15 RC,360,"REPAIR, TENDON OR MUSCLE, EXTENSOR, FOREARM AND/OR WRIST; SECONDARY, WITH FREE GRAFT (INCLUDES OBTAINING GRAFT), EACH TENDON OR MUSCLE",,,3054.93,13194.0,15 RC,360,"REPAIR, TENDON OR MUSCLE, FLEXOR, FOREARM AND/OR WRIST; PRIMARY, SINGLE, EACH TENDON OR MUSCLE",,,3054.93,13194.0,15 RC,360,"REPAIR, TENDON OR MUSCLE, UPPER ARM OR ELBOW, EACH TENDON OR MUSCLE, PRIMARY OR SECONDARY (EXCLUDES ROTATOR CUFF)",,,6649.0,15394.0,15 RC,360,"REPAIR, TENDON SHEATH, EXTENSOR, FOREARM AND/OR WRIST, WITH FREE GRAFT (INCLUDES OBTAINING GRAFT) (EG, FOR EXTENSOR CARPI ULNARIS SUBLUXATION)",,,3054.93,13194.0,15 RC,360,"REPAIR, TENDON, EXTENSOR, FOOT; PRIMARY OR SECONDARY, EACH TENDON",,,3054.93,9324.0,15 RC,360,"REPAIR, TENDON, EXTENSOR, FOOT; SECONDARY WITH FREE GRAFT, EACH TENDON (INCLUDES OBTAINING GRAFT)",,,6649.0,21454.0,15 RC,360,"REPLACEMENT (INCLUDING REMOVAL OF EXISTING DEVICE), OSSEOINTEGRATED IMPLANT, SKULL; WITH PERCUTANEOUS ATTACHMENT TO EXTERNAL SPEECH PROCESSOR",,,6726.11,15394.0,14 RC,360,"REPLACEMENT OF GASTRO-JEJUNOSTOMY TUBE, PERCUTANEOUS, UNDER FLUOROSCOPIC GUIDANCE INCLUDING CONTRAST INJECTION(S), IMAGE DOCUMENTATION AND REPORT",,,882.75,5449.0,15 RC,360,"REPLACEMENT OF GASTROSTOMY OR CECOSTOMY (OR OTHER COLONIC) TUBE, PERCUTANEOUS, UNDER FLUOROSCOPIC GUIDANCE INCLUDING CONTRAST INJECTION(S), IMAGE DOCUMENTATION AND REPORT",,,882.75,5449.0,15 RC,360,"REPLACEMENT OF GASTROSTOMY TUBE, PERCUTANEOUS, INCLUDES REMOVAL, WHEN PERFORMED, WITHOUT IMAGING OR ENDOSCOPIC GUIDANCE; NOT REQUIRING REVISION OF GASTROSTOMY TRACT",,,228.99,5449.0,15 RC,360,"REPLACEMENT OF GASTROSTOMY TUBE, PERCUTANEOUS, INCLUDES REMOVAL, WHEN PERFORMED, WITHOUT IMAGING OR ENDOSCOPIC GUIDANCE; REQUIRING REVISION OF GASTROSTOMY TRACT",,,228.99,5449.0,15 RC,360,REPLACEMENT OF TISSUE EXPANDER WITH PERMANENT IMPLANT,,,6649.0,15394.0,15 RC,360,"REPLACEMENT OR IRRIGATION, VENTRICULAR CATHETER",,,3012.0,6589.14,15 RC,360,"REPLACEMENT OR REVISION OF CEREBROSPINAL FLUID SHUNT, OBSTRUCTED VALVE, OR DISTAL CATHETER IN SHUNT SYSTEM",,,5152.0,15394.0,15 RC,360,"REPLACEMENT, CATHETER ONLY, OF CENTRAL VENOUS ACCESS DEVICE, WITH SUBCUTANEOUS PORT OR PUMP, CENTRAL OR PERIPHERAL INSERTION SITE",,,2963.5,13194.0,15 RC,360,"REPLACEMENT, COMPLETE, OF A TUNNELED CENTRALLY INSERTED CENTRAL VENOUS ACCESS DEVICE, WITH SUBCUTANEOUS PORT, THROUGH SAME VENOUS ACCESS",,,2963.5,13194.0,15 RC,360,"REPLACEMENT, COMPLETE, OF A TUNNELED CENTRALLY INSERTED CENTRAL VENOUS CATHETER, WITHOUT SUBCUTANEOUS PORT OR PUMP, THROUGH SAME VENOUS ACCESS",,,2963.5,13194.0,15 RC,360,"REPOSITIONING OF INTRAOCULAR LENS PROSTHESIS, REQUIRING AN INCISION (SEPARATE PROCEDURE)",,,2147.4,10561.0,15 RC,360,REPOSITIONING OF PREVIOUSLY IMPLANTED TRANSVENOUS PACEMAKER OR IMPLANTABLE DEFIBRILLATOR (RIGHT ATRIAL OR RIGHT VENTRICULAR) ELECTRODE,,,2963.5,13194.0,14 RC,360,"RESECTION OF LIP, MORE THAN ONE-FOURTH, WITHOUT RECONSTRUCTION",,,3053.48,9324.0,15 RC,360,RESECTION OF PALATE OR EXTENSIVE RESECTION OF LESION,,,5514.0,10561.0,15 RC,360,RESECTION OF SCROTUM,,,3247.35,9324.0,15 RC,360,"RESECTION OR EXCISION OF NEOPLASTIC, VASCULAR OR INFECTIOUS LESION OF BASE OF ANTERIOR CRANIAL FOSSA; EXTRADURAL",,,2533.0,4850.0,2 RC,360,"RESECTION OR EXCISION OF NEOPLASTIC, VASCULAR OR INFECTIOUS LESION OF INFRATEMPORAL FOSSA, PARAPHARYNGEAL SPACE, PETROUS APEX; EXTRADURAL",,,2533.0,4850.0,2 RC,360,"RESECTION OR EXCISION OF NEOPLASTIC, VASCULAR OR INFECTIOUS LESION OF INFRATEMPORAL FOSSA, PARAPHARYNGEAL SPACE, PETROUS APEX; INTRADURAL, INCLUDING DURAL REPAIR, WITH OR WITHOUT GRAFT",,,2533.0,4850.0,2 RC,360,RESECTION OR TRANSPLANTATION OF LONG TENDON OF BICEPS,,,6726.11,13194.0,15 RC,360,"RESECTION, CONDYLE(S), DISTAL END OF PHALANX, EACH TOE",,,3054.93,9324.0,15 RC,360,"RESECTION, PARTIAL OR COMPLETE, PHALANGEAL BASE, EACH TOE",,,3054.93,9324.0,15 RC,360,"RETROBULBAR INJECTION; MEDICATION (SEPARATE PROCEDURE, DOES NOT INCLUDE SUPPLY OF MEDICATION)",,,281.46,1251.0,13 RC,360,"RETROPERITONEAL TRANSABDOMINAL LYMPHADENECTOMY, EXTENSIVE, INCLUDING PELVIC, AORTIC, AND RENAL NODES (SEPARATE PROCEDURE)",,,2533.0,4850.0,2 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL, POPLITEAL ARTERY(S), UNILATERAL; WITH TRANSLUMINAL ANGIOPLASTY",,,5368.21,21454.0,14 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL, POPLITEAL ARTERY(S), UNILATERAL; WITH TRANSLUMINAL STENT PLACEMENT(S) AND ATHERECTOMY, INCLUDES ANGIOPLASTY WITHIN THE SAME VESSEL, WHEN",,,10561.0,30820.0,14 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL, POPLITEAL ARTERY(S), UNILATERAL; WITH TRANSLUMINAL STENT PLACEMENT(S), INCLUDES ANGIOPLASTY WITHIN THE SAME VESSEL, WHEN PERFORMED",,,10561.0,30725.0,14 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, ILIAC ARTERY, EACH ADDITIONAL IPSILATERAL ILIAC VESSEL; WITH TRANSLUMINAL STENT PLACEMENT(S), INCLUDES ANGIOPLASTY WITHIN THE SAME VESSEL, WHEN P",,,5449.0,21454.0,3 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, ILIAC ARTERY, UNILATERAL, INITIAL VESSEL; WITH TRANSLUMINAL ANGIOPLASTY",,,5368.21,21454.0,14 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, ILIAC ARTERY, UNILATERAL, INITIAL VESSEL; WITH TRANSLUMINAL STENT PLACEMENT(S), INCLUDES ANGIOPLASTY WITHIN THE SAME VESSEL, WHEN PERFORMED",,,10561.0,30725.0,14 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PERONEAL; WITH INTRAVASCULAR LITHOTRIPSY, AND TRANSLUMINAL STENT PLACEMENT(S), INCLUDES ANGIOPLASTY WI",,,10561.0,30725.0,14 RC,360,"REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL, PERONEAL ARTERY, UNILATERAL, INITIAL VESSEL; WITH TRANSLUMINAL ANGIOPLASTY",,,10561.0,21454.0,14 RC,360,REVISION (INCLUDING REMOVAL) OF PROSTHETIC VAGINAL GRAFT; VAGINAL APPROACH,,,2993.65,9324.0,15 RC,360,"REVISION INCLUDING REPLACEMENT, WHEN PERFORMED, OF SPINAL NEUROSTIMULATOR ELECTRODE PLATE/PADDLE(S) PLACED VIA LAMINOTOMY OR LAMINECTOMY, INCLUDING FLUOROSCOPY, WHEN PERFORMED",,,5449.0,21454.0,15 RC,360,REVISION OF AQUEOUS SHUNT TO EXTRAOCULAR EQUATORIAL PLATE RESERVOIR; WITH GRAFT,,,2147.4,9324.0,15 RC,360,REVISION OF COLOSTOMY; SIMPLE (RELEASE OF SUPERFICIAL SCAR) (SEPARATE PROCEDURE),,,3446.95,13194.0,15 RC,360,REVISION OF ILEOSTOMY; SIMPLE (RELEASE OF SUPERFICIAL SCAR) (SEPARATE PROCEDURE),,,3446.95,13194.0,15 RC,360,"REVISION OF PERI-IMPLANT CAPSULE, BREAST, INCLUDING CAPSULOTOMY, CAPSULORRHAPHY, AND/OR PARTIAL CAPSULECTOMY",,,3605.42,13194.0,15 RC,360,REVISION OF PRIOR HYPOSPADIAS REPAIR REQUIRING EXTENSIVE DISSECTION AND EXCISION OF PREVIOUSLY CONSTRUCTED STRUCTURES INCLUDING RE-RELEASE OF CHORDEE AND RECONSTRUCTION OF URETHRA AND PENIS BY USE OF ,,,4786.44,15394.0,15 RC,360,"REVISION OF RECONSTRUCTED BREAST (EG, SIGNIFICANT REMOVAL OF TISSUE, RE-ADVANCEMENT AND/OR RE-INSET OF FLAPS IN AUTOLOGOUS RECONSTRUCTION OR SIGNIFICANT CAPSULAR REVISION COMBINED WITH SOFT TISSUE EXC",,,6140.22,15394.0,15 RC,360,REVISION OF STAPEDECTOMY OR STAPEDOTOMY,,,5569.83,15394.0,15 RC,360,"REVISION OF TOTAL HIP ARTHROPLASTY; BOTH COMPONENTS, WITH OR WITHOUT AUTOGRAFT OR ALLOGRAFT",,,13764.0,30725.0,3 RC,360,"REVISION OF TOTAL SHOULDER ARTHROPLASTY, INCLUDING ALLOGRAFT WHEN PERFORMED; HUMERAL AND GLENOID COMPONENT",,,12615.0,21454.0,3 RC,360,"REVISION OF TOTAL SHOULDER ARTHROPLASTY, INCLUDING ALLOGRAFT WHEN PERFORMED; HUMERAL OR GLENOID COMPONENT",,,9974.0,15394.0,14 RC,360,REVISION OF TRACHEOSTOMY SCAR,,,3053.48,9324.0,15 RC,360,REVISION OF URINARY-CUTANEOUS ANASTOMOSIS (ANY TYPE UROSTOMY);,,,3247.35,9324.0,13 RC,360,REVISION OF URINARY-CUTANEOUS ANASTOMOSIS (ANY TYPE UROSTOMY); WITH REPAIR OF FASCIAL DEFECT AND HERNIA,,,2533.0,4850.0,2 RC,360,REVISION OR REMOVAL OF CRANIAL NEUROSTIMULATOR PULSE GENERATOR OR RECEIVER,,,4121.0,13194.0,15 RC,360,"REVISION OR REMOVAL OF IMPLANTED SPINAL NEUROSTIMULATOR PULSE GENERATOR OR RECEIVER, WITH DETACHABLE CONNECTION TO ELECTRODE ARRAY",,,3237.97,13194.0,15 RC,360,REVISION OR REMOVAL OF INTRACRANIAL NEUROSTIMULATOR ELECTRODES,,,3237.97,13194.0,13 RC,360,REVISION OR REMOVAL OF PERIPHERAL NEUROSTIMULATOR ELECTRODE ARRAY,,,3237.97,13194.0,15 RC,360,"REVISION OR REMOVAL OF PERIPHERAL, SACRAL, OR GASTRIC NEUROSTIMULATOR PULSE GENERATOR OR RECEIVER, WITH DETACHABLE CONNECTION TO ELECTRODE ARRAY",,,3237.97,13194.0,15 RC,360,"REVISION OR REPAIR OF OPERATIVE WOUND OF ANTERIOR SEGMENT, ANY TYPE, EARLY OR LATE, MAJOR OR MINOR PROCEDURE",,,2196.57,9324.0,15 RC,360,"REVISION OR REPLACEMENT OF CRANIAL NERVE (EG, VAGUS NERVE) NEUROSTIMULATOR ELECTRODE ARRAY, INCLUDING CONNECTION TO EXISTING PULSE GENERATOR",,,7278.0,21454.0,15 RC,360,"REVISION OR REPLACEMENT OF HYPOGLOSSAL NERVE NEUROSTIMULATOR ARRAY AND DISTAL RESPIRATORY SENSOR ELECTRODE OR ELECTRODE ARRAY, INCLUDING CONNECTION TO EXISTING PULSE GENERATOR",,,7278.0,30725.0,14 RC,360,"REVISION, OPEN, ARTERIOVENOUS FISTULA; WITH THROMBECTOMY, AUTOGENOUS OR NONAUTOGENOUS DIALYSIS GRAFT (SEPARATE PROCEDURE)",,,5089.69,21454.0,15 RC,360,"REVISION, OPEN, ARTERIOVENOUS FISTULA; WITHOUT THROMBECTOMY, AUTOGENOUS OR NONAUTOGENOUS DIALYSIS GRAFT (SEPARATE PROCEDURE)",,,5089.69,21454.0,15 RC,360,RHINECTOMY; PARTIAL,,,5569.83,15394.0,15 RC,360,RHINECTOMY; TOTAL,,,5569.83,15394.0,15 RC,360,"RHINOPLASTY FOR NASAL DEFORMITY SECONDARY TO CONGENITAL CLEFT LIP AND/OR PALATE, INCLUDING COLUMELLAR LENGTHENING; TIP ONLY",,,5569.83,15394.0,15 RC,360,"RHINOPLASTY FOR NASAL DEFORMITY SECONDARY TO CONGENITAL CLEFT LIP AND/OR PALATE, INCLUDING COLUMELLAR LENGTHENING; TIP, SEPTUM, OSTEOTOMIES",,,5569.83,17457.0,15 RC,360,"RHINOPLASTY, PRIMARY; INCLUDING MAJOR SEPTAL REPAIR",,,5569.83,15394.0,15 RC,360,"RHINOPLASTY, PRIMARY; LATERAL AND ALAR CARTILAGES AND/OR ELEVATION OF NASAL TIP",,,5514.0,10561.0,15 RC,360,"RHINOPLASTY, SECONDARY; INTERMEDIATE REVISION (BONY WORK WITH OSTEOTOMIES)",,,5569.83,15394.0,15 RC,360,"RHINOPLASTY, SECONDARY; MAJOR REVISION (NASAL TIP WORK AND OSTEOTOMIES)",,,5569.83,15394.0,15 RC,360,"RHINOPLASTY, SECONDARY; MINOR REVISION (SMALL AMOUNT OF NASAL TIP WORK)",,,5514.0,9324.0,15 RC,360,"RHYTIDECTOMY; CHEEK, CHIN, AND NECK",,,3446.95,13194.0,15 RC,360,RHYTIDECTOMY; FOREHEAD,,,1722.29,8413.0,15 RC,360,RHYTIDECTOMY; GLABELLAR FROWN LINES,,,3446.95,13194.0,15 RC,360,RHYTIDECTOMY; SUPERFICIAL MUSCULOAPONEUROTIC SYSTEM (SMAS) FLAP,,,3446.95,13194.0,15 RC,360,"SALPINGECTOMY, COMPLETE OR PARTIAL, UNILATERAL OR BILATERAL (SEPARATE PROCEDURE)",,,7444.0,13194.0,3 RC,360,"SALPINGO-OOPHORECTOMY, COMPLETE OR PARTIAL, UNILATERAL OR BILATERAL (SEPARATE PROCEDURE)",,,9974.0,15394.0,3 RC,360,SCLERAL REINFORCEMENT (SEPARATE PROCEDURE); WITH GRAFT,,,3787.69,9324.0,15 RC,360,"SCLEROTHERAPY OF A FLUID COLLECTION (EG, LYMPHOCELE, CYST, OR SEROMA), PERCUTANEOUS, INCLUDING CONTRAST INJECTION(S), SCLEROSANT INJECTION(S), DIAGNOSTIC STUDY, IMAGING GUIDANCE (EG, ULTRASOUND, FLUOR",,,1525.52,12408.0,15 RC,360,SCROTAL EXPLORATION,,,3247.35,9324.0,15 RC,360,SCROTOPLASTY; COMPLICATED,,,4786.44,9324.0,15 RC,360,SCROTOPLASTY; SIMPLE,,,3247.35,15394.0,15 RC,360,"SECONDARY CLOSURE OF SURGICAL WOUND OR DEHISCENCE, EXTENSIVE OR COMPLICATED",,,1722.29,7278.0,15 RC,360,"SECONDARY REPAIR OF DURA FOR CEREBROSPINAL FLUID LEAK, ANTERIOR, MIDDLE OR POSTERIOR CRANIAL FOSSA FOLLOWING SURGERY OF THE SKULL BASE; BY FREE TISSUE GRAFT (EG, PERICRANIUM, FASCIA, TENSOR FASCIA LAT",,,2533.0,4850.0,2 RC,360,"SELECTIVE CATHETER PLACEMENT, ARTERIAL SYSTEM; EACH FIRST ORDER ABDOMINAL, PELVIC, OR LOWER EXTREMITY ARTERY BRANCH, WITHIN A VASCULAR FAMILY",,,777.0,7278.0,3 RC,360,"SELECTIVE CATHETER PLACEMENT, ARTERIAL SYSTEM; INITIAL THIRD ORDER OR MORE SELECTIVE ABDOMINAL, PELVIC, OR LOWER EXTREMITY ARTERY BRANCH, WITHIN A VASCULAR FAMILY",,,777.0,7278.0,3 RC,360,"SELECTIVE CATHETER PLACEMENT, VENOUS SYSTEM; FIRST ORDER BRANCH (EG, RENAL VEIN, JUGULAR VEIN)",,,777.0,5449.0,3 RC,360,"SELECTIVE CATHETER PLACEMENT, VENOUS SYSTEM; SECOND ORDER, OR MORE SELECTIVE, BRANCH (EG, LEFT ADRENAL VEIN, PETROSAL SINUS)",,,777.0,5449.0,3 RC,360,"SEPTOPLASTY OR SUBMUCOUS RESECTION, WITH OR WITHOUT CARTILAGE SCORING, CONTOURING OR REPLACEMENT WITH GRAFT",,,3053.48,10561.0,15 RC,360,"SESAMOIDECTOMY, FIRST TOE (SEPARATE PROCEDURE)",,,3054.93,10561.0,15 RC,360,"SESAMOIDECTOMY, THUMB OR FINGER (SEPARATE PROCEDURE)",,,1506.85,10561.0,15 RC,360,"SEVERING ADHESIONS OF ANTERIOR SEGMENT OF EYE, INCISIONAL TECHNIQUE (WITH OR WITHOUT INJECTION OF AIR OR LIQUID) (SEPARATE PROCEDURE); ANTERIOR SYNECHIAE, EXCEPT GONIOSYNECHIAE",,,2147.4,10561.0,15 RC,360,"SEVERING ADHESIONS OF ANTERIOR SEGMENT OF EYE, INCISIONAL TECHNIQUE (WITH OR WITHOUT INJECTION OF AIR OR LIQUID) (SEPARATE PROCEDURE); CORNEOVITREAL ADHESIONS",,,3787.69,10561.0,15 RC,360,"SEVERING ADHESIONS OF ANTERIOR SEGMENT OF EYE, INCISIONAL TECHNIQUE (WITH OR WITHOUT INJECTION OF AIR OR LIQUID) (SEPARATE PROCEDURE); GONIOSYNECHIAE",,,2147.4,9324.0,15 RC,360,"SEVERING ADHESIONS OF ANTERIOR SEGMENT OF EYE, INCISIONAL TECHNIQUE (WITH OR WITHOUT INJECTION OF AIR OR LIQUID) (SEPARATE PROCEDURE); POSTERIOR SYNECHIAE",,,2147.4,10561.0,15 RC,360,SEVERING OF TARSORRHAPHY,,,911.92,5449.0,15 RC,360,"SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 1.1 TO 2.0 CM",,,376.18,1251.0,13 RC,360,"SHAVING OF EPIDERMAL OR DERMAL LESION, SINGLE LESION, SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.6 TO 1.0 CM",,,187.08,1251.0,13 RC,360,"SIALOLITHOTOMY; PAROTID, EXTRAORAL OR COMPLICATED INTRAORAL",,,3012.0,7278.0,15 RC,360,"SIALOLITHOTOMY; SUBMANDIBULAR (SUBMAXILLARY), COMPLICATED, INTRAORAL",,,3053.48,9324.0,15 RC,360,"SIALOLITHOTOMY; SUBMANDIBULAR (SUBMAXILLARY), SUBLINGUAL OR PAROTID, UNCOMPLICATED, INTRAORAL",,,3012.0,5449.0,14 RC,360,"SIGMOIDOSCOPY, FLEXIBLE; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,858.41,5449.0,15 RC,360,"SIGMOIDOSCOPY, FLEXIBLE; WITH BAND LIGATION(S) (EG, HEMORRHOIDS)",,,1110.16,8213.0,15 RC,360,"SIGMOIDOSCOPY, FLEXIBLE; WITH BIOPSY, SINGLE OR MULTIPLE",,,858.41,5449.0,15 RC,360,"SIGMOIDOSCOPY, FLEXIBLE; WITH ENDOSCOPIC MUCOSAL RESECTION",,,2582.07,8213.0,15 RC,360,"SIGMOIDOSCOPY, FLEXIBLE; WITH REMOVAL OF FOREIGN BODY(S)",,,1110.16,5449.0,15 RC,360,"SIMPLE REPAIR OF SUPERFICIAL WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 2.5 CM OR LESS",,,187.08,1251.0,13 RC,360,"SIMPLE REPAIR OF SUPERFICIAL WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 2.6 CM TO 5.0 CM",,,187.08,1251.0,13 RC,360,"SIMPLE REPAIR OF SUPERFICIAL WOUNDS OF SCALP, NECK, AXILLAE, EXTERNAL GENITALIA, TRUNK AND/OR EXTREMITIES (INCLUDING HANDS AND FEET); 12.6 CM TO 20.0 CM",,,376.18,7278.0,15 RC,360,"SIMPLE REPAIR OF SUPERFICIAL WOUNDS OF SCALP, NECK, AXILLAE, EXTERNAL GENITALIA, TRUNK AND/OR EXTREMITIES (INCLUDING HANDS AND FEET); 2.5 CM OR LESS",,,187.08,5449.0,14 RC,360,"SIMPLE REPAIR OF SUPERFICIAL WOUNDS OF SCALP, NECK, AXILLAE, EXTERNAL GENITALIA, TRUNK AND/OR EXTREMITIES (INCLUDING HANDS AND FEET); 2.6 CM TO 7.5 CM",,,187.08,1251.0,13 RC,360,"SINUSOTOMY FRONTAL; NONOBLITERATIVE, WITH OSTEOPLASTIC FLAP, BROW INCISION",,,5569.83,15394.0,15 RC,360,"SINUSOTOMY FRONTAL; NONOBLITERATIVE, WITH OSTEOPLASTIC FLAP, CORONAL INCISION",,,5569.83,15394.0,15 RC,360,"SINUSOTOMY, MAXILLARY (ANTROTOMY); INTRANASAL",,,3053.48,9324.0,15 RC,360,"SINUSOTOMY, MAXILLARY (ANTROTOMY); RADICAL (CALDWELL-LUC) WITH REMOVAL OF ANTROCHOANAL POLYPS",,,5569.83,15394.0,15 RC,360,"SINUSOTOMY, MAXILLARY (ANTROTOMY); RADICAL (CALDWELL-LUC) WITHOUT REMOVAL OF ANTROCHOANAL POLYPS",,,5569.83,15394.0,15 RC,360,"SLING OPERATION FOR STRESS INCONTINENCE (EG, FASCIA OR SYNTHETIC)",,,4647.86,15394.0,15 RC,360,"SLITTING OF PREPUCE, DORSAL OR LATERAL (SEPARATE PROCEDURE); EXCEPT NEWBORN",,,1928.76,9324.0,15 RC,360,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, NOT INCLUDING ILEUM; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDU",,,1786.09,7278.0,15 RC,360,SNIP INCISION OF LACRIMAL PUNCTUM,,,281.46,5449.0,15 RC,360,"SPHINCTEROTOMY, ANAL, DIVISION OF SPHINCTER (SEPARATE PROCEDURE)",,,2582.07,8413.0,15 RC,360,"SPINAL PUNCTURE, LUMBAR, DIAGNOSTIC;",,,652.03,5449.0,15 RC,360,SPLENECTOMY; TOTAL (SEPARATE PROCEDURE),,,2533.0,4850.0,2 RC,360,"SPLIT-THICKNESS AUTOGRAFT, FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS; EACH ADDITIONAL 100 SQ CM, OR EACH ADDITIONAL 1% OF BODY AREA OF INFANTS AND",,,777.0,8413.0,3 RC,360,"SPLIT-THICKNESS AUTOGRAFT, FACE, SCALP, EYELIDS, MOUTH, NECK, EARS, ORBITS, GENITALIA, HANDS, FEET, AND/OR MULTIPLE DIGITS; FIRST 100 SQ CM OR LESS, OR 1% OF BODY AREA OF INFANTS AND CHILDREN (EXCEPT ",,,3446.95,13194.0,15 RC,360,"SPLIT-THICKNESS AUTOGRAFT, TRUNK, ARMS, LEGS; EACH ADDITIONAL 100 SQ CM, OR EACH ADDITIONAL 1% OF BODY AREA OF INFANTS AND CHILDREN, OR PART THEREOF (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PR",,,777.0,8413.0,3 RC,360,"SPLIT-THICKNESS AUTOGRAFT, TRUNK, ARMS, LEGS; FIRST 100 SQ CM OR LESS, OR 1% OF BODY AREA OF INFANTS AND CHILDREN (EXCEPT 15050)",,,1722.29,7278.0,15 RC,360,"STAB PHLEBECTOMY OF VARICOSE VEINS, 1 EXTREMITY; 10-20 STAB INCISIONS",,,2963.5,13194.0,15 RC,360,"STAB PHLEBECTOMY OF VARICOSE VEINS, 1 EXTREMITY; MORE THAN 20 INCISIONS",,,2963.5,13194.0,15 RC,360,"STAPEDECTOMY OR STAPEDOTOMY WITH REESTABLISHMENT OF OSSICULAR CONTINUITY, WITH OR WITHOUT USE OF FOREIGN MATERIAL;",,,5569.83,15394.0,15 RC,360,"STAPEDECTOMY OR STAPEDOTOMY WITH REESTABLISHMENT OF OSSICULAR CONTINUITY, WITH OR WITHOUT USE OF FOREIGN MATERIAL; WITH FOOTPLATE DRILL OUT",,,5569.83,15394.0,15 RC,360,"STEREOTACTIC BIOPSY, ASPIRATION, OR EXCISION, INCLUDING BURR HOLE(S), FOR INTRACRANIAL LESION; WITH COMPUTED TOMOGRAPHY AND/OR MAGNETIC RESONANCE GUIDANCE",,,2533.0,4850.0,2 RC,360,"STEREOTACTIC COMPUTER-ASSISTED (NAVIGATIONAL) PROCEDURE; CRANIAL, EXTRADURAL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"STEREOTACTIC COMPUTER-ASSISTED (NAVIGATIONAL) PROCEDURE; CRANIAL, INTRADURAL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,STEREOTACTIC COMPUTER-ASSISTED (NAVIGATIONAL) PROCEDURE; SPINAL (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,5449.0,3 RC,360,STEREOTACTIC IMPLANTATION OF DEPTH ELECTRODES INTO THE CEREBRUM FOR LONG-TERM SEIZURE MONITORING,,,3012.0,5239.0,2 RC,360,"STRABISMUS SURGERY BY POSTERIOR FIXATION SUTURE TECHNIQUE, WITH OR WITHOUT MUSCLE RECESSION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,10561.0,3 RC,360,STRABISMUS SURGERY ON PATIENT WITH PREVIOUS EYE SURGERY OR INJURY THAT DID NOT INVOLVE THE EXTRAOCULAR MUSCLES (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,10561.0,3 RC,360,"STRABISMUS SURGERY ON PATIENT WITH SCARRING OF EXTRAOCULAR MUSCLES (EG, PRIOR OCULAR INJURY, STRABISMUS OR RETINAL DETACHMENT SURGERY) OR RESTRICTIVE MYOPATHY (EG, DYSTHYROID OPHTHALMOPATHY) (LIST SEP",,,777.0,10561.0,3 RC,360,"STRABISMUS SURGERY, ANY PROCEDURE, SUPERIOR OBLIQUE MUSCLE",,,2196.57,10561.0,15 RC,360,"STRABISMUS SURGERY, RECESSION OR RESECTION PROCEDURE; 1 HORIZONTAL MUSCLE",,,2196.57,9324.0,15 RC,360,"STRABISMUS SURGERY, RECESSION OR RESECTION PROCEDURE; 1 VERTICAL MUSCLE (EXCLUDING SUPERIOR OBLIQUE)",,,2196.57,10561.0,15 RC,360,"STRABISMUS SURGERY, RECESSION OR RESECTION PROCEDURE; 2 HORIZONTAL MUSCLES",,,3550.55,13194.0,15 RC,360,"STRABISMUS SURGERY, RECESSION OR RESECTION PROCEDURE; 2 OR MORE VERTICAL MUSCLES (EXCLUDING SUPERIOR OBLIQUE)",,,2196.57,10561.0,15 RC,360,SUBCONJUNCTIVAL INJECTION,,,375.71,1251.0,13 RC,360,"SUBMUCOUS RESECTION INFERIOR TURBINATE, PARTIAL OR COMPLETE, ANY METHOD",,,3053.48,9324.0,15 RC,360,SUCTION ASSISTED LIPECTOMY; HEAD AND NECK,,,3446.95,13194.0,15 RC,360,SUCTION ASSISTED LIPECTOMY; LOWER EXTREMITY,,,3446.95,13194.0,15 RC,360,SUCTION ASSISTED LIPECTOMY; TRUNK,,,3446.95,13194.0,15 RC,360,SUCTION ASSISTED LIPECTOMY; UPPER EXTREMITY,,,1722.29,8413.0,15 RC,360,SUPRAHYOID LYMPHADENECTOMY,,,5152.0,9324.0,15 RC,360,"SURGERY OF COMPLEX INTRACRANIAL ANEURYSM, INTRACRANIAL APPROACH; CAROTID CIRCULATION",,,2533.0,4850.0,2 RC,360,SURGICAL CLOSURE TRACHEOSTOMY OR FISTULA; WITH PLASTIC REPAIR,,,3053.48,9324.0,15 RC,360,SURGICAL CLOSURE TRACHEOSTOMY OR FISTULA; WITHOUT PLASTIC REPAIR,,,3053.48,9324.0,15 RC,360,"SURGICAL PREPARATION OR CREATION OF RECIPIENT SITE BY EXCISION OF OPEN WOUNDS, BURN ESCHAR, OR SCAR (INCLUDING SUBCUTANEOUS TISSUES), OR INCISIONAL RELEASE OF SCAR CONTRACTURE, FACE, SCALP, EYELIDS, M",,,576.34,7278.0,18 RC,360,"SURGICAL PREPARATION OR CREATION OF RECIPIENT SITE BY EXCISION OF OPEN WOUNDS, BURN ESCHAR, OR SCAR (INCLUDING SUBCUTANEOUS TISSUES), OR INCISIONAL RELEASE OF SCAR CONTRACTURE, TRUNK, ARMS, LEGS; EACH",,,777.0,5449.0,3 RC,360,"SURGICAL PREPARATION OR CREATION OF RECIPIENT SITE BY EXCISION OF OPEN WOUNDS, BURN ESCHAR, OR SCAR (INCLUDING SUBCUTANEOUS TISSUES), OR INCISIONAL RELEASE OF SCAR CONTRACTURE, TRUNK, ARMS, LEGS; FIRS",,,1722.29,7278.0,15 RC,360,SURGICAL TECHNIQUES REQUIRING USE OF ROBOTIC SURGICAL SYSTEM (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,,,0 RC,360,SURGICAL TREATMENT OF ANAL FISTULA (FISTULECTOMY/FISTULOTOMY); INTERSPHINCTERIC,,,2582.07,9324.0,15 RC,360,SURGICAL TREATMENT OF ANAL FISTULA (FISTULECTOMY/FISTULOTOMY); SECOND STAGE,,,2582.07,9324.0,15 RC,360,SURGICAL TREATMENT OF ANAL FISTULA (FISTULECTOMY/FISTULOTOMY); SUBCUTANEOUS,,,2582.07,9324.0,15 RC,360,"SURGICAL TREATMENT OF ANAL FISTULA (FISTULECTOMY/FISTULOTOMY); TRANSSPHINCTERIC, SUPRASPHINCTERIC, EXTRASPHINCTERIC OR MULTIPLE, INCLUDING PLACEMENT OF SETON, WHEN PERFORMED",,,2582.07,10561.0,15 RC,360,"SURGICAL TREATMENT OF ECTOPIC PREGNANCY; INTERSTITIAL, UTERINE PREGNANCY WITH PARTIAL RESECTION OF UTERUS",,,2533.0,4850.0,2 RC,360,"SUTURE OF 1 NERVE; HAND OR FOOT, COMMON SENSORY NERVE",,,5152.0,15394.0,15 RC,360,SUTURE OF 1 NERVE; ULNAR MOTOR,,,6029.68,15394.0,15 RC,360,"SUTURE OF DIGITAL NERVE, HAND OR FOOT; 1 NERVE",,,1838.62,13194.0,15 RC,360,"SUTURE OF DIGITAL NERVE, HAND OR FOOT; EACH ADDITIONAL DIGITAL NERVE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,SUTURE OF FACIAL NERVE; EXTRACRANIAL,,,6029.68,15394.0,15 RC,360,"SUTURE OF FACIAL NERVE; INFRATEMPORAL, WITH OR WITHOUT GRAFTING",,,6029.68,15394.0,15 RC,360,SUTURE OF INFRAPATELLAR TENDON; PRIMARY,,,4121.0,13194.0,15 RC,360,"SUTURE OF INFRAPATELLAR TENDON; SECONDARY RECONSTRUCTION, INCLUDING FASCIAL OR TENDON GRAFT",,,6649.0,13194.0,15 RC,360,"SUTURE OF IRIS, CILIARY BODY (SEPARATE PROCEDURE) WITH RETRIEVAL OF SUTURE THROUGH SMALL INCISION (EG, MCCANNEL SUTURE)",,,2147.4,9324.0,15 RC,360,"SUTURE OF LARGE INTESTINE (COLORRHAPHY) FOR PERFORATED ULCER, DIVERTICULUM, WOUND, INJURY OR RUPTURE (SINGLE OR MULTIPLE PERFORATIONS); WITHOUT COLOSTOMY",,,2533.0,4850.0,2 RC,360,"SUTURE OF MAJOR PERIPHERAL NERVE, ARM OR LEG, EXCEPT SCIATIC; INCLUDING TRANSPOSITION",,,5152.0,15394.0,15 RC,360,"SUTURE OF MAJOR PERIPHERAL NERVE, ARM OR LEG, EXCEPT SCIATIC; WITHOUT TRANSPOSITION",,,5152.0,15394.0,15 RC,360,"SUTURE OF NERVE; REQUIRING EXTENSIVE MOBILIZATION, OR TRANSPOSITION OF NERVE (LIST SEPARATELY IN ADDITION TO CODE FOR NERVE SUTURE)",,,777.0,8413.0,3 RC,360,SUTURE OF QUADRICEPS OR HAMSTRING MUSCLE RUPTURE; PRIMARY,,,6649.0,13194.0,15 RC,360,"SUTURE OF QUADRICEPS OR HAMSTRING MUSCLE RUPTURE; SECONDARY RECONSTRUCTION, INCLUDING FASCIAL OR TENDON GRAFT",,,6649.0,13194.0,15 RC,360,"SUTURE OF RECENT WOUND, EYELID, INVOLVING LID MARGIN, TARSUS, AND/OR PALPEBRAL CONJUNCTIVA DIRECT CLOSURE; FULL THICKNESS",,,2196.57,9324.0,15 RC,360,"SUTURE OF SMALL INTESTINE (ENTERORRHAPHY) FOR PERFORATED ULCER, DIVERTICULUM, WOUND, INJURY OR RUPTURE; SINGLE PERFORATION",,,5514.0,9324.0,2 RC,360,SUTURE OF TRACHEAL WOUND OR INJURY; CERVICAL,,,3012.0,7278.0,3 RC,360,"SYMPATHECTOMY; DIGITAL ARTERIES, EACH DIGIT",,,1838.62,9324.0,13 RC,360,"SYNOVECTOMY, EXTENSOR TENDON SHEATH, WRIST, SINGLE COMPARTMENT;",,,1506.85,9324.0,15 RC,360,"SYNOVECTOMY, TENDON SHEATH, RADICAL (TENOSYNOVECTOMY), FLEXOR TENDON, PALM AND/OR FINGER, EACH TENDON",,,1506.85,8413.0,15 RC,360,TALECTOMY (ASTRAGALECTOMY),,,5514.0,9324.0,15 RC,360,"TANGENTIAL BIOPSY OF SKIN (EG, SHAVE, SCOOP, SAUCERIZE, CURETTE); EACH SEPARATE/ADDITIONAL LESION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,"TANGENTIAL BIOPSY OF SKIN (EG, SHAVE, SCOOP, SAUCERIZE, CURETTE); SINGLE LESION",,,187.08,5449.0,14 RC,360,"TEMPORARY CLOSURE OF EYELIDS BY SUTURE (EG, FROST SUTURE)",,,911.92,5449.0,15 RC,360,"TENDON GRAFT, FROM A DISTANCE (EG, PALMARIS, TOE EXTENSOR, PLANTARIS)",,,6726.11,13194.0,15 RC,360,"TENDON LENGTHENING, UPPER ARM OR ELBOW, EACH TENDON",,,3054.93,13194.0,15 RC,360,"TENDON SHEATH INCISION (EG, FOR TRIGGER FINGER)",,,1506.85,7278.0,15 RC,360,"TENDON TRANSPLANTATION OR TRANSFER, FLEXOR OR EXTENSOR, FOREARM AND/OR WRIST, SINGLE; EACH TENDON",,,3054.93,13194.0,15 RC,360,"TENDON TRANSPLANTATION OR TRANSFER, FLEXOR OR EXTENSOR, FOREARM AND/OR WRIST, SINGLE; WITH TENDON GRAFT(S) (INCLUDES OBTAINING GRAFT), EACH TENDON",,,3054.93,15394.0,15 RC,360,TENODESIS AT WRIST; FLEXORS OF FINGERS,,,3054.93,13194.0,15 RC,360,TENODESIS OF BICEPS TENDON AT ELBOW (SEPARATE PROCEDURE),,,6649.0,15394.0,15 RC,360,TENODESIS OF LONG TENDON OF BICEPS,,,6726.11,15394.0,15 RC,360,"TENOLYSIS, COMPLEX, EXTENSOR TENDON, FINGER, INCLUDING FOREARM, EACH TENDON",,,3054.93,13194.0,15 RC,360,"TENOLYSIS, EXTENSOR TENDON, HAND OR FINGER, EACH TENDON",,,3012.0,8413.0,15 RC,360,"TENOLYSIS, FLEXOR OR EXTENSOR TENDON, FOREARM AND/OR WRIST, SINGLE, EACH TENDON",,,3054.93,9324.0,15 RC,360,"TENOLYSIS, FLEXOR OR EXTENSOR TENDON, LEG AND/OR ANKLE; MULTIPLE TENDONS (THROUGH SEPARATE INCISION[S])",,,3054.93,13194.0,15 RC,360,"TENOLYSIS, FLEXOR OR EXTENSOR TENDON, LEG AND/OR ANKLE; SINGLE, EACH TENDON",,,3054.93,13194.0,15 RC,360,"TENOLYSIS, FLEXOR TENDON; PALM AND FINGER, EACH TENDON",,,3054.93,13194.0,15 RC,360,"TENOLYSIS, FLEXOR TENDON; PALM OR FINGER, EACH TENDON",,,1506.85,8413.0,15 RC,360,"TENOLYSIS, FLEXOR, FOOT; MULTIPLE TENDONS",,,3054.93,9324.0,15 RC,360,"TENOLYSIS, FLEXOR, FOOT; SINGLE TENDON",,,1506.85,9324.0,14 RC,360,"TENOTOMY, ABDUCTORS AND/OR EXTENSOR(S) OF HIP, OPEN (SEPARATE PROCEDURE)",,,3054.93,13194.0,14 RC,360,"TENOTOMY, ADDUCTOR OF HIP, OPEN",,,3054.93,13194.0,15 RC,360,"TENOTOMY, ELBOW, LATERAL OR MEDIAL (EG, EPICONDYLITIS, TENNIS ELBOW, GOLFER'S ELBOW); DEBRIDEMENT, SOFT TISSUE AND/OR BONE, OPEN WITH TENDON REPAIR OR REATTACHMENT",,,3054.93,17457.0,15 RC,360,"TENOTOMY, EXTENSOR, HAND OR FINGER, OPEN, EACH TENDON",,,1506.85,8413.0,15 RC,360,"TENOTOMY, FLEXOR, FINGER, OPEN, EACH TENDON",,,1506.85,8413.0,15 RC,360,"TENOTOMY, HIP FLEXOR(S), OPEN (SEPARATE PROCEDURE)",,,8413.0,21454.0,3 RC,360,"TENOTOMY, OPEN, ELBOW TO SHOULDER, EACH TENDON",,,3054.93,9324.0,15 RC,360,"TENOTOMY, OPEN, EXTENSOR, FOOT OR TOE, EACH TENDON",,,1506.85,9324.0,15 RC,360,"TENOTOMY, OPEN, FLEXOR OR EXTENSOR TENDON, FOREARM AND/OR WRIST, SINGLE, EACH TENDON",,,3054.93,13194.0,15 RC,360,"TENOTOMY, OPEN, HAMSTRING, KNEE TO HIP; MULTIPLE TENDONS, 1 LEG",,,3054.93,9324.0,15 RC,360,"TENOTOMY, OPEN, TENDON FLEXOR; FOOT, SINGLE OR MULTIPLE TENDON(S) (SEPARATE PROCEDURE)",,,1506.85,9324.0,14 RC,360,"TENOTOMY, OPEN, TENDON FLEXOR; TOE, SINGLE TENDON (SEPARATE PROCEDURE)",,,1506.85,9324.0,14 RC,360,"TENOTOMY, PERCUTANEOUS, ACHILLES TENDON (SEPARATE PROCEDURE); GENERAL ANESTHESIA",,,3054.93,9324.0,15 RC,360,"TENOTOMY, PERCUTANEOUS, TOE; SINGLE TENDON",,,1506.85,9324.0,14 RC,360,"TENOTOMY, SHOULDER AREA; MULTIPLE TENDONS THROUGH SAME INCISION",,,5152.0,13194.0,15 RC,360,"TENOTOMY, SHOULDER AREA; SINGLE TENDON",,,5152.0,13194.0,15 RC,360,"THORACENTESIS, NEEDLE OR CATHETER, ASPIRATION OF THE PLEURAL SPACE; WITHOUT IMAGING GUIDANCE",,,582.12,5449.0,15 RC,360,"THORACIC FASCIAL PLANE BLOCK, BILATERAL; BY INJECTION(S), INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,777.0,5449.0,3 RC,360,"THORACIC FASCIAL PLANE BLOCK, UNILATERAL; BY INJECTION(S), INCLUDING IMAGING GUIDANCE, WHEN PERFORMED",,,777.0,5449.0,3 RC,360,"THORACOSCOPY, DIAGNOSTIC (SEPARATE PROCEDURE); LUNGS, PERICARDIAL SAC, MEDIASTINAL OR PLEURAL SPACE, WITHOUT BIOPSY",,,5493.28,15394.0,14 RC,360,"THORACOSCOPY, DIAGNOSTIC (SEPARATE PROCEDURE); MEDIASTINAL SPACE, WITH BIOPSY",,,5493.28,15394.0,14 RC,360,"THORACOSCOPY, SURGICAL; WITH DIAGNOSTIC WEDGE RESECTION FOLLOWED BY ANATOMIC LUNG RESECTION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,2533.0,4850.0,2 RC,360,"THORACOSCOPY, SURGICAL; WITH LOBECTOMY (SINGLE LOBE)",,,2533.0,4850.0,2 RC,360,"THORACOSCOPY, SURGICAL; WITH MEDIASTINAL AND REGIONAL LYMPHADENECTOMY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,2533.0,4850.0,2 RC,360,"THORACOSCOPY, SURGICAL; WITH PLEURODESIS (EG, MECHANICAL OR CHEMICAL)",,,17956.0,30725.0,2 RC,360,"THORACOSCOPY, SURGICAL; WITH THERAPEUTIC WEDGE RESECTION (EG, MASS, NODULE), INITIAL UNILATERAL",,,2533.0,4850.0,2 RC,360,"THORACOSCOPY, SURGICAL; WITH THORACIC SYMPATHECTOMY",,,7278.0,13194.0,3 RC,360,THORACOSCOPY; WITH BIOPSY(IES) OF PLEURA,,,5493.28,17457.0,15 RC,360,"THORACOSCOPY; WITH DIAGNOSTIC BIOPSY(IES) OF LUNG INFILTRATE(S) (EG, WEDGE, INCISIONAL), UNILATERAL",,,8413.0,17457.0,15 RC,360,"THORACOSCOPY; WITH DIAGNOSTIC BIOPSY(IES) OF LUNG NODULE(S) OR MASS(ES) (EG, WEDGE, INCISIONAL), UNILATERAL",,,8413.0,17457.0,15 RC,360,THORACOTOMY; WITH CARDIAC MASSAGE,,,2533.0,4850.0,2 RC,360,"THORACOTOMY; WITH THERAPEUTIC WEDGE RESECTION (EG, MASS, NODULE), INITIAL",,,2533.0,4850.0,2 RC,360,"THYMECTOMY, PARTIAL OR TOTAL; TRANSCERVICAL APPROACH (SEPARATE PROCEDURE)",,,5569.83,15394.0,14 RC,360,"THYROIDECTOMY, INCLUDING SUBSTERNAL THYROID; CERVICAL APPROACH",,,5569.83,15394.0,14 RC,360,"THYROIDECTOMY, INCLUDING SUBSTERNAL THYROID; STERNAL SPLIT OR TRANSTHORACIC APPROACH",,,3012.0,5239.0,2 RC,360,"THYROIDECTOMY, REMOVAL OF ALL REMAINING THYROID TISSUE FOLLOWING PREVIOUS REMOVAL OF A PORTION OF THYROID",,,5569.83,15394.0,14 RC,360,"THYROIDECTOMY, TOTAL OR COMPLETE",,,5493.28,21454.0,14 RC,360,"THYROIDECTOMY, TOTAL OR SUBTOTAL FOR MALIGNANCY; WITH LIMITED NECK DISSECTION",,,5569.83,15394.0,14 RC,360,"THYROIDECTOMY, TOTAL OR SUBTOTAL FOR MALIGNANCY; WITH RADICAL NECK DISSECTION",,,5514.0,15291.0,3 RC,360,"TISSUE EXPANDER PLACEMENT IN BREAST RECONSTRUCTION, INCLUDING SUBSEQUENT EXPANSION(S)",,,9350.0,21454.0,15 RC,360,TONSILLECTOMY AND ADENOIDECTOMY; AGE 12 OR OVER,,,3053.48,12615.0,15 RC,360,TONSILLECTOMY AND ADENOIDECTOMY; YOUNGER THAN AGE 12,,,5514.0,9324.0,15 RC,360,"TONSILLECTOMY, PRIMARY OR SECONDARY; AGE 12 OR OVER",,,3053.48,10561.0,15 RC,360,"TONSILLECTOMY, PRIMARY OR SECONDARY; YOUNGER THAN AGE 12",,,5514.0,10561.0,15 RC,360,"TOTAL ABDOMINAL HYSTERECTOMY (CORPUS AND CERVIX), WITH OR WITHOUT REMOVAL OF TUBE(S), WITH OR WITHOUT REMOVAL OF OVARY(S);",,,7444.0,15291.0,3 RC,360,"TOTAL DISC ARTHROPLASTY (ARTIFICIAL DISC), ANTERIOR APPROACH, INCLUDING DISCECTOMY WITH END PLATE PREPARATION (INCLUDES OSTEOPHYTECTOMY FOR NERVE ROOT OR SPINAL CORD DECOMPRESSION AND MICRODISSECTION)",,,777.0,21454.0,17 RC,360,TOTAL FACIAL NERVE DECOMPRESSION AND/OR REPAIR (MAY INCLUDE GRAFT),,,5569.83,15394.0,14 RC,360,"TOTAL THYROID LOBECTOMY, UNILATERAL; WITH CONTRALATERAL SUBTOTAL LOBECTOMY, INCLUDING ISTHMUSECTOMY",,,5493.28,21454.0,15 RC,360,"TOTAL THYROID LOBECTOMY, UNILATERAL; WITH OR WITHOUT ISTHMUSECTOMY",,,5152.0,21454.0,15 RC,360,"TRACHELECTOMY (CERVICECTOMY), AMPUTATION OF CERVIX (SEPARATE PROCEDURE)",,,4647.86,9324.0,15 RC,360,"TRACHELORRHAPHY, PLASTIC REPAIR OF UTERINE CERVIX, VAGINAL APPROACH",,,2993.65,9324.0,15 RC,360,TRACHEOBRONCHOSCOPY THROUGH ESTABLISHED TRACHEOSTOMY INCISION,,,479.48,5449.0,15 RC,360,"TRACHEOSTOMA REVISION; COMPLEX, WITH FLAP ROTATION",,,5152.0,15394.0,15 RC,360,"TRACHEOSTOMA REVISION; SIMPLE, WITHOUT FLAP ROTATION",,,3053.48,9324.0,15 RC,360,"TRACHEOSTOMY, PLANNED (SEPARATE PROCEDURE);",,,3053.48,9324.0,15 RC,360,TRACHEOTOMY TUBE CHANGE PRIOR TO ESTABLISHMENT OF FISTULA TRACT,,,218.65,5449.0,15 RC,360,"TRANSCATHETER PLACEMENT OF AN INTRAVASCULAR STENT(S) (EXCEPT LOWER EXTREMITY ARTERY(S) FOR OCCLUSIVE DISEASE, CERVICAL CAROTID, EXTRACRANIAL VERTEBRAL OR INTRATHORACIC CAROTID, INTRACRANIAL, OR CORONA",,,5449.0,30725.0,17 RC,360,"TRANSCATHETER PLACEMENT OF AN INTRAVASCULAR STENT(S), OPEN OR PERCUTANEOUS, INCLUDING RADIOLOGICAL SUPERVISION AND INTERPRETATION AND INCLUDING ANGIOPLASTY WITHIN THE SAME VESSEL, WHEN PERFORMED; INIT",,,8413.0,30725.0,14 RC,360,"TRANSCERVICAL INTRODUCTION OF FALLOPIAN TUBE CATHETER FOR DIAGNOSIS AND/OR RE-ESTABLISHING PATENCY (ANY METHOD), WITH OR WITHOUT HYSTEROSALPINGOGRAPHY",,,2993.65,9324.0,14 RC,360,"TRANSECTION OR AVULSION OF OTHER SPINAL NERVE, EXTRADURAL",,,1838.62,9324.0,15 RC,360,"TRANSECTION OR AVULSION OF; FACIAL NERVE, DIFFERENTIAL OR COMPLETE",,,1838.62,9324.0,15 RC,360,TRANSECTION OR AVULSION OF; GREATER OCCIPITAL NERVE,,,1838.62,9324.0,15 RC,360,TRANSFER OF TENDON TO RESTORE INTRINSIC FUNCTION; ALL 4 FINGERS,,,3054.93,13194.0,15 RC,360,TRANSFER OF TENDON TO RESTORE INTRINSIC FUNCTION; RING AND SMALL FINGER,,,3054.93,13194.0,15 RC,360,"TRANSFER OR TRANSPLANT OF SINGLE TENDON (WITH MUSCLE REDIRECTION OR REROUTING); DEEP (EG, ANTERIOR TIBIAL OR POSTERIOR TIBIAL THROUGH INTEROSSEOUS SPACE, FLEXOR DIGITORUM LONGUS, FLEXOR HALLUCIS LONGU",,,6726.11,15394.0,15 RC,360,"TRANSFER OR TRANSPLANT OF SINGLE TENDON (WITH MUSCLE REDIRECTION OR REROUTING); SUPERFICIAL (EG, ANTERIOR TIBIAL EXTENSORS INTO MIDFOOT)",,,6726.11,15394.0,15 RC,360,"TRANSFER OR TRANSPLANT OF TENDON, CARPOMETACARPAL AREA OR DORSUM OF HAND; WITH FREE TENDON GRAFT (INCLUDES OBTAINING GRAFT), EACH TENDON",,,3054.93,13194.0,15 RC,360,"TRANSFER OR TRANSPLANT OF TENDON, CARPOMETACARPAL AREA OR DORSUM OF HAND; WITHOUT FREE GRAFT, EACH TENDON",,,3054.93,13194.0,15 RC,360,"TRANSFER OR TRANSPLANT OF TENDON, PALMAR; WITHOUT FREE TENDON GRAFT, EACH TENDON",,,3054.93,13194.0,15 RC,360,"TRANSFER, FINGER TO ANOTHER POSITION WITHOUT MICROVASCULAR ANASTOMOSIS",,,6649.0,13194.0,15 RC,360,"TRANSFER, INTERMEDIATE, OF ANY PEDICLE FLAP (EG, ABDOMEN TO WRIST, WALKING TUBE), ANY LOCATION",,,1722.29,12615.0,15 RC,360,"TRANSLUMINAL BALLOON ANGIOPLASTY (EXCEPT DIALYSIS CIRCUIT), OPEN OR PERCUTANEOUS, INCLUDING ALL IMAGING AND RADIOLOGICAL SUPERVISION AND INTERPRETATION NECESSARY TO PERFORM THE ANGIOPLASTY WITHIN THE ",,,777.0,21454.0,17 RC,360,"TRANSLUMINAL BALLOON ANGIOPLASTY (EXCEPT LOWER EXTREMITY ARTERY(IES) FOR OCCLUSIVE DISEASE, INTRACRANIAL, CORONARY, PULMONARY, OR DIALYSIS CIRCUIT), OPEN OR PERCUTANEOUS, INCLUDING ALL IMAGING AND RAD",,,5368.21,21454.0,14 RC,360,"TRANSLUMINAL BALLOON ANGIOPLASTY, CENTRAL DIALYSIS SEGMENT, PERFORMED THROUGH DIALYSIS CIRCUIT, INCLUDING ALL IMAGING AND RADIOLOGICAL SUPERVISION AND INTERPRETATION REQUIRED TO PERFORM THE ANGIOPLAST",,,777.0,5449.0,3 RC,360,"TRANSPEDICULAR APPROACH WITH DECOMPRESSION OF SPINAL CORD, EQUINA AND/OR NERVE ROOT(S) (EG, HERNIATED INTERVERTEBRAL DISC), SINGLE SEGMENT; LUMBAR (INCLUDING TRANSFACET, OR LATERAL EXTRAFORAMINAL APPR",,,6726.11,21454.0,15 RC,360,"TRANSPERINEAL PLACEMENT OF BIODEGRADABLE MATERIAL, PERI-PROSTATIC, SINGLE OR MULTIPLE INJECTION(S), INCLUDING IMAGE GUIDANCE, WHEN PERFORMED",,,4786.44,21454.0,15 RC,360,"TRANSPOSITION PROCEDURE (EG, FOR PARETIC EXTRAOCULAR MUSCLE), ANY EXTRAOCULAR MUSCLE (SPECIFY) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,10561.0,3 RC,360,"TRANSPOSITION, OVARY(S)",,,7444.0,13194.0,3 RC,360,TRANSURETHRAL DESTRUCTION OF PROSTATE TISSUE; BY RADIOFREQUENCY GENERATED WATER VAPOR THERMOTHERAPY,,,3247.35,17457.0,15 RC,360,TRANSURETHRAL DESTRUCTION OF PROSTATE TISSUE; BY RADIOFREQUENCY THERMOTHERAPY,,,3247.35,15394.0,14 RC,360,"TRANSURETHRAL ELECTROSURGICAL RESECTION OF PROSTATE, INCLUDING CONTROL OF POSTOPERATIVE BLEEDING, COMPLETE (VASECTOMY, MEATOTOMY, CYSTOURETHROSCOPY, URETHRAL CALIBRATION AND/OR DILATION, AND INTERNAL ",,,4786.44,15394.0,15 RC,360,TRANSURETHRAL INCISION OF PROSTATE,,,3247.35,9324.0,15 RC,360,TRANSURETHRAL RESECTION OF BLADDER NECK (SEPARATE PROCEDURE),,,3247.35,9324.0,15 RC,360,TRANSURETHRAL RESECTION; OF POSTOPERATIVE BLADDER NECK CONTRACTURE,,,3247.35,9324.0,15 RC,360,"TRANSURETHRAL RESECTION; RESIDUAL OR REGROWTH OF OBSTRUCTIVE PROSTATE TISSUE INCLUDING CONTROL OF POSTOPERATIVE BLEEDING, COMPLETE (VASECTOMY, MEATOTOMY, CYSTOURETHROSCOPY, URETHRAL CALIBRATION AND/OR",,,4786.44,15394.0,15 RC,360,"TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK (ABDOMINAL PLANE BLOCK, RECTUS SHEATH BLOCK) BILATERAL; BY CONTINUOUS INFUSIONS (INCLUDES IMAGING GUIDANCE, WHEN PERFORMED)",,,777.0,7278.0,3 RC,360,"TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK (ABDOMINAL PLANE BLOCK, RECTUS SHEATH BLOCK) BILATERAL; BY INJECTIONS (INCLUDES IMAGING GUIDANCE, WHEN PERFORMED)",,,777.0,7278.0,3 RC,360,"TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK (ABDOMINAL PLANE BLOCK, RECTUS SHEATH BLOCK) UNILATERAL; BY CONTINUOUS INFUSION(S) (INCLUDES IMAGING GUIDANCE, WHEN PERFORMED)",,,777.0,7278.0,3 RC,360,"TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK (ABDOMINAL PLANE BLOCK, RECTUS SHEATH BLOCK) UNILATERAL; BY INJECTION(S) (INCLUDES IMAGING GUIDANCE, WHEN PERFORMED)",,,777.0,7278.0,3 RC,360,"TREATMENT OF EXTENSIVE OR PROGRESSIVE RETINOPATHY (EG, DIABETIC RETINOPATHY), PHOTOCOAGULATION",,,516.52,5449.0,15 RC,360,"TREATMENT OF EXTENSIVE OR PROGRESSIVE RETINOPATHY, 1 OR MORE SESSIONS, PRETERM INFANT (LESS THAN 37 WEEKS GESTATION AT BIRTH), PERFORMED FROM BIRTH UP TO 1 YEAR OF AGE (EG, RETINOPATHY OF PREMATURITY)",,,516.52,7278.0,14 RC,360,"TREATMENT OF HUMERAL SHAFT FRACTURE, WITH INSERTION OF INTRAMEDULLARY IMPLANT, WITH OR WITHOUT CERCLAGE AND/OR LOCKING SCREWS",,,8213.0,21454.0,15 RC,360,"TREATMENT OF INCOMPLETE ABORTION, ANY TRIMESTER, COMPLETED SURGICALLY",,,2993.65,12615.0,15 RC,360,"TREATMENT OF INTERTROCHANTERIC, PERITROCHANTERIC, OR SUBTROCHANTERIC FEMORAL FRACTURE; WITH INTRAMEDULLARY IMPLANT, WITH OR WITHOUT INTERLOCKING SCREWS AND/OR CERCLAGE",,,9974.0,15394.0,3 RC,360,"TREATMENT OF INTERTROCHANTERIC, PERITROCHANTERIC, OR SUBTROCHANTERIC FEMORAL FRACTURE; WITH PLATE/SCREW TYPE IMPLANT, WITH OR WITHOUT CERCLAGE",,,12615.0,21454.0,3 RC,360,"TREATMENT OF MISSED ABORTION, COMPLETED SURGICALLY; FIRST TRIMESTER",,,2993.65,12615.0,15 RC,360,"TREATMENT OF MISSED ABORTION, COMPLETED SURGICALLY; SECOND TRIMESTER",,,2993.65,12615.0,15 RC,360,"TREATMENT OF SEPTIC ABORTION, COMPLETED SURGICALLY",,,2533.0,7278.0,3 RC,360,"TREATMENT OF SLIPPED FEMORAL EPIPHYSIS; BY SINGLE OR MULTIPLE PINNING, IN SITU",,,12615.0,21454.0,3 RC,360,"TREATMENT OF SPONTANEOUS HIP DISLOCATION (DEVELOPMENTAL, INCLUDING CONGENITAL OR PATHOLOGICAL), BY ABDUCTION, SPLINT OR TRACTION; WITH MANIPULATION, REQUIRING ANESTHESIA",,,1506.85,8413.0,15 RC,360,TREATMENT OF SUPERFICIAL WOUND DEHISCENCE; SIMPLE CLOSURE,,,576.34,5449.0,15 RC,360,TREATMENT OF SUPERFICIAL WOUND DEHISCENCE; WITH PACKING,,,376.18,5449.0,15 RC,360,"TREATMENT OF TIBIAL SHAFT FRACTURE (WITH OR WITHOUT FIBULAR FRACTURE) BY INTRAMEDULLARY IMPLANT, WITH OR WITHOUT INTERLOCKING SCREWS AND/OR CERCLAGE",,,8213.0,21454.0,15 RC,360,"TUBE THORACOSTOMY, INCLUDES CONNECTION TO DRAINAGE SYSTEM (EG, WATER SEAL), WHEN PERFORMED, OPEN (SEPARATE PROCEDURE)",,,1462.62,7278.0,15 RC,360,"TWIST DRILL HOLE(S) FOR SUBDURAL, INTRACEREBRAL, OR VENTRICULAR PUNCTURE; FOR IMPLANTING VENTRICULAR CATHETER, PRESSURE RECORDING DEVICE, OR OTHER INTRACEREBRAL MONITORING DEVICE",,,2533.0,4850.0,2 RC,360,"TWIST DRILL, BURR HOLE, CRANIOTOMY, OR CRANIECTOMY WITH STEREOTACTIC IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY IN SUBCORTICAL SITE (EG, THALAMUS, GLOBUS PALLIDUS, SUBTHALAMIC NUCLEUS, PERIVENTRI",,,2533.0,4850.0,8 RC,360,"TYMPANIC MEMBRANE REPAIR, WITH OR WITHOUT SITE PREPARATION OF PERFORATION FOR CLOSURE, WITH OR WITHOUT PATCH",,,1394.69,9324.0,14 RC,360,"TYMPANOLYSIS, TRANSCANAL",,,3053.48,15394.0,15 RC,360,"TYMPANOPLASTY WITH ANTROTOMY OR MASTOIDOTOMY (INCLUDING CANALPLASTY, ATTICOTOMY, MIDDLE EAR SURGERY, AND/OR TYMPANIC MEMBRANE REPAIR); WITH OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH ANTROTOMY OR MASTOIDOTOMY (INCLUDING CANALPLASTY, ATTICOTOMY, MIDDLE EAR SURGERY, AND/OR TYMPANIC MEMBRANE REPAIR); WITH OSSICULAR CHAIN RECONSTRUCTION AND SYNTHETIC PROSTHESIS (EG,",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH ANTROTOMY OR MASTOIDOTOMY (INCLUDING CANALPLASTY, ATTICOTOMY, MIDDLE EAR SURGERY, AND/OR TYMPANIC MEMBRANE REPAIR); WITHOUT OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH MASTOIDECTOMY (INCLUDING CANALPLASTY, MIDDLE EAR SURGERY, TYMPANIC MEMBRANE REPAIR); RADICAL OR COMPLETE, WITH OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH MASTOIDECTOMY (INCLUDING CANALPLASTY, MIDDLE EAR SURGERY, TYMPANIC MEMBRANE REPAIR); RADICAL OR COMPLETE, WITHOUT OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH MASTOIDECTOMY (INCLUDING CANALPLASTY, MIDDLE EAR SURGERY, TYMPANIC MEMBRANE REPAIR); WITH INTACT OR RECONSTRUCTED CANAL WALL, WITH OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH MASTOIDECTOMY (INCLUDING CANALPLASTY, MIDDLE EAR SURGERY, TYMPANIC MEMBRANE REPAIR); WITH INTACT OR RECONSTRUCTED WALL, WITHOUT OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH MASTOIDECTOMY (INCLUDING CANALPLASTY, MIDDLE EAR SURGERY, TYMPANIC MEMBRANE REPAIR); WITH OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITH MASTOIDECTOMY (INCLUDING CANALPLASTY, MIDDLE EAR SURGERY, TYMPANIC MEMBRANE REPAIR); WITHOUT OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITHOUT MASTOIDECTOMY (INCLUDING CANALPLASTY, ATTICOTOMY AND/OR MIDDLE EAR SURGERY), INITIAL OR REVISION; WITH OSSICULAR CHAIN RECONSTRUCTION (EG, POSTFENESTRATION)",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITHOUT MASTOIDECTOMY (INCLUDING CANALPLASTY, ATTICOTOMY AND/OR MIDDLE EAR SURGERY), INITIAL OR REVISION; WITH OSSICULAR CHAIN RECONSTRUCTION AND SYNTHETIC PROSTHESIS (EG, PARTIAL OSSICU",,,5569.83,15394.0,15 RC,360,"TYMPANOPLASTY WITHOUT MASTOIDECTOMY (INCLUDING CANALPLASTY, ATTICOTOMY AND/OR MIDDLE EAR SURGERY), INITIAL OR REVISION; WITHOUT OSSICULAR CHAIN RECONSTRUCTION",,,5569.83,15394.0,15 RC,360,"TYMPANOSTOMY (REQUIRING INSERTION OF VENTILATING TUBE), GENERAL ANESTHESIA",,,1394.69,8413.0,15 RC,360,"TYMPANOSTOMY (REQUIRING INSERTION OF VENTILATING TUBE), LOCAL OR TOPICAL ANESTHESIA",,,479.48,8413.0,15 RC,360,"UMBILECTOMY, OMPHALECTOMY, EXCISION OF UMBILICUS (SEPARATE PROCEDURE)",,,3322.75,13194.0,15 RC,360,"UNLISTED HYSTEROSCOPY PROCEDURE, UTERUS",,,189.41,8413.0,14 RC,360,"UNLISTED LAPAROSCOPIC PROCEDURE, LIVER",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, ABDOMEN, PERITONEUM AND OMENTUM",,,5449.0,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, APPENDIX",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, BLADDER",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, ESOPHAGUS",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, HERNIOPLASTY, HERNIORRHAPHY, HERNIOTOMY",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, INTESTINE (EXCEPT RECTUM)",,,5493.28,15394.0,13 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, LYMPHATIC SYSTEM",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, MATERNITY CARE AND DELIVERY",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, OVIDUCT, OVARY",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, SPERMATIC CORD",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, SPLEEN",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, STOMACH",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, URETER",,,5493.28,15394.0,14 RC,360,"UNLISTED LAPAROSCOPY PROCEDURE, UTERUS",,,5493.28,15394.0,14 RC,360,"UNLISTED MUSCULOSKELETAL PROCEDURE, HEAD",,,218.65,1251.0,13 RC,360,"UNLISTED PROCEDURE, ABDOMEN, MUSCULOSKELETAL SYSTEM",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, ABDOMEN, PERITONEUM AND OMENTUM",,,882.75,5449.0,14 RC,360,"UNLISTED PROCEDURE, ACCESSORY SINUSES",,,218.65,1251.0,13 RC,360,"UNLISTED PROCEDURE, ANTERIOR SEGMENT OF EYE",,,2147.4,5449.0,14 RC,360,"UNLISTED PROCEDURE, ANUS",,,858.41,5449.0,14 RC,360,"UNLISTED PROCEDURE, ARTHROSCOPY",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, BREAST",,,3605.42,9324.0,14 RC,360,"UNLISTED PROCEDURE, CARDIAC SURGERY",,,582.12,3517.0,13 RC,360,"UNLISTED PROCEDURE, COLON",,,858.41,9350.0,15 RC,360,"UNLISTED PROCEDURE, DENTOALVEOLAR STRUCTURES",,,218.65,5449.0,14 RC,360,"UNLISTED PROCEDURE, ENDOCRINE SYSTEM",,,5449.0,21454.0,14 RC,360,"UNLISTED PROCEDURE, EYELIDS",,,281.46,1251.0,13 RC,360,"UNLISTED PROCEDURE, FEMALE GENITAL SYSTEM (NONOBSTETRICAL)",,,189.41,5449.0,14 RC,360,"UNLISTED PROCEDURE, FEMUR OR KNEE",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, FOOT OR TOES",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, HEMIC OR LYMPHATIC SYSTEM",,,411.62,5449.0,14 RC,360,"UNLISTED PROCEDURE, HUMERUS OR ELBOW",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, INNER EAR",,,218.65,5449.0,14 RC,360,"UNLISTED PROCEDURE, LACRIMAL SYSTEM",,,281.46,1251.0,13 RC,360,"UNLISTED PROCEDURE, LARYNX",,,218.65,5449.0,14 RC,360,"UNLISTED PROCEDURE, LEG OR ANKLE",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, MALE GENITAL SYSTEM",,,228.99,7278.0,14 RC,360,"UNLISTED PROCEDURE, MATERNITY CARE AND DELIVERY",,,189.41,7278.0,14 RC,360,"UNLISTED PROCEDURE, MIDDLE EAR",,,218.65,5449.0,14 RC,360,"UNLISTED PROCEDURE, MUSCULOSKELETAL SYSTEM, GENERAL",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, NECK OR THORAX",,,218.65,1251.0,13 RC,360,"UNLISTED PROCEDURE, NERVOUS SYSTEM",,,277.93,5449.0,14 RC,360,"UNLISTED PROCEDURE, NOSE",,,218.65,5449.0,14 RC,360,"UNLISTED PROCEDURE, PELVIS OR HIP JOINT",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, PHARYNX, ADENOIDS, OR TONSILS",,,218.65,5449.0,14 RC,360,"UNLISTED PROCEDURE, POSTERIOR SEGMENT",,,2147.4,5239.0,13 RC,360,"UNLISTED PROCEDURE, RECTUM",,,858.41,3517.0,13 RC,360,"UNLISTED PROCEDURE, SALIVARY GLANDS OR DUCTS",,,218.65,5449.0,14 RC,360,"UNLISTED PROCEDURE, SKIN, MUCOUS MEMBRANE AND SUBCUTANEOUS TISSUE",,,187.08,5449.0,14 RC,360,"UNLISTED PROCEDURE, SMALL INTESTINE",,,882.75,5449.0,14 RC,360,"UNLISTED PROCEDURE, SPINE",,,225.85,5449.0,14 RC,360,"UNLISTED PROCEDURE, TONGUE, FLOOR OF MOUTH",,,218.65,1251.0,13 RC,360,"UNLISTED PROCEDURE, TRACHEA, BRONCHI",,,182.79,5449.0,14 RC,360,"UNLISTED PROCEDURE, URINARY SYSTEM",,,228.99,5449.0,14 RC,360,"UNLISTED PROCEDURE, VASCULAR SURGERY",,,582.12,7278.0,14 RC,360,"UNLISTED PROCEDURE, VESTIBULE OF MOUTH",,,218.65,12615.0,14 RC,360,"URETERAL ENDOSCOPY THROUGH ESTABLISHED URETEROSTOMY, WITH OR WITHOUT IRRIGATION, INSTILLATION, OR URETEROPYELOGRAPHY, EXCLUSIVE OF RADIOLOGIC SERVICE;",,,2246.0,5449.0,15 RC,360,"URETERAL ENDOSCOPY THROUGH ESTABLISHED URETEROSTOMY, WITH OR WITHOUT IRRIGATION, INSTILLATION, OR URETEROPYELOGRAPHY, EXCLUSIVE OF RADIOLOGIC SERVICE; WITH REMOVAL OF FOREIGN BODY OR CALCULUS",,,4121.0,9324.0,15 RC,360,"URETERAL ENDOSCOPY THROUGH ESTABLISHED URETEROSTOMY, WITH OR WITHOUT IRRIGATION, INSTILLATION, OR URETEROPYELOGRAPHY, EXCLUSIVE OF RADIOLOGIC SERVICE; WITH URETERAL CATHETERIZATION, WITH OR WITHOUT DI",,,3012.0,5449.0,15 RC,360,"URETERECTOMY, WITH BLADDER CUFF (SEPARATE PROCEDURE)",,,2533.0,13764.0,3 RC,360,"URETEROCALYCOSTOMY, ANASTOMOSIS OF URETER TO RENAL CALYX",,,2533.0,4850.0,2 RC,360,"URETEROLYSIS, WITH OR WITHOUT REPOSITIONING OF URETER FOR RETROPERITONEAL FIBROSIS",,,2533.0,4850.0,2 RC,360,URETERONEOCYSTOSTOMY; ANASTOMOSIS OF SINGLE URETER TO BLADDER,,,5514.0,9324.0,2 RC,360,URETERONEOCYSTOSTOMY; WITH VESICO-PSOAS HITCH OR BLADDER FLAP,,,2533.0,4850.0,2 RC,360,"URETEROSTOMY, TRANSPLANTATION OF URETER TO SKIN",,,2533.0,4850.0,2 RC,360,"URETEROTOMY FOR INSERTION OF INDWELLING STENT, ALL TYPES",,,2533.0,12615.0,3 RC,360,URETEROURETEROSTOMY,,,2533.0,4850.0,2 RC,360,"URETHRECTOMY, TOTAL, INCLUDING CYSTOSTOMY; FEMALE",,,3247.35,13194.0,15 RC,360,"URETHRECTOMY, TOTAL, INCLUDING CYSTOSTOMY; MALE",,,4786.44,12615.0,15 RC,360,"URETHROMEATOPLASTY, WITH MUCOSAL ADVANCEMENT",,,3247.35,13194.0,15 RC,360,"URETHROMEATOPLASTY, WITH PARTIAL EXCISION OF DISTAL URETHRAL SEGMENT (RICHARDSON TYPE PROCEDURE)",,,3247.35,9324.0,15 RC,360,URETHROPLASTY FOR SECOND STAGE HYPOSPADIAS REPAIR (INCLUDING URINARY DIVERSION) WITH FREE SKIN GRAFT OBTAINED FROM SITE OTHER THAN GENITALIA,,,6649.0,13194.0,15 RC,360,URETHROPLASTY FOR SECOND STAGE HYPOSPADIAS REPAIR (INCLUDING URINARY DIVERSION); GREATER THAN 3 CM,,,3247.35,13194.0,15 RC,360,URETHROPLASTY FOR SECOND STAGE HYPOSPADIAS REPAIR (INCLUDING URINARY DIVERSION); LESS THAN 3 CM,,,4786.44,15394.0,15 RC,360,"URETHROPLASTY, 1-STAGE RECONSTRUCTION OF MALE ANTERIOR URETHRA",,,4786.44,13194.0,15 RC,360,"URETHROPLASTY, 2-STAGE RECONSTRUCTION OR REPAIR OF PROSTATIC OR MEMBRANOUS URETHRA; FIRST STAGE",,,4786.44,13194.0,15 RC,360,"URETHROPLASTY, 2-STAGE RECONSTRUCTION OR REPAIR OF PROSTATIC OR MEMBRANOUS URETHRA; SECOND STAGE",,,4786.44,13194.0,15 RC,360,"URETHROPLASTY, RECONSTRUCTION OF FEMALE URETHRA",,,4786.44,13194.0,15 RC,360,"URETHROPLASTY, TRANSPUBIC OR PERINEAL, 1-STAGE, FOR RECONSTRUCTION OR REPAIR OF PROSTATIC OR MEMBRANOUS URETHRA",,,9974.0,15394.0,2 RC,360,"URETHROPLASTY; FIRST STAGE, FOR FISTULA, DIVERTICULUM, OR STRICTURE (EG, JOHANNSEN TYPE)",,,4786.44,13194.0,15 RC,360,"URETHROPLASTY; SECOND STAGE (FORMATION OF URETHRA), INCLUDING URINARY DIVERSION",,,4786.44,13194.0,15 RC,360,"URETHRORRHAPHY, SUTURE OF URETHRAL WOUND OR INJURY; PENILE",,,4786.44,13194.0,15 RC,360,"URINARY UNDIVERSION (EG, TAKING DOWN OF URETEROILEAL CONDUIT, URETEROSIGMOIDOSTOMY OR URETEROENTEROSTOMY WITH URETEROURETEROSTOMY OR URETERONEOCYSTOSTOMY)",,,2533.0,4850.0,2 RC,360,USE OF OPHTHALMIC ENDOSCOPE (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,5449.0,3 RC,360,UTERINE EVACUATION AND CURETTAGE FOR HYDATIDIFORM MOLE,,,2993.65,12615.0,15 RC,360,"UVULECTOMY, EXCISION OF UVULA",,,3012.0,7278.0,15 RC,360,"VAGINAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS;",,,4647.86,17457.0,15 RC,360,"VAGINAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS; WITH REMOVAL OF TUBE(S), AND/OR OVARY(S)",,,4647.86,17457.0,15 RC,360,"VAGINAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS; WITH REMOVAL OF TUBE(S), AND/OR OVARY(S), WITH REPAIR OF ENTEROCELE",,,4647.86,17457.0,15 RC,360,"VAGINAL HYSTERECTOMY, FOR UTERUS 250 G OR LESS; WITH REPAIR OF ENTEROCELE",,,4647.86,17457.0,15 RC,360,"VAGINAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G; WITH REMOVAL OF TUBE(S) AND/OR OVARY(S)",,,4647.86,15394.0,14 RC,360,"VAGINAL HYSTERECTOMY, FOR UTERUS GREATER THAN 250 G; WITH REPAIR OF ENTEROCELE",,,4647.86,15394.0,14 RC,360,"VAGINECTOMY, COMPLETE REMOVAL OF VAGINAL WALL;",,,2533.0,8413.0,3 RC,360,VAGINOPLASTY FOR INTERSEX STATE,,,4647.86,9324.0,14 RC,360,"VAGOTOMY INCLUDING PYLOROPLASTY, WITH OR WITHOUT GASTROSTOMY; PARIETAL CELL (HIGHLY SELECTIVE)",,,2533.0,4850.0,2 RC,360,"VASCULAR EMBOLIZATION OR OCCLUSION, INCLUSIVE OF ALL RADIOLOGICAL SUPERVISION AND INTERPRETATION, INTRAPROCEDURAL ROADMAPPING, AND IMAGING GUIDANCE NECESSARY TO COMPLETE THE INTERVENTION; ARTERIAL, OT",,,8413.0,30725.0,14 RC,360,"VASCULAR EMBOLIZATION OR OCCLUSION, INCLUSIVE OF ALL RADIOLOGICAL SUPERVISION AND INTERPRETATION, INTRAPROCEDURAL ROADMAPPING, AND IMAGING GUIDANCE NECESSARY TO COMPLETE THE INTERVENTION; FOR ARTERIAL",,,8413.0,30725.0,14 RC,360,"VASCULAR EMBOLIZATION OR OCCLUSION, INCLUSIVE OF ALL RADIOLOGICAL SUPERVISION AND INTERPRETATION, INTRAPROCEDURAL ROADMAPPING, AND IMAGING GUIDANCE NECESSARY TO COMPLETE THE INTERVENTION; FOR TUMORS, ",,,8413.0,30725.0,14 RC,360,"VASCULAR EMBOLIZATION OR OCCLUSION, INCLUSIVE OF ALL RADIOLOGICAL SUPERVISION AND INTERPRETATION, INTRAPROCEDURAL ROADMAPPING, AND IMAGING GUIDANCE NECESSARY TO COMPLETE THE INTERVENTION; VENOUS, OTHE",,,8413.0,30725.0,14 RC,360,"VASECTOMY, UNILATERAL OR BILATERAL (SEPARATE PROCEDURE), INCLUDING POSTOPERATIVE SEMEN EXAMINATION(S)",,,1928.76,9324.0,15 RC,360,VENTILATING TUBE REMOVAL REQUIRING GENERAL ANESTHESIA,,,3053.48,13194.0,15 RC,360,"VENTRICULOCISTERNOSTOMY, THIRD VENTRICLE;",,,2533.0,4850.0,2 RC,360,"VERTEBRAL CORPECTOMY (VERTEBRAL BODY RESECTION), PARTIAL OR COMPLETE, ANTERIOR APPROACH WITH DECOMPRESSION OF SPINAL CORD AND/OR NERVE ROOT(S); CERVICAL, EACH ADDITIONAL SEGMENT (LIST SEPARATELY IN AD",,,2533.0,4850.0,2 RC,360,"VERTEBRAL CORPECTOMY (VERTEBRAL BODY RESECTION), PARTIAL OR COMPLETE, ANTERIOR APPROACH WITH DECOMPRESSION OF SPINAL CORD AND/OR NERVE ROOT(S); CERVICAL, SINGLE SEGMENT",,,13844.0,21454.0,2 RC,360,"VESICULECTOMY, ANY APPROACH",,,2246.0,5449.0,3 RC,360,VESTIBULOPLASTY; ANTERIOR,,,5152.0,9324.0,15 RC,360,"VESTIBULOPLASTY; COMPLEX (INCLUDING RIDGE EXTENSION, MUSCLE REPOSITIONING)",,,5569.83,15394.0,15 RC,360,"VITRECTOMY, MECHANICAL, PARS PLANA APPROACH;",,,3787.69,15394.0,15 RC,360,"VITRECTOMY, MECHANICAL, PARS PLANA APPROACH; WITH ENDOLASER PANRETINAL PHOTOCOAGULATION",,,3787.69,15394.0,15 RC,360,"VITRECTOMY, MECHANICAL, PARS PLANA APPROACH; WITH FOCAL ENDOLASER PHOTOCOAGULATION",,,3787.69,15394.0,15 RC,360,"VITRECTOMY, MECHANICAL, PARS PLANA APPROACH; WITH REMOVAL OF INTERNAL LIMITING MEMBRANE OF RETINA (EG, FOR REPAIR OF MACULAR HOLE, DIABETIC MACULAR EDEMA), INCLUDES, IF PERFORMED, INTRAOCULAR TAMPONAD",,,3787.69,17457.0,15 RC,360,"VITRECTOMY, MECHANICAL, PARS PLANA APPROACH; WITH REMOVAL OF PRERETINAL CELLULAR MEMBRANE (EG, MACULAR PUCKER)",,,3787.69,17457.0,15 RC,360,"VOIDING PRESSURE STUDIES, INTRA-ABDOMINAL (IE, RECTAL, GASTRIC, INTRAPERITONEAL) (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,360,VULVECTOMY SIMPLE; COMPLETE,,,2993.65,13764.0,15 RC,360,VULVECTOMY SIMPLE; PARTIAL,,,2993.65,12615.0,15 RC,360,"VULVECTOMY, RADICAL, COMPLETE;",,,17956.0,30725.0,2 RC,360,"VULVECTOMY, RADICAL, PARTIAL;",,,7444.0,15291.0,3 RC,360,"WEDGE EXCISION OF SKIN OF NAIL FOLD (EG, FOR INGROWN TOENAIL)",,,376.18,5449.0,14 RC,361,"3D PREDICTIVE MODEL GENERATION FOR PRE-PLANNING OF A CARDIAC PROCEDURE, USING DATA FROM CARDIAC COMPUTED TOMOGRAPHIC ANGIOGRAPHY AND/OR MAGNETIC RESONANCE IMAGING WITH REPORT",,,957.91,1046.79,11 RC,361,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, EYELIDS, NOSE, EARS AND/OR LIPS; DEFECT 10 SQ CM OR LESS",,,1722.29,8413.0,15 RC,361,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, FOREHEAD, CHEEKS, CHIN, MOUTH, NECK, AXILLAE, GENITALIA, HANDS AND/OR FEET; DEFECT 10 SQ CM OR LESS",,,1722.29,7278.0,15 RC,361,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, SCALP, ARMS AND/OR LEGS; DEFECT 10 SQ CM OR LESS",,,1722.29,8413.0,15 RC,361,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, TRUNK; DEFECT 10 SQ CM OR LESS",,,1722.29,7278.0,15 RC,361,"ADJACENT TISSUE TRANSFER OR REARRANGEMENT, TRUNK; DEFECT 10.1 SQ CM TO 30.0 SQ CM",,,1722.29,8413.0,15 RC,361,"ADJUSTMENT OR REVISION OF EXTERNAL FIXATION SYSTEM REQUIRING ANESTHESIA (EG, NEW PIN[S] OR WIRE[S] AND/OR NEW RING[S] OR BAR[S])",,,6649.0,13194.0,15 RC,361,"AMPUTATION, FINGER OR THUMB, PRIMARY OR SECONDARY, ANY JOINT OR PHALANX, SINGLE, INCLUDING NEURECTOMIES; WITH DIRECT CLOSURE",,,3012.0,7278.0,15 RC,361,"ANOSCOPY; WITH DILATION (EG, BALLOON, GUIDE WIRE, BOUGIE)",,,1110.16,5449.0,14 RC,361,"APPLICATION OF CLUBFOOT CAST WITH MOLDING OR MANIPULATION, LONG OR SHORT LEG",,,148.57,1251.0,13 RC,361,APPLICATION OF LONG LEG CAST (THIGH TO TOES);,,,250.06,5449.0,14 RC,361,APPLICATION OF SHORT LEG CAST (BELOW KNEE TO TOES);,,,250.06,1251.0,13 RC,361,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA GREATER THAN OR EQUAL TO 100 SQ CM; FIRST 100 SQ CM WOUND SURFACE AREA, OR 1% OF BODY AREA OF INFANTS AND CHILDREN",,,3446.95,13194.0,15 RC,361,"APPLICATION OF SKIN SUBSTITUTE GRAFT TO TRUNK, ARMS, LEGS, TOTAL WOUND SURFACE AREA UP TO 100 SQ CM; FIRST 25 SQ CM OR LESS WOUND SURFACE AREA",,,1722.29,7278.0,15 RC,361,"ARTHROCENTESIS, ASPIRATION AND/OR INJECTION, INTERMEDIATE JOINT OR BURSA (EG, TEMPOROMANDIBULAR, ACROMIOCLAVICULAR, WRIST, ELBOW OR ANKLE, OLECRANON BURSA); WITHOUT ULTRASOUND GUIDANCE",,,277.93,5449.0,15 RC,361,"AUDITORY EVOKED POTENTIALS; FOR THRESHOLD ESTIMATION AT MULTIPLE FREQUENCIES, WITH INTERPRETATION AND REPORT",,,293.19,320.4,11 RC,361,"BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, INGUINOFEMORAL NODE(S)",,,3605.42,13194.0,14 RC,361,"BIOPSY OR EXCISION OF LYMPH NODE(S); OPEN, SUPERFICIAL",,,3605.42,9324.0,15 RC,361,"BIOPSY; NASOPHARYNX, VISIBLE LESION, SIMPLE",,,3012.0,5449.0,15 RC,361,"CERCLAGE OF CERVIX, DURING PREGNANCY; VAGINAL",,,2993.65,9324.0,15 RC,361,"CHEMODENERVATION OF ONE EXTREMITY; EACH ADDITIONAL EXTREMITY, 5 OR MORE MUSCLES (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,5449.0,3 RC,361,"CHEMODENERVATION OF PAROTID AND SUBMANDIBULAR SALIVARY GLANDS, BILATERAL",,,277.93,5449.0,14 RC,361,"CHEMOTHERAPY ADMINISTRATION, INTO CNS (EG, INTRATHECAL), REQUIRING AND INCLUDING SPINAL PUNCTURE",,,312.3,341.28,11 RC,361,"CIRCUMCISION, SURGICAL EXCISION OTHER THAN CLAMP, DEVICE, OR DORSAL SLIT; OLDER THAN 28 DAYS OF AGE",,,1928.76,9324.0,15 RC,361,CLOSED TREATMENT OF RADIAL HEAD OR NECK FRACTURE; WITH MANIPULATION,,,777.0,5449.0,15 RC,361,COLLECTION OF VENOUS BLOOD BY VENIPUNCTURE,,,6.83,9.64,12 RC,361,"COLONOSCOPY, FLEXIBLE; WITH BIOPSY, SINGLE OR MULTIPLE",,,1110.16,7278.0,15 RC,361,"DEBRIDEMENT, MASTOIDECTOMY CAVITY, SIMPLE (EG, ROUTINE CLEANING)",,,187.08,1251.0,13 RC,361,"DILATION AND CURETTAGE, DIAGNOSTIC AND/OR THERAPEUTIC (NONOBSTETRICAL)",,,2993.65,9324.0,15 RC,361,DILATION OF ANAL SPHINCTER (SEPARATE PROCEDURE) UNDER ANESTHESIA OTHER THAN LOCAL,,,1110.16,5449.0,15 RC,361,DILATION OF RECTAL STRICTURE (SEPARATE PROCEDURE) UNDER ANESTHESIA OTHER THAN LOCAL,,,1110.16,5449.0,15 RC,361,DILATION SALIVARY DUCT,,,1394.69,5449.0,15 RC,361,"DRAINAGE EXTERNAL EAR, ABSCESS OR HEMATOMA; SIMPLE",,,662.46,5449.0,14 RC,361,DRESSING CHANGE (FOR OTHER THAN BURNS) UNDER ANESTHESIA (OTHER THAN LOCAL),,,576.34,5449.0,14 RC,361,"DUODENAL INTUBATION AND ASPIRATION, DIAGNOSTIC, INCLUDES IMAGE GUIDANCE; COLLECTION OF MULTIPLE FRACTIONAL SPECIMENS WITH PANCREATIC OR GALLBLADDER STIMULATION, SINGLE OR DOUBLE LUMEN TUBE, INCLUDES D",,,882.75,5449.0,15 RC,361,ELECTRICAL STIMULATION FOR GUIDANCE IN CONJUNCTION WITH CHEMODENERVATION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,,,0 RC,361,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH BIOPSY, SINGLE OR MULTIPLE",,,882.75,7278.0,15 RC,361,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF FOREIGN BODY(S)",,,882.75,7278.0,15 RC,361,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC BALLOON DILATION (LESS THAN 30 MM DIAMETER)",,,1786.09,7278.0,15 RC,361,EXCISION AURAL POLYP,,,1394.69,7278.0,14 RC,361,"EXCISION OF LESION OF MUCOSA AND SUBMUCOSA, VESTIBULE OF MOUTH; WITH SIMPLE REPAIR",,,1394.69,5449.0,14 RC,361,"EXCISION OF SKIN AND SUBCUTANEOUS TISSUE FOR HIDRADENITIS, AXILLARY; WITH SIMPLE OR INTERMEDIATE REPAIR",,,2694.74,9324.0,15 RC,361,"EXCISION SOFT TISSUE LESION, EXTERNAL AUDITORY CANAL",,,2694.74,7278.0,15 RC,361,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS",,,1525.52,7278.0,15 RC,361,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM",,,1525.52,5449.0,15 RC,361,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 RC,361,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,5449.0,15 RC,361,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,15 RC,361,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,5449.0,15 RC,361,"EXCISION, BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), TRUNK, ARMS OR LEGS; EXCISED DIAMETER OVER 4.0 CM",,,1525.52,7278.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,7278.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,1525.52,7278.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM",,,2694.74,9324.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM",,,662.46,5449.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM",,,662.46,5449.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM",,,662.46,7278.0,15 RC,361,"EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM",,,1525.52,7278.0,15 RC,361,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 0.5 CM OR LESS",,,662.46,7278.0,15 RC,361,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 1.1 TO 2.0 CM",,,662.46,5449.0,15 RC,361,"EXCISION, OTHER BENIGN LESION INCLUDING MARGINS, EXCEPT SKIN TAG (UNLESS LISTED ELSEWHERE), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; EXCISED DIAMETER 2.1 TO 3.0 CM",,,1525.52,5449.0,15 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF ABDOMINAL WALL, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,12408.0,15 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF BACK OR FLANK, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF BACK OR FLANK, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF FACE OR SCALP, SUBCUTANEOUS; LESS THAN 2 CM",,,1525.52,5449.0,14 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF LEG OR ANKLE AREA, SUBFASCIAL (EG, INTRAMUSCULAR); 5 CM OR GREATER",,,2694.74,17457.0,15 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF NECK OR ANTERIOR THORAX, SUBCUTANEOUS; 3 CM OR GREATER",,,2694.74,17457.0,15 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF NECK OR ANTERIOR THORAX, SUBCUTANEOUS; LESS THAN 3 CM",,,1525.52,7278.0,15 RC,361,"EXCISION, TUMOR, SOFT TISSUE OF NECK OR ANTERIOR THORAX, SUBFASCIAL (EG, INTRAMUSCULAR); LESS THAN 5 CM",,,2694.74,9324.0,15 RC,361,EXPLORATION FOR UNDESCENDED TESTIS (INGUINAL OR SCROTAL AREA),,,3322.75,13194.0,15 RC,361,FORESKIN MANIPULATION INCLUDING LYSIS OF PREPUTIAL ADHESIONS AND STRETCHING,,,228.99,5449.0,15 RC,361,"GASTROSTOMY, OPEN; WITHOUT CONSTRUCTION OF GASTRIC TUBE (EG, STAMM PROCEDURE) (SEPARATE PROCEDURE)",,,1786.09,9324.0,13 RC,361,"IMPLANTATION OF INTRAVITREAL DRUG DELIVERY SYSTEM (EG, GANCICLOVIR IMPLANT), INCLUDES CONCOMITANT REMOVAL OF VITREOUS",,,8213.0,15808.87,15 RC,361,INCISION AND DRAINAGE OF PILONIDAL CYST; COMPLICATED,,,662.46,5449.0,14 RC,361,"INCISION AND REMOVAL OF FOREIGN BODY, SUBCUTANEOUS TISSUES; SIMPLE",,,376.18,5449.0,14 RC,361,"INITIAL TREATMENT, FIRST DEGREE BURN, WHEN NO MORE THAN LOCAL TREATMENT IS REQUIRED",,,187.08,1251.0,13 RC,361,"INJECTION PROCEDURE FOR SACROILIAC JOINT; PROVISION OF ANESTHETIC, STEROID AND/OR OTHER THERAPEUTIC AGENT, WITH OR WITHOUT ARTHROGRAPHY",,,652.03,5449.0,14 RC,361,INJECTION(S); SINGLE TENDON ORIGIN/INSERTION,,,277.93,5449.0,15 RC,361,"INJECTION, INTRALESIONAL; UP TO AND INCLUDING 7 LESIONS",,,187.08,5449.0,14 RC,361,"INSERTION, DRUG-DELIVERY IMPLANT (IE, BIORESORBABLE, BIODEGRADABLE, NON-BIODEGRADABLE)",,,121.37,5449.0,14 RC,361,"INSTILLATION(S), VIA CHEST TUBE/CATHETER, AGENT FOR FIBRINOLYSIS (EG, FIBRINOLYTIC AGENT FOR BREAK UP OF MULTILOCULATED EFFUSION); SUBSEQUENT DAY",,,582.12,5449.0,15 RC,361,INTRAVITREAL INJECTION OF A PHARMACOLOGIC AGENT (SEPARATE PROCEDURE),,,312.3,5449.0,15 RC,361,"LARYNGOSCOPY, DIRECT, WITH INJECTION INTO VOCAL CORD(S), THERAPEUTIC;",,,3012.0,7278.0,15 RC,361,"LARYNGOSCOPY, FLEXIBLE; DIAGNOSTIC",,,182.79,7278.0,14 RC,361,LYSIS OF LABIAL ADHESIONS,,,2993.65,9324.0,15 RC,361,LYSIS OR EXCISION OF PENILE POST-CIRCUMCISION ADHESIONS,,,1928.76,9324.0,15 RC,361,"MASTECTOMY, PARTIAL (EG, LUMPECTOMY, TYLECTOMY, QUADRANTECTOMY, SEGMENTECTOMY);",,,3605.42,9324.0,15 RC,361,MYRINGOTOMY INCLUDING ASPIRATION AND/OR EUSTACHIAN TUBE INFLATION REQUIRING GENERAL ANESTHESIA,,,3012.0,8413.0,15 RC,361,"NEGATIVE PRESSURE WOUND THERAPY (EG, VACUUM ASSISTED DRAINAGE COLLECTION), UTILIZING DURABLE MEDICAL EQUIPMENT (DME), INCLUDING TOPICAL APPLICATION(S), WOUND ASSESSMENT, AND INSTRUCTION(S) FOR ONGOING",,,187.08,204.44,11 RC,361,"NEGATIVE PRESSURE WOUND THERAPY, (EG, VACUUM ASSISTED DRAINAGE COLLECTION), UTILIZING DISPOSABLE, NON-DURABLE MEDICAL EQUIPMENT INCLUDING PROVISION OF EXUDATE MANAGEMENT COLLECTION SYSTEM, TOPICAL APP",,,376.18,411.08,22 RC,361,"NEUROPLASTY, MAJOR PERIPHERAL NERVE, ARM OR LEG, OPEN; OTHER THAN SPECIFIED",,,1838.62,9324.0,15 RC,361,"NEUROPLASTY, MAJOR PERIPHERAL NERVE, ARM OR LEG, OPEN; SCIATIC NERVE",,,1838.62,9324.0,15 RC,361,OTOLARYNGOLOGIC EXAMINATION UNDER GENERAL ANESTHESIA,,,479.48,1251.0,13 RC,361,PARTIAL HYMENECTOMY OR REVISION OF HYMENAL RING,,,2993.65,9324.0,15 RC,361,PELVIC EXAMINATION UNDER ANESTHESIA (OTHER THAN LOCAL),,,2993.65,9324.0,15 RC,361,REMOVAL FOREIGN BODY FROM EXTERNAL AUDITORY CANAL; WITH GENERAL ANESTHESIA,,,1525.52,5449.0,15 RC,361,REMOVAL FOREIGN BODY FROM EXTERNAL AUDITORY CANAL; WITHOUT GENERAL ANESTHESIA,,,121.37,1251.0,13 RC,361,"REMOVAL IMPACTED CERUMEN REQUIRING INSTRUMENTATION, UNILATERAL",,,55.93,5449.0,14 RC,361,"REMOVAL IMPACTED CERUMEN USING IRRIGATION/LAVAGE, UNILATERAL",,,55.93,5449.0,14 RC,361,"REMOVAL OF DEVITALIZED TISSUE FROM WOUND(S), NON-SELECTIVE DEBRIDEMENT, WITHOUT ANESTHESIA (EG, WET-TO-MOIST DRESSINGS, ENZYMATIC, ABRASION, LARVAL THERAPY), INCLUDING TOPICAL APPLICATION(S), WOUND AS",,,187.08,204.44,11 RC,361,"REMOVAL OF IMPLANT; DEEP (EG, BURIED WIRE, PIN, SCREW, METAL BAND, NAIL, ROD OR PLATE)",,,2694.74,9324.0,15 RC,361,"REMOVAL OF SKIN TAGS, MULTIPLE FIBROCUTANEOUS TAGS, ANY AREA; UP TO AND INCLUDING 15 LESIONS",,,187.08,5449.0,14 RC,361,"REMOVAL OF SUTURES OR STAPLES REQUIRING ANESTHESIA (IE, GENERAL ANESTHESIA, MODERATE SEDATION)",,,1722.29,5449.0,15 RC,361,REMOVAL OR BIVALVING; FULL ARM OR FULL LEG CAST,,,250.06,1251.0,13 RC,361,"REMOVAL WITH REINSERTION, NON-BIODEGRADABLE DRUG DELIVERY IMPLANT",,,375.71,5449.0,14 RC,361,"REMOVAL, NON-BIODEGRADABLE DRUG DELIVERY IMPLANT",,,375.71,5449.0,14 RC,361,"REMOVAL, UNDER ANESTHESIA, OF EXTERNAL FIXATION SYSTEM",,,1506.85,5449.0,15 RC,361,"REPAIR OF ANTERIOR ABDOMINAL HERNIA(S) (IE, EPIGASTRIC, INCISIONAL, VENTRAL, UMBILICAL, SPIGELIAN), ANY APPROACH (IE, OPEN, LAPAROSCOPIC, ROBOTIC), INITIAL, INCLUDING IMPLANTATION OF MESH OR OTHER PRO",,,5493.28,21454.0,14 RC,361,"REPAIR, COMPLEX, SCALP, ARMS, AND/OR LEGS; 2.6 CM TO 7.5 CM",,,576.34,8413.0,15 RC,361,"REPAIR, INTERMEDIATE, WOUNDS OF FACE, EARS, EYELIDS, NOSE, LIPS AND/OR MUCOUS MEMBRANES; 2.6 CM TO 5.0 CM",,,376.18,5449.0,14 RC,361,"REPAIR, INTERMEDIATE, WOUNDS OF NECK, HANDS, FEET AND/OR EXTERNAL GENITALIA; 2.5 CM OR LESS",,,376.18,5449.0,14 RC,361,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 2.5 CM OR LESS",,,376.18,5449.0,14 RC,361,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 2.6 CM TO 7.5 CM",,,376.18,5449.0,14 RC,361,"REPAIR, INTERMEDIATE, WOUNDS OF SCALP, AXILLAE, TRUNK AND/OR EXTREMITIES (EXCLUDING HANDS AND FEET); 7.6 CM TO 12.5 CM",,,376.18,7278.0,15 RC,361,"SIGMOIDOSCOPY, FLEXIBLE; WITH BIOPSY, SINGLE OR MULTIPLE",,,858.41,5449.0,15 RC,361,"SIMPLE REPAIR OF SUPERFICIAL WOUNDS OF SCALP, NECK, AXILLAE, EXTERNAL GENITALIA, TRUNK AND/OR EXTREMITIES (INCLUDING HANDS AND FEET); 2.5 CM OR LESS",,,187.08,5449.0,14 RC,361,SUBCUTANEOUS HORMONE PELLET IMPLANTATION (IMPLANTATION OF ESTRADIOL AND/OR TESTOSTERONE PELLETS BENEATH THE SKIN),,,375.71,5449.0,14 RC,361,"SURGICAL PREPARATION OR CREATION OF RECIPIENT SITE BY EXCISION OF OPEN WOUNDS, BURN ESCHAR, OR SCAR (INCLUDING SUBCUTANEOUS TISSUES), OR INCISIONAL RELEASE OF SCAR CONTRACTURE, TRUNK, ARMS, LEGS; FIRS",,,1722.29,7278.0,15 RC,361,"TENOTOMY, PERCUTANEOUS, ACHILLES TENDON (SEPARATE PROCEDURE); GENERAL ANESTHESIA",,,3054.93,9324.0,15 RC,361,"THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INJECTION (SPECIFY SUBSTANCE OR DRUG); SUBCUTANEOUS OR INTRAMUSCULAR",,,67.01,73.22,11 RC,361,"TREATMENT OF INCOMPLETE ABORTION, ANY TRIMESTER, COMPLETED SURGICALLY",,,2993.65,12615.0,15 RC,361,TREATMENT OF SUPERFICIAL WOUND DEHISCENCE; SIMPLE CLOSURE,,,576.34,5449.0,15 RC,361,"TYMPANOSTOMY (REQUIRING INSERTION OF VENTILATING TUBE), GENERAL ANESTHESIA",,,1394.69,8413.0,15 RC,361,"ULTRASONIC GUIDANCE FOR NEEDLE PLACEMENT (EG, BIOPSY, ASPIRATION, INJECTION, LOCALIZATION DEVICE), IMAGING SUPERVISION AND INTERPRETATION",,,,,0 RC,361,"UNLISTED LAPAROSCOPY PROCEDURE, APPENDIX",,,5493.28,15394.0,14 RC,361,"UNLISTED LAPAROSCOPY PROCEDURE, UTERUS",,,5493.28,15394.0,14 RC,361,"UNLISTED PROCEDURE, COLON",,,858.41,9350.0,15 RC,361,"UNLISTED PROCEDURE, DENTOALVEOLAR STRUCTURES",,,218.65,5449.0,14 RC,361,"UNLISTED PROCEDURE, ENDOCRINE SYSTEM",,,5449.0,21454.0,14 RC,361,"UNLISTED PROCEDURE, NOSE",,,218.65,5449.0,14 RC,361,"UNLISTED PROCEDURE, SMALL INTESTINE",,,882.75,5449.0,14 RC,361,"URETHROMEATOPLASTY, WITH MUCOSAL ADVANCEMENT",,,3247.35,13194.0,15 RC,361,"VENIPUNCTURE, YOUNGER THAN AGE 3 YEARS, NECESSITATING THE SKILL OF A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL, NOT TO BE USED FOR ROUTINE VENIPUNCTURE; OTHER VEIN",,,,,0 RC,361,VENTILATING TUBE REMOVAL REQUIRING GENERAL ANESTHESIA,,,3053.48,13194.0,15 RC,361,"VENTRICULAR PUNCTURE THROUGH PREVIOUS BURR HOLE, FONTANELLE, SUTURE, OR IMPLANTED VENTRICULAR CATHETER/RESERVOIR; WITHOUT INJECTION",,,838.24,5449.0,15 RC,481,ADDITIONAL LINEAR OR FOCAL INTRACARDIAC CATHETER ABLATION OF THE LEFT OR RIGHT ATRIUM FOR TREATMENT OF ATRIAL FIBRILLATION REMAINING AFTER COMPLETION OF PULMONARY VEIN ISOLATION (LIST SEPARATELY IN AD,,,777.0,9423.0,4 RC,481,COMPREHENSIVE ELECTROPHYSIOLOGIC EVALUATION INCLUDING INSERTION AND REPOSITIONING OF MULTIPLE ELECTRODE CATHETERS WITH INDUCTION OR ATTEMPTED INDUCTION OF ARRHYTHMIA; WITH LEFT ATRIAL PACING AND RECOR,,,777.0,15291.0,4 RC,481,COMPREHENSIVE ELECTROPHYSIOLOGIC EVALUATION INCLUDING INSERTION AND REPOSITIONING OF MULTIPLE ELECTRODE CATHETERS WITH INDUCTION OR ATTEMPTED INDUCTION OF ARRHYTHMIA; WITH RIGHT ATRIAL PACING AND RECO,,,7144.51,21454.0,15 RC,481,"COMPREHENSIVE ELECTROPHYSIOLOGIC EVALUATION WITH INSERTION AND REPOSITIONING OF MULTIPLE ELECTRODE CATHETERS, INDUCTION OR ATTEMPTED INDUCTION OF AN ARRHYTHMIA WITH RIGHT ATRIAL PACING AND RECORDING A",,,9423.0,30351.0,30 RC,481,"COMPREHENSIVE ELECTROPHYSIOLOGIC EVALUATION WITH TRANSSEPTAL CATHETERIZATIONS, INSERTION AND REPOSITIONING OF MULTIPLE ELECTRODE CATHETERS, INDUCTION OR ATTEMPTED INDUCTION OF AN ARRHYTHMIA INCLUDING ",,,9423.0,30351.0,15 RC,481,"EVALUATION OF CARDIOVASCULAR FUNCTION WITH TILT TABLE EVALUATION, WITH CONTINUOUS ECG MONITORING AND INTERMITTENT BLOOD PRESSURE MONITORING, WITH OR WITHOUT PHARMACOLOGICAL INTERVENTION",,,499.58,9423.0,14 RC,481,"INTRACARDIAC CATHETER ABLATION OF A DISCRETE MECHANISM OF ARRHYTHMIA WHICH IS DISTINCT FROM THE PRIMARY ABLATED MECHANISM, INCLUDING REPEAT DIAGNOSTIC MANEUVERS, TO TREAT A SPONTANEOUS OR INDUCED ARRH",,,777.0,9423.0,4 RC,481,"INTRACARDIAC CATHETER ABLATION OF ATRIOVENTRICULAR NODE FUNCTION, ATRIOVENTRICULAR CONDUCTION FOR CREATION OF COMPLETE HEART BLOCK, WITH OR WITHOUT TEMPORARY PACEMAKER PLACEMENT",,,7144.51,21454.0,15 RC,481,"INTRACARDIAC ECHOCARDIOGRAPHY DURING THERAPEUTIC/DIAGNOSTIC INTERVENTION, INCLUDING IMAGING SUPERVISION AND INTERPRETATION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)",,,777.0,9423.0,3 RC,481,INTRACARDIAC ELECTROPHYSIOLOGIC 3-DIMENSIONAL MAPPING (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,9423.0,3 RC,481,"PERCUTANEOUS TRANSCATHETER PLACEMENT OF DRUG ELUTING INTRACORONARY STENT(S), WITH CORONARY ANGIOPLASTY WHEN PERFORMED; SINGLE MAJOR CORONARY ARTERY OR BRANCH",,,10677.6,30725.0,15 RC,481,"PERCUTANEOUS TRANSLUMINAL CORONARY ATHERECTOMY, WITH DRUG ELUTING INTRACORONARY STENT, WITH CORONARY ANGIOPLASTY WHEN PERFORMED; SINGLE MAJOR CORONARY ARTERY OR BRANCH",,,16059.0,30725.0,15 RC,481,"PERCUTANEOUS TRANSLUMINAL REVASCULARIZATION OF CHRONIC TOTAL OCCLUSION, CORONARY ARTERY, CORONARY ARTERY BRANCH, OR CORONARY ARTERY BYPASS GRAFT, ANY COMBINATION OF DRUG-ELUTING INTRACORONARY STENT, A",,,16059.0,30725.0,15 RC,481,PROGRAMMED STIMULATION AND PACING AFTER INTRAVENOUS DRUG INFUSION (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE),,,777.0,9423.0,3 RC,750,"ANASTOMOSIS, OF EXTRAHEPATIC BILIARY DUCTS AND GASTROINTESTINAL TRACT",,,2533.0,4850.0,2 RC,750,"ANASTOMOSIS, OF INTRAHEPATIC DUCTS AND GASTROINTESTINAL TRACT",,,2533.0,4850.0,2 RC,750,"ANORECTAL EXAM, SURGICAL, REQUIRING ANESTHESIA (GENERAL, SPINAL, OR EPIDURAL), DIAGNOSTIC",,,2582.07,7278.0,15 RC,750,"BIOPSY OF LIVER, NEEDLE; PERCUTANEOUS",,,1525.52,5449.0,15 RC,750,"BIOPSY OF PANCREAS, PERCUTANEOUS NEEDLE",,,1525.52,5449.0,15 RC,750,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; DIAGNOSTIC, WITH CELL WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,1623.65,7278.0,15 RC,750,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH BRONCHIAL ALVEOLAR LAVAGE",,,1623.65,7278.0,15 RC,750,"BRONCHOSCOPY, RIGID OR FLEXIBLE, INCLUDING FLUOROSCOPIC GUIDANCE, WHEN PERFORMED; WITH BRUSHING OR PROTECTED BRUSHINGS",,,1623.65,7278.0,15 RC,750,"COLONOSCOPY THROUGH STOMA; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,858.41,5449.0,15 RC,750,"COLONOSCOPY THROUGH STOMA; WITH BIOPSY, SINGLE OR MULTIPLE",,,1110.16,5449.0,15 RC,750,"COLONOSCOPY THROUGH STOMA; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,1110.16,8213.0,15 RC,750,COLONOSCOPY THROUGH STOMA; WITH REMOVAL OF FOREIGN BODY(S),,,858.41,5449.0,15 RC,750,"COLONOSCOPY THROUGH STOMA; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE",,,1110.16,5449.0,15 RC,750,COLONOSCOPY THROUGH STOMA; WITH TRANSENDOSCOPIC BALLOON DILATION,,,1110.16,8213.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S) (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,1110.16,8213.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH BIOPSY, SINGLE OR MULTIPLE",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH CONTROL OF BLEEDING, ANY METHOD",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH ENDOSCOPIC MUCOSAL RESECTION",,,2582.07,8213.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH ENDOSCOPIC ULTRASOUND EXAMINATION LIMITED TO THE RECTUM, SIGMOID, DESCENDING, TRANSVERSE, OR ASCENDING COLON AND CECUM, AND ADJACENT STRUCTURES",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH REMOVAL OF FOREIGN BODY(S)",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY HOT BIOPSY FORCEPS",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH TRANSENDOSCOPIC BALLOON DILATION",,,1110.16,7278.0,15 RC,750,"COLONOSCOPY, FLEXIBLE; WITH TRANSENDOSCOPIC ULTRASOUND GUIDED INTRAMURAL OR TRANSMURAL FINE NEEDLE ASPIRATION/BIOPSY(S), INCLUDES ENDOSCOPIC ULTRASOUND EXAMINATION LIMITED TO THE RECTUM, SIGMOID, DESC",,,1110.16,7278.0,15 RC,750,"COLORECTAL CANCER SCREENING; ALTERNATIVE TO G0105, SCREENING COLONOSCOPY, BARIUM ENEMA.",,,,,0 RC,750,COLORECTAL CANCER SCREENING; COLONOSCOPY ON INDIVIDUAL AT HIGH RISK,,,858.41,7278.0,14 RC,750,COLORECTAL CANCER SCREENING; COLONOSCOPY ON INDIVIDUAL NOT MEETING CRITERIA FOR HIGH RISK,,,858.41,7278.0,14 RC,750,"DESTRUCTION OF INTERNAL HEMORRHOID(S) BY THERMAL ENERGY (EG, INFRARED COAGULATION, CAUTERY, RADIOFREQUENCY)",,,1110.16,9350.0,15 RC,750,DILATION OF ANAL SPHINCTER (SEPARATE PROCEDURE) UNDER ANESTHESIA OTHER THAN LOCAL,,,1110.16,5449.0,15 RC,750,ENDOSCOPIC CANNULATION OF PAPILLA WITH DIRECT VISUALIZATION OF PANCREATIC/COMMON BILE DUCT(S) (LIST SEPARATELY IN ADDITION TO CODE(S) FOR PRIMARY PROCEDURE),,,777.0,17457.0,4 RC,750,"ENDOSCOPIC EVALUATION OF SMALL INTESTINAL POUCH (EG, KOCK POUCH, ILEAL RESERVOIR [S OR J]); DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,858.41,5449.0,15 RC,750,"ENDOSCOPIC EVALUATION OF SMALL INTESTINAL POUCH (EG, KOCK POUCH, ILEAL RESERVOIR [S OR J]); WITH BIOPSY, SINGLE OR MULTIPLE",,,858.41,5449.0,15 RC,750,"ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,3582.12,9324.0,15 RC,750,"ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S), INCLUDING PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED",,,3582.12,17457.0,15 RC,750,"ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH BIOPSY, SINGLE OR MULTIPLE",,,3582.12,9324.0,15 RC,750,"ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH REMOVAL AND EXCHANGE OF STENT(S), BILIARY OR PANCREATIC DUCT, INCLUDING PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED, INCLU",,,5514.0,17457.0,15 RC,750,ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH REMOVAL OF CALCULI/DEBRIS FROM BILIARY/PANCREATIC DUCT(S),,,3582.12,9324.0,15 RC,750,ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH REMOVAL OF FOREIGN BODY(S) OR STENT(S) FROM BILIARY/PANCREATIC DUCT(S),,,1786.09,17457.0,15 RC,750,ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH SPHINCTEROTOMY/PAPILLOTOMY,,,3582.12,9324.0,15 RC,750,"ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP); WITH TRANS-ENDOSCOPIC BALLOON DILATION OF BILIARY/PANCREATIC DUCT(S) OR OF AMPULLA (SPHINCTEROPLASTY), INCLUDING SPHINCTEROTOMY, WHEN PERFORMED, ",,,3582.12,17457.0,15 RC,750,"ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD), INCLUDING ENDOSCOPY OR COLONOSCOPY, MUCOSAL CLOSURE, WHEN PERFORMED",,,3582.12,9324.0,14 RC,750,"ESOPHAGEAL BALLOON DISTENSION STUDY, DIAGNOSTIC, WITH PROVOCATION WHEN PERFORMED",,,499.58,1251.0,13 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,882.75,5449.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S) (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,1786.09,9350.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH BAND LIGATION OF ESOPHAGEAL/GASTRIC VARICES",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH CONTROL OF BLEEDING, ANY METHOD",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DILATION OF ESOPHAGUS WITH BALLOON (30 MM DIAMETER OR LARGER) (INCLUDES FLUOROSCOPIC GUIDANCE, WHEN PERFORMED)",,,1786.09,9350.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DILATION OF GASTRIC/DUODENAL STRICTURE(S) (EG, BALLOON, BOUGIE)",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,882.75,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH ENDOSCOPIC MUCOSAL RESECTION",,,1786.09,8413.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH ENDOSCOPIC ULTRASOUND EXAMINATION LIMITED TO THE ESOPHAGUS, STOMACH OR DUODENUM, AND ADJACENT STRUCTURES",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH ENDOSCOPIC ULTRASOUND EXAMINATION, INCLUDING THE ESOPHAGUS, STOMACH, AND EITHER THE DUODENUM OR A SURGICALLY ALTERED STOMACH WHERE THE JEJUNUM IS ",,,1786.09,8413.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH INJECTION SCLEROSIS OF ESOPHAGEAL/GASTRIC VARICES",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH INSERTION OF GUIDE WIRE FOLLOWED BY PASSAGE OF DILATOR(S) THROUGH ESOPHAGUS OVER GUIDE WIRE",,,882.75,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH INSERTION OF INTRALUMINAL TUBE OR CATHETER",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH PLACEMENT OF ENDOSCOPIC STENT (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,5604.81,17457.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF FOREIGN BODY(S)",,,882.75,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY HOT BIOPSY FORCEPS",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC BALLOON DILATION OF ESOPHAGUS (LESS THAN 30 MM DIAMETER)",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC ULTRASOUND-GUIDED INTRAMURAL OR TRANSMURAL FINE NEEDLE ASPIRATION/BIOPSY(S) (INCLUDES ENDOSCOPIC ULTRASOUND EXAMINATION OF THE ESO",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC ULTRASOUND-GUIDED INTRAMURAL OR TRANSMURAL FINE NEEDLE ASPIRATION/BIOPSY(S), (INCLUDES ENDOSCOPIC ULTRASOUND EXAMINATION LIMITED T",,,1786.09,7278.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC ULTRASOUND-GUIDED TRANSMURAL INJECTION OF DIAGNOSTIC OR THERAPEUTIC SUBSTANCE(S) (EG, ANESTHETIC, NEUROLYTIC AGENT) OR FIDUCIAL MA",,,1786.09,9350.0,15 RC,750,"ESOPHAGOGASTRODUODENOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSMURAL DRAINAGE OF PSEUDOCYST (INCLUDES PLACEMENT OF TRANSMURAL DRAINAGE CATHETER[S]/STENT[S], WHEN PERFORMED, AND ENDOSCOPIC ULTRASOUND, WHEN",,,5152.0,9324.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; DIAGNOSTIC, INCLUDING COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING, WHEN PERFORMED (SEPARATE PROCEDURE)",,,882.75,5449.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S) (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,3582.12,17457.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH BAND LIGATION OF ESOPHAGEAL VARICES",,,1786.09,5449.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH BIOPSY, SINGLE OR MULTIPLE",,,1786.09,5449.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH CONTROL OF BLEEDING, ANY METHOD",,,1786.09,7278.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH DILATION OF ESOPHAGUS, BY BALLOON OR DILATOR, RETROGRADE (INCLUDES FLUOROSCOPIC GUIDANCE, WHEN PERFORMED)",,,1786.09,9350.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH DIRECTED SUBMUCOSAL INJECTION(S), ANY SUBSTANCE",,,1786.09,5449.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH ENDOSCOPIC MUCOSAL RESECTION",,,1786.09,7278.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH INSERTION OF GUIDE WIRE FOLLOWED BY PASSAGE OF DILATOR(S) OVER GUIDE WIRE",,,1786.09,5449.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH PLACEMENT OF ENDOSCOPIC STENT (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,5604.81,17457.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH REMOVAL OF FOREIGN BODY(S)",,,1786.09,5449.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC BALLOON DILATION (LESS THAN 30 MM DIAMETER)",,,1786.09,7278.0,15 RC,750,"ESOPHAGOSCOPY, FLEXIBLE, TRANSORAL; WITH TRANSENDOSCOPIC ULTRASOUND-GUIDED INTRAMURAL OR TRANSMURAL FINE NEEDLE ASPIRATION/BIOPSY(S)",,,1786.09,7278.0,15 RC,750,"ESOPHAGOSCOPY, RIGID, TRANSORAL WITH DIVERTICULECTOMY OF HYPOPHARYNX OR CERVICAL ESOPHAGUS (EG, ZENKER'S DIVERTICULUM), WITH CRICOPHARYNGEAL MYOTOMY, INCLUDES USE OF TELESCOPE OR OPERATING MICROSCOPE ",,,5514.0,17457.0,15 RC,750,"ILEOSCOPY, THROUGH STOMA; WITH TRANSENDOSCOPIC BALLOON DILATION",,,1786.09,8213.0,15 RC,750,"INJECTION, ANESTHETIC AGENT; CELIAC PLEXUS, WITH OR WITHOUT RADIOLOGIC MONITORING",,,838.24,5449.0,15 RC,750,"INJECTION, INTRALESIONAL; UP TO AND INCLUDING 7 LESIONS",,,187.08,5449.0,14 RC,750,INSERTION OF INTRAUTERINE DEVICE (IUD),,,777.0,5449.0,3 RC,750,"INTRODUCTION OF NEEDLE(S) AND/OR CATHETER(S), DIALYSIS CIRCUIT, WITH DIAGNOSTIC ANGIOGRAPHY OF THE DIALYSIS CIRCUIT, INCLUDING ALL DIRECT PUNCTURE(S) AND CATHETER PLACEMENT(S), INJECTION(S) OF CONTRAS",,,5368.21,21454.0,14 RC,750,"LAPAROSCOPY, SURGICAL, APPENDECTOMY",,,5493.28,21454.0,15 RC,750,"LAPAROSCOPY, SURGICAL; CHOLECYSTOENTEROSTOMY",,,2533.0,15291.0,3 RC,750,"LARYNGOSCOPY DIRECT, WITH OR WITHOUT TRACHEOSCOPY; WITH DILATION, INITIAL",,,3471.41,9324.0,15 RC,750,"NASO- OR ORO-GASTRIC TUBE PLACEMENT, REQUIRING PHYSICIAN'S SKILL AND FLUOROSCOPIC GUIDANCE (INCLUDES FLUOROSCOPY, IMAGE DOCUMENTATION AND REPORT)",,,375.71,7278.0,14 RC,750,PELVIC EXAMINATION UNDER ANESTHESIA (OTHER THAN LOCAL),,,2993.65,9324.0,15 RC,750,"PLACEMENT OF ACCESS THROUGH THE BILIARY TREE AND INTO SMALL BOWEL TO ASSIST WITH AN ENDOSCOPIC BILIARY PROCEDURE (EG, RENDEZVOUS PROCEDURE), PERCUTANEOUS, INCLUDING DIAGNOSTIC CHOLANGIOGRAPHY WHEN PER",,,5874.98,17457.0,15 RC,750,"PREPARATION OF FECAL MICROBIOTA FOR INSTILLATION, INCLUDING ASSESSMENT OF DONOR SPECIMEN",,,5449.0,5449.0,1 RC,750,"PREPARATION WITH INSTILLATION OF FECAL MICROBIOTA BY ANY METHOD, INCLUDING ASSESSMENT OF DONOR SPECIMEN",,,858.41,5449.0,12 RC,750,"PROCTOSIGMOIDOSCOPY, RIGID; DIAGNOSTIC, WITH OR WITHOUT COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING (SEPARATE PROCEDURE)",,,858.41,5449.0,15 RC,750,"PROCTOSIGMOIDOSCOPY, RIGID; WITH REMOVAL OF SINGLE TUMOR, POLYP, OR OTHER LESION BY SNARE TECHNIQUE",,,1110.16,5449.0,15 RC,750,"PUNCH BIOPSY OF SKIN (INCLUDING SIMPLE CLOSURE, WHEN PERFORMED); SINGLE LESION",,,376.18,5449.0,14 RC,750,REMOVAL OF ESOPHAGEAL SPHINCTER AUGMENTATION DEVICE,,,5493.28,21454.0,14 RC,750,REMOVAL OF INTRAUTERINE DEVICE (IUD),,,286.41,5449.0,15 RC,750,"REPLACEMENT OF GASTROSTOMY OR CECOSTOMY (OR OTHER COLONIC) TUBE, PERCUTANEOUS, UNDER FLUOROSCOPIC GUIDANCE INCLUDING CONTRAST INJECTION(S), IMAGE DOCUMENTATION AND REPORT",,,882.75,5449.0,15 RC,750,"REPLACEMENT OF GASTROSTOMY TUBE, PERCUTANEOUS, INCLUDES REMOVAL, WHEN PERFORMED, WITHOUT IMAGING OR ENDOSCOPIC GUIDANCE; NOT REQUIRING REVISION OF GASTROSTOMY TRACT",,,228.99,5449.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S) (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,1110.16,8213.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH BAND LIGATION(S) (EG, HEMORRHOIDS)",,,1110.16,8213.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH CONTROL OF BLEEDING, ANY METHOD",,,1110.16,5449.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH ENDOSCOPIC MUCOSAL RESECTION",,,2582.07,8213.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH PLACEMENT OF ENDOSCOPIC STENT (INCLUDES PRE- AND POST-DILATION AND GUIDE WIRE PASSAGE, WHEN PERFORMED)",,,3012.0,8213.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH REMOVAL OF FOREIGN BODY(S)",,,1110.16,5449.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY HOT BIOPSY FORCEPS",,,858.41,5449.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE",,,1110.16,5449.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH TRANSENDOSCOPIC BALLOON DILATION",,,1110.16,5449.0,15 RC,750,"SIGMOIDOSCOPY, FLEXIBLE; WITH TRANSENDOSCOPIC ULTRASOUND GUIDED INTRAMURAL OR TRANSMURAL FINE NEEDLE ASPIRATION/BIOPSY(S)",,,1110.16,5449.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, INCLUDING ILEUM; DIAGNOSTIC, WITH OR WITHOUT COLLECTION OF SPECIMEN(S) BY BRUSHING OR WASHING (SEPARATE PROCEDURE)",,,1786.09,7278.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, INCLUDING ILEUM; WITH BIOPSY, SINGLE OR MULTIPLE",,,1786.09,7278.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, NOT INCLUDING ILEUM; WITH ABLATION OF TUMOR(S), POLYP(S), OR OTHER LESION(S) NOT AMENABLE TO REMOVAL BY HOT BIOPSY FORCEPS, B",,,1786.09,7278.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, NOT INCLUDING ILEUM; WITH BIOPSY, SINGLE OR MULTIPLE",,,1786.09,7278.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, NOT INCLUDING ILEUM; WITH CONTROL OF BLEEDING (EG, INJECTION, BIPOLAR CAUTERY, UNIPOLAR CAUTERY, LASER, HEATER PROBE, STAPLER",,,1786.09,7278.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, NOT INCLUDING ILEUM; WITH PLACEMENT OF PERCUTANEOUS JEJUNOSTOMY TUBE",,,1786.09,7278.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, NOT INCLUDING ILEUM; WITH REMOVAL OF FOREIGN BODY(S)",,,1786.09,7278.0,15 RC,750,"SMALL INTESTINAL ENDOSCOPY, ENTEROSCOPY BEYOND SECOND PORTION OF DUODENUM, NOT INCLUDING ILEUM; WITH REMOVAL OF TUMOR(S), POLYP(S), OR OTHER LESION(S) BY SNARE TECHNIQUE",,,1786.09,7278.0,15 RC,750,"STENT, COATED/COVERED, WITH DELIVERY SYSTEM",,,,,0 RC,750,"STENT, NON-CORONARY, TEMPORARY, WITHOUT DELIVERY SYSTEM",,,,,0 RC,750,"UNLISTED LAPAROSCOPY PROCEDURE, ESOPHAGUS",,,5493.28,15394.0,14 RC,750,"UNLISTED LAPAROSCOPY PROCEDURE, INTESTINE (EXCEPT RECTUM)",,,5493.28,15394.0,13 RC,750,"UNLISTED LAPAROSCOPY PROCEDURE, STOMACH",,,5493.28,15394.0,14 RC,750,"UNLISTED PROCEDURE, BILIARY TRACT",,,882.75,5239.0,13 RC,750,"UNLISTED PROCEDURE, COLON",,,858.41,9350.0,15 RC,750,"UNLISTED PROCEDURE, ESOPHAGUS",,,882.75,5449.0,14 RC,750,"UNLISTED PROCEDURE, LIVER",,,662.46,3517.0,13 RC,750,"UNLISTED PROCEDURE, PANCREAS",,,662.46,3517.0,16 RC,750,"UNLISTED PROCEDURE, RECTUM",,,858.41,3517.0,13 RC,750,"UNLISTED PROCEDURE, SMALL INTESTINE",,,882.75,5449.0,14 RC,750,"UNLISTED PROCEDURE, STOMACH",,,882.75,5449.0,14